0	1	2	3	4	5
0	*	0 1	0 1	0.9999876022338867	O
1	*	1 2	1 2	0.999988317489624	O
2	IGNORE	3 8	3 8	0.999987006187439	O
5	LINE	10 13	10 13	0.9999884366989136	O
8	*	15 16	15 16	0.9999886751174927	O
9	*	16 17	16 17	0.9999887943267822	O
10	*	18 19	18 19	0.9999886751174927	O
11	*	19 20	19 20	0.9999889135360718	O
12	IGNORE	21 26	21 26	0.9999872446060181	O
15	LINE	28 31	28 31	0.9999887943267822	O
18	*	33 34	33 34	0.9999886751174927	O
19	*	34 35	34 35	0.9999885559082031	O
20	*	36 37	36 37	0.9999885559082031	O
21	*	37 38	37 38	0.9999885559082031	O
22	IGNORE	39 44	39 44	0.9999871253967285	O
25	LINE	46 49	46 49	0.9999885559082031	O
28	*	51 52	51 52	0.9999887943267822	O
29	*	52 53	52 53	0.9999887943267822	O
30	Two	54 57	54 57	0.9999860525131226	O
31	modes	58 63	58 63	0.9999872446060181	O
32	of	64 66	64 66	0.9999885559082031	O
33	microsatellite	67 80	67 80	0.9999873638153076	O
37	instability	82 93	82 93	0.9999881982803345	O
38	in	94 96	94 96	0.9999886751174927	O
39	human	97 102	97 102	0.9998121857643127	O
40	cancer	103 109	103 109	0.9999850988388062	O
41	:	110 111	110 111	0.9999884366989136	O
42	differential	112 124	112 124	0.9999854564666748	O
43	connection	125 135	125 135	0.9999877214431763	O
44	of	136 138	136 138	0.9999886751174927	O
45	defective	139 147	139 147	0.9999885559082031	O
47	DNA	149 152	149 152	0.9999877214431763	O
48	mismatch	153 160	153 160	0.9999886751174927	O
51	repair	162 168	162 168	0.9999877214431763	O
52	to	169 171	169 171	0.9999887943267822	O
53	dinucleotide	172 183	172 183	0.9999854564666748	O
57	repeat	185 191	185 191	0.9999849796295166	O
58	instability	192 203	192 203	0.9999885559082031	O
59	Abstract	204 211	204 211	0.9999880790710449	O
62	Microsatellite	213 226	213 226	0.999985933303833	O
66	instability	228 239	228 239	0.999988317489624	O
67	(	240 241	240 241	0.9999889135360718	O
68	MSI	242 244	242 244	0.9999856948852539	O
70	)	245 246	245 246	0.9999891519546509	O
71	is	247 249	247 249	0.9999880790710449	O
72	associated	250 260	250 260	0.9999887943267822	O
73	with	261 265	261 265	0.9999889135360718	O
74	defective	266 274	266 274	0.9999877214431763	O
76	DNA	276 279	276 279	0.9999871253967285	O
77	mismatch	280 287	280 287	0.9999885559082031	O
80	repair	289 295	289 295	0.9999866485595703	O
81	in	296 298	296 298	0.9999880790710449	O
82	various	299 306	299 306	0.9999808073043823	O
83	human	307 312	307 312	0.9997679591178894	O
84	malignancies	313 324	313 324	0.9999853372573853	O
88	.	326 327	326 327	0.9999508857727051	O
89	Using	0 5	328 333	0.9999845027923584	O
90	a	6 7	334 335	0.9999865293502808	O
91	unique	8 14	336 342	0.9999834299087524	O
92	fluorescent	15 26	343 354	0.9999229907989502	O
93	technique	27 36	355 364	0.9999788999557495	O
94	,	37 38	365 366	0.9999854564666748	O
95	we	39 41	367 369	0.999981164932251	O
96	have	42 46	370 374	0.9999840259552002	O
97	observed	47 55	375 383	0.9999837875366211	O
98	two	56 59	384 387	0.9999799728393555	O
99	distinct	60 68	388 396	0.9999804496765137	O
100	modes	69 74	397 402	0.9999808073043823	O
101	of	75 77	403 405	0.9999858140945435	O
102	dinucleotide	78 89	406 417	0.9999843835830688	O
106	microsatellite	91 104	419 432	0.9999858140945435	O
110	alterations	106 117	434 445	0.999984860420227	O
111	in	118 120	446 448	0.9999843835830688	O
112	human	121 126	449 454	0.9979158043861389	O
113	colorectal	127 136	455 464	0.9999815225601196	O
116	cancer	138 144	466 472	0.9999831914901733	O
117	.	145 146	473 474	0.9999591112136841	O
118	Type	0 4	475 479	0.9999864101409912	O
119	A	5 6	480 481	0.9999815225601196	O
120	alterations	7 18	482 493	0.9999786615371704	O
121	are	19 22	494 497	0.9999823570251465	O
122	defined	23 30	498 505	0.9999818801879883	O
123	as	31 33	506 508	0.9999868869781494	O
124	length	34 40	509 515	0.9999839067459106	O
125	changes	41 48	516 523	0.9999861717224121	O
126	of	49 51	524 526	0.9999873638153076	O
127	≤6	52 53	527 528	0.9999864101409912	O
129	bp	55 56	530 531	0.9999868869781494	O
131	.	58 59	533 534	0.9999592304229736	O
132	Type	0 4	535 539	0.9999867677688599	O
133	B	5 6	540 541	0.9999816417694092	O
134	changes	7 14	542 549	0.9999839067459106	O
135	are	15 18	550 553	0.9999849796295166	O
136	more	19 23	554 558	0.999982476234436	O
137	drastic	24 31	559 566	0.9999778270721436	O
138	and	32 35	567 570	0.9999797344207764	O
139	involve	36 43	571 578	0.9999814033508301	O
140	modifications	44 57	579 592	0.9999819993972778	O
141	of	58 60	593 595	0.999987006187439	O
142	≥8	61 62	596 597	0.9999855756759644	O
144	bp	64 65	599 600	0.9999866485595703	O
146	.	67 68	602 603	0.9999626874923706	O
147	We	0 2	604 606	0.9999692440032959	O
148	show	3 7	607 611	0.9999531507492065	O
149	here	8 12	612 616	0.9999651908874512	O
150	that	13 17	617 621	0.9999821186065674	O
151	defective	18 26	622 630	0.9999796152114868	O
153	mismatch	28 35	632 639	0.9999830722808838	O
156	repair	37 43	641 647	0.9999840259552002	O
157	is	44 46	648 650	0.9999822378158569	O
158	necessary	47 56	651 660	0.9999842643737793	O
159	and	57 60	661 664	0.9999812841415405	O
160	sufficient	61 71	665 675	0.9999603033065796	O
161	for	72 75	676 679	0.999983549118042	O
162	Type	76 80	680 684	0.9999845027923584	O
163	A	81 82	685 686	0.9999809265136719	O
164	changes	83 90	687 694	0.9999798536300659	O
165	.	91 92	695 696	0.999920129776001	O
166	These	0 5	697 702	0.9999679327011108	O
167	changes	6 13	703 710	0.9999475479125977	O
168	were	14 18	711 715	0.9999738931655884	O
169	observed	19 27	716 724	0.9999611377716064	O
170	in	28 30	725 727	0.9999746084213257	O
171	cell	31 35	728 732	0.9998666048049927	O
172	lines	36 41	733 738	0.999849796295166	O
173	and	42 45	739 742	0.999962329864502	O
174	in	46 48	743 745	0.9999690055847168	O
175	tumours	49 55	746 752	0.9999697208404541	O
178	from	57 61	754 758	0.9999617338180542	O
179	mismatch	62 69	759 766	0.9999772310256958	O
182	repair	71 77	768 774	0.9999834299087524	O
183	gene	78 82	775 779	0.9999825954437256	O
184	-	82 83	779 780	0.9999814033508301	O
185	knockout	83 91	780 788	0.9998342990875244	O
186	mice	92 96	789 793	0.8895719051361084	O
187	.	97 98	794 795	0.9998675584793091	O
188	No	0 2	796 798	0.9999597072601318	O
189	Type	3 7	799 803	0.9999799728393555	O
190	B	8 9	804 805	0.9999743700027466	O
191	instability	10 21	806 817	0.9999768733978271	O
192	was	22 25	818 821	0.9999769926071167	O
193	seen	26 30	822 826	0.9999762773513794	O
194	in	31 33	827 829	0.9999796152114868	O
195	these	34 39	830 835	0.9999791383743286	O
196	cells	40 45	836 841	0.9999580383300781	O
197	or	46 48	842 844	0.9999611377716064	O
198	tumours	49 55	845 851	0.9999737739562988	O
201	.	57 58	853 854	0.9998713731765747	O
202	In	0 2	855 857	0.99997878074646	O
203	a	3 4	858 859	0.999976634979248	O
204	panel	5 10	860 865	0.9999488592147827	O
205	of	11 13	866 868	0.999967098236084	O
206	human	14 19	869 874	0.7243511080741882	species
207	colorectal	20 29	875 884	0.9999442100524902	O
210	tumours	31 37	886 892	0.999981164932251	O
213	,	39 40	894 895	0.999982476234436	O
214	both	41 45	896 900	0.9999841451644897	O
215	Type	46 50	901 905	0.999987006187439	O
216	A	51 52	906 907	0.9999862909317017	O
217	MSI	53 55	908 910	0.9999872446060181	O
219	and	57 60	912 915	0.9999855756759644	O
220	Type	61 65	916 920	0.9999871253967285	O
221	B	66 67	921 922	0.9999840259552002	O
222	instability	68 79	923 934	0.9999836683273315	O
223	were	80 84	935 939	0.9999843835830688	O
224	observed	85 93	940 948	0.9999834299087524	O
225	.	94 95	949 950	0.9999517202377319	O
226	Both	0 4	951 955	0.9999778270721436	O
227	types	5 10	956 961	0.9999865293502808	O
228	of	11 13	962 964	0.9999865293502808	O
229	MSI	14 16	965 967	0.9999815225601196	O
231	were	18 22	969 973	0.9999856948852539	O
232	associated	23 33	974 984	0.9999867677688599	O
233	with	34 38	985 989	0.9999877214431763	O
234	hMSH2	39 43	990 994	0.9999880790710449	O
238	or	45 47	996 998	0.9999868869781494	O
239	hMLH1	48 52	999 1003	0.9999879598617554	O
242	mismatch	54 61	1005 1012	0.9999880790710449	O
245	repair	63 69	1014 1020	0.9999878406524658	O
246	gene	70 74	1021 1025	0.9999884366989136	O
247	alterations	75 86	1026 1037	0.9999873638153076	O
248	.	87 88	1038 1039	0.9999417066574097	O
249	Intriguingly	0 11	1040 1051	0.999988317489624	O
253	,	13 14	1053 1054	0.9999881982803345	O
254	p53	15 17	1055 1057	0.9999854564666748	O
256	mutations	19 28	1059 1068	0.9999855756759644	O
257	,	29 30	1069 1070	0.999988317489624	O
258	which	31 36	1071 1076	0.999988317489624	O
259	are	37 40	1077 1080	0.9999880790710449	O
260	generally	41 50	1081 1090	0.9999847412109375	O
261	regarded	51 59	1091 1099	0.9999868869781494	O
262	as	60 62	1100 1102	0.9999885559082031	O
263	uncommon	63 71	1103 1111	0.9999865293502808	O
264	in	72 74	1112 1114	0.9999880790710449	O
265	human	75 80	1115 1120	0.9656299352645874	O
266	tumours	81 87	1121 1127	0.9999871253967285	O
269	of	89 91	1129 1131	0.9999880790710449	O
270	the	92 95	1132 1135	0.9999884366989136	O
271	MSI	96 98	1136 1138	0.9999865293502808	O
273	+	99 100	1139 1140	0.9999877214431763	O
274	phenotype	101 109	1141 1149	0.9999889135360718	O
277	,	111 112	1151 1152	0.9999862909317017	O
278	were	113 117	1153 1157	0.9999879598617554	O
279	frequently	118 128	1158 1168	0.9999873638153076	O
280	associated	129 139	1169 1179	0.9999891519546509	O
281	with	140 144	1180 1184	0.9999891519546509	O
282	Type	145 149	1185 1189	0.9999881982803345	O
283	A	150 151	1190 1191	0.9999878406524658	O
284	instability	152 163	1192 1203	0.9999874830245972	O
285	,	164 165	1204 1205	0.9999885559082031	O
286	whereas	166 173	1206 1213	0.9999873638153076	O
287	none	174 178	1214 1218	0.9999833106994629	O
288	was	179 182	1219 1222	0.999988317489624	O
289	found	183 188	1223 1228	0.9999878406524658	O
290	in	189 191	1229 1231	0.9999884366989136	O
291	tumours	192 198	1232 1238	0.9999871253967285	O
294	with	200 204	1240 1244	0.9999886751174927	O
295	Type	205 209	1245 1249	0.9999881982803345	O
296	B	210 211	1250 1251	0.9999865293502808	O
297	instability	212 223	1252 1263	0.9999884366989136	O
298	,	224 225	1264 1265	0.9999885559082031	O
299	reflecting	226 236	1266 1276	0.9999878406524658	O
300	the	237 240	1277 1280	0.9999889135360718	O
301	prevailing	241 251	1281 1291	0.9999812841415405	O
302	viewpoint	252 261	1292 1301	0.9999852180480957	O
303	.	262 263	1302 1303	0.9999661445617676	O
304	Inspection	0 9	1304 1313	0.9999873638153076	O
307	of	11 13	1315 1317	0.9999876022338867	O
308	published	14 23	1318 1327	0.9999775886535645	O
309	data	24 28	1328 1332	0.9999864101409912	O
310	reveals	29 36	1333 1340	0.9999856948852539	O
311	that	37 41	1341 1345	0.9999886751174927	O
312	the	42 45	1346 1349	0.9999880790710449	O
313	microsatellite	46 59	1350 1363	0.9999867677688599	O
317	instability	61 72	1365 1376	0.9999877214431763	O
318	that	73 77	1377 1381	0.9999884366989136	O
319	has	78 81	1382 1385	0.9999884366989136	O
320	been	82 86	1386 1390	0.999988317489624	O
321	observed	87 95	1391 1399	0.9999868869781494	O
322	in	96 98	1400 1402	0.9999874830245972	O
323	various	99 106	1403 1410	0.9999699592590332	O
324	malignancies	107 118	1411 1422	0.9999831914901733	O
328	,	120 121	1424 1425	0.9999876022338867	O
329	including	122 131	1426 1435	0.9999872446060181	O
330	those	132 137	1436 1441	0.9999860525131226	O
331	associated	138 148	1442 1452	0.9999878406524658	O
332	with	149 153	1453 1457	0.9999889135360718	O
333	Hereditary	154 163	1458 1467	0.9999792575836182	O
336	Non	165 168	1469 1472	0.9999856948852539	O
337	-	168 169	1472 1473	0.9999880790710449	O
338	Polyposis	169 177	1473 1481	0.9999855756759644	O
342	Colorectal	179 188	1483 1492	0.9999842643737793	O
345	Cancer	190 196	1494 1500	0.9999855756759644	O
346	(	197 198	1501 1502	0.9999880790710449	O
347	HNPCC	199 203	1503 1507	0.9999629259109497	O
350	)	204 205	1508 1509	0.9999886751174927	O
351	,	206 207	1510 1511	0.9999852180480957	O
352	is	208 210	1512 1514	0.9999872446060181	O
353	predominantly	211 224	1515 1528	0.9999856948852539	O
354	Type	225 229	1529 1533	0.9999874830245972	O
355	B	230 231	1534 1535	0.9999856948852539	O
356	.	231 232	1535 1536	0.9999867677688599	O
357	Our	233 236	1537 1540	0.9999829530715942	O
358	findings	237 245	1541 1549	0.9999862909317017	O
359	indicate	246 254	1550 1558	0.9999860525131226	O
360	that	255 259	1559 1563	0.9999891519546509	O
361	Type	260 264	1564 1568	0.9999877214431763	O
362	B	265 266	1569 1570	0.999985933303833	O
363	instability	267 278	1571 1582	0.9999873638153076	O
364	is	279 281	1583 1585	0.9999887943267822	O
365	not	282 285	1586 1589	0.9999864101409912	O
366	a	286 287	1590 1591	0.9999889135360718	O
367	simple	288 294	1592 1598	0.9999849796295166	O
368	reflection	295 305	1599 1609	0.9999871253967285	O
369	of	306 308	1610 1612	0.9999887943267822	O
370	a	309 310	1613 1614	0.9999885559082031	O
371	repair	311 317	1615 1621	0.9999809265136719	O
372	defect	318 324	1622 1628	0.9999878406524658	O
373	.	325 326	1629 1630	0.9999618530273438	O
374	We	0 2	1631 1633	0.9999798536300659	O
375	suggest	3 10	1634 1641	0.999983549118042	O
376	that	11 15	1642 1646	0.9999877214431763	O
377	there	16 21	1647 1652	0.9999877214431763	O
378	are	22 25	1653 1656	0.9999878406524658	O
379	at	26 28	1657 1659	0.9999879598617554	O
380	least	29 34	1660 1665	0.9999878406524658	O
381	two	35 38	1666 1669	0.9999829530715942	O
382	qualitatively	39 51	1670 1682	0.9999886751174927	O
386	distinct	53 61	1684 1692	0.999984860420227	O
387	modes	62 67	1693 1698	0.9999876022338867	O
388	of	68 70	1699 1701	0.9999881982803345	O
389	dinucleotide	71 82	1702 1713	0.9999865293502808	O
393	MSI	84 86	1715 1717	0.9999877214431763	O
395	in	88 90	1719 1721	0.9999865293502808	O
396	human	91 96	1722 1727	0.9985413551330566	O
397	colorectal	97 106	1728 1737	0.9999856948852539	O
400	cancer	108 114	1739 1745	0.9999861717224121	O
401	,	115 116	1746 1747	0.9999852180480957	O
402	and	117 120	1748 1751	0.9999843835830688	O
403	that	121 125	1752 1756	0.9999880790710449	O
404	different	126 135	1757 1766	0.9999845027923584	O
405	molecular	136 145	1767 1776	0.9999843835830688	O
406	mechanisms	146 156	1777 1787	0.9999868869781494	O
407	may	157 160	1788 1791	0.9999873638153076	O
408	underlie	161 168	1792 1799	0.999988317489624	O
410	these	170 175	1801 1806	0.9999876022338867	O
411	modes	176 181	1807 1812	0.9999874830245972	O
412	of	182 184	1813 1815	0.999988317489624	O
413	MSI	185 187	1816 1818	0.9999865293502808	O
415	.	188 189	1819 1820	0.9999691247940063	O
416	The	0 3	1821 1824	0.9999868869781494	O
417	relationship	4 16	1825 1837	0.9999858140945435	O
418	between	17 24	1838 1845	0.9999879598617554	O
419	MSI	25 27	1846 1848	0.9999837875366211	O
421	and	29 32	1850 1853	0.9999879598617554	O
422	defective	33 41	1854 1862	0.9999854564666748	O
424	mismatch	43 50	1864 1871	0.9999871253967285	O
427	repair	52 58	1873 1879	0.9999874830245972	O
428	may	59 62	1880 1883	0.999985933303833	O
429	be	63 65	1884 1886	0.9999880790710449	O
430	more	66 70	1887 1891	0.9999872446060181	O
431	complex	71 78	1892 1899	0.9999858140945435	O
432	than	79 83	1900 1904	0.9999871253967285	O
433	hitherto	84 91	1905 1912	0.9999858140945435	O
436	suspected	93 102	1914 1923	0.9999864101409912	O
437	.	103 104	1924 1925	0.9999887943267822	O
438	*	105 106	1926 1927	0.9999876022338867	O
439	*	106 107	1927 1928	0.9999829530715942	O
440	IGNORE	0 5	1929 1934	0.9999858140945435	O
443	LINE	7 10	1936 1939	0.9999881982803345	O
446	*	12 13	1941 1942	0.9999884366989136	O
447	*	13 14	1942 1943	0.999988317489624	O
448	*	15 16	1944 1945	0.999988317489624	O
449	*	16 17	1945 1946	0.9999884366989136	O
450	IGNORE	18 23	1947 1952	0.9999872446060181	O
453	LINE	25 28	1954 1957	0.9999885559082031	O
456	*	30 31	1959 1960	0.999988317489624	O
457	*	31 32	1960 1961	0.999988317489624	O
458	*	33 34	1962 1963	0.9999881982803345	O
459	*	34 35	1963 1964	0.9999880790710449	O
460	IGNORE	36 41	1965 1970	0.9999867677688599	O
463	LINE	43 46	1972 1975	0.999988317489624	O
466	*	48 49	1977 1978	0.999988317489624	O
467	*	49 50	1978 1979	0.9999884366989136	O
468	Analysis	51 59	1980 1988	0.9999877214431763	O
469	of	60 62	1989 1991	0.999988317489624	O
470	microsatellites	63 77	1992 2006	0.9999876022338867	O
474	in	79 81	2008 2010	0.9999877214431763	O
475	MEFs	82 85	2011 2014	0.9979562759399414	O
478	and	87 90	2016 2019	0.9999692440032959	O
479	tumours	91 97	2020 2026	0.999961256980896	O
482	from	99 103	2028 2032	0.9999556541442871	O
483	MMR	104 106	2033 2035	0.9999836683273315	O
485	-	107 108	2036 2037	0.9999878406524658	O
486	defective	108 116	2037 2045	0.9999761581420898	O
488	animals	118 125	2047 2054	0.7193062901496887	O
489	therefore	126 135	2055 2064	0.9999853372573853	O
490	indicates	136 145	2065 2074	0.999985933303833	O
491	that	146 150	2075 2079	0.999988317489624	O
492	Type	151 155	2080 2084	0.9999867677688599	O
493	A	156 157	2085 2086	0.9999829530715942	O
494	MSI	158 160	2087 2089	0.9999856948852539	O
496	is	162 164	2091 2093	0.9999872446060181	O
497	a	165 166	2094 2095	0.9999884366989136	O
498	direct	167 173	2096 2102	0.9999786615371704	O
499	consequence	174 185	2103 2114	0.9999874830245972	O
500	of	186 188	2115 2117	0.9999881982803345	O
501	defective	189 197	2118 2126	0.9999858140945435	O
503	MMR	199 201	2128 2130	0.9999856948852539	O
505	.	202 203	2131 2132	0.9999666213989258	O
506	The	0 3	2133 2136	0.9999873638153076	O
507	absence	4 11	2137 2144	0.9999866485595703	O
508	of	12 14	2145 2147	0.9999886751174927	O
509	more	15 19	2148 2152	0.9999862909317017	O
510	extensive	20 29	2153 2162	0.9999850988388062	O
511	microsatellite	30 43	2163 2176	0.9999880790710449	O
515	length	45 51	2178 2184	0.9999880790710449	O
516	changes	52 59	2185 2192	0.9999878406524658	O
517	may	60 63	2193 2196	0.9999854564666748	O
518	indicate	64 72	2197 2205	0.9999862909317017	O
519	further	73 80	2206 2213	0.9999809265136719	O
520	that	81 85	2214 2218	0.9999886751174927	O
521	an	86 88	2219 2221	0.9999880790710449	O
522	Msh2	89 92	2222 2225	0.9999881982803345	O
525	or	94 96	2227 2229	0.9999876022338867	O
526	Mlh1	97 100	2230 2233	0.9999865293502808	O
530	defect	102 108	2235 2241	0.9999864101409912	O
531	is	109 111	2242 2244	0.9999874830245972	O
532	insufficient	112 124	2245 2257	0.9999825954437256	O
533	for	125 128	2258 2261	0.9999866485595703	O
534	the	129 132	2262 2265	0.9999878406524658	O
535	development	133 144	2266 2277	0.9999861717224121	O
536	of	145 147	2278 2280	0.999988317489624	O
537	Type	148 152	2281 2285	0.9999871253967285	O
538	B	153 154	2286 2287	0.9999841451644897	O
539	instability	155 166	2288 2299	0.999985933303833	O
540	.	167 168	2300 2301	0.9999659061431885	O
541	Mismatch	0 7	2302 2309	0.9999830722808838	O
544	repair	9 15	2311 2317	0.999985933303833	O
545	gene	16 20	2318 2322	0.999988317489624	O
546	inactivation	21 32	2323 2334	0.9999887943267822	O
549	is	34 36	2336 2338	0.9999860525131226	O
550	associated	37 47	2339 2349	0.9999879598617554	O
551	with	48 52	2350 2354	0.9999887943267822	O
552	both	53 57	2355 2359	0.999985933303833	O
553	Type	58 62	2360 2364	0.9999881982803345	O
554	A	63 64	2365 2366	0.9999881982803345	O
555	and	65 68	2367 2370	0.9999871253967285	O
556	Type	69 73	2371 2375	0.9999880790710449	O
557	B	74 75	2376 2377	0.9999862909317017	O
558	MSI	76 78	2378 2380	0.999987006187439	O
560	in	80 82	2382 2384	0.9999867677688599	O
561	human	83 88	2385 2390	0.9993067979812622	O
562	colorectal	89 98	2391 2400	0.9999841451644897	O
565	cancer	100 106	2402 2408	0.9999836683273315	O
566	HNPCC	107 111	2409 2413	0.9999755620956421	O
569	patients	113 121	2415 2423	0.9999756813049316	O
570	inherit	122 129	2424 2431	0.9999755620956421	O
571	mutations	130 139	2432 2441	0.999985933303833	O
572	in	140 142	2442 2444	0.9999889135360718	O
573	MMR	143 145	2445 2447	0.9999866485595703	O
575	genes	147 152	2449 2454	0.9999885559082031	O
576	(	153 154	2455 2456	0.9999897480010986	O
577	6	154 155	2456 2457	0.9999892711639404	O
578	,	155 156	2457 2458	0.9999885559082031	O
579	7	156 157	2458 2459	0.9999885559082031	O
580	)	158 159	2460 2461	0.9999895095825195	O
581	.	160 161	2462 2463	0.9999727010726929	O
582	More	0 4	2464 2468	0.9999828338623047	O
583	than	5 9	2469 2473	0.9999849796295166	O
584	90	10 12	2474 2476	0.9999719858169556	O
585	%	13 14	2477 2478	0.9999845027923584	O
586	of	15 17	2479 2481	0.9999827146530151	O
587	HNPCC	18 22	2482 2486	0.9999370574951172	O
590	tumours	24 30	2488 2494	0.9999839067459106	O
593	are	32 35	2496 2499	0.9999860525131226	O
594	MSI	36 38	2500 2502	0.9999856948852539	O
596	+	39 40	2503 2504	0.9999877214431763	O
597	(	41 42	2505 2506	0.999988317489624	O
598	20	43 45	2507 2509	0.9999837875366211	O
599	)	46 47	2510 2511	0.9999885559082031	O
600	.	48 49	2512 2513	0.9999622106552124	O
601	The	0 3	2514 2517	0.9999877214431763	O
602	MSI	4 6	2518 2520	0.9999840259552002	O
604	+	7 8	2521 2522	0.9999854564666748	O
605	phenotype	9 17	2523 2531	0.9999885559082031	O
608	is	19 21	2533 2535	0.9999861717224121	O
609	also	22 26	2536 2540	0.9999858140945435	O
610	frequent	27 35	2541 2549	0.9999860525131226	O
611	among	36 41	2550 2555	0.9999854564666748	O
612	sporadic	42 49	2556 2563	0.9999761581420898	O
614	colorectal	51 60	2565 2574	0.9999812841415405	O
617	carcinomas	62 71	2576 2585	0.9999850988388062	O
621	(	73 74	2587 2588	0.9999895095825195	O
622	2	75 76	2589 2590	0.9999876022338867	O
623	–	76 77	2590 2591	0.999984622001648	O
624	4	77 78	2591 2592	0.9999876022338867	O
625	,	78 79	2592 2593	0.9999884366989136	O
626	6	79 80	2593 2594	0.9999880790710449	O
627	,	80 81	2594 2595	0.9999884366989136	O
628	21	81 83	2595 2597	0.9999865293502808	O
629	)	84 85	2598 2599	0.9999892711639404	O
630	.	86 87	2600 2601	0.9999701976776123	O
631	Inspection	0 9	2602 2611	0.9999881982803345	O
634	of	11 13	2613 2615	0.9999885559082031	O
635	published	14 23	2616 2625	0.9999842643737793	O
636	data	24 28	2626 2630	0.9999886751174927	O
637	derived	29 36	2631 2638	0.99998939037323	O
638	from	37 41	2639 2643	0.99998939037323	O
639	the	42 45	2644 2647	0.9999890327453613	O
640	conventional	46 58	2648 2660	0.9999853372573853	O
641	microsatellite	59 72	2661 2674	0.9999887943267822	O
645	analysis	74 82	2676 2684	0.9999891519546509	O
646	reveals	83 90	2685 2692	0.9999878406524658	O
647	that	91 95	2693 2697	0.9999895095825195	O
648	microsatellite	96 109	2698 2711	0.9999881982803345	O
652	changes	111 118	2713 2720	0.9999879598617554	O
653	thus	119 123	2721 2725	0.9999887943267822	O
654	far	124 127	2726 2729	0.9999886751174927	O
655	reported	128 136	2730 2738	0.9999867677688599	O
656	in	137 139	2739 2741	0.9999886751174927	O
657	various	140 147	2742 2749	0.9999815225601196	O
658	tumours	148 154	2750 2756	0.9999866485595703	O
661	,	156 157	2758 2759	0.9999887943267822	O
662	including	158 167	2760 2769	0.9999887943267822	O
663	those	168 173	2770 2775	0.9999886751174927	O
664	in	174 176	2776 2778	0.9999887943267822	O
665	HNPCC	177 181	2779 2783	0.9999834299087524	O
668	individuals	183 194	2785 2796	0.9999648332595825	O
669	,	195 196	2797 2798	0.999987006187439	O
670	are	197 200	2799 2802	0.9999886751174927	O
671	largely	201 208	2803 2810	0.9999877214431763	O
672	Type	209 213	2811 2815	0.9999864101409912	O
673	B	214 215	2816 2817	0.9999876022338867	O
674	(	216 217	2818 2819	0.9999897480010986	O
675	2	218 219	2820 2821	0.999988317489624	O
676	–	219 220	2821 2822	0.9999880790710449	O
677	4	220 221	2822 2823	0.9999879598617554	O
678	,	221 222	2823 2824	0.9999887943267822	O
679	20	222 224	2824 2826	0.9999880790710449	O
680	–	224 225	2826 2827	0.999988317489624	O
681	22	225 227	2827 2829	0.9999873638153076	O
682	)	228 229	2830 2831	0.99998939037323	O
683	.	230 231	2832 2833	0.9999698400497437	O
684	We	0 2	2834 2836	0.9999797344207764	O
685	considered	3 13	2837 2847	0.9999839067459106	O
686	the	14 17	2848 2851	0.9999872446060181	O
687	possibility	18 29	2852 2863	0.9999841451644897	O
688	that	30 34	2864 2868	0.9999879598617554	O
689	the	35 38	2869 2872	0.9999877214431763	O
690	more	39 43	2873 2877	0.9999855756759644	O
691	subtle	44 50	2878 2884	0.9999850988388062	O
692	Type	51 55	2885 2889	0.9999876022338867	O
693	A	56 57	2890 2891	0.9999853372573853	O
694	MSI	58 60	2892 2894	0.9999849796295166	O
696	might	62 67	2896 2901	0.9999850988388062	O
697	have	68 72	2902 2906	0.999988317489624	O
698	remained	73 81	2907 2915	0.9999879598617554	O
699	undetected	82 91	2916 2925	0.9999884366989136	O
702	in	93 95	2927 2929	0.9999884366989136	O
703	some	96 100	2930 2934	0.9999858140945435	O
704	cases	101 106	2935 2940	0.9999867677688599	O
705	.	107 108	2941 2942	0.9999501705169678	O
706	Using	0 5	2943 2948	0.9999864101409912	O
707	our	6 9	2949 2952	0.9999828338623047	O
708	fluorescent	10 21	2953 2964	0.9999099969863892	O
709	assay	22 26	2965 2969	0.9999866485595703	O
711	with	28 32	2971 2975	0.9999867677688599	O
712	a	33 34	2976 2977	0.9999886751174927	O
713	panel	35 40	2978 2983	0.9999866485595703	O
714	of	41 43	2984 2986	0.999988317489624	O
715	five	44 48	2987 2991	0.999984860420227	O
716	dinucleotide	49 60	2992 3003	0.9999861717224121	O
720	repeat	62 68	3005 3011	0.9999864101409912	O
721	microsatellites	69 83	3012 3026	0.9999881982803345	O
725	,	85 86	3028 3029	0.9999867677688599	O
726	we	87 89	3030 3032	0.9999852180480957	O
727	found	90 95	3033 3038	0.9999868869781494	O
728	that	96 100	3039 3043	0.9999884366989136	O
729	the	101 104	3044 3047	0.9999884366989136	O
730	frequencies	105 116	3048 3059	0.9999849796295166	O
731	of	117 119	3060 3062	0.999988317489624	O
732	Type	120 124	3063 3067	0.9999878406524658	O
733	A	125 126	3068 3069	0.9999877214431763	O
734	and	127 130	3070 3073	0.9999874830245972	O
735	Type	131 135	3074 3078	0.9999880790710449	O
736	B	136 137	3079 3080	0.9999866485595703	O
737	MSI	138 140	3081 3083	0.9999867677688599	O
739	among	142 147	3085 3090	0.9999864101409912	O
740	79	148 150	3091 3093	0.9999494552612305	O
741	colorectal	151 160	3094 3103	0.9999780654907227	O
744	carcinomas	162 171	3105 3114	0.9999836683273315	O
748	were	173 177	3116 3120	0.9999881982803345	O
749	30	178 180	3121 3123	0.9999850988388062	O
750	%	181 182	3124 3125	0.9999885559082031	O
751	and	183 186	3126 3129	0.9999861717224121	O
752	17	187 189	3130 3132	0.9999831914901733	O
753	%	190 191	3133 3134	0.999988317489624	O
754	,	192 193	3135 3136	0.9999871253967285	O
755	respectively	194 206	3137 3149	0.9999871253967285	O
756	.	207 208	3150 3151	0.9999650716781616	O
757	In	0 2	3152 3154	0.9999878406524658	O
758	agreement	3 12	3155 3164	0.9999868869781494	O
759	with	13 17	3165 3169	0.9999880790710449	O
760	previous	18 26	3170 3178	0.9999839067459106	O
761	observations	27 39	3179 3191	0.9999842643737793	O
762	that	40 44	3192 3196	0.9999885559082031	O
763	Type	45 49	3197 3201	0.999988317489624	O
764	B	50 51	3202 3203	0.9999868869781494	O
765	instability	52 63	3204 3215	0.9999873638153076	O
766	is	64 66	3216 3218	0.9999886751174927	O
767	common	67 73	3219 3225	0.999987006187439	O
768	in	74 76	3226 3228	0.9999885559082031	O
769	HNPCC	77 81	3229 3233	0.9999849796295166	O
772	colon	83 87	3235 3239	0.9999836683273315	O
774	tumours	89 95	3241 3247	0.9999880790710449	O
777	,	97 98	3249 3250	0.9999881982803345	O
778	the	99 102	3251 3254	0.9999884366989136	O
779	IC690	103 107	3255 3259	0.9999881982803345	O
783	tumour	109 114	3261 3266	0.9999889135360718	O
785	and	116 119	3268 3271	0.9999871253967285	O
786	the	120 123	3272 3275	0.9999872446060181	O
787	colorectal	124 133	3276 3285	0.9999822378158569	O
790	carcinoma	135 143	3287 3295	0.9999855756759644	O
793	cell	145 149	3297 3301	0.9999836683273315	O
794	line	150 154	3302 3306	0.999985933303833	O
795	,	155 156	3307 3308	0.9999884366989136	O
796	NoTa	157 160	3309 3312	0.9999867677688599	O
799	(	162 163	3314 3315	0.99998939037323	O
800	Table	164 169	3316 3321	0.9999876022338867	O
801	1	170 171	3322 3323	0.9999890327453613	O
802	)	172 173	3324 3325	0.9999896287918091	O
803	,	174 175	3326 3327	0.9999891519546509	O
804	both	176 180	3328 3332	0.9999876022338867	O
805	of	181 183	3333 3335	0.999988317489624	O
806	which	184 189	3336 3341	0.9999885559082031	O
807	were	190 194	3342 3346	0.9999889135360718	O
808	derived	195 202	3347 3354	0.9999886751174927	O
809	from	203 207	3355 3359	0.9999885559082031	O
810	patients	208 216	3360 3368	0.9999847412109375	O
811	who	217 220	3369 3372	0.9999886751174927	O
812	fulfilled	221 230	3373 3382	0.9999876022338867	O
813	the	231 234	3383 3386	0.9999890327453613	O
814	Amsterdam	235 244	3387 3396	0.9999814033508301	O
815	Criteria	245 252	3397 3404	0.9999881982803345	O
818	II	254 256	3406 3408	0.9999862909317017	O
819	for	257 260	3409 3412	0.9999872446060181	O
820	HNPCC	261 265	3413 3417	0.9999864101409912	O
823	(	267 268	3419 3420	0.9999896287918091	O
824	23	269 271	3421 3423	0.9999873638153076	O
825	)	272 273	3424 3425	0.9999896287918091	O
826	,	274 275	3426 3427	0.999987006187439	O
827	exhibited	276 285	3428 3437	0.9999861717224121	O
828	Type	286 290	3438 3442	0.9999881982803345	O
829	B	291 292	3443 3444	0.9999873638153076	O
830	instability	293 304	3445 3456	0.9999879598617554	O
831	(	305 306	3457 3458	0.9999895095825195	O
832	Figure	307 313	3459 3465	0.9999871253967285	O
833	1G	314 315	3466 3467	0.9999885559082031	O
835	and	317 320	3469 3472	0.999988317489624	O
836	H	321 322	3473 3474	0.9999817609786987	O
837	)	322 323	3474 3475	0.99998939037323	O
838	.	324 325	3476 3477	0.9999710321426392	O
839	Our	0 3	3478 3481	0.9999834299087524	O
840	finding	4 11	3482 3489	0.9999855756759644	O
841	that	12 16	3490 3494	0.9999879598617554	O
842	17	17 19	3495 3497	0.9999778270721436	O
843	%	20 21	3498 3499	0.9999867677688599	O
844	of	22 24	3500 3502	0.9999861717224121	O
845	colorectal	25 34	3503 3512	0.999977707862854	O
848	tumours	36 42	3514 3520	0.9999865293502808	O
851	display	44 51	3522 3529	0.9999864101409912	O
852	Type	52 56	3530 3534	0.9999876022338867	O
853	B	57 58	3535 3536	0.9999856948852539	O
854	MSI	59 61	3537 3539	0.9999880790710449	O
856	is	63 65	3541 3543	0.9999867677688599	O
857	consistent	66 76	3544 3554	0.9999880790710449	O
858	with	77 81	3555 3559	0.9999891519546509	O
859	the	82 85	3560 3563	0.9999889135360718	O
860	generally	86 95	3564 3573	0.9999867677688599	O
861	reported	96 104	3574 3582	0.9999865293502808	O
862	figure	105 111	3583 3589	0.9999877214431763	O
863	of	112 114	3590 3592	0.9999890327453613	O
864	around	115 121	3593 3599	0.9999885559082031	O
865	20	122 124	3600 3602	0.9999874830245972	O
866	%	125 126	3603 3604	0.9999891519546509	O
867	for	127 130	3605 3608	0.9999887943267822	O
868	MSI	131 133	3609 3611	0.9999885559082031	O
870	among	135 140	3613 3618	0.999985933303833	O
871	colorectal	141 150	3619 3628	0.9999843835830688	O
874	carcinomas	152 161	3630 3639	0.9999865293502808	O
878	(	163 164	3641 3642	0.99998939037323	O
879	20	165 167	3643 3645	0.9999879598617554	O
880	,	167 168	3645 3646	0.9999884366989136	O
881	24	168 170	3646 3648	0.9999878406524658	O
882	,	170 171	3648 3649	0.9999878406524658	O
883	25	171 173	3649 3651	0.9999868869781494	O
884	)	174 175	3652 3653	0.9999891519546509	O
885	.	176 177	3654 3655	0.9999728202819824	O
886	The	0 3	3656 3659	0.9999853372573853	O
887	observation	4 15	3660 3671	0.9999772310256958	O
888	that	16 20	3672 3676	0.999987006187439	O
889	a	21 22	3677 3678	0.9999880790710449	O
890	further	23 30	3679 3686	0.9999819993972778	O
891	30	31 33	3687 3689	0.9999756813049316	O
892	%	34 35	3690 3691	0.9999867677688599	O
893	of	36 38	3692 3694	0.9999855756759644	O
894	tumours	39 45	3695 3701	0.9999850988388062	O
897	displayed	47 56	3703 3712	0.9999841451644897	O
898	Type	57 61	3713 3717	0.9999877214431763	O
899	A	62 63	3718 3719	0.9999860525131226	O
900	MSI	64 66	3720 3722	0.999987006187439	O
902	suggests	68 76	3724 3732	0.999982476234436	O
903	that	77 81	3733 3737	0.9999885559082031	O
904	the	82 85	3738 3741	0.9999885559082031	O
905	frequency	86 95	3742 3751	0.999987006187439	O
906	of	96 98	3752 3754	0.9999884366989136	O
907	MSI	99 101	3755 3757	0.999987006187439	O
909	,	103 104	3759 3760	0.9999880790710449	O
910	at	105 107	3761 3763	0.9999878406524658	O
911	least	108 113	3764 3769	0.9999830722808838	O
912	in	114 116	3770 3772	0.9999868869781494	O
913	colorectal	117 126	3773 3782	0.9999840259552002	O
916	carcinomas	128 137	3784 3793	0.9999867677688599	O
920	,	139 140	3795 3796	0.9999864101409912	O
921	has	141 144	3797 3800	0.9999873638153076	O
922	previously	145 155	3801 3811	0.9999815225601196	O
923	been	156 160	3812 3816	0.9999880790710449	O
924	underestimated	161 174	3817 3830	0.9999852180480957	O
927	.	176 177	3832 3833	0.9999651908874512	O
928	The	0 3	3834 3837	0.999987006187439	O
929	relationship	4 16	3838 3850	0.9999861717224121	O
930	between	17 24	3851 3858	0.9999877214431763	O
931	MSI	25 27	3859 3861	0.9999850988388062	O
933	and	29 32	3863 3866	0.9999871253967285	O
934	defective	33 41	3867 3875	0.999985933303833	O
936	MMR	43 45	3877 3879	0.999985933303833	O
938	in	47 49	3881 3883	0.9999879598617554	O
939	our	50 53	3884 3887	0.9999772310256958	O
940	set	54 57	3888 3891	0.9999823570251465	O
941	of	58 60	3892 3894	0.9999852180480957	O
942	colorectal	61 70	3895 3904	0.9999792575836182	O
945	tumours	72 78	3906 3912	0.9999853372573853	O
948	was	80 83	3914 3917	0.9999860525131226	O
949	investigated	84 96	3918 3930	0.9999858140945435	O
950	further	97 104	3931 3938	0.9999842643737793	O
951	.	105 106	3939 3940	0.9999650716781616	O
952	hMSH2	0 4	3941 3945	0.999988317489624	O
956	and	6 9	3947 3950	0.9999864101409912	O
957	hMLH1	10 14	3951 3955	0.9999878406524658	O
960	MMR	16 18	3957 3959	0.9999867677688599	O
962	genes	20 25	3961 3966	0.9999865293502808	O
963	of	26 28	3967 3969	0.9999862909317017	O
964	12	29 31	3970 3972	0.9999531507492065	O
965	tumours	32 38	3973 3979	0.9999852180480957	O
968	with	40 44	3981 3985	0.9999877214431763	O
969	Type	45 49	3986 3990	0.9999880790710449	O
970	A	50 51	3991 3992	0.9999876022338867	O
971	and	52 55	3993 3996	0.9999852180480957	O
972	9	56 57	3997 3998	0.9999746084213257	O
973	with	58 62	3999 4003	0.9999874830245972	O
974	Type	63 67	4004 4008	0.9999886751174927	O
975	B	68 69	4009 4010	0.9999854564666748	O
976	MSI	70 72	4011 4013	0.9999868869781494	O
978	were	74 78	4015 4019	0.9999866485595703	O
979	sequenced	79 87	4020 4028	0.9999842643737793	O
981	.	89 90	4030 4031	0.9999634027481079	O
982	The	0 3	4032 4035	0.9999887943267822	O
983	same	4 8	4036 4040	0.9999861717224121	O
984	genes	9 14	4041 4046	0.9999854564666748	O
985	in	15 17	4047 4049	0.9999885559082031	O
986	the	18 21	4050 4053	0.9999884366989136	O
987	NoTa	22 25	4054 4057	0.9999839067459106	O
990	cell	27 31	4059 4063	0.9999872446060181	O
991	line	32 36	4064 4068	0.9999878406524658	O
992	were	37 41	4069 4073	0.9999885559082031	O
993	also	42 46	4074 4078	0.9999886751174927	O
994	sequenced	47 55	4079 4087	0.9999867677688599	O
996	(	57 58	4089 4090	0.99998939037323	O
997	Figure	59 65	4091 4097	0.9999879598617554	O
998	3A	66 67	4098 4099	0.9999885559082031	O
1000	and	69 72	4101 4104	0.9999884366989136	O
1001	Table	73 78	4105 4110	0.9999878406524658	O
1002	1	79 80	4111 4112	0.9999886751174927	O
1003	)	81 82	4113 4114	0.99998939037323	O
1004	.	83 84	4115 4116	0.9999785423278809	O
1005	Sequence	0 7	4117 4124	0.999982476234436	O
1007	alterations	9 20	4126 4137	0.9999816417694092	O
1008	causing	21 28	4138 4145	0.9999818801879883	O
1009	amino	29 34	4146 4151	0.9999794960021973	O
1010	acid	35 39	4152 4156	0.9999836683273315	O
1011	substitutions	40 52	4157 4169	0.9999808073043823	O
1013	were	54 58	4171 4175	0.9999817609786987	O
1014	identified	59 69	4176 4186	0.9999803304672241	O
1015	in	70 72	4187 4189	0.9999834299087524	O
1016	5	73 74	4190 4191	0.9999721050262451	O
1017	of	75 77	4192 4194	0.9999828338623047	O
1018	the	78 81	4195 4198	0.9999798536300659	O
1019	21	82 84	4199 4201	0.9999336004257202	O
1020	tumours	85 91	4202 4208	0.9999803304672241	O
1023	.	93 94	4210 4211	0.9999233484268188	O
1024	Four	0 4	4212 4216	0.9998674392700195	O
1025	of	5 7	4217 4219	0.9999818801879883	O
1026	these	8 13	4220 4225	0.999976634979248	O
1027	(	14 15	4226 4227	0.9999830722808838	O
1028	80	16 18	4228 4230	0.9999397993087769	O
1029	%	19 20	4231 4232	0.9999810457229614	O
1030	)	21 22	4233 4234	0.9999825954437256	O
1031	were	23 27	4235 4239	0.9999810457229614	O
1032	associated	28 38	4240 4250	0.9999794960021973	O
1033	with	39 43	4251 4255	0.9999828338623047	O
1034	Type	44 48	4256 4260	0.9999833106994629	O
1035	A	49 50	4261 4262	0.9999786615371704	O
1036	MSI	51 53	4263 4265	0.9999812841415405	O
1038	.	54 55	4266 4267	0.9999122619628906	O
1039	In	0 2	4268 4270	0.9999879598617554	O
1040	addition	3 11	4271 4279	0.999985933303833	O
1041	,	12 13	4280 4281	0.9999881982803345	O
1042	one	14 17	4282 4285	0.999981164932251	O
1043	patient	18 25	4286 4293	0.9999850988388062	O
1044	with	26 30	4294 4298	0.9999891519546509	O
1045	Type	31 35	4299 4303	0.999988317489624	O
1046	A	36 37	4304 4305	0.9999873638153076	O
1047	MSI	38 40	4306 4308	0.9999858140945435	O
1049	(	42 43	4310 4311	0.9999897480010986	O
1050	IC793	44 48	4312 4316	0.9999891519546509	O
1055	)	50 51	4318 4319	0.9999897480010986	O
1056	in	52 54	4320 4322	0.9999889135360718	O
1057	whom	55 59	4323 4327	0.9999880790710449	O
1058	no	60 62	4328 4330	0.9999866485595703	O
1059	mutation	63 71	4331 4339	0.9999858140945435	O
1060	was	72 75	4340 4343	0.9999892711639404	O
1061	identified	76 86	4344 4354	0.9999885559082031	O
1062	was	87 90	4355 4358	0.9999890327453613	O
1063	negative	91 99	4359 4367	0.9999868869781494	O
1064	for	100 103	4368 4371	0.9999895095825195	O
1065	immunohistochemical	104 122	4372 4390	0.9999892711639404	O
1071	staining	124 131	4392 4399	0.9999891519546509	O
1073	of	133 135	4401 4403	0.9999891519546509	O
1074	hMLH1	136 140	4404 4408	0.9999887943267822	O
1077	(	142 143	4410 4411	0.9999897480010986	O
1078	Figure	144 150	4412 4418	0.9999872446060181	O
1079	3B	151 152	4419 4420	0.9999885559082031	O
1081	,	154 155	4422 4423	0.9999889135360718	O
1082	panel	156 161	4424 4429	0.9999886751174927	O
1083	b	162 163	4430 4431	0.9999884366989136	O
1084	)	164 165	4432 4433	0.9999896287918091	O
1085	.	166 167	4434 4435	0.9999758005142212	O
1086	This	0 4	4436 4440	0.9999833106994629	O
1087	is	5 7	4441 4443	0.999984860420227	O
1088	consistent	8 18	4444 4454	0.9999831914901733	O
1089	with	19 23	4455 4459	0.9999866485595703	O
1090	a	24 25	4460 4461	0.9999860525131226	O
1091	possible	26 34	4462 4470	0.9999852180480957	O
1092	epigenetic	35 44	4471 4480	0.9999867677688599	O
1096	hMLH1	46 50	4482 4486	0.9999841451644897	O
1099	gene	52 56	4488 4492	0.9999877214431763	O
1100	silencing	57 65	4493 4501	0.9999871253967285	O
1103	(	67 68	4503 4504	0.9999887943267822	O
1104	26	69 71	4505 4507	0.9999881982803345	O
1105	–	71 72	4507 4508	0.9999852180480957	O
1106	28	72 74	4508 4510	0.9999871253967285	O
1107	)	75 76	4511 4512	0.9999887943267822	O
1108	.	77 78	4513 4514	0.9999665021896362	O
1109	In	0 2	4515 4517	0.9999895095825195	O
1110	one	3 6	4518 4521	0.9999884366989136	O
1111	other	7 12	4522 4527	0.9999878406524658	O
1112	Type	13 17	4528 4532	0.9999891519546509	O
1113	A	18 19	4533 4534	0.999988317489624	O
1114	case	20 24	4535 4539	0.9999897480010986	O
1115	(	25 26	4540 4541	0.9999899864196777	O
1116	IC669	27 31	4542 4546	0.9999897480010986	O
1121	)	33 34	4548 4549	0.9999899864196777	O
1122	and	35 38	4550 4553	0.9999887943267822	O
1123	one	39 42	4554 4557	0.9999889135360718	O
1124	Type	43 47	4558 4562	0.9999891519546509	O
1125	B	48 49	4563 4564	0.999988317489624	O
1126	case	50 54	4565 4569	0.9999896287918091	O
1127	(	55 56	4570 4571	0.9999898672103882	O
1128	IC690	57 61	4572 4576	0.9999897480010986	O
1132	)	63 64	4578 4579	0.9999898672103882	O
1133	,	65 66	4580 4581	0.9999895095825195	O
1134	there	67 72	4582 4587	0.9999898672103882	O
1135	was	73 76	4588 4591	0.9999898672103882	O
1136	an	77 79	4592 4594	0.9999897480010986	O
1137	abnormal	80 88	4595 4603	0.9999895095825195	O
1138	intracellular	89 101	4604 4616	0.9999899864196777	O
1141	distribution	103 115	4618 4630	0.9999895095825195	O
1142	of	116 118	4631 4633	0.9999896287918091	O
1143	hMLH1	119 123	4634 4638	0.9999891519546509	O
1146	which	125 130	4640 4645	0.9999898672103882	O
1147	remained	131 139	4646 4654	0.9999889135360718	O
1148	predominantly	140 153	4655 4668	0.9999889135360718	O
1149	cytoplasmic	154 164	4669 4679	0.9999895095825195	O
1154	(	166 167	4681 4682	0.9999899864196777	O
1155	Figure	168 174	4683 4689	0.9999884366989136	O
1156	3B	175 176	4690 4691	0.9999887943267822	O
1158	,	178 179	4693 4694	0.9999892711639404	O
1159	panels	180 186	4695 4701	0.9999884366989136	O
1160	c	187 188	4702 4703	0.99998939037323	O
1161	and	189 192	4704 4707	0.9999889135360718	O
1162	d	193 194	4708 4709	0.9999878406524658	O
1163	)	195 196	4710 4711	0.9999897480010986	O
1164	.	197 198	4712 4713	0.9999769926071167	O
1165	Among	0 5	4714 4719	0.9999861717224121	O
1166	the	6 9	4720 4723	0.999987006187439	O
1167	10	10 12	4724 4726	0.9999468326568604	O
1168	tumours	13 19	4727 4733	0.9999836683273315	O
1171	displaying	21 31	4735 4745	0.9999847412109375	O
1172	Type	32 36	4746 4750	0.999987006187439	O
1173	B	37 38	4751 4752	0.9999836683273315	O
1174	MSI	39 41	4753 4755	0.9999864101409912	O
1176	,	43 44	4757 4758	0.9999871253967285	O
1177	there	45 50	4759 4764	0.9999885559082031	O
1178	was	51 54	4765 4768	0.9999881982803345	O
1179	an	55 57	4769 4771	0.9999887943267822	O
1180	example	58 65	4772 4779	0.9999831914901733	O
1181	of	66 68	4780 4782	0.9999886751174927	O
1182	base	69 73	4783 4787	0.9999878406524658	O
1183	substitutions	74 86	4788 4800	0.9999880790710449	O
1185	causing	88 95	4802 4809	0.9999889135360718	O
1186	amino	96 101	4810 4815	0.9999880790710449	O
1187	acid	102 106	4816 4820	0.999988317489624	O
1188	change	107 113	4821 4827	0.999988317489624	O
1189	in	114 116	4828 4830	0.9999889135360718	O
1190	hMLH1	117 121	4831 4835	0.9999885559082031	O
1193	.	123 124	4837 4838	0.9999765157699585	O
1194	In	0 2	4839 4841	0.9999879598617554	O
1195	this	3 7	4842 4846	0.9999885559082031	O
1196	case	8 12	4847 4851	0.999987006187439	O
1197	,	13 14	4852 4853	0.99998939037323	O
1198	IC690	15 19	4854 4858	0.9999890327453613	O
1202	,	21 22	4860 4861	0.9999887943267822	O
1203	the	23 26	4862 4865	0.9999890327453613	O
1204	failure	27 34	4866 4873	0.9999873638153076	O
1205	of	35 37	4874 4876	0.9999895095825195	O
1206	hMLH1	38 42	4877 4881	0.9999877214431763	O
1209	to	44 46	4883 4885	0.9999890327453613	O
1210	localize	47 54	4886 4893	0.9999885559082031	O
1212	to	56 58	4895 4897	0.9999881982803345	O
1213	the	59 62	4898 4901	0.9999889135360718	O
1214	nucleus	63 70	4902 4909	0.9999868869781494	O
1215	was	71 74	4910 4913	0.9999891519546509	O
1216	associated	75 85	4914 4924	0.9999895095825195	O
1217	with	86 90	4925 4929	0.9999896287918091	O
1218	the	91 94	4930 4933	0.9999895095825195	O
1219	codon	95 99	4934 4938	0.99998939037323	O
1221	226	101 104	4940 4943	0.9999862909317017	O
1222	mutation	105 113	4944 4952	0.9999890327453613	O
1223	in	114 116	4953 4955	0.9999897480010986	O
1224	exon	117 120	4956 4959	0.9999896287918091	O
1226	8	122 123	4961 4962	0.9999892711639404	O
1227	(	124 125	4963 4964	0.9999897480010986	O
1228	Figure	126 132	4965 4971	0.999987006187439	O
1229	3A	133 134	4972 4973	0.9999889135360718	O
1231	,	136 137	4975 4976	0.9999890327453613	O
1232	panel	138 143	4977 4982	0.9999879598617554	O
1233	c	144 145	4983 4984	0.99998939037323	O
1234	)	146 147	4985 4986	0.9999896287918091	O
1235	.	148 149	4987 4988	0.9999783039093018	O
1236	These	0 5	4989 4994	0.9999849796295166	O
1237	findings	6 14	4995 5003	0.9999822378158569	O
1238	suggest	15 22	5004 5011	0.9999840259552002	O
1239	that	23 27	5012 5016	0.9999876022338867	O
1240	Type	28 32	5017 5021	0.9999868869781494	O
1241	A	33 34	5022 5023	0.9999828338623047	O
1242	instability	35 46	5024 5035	0.9999828338623047	O
1243	,	47 48	5036 5037	0.9999865293502808	O
1244	as	49 51	5038 5040	0.9999836683273315	O
1245	well	52 56	5041 5045	0.9999864101409912	O
1246	as	57 59	5046 5048	0.9999876022338867	O
1247	Type	60 64	5049 5053	0.9999872446060181	O
1248	B	65 66	5054 5055	0.999983549118042	O
1249	,	67 68	5056 5057	0.9999864101409912	O
1250	is	69 71	5058 5060	0.9999866485595703	O
1251	indeed	72 78	5061 5067	0.9999755620956421	O
1252	associated	79 89	5068 5078	0.9999879598617554	O
1253	with	90 94	5079 5083	0.9999876022338867	O
1254	MMR	95 97	5084 5086	0.9999858140945435	O
1256	defects	99 106	5088 5095	0.9999862909317017	O
1257	.	107 108	5096 5097	0.999988317489624	O
1258	*	109 110	5098 5099	0.9999862909317017	O
1259	*	110 111	5099 5100	0.9999786615371704	O
1260	IGNORE	0 5	5101 5106	0.9999856948852539	O
1263	LINE	7 10	5108 5111	0.9999880790710449	O
1266	*	12 13	5113 5114	0.9999885559082031	O
1267	*	13 14	5114 5115	0.9999884366989136	O
1268	*	15 16	5116 5117	0.9999884366989136	O
1269	*	16 17	5117 5118	0.9999884366989136	O
1270	IGNORE	18 23	5119 5124	0.999987006187439	O
1273	LINE	25 28	5126 5129	0.9999884366989136	O
1276	*	30 31	5131 5132	0.999988317489624	O
1277	*	31 32	5132 5133	0.999988317489624	O
1278	*	33 34	5134 5135	0.9999881982803345	O
1279	*	34 35	5135 5136	0.9999881982803345	O
1280	IGNORE	36 41	5137 5142	0.9999865293502808	O
1283	LINE	43 46	5144 5147	0.9999881982803345	O
1286	*	48 49	5149 5150	0.999988317489624	O
1287	*	49 50	5150 5151	0.999988317489624	O
1288	DISCUSSION	51 60	5152 5161	0.9999885559082031	O
1293	The	62 65	5163 5166	0.999988317489624	O
1294	fluorescent	66 77	5167 5178	0.9999570846557617	O
1295	technique	78 87	5179 5188	0.9999853372573853	O
1296	we	88 90	5189 5191	0.9999877214431763	O
1297	used	91 95	5192 5196	0.9999871253967285	O
1298	here	96 100	5197 5201	0.9999872446060181	O
1299	allows	101 107	5202 5208	0.9999873638153076	O
1300	the	108 111	5209 5212	0.9999887943267822	O
1301	unequivocal	112 122	5213 5223	0.9999889135360718	O
1305	designation	124 135	5225 5236	0.9999881982803345	O
1306	of	136 138	5237 5239	0.9999885559082031	O
1307	Type	139 143	5240 5244	0.9999884366989136	O
1308	A	144 145	5245 5246	0.9999880790710449	O
1309	and	146 149	5247 5250	0.999987006187439	O
1310	Type	150 154	5251 5255	0.9999880790710449	O
1311	B	155 156	5256 5257	0.999984622001648	O
1312	MSI	157 159	5258 5260	0.9999866485595703	O
1314	,	161 162	5262 5263	0.9999866485595703	O
1315	and	163 166	5264 5267	0.9999876022338867	O
1316	has	167 170	5268 5271	0.9999879598617554	O
1317	revealed	171 179	5272 5280	0.9999879598617554	O
1318	a	180 181	5281 5282	0.9999887943267822	O
1319	previously	182 192	5283 5293	0.9999881982803345	O
1320	unrecognized	193 204	5294 5305	0.999988317489624	O
1325	complexity	206 216	5307 5317	0.9999874830245972	O
1326	in	217 219	5318 5320	0.9999884366989136	O
1327	the	220 223	5321 5324	0.9999887943267822	O
1328	relationship	224 236	5325 5337	0.9999880790710449	O
1329	between	237 244	5338 5345	0.9999885559082031	O
1330	dinucleotide	245 256	5346 5357	0.9999873638153076	O
1334	MSI	258 260	5359 5361	0.9999879598617554	O
1336	and	262 265	5363 5366	0.9999879598617554	O
1337	defective	266 274	5367 5375	0.999985933303833	O
1339	DNA	276 279	5377 5380	0.999984622001648	O
1340	MMR	280 282	5381 5383	0.9999871253967285	O
1342	in	284 286	5385 5387	0.9999877214431763	O
1343	human	287 292	5388 5393	0.99991774559021	O
1344	cancer	293 299	5394 5400	0.999984622001648	O
1345	.	300 301	5401 5402	0.9999493360519409	O
1346	Type	0 4	5403 5407	0.9999885559082031	O
1347	A	5 6	5408 5409	0.9999874830245972	O
1348	MSI	7 9	5410 5412	0.9999868869781494	O
1350	(	11 12	5414 5415	0.9999892711639404	O
1351	changes	13 20	5416 5423	0.9999880790710449	O
1352	≤	21 22	5424 5425	0.999987006187439	O
1353	6	23 24	5426 5427	0.9999887943267822	O
1354	bp	25 26	5428 5429	0.9999884366989136	O
1356	)	28 29	5431 5432	0.9999895095825195	O
1357	is	30 32	5433 5435	0.999988317489624	O
1358	clearly	33 40	5436 5443	0.9999854564666748	O
1359	linked	41 47	5444 5450	0.9999887943267822	O
1360	with	48 52	5451 5455	0.9999892711639404	O
1361	MMR	53 55	5456 5458	0.9999866485595703	O
1363	inactivation	57 68	5460 5471	0.9999895095825195	O
1366	in	70 72	5473 5475	0.9999877214431763	O
1367	both	73 77	5476 5480	0.9999784231185913	O
1368	mice	78 82	5481 5485	0.8211661577224731	species
1369	and	83 86	5486 5489	0.9999589920043945	O
1370	humans	87 93	5490 5496	0.9565435647964478	species
1371	,	94 95	5497 5498	0.9999881982803345	O
1372	which	96 101	5499 5504	0.9999891519546509	O
1373	implies	102 109	5505 5512	0.9999862909317017	O
1374	that	110 114	5513 5517	0.9999895095825195	O
1375	Type	115 119	5518 5522	0.9999884366989136	O
1376	A	120 121	5523 5524	0.9999871253967285	O
1377	MSI	122 124	5525 5527	0.999987006187439	O
1379	is	126 128	5529 5531	0.9999891519546509	O
1380	a	129 130	5532 5533	0.9999895095825195	O
1381	direct	131 137	5534 5540	0.999982476234436	O
1382	consequence	138 149	5541 5552	0.9999884366989136	O
1383	of	150 152	5553 5555	0.9999891519546509	O
1384	defective	153 161	5556 5564	0.9999860525131226	O
1386	MMR	163 165	5566 5568	0.9999868869781494	O
1388	.	166 167	5569 5570	0.9999716281890869	O
1389	Since	0 5	5571 5576	0.9999732971191406	O
1390	we	6 8	5577 5579	0.999974250793457	O
1391	found	9 14	5580 5585	0.9999816417694092	O
1392	no	15 17	5586 5588	0.999981164932251	O
1393	evidence	18 26	5589 5597	0.9999697208404541	O
1394	of	27 29	5598 5600	0.9999865293502808	O
1395	Type	30 34	5601 5605	0.9999868869781494	O
1396	B	35 36	5606 5607	0.9999847412109375	O
1397	instability	37 48	5608 5619	0.9999837875366211	O
1398	(	49 50	5620 5621	0.9999879598617554	O
1399	changes	51 58	5622 5629	0.9999872446060181	O
1400	≥	59 60	5630 5631	0.9999873638153076	O
1401	8	61 62	5632 5633	0.9999878406524658	O
1402	bp	63 64	5634 5635	0.9999872446060181	O
1404	)	66 67	5637 5638	0.999988317489624	O
1405	in	68 70	5639 5641	0.9999860525131226	O
1406	MMR	71 73	5642 5644	0.9999809265136719	O
1408	-	74 75	5645 5646	0.9999865293502808	O
1409	defective	75 83	5646 5654	0.9999591112136841	O
1411	animals	85 92	5656 5663	0.56892329454422	O
1412	,	93 94	5664 5665	0.9999841451644897	O
1413	it	95 97	5666 5668	0.9999865293502808	O
1414	is	98 100	5669 5671	0.9999847412109375	O
1415	possible	101 109	5672 5680	0.999983549118042	O
1416	that	110 114	5681 5685	0.9999872446060181	O
1417	changes	115 122	5686 5693	0.9999866485595703	O
1418	in	123 125	5694 5696	0.999988317489624	O
1419	addition	126 134	5697 5705	0.9999873638153076	O
1420	to	135 137	5706 5708	0.9999881982803345	O
1421	repair	138 144	5709 5715	0.9999810457229614	O
1422	deficiency	145 155	5716 5726	0.9999871253967285	O
1423	contribute	156 166	5727 5737	0.9999858140945435	O
1424	to	167 169	5738 5740	0.9999873638153076	O
1425	,	170 171	5741 5742	0.999983549118042	O
1426	or	172 174	5743 5745	0.9999657869338989	O
1427	are	175 178	5746 5749	0.9999861717224121	O
1428	responsible	179 190	5750 5761	0.9999858140945435	O
1429	for	191 194	5762 5765	0.9999866485595703	O
1430	,	195 196	5766 5767	0.9999860525131226	O
1431	Type	197 201	5768 5772	0.9999868869781494	O
1432	B	202 203	5773 5774	0.9999822378158569	O
1433	MSI	204 206	5775 5777	0.9999816417694092	O
1435	.	207 208	5778 5779	0.9999663829803467	O
1436	One	0 3	5780 5783	0.9999827146530151	O
1437	important	4 13	5784 5793	0.9999825954437256	O
1438	finding	14 21	5794 5801	0.999980092048645	O
1439	of	22 24	5802 5804	0.9999834299087524	O
1440	this	25 29	5805 5809	0.9999827146530151	O
1441	study	30 35	5810 5815	0.9999666213989258	O
1442	is	36 38	5816 5818	0.9999818801879883	O
1443	that	39 43	5819 5823	0.9999840259552002	O
1444	Type	44 48	5824 5828	0.9999828338623047	O
1445	A	49 50	5829 5830	0.9999779462814331	O
1446	instability	51 62	5831 5842	0.9999796152114868	O
1447	is	63 65	5843 5845	0.9999837875366211	O
1448	frequent	66 74	5846 5854	0.9999788999557495	O
1449	among	75 80	5855 5860	0.9999792575836182	O
1450	human	81 86	5861 5866	0.6551873683929443	O
1451	tumours	87 93	5867 5873	0.9999796152114868	O
1454	.	95 96	5875 5876	0.9999450445175171	O
1455	Type	0 4	5877 5881	0.9999850988388062	O
1456	A	5 6	5882 5883	0.9999814033508301	O
1457	MSI	7 9	5884 5886	0.9999821186065674	O
1459	predominated	11 22	5888 5899	0.9999843835830688	O
1462	in	24 26	5901 5903	0.999982476234436	O
1463	our	27 30	5904 5907	0.999953031539917	O
1464	large	31 36	5908 5913	0.9999699592590332	O
1465	panel	37 42	5914 5919	0.9999799728393555	O
1466	of	43 45	5920 5922	0.9999821186065674	O
1467	colorectal	46 55	5923 5932	0.999971866607666	O
1470	carcinomas	57 66	5934 5943	0.9999818801879883	O
1474	.	68 69	5945 5946	0.9999241828918457	O
1475	We	0 2	5947 5949	0.9999774694442749	O
1476	suggest	3 10	5950 5957	0.9999839067459106	O
1477	that	11 15	5958 5962	0.9999885559082031	O
1478	,	16 17	5963 5964	0.9999879598617554	O
1479	because	18 25	5965 5972	0.9999853372573853	O
1480	the	26 29	5973 5976	0.9999881982803345	O
1481	changes	30 37	5977 5984	0.999985933303833	O
1482	associated	38 48	5985 5995	0.9999885559082031	O
1483	with	49 53	5996 6000	0.9999887943267822	O
1484	Type	54 58	6001 6005	0.9999872446060181	O
1485	A	59 60	6006 6007	0.9999849796295166	O
1486	instability	61 72	6008 6019	0.9999850988388062	O
1487	are	73 76	6020 6023	0.9999877214431763	O
1488	more	77 81	6024 6028	0.9999864101409912	O
1489	subtle	82 88	6029 6035	0.9999862909317017	O
1490	,	89 90	6036 6037	0.9999874830245972	O
1491	the	91 94	6038 6041	0.9999886751174927	O
1492	frequency	95 104	6042 6051	0.9999873638153076	O
1493	of	105 107	6052 6054	0.9999886751174927	O
1494	MSI	108 110	6055 6057	0.9999867677688599	O
1496	among	112 117	6059 6064	0.9999841451644897	O
1497	colorectal	118 127	6065 6074	0.9999818801879883	O
1500	tumours	129 135	6076 6082	0.999987006187439	O
1503	may	137 140	6084 6087	0.9999865293502808	O
1504	have	141 145	6088 6092	0.999988317489624	O
1505	been	146 150	6093 6097	0.9999880790710449	O
1506	considerably	151 163	6098 6110	0.9999871253967285	O
1507	underestimated	164 177	6111 6124	0.9999868869781494	O
1510	.	179 180	6126 6127	0.9999734163284302	O
1511	Our	0 3	6128 6131	0.9999796152114868	O
1512	findings	4 12	6132 6140	0.999983549118042	O
1513	also	13 17	6141 6145	0.9999829530715942	O
1514	reveal	18 24	6146 6152	0.9999836683273315	O
1515	a	25 26	6153 6154	0.9999879598617554	O
1516	hitherto	27 34	6155 6162	0.9999831914901733	O
1519	unrecognized	36 47	6164 6175	0.9999867677688599	O
1524	association	49 60	6177 6188	0.999987006187439	O
1525	between	61 68	6189 6196	0.9999876022338867	O
1526	defective	69 77	6197 6205	0.9999873638153076	O
1528	MMR	79 81	6207 6209	0.9999866485595703	O
1530	and	83 86	6211 6214	0.9999873638153076	O
1531	p53	87 89	6215 6217	0.9999872446060181	O
1533	mutation	91 99	6219 6227	0.9999871253967285	O
1534	.	100 101	6228 6229	0.9999600648880005	O
1535	Significantly	0 12	6230 6242	0.999983549118042	O
1538	,	14 15	6244 6245	0.9999872446060181	O
1539	Type	16 20	6246 6250	0.999985933303833	O
1540	A	21 22	6251 6252	0.9999839067459106	O
1541	MSI	23 25	6253 6255	0.9999855756759644	O
1543	was	27 30	6257 6260	0.9999867677688599	O
1544	strongly	31 39	6261 6269	0.9999847412109375	O
1545	associated	40 50	6270 6280	0.9999881982803345	O
1546	with	51 55	6281 6285	0.9999881982803345	O
1547	p53	56 58	6286 6288	0.9999871253967285	O
1549	mutation	60 68	6290 6298	0.9999868869781494	O
1550	in	69 71	6299 6301	0.9999868869781494	O
1551	human	72 77	6302 6307	0.9983307719230652	O
1552	colorectal	78 87	6308 6317	0.9999808073043823	O
1555	tumours	89 95	6319 6325	0.9999860525131226	O
1558	.	97 98	6327 6328	0.9999603033065796	O
1559	Since	0 5	6329 6334	0.9999815225601196	O
1560	Type	6 10	6335 6339	0.9999850988388062	O
1561	A	11 12	6340 6341	0.999980092048645	O
1562	instability	13 24	6342 6353	0.9999819993972778	O
1563	is	25 27	6354 6356	0.9999878406524658	O
1564	unequivocally	28 40	6357 6369	0.9999884366989136	O
1568	associated	42 52	6371 6381	0.9999881982803345	O
1569	with	53 57	6382 6386	0.9999881982803345	O
1570	MMR	58 60	6387 6389	0.9999841451644897	O
1572	deficiency	62 72	6391 6401	0.9999852180480957	O
1573	,	73 74	6402 6403	0.9999855756759644	O
1574	this	75 79	6404 6408	0.9999880790710449	O
1575	novel	80 85	6409 6414	0.9999866485595703	O
1576	finding	86 93	6415 6422	0.9999866485595703	O
1577	implies	94 101	6423 6430	0.9999850988388062	O
1578	that	102 106	6431 6435	0.9999885559082031	O
1579	,	107 108	6436 6437	0.9999880790710449	O
1580	in	109 111	6438 6440	0.9999881982803345	O
1581	contrast	112 120	6441 6449	0.9999858140945435	O
1582	to	121 123	6450 6452	0.9999876022338867	O
1583	prevailing	124 134	6453 6463	0.9999836683273315	O
1584	opinion	135 142	6464 6471	0.9999850988388062	O
1585	,	143 144	6472 6473	0.9999880790710449	O
1586	p53	145 147	6474 6476	0.9999867677688599	O
1588	mutations	149 158	6478 6487	0.9999864101409912	O
1589	are	159 162	6488 6491	0.9999878406524658	O
1590	common	163 169	6492 6498	0.9999865293502808	O
1591	in	170 172	6499 6501	0.9999878406524658	O
1592	MMR	173 175	6502 6504	0.999983549118042	O
1594	-	176 177	6505 6506	0.999988317489624	O
1595	defective	177 185	6506 6514	0.9999833106994629	O
1597	tumours	187 193	6516 6522	0.9999864101409912	O
1600	,	195 196	6524 6525	0.9999849796295166	O
1601	at	197 199	6526 6528	0.9999868869781494	O
1602	least	200 205	6529 6534	0.9999802112579346	O
1603	in	206 208	6535 6537	0.9999861717224121	O
1604	human	209 214	6538 6543	0.9948892593383789	O
1605	colorectal	215 224	6544 6553	0.9999841451644897	O
1608	cancer	226 232	6555 6561	0.9999852180480957	O
1609	.	233 234	6562 6563	0.9999547004699707	O
1610	Established	0 11	6564 6575	0.9999798536300659	O
1611	guidelines	12 22	6576 6586	0.9999837875366211	O
1612	for	23 26	6587 6590	0.9999865293502808	O
1613	classification	27 41	6591 6605	0.9999849796295166	O
1614	of	42 44	6606 6608	0.9999873638153076	O
1615	MSI	45 47	6609 6611	0.9999761581420898	O
1617	utilize	49 56	6613 6620	0.9999802112579346	O
1618	the	57 60	6621 6624	0.9999881982803345	O
1619	frequency	61 70	6625 6634	0.9999878406524658	O
1620	of	71 73	6635 6637	0.9999885559082031	O
1621	changes	74 81	6638 6645	0.9999872446060181	O
1622	in	82 84	6646 6648	0.9999889135360718	O
1623	a	85 86	6649 6650	0.9999887943267822	O
1624	defined	87 94	6651 6658	0.9999867677688599	O
1625	set	95 98	6659 6662	0.9999884366989136	O
1626	of	99 101	6663 6665	0.9999887943267822	O
1627	microsatellite	102 115	6666 6679	0.999988317489624	O
1631	markers	117 124	6681 6688	0.999988317489624	O
1632	,	125 126	6689 6690	0.9999879598617554	O
1633	i	127 128	6691 6692	0.9999885559082031	O
1634	.	129 130	6693 6694	0.9999876022338867	O
1635	e	130 131	6694 6695	0.9999874830245972	O
1636	.	132 133	6696 6697	0.9999762773513794	O
1637	MSI	0 2	6698 6700	0.9999856948852539	O
1639	-	3 4	6701 6702	0.9999876022338867	O
1640	H	4 5	6702 6703	0.9999830722808838	O
1641	and	6 9	6704 6707	0.9999858140945435	O
1642	-	10 11	6708 6709	0.9999876022338867	O
1643	L	11 12	6709 6710	0.9999854564666748	O
1644	(	13 14	6711 6712	0.9999881982803345	O
1645	10	15 17	6713 6715	0.9999812841415405	O
1646	)	18 19	6716 6717	0.9999873638153076	O
1647	.	20 21	6718 6719	0.9999301433563232	O
1648	However	0 7	6720 6727	0.9999840259552002	O
1649	,	8 9	6728 6729	0.9999871253967285	O
1650	qualitative	10 20	6730 6740	0.9999887943267822	O
1653	differences	22 33	6742 6753	0.9999858140945435	O
1654	in	34 36	6754 6756	0.9999881982803345	O
1655	microsatellite	37 50	6757 6770	0.9999881982803345	O
1659	changes	52 59	6772 6779	0.9999868869781494	O
1660	are	60 63	6780 6783	0.9999861717224121	O
1661	not	64 67	6784 6787	0.9999864101409912	O
1662	widely	68 74	6788 6794	0.9999868869781494	O
1663	discussed	75 84	6795 6804	0.999985933303833	O
1664	.	85 86	6805 6806	0.9999396800994873	O
1665	In	0 2	6807 6809	0.9999871253967285	O
1666	one	3 6	6810 6813	0.9999876022338867	O
1667	of	7 9	6814 6816	0.9999873638153076	O
1668	the	10 13	6817 6820	0.9999877214431763	O
1669	earliest	14 22	6821 6829	0.9999855756759644	O
1670	report	23 29	6830 6836	0.9999840259552002	O
1671	of	30 32	6837 6839	0.9999868869781494	O
1672	the	33 36	6840 6843	0.9999872446060181	O
1673	MSI	37 39	6844 6846	0.9999817609786987	O
1675	phenomenon	41 51	6848 6858	0.9999849796295166	O
1676	,	52 53	6859 6860	0.9999873638153076	O
1677	however	54 61	6861 6868	0.9999858140945435	O
1678	,	62 63	6869 6870	0.9999864101409912	O
1679	Thibodeau	64 72	6871 6879	0.9999865293502808	O
1684	et	74 76	6881 6883	0.999987006187439	O
1685	al	77 79	6884 6886	0.9999862909317017	O
1686	.	80 81	6887 6888	0.9999722242355347	O
1687	divided	0 7	6889 6896	0.9999849796295166	O
1688	microsatellite	8 21	6897 6910	0.9999877214431763	O
1692	changes	23 30	6912 6919	0.9999876022338867	O
1693	into	31 35	6920 6924	0.9999886751174927	O
1694	two	36 39	6925 6928	0.999987006187439	O
1695	categories	40 50	6929 6939	0.9999876022338867	O
1696	;	51 52	6940 6941	0.9999879598617554	O
1697	Type	53 57	6942 6946	0.9999884366989136	O
1698	I	58 59	6947 6948	0.9999886751174927	O
1699	and	60 63	6949 6952	0.9999878406524658	O
1700	II	64 66	6953 6955	0.999982476234436	O
1701	mutations	67 76	6956 6965	0.9999856948852539	O
1702	(	77 78	6966 6967	0.9999895095825195	O
1703	3	79 80	6968 6969	0.9999872446060181	O
1704	)	81 82	6970 6971	0.9999895095825195	O
1705	.	83 84	6972 6973	0.9999780654907227	O
1706	The	0 3	6974 6977	0.9999884366989136	O
1707	former	4 10	6978 6984	0.9999864101409912	O
1708	was	11 14	6985 6988	0.9999879598617554	O
1709	defined	15 22	6989 6996	0.9999841451644897	O
1710	a	23 24	6997 6998	0.9999891519546509	O
1711	‘	25 26	6999 7000	0.9999852180480957	O
1712	significant	26 37	7000 7011	0.9999874830245972	O
1713	increase	38 46	7012 7020	0.9999873638153076	O
1714	(	47 48	7021 7022	0.9999891519546509	O
1715	expansion	49 58	7023 7032	0.9999865293502808	O
1716	)	59 60	7033 7034	0.9999891519546509	O
1717	or	61 63	7035 7037	0.9999884366989136	O
1718	decrease	64 72	7038 7046	0.9999858140945435	O
1719	(	73 74	7047 7048	0.9999891519546509	O
1720	deletion	75 82	7049 7056	0.9999885559082031	O
1723	)	84 85	7058 7059	0.99998939037323	O
1724	in	86 88	7060 7062	0.9999891519546509	O
1725	the	89 92	7063 7066	0.9999895095825195	O
1726	apparent	93 101	7067 7075	0.9999889135360718	O
1727	fragment	102 110	7076 7084	0.9999876022338867	O
1728	size	111 115	7085 7089	0.9999886751174927	O
1729	’	116 117	7090 7091	0.9999808073043823	O
1730	and	118 121	7092 7095	0.9999873638153076	O
1731	the	122 125	7096 7099	0.9999880790710449	O
1732	latter	126 132	7100 7106	0.9999830722808838	O
1733	as	133 135	7107 7109	0.9999886751174927	O
1734	a	136 137	7110 7111	0.99998939037323	O
1735	‘	138 139	7112 7113	0.9999885559082031	O
1736	single	139 145	7113 7119	0.9999887943267822	O
1737	2	146 147	7120 7121	0.9999877214431763	O
1738	bp	148 149	7122 7123	0.9999885559082031	O
1740	change	151 157	7125 7131	0.9999889135360718	O
1741	’	157 158	7131 7132	0.9999856948852539	O
1742	.	159 160	7133 7134	0.9999734163284302	O
1743	This	0 4	7135 7139	0.9999731779098511	O
1744	distinction	5 16	7140 7151	0.9999314546585083	O
1745	has	17 20	7152 7155	0.9999772310256958	O
1746	received	21 29	7156 7164	0.9999765157699585	O
1747	little	30 36	7165 7171	0.9999704360961914	O
1748	attention	37 46	7172 7181	0.9999657869338989	O
1749	since	47 52	7182 7187	0.9999784231185913	O
1750	then	53 57	7188 7192	0.9999785423278809	O
1751	.	58 59	7193 7194	0.9998902082443237	O
1752	Our	0 3	7195 7198	0.9999829530715942	O
1753	data	4 8	7199 7203	0.9999839067459106	O
1754	indicate	9 17	7204 7212	0.9999837875366211	O
1755	that	18 22	7213 7217	0.9999885559082031	O
1756	Type	23 27	7218 7222	0.9999880790710449	O
1757	A	28 29	7223 7224	0.9999839067459106	O
1758	MSI	30 32	7225 7227	0.9999850988388062	O
1760	,	34 35	7229 7230	0.9999886751174927	O
1761	which	36 41	7231 7236	0.9999889135360718	O
1762	appears	42 49	7237 7244	0.9999881982803345	O
1763	similar	50 57	7245 7252	0.9999867677688599	O
1764	to	58 60	7253 7255	0.9999887943267822	O
1765	their	61 66	7256 7261	0.9999871253967285	O
1766	Type	67 71	7262 7266	0.9999885559082031	O
1767	II	72 74	7267 7269	0.9999845027923584	O
1768	mutation	75 83	7270 7278	0.9999864101409912	O
1769	,	84 85	7279 7280	0.9999872446060181	O
1770	is	86 88	7281 7283	0.9999880790710449	O
1771	more	89 93	7284 7288	0.9999873638153076	O
1772	frequent	94 102	7289 7297	0.9999871253967285	O
1773	than	103 107	7298 7302	0.9999876022338867	O
1774	hitherto	108 115	7303 7310	0.9999865293502808	O
1777	suspected	117 126	7312 7321	0.9999860525131226	O
1778	,	127 128	7322 7323	0.999984860420227	O
1779	and	129 132	7324 7327	0.9999854564666748	O
1780	suggest	133 140	7328 7335	0.9999836683273315	O
1781	that	141 145	7336 7340	0.9999885559082031	O
1782	it	146 148	7341 7343	0.999988317489624	O
1783	represents	149 159	7344 7354	0.9999867677688599	O
1784	the	160 163	7355 7358	0.9999880790710449	O
1785	bona	164 167	7359 7362	0.9999885559082031	O
1787	fide	169 172	7364 7367	0.9999880790710449	O
1789	MMR	174 176	7369 7371	0.9999864101409912	O
1791	-	177 178	7372 7373	0.9999890327453613	O
1792	deficient	178 186	7373 7381	0.9999878406524658	O
1794	phenotype	188 196	7383 7391	0.9999885559082031	O
1797	.	198 199	7393 7394	0.9999573230743408	O
1798	On	0 2	7395 7397	0.9999874830245972	O
1799	the	3 6	7398 7401	0.9999878406524658	O
1800	other	7 12	7402 7407	0.9999872446060181	O
1801	hand	13 17	7408 7412	0.9999877214431763	O
1802	,	18 19	7413 7414	0.999988317489624	O
1803	Type	20 24	7415 7419	0.9999880790710449	O
1804	I	25 26	7420 7421	0.9999867677688599	O
1805	mutations	27 36	7422 7431	0.9999862909317017	O
1806	may	37 40	7432 7435	0.9999874830245972	O
1807	correspond	41 51	7436 7446	0.9999877214431763	O
1808	to	52 54	7447 7449	0.9999887943267822	O
1809	our	55 58	7450 7453	0.999980092048645	O
1810	Type	59 63	7454 7458	0.9999880790710449	O
1811	B	64 65	7459 7460	0.9999864101409912	O
1812	instability	66 77	7461 7472	0.9999862909317017	O
1813	.	78 79	7473 7474	0.999971866607666	O
1814	The	0 3	7475 7478	0.9999858140945435	O
1815	problem	4 11	7479 7486	0.999982476234436	O
1816	is	12 14	7487 7489	0.9999854564666748	O
1817	that	15 19	7490 7494	0.999987006187439	O
1818	mutations	20 29	7495 7504	0.9999845027923584	O
1819	in	30 32	7505 7507	0.9999879598617554	O
1820	MMR	33 35	7508 7510	0.9999840259552002	O
1822	genes	37 42	7512 7517	0.9999866485595703	O
1823	have	43 47	7518 7522	0.9999873638153076	O
1824	been	48 52	7523 7527	0.9999878406524658	O
1825	reported	53 61	7528 7536	0.9999853372573853	O
1826	in	62 64	7537 7539	0.9999862909317017	O
1827	tumours	65 71	7540 7546	0.999984622001648	O
1830	displaying	73 83	7548 7558	0.9999808073043823	O
1831	this	84 88	7559 7563	0.9999860525131226	O
1832	type	89 93	7564 7568	0.9999864101409912	O
1833	of	94 96	7569 7571	0.999987006187439	O
1834	instability	97 108	7572 7583	0.9999828338623047	O
1835	.	109 110	7584 7585	0.9999593496322632	O
1836	More	0 4	7586 7590	0.999987006187439	O
1837	than	5 9	7591 7595	0.9999878406524658	O
1838	90	10 12	7596 7598	0.9999773502349854	O
1839	%	13 14	7599 7600	0.9999868869781494	O
1840	of	15 17	7601 7603	0.9999856948852539	O
1841	HNPCC	18 22	7604 7608	0.9999436140060425	O
1844	tumours	24 30	7610 7616	0.9999858140945435	O
1847	are	32 35	7618 7621	0.9999881982803345	O
1848	MSI	36 38	7622 7624	0.9999866485595703	O
1850	+	39 40	7625 7626	0.9999884366989136	O
1851	(	41 42	7627 7628	0.9999896287918091	O
1852	20	43 45	7629 7631	0.9999866485595703	O
1853	)	46 47	7632 7633	0.9999895095825195	O
1854	,	48 49	7634 7635	0.9999872446060181	O
1855	and	50 53	7636 7639	0.9999876022338867	O
1856	this	54 58	7640 7644	0.9999889135360718	O
1857	type	59 63	7645 7649	0.9999887943267822	O
1858	of	64 66	7650 7652	0.9999889135360718	O
1859	MSI	67 69	7653 7655	0.9999868869781494	O
1861	can	71 74	7657 7660	0.9999880790710449	O
1862	be	75 77	7661 7663	0.9999891519546509	O
1863	categorized	78 89	7664 7675	0.9999886751174927	O
1864	as	90 92	7676 7678	0.9999890327453613	O
1865	Type	93 97	7679 7683	0.9999884366989136	O
1866	B	98 99	7684 7685	0.9999879598617554	O
1867	/	99 100	7685 7686	0.9999889135360718	O
1868	Type	100 104	7686 7690	0.999988317489624	O
1869	I	105 106	7691 7692	0.9999886751174927	O
1870	(	107 108	7693 7694	0.9999896287918091	O
1871	2	109 110	7695 7696	0.9999878406524658	O
1872	–	110 111	7696 7697	0.9999867677688599	O
1873	4	111 112	7697 7698	0.9999877214431763	O
1874	,	112 113	7698 7699	0.9999886751174927	O
1875	20	113 115	7699 7701	0.9999878406524658	O
1876	–	115 116	7701 7702	0.9999876022338867	O
1877	22	116 118	7702 7704	0.9999878406524658	O
1878	)	119 120	7705 7706	0.9999892711639404	O
1879	.	121 122	7707 7708	0.9999743700027466	O
1880	However	0 7	7709 7716	0.9999867677688599	O
1881	,	8 9	7717 7718	0.9999889135360718	O
1882	the	10 13	7719 7722	0.9999889135360718	O
1883	frequencies	14 25	7723 7734	0.9999856948852539	O
1884	of	26 28	7735 7737	0.9999886751174927	O
1885	mutation	29 37	7738 7746	0.9999858140945435	O
1886	in	38 40	7747 7749	0.9999884366989136	O
1887	the	41 44	7750 7753	0.9999890327453613	O
1888	two	45 48	7754 7757	0.9999862909317017	O
1889	major	49 54	7758 7763	0.9999856948852539	O
1890	MMR	55 57	7764 7766	0.9999843835830688	O
1892	genes	59 64	7768 7773	0.9999880790710449	O
1893	,	65 66	7774 7775	0.9999886751174927	O
1894	hMSH2	67 71	7776 7780	0.9999887943267822	O
1898	and	73 76	7782 7785	0.9999884366989136	O
1899	hMLH1	77 81	7786 7790	0.9999884366989136	O
1902	,	83 84	7792 7793	0.999987006187439	O
1903	in	85 87	7794 7796	0.9999892711639404	O
1904	HNPCC	88 92	7797 7801	0.9999854564666748	O
1907	kindred	94 100	7803 7809	0.9999881982803345	O
1909	are	102 105	7811 7814	0.9999886751174927	O
1910	not	106 109	7815 7818	0.9999886751174927	O
1911	high	110 114	7819 7823	0.999988317489624	O
1912	in	115 117	7824 7826	0.99998939037323	O
1913	some	118 122	7827 7831	0.9999884366989136	O
1914	reports	123 130	7832 7839	0.9999862909317017	O
1915	(	131 132	7840 7841	0.9999897480010986	O
1916	35	133 135	7842 7844	0.9999886751174927	O
1917	–	135 136	7844 7845	0.9999856948852539	O
1918	40	136 138	7845 7847	0.9999872446060181	O
1919	)	139 140	7848 7849	0.9999896287918091	O
1920	.	141 142	7850 7851	0.9999797344207764	O
1921	Among	0 5	7852 7857	0.9999860525131226	O
1922	the	6 9	7858 7861	0.9999871253967285	O
1923	panel	10 15	7862 7867	0.9999803304672241	O
1924	of	16 18	7868 7870	0.9999858140945435	O
1925	tumours	19 25	7871 7877	0.999983549118042	O
1928	displaying	27 37	7879 7889	0.9999845027923584	O
1929	Type	38 42	7890 7894	0.9999865293502808	O
1930	B	43 44	7895 7896	0.9999841451644897	O
1931	MSI	45 47	7897 7899	0.999987006187439	O
1933	,	49 50	7901 7902	0.9999874830245972	O
1934	we	51 53	7903 7905	0.9999862909317017	O
1935	found	54 59	7906 7911	0.9999887943267822	O
1936	a	60 61	7912 7913	0.9999891519546509	O
1937	base	62 66	7914 7918	0.9999884366989136	O
1938	substitution	67 79	7919 7931	0.9999880790710449	O
1939	mutation	80 88	7932 7940	0.9999881982803345	O
1940	in	89 91	7941 7943	0.9999890327453613	O
1941	hMLH1	92 96	7944 7948	0.9999890327453613	O
1944	and	98 101	7950 7953	0.9999880790710449	O
1945	one	102 105	7954 7957	0.9999855756759644	O
1946	case	106 110	7958 7962	0.9999878406524658	O
1947	with	111 115	7963 7967	0.9999886751174927	O
1948	a	116 117	7968 7969	0.9999891519546509	O
1949	possible	118 126	7970 7978	0.9999886751174927	O
1950	hMLH1	127 131	7979 7983	0.9999887943267822	O
1953	silencing	133 141	7985 7993	0.9999890327453613	O
1956	.	143 144	7995 7996	0.9999773502349854	O
1957	This	0 4	7997 8001	0.9999877214431763	O
1958	incidence	5 14	8002 8011	0.9999868869781494	O
1959	of	15 17	8012 8014	0.9999891519546509	O
1960	MMR	18 20	8015 8017	0.9999856948852539	O
1962	gene	22 26	8019 8023	0.9999879598617554	O
1963	inactivation	27 38	8024 8035	0.9999892711639404	O
1966	in	40 42	8037 8039	0.9999895095825195	O
1967	the	43 46	8040 8043	0.9999892711639404	O
1968	Type	47 51	8044 8048	0.9999880790710449	O
1969	B	52 53	8049 8050	0.9999868869781494	O
1970	group	54 59	8051 8056	0.9999889135360718	O
1971	is	60 62	8057 8059	0.9999884366989136	O
1972	not	63 66	8060 8063	0.9999887943267822	O
1973	unduly	67 72	8064 8069	0.9999892711639404	O
1976	low	74 77	8071 8074	0.9999879598617554	O
1977	,	78 79	8075 8076	0.9999876022338867	O
1978	compared	80 88	8077 8085	0.9999884366989136	O
1979	with	89 93	8086 8090	0.9999887943267822	O
1980	the	94 97	8091 8094	0.9999889135360718	O
1981	reported	98 106	8095 8103	0.9999868869781494	O
1982	frequencies	107 118	8104 8115	0.9999878406524658	O
1983	in	119 121	8116 8118	0.9999886751174927	O
1984	the	122 125	8119 8122	0.9999886751174927	O
1985	literature	126 136	8123 8133	0.999984860420227	O
1986	(	137 138	8134 8135	0.9999897480010986	O
1987	25	139 141	8136 8138	0.9999886751174927	O
1988	,	141 142	8138 8139	0.9999890327453613	O
1989	36	142 144	8139 8141	0.9999887943267822	O
1990	,	144 145	8141 8142	0.9999891519546509	O
1991	41	145 147	8142 8144	0.9999886751174927	O
1992	–	147 148	8144 8145	0.999984622001648	O
1993	43	148 150	8145 8147	0.9999874830245972	O
1994	)	151 152	8148 8149	0.9999896287918091	O
1995	.	153 154	8150 8151	0.9999786615371704	O
1996	The	0 3	8152 8155	0.9999876022338867	O
1997	relationship	4 16	8156 8168	0.9999862909317017	O
1998	between	17 24	8169 8176	0.9999884366989136	O
1999	Type	25 29	8177 8181	0.9999876022338867	O
2000	B	30 31	8182 8183	0.9999833106994629	O
2001	MSI	32 34	8184 8186	0.999985933303833	O
2003	and	36 39	8188 8191	0.9999877214431763	O
2004	defective	40 48	8192 8200	0.9999858140945435	O
2006	MMR	50 52	8202 8204	0.9999867677688599	O
2008	is	54 56	8206 8208	0.9999880790710449	O
2009	probably	57 65	8209 8217	0.9999881982803345	O
2010	more	66 70	8218 8222	0.9999880790710449	O
2011	complex	71 78	8223 8230	0.9999871253967285	O
2012	than	79 83	8231 8235	0.9999872446060181	O
2013	hitherto	84 91	8236 8243	0.9999862909317017	O
2016	suspected	93 102	8245 8254	0.9999871253967285	O
2017	.	103 104	8255 8256	0.9999891519546509	O
2018	*	105 106	8257 8258	0.9999878406524658	O
2019	*	106 107	8258 8259	0.9999833106994629	O
2020	IGNORE	0 5	8260 8265	0.9999861717224121	O
2023	LINE	7 10	8267 8270	0.9999886751174927	O
2026	*	12 13	8272 8273	0.9999891519546509	O
2027	*	13 14	8273 8274	0.9999891519546509	O
2028	*	15 16	8275 8276	0.9999891519546509	O
2029	*	16 17	8276 8277	0.9999891519546509	O
2030	IGNORE	18 23	8278 8283	0.9999878406524658	O
2033	LINE	25 28	8285 8288	0.9999892711639404	O
2036	*	30 31	8290 8291	0.9999889135360718	O
2037	*	31 32	8291 8292	0.9999889135360718	O
2038	*	33 34	8293 8294	0.9999889135360718	O
2039	*	34 35	8294 8295	0.9999890327453613	O
2040	IGNORE	36 41	8296 8301	0.9999877214431763	O
2043	LINE	43 46	8303 8306	0.9999891519546509	O
2046	*	48 49	8308 8309	0.9999890327453613	O
2047	*	49 50	8309 8310	0.9999890327453613	O
2048	Background	51 61	8311 8321	0.9999855756759644	O
2049	Cancer	62 68	8322 8328	0.9999860525131226	O
2050	is	69 71	8329 8331	0.9999887943267822	O
2051	thought	72 79	8332 8339	0.999987006187439	O
2052	to	80 82	8340 8342	0.9999890327453613	O
2053	arise	83 88	8343 8348	0.9999890327453613	O
2054	through	89 96	8349 8356	0.9999876022338867	O
2055	a	97 98	8357 8358	0.9999892711639404	O
2056	multistep	99 107	8359 8367	0.9999879598617554	O
2059	process	109 116	8369 8376	0.9999880790710449	O
2060	involving	117 126	8377 8386	0.9999891519546509	O
2061	sequential	127 136	8387 8396	0.9999892711639404	O
2063	cycles	138 144	8398 8404	0.9999879598617554	O
2064	of	145 147	8405 8407	0.9999891519546509	O
2065	mutation	148 156	8408 8416	0.9999858140945435	O
2066	and	157 160	8417 8420	0.9999881982803345	O
2067	selection	161 170	8421 8430	0.9999845027923584	O
2068	[	171 172	8431 8432	0.99998939037323	O
2069	1	172 173	8432 8433	0.9999872446060181	O
2070	]	173 174	8433 8434	0.9999889135360718	O
2071	.	175 176	8435 8436	0.9999781847000122	O
2072	The	0 3	8437 8440	0.9999862909317017	O
2073	identities	4 14	8441 8451	0.999984622001648	O
2074	and	15 18	8452 8455	0.9999858140945435	O
2075	numbers	19 26	8456 8463	0.9999836683273315	O
2076	of	27 29	8464 8466	0.9999867677688599	O
2077	mutations	30 39	8467 8476	0.9999688863754272	O
2078	required	40 48	8477 8485	0.9999845027923584	O
2079	for	49 52	8486 8489	0.9999860525131226	O
2080	transformation	53 67	8490 8504	0.9999701976776123	O
2081	are	68 71	8505 8508	0.9999847412109375	O
2082	uncertain	72 81	8509 8518	0.9999843835830688	O
2083	,	82 83	8519 8520	0.9999847412109375	O
2084	but	84 87	8521 8524	0.9999829530715942	O
2085	perhaps	88 95	8525 8532	0.9999842643737793	O
2086	six	96 99	8533 8536	0.999969482421875	O
2087	general	100 107	8537 8544	0.9999748468399048	O
2088	cellular	108 116	8545 8553	0.9999561309814453	O
2089	functions	117 126	8554 8563	0.9999746084213257	O
2090	are	127 130	8564 8567	0.9999864101409912	O
2091	typically	131 140	8568 8577	0.9999834299087524	O
2092	altered	141 148	8578 8585	0.9999809265136719	O
2093	[	149 150	8586 8587	0.9999880790710449	O
2094	2	150 151	8587 8588	0.9999823570251465	O
2095	]	151 152	8588 8589	0.9999873638153076	O
2096	.	153 154	8590 8591	0.9999725818634033	O
2097	Numbers	0 7	8592 8599	0.9999808073043823	O
2098	of	8 10	8600 8602	0.999987006187439	O
2099	oncogenic	11 19	8603 8611	0.9999843835830688	O
2102	mutations	21 30	8613 8622	0.9999822378158569	O
2103	may	31 34	8623 8626	0.9999805688858032	O
2104	also	35 39	8627 8631	0.999983549118042	O
2105	be	40 42	8632 8634	0.9999868869781494	O
2106	inferred	43 50	8635 8642	0.9999878406524658	O
2108	from	52 56	8644 8648	0.9999866485595703	O
2109	the	57 60	8649 8652	0.9999877214431763	O
2110	age	61 64	8653 8656	0.9999814033508301	O
2111	-	64 65	8656 8657	0.9999884366989136	O
2112	related	65 72	8657 8664	0.9999866485595703	O
2113	increases	73 82	8665 8674	0.9999845027923584	O
2114	in	83 85	8675 8677	0.9999874830245972	O
2115	frequencies	86 97	8678 8689	0.999984860420227	O
2116	observed	98 106	8690 8698	0.999984860420227	O
2117	with	107 111	8699 8703	0.9999809265136719	O
2118	many	112 116	8704 8708	0.9999792575836182	O
2119	cancer	117 123	8709 8715	0.9999810457229614	O
2120	types	124 129	8716 8721	0.9999837875366211	O
2121	.	130 131	8722 8723	0.9999570846557617	O
2122	For	0 3	8724 8727	0.9999847412109375	O
2123	example	4 11	8728 8735	0.9999843835830688	O
2124	,	12 13	8736 8737	0.9999880790710449	O
2125	logarithms	14 23	8738 8747	0.9999874830245972	O
2129	of	25 27	8749 8751	0.9999878406524658	O
2130	cancer	28 34	8752 8758	0.9999839067459106	O
2131	frequencies	35 46	8759 8770	0.9999867677688599	O
2132	versus	47 53	8771 8777	0.9999876022338867	O
2133	age	54 57	8778 8781	0.9999845027923584	O
2134	typically	58 67	8782 8791	0.9999854564666748	O
2135	yield	68 73	8792 8797	0.9999879598617554	O
2136	straight	74 82	8798 8806	0.9999876022338867	O
2137	lines	83 88	8807 8812	0.999988317489624	O
2138	,	89 90	8813 8814	0.9999877214431763	O
2139	with	91 95	8815 8819	0.9999884366989136	O
2140	slopes	96 102	8820 8826	0.9999802112579346	O
2141	proportional	103 115	8827 8839	0.9999879598617554	O
2142	to	116 118	8840 8842	0.9999890327453613	O
2143	numbers	119 126	8843 8850	0.9999878406524658	O
2144	of	127 129	8851 8853	0.999988317489624	O
2145	cancer	130 136	8854 8860	0.9999840259552002	O
2146	mutations	137 146	8861 8870	0.9999861717224121	O
2147	[	147 148	8871 8872	0.9999891519546509	O
2148	3	148 149	8872 8873	0.9999867677688599	O
2149	]	149 150	8873 8874	0.9999887943267822	O
2150	.	151 152	8875 8876	0.9999804496765137	O
2151	Colorectal	0 9	8877 8886	0.9999793767929077	O
2154	cancer	11 17	8888 8894	0.9999836683273315	O
2155	epidemiology	18 29	8895 8906	0.9999884366989136	O
2159	is	31 33	8908 8910	0.9999861717224121	O
2160	consistent	34 44	8911 8921	0.9999865293502808	O
2161	with	45 49	8922 8926	0.9999884366989136	O
2162	approximately	50 63	8927 8940	0.9999881982803345	O
2163	five	64 68	8941 8945	0.999988317489624	O
2164	to	69 71	8946 8948	0.9999884366989136	O
2165	seven	72 77	8949 8954	0.9999867677688599	O
2166	oncogenic	78 86	8955 8963	0.9999872446060181	O
2169	mutations	88 97	8965 8974	0.9999860525131226	O
2170	before	98 104	8975 8981	0.999984860420227	O
2171	transformation	105 119	8982 8996	0.9999858140945435	O
2172	[	120 121	8997 8998	0.9999895095825195	O
2173	3	121 122	8998 8999	0.9999885559082031	O
2174	-	122 123	8999 9000	0.9999892711639404	O
2175	6	123 124	9000 9001	0.999988317489624	O
2176	]	124 125	9001 9002	0.9999890327453613	O
2177	.	126 127	9003 9004	0.9999735355377197	O
2178	The	0 3	9005 9008	0.9999836683273315	O
2179	variability	4 14	9009 9019	0.9999864101409912	O
2181	in	16 18	9021 9023	0.9999860525131226	O
2182	estimated	19 28	9024 9033	0.999983549118042	O
2183	numbers	29 36	9034 9041	0.9999860525131226	O
2184	of	37 39	9042 9044	0.9999871253967285	O
2185	mutations	40 49	9045 9054	0.9999810457229614	O
2186	may	50 53	9055 9058	0.9999761581420898	O
2187	reflect	54 61	9059 9066	0.9999831914901733	O
2188	a	62 63	9067 9068	0.9999866485595703	O
2189	number	64 70	9069 9075	0.9999843835830688	O
2190	of	71 73	9076 9078	0.9999860525131226	O
2191	differences	74 85	9079 9090	0.9999818801879883	O
2192	.	86 87	9091 9092	0.9999442100524902	O
2193	For	0 3	9093 9096	0.9999845027923584	O
2194	example	4 11	9097 9104	0.9999834299087524	O
2195	,	12 13	9105 9106	0.9999874830245972	O
2196	estimates	14 23	9107 9116	0.9999724626541138	O
2197	vary	24 28	9117 9121	0.9999847412109375	O
2198	between	29 36	9122 9129	0.999983549118042	O
2199	populations	37 48	9130 9141	0.9999219179153442	O
2200	,	49 50	9142 9143	0.9999856948852539	O
2201	with	51 55	9144 9148	0.9999876022338867	O
2202	five	56 60	9149 9153	0.9999879598617554	O
2203	to	61 63	9154 9156	0.9999886751174927	O
2204	six	64 67	9157 9160	0.9999880790710449	O
2205	mutations	68 77	9161 9170	0.9999868869781494	O
2206	in	78 80	9171 9173	0.9999886751174927	O
2207	England	81 88	9174 9181	0.9998772144317627	O
2208	and	89 92	9182 9185	0.9999880790710449	O
2209	six	93 96	9186 9189	0.9999881982803345	O
2210	to	97 99	9190 9192	0.9999885559082031	O
2211	seven	100 105	9193 9198	0.9999874830245972	O
2212	mutations	106 115	9199 9208	0.9999878406524658	O
2213	in	116 118	9209 9211	0.9999880790710449	O
2214	Finland	119 126	9212 9219	0.9992325305938721	O
2215	[	127 128	9220 9221	0.9999889135360718	O
2216	4	128 129	9221 9222	0.9999861717224121	O
2217	]	129 130	9222 9223	0.9999884366989136	O
2218	.	131 132	9224 9225	0.9999747276306152	O
2219	Recent	0 6	9226 9232	0.9999802112579346	O
2220	advances	7 15	9233 9241	0.999983549118042	O
2221	in	16 18	9242 9244	0.9999858140945435	O
2222	cancer	19 25	9245 9251	0.9999825954437256	O
2223	genetics	26 34	9252 9260	0.9999815225601196	O
2224	also	35 39	9261 9265	0.9999791383743286	O
2225	reveal	40 46	9266 9272	0.999980092048645	O
2226	biologic	47 54	9273 9280	0.9999798536300659	O
2229	colorectal	56 65	9282 9291	0.9999816417694092	O
2232	cancer	67 73	9293 9299	0.9999834299087524	O
2233	heterogeneity	74 86	9300 9312	0.9999871253967285	O
2237	.	88 89	9314 9315	0.9999228715896606	O
2238	Approximately	0 13	9316 9329	0.999984622001648	O
2239	5	14 15	9330 9331	0.9999797344207764	O
2240	%	16 17	9332 9333	0.999983549118042	O
2241	of	18 20	9334 9336	0.9999834299087524	O
2242	all	21 24	9337 9340	0.999972939491272	O
2243	colorectal	25 34	9341 9350	0.9999784231185913	O
2246	cancers	36 42	9352 9358	0.9999831914901733	O
2248	have	44 48	9360 9364	0.9999853372573853	O
2249	strong	49 55	9365 9371	0.9999673366546631	O
2250	familial	56 63	9372 9379	0.9999878406524658	O
2253	predispositions	65 79	9381 9395	0.9999884366989136	O
2257	and	81 84	9397 9400	0.9999834299087524	O
2258	arise	85 90	9401 9406	0.9999850988388062	O
2259	in	91 93	9407 9409	0.9999880790710449	O
2260	individuals	94 105	9410 9421	0.9999669790267944	O
2261	with	106 110	9422 9426	0.999988317489624	O
2262	germline	111 118	9427 9434	0.9999879598617554	O
2266	mutations	120 129	9436 9445	0.9999871253967285	O
2267	in	130 132	9446 9448	0.9999889135360718	O
2268	critical	133 141	9449 9457	0.9999876022338867	O
2269	susceptibility	142 155	9458 9471	0.9999881982803345	O
2274	loci	157 160	9473 9476	0.9999887943267822	O
2276	[	162 163	9478 9479	0.9999889135360718	O
2277	7	163 164	9479 9480	0.9999871253967285	O
2278	]	164 165	9480 9481	0.9999880790710449	O
2279	.	166 167	9482 9483	0.9999743700027466	O
2280	Such	0 4	9484 9488	0.9999696016311646	O
2281	hereditary	5 15	9489 9499	0.9997363686561584	O
2282	cancers	16 22	9500 9506	0.9999809265136719	O
2284	(	24 25	9508 9509	0.9999850988388062	O
2285	familial	26 33	9510 9517	0.9999068975448608	O
2288	adenomatous	35 45	9519 9529	0.9999819993972778	O
2292	polyposis	47 55	9531 9539	0.999984860420227	O
2296	(	57 58	9541 9542	0.9999879598617554	O
2297	FAP	59 61	9543 9545	0.9999574422836304	O
2299	)	63 64	9547 9548	0.9999877214431763	O
2300	and	65 68	9549 9552	0.9999843835830688	O
2301	hereditary	69 79	9553 9563	0.999870777130127	O
2302	nonpolyposis	80 91	9564 9575	0.9999697208404541	O
2307	colorectal	93 102	9577 9586	0.9999845027923584	O
2310	cancer	104 110	9588 9594	0.9999864101409912	O
2311	(	111 112	9595 9596	0.9999879598617554	O
2312	HNPCC	113 117	9597 9601	0.9999614953994751	O
2315	)	118 119	9602 9603	0.9999871253967285	O
2316	)	120 121	9604 9605	0.9999825954437256	O
2317	typically	122 131	9606 9615	0.9999825954437256	O
2318	present	132 139	9616 9623	0.9999836683273315	O
2319	at	140 142	9624 9626	0.9999874830245972	O
2320	younger	143 150	9627 9634	0.9999823570251465	O
2321	ages	151 155	9635 9639	0.9999853372573853	O
2322	and	156 159	9640 9643	0.999985933303833	O
2323	should	160 166	9644 9650	0.9999803304672241	O
2324	require	167 174	9651 9658	0.9999867677688599	O
2325	fewer	175 180	9659 9664	0.9999852180480957	O
2326	somatic	181 187	9665 9671	0.9999865293502808	O
2328	mutations	189 198	9673 9682	0.999985933303833	O
2329	than	199 203	9683 9687	0.9999866485595703	O
2330	their	204 209	9688 9693	0.9999864101409912	O
2331	sporadic	210 217	9694 9701	0.9999834299087524	O
2333	counterparts	219 231	9703 9715	0.9999830722808838	O
2334	because	232 239	9716 9723	0.9999845027923584	O
2335	one	240 243	9724 9727	0.9999856948852539	O
2336	mutation	244 252	9728 9736	0.9999849796295166	O
2337	is	253 255	9737 9739	0.9999868869781494	O
2338	inherited	256 265	9740 9749	0.9999810457229614	O
2339	.	266 267	9750 9751	0.9999563694000244	O
2340	Genetic	0 6	9752 9758	0.999984860420227	O
2342	instability	8 19	9760 9771	0.9999837875366211	O
2343	also	20 24	9772 9776	0.9999845027923584	O
2344	divides	25 32	9777 9784	0.9999860525131226	O
2345	colorectal	33 42	9785 9794	0.9999828338623047	O
2348	cancers	44 50	9796 9802	0.9999840259552002	O
2350	into	52 56	9804 9808	0.9999873638153076	O
2351	two	57 60	9809 9812	0.9999836683273315	O
2352	groups	61 67	9813 9819	0.9999862909317017	O
2353	[	68 69	9820 9821	0.9999886751174927	O
2354	8	69 70	9821 9822	0.9999849796295166	O
2355	]	70 71	9822 9823	0.9999880790710449	O
2356	.	72 73	9824 9825	0.9999722242355347	O
2357	Approximately	0 13	9826 9839	0.9999834299087524	O
2358	10	14 16	9840 9842	0.9999783039093018	O
2359	to	17 19	9843 9845	0.9999819993972778	O
2360	15	20 22	9846 9848	0.999961256980896	O
2361	%	23 24	9849 9850	0.9999830722808838	O
2362	of	25 27	9851 9853	0.9999818801879883	O
2363	sporadic	28 35	9854 9861	0.9999048709869385	O
2365	cancers	37 43	9863 9869	0.9999786615371704	O
2367	exhibit	45 52	9871 9878	0.9999834299087524	O
2368	microsatellite	53 66	9879 9892	0.9999865293502808	O
2372	instability	68 79	9894 9905	0.9999874830245972	O
2373	(	80 81	9906 9907	0.9999881982803345	O
2374	MSI	82 84	9908 9910	0.9999852180480957	O
2376	)	85 86	9911 9912	0.9999891519546509	O
2377	secondary	87 96	9913 9922	0.9999886751174927	O
2378	to	97 99	9923 9925	0.9999887943267822	O
2379	somatic	100 106	9926 9932	0.9999878406524658	O
2381	loss	108 112	9934 9938	0.9999884366989136	O
2382	of	113 115	9939 9941	0.9999885559082031	O
2383	DNA	116 119	9942 9945	0.9999874830245972	O
2384	mismatch	120 127	9946 9953	0.9999884366989136	O
2387	repair	129 135	9955 9961	0.9999876022338867	O
2388	(	136 137	9962 9963	0.999988317489624	O
2389	MMR	138 140	9964 9966	0.9999865293502808	O
2391	)	142 143	9968 9969	0.9999890327453613	O
2392	.	144 145	9970 9971	0.9999628067016602	O
2393	Most	0 4	9972 9976	0.9999812841415405	O
2394	other	5 10	9977 9982	0.9999620914459229	O
2395	cancers	11 17	9983 9989	0.9999798536300659	O
2397	exhibit	19 26	9991 9998	0.9999821186065674	O
2398	chromosomal	27 37	9999 10009	0.9999864101409912	O
2402	instability	39 50	10011 10022	0.9999843835830688	O
2403	(	51 52	10023 10024	0.9999867677688599	O
2404	CIN	53 55	10025 10027	0.9999793767929077	O
2406	)	57 58	10029 10030	0.9999886751174927	O
2407	characterized	59 72	10031 10044	0.9999874830245972	O
2408	by	73 75	10045 10047	0.9999884366989136	O
2409	aneuploidy	76 85	10048 10057	0.9999884366989136	O
2414	and	87 90	10059 10062	0.9999880790710449	O
2415	loss	91 95	10063 10067	0.9999878406524658	O
2416	of	96 98	10068 10070	0.9999889135360718	O
2417	heterozygosity	99 112	10071 10084	0.9999884366989136	O
2422	(	114 115	10086 10087	0.9999892711639404	O
2423	LOH	116 118	10088 10090	0.9999880790710449	O
2425	)	119 120	10091 10092	0.9999896287918091	O
2426	[	121 122	10093 10094	0.9999895095825195	O
2427	7	122 123	10094 10095	0.9999889135360718	O
2428	,	123 124	10095 10096	0.9999885559082031	O
2429	8	124 125	10096 10097	0.9999879598617554	O
2430	]	125 126	10097 10098	0.9999887943267822	O
2431	.	127 128	10099 10100	0.999976396560669	O
2432	CIN	0 2	10101 10103	0.9999803304672241	O
2434	and	4 7	10105 10108	0.9999858140945435	O
2435	MSI	8 10	10109 10111	0.999984860420227	O
2437	+	11 12	10112 10113	0.999983549118042	O
2438	colorectal	13 22	10114 10123	0.9999792575836182	O
2441	cancers	24 30	10125 10131	0.9999827146530151	O
2443	have	32 36	10133 10137	0.9999854564666748	O
2444	different	37 46	10138 10147	0.9999854564666748	O
2445	characteristics	47 62	10148 10163	0.9999861717224121	O
2446	with	63 67	10164 10168	0.9999881982803345	O
2447	respect	68 75	10169 10176	0.9999885559082031	O
2448	to	76 78	10177 10179	0.9999889135360718	O
2449	mutated	79 85	10180 10186	0.9999879598617554	O
2452	loci	87 90	10188 10191	0.9999885559082031	O
2454	,	92 93	10193 10194	0.9999868869781494	O
2455	tumor	94 99	10195 10200	0.9999841451644897	O
2456	location	100 108	10201 10209	0.9999862909317017	O
2457	,	109 110	10210 10211	0.999988317489624	O
2458	morphology	111 121	10212 10222	0.9999849796295166	O
2459	,	122 123	10223 10224	0.9999877214431763	O
2460	and	124 127	10225 10228	0.9999878406524658	O
2461	clinical	128 136	10229 10237	0.9999842643737793	O
2462	outcomes	137 145	10238 10246	0.9999860525131226	O
2463	[	146 147	10247 10248	0.99998939037323	O
2464	7	147 148	10248 10249	0.9999887943267822	O
2465	,	148 149	10249 10250	0.9999886751174927	O
2466	8	149 150	10250 10251	0.9999877214431763	O
2467	]	150 151	10251 10252	0.9999889135360718	O
2468	.	152 153	10253 10254	0.9999780654907227	O
2469	Numbers	0 7	10255 10262	0.9999686479568481	O
2470	of	8 10	10263 10265	0.9999821186065674	O
2471	oncogenic	11 19	10266 10274	0.9999808073043823	O
2474	mutations	21 30	10276 10285	0.9999797344207764	O
2475	may	31 34	10286 10289	0.999962568283081	O
2476	differ	35 41	10290 10296	0.9999703168869019	O
2477	between	42 49	10297 10304	0.9999662637710571	O
2478	cancer	50 56	10305 10311	0.9999704360961914	O
2479	subtypes	57 64	10312 10319	0.9999852180480957	O
2482	.	66 67	10321 10322	0.9998205304145813	O
2483	Therefore	0 9	10323 10332	0.9999833106994629	O
2484	,	10 11	10333 10334	0.999985933303833	O
2485	colorectal	12 21	10335 10344	0.9999804496765137	O
2488	cancers	23 29	10346 10352	0.9999834299087524	O
2490	arising	31 38	10354 10361	0.999987006187439	O
2491	in	39 41	10362 10364	0.9999880790710449	O
2492	a	42 43	10365 10366	0.9999879598617554	O
2493	population	44 54	10367 10377	0.9999809265136719	O
2494	-	54 55	10377 10378	0.9999885559082031	O
2495	based	55 60	10378 10383	0.999985933303833	O
2496	setting	61 68	10384 10391	0.9999845027923584	O
2497	were	69 73	10392 10396	0.9999881982803345	O
2498	molecularly	74 84	10397 10407	0.9999833106994629	O
2500	classified	86 96	10409 10419	0.9999881982803345	O
2501	as	97 99	10420 10422	0.9999884366989136	O
2502	either	100 106	10423 10429	0.9999872446060181	O
2503	sporadic	107 114	10430 10437	0.9999871253967285	O
2505	or	116 118	10439 10441	0.9999861717224121	O
2506	hereditary	119 129	10442 10452	0.9999788999557495	O
2507	,	130 131	10453 10454	0.999984860420227	O
2508	and	132 135	10455 10458	0.999987006187439	O
2509	MSI	136 138	10459 10461	0.9999877214431763	O
2511	+	139 140	10462 10463	0.9999885559082031	O
2512	or	141 143	10464 10466	0.9999874830245972	O
2513	MSI	144 146	10467 10469	0.9999874830245972	O
2515	-	147 148	10470 10471	0.9999873638153076	O
2516	.	148 149	10471 10472	0.9999669790267944	O
2517	Cancers	0 6	10473 10479	0.9999706745147705	O
2519	were	8 12	10481 10485	0.9999852180480957	O
2520	also	13 17	10486 10490	0.9999842643737793	O
2521	classified	18 28	10491 10501	0.999984860420227	O
2522	with	29 33	10502 10506	0.9999872446060181	O
2523	respect	34 41	10507 10514	0.999987006187439	O
2524	to	42 44	10515 10517	0.9999881982803345	O
2525	clinical	45 53	10518 10526	0.9999793767929077	O
2526	stage	54 59	10527 10532	0.9999850988388062	O
2527	because	60 67	10533 10540	0.9999834299087524	O
2528	additional	68 78	10541 10551	0.9999816417694092	O
2529	mutations	79 88	10552 10561	0.9999809265136719	O
2530	may	89 92	10562 10565	0.9999862909317017	O
2531	be	93 95	10566 10568	0.9999876022338867	O
2532	required	96 104	10569 10577	0.9999867677688599	O
2533	for	105 108	10578 10581	0.9999862909317017	O
2534	invasion	109 117	10582 10590	0.9999806880950928	O
2535	or	118 120	10591 10593	0.9999822378158569	O
2536	metastasis	121 130	10594 10603	0.9999814033508301	O
2539	.	132 133	10605 10606	0.9999533891677856	O
2540	Ages	0 4	10607 10611	0.9999842643737793	O
2541	at	5 7	10612 10614	0.9999879598617554	O
2542	cancer	8 14	10615 10621	0.9999843835830688	O
2543	for	15 18	10622 10625	0.9999889135360718	O
2544	each	19 23	10626 10630	0.99998939037323	O
2545	subgroup	24 32	10631 10639	0.9999865293502808	O
2546	were	33 37	10640 10644	0.9999874830245972	O
2547	used	38 42	10645 10649	0.9999879598617554	O
2548	to	43 45	10650 10652	0.9999886751174927	O
2549	infer	46 50	10653 10657	0.9999890327453613	O
2551	numbers	52 59	10659 10666	0.9999878406524658	O
2552	of	60 62	10667 10669	0.9999887943267822	O
2553	mutations	63 72	10670 10679	0.999984860420227	O
2554	required	73 81	10680 10688	0.9999880790710449	O
2555	for	82 85	10689 10692	0.9999891519546509	O
2556	each	86 90	10693 10697	0.9999886751174927	O
2557	type	91 95	10698 10702	0.999988317489624	O
2558	of	96 98	10703 10705	0.9999885559082031	O
2559	colorectal	99 108	10706 10715	0.9999871253967285	O
2562	cancer	110 116	10717 10723	0.9999878406524658	O
2563	.	117 118	10724 10725	0.9999887943267822	O
2564	*	119 120	10726 10727	0.999988317489624	O
2565	*	120 121	10727 10728	0.9999853372573853	O
2566	IGNORE	0 5	10729 10734	0.9999864101409912	O
2569	LINE	7 10	10736 10739	0.9999887943267822	O
2572	*	12 13	10741 10742	0.9999890327453613	O
2573	*	13 14	10742 10743	0.9999890327453613	O
2574	*	15 16	10744 10745	0.9999887943267822	O
2575	*	16 17	10745 10746	0.9999889135360718	O
2576	IGNORE	18 23	10747 10752	0.9999878406524658	O
2579	LINE	25 28	10754 10757	0.9999890327453613	O
2582	*	30 31	10759 10760	0.9999887943267822	O
2583	*	31 32	10760 10761	0.9999887943267822	O
2584	*	33 34	10762 10763	0.9999886751174927	O
2585	*	34 35	10763 10764	0.9999886751174927	O
2586	IGNORE	36 41	10765 10770	0.9999876022338867	O
2589	LINE	43 46	10772 10775	0.9999889135360718	O
2592	*	48 49	10777 10778	0.9999889135360718	O
2593	*	49 50	10778 10779	0.9999885559082031	O
2594	Conclusion	51 60	10780 10789	0.9999881982803345	O
2597	The	62 65	10791 10794	0.999988317489624	O
2598	biology	66 73	10795 10802	0.9999817609786987	O
2599	of	74 76	10803 10805	0.9999884366989136	O
2600	cancer	77 83	10806 10812	0.9999850988388062	O
2601	must	84 88	10813 10817	0.9999847412109375	O
2602	underlie	89 96	10818 10825	0.9999884366989136	O
2604	the	98 101	10827 10830	0.9999885559082031	O
2605	epidemiology	102 113	10831 10842	0.9999889135360718	O
2609	of	115 117	10844 10846	0.9999880790710449	O
2610	cancer	118 124	10847 10853	0.9999842643737793	O
2611	.	125 126	10854 10855	0.9999723434448242	O
2612	Here	0 4	10856 10860	0.9999709129333496	O
2613	we	5 7	10861 10863	0.9999747276306152	O
2614	illustrate	8 18	10864 10874	0.9999685287475586	O
2615	that	19 23	10875 10879	0.9999850988388062	O
2616	multistage	24 33	10880 10889	0.9999847412109375	O
2619	models	35 41	10891 10897	0.9999744892120361	O
2620	provide	42 49	10898 10905	0.9999834299087524	O
2621	conceptually	50 61	10906 10917	0.999983549118042	O
2623	plausible	63 72	10919 10928	0.9999840259552002	O
2624	solutions	73 82	10929 10938	0.9999791383743286	O
2625	even	83 87	10939 10943	0.9999836683273315	O
2626	when	88 92	10944 10948	0.9999852180480957	O
2627	colorectal	93 102	10949 10958	0.9999841451644897	O
2630	cancers	104 110	10960 10966	0.9999845027923584	O
2632	are	112 115	10968 10971	0.9999868869781494	O
2633	divided	116 123	10972 10979	0.9999872446060181	O
2634	into	124 128	10980 10984	0.9999877214431763	O
2635	biologically	129 140	10985 10996	0.9999794960021973	O
2637	relevant	142 150	10998 11006	0.9999871253967285	O
2638	and	151 154	11007 11010	0.9999852180480957	O
2639	quite	155 160	11011 11016	0.9999818801879883	O
2640	different	161 170	11017 11026	0.999984860420227	O
2641	subtypes	171 178	11027 11034	0.9999879598617554	O
2644	.	180 181	11036 11037	0.9999300241470337	O
2645	Ages	0 4	11038 11042	0.9999818801879883	O
2646	at	5 7	11043 11045	0.9999866485595703	O
2647	cancer	8 14	11046 11052	0.9999831914901733	O
2648	are	15 18	11053 11056	0.9999865293502808	O
2649	consistent	19 29	11057 11067	0.9999858140945435	O
2650	with	30 34	11068 11072	0.9999887943267822	O
2651	five	35 39	11073 11077	0.9999877214431763	O
2652	or	40 42	11078 11080	0.9999885559082031	O
2653	six	43 46	11081 11084	0.9999866485595703	O
2654	somatic	47 53	11085 11091	0.9999865293502808	O
2656	oncogenic	55 63	11093 11101	0.9999876022338867	O
2659	mutations	65 74	11103 11112	0.9999877214431763	O
2660	for	75 78	11113 11116	0.9999879598617554	O
2661	hereditary	79 89	11117 11127	0.9999492168426514	O
2662	(	90 91	11128 11129	0.9999878406524658	O
2663	HNPCC	92 96	11130 11134	0.999981164932251	O
2666	)	98 99	11136 11137	0.9999886751174927	O
2667	MSI	100 102	11138 11140	0.9999860525131226	O
2669	+	103 104	11141 11142	0.9999861717224121	O
2670	cancers	105 111	11143 11149	0.999984622001648	O
2672	and	113 116	11151 11154	0.9999884366989136	O
2673	seven	117 122	11155 11160	0.9999871253967285	O
2674	or	123 125	11161 11163	0.9999886751174927	O
2675	eight	126 131	11164 11169	0.9999868869781494	O
2676	mutations	132 141	11170 11179	0.9999867677688599	O
2677	for	142 145	11180 11183	0.9999880790710449	O
2678	its	146 149	11184 11187	0.9999878406524658	O
2679	sporadic	150 157	11188 11195	0.9999843835830688	O
2681	counterpart	159 170	11197 11208	0.999984860420227	O
2682	.	171 172	11209 11210	0.9999644756317139	O
2683	The	0 3	11211 11214	0.9999874830245972	O
2684	apparent	4 12	11215 11223	0.9999866485595703	O
2685	requirement	13 24	11224 11235	0.9999866485595703	O
2686	for	25 28	11236 11239	0.9999884366989136	O
2687	more	29 33	11240 11244	0.9999880790710449	O
2688	than	34 38	11245 11249	0.9999881982803345	O
2689	one	39 42	11250 11253	0.9999881982803345	O
2690	additional	43 53	11254 11264	0.9999860525131226	O
2691	somatic	54 60	11265 11271	0.9999872446060181	O
2693	mutation	62 70	11273 11281	0.9999860525131226	O
2694	in	71 73	11282 11284	0.9999881982803345	O
2695	sporadic	74 81	11285 11292	0.999985933303833	O
2697	MSI	83 85	11294 11296	0.9999842643737793	O
2699	+	86 87	11297 11298	0.9999854564666748	O
2700	cancers	88 94	11299 11305	0.9999845027923584	O
2702	may	96 99	11307 11310	0.9999841451644897	O
2703	reflect	100 107	11311 11318	0.9999865293502808	O
2704	that	108 112	11319 11323	0.9999881982803345	O
2705	MMR	113 115	11324 11326	0.9999861717224121	O
2707	inactivation	117 128	11328 11339	0.9999889135360718	O
2710	is	130 132	11341 11343	0.9999879598617554	O
2711	commonly	133 141	11344 11352	0.9999853372573853	O
2712	epigenetic	142 151	11353 11362	0.9999887943267822	O
2716	,	153 154	11364 11365	0.9999872446060181	O
2717	which	155 160	11366 11371	0.9999884366989136	O
2718	may	161 164	11372 11375	0.9999879598617554	O
2719	involve	165 172	11376 11383	0.999988317489624	O
2720	multiple	173 181	11384 11392	0.999984860420227	O
2721	steps	182 187	11393 11398	0.9999833106994629	O
2722	.	188 189	11399 11400	0.9999591112136841	O
2723	Ages	0 4	11401 11405	0.9999817609786987	O
2724	at	5 7	11406 11408	0.9999878406524658	O
2725	MSI	8 10	11409 11411	0.9999861717224121	O
2727	-	11 12	11412 11413	0.9999862909317017	O
2728	cancers	13 19	11414 11420	0.9999828338623047	O
2730	were	21 25	11422 11426	0.9999874830245972	O
2731	consistent	26 36	11427 11437	0.9999868869781494	O
2732	with	37 41	11438 11442	0.9999887943267822	O
2733	six	42 45	11443 11446	0.9999874830245972	O
2734	or	46 48	11447 11449	0.9999877214431763	O
2735	seven	49 54	11450 11455	0.9999828338623047	O
2736	oncogenic	55 63	11456 11464	0.9999871253967285	O
2739	mutations	65 74	11466 11475	0.9999867677688599	O
2740	,	75 76	11476 11477	0.9999880790710449	O
2741	with	77 81	11478 11482	0.9999881982803345	O
2742	similar	82 89	11483 11490	0.9999839067459106	O
2743	estimates	90 99	11491 11500	0.9999836683273315	O
2744	for	100 103	11501 11504	0.9999877214431763	O
2745	all	104 107	11505 11508	0.9999877214431763	O
2746	clinical	108 116	11509 11517	0.9999853372573853	O
2747	stages	117 123	11518 11524	0.9999878406524658	O
2748	,	124 125	11525 11526	0.9999881982803345	O
2749	suggesting	126 136	11527 11537	0.9999873638153076	O
2750	that	137 141	11538 11542	0.9999889135360718	O
2751	mutations	142 151	11543 11552	0.9999855756759644	O
2752	acquired	152 160	11553 11561	0.9999876022338867	O
2753	very	161 165	11562 11566	0.999988317489624	O
2754	early	166 171	11567 11572	0.9999890327453613	O
2755	in	172 174	11573 11575	0.9999892711639404	O
2756	life	175 179	11576 11580	0.9999866485595703	O
2757	dictate	180 186	11581 11587	0.9999886751174927	O
2760	the	188 191	11589 11592	0.9999881982803345	O
2761	cancer	192 198	11593 11599	0.9999833106994629	O
2762	phenotype	199 207	11600 11608	0.9999886751174927	O
2765	at	209 211	11610 11612	0.9999881982803345	O
2766	the	212 215	11613 11616	0.9999889135360718	O
2767	time	216 220	11617 11621	0.9999881982803345	O
2768	of	221 223	11622 11624	0.9999887943267822	O
2769	transformation	224 238	11625 11639	0.9999840259552002	O
2770	.	239 240	11640 11641	0.999966025352478	O
2771	Better	0 6	11642 11648	0.9999833106994629	O
2772	integration	7 18	11649 11660	0.999982476234436	O
2773	of	19 21	11661 11663	0.9999854564666748	O
2774	cancer	22 28	11664 11670	0.999981164932251	O
2775	epidemiology	29 40	11671 11682	0.9999874830245972	O
2779	with	42 46	11684 11688	0.9999839067459106	O
2780	its	47 50	11689 11692	0.9999865293502808	O
2781	biology	51 58	11693 11700	0.999981164932251	O
2782	remains	59 66	11701 11708	0.9999736547470093	O
2783	a	67 68	11709 11710	0.9999836683273315	O
2784	further	69 76	11711 11718	0.9999806880950928	O
2785	challenge	77 86	11719 11728	0.99997878074646	O
2786	.	87 88	11729 11730	0.9999097585678101	O
2787	Background	0 10	11731 11741	0.9999754428863525	O
2788	Carcinogenesis	11 24	11742 11755	0.9999775886535645	O
2792	is	26 28	11757 11759	0.9999847412109375	O
2793	a	29 30	11760 11761	0.9999871253967285	O
2794	multi	31 36	11762 11767	0.9999818801879883	O
2795	-	36 37	11767 11768	0.9999876022338867	O
2796	step	37 41	11768 11772	0.9999785423278809	O
2797	process	42 49	11773 11780	0.9999810457229614	O
2798	that	50 54	11781 11785	0.999985933303833	O
2799	involves	55 63	11786 11794	0.9999830722808838	O
2800	the	64 67	11795 11798	0.9999862909317017	O
2801	accumulation	68 80	11799 11811	0.9999783039093018	O
2802	of	81 83	11812 11814	0.9999868869781494	O
2803	numerous	84 92	11815 11823	0.999962329864502	O
2804	genetic	93 100	11824 11831	0.9999816417694092	O
2805	and	101 104	11832 11835	0.9999843835830688	O
2806	epigenetic	105 114	11836 11845	0.9999862909317017	O
2810	changes	116 123	11847 11854	0.999984860420227	O
2811	in	124 126	11855 11857	0.9999856948852539	O
2812	cells	127 132	11858 11863	0.9999723434448242	O
2813	[	133 134	11864 11865	0.9999886751174927	O
2814	1	134 135	11865 11866	0.999984622001648	O
2815	]	135 136	11866 11867	0.9999880790710449	O
2816	.	137 138	11868 11869	0.9999781847000122	O
2817	These	0 5	11870 11875	0.9999849796295166	O
2818	genetic	6 13	11876 11883	0.9999814033508301	O
2819	aberrations	14 24	11884 11894	0.9999864101409912	O
2822	affect	26 32	11896 11902	0.9999840259552002	O
2823	a	33 34	11903 11904	0.9999880790710449	O
2824	limited	35 42	11905 11912	0.9999854564666748	O
2825	number	43 49	11913 11919	0.9999872446060181	O
2826	of	50 52	11920 11922	0.9999878406524658	O
2827	identified	53 63	11923 11933	0.9999792575836182	O
2828	pathways	64 72	11934 11942	0.9999781847000122	O
2829	that	73 77	11943 11947	0.9999862909317017	O
2830	are	78 81	11948 11951	0.9999867677688599	O
2831	involved	82 90	11952 11960	0.9999853372573853	O
2832	in	91 93	11961 11963	0.9999868869781494	O
2833	(	94 95	11964 11965	0.9999841451644897	O
2834	colorectal	96 105	11966 11975	0.9999836683273315	O
2837	)	107 108	11977 11978	0.9999866485595703	O
2838	carcinogenesis	109 122	11979 11992	0.9999845027923584	O
2842	[	124 125	11994 11995	0.9999889135360718	O
2843	2	125 126	11995 11996	0.9999856948852539	O
2844	]	126 127	11996 11997	0.9999880790710449	O
2845	.	128 129	11998 11999	0.9999774694442749	O
2846	A	0 1	12000 12001	0.9999874830245972	O
2847	genetic	2 9	12002 12009	0.9999825954437256	O
2848	model	10 15	12010 12015	0.9999804496765137	O
2849	for	16 19	12016 12019	0.9999849796295166	O
2850	sporadic	20 27	12020 12027	0.9999804496765137	O
2852	colorectal	29 38	12029 12038	0.9999762773513794	O
2855	cancer	40 46	12040 12046	0.9999839067459106	O
2856	has	47 50	12047 12050	0.9999866485595703	O
2857	been	51 55	12051 12055	0.999987006187439	O
2858	proposed	56 64	12056 12064	0.9999852180480957	O
2859	,	65 66	12065 12066	0.9999877214431763	O
2860	which	67 72	12067 12072	0.9999880790710449	O
2861	describes	73 82	12073 12082	0.9999864101409912	O
2862	the	83 86	12083 12086	0.999988317489624	O
2863	sequential	87 96	12087 12096	0.9999865293502808	O
2865	accumulation	98 110	12098 12110	0.9999854564666748	O
2866	of	111 113	12111 12113	0.9999880790710449	O
2867	specific	114 122	12114 12122	0.9999856948852539	O
2868	genetic	123 130	12123 12130	0.9999845027923584	O
2869	alterations	131 142	12131 12142	0.9999860525131226	O
2870	in	143 145	12143 12145	0.9999881982803345	O
2871	various	146 153	12146 12153	0.9999867677688599	O
2872	pathways	154 162	12154 12162	0.9999845027923584	O
2873	,	163 164	12163 12164	0.9999864101409912	O
2874	involving	165 174	12165 12174	0.9999876022338867	O
2875	tumour	175 180	12175 12180	0.9999874830245972	O
2877	suppressor	182 191	12182 12191	0.9999861717224121	O
2879	genes	193 198	12193 12198	0.9999877214431763	O
2880	(	199 200	12199 12200	0.9999845027923584	O
2881	e	201 202	12201 12202	0.9999880790710449	O
2882	.	203 204	12203 12204	0.9999872446060181	O
2883	g	204 205	12204 12205	0.9999868869781494	O
2884	.	206 207	12206 12207	0.9999724626541138	O
2885	APC	0 2	12208 12210	0.999980092048645	O
2887	,	4 5	12212 12213	0.9999866485595703	O
2888	SMAD4	6 10	12214 12218	0.9999788999557495	O
2891	,	12 13	12220 12221	0.9999862909317017	O
2892	TP53	14 17	12222 12225	0.9999829530715942	O
2895	)	19 20	12227 12228	0.9999854564666748	O
2896	and	21 24	12229 12232	0.9999850988388062	O
2897	oncogenes	25 33	12233 12241	0.9999843835830688	O
2901	(	35 36	12243 12244	0.9999866485595703	O
2902	e	37 38	12245 12246	0.9999872446060181	O
2903	.	39 40	12247 12248	0.9999865293502808	O
2904	g	40 41	12248 12249	0.9999856948852539	O
2905	.	42 43	12250 12251	0.999970555305481	O
2906	CTNNB1	0 5	12252 12257	0.9999818801879883	O
2911	,	7 8	12259 12260	0.9999860525131226	O
2912	K	9 10	12261 12262	0.9999827146530151	O
2913	-	10 11	12262 12263	0.9999881982803345	O
2914	ras	11 13	12263 12265	0.9999845027923584	O
2916	)	15 16	12267 12268	0.9999817609786987	O
2917	[	17 18	12269 12270	0.9999887943267822	O
2918	3	18 19	12270 12271	0.9999856948852539	O
2919	,	19 20	12271 12272	0.9999867677688599	O
2920	4	20 21	12272 12273	0.9999827146530151	O
2921	]	21 22	12273 12274	0.9999877214431763	O
2922	.	23 24	12275 12276	0.999967098236084	O
2923	Important	0 9	12277 12286	0.9999828338623047	O
2924	molecular	10 19	12287 12296	0.9999819993972778	O
2925	pathways	20 28	12297 12305	0.9999853372573853	O
2926	that	29 33	12306 12310	0.9999856948852539	O
2927	upon	34 38	12311 12315	0.9999834299087524	O
2928	activation	39 49	12316 12326	0.999976396560669	O
2929	affect	50 56	12327 12333	0.9999833106994629	O
2930	the	57 60	12334 12337	0.9999878406524658	O
2931	early	61 66	12338 12343	0.9999873638153076	O
2932	and	67 70	12344 12347	0.9999868869781494	O
2933	intermediate	71 83	12348 12360	0.9999853372573853	O
2934	stages	84 90	12361 12367	0.9999850988388062	O
2935	of	91 93	12368 12370	0.9999865293502808	O
2936	colorectal	94 103	12371 12380	0.9999815225601196	O
2939	carcinogenesis	105 118	12382 12395	0.999984622001648	O
2943	are	120 123	12397 12400	0.9999864101409912	O
2944	the	124 127	12401 12404	0.9999866485595703	O
2945	Wnt	128 130	12405 12407	0.9999784231185913	O
2947	and	132 135	12409 12412	0.999987006187439	O
2948	Ras	136 138	12413 12415	0.99997878074646	O
2950	signalling	140 150	12417 12427	0.9999860525131226	O
2951	pathways	151 159	12428 12436	0.9999881982803345	O
2952	,	160 161	12437 12438	0.9999871253967285	O
2953	whereas	162 169	12439 12446	0.9999858140945435	O
2954	TP53	170 173	12447 12450	0.999987006187439	O
2957	inactivation	175 186	12452 12463	0.9999887943267822	O
2960	is	188 190	12465 12467	0.9999878406524658	O
2961	considered	191 201	12468 12478	0.999984622001648	O
2962	a	202 203	12479 12480	0.9999886751174927	O
2963	late	204 208	12481 12485	0.9999831914901733	O
2964	event	209 214	12486 12491	0.9999862909317017	O
2965	.	215 216	12492 12493	0.9999629259109497	O
2966	Activation	0 9	12494 12503	0.9999808073043823	O
2968	of	11 13	12505 12507	0.9999865293502808	O
2969	the	14 17	12508 12511	0.9999853372573853	O
2970	Wnt	18 20	12512 12514	0.9999674558639526	O
2972	pathway	22 29	12516 12523	0.9999828338623047	O
2973	plays	30 35	12524 12529	0.9999853372573853	O
2974	a	36 37	12530 12531	0.9999876022338867	O
2975	central	38 45	12532 12539	0.999984860420227	O
2976	role	46 50	12540 12544	0.9999868869781494	O
2977	in	51 53	12545 12547	0.9999864101409912	O
2978	the	54 57	12548 12551	0.9999871253967285	O
2979	aetiology	58 66	12552 12560	0.9999866485595703	O
2982	of	68 70	12562 12564	0.9999867677688599	O
2983	most	71 75	12565 12569	0.9999819993972778	O
2984	colorectal	76 85	12570 12579	0.9999830722808838	O
2987	cancers	87 93	12581 12587	0.9999842643737793	O
2989	and	95 98	12589 12592	0.9999822378158569	O
2990	is	99 101	12593 12595	0.9999858140945435	O
2991	often	102 107	12596 12601	0.9999841451644897	O
2992	the	108 111	12602 12605	0.999987006187439	O
2993	result	112 118	12606 12612	0.9999862909317017	O
2994	of	119 121	12613 12615	0.9999879598617554	O
2995	mutations	122 131	12616 12625	0.9999833106994629	O
2996	in	132 134	12626 12628	0.9999879598617554	O
2997	the	135 138	12629 12632	0.999988317489624	O
2998	N	139 140	12633 12634	0.9999866485595703	O
2999	-	140 141	12634 12635	0.9999881982803345	O
3000	terminal	141 149	12635 12643	0.9999866485595703	O
3001	domain	150 156	12644 12650	0.9999874830245972	O
3002	of	157 159	12651 12653	0.9999881982803345	O
3003	the	160 163	12654 12657	0.9999878406524658	O
3004	APC	164 166	12658 12660	0.9999828338623047	O
3006	gene	168 172	12662 12666	0.9999867677688599	O
3007	,	173 174	12667 12668	0.9999852180480957	O
3008	that	175 179	12669 12673	0.9999874830245972	O
3009	lead	180 184	12674 12678	0.9999861717224121	O
3010	to	185 187	12679 12681	0.9999880790710449	O
3011	partial	188 195	12682 12689	0.999988317489624	O
3012	or	196 198	12690 12692	0.9999868869781494	O
3013	complete	199 207	12693 12701	0.9999871253967285	O
3014	loss	208 212	12702 12706	0.9999861717224121	O
3015	of	213 215	12707 12709	0.999988317489624	O
3016	this	216 220	12710 12714	0.9999880790710449	O
3017	region	221 227	12715 12721	0.999983549118042	O
3018	and	228 231	12722 12725	0.9999877214431763	O
3019	thereby	232 239	12726 12733	0.9999841451644897	O
3020	to	240 242	12734 12736	0.9999871253967285	O
3021	loss	243 247	12737 12741	0.9999858140945435	O
3022	of	248 250	12742 12744	0.9999879598617554	O
3023	the	251 254	12745 12748	0.9999866485595703	O
3024	β	255 256	12749 12750	0.9999849796295166	O
3025	-	256 257	12750 12751	0.9999880790710449	O
3026	catenin	257 263	12751 12757	0.9999845027923584	O
3029	regulating	265 275	12759 12769	0.9999821186065674	O
3030	function	276 284	12770 12778	0.9999866485595703	O
3031	[	285 286	12779 12780	0.9999884366989136	O
3032	5	286 287	12780 12781	0.9999854564666748	O
3033	,	287 288	12781 12782	0.9999855756759644	O
3034	6	288 289	12782 12783	0.9999836683273315	O
3035	]	289 290	12783 12784	0.9999872446060181	O
3036	.	291 292	12785 12786	0.9999754428863525	O
3037	Conversely	0 10	12787 12797	0.999983549118042	O
3038	,	11 12	12798 12799	0.9999878406524658	O
3039	in	13 15	12800 12802	0.9999845027923584	O
3040	tumours	16 22	12803 12809	0.9999821186065674	O
3043	lacking	24 31	12811 12818	0.9999810457229614	O
3044	these	32 37	12819 12824	0.9999864101409912	O
3045	APC	38 40	12825 12827	0.9999792575836182	O
3047	mutations	42 51	12829 12838	0.9999862909317017	O
3048	[	52 53	12839 12840	0.9999890327453613	O
3049	7	53 54	12840 12841	0.9999865293502808	O
3050	]	54 55	12841 12842	0.999988317489624	O
3051	,	56 57	12843 12844	0.9999877214431763	O
3052	activating	58 67	12845 12854	0.9999854564666748	O
3054	missense	69 76	12856 12863	0.9999879598617554	O
3056	mutations	78 87	12865 12874	0.9999874830245972	O
3057	at	88 90	12875 12877	0.9999880790710449	O
3058	one	91 94	12878 12881	0.9999881982803345	O
3059	of	95 97	12882 12884	0.999988317489624	O
3060	the	98 101	12885 12888	0.9999880790710449	O
3061	phosphorylation	102 116	12889 12903	0.9999876022338867	O
3066	sites	118 123	12905 12910	0.999988317489624	O
3067	at	124 126	12911 12913	0.9999884366989136	O
3068	codons	127 132	12914 12919	0.9999880790710449	O
3071	31	134 136	12921 12923	0.9999861717224121	O
3072	,	137 138	12924 12925	0.9999876022338867	O
3073	33	139 141	12926 12928	0.9999849796295166	O
3074	,	142 143	12929 12930	0.9999872446060181	O
3075	37	144 146	12931 12933	0.9999831914901733	O
3076	and	147 150	12934 12937	0.9999873638153076	O
3077	45	151 153	12938 12940	0.9999822378158569	O
3078	of	154 156	12941 12943	0.9999881982803345	O
3079	exon	157 160	12944 12947	0.999988317489624	O
3081	3	162 163	12949 12950	0.9999853372573853	O
3082	of	164 166	12951 12953	0.9999884366989136	O
3083	the	167 170	12954 12957	0.9999884366989136	O
3084	CTNNB1	171 176	12958 12963	0.9999849796295166	O
3089	gene	178 182	12965 12969	0.9999879598617554	O
3090	(	183 184	12970 12971	0.9999881982803345	O
3091	encoding	185 193	12972 12980	0.9999871253967285	O
3092	the	194 197	12981 12984	0.9999873638153076	O
3093	β	198 199	12985 12986	0.9999845027923584	O
3094	-	199 200	12986 12987	0.999988317489624	O
3095	catenin	200 206	12987 12993	0.9999856948852539	O
3098	protein	208 215	12995 13002	0.9999864101409912	O
3099	)	216 217	13003 13004	0.9999890327453613	O
3100	can	218 221	13005 13008	0.9999861717224121	O
3101	render	222 228	13009 13015	0.9999867677688599	O
3102	it	229 231	13016 13018	0.9999881982803345	O
3103	stable	232 238	13019 13025	0.9999850988388062	O
3104	as	239 241	13026 13028	0.9999874830245972	O
3105	it	242 244	13029 13031	0.9999885559082031	O
3106	can	245 248	13032 13035	0.9999877214431763	O
3107	no	249 251	13036 13038	0.999987006187439	O
3108	longer	252 258	13039 13045	0.9999855756759644	O
3109	be	259 261	13046 13048	0.9999878406524658	O
3110	tagged	262 267	13049 13054	0.9999852180480957	O
3112	for	269 272	13056 13059	0.9999860525131226	O
3113	cellular	273 281	13060 13068	0.9999815225601196	O
3114	degradation	282 293	13069 13080	0.9999829530715942	O
3115	.	294 295	13081 13082	0.999962329864502	O
3116	Activation	0 9	13083 13092	0.999985933303833	O
3118	of	11 13	13094 13096	0.9999878406524658	O
3119	the	14 17	13097 13100	0.9999873638153076	O
3120	Ras	18 20	13101 13103	0.9999806880950928	O
3122	pathway	22 29	13105 13112	0.999982476234436	O
3123	in	30 32	13113 13115	0.9999856948852539	O
3124	cancer	33 39	13116 13122	0.999980092048645	O
3125	is	40 42	13123 13125	0.9999862909317017	O
3126	marked	43 49	13126 13132	0.9999865293502808	O
3127	by	50 52	13133 13135	0.999988317489624	O
3128	the	53 56	13136 13139	0.9999880790710449	O
3129	loss	57 61	13140 13144	0.9999850988388062	O
3130	of	62 64	13145 13147	0.9999884366989136	O
3131	the	65 68	13148 13151	0.9999881982803345	O
3132	intrinsic	69 78	13152 13161	0.9999843835830688	O
3133	GTPase	79 84	13162 13167	0.9999827146530151	O
3136	activity	86 94	13169 13177	0.9999877214431763	O
3137	of	95 97	13178 13180	0.999988317489624	O
3138	the	98 101	13181 13184	0.9999877214431763	O
3139	Ras	102 104	13185 13187	0.9999821186065674	O
3141	protein	106 113	13189 13196	0.9999799728393555	O
3142	,	114 115	13197 13198	0.9999884366989136	O
3143	which	116 121	13199 13204	0.9999890327453613	O
3144	can	122 125	13205 13208	0.9999876022338867	O
3145	be	126 128	13209 13211	0.9999887943267822	O
3146	ascribed	129 136	13212 13219	0.9999885559082031	O
3148	to	138 140	13221 13223	0.9999886751174927	O
3149	missense	141 148	13224 13231	0.9999881982803345	O
3151	mutations	150 159	13233 13242	0.9999879598617554	O
3152	in	160 162	13243 13245	0.9999889135360718	O
3153	codons	163 168	13246 13251	0.9999884366989136	O
3156	12	170 172	13253 13255	0.9999873638153076	O
3157	and	173 176	13256 13259	0.9999873638153076	O
3158	13	177 179	13260 13262	0.9999839067459106	O
3159	of	180 182	13263 13265	0.9999881982803345	O
3160	exon	183 186	13266 13269	0.9999886751174927	O
3162	1	188 189	13271 13272	0.9999879598617554	O
3163	,	190 191	13273 13274	0.9999886751174927	O
3164	which	192 197	13275 13280	0.9999889135360718	O
3165	are	198 201	13281 13284	0.9999884366989136	O
3166	responsible	202 213	13285 13296	0.9999889135360718	O
3167	for	214 217	13297 13300	0.9999890327453613	O
3168	90	218 220	13301 13303	0.999985933303833	O
3169	%	221 222	13304 13305	0.9999873638153076	O
3170	activating	223 232	13306 13315	0.999987006187439	O
3172	mutations	234 243	13317 13326	0.9999864101409912	O
3173	in	244 246	13327 13329	0.999988317489624	O
3174	the	247 250	13330 13333	0.9999877214431763	O
3175	of	251 253	13334 13336	0.9999877214431763	O
3176	the	254 257	13337 13340	0.9999881982803345	O
3177	K	258 259	13341 13342	0.999983549118042	O
3178	-	259 260	13342 13343	0.9999885559082031	O
3179	ras	260 262	13343 13345	0.9999860525131226	O
3181	gene	264 268	13347 13351	0.9999877214431763	O
3182	[	269 270	13352 13353	0.9999889135360718	O
3183	8	270 271	13353 13354	0.9999865293502808	O
3184	]	271 272	13354 13355	0.999988317489624	O
3185	.	273 274	13356 13357	0.9999737739562988	O
3186	According	0 9	13358 13367	0.9999840259552002	O
3187	to	10 12	13368 13370	0.999987006187439	O
3188	the	13 16	13371 13374	0.9999876022338867	O
3189	paradigm	17 25	13375 13383	0.9999693632125854	O
3190	for	26 29	13384 13387	0.9999842643737793	O
3191	colorectal	30 39	13388 13397	0.9999817609786987	O
3194	cancer	41 47	13399 13405	0.9999836683273315	O
3195	development	48 59	13406 13417	0.9999822378158569	O
3196	,	60 61	13418 13419	0.9999865293502808	O
3197	mutations	62 71	13420 13429	0.9999794960021973	O
3198	in	72 74	13430 13432	0.999987006187439	O
3199	the	75 78	13433 13436	0.9999871253967285	O
3200	APC	79 81	13437 13439	0.9999840259552002	O
3202	and	83 86	13441 13444	0.9999867677688599	O
3203	K	87 88	13445 13446	0.9999825954437256	O
3204	-	88 89	13446 13447	0.9999885559082031	O
3205	ras	89 91	13447 13449	0.999984860420227	O
3207	are	93 96	13451 13454	0.9999874830245972	O
3208	thought	97 104	13455 13462	0.9999860525131226	O
3209	to	105 107	13463 13465	0.9999878406524658	O
3210	contribute	108 118	13466 13476	0.9999864101409912	O
3211	to	119 121	13477 13479	0.9999881982803345	O
3212	the	122 125	13480 13483	0.999988317489624	O
3213	early	126 131	13484 13489	0.9999858140945435	O
3214	developmental	132 145	13490 13503	0.9999834299087524	O
3215	stages	146 152	13504 13510	0.9999862909317017	O
3216	of	153 155	13511 13513	0.999987006187439	O
3217	colorectal	156 165	13514 13523	0.9999845027923584	O
3220	cancer	167 173	13525 13531	0.9999853372573853	O
3221	[	174 175	13532 13533	0.9999886751174927	O
3222	3	175 176	13533 13534	0.9999842643737793	O
3223	]	176 177	13534 13535	0.9999878406524658	O
3224	.	178 179	13536 13537	0.9999767541885376	O
3225	However	0 7	13538 13545	0.999987006187439	O
3226	,	8 9	13546 13547	0.9999889135360718	O
3227	a	10 11	13548 13549	0.9999885559082031	O
3228	recent	12 18	13550 13556	0.999987006187439	O
3229	study	19 24	13557 13562	0.9999880790710449	O
3230	based	25 30	13563 13568	0.9999889135360718	O
3231	on	31 33	13569 13571	0.9999891519546509	O
3232	the	34 37	13572 13575	0.9999891519546509	O
3233	analysis	38 46	13576 13584	0.9999887943267822	O
3234	of	47 49	13585 13587	0.9999890327453613	O
3235	APC	50 52	13588 13590	0.9999864101409912	O
3237	,	54 55	13592 13593	0.9999890327453613	O
3238	K	56 57	13594 13595	0.9999865293502808	O
3239	-	57 58	13595 13596	0.9999892711639404	O
3240	ras	58 60	13596 13598	0.9999881982803345	O
3242	and	62 65	13600 13603	0.9999889135360718	O
3243	TP53	66 69	13604 13607	0.9999876022338867	O
3246	genes	71 76	13609 13614	0.9999884366989136	O
3247	concluded	77 86	13615 13624	0.9999877214431763	O
3248	that	87 91	13625 13629	0.9999892711639404	O
3249	simultaneous	92 104	13630 13642	0.9999866485595703	O
3250	occurrence	105 115	13643 13653	0.9999886751174927	O
3251	of	116 118	13654 13656	0.9999891519546509	O
3252	all	119 122	13657 13660	0.9999890327453613	O
3253	three	123 128	13661 13666	0.9999856948852539	O
3254	genetic	129 136	13667 13674	0.9999880790710449	O
3255	alterations	137 148	13675 13686	0.9999874830245972	O
3256	is	149 151	13687 13689	0.9999891519546509	O
3257	rare	152 156	13690 13694	0.9999871253967285	O
3258	and	157 160	13695 13698	0.9999877214431763	O
3259	that	161 165	13699 13703	0.9999892711639404	O
3260	multiple	166 174	13704 13712	0.9999872446060181	O
3261	genetic	175 182	13713 13720	0.999988317489624	O
3262	pathways	183 191	13721 13729	0.9999860525131226	O
3263	may	192 195	13730 13733	0.9999885559082031	O
3264	be	196 198	13734 13736	0.9999890327453613	O
3265	relevant	199 207	13737 13745	0.9999880790710449	O
3266	to	208 210	13746 13748	0.9999880790710449	O
3267	colorectal	211 220	13749 13758	0.9999854564666748	O
3270	cancer	222 228	13760 13766	0.9999861717224121	O
3271	[	229 230	13767 13768	0.9999889135360718	O
3272	9	230 231	13768 13769	0.999987006187439	O
3273	]	231 232	13769 13770	0.9999887943267822	O
3274	.	233 234	13771 13772	0.9999791383743286	O
3275	Genetic	0 6	13773 13779	0.9999829530715942	O
3277	instability	8 19	13781 13792	0.9999821186065674	O
3278	is	20 22	13793 13795	0.9999834299087524	O
3279	seen	23 27	13796 13800	0.9999815225601196	O
3280	in	28 30	13801 13803	0.9999842643737793	O
3281	most	31 35	13804 13808	0.9999828338623047	O
3282	types	36 41	13809 13814	0.9999827146530151	O
3283	of	42 44	13815 13817	0.9999831914901733	O
3284	cancer	45 51	13818 13824	0.9999809265136719	O
3285	[	52 53	13825 13826	0.9999878406524658	O
3286	10	53 55	13826 13828	0.9999834299087524	O
3287	]	55 56	13828 13829	0.9999871253967285	O
3288	.	57 58	13830 13831	0.9999669790267944	O
3289	Two	0 3	13832 13835	0.9999761581420898	O
3290	distinct	4 12	13836 13844	0.9999768733978271	O
3291	types	13 18	13845 13850	0.9999845027923584	O
3292	of	19 21	13851 13853	0.9999847412109375	O
3293	genetic	22 29	13854 13861	0.9999840259552002	O
3294	instability	30 41	13862 13873	0.9999814033508301	O
3295	appear	42 48	13874 13880	0.9999831914901733	O
3296	to	49 51	13881 13883	0.9999852180480957	O
3297	occur	52 57	13884 13889	0.9999854564666748	O
3298	in	58 60	13890 13892	0.9999833106994629	O
3299	colorectal	61 70	13893 13902	0.9999816417694092	O
3302	cancer	72 78	13904 13910	0.9999850988388062	O
3303	[	79 80	13911 13912	0.9999887943267822	O
3304	11	80 82	13912 13914	0.9999858140945435	O
3305	]	82 83	13914 13915	0.999988317489624	O
3306	:	84 85	13916 13917	0.9999861717224121	O
3307	chromosomal	86 96	13918 13928	0.9999868869781494	O
3311	and	98 101	13930 13933	0.9999840259552002	O
3312	microsatellite	102 115	13934 13947	0.9999853372573853	O
3316	instability	117 128	13949 13960	0.9999864101409912	O
3317	.	129 130	13961 13962	0.9999608993530273	O
3318	Chromosomal	0 10	13963 13973	0.9999834299087524	O
3322	instability	12 23	13975 13986	0.9999819993972778	O
3323	results	24 31	13987 13994	0.9999845027923584	O
3324	in	32 34	13995 13997	0.9999872446060181	O
3325	gains	35 40	13998 14003	0.999987006187439	O
3326	or	41 43	14004 14006	0.9999854564666748	O
3327	losses	44 50	14007 14013	0.9999842643737793	O
3328	of	51 53	14014 14016	0.9999879598617554	O
3329	entire	54 60	14017 14023	0.9999864101409912	O
3330	chromosomes	61 71	14024 14034	0.9999860525131226	O
3332	or	73 75	14036 14038	0.9999855756759644	O
3333	parts	76 81	14039 14044	0.9999861717224121	O
3334	of	82 84	14045 14047	0.999988317489624	O
3335	them	85 89	14048 14052	0.9999866485595703	O
3336	,	90 91	14053 14054	0.9999812841415405	O
3337	and	92 95	14055 14058	0.9999840259552002	O
3338	gives	96 101	14059 14064	0.9999866485595703	O
3339	rise	102 106	14065 14069	0.9999873638153076	O
3340	to	107 109	14070 14072	0.9999874830245972	O
3341	aneuploid	110 118	14073 14081	0.9999871253967285	O
3346	tumours	120 126	14083 14089	0.9999873638153076	O
3349	and	128 131	14091 14094	0.9999841451644897	O
3350	occurs	132 138	14095 14101	0.9999843835830688	O
3351	in	139 141	14102 14104	0.9999858140945435	O
3352	the	142 145	14105 14108	0.9999861717224121	O
3353	majority	146 154	14109 14117	0.9999836683273315	O
3354	of	155 157	14118 14120	0.999984622001648	O
3355	cancers	158 164	14121 14127	0.9999778270721436	O
3357	.	166 167	14129 14130	0.9999470710754395	O
3358	A	0 1	14131 14132	0.999987006187439	O
3359	smaller	2 9	14133 14140	0.9999771118164062	O
3360	proportion	10 20	14141 14151	0.9999843835830688	O
3361	of	21 23	14152 14154	0.9999842643737793	O
3362	colorectal	24 33	14155 14164	0.9999772310256958	O
3365	cancers	35 41	14166 14172	0.9999833106994629	O
3367	displays	43 51	14174 14182	0.9999839067459106	O
3368	microsatellite	52 65	14183 14196	0.9999877214431763	O
3372	instability	67 78	14198 14209	0.9999878406524658	O
3373	,	79 80	14210 14211	0.9999878406524658	O
3374	represented	81 92	14212 14223	0.9999873638153076	O
3375	by	93 95	14224 14226	0.9999887943267822	O
3376	diploid	96 102	14227 14233	0.9999867677688599	O
3379	cells	104 109	14235 14240	0.9999865293502808	O
3380	acquiring	110 119	14241 14250	0.9999855756759644	O
3381	high	120 124	14251 14255	0.9999861717224121	O
3382	mutation	125 133	14256 14264	0.9999873638153076	O
3383	rates	134 139	14265 14270	0.9999885559082031	O
3384	,	140 141	14271 14272	0.9999871253967285	O
3385	and	142 145	14273 14276	0.9999872446060181	O
3386	was	146 149	14277 14280	0.9999881982803345	O
3387	found	150 155	14281 14286	0.9999873638153076	O
3388	to	156 158	14287 14289	0.9999887943267822	O
3389	be	159 161	14290 14292	0.9999891519546509	O
3390	associated	162 172	14293 14303	0.9999890327453613	O
3391	with	173 177	14304 14308	0.9999890327453613	O
3392	defective	178 186	14309 14317	0.9999878406524658	O
3394	mismatch	188 195	14319 14326	0.9999881982803345	O
3397	repair	197 203	14328 14334	0.9999876022338867	O
3398	[	204 205	14335 14336	0.9999892711639404	O
3399	12	205 207	14336 14338	0.9999874830245972	O
3400	]	207 208	14338 14339	0.9999885559082031	O
3401	.	209 210	14340 14341	0.9999746084213257	O
3402	These	0 5	14342 14347	0.999982476234436	O
3403	tumours	6 12	14348 14354	0.999984860420227	O
3406	are	14 17	14356 14359	0.9999850988388062	O
3407	less	18 22	14360 14364	0.9999759197235107	O
3408	likely	23 29	14365 14371	0.9999871253967285	O
3409	to	30 32	14372 14374	0.9999866485595703	O
3410	harbour	33 40	14375 14382	0.9999864101409912	O
3411	mutations	41 50	14383 14392	0.9999858140945435	O
3412	in	51 53	14393 14395	0.999988317489624	O
3413	genes	54 59	14396 14401	0.9999877214431763	O
3414	associated	60 70	14402 14412	0.999988317489624	O
3415	with	71 75	14413 14417	0.999988317489624	O
3416	chromosomally	76 88	14418 14430	0.9999884366989136	O
3421	instable	90 97	14432 14439	0.999988317489624	O
3423	and	99 102	14441 14444	0.9999873638153076	O
3424	generally	103 112	14445 14454	0.9999840259552002	O
3425	aneuploid	113 121	14455 14463	0.9999886751174927	O
3430	tumours	123 129	14465 14471	0.9999879598617554	O
3433	,	131 132	14473 14474	0.9999878406524658	O
3434	such	133 137	14475 14479	0.9999877214431763	O
3435	as	138 140	14480 14482	0.9999886751174927	O
3436	APC	141 143	14483 14485	0.9999852180480957	O
3438	,	145 146	14487 14488	0.9999880790710449	O
3439	K	147 148	14489 14490	0.999985933303833	O
3440	-	148 149	14490 14491	0.9999890327453613	O
3441	ras	149 151	14491 14493	0.9999873638153076	O
3443	and	153 156	14495 14498	0.9999880790710449	O
3444	TP53	157 160	14499 14502	0.9999876022338867	O
3447	[	162 163	14504 14505	0.9999892711639404	O
3448	13	163 165	14505 14507	0.9999879598617554	O
3449	-	165 166	14507 14508	0.9999891519546509	O
3450	21	166 168	14508 14510	0.9999879598617554	O
3451	]	168 169	14510 14511	0.9999889135360718	O
3452	,	170 171	14512 14513	0.9999876022338867	O
3453	suggesting	172 182	14514 14524	0.9999853372573853	O
3454	that	183 187	14525 14529	0.9999873638153076	O
3455	these	188 193	14530 14535	0.9999865293502808	O
3456	tumours	194 200	14536 14542	0.9999852180480957	O
3459	form	202 206	14544 14548	0.999987006187439	O
3460	a	207 208	14549 14550	0.9999879598617554	O
3461	distinct	209 217	14551 14559	0.9999847412109375	O
3462	group	218 223	14560 14565	0.999984622001648	O
3463	.	224 225	14566 14567	0.9999536275863647	O
3464	Moreover	0 8	14568 14576	0.999982476234436	O
3465	,	9 10	14577 14578	0.9999878406524658	O
3466	microsatellite	11 24	14579 14592	0.9999856948852539	O
3470	instable	26 33	14594 14601	0.9999872446060181	O
3472	tumours	35 41	14603 14609	0.9999873638153076	O
3475	are	43 46	14611 14614	0.9999871253967285	O
3476	found	47 52	14615 14620	0.9999876022338867	O
3477	predominantly	53 66	14621 14634	0.9999868869781494	O
3478	in	67 69	14635 14637	0.9999876022338867	O
3479	the	70 73	14638 14641	0.9999876022338867	O
3480	proximal	74 81	14642 14649	0.999984860420227	O
3482	colon	83 87	14651 14655	0.9999839067459106	O
3484	[	89 90	14657 14658	0.9999892711639404	O
3485	22	90 92	14658 14660	0.999988317489624	O
3486	,	92 93	14660 14661	0.9999887943267822	O
3487	23	93 95	14661 14663	0.999988317489624	O
3488	]	95 96	14663 14664	0.9999889135360718	O
3489	,	97 98	14665 14666	0.9999880790710449	O
3490	are	99 102	14667 14670	0.9999877214431763	O
3491	more	103 107	14671 14675	0.9999866485595703	O
3492	likely	108 114	14676 14682	0.9999886751174927	O
3493	to	115 117	14683 14685	0.999988317489624	O
3494	occur	118 123	14686 14691	0.9999881982803345	O
3495	in	124 126	14692 14694	0.9999879598617554	O
3496	patients	127 135	14695 14703	0.9999853372573853	O
3497	with	136 140	14704 14708	0.9999885559082031	O
3498	a	141 142	14709 14710	0.9999886751174927	O
3499	positive	143 151	14711 14719	0.9999872446060181	O
3500	family	152 158	14720 14726	0.9999833106994629	O
3501	history	159 166	14727 14734	0.9999873638153076	O
3502	of	167 169	14735 14737	0.9999879598617554	O
3503	colorectal	170 179	14738 14747	0.9999860525131226	O
3506	cancer	181 187	14749 14755	0.9999871253967285	O
3507	[	188 189	14756 14757	0.9999892711639404	O
3508	22	189 191	14757 14759	0.9999884366989136	O
3509	,	191 192	14759 14760	0.9999887943267822	O
3510	23	192 194	14760 14762	0.9999881982803345	O
3511	]	194 195	14762 14763	0.9999887943267822	O
3512	,	196 197	14764 14765	0.999988317489624	O
3513	are	198 201	14766 14769	0.9999878406524658	O
3514	often	202 207	14770 14775	0.9999872446060181	O
3515	less	208 212	14776 14780	0.9999868869781494	O
3516	differentiated	213 227	14781 14795	0.9999841451644897	O
3517	than	228 232	14796 14800	0.9999880790710449	O
3518	microsatellite	233 246	14801 14814	0.9999867677688599	O
3522	stable	248 254	14816 14822	0.9999825954437256	O
3523	tumours	255 261	14823 14829	0.9999881982803345	O
3526	[	263 264	14831 14832	0.9999890327453613	O
3527	22	264 266	14832 14834	0.9999880790710449	O
3528	]	266 267	14834 14835	0.9999889135360718	O
3529	,	268 269	14836 14837	0.9999873638153076	O
3530	and	270 273	14838 14841	0.9999876022338867	O
3531	occur	274 279	14842 14847	0.9999873638153076	O
3532	more	280 284	14848 14852	0.9999872446060181	O
3533	frequently	285 295	14853 14863	0.9999880790710449	O
3534	in	296 298	14864 14866	0.9999873638153076	O
3535	women	299 304	14867 14872	0.9999136924743652	O
3536	[	305 306	14873 14874	0.9999890327453613	O
3537	24	306 308	14874 14876	0.999987006187439	O
3538	]	308 309	14876 14877	0.9999887943267822	O
3539	and	310 313	14878 14881	0.999984860420227	O
3540	at	314 316	14882 14884	0.9999866485595703	O
3541	older	317 322	14885 14890	0.9999823570251465	O
3542	age	323 326	14891 14894	0.9999866485595703	O
3543	[	327 328	14895 14896	0.9999890327453613	O
3544	25	328 330	14896 14898	0.9999864101409912	O
3545	]	330 331	14898 14899	0.9999887943267822	O
3546	.	332 333	14900 14901	0.9999651908874512	O
3547	Moreover	0 8	14902 14910	0.9999784231185913	O
3548	,	9 10	14911 14912	0.9999874830245972	O
3549	in	11 13	14913 14915	0.9999837875366211	O
3550	tumours	14 20	14916 14922	0.9999808073043823	O
3553	displaying	22 32	14924 14934	0.9999830722808838	O
3554	microsatellite	33 46	14935 14948	0.9999873638153076	O
3558	instability	48 59	14950 14961	0.9999874830245972	O
3559	,	60 61	14962 14963	0.9999877214431763	O
3560	mutations	62 71	14964 14973	0.9999837875366211	O
3561	the	72 75	14974 14977	0.9999876022338867	O
3562	CTNNB1	76 81	14978 14983	0.9999856948852539	O
3567	gene	83 87	14985 14989	0.999988317489624	O
3568	were	88 92	14990 14994	0.9999878406524658	O
3569	more	93 97	14995 14999	0.9999866485595703	O
3570	frequent	98 106	15000 15008	0.9999879598617554	O
3571	[	107 108	15009 15010	0.9999890327453613	O
3572	26	108 110	15010 15012	0.9999877214431763	O
3573	]	110 111	15012 15013	0.9999889135360718	O
3574	.	112 113	15014 15015	0.9999749660491943	O
3575	Methods	0 6	15016 15022	0.9999691247940063	O
3577	Study	8 13	15024 15029	0.9999644756317139	O
3578	population	14 24	15030 15040	0.9999730587005615	O
3579	The	25 28	15041 15044	0.9999717473983765	O
3580	prospective	29 40	15045 15056	0.9998893737792969	O
3581	Netherlands	41 52	15057 15068	0.9990525841712952	O
3582	Cohort	53 58	15069 15074	0.9999744892120361	O
3585	Study	60 65	15076 15081	0.9999692440032959	O
3586	on	66 68	15082 15084	0.9999769926071167	O
3587	diet	69 73	15085 15089	0.9999498128890991	O
3588	and	74 77	15090 15093	0.9999740123748779	O
3589	cancer	78 84	15094 15100	0.9999746084213257	O
3590	was	85 88	15101 15104	0.9999837875366211	O
3591	initiated	89 98	15105 15114	0.999982476234436	O
3592	in	99 101	15115 15117	0.999983549118042	O
3593	September	102 111	15118 15127	0.9999837875366211	O
3594	1986	112 116	15128 15132	0.9999760389328003	O
3595	.	117 118	15133 15134	0.9999412298202515	O
3596	The	0 3	15135 15138	0.9999772310256958	O
3597	study	4 9	15139 15144	0.9999740123748779	O
3598	design	10 16	15145 15151	0.9999740123748779	O
3599	has	17 20	15152 15155	0.999981164932251	O
3600	been	21 25	15156 15160	0.999983549118042	O
3601	described	26 35	15161 15170	0.9999808073043823	O
3602	in	36 38	15171 15173	0.9999854564666748	O
3603	detail	39 45	15174 15180	0.9999833106994629	O
3604	elsewhere	46 55	15181 15190	0.999980092048645	O
3605	[	56 57	15191 15192	0.999985933303833	O
3606	29	57 59	15192 15194	0.9999805688858032	O
3607	]	59 60	15194 15195	0.999984860420227	O
3608	.	61 62	15196 15197	0.9999573230743408	O
3609	The	0 3	15198 15201	0.9999639987945557	O
3610	study	4 9	15202 15207	0.9999643564224243	O
3611	population	10 20	15208 15218	0.9999691247940063	O
3612	originated	21 31	15219 15229	0.9999699592590332	O
3613	from	32 36	15230 15234	0.9999780654907227	O
3614	204	37 40	15235 15238	0.9999138116836548	O
3615	municipal	41 50	15239 15248	0.9999241828918457	O
3616	population	51 61	15249 15259	0.9999672174453735	O
3617	registries	62 71	15260 15269	0.9999830722808838	O
3620	throughout	73 83	15271 15281	0.9999686479568481	O
3621	the	84 87	15282 15285	0.9999659061431885	O
3622	Netherlands	88 99	15286 15297	0.997012734413147	O
3623	,	100 101	15298 15299	0.9999690055847168	O
3624	and	102 105	15300 15303	0.9999716281890869	O
3625	included	106 114	15304 15312	0.9999779462814331	O
3626	a	115 116	15313 15314	0.9999809265136719	O
3627	total	117 122	15315 15320	0.9999810457229614	O
3628	of	123 125	15321 15323	0.9999823570251465	O
3629	58	126 128	15324 15326	0.9999692440032959	O
3630	,	128 129	15326 15327	0.9999816417694092	O
3631	279	129 131	15327 15329	0.9999793767929077	O
3633	men	133 136	15331 15334	0.9999452829360962	O
3634	and	137 140	15335 15338	0.9999804496765137	O
3635	62	141 143	15339 15341	0.9999721050262451	O
3636	,	143 144	15341 15342	0.9999818801879883	O
3637	573	144 146	15342 15344	0.9999812841415405	O
3639	women	148 153	15346 15351	0.9997814297676086	O
3640	between	154 161	15352 15359	0.9999791383743286	O
3641	the	162 165	15360 15363	0.9999829530715942	O
3642	ages	166 170	15364 15368	0.9999825954437256	O
3643	of	171 173	15369 15371	0.9999842643737793	O
3644	55	174 176	15372 15374	0.9999778270721436	O
3645	and	177 180	15375 15378	0.9999829530715942	O
3646	69	181 183	15379 15381	0.9999747276306152	O
3647	years	184 189	15382 15387	0.9999818801879883	O
3648	at	190 192	15388 15390	0.9999854564666748	O
3649	baseline	193 200	15391 15398	0.9999827146530151	O
3651	.	202 203	15400 15401	0.9999325275421143	O
3652	Incident	0 8	15402 15410	0.9999655485153198	O
3653	cancer	9 15	15411 15417	0.9999768733978271	O
3654	cases	16 21	15418 15423	0.9999791383743286	O
3655	are	22 25	15424 15427	0.9999769926071167	O
3656	identified	26 36	15428 15438	0.9999830722808838	O
3657	by	37 39	15439 15441	0.9999855756759644	O
3658	monitoring	40 50	15442 15452	0.9999809265136719	O
3659	of	51 53	15453 15455	0.9999861717224121	O
3660	the	54 57	15456 15459	0.9999856948852539	O
3661	entire	58 64	15460 15466	0.9999818801879883	O
3662	cohort	65 70	15467 15472	0.9999855756759644	O
3665	for	72 75	15474 15477	0.9999822378158569	O
3666	cancer	76 82	15478 15484	0.9999803304672241	O
3667	occurrence	83 93	15485 15495	0.9999842643737793	O
3668	through	94 101	15496 15503	0.9999865293502808	O
3669	annual	102 108	15504 15510	0.9999854564666748	O
3670	record	109 115	15511 15517	0.9999839067459106	O
3671	linkage	116 122	15518 15524	0.9999855756759644	O
3673	to	124 126	15526 15528	0.9999868869781494	O
3674	the	127 130	15529 15532	0.9999854564666748	O
3675	Netherlands	131 142	15533 15544	0.9968311190605164	O
3676	Cancer	143 149	15545 15551	0.9999833106994629	O
3677	Registry	150 157	15552 15559	0.9999850988388062	O
3679	,	159 160	15561 15562	0.9999855756759644	O
3680	i	161 162	15563 15564	0.9999871253967285	O
3681	.	163 164	15565 15566	0.9999853372573853	O
3682	e	164 165	15566 15567	0.9999855756759644	O
3683	.	166 167	15568 15569	0.9999700784683228	O
3684	nine	0 4	15570 15574	0.9999798536300659	O
3685	regional	5 13	15575 15583	0.9999785423278809	O
3686	cancer	14 20	15584 15590	0.9999821186065674	O
3687	registries	21 30	15591 15600	0.9999873638153076	O
3690	throughout	32 42	15602 15612	0.9999791383743286	O
3691	the	43 46	15613 15616	0.9999774694442749	O
3692	Netherlands	47 58	15617 15628	0.9989575147628784	O
3693	,	59 60	15629 15630	0.9999806880950928	O
3694	and	61 64	15631 15634	0.9999841451644897	O
3695	to	65 67	15635 15637	0.9999852180480957	O
3696	PALGA	68 72	15638 15642	0.9999858140945435	O
3699	,	74 75	15644 15645	0.999987006187439	O
3700	a	76 77	15646 15647	0.9999873638153076	O
3701	nationwide	78 88	15648 15658	0.9999792575836182	O
3702	network	89 96	15659 15666	0.9999854564666748	O
3703	and	97 100	15667 15670	0.9999872446060181	O
3704	registry	101 109	15671 15679	0.9999865293502808	O
3705	of	110 112	15680 15682	0.999987006187439	O
3706	histo	113 117	15683 15687	0.9999872446060181	O
3708	-	119 120	15689 15690	0.9999880790710449	O
3709	and	121 124	15691 15694	0.9999873638153076	O
3710	cytopathology	125 137	15695 15707	0.9999878406524658	O
3715	[	139 140	15709 15710	0.9999885559082031	O
3716	30	140 142	15710 15712	0.9999855756759644	O
3717	]	142 143	15712 15713	0.9999879598617554	O
3718	.	144 145	15714 15715	0.999970555305481	O
3719	Together	0 8	15716 15724	0.9999825954437256	O
3720	,	9 10	15725 15726	0.9999864101409912	O
3721	the	11 14	15727 15730	0.9999862909317017	O
3722	NCR	15 17	15731 15733	0.999985933303833	O
3724	and	19 22	15735 15738	0.999987006187439	O
3725	PALGA	23 27	15739 15743	0.9999852180480957	O
3728	provide	29 36	15745 15752	0.9999853372573853	O
3729	a	37 38	15753 15754	0.9999878406524658	O
3730	near	39 43	15755 15759	0.9999865293502808	O
3731	100	44 47	15760 15763	0.9999837875366211	O
3732	%	48 49	15764 15765	0.9999878406524658	O
3733	coverage	50 58	15766 15774	0.9999852180480957	O
3734	of	59 61	15775 15777	0.9999868869781494	O
3735	the	62 65	15778 15781	0.999984622001648	O
3736	municipalities	66 80	15782 15796	0.9999744892120361	O
3737	included	81 89	15797 15805	0.9999861717224121	O
3738	in	90 92	15806 15808	0.9999862909317017	O
3739	the	93 96	15809 15812	0.9999871253967285	O
3740	NLCS	97 100	15813 15816	0.9999834299087524	O
3742	.	101 102	15817 15818	0.9999675750732422	O
3743	The	0 3	15819 15822	0.9999887943267822	O
3744	first	4 9	15823 15828	0.9999885559082031	O
3745	2	10 11	15829 15830	0.9999876022338867	O
3746	.	11 12	15830 15831	0.9999881982803345	O
3747	3	12 13	15831 15832	0.9999856948852539	O
3748	years	14 19	15833 15838	0.9999886751174927	O
3749	of	20 22	15839 15841	0.9999887943267822	O
3750	follow	23 29	15842 15848	0.9999872446060181	O
3751	up	30 32	15849 15851	0.999988317489624	O
3752	were	33 37	15852 15856	0.9999881982803345	O
3753	excluded	38 46	15857 15865	0.9999847412109375	O
3754	because	47 54	15866 15873	0.9999884366989136	O
3755	of	55 57	15874 15876	0.99998939037323	O
3756	possible	58 66	15877 15885	0.9999885559082031	O
3757	pre	67 70	15886 15889	0.9999895095825195	O
3758	-	70 71	15889 15890	0.9999896287918091	O
3759	clinical	71 79	15890 15898	0.9999881982803345	O
3760	disease	80 87	15899 15906	0.9999880790710449	O
3761	affecting	88 97	15907 15916	0.9999884366989136	O
3762	exposure	98 106	15917 15925	0.9999845027923584	O
3763	status	107 113	15926 15932	0.9999891519546509	O
3764	and	114 117	15933 15936	0.9999877214431763	O
3765	because	118 125	15937 15944	0.9999881982803345	O
3766	of	126 128	15945 15947	0.9999895095825195	O
3767	incomplete	129 139	15948 15958	0.9999881982803345	O
3768	nationwide	140 150	15959 15969	0.9999858140945435	O
3769	coverage	151 159	15970 15978	0.9999881982803345	O
3770	of	160 162	15979 15981	0.9999892711639404	O
3771	PALGA	163 167	15982 15986	0.9999880790710449	O
3774	in	169 171	15988 15990	0.99998939037323	O
3775	some	172 176	15991 15995	0.9999874830245972	O
3776	of	177 179	15996 15998	0.9999889135360718	O
3777	the	180 183	15999 16002	0.9999884366989136	O
3778	municipalities	184 198	16003 16017	0.9999809265136719	O
3779	included	199 207	16018 16026	0.9999885559082031	O
3780	in	208 210	16027 16029	0.999988317489624	O
3781	the	211 214	16030 16033	0.9999887943267822	O
3782	NLCS	215 218	16034 16037	0.9999830722808838	O
3784	in	220 222	16039 16041	0.9999885559082031	O
3785	that	223 227	16042 16046	0.9999881982803345	O
3786	period	228 234	16047 16053	0.9999860525131226	O
3787	.	235 236	16054 16055	0.9999679327011108	O
3788	From	0 4	16056 16060	0.9999847412109375	O
3789	1989	5 9	16061 16065	0.9999779462814331	O
3790	until	10 15	16066 16071	0.9999842643737793	O
3791	1994	16 20	16072 16076	0.999977707862854	O
3792	,	21 22	16077 16078	0.9999862909317017	O
3793	929	23 25	16079 16081	0.9999772310256958	O
3795	incident	27 35	16083 16091	0.999964714050293	O
3796	cases	36 41	16092 16097	0.9999794960021973	O
3797	with	42 46	16098 16102	0.9999833106994629	O
3798	histologically	47 60	16103 16116	0.9999847412109375	O
3802	confirmed	62 71	16118 16127	0.9999833106994629	O
3803	colorectal	72 81	16128 16137	0.9999799728393555	O
3806	cancer	83 89	16139 16145	0.9999840259552002	O
3807	were	90 94	16146 16150	0.9999854564666748	O
3808	identified	95 105	16151 16161	0.9999852180480957	O
3809	within	106 112	16162 16168	0.9999839067459106	O
3810	the	113 116	16169 16172	0.9999855756759644	O
3811	cohort	117 122	16173 16178	0.9999860525131226	O
3814	,	124 125	16180 16181	0.999985933303833	O
3815	of	126 128	16182 16184	0.999987006187439	O
3816	whom	129 133	16185 16189	0.9999873638153076	O
3817	819	134 136	16190 16192	0.999985933303833	O
3819	could	138 143	16194 16199	0.9999855756759644	O
3820	also	144 148	16200 16204	0.9999864101409912	O
3821	be	149 151	16205 16207	0.9999878406524658	O
3822	linked	152 158	16208 16214	0.9999871253967285	O
3823	to	159 161	16215 16217	0.9999884366989136	O
3824	a	162 163	16218 16219	0.9999884366989136	O
3825	PALGA	164 168	16220 16224	0.9999862909317017	O
3828	report	170 176	16226 16232	0.9999864101409912	O
3829	of	177 179	16233 16235	0.9999873638153076	O
3830	the	180 183	16236 16239	0.9999862909317017	O
3831	lesion	184 189	16240 16245	0.9999841451644897	O
3833	.	191 192	16247 16248	0.9999650716781616	O
3834	The	0 3	16249 16252	0.9999825954437256	O
3835	PALGA	4 8	16253 16257	0.999983549118042	O
3838	reports	10 17	16259 16266	0.9999822378158569	O
3839	were	18 22	16267 16271	0.9999775886535645	O
3840	used	23 27	16272 16276	0.9999792575836182	O
3841	to	28 30	16277 16279	0.9999819993972778	O
3842	identify	31 39	16280 16288	0.9999825954437256	O
3843	and	40 43	16289 16292	0.9999810457229614	O
3844	locate	44 50	16293 16299	0.999976634979248	O
3845	tumour	51 56	16300 16305	0.9999831914901733	O
3847	tissue	58 64	16307 16313	0.9999791383743286	O
3848	from	65 69	16314 16318	0.999983549118042	O
3849	eligible	70 78	16319 16327	0.999977707862854	O
3850	colorectal	79 88	16328 16337	0.9999818801879883	O
3853	cancer	90 96	16339 16345	0.9999822378158569	O
3854	patients	97 105	16346 16354	0.9999765157699585	O
3855	in	106 108	16355 16357	0.9999781847000122	O
3856	Dutch	109 114	16358 16363	0.9829410910606384	O
3857	pathology	115 123	16364 16372	0.9999821186065674	O
3859	laboratories	125 137	16374 16386	0.9999802112579346	O
3860	.	138 139	16387 16388	0.9999396800994873	O
3861	Colon	0 4	16389 16393	0.9999740123748779	O
3863	and	6 9	16395 16398	0.9999815225601196	O
3864	rectal	10 15	16399 16404	0.9999768733978271	O
3867	cancer	17 23	16406 16412	0.999984860420227	O
3868	were	24 28	16413 16417	0.9999847412109375	O
3869	classified	29 39	16418 16428	0.9999845027923584	O
3870	according	40 49	16429 16438	0.9999878406524658	O
3871	to	50 52	16439 16441	0.9999885559082031	O
3872	site	53 57	16442 16446	0.999985933303833	O
3873	as	58 60	16447 16449	0.9999885559082031	O
3874	follows	61 68	16450 16457	0.9999880790710449	O
3875	,	69 70	16458 16459	0.9999873638153076	O
3876	colon	71 75	16460 16464	0.999987006187439	O
3878	:	77 78	16466 16467	0.9999878406524658	O
3879	cecum	79 83	16468 16472	0.9999877214431763	O
3882	through	85 92	16474 16481	0.9999862909317017	O
3883	sigmoid	93 99	16482 16488	0.9999833106994629	O
3887	colon	101 105	16490 16494	0.9999879598617554	O
3889	(	107 108	16496 16497	0.99998939037323	O
3890	ICD	109 111	16498 16500	0.9999890327453613	O
3892	-	112 113	16501 16502	0.9999889135360718	O
3893	O	113 114	16502 16503	0.9999884366989136	O
3894	codes	115 120	16504 16509	0.9999890327453613	O
3895	153	121 124	16510 16513	0.999988317489624	O
3896	.	124 125	16513 16514	0.9999891519546509	O
3897	0	125 126	16514 16515	0.9999887943267822	O
3898	,	126 127	16515 16516	0.9999884366989136	O
3899	153	128 131	16517 16520	0.9999879598617554	O
3900	.	131 132	16520 16521	0.9999890327453613	O
3901	1	132 133	16521 16522	0.9999886751174927	O
3902	,	134 135	16523 16524	0.9999886751174927	O
3903	153	136 139	16525 16528	0.9999880790710449	O
3904	.	139 140	16528 16529	0.9999890327453613	O
3905	2	140 141	16529 16530	0.9999878406524658	O
3906	,	142 143	16531 16532	0.9999886751174927	O
3907	153	144 147	16533 16536	0.9999880790710449	O
3908	.	147 148	16536 16537	0.9999890327453613	O
3909	3	148 149	16537 16538	0.9999879598617554	O
3910	,	150 151	16539 16540	0.9999885559082031	O
3911	153	152 155	16541 16544	0.9999878406524658	O
3912	.	155 156	16544 16545	0.9999889135360718	O
3913	4	156 157	16545 16546	0.9999873638153076	O
3914	,	158 159	16547 16548	0.9999885559082031	O
3915	153	160 163	16549 16552	0.9999874830245972	O
3916	.	163 164	16552 16553	0.9999887943267822	O
3917	5	164 165	16553 16554	0.9999879598617554	O
3918	,	166 167	16555 16556	0.9999885559082031	O
3919	153	168 171	16557 16560	0.9999878406524658	O
3920	.	171 172	16560 16561	0.9999889135360718	O
3921	6	172 173	16561 16562	0.9999879598617554	O
3922	,	174 175	16563 16564	0.999988317489624	O
3923	153	176 179	16565 16568	0.9999877214431763	O
3924	.	179 180	16568 16569	0.9999890327453613	O
3925	7	180 181	16569 16570	0.9999878406524658	O
3926	)	182 183	16571 16572	0.9999891519546509	O
3927	,	184 185	16573 16574	0.9999886751174927	O
3928	rectosigmoid	186 197	16575 16586	0.9999880790710449	O
3934	(	199 200	16588 16589	0.99998939037323	O
3935	ICD	201 203	16590 16592	0.9999891519546509	O
3937	-	204 205	16593 16594	0.9999890327453613	O
3938	O	205 206	16594 16595	0.9999886751174927	O
3939	code	207 211	16596 16600	0.9999889135360718	O
3940	154	212 215	16601 16604	0.9999878406524658	O
3941	.	215 216	16604 16605	0.9999891519546509	O
3942	0	216 217	16605 16606	0.9999885559082031	O
3943	)	217 218	16606 16607	0.9999892711639404	O
3944	,	219 220	16608 16609	0.9999877214431763	O
3945	and	221 224	16610 16613	0.9999880790710449	O
3946	rectum	225 230	16614 16619	0.9999865293502808	O
3949	(	232 233	16621 16622	0.9999892711639404	O
3950	ICD	234 236	16623 16625	0.9999890327453613	O
3952	-	237 238	16626 16627	0.9999890327453613	O
3953	O	238 239	16627 16628	0.999988317489624	O
3954	code	240 244	16629 16633	0.9999887943267822	O
3955	154	245 248	16634 16637	0.9999874830245972	O
3956	.	248 249	16637 16638	0.9999889135360718	O
3957	1	249 250	16638 16639	0.9999884366989136	O
3958	)	251 252	16640 16641	0.9999892711639404	O
3959	.	253 254	16642 16643	0.9999415874481201	O
3960	Tissue	0 5	16644 16649	0.9999861717224121	O
3963	samples	7 14	16651 16658	0.9999840259552002	O
3964	Tumour	15 20	16659 16664	0.999977707862854	O
3966	material	22 30	16666 16674	0.9999853372573853	O
3967	of	31 33	16675 16677	0.999985933303833	O
3968	colorectal	34 43	16678 16687	0.9999803304672241	O
3971	cancer	45 51	16689 16695	0.9999839067459106	O
3972	patients	52 60	16696 16704	0.999980092048645	O
3973	was	61 64	16705 16708	0.9999880790710449	O
3974	collected	65 74	16709 16718	0.9999879598617554	O
3975	after	75 80	16719 16724	0.9999886751174927	O
3976	approval	81 89	16725 16733	0.9999880790710449	O
3977	by	90 92	16734 16736	0.9999887943267822	O
3978	the	93 96	16737 16740	0.9999890327453613	O
3979	Ethical	97 103	16741 16747	0.9999878406524658	O
3981	Review	105 111	16749 16755	0.9999873638153076	O
3982	Board	112 117	16756 16761	0.9999876022338867	O
3983	of	118 120	16762 16764	0.9999881982803345	O
3984	Maastricht	121 130	16765 16774	0.9999847412109375	O
3988	University	132 142	16776 16786	0.9999880790710449	O
3989	,	143 144	16787 16788	0.9999886751174927	O
3990	PALGA	145 149	16789 16793	0.9999871253967285	O
3993	and	151 154	16795 16798	0.9999881982803345	O
3994	the	155 158	16799 16802	0.9999886751174927	O
3995	NCR	159 161	16803 16805	0.9999879598617554	O
3997	.	162 163	16806 16807	0.999977707862854	O
3998	Tissue	0 5	16808 16813	0.9999780654907227	O
4001	samples	7 14	16815 16822	0.9999784231185913	O
4002	from	15 19	16823 16827	0.9999794960021973	O
4003	819	20 22	16828 16830	0.9999682903289795	O
4005	colorectal	24 33	16832 16841	0.9999699592590332	O
4008	cancer	35 41	16843 16849	0.9999798536300659	O
4009	patients	42 50	16850 16858	0.9999425411224365	O
4010	were	51 55	16859 16863	0.9999806880950928	O
4011	localized	56 65	16864 16873	0.9999809265136719	O
4012	in	66 68	16874 16876	0.9999814033508301	O
4013	54	69 71	16877 16879	0.9999576807022095	O
4014	pathology	72 80	16880 16888	0.999982476234436	O
4016	laboratories	82 94	16890 16902	0.9999769926071167	O
4017	throughout	95 105	16903 16913	0.9999738931655884	O
4018	the	106 109	16914 16917	0.9999701976776123	O
4019	Netherlands	110 121	16918 16929	0.9993508458137512	O
4020	.	122 123	16930 16931	0.9999330043792725	O
4021	Forty	0 5	16932 16937	0.9999171495437622	O
4022	-	5 6	16937 16938	0.9999814033508301	O
4023	four	6 10	16938 16942	0.9999525547027588	O
4024	(	11 12	16943 16944	0.9999821186065674	O
4025	5	13 14	16945 16946	0.9999606609344482	O
4026	%	15 16	16947 16948	0.9999822378158569	O
4027	)	17 18	16949 16950	0.9999836683273315	O
4028	tumour	19 24	16951 16956	0.999974250793457	O
4030	tissue	26 32	16958 16964	0.9999758005142212	O
4031	samples	33 40	16965 16972	0.9999821186065674	O
4032	could	41 46	16973 16978	0.9999812841415405	O
4033	not	47 50	16979 16982	0.9999821186065674	O
4034	be	51 53	16983 16985	0.9999854564666748	O
4035	retrieved	54 63	16986 16995	0.9999861717224121	O
4036	from	64 68	16996 17000	0.9999850988388062	O
4037	the	69 72	17001 17004	0.9999828338623047	O
4038	pathology	73 81	17005 17013	0.9999792575836182	O
4040	archives	83 91	17015 17023	0.9999759197235107	O
4041	.	92 93	17024 17025	0.9999334812164307	O
4042	Of	0 2	17026 17028	0.9999841451644897	O
4043	775	3 5	17029 17031	0.9999724626541138	O
4045	available	7 16	17033 17042	0.9999744892120361	O
4046	tissue	17 23	17043 17049	0.9999699592590332	O
4047	samples	24 31	17050 17057	0.9999812841415405	O
4048	,	32 33	17058 17059	0.9999818801879883	O
4049	737	34 37	17060 17063	0.9999644756317139	O
4050	(	38 39	17064 17065	0.9999852180480957	O
4051	95	40 42	17066 17068	0.9999754428863525	O
4052	%	43 44	17069 17070	0.999984860420227	O
4053	)	45 46	17071 17072	0.9999856948852539	O
4054	contained	47 56	17073 17082	0.9999840259552002	O
4055	sufficient	57 67	17083 17093	0.9999815225601196	O
4056	tumour	68 73	17094 17099	0.999984622001648	O
4058	material	75 83	17101 17109	0.9999840259552002	O
4059	for	84 87	17110 17113	0.9999825954437256	O
4060	molecular	88 97	17114 17123	0.9999829530715942	O
4061	analyses	98 106	17124 17132	0.9999842643737793	O
4062	.	107 108	17133 17134	0.9999508857727051	O
4063	Tissue	0 5	17135 17140	0.9999788999557495	O
4066	sections	7 15	17142 17150	0.9999673366546631	O
4067	were	16 20	17151 17155	0.9999828338623047	O
4068	cut	21 24	17156 17159	0.9999759197235107	O
4069	from	25 29	17160 17164	0.9999839067459106	O
4070	each	30 34	17165 17169	0.9999845027923584	O
4071	sample	35 41	17170 17176	0.999982476234436	O
4072	,	42 43	17177 17178	0.9999849796295166	O
4073	which	44 49	17179 17184	0.9999864101409912	O
4074	were	50 54	17185 17189	0.9999865293502808	O
4075	used	55 59	17190 17194	0.999985933303833	O
4076	for	60 63	17195 17198	0.9999879598617554	O
4077	DNA	64 67	17199 17202	0.9999852180480957	O
4078	isolation	68 77	17203 17212	0.9999881982803345	O
4079	and	78 81	17213 17216	0.9999872446060181	O
4080	immunohistochemical	82 100	17217 17235	0.9999873638153076	O
4086	analysis	102 110	17237 17245	0.9999881982803345	O
4087	.	111 112	17246 17247	0.9999376535415649	O
4088	DNA	0 3	17248 17251	0.999982476234436	O
4089	isolation	4 13	17252 17261	0.9999849796295166	O
4090	DNA	14 17	17262 17265	0.9999837875366211	O
4091	isolation	18 27	17266 17275	0.9999847412109375	O
4092	was	28 31	17276 17279	0.9999865293502808	O
4093	described	32 41	17280 17289	0.9999856948852539	O
4094	in	42 44	17290 17292	0.9999878406524658	O
4095	detail	45 51	17293 17299	0.9999866485595703	O
4096	elsewhere	52 61	17300 17309	0.9999841451644897	O
4097	[	62 63	17310 17311	0.999988317489624	O
4098	27	63 65	17311 17313	0.9999834299087524	O
4099	]	65 66	17313 17314	0.9999878406524658	O
4100	.	67 68	17315 17316	0.9999686479568481	O
4101	Briefly	0 6	17317 17323	0.9999825954437256	O
4104	,	8 9	17325 17326	0.999988317489624	O
4105	a	10 11	17327 17328	0.9999886751174927	O
4106	4	12 13	17329 17330	0.9999871253967285	O
4107	μm	14 15	17331 17332	0.999984622001648	O
4109	section	17 24	17334 17341	0.9999829530715942	O
4110	,	25 26	17342 17343	0.9999880790710449	O
4111	cut	27 30	17344 17347	0.9999860525131226	O
4112	from	31 35	17348 17352	0.999988317489624	O
4113	each	36 40	17353 17357	0.9999881982803345	O
4114	paraffin	41 48	17358 17365	0.9999874830245972	O
4116	-	49 50	17366 17367	0.9999891519546509	O
4117	embedded	50 58	17367 17375	0.999983549118042	O
4118	tumour	59 64	17376 17381	0.999985933303833	O
4120	tissue	66 72	17383 17389	0.9999881982803345	O
4121	block	73 78	17390 17395	0.999987006187439	O
4122	,	79 80	17396 17397	0.9999878406524658	O
4123	was	81 84	17398 17401	0.9999889135360718	O
4124	stained	85 92	17402 17409	0.9999866485595703	O
4125	with	93 97	17410 17414	0.9999890327453613	O
4126	haematoxylin	98 109	17415 17426	0.9999866485595703	O
4131	and	111 114	17428 17431	0.9999884366989136	O
4132	eosin	115 119	17432 17436	0.9999878406524658	O
4135	(	121 122	17438 17439	0.9999891519546509	O
4136	HE	123 124	17440 17441	0.9999860525131226	O
4138	)	126 127	17443 17444	0.9999891519546509	O
4139	for	128 131	17445 17448	0.9999886751174927	O
4140	histopathological	132 148	17449 17465	0.9999872446060181	O
4144	examination	150 161	17467 17478	0.9999877214431763	O
4145	by	162 164	17479 17481	0.9999879598617554	O
4146	a	165 166	17482 17483	0.9999886751174927	O
4147	pathologist	167 177	17484 17494	0.9999854564666748	O
4149	.	179 180	17496 17497	0.9999704360961914	O
4150	Five	0 4	17498 17502	0.9999798536300659	O
4151	20	5 7	17503 17505	0.9999815225601196	O
4152	μm	8 9	17506 17507	0.9999804496765137	O
4154	sections	11 19	17509 17517	0.9999728202819824	O
4155	of	20 22	17518 17520	0.9999834299087524	O
4156	tumour	23 28	17521 17526	0.9999772310256958	O
4158	tissue	30 36	17528 17534	0.9999755620956421	O
4159	were	37 41	17535 17539	0.9999842643737793	O
4160	cut	42 45	17540 17543	0.9999802112579346	O
4161	from	46 50	17544 17548	0.9999860525131226	O
4162	each	51 55	17549 17553	0.999985933303833	O
4163	sample	56 62	17554 17560	0.9999845027923584	O
4164	for	63 66	17561 17564	0.9999862909317017	O
4165	DNA	67 70	17565 17568	0.9999841451644897	O
4166	isolation	71 80	17569 17578	0.9999868869781494	O
4167	.	81 82	17579 17580	0.9999483823776245	O
4168	Tumour	0 5	17581 17586	0.9999310970306396	O
4170	tissue	7 13	17588 17594	0.9999724626541138	O
4171	was	14 17	17595 17598	0.9999812841415405	O
4172	separated	18 27	17599 17608	0.9999791383743286	O
4173	from	28 32	17609 17613	0.9999842643737793	O
4174	normal	33 39	17614 17620	0.9999436140060425	O
4175	colon	40 44	17621 17625	0.9999634027481079	O
4177	epithelium	46 55	17627 17636	0.9999847412109375	O
4181	using	57 62	17638 17643	0.9999872446060181	O
4182	the	63 66	17644 17647	0.9999881982803345	O
4183	HE	67 68	17648 17649	0.9999831914901733	O
4185	section	70 77	17651 17658	0.9999867677688599	O
4186	as	78 80	17659 17661	0.9999884366989136	O
4187	a	81 82	17662 17663	0.9999885559082031	O
4188	reference	83 92	17664 17673	0.9999829530715942	O
4189	.	93 94	17674 17675	0.9999462366104126	O
4190	Genomic	0 6	17676 17682	0.9999843835830688	O
4193	DNA	8 11	17684 17687	0.9999765157699585	O
4194	was	12 15	17688 17691	0.9999842643737793	O
4195	extracted	16 25	17692 17701	0.9999833106994629	O
4196	from	26 30	17702 17706	0.9999861717224121	O
4197	macrodissected	31 44	17707 17720	0.9999797344207764	O
4201	tumour	46 51	17722 17727	0.9999830722808838	O
4203	tissue	53 59	17729 17735	0.9999837875366211	O
4204	using	60 65	17736 17741	0.9999871253967285	O
4205	proteinase	66 75	17742 17751	0.9999836683273315	O
4207	K	77 78	17753 17754	0.999985933303833	O
4208	(	79 80	17755 17756	0.9999873638153076	O
4209	Qiagen	81 86	17757 17762	0.9999804496765137	O
4212	,	88 89	17764 17765	0.9999876022338867	O
4213	St	90 92	17766 17768	0.9999842643737793	O
4214	.	93 94	17769 17770	0.9999773502349854	O
4215	Louis	0 5	17771 17776	0.9999690055847168	O
4216	,	6 7	17777 17778	0.9999873638153076	O
4217	MO	8 9	17779 17780	0.9999828338623047	O
4219	,	11 12	17782 17783	0.9999877214431763	O
4220	USA	13 16	17784 17787	0.9999717473983765	O
4221	)	17 18	17788 17789	0.9999864101409912	O
4222	and	19 22	17790 17793	0.999985933303833	O
4223	the	23 26	17794 17797	0.9999862909317017	O
4224	Puregene	27 34	17798 17805	0.999981164932251	O
4226	DNA	36 39	17807 17810	0.9999843835830688	O
4227	isolation	40 49	17811 17820	0.9999862909317017	O
4228	kit	50 53	17821 17824	0.9999868869781494	O
4229	(	54 55	17825 17826	0.9999884366989136	O
4230	Gentra	56 61	17827 17832	0.9999872446060181	O
4232	Systems	63 70	17834 17841	0.9999862909317017	O
4233	,	71 72	17842 17843	0.9999874830245972	O
4234	Minneapolis	73 84	17844 17855	0.9999465942382812	O
4235	,	85 86	17856 17857	0.9999866485595703	O
4236	MN	87 88	17858 17859	0.9999834299087524	O
4238	,	90 91	17861 17862	0.9999877214431763	O
4239	USA	92 95	17863 17866	0.9999827146530151	O
4240	)	96 97	17867 17868	0.999988317489624	O
4241	.	98 99	17869 17870	0.9999581575393677	O
4242	DNA	0 3	17871 17874	0.9999697208404541	O
4243	concentration	4 17	17875 17888	0.9999779462814331	O
4244	and	18 21	17889 17892	0.9999769926071167	O
4245	purity	22 28	17893 17899	0.9999780654907227	O
4246	was	29 32	17900 17903	0.9999717473983765	O
4247	measured	33 41	17904 17912	0.9999748468399048	O
4248	at	42 44	17913 17915	0.9999816417694092	O
4249	260	45 48	17916 17919	0.9999806880950928	O
4250	and	49 52	17920 17923	0.9999797344207764	O
4251	280	53 56	17924 17927	0.9999758005142212	O
4252	nm	57 59	17928 17930	0.9999827146530151	O
4253	.	60 61	17931 17932	0.9998917579650879	O
4254	Conclusion	0 9	17933 17942	0.9999794960021973	O
4257	In	11 13	17944 17946	0.9999854564666748	O
4258	conclusion	14 24	17947 17957	0.9999798536300659	O
4259	,	25 26	17958 17959	0.9999855756759644	O
4260	this	27 31	17960 17964	0.9999842643737793	O
4261	study	32 37	17965 17970	0.9999771118164062	O
4262	shows	38 43	17971 17976	0.9999775886535645	O
4263	that	44 48	17977 17981	0.9999850988388062	O
4264	mutations	49 58	17982 17991	0.9999809265136719	O
4265	in	59 61	17992 17994	0.9999862909317017	O
4266	the	62 65	17995 17998	0.9999856948852539	O
4267	CTNNB1	66 71	17999 18004	0.9999818801879883	O
4272	gene	73 77	18006 18010	0.9999852180480957	O
4273	are	78 81	18011 18014	0.9999852180480957	O
4274	presumably	82 92	18015 18025	0.9999841451644897	O
4275	of	93 95	18026 18028	0.9999864101409912	O
4276	minor	96 101	18029 18034	0.9999798536300659	O
4277	importance	102 112	18035 18045	0.9999858140945435	O
4278	in	113 115	18046 18048	0.9999839067459106	O
4279	sporadic	116 123	18049 18056	0.9999821186065674	O
4281	colorectal	125 134	18058 18067	0.9999814033508301	O
4284	cancer	136 142	18069 18075	0.9999837875366211	O
4285	.	143 144	18076 18077	0.999954342842102	O
4286	Although	0 8	18078 18086	0.9999831914901733	O
4287	APC	9 11	18087 18089	0.9999815225601196	O
4289	and	13 16	18091 18094	0.9999850988388062	O
4290	K	17 18	18095 18096	0.9999806880950928	O
4291	-	18 19	18096 18097	0.9999877214431763	O
4292	ras	19 21	18097 18099	0.9999836683273315	O
4294	mutations	23 32	18101 18110	0.9999867677688599	O
4295	are	33 36	18111 18114	0.9999873638153076	O
4296	often	37 42	18115 18120	0.9999864101409912	O
4297	observed	43 51	18121 18129	0.9999868869781494	O
4298	seperately	52 61	18130 18139	0.9999885559082031	O
4301	in	63 65	18141 18143	0.9999867677688599	O
4302	a	66 67	18144 18145	0.9999841451644897	O
4303	tumour	68 73	18146 18151	0.9999850988388062	O
4305	,	75 76	18153 18154	0.9999836683273315	O
4306	these	77 82	18155 18160	0.9999874830245972	O
4307	mutations	83 92	18161 18170	0.9999839067459106	O
4308	seem	93 97	18171 18175	0.9999828338623047	O
4309	to	98 100	18176 18178	0.9999873638153076	O
4310	also	101 105	18179 18183	0.9999855756759644	O
4311	occur	106 111	18184 18189	0.9999881982803345	O
4312	in	112 114	18190 18192	0.9999889135360718	O
4313	a	115 116	18193 18194	0.9999889135360718	O
4314	co	117 119	18195 18197	0.9999878406524658	O
4315	-	119 120	18197 18198	0.9999886751174927	O
4316	dependent	120 129	18198 18207	0.9999871253967285	O
4317	manner	130 136	18208 18214	0.999988317489624	O
4318	.	137 138	18215 18216	0.9999637603759766	O
4319	Tumours	0 6	18217 18223	0.9999805688858032	O
4322	that	8 12	18225 18229	0.9999837875366211	O
4323	display	13 20	18230 18237	0.9999808073043823	O
4324	mismatch	21 28	18238 18245	0.9999845027923584	O
4327	repair	30 36	18247 18253	0.9999850988388062	O
4328	deficiency	37 47	18254 18264	0.9999841451644897	O
4329	,	48 49	18265 18266	0.9999817609786987	O
4330	may	50 53	18267 18270	0.9999843835830688	O
4331	form	54 58	18271 18275	0.9999861717224121	O
4332	a	59 60	18276 18277	0.9999866485595703	O
4333	distinct	61 69	18278 18286	0.9999849796295166	O
4334	sub	70 73	18287 18290	0.9999877214431763	O
4335	-	73 74	18290 18291	0.9999872446060181	O
4336	group	74 79	18291 18296	0.9999862909317017	O
4337	as	80 82	18297 18299	0.9999852180480957	O
4338	they	83 87	18300 18304	0.9999864101409912	O
4339	differ	88 94	18305 18311	0.999983549118042	O
4340	from	95 99	18312 18316	0.9999843835830688	O
4341	tumours	100 106	18317 18323	0.9999854564666748	O
4344	with	108 112	18325 18329	0.9999852180480957	O
4345	APC	113 115	18330 18332	0.999984860420227	O
4347	and	117 120	18334 18337	0.9999874830245972	O
4348	/	120 121	18337 18338	0.999987006187439	O
4349	or	121 123	18338 18340	0.9999872446060181	O
4350	K	124 125	18341 18342	0.9999827146530151	O
4351	-	125 126	18342 18343	0.9999877214431763	O
4352	ras	126 128	18343 18345	0.9999845027923584	O
4354	mutations	130 139	18347 18356	0.9999865293502808	O
4355	with	140 144	18357 18361	0.9999868869781494	O
4356	regard	145 151	18362 18368	0.999987006187439	O
4357	to	152 154	18369 18371	0.9999876022338867	O
4358	age	155 158	18372 18375	0.9999847412109375	O
4359	,	159 160	18376 18377	0.9999868869781494	O
4360	sex	161 164	18378 18381	0.9999790191650391	O
4361	,	165 166	18382 18383	0.9999865293502808	O
4362	tumour	167 172	18384 18389	0.9999854564666748	O
4364	sub	174 177	18391 18394	0.9999877214431763	O
4365	-	177 178	18394 18395	0.9999873638153076	O
4366	localisation	178 189	18395 18406	0.999987006187439	O
4368	and	191 194	18408 18411	0.9999866485595703	O
4369	differentiation	195 210	18412 18427	0.9999830722808838	O
4370	.	211 212	18428 18429	0.9999868869781494	O
4371	*	213 214	18430 18431	0.9999854564666748	O
4372	*	214 215	18431 18432	0.9999659061431885	O
4373	IGNORE	0 5	18433 18438	0.9999849796295166	O
4376	LINE	7 10	18440 18443	0.9999878406524658	O
4379	*	12 13	18445 18446	0.999988317489624	O
4380	*	13 14	18446 18447	0.9999881982803345	O
4381	*	15 16	18448 18449	0.9999881982803345	O
4382	*	16 17	18449 18450	0.9999884366989136	O
4383	IGNORE	18 23	18451 18456	0.9999871253967285	O
4386	LINE	25 28	18458 18461	0.9999884366989136	O
4389	*	30 31	18463 18464	0.9999881982803345	O
4390	*	31 32	18464 18465	0.9999881982803345	O
4391	*	33 34	18466 18467	0.9999880790710449	O
4392	*	34 35	18467 18468	0.9999881982803345	O
4393	IGNORE	36 41	18469 18474	0.9999866485595703	O
4396	LINE	43 46	18476 18479	0.9999881982803345	O
4399	*	48 49	18481 18482	0.999988317489624	O
4400	*	49 50	18482 18483	0.999988317489624	O
4401	Background	51 61	18484 18494	0.9999854564666748	O
4402	BRAF	62 65	18495 18498	0.999984622001648	O
4404	is	67 69	18500 18502	0.9999881982803345	O
4405	a	70 71	18503 18504	0.9999886751174927	O
4406	member	72 78	18505 18511	0.9999877214431763	O
4407	of	79 81	18512 18514	0.9999881982803345	O
4408	the	82 85	18515 18518	0.9999876022338867	O
4409	RAF	86 89	18519 18522	0.9999790191650391	O
4410	family	90 96	18523 18529	0.9999867677688599	O
4411	of	97 99	18530 18532	0.9999878406524658	O
4412	kinases	100 106	18533 18539	0.9999810457229614	O
4414	that	108 112	18541 18545	0.9999879598617554	O
4415	acts	113 117	18546 18550	0.9999865293502808	O
4416	upstream	118 126	18551 18559	0.9999850988388062	O
4417	of	127 129	18560 18562	0.9999878406524658	O
4418	the	130 133	18563 18566	0.9999862909317017	O
4419	MEK1	134 137	18567 18570	0.9999785423278809	O
4422	/	138 139	18571 18572	0.9999881982803345	O
4423	2	139 140	18572 18573	0.999984622001648	O
4424	kinases	141 147	18574 18580	0.9999865293502808	O
4426	in	149 151	18582 18584	0.9999871253967285	O
4427	response	152 160	18585 18593	0.9999866485595703	O
4428	to	161 163	18594 18596	0.9999876022338867	O
4429	RAS	164 166	18597 18599	0.9999816417694092	O
4431	signals	168 175	18601 18608	0.9999849796295166	O
4432	.	176 177	18609 18610	0.999936580657959	O
4433	Activating	0 9	18611 18620	0.9999841451644897	O
4435	mutations	11 20	18622 18631	0.9999866485595703	O
4436	in	21 23	18632 18634	0.9999877214431763	O
4437	BRAF	24 27	18635 18638	0.9999825954437256	O
4439	have	29 33	18640 18644	0.9999874830245972	O
4440	been	34 38	18645 18649	0.9999880790710449	O
4441	reported	39 47	18650 18658	0.9999865293502808	O
4442	in	48 50	18659 18661	0.9999889135360718	O
4443	5	51 52	18662 18663	0.9999879598617554	O
4444	–	52 53	18663 18664	0.9999819993972778	O
4445	15	53 55	18664 18666	0.999984622001648	O
4446	%	56 57	18667 18668	0.999987006187439	O
4447	of	58 60	18669 18671	0.9999864101409912	O
4448	colorectal	61 70	18672 18681	0.999982476234436	O
4451	carcinomas	72 81	18683 18692	0.9999853372573853	O
4455	(	83 84	18694 18695	0.9999852180480957	O
4456	CRC	85 87	18696 18698	0.9999817609786987	O
4458	)	89 90	18700 18701	0.9999885559082031	O
4459	,	91 92	18702 18703	0.9999872446060181	O
4460	with	93 97	18704 18708	0.9999880790710449	O
4461	by	98 100	18709 18711	0.999988317489624	O
4462	far	101 104	18712 18715	0.9999886751174927	O
4463	the	105 108	18716 18719	0.9999889135360718	O
4464	most	109 113	18720 18724	0.9999889135360718	O
4465	common	114 120	18725 18731	0.999988317489624	O
4466	mutation	121 129	18732 18740	0.9999872446060181	O
4467	being	130 135	18741 18746	0.9999891519546509	O
4468	a	136 137	18747 18748	0.9999887943267822	O
4469	1796T	138 142	18749 18753	0.9999843835830688	O
4471	to	144 146	18755 18757	0.9999874830245972	O
4472	A	147 148	18758 18759	0.9999866485595703	O
4473	transversion	149 160	18760 18771	0.9999887943267822	O
4475	leading	162 169	18773 18780	0.9999884366989136	O
4476	to	170 172	18781 18783	0.9999889135360718	O
4477	a	173 174	18784 18785	0.9999890327453613	O
4478	V600E	175 179	18786 18790	0.999988317489624	O
4482	substitution	181 193	18792 18804	0.9999886751174927	O
4483	[	194 195	18805 18806	0.99998939037323	O
4484	1	195 196	18806 18807	0.9999891519546509	O
4485	-	196 197	18807 18808	0.9999891519546509	O
4486	3	197 198	18808 18809	0.9999879598617554	O
4487	]	198 199	18809 18810	0.9999890327453613	O
4488	.	200 201	18811 18812	0.9999738931655884	O
4489	The	0 3	18813 18816	0.9999881982803345	O
4490	BRAF	4 7	18817 18820	0.9999834299087524	O
4492	V600E	9 13	18822 18826	0.9999880790710449	O
4496	hotspot	15 21	18828 18834	0.9999887943267822	O
4499	mutation	23 31	18836 18844	0.9999887943267822	O
4500	is	32 34	18845 18847	0.9999886751174927	O
4501	strongly	35 43	18848 18856	0.9999878406524658	O
4502	associated	44 54	18857 18867	0.9999896287918091	O
4503	with	55 59	18868 18872	0.9999895095825195	O
4504	the	60 63	18873 18876	0.9999890327453613	O
4505	microsatellite	64 77	18877 18890	0.9999876022338867	O
4509	instability	79 90	18892 18903	0.9999877214431763	O
4510	(	91 92	18904 18905	0.9999895095825195	O
4511	MSI	93 95	18906 18908	0.999985933303833	O
4513	+	96 97	18909 18910	0.9999886751174927	O
4514	)	98 99	18911 18912	0.9999892711639404	O
4515	phenotype	100 108	18913 18921	0.99998939037323	O
4518	but	110 113	18923 18926	0.9999862909317017	O
4519	is	114 116	18927 18929	0.9999891519546509	O
4520	mutually	117 125	18930 18938	0.999988317489624	O
4521	exclusive	126 135	18939 18948	0.9999895095825195	O
4522	with	136 140	18949 18953	0.9999892711639404	O
4523	KRAS	141 144	18954 18957	0.9999840259552002	O
4526	mutations	146 155	18959 18968	0.9999880790710449	O
4527	[	156 157	18969 18970	0.9999896287918091	O
4528	4	157 158	18970 18971	0.9999881982803345	O
4529	-	158 159	18971 18972	0.99998939037323	O
4530	7	159 160	18972 18973	0.9999881982803345	O
4531	]	160 161	18973 18974	0.9999891519546509	O
4532	.	162 163	18975 18976	0.9999728202819824	O
4533	Interestingly	0 12	18977 18989	0.9999868869781494	O
4535	,	14 15	18991 18992	0.9999886751174927	O
4536	BRAF	16 19	18993 18996	0.9999815225601196	O
4538	mutations	21 30	18998 19007	0.999984622001648	O
4539	are	31 34	19008 19011	0.999988317489624	O
4540	found	35 40	19012 19017	0.9999884366989136	O
4541	only	41 45	19018 19022	0.9999874830245972	O
4542	in	46 48	19023 19025	0.9999890327453613	O
4543	MSI	49 51	19026 19028	0.9999864101409912	O
4545	+	52 53	19029 19030	0.9999876022338867	O
4546	sporadic	54 61	19031 19038	0.9999862909317017	O
4548	tumors	63 69	19040 19046	0.999985933303833	O
4549	that	70 74	19047 19051	0.9999889135360718	O
4550	result	75 81	19052 19058	0.9999880790710449	O
4551	from	82 86	19059 19063	0.9999889135360718	O
4552	aberrant	87 94	19064 19071	0.9999889135360718	O
4555	MLH1	96 99	19073 19076	0.9999871253967285	O
4558	promoter	101 109	19078 19086	0.9999890327453613	O
4559	methylation	110 120	19087 19097	0.9999887943267822	O
4562	and	122 125	19099 19102	0.999988317489624	O
4563	do	126 128	19103 19105	0.9999868869781494	O
4564	not	129 132	19106 19109	0.9999867677688599	O
4565	occur	133 138	19110 19115	0.9999884366989136	O
4566	in	139 141	19116 19118	0.9999887943267822	O
4567	MSI	142 144	19119 19121	0.9999861717224121	O
4569	+	145 146	19122 19123	0.9999862909317017	O
4570	tumors	147 153	19124 19130	0.9999867677688599	O
4571	from	154 158	19131 19135	0.9999867677688599	O
4572	hereditary	159 169	19136 19146	0.9999504089355469	O
4573	non	170 173	19147 19150	0.9999852180480957	O
4574	-	173 174	19150 19151	0.9999874830245972	O
4575	polyposis	174 182	19151 19159	0.9999847412109375	O
4579	colorectal	184 193	19161 19170	0.9999854564666748	O
4582	cancer	195 201	19172 19178	0.999987006187439	O
4583	(	202 203	19179 19180	0.9999881982803345	O
4584	HNPCC	204 208	19181 19185	0.9999735355377197	O
4587	)	210 211	19187 19188	0.9999881982803345	O
4588	patients	212 220	19189 19197	0.9999823570251465	O
4589	[	221 222	19198 19199	0.99998939037323	O
4590	5	222 223	19199 19200	0.9999877214431763	O
4591	,	223 224	19200 19201	0.9999881982803345	O
4592	8	224 225	19201 19202	0.9999881982803345	O
4593	-	225 226	19202 19203	0.9999891519546509	O
4594	10	226 228	19203 19205	0.9999864101409912	O
4595	]	228 229	19205 19206	0.9999889135360718	O
4596	,	230 231	19207 19208	0.9999887943267822	O
4597	thus	232 236	19209 19213	0.9999885559082031	O
4598	providing	237 246	19214 19223	0.9999887943267822	O
4599	a	247 248	19224 19225	0.9999891519546509	O
4600	convenient	249 259	19226 19236	0.9999837875366211	O
4601	discriminator	260 272	19237 19249	0.9999886751174927	O
4604	between	274 281	19251 19258	0.9999858140945435	O
4605	sporadic	282 289	19259 19266	0.9999858140945435	O
4607	and	291 294	19268 19271	0.9999853372573853	O
4608	familial	295 302	19272 19279	0.9999784231185913	O
4611	cases	304 309	19281 19286	0.9999862909317017	O
4612	.	310 311	19287 19288	0.9999611377716064	O
4613	The	0 3	19289 19292	0.9999866485595703	O
4614	majority	4 12	19293 19301	0.9999849796295166	O
4615	of	13 15	19302 19304	0.9999872446060181	O
4616	MSI	16 18	19305 19307	0.9999853372573853	O
4618	+	19 20	19308 19309	0.9999854564666748	O
4619	sporadic	21 28	19310 19317	0.9999819993972778	O
4621	tumors	30 36	19319 19325	0.9999815225601196	O
4622	belong	37 43	19326 19332	0.9999876022338867	O
4623	to	44 46	19333 19335	0.9999887943267822	O
4624	a	47 48	19336 19337	0.9999892711639404	O
4625	larger	49 55	19338 19344	0.9999827146530151	O
4626	CRC	56 58	19345 19347	0.999976396560669	O
4628	group	60 65	19349 19354	0.9999885559082031	O
4629	referred	66 74	19355 19363	0.999988317489624	O
4630	to	75 77	19364 19366	0.9999884366989136	O
4631	as	78 80	19367 19369	0.9999886751174927	O
4632	the	81 84	19370 19373	0.9999885559082031	O
4633	CpG	85 87	19374 19376	0.9999885559082031	O
4636	island	89 95	19378 19384	0.9999885559082031	O
4637	methylator	96 105	19385 19394	0.9999885559082031	O
4640	phenotype	107 115	19396 19404	0.9999891519546509	O
4643	(	117 118	19406 19407	0.9999891519546509	O
4644	CIMP	119 122	19408 19411	0.9999884366989136	O
4647	+	123 124	19412 19413	0.9999881982803345	O
4648	)	125 126	19414 19415	0.9999892711639404	O
4649	that	127 131	19416 19420	0.9999889135360718	O
4650	is	132 134	19421 19423	0.9999889135360718	O
4651	characterised	135 148	19424 19437	0.9999852180480957	O
4652	by	149 151	19438 19440	0.9999892711639404	O
4653	widespread	152 162	19441 19451	0.9999867677688599	O
4654	hypermethylation	163 178	19452 19467	0.9999892711639404	O
4659	of	180 182	19469 19471	0.9999889135360718	O
4660	CpG	183 185	19472 19474	0.9999887943267822	O
4663	islands	187 194	19476 19483	0.9999884366989136	O
4664	located	195 202	19484 19491	0.9999890327453613	O
4665	with	203 207	19492 19496	0.9999880790710449	O
4666	gene	208 212	19497 19501	0.9999879598617554	O
4667	promoter	213 221	19502 19510	0.9999886751174927	O
4668	regions	222 229	19511 19518	0.9999886751174927	O
4669	[	230 231	19519 19520	0.9999891519546509	O
4670	11	231 233	19520 19522	0.9999879598617554	O
4671	]	233 234	19522 19523	0.9999889135360718	O
4672	.	235 236	19524 19525	0.9999721050262451	O
4673	Both	0 4	19526 19530	0.9999805688858032	O
4674	MSI	5 7	19531 19533	0.9999834299087524	O
4676	+	8 9	19534 19535	0.9999871253967285	O
4677	and	10 13	19536 19539	0.9999841451644897	O
4678	CIMP	14 17	19540 19543	0.9999815225601196	O
4681	+	18 19	19544 19545	0.9999872446060181	O
4682	tumors	20 26	19546 19552	0.9999821186065674	O
4683	are	27 30	19553 19556	0.9999856948852539	O
4684	thought	31 38	19557 19564	0.9999845027923584	O
4685	to	39 41	19565 19567	0.9999860525131226	O
4686	arise	42 47	19568 19573	0.9999858140945435	O
4687	from	48 52	19574 19578	0.9999843835830688	O
4688	large	53 58	19579 19584	0.9999418258666992	O
4689	hyperplastic	59 70	19585 19596	0.9999827146530151	O
4693	polyps	72 77	19598 19603	0.9999856948852539	O
4696	and	79 82	19605 19608	0.9999816417694092	O
4697	serrated	83 90	19609 19616	0.9999784231185913	O
4700	adenomas	92 99	19618 19625	0.999983549118042	O
4703	[	101 102	19627 19628	0.9999891519546509	O
4704	12	102 104	19628 19630	0.9999886751174927	O
4705	,	104 105	19630 19631	0.9999886751174927	O
4706	13	105 107	19631 19633	0.999987006187439	O
4707	]	107 108	19633 19634	0.9999887943267822	O
4708	and	109 112	19635 19638	0.9999865293502808	O
4709	recent	113 119	19639 19645	0.9999853372573853	O
4710	work	120 124	19646 19650	0.9999815225601196	O
4711	has	125 128	19651 19654	0.9999879598617554	O
4712	demonstrated	129 141	19655 19667	0.9999871253967285	O
4713	a	142 143	19668 19669	0.9999885559082031	O
4714	high	144 148	19670 19674	0.9999876022338867	O
4715	frequency	149 158	19675 19684	0.999987006187439	O
4716	of	159 161	19685 19687	0.9999880790710449	O
4717	BRAF	162 165	19688 19691	0.9999841451644897	O
4719	mutations	167 176	19693 19702	0.9999865293502808	O
4720	in	177 179	19703 19705	0.9999872446060181	O
4721	these	180 185	19706 19711	0.999987006187439	O
4722	lesions	186 193	19712 19719	0.9999815225601196	O
4723	[	194 195	19720 19721	0.9999891519546509	O
4724	7	195 196	19721 19722	0.999988317489624	O
4725	,	196 197	19722 19723	0.9999886751174927	O
4726	14	197 199	19723 19725	0.9999874830245972	O
4727	,	199 200	19725 19726	0.9999881982803345	O
4728	15	200 202	19726 19728	0.9999866485595703	O
4729	]	202 203	19728 19729	0.9999884366989136	O
4730	.	204 205	19730 19731	0.9999713897705078	O
4731	Although	0 8	19732 19740	0.999984622001648	O
4732	the	9 12	19741 19744	0.9999886751174927	O
4733	positive	13 21	19745 19753	0.9999876022338867	O
4734	association	22 33	19754 19765	0.9999890327453613	O
4735	with	34 38	19766 19770	0.99998939037323	O
4736	MSI	39 41	19771 19773	0.9999861717224121	O
4738	+	42 43	19774 19775	0.9999880790710449	O
4739	and	44 47	19776 19779	0.9999885559082031	O
4740	inverse	48 55	19780 19787	0.9999847412109375	O
4741	association	56 67	19788 19799	0.99998939037323	O
4742	with	68 72	19800 19804	0.99998939037323	O
4743	KRAS	73 76	19805 19808	0.9999853372573853	O
4746	mutation	78 86	19810 19818	0.9999890327453613	O
4747	have	87 91	19819 19823	0.9999881982803345	O
4748	been	92 96	19824 19828	0.999988317489624	O
4749	well	97 101	19829 19833	0.9999874830245972	O
4750	documented	102 112	19834 19844	0.9999879598617554	O
4751	,	113 114	19845 19846	0.9999861717224121	O
4752	little	115 121	19847 19853	0.9999868869781494	O
4753	is	122 124	19854 19856	0.9999886751174927	O
4754	known	125 130	19857 19862	0.9999881982803345	O
4755	about	131 136	19863 19868	0.9999885559082031	O
4756	the	137 140	19869 19872	0.9999884366989136	O
4757	other	141 146	19873 19878	0.9999854564666748	O
4758	properties	147 157	19879 19889	0.9999840259552002	O
4759	of	158 160	19890 19892	0.9999873638153076	O
4760	tumors	161 167	19893 19899	0.9999841451644897	O
4761	with	168 172	19900 19904	0.9999886751174927	O
4762	BRAF	173 176	19905 19908	0.9999845027923584	O
4764	mutation	178 186	19910 19918	0.9999889135360718	O
4765	.	187 188	19919 19920	0.9999662637710571	O
4766	In	0 2	19921 19923	0.9999856948852539	O
4767	the	3 6	19924 19927	0.9999855756759644	O
4768	present	7 14	19928 19935	0.9999843835830688	O
4769	study	15 20	19936 19941	0.9999855756759644	O
4770	we	21 23	19942 19944	0.9999836683273315	O
4771	analysed	24 31	19945 19952	0.9999865293502808	O
4774	for	33 36	19954 19957	0.9999847412109375	O
4775	BRAF	37 40	19958 19961	0.9999818801879883	O
4777	V600E	42 46	19963 19967	0.999987006187439	O
4781	mutations	48 57	19969 19978	0.999985933303833	O
4782	in	58 60	19979 19981	0.9999861717224121	O
4783	a	61 62	19982 19983	0.9999858140945435	O
4784	consecutive	63 74	19984 19995	0.9999793767929077	O
4785	series	75 81	19996 20002	0.9999779462814331	O
4786	of	82 84	20003 20005	0.9999840259552002	O
4787	275	85 88	20006 20009	0.9999483823776245	O
4788	CRCs	89 92	20010 20013	0.9999630451202393	O
4790	that	94 98	20015 20019	0.9999855756759644	O
4791	were	99 103	20020 20024	0.9999865293502808	O
4792	well	104 108	20025 20029	0.9999841451644897	O
4793	characterised	109 122	20030 20043	0.9999771118164062	O
4794	for	123 126	20044 20047	0.9999840259552002	O
4795	the	127 130	20048 20051	0.9999864101409912	O
4796	major	131 136	20052 20057	0.9999839067459106	O
4797	pathological	137 148	20058 20069	0.9999867677688599	O
4799	and	150 153	20071 20074	0.9999850988388062	O
4800	molecular	154 163	20075 20084	0.9999761581420898	O
4801	features	164 172	20085 20093	0.9999843835830688	O
4802	of	173 175	20094 20096	0.9999856948852539	O
4803	this	176 180	20097 20101	0.999984622001648	O
4804	disease	181 188	20102 20109	0.9999816417694092	O
4805	.	189 190	20110 20111	0.9999550580978394	O
4806	Our	0 3	20112 20115	0.9999712705612183	O
4807	results	4 11	20116 20123	0.9999774694442749	O
4808	demonstrate	12 23	20124 20135	0.9999617338180542	O
4809	that	24 28	20136 20140	0.9999839067459106	O
4810	oncogenic	29 37	20141 20149	0.9999849796295166	O
4813	BRAF	39 42	20151 20154	0.9999809265136719	O
4815	mutation	44 52	20156 20164	0.9999839067459106	O
4816	occurs	53 59	20165 20171	0.9999836683273315	O
4817	preferentially	60 73	20172 20185	0.9999850988388062	O
4820	within	75 81	20187 20193	0.9999814033508301	O
4821	a	82 83	20194 20195	0.9999822378158569	O
4822	subgroup	84 92	20196 20204	0.9999778270721436	O
4823	of	93 95	20205 20207	0.9999803304672241	O
4824	CRCs	96 99	20208 20211	0.9999549388885498	O
4826	that	101 105	20213 20217	0.9999808073043823	O
4827	have	106 110	20218 20222	0.9999791383743286	O
4828	distinctive	111 122	20223 20234	0.9999767541885376	O
4829	features	123 131	20235 20243	0.9999799728393555	O
4830	.	132 133	20244 20245	0.9999215602874756	O
4831	It	0 2	20246 20248	0.9999861717224121	O
4832	could	3 8	20249 20254	0.9999823570251465	O
4833	therefore	9 18	20255 20264	0.999984622001648	O
4834	be	19 21	20265 20267	0.9999865293502808	O
4835	used	22 26	20268 20272	0.9999853372573853	O
4836	as	27 29	20273 20275	0.9999867677688599	O
4837	a	30 31	20276 20277	0.9999876022338867	O
4838	convenient	32 42	20278 20288	0.9999791383743286	O
4839	marker	43 49	20289 20295	0.9999856948852539	O
4840	for	50 53	20296 20299	0.9999865293502808	O
4841	the	54 57	20300 20303	0.999987006187439	O
4842	further	58 65	20304 20311	0.9999864101409912	O
4843	characterisation	66 81	20312 20327	0.9999853372573853	O
4845	of	83 85	20329 20331	0.9999872446060181	O
4846	these	86 91	20332 20337	0.9999840259552002	O
4847	tumors	92 98	20338 20344	0.9999814033508301	O
4848	,	99 100	20345 20346	0.9999861717224121	O
4849	particularly	101 113	20347 20359	0.9999847412109375	O
4850	in	114 116	20360 20362	0.9999876022338867	O
4851	relation	117 125	20363 20371	0.9999865293502808	O
4852	to	126 128	20372 20374	0.9999873638153076	O
4853	their	129 134	20375 20380	0.9999864101409912	O
4854	prognosis	135 143	20381 20389	0.9999876022338867	O
4857	and	145 148	20391 20394	0.9999852180480957	O
4858	response	149 157	20395 20403	0.9999860525131226	O
4859	to	158 160	20404 20406	0.9999879598617554	O
4860	adjuvant	161 168	20407 20414	0.9999879598617554	O
4863	chemotherapy	170 181	20416 20427	0.9999862909317017	O
4866	.	183 184	20429 20430	0.9999874830245972	O
4867	*	185 186	20431 20432	0.9999864101409912	O
4868	*	186 187	20432 20433	0.9999769926071167	O
4869	IGNORE	0 5	20434 20439	0.9999867677688599	O
4872	LINE	7 10	20441 20444	0.9999892711639404	O
4875	*	12 13	20446 20447	0.9999891519546509	O
4876	*	13 14	20447 20448	0.9999891519546509	O
4877	*	15 16	20449 20450	0.9999891519546509	O
4878	*	16 17	20450 20451	0.99998939037323	O
4879	IGNORE	18 23	20452 20457	0.9999880790710449	O
4882	LINE	25 28	20459 20462	0.99998939037323	O
4885	*	30 31	20464 20465	0.9999889135360718	O
4886	*	31 32	20465 20466	0.9999889135360718	O
4887	*	33 34	20467 20468	0.9999887943267822	O
4888	*	34 35	20468 20469	0.9999887943267822	O
4889	IGNORE	36 41	20470 20475	0.9999876022338867	O
4892	LINE	43 46	20477 20480	0.9999891519546509	O
4895	*	48 49	20482 20483	0.9999890327453613	O
4896	*	49 50	20483 20484	0.9999891519546509	O
4897	Results	51 58	20485 20492	0.9999892711639404	O
4898	Figure	59 65	20493 20499	0.9999892711639404	O
4899	1A	66 68	20500 20502	0.9999896287918091	O
4900	shows	69 74	20503 20508	0.9999895095825195	O
4901	representative	75 89	20509 20523	0.9999885559082031	O
4902	Fluorescent	90 100	20524 20534	0.9999885559082031	O
4906	-	101 102	20535 20536	0.99998939037323	O
4907	SSCP	102 105	20536 20539	0.9999885559082031	O
4909	results	107 114	20541 20548	0.9999895095825195	O
4910	for	115 118	20549 20552	0.9999892711639404	O
4911	the	119 122	20553 20556	0.9999896287918091	O
4912	screening	123 132	20557 20566	0.9999871253967285	O
4913	of	133 135	20567 20569	0.9999895095825195	O
4914	BRAF	136 139	20570 20573	0.9999849796295166	O
4916	mutations	141 150	20575 20584	0.9999880790710449	O
4917	in	151 153	20585 20587	0.9999897480010986	O
4918	this	154 158	20588 20592	0.9999890327453613	O
4919	CRC	159 161	20593 20595	0.9999830722808838	O
4921	series	163 169	20597 20603	0.9999871253967285	O
4922	,	170 171	20604 20605	0.99998939037323	O
4923	while	172 177	20606 20611	0.99998939037323	O
4924	Figure	178 184	20612 20618	0.9999885559082031	O
4925	1B	185 186	20619 20620	0.9999895095825195	O
4927	shows	188 193	20622 20627	0.99998939037323	O
4928	DNA	194 197	20628 20631	0.9999885559082031	O
4929	sequencing	198 207	20632 20641	0.9999889135360718	O
4931	confirmation	209 221	20643 20655	0.99998939037323	O
4932	of	222 224	20656 20658	0.9999897480010986	O
4933	the	225 228	20659 20662	0.9999898672103882	O
4934	1799T	229 233	20663 20667	0.999987006187439	O
4936	to	235 237	20669 20671	0.9999887943267822	O
4937	A	238 239	20672 20673	0.9999877214431763	O
4938	transversion	240 251	20674 20685	0.9999891519546509	O
4940	resulting	253 262	20687 20696	0.99998939037323	O
4941	in	263 265	20697 20699	0.99998939037323	O
4942	the	266 269	20700 20703	0.99998939037323	O
4943	V600E	270 274	20704 20708	0.9999881982803345	O
4947	mutation	276 284	20710 20718	0.9999886751174927	O
4948	.	285 286	20719 20720	0.9999727010726929	O
4949	The	0 3	20721 20724	0.9999881982803345	O
4950	overall	4 11	20725 20732	0.999988317489624	O
4951	frequency	12 21	20733 20742	0.9999873638153076	O
4952	of	22 24	20743 20745	0.9999878406524658	O
4953	BRAF	25 28	20746 20749	0.999982476234436	O
4955	mutation	30 38	20751 20759	0.9999855756759644	O
4956	was	39 42	20760 20763	0.999988317489624	O
4957	8	43 44	20764 20765	0.9999847412109375	O
4958	.	44 45	20765 20766	0.9999884366989136	O
4959	4	45 46	20766 20767	0.9999840259552002	O
4960	%	47 48	20768 20769	0.9999887943267822	O
4961	(	49 50	20770 20771	0.9999891519546509	O
4962	23	51 53	20772 20774	0.9999866485595703	O
4963	/	53 54	20774 20775	0.9999890327453613	O
4964	275	54 57	20775 20778	0.9999823570251465	O
4965	)	58 59	20779 20780	0.9999891519546509	O
4966	,	60 61	20781 20782	0.9999880790710449	O
4967	comparing	62 71	20783 20792	0.9999880790710449	O
4968	favourably	72 81	20793 20802	0.9999854564666748	O
4970	with	83 87	20804 20808	0.9999889135360718	O
4971	frequencies	88 99	20809 20820	0.9999878406524658	O
4972	of	100 102	20821 20823	0.9999889135360718	O
4973	9	103 104	20824 20825	0.9999884366989136	O
4974	–	104 105	20825 20826	0.999985933303833	O
4975	11	105 107	20826 20828	0.9999880790710449	O
4976	%	108 109	20829 20830	0.9999889135360718	O
4977	reported	110 118	20831 20839	0.9999880790710449	O
4978	for	119 122	20840 20843	0.9999890327453613	O
4979	other	123 128	20844 20849	0.9999881982803345	O
4980	large	129 134	20850 20855	0.999981164932251	O
4981	studies	135 142	20856 20863	0.9999837875366211	O
4982	of	143 145	20864 20866	0.9999877214431763	O
4983	this	146 150	20867 20871	0.9999862909317017	O
4984	tumor	151 156	20872 20877	0.9999839067459106	O
4985	type	157 161	20878 20882	0.999987006187439	O
4986	[	162 163	20883 20884	0.9999891519546509	O
4987	6	163 164	20884 20885	0.9999884366989136	O
4988	,	164 165	20885 20886	0.9999887943267822	O
4989	16	165 167	20886 20888	0.9999879598617554	O
4990	,	167 168	20888 20889	0.9999884366989136	O
4991	17	168 170	20889 20891	0.9999862909317017	O
4992	]	170 171	20891 20892	0.9999886751174927	O
4993	.	172 173	20893 20894	0.9999746084213257	O
4994	The	0 3	20895 20898	0.9999855756759644	O
4995	mean	4 8	20899 20903	0.9999849796295166	O
4996	age	9 12	20904 20907	0.9999797344207764	O
4997	of	13 15	20908 20910	0.9999852180480957	O
4998	patients	16 24	20911 20919	0.9999829530715942	O
4999	with	25 29	20920 20924	0.9999879598617554	O
5000	and	30 33	20925 20928	0.9999850988388062	O
5001	without	34 41	20929 20936	0.9999868869781494	O
5002	BRAF	42 45	20937 20940	0.9999818801879883	O
5004	mutation	47 55	20942 20950	0.9999858140945435	O
5005	was	56 59	20951 20954	0.9999867677688599	O
5006	identical	60 69	20955 20964	0.9999819993972778	O
5007	(	70 71	20965 20966	0.9999879598617554	O
5008	Table	72 77	20967 20972	0.9999843835830688	O
5009	1	78 79	20973 20974	0.9999873638153076	O
5010	)	80 81	20975 20976	0.9999885559082031	O
5011	.	82 83	20977 20978	0.9999711513519287	O
5012	Strong	0 6	20979 20985	0.9999741315841675	O
5013	associations	7 19	20986 20998	0.9999831914901733	O
5014	were	20 24	20999 21003	0.9999834299087524	O
5015	observed	25 33	21004 21012	0.9999803304672241	O
5016	between	34 41	21013 21020	0.9999866485595703	O
5017	BRAF	42 45	21021 21024	0.9999798536300659	O
5019	mutation	47 55	21026 21034	0.9999847412109375	O
5020	and	56 59	21035 21038	0.9999867677688599	O
5021	tumor	60 65	21039 21044	0.9999817609786987	O
5022	origin	66 72	21045 21051	0.9999830722808838	O
5023	in	73 75	21052 21054	0.9999868869781494	O
5024	the	76 79	21055 21058	0.9999878406524658	O
5025	proximal	80 87	21059 21066	0.9999864101409912	O
5027	side	89 93	21068 21072	0.9999849796295166	O
5028	of	94 96	21073 21075	0.9999868869781494	O
5029	the	97 100	21076 21079	0.9999860525131226	O
5030	large	101 106	21080 21085	0.9999765157699585	O
5031	bowel	107 111	21086 21090	0.999980092048645	O
5033	,	113 114	21092 21093	0.9999866485595703	O
5034	poor	115 119	21094 21098	0.999984860420227	O
5035	histological	120 131	21099 21110	0.9999871253967285	O
5038	grade	133 138	21112 21117	0.9999854564666748	O
5039	,	139 140	21118 21119	0.9999872446060181	O
5040	mucinous	141 148	21120 21127	0.9999852180480957	O
5044	appearance	150 160	21129 21139	0.9999845027923584	O
5045	and	161 164	21140 21143	0.9999855756759644	O
5046	the	165 168	21144 21147	0.9999865293502808	O
5047	presence	169 177	21148 21156	0.9999849796295166	O
5048	of	178 180	21157 21159	0.9999874830245972	O
5049	infiltrating	181 192	21160 21171	0.9999858140945435	O
5053	lymphocytes	194 204	21173 21183	0.9999856948852539	O
5056	.	206 207	21185 21186	0.9999456405639648	O
5057	Higher	0 6	21187 21193	0.9999842643737793	O
5058	frequencies	7 18	21194 21205	0.9999845027923584	O
5059	of	19 21	21206 21208	0.9999871253967285	O
5060	BRAF	22 25	21209 21212	0.9999790191650391	O
5062	mutation	27 35	21214 21222	0.9999853372573853	O
5063	were	36 40	21223 21227	0.9999872446060181	O
5064	also	41 45	21228 21232	0.9999861717224121	O
5065	observed	46 54	21233 21241	0.9999865293502808	O
5066	in	55 57	21242 21244	0.9999878406524658	O
5067	females	58 65	21245 21252	0.9999363422393799	O
5068	and	66 69	21253 21256	0.9999849796295166	O
5069	in	70 72	21257 21259	0.999987006187439	O
5070	node	73 77	21260 21264	0.999984622001648	O
5071	negative	78 86	21265 21273	0.9999823570251465	O
5072	tumors	87 93	21274 21280	0.9999845027923584	O
5073	but	94 97	21281 21284	0.9999847412109375	O
5074	these	98 103	21285 21290	0.9999866485595703	O
5075	did	104 107	21291 21294	0.9999874830245972	O
5076	not	108 111	21295 21298	0.999987006187439	O
5077	reach	112 117	21299 21304	0.999985933303833	O
5078	significance	118 130	21305 21317	0.9999865293502808	O
5079	.	131 132	21318 21319	0.9999855756759644	O
5080	(	133 134	21320 21321	0.9999445676803589	O
5081	A	0 1	21322 21323	0.9999855756759644	O
5082	)	2 3	21324 21325	0.9999886751174927	O
5083	Representative	4 18	21326 21340	0.9999854564666748	O
5084	F	19 20	21341 21342	0.9999836683273315	O
5085	-	20 21	21342 21343	0.9999881982803345	O
5086	SSCP	21 24	21343 21346	0.9999866485595703	O
5088	gel	26 29	21348 21351	0.9999840259552002	O
5089	used	30 34	21352 21356	0.9999867677688599	O
5090	to	35 37	21357 21359	0.9999877214431763	O
5091	detect	38 44	21360 21366	0.9999873638153076	O
5092	BRAF	45 48	21367 21370	0.9999828338623047	O
5094	mutationsin	50 60	21372 21382	0.999985933303833	O
5096	colorectal	62 71	21384 21393	0.9999864101409912	O
5099	cancer	73 79	21395 21401	0.9999864101409912	O
5100	.	80 81	21402 21403	0.9999659061431885	O
5101	WT	0 1	21404 21405	0.9999840259552002	O
5103	,	3 4	21407 21408	0.9999872446060181	O
5104	wild	5 9	21409 21413	0.9999865293502808	O
5105	-	9 10	21413 21414	0.9999877214431763	O
5106	type	10 14	21414 21418	0.9999868869781494	O
5107	;	15 16	21419 21420	0.9999867677688599	O
5108	M	17 18	21421 21422	0.9999809265136719	O
5109	,	19 20	21423 21424	0.9999877214431763	O
5110	mutation	21 29	21425 21433	0.9999828338623047	O
5111	.	30 31	21434 21435	0.9999860525131226	O
5112	(	32 33	21436 21437	0.99993896484375	O
5113	B	0 1	21438 21439	0.9999849796295166	O
5114	)	2 3	21440 21441	0.9999892711639404	O
5115	DNA	4 7	21442 21445	0.9999876022338867	O
5116	sequencing	8 17	21446 21455	0.9999885559082031	O
5118	gel	19 22	21457 21460	0.999985933303833	O
5119	resultconfirms	23 36	21461 21474	0.9999874830245972	O
5123	the	38 41	21476 21479	0.9999895095825195	O
5124	presence	42 50	21480 21488	0.99998939037323	O
5125	of	51 53	21489 21491	0.9999896287918091	O
5126	a	54 55	21492 21493	0.9999896287918091	O
5127	1799T	56 60	21494 21498	0.9999867677688599	O
5129	to	62 64	21500 21502	0.9999886751174927	O
5130	A	65 66	21503 21504	0.9999877214431763	O
5131	mutation	67 75	21505 21513	0.9999891519546509	O
5132	giving	76 82	21514 21520	0.99998939037323	O
5133	rise	83 87	21521 21525	0.9999892711639404	O
5134	to	88 90	21526 21528	0.9999895095825195	O
5135	the	91 94	21529 21532	0.9999892711639404	O
5136	V600E	95 99	21533 21537	0.9999885559082031	O
5140	mutation	101 109	21539 21547	0.9999892711639404	O
5141	.	110 111	21548 21549	0.9999803304672241	O
5142	Associations	0 11	21550 21561	0.9999337196350098	O
5144	between	13 20	21563 21570	0.9999685287475586	O
5145	BRAF	21 24	21571 21574	0.999962568283081	O
5147	mutation	26 34	21576 21584	0.9999716281890869	O
5148	and	35 38	21585 21588	0.9999738931655884	O
5149	clinicopathological	39 57	21589 21607	0.9999711513519287	O
5153	features	59 67	21609 21617	0.9999740123748779	O
5154	of	68 70	21618 21620	0.9999768733978271	O
5155	colorectal	71 80	21621 21630	0.9999592304229736	O
5158	cancer	82 88	21632 21638	0.9999749660491943	O
5159	.	89 90	21639 21640	0.9946278929710388	O
5160	a	0 1	21641 21642	0.9999873638153076	O
5161	Data	2 6	21643 21647	0.9999839067459106	O
5162	was	7 10	21648 21651	0.9999878406524658	O
5163	unavailable	11 22	21652 21663	0.9999855756759644	O
5164	for	23 26	21664 21667	0.9999871253967285	O
5165	gender	27 33	21668 21674	0.9999822378158569	O
5166	in	34 36	21675 21677	0.9999889135360718	O
5167	43	37 39	21678 21680	0.9999805688858032	O
5168	cases	40 45	21681 21686	0.9999878406524658	O
5169	,	46 47	21687 21688	0.9999887943267822	O
5170	infiltrating	48 59	21689 21700	0.9999889135360718	O
5174	lymphocytes	61 71	21702 21712	0.9999887943267822	O
5177	in	73 75	21714 21716	0.99998939037323	O
5178	55	76 78	21717 21719	0.9999792575836182	O
5179	cases	79 84	21720 21725	0.9999886751174927	O
5180	,	85 86	21726 21727	0.9999887943267822	O
5181	nodal	87 91	21728 21732	0.9999853372573853	O
5183	involvement	93 104	21734 21745	0.999988317489624	O
5184	in	105 107	21746 21748	0.9999890327453613	O
5185	77	108 110	21749 21751	0.9999812841415405	O
5186	cases	111 116	21752 21757	0.9999886751174927	O
5187	,	117 118	21758 21759	0.9999886751174927	O
5188	tumor	119 124	21760 21765	0.9999854564666748	O
5189	site	125 129	21766 21770	0.9999852180480957	O
5190	in	130 132	21771 21773	0.9999891519546509	O
5191	56	133 135	21774 21776	0.9999842643737793	O
5192	cases	136 141	21777 21782	0.9999887943267822	O
5193	,	142 143	21783 21784	0.9999886751174927	O
5194	grade	144 149	21785 21790	0.999980092048645	O
5195	in	150 152	21791 21793	0.9999889135360718	O
5196	106	153 156	21794 21797	0.9999779462814331	O
5197	cases	157 162	21798 21803	0.999988317489624	O
5198	and	163 166	21804 21807	0.9999881982803345	O
5199	mucinous	167 174	21808 21815	0.9999856948852539	O
5203	appearance	176 186	21817 21827	0.9999856948852539	O
5204	in	187 189	21828 21830	0.9999890327453613	O
5205	89	190 192	21831 21833	0.9999803304672241	O
5206	cases	193 198	21834 21839	0.9999880790710449	O
5207	.	199 200	21840 21841	0.9999666213989258	O
5208	BRAF	0 3	21842 21845	0.9999805688858032	O
5210	mutations	5 14	21847 21856	0.9999877214431763	O
5211	showed	15 21	21857 21863	0.9999866485595703	O
5212	no	22 24	21864 21866	0.9999836683273315	O
5213	association	25 36	21867 21878	0.9999858140945435	O
5214	with	37 41	21879 21883	0.999988317489624	O
5215	TP53	42 45	21884 21887	0.9999840259552002	O
5218	mutations	47 56	21889 21898	0.9999873638153076	O
5219	and	57 60	21899 21902	0.9999872446060181	O
5220	were	61 65	21903 21907	0.9999881982803345	O
5221	mutually	66 74	21908 21916	0.9999872446060181	O
5222	exclusive	75 84	21917 21926	0.9999892711639404	O
5223	with	85 89	21927 21931	0.9999887943267822	O
5224	the	90 93	21932 21935	0.9999890327453613	O
5225	presence	94 102	21936 21944	0.9999887943267822	O
5226	of	103 105	21945 21947	0.9999889135360718	O
5227	KRAS	106 109	21948 21951	0.999980092048645	O
5230	mutations	111 120	21953 21962	0.9999879598617554	O
5231	(	121 122	21963 21964	0.99998939037323	O
5232	Table	123 128	21965 21970	0.9999856948852539	O
5233	2	129 130	21971 21972	0.9999874830245972	O
5234	)	131 132	21973 21974	0.99998939037323	O
5235	.	133 134	21975 21976	0.9999784231185913	O
5236	In	0 2	21977 21979	0.9999860525131226	O
5237	contrast	3 11	21980 21988	0.9999828338623047	O
5238	,	12 13	21989 21990	0.9999867677688599	O
5239	BRAF	14 17	21991 21994	0.9999805688858032	O
5241	mutations	19 28	21996 22005	0.9999836683273315	O
5242	were	29 33	22006 22010	0.9999862909317017	O
5243	approximately	34 47	22011 22024	0.9999872446060181	O
5244	10	48 50	22025 22027	0.9999837875366211	O
5245	-	50 51	22027 22028	0.9999878406524658	O
5246	fold	51 55	22028 22032	0.9999856948852539	O
5247	more	56 60	22033 22037	0.999984622001648	O
5248	frequent	61 69	22038 22046	0.9999860525131226	O
5249	in	70 72	22047 22049	0.9999867677688599	O
5250	MSI	73 75	22050 22052	0.9999852180480957	O
5252	+	76 77	22053 22054	0.9999874830245972	O
5253	and	78 81	22055 22058	0.9999850988388062	O
5254	CIMP	82 85	22059 22062	0.9999834299087524	O
5257	+	86 87	22063 22064	0.9999856948852539	O
5258	tumors	88 94	22065 22071	0.999984622001648	O
5259	compared	95 103	22072 22080	0.9999808073043823	O
5260	to	104 106	22081 22083	0.9999755620956421	O
5261	tumors	107 113	22084 22090	0.9999842643737793	O
5262	without	114 121	22091 22098	0.9999830722808838	O
5263	these	122 127	22099 22104	0.9999876022338867	O
5264	phenotypes	128 137	22105 22114	0.9999876022338867	O
5268	.	139 140	22116 22117	0.999948263168335	O
5269	A	0 1	22118 22119	0.9999874830245972	O
5270	strong	2 8	22120 22126	0.9999837875366211	O
5271	association	9 20	22127 22138	0.9999858140945435	O
5272	was	21 24	22139 22142	0.9999871253967285	O
5273	also	25 29	22143 22147	0.9999855756759644	O
5274	seen	30 34	22148 22152	0.9999850988388062	O
5275	with	35 39	22153 22157	0.9999887943267822	O
5276	methylation	40 50	22158 22168	0.9999884366989136	O
5279	of	52 54	22170 22172	0.9999887943267822	O
5280	the	55 58	22173 22176	0.9999890327453613	O
5281	MLH1	59 62	22177 22180	0.9999847412109375	O
5284	gene	64 68	22182 22186	0.9999885559082031	O
5285	promoter	69 77	22187 22195	0.9999880790710449	O
5286	and	78 81	22196 22199	0.9999867677688599	O
5287	in	82 84	22200 22202	0.9999885559082031	O
5288	particular	85 95	22203 22213	0.9999850988388062	O
5289	with	96 100	22214 22218	0.9999887943267822	O
5290	methylation	101 111	22219 22229	0.9999880790710449	O
5293	of	113 115	22231 22233	0.9999890327453613	O
5294	its	116 119	22234 22237	0.9999889135360718	O
5295	proximal	120 127	22238 22245	0.9999886751174927	O
5297	region	129 135	22247 22253	0.999988317489624	O
5298	.	136 137	22254 22255	0.9999668598175049	O
5299	We	0 2	22256 22258	0.9999842643737793	O
5300	have	3 7	22259 22263	0.999985933303833	O
5301	previously	8 18	22264 22274	0.999983549118042	O
5302	examined	19 27	22275 22283	0.9999864101409912	O
5303	the	28 31	22284 22287	0.9999884366989136	O
5304	methylation	32 42	22288 22298	0.999987006187439	O
5307	status	44 50	22300 22306	0.999988317489624	O
5308	of	51 53	22307 22309	0.9999886751174927	O
5309	7	54 55	22310 22311	0.9999860525131226	O
5310	different	56 65	22312 22321	0.9999853372573853	O
5311	CpG	66 68	22322 22324	0.9999874830245972	O
5314	islands	70 77	22326 22333	0.9999855756759644	O
5315	in	78 80	22334 22336	0.9999878406524658	O
5316	this	81 85	22337 22341	0.9999845027923584	O
5317	CRC	86 88	22342 22344	0.9999774694442749	O
5319	series	90 96	22346 22352	0.9999856948852539	O
5320	[	97 98	22353 22354	0.9999889135360718	O
5321	18	98 100	22354 22356	0.9999862909317017	O
5322	]	100 101	22356 22357	0.9999889135360718	O
5323	.	102 103	22358 22359	0.9999731779098511	O
5324	The	0 3	22360 22363	0.9999860525131226	O
5325	mean	4 8	22364 22368	0.9999842643737793	O
5326	number	9 15	22369 22375	0.9999856948852539	O
5327	of	16 18	22376 22378	0.9999866485595703	O
5328	these	19 24	22379 22384	0.9999861717224121	O
5329	methylated	25 34	22385 22394	0.9999856948852539	O
5332	sites	36 41	22396 22401	0.9999839067459106	O
5333	was	42 45	22402 22405	0.9999861717224121	O
5334	3	46 47	22406 22407	0.9999840259552002	O
5335	-	47 48	22407 22408	0.9999884366989136	O
5336	fold	48 52	22408 22412	0.9999868869781494	O
5337	higher	53 59	22413 22419	0.9999837875366211	O
5338	in	60 62	22420 22422	0.9999847412109375	O
5339	tumors	63 69	22423 22429	0.9999798536300659	O
5340	with	70 74	22430 22434	0.9999873638153076	O
5341	BRAF	75 78	22435 22438	0.9999827146530151	O
5343	mutation	80 88	22440 22448	0.9999861717224121	O
5344	compared	89 97	22449 22457	0.9999864101409912	O
5345	to	98 100	22458 22460	0.9999843835830688	O
5346	those	101 106	22461 22466	0.9999862909317017	O
5347	without	107 114	22467 22474	0.9999839067459106	O
5348	(	115 116	22475 22476	0.9999885559082031	O
5349	2	117 118	22477 22478	0.9999850988388062	O
5350	.	118 119	22478 22479	0.9999886751174927	O
5351	6	119 120	22479 22480	0.9999877214431763	O
5352	±	121 122	22481 22482	0.9999887943267822	O
5353	1	123 124	22483 22484	0.9999886751174927	O
5354	.	124 125	22484 22485	0.9999887943267822	O
5355	7	125 126	22485 22486	0.9999877214431763	O
5356	vs	127 129	22487 22489	0.9999872446060181	O
5357	0	130 131	22490 22491	0.9999876022338867	O
5358	.	131 132	22491 22492	0.9999886751174927	O
5359	8	132 133	22492 22493	0.9999858140945435	O
5360	±	134 135	22494 22495	0.9999884366989136	O
5361	1	136 137	22496 22497	0.9999880790710449	O
5362	.	137 138	22497 22498	0.9999885559082031	O
5363	0	138 139	22498 22499	0.9999862909317017	O
5364	;	140 141	22500 22501	0.9999868869781494	O
5365	P	142 143	22502 22503	0.9999884366989136	O
5366	<	144 145	22504 22505	0.9999877214431763	O
5367	0	146 147	22506 22507	0.9999886751174927	O
5368	.	147 148	22507 22508	0.9999886751174927	O
5369	001	148 150	22508 22510	0.9999885559082031	O
5371	)	152 153	22512 22513	0.999988317489624	O
5372	.	154 155	22514 22515	0.9999630451202393	O
5373	Multivariate	0 11	22516 22527	0.9999854564666748	O
5376	analysis	13 21	22529 22537	0.9999868869781494	O
5377	revealed	22 30	22538 22546	0.9999855756759644	O
5378	that	31 35	22547 22551	0.9999887943267822	O
5379	MSI	36 38	22552 22554	0.9999854564666748	O
5381	+	39 40	22555 22556	0.9999873638153076	O
5382	was	41 44	22557 22560	0.9999885559082031	O
5383	the	45 48	22561 22564	0.9999885559082031	O
5384	only	49 53	22565 22569	0.9999877214431763	O
5385	significant	54 65	22570 22581	0.9999877214431763	O
5386	independent	66 77	22582 22593	0.9999864101409912	O
5387	predictor	78 86	22594 22602	0.999987006187439	O
5389	of	88 90	22604 22606	0.9999879598617554	O
5390	BRAF	91 94	22607 22610	0.9999828338623047	O
5392	mutation	96 104	22612 22620	0.9999867677688599	O
5393	(	105 106	22621 22622	0.9999892711639404	O
5394	RR	107 108	22623 22624	0.9999881982803345	O
5396	=	110 111	22626 22627	0.9999881982803345	O
5397	6	112 113	22628 22629	0.9999861717224121	O
5398	.	113 114	22629 22630	0.9999889135360718	O
5399	3	114 115	22630 22631	0.9999864101409912	O
5400	,	116 117	22632 22633	0.9999880790710449	O
5401	95	118 120	22634 22636	0.9999880790710449	O
5402	%	121 122	22637 22638	0.9999886751174927	O
5403	C	122 123	22638 22639	0.9999872446060181	O
5404	I	124 125	22640 22641	0.999988317489624	O
5405	[	126 127	22642 22643	0.9999886751174927	O
5406	1	127 128	22643 22644	0.9999879598617554	O
5407	.	128 129	22644 22645	0.9999889135360718	O
5408	2	129 130	22645 22646	0.9999867677688599	O
5409	–	130 131	22646 22647	0.9999847412109375	O
5410	32	131 133	22647 22649	0.9999796152114868	O
5411	.	133 134	22649 22650	0.9999886751174927	O
5412	3	134 135	22650 22651	0.9999868869781494	O
5413	]	135 136	22651 22652	0.9999877214431763	O
5414	;	137 138	22653 22654	0.9999876022338867	O
5415	P	139 140	22655 22656	0.999988317489624	O
5416	=	141 142	22657 22658	0.999988317489624	O
5417	0	143 144	22659 22660	0.9999885559082031	O
5418	.	144 145	22660 22661	0.9999886751174927	O
5419	028	145 147	22661 22663	0.9999867677688599	O
5421	)	149 150	22665 22666	0.9999885559082031	O
5422	in	151 153	22667 22669	0.9999885559082031	O
5423	a	154 155	22670 22671	0.9999890327453613	O
5424	model	156 161	22672 22677	0.9999852180480957	O
5425	that	162 166	22678 22682	0.9999879598617554	O
5426	included	167 175	22683 22691	0.9999879598617554	O
5427	CIMP	176 179	22692 22695	0.9999868869781494	O
5430	+	180 181	22696 22697	0.9999871253967285	O
5431	,	182 183	22698 22699	0.9999872446060181	O
5432	tumor	184 189	22700 22705	0.9999834299087524	O
5433	site	190 194	22706 22710	0.9999817609786987	O
5434	,	195 196	22711 22712	0.9999877214431763	O
5435	histological	197 208	22713 22724	0.9999876022338867	O
5438	grade	210 215	22726 22731	0.9999842643737793	O
5439	,	216 217	22732 22733	0.9999881982803345	O
5440	presence	218 226	22734 22742	0.9999874830245972	O
5441	of	227 229	22743 22745	0.9999886751174927	O
5442	infiltrating	230 241	22746 22757	0.9999880790710449	O
5446	lymphocytes	243 253	22759 22769	0.9999874830245972	O
5449	and	255 258	22771 22774	0.9999871253967285	O
5450	mucinous	259 266	22775 22782	0.9999864101409912	O
5454	appearance	268 278	22784 22794	0.9999847412109375	O
5455	.	279 280	22795 22796	0.9999502897262573	O
5456	Associations	0 11	22797 22808	0.9999361038208008	O
5458	between	13 20	22810 22817	0.9999675750732422	O
5459	BRAF	21 24	22818 22821	0.9999649524688721	O
5461	mutation	26 34	22823 22831	0.9999747276306152	O
5462	and	35 38	22832 22835	0.999974250793457	O
5463	molecular	39 48	22836 22845	0.9999721050262451	O
5464	features	49 57	22846 22854	0.9999746084213257	O
5465	of	58 60	22855 22857	0.9999779462814331	O
5466	colorectal	61 70	22858 22867	0.999962568283081	O
5469	cancer	72 78	22869 22875	0.9999755620956421	O
5470	.	79 80	22876 22877	0.9950112104415894	O
5471	a	0 1	22878 22879	0.9999886751174927	O
5472	Data	2 6	22880 22884	0.9999865293502808	O
5473	was	7 10	22885 22888	0.9999889135360718	O
5474	unavailable	11 22	22889 22900	0.9999873638153076	O
5475	for	23 26	22901 22904	0.9999889135360718	O
5476	MSI	27 29	22905 22907	0.9999887943267822	O
5478	status	31 37	22909 22915	0.9999895095825195	O
5479	in	38 40	22916 22918	0.9999895095825195	O
5480	40	41 43	22919 22921	0.999982476234436	O
5481	cases	44 49	22922 22927	0.9999891519546509	O
5482	,	50 51	22928 22929	0.9999895095825195	O
5483	methylation	52 62	22930 22940	0.9999884366989136	O
5486	status	64 70	22942 22948	0.9999892711639404	O
5487	in	71 73	22949 22951	0.99998939037323	O
5488	83	74 76	22952 22954	0.9999804496765137	O
5489	cases	77 82	22955 22960	0.9999892711639404	O
5490	,	83 84	22961 22962	0.9999895095825195	O
5491	KRAS	85 88	22963 22966	0.9999840259552002	O
5494	mutation	90 98	22968 22976	0.9999891519546509	O
5495	in	99 101	22977 22979	0.9999892711639404	O
5496	26	102 104	22980 22982	0.9999878406524658	O
5497	cases	105 110	22983 22988	0.9999892711639404	O
5498	and	111 114	22989 22992	0.9999892711639404	O
5499	TP53	115 118	22993 22996	0.9999878406524658	O
5502	mutation	120 128	22998 23006	0.9999889135360718	O
5503	in	129 131	23007 23009	0.99998939037323	O
5504	26	132 134	23010 23012	0.9999877214431763	O
5505	cases	135 140	23013 23018	0.9999889135360718	O
5506	We	141 143	23019 23021	0.9999881982803345	O
5507	next	144 148	23022 23026	0.9999877214431763	O
5508	examined	149 157	23027 23035	0.9999889135360718	O
5509	whether	158 165	23036 23043	0.9999887943267822	O
5510	the	166 169	23044 23047	0.9999890327453613	O
5511	characteristic	170 184	23048 23062	0.9999874830245972	O
5512	features	185 193	23063 23071	0.9999874830245972	O
5513	of	194 196	23072 23074	0.9999889135360718	O
5514	tumors	197 203	23075 23081	0.9999834299087524	O
5515	with	204 208	23082 23086	0.9999892711639404	O
5516	BRAF	209 212	23087 23090	0.999985933303833	O
5518	mutation	214 222	23092 23100	0.9999887943267822	O
5519	were	223 227	23101 23105	0.9999887943267822	O
5520	still	228 233	23106 23111	0.9999877214431763	O
5521	apparent	234 242	23112 23120	0.9999889135360718	O
5522	following	243 252	23121 23130	0.9999890327453613	O
5523	stratification	253 266	23131 23144	0.9999895095825195	O
5527	into	268 272	23146 23150	0.9999889135360718	O
5528	MSI	273 275	23151 23153	0.9999879598617554	O
5530	and	277 280	23155 23158	0.9999885559082031	O
5531	CIMP	281 284	23159 23162	0.9999865293502808	O
5534	phenotypes	286 295	23164 23173	0.9999892711639404	O
5538	.	297 298	23175 23176	0.999969482421875	O
5539	Although	0 8	23177 23185	0.9999858140945435	O
5540	the	9 12	23186 23189	0.9999881982803345	O
5541	statistical	13 24	23190 23201	0.9999878406524658	O
5542	power	25 30	23202 23207	0.9999864101409912	O
5543	of	31 33	23208 23210	0.999988317489624	O
5544	this	34 38	23211 23215	0.9999887943267822	O
5545	subgroup	39 47	23216 23224	0.9999867677688599	O
5546	analysis	48 56	23225 23233	0.9999881982803345	O
5547	was	57 60	23234 23237	0.9999877214431763	O
5548	limited	61 68	23238 23245	0.999984860420227	O
5549	,	69 70	23246 23247	0.9999873638153076	O
5550	the	71 74	23248 23251	0.9999885559082031	O
5551	morphological	75 87	23252 23264	0.9999887943267822	O
5554	features	89 97	23266 23274	0.9999881982803345	O
5555	of	98 100	23275 23277	0.9999889135360718	O
5556	infiltrating	101 112	23278 23289	0.9999887943267822	O
5560	lymphocytes	114 124	23291 23301	0.999988317489624	O
5563	,	126 127	23303 23304	0.9999885559082031	O
5564	poor	128 132	23305 23309	0.9999868869781494	O
5565	histological	133 144	23310 23321	0.9999889135360718	O
5568	grade	146 151	23323 23328	0.9999881982803345	O
5569	and	152 155	23329 23332	0.9999885559082031	O
5570	mucinous	156 163	23333 23340	0.9999879598617554	O
5574	appearance	165 175	23342 23352	0.999987006187439	O
5575	were	176 180	23353 23357	0.9999885559082031	O
5576	clearly	181 188	23358 23365	0.9999856948852539	O
5577	associated	189 199	23366 23376	0.9999892711639404	O
5578	with	200 204	23377 23381	0.9999892711639404	O
5579	BRAF	205 208	23382 23385	0.9999858140945435	O
5581	mutation	210 218	23387 23395	0.9999880790710449	O
5582	regardless	219 229	23396 23406	0.9999876022338867	O
5583	of	230 232	23407 23409	0.9999891519546509	O
5584	tumor	233 238	23410 23415	0.9999855756759644	O
5585	MSI	239 241	23416 23418	0.9999878406524658	O
5587	status	243 249	23420 23426	0.9999890327453613	O
5588	(	250 251	23427 23428	0.9999891519546509	O
5589	Table	252 257	23429 23434	0.9999864101409912	O
5590	3	258 259	23435 23436	0.9999880790710449	O
5591	)	260 261	23437 23438	0.99998939037323	O
5592	.	262 263	23439 23440	0.9999744892120361	O
5593	Similarly	0 9	23441 23450	0.9999840259552002	O
5594	,	10 11	23451 23452	0.9999877214431763	O
5595	these	12 17	23453 23458	0.9999858140945435	O
5596	features	18 26	23459 23467	0.9999823570251465	O
5597	were	27 31	23468 23472	0.9999876022338867	O
5598	each	32 36	23473 23477	0.999976396560669	O
5599	more	37 41	23478 23482	0.9999860525131226	O
5600	common	42 48	23483 23489	0.9999868869781494	O
5601	in	49 51	23490 23492	0.999987006187439	O
5602	tumors	52 58	23493 23499	0.9999808073043823	O
5603	with	59 63	23500 23504	0.9999877214431763	O
5604	BRAF	64 67	23505 23508	0.9999840259552002	O
5606	mutation	69 77	23510 23518	0.9999871253967285	O
5607	in	78 80	23519 23521	0.9999887943267822	O
5608	both	81 85	23522 23526	0.999987006187439	O
5609	the	86 89	23527 23530	0.9999879598617554	O
5610	CIMP	90 93	23531 23534	0.999987006187439	O
5613	-	94 95	23535 23536	0.9999881982803345	O
5614	and	96 99	23537 23540	0.9999868869781494	O
5615	CIMP	100 103	23541 23544	0.9999873638153076	O
5618	+	104 105	23545 23546	0.9999861717224121	O
5619	subgroups	106 114	23547 23555	0.9999876022338867	O
5621	(	116 117	23557 23558	0.9999889135360718	O
5622	Table	118 123	23559 23564	0.9999850988388062	O
5623	4	124 125	23565 23566	0.9999867677688599	O
5624	)	125 126	23566 23567	0.9999891519546509	O
5625	.	127 128	23568 23569	0.9999752044677734	O
5626	Similar	0 7	23570 23577	0.999987006187439	O
5627	to	8 10	23578 23580	0.9999879598617554	O
5628	previous	11 19	23581 23589	0.9999836683273315	O
5629	observations	20 32	23590 23602	0.9999833106994629	O
5630	in	33 35	23603 23605	0.9999871253967285	O
5631	a	36 37	23606 23607	0.9999878406524658	O
5632	separate	38 46	23608 23616	0.9999783039093018	O
5633	CRC	47 49	23617 23619	0.9999784231185913	O
5635	cohort	51 56	23621 23626	0.9999879598617554	O
5638	[	58 59	23628 23629	0.9999884366989136	O
5639	20	59 61	23629 23631	0.9999864101409912	O
5640	]	61 62	23631 23632	0.9999880790710449	O
5641	,	63 64	23633 23634	0.9999884366989136	O
5642	the	65 68	23635 23638	0.9999885559082031	O
5643	frequency	69 78	23639 23648	0.9999879598617554	O
5644	of	79 81	23649 23651	0.999988317489624	O
5645	KRAS	82 85	23652 23655	0.9999837875366211	O
5648	mutation	87 95	23657 23665	0.9999876022338867	O
5649	was	96 99	23666 23669	0.9999884366989136	O
5650	lower	100 105	23670 23675	0.9999850988388062	O
5651	in	106 108	23676 23678	0.9999891519546509	O
5652	MSI	109 111	23679 23681	0.9999880790710449	O
5654	+	112 113	23682 23683	0.999988317489624	O
5655	compared	114 122	23684 23692	0.9999878406524658	O
5656	to	123 125	23693 23695	0.9999881982803345	O
5657	MSI	126 128	23696 23698	0.9999876022338867	O
5659	-	129 130	23699 23700	0.9999862909317017	O
5660	tumors	131 137	23701 23707	0.9999867677688599	O
5661	(	138 139	23708 23709	0.9999890327453613	O
5662	P	140 141	23710 23711	0.9999886751174927	O
5663	=	142 143	23712 23713	0.999988317489624	O
5664	0	144 145	23714 23715	0.9999884366989136	O
5665	.	145 146	23715 23716	0.9999885559082031	O
5666	034	146 148	23716 23718	0.9999874830245972	O
5668	;	150 151	23720 23721	0.999988317489624	O
5669	Table	152 157	23722 23727	0.9999872446060181	O
5670	3	158 159	23728 23729	0.9999874830245972	O
5671	)	160 161	23730 23731	0.9999889135360718	O
5672	,	162 163	23732 23733	0.9999889135360718	O
5673	while	164 169	23734 23739	0.999988317489624	O
5674	the	170 173	23740 23743	0.9999886751174927	O
5675	frequency	174 183	23744 23753	0.9999880790710449	O
5676	of	184 186	23754 23756	0.9999884366989136	O
5677	TP53	187 190	23757 23760	0.9999872446060181	O
5680	mutation	192 200	23762 23770	0.9999877214431763	O
5681	was	201 204	23771 23774	0.9999885559082031	O
5682	also	205 209	23775 23779	0.9999871253967285	O
5683	considerably	210 222	23780 23792	0.9999850988388062	O
5684	lower	223 228	23793 23798	0.9999866485595703	O
5685	in	229 231	23799 23801	0.9999889135360718	O
5686	MSI	232 234	23802 23804	0.9999876022338867	O
5688	+	235 236	23805 23806	0.999987006187439	O
5689	tumors	237 243	23807 23813	0.9999874830245972	O
5690	with	244 248	23814 23818	0.9999886751174927	O
5691	wildtype	249 256	23819 23826	0.999988317489624	O
5693	BRAF	258 261	23828 23831	0.9999868869781494	O
5695	than	263 267	23833 23837	0.9999878406524658	O
5696	in	268 270	23838 23840	0.9999885559082031	O
5697	MSI	271 273	23841 23843	0.9999871253967285	O
5699	-	274 275	23844 23845	0.9999858140945435	O
5700	tumors	276 282	23846 23852	0.9999866485595703	O
5701	with	283 287	23853 23857	0.9999880790710449	O
5702	wildtype	288 295	23858 23865	0.9999874830245972	O
5704	BRAF	297 300	23867 23870	0.9999866485595703	O
5706	(	302 303	23872 23873	0.9999889135360718	O
5707	P	304 305	23874 23875	0.9999886751174927	O
5708	=	306 307	23876 23877	0.999988317489624	O
5709	0	308 309	23878 23879	0.9999885559082031	O
5710	.	309 310	23879 23880	0.9999885559082031	O
5711	014	310 312	23880 23882	0.9999876022338867	O
5713	)	314 315	23884 23885	0.9999889135360718	O
5714	.	316 317	23886 23887	0.9999880790710449	O
5715	*	318 319	23888 23889	0.9999866485595703	O
5716	*	319 320	23889 23890	0.9999771118164062	O
5717	IGNORE	0 5	23891 23896	0.999985933303833	O
5720	LINE	7 10	23898 23901	0.9999887943267822	O
5723	*	12 13	23903 23904	0.9999889135360718	O
5724	*	13 14	23904 23905	0.9999889135360718	O
5725	*	15 16	23906 23907	0.9999887943267822	O
5726	*	16 17	23907 23908	0.9999887943267822	O
5727	IGNORE	18 23	23909 23914	0.9999877214431763	O
5730	LINE	25 28	23916 23919	0.9999890327453613	O
5733	*	30 31	23921 23922	0.9999886751174927	O
5734	*	31 32	23922 23923	0.9999885559082031	O
5735	*	33 34	23924 23925	0.9999885559082031	O
5736	*	34 35	23925 23926	0.9999884366989136	O
5737	IGNORE	36 41	23927 23932	0.9999871253967285	O
5740	LINE	43 46	23934 23937	0.9999889135360718	O
5743	*	48 49	23939 23940	0.9999887943267822	O
5744	*	49 50	23940 23941	0.9999887943267822	O
5745	Mismatch	51 58	23942 23949	0.9999880790710449	O
5748	repair	60 66	23951 23957	0.999988317489624	O
5749	and	67 70	23958 23961	0.999988317489624	O
5750	treatment	71 80	23962 23971	0.9999861717224121	O
5751	resistance	81 91	23972 23982	0.9999880790710449	O
5752	in	92 94	23983 23985	0.9999880790710449	O
5753	ovarian	95 101	23986 23992	0.9999841451644897	O
5756	cancer	103 109	23994 24000	0.9999878406524658	O
5757	Abstract	110 117	24001 24008	0.9999877214431763	O
5760	Background	119 129	24010 24020	0.999984622001648	O
5761	The	130 133	24021 24024	0.9999839067459106	O
5762	treatment	134 143	24025 24034	0.9999812841415405	O
5763	of	144 146	24035 24037	0.9999854564666748	O
5764	ovarian	147 153	24038 24044	0.9999819993972778	O
5767	cancer	155 161	24046 24052	0.9999855756759644	O
5768	is	162 164	24053 24055	0.9999858140945435	O
5769	hindered	165 172	24056 24063	0.9999815225601196	O
5771	by	174 176	24065 24067	0.9999871253967285	O
5772	intrinsic	177 186	24068 24077	0.9999845027923584	O
5773	or	187 189	24078 24080	0.9999821186065674	O
5774	acquired	190 198	24081 24089	0.999970555305481	O
5775	resistance	199 209	24090 24100	0.9999854564666748	O
5776	to	210 212	24101 24103	0.999987006187439	O
5777	platinum	213 221	24104 24112	0.9999839067459106	O
5778	-	221 222	24112 24113	0.9999881982803345	O
5779	based	222 227	24113 24118	0.9999872446060181	O
5780	chemotherapy	228 239	24119 24130	0.9999865293502808	O
5783	.	241 242	24132 24133	0.9999673366546631	O
5784	The	0 3	24134 24137	0.999987006187439	O
5785	aim	4 7	24138 24141	0.9999865293502808	O
5786	of	8 10	24142 24144	0.9999880790710449	O
5787	this	11 15	24145 24149	0.9999877214431763	O
5788	study	16 21	24150 24155	0.9999852180480957	O
5789	is	22 24	24156 24158	0.9999868869781494	O
5790	to	25 27	24159 24161	0.9999877214431763	O
5791	determine	28 37	24162 24171	0.9999865293502808	O
5792	the	38 41	24172 24175	0.9999884366989136	O
5793	frequency	42 51	24176 24185	0.9999860525131226	O
5794	of	52 54	24186 24188	0.9999881982803345	O
5795	mismatch	55 62	24189 24196	0.9999872446060181	O
5798	repair	64 70	24198 24204	0.999987006187439	O
5799	(	71 72	24205 24206	0.9999885559082031	O
5800	MMR	73 75	24207 24209	0.9999861717224121	O
5802	)	77 78	24211 24212	0.9999885559082031	O
5803	inactivation	79 90	24213 24224	0.9999889135360718	O
5806	in	92 94	24226 24228	0.9999860525131226	O
5807	ovarian	95 101	24229 24235	0.9999809265136719	O
5810	cancer	103 109	24237 24243	0.9999862909317017	O
5811	and	110 113	24244 24247	0.9999866485595703	O
5812	its	114 117	24248 24251	0.9999885559082031	O
5813	association	118 129	24252 24263	0.9999872446060181	O
5814	with	130 134	24264 24268	0.9999876022338867	O
5815	resistance	135 145	24269 24279	0.9999866485595703	O
5816	to	146 148	24280 24282	0.9999877214431763	O
5817	platinum	149 157	24283 24291	0.9999858140945435	O
5818	-	157 158	24291 24292	0.9999881982803345	O
5819	based	158 163	24292 24297	0.9999873638153076	O
5820	chemotherapy	164 175	24298 24309	0.9999868869781494	O
5823	.	177 178	24311 24312	0.9999675750732422	O
5824	Methods	0 6	24313 24319	0.999980092048645	O
5826	We	8 10	24321 24323	0.999983549118042	O
5827	determined	11 21	24324 24334	0.9999864101409912	O
5828	,	22 23	24335 24336	0.9999866485595703	O
5829	microsatellite	24 37	24337 24350	0.9999865293502808	O
5833	instability	39 50	24352 24363	0.9999867677688599	O
5834	(	51 52	24364 24365	0.9999884366989136	O
5835	MSI	53 55	24366 24368	0.9999866485595703	O
5837	)	56 57	24369 24370	0.9999887943267822	O
5838	as	58 60	24371 24373	0.9999884366989136	O
5839	a	61 62	24374 24375	0.9999885559082031	O
5840	marker	63 69	24376 24382	0.9999877214431763	O
5841	for	70 73	24383 24386	0.9999884366989136	O
5842	MMR	74 76	24387 24389	0.9999850988388062	O
5844	inactivation	78 89	24391 24402	0.9999886751174927	O
5847	(	91 92	24404 24405	0.9999889135360718	O
5848	analysis	93 101	24406 24414	0.9999880790710449	O
5849	of	102 104	24415 24417	0.9999885559082031	O
5850	BAT25	105 109	24418 24422	0.9999880790710449	O
5853	and	111 114	24424 24427	0.9999880790710449	O
5854	BAT26	115 119	24428 24432	0.9999873638153076	O
5857	)	121 122	24434 24435	0.9999887943267822	O
5858	,	123 124	24436 24437	0.999988317489624	O
5859	MLH1	125 128	24438 24441	0.9999872446060181	O
5862	promoter	130 138	24443 24451	0.9999874830245972	O
5863	methylation	139 149	24452 24462	0.9999879598617554	O
5866	status	151 157	24464 24470	0.9999885559082031	O
5867	(	158 159	24471 24472	0.9999886751174927	O
5868	methylation	160 170	24473 24483	0.9999876022338867	O
5871	specific	172 180	24485 24493	0.9999879598617554	O
5872	PCR	181 183	24494 24496	0.9999873638153076	O
5874	on	185 187	24498 24500	0.9999878406524658	O
5875	bisulfite	188 196	24501 24509	0.9999876022338867	O
5879	treated	198 205	24511 24518	0.9999865293502808	O
5880	DNA	206 209	24519 24522	0.9999860525131226	O
5881	)	210 211	24523 24524	0.9999886751174927	O
5882	and	212 215	24525 24528	0.9999881982803345	O
5883	mRNA	216 219	24529 24532	0.9999871253967285	O
5885	expression	221 231	24534 24544	0.9999877214431763	O
5886	of	232 234	24545 24547	0.9999881982803345	O
5887	MLH1	235 238	24548 24551	0.9999874830245972	O
5890	,	240 241	24553 24554	0.9999876022338867	O
5891	MSH2	242 245	24555 24558	0.9999876022338867	O
5894	,	247 248	24560 24561	0.9999876022338867	O
5895	MSH3	249 252	24562 24565	0.9999873638153076	O
5898	,	254 255	24567 24568	0.9999876022338867	O
5899	MSH6	256 259	24569 24572	0.9999874830245972	O
5902	and	261 264	24574 24577	0.9999874830245972	O
5903	PMS2	265 268	24578 24581	0.9999814033508301	O
5906	(	270 271	24583 24584	0.999988317489624	O
5907	quantitative	271 283	24584 24596	0.9999829530715942	O
5908	RT	284 285	24597 24598	0.9999873638153076	O
5910	-	286 287	24599 24600	0.9999878406524658	O
5911	PCR	287 289	24600 24602	0.9999868869781494	O
5913	)	291 292	24604 24605	0.9999884366989136	O
5914	in	293 295	24606 24608	0.9999871253967285	O
5915	75	296 298	24609 24611	0.9998654127120972	O
5916	ovarian	299 305	24612 24618	0.9999719858169556	O
5919	carcinomas	307 316	24620 24629	0.9999805688858032	O
5923	and	318 321	24631 24634	0.9999784231185913	O
5924	eight	322 327	24635 24640	0.9999715089797974	O
5925	ovarian	328 334	24641 24647	0.9999760389328003	O
5928	cancer	336 342	24649 24655	0.9999834299087524	O
5929	cell	343 347	24656 24660	0.9999761581420898	O
5930	lines	348 353	24661 24666	0.9999815225601196	O
5931	Results	354 361	24667 24674	0.9999855756759644	O
5932	MSI	362 364	24675 24677	0.9999871253967285	O
5934	was	366 369	24679 24682	0.9999887943267822	O
5935	detected	370 378	24683 24691	0.9999885559082031	O
5936	in	379 381	24692 24694	0.9999889135360718	O
5937	three	382 387	24695 24700	0.9999781847000122	O
5938	of	388 390	24701 24703	0.9999881982803345	O
5939	the	391 394	24704 24707	0.9999880790710449	O
5940	eight	395 400	24708 24713	0.9999755620956421	O
5941	cell	401 405	24714 24718	0.9999790191650391	O
5942	lines	406 411	24719 24724	0.9999856948852539	O
5943	i	412 413	24725 24726	0.9999879598617554	O
5944	.	414 415	24727 24728	0.9999878406524658	O
5945	e	415 416	24728 24729	0.9999872446060181	O
5946	.	417 418	24730 24731	0.9999728202819824	O
5947	A2780	0 4	24732 24736	0.9999871253967285	O
5950	(	6 7	24738 24739	0.9999897480010986	O
5951	no	8 10	24740 24742	0.99998939037323	O
5952	MLH1	11 14	24743 24746	0.9999886751174927	O
5955	mRNA	16 19	24748 24751	0.9999897480010986	O
5957	expression	21 31	24753 24763	0.9999896287918091	O
5958	due	32 35	24764 24767	0.9999897480010986	O
5959	to	36 38	24768 24770	0.9999897480010986	O
5960	promoter	39 47	24771 24779	0.99998939037323	O
5961	methylation	48 58	24780 24790	0.99998939037323	O
5964	)	60 61	24792 24793	0.9999901056289673	O
5965	,	62 63	24794 24795	0.9999895095825195	O
5966	SKOV3	64 68	24796 24800	0.999984860420227	O
5970	(	70 71	24802 24803	0.9999898672103882	O
5971	no	72 74	24804 24806	0.9999895095825195	O
5972	MLH1	75 78	24807 24810	0.9999887943267822	O
5975	mRNA	80 83	24812 24815	0.9999895095825195	O
5977	expression	85 95	24817 24827	0.9999895095825195	O
5978	)	96 97	24828 24829	0.9999897480010986	O
5979	and	98 101	24830 24833	0.99998939037323	O
5980	2774	102 105	24834 24837	0.9999876022338867	O
5983	(	107 108	24839 24840	0.9999898672103882	O
5984	no	109 111	24841 24843	0.9999895095825195	O
5985	altered	112 119	24844 24851	0.9999886751174927	O
5986	expression	120 130	24852 24862	0.99998939037323	O
5987	of	131 133	24863 24865	0.99998939037323	O
5988	MMR	134 136	24866 24868	0.9999876022338867	O
5990	genes	138 143	24870 24875	0.9999892711639404	O
5991	)	144 145	24876 24877	0.9999898672103882	O
5992	.	146 147	24878 24879	0.9999716281890869	O
5993	Overall	0 7	24880 24887	0.9999816417694092	O
5994	,	8 9	24888 24889	0.9999858140945435	O
5995	there	10 15	24890 24895	0.9999853372573853	O
5996	was	16 19	24896 24899	0.999984860420227	O
5997	no	20 22	24900 24902	0.9999756813049316	O
5998	association	23 34	24903 24914	0.999983549118042	O
5999	between	35 42	24915 24922	0.9999853372573853	O
6000	cisplatin	43 51	24923 24931	0.999983549118042	O
6005	response	53 61	24933 24941	0.9999850988388062	O
6006	and	62 65	24942 24945	0.9999866485595703	O
6007	MMR	66 68	24946 24948	0.9999845027923584	O
6009	status	70 76	24950 24956	0.9999865293502808	O
6010	in	77 79	24957 24959	0.9999858140945435	O
6011	these	80 85	24960 24965	0.9999834299087524	O
6012	eight	86 91	24966 24971	0.9999628067016602	O
6013	cell	92 96	24972 24976	0.9999606609344482	O
6014	lines	97 102	24977 24982	0.9999797344207764	O
6015	.	103 104	24983 24984	0.9999407529830933	O
6016	Seven	0 5	24985 24990	0.9999525547027588	O
6017	of	6 8	24991 24993	0.9999833106994629	O
6018	the	9 12	24994 24997	0.9999775886535645	O
6019	75	13 15	24998 25000	0.9997743964195251	O
6020	ovarian	16 22	25001 25007	0.999883770942688	O
6023	carcinomas	24 33	25009 25018	0.9999752044677734	O
6027	showed	35 41	25020 25026	0.9999853372573853	O
6028	MLH1	42 45	25027 25030	0.9999856948852539	O
6031	promoter	47 55	25032 25040	0.9999881982803345	O
6032	methylation	56 66	25041 25051	0.999988317489624	O
6035	,	68 69	25053 25054	0.9999847412109375	O
6036	however	70 77	25055 25062	0.9999827146530151	O
6037	,	78 79	25063 25064	0.9999847412109375	O
6038	none	80 84	25065 25069	0.9999808073043823	O
6039	of	85 87	25070 25072	0.9999865293502808	O
6040	these	88 93	25073 25078	0.9999853372573853	O
6041	showed	94 100	25079 25085	0.9999872446060181	O
6042	MSI	101 103	25086 25088	0.9999834299087524	O
6044	.	104 105	25089 25090	0.9999711513519287	O
6045	Forty	0 5	25091 25096	0.9999502897262573	O
6046	-	5 6	25096 25097	0.9999837875366211	O
6047	six	6 9	25097 25100	0.9999685287475586	O
6048	of	10 12	25101 25103	0.9999821186065674	O
6049	these	13 18	25104 25109	0.9999749660491943	O
6050	patients	19 27	25110 25118	0.9999755620956421	O
6051	received	28 36	25119 25127	0.9999827146530151	O
6052	platinum	37 45	25128 25136	0.9999828338623047	O
6053	-	45 46	25136 25137	0.9999871253967285	O
6054	based	46 51	25137 25142	0.9999856948852539	O
6055	chemotherapy	52 63	25143 25154	0.9999850988388062	O
6058	(	65 66	25156 25157	0.9999872446060181	O
6059	11	67 69	25158 25160	0.9999792575836182	O
6060	non	70 73	25161 25164	0.9999853372573853	O
6061	-	73 74	25164 25165	0.999987006187439	O
6062	responders	74 83	25165 25174	0.9999867677688599	O
6064	,	85 86	25176 25177	0.9999866485595703	O
6065	34	87 89	25178 25180	0.9999756813049316	O
6066	responders	90 99	25181 25190	0.9999867677688599	O
6068	,	101 102	25192 25193	0.9999865293502808	O
6069	one	103 106	25194 25197	0.9999861717224121	O
6070	unknown	107 114	25198 25205	0.9999860525131226	O
6071	response	115 123	25206 25214	0.999987006187439	O
6072	)	124 125	25215 25216	0.9999868869781494	O
6073	.	126 127	25217 25218	0.9999533891677856	O
6074	The	0 3	25219 25222	0.9999858140945435	O
6075	resistance	4 14	25223 25233	0.999982476234436	O
6076	seen	15 19	25234 25238	0.9999845027923584	O
6077	in	20 22	25239 25241	0.9999878406524658	O
6078	the	23 26	25242 25245	0.999985933303833	O
6079	eleven	27 33	25246 25252	0.9999755620956421	O
6080	non	34 37	25253 25256	0.9999845027923584	O
6081	-	37 38	25256 25257	0.9999864101409912	O
6082	responders	38 47	25257 25266	0.999984860420227	O
6084	was	49 52	25268 25271	0.9999866485595703	O
6085	not	53 56	25272 25275	0.9999868869781494	O
6086	related	57 64	25276 25283	0.9999880790710449	O
6087	to	65 67	25284 25286	0.9999887943267822	O
6088	MSI	68 70	25287 25289	0.9999860525131226	O
6090	and	72 75	25291 25294	0.9999878406524658	O
6091	therefore	76 85	25295 25304	0.9999871253967285	O
6092	also	86 90	25305 25309	0.9999867677688599	O
6093	not	91 94	25310 25313	0.9999866485595703	O
6094	to	95 97	25314 25316	0.999988317489624	O
6095	MMR	98 100	25317 25319	0.999987006187439	O
6097	inactivation	102 113	25321 25332	0.99998939037323	O
6100	.	115 116	25334 25335	0.9999717473983765	O
6101	Conclusion	0 9	25336 25345	0.9999847412109375	O
6104	No	11 13	25347 25349	0.9999836683273315	O
6105	MMR	14 16	25350 25352	0.9999871253967285	O
6107	inactivation	18 29	25354 25365	0.9999890327453613	O
6110	was	31 34	25367 25370	0.9999879598617554	O
6111	detected	35 43	25371 25379	0.9999881982803345	O
6112	in	44 46	25380 25382	0.9999884366989136	O
6113	75	47 49	25383 25385	0.99996018409729	O
6114	ovarian	50 56	25386 25392	0.9999759197235107	O
6117	carcinoma	58 66	25394 25402	0.9999852180480957	O
6120	specimens	68 77	25404 25413	0.999981164932251	O
6121	and	78 81	25414 25417	0.9999860525131226	O
6122	no	82 84	25418 25420	0.9999855756759644	O
6123	association	85 96	25421 25432	0.9999878406524658	O
6124	was	97 100	25433 25436	0.9999881982803345	O
6125	seen	101 105	25437 25441	0.9999861717224121	O
6126	between	106 113	25442 25449	0.999988317489624	O
6127	MMR	114 116	25450 25452	0.9999872446060181	O
6129	inactivation	118 129	25454 25465	0.9999892711639404	O
6132	and	131 134	25467 25470	0.9999884366989136	O
6133	resistance	135 145	25471 25481	0.9999839067459106	O
6134	in	146 148	25482 25484	0.9999880790710449	O
6135	the	149 152	25485 25488	0.9999855756759644	O
6136	ovarian	153 159	25489 25495	0.9999814033508301	O
6139	cancer	161 167	25497 25503	0.9999852180480957	O
6140	cell	168 172	25504 25508	0.9999693632125854	O
6141	lines	173 178	25509 25514	0.9999823570251465	O
6142	as	179 181	25515 25517	0.9999834299087524	O
6143	well	182 186	25518 25522	0.9999830722808838	O
6144	as	187 189	25523 25525	0.9999837875366211	O
6145	the	190 193	25526 25529	0.9999799728393555	O
6146	ovarian	194 200	25530 25536	0.9999793767929077	O
6149	carcinomas	202 211	25538 25547	0.9999852180480957	O
6153	.	213 214	25549 25550	0.9999510049819946	O
6154	In	0 2	25551 25553	0.9999866485595703	O
6155	the	3 6	25554 25557	0.9999866485595703	O
6156	discussion	7 17	25558 25568	0.9999834299087524	O
6157	,	18 19	25569 25570	0.9999871253967285	O
6158	the	20 23	25571 25574	0.9999865293502808	O
6159	results	24 31	25575 25582	0.9999850988388062	O
6160	were	32 36	25583 25587	0.9999873638153076	O
6161	compared	37 45	25588 25596	0.9999854564666748	O
6162	to	46 48	25597 25599	0.9999878406524658	O
6163	that	49 53	25600 25604	0.9999879598617554	O
6164	of	54 56	25605 25607	0.9999880790710449	O
6165	twenty	57 63	25608 25614	0.9999817609786987	O
6166	similar	64 71	25615 25622	0.9999842643737793	O
6167	studies	72 79	25623 25630	0.9999860525131226	O
6168	in	80 82	25631 25633	0.9999879598617554	O
6169	the	83 86	25634 25637	0.9999879598617554	O
6170	literature	87 97	25638 25648	0.9999864101409912	O
6171	including	98 107	25649 25658	0.9999878406524658	O
6172	in	108 110	25659 25661	0.9999884366989136	O
6173	total	111 116	25662 25667	0.9999855756759644	O
6174	1315	117 120	25668 25671	0.9999812841415405	O
6176	ovarian	122 128	25673 25679	0.9999810457229614	O
6179	cancer	130 136	25681 25687	0.9999852180480957	O
6180	patients	137 145	25688 25696	0.9999830722808838	O
6181	.	146 147	25697 25698	0.9999659061431885	O
6182	Although	0 8	25699 25707	0.9999845027923584	O
6183	no	9 11	25708 25710	0.9999852180480957	O
6184	association	12 23	25711 25722	0.999987006187439	O
6185	between	24 31	25723 25730	0.9999873638153076	O
6186	response	32 40	25731 25739	0.9999830722808838	O
6187	and	41 44	25740 25743	0.9999879598617554	O
6188	MMR	45 47	25744 25746	0.9999861717224121	O
6190	status	49 55	25748 25754	0.999987006187439	O
6191	was	56 59	25755 25758	0.999987006187439	O
6192	seen	60 64	25759 25763	0.9999829530715942	O
6193	in	65 67	25764 25766	0.9999866485595703	O
6194	the	68 71	25767 25770	0.9999861717224121	O
6195	primary	72 79	25771 25778	0.9999850988388062	O
6196	tumor	80 85	25779 25784	0.999984622001648	O
6197	the	86 89	25785 25788	0.9999873638153076	O
6198	possible	90 98	25789 25797	0.9999871253967285	O
6199	role	99 103	25798 25802	0.9999871253967285	O
6200	of	104 106	25803 25805	0.999988317489624	O
6201	MMR	107 109	25806 25808	0.9999867677688599	O
6203	inactivation	111 122	25810 25821	0.9999884366989136	O
6206	in	124 126	25823 25825	0.9999879598617554	O
6207	acquired	127 135	25826 25834	0.999984860420227	O
6208	resistance	136 146	25835 25845	0.999985933303833	O
6209	deserves	147 155	25846 25854	0.9999847412109375	O
6210	further	156 163	25855 25862	0.9999877214431763	O
6211	investigation	164 177	25863 25876	0.9999866485595703	O
6212	.	178 179	25877 25878	0.9999880790710449	O
6213	*	180 181	25879 25880	0.9999874830245972	O
6214	*	181 182	25880 25881	0.9999774694442749	O
6215	IGNORE	0 5	25882 25887	0.9999856948852539	O
6218	LINE	7 10	25889 25892	0.9999885559082031	O
6221	*	12 13	25894 25895	0.9999890327453613	O
6222	*	13 14	25895 25896	0.9999890327453613	O
6223	*	15 16	25897 25898	0.9999889135360718	O
6224	*	16 17	25898 25899	0.9999889135360718	O
6225	IGNORE	18 23	25900 25905	0.9999874830245972	O
6228	LINE	25 28	25907 25910	0.9999891519546509	O
6231	*	30 31	25912 25913	0.9999889135360718	O
6232	*	31 32	25913 25914	0.9999889135360718	O
6233	*	33 34	25915 25916	0.9999887943267822	O
6234	*	34 35	25916 25917	0.9999887943267822	O
6235	IGNORE	36 41	25918 25923	0.9999873638153076	O
6238	LINE	43 46	25925 25928	0.9999889135360718	O
6241	*	48 49	25930 25931	0.9999890327453613	O
6242	*	49 50	25931 25932	0.9999890327453613	O
6243	Interestingly	51 63	25933 25945	0.9999878406524658	O
6245	,	65 66	25947 25948	0.9999890327453613	O
6246	a	67 68	25949 25950	0.9999890327453613	O
6247	number	69 75	25951 25957	0.9999877214431763	O
6248	of	76 78	25958 25960	0.9999886751174927	O
6249	in	79 81	25961 25963	0.9999890327453613	O
6250	vitro	82 86	25964 25968	0.9999885559082031	O
6253	studies	88 95	25970 25977	0.999985933303833	O
6254	have	96 100	25978 25982	0.9999874830245972	O
6255	suggested	101 110	25983 25992	0.9999864101409912	O
6256	a	111 112	25993 25994	0.9999890327453613	O
6257	relationship	113 125	25995 26007	0.9999874830245972	O
6258	between	126 133	26008 26015	0.9999886751174927	O
6259	MMR	134 136	26016 26018	0.9999867677688599	O
6261	deficiency	138 148	26020 26030	0.9999872446060181	O
6262	and	149 152	26031 26034	0.9999884366989136	O
6263	platinum	153 161	26035 26043	0.9999825954437256	O
6264	-	161 162	26043 26044	0.9999876022338867	O
6265	drug	162 166	26044 26048	0.9999868869781494	O
6266	resistance	167 177	26049 26059	0.9999872446060181	O
6267	.	178 179	26060 26061	0.9999651908874512	O
6268	Several	0 7	26062 26069	0.9999783039093018	O
6269	resistant	8 17	26070 26079	0.9999792575836182	O
6270	sublines	18 25	26080 26087	0.9999841451644897	O
6272	of	27 29	26089 26091	0.9999830722808838	O
6273	ovarian	30 36	26092 26098	0.9999561309814453	O
6276	and	38 41	26100 26103	0.9999685287475586	O
6277	melanoma	42 49	26104 26111	0.9994679093360901	O
6280	cell	51 55	26113 26117	0.9999663829803467	O
6281	lines	56 61	26118 26123	0.9999843835830688	O
6282	generated	62 71	26124 26133	0.9999864101409912	O
6283	by	72 74	26134 26136	0.999988317489624	O
6284	cisplatin	75 83	26137 26145	0.9999867677688599	O
6289	selection	85 94	26147 26156	0.9999874830245972	O
6290	,	95 96	26157 26158	0.9999822378158569	O
6291	appeared	97 105	26159 26167	0.9999867677688599	O
6292	to	106 108	26168 26170	0.9999884366989136	O
6293	be	109 111	26171 26173	0.9999885559082031	O
6294	MMR	112 114	26174 26176	0.9999866485595703	O
6296	deficient	116 124	26178 26186	0.9999889135360718	O
6298	[	126 127	26188 26189	0.9999891519546509	O
6299	11	127 129	26189 26191	0.9999885559082031	O
6300	-	129 130	26191 26192	0.9999889135360718	O
6301	15	130 132	26192 26194	0.9999877214431763	O
6302	]	132 133	26194 26195	0.9999886751174927	O
6303	.	134 135	26196 26197	0.9999656677246094	O
6304	In	0 2	26198 26200	0.9999876022338867	O
6305	addition	3 11	26201 26209	0.9999847412109375	O
6306	,	12 13	26210 26211	0.999988317489624	O
6307	a	14 15	26212 26213	0.9999840259552002	O
6308	colon	16 20	26214 26218	0.999982476234436	O
6310	(	22 23	26220 26221	0.9999884366989136	O
6311	HCT116	24 29	26222 26227	0.999985933303833	O
6315	)	31 32	26229 26230	0.9999886751174927	O
6316	and	33 36	26231 26234	0.9999856948852539	O
6317	an	37 39	26235 26237	0.9999865293502808	O
6318	endometrioid	40 51	26238 26249	0.9999839067459106	O
6322	cell	53 57	26251 26255	0.9999864101409912	O
6323	line	58 62	26256 26260	0.9999865293502808	O
6324	(	63 64	26261 26262	0.9999885559082031	O
6325	HEC59	65 69	26263 26267	0.9999686479568481	O
6329	)	71 72	26269 26270	0.9999892711639404	O
6330	,	73 74	26271 26272	0.9999880790710449	O
6331	deficient	75 83	26273 26281	0.9999881982803345	O
6333	for	85 88	26283 26286	0.9999887943267822	O
6334	MLH1	89 92	26287 26290	0.9999886751174927	O
6337	and	94 97	26292 26295	0.9999885559082031	O
6338	MSH2	98 101	26296 26299	0.999988317489624	O
6341	respectively	103 115	26301 26313	0.9999876022338867	O
6342	,	116 117	26314 26315	0.999988317489624	O
6343	were	118 122	26316 26320	0.9999885559082031	O
6344	2	123 124	26321 26322	0.9999860525131226	O
6345	.	124 125	26322 26323	0.9999889135360718	O
6346	1	125 126	26323 26324	0.9999876022338867	O
6347	and	127 130	26325 26328	0.9999871253967285	O
6348	1	131 132	26329 26330	0.9999881982803345	O
6349	.	132 133	26330 26331	0.9999889135360718	O
6350	8	133 134	26331 26332	0.9999873638153076	O
6351	fold	135 139	26333 26337	0.9999856948852539	O
6352	resistant	140 149	26338 26347	0.9999865293502808	O
6353	to	150 152	26348 26350	0.9999879598617554	O
6354	cisplatin	153 161	26351 26359	0.999987006187439	O
6359	compared	163 171	26361 26369	0.9999878406524658	O
6360	to	172 174	26370 26372	0.9999884366989136	O
6361	cell	175 179	26373 26377	0.9999860525131226	O
6362	lines	180 185	26378 26383	0.9999876022338867	O
6363	complemented	186 197	26384 26395	0.9999856948852539	O
6365	with	199 203	26397 26401	0.9999890327453613	O
6366	chromosome	204 214	26402 26412	0.9999890327453613	O
6367	3	215 216	26413 26414	0.9999874830245972	O
6368	,	217 218	26415 26416	0.9999889135360718	O
6369	containing	219 229	26417 26427	0.9999892711639404	O
6370	MLH1	230 233	26428 26431	0.9999884366989136	O
6373	,	235 236	26433 26434	0.9999881982803345	O
6374	or	237 239	26435 26437	0.9999885559082031	O
6375	chromosome	240 250	26438 26448	0.9999889135360718	O
6376	2	251 252	26449 26450	0.9999860525131226	O
6377	,	253 254	26451 26452	0.999988317489624	O
6378	containing	255 265	26453 26463	0.9999891519546509	O
6379	MSH2	266 269	26464 26467	0.9999877214431763	O
6382	[	271 272	26469 26470	0.99998939037323	O
6383	15	272 274	26470 26472	0.9999879598617554	O
6384	-	274 275	26472 26473	0.9999895095825195	O
6385	17	275 277	26473 26475	0.999985933303833	O
6386	]	277 278	26475 26476	0.9999892711639404	O
6387	.	279 280	26477 26478	0.999967098236084	O
6388	These	0 5	26479 26484	0.9999821186065674	O
6389	in	6 8	26485 26487	0.9999852180480957	O
6390	vitro	9 13	26488 26492	0.999984860420227	O
6393	studies	15 22	26494 26501	0.9999741315841675	O
6394	suggest	23 30	26502 26509	0.9999779462814331	O
6395	that	31 35	26510 26514	0.9999862909317017	O
6396	inactivation	36 47	26515 26526	0.9999868869781494	O
6399	of	49 51	26528 26530	0.9999873638153076	O
6400	proteins	52 60	26531 26539	0.9999581575393677	O
6401	involved	61 69	26540 26548	0.9999862909317017	O
6402	in	70 72	26549 26551	0.9999876022338867	O
6403	the	73 76	26552 26555	0.9999874830245972	O
6404	initiation	77 87	26556 26566	0.9999871253967285	O
6405	of	88 90	26567 26569	0.9999884366989136	O
6406	MMR	91 93	26570 26572	0.9999855756759644	O
6408	might	95 100	26574 26579	0.9999767541885376	O
6409	cause	101 106	26580 26585	0.9999833106994629	O
6410	cisplatin	107 115	26586 26594	0.9999852180480957	O
6415	resistance	117 127	26596 26606	0.9999849796295166	O
6416	.	128 129	26607 26608	0.9999608993530273	O
6417	It	0 2	26609 26611	0.999987006187439	O
6418	is	3 5	26612 26614	0.9999855756759644	O
6419	thought	6 13	26615 26622	0.9999858140945435	O
6420	that	14 18	26623 26627	0.9999881982803345	O
6421	the	19 22	26628 26631	0.9999874830245972	O
6422	DNA	23 26	26632 26635	0.9999785423278809	O
6423	damage	27 33	26636 26642	0.9999852180480957	O
6424	caused	34 40	26643 26649	0.9999881982803345	O
6425	by	41 43	26650 26652	0.9999886751174927	O
6426	platin	44 49	26653 26658	0.9999861717224121	O
6429	-	50 51	26659 26660	0.9999866485595703	O
6430	drugs	51 56	26660 26665	0.999984860420227	O
6431	is	57 59	26666 26668	0.9999880790710449	O
6432	recognized	60 70	26669 26679	0.9999877214431763	O
6433	by	71 73	26680 26682	0.9999891519546509	O
6434	MMR	74 76	26683 26685	0.9999876022338867	O
6436	.	77 78	26686 26687	0.9999740123748779	O
6437	The	0 3	26688 26691	0.999980092048645	O
6438	cell	4 8	26692 26696	0.9999434947967529	O
6439	will	9 13	26697 26701	0.9999783039093018	O
6440	then	14 18	26702 26706	0.999975323677063	O
6441	undergo	19 26	26707 26714	0.9999804496765137	O
6442	several	27 34	26715 26722	0.9999796152114868	O
6443	unsuccessful	35 47	26723 26735	0.9999550580978394	O
6444	repair	48 54	26736 26742	0.9999512434005737	O
6445	cycles	55 61	26743 26749	0.9999788999557495	O
6446	,	62 63	26750 26751	0.999983549118042	O
6447	finally	64 71	26752 26759	0.9999806880950928	O
6448	resulting	72 81	26760 26769	0.9999839067459106	O
6449	in	82 84	26770 26772	0.9999854564666748	O
6450	the	85 88	26773 26776	0.999984622001648	O
6451	induction	89 98	26777 26786	0.9999604225158691	O
6452	of	99 101	26787 26789	0.999985933303833	O
6453	apoptosis	102 110	26790 26798	0.9999841451644897	O
6456	.	112 113	26800 26801	0.999934196472168	O
6457	When	0 4	26802 26806	0.9999873638153076	O
6458	MMR	5 7	26807 26809	0.9999872446060181	O
6460	is	9 11	26811 26813	0.9999877214431763	O
6461	inactive	12 20	26814 26822	0.9999831914901733	O
6462	the	21 24	26823 26826	0.9999873638153076	O
6463	DNA	25 28	26827 26830	0.999982476234436	O
6464	damage	29 35	26831 26837	0.9999872446060181	O
6465	caused	36 42	26838 26844	0.9999885559082031	O
6466	by	43 45	26845 26847	0.9999892711639404	O
6467	platin	46 51	26848 26853	0.9999881982803345	O
6470	-	52 53	26854 26855	0.9999885559082031	O
6471	drugs	53 58	26855 26860	0.9999877214431763	O
6472	will	59 63	26861 26865	0.9999886751174927	O
6473	not	64 67	26866 26869	0.999988317489624	O
6474	be	68 70	26870 26872	0.9999889135360718	O
6475	picked	71 77	26873 26879	0.9999880790710449	O
6476	up	78 80	26880 26882	0.9999885559082031	O
6477	and	81 84	26883 26886	0.9999880790710449	O
6478	will	85 89	26887 26891	0.9999880790710449	O
6479	therefore	90 99	26892 26901	0.9999860525131226	O
6480	not	100 103	26902 26905	0.9999866485595703	O
6481	result	104 110	26906 26912	0.9999876022338867	O
6482	in	111 113	26913 26915	0.9999886751174927	O
6483	apoptosis	114 122	26916 26924	0.9999886751174927	O
6486	rendering	124 133	26926 26935	0.9999865293502808	O
6487	the	134 137	26936 26939	0.9999874830245972	O
6488	cells	138 143	26940 26945	0.9999853372573853	O
6489	resistant	144 153	26946 26955	0.9999872446060181	O
6490	to	154 156	26956 26958	0.9999887943267822	O
6491	platin	157 162	26959 26964	0.9999885559082031	O
6494	-	163 164	26965 26966	0.9999884366989136	O
6495	drugs	164 169	26966 26971	0.9999874830245972	O
6496	.	170 171	26972 26973	0.9999685287475586	O
6497	Several	0 7	26974 26981	0.9999850988388062	O
6498	studies	8 15	26982 26989	0.9999843835830688	O
6499	have	16 20	26990 26994	0.999987006187439	O
6500	determined	21 31	26995 27005	0.9999874830245972	O
6501	the	32 35	27006 27009	0.9999891519546509	O
6502	frequency	36 45	27010 27019	0.9999872446060181	O
6503	of	46 48	27020 27022	0.9999890327453613	O
6504	MMR	49 51	27023 27025	0.999985933303833	O
6506	inactivation	53 64	27027 27038	0.9999891519546509	O
6509	in	66 68	27040 27042	0.9999876022338867	O
6510	ovarian	69 75	27043 27049	0.9999833106994629	O
6513	cancer	77 83	27051 27057	0.9999866485595703	O
6514	using	84 89	27058 27063	0.9999886751174927	O
6515	MSI	90 92	27064 27066	0.9999871253967285	O
6517	as	94 96	27068 27070	0.99998939037323	O
6518	a	97 98	27071 27072	0.9999895095825195	O
6519	marker	99 105	27073 27079	0.9999889135360718	O
6520	[	106 107	27080 27081	0.9999895095825195	O
6521	18	107 109	27081 27083	0.9999878406524658	O
6522	-	109 110	27083 27084	0.9999895095825195	O
6523	37	110 112	27084 27086	0.9999862909317017	O
6524	]	112 113	27086 27087	0.9999895095825195	O
6525	.	114 115	27088 27089	0.9999781847000122	O
6526	However	0 7	27090 27097	0.9999861717224121	O
6527	,	8 9	27098 27099	0.9999884366989136	O
6528	there	10 15	27100 27105	0.9999885559082031	O
6529	was	16 19	27106 27109	0.9999885559082031	O
6530	a	20 21	27110 27111	0.9999890327453613	O
6531	wide	22 26	27112 27116	0.9999878406524658	O
6532	range	27 32	27117 27122	0.9999866485595703	O
6533	observed	33 41	27123 27131	0.9999849796295166	O
6534	(	42 43	27132 27133	0.9999892711639404	O
6535	0	44 45	27134 27135	0.9999865293502808	O
6536	%	46 47	27136 27137	0.9999891519546509	O
6537	–	48 49	27138 27139	0.9999818801879883	O
6538	39	49 51	27139 27141	0.9999786615371704	O
6539	%	52 53	27142 27143	0.9999889135360718	O
6540	)	54 55	27144 27145	0.9999886751174927	O
6541	and	56 59	27146 27149	0.999987006187439	O
6542	so	60 62	27150 27152	0.9999877214431763	O
6543	far	63 66	27153 27156	0.9999874830245972	O
6544	only	67 71	27157 27161	0.9999880790710449	O
6545	a	72 73	27162 27163	0.9999890327453613	O
6546	few	74 77	27164 27167	0.9999877214431763	O
6547	studies	78 85	27168 27175	0.9999854564666748	O
6548	have	86 90	27176 27180	0.9999878406524658	O
6549	linked	91 97	27181 27187	0.9999874830245972	O
6550	MMR	98 100	27188 27190	0.9999874830245972	O
6552	inactivation	102 113	27192 27203	0.9999897480010986	O
6555	to	115 117	27205 27207	0.9999892711639404	O
6556	platinum	118 126	27208 27216	0.9999872446060181	O
6557	-	126 127	27216 27217	0.99998939037323	O
6558	based	127 132	27217 27222	0.9999880790710449	O
6559	chemotherapy	133 144	27223 27234	0.9999874830245972	O
6562	resistance	146 156	27236 27246	0.9999879598617554	O
6563	.	157 158	27247 27248	0.9999747276306152	O
6564	Thus	0 4	27249 27253	0.9999862909317017	O
6565	,	5 6	27254 27255	0.9999880790710449	O
6566	there	7 12	27256 27261	0.9999877214431763	O
6567	is	13 15	27262 27264	0.9999872446060181	O
6568	still	16 21	27265 27270	0.999983549118042	O
6569	no	22 24	27271 27273	0.999985933303833	O
6570	general	25 32	27274 27281	0.9999864101409912	O
6571	agreement	33 42	27282 27291	0.999985933303833	O
6572	about	43 48	27292 27297	0.9999878406524658	O
6573	the	49 52	27298 27301	0.9999885559082031	O
6574	frequency	53 62	27302 27311	0.9999874830245972	O
6575	of	63 65	27312 27314	0.9999886751174927	O
6576	MMR	66 68	27315 27317	0.9999865293502808	O
6578	inactivation	70 81	27319 27330	0.9999891519546509	O
6581	and	83 86	27332 27335	0.9999872446060181	O
6582	its	87 90	27336 27339	0.9999887943267822	O
6583	possible	91 99	27340 27348	0.9999865293502808	O
6584	involvement	100 111	27349 27360	0.9999872446060181	O
6585	in	112 114	27361 27363	0.9999877214431763	O
6586	the	115 118	27364 27367	0.9999871253967285	O
6587	platinum	119 127	27368 27376	0.9999856948852539	O
6588	-	127 128	27376 27377	0.9999885559082031	O
6589	based	128 133	27377 27382	0.9999867677688599	O
6590	chemotherapy	134 145	27383 27394	0.999985933303833	O
6593	resistance	147 157	27396 27406	0.9999873638153076	O
6594	seen	158 162	27407 27411	0.9999858140945435	O
6595	in	163 165	27412 27414	0.9999877214431763	O
6596	ovarian	166 172	27415 27421	0.9999836683273315	O
6599	cancer	174 180	27423 27429	0.9999852180480957	O
6600	patients	181 189	27430 27438	0.9999816417694092	O
6601	.	190 191	27439 27440	0.9999631643295288	O
6602	The	0 3	27441 27444	0.9999871253967285	O
6603	aim	4 7	27445 27448	0.9999867677688599	O
6604	of	8 10	27449 27451	0.9999881982803345	O
6605	this	11 15	27452 27456	0.9999878406524658	O
6606	study	16 21	27457 27462	0.9999853372573853	O
6607	is	22 24	27463 27465	0.9999868869781494	O
6608	to	25 27	27466 27468	0.9999879598617554	O
6609	determine	28 37	27469 27478	0.999987006187439	O
6610	the	38 41	27479 27482	0.9999885559082031	O
6611	frequency	42 51	27483 27492	0.9999862909317017	O
6612	of	52 54	27493 27495	0.9999884366989136	O
6613	mismatch	55 62	27496 27503	0.9999874830245972	O
6616	repair	64 70	27505 27511	0.9999873638153076	O
6617	(	71 72	27512 27513	0.9999886751174927	O
6618	MMR	73 75	27514 27516	0.9999865293502808	O
6620	)	77 78	27518 27519	0.9999887943267822	O
6621	inactivation	79 90	27520 27531	0.9999891519546509	O
6624	in	92 94	27533 27535	0.9999866485595703	O
6625	ovarian	95 101	27536 27542	0.9999815225601196	O
6628	cancer	103 109	27544 27550	0.9999864101409912	O
6629	and	110 113	27551 27554	0.9999856948852539	O
6630	whether	114 121	27555 27562	0.9999871253967285	O
6631	it	122 124	27563 27565	0.9999885559082031	O
6632	is	125 127	27566 27568	0.999988317489624	O
6633	associated	128 138	27569 27579	0.9999885559082031	O
6634	with	139 143	27580 27584	0.9999884366989136	O
6635	platinum	144 152	27585 27593	0.9999862909317017	O
6636	-	152 153	27593 27594	0.9999886751174927	O
6637	based	153 158	27594 27599	0.9999871253967285	O
6638	chemotherapy	159 170	27600 27611	0.9999864101409912	O
6641	resistance	172 182	27613 27623	0.999987006187439	O
6642	.	183 184	27624 27625	0.9999696016311646	O
6643	To	0 2	27626 27628	0.9999688863754272	O
6644	this	3 7	27629 27633	0.9999819993972778	O
6645	purpose	8 15	27634 27641	0.9999783039093018	O
6646	we	16 18	27642 27644	0.9999735355377197	O
6647	analyzed	19 27	27645 27653	0.999974250793457	O
6648	seventy	28 35	27654 27661	0.9998619556427002	O
6649	-	35 36	27661 27662	0.9999773502349854	O
6650	five	36 40	27662 27666	0.9999264478683472	O
6651	ovarian	41 47	27667 27673	0.9999465942382812	O
6654	carcinomas	49 58	27675 27684	0.9999788999557495	O
6658	and	60 63	27686 27689	0.9999756813049316	O
6659	eight	64 69	27690 27695	0.999953031539917	O
6660	ovarian	70 76	27696 27702	0.999962329864502	O
6663	cancer	78 84	27704 27710	0.9999802112579346	O
6664	cell	85 89	27711 27715	0.9999483823776245	O
6665	lines	90 95	27716 27721	0.9999799728393555	O
6666	.	96 97	27722 27723	0.9999313354492188	O
6667	In	0 2	27724 27726	0.9999879598617554	O
6668	the	3 6	27727 27730	0.9999878406524658	O
6669	discussion	7 17	27731 27741	0.9999853372573853	O
6670	,	18 19	27742 27743	0.999988317489624	O
6671	the	20 23	27744 27747	0.9999876022338867	O
6672	results	24 31	27748 27755	0.9999864101409912	O
6673	were	32 36	27756 27760	0.9999885559082031	O
6674	compared	37 45	27761 27769	0.9999873638153076	O
6675	to	46 48	27770 27772	0.9999889135360718	O
6676	that	49 53	27773 27777	0.9999885559082031	O
6677	of	54 56	27778 27780	0.9999886751174927	O
6678	twenty	57 63	27781 27787	0.9999833106994629	O
6679	similar	64 71	27788 27795	0.9999850988388062	O
6680	studies	72 79	27796 27803	0.9999867677688599	O
6681	in	80 82	27804 27806	0.9999884366989136	O
6682	the	83 86	27807 27810	0.9999885559082031	O
6683	literature	87 97	27811 27821	0.9999871253967285	O
6684	including	98 107	27822 27831	0.9999889135360718	O
6685	in	108 110	27832 27834	0.9999890327453613	O
6686	total	111 116	27835 27840	0.999987006187439	O
6687	1315	117 120	27841 27844	0.9999819993972778	O
6689	ovarian	122 128	27846 27852	0.9999830722808838	O
6692	cancer	130 136	27854 27860	0.9999868869781494	O
6693	patients	137 145	27861 27869	0.9999854564666748	O
6694	.	146 147	27870 27871	0.9999892711639404	O
6695	*	148 149	27872 27873	0.9999887943267822	O
6696	*	149 150	27873 27874	0.999984860420227	O
6697	IGNORE	0 5	27875 27880	0.999987006187439	O
6700	LINE	7 10	27882 27885	0.9999892711639404	O
6703	*	12 13	27887 27888	0.9999895095825195	O
6704	*	13 14	27888 27889	0.99998939037323	O
6705	*	15 16	27890 27891	0.99998939037323	O
6706	*	16 17	27891 27892	0.9999895095825195	O
6707	IGNORE	18 23	27893 27898	0.9999881982803345	O
6710	LINE	25 28	27900 27903	0.99998939037323	O
6713	*	30 31	27905 27906	0.9999891519546509	O
6714	*	31 32	27906 27907	0.9999892711639404	O
6715	*	33 34	27908 27909	0.9999891519546509	O
6716	*	34 35	27909 27910	0.9999891519546509	O
6717	IGNORE	36 41	27911 27916	0.9999881982803345	O
6720	LINE	43 46	27918 27921	0.9999892711639404	O
6723	*	48 49	27923 27924	0.9999892711639404	O
6724	*	49 50	27924 27925	0.9999891519546509	O
6725	Another	51 58	27926 27933	0.9999876022338867	O
6726	difference	59 69	27934 27944	0.9999885559082031	O
6727	between	70 77	27945 27952	0.9999878406524658	O
6728	the	78 81	27953 27956	0.9999889135360718	O
6729	studies	82 89	27957 27964	0.9999853372573853	O
6730	is	90 92	27965 27967	0.9999891519546509	O
6731	the	93 96	27968 27971	0.99998939037323	O
6732	distribution	97 109	27972 27984	0.9999885559082031	O
6733	of	110 112	27985 27987	0.9999890327453613	O
6734	the	113 116	27988 27991	0.9999887943267822	O
6735	various	117 124	27992 27999	0.9999850988388062	O
6736	histological	125 136	28000 28011	0.9999880790710449	O
6739	types	138 143	28013 28018	0.9999878406524658	O
6740	of	144 146	28019 28021	0.9999879598617554	O
6741	the	147 150	28022 28025	0.999987006187439	O
6742	ovarian	151 157	28026 28032	0.9999794960021973	O
6745	carcinoma	159 167	28034 28042	0.9999862909317017	O
6748	tissues	169 176	28044 28051	0.9999856948852539	O
6749	analyzed	177 185	28052 28060	0.999987006187439	O
6750	(	186 187	28061 28062	0.9999892711639404	O
6751	Table	188 193	28063 28068	0.9999856948852539	O
6752	2	194 195	28069 28070	0.9999873638153076	O
6753	)	196 197	28071 28072	0.9999892711639404	O
6754	.	198 199	28073 28074	0.9999808073043823	O
6755	This	0 4	28075 28079	0.9999872446060181	O
6756	difference	5 15	28080 28090	0.9999855756759644	O
6757	in	16 18	28091 28093	0.9999881982803345	O
6758	the	19 22	28094 28097	0.999988317489624	O
6759	distribution	23 35	28098 28110	0.999987006187439	O
6760	could	36 41	28111 28116	0.9999852180480957	O
6761	be	42 44	28117 28119	0.9999885559082031	O
6762	a	45 46	28120 28121	0.9999886751174927	O
6763	cause	47 52	28122 28127	0.9999871253967285	O
6764	for	53 56	28128 28131	0.999988317489624	O
6765	the	57 60	28132 28135	0.9999889135360718	O
6766	wide	61 65	28136 28140	0.9999886751174927	O
6767	range	66 71	28141 28146	0.9999887943267822	O
6768	in	72 74	28147 28149	0.9999887943267822	O
6769	the	75 78	28150 28153	0.9999891519546509	O
6770	MSI	79 81	28154 28156	0.9999853372573853	O
6772	frequency	83 92	28158 28167	0.9999880790710449	O
6773	especially	93 103	28168 28178	0.999987006187439	O
6774	since	104 109	28179 28184	0.9999867677688599	O
6775	it	110 112	28185 28187	0.9999889135360718	O
6776	has	113 116	28188 28191	0.9999884366989136	O
6777	been	117 121	28192 28196	0.9999881982803345	O
6778	suggested	122 131	28197 28206	0.9999879598617554	O
6779	that	132 136	28207 28211	0.9999890327453613	O
6780	certain	137 144	28212 28219	0.9999874830245972	O
6781	histological	145 156	28220 28231	0.9999881982803345	O
6784	types	158 163	28233 28238	0.9999876022338867	O
6785	have	164 168	28239 28243	0.9999881982803345	O
6786	a	169 170	28244 28245	0.9999887943267822	O
6787	higher	171 177	28246 28252	0.999987006187439	O
6788	frequency	178 187	28253 28262	0.999988317489624	O
6789	of	188 190	28263 28265	0.9999886751174927	O
6790	MSI	191 193	28266 28268	0.9999862909317017	O
6792	.	194 195	28269 28270	0.9999744892120361	O
6793	To	0 2	28271 28273	0.9999879598617554	O
6794	determine	3 12	28274 28283	0.9999881982803345	O
6795	whether	13 20	28284 28291	0.9999889135360718	O
6796	there	21 26	28292 28297	0.9999889135360718	O
6797	is	27 29	28298 28300	0.9999887943267822	O
6798	a	30 31	28301 28302	0.9999892711639404	O
6799	relation	32 40	28303 28311	0.9999879598617554	O
6800	between	41 48	28312 28319	0.9999895095825195	O
6801	histology	49 57	28320 28328	0.9999889135360718	O
6803	and	59 62	28330 28333	0.9999891519546509	O
6804	MSI	63 65	28334 28336	0.9999843835830688	O
6806	within	67 73	28338 28344	0.9999885559082031	O
6807	these	74 79	28345 28350	0.99998939037323	O
6808	studies	80 87	28351 28358	0.9999837875366211	O
6809	,	88 89	28359 28360	0.9999889135360718	O
6810	we	90 92	28361 28363	0.9999881982803345	O
6811	looked	93 99	28364 28370	0.9999885559082031	O
6812	at	100 102	28371 28373	0.9999892711639404	O
6813	the	103 106	28374 28377	0.99998939037323	O
6814	frequency	107 116	28378 28387	0.9999876022338867	O
6815	of	117 119	28388 28390	0.9999892711639404	O
6816	MSI	120 122	28391 28393	0.9999860525131226	O
6818	per	124 127	28395 28398	0.9999887943267822	O
6819	histological	128 139	28399 28410	0.99998939037323	O
6822	type	141 145	28412 28416	0.9999890327453613	O
6823	for	146 149	28417 28420	0.9999890327453613	O
6824	the	150 153	28421 28424	0.9999891519546509	O
6825	628	154 156	28425 28427	0.999983549118042	O
6827	patients	158 166	28429 28437	0.9999837875366211	O
6828	with	167 171	28438 28442	0.9999891519546509	O
6829	known	172 177	28443 28448	0.9999867677688599	O
6830	histology	178 186	28449 28457	0.9999891519546509	O
6832	(	188 189	28459 28460	0.9999895095825195	O
6833	Table	190 195	28461 28466	0.9999871253967285	O
6834	2	196 197	28467 28468	0.9999880790710449	O
6835	)	198 199	28469 28470	0.9999896287918091	O
6836	.	200 201	28471 28472	0.9999812841415405	O
6837	The	0 3	28473 28476	0.9999891519546509	O
6838	summary	4 11	28477 28484	0.9999856948852539	O
6839	of	12 14	28485 28487	0.9999887943267822	O
6840	these	15 20	28488 28493	0.9999880790710449	O
6841	studies	21 28	28494 28501	0.9999839067459106	O
6842	suggests	29 37	28502 28510	0.999987006187439	O
6843	that	38 42	28511 28515	0.99998939037323	O
6844	the	43 46	28516 28519	0.9999895095825195	O
6845	frequency	47 56	28520 28529	0.999988317489624	O
6846	of	57 59	28530 28532	0.9999892711639404	O
6847	MSI	60 62	28533 28535	0.9999872446060181	O
6849	is	64 66	28537 28539	0.9999885559082031	O
6850	higher	67 73	28540 28546	0.9999860525131226	O
6851	in	74 76	28547 28549	0.9999886751174927	O
6852	the	77 80	28550 28553	0.9999865293502808	O
6853	mucinous	81 88	28554 28561	0.9999854564666748	O
6857	and	90 93	28563 28566	0.9999852180480957	O
6858	endometrioid	94 105	28567 28578	0.9999822378158569	O
6862	adenocarcinoma	107 120	28580 28593	0.9999884366989136	O
6867	compared	122 130	28595 28603	0.9999877214431763	O
6868	to	131 133	28604 28606	0.999988317489624	O
6869	clear	134 139	28607 28612	0.9999862909317017	O
6870	cell	140 144	28613 28617	0.9999880790710449	O
6871	and	145 148	28618 28621	0.999987006187439	O
6872	serous	149 154	28622 28627	0.9999761581420898	O
6874	adenocarcinoma	156 169	28629 28642	0.9999881982803345	O
6879	(	171 172	28644 28645	0.9999896287918091	O
6880	the	173 176	28646 28649	0.99998939037323	O
6881	overall	177 184	28650 28657	0.9999892711639404	O
6882	frequencies	185 196	28658 28669	0.9999889135360718	O
6883	of	197 199	28670 28672	0.99998939037323	O
6884	MSI	200 202	28673 28675	0.9999881982803345	O
6886	were	204 208	28677 28681	0.9999890327453613	O
6887	22	209 211	28682 28684	0.999988317489624	O
6888	%	212 213	28685 28686	0.9999896287918091	O
6889	,	214 215	28687 28688	0.9999881982803345	O
6890	16	216 218	28689 28691	0.9999861717224121	O
6891	%	219 220	28692 28693	0.99998939037323	O
6892	,	221 222	28694 28695	0.9999881982803345	O
6893	9	223 224	28696 28697	0.9999865293502808	O
6894	%	225 226	28698 28699	0.99998939037323	O
6895	and	227 230	28700 28703	0.9999877214431763	O
6896	8	231 232	28704 28705	0.9999861717224121	O
6897	%	233 234	28706 28707	0.9999892711639404	O
6898	,	235 236	28708 28709	0.9999884366989136	O
6899	respectively	237 249	28710 28722	0.9999884366989136	O
6900	)	250 251	28723 28724	0.9999891519546509	O
6901	(	252 253	28725 28726	0.99998939037323	O
6902	Table	254 259	28727 28732	0.9999864101409912	O
6903	2	260 261	28733 28734	0.9999874830245972	O
6904	)	262 263	28735 28736	0.9999895095825195	O
6905	.	264 265	28737 28738	0.9999790191650391	O
6906	We	0 2	28739 28741	0.999982476234436	O
6907	hypothesize	3 13	28742 28752	0.9999880790710449	O
6912	that	15 19	28754 28758	0.9999891519546509	O
6913	mucinous	20 27	28759 28766	0.9999879598617554	O
6917	and	29 32	28768 28771	0.9999873638153076	O
6918	endometrioid	33 44	28772 28783	0.9999879598617554	O
6922	histology	46 54	28785 28793	0.9999890327453613	O
6924	might	56 61	28795 28800	0.9999860525131226	O
6925	be	62 64	28801 28803	0.9999885559082031	O
6926	prone	65 70	28804 28809	0.9999852180480957	O
6927	to	71 73	28810 28812	0.9999889135360718	O
6928	a	74 75	28813 28814	0.9999892711639404	O
6929	higher	76 82	28815 28821	0.9999873638153076	O
6930	MSI	83 85	28822 28824	0.9999874830245972	O
6932	frequency	87 96	28826 28835	0.9999885559082031	O
6933	since	97 102	28836 28841	0.9999855756759644	O
6934	sporadic	103 110	28842 28849	0.9999867677688599	O
6936	endometrial	112 122	28851 28861	0.9999866485595703	O
6940	carcinoma	124 132	28863 28871	0.9999874830245972	O
6943	,	134 135	28873 28874	0.9999885559082031	O
6944	which	136 141	28875 28880	0.9999890327453613	O
6945	is	142 144	28881 28883	0.9999885559082031	O
6946	closely	145 152	28884 28891	0.9999878406524658	O
6947	related	153 160	28892 28899	0.9999886751174927	O
6948	to	161 163	28900 28902	0.9999889135360718	O
6949	endometrioid	164 175	28903 28914	0.9999874830245972	O
6953	ovarian	177 183	28916 28922	0.9999858140945435	O
6956	cancer	185 191	28924 28930	0.9999879598617554	O
6957	,	192 193	28931 28932	0.9999873638153076	O
6958	has	194 197	28933 28936	0.9999884366989136	O
6959	a	198 199	28937 28938	0.9999890327453613	O
6960	MSI	200 202	28939 28941	0.9999880790710449	O
6962	frequency	204 213	28943 28952	0.9999889135360718	O
6963	of	214 216	28953 28955	0.9999889135360718	O
6964	20	217 219	28956 28958	0.9999877214431763	O
6965	–	219 220	28958 28959	0.999983549118042	O
6966	30	220 222	28959 28961	0.9999865293502808	O
6967	%	223 224	28962 28963	0.9999890327453613	O
6968	[	225 226	28964 28965	0.9999887943267822	O
6969	49	226 228	28965 28967	0.9999861717224121	O
6970	-	228 229	28967 28968	0.9999891519546509	O
6971	51	229 231	28968 28970	0.9999854564666748	O
6972	]	231 232	28970 28971	0.9999889135360718	O
6973	and	233 236	28972 28975	0.9999885559082031	O
6974	MSI	237 239	28976 28978	0.9999881982803345	O
6976	is	241 243	28980 28982	0.9999891519546509	O
6977	almost	244 250	28983 28989	0.9999890327453613	O
6978	universal	251 260	28990 28999	0.9999866485595703	O
6979	present	261 268	29000 29007	0.9999866485595703	O
6980	in	269 271	29008 29010	0.9999881982803345	O
6981	the	272 275	29011 29014	0.9999847412109375	O
6982	colorectal	276 285	29015 29024	0.9999822378158569	O
6985	tumors	287 293	29026 29032	0.9999855756759644	O
6986	of	294 296	29033 29035	0.9999880790710449	O
6987	the	297 300	29036 29039	0.9999879598617554	O
6988	hereditary	301 311	29040 29050	0.999920129776001	O
6989	nonpolyposis	312 323	29051 29062	0.9999850988388062	O
6994	colon	325 329	29064 29068	0.9999847412109375	O
6996	cancer	331 337	29070 29076	0.999987006187439	O
6997	(	338 339	29077 29078	0.9999878406524658	O
6998	HNPCC	340 344	29079 29083	0.9999730587005615	O
7001	)	346 347	29085 29086	0.9999880790710449	O
7002	syndrome	348 356	29087 29095	0.9999797344207764	O
7003	which	357 362	29096 29101	0.9999872446060181	O
7004	all	363 366	29102 29105	0.9999819993972778	O
7005	have	367 371	29106 29110	0.9999881982803345	O
7006	a	372 373	29111 29112	0.9999890327453613	O
7007	mucinous	374 381	29113 29120	0.9999872446060181	O
7011	histological	383 394	29122 29133	0.9999890327453613	O
7014	type	396 400	29135 29139	0.9999881982803345	O
7015	.	401 402	29140 29141	0.9999607801437378	O
7016	Therefore	0 9	29142 29151	0.9999849796295166	O
7017	,	10 11	29152 29153	0.999988317489624	O
7018	the	12 15	29154 29157	0.9999872446060181	O
7019	different	16 25	29158 29167	0.9999847412109375	O
7020	histology	26 34	29168 29176	0.9999867677688599	O
7022	'	36 37	29178 29179	0.9999879598617554	O
7023	s	37 38	29179 29180	0.999988317489624	O
7024	of	39 41	29181 29183	0.9999864101409912	O
7025	the	42 45	29184 29187	0.999984622001648	O
7026	ovarian	46 52	29188 29194	0.9999715089797974	O
7029	carcinomas	54 63	29196 29205	0.999985933303833	O
7033	included	65 73	29207 29215	0.999988317489624	O
7034	in	74 76	29216 29218	0.9999886751174927	O
7035	the	77 80	29219 29222	0.9999881982803345	O
7036	several	81 88	29223 29230	0.9999847412109375	O
7037	studies	89 96	29231 29238	0.9999855756759644	O
7038	seems	97 102	29239 29244	0.9999862909317017	O
7039	to	103 105	29245 29247	0.9999884366989136	O
7040	be	106 108	29248 29250	0.9999889135360718	O
7041	a	109 110	29251 29252	0.9999890327453613	O
7042	plausible	111 120	29253 29262	0.9999852180480957	O
7043	cause	121 126	29263 29268	0.999988317489624	O
7044	for	127 130	29269 29272	0.9999880790710449	O
7045	the	131 134	29273 29276	0.9999886751174927	O
7046	wide	135 139	29277 29281	0.9999885559082031	O
7047	range	140 145	29282 29287	0.9999886751174927	O
7048	in	146 148	29288 29290	0.9999892711639404	O
7049	MSI	149 151	29291 29293	0.9999865293502808	O
7051	frequency	153 162	29295 29304	0.9999880790710449	O
7052	reported	163 171	29305 29313	0.9999876022338867	O
7053	in	172 174	29314 29316	0.9999886751174927	O
7054	these	175 180	29317 29322	0.9999879598617554	O
7055	studies	181 188	29323 29330	0.999984622001648	O
7056	.	189 190	29331 29332	0.9999650716781616	O
7057	Next	0 4	29333 29337	0.9999850988388062	O
7058	we	5 7	29338 29340	0.9999880790710449	O
7059	addressed	8 17	29341 29350	0.9999878406524658	O
7060	the	18 21	29351 29354	0.9999891519546509	O
7061	second	22 28	29355 29361	0.9999874830245972	O
7062	part	29 33	29362 29366	0.9999887943267822	O
7063	of	34 36	29367 29369	0.9999889135360718	O
7064	the	37 40	29370 29373	0.9999889135360718	O
7065	aim	41 44	29374 29377	0.9999877214431763	O
7066	of	45 47	29378 29380	0.9999887943267822	O
7067	this	48 52	29381 29385	0.9999892711639404	O
7068	study	53 58	29386 29391	0.9999873638153076	O
7069	,	59 60	29392 29393	0.9999874830245972	O
7070	is	61 63	29394 29396	0.9999886751174927	O
7071	MMR	64 66	29397 29399	0.999987006187439	O
7073	inactivation	68 79	29401 29412	0.99998939037323	O
7076	associated	81 91	29414 29424	0.9999891519546509	O
7077	with	92 96	29425 29429	0.9999887943267822	O
7078	resistance	97 107	29430 29440	0.9999866485595703	O
7079	to	108 110	29441 29443	0.9999878406524658	O
7080	platinum	111 119	29444 29452	0.9999861717224121	O
7081	-	119 120	29452 29453	0.9999887943267822	O
7082	based	120 125	29453 29458	0.9999877214431763	O
7083	chemotherapy	126 137	29459 29470	0.9999873638153076	O
7086	in	139 141	29472 29474	0.9999877214431763	O
7087	ovarian	142 148	29475 29481	0.9999855756759644	O
7090	cancer	150 156	29483 29489	0.999987006187439	O
7091	.	157 158	29490 29491	0.9999691247940063	O
7092	Forty	0 5	29492 29497	0.9999314546585083	O
7093	-	5 6	29497 29498	0.9999830722808838	O
7094	six	6 9	29498 29501	0.9999711513519287	O
7095	of	10 12	29502 29504	0.999983549118042	O
7096	the	13 16	29505 29508	0.999981164932251	O
7097	75	17 19	29509 29511	0.9998664855957031	O
7098	ovarian	20 26	29512 29518	0.9999231100082397	O
7101	carcinomas	28 37	29520 29529	0.9999806880950928	O
7105	we	39 41	29531 29533	0.9999818801879883	O
7106	analyzed	42 50	29534 29542	0.9999825954437256	O
7107	had	51 54	29543 29546	0.9999841451644897	O
7108	been	55 59	29547 29551	0.9999871253967285	O
7109	treated	60 67	29552 29559	0.9999866485595703	O
7110	with	68 72	29560 29564	0.999987006187439	O
7111	platinum	73 81	29565 29573	0.9999843835830688	O
7112	-	81 82	29573 29574	0.999988317489624	O
7113	based	82 87	29574 29579	0.9999866485595703	O
7114	chemotherapy	88 99	29580 29591	0.9999861717224121	O
7117	,	101 102	29593 29594	0.9999854564666748	O
7118	eleven	103 109	29595 29601	0.9999768733978271	O
7119	did	110 113	29602 29605	0.9999867677688599	O
7120	not	114 117	29606 29609	0.9999866485595703	O
7121	respond	118 125	29610 29617	0.9999850988388062	O
7122	and	126 129	29618 29621	0.9999856948852539	O
7123	34	130 132	29622 29624	0.999968409538269	O
7124	did	133 136	29625 29628	0.9999853372573853	O
7125	.	137 138	29629 29630	0.9999529123306274	O
7126	For	0 3	29631 29634	0.9999815225601196	O
7127	one	4 7	29635 29638	0.9999686479568481	O
7128	patient	8 15	29639 29646	0.9999784231185913	O
7129	the	16 19	29647 29650	0.999984622001648	O
7130	response	20 28	29651 29659	0.9999805688858032	O
7131	was	29 32	29660 29663	0.999985933303833	O
7132	not	33 36	29664 29667	0.9999850988388062	O
7133	known	37 42	29668 29673	0.9999852180480957	O
7134	.	43 44	29674 29675	0.9999152421951294	O
7135	Methylation	0 10	29676 29686	0.9999867677688599	O
7138	of	12 14	29688 29690	0.9999876022338867	O
7139	the	15 18	29691 29694	0.9999879598617554	O
7140	MLH1	19 22	29695 29698	0.9999829530715942	O
7143	promoter	24 32	29700 29708	0.9999854564666748	O
7144	was	33 36	29709 29712	0.9999885559082031	O
7145	detected	37 45	29713 29721	0.9999886751174927	O
7146	in	46 48	29722 29724	0.9999892711639404	O
7147	two	49 52	29725 29728	0.9999850988388062	O
7148	of	53 55	29729 29731	0.9999892711639404	O
7149	the	56 59	29732 29735	0.9999887943267822	O
7150	eleven	60 66	29736 29742	0.9999750852584839	O
7151	non	67 70	29743 29746	0.999987006187439	O
7152	-	70 71	29746 29747	0.9999879598617554	O
7153	responders	71 80	29747 29756	0.9999873638153076	O
7155	(	82 83	29758 29759	0.99998939037323	O
7156	18	84 86	29760 29762	0.9999842643737793	O
7157	%	87 88	29763 29764	0.9999891519546509	O
7158	)	89 90	29765 29766	0.9999892711639404	O
7159	and	91 94	29767 29770	0.9999868869781494	O
7160	four	95 99	29771 29775	0.9999817609786987	O
7161	of	100 102	29776 29778	0.9999892711639404	O
7162	the	103 106	29779 29782	0.9999886751174927	O
7163	34	107 109	29783 29785	0.9999692440032959	O
7164	responders	110 119	29786 29795	0.9999877214431763	O
7166	(	121 122	29797 29798	0.99998939037323	O
7167	12	123 125	29799 29801	0.9999866485595703	O
7168	%	126 127	29802 29803	0.99998939037323	O
7169	)	128 129	29804 29805	0.99998939037323	O
7170	and	130 133	29806 29809	0.9999874830245972	O
7171	this	134 138	29810 29814	0.9999886751174927	O
7172	was	139 142	29815 29818	0.9999891519546509	O
7173	not	143 146	29819 29822	0.9999872446060181	O
7174	significantly	147 160	29823 29836	0.999988317489624	O
7175	different	161 170	29837 29846	0.9999868869781494	O
7176	(	171 172	29847 29848	0.9999891519546509	O
7177	p	173 174	29849 29850	0.9999889135360718	O
7178	=	175 176	29851 29852	0.9999886751174927	O
7179	0	177 178	29853 29854	0.99998939037323	O
7180	.	178 179	29854 29855	0.9999890327453613	O
7181	664	179 181	29855 29857	0.9999864101409912	O
7183	)	183 184	29859 29860	0.9999889135360718	O
7184	.	185 186	29861 29862	0.9999691247940063	O
7185	Since	0 5	29863 29868	0.9999802112579346	O
7186	we	6 8	29869 29871	0.9999853372573853	O
7187	did	9 12	29872 29875	0.9999880790710449	O
7188	not	13 16	29876 29879	0.9999877214431763	O
7189	detect	17 23	29880 29886	0.9999879598617554	O
7190	any	24 27	29887 29890	0.999987006187439	O
7191	MSI	28 30	29891 29893	0.9999873638153076	O
7193	,	32 33	29895 29896	0.9999861717224121	O
7194	the	34 37	29897 29900	0.9999881982803345	O
7195	resistance	38 48	29901 29911	0.999984622001648	O
7196	seen	49 53	29912 29916	0.9999880790710449	O
7197	in	54 56	29917 29919	0.9999895095825195	O
7198	the	57 60	29920 29923	0.9999887943267822	O
7199	eleven	61 67	29924 29930	0.9999810457229614	O
7200	patients	68 76	29931 29939	0.999984622001648	O
7201	could	77 82	29940 29945	0.9999873638153076	O
7202	not	83 86	29946 29949	0.9999871253967285	O
7203	be	87 89	29950 29952	0.9999889135360718	O
7204	associated	90 100	29953 29963	0.9999890327453613	O
7205	with	101 105	29964 29968	0.9999889135360718	O
7206	MSI	106 108	29969 29971	0.9999880790710449	O
7208	and	110 113	29973 29976	0.9999874830245972	O
7209	MMR	114 116	29977 29979	0.9999871253967285	O
7211	inactivation	118 129	29981 29992	0.9999895095825195	O
7214	.	131 132	29994 29995	0.9999725818634033	O
7215	The	0 3	29996 29999	0.9999858140945435	O
7216	relation	4 12	30000 30008	0.9999806880950928	O
7217	between	13 20	30009 30016	0.9999854564666748	O
7218	MMR	21 23	30017 30019	0.9999799728393555	O
7220	deficiency	25 35	30021 30031	0.9999814033508301	O
7221	and	36 39	30032 30035	0.9999856948852539	O
7222	platinum	40 48	30036 30044	0.999976396560669	O
7223	-	48 49	30044 30045	0.9999833106994629	O
7224	drug	49 53	30045 30049	0.9999834299087524	O
7225	resistance	54 64	30050 30060	0.999983549118042	O
7226	has	65 68	30061 30064	0.9999853372573853	O
7227	been	69 73	30065 30069	0.999987006187439	O
7228	investigated	74 86	30070 30082	0.9999840259552002	O
7229	in	87 89	30083 30085	0.9999879598617554	O
7230	only	90 94	30086 30090	0.9999850988388062	O
7231	a	95 96	30091 30092	0.9999880790710449	O
7232	few	97 100	30093 30096	0.9999850988388062	O
7233	in	101 103	30097 30099	0.9999876022338867	O
7234	vivo	104 107	30100 30103	0.9999860525131226	O
7236	studies	109 116	30105 30112	0.9999841451644897	O
7237	.	117 118	30113 30114	0.9999589920043945	O
7238	Similarly	0 9	30115 30124	0.9999852180480957	O
7239	to	10 12	30125 30127	0.9999880790710449	O
7240	our	13 16	30128 30131	0.9999860525131226	O
7241	result	17 23	30132 30138	0.9999877214431763	O
7242	,	24 25	30139 30140	0.9999885559082031	O
7243	no	26 28	30141 30143	0.9999867677688599	O
7244	MSI	29 31	30144 30146	0.9999861717224121	O
7246	was	33 36	30148 30151	0.9999889135360718	O
7247	detected	37 45	30152 30160	0.9999890327453613	O
7248	by	46 48	30161 30163	0.9999886751174927	O
7249	Mesquita	49 56	30164 30171	0.9999866485595703	O
7253	et	58 60	30173 30175	0.9999886751174927	O
7254	al	61 63	30176 30178	0.9999879598617554	O
7255	.	64 65	30179 30180	0.9999881982803345	O
7256	[	66 67	30181 30182	0.999975323677063	O
7257	18	0 2	30182 30184	0.9999699592590332	O
7258	]	2 3	30184 30185	0.9999661445617676	O
7259	who	4 7	30186 30189	0.9999808073043823	O
7260	studied	8 15	30190 30197	0.9999737739562988	O
7261	34	16 18	30198 30200	0.9999337196350098	O
7262	ovarian	19 25	30201 30207	0.999951958656311	O
7265	carcinomas	27 36	30209 30218	0.9999810457229614	O
7269	of	38 40	30220 30222	0.9999843835830688	O
7270	which	41 46	30223 30228	0.999984860420227	O
7271	seven	47 52	30229 30234	0.9999679327011108	O
7272	did	53 56	30235 30238	0.9999853372573853	O
7273	not	57 60	30239 30242	0.9999849796295166	O
7274	respond	61 68	30243 30250	0.9999864101409912	O
7275	to	69 71	30251 30253	0.9999873638153076	O
7276	cisplatin	72 80	30254 30262	0.9999876022338867	O
7281	/	81 82	30263 30264	0.9999877214431763	O
7282	paclitaxel	82 91	30264 30273	0.9999873638153076	O
7287	therapy	93 100	30275 30282	0.9999868869781494	O
7288	.	101 102	30283 30284	0.999957799911499	O
7289	So	0 2	30285 30287	0.9999827146530151	O
7290	the	3 6	30288 30291	0.9999872446060181	O
7291	resistance	7 17	30292 30302	0.9999822378158569	O
7292	seen	18 22	30303 30307	0.9999865293502808	O
7293	in	23 25	30308 30310	0.999988317489624	O
7294	these	26 31	30311 30316	0.9999861717224121	O
7295	seven	32 37	30317 30322	0.9999736547470093	O
7296	nonresponding	38 50	30323 30335	0.9999864101409912	O
7300	patients	52 60	30337 30345	0.9999819993972778	O
7301	was	61 64	30346 30349	0.9999868869781494	O
7302	also	65 69	30350 30354	0.9999862909317017	O
7303	not	70 73	30355 30358	0.9999867677688599	O
7304	associated	74 84	30359 30369	0.9999884366989136	O
7305	with	85 89	30370 30374	0.9999885559082031	O
7306	MMR	90 92	30375 30377	0.9999867677688599	O
7308	inactivation	94 105	30379 30390	0.9999891519546509	O
7311	.	107 108	30392 30393	0.9999699592590332	O
7312	In	0 2	30394 30396	0.9999783039093018	O
7313	contrast	3 11	30397 30405	0.9999749660491943	O
7314	,	12 13	30406 30407	0.9999798536300659	O
7315	Samimi	14 19	30408 30413	0.9998718500137329	O
7317	et	21 23	30415 30417	0.9999803304672241	O
7318	al	24 26	30418 30420	0.9999785423278809	O
7319	.	27 28	30421 30422	0.9999791383743286	O
7320	[	29 30	30423 30424	0.999943733215332	O
7321	52	0 2	30424 30426	0.9999707937240601	O
7322	]	2 3	30426 30427	0.999971866607666	O
7323	found	4 9	30428 30433	0.9999825954437256	O
7324	an	10 12	30434 30436	0.9999865293502808	O
7325	inverse	13 20	30437 30444	0.999976634979248	O
7326	relation	21 29	30445 30453	0.9999828338623047	O
7327	between	30 37	30454 30461	0.9999852180480957	O
7328	MLH1	38 41	30462 30465	0.9999809265136719	O
7331	protein	43 50	30467 30474	0.9999819993972778	O
7332	expression	51 61	30475 30485	0.9999854564666748	O
7333	and	62 65	30486 30489	0.9999855756759644	O
7334	the	66 69	30490 30493	0.9999841451644897	O
7335	response	70 78	30494 30502	0.9999818801879883	O
7336	to	79 81	30503 30505	0.9999854564666748	O
7337	platinum	82 90	30506 30514	0.9999828338623047	O
7338	-	90 91	30514 30515	0.9999871253967285	O
7339	based	91 96	30515 30520	0.9999849796295166	O
7340	chemotherapy	97 108	30521 30532	0.9999839067459106	O
7343	in	110 112	30534 30536	0.9999839067459106	O
7344	54	113 115	30537 30539	0.9999539852142334	O
7345	ovarian	116 122	30540 30546	0.9999631643295288	O
7348	carcinomas	124 133	30548 30557	0.9999816417694092	O
7352	.	135 136	30559 30560	0.9999557733535767	O
7353	Again	0 5	30561 30566	0.9999842643737793	O
7354	,	6 7	30567 30568	0.999987006187439	O
7355	the	8 11	30569 30572	0.9999860525131226	O
7356	number	12 18	30573 30579	0.9999831914901733	O
7357	of	19 21	30580 30582	0.9999843835830688	O
7358	ovarian	22 28	30583 30589	0.9999681711196899	O
7361	carcinomas	30 39	30591 30600	0.9999825954437256	O
7365	included	41 49	30602 30610	0.9999860525131226	O
7366	in	50 52	30611 30613	0.9999871253967285	O
7367	these	53 58	30614 30619	0.9999872446060181	O
7368	studies	59 66	30620 30627	0.9999802112579346	O
7369	is	67 69	30628 30630	0.9999864101409912	O
7370	small	70 75	30631 30636	0.999984860420227	O
7371	and	76 79	30637 30640	0.9999861717224121	O
7372	no	80 82	30641 30643	0.9999864101409912	O
7373	further	83 90	30644 30651	0.9999853372573853	O
7374	conclusion	91 101	30652 30662	0.9999850988388062	O
7375	can	102 105	30663 30666	0.9999856948852539	O
7376	be	106 108	30667 30669	0.9999867677688599	O
7377	drawn	109 114	30670 30675	0.9999849796295166	O
7378	from	115 119	30676 30680	0.9999860525131226	O
7379	these	120 125	30681 30686	0.9999877214431763	O
7380	results	126 133	30687 30694	0.9999866485595703	O
7381	.	134 135	30695 30696	0.9999881982803345	O
7382	*	136 137	30697 30698	0.9999873638153076	O
7383	*	137 138	30698 30699	0.999977707862854	O
7384	IGNORE	0 5	30700 30705	0.999987006187439	O
7387	LINE	7 10	30707 30710	0.9999891519546509	O
7390	*	12 13	30712 30713	0.9999892711639404	O
7391	*	13 14	30713 30714	0.9999892711639404	O
7392	*	15 16	30715 30716	0.9999892711639404	O
7393	*	16 17	30716 30717	0.99998939037323	O
7394	IGNORE	18 23	30718 30723	0.9999880790710449	O
7397	LINE	25 28	30725 30728	0.99998939037323	O
7400	*	30 31	30730 30731	0.9999890327453613	O
7401	*	31 32	30731 30732	0.9999890327453613	O
7402	*	33 34	30733 30734	0.9999890327453613	O
7403	*	34 35	30734 30735	0.9999890327453613	O
7404	IGNORE	36 41	30736 30741	0.9999877214431763	O
7407	LINE	43 46	30743 30746	0.9999892711639404	O
7410	*	48 49	30748 30749	0.9999891519546509	O
7411	*	49 50	30749 30750	0.9999890327453613	O
7412	Since	51 56	30751 30756	0.9999856948852539	O
7413	platinum	57 65	30757 30765	0.999984860420227	O
7414	-	65 66	30765 30766	0.9999887943267822	O
7415	drug	66 70	30766 30770	0.9999877214431763	O
7416	resistance	71 81	30771 30781	0.9999886751174927	O
7417	is	82 84	30782 30784	0.99998939037323	O
7418	thought	85 92	30785 30792	0.9999885559082031	O
7419	to	93 95	30793 30795	0.9999891519546509	O
7420	be	96 98	30796 30798	0.99998939037323	O
7421	multifactorial	99 112	30799 30812	0.9999885559082031	O
7425	the	114 117	30814 30817	0.9999890327453613	O
7426	involvement	118 129	30818 30829	0.99998939037323	O
7427	of	130 132	30830 30832	0.9999895095825195	O
7428	other	133 138	30833 30838	0.9999871253967285	O
7429	resistance	139 149	30839 30849	0.9999876022338867	O
7430	mechanisms	150 160	30850 30860	0.99998939037323	O
7431	could	161 166	30861 30866	0.9999880790710449	O
7432	have	167 171	30867 30871	0.9999892711639404	O
7433	overruled	172 180	30872 30880	0.9999892711639404	O
7436	the	182 185	30882 30885	0.9999895095825195	O
7437	possible	186 194	30886 30894	0.9999881982803345	O
7438	contribution	195 207	30895 30907	0.9999890327453613	O
7439	of	208 210	30908 30910	0.9999896287918091	O
7440	MMR	211 213	30911 30913	0.9999876022338867	O
7442	status	215 221	30915 30921	0.99998939037323	O
7443	.	222 223	30922 30923	0.9999686479568481	O
7444	However	0 7	30924 30931	0.9999850988388062	O
7445	,	8 9	30932 30933	0.999988317489624	O
7446	platinum	10 18	30934 30942	0.999976634979248	O
7447	treatment	19 28	30943 30952	0.9999871253967285	O
7448	does	29 33	30953 30957	0.9999840259552002	O
7449	seem	34 38	30958 30962	0.9999850988388062	O
7450	to	39 41	30963 30965	0.9999877214431763	O
7451	select	42 48	30966 30972	0.9999853372573853	O
7452	for	49 52	30973 30976	0.9999880790710449	O
7453	MMR	53 55	30977 30979	0.9999841451644897	O
7455	deficient	57 65	30981 30989	0.9999877214431763	O
7457	cells	67 72	30991 30996	0.9999874830245972	O
7458	since	73 78	30997 31002	0.999985933303833	O
7459	in	79 81	31003 31005	0.9999887943267822	O
7460	vitro	82 86	31006 31010	0.999988317489624	O
7463	enrichment	88 97	31012 31021	0.9999890327453613	O
7466	for	99 102	31023 31026	0.9999887943267822	O
7467	MLH1	103 106	31027 31030	0.9999866485595703	O
7470	deficient	108 116	31032 31040	0.999988317489624	O
7472	colon	118 122	31042 31046	0.9999830722808838	O
7474	cancer	124 130	31048 31054	0.9999872446060181	O
7475	HCT116	131 136	31055 31060	0.9999877214431763	O
7479	cells	138 143	31062 31067	0.9999880790710449	O
7480	in	144 146	31068 31070	0.9999885559082031	O
7481	a	147 148	31071 31072	0.9999886751174927	O
7482	mixed	149 154	31073 31078	0.9999840259552002	O
7483	cell	155 159	31079 31083	0.9999871253967285	O
7484	population	160 170	31084 31094	0.9999880790710449	O
7485	was	171 174	31095 31098	0.999988317489624	O
7486	seen	175 179	31099 31103	0.9999871253967285	O
7487	after	180 185	31104 31109	0.9999874830245972	O
7488	cisplatin	186 194	31110 31118	0.9999874830245972	O
7493	treatment	196 205	31120 31129	0.9999884366989136	O
7494	[	206 207	31130 31131	0.9999889135360718	O
7495	53	207 209	31131 31133	0.999984622001648	O
7496	]	209 210	31133 31134	0.9999886751174927	O
7497	.	211 212	31135 31136	0.999974250793457	O
7498	In	0 2	31137 31139	0.9999880790710449	O
7499	addition	3 11	31140 31148	0.9999855756759644	O
7500	,	12 13	31149 31150	0.9999886751174927	O
7501	several	14 21	31151 31158	0.9999853372573853	O
7502	in	22 24	31159 31161	0.9999885559082031	O
7503	vivo	25 28	31162 31165	0.9999867677688599	O
7505	studies	30 37	31167 31174	0.9999849796295166	O
7506	found	38 43	31175 31180	0.9999865293502808	O
7507	an	44 46	31181 31183	0.9999890327453613	O
7508	increase	47 55	31184 31192	0.999985933303833	O
7509	in	56 58	31193 31195	0.9999891519546509	O
7510	the	59 62	31196 31199	0.9999891519546509	O
7511	percentage	63 73	31200 31210	0.9999878406524658	O
7512	of	74 76	31211 31213	0.9999886751174927	O
7513	MSI	77 79	31214 31216	0.9999874830245972	O
7515	and	81 84	31218 31221	0.9999886751174927	O
7516	MLH1	85 88	31222 31225	0.9999881982803345	O
7519	methylation	90 100	31227 31237	0.9999889135360718	O
7522	after	102 107	31239 31244	0.9999881982803345	O
7523	platinum	108 116	31245 31253	0.9999865293502808	O
7524	-	116 117	31253 31254	0.9999891519546509	O
7525	based	117 122	31254 31259	0.9999878406524658	O
7526	chemotherapy	123 134	31260 31271	0.9999878406524658	O
7529	as	136 138	31273 31275	0.9999884366989136	O
7530	well	139 143	31276 31280	0.9999886751174927	O
7531	as	144 146	31281 31283	0.9999889135360718	O
7532	a	147 148	31284 31285	0.9999889135360718	O
7533	decrease	149 157	31286 31294	0.9999827146530151	O
7534	in	158 160	31295 31297	0.9999889135360718	O
7535	the	161 164	31298 31301	0.9999887943267822	O
7536	percentage	165 175	31302 31312	0.9999881982803345	O
7537	of	176 178	31313 31315	0.9999885559082031	O
7538	cells	179 184	31316 31321	0.9999867677688599	O
7539	positive	185 193	31322 31330	0.9999880790710449	O
7540	for	194 197	31331 31334	0.9999891519546509	O
7541	MLH1	198 201	31335 31338	0.9999884366989136	O
7544	and	203 206	31340 31343	0.9999889135360718	O
7545	MSH2	207 210	31344 31347	0.999988317489624	O
7548	[	212 213	31349 31350	0.99998939037323	O
7549	14	213 215	31350 31352	0.9999884366989136	O
7550	,	215 216	31352 31353	0.9999889135360718	O
7551	19	216 218	31353 31355	0.9999877214431763	O
7552	,	218 219	31355 31356	0.9999886751174927	O
7553	25	219 221	31356 31358	0.9999871253967285	O
7554	,	221 222	31358 31359	0.9999886751174927	O
7555	52	222 224	31359 31361	0.9999825954437256	O
7556	]	224 225	31361 31362	0.9999884366989136	O
7557	.	226 227	31363 31364	0.9999769926071167	O
7558	Moreover	0 8	31365 31373	0.9999825954437256	O
7559	,	9 10	31374 31375	0.9999876022338867	O
7560	an	11 13	31376 31378	0.9999874830245972	O
7561	increase	14 22	31379 31387	0.999983549118042	O
7562	in	23 25	31388 31390	0.9999874830245972	O
7563	MLH1	26 29	31391 31394	0.9999862909317017	O
7566	methylation	31 41	31396 31406	0.9999879598617554	O
7569	after	43 48	31408 31413	0.9999872446060181	O
7570	platinum	49 57	31414 31422	0.9999866485595703	O
7571	-	57 58	31422 31423	0.9999886751174927	O
7572	based	58 63	31423 31428	0.9999877214431763	O
7573	chemotherapy	64 75	31429 31440	0.9999876022338867	O
7576	was	77 80	31442 31445	0.9999874830245972	O
7577	associated	81 91	31446 31456	0.9999876022338867	O
7578	with	92 96	31457 31461	0.9999874830245972	O
7579	poor	97 101	31462 31466	0.9999836683273315	O
7580	survival	102 110	31467 31475	0.9999855756759644	O
7581	in	111 113	31476 31478	0.9999862909317017	O
7582	ovarian	114 120	31479 31485	0.9999804496765137	O
7585	cancer	122 128	31487 31493	0.9999847412109375	O
7586	patients	129 137	31494 31502	0.9999837875366211	O
7587	[	138 139	31503 31504	0.9999885559082031	O
7588	19	139 141	31504 31506	0.9999861717224121	O
7589	]	141 142	31506 31507	0.9999881982803345	O
7590	.	143 144	31508 31509	0.9999730587005615	O
7591	These	0 5	31510 31515	0.9999866485595703	O
7592	results	6 13	31516 31523	0.9999861717224121	O
7593	as	14 16	31524 31526	0.9999849796295166	O
7594	well	17 21	31527 31531	0.9999861717224121	O
7595	as	22 24	31532 31534	0.9999871253967285	O
7596	the	25 28	31535 31538	0.9999878406524658	O
7597	in	29 31	31539 31541	0.9999890327453613	O
7598	vitro	32 36	31542 31546	0.9999886751174927	O
7601	studies	38 45	31548 31555	0.9999868869781494	O
7602	mentioned	46 55	31556 31565	0.9999867677688599	O
7603	in	56 58	31566 31568	0.9999884366989136	O
7604	the	59 62	31569 31572	0.9999891519546509	O
7605	introduction	63 75	31573 31585	0.9999871253967285	O
7606	,	76 77	31586 31587	0.9999829530715942	O
7607	suggest	78 85	31588 31595	0.9999852180480957	O
7608	that	86 90	31596 31600	0.9999889135360718	O
7609	MMR	91 93	31601 31603	0.9999864101409912	O
7611	inactivation	95 106	31605 31616	0.99998939037323	O
7614	causes	108 114	31618 31624	0.9999879598617554	O
7615	a	115 116	31625 31626	0.9999886751174927	O
7616	low	117 120	31627 31630	0.9999874830245972	O
7617	level	121 126	31631 31636	0.9999884366989136	O
7618	resistance	127 137	31637 31647	0.9999881982803345	O
7619	to	138 140	31648 31650	0.999988317489624	O
7620	platinum	141 149	31651 31659	0.9999866485595703	O
7621	-	149 150	31659 31660	0.9999890327453613	O
7622	based	150 155	31660 31665	0.999988317489624	O
7623	chemotherapy	156 167	31666 31677	0.9999878406524658	O
7626	which	169 174	31679 31684	0.9999887943267822	O
7627	does	175 179	31685 31689	0.9999876022338867	O
7628	not	180 183	31690 31693	0.9999842643737793	O
7629	play	184 188	31694 31698	0.9999880790710449	O
7630	a	189 190	31699 31700	0.9999885559082031	O
7631	significant	191 202	31701 31712	0.9999876022338867	O
7632	role	203 207	31713 31717	0.9999877214431763	O
7633	in	208 210	31718 31720	0.9999885559082031	O
7634	intrinsic	211 220	31721 31730	0.9999865293502808	O
7635	resistance	221 231	31731 31741	0.9999872446060181	O
7636	.	232 233	31742 31743	0.9999668598175049	O
7637	However	0 7	31744 31751	0.9999841451644897	O
7638	,	8 9	31752 31753	0.9999880790710449	O
7639	due	10 13	31754 31757	0.9999867677688599	O
7640	to	14 16	31758 31760	0.9999884366989136	O
7641	selection	17 26	31761 31770	0.9999845027923584	O
7642	during	27 33	31771 31777	0.9999871253967285	O
7643	chemotherapy	34 45	31778 31789	0.9999853372573853	O
7646	MMR	47 49	31791 31793	0.9999867677688599	O
7648	inactivation	51 62	31795 31806	0.9999890327453613	O
7651	might	64 69	31808 31813	0.9999855756759644	O
7652	play	70 74	31814 31818	0.9999879598617554	O
7653	a	75 76	31819 31820	0.9999886751174927	O
7654	greater	77 84	31821 31828	0.999984860420227	O
7655	role	85 89	31829 31833	0.9999874830245972	O
7656	in	90 92	31834 31836	0.9999876022338867	O
7657	the	93 96	31837 31840	0.9999864101409912	O
7658	acquired	97 105	31841 31849	0.999980092048645	O
7659	resistance	106 116	31850 31860	0.9999852180480957	O
7660	.	117 118	31861 31862	0.9999696016311646	O
7661	We	0 2	31863 31865	0.9999847412109375	O
7662	therefore	3 12	31866 31875	0.9999855756759644	O
7663	propose	13 20	31876 31883	0.9999847412109375	O
7664	that	21 25	31884 31888	0.9999886751174927	O
7665	the	26 29	31889 31892	0.9999886751174927	O
7666	role	30 34	31893 31897	0.9999871253967285	O
7667	of	35 37	31898 31900	0.9999887943267822	O
7668	MMR	38 40	31901 31903	0.9999856948852539	O
7670	inactivation	42 53	31905 31916	0.9999890327453613	O
7673	in	55 57	31918 31920	0.9999885559082031	O
7674	acquired	58 66	31921 31929	0.9999850988388062	O
7675	resistance	67 77	31930 31940	0.9999860525131226	O
7676	in	78 80	31941 31943	0.9999881982803345	O
7677	ovarian	81 87	31944 31950	0.9999853372573853	O
7680	cancer	89 95	31952 31958	0.9999868869781494	O
7681	should	96 102	31959 31965	0.9999874830245972	O
7682	be	103 105	31966 31968	0.9999884366989136	O
7683	further	106 113	31969 31976	0.9999871253967285	O
7684	investigated	114 126	31977 31989	0.9999860525131226	O
7685	.	127 128	31990 31991	0.9999890327453613	O
7686	*	129 130	31992 31993	0.9999881982803345	O
7687	*	130 131	31993 31994	0.9999837875366211	O
7688	IGNORE	0 5	31995 32000	0.9999867677688599	O
7691	LINE	7 10	32002 32005	0.9999889135360718	O
7694	*	12 13	32007 32008	0.9999892711639404	O
7695	*	13 14	32008 32009	0.9999891519546509	O
7696	*	15 16	32010 32011	0.9999891519546509	O
7697	*	16 17	32011 32012	0.9999892711639404	O
7698	IGNORE	18 23	32013 32018	0.999988317489624	O
7701	LINE	25 28	32020 32023	0.9999892711639404	O
7704	*	30 31	32025 32026	0.9999891519546509	O
7705	*	31 32	32026 32027	0.9999890327453613	O
7706	*	33 34	32028 32029	0.9999890327453613	O
7707	*	34 35	32029 32030	0.9999890327453613	O
7708	IGNORE	36 41	32031 32036	0.9999879598617554	O
7711	LINE	43 46	32038 32041	0.9999892711639404	O
7714	*	48 49	32043 32044	0.9999891519546509	O
7715	*	49 50	32044 32045	0.9999890327453613	O
7716	Whole	51 56	32046 32051	0.9999889135360718	O
7717	-	56 57	32051 32052	0.99998939037323	O
7718	chromosome	57 67	32052 32062	0.9999885559082031	O
7719	plots	68 73	32063 32068	0.9999856948852539	O
7720	of	74 76	32069 32071	0.99998939037323	O
7721	running	77 84	32072 32079	0.9999878406524658	O
7722	average	85 92	32080 32087	0.9999880790710449	O
7723	of	93 95	32088 32090	0.9999892711639404	O
7724	fractions	96 104	32091 32099	0.9999878406524658	O
7726	of	106 108	32101 32103	0.9999886751174927	O
7727	samples	109 116	32104 32111	0.9999879598617554	O
7728	showing	117 124	32112 32119	0.9999889135360718	O
7729	up	125 127	32120 32122	0.9999889135360718	O
7730	-	127 128	32122 32123	0.9999892711639404	O
7731	/	128 129	32123 32124	0.999988317489624	O
7732	down	129 133	32124 32128	0.9999874830245972	O
7733	-	133 134	32128 32129	0.9999892711639404	O
7734	regulation	134 144	32129 32139	0.9999881982803345	O
7735	in	145 147	32140 32142	0.9999890327453613	O
7736	tumor	148 153	32143 32148	0.9999836683273315	O
7737	versus	154 160	32149 32155	0.9999849796295166	O
7738	normal	161 167	32156 32162	0.9999814033508301	O
7739	samples	168 175	32163 32170	0.9999881982803345	O
7740	(	176 177	32171 32172	0.99998939037323	O
7741	Chromosome	178 187	32173 32182	0.9999891519546509	O
7745	17	189 191	32184 32186	0.9999876022338867	O
7746	,	191 192	32186 32187	0.9999889135360718	O
7747	18	192 194	32187 32189	0.9999880790710449	O
7748	,	194 195	32189 32190	0.9999890327453613	O
7749	19	195 197	32190 32192	0.9999871253967285	O
7750	,	197 198	32192 32193	0.9999890327453613	O
7751	20	198 200	32193 32195	0.999987006187439	O
7752	,	200 201	32195 32196	0.9999891519546509	O
7753	21	201 203	32196 32198	0.9999876022338867	O
7754	,	203 204	32198 32199	0.9999890327453613	O
7755	22	204 206	32199 32201	0.9999871253967285	O
7756	,	206 207	32201 32202	0.9999890327453613	O
7757	X	207 208	32202 32203	0.9999867677688599	O
7758	,	208 209	32203 32204	0.999988317489624	O
7759	Y	209 210	32204 32205	0.9999815225601196	O
7760	)	210 211	32205 32206	0.99998939037323	O
7761	.	212 213	32207 32208	0.9999634027481079	O
7762	For	0 3	32209 32212	0.9999839067459106	O
7763	each	4 8	32213 32217	0.9999868869781494	O
7764	chromosome	9 19	32218 32228	0.999983549118042	O
7765	you	20 23	32229 32232	0.9999779462814331	O
7766	see	24 27	32233 32236	0.9999825954437256	O
7767	a	28 29	32237 32238	0.9999871253967285	O
7768	separate	30 38	32239 32247	0.9999856948852539	O
7769	figure	39 45	32248 32254	0.999983549118042	O
7770	.	46 47	32255 32256	0.9999607801437378	O
7771	Gray	0 4	32257 32261	0.9999821186065674	O
7772	dots	5 9	32262 32266	0.9999810457229614	O
7773	denote	10 16	32267 32273	0.9999752044677734	O
7774	the	17 20	32274 32277	0.9999866485595703	O
7775	number	21 27	32278 32284	0.9999831914901733	O
7776	of	28 30	32285 32287	0.9999858140945435	O
7777	patients	31 39	32288 32296	0.9999730587005615	O
7778	with	40 44	32297 32301	0.9999867677688599	O
7779	up	45 47	32302 32304	0.9999872446060181	O
7780	-	48 49	32305 32306	0.9999878406524658	O
7781	or	50 52	32307 32309	0.9999854564666748	O
7782	down	53 57	32310 32314	0.9999864101409912	O
7783	-	57 58	32314 32315	0.9999879598617554	O
7784	regulation	58 68	32315 32325	0.9999866485595703	O
7785	for	69 72	32326 32329	0.9999874830245972	O
7786	a	73 74	32330 32331	0.9999881982803345	O
7787	single	75 81	32332 32338	0.9999868869781494	O
7788	gene	82 86	32339 32343	0.9999840259552002	O
7789	.	87 88	32344 32345	0.9999223947525024	O
7790	Orange	0 6	32346 32352	0.9999750852584839	O
7791	/	6 7	32352 32353	0.9999849796295166	O
7792	green	7 12	32353 32358	0.9999830722808838	O
7793	lines	13 18	32359 32364	0.9999843835830688	O
7794	represent	19 28	32365 32374	0.9999815225601196	O
7795	a	29 30	32375 32376	0.9999866485595703	O
7796	running	31 38	32377 32384	0.999980092048645	O
7797	average	39 46	32385 32392	0.9999843835830688	O
7798	of	47 49	32393 32395	0.999985933303833	O
7799	these	50 55	32396 32401	0.9999860525131226	O
7800	values	56 62	32402 32408	0.99997878074646	O
7801	.	63 64	32409 32410	0.9999347925186157	O
7802	The	0 3	32411 32414	0.999983549118042	O
7803	plots	4 9	32415 32420	0.9999781847000122	O
7804	are	10 13	32421 32424	0.9999833106994629	O
7805	made	14 18	32425 32429	0.9999839067459106	O
7806	to	19 21	32430 32432	0.9999852180480957	O
7807	be	22 24	32433 32435	0.9999865293502808	O
7808	easily	25 31	32436 32442	0.9999806880950928	O
7809	comparable	32 42	32443 32453	0.9999831914901733	O
7810	with	43 47	32454 32458	0.9999868869781494	O
7811	whole	48 53	32459 32464	0.9999864101409912	O
7812	-	53 54	32464 32465	0.9999878406524658	O
7813	genome	54 60	32465 32471	0.9999860525131226	O
7814	CGH	61 63	32472 32474	0.9999871253967285	O
7817	plots	65 70	32476 32481	0.9999867677688599	O
7818	(	71 72	32482 32483	0.9999829530715942	O
7819	like	73 77	32484 32488	0.9999862909317017	O
7820	e	78 79	32489 32490	0.9999872446060181	O
7821	.	79 80	32490 32491	0.9999872446060181	O
7822	g	80 81	32491 32492	0.9999865293502808	O
7823	.	82 83	32493 32494	0.9999704360961914	O
7824	those	0 5	32495 32500	0.9999810457229614	O
7825	in	6 8	32501 32503	0.9999833106994629	O
7826	Knosel	9 14	32504 32509	0.9999619722366333	O
7829	et	16 18	32511 32513	0.999984622001648	O
7830	al	19 21	32514 32516	0.9999836683273315	O
7831	.	22 23	32517 32518	0.999984860420227	O
7832	[	24 25	32519 32520	0.9999589920043945	O
7833	21	0 2	32520 32522	0.9999761581420898	O
7834	]	2 3	32522 32523	0.9999815225601196	O
7835	)	4 5	32524 32525	0.9999862909317017	O
7836	Further	6 13	32526 32533	0.9999842643737793	O
7837	details	14 21	32534 32541	0.999985933303833	O
7838	of	22 24	32542 32544	0.9999877214431763	O
7839	plot	25 29	32545 32549	0.9999812841415405	O
7840	construction	30 42	32550 32562	0.9999847412109375	O
7841	are	43 46	32563 32566	0.9999864101409912	O
7842	described	47 56	32567 32576	0.9999860525131226	O
7843	in	57 59	32577 32579	0.9999879598617554	O
7844	the	60 63	32580 32583	0.999988317489624	O
7845	methods	64 71	32584 32591	0.999984860420227	O
7846	section	72 79	32592 32599	0.9999867677688599	O
7847	.	80 81	32600 32601	0.9999735355377197	O
7848	Individual	0 10	32602 32612	0.9999160766601562	O
7849	chromosomal	11 21	32613 32623	0.9999816417694092	O
7853	islands	23 30	32625 32632	0.9999653100967407	O
7854	of	31 33	32633 32635	0.9999793767929077	O
7855	up	34 36	32636 32638	0.9999847412109375	O
7856	-	37 38	32639 32640	0.9999860525131226	O
7857	or	39 41	32641 32643	0.9999643564224243	O
7858	down	42 46	32644 32648	0.9999819993972778	O
7859	-	46 47	32648 32649	0.9999856948852539	O
7860	regulation	47 57	32649 32659	0.9999788999557495	O
7861	.	58 59	32660 32661	0.9986388087272644	O
7862	These	0 5	32662 32667	0.9999880790710449	O
7863	are	6 9	32668 32671	0.9999886751174927	O
7864	condensed	10 18	32672 32680	0.9999892711639404	O
7867	results	20 27	32682 32689	0.9999890327453613	O
7868	of	28 30	32690 32692	0.9999891519546509	O
7869	the	31 34	32693 32696	0.9999891519546509	O
7870	ChARM	35 39	32697 32701	0.9999862909317017	O
7873	analyses	41 49	32703 32711	0.9999881982803345	O
7874	:	50 51	32712 32713	0.9999886751174927	O
7875	overlapping	52 63	32714 32725	0.99998939037323	O
7876	regions	64 71	32726 32733	0.99998939037323	O
7877	with	72 76	32734 32738	0.9999896287918091	O
7878	evidence	77 85	32739 32747	0.9999896287918091	O
7879	for	86 89	32748 32751	0.9999897480010986	O
7880	up	90 92	32752 32754	0.9999892711639404	O
7881	-	93 94	32755 32756	0.9999895095825195	O
7882	or	95 97	32757 32759	0.9999885559082031	O
7883	down	98 102	32760 32764	0.9999885559082031	O
7884	-	102 103	32764 32765	0.9999896287918091	O
7885	regulation	103 113	32765 32775	0.9999880790710449	O
7886	from	114 118	32776 32780	0.9999896287918091	O
7887	various	119 126	32781 32788	0.9999885559082031	O
7888	analyses	127 135	32789 32797	0.999988317489624	O
7889	of	136 138	32798 32800	0.9999896287918091	O
7890	different	139 148	32801 32810	0.9999891519546509	O
7891	cross	149 154	32811 32816	0.9999891519546509	O
7892	-	154 155	32816 32817	0.9999896287918091	O
7893	correlation	155 166	32817 32828	0.9999887943267822	O
7894	window	167 173	32829 32835	0.9999890327453613	O
7895	sizes	174 179	32836 32841	0.9999890327453613	O
7896	have	180 184	32842 32846	0.9999895095825195	O
7897	been	185 189	32847 32851	0.9999895095825195	O
7898	fused	190 195	32852 32857	0.9999885559082031	O
7899	into	196 200	32858 32862	0.9999896287918091	O
7900	single	201 207	32863 32869	0.9999886751174927	O
7901	regions	208 215	32870 32877	0.99998939037323	O
7902	.	216 217	32878 32879	0.9999761581420898	O
7903	The	0 3	32880 32883	0.999988317489624	O
7904	original	4 12	32884 32892	0.9999872446060181	O
7905	ChARM	13 17	32893 32897	0.9999864101409912	O
7908	output	19 25	32899 32905	0.9999849796295166	O
7909	including	26 35	32906 32915	0.9999889135360718	O
7910	p	36 37	32916 32917	0.999988317489624	O
7911	values	38 44	32918 32924	0.9999886751174927	O
7912	for	45 48	32925 32928	0.9999892711639404	O
7913	each	49 53	32929 32933	0.9999896287918091	O
7914	region	54 60	32934 32940	0.9999876022338867	O
7915	and	61 64	32941 32944	0.9999880790710449	O
7916	additional	65 75	32945 32955	0.9999879598617554	O
7917	annotation	76 85	32956 32965	0.9999891519546509	O
7920	can	87 90	32967 32970	0.9999877214431763	O
7921	be	91 93	32971 32973	0.9999887943267822	O
7922	found	94 99	32974 32979	0.9999880790710449	O
7923	in	100 102	32980 32982	0.9999890327453613	O
7924	Additional	103 113	32983 32993	0.9999878406524658	O
7925	file	114 118	32994 32998	0.999988317489624	O
7926	1	119 120	32999 33000	0.9999887943267822	O
7927	.	121 122	33001 33002	0.9999822378158569	O
7928	Hereditary	0 9	33003 33012	0.9999754428863525	O
7931	colorectal	11 20	33014 33023	0.9999809265136719	O
7934	cancer	22 28	33025 33031	0.9999839067459106	O
7935	syndromes	29 37	33032 33040	0.9999794960021973	O
7937	are	39 42	33042 33045	0.9999862909317017	O
7938	indicated	43 52	33046 33055	0.9999855756759644	O
7939	along	53 58	33056 33061	0.999988317489624	O
7940	with	59 63	33062 33066	0.9999886751174927	O
7941	their	64 69	33067 33072	0.9999885559082031	O
7942	OMIM	70 73	33073 33076	0.999988317489624	O
7945	ID	75 77	33078 33080	0.9999868869781494	O
7946	.	77 78	33080 33081	0.9999769926071167	O
7947	Gene	0 4	33082 33086	0.999987006187439	O
7948	symbols	5 12	33087 33094	0.9999871253967285	O
7949	are	13 16	33095 33098	0.9999876022338867	O
7950	official	17 25	33099 33107	0.9999866485595703	O
7951	or	26 28	33108 33110	0.9999867677688599	O
7952	provisional	29 40	33111 33122	0.9999877214431763	O
7953	HUGO	41 44	33123 33126	0.9999877214431763	O
7957	symbols	46 53	33128 33135	0.9999881982803345	O
7958	if	54 56	33136 33138	0.9999881982803345	O
7959	available	57 66	33139 33148	0.9999886751174927	O
7960	,	67 68	33149 33150	0.9999871253967285	O
7961	otherwise	69 78	33151 33160	0.9999871253967285	O
7962	names	79 84	33161 33166	0.9999884366989136	O
7963	of	85 87	33167 33169	0.9999887943267822	O
7964	Unigene	88 94	33170 33176	0.9999886751174927	O
7967	clusters	96 104	33178 33186	0.9999891519546509	O
7968	.	105 106	33187 33188	0.9999712705612183	O
7969	Information	0 11	33189 33200	0.9999837875366211	O
7970	about	12 17	33201 33206	0.999985933303833	O
7971	known	18 23	33207 33212	0.9999784231185913	O
7972	tumor	24 29	33213 33218	0.9999796152114868	O
7973	genes	30 35	33219 33224	0.999983549118042	O
7974	in	36 38	33225 33227	0.9999872446060181	O
7975	misregulated	39 50	33228 33239	0.9999871253967285	O
7980	regions	52 59	33241 33248	0.9999861717224121	O
7981	were	60 64	33249 33253	0.9999831914901733	O
7982	extracted	65 74	33254 33263	0.9999858140945435	O
7983	from	75 79	33264 33268	0.9999868869781494	O
7984	the	80 83	33269 33272	0.9999867677688599	O
7985	literature	84 94	33273 33283	0.9999754428863525	O
7986	.	95 96	33284 33285	0.9999561309814453	O
7987	Tumor	0 4	33286 33290	0.9999712705612183	O
7989	-	5 6	33291 33292	0.9999867677688599	O
7990	associated	6 16	33292 33302	0.9999852180480957	O
7991	genes	17 22	33303 33308	0.9999816417694092	O
7992	are	23 26	33309 33312	0.9999831914901733	O
7993	located	27 34	33313 33320	0.9999858140945435	O
7994	within	35 41	33321 33327	0.9999850988388062	O
7995	expression	42 52	33328 33338	0.9999823570251465	O
7996	islands	53 60	33339 33346	0.9999855756759644	O
7997	or	61 63	33347 33349	0.999980092048645	O
7998	in	64 66	33350 33352	0.999987006187439	O
7999	near	67 71	33353 33357	0.9999868869781494	O
8000	vicinity	72 80	33358 33366	0.9999837875366211	O
8001	.	81 82	33367 33368	0.9999048709869385	O
8002	Statistics	0 10	33369 33379	0.999970555305481	O
8003	on	11 13	33380 33382	0.9999754428863525	O
8004	expression	14 24	33383 33393	0.9999756813049316	O
8005	imbalances	25 34	33394 33403	0.9999827146530151	O
8009	across	36 42	33405 33411	0.9999780654907227	O
8010	human	43 48	33412 33417	0.999880313873291	O
8011	chromosomes	49 59	33418 33428	0.9999788999557495	O
8013	.	61 62	33430 33431	0.9992377758026123	O
8014	Here	0 4	33432 33436	0.9999818801879883	O
8015	,	5 6	33437 33438	0.9999861717224121	O
8016	estimates	7 16	33439 33448	0.9999822378158569	O
8017	of	17 19	33449 33451	0.9999872446060181	O
8018	portions	20 28	33452 33460	0.9999850988388062	O
8019	of	29 31	33461 33463	0.9999873638153076	O
8020	chromosomes	32 42	33464 33474	0.9999837875366211	O
8022	that	44 48	33476 33480	0.9999872446060181	O
8023	are	49 52	33481 33484	0.9999871253967285	O
8024	affected	53 61	33485 33493	0.9999843835830688	O
8025	by	62 64	33494 33496	0.9999878406524658	O
8026	regional	65 73	33497 33505	0.9999841451644897	O
8027	regulation	74 84	33506 33516	0.9999852180480957	O
8028	of	85 87	33517 33519	0.9999881982803345	O
8029	expression	88 98	33520 33530	0.9999825954437256	O
8030	are	99 102	33531 33534	0.9999852180480957	O
8031	given	103 108	33535 33540	0.9999847412109375	O
8032	.	109 110	33541 33542	0.9999529123306274	O
8033	The	0 3	33543 33546	0.9999887943267822	O
8034	second	4 10	33547 33553	0.9999872446060181	O
8035	column	11 17	33554 33560	0.9999850988388062	O
8036	gives	18 23	33561 33566	0.9999872446060181	O
8037	the	24 27	33567 33570	0.9999889135360718	O
8038	number	28 34	33571 33577	0.9999879598617554	O
8039	of	35 37	33578 33580	0.9999889135360718	O
8040	genes	38 43	33581 33586	0.9999864101409912	O
8041	on	44 46	33587 33589	0.9999885559082031	O
8042	a	47 48	33590 33591	0.9999891519546509	O
8043	particular	49 59	33592 33602	0.9999881982803345	O
8044	chromosome	60 70	33603 33613	0.9999871253967285	O
8045	that	71 75	33614 33618	0.9999885559082031	O
8046	were	76 80	33619 33623	0.9999886751174927	O
8047	included	81 89	33624 33632	0.9999887943267822	O
8048	in	90 92	33633 33635	0.9999886751174927	O
8049	our	93 96	33636 33639	0.9999878406524658	O
8050	analysis	97 105	33640 33648	0.9999884366989136	O
8051	.	106 107	33649 33650	0.9999698400497437	O
8052	The	0 3	33651 33654	0.9999878406524658	O
8053	following	4 13	33655 33664	0.999985933303833	O
8054	columns	14 21	33665 33672	0.9999529123306274	O
8055	contain	22 29	33673 33680	0.9999871253967285	O
8056	the	30 33	33681 33684	0.9999880790710449	O
8057	numbers	34 41	33685 33692	0.9999849796295166	O
8058	of	42 44	33693 33695	0.9999881982803345	O
8059	genes	45 50	33696 33701	0.9999842643737793	O
8060	that	51 55	33702 33706	0.9999881982803345	O
8061	are	56 59	33707 33710	0.9999881982803345	O
8062	located	60 67	33711 33718	0.9999884366989136	O
8063	in	68 70	33719 33721	0.9999884366989136	O
8064	deregulated	71 81	33722 33732	0.9999880790710449	O
8067	expression	83 93	33734 33744	0.9999866485595703	O
8068	islands	94 101	33745 33752	0.999988317489624	O
8069	(	102 103	33753 33754	0.9999891519546509	O
8070	up	103 105	33754 33756	0.9999890327453613	O
8071	/	105 106	33756 33757	0.9999884366989136	O
8072	down	106 110	33757 33761	0.9999879598617554	O
8073	)	111 112	33762 33763	0.9999890327453613	O
8074	.	113 114	33764 33765	0.9999722242355347	O
8075	Individual	0 10	33766 33776	0.9999862909317017	O
8076	chromosomal	11 21	33777 33787	0.9999892711639404	O
8080	islands	23 30	33789 33796	0.9999877214431763	O
8081	with	31 35	33797 33801	0.9999877214431763	O
8082	gain	36 40	33802 33806	0.9999889135360718	O
8083	of	41 43	33807 33809	0.9999896287918091	O
8084	expression	44 54	33810 33820	0.9999891519546509	O
8085	8q11	55 58	33821 33824	0.9999891519546509	O
8088	.	59 60	33825 33826	0.9999896287918091	O
8089	23	60 62	33826 33828	0.9999891519546509	O
8090	-	62 63	33828 33829	0.9999897480010986	O
8091	q21	63 65	33829 33831	0.9999891519546509	O
8093	.	66 67	33832 33833	0.9999897480010986	O
8094	13	67 69	33833 33835	0.9999885559082031	O
8095	Gain	70 73	33836 33839	0.9999884366989136	O
8097	of	75 77	33841 33843	0.99998939037323	O
8098	expression	78 88	33844 33854	0.9999887943267822	O
8099	in	89 91	33855 33857	0.9999896287918091	O
8100	region	92 98	33858 33864	0.9999889135360718	O
8101	8q11	99 102	33865 33868	0.9999891519546509	O
8104	.	103 104	33869 33870	0.9999896287918091	O
8105	23	104 106	33870 33872	0.9999889135360718	O
8106	-	106 107	33872 33873	0.9999895095825195	O
8107	q21	107 109	33873 33875	0.9999891519546509	O
8109	.	110 111	33876 33877	0.9999895095825195	O
8110	13	111 113	33877 33879	0.999988317489624	O
8111	is	114 116	33880 33882	0.9999895095825195	O
8112	strongest	117 126	33883 33892	0.999988317489624	O
8113	in	127 129	33893 33895	0.9999895095825195	O
8114	a	130 131	33896 33897	0.9999895095825195	O
8115	small	132 137	33898 33903	0.9999879598617554	O
8116	interval	138 146	33904 33912	0.9999889135360718	O
8117	(	147 148	33913 33914	0.9999898672103882	O
8118	8q12	149 152	33915 33918	0.9999890327453613	O
8121	.	153 154	33919 33920	0.9999895095825195	O
8122	1	154 155	33920 33921	0.9999892711639404	O
8123	)	156 157	33922 33923	0.9999898672103882	O
8124	that	158 162	33924 33928	0.9999896287918091	O
8125	spans	163 168	33929 33934	0.9999884366989136	O
8126	genes	169 174	33935 33940	0.9999880790710449	O
8127	from	175 179	33941 33945	0.9999891519546509	O
8128	TCEA1	180 184	33946 33950	0.9999887943267822	O
8132	to	186 188	33952 33954	0.9999890327453613	O
8133	PLAG1	189 193	33955 33959	0.9999878406524658	O
8137	(	195 196	33961 33962	0.9999896287918091	O
8138	see	197 200	33963 33966	0.9999864101409912	O
8139	Figures	201 207	33967 33973	0.9999847412109375	O
8141	6	209 210	33975 33976	0.9999890327453613	O
8142	,	211 212	33977 33978	0.9999887943267822	O
8143	7	213 214	33979 33980	0.9999879598617554	O
8144	,	215 216	33981 33982	0.9999884366989136	O
8145	8	217 218	33983 33984	0.999987006187439	O
8146	)	219 220	33985 33986	0.99998939037323	O
8147	.	221 222	33987 33988	0.9999771118164062	O
8148	There	0 5	33989 33994	0.9999865293502808	O
8149	have	6 10	33995 33999	0.9999865293502808	O
8150	been	11 15	34000 34004	0.9999874830245972	O
8151	numerous	16 24	34005 34013	0.9999841451644897	O
8152	reports	25 32	34014 34021	0.999984860420227	O
8153	of	33 35	34022 34024	0.9999880790710449	O
8154	copy	36 40	34025 34029	0.999988317489624	O
8155	number	41 47	34030 34036	0.9999879598617554	O
8156	gains	48 53	34037 34042	0.9999865293502808	O
8157	of	54 56	34043 34045	0.9999886751174927	O
8158	chromosome	57 67	34046 34056	0.9999885559082031	O
8159	8q	68 69	34057 34058	0.9999877214431763	O
8161	in	71 73	34060 34062	0.9999879598617554	O
8162	CRC	74 76	34063 34065	0.9999793767929077	O
8164	[	78 79	34067 34068	0.9999890327453613	O
8165	18	79 81	34068 34070	0.9999874830245972	O
8166	,	81 82	34070 34071	0.9999887943267822	O
8167	21	82 84	34071 34073	0.9999876022338867	O
8168	,	84 85	34073 34074	0.9999886751174927	O
8169	23	85 87	34074 34076	0.999987006187439	O
8170	,	87 88	34076 34077	0.999988317489624	O
8171	25	88 90	34077 34079	0.9999868869781494	O
8172	]	91 92	34080 34081	0.9999876022338867	O
8173	which	93 98	34082 34087	0.9999880790710449	O
8174	suggests	99 107	34088 34096	0.9999864101409912	O
8175	a	108 109	34097 34098	0.9999887943267822	O
8176	possible	110 118	34099 34107	0.9999876022338867	O
8177	mechanism	119 128	34108 34117	0.9999872446060181	O
8178	leading	129 136	34118 34125	0.9999878406524658	O
8179	to	137 139	34126 34128	0.9999886751174927	O
8180	over	140 144	34129 34133	0.9999885559082031	O
8181	-	144 145	34133 34134	0.9999889135360718	O
8182	expression	145 155	34134 34144	0.9999871253967285	O
8183	in	156 158	34145 34147	0.9999878406524658	O
8184	our	159 162	34148 34151	0.9999624490737915	O
8185	patients	163 171	34152 34160	0.9999802112579346	O
8186	.	172 173	34161 34162	0.9999656677246094	O
8187	The	0 3	34163 34166	0.9999861717224121	O
8188	known	4 9	34167 34172	0.999976396560669	O
8189	blood	10 15	34173 34178	0.9999791383743286	O
8190	cell	16 20	34179 34183	0.9999849796295166	O
8191	oncogene	21 28	34184 34191	0.9999866485595703	O
8194	LYN	30 32	34193 34195	0.9999837875366211	O
8197	is	34 36	34197 34199	0.9999854564666748	O
8198	located	37 44	34200 34207	0.9999878406524658	O
8199	in	45 47	34208 34210	0.9999880790710449	O
8200	this	48 52	34211 34215	0.9999885559082031	O
8201	interval	53 61	34216 34224	0.999984622001648	O
8202	and	62 65	34225 34228	0.9999839067459106	O
8203	it	66 68	34229 34231	0.9999877214431763	O
8204	is	69 71	34232 34234	0.9999876022338867	O
8205	up	72 74	34235 34237	0.9999861717224121	O
8206	-	74 75	34237 34238	0.9999886751174927	O
8207	regulated	75 84	34238 34247	0.9999865293502808	O
8208	in	85 87	34248 34250	0.999987006187439	O
8209	several	88 95	34251 34258	0.999971866607666	O
8210	of	96 98	34259 34261	0.9999847412109375	O
8211	our	99 102	34262 34265	0.999885082244873	O
8212	tumor	103 108	34266 34271	0.9999785423278809	O
8213	samples	109 116	34272 34279	0.9999829530715942	O
8214	.	117 118	34280 34281	0.9999585151672363	O
8215	It	0 2	34282 34284	0.9999864101409912	O
8216	has	3 6	34285 34288	0.9999860525131226	O
8217	been	7 11	34289 34293	0.9999861717224121	O
8218	reported	12 20	34294 34302	0.9999847412109375	O
8219	before	21 27	34303 34309	0.999977707862854	O
8220	that	28 32	34310 34314	0.9999864101409912	O
8221	LYN	33 35	34315 34317	0.999976634979248	O
8224	is	37 39	34319 34321	0.9999860525131226	O
8225	expressed	40 49	34322 34331	0.9999829530715942	O
8226	in	50 52	34332 34334	0.9999847412109375	O
8227	colorectal	53 62	34335 34344	0.999976634979248	O
8230	tumors	64 70	34346 34352	0.999983549118042	O
8231	[	71 72	34353 34354	0.999988317489624	O
8232	26	72 74	34354 34356	0.9999849796295166	O
8233	]	74 75	34356 34357	0.9999876022338867	O
8234	.	76 77	34358 34359	0.9999710321426392	O
8235	The	0 3	34360 34363	0.9999864101409912	O
8236	concerted	4 12	34364 34372	0.9999849796295166	O
8238	up	14 16	34374 34376	0.9999862909317017	O
8239	-	16 17	34376 34377	0.9999884366989136	O
8240	regulation	17 27	34377 34387	0.9999855756759644	O
8241	of	28 30	34388 34390	0.9999877214431763	O
8242	LYN	31 33	34391 34393	0.9999855756759644	O
8245	along	35 40	34395 34400	0.9999874830245972	O
8246	with	41 45	34401 34405	0.9999880790710449	O
8247	other	46 51	34406 34411	0.9999866485595703	O
8248	genes	52 57	34412 34417	0.9999854564666748	O
8249	in	58 60	34418 34420	0.999988317489624	O
8250	this	61 65	34421 34425	0.999988317489624	O
8251	region	66 72	34426 34432	0.999984622001648	O
8252	suggests	73 81	34433 34441	0.9999790191650391	O
8253	a	82 83	34442 34443	0.9999878406524658	O
8254	role	84 88	34444 34448	0.999984622001648	O
8255	for	89 92	34449 34452	0.9999867677688599	O
8256	LYN	93 95	34453 34455	0.9999858140945435	O
8259	in	97 99	34457 34459	0.9999852180480957	O
8260	CRC	100 102	34460 34462	0.9999785423278809	O
8262	.	103 104	34463 34464	0.999963641166687	O
8263	Another	0 7	34465 34472	0.9999876022338867	O
8264	interesting	8 19	34473 34484	0.9999866485595703	O
8265	gene	20 24	34485 34489	0.9999850988388062	O
8266	in	25 27	34490 34492	0.9999886751174927	O
8267	this	28 32	34493 34497	0.9999890327453613	O
8268	interval	33 41	34498 34506	0.9999847412109375	O
8269	is	42 44	34507 34509	0.9999885559082031	O
8270	PLAG1	45 49	34510 34514	0.9999853372573853	O
8274	(	51 52	34516 34517	0.9999891519546509	O
8275	pleomorphic	53 63	34518 34528	0.9999865293502808	O
8278	adenoma	65 71	34530 34536	0.999984860420227	O
8281	gene	73 77	34538 34542	0.9999886751174927	O
8282	1	78 79	34543 34544	0.9999886751174927	O
8283	)	80 81	34545 34546	0.9999892711639404	O
8284	for	82 85	34547 34550	0.9999854564666748	O
8285	which	86 91	34551 34556	0.9999887943267822	O
8286	chromosomal	92 102	34557 34567	0.9999886751174927	O
8290	aberrations	104 114	34569 34579	0.9999890327453613	O
8293	have	116 120	34581 34585	0.9999887943267822	O
8294	been	121 125	34586 34590	0.9999885559082031	O
8295	described	126 135	34591 34600	0.9999871253967285	O
8296	that	136 140	34601 34605	0.9999885559082031	O
8297	lead	141 145	34606 34610	0.9999873638153076	O
8298	to	146 148	34611 34613	0.9999887943267822	O
8299	over	149 153	34614 34618	0.9999881982803345	O
8300	-	153 154	34618 34619	0.9999887943267822	O
8301	expression	154 164	34619 34629	0.9999858140945435	O
8302	in	165 167	34630 34632	0.9999864101409912	O
8303	salivary	168 175	34633 34640	0.9999607801437378	O
8306	gland	177 181	34642 34646	0.999983549118042	O
8308	tumors	183 189	34648 34654	0.999985933303833	O
8309	[	190 191	34655 34656	0.9999891519546509	O
8310	27	191 193	34656 34658	0.9999874830245972	O
8311	,	193 194	34658 34659	0.9999878406524658	O
8312	28	194 196	34659 34661	0.9999868869781494	O
8313	]	196 197	34661 34662	0.9999889135360718	O
8314	.	198 199	34663 34664	0.9999756813049316	O
8315	No	0 2	34665 34667	0.9999864101409912	O
8316	informative	3 13	34668 34678	0.9999884366989136	O
8318	expression	15 25	34680 34690	0.999984860420227	O
8319	measures	26 34	34691 34699	0.9999861717224121	O
8320	were	35 39	34700 34704	0.9999879598617554	O
8321	obtained	40 48	34705 34713	0.9999874830245972	O
8322	for	49 52	34714 34717	0.999988317489624	O
8323	the	53 56	34718 34721	0.9999886751174927	O
8324	MOS	57 59	34722 34724	0.9999845027923584	O
8326	protein	61 68	34726 34733	0.9999873638153076	O
8327	kinase	69 75	34734 34740	0.999987006187439	O
8328	gene	76 80	34741 34745	0.9999887943267822	O
8329	which	81 86	34746 34751	0.99998939037323	O
8330	is	87 89	34752 34754	0.9999892711639404	O
8331	located	90 97	34755 34762	0.9999892711639404	O
8332	between	98 105	34763 34770	0.9999886751174927	O
8333	RPS20	106 110	34771 34775	0.9999885559082031	O
8336	and	112 115	34777 34780	0.9999892711639404	O
8337	PLAG1	116 120	34781 34785	0.999988317489624	O
8341	,	122 123	34787 34788	0.999988317489624	O
8342	although	124 132	34789 34797	0.9999861717224121	O
8343	this	133 137	34798 34802	0.9999889135360718	O
8344	may	138 141	34803 34806	0.9999886751174927	O
8345	be	142 144	34807 34809	0.9999891519546509	O
8346	due	145 148	34810 34813	0.9999886751174927	O
8347	to	149 151	34814 34816	0.9999892711639404	O
8348	technical	152 161	34817 34826	0.9999861717224121	O
8349	limitations	162 173	34827 34838	0.9999878406524658	O
8350	.	174 175	34839 34840	0.999976396560669	O
8351	Genes	0 4	34841 34845	0.9999843835830688	O
8353	encoding	6 14	34847 34855	0.9999853372573853	O
8354	components	15 25	34856 34866	0.9999842643737793	O
8355	of	26 28	34867 34869	0.9999860525131226	O
8356	the	29 32	34870 34873	0.9999860525131226	O
8357	translation	33 44	34874 34885	0.9999748468399048	O
8358	machinery	45 54	34886 34895	0.9999814033508301	O
8359	,	55 56	34896 34897	0.9999860525131226	O
8360	the	57 60	34898 34901	0.9999860525131226	O
8361	mitochondrial	61 74	34902 34915	0.9999697208404541	O
8362	ribosomal	75 83	34916 34924	0.9999876022338867	O
8365	protein	85 92	34926 34933	0.9999880790710449	O
8366	MRPL15	93 98	34934 34939	0.9999865293502808	O
8369	and	100 103	34941 34944	0.9999873638153076	O
8370	cytosolic	104 112	34945 34953	0.9999867677688599	O
8374	ribosomal	114 122	34955 34963	0.9999872446060181	O
8377	proteins	124 132	34965 34973	0.999988317489624	O
8378	RPL7	133 136	34974 34977	0.9999886751174927	O
8381	and	138 141	34979 34982	0.9999877214431763	O
8382	RPS20	142 146	34983 34987	0.9999885559082031	O
8385	,	148 149	34989 34990	0.9999862909317017	O
8386	are	150 153	34991 34994	0.9999867677688599	O
8387	located	154 161	34995 35002	0.9999881982803345	O
8388	in	162 164	35003 35005	0.9999880790710449	O
8389	this	165 169	35006 35010	0.9999887943267822	O
8390	region	170 176	35011 35017	0.9999872446060181	O
8391	,	177 178	35018 35019	0.9999858140945435	O
8392	highlighting	179 191	35020 35032	0.9999833106994629	O
8393	the	192 195	35033 35036	0.9999874830245972	O
8394	need	196 200	35037 35041	0.9999850988388062	O
8395	for	201 204	35042 35045	0.9999873638153076	O
8396	enhanced	205 213	35046 35054	0.9999822378158569	O
8397	translation	214 225	35055 35066	0.9999774694442749	O
8398	in	226 228	35067 35069	0.9999855756759644	O
8399	cancer	229 235	35070 35076	0.9999812841415405	O
8400	cells	236 241	35077 35082	0.999976634979248	O
8401	.	242 243	35083 35084	0.9999572038650513	O
8402	The	0 3	35085 35088	0.9999874830245972	O
8403	concomitant	4 14	35089 35099	0.9999873638153076	O
8407	down	16 20	35101 35105	0.9999860525131226	O
8408	-	20 21	35105 35106	0.9999887943267822	O
8409	regulation	21 31	35106 35116	0.9999868869781494	O
8410	of	32 34	35117 35119	0.9999880790710449	O
8411	the	35 38	35120 35123	0.9999880790710449	O
8412	TOX	39 41	35124 35126	0.9999834299087524	O
8414	and	43 46	35128 35131	0.9999878406524658	O
8415	ANKTM1	47 52	35132 35137	0.9999843835830688	O
8419	genes	54 59	35139 35144	0.9999877214431763	O
8420	in	60 62	35145 35147	0.9999878406524658	O
8421	many	63 67	35148 35152	0.9999821186065674	O
8422	patients	68 76	35153 35161	0.9999691247940063	O
8423	in	77 79	35162 35164	0.999987006187439	O
8424	an	80 82	35165 35167	0.9999886751174927	O
8425	environment	83 94	35168 35179	0.9999805688858032	O
8426	of	95 97	35180 35182	0.9999884366989136	O
8427	transcriptional	98 112	35183 35197	0.9999861717224121	O
8429	activation	114 124	35199 35209	0.9999865293502808	O
8430	is	125 127	35210 35212	0.999988317489624	O
8431	remarkable	128 138	35213 35223	0.9999861717224121	O
8432	,	139 140	35224 35225	0.9999868869781494	O
8433	but	141 144	35226 35229	0.9999864101409912	O
8434	the	145 148	35230 35233	0.9999884366989136	O
8435	functional	149 159	35234 35244	0.9999792575836182	O
8436	significance	160 172	35245 35257	0.9999876022338867	O
8437	remains	173 180	35258 35265	0.999987006187439	O
8438	unclear	181 188	35266 35273	0.9999858140945435	O
8439	.	189 190	35274 35275	0.9999650716781616	O
8440	Buffart	0 6	35276 35282	0.999894380569458	O
8443	et	8 10	35284 35286	0.9999651908874512	O
8444	al	11 13	35287 35289	0.9999594688415527	O
8445	.	14 15	35290 35291	0.9999096393585205	O
8446	have	0 4	35292 35296	0.9999854564666748	O
8447	reported	5 13	35297 35305	0.9999872446060181	O
8448	amplifications	14 27	35306 35319	0.9999884366989136	O
8452	of	29 31	35321 35323	0.9999886751174927	O
8453	8q11	32 35	35324 35327	0.9999868869781494	O
8456	-	36 37	35328 35329	0.9999892711639404	O
8457	q24	37 39	35329 35331	0.9999886751174927	O
8459	in	41 43	35333 35335	0.9999871253967285	O
8460	metastasizing	44 56	35336 35348	0.9999834299087524	O
8464	CRC	58 60	35350 35352	0.9999746084213257	O
8466	[	62 63	35354 35355	0.9999890327453613	O
8467	29	63 65	35355 35357	0.9999860525131226	O
8468	]	65 66	35357 35358	0.9999892711639404	O
8469	,	67 68	35359 35360	0.9999878406524658	O
8470	highlighting	69 81	35361 35373	0.9999866485595703	O
8471	a	82 83	35374 35375	0.9999890327453613	O
8472	possible	84 92	35376 35384	0.9999874830245972	O
8473	mechanism	93 102	35385 35394	0.9999880790710449	O
8474	for	103 106	35395 35398	0.999988317489624	O
8475	gain	107 111	35399 35403	0.9999881982803345	O
8476	of	112 114	35404 35406	0.9999891519546509	O
8477	expression	115 125	35407 35417	0.9999881982803345	O
8478	in	126 128	35418 35420	0.9999890327453613	O
8479	this	129 133	35421 35425	0.9999891519546509	O
8480	region	134 140	35426 35432	0.9999867677688599	O
8481	.	141 142	35433 35434	0.9999719858169556	O
8482	In	0 2	35435 35437	0.999987006187439	O
8483	summary	3 10	35438 35445	0.9999847412109375	O
8484	,	11 12	35446 35447	0.9999867677688599	O
8485	our	13 16	35448 35451	0.9999792575836182	O
8486	analysis	17 25	35452 35460	0.9999812841415405	O
8487	suggests	26 34	35461 35469	0.9999840259552002	O
8488	that	35 39	35470 35474	0.9999879598617554	O
8489	chromosomal	40 50	35475 35485	0.999987006187439	O
8493	region	52 58	35487 35493	0.999987006187439	O
8494	8q12	59 62	35494 35497	0.9999864101409912	O
8497	.	63 64	35498 35499	0.9999874830245972	O
8498	1	64 65	35499 35500	0.999987006187439	O
8499	is	66 68	35501 35503	0.9999871253967285	O
8500	a	69 70	35504 35505	0.9999873638153076	O
8501	candidate	71 80	35506 35515	0.9999839067459106	O
8502	target	81 87	35516 35522	0.9999847412109375	O
8503	region	88 94	35523 35529	0.9999860525131226	O
8504	for	95 98	35530 35533	0.9999862909317017	O
8505	genetic	99 106	35534 35541	0.9999858140945435	O
8506	alterations	107 118	35542 35553	0.9999855756759644	O
8507	that	119 123	35554 35558	0.9999874830245972	O
8508	lead	124 128	35559 35563	0.9999856948852539	O
8509	to	129 131	35564 35566	0.9999877214431763	O
8510	over	132 136	35567 35571	0.9999878406524658	O
8511	-	136 137	35571 35572	0.9999880790710449	O
8512	expression	137 147	35572 35582	0.9999860525131226	O
8513	in	148 150	35583 35585	0.9999861717224121	O
8514	CRC	151 153	35586 35588	0.9999806880950928	O
8516	.	154 155	35589 35590	0.9999877214431763	O
8517	*	156 157	35591 35592	0.9999866485595703	O
8518	*	157 158	35592 35593	0.9999716281890869	O
8519	IGNORE	0 5	35594 35599	0.9999862909317017	O
8522	LINE	7 10	35601 35604	0.999988317489624	O
8525	*	12 13	35606 35607	0.9999887943267822	O
8526	*	13 14	35607 35608	0.9999887943267822	O
8527	*	15 16	35609 35610	0.9999887943267822	O
8528	*	16 17	35610 35611	0.9999889135360718	O
8529	IGNORE	18 23	35612 35617	0.9999878406524658	O
8532	LINE	25 28	35619 35622	0.9999887943267822	O
8535	*	30 31	35624 35625	0.9999886751174927	O
8536	*	31 32	35625 35626	0.9999886751174927	O
8537	*	33 34	35627 35628	0.9999886751174927	O
8538	*	34 35	35628 35629	0.9999887943267822	O
8539	IGNORE	36 41	35630 35635	0.9999872446060181	O
8542	LINE	43 46	35637 35640	0.9999886751174927	O
8545	*	48 49	35642 35643	0.9999889135360718	O
8546	*	49 50	35643 35644	0.9999887943267822	O
8547	Up	51 53	35645 35647	0.9999878406524658	O
8548	-	53 54	35647 35648	0.9999892711639404	O
8549	regulation	54 64	35648 35658	0.9999889135360718	O
8550	of	65 67	35659 35661	0.9999887943267822	O
8551	mRNA	68 71	35662 35665	0.9999885559082031	O
8553	expression	73 83	35667 35677	0.999988317489624	O
8554	in	84 86	35678 35680	0.9999891519546509	O
8555	human	87 92	35681 35686	0.9999736547470093	O
8556	chromosomal	93 103	35687 35697	0.9999886751174927	O
8560	region	105 111	35699 35705	0.9999887943267822	O
8561	8q11	112 115	35706 35709	0.9999884366989136	O
8564	.	116 117	35710 35711	0.9999890327453613	O
8565	23	117 119	35711 35713	0.9999878406524658	O
8566	-	119 120	35713 35714	0.9999890327453613	O
8567	q21	120 122	35714 35716	0.9999885559082031	O
8569	.	123 124	35717 35718	0.9999890327453613	O
8570	13	124 126	35718 35720	0.9999871253967285	O
8571	(	127 128	35721 35722	0.9999891519546509	O
8572	T	129 130	35723 35724	0.999988317489624	O
8573	/	130 131	35724 35725	0.9999884366989136	O
8574	N	131 132	35725 35726	0.9999872446060181	O
8575	relative	133 141	35727 35735	0.9999880790710449	O
8576	expression	142 152	35736 35746	0.9999880790710449	O
8577	heat	153 157	35747 35751	0.999988317489624	O
8578	map	158 161	35752 35755	0.9999881982803345	O
8579	)	162 163	35756 35757	0.99998939037323	O
8580	.	164 165	35758 35759	0.9999566078186035	O
8581	Heat	0 4	35760 35764	0.9999792575836182	O
8582	map	5 8	35765 35768	0.9999709129333496	O
8583	of	9 11	35769 35771	0.9999856948852539	O
8584	fold	12 16	35772 35776	0.999984622001648	O
8585	change	17 23	35777 35783	0.9999850988388062	O
8586	of	24 26	35784 35786	0.9999858140945435	O
8587	tumor	27 32	35787 35792	0.9999821186065674	O
8588	-	32 33	35792 35793	0.9999873638153076	O
8589	versus	33 39	35793 35799	0.9999862909317017	O
8590	-	39 40	35799 35800	0.9999864101409912	O
8591	normal	40 46	35800 35806	0.9999821186065674	O
8592	expression	47 57	35807 35817	0.9999843835830688	O
8593	.	58 59	35818 35819	0.9997835755348206	O
8594	Genes	0 4	35820 35824	0.999983549118042	O
8596	are	6 9	35826 35829	0.9999847412109375	O
8597	given	10 15	35830 35835	0.9999822378158569	O
8598	in	16 18	35836 35838	0.9999867677688599	O
8599	chromosomal	19 29	35839 35849	0.999988317489624	O
8603	order	31 36	35851 35856	0.9999862909317017	O
8604	on	37 39	35857 35859	0.9999871253967285	O
8605	the	40 43	35860 35863	0.9999884366989136	O
8606	horizontal	44 54	35864 35874	0.9999852180480957	O
8607	axis	55 59	35875 35879	0.999987006187439	O
8608	.	60 61	35880 35881	0.9999489784240723	O
8609	Patient	0 6	35882 35888	0.9999853372573853	O
8611	codes	8 13	35890 35895	0.9999815225601196	O
8612	are	14 17	35896 35899	0.9999818801879883	O
8613	given	18 23	35900 35905	0.9999805688858032	O
8614	on	24 26	35906 35908	0.9999850988388062	O
8615	the	27 30	35909 35912	0.9999866485595703	O
8616	vertical	31 39	35913 35921	0.9999815225601196	O
8617	axis	40 44	35922 35926	0.9999868869781494	O
8618	.	45 46	35927 35928	0.9999494552612305	O
8619	The	0 3	35929 35932	0.9999879598617554	O
8620	legend	4 10	35933 35939	0.9999767541885376	O
8621	depicts	11 18	35940 35947	0.9999865293502808	O
8622	which	19 24	35948 35953	0.9999889135360718	O
8623	colors	25 31	35954 35960	0.9999873638153076	O
8624	code	32 36	35961 35965	0.9999885559082031	O
8625	for	37 40	35966 35969	0.9999881982803345	O
8626	which	41 46	35970 35975	0.9999892711639404	O
8627	expression	47 57	35976 35986	0.9999866485595703	O
8628	changes	58 65	35987 35994	0.9999886751174927	O
8629	on	66 68	35995 35997	0.9999892711639404	O
8630	a	69 70	35998 35999	0.9999895095825195	O
8631	loge	71 74	36000 36003	0.9999885559082031	O
8633	scale	76 81	36005 36010	0.9999886751174927	O
8634	(	82 83	36011 36012	0.9999895095825195	O
8635	green	84 89	36013 36018	0.999988317489624	O
8636	:	90 91	36019 36020	0.99998939037323	O
8637	down	92 96	36021 36025	0.999988317489624	O
8638	in	97 99	36026 36028	0.9999895095825195	O
8639	tumor	100 105	36029 36034	0.9999876022338867	O
8640	;	106 107	36035 36036	0.9999889135360718	O
8641	red	108 111	36037 36040	0.9999871253967285	O
8642	:	112 113	36041 36042	0.9999890327453613	O
8643	up	114 116	36043 36045	0.999988317489624	O
8644	in	117 119	36046 36048	0.9999892711639404	O
8645	tumor	120 125	36049 36054	0.9999878406524658	O
8646	)	126 127	36055 36056	0.99998939037323	O
8647	.	128 129	36057 36058	0.9999772310256958	O
8648	View	0 4	36059 36063	0.9999744892120361	O
8649	in	5 7	36064 36066	0.9999827146530151	O
8650	conjunction	8 19	36067 36078	0.9999829530715942	O
8651	with	20 24	36079 36083	0.9999816417694092	O
8652	Figures	25 31	36084 36090	0.9999778270721436	O
8654	7	33 34	36092 36093	0.9999853372573853	O
8655	and	35 38	36094 36097	0.9999840259552002	O
8656	8	39 40	36098 36099	0.9999799728393555	O
8657	.	40 41	36099 36100	0.999962329864502	O
8658	Up	0 2	36101 36103	0.9999865293502808	O
8659	-	2 3	36103 36104	0.9999884366989136	O
8660	regulation	3 13	36104 36114	0.9999860525131226	O
8661	of	14 16	36115 36117	0.9999876022338867	O
8662	mRNA	17 20	36118 36121	0.9999866485595703	O
8664	expression	22 32	36123 36133	0.9999865293502808	O
8665	in	33 35	36134 36136	0.999988317489624	O
8666	human	36 41	36137 36142	0.9999773502349854	O
8667	chromosomal	42 52	36143 36153	0.9999887943267822	O
8671	region	54 60	36155 36161	0.9999889135360718	O
8672	8q11	61 64	36162 36165	0.9999879598617554	O
8675	.	65 66	36166 36167	0.9999887943267822	O
8676	23	66 68	36167 36169	0.9999876022338867	O
8677	-	68 69	36169 36170	0.9999891519546509	O
8678	q21	69 71	36170 36172	0.9999889135360718	O
8680	.	72 73	36173 36174	0.9999890327453613	O
8681	13	73 75	36174 36176	0.9999879598617554	O
8682	(	76 77	36177 36178	0.9999892711639404	O
8683	patient	78 85	36179 36186	0.9999855756759644	O
8684	counts	86 92	36187 36193	0.9999877214431763	O
8685	with	93 97	36194 36198	0.9999884366989136	O
8686	coordinate	98 108	36199 36209	0.999985933303833	O
8687	up	109 111	36210 36212	0.9999891519546509	O
8688	-	111 112	36212 36213	0.9999892711639404	O
8689	regulation	112 122	36213 36223	0.9999884366989136	O
8690	)	123 124	36224 36225	0.9999895095825195	O
8691	.	125 126	36226 36227	0.9999620914459229	O
8692	Grayscale	0 8	36228 36236	0.9999833106994629	O
8695	plot	10 14	36238 36242	0.9999784231185913	O
8696	of	15 17	36243 36245	0.9999854564666748	O
8697	cross	18 23	36246 36251	0.9999852180480957	O
8698	-	23 24	36251 36252	0.9999864101409912	O
8699	comparison	24 34	36252 36262	0.9999829530715942	O
8700	of	35 37	36263 36265	0.9999866485595703	O
8701	up	38 40	36266 36268	0.9999856948852539	O
8702	-	40 41	36268 36269	0.9999880790710449	O
8703	regulation	41 51	36269 36279	0.999984860420227	O
8704	patterns	52 60	36280 36288	0.9999868869781494	O
8705	across	61 67	36289 36295	0.9999872446060181	O
8706	patients	68 76	36296 36304	0.999980092048645	O
8707	for	77 80	36305 36308	0.9999862909317017	O
8708	gene	81 85	36309 36313	0.999987006187439	O
8709	pairs	86 91	36314 36319	0.9999874830245972	O
8710	in	92 94	36320 36322	0.9999871253967285	O
8711	a	95 96	36323 36324	0.9999871253967285	O
8712	particular	97 107	36325 36335	0.9999837875366211	O
8713	region	108 114	36336 36342	0.999984622001648	O
8714	.	115 116	36343 36344	0.9998838901519775	O
8715	Both	0 4	36345 36349	0.9999842643737793	O
8716	,	5 6	36350 36351	0.9999845027923584	O
8717	horizontal	7 17	36352 36362	0.9999842643737793	O
8718	and	18 21	36363 36366	0.9999843835830688	O
8719	vertical	22 30	36367 36375	0.9999747276306152	O
8720	axes	31 35	36376 36380	0.9999793767929077	O
8721	comprise	36 44	36381 36389	0.999984622001648	O
8722	the	45 48	36390 36393	0.9999866485595703	O
8723	same	49 53	36394 36398	0.9999818801879883	O
8724	genes	54 59	36399 36404	0.999982476234436	O
8725	in	60 62	36405 36407	0.9999858140945435	O
8726	chromosomal	63 73	36408 36418	0.9999876022338867	O
8730	order	75 80	36420 36425	0.9999836683273315	O
8731	.	81 82	36426 36427	0.9999096393585205	O
8732	In	0 2	36428 36430	0.9999889135360718	O
8733	each	3 7	36431 36435	0.9999891519546509	O
8734	square	8 14	36436 36442	0.9999853372573853	O
8735	total	15 20	36443 36448	0.999988317489624	O
8736	counts	21 27	36449 36455	0.9999871253967285	O
8737	of	28 30	36456 36458	0.9999880790710449	O
8738	patients	31 39	36459 36467	0.9999840259552002	O
8739	with	40 44	36468 36472	0.9999892711639404	O
8740	consistent	45 55	36473 36483	0.9999881982803345	O
8741	up	56 58	36484 36486	0.9999889135360718	O
8742	-	58 59	36486 36487	0.99998939037323	O
8743	regulation	59 69	36487 36497	0.9999885559082031	O
8744	in	70 72	36498 36500	0.9999897480010986	O
8745	two	73 76	36501 36504	0.9999884366989136	O
8746	genes	77 82	36505 36510	0.9999873638153076	O
8747	are	83 86	36511 36514	0.9999890327453613	O
8748	coded	87 92	36515 36520	0.9999892711639404	O
8749	by	93 95	36521 36523	0.9999895095825195	O
8750	different	96 105	36524 36533	0.9999878406524658	O
8751	shades	106 112	36534 36540	0.999987006187439	O
8752	of	113 115	36541 36543	0.9999889135360718	O
8753	gray	116 120	36544 36548	0.999985933303833	O
8754	.	121 122	36549 36550	0.9999756813049316	O
8755	Dark	0 4	36551 36555	0.9999840259552002	O
8756	squared	5 12	36556 36563	0.9999792575836182	O
8757	regions	13 20	36564 36571	0.9999825954437256	O
8758	along	21 26	36572 36577	0.9999847412109375	O
8759	the	27 30	36578 36581	0.9999853372573853	O
8760	diagonal	31 39	36582 36590	0.9999505281448364	O
8761	indicate	40 48	36591 36599	0.9999749660491943	O
8762	coordinated	49 60	36600 36611	0.9999760389328003	O
8763	regulation	61 71	36612 36622	0.9999690055847168	O
8764	in	72 74	36623 36625	0.9999837875366211	O
8765	patient	75 82	36626 36633	0.999962568283081	O
8766	subgroups	83 91	36634 36642	0.9999828338623047	O
8768	.	93 94	36644 36645	0.9999102354049683	O
8769	Note	0 4	36646 36650	0.9999856948852539	O
8770	,	5 6	36651 36652	0.9999881982803345	O
8771	that	7 11	36653 36657	0.9999884366989136	O
8772	many	12 16	36658 36662	0.9999866485595703	O
8773	more	17 21	36663 36667	0.999985933303833	O
8774	patients	22 30	36668 36676	0.9999815225601196	O
8775	show	31 35	36677 36681	0.9999889135360718	O
8776	up	36 38	36682 36684	0.9999889135360718	O
8777	-	38 39	36684 36685	0.9999892711639404	O
8778	regulation	39 49	36685 36695	0.9999885559082031	O
8779	as	50 52	36696 36698	0.9999891519546509	O
8780	indicated	53 62	36699 36708	0.99998939037323	O
8781	by	63 65	36709 36711	0.99998939037323	O
8782	dark	66 70	36712 36716	0.9999892711639404	O
8783	spots	71 76	36717 36722	0.9999892711639404	O
8784	in	77 79	36723 36725	0.9999892711639404	O
8785	this	80 84	36726 36730	0.9999892711639404	O
8786	figure	85 91	36731 36737	0.9999885559082031	O
8787	than	92 96	36738 36742	0.9999884366989136	O
8788	down	97 101	36743 36747	0.9999885559082031	O
8789	-	101 102	36747 36748	0.9999890327453613	O
8790	regulation	102 112	36748 36758	0.9999886751174927	O
8791	as	113 115	36759 36761	0.9999887943267822	O
8792	indicated	116 125	36762 36771	0.9999887943267822	O
8793	by	126 128	36772 36774	0.9999889135360718	O
8794	dark	129 133	36775 36779	0.9999890327453613	O
8795	spots	134 139	36780 36785	0.9999891519546509	O
8796	in	140 142	36786 36788	0.9999890327453613	O
8797	Figure	143 149	36789 36795	0.9999873638153076	O
8798	8	150 151	36796 36797	0.9999881982803345	O
8799	.	151 152	36797 36798	0.9999806880950928	O
8800	The	0 3	36799 36802	0.9999881982803345	O
8801	left	4 8	36803 36807	0.9999850988388062	O
8802	region	9 15	36808 36814	0.9999878406524658	O
8803	of	16 18	36815 36817	0.999988317489624	O
8804	exceptionally	19 32	36818 36831	0.9999856948852539	O
8805	strong	33 39	36832 36838	0.999987006187439	O
8806	up	40 42	36839 36841	0.9999877214431763	O
8807	-	42 43	36841 36842	0.9999889135360718	O
8808	regulation	43 53	36842 36852	0.999987006187439	O
8809	spans	54 59	36853 36858	0.9999865293502808	O
8810	TCEA1	60 64	36859 36863	0.9999878406524658	O
8814	,	66 67	36865 36866	0.9999886751174927	O
8815	LYPLA1	68 73	36867 36872	0.9999878406524658	O
8819	,	75 76	36874 36875	0.9999887943267822	O
8820	MRPL15	77 82	36876 36881	0.999987006187439	O
8823	,	84 85	36883 36884	0.9999890327453613	O
8824	the	86 89	36885 36888	0.9999885559082031	O
8825	known	90 95	36889 36894	0.9999829530715942	O
8826	tumor	96 101	36895 36900	0.9999849796295166	O
8827	gene	102 106	36901 36905	0.9999886751174927	O
8828	LYN	107 109	36906 36908	0.999987006187439	O
8831	,	111 112	36910 36911	0.9999879598617554	O
8832	and	113 116	36912 36915	0.9999885559082031	O
8833	PLAG1	117 121	36916 36920	0.9999872446060181	O
8837	.	123 124	36922 36923	0.9999698400497437	O
8838	Note	0 4	36924 36928	0.9999630451202393	O
8839	that	5 9	36929 36933	0.9999852180480957	O
8840	TOX	10 12	36934 36936	0.9999746084213257	O
8842	and	14 17	36938 36941	0.999984860420227	O
8843	ANKTM1	18 23	36942 36947	0.9999806880950928	O
8847	are	25 28	36949 36952	0.999984622001648	O
8848	down	29 33	36953 36957	0.9999808073043823	O
8849	-	33 34	36957 36958	0.9999874830245972	O
8850	regulated	34 43	36958 36967	0.9999830722808838	O
8851	in	44 46	36968 36970	0.9999853372573853	O
8852	approximately	47 60	36971 36984	0.9999845027923584	O
8853	half	61 65	36985 36989	0.9999796152114868	O
8854	of	66 68	36990 36992	0.9999830722808838	O
8855	the	69 72	36993 36996	0.9999754428863525	O
8856	tumor	73 78	36997 37002	0.9999634027481079	O
8857	samples	79 86	37003 37010	0.9999758005142212	O
8858	.	87 88	37011 37012	0.9999409914016724	O
8859	Up	0 2	37013 37015	0.9999854564666748	O
8860	-	2 3	37015 37016	0.9999881982803345	O
8861	regulation	3 13	37016 37026	0.9999860525131226	O
8862	of	14 16	37027 37029	0.9999874830245972	O
8863	mRNA	17 20	37030 37033	0.9999865293502808	O
8865	expression	22 32	37035 37045	0.9999864101409912	O
8866	in	33 35	37046 37048	0.999988317489624	O
8867	human	36 41	37049 37054	0.999975323677063	O
8868	chromosomal	42 52	37055 37065	0.9999886751174927	O
8872	region	54 60	37067 37073	0.9999889135360718	O
8873	8q11	61 64	37074 37077	0.9999878406524658	O
8876	.	65 66	37078 37079	0.9999887943267822	O
8877	23	66 68	37079 37081	0.9999876022338867	O
8878	-	68 69	37081 37082	0.9999891519546509	O
8879	q21	69 71	37082 37084	0.9999887943267822	O
8881	.	72 73	37085 37086	0.9999889135360718	O
8882	13	73 75	37086 37088	0.9999879598617554	O
8883	(	76 77	37089 37090	0.9999891519546509	O
8884	patient	78 85	37091 37098	0.9999854564666748	O
8885	counts	86 92	37099 37105	0.9999877214431763	O
8886	with	93 97	37106 37110	0.9999885559082031	O
8887	coordinate	98 108	37111 37121	0.9999861717224121	O
8888	down	109 113	37122 37126	0.9999879598617554	O
8889	-	113 114	37126 37127	0.9999891519546509	O
8890	regulation	114 124	37127 37137	0.9999885559082031	O
8891	)	125 126	37138 37139	0.9999895095825195	O
8892	.	127 128	37140 37141	0.9999600648880005	O
8893	Grayscale	0 8	37142 37150	0.9999833106994629	O
8896	plot	10 14	37152 37156	0.9999785423278809	O
8897	of	15 17	37157 37159	0.9999854564666748	O
8898	cross	18 23	37160 37165	0.9999850988388062	O
8899	-	23 24	37165 37166	0.9999864101409912	O
8900	comparison	24 34	37166 37176	0.9999830722808838	O
8901	of	35 37	37177 37179	0.9999865293502808	O
8902	down	38 42	37180 37184	0.9999840259552002	O
8903	-	42 43	37184 37185	0.9999879598617554	O
8904	regulation	43 53	37185 37195	0.999984622001648	O
8905	patterns	54 62	37196 37204	0.9999867677688599	O
8906	across	63 69	37205 37211	0.9999871253967285	O
8907	patients	70 78	37212 37220	0.9999799728393555	O
8908	for	79 82	37221 37224	0.9999860525131226	O
8909	gene	83 87	37225 37229	0.999987006187439	O
8910	pairs	88 93	37230 37235	0.9999872446060181	O
8911	in	94 96	37236 37238	0.9999872446060181	O
8912	a	97 98	37239 37240	0.9999873638153076	O
8913	particular	99 109	37241 37251	0.9999840259552002	O
8914	region	110 116	37252 37258	0.999984860420227	O
8915	.	117 118	37259 37260	0.9998812675476074	O
8916	Both	0 4	37261 37265	0.9999842643737793	O
8917	,	5 6	37266 37267	0.9999845027923584	O
8918	horizontal	7 17	37268 37278	0.9999842643737793	O
8919	and	18 21	37279 37282	0.9999843835830688	O
8920	vertical	22 30	37283 37291	0.9999747276306152	O
8921	axes	31 35	37292 37296	0.9999793767929077	O
8922	comprise	36 44	37297 37305	0.999984622001648	O
8923	the	45 48	37306 37309	0.9999866485595703	O
8924	same	49 53	37310 37314	0.9999818801879883	O
8925	genes	54 59	37315 37320	0.999982476234436	O
8926	in	60 62	37321 37323	0.9999858140945435	O
8927	chromosomal	63 73	37324 37334	0.9999876022338867	O
8931	order	75 80	37336 37341	0.9999836683273315	O
8932	.	81 82	37342 37343	0.9999096393585205	O
8933	In	0 2	37344 37346	0.9999889135360718	O
8934	each	3 7	37347 37351	0.9999890327453613	O
8935	square	8 14	37352 37358	0.9999855756759644	O
8936	total	15 20	37359 37364	0.9999881982803345	O
8937	counts	21 27	37365 37371	0.9999871253967285	O
8938	of	28 30	37372 37374	0.9999880790710449	O
8939	patients	31 39	37375 37383	0.9999837875366211	O
8940	with	40 44	37384 37388	0.9999891519546509	O
8941	consistent	45 55	37389 37399	0.999988317489624	O
8942	down	56 60	37400 37404	0.999988317489624	O
8943	-	60 61	37404 37405	0.99998939037323	O
8944	regulation	61 71	37405 37415	0.9999885559082031	O
8945	in	72 74	37416 37418	0.9999897480010986	O
8946	two	75 78	37419 37422	0.999988317489624	O
8947	genes	79 84	37423 37428	0.9999873638153076	O
8948	are	85 88	37429 37432	0.9999889135360718	O
8949	coded	89 94	37433 37438	0.9999892711639404	O
8950	by	95 97	37439 37441	0.9999895095825195	O
8951	different	98 107	37442 37451	0.9999877214431763	O
8952	shades	108 114	37452 37458	0.999987006187439	O
8953	of	115 117	37459 37461	0.9999889135360718	O
8954	gray	118 122	37462 37466	0.999985933303833	O
8955	.	123 124	37467 37468	0.9999755620956421	O
8956	Dark	0 4	37469 37473	0.9999840259552002	O
8957	squared	5 12	37474 37481	0.9999792575836182	O
8958	regions	13 20	37482 37489	0.9999825954437256	O
8959	along	21 26	37490 37495	0.9999847412109375	O
8960	the	27 30	37496 37499	0.9999853372573853	O
8961	diagonal	31 39	37500 37508	0.9999505281448364	O
8962	indicate	40 48	37509 37517	0.9999749660491943	O
8963	coordinated	49 60	37518 37529	0.9999760389328003	O
8964	regulation	61 71	37530 37540	0.9999690055847168	O
8965	in	72 74	37541 37543	0.9999837875366211	O
8966	patient	75 82	37544 37551	0.999962568283081	O
8967	subgroups	83 91	37552 37560	0.9999828338623047	O
8969	.	93 94	37562 37563	0.9999102354049683	O
8970	View	0 4	37564 37568	0.999974250793457	O
8971	in	5 7	37569 37571	0.9999828338623047	O
8972	conjunction	8 19	37572 37583	0.9999829530715942	O
8973	with	20 24	37584 37588	0.9999818801879883	O
8974	Figures	25 31	37589 37595	0.9999780654907227	O
8976	6	33 34	37597 37598	0.9999847412109375	O
8977	and	35 38	37599 37602	0.9999840259552002	O
8978	7	39 40	37603 37604	0.9999809265136719	O
8979	.	40 41	37604 37605	0.9999614953994751	O
8980	20q11	0 4	37606 37610	0.9999879598617554	O
8983	.	5 6	37611 37612	0.9999896287918091	O
8984	22	6 8	37612 37614	0.9999885559082031	O
8985	-	8 9	37614 37615	0.9999897480010986	O
8986	q11	9 11	37615 37617	0.9999892711639404	O
8988	.	12 13	37618 37619	0.99998939037323	O
8989	23	13 15	37619 37621	0.9999884366989136	O
8990	The	16 19	37622 37625	0.9999873638153076	O
8991	region	20 26	37626 37632	0.9999889135360718	O
8992	20q11	27 31	37633 37637	0.999988317489624	O
8995	.	32 33	37638 37639	0.9999895095825195	O
8996	22	33 35	37639 37641	0.9999886751174927	O
8997	-	35 36	37641 37642	0.9999896287918091	O
8998	q11	36 38	37642 37644	0.99998939037323	O
9000	.	39 40	37645 37646	0.99998939037323	O
9001	23	40 42	37646 37648	0.999988317489624	O
9002	was	43 46	37649 37652	0.9999884366989136	O
9003	among	47 52	37653 37658	0.9999886751174927	O
9004	the	53 56	37659 37662	0.9999891519546509	O
9005	most	57 61	37663 37667	0.9999887943267822	O
9006	frequently	62 72	37668 37678	0.9999884366989136	O
9007	up	73 75	37679 37681	0.9999885559082031	O
9008	-	75 76	37681 37682	0.9999896287918091	O
9009	regulated	76 85	37682 37691	0.9999874830245972	O
9010	regions	86 93	37692 37699	0.9999887943267822	O
9011	(	94 95	37700 37701	0.9999896287918091	O
9012	see	96 99	37702 37705	0.9999877214431763	O
9013	Figures	100 106	37706 37712	0.9999861717224121	O
9015	12	108 110	37714 37716	0.9999891519546509	O
9016	,	111 112	37717 37718	0.9999887943267822	O
9017	13	113 115	37719 37721	0.9999885559082031	O
9018	,	116 117	37722 37723	0.9999886751174927	O
9019	14	118 120	37724 37726	0.9999885559082031	O
9020	)	121 122	37727 37728	0.9999896287918091	O
9021	.	123 124	37729 37730	0.9999796152114868	O
9022	Amplifications	0 13	37731 37744	0.9999879598617554	O
9026	of	15 17	37746 37748	0.9999877214431763	O
9027	regions	18 25	37749 37756	0.9999866485595703	O
9028	on	26 28	37757 37759	0.9999879598617554	O
9029	chromosome	29 39	37760 37770	0.999988317489624	O
9030	20q	40 42	37771 37773	0.999983549118042	O
9032	have	44 48	37775 37779	0.9999871253967285	O
9033	been	49 53	37780 37784	0.9999881982803345	O
9034	identified	54 64	37785 37795	0.9999877214431763	O
9035	independently	65 78	37796 37809	0.9999861717224121	O
9036	by	79 81	37810 37812	0.9999881982803345	O
9037	several	82 89	37813 37820	0.9999861717224121	O
9038	groups	90 96	37821 37827	0.9999783039093018	O
9039	in	97 99	37828 37830	0.9999823570251465	O
9040	CRCs	100 103	37831 37834	0.9999775886535645	O
9042	[	105 106	37836 37837	0.9999890327453613	O
9043	19	106 108	37837 37839	0.9999867677688599	O
9044	,	108 109	37839 37840	0.9999885559082031	O
9045	21	109 111	37840 37842	0.9999876022338867	O
9046	,	111 112	37842 37843	0.9999885559082031	O
9047	23	112 114	37843 37845	0.9999873638153076	O
9048	,	114 115	37845 37846	0.9999884366989136	O
9049	24	115 117	37846 37848	0.9999873638153076	O
9050	]	117 118	37848 37849	0.9999885559082031	O
9051	.	119 120	37850 37851	0.9999717473983765	O
9052	The	0 3	37852 37855	0.9999885559082031	O
9053	interval	4 12	37856 37864	0.999984860420227	O
9054	comprises	13 22	37865 37874	0.9999881982803345	O
9055	the	23 26	37875 37878	0.9999886751174927	O
9056	known	27 32	37879 37884	0.9999858140945435	O
9057	tumor	33 38	37885 37890	0.9999853372573853	O
9058	gene	39 43	37891 37895	0.999988317489624	O
9059	SRC	44 46	37896 37898	0.9999867677688599	O
9061	(	48 49	37900 37901	0.9999897480010986	O
9062	located	50 57	37902 37909	0.9999890327453613	O
9063	between	58 65	37910 37917	0.9999886751174927	O
9064	MANBAL	66 71	37918 37923	0.9999879598617554	O
9068	and	73 76	37925 37928	0.99998939037323	O
9069	BLCAP	77 81	37929 37933	0.9999880790710449	O
9072	in	83 85	37935 37937	0.9999897480010986	O
9073	Figures	86 92	37938 37944	0.9999872446060181	O
9075	12	94 96	37946 37948	0.99998939037323	O
9076	,	97 98	37949 37950	0.9999890327453613	O
9077	13	99 101	37951 37953	0.9999886751174927	O
9078	,	102 103	37954 37955	0.9999890327453613	O
9079	14	104 106	37956 37958	0.9999887943267822	O
9080	)	107 108	37959 37960	0.9999897480010986	O
9081	for	109 112	37961 37964	0.9999885559082031	O
9082	which	113 118	37965 37970	0.9999895095825195	O
9083	no	119 121	37971 37973	0.9999886751174927	O
9084	informative	122 132	37974 37984	0.9999895095825195	O
9086	expression	134 144	37986 37996	0.9999874830245972	O
9087	measures	145 153	37997 38005	0.9999881982803345	O
9088	were	154 158	38006 38010	0.9999887943267822	O
9089	obtained	159 167	38011 38019	0.9999890327453613	O
9090	.	168 169	38020 38021	0.9999793767929077	O
9091	We	0 2	38022 38024	0.9999827146530151	O
9092	note	3 7	38025 38029	0.9999852180480957	O
9093	that	8 12	38030 38034	0.999988317489624	O
9094	it	13 15	38035 38037	0.9999880790710449	O
9095	is	16 18	38038 38040	0.9999868869781494	O
9096	possible	19 27	38041 38049	0.9999864101409912	O
9097	that	28 32	38050 38054	0.9999886751174927	O
9098	the	33 36	38055 38058	0.9999887943267822	O
9099	SRC	37 39	38059 38061	0.9999842643737793	O
9101	gene	41 45	38063 38067	0.9999889135360718	O
9102	is	46 48	38068 38070	0.9999885559082031	O
9103	the	49 52	38071 38074	0.9999886751174927	O
9104	primary	53 60	38075 38082	0.9999881982803345	O
9105	target	61 67	38083 38089	0.9999879598617554	O
9106	of	68 70	38090 38092	0.9999891519546509	O
9107	up	71 73	38093 38095	0.9999895095825195	O
9108	-	73 74	38095 38096	0.9999895095825195	O
9109	regulation	74 84	38096 38106	0.9999886751174927	O
9110	in	85 87	38107 38109	0.9999880790710449	O
9111	our	88 91	38110 38113	0.9998902082443237	O
9112	CRC	92 94	38114 38116	0.9999761581420898	O
9114	patients	96 104	38118 38126	0.9999790191650391	O
9115	,	105 106	38127 38128	0.999985933303833	O
9116	the	107 110	38129 38132	0.9999886751174927	O
9117	up	111 113	38133 38135	0.9999895095825195	O
9118	-	113 114	38135 38136	0.9999895095825195	O
9119	regulation	114 124	38136 38146	0.99998939037323	O
9120	of	125 127	38147 38149	0.9999891519546509	O
9121	other	128 133	38150 38155	0.9999878406524658	O
9122	genes	134 139	38156 38161	0.9999878406524658	O
9123	being	140 145	38162 38167	0.9999885559082031	O
9124	just	146 150	38168 38172	0.9999872446060181	O
9125	piggy	151 155	38173 38177	0.9999880790710449	O
9127	-	156 157	38178 38179	0.9999895095825195	O
9128	back	157 161	38179 38183	0.9999880790710449	O
9129	effects	162 169	38184 38191	0.9999881982803345	O
9130	.	170 171	38192 38193	0.9999724626541138	O
9131	However	0 7	38194 38201	0.999981164932251	O
9132	,	8 9	38202 38203	0.999987006187439	O
9133	also	10 14	38204 38208	0.9999840259552002	O
9134	the	15 18	38209 38212	0.9999861717224121	O
9135	up	19 21	38213 38215	0.9999858140945435	O
9136	-	21 22	38215 38216	0.9999877214431763	O
9137	regulation	22 32	38216 38226	0.9999855756759644	O
9138	of	33 35	38227 38229	0.9999868869781494	O
9139	the	36 39	38230 38233	0.9999864101409912	O
9140	CTNN1L1	40 46	38234 38240	0.9999837875366211	O
9146	transcript	48 57	38242 38251	0.9999873638153076	O
9148	could	59 64	38253 38258	0.9999834299087524	O
9149	be	65 67	38259 38261	0.999987006187439	O
9150	of	68 70	38262 38264	0.9999867677688599	O
9151	potential	71 80	38265 38274	0.9999839067459106	O
9152	functional	81 91	38275 38285	0.9999760389328003	O
9153	significance	92 104	38286 38298	0.9999861717224121	O
9154	for	105 108	38299 38302	0.9999815225601196	O
9155	CRC	109 111	38303 38305	0.9999688863754272	O
9157	development	113 124	38307 38318	0.9999774694442749	O
9158	.	125 126	38319 38320	0.9999531507492065	O
9159	CTNN1L1	0 6	38321 38327	0.9999828338623047	O
9165	shows	8 13	38329 38334	0.9999852180480957	O
9166	partial	14 21	38335 38342	0.9999868869781494	O
9167	homology	22 29	38343 38350	0.999987006187439	O
9169	to	31 33	38352 38354	0.9999873638153076	O
9170	the	34 37	38355 38358	0.9999876022338867	O
9171	known	38 43	38359 38364	0.9999802112579346	O
9172	colorectal	44 53	38365 38374	0.9999842643737793	O
9175	cancer	55 61	38376 38382	0.9999847412109375	O
9176	gene	62 66	38383 38387	0.9999862909317017	O
9177	beta	67 71	38388 38392	0.9999860525131226	O
9178	-	71 72	38392 38393	0.9999885559082031	O
9179	catenin	72 78	38393 38399	0.9999861717224121	O
9182	in	80 82	38401 38403	0.9999880790710449	O
9183	the	83 86	38404 38407	0.9999881982803345	O
9184	armadillo	87 95	38408 38416	0.9999855756759644	O
9187	repeat	97 103	38418 38424	0.9999847412109375	O
9188	region	104 110	38425 38431	0.9999881982803345	O
9189	and	111 114	38432 38435	0.9999864101409912	O
9190	has	115 118	38436 38439	0.9999864101409912	O
9191	a	119 120	38440 38441	0.9999879598617554	O
9192	nuclear	121 128	38442 38449	0.999984860420227	O
9193	localization	129 140	38450 38461	0.9999864101409912	O
9195	signal	142 148	38463 38469	0.999988317489624	O
9196	,	149 150	38470 38471	0.9999872446060181	O
9197	suggesting	151 161	38472 38482	0.9999852180480957	O
9198	that	162 166	38483 38487	0.9999874830245972	O
9199	it	167 169	38488 38490	0.9999874830245972	O
9200	could	170 175	38491 38496	0.9999814033508301	O
9201	play	176 180	38497 38501	0.9999872446060181	O
9202	an	181 183	38502 38504	0.9999881982803345	O
9203	important	184 193	38505 38514	0.9999868869781494	O
9204	role	194 198	38515 38519	0.999987006187439	O
9205	in	199 201	38520 38522	0.9999876022338867	O
9206	signal	202 208	38523 38529	0.9999856948852539	O
9207	transduction	209 220	38530 38541	0.9999879598617554	O
9209	to	222 224	38543 38545	0.9999856948852539	O
9210	the	225 228	38546 38549	0.9999877214431763	O
9211	nucleus	229 236	38550 38557	0.9999819993972778	O
9212	in	237 239	38558 38560	0.9999845027923584	O
9213	CRC	240 242	38561 38563	0.9999788999557495	O
9215	.	243 244	38564 38565	0.9999477863311768	O
9216	Also	0 4	38566 38570	0.9999847412109375	O
9217	up	5 7	38571 38573	0.9999881982803345	O
9218	-	7 8	38573 38574	0.9999887943267822	O
9219	regulation	8 18	38574 38584	0.9999873638153076	O
9220	of	19 21	38585 38587	0.9999884366989136	O
9221	the	22 25	38588 38591	0.9999881982803345	O
9222	E3	26 27	38592 38593	0.9999856948852539	O
9224	ubiquitin	29 37	38595 38603	0.9999871253967285	O
9228	ligase	39 44	38605 38610	0.9999872446060181	O
9231	Itchy	46 50	38612 38616	0.9999884366989136	O
9233	(	52 53	38618 38619	0.9999891519546509	O
9234	ITCH	54 57	38620 38623	0.9999864101409912	O
9236	)	58 59	38624 38625	0.99998939037323	O
9237	could	60 65	38626 38631	0.9999872446060181	O
9238	be	66 68	38632 38634	0.9999890327453613	O
9239	of	69 71	38635 38637	0.9999887943267822	O
9240	potential	72 81	38638 38647	0.9999876022338867	O
9241	importance	82 92	38648 38658	0.9999884366989136	O
9242	as	93 95	38659 38661	0.9999880790710449	O
9243	selective	96 105	38662 38671	0.9999871253967285	O
9244	ubiquitin	106 114	38672 38680	0.9999886751174927	O
9248	-	115 116	38681 38682	0.9999889135360718	O
9249	tagging	116 122	38682 38688	0.9999873638153076	O
9251	of	124 126	38690 38692	0.999988317489624	O
9252	signaling	127 136	38693 38702	0.9999583959579468	O
9253	proteins	137 145	38703 38711	0.9999814033508301	O
9254	for	146 149	38712 38715	0.999987006187439	O
9255	destruction	150 161	38716 38727	0.9999828338623047	O
9256	is	162 164	38728 38730	0.9999879598617554	O
9257	an	165 167	38731 38733	0.9999887943267822	O
9258	emerging	168 176	38734 38742	0.9999860525131226	O
9259	mechanism	177 186	38743 38752	0.9999865293502808	O
9260	in	187 189	38753 38755	0.9999871253967285	O
9261	cancer	190 196	38756 38762	0.9999818801879883	O
9262	biology	197 204	38763 38770	0.9999639987945557	O
9263	.	205 206	38771 38772	0.9999650716781616	O
9264	The	0 3	38773 38776	0.9999808073043823	O
9265	need	4 8	38777 38781	0.9999744892120361	O
9266	for	9 12	38782 38785	0.9999829530715942	O
9267	accelerated	13 24	38786 38797	0.9999736547470093	O
9268	protein	25 32	38798 38805	0.9999545812606812	O
9269	synthesis	33 42	38806 38815	0.9999819993972778	O
9270	in	43 45	38816 38818	0.9999805688858032	O
9271	cancer	46 52	38819 38825	0.999972939491272	O
9272	cells	53 58	38826 38831	0.9999406337738037	O
9273	is	59 61	38832 38834	0.9999788999557495	O
9274	reflected	62 71	38835 38844	0.9999774694442749	O
9275	by	72 74	38845 38847	0.999984622001648	O
9276	the	75 78	38848 38851	0.9999845027923584	O
9277	up	79 81	38852 38854	0.9999841451644897	O
9278	-	81 82	38854 38855	0.999985933303833	O
9279	regulation	82 92	38855 38865	0.9999831914901733	O
9280	of	93 95	38866 38868	0.9999849796295166	O
9281	the	96 99	38869 38872	0.9999836683273315	O
9282	translation	100 111	38873 38884	0.9999761581420898	O
9283	initiation	112 122	38885 38895	0.9999850988388062	O
9284	factor	123 129	38896 38902	0.9999860525131226	O
9285	EIF2S2	130 135	38903 38908	0.9999843835830688	O
9290	.	137 138	38910 38911	0.9999567270278931	O
9291	Remarkably	0 9	38912 38921	0.9999871253967285	O
9294	,	11 12	38923 38924	0.9999891519546509	O
9295	we	13 15	38925 38927	0.9999858140945435	O
9296	found	16 21	38928 38933	0.9999885559082031	O
9297	dramatic	22 30	38934 38942	0.9999877214431763	O
9298	down	31 35	38943 38947	0.9999886751174927	O
9299	-	35 36	38947 38948	0.9999897480010986	O
9300	regulation	36 46	38948 38958	0.9999890327453613	O
9301	against	47 54	38959 38966	0.9999886751174927	O
9302	the	55 58	38967 38970	0.9999897480010986	O
9303	regional	59 67	38971 38979	0.9999868869781494	O
9304	trend	68 73	38980 38985	0.9999885559082031	O
9305	of	74 76	38986 38988	0.9999895095825195	O
9306	C20orf110	77 85	38989 38997	0.99998939037323	O
9311	alias	87 92	38999 39004	0.9999885559082031	O
9312	p53	93 95	39005 39007	0.99998939037323	O
9314	-	96 97	39008 39009	0.9999892711639404	O
9315	inducible	97 105	39009 39017	0.9999889135360718	O
9318	protein	107 114	39019 39026	0.99998939037323	O
9319	2	115 116	39027 39028	0.9999887943267822	O
9320	(	117 118	39029 39030	0.9999892711639404	O
9321	TP53INP2	119 126	39031 39038	0.999988317489624	O
9327	)	128 129	39040 39041	0.9999898672103882	O
9328	whose	130 135	39042 39047	0.9999892711639404	O
9329	expression	136 146	39048 39058	0.9999877214431763	O
9330	is	147 149	39059 39061	0.9999895095825195	O
9331	usually	150 157	39062 39069	0.9999872446060181	O
9332	positively	158 168	39070 39080	0.9999886751174927	O
9333	controlled	169 179	39081 39091	0.99998939037323	O
9334	by	180 182	39092 39094	0.9999892711639404	O
9335	the	183 186	39095 39098	0.99998939037323	O
9336	p53	187 189	39099 39101	0.99998939037323	O
9338	protein	191 198	39103 39110	0.9999891519546509	O
9339	.	199 200	39111 39112	0.9999744892120361	O
9340	For	0 3	39113 39116	0.9999839067459106	O
9341	unknown	4 11	39117 39124	0.9999864101409912	O
9342	reasons	12 19	39125 39132	0.9999874830245972	O
9343	p53	20 22	39133 39135	0.9999862909317017	O
9345	seems	24 29	39137 39142	0.9999860525131226	O
9346	to	30 32	39143 39145	0.9999879598617554	O
9347	be	33 35	39146 39148	0.9999884366989136	O
9348	unable	36 42	39149 39155	0.9999812841415405	O
9349	to	43 45	39156 39158	0.9999876022338867	O
9350	induce	46 52	39159 39165	0.9999840259552002	O
9351	TP53INP2	53 60	39166 39173	0.999987006187439	O
9357	expression	62 72	39175 39185	0.9999879598617554	O
9358	in	73 75	39186 39188	0.9999871253967285	O
9359	the	76 79	39189 39192	0.9999866485595703	O
9360	majority	80 88	39193 39201	0.999984622001648	O
9361	of	89 91	39202 39204	0.9999849796295166	O
9362	CRCs	92 95	39205 39208	0.9999706745147705	O
9364	studied	97 104	39210 39217	0.9999858140945435	O
9365	here	105 109	39218 39222	0.9999840259552002	O
9366	.	110 111	39223 39224	0.9999889135360718	O
9367	*	112 113	39225 39226	0.9999878406524658	O
9368	*	113 114	39226 39227	0.999982476234436	O
9369	IGNORE	0 5	39228 39233	0.9999866485595703	O
9372	LINE	7 10	39235 39238	0.9999889135360718	O
9375	*	12 13	39240 39241	0.9999891519546509	O
9376	*	13 14	39241 39242	0.9999891519546509	O
9377	*	15 16	39243 39244	0.9999891519546509	O
9378	*	16 17	39244 39245	0.9999891519546509	O
9379	IGNORE	18 23	39246 39251	0.999988317489624	O
9382	LINE	25 28	39253 39256	0.9999891519546509	O
9385	*	30 31	39258 39259	0.9999889135360718	O
9386	*	31 32	39259 39260	0.9999889135360718	O
9387	*	33 34	39261 39262	0.9999890327453613	O
9388	*	34 35	39262 39263	0.9999889135360718	O
9389	IGNORE	36 41	39264 39269	0.9999878406524658	O
9392	LINE	43 46	39271 39274	0.9999891519546509	O
9395	*	48 49	39276 39277	0.9999890327453613	O
9396	*	49 50	39277 39278	0.9999890327453613	O
9397	Down	51 55	39279 39283	0.999988317489624	O
9398	-	55 56	39283 39284	0.99998939037323	O
9399	regulation	56 66	39284 39294	0.9999891519546509	O
9400	of	67 69	39295 39297	0.9999889135360718	O
9401	mRNA	70 73	39298 39301	0.9999889135360718	O
9403	expression	75 85	39303 39313	0.9999889135360718	O
9404	in	86 88	39314 39316	0.9999895095825195	O
9405	human	89 94	39317 39322	0.9999780654907227	O
9406	chromosomal	95 105	39323 39333	0.9999890327453613	O
9410	region	107 113	39335 39341	0.9999891519546509	O
9411	14q24	114 118	39342 39346	0.9999890327453613	O
9414	.	119 120	39347 39348	0.99998939037323	O
9415	1	120 121	39348 39349	0.9999890327453613	O
9416	-	121 122	39349 39350	0.99998939037323	O
9417	14q24	122 126	39350 39354	0.9999886751174927	O
9420	.	127 128	39355 39356	0.9999892711639404	O
9421	3	128 129	39356 39357	0.9999880790710449	O
9422	–	130 131	39358 39359	0.9999810457229614	O
9423	the	132 135	39360 39363	0.9999890327453613	O
9424	FOS	136 138	39364 39366	0.9999854564666748	O
9426	region	140 146	39368 39374	0.9999890327453613	O
9427	(	147 148	39375 39376	0.9999890327453613	O
9428	patient	149 156	39377 39384	0.9999860525131226	O
9429	counts	157 163	39385 39391	0.9999879598617554	O
9430	with	164 168	39392 39396	0.9999881982803345	O
9431	coordinate	169 179	39397 39407	0.9999864101409912	O
9432	up	180 182	39408 39410	0.9999891519546509	O
9433	-	182 183	39410 39411	0.99998939037323	O
9434	regulation	183 193	39411 39421	0.9999885559082031	O
9435	)	194 195	39422 39423	0.9999895095825195	O
9436	.	196 197	39424 39425	0.9999618530273438	O
9437	Grayscale	0 8	39426 39434	0.9999871253967285	O
9440	cross	10 15	39436 39441	0.9999881982803345	O
9441	-	15 16	39441 39442	0.9999891519546509	O
9442	comparison	16 26	39442 39452	0.9999867677688599	O
9443	plot	27 31	39453 39457	0.9999840259552002	O
9444	of	32 34	39458 39460	0.9999880790710449	O
9445	up	35 37	39461 39463	0.9999873638153076	O
9446	-	37 38	39463 39464	0.9999890327453613	O
9447	regulation	38 48	39464 39474	0.9999855756759644	O
9448	patterns	49 57	39475 39483	0.9999881982803345	O
9449	across	58 64	39484 39490	0.9999878406524658	O
9450	patients	65 73	39491 39499	0.9999814033508301	O
9451	(	74 75	39500 39501	0.9999891519546509	O
9452	analogous	76 85	39502 39511	0.9999878406524658	O
9453	to	86 88	39512 39514	0.9999891519546509	O
9454	Figures	89 95	39515 39521	0.9999867677688599	O
9456	7	97 98	39523 39524	0.9999887943267822	O
9457	,	99 100	39525 39526	0.9999886751174927	O
9458	10	101 103	39527 39529	0.9999877214431763	O
9459	,	104 105	39530 39531	0.9999886751174927	O
9460	13	106 108	39532 39534	0.9999868869781494	O
9461	)	109 110	39535 39536	0.9999892711639404	O
9462	.	111 112	39537 39538	0.9999794960021973	O
9463	View	0 4	39539 39543	0.9999786615371704	O
9464	this	5 9	39544 39548	0.9999858140945435	O
9465	plot	10 14	39549 39553	0.999981164932251	O
9466	in	15 17	39554 39556	0.9999843835830688	O
9467	conjunction	18 29	39557 39568	0.9999847412109375	O
9468	with	30 34	39569 39573	0.9999849796295166	O
9469	Figures	35 41	39574 39580	0.9999817609786987	O
9471	30	43 45	39582 39584	0.9999856948852539	O
9472	and	46 49	39585 39588	0.9999854564666748	O
9473	32	50 52	39589 39591	0.9999796152114868	O
9474	.	53 54	39592 39593	0.9999523162841797	O
9475	Down	0 4	39594 39598	0.9999864101409912	O
9476	-	4 5	39598 39599	0.9999889135360718	O
9477	regulation	5 15	39599 39609	0.9999866485595703	O
9478	of	16 18	39610 39612	0.9999879598617554	O
9479	mRNA	19 22	39613 39616	0.999987006187439	O
9481	expression	24 34	39618 39628	0.9999868869781494	O
9482	in	35 37	39629 39631	0.9999889135360718	O
9483	human	38 43	39632 39637	0.9999737739562988	O
9484	chromosomal	44 54	39638 39648	0.9999890327453613	O
9488	region	56 62	39650 39656	0.9999892711639404	O
9489	14q24	63 67	39657 39661	0.999988317489624	O
9492	.	68 69	39662 39663	0.99998939037323	O
9493	1	69 70	39663 39664	0.9999890327453613	O
9494	-	70 71	39664 39665	0.99998939037323	O
9495	14q24	71 75	39665 39669	0.9999885559082031	O
9498	.	76 77	39670 39671	0.9999892711639404	O
9499	3	77 78	39671 39672	0.9999880790710449	O
9500	–	79 80	39673 39674	0.999981164932251	O
9501	the	81 84	39675 39678	0.9999890327453613	O
9502	FOS	85 87	39679 39681	0.9999862909317017	O
9504	region	89 95	39683 39689	0.9999890327453613	O
9505	(	96 97	39690 39691	0.99998939037323	O
9506	patient	98 105	39692 39699	0.9999874830245972	O
9507	counts	106 112	39700 39706	0.999988317489624	O
9508	with	113 117	39707 39711	0.9999885559082031	O
9509	coordinate	118 128	39712 39722	0.999985933303833	O
9510	down	129 133	39723 39727	0.9999886751174927	O
9511	-	133 134	39727 39728	0.99998939037323	O
9512	regulation	134 144	39728 39738	0.9999881982803345	O
9513	)	145 146	39739 39740	0.9999896287918091	O
9514	.	147 148	39741 39742	0.9999674558639526	O
9515	Grayscale	0 8	39743 39751	0.9999871253967285	O
9518	cross	10 15	39753 39758	0.9999881982803345	O
9519	-	15 16	39758 39759	0.9999890327453613	O
9520	comparison	16 26	39759 39769	0.9999866485595703	O
9521	plot	27 31	39770 39774	0.9999840259552002	O
9522	of	32 34	39775 39777	0.9999879598617554	O
9523	down	35 39	39778 39782	0.9999858140945435	O
9524	-	39 40	39782 39783	0.9999890327453613	O
9525	regulation	40 50	39783 39793	0.9999850988388062	O
9526	patterns	51 59	39794 39802	0.9999878406524658	O
9527	across	60 66	39803 39809	0.9999877214431763	O
9528	patients	67 75	39810 39818	0.9999815225601196	O
9529	(	76 77	39819 39820	0.9999891519546509	O
9530	analogous	78 87	39821 39830	0.9999878406524658	O
9531	to	88 90	39831 39833	0.9999891519546509	O
9532	Figures	91 97	39834 39840	0.9999865293502808	O
9534	8	99 100	39842 39843	0.9999890327453613	O
9535	,	101 102	39844 39845	0.9999886751174927	O
9536	11	103 105	39846 39848	0.999988317489624	O
9537	,	106 107	39849 39850	0.9999886751174927	O
9538	14	108 110	39851 39853	0.9999880790710449	O
9539	)	111 112	39854 39855	0.99998939037323	O
9540	.	113 114	39856 39857	0.9999798536300659	O
9541	View	0 4	39858 39862	0.9999790191650391	O
9542	this	5 9	39863 39867	0.999985933303833	O
9543	plot	10 14	39868 39872	0.9999817609786987	O
9544	in	15 17	39873 39875	0.999984622001648	O
9545	conjunction	18 29	39876 39887	0.9999847412109375	O
9546	with	30 34	39888 39892	0.9999850988388062	O
9547	Figures	35 41	39893 39899	0.9999818801879883	O
9549	30	43 45	39901 39903	0.9999858140945435	O
9550	and	46 49	39904 39907	0.9999855756759644	O
9551	31	50 52	39908 39910	0.9999830722808838	O
9552	.	53 54	39911 39912	0.9999555349349976	O
9553	Note	0 4	39913 39917	0.9999855756759644	O
9554	,	5 6	39918 39919	0.9999880790710449	O
9555	that	7 11	39920 39924	0.9999885559082031	O
9556	many	12 16	39925 39929	0.9999866485595703	O
9557	more	17 21	39930 39934	0.9999860525131226	O
9558	patients	22 30	39935 39943	0.9999808073043823	O
9559	show	31 35	39944 39948	0.9999885559082031	O
9560	down	36 40	39949 39953	0.9999887943267822	O
9561	-	40 41	39953 39954	0.9999892711639404	O
9562	regulation	41 51	39954 39964	0.9999885559082031	O
9563	as	52 54	39965 39967	0.99998939037323	O
9564	indicated	55 64	39968 39977	0.9999892711639404	O
9565	by	65 67	39978 39980	0.99998939037323	O
9566	dark	68 72	39981 39985	0.9999892711639404	O
9567	spots	73 78	39986 39991	0.9999892711639404	O
9568	in	79 81	39992 39994	0.99998939037323	O
9569	this	82 86	39995 39999	0.99998939037323	O
9570	plot	87 91	40000 40004	0.9999874830245972	O
9571	than	92 96	40005 40009	0.999988317489624	O
9572	up	97 99	40010 40012	0.9999887943267822	O
9573	-	99 100	40012 40013	0.9999891519546509	O
9574	regulation	100 110	40013 40023	0.9999885559082031	O
9575	as	111 113	40024 40026	0.9999889135360718	O
9576	indicated	114 123	40027 40036	0.9999889135360718	O
9577	by	124 126	40037 40039	0.9999890327453613	O
9578	dark	127 131	40040 40044	0.9999890327453613	O
9579	spots	132 137	40045 40050	0.9999891519546509	O
9580	in	138 140	40051 40053	0.9999891519546509	O
9581	Figure	141 147	40054 40060	0.9999876022338867	O
9582	31	148 150	40061 40063	0.9999881982803345	O
9583	.	151 152	40064 40065	0.9999812841415405	O
9584	This	0 4	40066 40070	0.9999876022338867	O
9585	region	5 11	40071 40077	0.9999836683273315	O
9586	has	12 15	40078 40081	0.999987006187439	O
9587	been	16 20	40082 40086	0.9999876022338867	O
9588	reported	21 29	40087 40095	0.9999861717224121	O
9589	in	30 32	40096 40098	0.9999876022338867	O
9590	other	33 38	40099 40104	0.999984622001648	O
9591	studies	39 46	40105 40112	0.9999809265136719	O
9592	to	47 49	40113 40115	0.9999873638153076	O
9593	be	50 52	40116 40118	0.9999886751174927	O
9594	frequently	53 63	40119 40129	0.9999874830245972	O
9595	deleted	64 71	40130 40137	0.9999855756759644	O
9596	in	72 74	40138 40140	0.9999868869781494	O
9597	colon	75 79	40141 40145	0.9999778270721436	O
9599	cancer	81 87	40147 40153	0.999984622001648	O
9600	metastases	88 97	40154 40163	0.9999861717224121	O
9603	(	99 100	40165 40166	0.9999885559082031	O
9604	see	101 104	40167 40170	0.999984860420227	O
9605	Table	105 110	40171 40176	0.9999862909317017	O
9606	1	111 112	40177 40178	0.9999879598617554	O
9607	)	113 114	40179 40180	0.9999887943267822	O
9608	.	115 116	40181 40182	0.9999736547470093	O
9609	The	0 3	40183 40186	0.9999881982803345	O
9610	FOS	4 6	40187 40189	0.9999829530715942	O
9612	oncogene	8 15	40191 40198	0.9999885559082031	O
9615	is	17 19	40200 40202	0.9999885559082031	O
9616	the	20 23	40203 40206	0.9999891519546509	O
9617	5th	24 27	40207 40210	0.999984622001648	O
9618	gene	28 32	40211 40215	0.9999877214431763	O
9619	from	33 37	40216 40220	0.9999890327453613	O
9620	the	38 41	40221 40224	0.9999895095825195	O
9621	right	42 47	40225 40230	0.9999876022338867	O
9622	and	48 51	40231 40234	0.999987006187439	O
9623	is	52 54	40235 40237	0.9999887943267822	O
9624	one	55 58	40238 40241	0.9999892711639404	O
9625	of	59 61	40242 40244	0.9999887943267822	O
9626	the	62 65	40245 40248	0.9999889135360718	O
9627	most	66 70	40249 40253	0.9999887943267822	O
9628	strongly	71 79	40254 40262	0.9999858140945435	O
9629	down	80 84	40263 40267	0.9999855756759644	O
9630	-	84 85	40267 40268	0.9999891519546509	O
9631	regulated	85 94	40268 40277	0.9999867677688599	O
9632	genes	95 100	40278 40283	0.9999881982803345	O
9633	in	101 103	40284 40286	0.9999885559082031	O
9634	this	104 108	40287 40291	0.9999887943267822	O
9635	region	109 115	40292 40298	0.9999873638153076	O
9636	.	116 117	40299 40300	0.9999659061431885	O
9637	Note	0 4	40301 40305	0.9999796152114868	O
9638	the	5 8	40306 40309	0.9999880790710449	O
9639	expression	9 19	40310 40320	0.9999871253967285	O
9640	of	20 22	40321 40323	0.9999885559082031	O
9641	MLH3	23 26	40324 40327	0.9999868869781494	O
9645	,	28 29	40329 40330	0.9999889135360718	O
9646	KIAA0317	30 37	40331 40338	0.999988317489624	O
9652	,	39 40	40340 40341	0.9999891519546509	O
9653	KIAA0440	41 48	40342 40349	0.999988317489624	O
9659	/	49 50	40350 40351	0.9999886751174927	O
9660	SIPA1L1	50 56	40351 40357	0.9999886751174927	O
9666	,	58 59	40359 40360	0.9999891519546509	O
9667	NUMB	60 63	40361 40364	0.9999884366989136	O
9670	,	65 66	40366 40367	0.9999891519546509	O
9671	SYNJ2BP	67 73	40368 40374	0.9999887943267822	O
9678	and	75 78	40376 40379	0.9999887943267822	O
9679	PSEN1	79 83	40380 40384	0.9999877214431763	O
9682	.	85 86	40386 40387	0.9999891519546509	O
9683	*	87 88	40388 40389	0.999988317489624	O
9684	*	88 89	40389 40390	0.9999793767929077	O
9685	IGNORE	0 5	40391 40396	0.9999861717224121	O
9688	LINE	7 10	40398 40401	0.9999886751174927	O
9691	*	12 13	40403 40404	0.9999891519546509	O
9692	*	13 14	40404 40405	0.9999891519546509	O
9693	*	15 16	40406 40407	0.9999891519546509	O
9694	*	16 17	40407 40408	0.9999891519546509	O
9695	IGNORE	18 23	40409 40414	0.9999878406524658	O
9698	LINE	25 28	40416 40419	0.9999891519546509	O
9701	*	30 31	40421 40422	0.9999889135360718	O
9702	*	31 32	40422 40423	0.9999889135360718	O
9703	*	33 34	40424 40425	0.9999887943267822	O
9704	*	34 35	40425 40426	0.9999887943267822	O
9705	IGNORE	36 41	40427 40432	0.9999874830245972	O
9708	LINE	43 46	40434 40437	0.9999889135360718	O
9711	*	48 49	40439 40440	0.9999887943267822	O
9712	*	49 50	40440 40441	0.9999887943267822	O
9713	Discussion	51 60	40442 40451	0.9999885559082031	O
9716	Global	62 68	40453 40459	0.999987006187439	O
9717	analysis	69 77	40460 40468	0.9999890327453613	O
9718	of	78 80	40469 40471	0.9999890327453613	O
9719	chromosomal	81 91	40472 40482	0.9999887943267822	O
9723	regions	93 100	40484 40491	0.9999885559082031	O
9724	with	101 105	40492 40496	0.9999884366989136	O
9725	expression	106 116	40497 40507	0.9999878406524658	O
9726	gain	117 121	40508 40512	0.9999889135360718	O
9727	or	122 124	40513 40515	0.9999887943267822	O
9728	loss	125 129	40516 40520	0.9999880790710449	O
9729	We	130 132	40521 40523	0.9999850988388062	O
9730	found	133 138	40524 40529	0.9999871253967285	O
9731	that	139 143	40530 40534	0.9999890327453613	O
9732	25	144 146	40535 40537	0.9999817609786987	O
9733	%	147 148	40538 40539	0.9999880790710449	O
9734	of	149 151	40540 40542	0.9999887943267822	O
9735	the	152 155	40543 40546	0.999988317489624	O
9736	genes	156 161	40547 40552	0.999981164932251	O
9737	lie	162 165	40553 40556	0.9999879598617554	O
9738	in	166 168	40557 40559	0.9999891519546509	O
9739	regions	169 176	40560 40567	0.9999877214431763	O
9740	that	177 181	40568 40572	0.9999884366989136	O
9741	are	182 185	40573 40576	0.9999886751174927	O
9742	affected	186 194	40577 40585	0.9999877214431763	O
9743	by	195 197	40586 40588	0.9999891519546509	O
9744	expression	198 208	40589 40599	0.9999879598617554	O
9745	imbalance	209 217	40600 40608	0.99998939037323	O
9748	in	219 221	40610 40612	0.9999884366989136	O
9749	colon	222 226	40613 40617	0.9999828338623047	O
9751	cancer	228 234	40619 40625	0.9999858140945435	O
9752	.	235 236	40626 40627	0.9999542236328125	O
9753	This	0 4	40628 40632	0.999984622001648	O
9754	does	5 9	40633 40637	0.9999837875366211	O
9755	not	10 13	40638 40641	0.999983549118042	O
9756	mean	14 18	40642 40646	0.9999817609786987	O
9757	that	19 23	40647 40651	0.9999879598617554	O
9758	25	24 26	40652 40654	0.9999804496765137	O
9759	%	27 28	40655 40656	0.9999874830245972	O
9760	of	29 31	40657 40659	0.9999880790710449	O
9761	the	32 35	40660 40663	0.9999865293502808	O
9762	genes	36 41	40664 40669	0.9999827146530151	O
9763	are	42 45	40670 40673	0.9999876022338867	O
9764	misregulated	46 57	40674 40685	0.9999881982803345	O
9769	as	59 61	40687 40689	0.9999861717224121	O
9770	many	62 66	40690 40694	0.9999879598617554	O
9771	genes	67 72	40695 40700	0.9999867677688599	O
9772	that	73 77	40701 40705	0.9999880790710449	O
9773	fall	78 82	40706 40710	0.9999873638153076	O
9774	into	83 87	40711 40715	0.9999877214431763	O
9775	these	88 93	40716 40721	0.9999879598617554	O
9776	regions	94 101	40722 40729	0.9999842643737793	O
9777	are	102 105	40730 40733	0.9999873638153076	O
9778	not	106 109	40734 40737	0.999987006187439	O
9779	expressed	110 119	40738 40747	0.9999855756759644	O
9780	at	120 122	40748 40750	0.9999880790710449	O
9781	all	123 126	40751 40754	0.9999864101409912	O
9782	in	127 129	40755 40757	0.9999837875366211	O
9783	tumors	130 136	40758 40764	0.9999754428863525	O
9784	and	137 140	40765 40768	0.9999799728393555	O
9785	in	141 143	40769 40771	0.999985933303833	O
9786	normal	144 150	40772 40778	0.9999642372131348	O
9787	epithelium	151 160	40779 40788	0.999984622001648	O
9791	of	162 164	40790 40792	0.9999831914901733	O
9792	the	165 168	40793 40796	0.9999821186065674	O
9793	colon	169 173	40797 40801	0.9999731779098511	O
9795	.	175 176	40803 40804	0.9999333620071411	O
9796	Additionally	0 12	40805 40817	0.9999837875366211	O
9797	,	13 14	40818 40819	0.999988317489624	O
9798	we	15 17	40820 40822	0.9999821186065674	O
9799	note	18 22	40823 40827	0.999985933303833	O
9800	that	23 27	40828 40832	0.9999892711639404	O
9801	these	28 33	40833 40838	0.999988317489624	O
9802	numbers	34 41	40839 40846	0.9999854564666748	O
9803	are	42 45	40847 40850	0.9999887943267822	O
9804	probably	46 54	40851 40859	0.9999886751174927	O
9805	an	55 57	40860 40862	0.9999895095825195	O
9806	upper	58 63	40863 40868	0.9999887943267822	O
9807	limit	64 69	40869 40874	0.9999886751174927	O
9808	because	70 77	40875 40882	0.9999880790710449	O
9809	the	78 81	40883 40886	0.9999892711639404	O
9810	sliding	82 89	40887 40894	0.9999881982803345	O
9811	window	90 96	40895 40901	0.9999889135360718	O
9812	approach	97 105	40902 40910	0.9999879598617554	O
9813	probably	106 114	40911 40919	0.9999886751174927	O
9814	included	115 123	40920 40928	0.9999891519546509	O
9815	several	124 131	40929 40936	0.9999880790710449	O
9816	genes	132 137	40937 40942	0.9999862909317017	O
9817	in	138 140	40943 40945	0.9999890327453613	O
9818	close	141 146	40946 40951	0.9999887943267822	O
9819	proximity	147 156	40952 40961	0.9999890327453613	O
9820	to	157 159	40962 40964	0.99998939037323	O
9821	the	160 163	40965 40968	0.9999892711639404	O
9822	boundaries	164 174	40969 40979	0.9999886751174927	O
9823	of	175 177	40980 40982	0.99998939037323	O
9824	misexpressed	178 189	40983 40994	0.9999884366989136	O
9827	regions	191 198	40996 41003	0.9999890327453613	O
9828	.	199 200	41004 41005	0.9999607801437378	O
9829	Nevertheless	0 12	41006 41018	0.9999767541885376	O
9830	,	13 14	41019 41020	0.9999872446060181	O
9831	the	15 18	41021 41024	0.999987006187439	O
9832	number	19 25	41025 41031	0.9999860525131226	O
9833	of	26 28	41032 41034	0.9999874830245972	O
9834	regions	29 36	41035 41042	0.9999845027923584	O
9835	of	37 39	41043 41045	0.9999874830245972	O
9836	imbalanced	40 49	41046 41055	0.9999876022338867	O
9840	expression	51 61	41057 41067	0.9999815225601196	O
9841	is	62 64	41068 41070	0.9999864101409912	O
9842	remarkable	65 75	41071 41081	0.9999850988388062	O
9843	and	76 79	41082 41085	0.9999828338623047	O
9844	suggest	80 87	41086 41093	0.9999815225601196	O
9845	that	88 92	41094 41098	0.9999874830245972	O
9846	there	93 98	41099 41104	0.9999874830245972	O
9847	is	99 101	41105 41107	0.9999877214431763	O
9848	extensive	102 111	41108 41117	0.9999769926071167	O
9849	regulation	112 122	41118 41128	0.9999688863754272	O
9850	in	123 125	41129 41131	0.9999850988388062	O
9851	CRC	126 128	41132 41134	0.9999728202819824	O
9853	at	130 132	41136 41138	0.9999876022338867	O
9854	the	133 136	41139 41142	0.9999885559082031	O
9855	genomic	137 143	41143 41149	0.9999878406524658	O
9858	level	145 150	41151 41156	0.9999872446060181	O
9859	.	151 152	41157 41158	0.9999561309814453	O
9860	Recently	0 8	41159 41167	0.9999692440032959	O
9861	,	9 10	41168 41169	0.9999802112579346	O
9862	Nakao	11 15	41170 41174	0.999977707862854	O
9865	et	17 19	41176 41178	0.9999798536300659	O
9866	al	20 22	41179 41181	0.9999808073043823	O
9867	.	23 24	41182 41183	0.9999535083770752	O
9868	estimated	0 9	41184 41193	0.9999855756759644	O
9869	from	10 14	41194 41198	0.9999872446060181	O
9870	genome	15 21	41199 41205	0.9999818801879883	O
9871	-	21 22	41205 41206	0.9999887943267822	O
9872	wide	22 26	41206 41210	0.9999853372573853	O
9873	array	27 32	41211 41216	0.9999860525131226	O
9874	CGH	33 35	41217 41219	0.9999860525131226	O
9877	data	37 41	41221 41225	0.9999864101409912	O
9878	that	42 46	41226 41230	0.999988317489624	O
9879	~	47 48	41231 41232	0.9999873638153076	O
9880	17	48 50	41232 41234	0.9999845027923584	O
9881	%	51 52	41235 41236	0.9999884366989136	O
9882	of	53 55	41237 41239	0.999988317489624	O
9883	the	56 59	41240 41243	0.9999881982803345	O
9884	human	60 65	41244 41249	0.9999189376831055	O
9885	genome	66 72	41250 41256	0.9999698400497437	O
9886	is	73 75	41257 41259	0.9999881982803345	O
9887	affected	76 84	41260 41268	0.9999876022338867	O
9888	by	85 87	41269 41271	0.9999885559082031	O
9889	DNA	88 91	41272 41275	0.9999864101409912	O
9890	copy	92 96	41276 41280	0.9999881982803345	O
9891	number	97 103	41281 41287	0.9999879598617554	O
9892	changes	104 111	41288 41295	0.9999878406524658	O
9893	in	112 114	41296 41298	0.9999885559082031	O
9894	CRC	115 117	41299 41301	0.9999827146530151	O
9896	[	119 120	41303 41304	0.9999890327453613	O
9897	23	120 122	41304 41306	0.9999872446060181	O
9898	]	122 123	41306 41307	0.9999885559082031	O
9899	.	124 125	41308 41309	0.9999754428863525	O
9900	Prior	0 5	41310 41315	0.9999834299087524	O
9901	to	6 8	41316 41318	0.9999884366989136	O
9902	a	9 10	41319 41320	0.9999886751174927	O
9903	more	11 15	41321 41325	0.9999877214431763	O
9904	detailed	16 24	41326 41334	0.9999872446060181	O
9905	analysis	25 33	41335 41343	0.9999873638153076	O
9906	of	34 36	41344 41346	0.9999886751174927	O
9907	individual	37 47	41347 41357	0.9999872446060181	O
9908	regions	48 55	41358 41365	0.999984860420227	O
9909	in	56 58	41366 41368	0.999988317489624	O
9910	this	59 63	41369 41373	0.9999885559082031	O
9911	study	64 69	41374 41379	0.9999860525131226	O
9912	,	70 71	41380 41381	0.9999874830245972	O
9913	this	72 76	41382 41386	0.9999880790710449	O
9914	suggested	77 86	41387 41396	0.9999860525131226	O
9915	that	87 91	41397 41401	0.9999890327453613	O
9916	not	92 95	41402 41405	0.9999874830245972	O
9917	all	96 99	41406 41409	0.9999873638153076	O
9918	regional	100 108	41410 41418	0.9999825954437256	O
9919	expression	109 119	41419 41429	0.9999808073043823	O
9920	changes	120 127	41430 41437	0.9999876022338867	O
9921	in	128 130	41438 41440	0.9999871253967285	O
9922	CRC	131 133	41441 41443	0.9999759197235107	O
9924	will	135 139	41445 41449	0.9999874830245972	O
9925	be	140 142	41450 41452	0.9999887943267822	O
9926	explainable	143 153	41453 41463	0.9999873638153076	O
9928	by	155 157	41465 41467	0.9999889135360718	O
9929	DNA	158 161	41468 41471	0.999988317489624	O
9930	copy	162 166	41472 41476	0.9999891519546509	O
9931	number	167 173	41477 41483	0.9999886751174927	O
9932	aberrations	174 184	41484 41494	0.99998939037323	O
9935	.	186 187	41496 41497	0.9999691247940063	O
9936	There	0 5	41498 41503	0.999984860420227	O
9937	are	6 9	41504 41507	0.9999849796295166	O
9938	only	10 14	41508 41512	0.9999808073043823	O
9939	slightly	15 23	41513 41521	0.9999815225601196	O
9940	more	24 28	41522 41526	0.9999836683273315	O
9941	genes	29 34	41527 41532	0.9999823570251465	O
9942	with	35 39	41533 41537	0.9999872446060181	O
9943	expression	40 50	41538 41548	0.9999873638153076	O
9944	loss	51 55	41549 41553	0.9999871253967285	O
9945	than	56 60	41554 41558	0.9999822378158569	O
9946	regions	61 68	41559 41566	0.9999788999557495	O
9947	with	69 73	41567 41571	0.9999873638153076	O
9948	expression	74 84	41572 41582	0.9999874830245972	O
9949	gain	85 89	41583 41587	0.9999871253967285	O
9950	.	90 91	41588 41589	0.999948263168335	O
9951	One	0 3	41590 41593	0.999943733215332	O
9952	can	4 7	41594 41597	0.9999722242355347	O
9953	argue	8 13	41598 41603	0.999961256980896	O
9954	that	14 18	41604 41608	0.9999825954437256	O
9955	a	19 20	41609 41610	0.9999786615371704	O
9956	tumor	21 26	41611 41616	0.9999779462814331	O
9957	ought	27 32	41617 41622	0.9999792575836182	O
9958	to	33 35	41623 41625	0.9999855756759644	O
9959	show	36 40	41626 41630	0.9999852180480957	O
9960	a	41 42	41631 41632	0.999987006187439	O
9961	higher	43 49	41633 41639	0.999984622001648	O
9962	frequency	50 59	41640 41649	0.9999854564666748	O
9963	of	60 62	41650 41652	0.9999872446060181	O
9964	expression	63 73	41653 41663	0.9999865293502808	O
9965	loss	74 78	41664 41668	0.9999871253967285	O
9966	than	79 83	41669 41673	0.9999845027923584	O
9967	expression	84 94	41674 41684	0.9999868869781494	O
9968	gain	95 99	41685 41689	0.9999877214431763	O
9969	.	100 101	41690 41691	0.9999454021453857	O
9970	Reasons	0 6	41692 41698	0.9999818801879883	O
9972	are	8 11	41700 41703	0.9999862909317017	O
9973	that	12 16	41704 41708	0.9999879598617554	O
9974	there	17 22	41709 41714	0.9999886751174927	O
9975	should	23 29	41715 41721	0.9999864101409912	O
9976	be	30 32	41722 41724	0.9999890327453613	O
9977	a	33 34	41725 41726	0.9999890327453613	O
9978	tendency	35 43	41727 41735	0.999985933303833	O
9979	to	44 46	41736 41738	0.9999890327453613	O
9980	lose	47 51	41739 41743	0.9999878406524658	O
9981	tumor	52 57	41744 41749	0.9999865293502808	O
9982	suppressor	58 67	41750 41759	0.9999881982803345	O
9984	genes	69 74	41761 41766	0.9999895095825195	O
9985	selectively	75 85	41767 41777	0.9999891519546509	O
9987	and	87 90	41779 41782	0.9999877214431763	O
9988	to	91 93	41783 41785	0.9999891519546509	O
9989	lose	94 98	41786 41790	0.9999887943267822	O
9990	non	99 102	41791 41794	0.9999890327453613	O
9991	-	102 103	41794 41795	0.9999892711639404	O
9992	essential	103 112	41795 41804	0.9999874830245972	O
9993	genes	113 118	41805 41810	0.9999892711639404	O
9994	(	119 120	41811 41812	0.99998939037323	O
9995	genomic	121 127	41813 41819	0.9999895095825195	O
9998	ballast	129 135	41821 41827	0.9999887943267822	O
10000	)	137 138	41829 41830	0.9999895095825195	O
10001	as	139 141	41831 41833	0.9999886751174927	O
10002	a	142 143	41834 41835	0.99998939037323	O
10003	side	144 148	41836 41840	0.9999886751174927	O
10004	effect	149 155	41841 41847	0.9999890327453613	O
10005	.	156 157	41848 41849	0.9999765157699585	O
10006	If	0 2	41850 41852	0.9999696016311646	O
10007	transcription	3 16	41853 41866	0.9999762773513794	O
10008	would	17 22	41867 41872	0.9999819993972778	O
10009	be	23 25	41873 41875	0.9999871253967285	O
10010	a	26 27	41876 41877	0.9999879598617554	O
10011	process	28 35	41878 41885	0.999985933303833	O
10012	that	36 40	41886 41890	0.9999876022338867	O
10013	is	41 43	41891 41893	0.9999878406524658	O
10014	predominantly	44 57	41894 41907	0.9999856948852539	O
10015	driven	58 64	41908 41914	0.9999881982803345	O
10016	by	65 67	41915 41917	0.9999887943267822	O
10017	positive	68 76	41918 41926	0.9999850988388062	O
10018	regulation	77 87	41927 41937	0.9999865293502808	O
10019	of	88 90	41938 41940	0.9999886751174927	O
10020	transcriptional	91 105	41941 41955	0.9999862909317017	O
10022	activators	107 116	41957 41966	0.9999877214431763	O
10025	,	118 119	41968 41969	0.9999853372573853	O
10026	one	120 123	41970 41973	0.9999842643737793	O
10027	would	124 129	41974 41979	0.9999862909317017	O
10028	assume	130 136	41980 41986	0.9999810457229614	O
10029	that	137 141	41987 41991	0.9999879598617554	O
10030	any	142 145	41992 41995	0.999985933303833	O
10031	partial	146 153	41996 42003	0.9999878406524658	O
10032	genome	154 160	42004 42010	0.9999821186065674	O
10033	loss	161 165	42011 42015	0.9999871253967285	O
10034	results	166 173	42016 42023	0.9999879598617554	O
10035	in	174 176	42024 42026	0.9999886751174927	O
10036	a	177 178	42027 42028	0.9999884366989136	O
10037	slow	179 183	42029 42033	0.9999866485595703	O
10038	down	184 188	42034 42038	0.9999874830245972	O
10039	of	189 191	42039 42041	0.9999884366989136	O
10040	transcription	192 205	42042 42055	0.9999809265136719	O
10041	.	206 207	42056 42057	0.9999687671661377	O
10042	In	0 2	42058 42060	0.9999865293502808	O
10043	the	3 6	42061 42064	0.9999877214431763	O
10044	light	7 12	42065 42070	0.9999850988388062	O
10045	of	13 15	42071 42073	0.9999873638153076	O
10046	these	16 21	42074 42079	0.9999867677688599	O
10047	considerations	22 36	42080 42094	0.999981164932251	O
10048	,	37 38	42095 42096	0.9999866485595703	O
10049	an	39 41	42097 42099	0.9999881982803345	O
10050	equally	42 49	42100 42107	0.9999818801879883	O
10051	high	50 54	42108 42112	0.9999867677688599	O
10052	number	55 61	42113 42119	0.9999868869781494	O
10053	of	62 64	42120 42122	0.9999877214431763	O
10054	regions	65 72	42123 42130	0.9999854564666748	O
10055	with	73 77	42131 42135	0.9999874830245972	O
10056	expression	78 88	42136 42146	0.9999861717224121	O
10057	gain	89 93	42147 42151	0.9999880790710449	O
10058	can	94 97	42152 42155	0.9999866485595703	O
10059	be	98 100	42156 42158	0.9999880790710449	O
10060	interpreted	101 112	42159 42170	0.9999868869781494	O
10061	in	113 115	42171 42173	0.9999881982803345	O
10062	two	116 119	42174 42177	0.999981164932251	O
10063	ways	120 124	42178 42182	0.9999853372573853	O
10064	.	125 126	42183 42184	0.9999740123748779	O
10065	Either	0 6	42185 42191	0.999984622001648	O
10066	positive	7 15	42192 42200	0.999984860420227	O
10067	selection	16 25	42201 42210	0.9999853372573853	O
10068	drives	26 32	42211 42217	0.999984622001648	O
10069	expression	33 43	42218 42228	0.9999850988388062	O
10070	gain	44 48	42229 42233	0.9999861717224121	O
10071	of	49 51	42234 42236	0.9999874830245972	O
10072	some	52 56	42237 42241	0.9999852180480957	O
10073	regions	57 64	42242 42249	0.9999797344207764	O
10074	in	65 67	42250 42252	0.9999856948852539	O
10075	cancer	68 74	42253 42259	0.9999674558639526	O
10076	cells	75 80	42260 42265	0.9999812841415405	O
10077	,	81 82	42266 42267	0.9999853372573853	O
10078	or	83 85	42268 42270	0.9999861717224121	O
10079	a	86 87	42271 42272	0.9999878406524658	O
10080	default	88 95	42273 42280	0.9999818801879883	O
10081	phenotype	96 104	42281 42289	0.9999880790710449	O
10084	of	106 108	42291 42293	0.9999877214431763	O
10085	transcription	109 122	42294 42307	0.9999849796295166	O
10086	suppression	123 134	42308 42319	0.9999872446060181	O
10087	dominates	135 143	42320 42328	0.9999858140945435	O
10089	in	145 147	42330 42332	0.9999866485595703	O
10090	normal	148 154	42333 42339	0.9999309778213501	O
10091	cells	155 160	42340 42345	0.9999819993972778	O
10092	which	161 166	42346 42351	0.9999873638153076	O
10093	is	167 169	42352 42354	0.9999871253967285	O
10094	relaxed	170 177	42355 42362	0.9999769926071167	O
10095	during	178 184	42363 42369	0.9999827146530151	O
10096	tumor	185 190	42370 42375	0.9999760389328003	O
10097	cell	191 195	42376 42380	0.9999828338623047	O
10098	development	196 207	42381 42392	0.9999560117721558	O
10099	.	208 209	42393 42394	0.9999196529388428	O
10100	Gene	0 4	42395 42399	0.9999873638153076	O
10101	expression	5 15	42400 42410	0.9999853372573853	O
10102	in	16 18	42411 42413	0.9999884366989136	O
10103	chromosomal	19 29	42414 42424	0.9999885559082031	O
10107	regions	31 38	42426 42433	0.9999874830245972	O
10108	with	39 43	42434 42438	0.9999867677688599	O
10109	frequent	44 52	42439 42447	0.9999873638153076	O
10110	DNA	53 56	42448 42451	0.9999872446060181	O
10111	copy	57 61	42452 42456	0.9999889135360718	O
10112	number	62 68	42457 42463	0.9999881982803345	O
10113	changes	69 76	42464 42471	0.9999881982803345	O
10114	in	77 79	42472 42474	0.9999881982803345	O
10115	CRC	80 82	42475 42477	0.9999823570251465	O
10117	Most	84 88	42479 42483	0.9999839067459106	O
10118	studies	89 96	42484 42491	0.9999843835830688	O
10119	reported	97 105	42492 42500	0.9999876022338867	O
10120	frequent	106 114	42501 42509	0.9999872446060181	O
10121	gains	115 120	42510 42515	0.9999880790710449	O
10122	of	121 123	42516 42518	0.9999891519546509	O
10123	chromosome	124 134	42519 42529	0.9999889135360718	O
10124	7	135 136	42530 42531	0.9999884366989136	O
10125	,	137 138	42532 42533	0.9999891519546509	O
10126	8q	139 140	42534 42535	0.9999881982803345	O
10128	,	142 143	42537 42538	0.9999890327453613	O
10129	13q	144 146	42539 42541	0.999987006187439	O
10131	,	148 149	42543 42544	0.9999891519546509	O
10132	20q	150 152	42545 42547	0.9999866485595703	O
10134	and	154 157	42549 42552	0.9999887943267822	O
10135	losses	158 164	42553 42559	0.9999868869781494	O
10136	of	165 167	42560 42562	0.9999891519546509	O
10137	4	168 169	42563 42564	0.9999860525131226	O
10138	and	170 173	42565 42568	0.9999887943267822	O
10139	18q	174 176	42569 42571	0.9999864101409912	O
10141	in	178 180	42573 42575	0.9999889135360718	O
10142	CRC	181 183	42576 42578	0.9999853372573853	O
10144	[	185 186	42580 42581	0.9999896287918091	O
10145	18	186 188	42581 42583	0.9999880790710449	O
10146	,	188 189	42583 42584	0.9999885559082031	O
10147	19	189 191	42584 42586	0.9999865293502808	O
10148	,	191 192	42586 42587	0.9999884366989136	O
10149	21	192 194	42587 42589	0.9999867677688599	O
10150	-	194 195	42589 42590	0.9999892711639404	O
10151	25	195 197	42590 42592	0.999985933303833	O
10152	]	197 198	42592 42593	0.9999884366989136	O
10153	.	199 200	42594 42595	0.9999721050262451	O
10154	These	0 5	42596 42601	0.9999884366989136	O
10155	broadly	6 13	42602 42609	0.9999876022338867	O
10156	-	13 14	42609 42610	0.9999890327453613	O
10157	defined	14 21	42610 42617	0.9999860525131226	O
10158	alterations	22 33	42618 42629	0.9999849796295166	O
10159	are	34 37	42630 42633	0.9999889135360718	O
10160	in	38 40	42634 42636	0.9999890327453613	O
10161	perfect	41 48	42637 42644	0.999988317489624	O
10162	agreement	49 58	42645 42654	0.9999890327453613	O
10163	with	59 63	42655 42659	0.99998939037323	O
10164	chromosome	64 74	42660 42670	0.9999881982803345	O
10165	-	74 75	42670 42671	0.99998939037323	O
10166	specific	75 83	42671 42679	0.99998939037323	O
10167	trends	84 90	42680 42686	0.9999885559082031	O
10168	in	91 93	42687 42689	0.9999891519546509	O
10169	our	94 97	42690 42693	0.999985933303833	O
10170	expression	98 108	42694 42704	0.9999881982803345	O
10171	data	109 113	42705 42709	0.9999891519546509	O
10172	,	114 115	42710 42711	0.9999891519546509	O
10173	especially	116 126	42712 42722	0.9999891519546509	O
10174	the	127 130	42723 42726	0.99998939037323	O
10175	exclusive	131 140	42727 42736	0.9999895095825195	O
10176	presence	141 149	42737 42745	0.9999895095825195	O
10177	of	150 152	42746 42748	0.9999895095825195	O
10178	domains	153 160	42749 42756	0.9999890327453613	O
10179	of	161 163	42757 42759	0.9999892711639404	O
10180	expression	164 174	42760 42770	0.9999890327453613	O
10181	gain	175 179	42771 42775	0.9999891519546509	O
10182	on	180 182	42776 42778	0.9999895095825195	O
10183	8	183 184	42779 42780	0.9999889135360718	O
10184	,	185 186	42781 42782	0.9999892711639404	O
10185	13	187 189	42783 42785	0.9999878406524658	O
10186	and	190 193	42786 42789	0.9999891519546509	O
10187	20	194 196	42790 42792	0.9999872446060181	O
10188	and	197 200	42793 42796	0.99998939037323	O
10189	the	201 204	42797 42800	0.99998939037323	O
10190	exclusive	205 214	42801 42810	0.9999892711639404	O
10191	presence	215 223	42811 42819	0.99998939037323	O
10192	of	224 226	42820 42822	0.9999892711639404	O
10193	domains	227 234	42823 42830	0.9999889135360718	O
10194	of	235 237	42831 42833	0.9999892711639404	O
10195	expression	238 248	42834 42844	0.9999886751174927	O
10196	loss	249 253	42845 42849	0.999988317489624	O
10197	on	254 256	42850 42852	0.9999892711639404	O
10198	chromosome	257 267	42853 42863	0.9999890327453613	O
10199	4	268 269	42864 42865	0.9999885559082031	O
10200	and	270 273	42866 42869	0.9999892711639404	O
10201	18	274 276	42870 42872	0.9999861717224121	O
10202	(	277 278	42873 42874	0.99998939037323	O
10203	see	279 282	42875 42878	0.999987006187439	O
10204	Table	283 288	42879 42884	0.9999877214431763	O
10205	2	289 290	42885 42886	0.999988317489624	O
10206	and	291 294	42887 42890	0.9999879598617554	O
10207	Figures	295 301	42891 42897	0.9999850988388062	O
10209	21	303 305	42899 42901	0.9999887943267822	O
10210	,	306 307	42902 42903	0.9999889135360718	O
10211	22	308 310	42904 42906	0.9999886751174927	O
10212	,	311 312	42907 42908	0.9999890327453613	O
10213	23	313 315	42909 42911	0.9999885559082031	O
10214	,	316 317	42912 42913	0.9999890327453613	O
10215	24	318 320	42914 42916	0.9999884366989136	O
10216	,	321 322	42917 42918	0.9999890327453613	O
10217	25	323 325	42919 42921	0.9999885559082031	O
10218	,	326 327	42922 42923	0.9999887943267822	O
10219	26	328 330	42924 42926	0.9999880790710449	O
10220	)	331 332	42927 42928	0.99998939037323	O
10221	.	333 334	42929 42930	0.9999761581420898	O
10222	There	0 5	42931 42936	0.9999876022338867	O
10223	is	6 8	42937 42939	0.9999877214431763	O
10224	a	9 10	42940 42941	0.999988317489624	O
10225	single	11 17	42942 42948	0.9999872446060181	O
10226	discrepancy	18 28	42949 42959	0.9999886751174927	O
10230	for	30 33	42961 42964	0.9999879598617554	O
10231	chromosome	34 44	42965 42975	0.9999878406524658	O
10232	7	45 46	42976 42977	0.9999876022338867	O
10233	:	47 48	42978 42979	0.999988317489624	O
10234	region	49 55	42980 42986	0.9999876022338867	O
10235	7q11	56 59	42987 42990	0.9999884366989136	O
10238	-	60 61	42991 42992	0.9999885559082031	O
10239	7q12	61 64	42992 42995	0.9999876022338867	O
10242	has	66 69	42997 43000	0.9999884366989136	O
10243	been	70 74	43001 43005	0.9999881982803345	O
10244	reported	75 83	43006 43014	0.9999872446060181	O
10245	as	84 86	43015 43017	0.9999885559082031	O
10246	amplified	87 95	43018 43026	0.9999877214431763	O
10248	in	97 99	43028 43030	0.9999881982803345	O
10249	CRC	100 102	43031 43033	0.9999806880950928	O
10251	,	104 105	43035 43036	0.9999877214431763	O
10252	but	106 109	43037 43040	0.999987006187439	O
10253	its	110 113	43041 43044	0.9999889135360718	O
10254	expression	114 124	43045 43055	0.9999852180480957	O
10255	is	125 127	43056 43058	0.999988317489624	O
10256	significantly	128 141	43059 43072	0.9999878406524658	O
10257	down	142 146	43073 43077	0.9999866485595703	O
10258	-	146 147	43077 43078	0.9999887943267822	O
10259	regulated	147 156	43078 43087	0.9999876022338867	O
10260	in	157 159	43088 43090	0.9999866485595703	O
10261	our	160 163	43091 43094	0.9998935461044312	O
10262	tumor	164 169	43095 43100	0.9999793767929077	O
10263	samples	170 177	43101 43108	0.9999818801879883	O
10264	.	178 179	43109 43110	0.9999885559082031	O
10265	*	180 181	43111 43112	0.9999874830245972	O
10266	*	181 182	43112 43113	0.9999797344207764	O
10267	IGNORE	0 5	43114 43119	0.9999861717224121	O
10270	LINE	7 10	43121 43124	0.9999887943267822	O
10273	*	12 13	43126 43127	0.9999891519546509	O
10274	*	13 14	43127 43128	0.9999891519546509	O
10275	*	15 16	43129 43130	0.9999890327453613	O
10276	*	16 17	43130 43131	0.9999891519546509	O
10277	IGNORE	18 23	43132 43137	0.9999877214431763	O
10280	LINE	25 28	43139 43142	0.9999890327453613	O
10283	*	30 31	43144 43145	0.9999887943267822	O
10284	*	31 32	43145 43146	0.9999887943267822	O
10285	*	33 34	43147 43148	0.9999887943267822	O
10286	*	34 35	43148 43149	0.9999887943267822	O
10287	IGNORE	36 41	43150 43155	0.9999876022338867	O
10290	LINE	43 46	43157 43160	0.9999889135360718	O
10293	*	48 49	43162 43163	0.9999889135360718	O
10294	*	49 50	43163 43164	0.9999887943267822	O
10295	Conclusion	51 60	43165 43174	0.9999884366989136	O
10298	Roughly	62 68	43176 43182	0.9999833106994629	O
10300	a	70 71	43184 43185	0.9999889135360718	O
10301	quarter	72 79	43186 43193	0.9999860525131226	O
10302	of	80 82	43194 43196	0.9999886751174927	O
10303	all	83 86	43197 43200	0.9999880790710449	O
10304	human	87 92	43201 43206	0.9999356269836426	O
10305	genes	93 98	43207 43212	0.9999855756759644	O
10306	is	99 101	43213 43215	0.9999887943267822	O
10307	located	102 109	43216 43223	0.9999889135360718	O
10308	in	110 112	43224 43226	0.9999889135360718	O
10309	islands	113 120	43227 43234	0.9999872446060181	O
10310	of	121 123	43235 43237	0.9999887943267822	O
10311	misregulated	124 135	43238 43249	0.999988317489624	O
10316	gene	137 141	43251 43255	0.9999881982803345	O
10317	expression	142 152	43256 43266	0.9999877214431763	O
10318	in	153 155	43267 43269	0.9999880790710449	O
10319	colorectal	156 165	43270 43279	0.9999860525131226	O
10322	cancer	167 173	43281 43287	0.9999856948852539	O
10323	.	174 175	43288 43289	0.9999659061431885	O
10324	There	0 5	43290 43295	0.9999834299087524	O
10325	are	6 9	43296 43299	0.9999839067459106	O
10326	only	10 14	43300 43304	0.9999796152114868	O
10327	slightly	15 23	43305 43313	0.9999812841415405	O
10328	more	24 28	43314 43318	0.9999829530715942	O
10329	down	29 33	43319 43323	0.999984622001648	O
10330	-	33 34	43323 43324	0.9999872446060181	O
10331	regulated	34 43	43324 43333	0.9999862909317017	O
10332	than	44 48	43334 43338	0.9999817609786987	O
10333	up	49 51	43339 43341	0.9999839067459106	O
10334	-	51 52	43341 43342	0.9999871253967285	O
10335	regulated	52 61	43342 43351	0.9999856948852539	O
10336	genes	62 67	43352 43357	0.9999833106994629	O
10337	.	68 69	43358 43359	0.9998992681503296	O
10338	Chromosomal	0 10	43360 43370	0.9999864101409912	O
10342	regions	12 19	43372 43379	0.9999856948852539	O
10343	that	20 24	43380 43384	0.999987006187439	O
10344	are	25 28	43385 43388	0.9999872446060181	O
10345	linked	29 35	43389 43395	0.9999732971191406	O
10346	to	36 38	43396 43398	0.9999874830245972	O
10347	hereditary	39 49	43399 43409	0.9996516704559326	O
10348	colorectal	50 59	43410 43419	0.9999817609786987	O
10351	cancer	61 67	43421 43427	0.9999853372573853	O
10352	often	68 73	43428 43433	0.999981164932251	O
10353	exhibit	74 81	43434 43441	0.9999845027923584	O
10354	deregulated	82 92	43442 43452	0.9999876022338867	O
10357	expression	94 104	43454 43464	0.9999862909317017	O
10358	,	105 106	43465 43466	0.9999866485595703	O
10359	suggesting	107 117	43467 43477	0.9999850988388062	O
10360	that	118 122	43478 43482	0.9999879598617554	O
10361	they	123 127	43483 43487	0.9999873638153076	O
10362	are	128 131	43488 43491	0.9999881982803345	O
10363	implicated	132 142	43492 43502	0.9999864101409912	O
10364	in	143 145	43503 43505	0.9999879598617554	O
10365	spontaneous	146 157	43506 43517	0.999833345413208	O
10366	CRC	158 160	43518 43520	0.9999805688858032	O
10368	not	162 165	43522 43525	0.9999864101409912	O
10369	only	166 170	43526 43530	0.9999865293502808	O
10370	through	171 178	43531 43538	0.9999871253967285	O
10371	collection	179 189	43539 43549	0.9999842643737793	O
10372	of	190 192	43550 43552	0.9999885559082031	O
10373	mutations	193 202	43553 43562	0.9999815225601196	O
10374	.	203 204	43563 43564	0.9999639987945557	O
10375	Thus	0 4	43565 43569	0.9999836683273315	O
10376	,	5 6	43570 43571	0.9999871253967285	O
10377	genes	7 12	43572 43577	0.9999843835830688	O
10378	in	13 15	43578 43580	0.9999873638153076	O
10379	these	16 21	43581 43586	0.9999878406524658	O
10380	chromosomal	22 32	43587 43597	0.9999884366989136	O
10384	hotspots	34 41	43599 43606	0.9999884366989136	O
10387	may	43 46	43608 43611	0.9999847412109375	O
10388	be	47 49	43612 43614	0.9999876022338867	O
10389	systematically	50 64	43615 43629	0.9999834299087524	O
10390	tested	65 71	43630 43636	0.9999853372573853	O
10391	in	72 74	43637 43639	0.9999862909317017	O
10392	patients	75 83	43640 43648	0.9999604225158691	O
10393	with	84 88	43649 43653	0.9999821186065674	O
10394	sporadic	89 96	43654 43661	0.9999808073043823	O
10396	CRC	98 100	43663 43665	0.9999700784683228	O
10398	for	102 105	43667 43670	0.9999868869781494	O
10399	molecular	106 115	43671 43680	0.999983549118042	O
10400	lesions	116 123	43681 43688	0.9999850988388062	O
10401	and	124 127	43689 43692	0.9999850988388062	O
10402	for	128 131	43693 43696	0.9999873638153076	O
10403	transcriptional	132 146	43697 43711	0.9999872446060181	O
10405	silencing	148 156	43713 43721	0.9999881982803345	O
10408	.	158 159	43723 43724	0.9999651908874512	O
10409	Chromosomal	0 10	43725 43735	0.9999877214431763	O
10413	regions	12 19	43737 43744	0.9999879598617554	O
10414	that	20 24	43745 43749	0.9999876022338867	O
10415	are	25 28	43750 43753	0.9999880790710449	O
10416	frequently	29 39	43754 43764	0.9999876022338867	O
10417	deleted	40 47	43765 43772	0.9999845027923584	O
10418	in	48 50	43773 43775	0.9999877214431763	O
10419	CRC	51 53	43776 43778	0.9999767541885376	O
10421	very	55 59	43780 43784	0.9999836683273315	O
10422	often	60 65	43785 43790	0.9999864101409912	O
10423	comprise	66 74	43791 43799	0.9999867677688599	O
10424	islands	75 82	43800 43807	0.9999852180480957	O
10425	in	83 85	43808 43810	0.9999884366989136	O
10426	which	86 91	43811 43816	0.9999880790710449	O
10427	we	92 94	43817 43819	0.9999842643737793	O
10428	found	95 100	43820 43825	0.999985933303833	O
10429	reduced	101 108	43826 43833	0.9999833106994629	O
10430	expression	109 119	43834 43844	0.9999849796295166	O
10431	.	120 121	43845 43846	0.999966025352478	O
10432	Although	0 8	43847 43855	0.9999831914901733	O
10433	many	9 13	43856 43860	0.9999861717224121	O
10434	regions	14 21	43861 43868	0.9999853372573853	O
10435	that	22 26	43869 43873	0.9999879598617554	O
10436	are	27 30	43874 43877	0.9999881982803345	O
10437	known	31 36	43878 43883	0.999983549118042	O
10438	to	37 39	43884 43886	0.9999884366989136	O
10439	be	40 42	43887 43889	0.9999885559082031	O
10440	amplified	43 51	43890 43898	0.9999878406524658	O
10442	in	53 55	43900 43902	0.9999856948852539	O
10443	colorectal	56 65	43903 43912	0.9999744892120361	O
10446	tumors	67 73	43914 43920	0.9999827146530151	O
10447	show	74 78	43921 43925	0.9999858140945435	O
10448	a	79 80	43926 43927	0.9999884366989136	O
10449	gain	81 85	43928 43932	0.9999877214431763	O
10450	of	86 88	43933 43935	0.9999891519546509	O
10451	expression	89 99	43936 43946	0.9999864101409912	O
10452	,	100 101	43947 43948	0.9999861717224121	O
10453	there	102 107	43949 43954	0.9999885559082031	O
10454	are	108 111	43955 43958	0.9999884366989136	O
10455	also	112 116	43959 43963	0.9999871253967285	O
10456	a	117 118	43964 43965	0.9999887943267822	O
10457	considerable	119 131	43966 43978	0.9999871253967285	O
10458	number	132 138	43979 43985	0.9999884366989136	O
10459	of	139 141	43986 43988	0.9999890327453613	O
10460	amplified	142 150	43989 43997	0.9999886751174927	O
10462	islands	152 159	43999 44006	0.9999862909317017	O
10463	that	160 164	44007 44011	0.9999889135360718	O
10464	show	165 169	44012 44016	0.9999877214431763	O
10465	no	170 172	44017 44019	0.9999872446060181	O
10466	alterations	173 184	44020 44031	0.9999858140945435	O
10467	or	185 187	44032 44034	0.9999866485595703	O
10468	even	188 192	44035 44039	0.9999873638153076	O
10469	down	193 197	44040 44044	0.9999864101409912	O
10470	-	197 198	44044 44045	0.9999889135360718	O
10471	regulation	198 208	44045 44055	0.9999864101409912	O
10472	.	209 210	44056 44057	0.9999617338180542	O
10473	Comparison	0 9	44058 44067	0.9999877214431763	O
10477	of	11 13	44069 44071	0.9999878406524658	O
10478	published	14 23	44072 44081	0.9999734163284302	O
10479	CGH	24 26	44082 44084	0.9999871253967285	O
10482	studies	28 35	44086 44093	0.9999876022338867	O
10483	with	36 40	44094 44098	0.9999874830245972	O
10484	our	41 44	44099 44102	0.9999847412109375	O
10485	expression	45 55	44103 44113	0.9999874830245972	O
10486	data	56 60	44114 44118	0.9999879598617554	O
10487	suggests	61 69	44119 44127	0.9999855756759644	O
10488	that	70 74	44128 44132	0.9999891519546509	O
10489	amplified	75 83	44133 44141	0.9999889135360718	O
10491	or	85 87	44143 44145	0.9999890327453613	O
10492	deleted	88 95	44146 44153	0.9999881982803345	O
10493	chromosomal	96 106	44154 44164	0.99998939037323	O
10497	regions	108 115	44166 44173	0.9999892711639404	O
10498	are	116 119	44174 44177	0.9999884366989136	O
10499	responsible	120 131	44178 44189	0.9999886751174927	O
10500	for	132 135	44190 44193	0.9999886751174927	O
10501	many	136 140	44194 44198	0.9999866485595703	O
10502	islands	141 148	44199 44206	0.9999831914901733	O
10503	with	149 153	44207 44211	0.9999877214431763	O
10504	aberrant	154 161	44212 44219	0.9999892711639404	O
10507	expression	163 173	44221 44231	0.9999871253967285	O
10508	.	174 175	44232 44233	0.9999712705612183	O
10509	However	0 7	44234 44241	0.9999866485595703	O
10510	,	8 9	44242 44243	0.9999884366989136	O
10511	we	10 12	44244 44246	0.9999864101409912	O
10512	suggest	13 20	44247 44254	0.9999873638153076	O
10513	that	21 25	44255 44259	0.9999887943267822	O
10514	it	26 28	44260 44262	0.9999885559082031	O
10515	is	29 31	44263 44265	0.9999886751174927	O
10516	necessary	32 41	44266 44275	0.9999885559082031	O
10517	to	42 44	44276 44278	0.9999889135360718	O
10518	invoke	45 50	44279 44284	0.9999889135360718	O
10520	other	52 57	44286 44291	0.9999879598617554	O
10521	mechanism	58 67	44292 44301	0.999988317489624	O
10522	like	68 72	44302 44306	0.9999880790710449	O
10523	epigenetic	73 82	44307 44316	0.9999890327453613	O
10527	regulation	84 94	44318 44328	0.9999886751174927	O
10528	of	95 97	44329 44331	0.9999886751174927	O
10529	chromatin	98 106	44332 44340	0.9999884366989136	O
10532	or	108 110	44342 44344	0.9999886751174927	O
10533	disruption	111 121	44345 44355	0.9999872446060181	O
10534	of	122 124	44356 44358	0.9999887943267822	O
10535	enhancer	125 132	44359 44366	0.9999865293502808	O
10537	actions	134 141	44368 44375	0.9999884366989136	O
10538	to	142 144	44376 44378	0.9999884366989136	O
10539	explain	145 152	44379 44386	0.9999877214431763	O
10540	the	153 156	44387 44390	0.9999887943267822	O
10541	remaining	157 166	44391 44400	0.9999867677688599	O
10542	expression	167 177	44401 44411	0.9999858140945435	O
10543	imbalances	178 187	44412 44421	0.9999889135360718	O
10547	.	189 190	44423 44424	0.9999891519546509	O
10548	*	191 192	44425 44426	0.9999877214431763	O
10549	*	192 193	44426 44427	0.9999786615371704	O
10550	IGNORE	0 5	44428 44433	0.999985933303833	O
10553	LINE	7 10	44435 44438	0.9999887943267822	O
10556	*	12 13	44440 44441	0.9999889135360718	O
10557	*	13 14	44441 44442	0.9999889135360718	O
10558	*	15 16	44443 44444	0.9999889135360718	O
10559	*	16 17	44444 44445	0.9999890327453613	O
10560	IGNORE	18 23	44446 44451	0.9999876022338867	O
10563	LINE	25 28	44453 44456	0.9999890327453613	O
10566	*	30 31	44458 44459	0.9999886751174927	O
10567	*	31 32	44459 44460	0.9999885559082031	O
10568	*	33 34	44461 44462	0.9999885559082031	O
10569	*	34 35	44462 44463	0.9999885559082031	O
10570	IGNORE	36 41	44464 44469	0.9999866485595703	O
10573	LINE	43 46	44471 44474	0.9999887943267822	O
10576	*	48 49	44476 44477	0.9999886751174927	O
10577	*	49 50	44477 44478	0.9999885559082031	O
10578	Non	51 54	44479 44482	0.9999874830245972	O
10579	-	54 55	44482 44483	0.9999890327453613	O
10580	dysplastic	55 64	44483 44492	0.9999880790710449	O
10584	serrated	66 73	44494 44501	0.9999877214431763	O
10587	polyps	75 80	44503 44508	0.9999872446060181	O
10590	:	82 83	44510 44511	0.9999887943267822	O
10591	HP	84 86	44512 44514	0.999982476234436	O
10592	and	87 90	44515 44518	0.9999878406524658	O
10593	SSA	91 93	44519 44521	0.9999868869781494	O
10595	Non	95 98	44523 44526	0.9999873638153076	O
10596	-	98 99	44526 44527	0.9999887943267822	O
10597	dysplastic	99 108	44527 44536	0.9999872446060181	O
10601	serrated	110 117	44538 44545	0.9999878406524658	O
10604	polyps	119 124	44547 44552	0.9999874830245972	O
10607	comprise	126 134	44554 44562	0.9999868869781494	O
10608	conventional	135 147	44563 44575	0.9999830722808838	O
10609	HPs	148 150	44576 44578	0.9999830722808838	O
10611	and	152 155	44580 44583	0.9999872446060181	O
10612	the	156 159	44584 44587	0.9999880790710449	O
10613	variant	160 167	44588 44595	0.9999856948852539	O
10614	lesion	168 173	44596 44601	0.9999871253967285	O
10616	which	175 180	44603 44608	0.9999890327453613	O
10617	has	181 184	44609 44612	0.9999887943267822	O
10618	been	185 189	44613 44617	0.9999886751174927	O
10619	described	190 199	44618 44627	0.9999873638153076	O
10620	as	200 202	44628 44630	0.9999886751174927	O
10621	SSA	203 205	44631 44633	0.9999854564666748	O
10623	.	207 208	44635 44636	0.99996018409729	O
10624	In	0 2	44637 44639	0.9999860525131226	O
10625	this	3 7	44640 44644	0.9999858140945435	O
10626	study	8 13	44645 44650	0.9999809265136719	O
10627	,	14 15	44651 44652	0.9999868869781494	O
10628	SSAs	16 19	44653 44656	0.99997878074646	O
10630	accounted	21 30	44658 44667	0.9999881982803345	O
10631	for	31 34	44668 44671	0.999988317489624	O
10632	approximately	35 48	44672 44685	0.9999876022338867	O
10633	3	49 50	44686 44687	0.9999827146530151	O
10634	%	51 52	44688 44689	0.999988317489624	O
10635	of	53 55	44690 44692	0.9999880790710449	O
10636	the	56 59	44693 44696	0.9999879598617554	O
10637	overall	60 67	44697 44704	0.9999862909317017	O
10638	series	68 74	44705 44711	0.9999798536300659	O
10639	of	75 77	44712 44714	0.9999860525131226	O
10640	polyps	78 83	44715 44720	0.999984860420227	O
10643	and	85 88	44722 44725	0.999982476234436	O
10644	were	89 93	44726 44730	0.9999877214431763	O
10645	more	94 98	44731 44735	0.9999858140945435	O
10646	age	99 102	44736 44739	0.9999841451644897	O
10647	-	102 103	44739 44740	0.9999886751174927	O
10648	related	103 110	44740 44747	0.9999887943267822	O
10649	than	111 115	44748 44752	0.9999867677688599	O
10650	HPs	116 118	44753 44755	0.9999513626098633	O
10652	.	120 121	44757 44758	0.999967098236084	O
10653	Importantly	0 10	44759 44769	0.9999866485595703	O
10655	,	12 13	44771 44772	0.9999891519546509	O
10656	SSAs	14 17	44773 44776	0.9999847412109375	O
10658	have	19 23	44778 44782	0.9999887943267822	O
10659	been	24 28	44783 44787	0.9999891519546509	O
10660	linked	29 35	44788 44794	0.9999867677688599	O
10661	with	36 40	44795 44799	0.9999892711639404	O
10662	the	41 44	44800 44803	0.9999887943267822	O
10663	subset	45 51	44804 44810	0.9999868869781494	O
10664	of	52 54	44811 44813	0.9999879598617554	O
10665	colorectal	55 64	44814 44823	0.9999831914901733	O
10668	cancer	66 72	44825 44831	0.999985933303833	O
10669	with	73 77	44832 44836	0.9999887943267822	O
10670	BRAF	78 81	44837 44840	0.9999866485595703	O
10672	mutation	83 91	44842 44850	0.9999889135360718	O
10673	,	92 93	44851 44852	0.9999891519546509	O
10674	DNA	94 97	44853 44856	0.999987006187439	O
10675	methylation	98 108	44857 44867	0.9999887943267822	O
10678	,	110 111	44869 44870	0.99998939037323	O
10679	MSI	112 114	44871 44873	0.9999867677688599	O
10681	and	116 119	44875 44878	0.9999889135360718	O
10682	serrated	120 127	44879 44886	0.999988317489624	O
10685	architecture	129 141	44888 44900	0.9999877214431763	O
10686	.	142 143	44901 44902	0.9999895095825195	O
10687	14	143 145	44902 44904	0.9999879598617554	O
10688	,	145 146	44904 44905	0.9999889135360718	O
10689	18	146 148	44905 44907	0.9999865293502808	O
10690	,	148 149	44907 44908	0.9999884366989136	O
10691	37	149 151	44908 44910	0.9999862909317017	O
10692	In	152 154	44911 44913	0.9999886751174927	O
10693	this	155 159	44914 44918	0.9999891519546509	O
10694	study	160 165	44919 44924	0.9999873638153076	O
10695	there	166 171	44925 44930	0.9999892711639404	O
10696	was	172 175	44931 44934	0.9999891519546509	O
10697	a	176 177	44935 44936	0.9999895095825195	O
10698	high	178 182	44937 44941	0.9999887943267822	O
10699	frequency	183 192	44942 44951	0.9999886751174927	O
10700	of	193 195	44952 44954	0.99998939037323	O
10701	BRAF	196 199	44955 44958	0.9999868869781494	O
10703	mutation	201 209	44960 44968	0.9999886751174927	O
10704	in	210 212	44969 44971	0.99998939037323	O
10705	conventional	213 225	44972 44984	0.9999841451644897	O
10706	HPs	226 228	44985 44987	0.999981164932251	O
10708	(	230 231	44989 44990	0.9999896287918091	O
10709	67	232 234	44991 44993	0.9999853372573853	O
10710	%	235 236	44994 44995	0.99998939037323	O
10711	)	237 238	44996 44997	0.9999895095825195	O
10712	as	239 241	44998 45000	0.9999876022338867	O
10713	well	242 246	45001 45005	0.9999881982803345	O
10714	as	247 249	45006 45008	0.9999884366989136	O
10715	in	250 252	45009 45011	0.9999890327453613	O
10716	SSAs	253 256	45012 45015	0.9999842643737793	O
10718	(	258 259	45017 45018	0.99998939037323	O
10719	81	260 262	45019 45021	0.9999853372573853	O
10720	%	263 264	45022 45023	0.9999892711639404	O
10721	)	265 266	45024 45025	0.9999895095825195	O
10722	.	267 268	45026 45027	0.9999686479568481	O
10723	Previous	0 8	45028 45036	0.9999874830245972	O
10724	reports	9 16	45037 45044	0.9999881982803345	O
10725	have	17 21	45045 45049	0.9999890327453613	O
10726	shown	22 27	45050 45055	0.9999889135360718	O
10727	very	28 32	45056 45060	0.9999886751174927	O
10728	similar	33 40	45061 45068	0.9999878406524658	O
10729	results	41 48	45069 45076	0.9999886751174927	O
10730	for	49 52	45077 45080	0.9999892711639404	O
10731	BRAF	53 56	45081 45084	0.9999864101409912	O
10733	mutation	58 66	45086 45094	0.9999895095825195	O
10734	in	67 69	45095 45097	0.9999898672103882	O
10735	SSA	70 72	45098 45100	0.9999889135360718	O
10737	,	74 75	45102 45103	0.9999897480010986	O
10738	16	75 77	45103 45105	0.9999885559082031	O
10739	but	78 81	45106 45109	0.9999886751174927	O
10740	higher	82 88	45110 45116	0.9999885559082031	O
10741	frequencies	89 100	45117 45128	0.9999890327453613	O
10742	of	101 103	45129 45131	0.99998939037323	O
10743	KRAS	104 107	45132 45135	0.9999845027923584	O
10746	mutation	109 117	45137 45145	0.9999895095825195	O
10747	and	118 121	45146 45149	0.99998939037323	O
10748	lower	122 127	45150 45155	0.9999872446060181	O
10749	frequencies	128 139	45156 45167	0.9999891519546509	O
10750	of	140 142	45168 45170	0.99998939037323	O
10751	BRAF	143 146	45171 45174	0.9999872446060181	O
10753	mutation	148 156	45176 45184	0.99998939037323	O
10754	in	157 159	45185 45187	0.9999898672103882	O
10755	HPs	160 162	45188 45190	0.9999836683273315	O
10757	.	163 164	45191 45192	0.9999897480010986	O
10758	12	164 166	45192 45194	0.9999891519546509	O
10759	,	166 167	45194 45195	0.99998939037323	O
10760	16	167 169	45195 45197	0.9999885559082031	O
10761	,	169 170	45197 45198	0.9999892711639404	O
10762	38	170 172	45198 45200	0.9999872446060181	O
10763	As	173 175	45201 45203	0.9999873638153076	O
10764	mentioned	176 185	45204 45213	0.9999879598617554	O
10765	in	186 188	45214 45216	0.99998939037323	O
10766	Materials	189 198	45217 45226	0.9999862909317017	O
10767	and	199 202	45227 45230	0.9999890327453613	O
10768	methods	203 210	45231 45238	0.999987006187439	O
10769	,	211 212	45239 45240	0.9999892711639404	O
10770	there	213 218	45241 45246	0.9999895095825195	O
10771	had	219 222	45247 45250	0.9999891519546509	O
10772	been	223 227	45251 45255	0.9999897480010986	O
10773	selection	228 237	45256 45265	0.9999886751174927	O
10774	of	238 240	45266 45268	0.9999896287918091	O
10775	larger	241 247	45269 45275	0.9999860525131226	O
10776	HPs	248 250	45276 45278	0.9999842643737793	O
10778	in	252 254	45280 45282	0.99998939037323	O
10779	an	255 257	45283 45285	0.99998939037323	O
10780	earlier	258 265	45286 45293	0.9999885559082031	O
10781	cell	266 270	45294 45298	0.9999881982803345	O
10782	kinetic	271 278	45299 45306	0.9999881982803345	O
10783	study	279 284	45307 45312	0.9999890327453613	O
10784	involving	285 294	45313 45322	0.9999896287918091	O
10785	the	295 298	45323 45326	0.99998939037323	O
10786	same	299 303	45327 45331	0.9999886751174927	O
10787	material	304 312	45332 45340	0.9999885559082031	O
10788	.	313 314	45341 45342	0.9999758005142212	O
10789	Large	0 5	45343 45348	0.9999481439590454	O
10790	HPs	6 8	45349 45351	0.9999741315841675	O
10792	are	10 13	45353 45356	0.9999874830245972	O
10793	more	14 18	45357 45361	0.9999871253967285	O
10794	likely	19 25	45362 45368	0.9999886751174927	O
10795	to	26 28	45369 45371	0.9999881982803345	O
10796	include	29 36	45372 45379	0.999988317489624	O
10797	the	37 40	45380 45383	0.9999877214431763	O
10798	subset	41 47	45384 45390	0.9999873638153076	O
10799	described	48 57	45391 45400	0.9999868869781494	O
10800	as	58 60	45401 45403	0.9999877214431763	O
10801	‘	61 62	45404 45405	0.9999862909317017	O
10802	microvesicular	62 75	45405 45418	0.9999862909317017	O
10805	’	76 77	45419 45420	0.9999759197235107	O
10806	,	78 79	45421 45422	0.9999876022338867	O
10807	in	80 82	45423 45425	0.9999874830245972	O
10808	which	83 88	45426 45431	0.9999881982803345	O
10809	the	89 92	45432 45435	0.9999864101409912	O
10810	columnar	93 100	45436 45443	0.999983549118042	O
10812	cells	102 107	45445 45450	0.9999856948852539	O
10813	contain	108 115	45451 45458	0.9999871253967285	O
10814	apical	116 121	45459 45464	0.9999884366989136	O
10816	mucin	123 127	45466 45470	0.9999861717224121	O
10819	droplets	129 136	45472 45479	0.9999880790710449	O
10821	within	138 144	45481 45487	0.9999878406524658	O
10822	small	145 150	45488 45493	0.999985933303833	O
10823	vesicles	151 158	45494 45501	0.9999874830245972	O
10826	while	160 165	45503 45508	0.9999843835830688	O
10827	goblet	166 171	45509 45514	0.9999828338623047	O
10830	cells	173 178	45516 45521	0.9999861717224121	O
10831	are	179 182	45522 45525	0.9999873638153076	O
10832	rendered	183 191	45526 45534	0.9999815225601196	O
10833	inconspicuous	192 204	45535 45547	0.999988317489624	O
10838	.	206 207	45549 45550	0.9999891519546509	O
10839	25BRAF	207 212	45550 45555	0.9999850988388062	O
10842	mutation	214 222	45557 45565	0.9999877214431763	O
10843	occurs	223 229	45566 45572	0.9999887943267822	O
10844	more	230 234	45573 45577	0.9999876022338867	O
10845	frequently	235 245	45578 45588	0.999988317489624	O
10846	in	246 248	45589 45591	0.9999885559082031	O
10847	the	249 252	45592 45595	0.9999880790710449	O
10848	microvesicular	253 266	45596 45609	0.9999866485595703	O
10851	variant	268 275	45611 45618	0.9999872446060181	O
10852	of	276 278	45619 45621	0.9999884366989136	O
10853	HP	279 281	45622 45624	0.999981164932251	O
10854	.	281 282	45624 45625	0.9999892711639404	O
10855	16	282 284	45625 45627	0.9999866485595703	O
10856	By	285 287	45628 45630	0.9999880790710449	O
10857	contrast	288 296	45631 45639	0.9999879598617554	O
10858	,	297 298	45640 45641	0.9999891519546509	O
10859	KRAS	299 302	45642 45645	0.9999828338623047	O
10862	mutation	304 312	45647 45655	0.9999876022338867	O
10863	occurs	313 319	45656 45662	0.9999886751174927	O
10864	much	320 324	45663 45667	0.9999877214431763	O
10865	more	325 329	45668 45672	0.9999878406524658	O
10866	commonly	330 338	45673 45681	0.9999884366989136	O
10867	in	339 341	45682 45684	0.9999885559082031	O
10868	the	342 345	45685 45688	0.9999884366989136	O
10869	goblet	346 351	45689 45694	0.9999864101409912	O
10872	cell	353 357	45696 45700	0.9999867677688599	O
10873	variant	358 365	45701 45708	0.9999878406524658	O
10874	of	366 368	45709 45711	0.9999885559082031	O
10875	HP	369 371	45712 45714	0.9999802112579346	O
10876	,	372 373	45715 45716	0.999988317489624	O
10877	which	374 379	45717 45722	0.9999886751174927	O
10878	is	380 382	45723 45725	0.9999881982803345	O
10879	usually	383 390	45726 45733	0.999987006187439	O
10880	small	391 396	45734 45739	0.9999843835830688	O
10881	,	397 398	45740 45741	0.9999843835830688	O
10882	located	399 406	45742 45749	0.9999872446060181	O
10883	in	407 409	45750 45752	0.9999873638153076	O
10884	the	410 413	45753 45756	0.9999879598617554	O
10885	left	414 418	45757 45761	0.9999749660491943	O
10886	colon	419 423	45762 45766	0.9999842643737793	O
10888	or	425 427	45768 45770	0.999982476234436	O
10889	rectum	428 433	45771 45776	0.999984622001648	O
10892	and	435 438	45778 45781	0.9999873638153076	O
10893	deviates	439 446	45782 45789	0.9999881982803345	O
10896	minimally	448 456	45791 45799	0.9999879598617554	O
10898	from	458 462	45801 45805	0.9999878406524658	O
10899	normal	463 469	45806 45812	0.999980092048645	O
10900	colorectal	470 479	45813 45822	0.9999852180480957	O
10903	mucosa	481 486	45824 45829	0.999984860420227	O
10906	in	488 490	45831 45833	0.9999886751174927	O
10907	terms	491 496	45834 45839	0.999988317489624	O
10908	of	497 499	45840 45842	0.9999886751174927	O
10909	differentiation	500 515	45843 45858	0.999984860420227	O
10910	and	516 519	45859 45862	0.9999880790710449	O
10911	architecture	520 532	45863 45875	0.9999828338623047	O
10912	.	533 534	45876 45877	0.9999890327453613	O
10913	16	534 536	45877 45879	0.9999877214431763	O
10914	,	536 537	45879 45880	0.9999879598617554	O
10915	25	537 539	45880 45882	0.9999856948852539	O
10916	The	540 543	45883 45886	0.9999881982803345	O
10917	latter	544 550	45887 45893	0.999985933303833	O
10918	were	551 555	45894 45898	0.9999879598617554	O
10919	under	556 561	45899 45904	0.9999872446060181	O
10920	-	561 562	45904 45905	0.9999884366989136	O
10921	represented	562 573	45905 45916	0.9999885559082031	O
10922	in	574 576	45917 45919	0.999988317489624	O
10923	this	577 581	45920 45924	0.9999889135360718	O
10924	series	582 588	45925 45931	0.9999872446060181	O
10925	(	589 590	45932 45933	0.9999889135360718	O
10926	details	591 598	45934 45941	0.9999855756759644	O
10927	not	599 602	45942 45945	0.9999884366989136	O
10928	shown	603 608	45946 45951	0.9999879598617554	O
10929	)	609 610	45952 45953	0.9999891519546509	O
10930	.	611 612	45954 45955	0.9999774694442749	O
10931	dysplastic	0 9	45956 45965	0.999984860420227	O
10935	serrated	11 18	45967 45974	0.9999843835830688	O
10938	polyps	20 25	45976 45981	0.999985933303833	O
10941	:	27 28	45983 45984	0.9999871253967285	O
10942	MP	29 31	45985 45987	0.9999812841415405	O
10943	and	32 35	45988 45991	0.9999877214431763	O
10944	SA	36 38	45992 45994	0.9999756813049316	O
10945	Serrated	39 46	45995 46002	0.9999839067459106	O
10947	polyps	48 53	46004 46009	0.999987006187439	O
10950	with	55 59	46011 46015	0.9999865293502808	O
10951	dysplasia	60 68	46016 46024	0.9999865293502808	O
10955	,	70 71	46026 46027	0.9999872446060181	O
10956	i	72 73	46028 46029	0.9999878406524658	O
10957	.	74 75	46030 46031	0.9999874830245972	O
10958	e	75 76	46031 46032	0.9999873638153076	O
10959	.	77 78	46033 46034	0.9999758005142212	O
10960	MPs	0 3	46035 46038	0.9999762773513794	O
10961	and	4 7	46039 46042	0.9999872446060181	O
10962	SAs	8 10	46043 46045	0.9999723434448242	O
10964	,	12 13	46047 46048	0.9999876022338867	O
10965	together	14 22	46049 46057	0.9999872446060181	O
10966	comprised	23 32	46058 46067	0.9999886751174927	O
10967	only	33 37	46068 46072	0.9999872446060181	O
10968	2	38 39	46073 46074	0.9999830722808838	O
10969	%	40 41	46075 46076	0.9999886751174927	O
10970	of	42 44	46077 46079	0.9999885559082031	O
10971	the	45 48	46080 46083	0.9999884366989136	O
10972	overall	49 56	46084 46091	0.9999879598617554	O
10973	consecutive	57 68	46092 46103	0.999985933303833	O
10974	series	69 75	46104 46110	0.9999858140945435	O
10975	of	76 78	46111 46113	0.9999880790710449	O
10976	1250	79 82	46114 46117	0.9999854564666748	O
10978	polyps	84 89	46119 46124	0.9999861717224121	O
10981	.	91 92	46126 46127	0.999969482421875	O
10982	While	0 5	46128 46133	0.9999872446060181	O
10983	mutation	6 14	46134 46142	0.9999862909317017	O
10984	of	15 17	46143 46145	0.9999884366989136	O
10985	KRAS	18 21	46146 46149	0.9999834299087524	O
10988	and	23 26	46151 46154	0.999988317489624	O
10989	BRAF	27 30	46155 46158	0.9999837875366211	O
10991	was	32 35	46160 46163	0.9999887943267822	O
10992	associated	36 46	46164 46174	0.9999889135360718	O
10993	with	47 51	46175 46179	0.9999889135360718	O
10994	conventional	52 64	46180 46192	0.9999746084213257	O
10995	adenoma	65 71	46193 46199	0.9999853372573853	O
10998	and	73 76	46201 46204	0.9999881982803345	O
10999	SSA	77 79	46205 46207	0.999983549118042	O
11001	,	81 82	46209 46210	0.9999887943267822	O
11002	respectively	83 95	46211 46223	0.999988317489624	O
11003	(	96 97	46224 46225	0.99998939037323	O
11004	see	98 101	46226 46229	0.9999877214431763	O
11005	above	102 107	46230 46235	0.9999886751174927	O
11006	)	108 109	46236 46237	0.9999897480010986	O
11007	,	110 111	46238 46239	0.9999890327453613	O
11008	BRAF	112 115	46240 46243	0.9999856948852539	O
11010	and	117 120	46245 46248	0.9999889135360718	O
11011	KRAS	121 124	46249 46252	0.9999850988388062	O
11014	mutation	126 134	46254 46262	0.9999884366989136	O
11015	occurred	135 143	46263 46271	0.9999895095825195	O
11016	with	144 148	46272 46276	0.9999891519546509	O
11017	similar	149 156	46277 46284	0.9999858140945435	O
11018	frequency	157 166	46285 46294	0.999988317489624	O
11019	in	167 169	46295 46297	0.9999891519546509	O
11020	both	170 174	46298 46302	0.9999868869781494	O
11021	MPs	175 178	46303 46306	0.9999740123748779	O
11022	(	179 180	46307 46308	0.9999896287918091	O
11023	40	181 183	46309 46311	0.9999867677688599	O
11024	%	184 185	46312 46313	0.9999892711639404	O
11025	and	186 189	46314 46317	0.9999885559082031	O
11026	50	190 192	46318 46320	0.9999852180480957	O
11027	%	193 194	46321 46322	0.9999891519546509	O
11028	,	195 196	46323 46324	0.9999881982803345	O
11029	respectively	197 209	46325 46337	0.9999886751174927	O
11030	)	210 211	46338 46339	0.9999890327453613	O
11031	and	212 215	46340 46343	0.9999868869781494	O
11032	SAs	216 218	46344 46346	0.9999701976776123	O
11034	(	220 221	46348 46349	0.99998939037323	O
11035	33	222 224	46350 46352	0.9999850988388062	O
11036	%	225 226	46353 46354	0.9999891519546509	O
11037	and	227 230	46355 46358	0.9999878406524658	O
11038	27	231 233	46359 46361	0.9999840259552002	O
11039	%	234 235	46362 46363	0.9999889135360718	O
11040	,	236 237	46364 46365	0.9999879598617554	O
11041	respectively	238 250	46366 46378	0.9999885559082031	O
11042	)	251 252	46379 46380	0.9999889135360718	O
11043	.	253 254	46381 46382	0.9999685287475586	O
11044	In	0 2	46383 46385	0.999988317489624	O
11045	the	3 6	46386 46389	0.9999881982803345	O
11046	literature	7 17	46390 46400	0.999982476234436	O
11047	,	18 19	46401 46402	0.9999887943267822	O
11048	the	20 23	46403 46406	0.9999887943267822	O
11049	frequency	24 33	46407 46416	0.9999876022338867	O
11050	of	34 36	46417 46419	0.9999886751174927	O
11051	BRAF	37 40	46420 46423	0.9999842643737793	O
11053	and	42 45	46425 46428	0.9999877214431763	O
11054	KRAS	46 49	46429 46432	0.9999816417694092	O
11057	mutation	51 59	46434 46442	0.9999880790710449	O
11058	in	60 62	46443 46445	0.99998939037323	O
11059	MP	63 65	46446 46448	0.9999808073043823	O
11060	or	66 68	46449 46451	0.999988317489624	O
11061	SA	69 71	46452 46454	0.9999758005142212	O
11062	has	72 75	46455 46458	0.9999889135360718	O
11063	ranged	76 82	46459 46465	0.9999886751174927	O
11064	from	83 87	46466 46470	0.9999892711639404	O
11065	36	88 90	46471 46473	0.9999879598617554	O
11066	to	91 93	46474 46476	0.9999891519546509	O
11067	100	94 97	46477 46480	0.9999855756759644	O
11068	%	98 99	46481 46482	0.9999890327453613	O
11069	and	100 103	46483 46486	0.9999879598617554	O
11070	from	104 108	46487 46491	0.9999887943267822	O
11071	0	109 110	46492 46493	0.9999878406524658	O
11072	%	111 112	46494 46495	0.9999892711639404	O
11073	to	113 115	46496 46498	0.9999887943267822	O
11074	60	116 118	46499 46501	0.9999853372573853	O
11075	%	119 120	46502 46503	0.9999891519546509	O
11076	,	121 122	46504 46505	0.9999884366989136	O
11077	respectively	123 135	46506 46518	0.9999881982803345	O
11078	.	136 137	46519 46520	0.99998939037323	O
11079	12	137 139	46520 46522	0.9999889135360718	O
11080	,	139 140	46522 46523	0.9999891519546509	O
11081	16	140 142	46523 46525	0.9999872446060181	O
11082	,	142 143	46525 46526	0.9999887943267822	O
11083	39	143 145	46526 46528	0.9999877214431763	O
11084	–	145 146	46528 46529	0.9999854564666748	O
11085	42	146 148	46529 46531	0.9999868869781494	O
11086	These	149 154	46532 46537	0.9999877214431763	O
11087	findings	155 163	46538 46546	0.9999862909317017	O
11088	indicate	164 172	46547 46555	0.9999873638153076	O
11089	that	173 177	46556 46560	0.9999891519546509	O
11090	this	178 182	46561 46565	0.999988317489624	O
11091	subset	183 189	46566 46572	0.999987006187439	O
11092	of	190 192	46573 46575	0.9999865293502808	O
11093	colorectal	193 202	46576 46585	0.9999836683273315	O
11096	polyps	204 209	46587 46592	0.9999849796295166	O
11099	is	211 213	46594 46596	0.9999889135360718	O
11100	likely	214 220	46597 46603	0.9999886751174927	O
11101	to	221 223	46604 46606	0.9999887943267822	O
11102	be	224 226	46607 46609	0.9999890327453613	O
11103	heterogeneous	227 239	46610 46622	0.9999890327453613	O
11107	in	241 243	46624 46626	0.9999889135360718	O
11108	terms	244 249	46627 46632	0.9999886751174927	O
11109	of	250 252	46633 46635	0.9999889135360718	O
11110	its	253 256	46636 46639	0.9999890327453613	O
11111	molecular	257 266	46640 46649	0.999985933303833	O
11112	origins	267 274	46650 46657	0.9999876022338867	O
11113	.	275 276	46658 46659	0.9999617338180542	O
11114	These	0 5	46660 46665	0.9999861717224121	O
11115	polyps	6 11	46666 46671	0.999983549118042	O
11118	were	13 17	46673 46677	0.9999877214431763	O
11119	therefore	18 27	46678 46687	0.9999867677688599	O
11120	reclassified	28 39	46688 46699	0.9999880790710449	O
11122	according	41 50	46701 46710	0.9999887943267822	O
11123	to	51 53	46711 46713	0.99998939037323	O
11124	their	54 59	46714 46719	0.9999892711639404	O
11125	resemblance	60 71	46720 46731	0.9999866485595703	O
11126	to	72 74	46732 46734	0.9999891519546509	O
11127	HP	75 77	46735 46737	0.9999823570251465	O
11128	or	78 80	46738 46740	0.9999892711639404	O
11129	SSA	81 83	46741 46743	0.9999868869781494	O
11131	(	85 86	46745 46746	0.9999897480010986	O
11132	Group	87 92	46747 46752	0.9999887943267822	O
11133	A	93 94	46753 46754	0.9999892711639404	O
11134	)	94 95	46754 46755	0.9999897480010986	O
11135	(	96 97	46756 46757	0.9999896287918091	O
11136	Figure	98 104	46758 46764	0.9999886751174927	O
11137	1A	105 107	46765 46767	0.9999897480010986	O
11138	,	107 108	46767 46768	0.9999892711639404	O
11139	B	108 109	46768 46769	0.9999889135360718	O
11140	,	109 110	46769 46770	0.9999891519546509	O
11141	E	110 111	46770 46771	0.9999890327453613	O
11142	,	111 112	46771 46772	0.9999892711639404	O
11143	F	112 113	46772 46773	0.999988317489624	O
11144	)	113 114	46773 46774	0.9999895095825195	O
11145	or	115 117	46775 46777	0.9999861717224121	O
11146	to	118 120	46778 46780	0.9999876022338867	O
11147	conventional	121 133	46781 46793	0.999983549118042	O
11148	adenoma	134 140	46794 46800	0.999985933303833	O
11151	(	142 143	46802 46803	0.9999895095825195	O
11152	Group	144 149	46804 46809	0.9999886751174927	O
11153	B	150 151	46810 46811	0.9999885559082031	O
11154	)	151 152	46811 46812	0.9999895095825195	O
11155	(	153 154	46813 46814	0.9999895095825195	O
11156	Figure	155 161	46815 46821	0.9999886751174927	O
11157	1C	162 163	46822 46823	0.9999891519546509	O
11159	,	164 165	46824 46825	0.9999890327453613	O
11160	D	165 166	46825 46826	0.9999879598617554	O
11161	)	166 167	46826 46827	0.9999896287918091	O
11162	.	168 169	46828 46829	0.9999737739562988	O
11163	Particular	0 9	46830 46839	0.9999861717224121	O
11165	histological	11 22	46841 46852	0.9999850988388062	O
11168	features	24 32	46854 46862	0.9999854564666748	O
11169	among	33 38	46863 46868	0.9999847412109375	O
11170	the	39 42	46869 46872	0.9999843835830688	O
11171	Group	43 48	46873 46878	0.999982476234436	O
11172	A	49 50	46879 46880	0.999980092048645	O
11173	polyps	51 56	46881 46886	0.9999853372573853	O
11176	were	58 62	46888 46892	0.9999866485595703	O
11177	:	63 64	46893 46894	0.9999871253967285	O
11178	marked	65 71	46895 46901	0.9999833106994629	O
11179	serration	72 80	46902 46910	0.9999880790710449	O
11182	,	82 83	46912 46913	0.9999877214431763	O
11183	a	84 85	46914 46915	0.9999877214431763	O
11184	papillary	86 94	46916 46924	0.9999878406524658	O
11188	or	96 98	46926 46928	0.9999858140945435	O
11189	villous	99 105	46929 46935	0.999985933303833	O
11192	architecture	107 119	46937 46949	0.9999866485595703	O
11193	,	120 121	46950 46951	0.9999880790710449	O
11194	a	122 123	46952 46953	0.9999881982803345	O
11195	relatively	124 134	46954 46964	0.9999867677688599	O
11196	abundant	135 143	46965 46973	0.9999874830245972	O
11197	eosinophilic	144 155	46974 46985	0.9999877214431763	O
11202	cytoplasm	157 165	46987 46995	0.9999881982803345	O
11207	,	167 168	46997 46998	0.9999879598617554	O
11208	columnar	169 176	46999 47006	0.9999858140945435	O
11210	cells	178 183	47008 47013	0.9999866485595703	O
11211	with	184 188	47014 47018	0.9999872446060181	O
11212	apical	189 194	47019 47024	0.9999885559082031	O
11214	mucin	196 200	47026 47030	0.9999864101409912	O
11217	droplets	202 209	47032 47039	0.9999876022338867	O
11219	,	211 212	47041 47042	0.9999873638153076	O
11220	nuclei	213 219	47043 47049	0.9999858140945435	O
11221	that	220 224	47050 47054	0.9999884366989136	O
11222	were	225 229	47055 47059	0.9999884366989136	O
11223	enlarged	230 238	47060 47068	0.999983549118042	O
11224	,	239 240	47069 47070	0.9999874830245972	O
11225	ovoid	241 245	47071 47075	0.9999874830245972	O
11228	,	247 248	47077 47078	0.9999872446060181	O
11229	vesicular	249 257	47079 47087	0.9999872446060181	O
11232	and	259 262	47089 47092	0.9999864101409912	O
11233	contained	263 272	47093 47102	0.9999860525131226	O
11234	a	273 274	47103 47104	0.9999880790710449	O
11235	prominent	275 284	47105 47114	0.9999855756759644	O
11236	nucleolus	285 293	47115 47123	0.9999879598617554	O
11240	,	295 296	47125 47126	0.9999842643737793	O
11241	and	297 300	47127 47130	0.999987006187439	O
11242	adjacent	301 309	47131 47139	0.9999793767929077	O
11243	non	310 313	47140 47143	0.9999862909317017	O
11244	-	313 314	47143 47144	0.9999880790710449	O
11245	dysplastic	314 323	47144 47153	0.9999864101409912	O
11249	serrated	325 332	47155 47162	0.9999878406524658	O
11252	polyp	334 338	47164 47168	0.9999873638153076	O
11255	.	340 341	47170 47171	0.9999403953552246	O
11256	Particular	0 9	47172 47181	0.9999867677688599	O
11258	histological	11 22	47183 47194	0.9999856948852539	O
11261	features	24 32	47196 47204	0.9999855756759644	O
11262	among	33 38	47205 47210	0.9999850988388062	O
11263	the	39 42	47211 47214	0.9999854564666748	O
11264	Group	43 48	47215 47220	0.9999823570251465	O
11265	B	49 50	47221 47222	0.9999762773513794	O
11266	polyps	51 56	47223 47228	0.9999853372573853	O
11269	were	58 62	47230 47234	0.9999871253967285	O
11270	:	63 64	47235 47236	0.9999871253967285	O
11271	some	65 69	47237 47241	0.9999853372573853	O
11272	glandular	70 78	47242 47250	0.9999876022338867	O
11275	serration	80 88	47252 47260	0.999988317489624	O
11278	,	90 91	47262 47263	0.9999884366989136	O
11279	frequent	92 100	47264 47272	0.9999840259552002	O
11280	villous	101 107	47273 47279	0.9999876022338867	O
11283	change	109 115	47281 47287	0.9999880790710449	O
11284	and	116 119	47288 47291	0.999988317489624	O
11285	epithelial	120 129	47292 47301	0.9999878406524658	O
11289	dysplasia	131 139	47303 47311	0.9999885559082031	O
11293	that	141 145	47313 47317	0.9999881982803345	O
11294	appeared	146 154	47318 47326	0.9999861717224121	O
11295	adenomatous	155 165	47327 47337	0.999985933303833	O
11299	(	167 168	47339 47340	0.9999887943267822	O
11300	cytoplasmic	169 179	47341 47351	0.9999889135360718	O
11305	basophilia	181 190	47353 47362	0.9999884366989136	O
11310	and	192 195	47364 47367	0.9999874830245972	O
11311	nuclei	196 202	47368 47374	0.9999856948852539	O
11312	that	203 207	47375 47379	0.9999884366989136	O
11313	were	208 212	47380 47384	0.9999887943267822	O
11314	elongated	213 222	47385 47394	0.9999803304672241	O
11315	,	223 224	47395 47396	0.999987006187439	O
11316	pseudostratified	225 240	47397 47412	0.9999885559082031	O
11320	and	242 245	47414 47417	0.9999873638153076	O
11321	hyperchromatic	246 259	47418 47431	0.9999880790710449	O
11325	without	261 268	47433 47440	0.9999843835830688	O
11326	a	269 270	47441 47442	0.9999880790710449	O
11327	prominent	271 280	47443 47452	0.9999837875366211	O
11328	nucleolus	281 289	47453 47461	0.9999876022338867	O
11332	)	291 292	47463 47464	0.9999864101409912	O
11333	.	293 294	47465 47466	0.9999624490737915	O
11334	Importantly	0 10	47467 47477	0.9999840259552002	O
11336	,	12 13	47479 47480	0.9999884366989136	O
11337	BRAF	14 17	47481 47484	0.9999828338623047	O
11339	mutation	19 27	47486 47494	0.9999861717224121	O
11340	occurred	28 36	47495 47503	0.9999886751174927	O
11341	more	37 41	47504 47508	0.9999874830245972	O
11342	frequently	42 52	47509 47519	0.9999880790710449	O
11343	among	53 58	47520 47525	0.9999881982803345	O
11344	Group	59 64	47526 47531	0.9999873638153076	O
11345	A	65 66	47532 47533	0.9999861717224121	O
11346	polyps	67 72	47534 47539	0.999988317489624	O
11349	(	74 75	47541 47542	0.9999890327453613	O
11350	P	76 77	47543 47544	0.9999889135360718	O
11351	<	78 79	47545 47546	0.999988317489624	O
11352	0	80 81	47547 47548	0.9999885559082031	O
11353	.	81 82	47548 47549	0.9999885559082031	O
11354	03	82 84	47549 47551	0.9999874830245972	O
11355	)	85 86	47552 47553	0.9999890327453613	O
11356	,	87 88	47554 47555	0.9999885559082031	O
11357	whereas	89 96	47556 47563	0.9999879598617554	O
11358	there	97 102	47564 47569	0.9999886751174927	O
11359	was	103 106	47570 47573	0.9999884366989136	O
11360	a	107 108	47574 47575	0.9999885559082031	O
11361	trend	109 114	47576 47581	0.9999874830245972	O
11362	for	115 118	47582 47585	0.9999885559082031	O
11363	KRAS	119 122	47586 47589	0.999985933303833	O
11366	to	124 126	47591 47593	0.9999881982803345	O
11367	be	127 129	47594 47596	0.9999884366989136	O
11368	more	130 134	47597 47601	0.9999880790710449	O
11369	frequent	135 143	47602 47610	0.9999885559082031	O
11370	among	144 149	47611 47616	0.9999881982803345	O
11371	Group	150 155	47617 47622	0.9999868869781494	O
11372	B	156 157	47623 47624	0.9999850988388062	O
11373	polyps	158 163	47625 47630	0.9999884366989136	O
11376	(	165 166	47632 47633	0.9999887943267822	O
11377	P	167 168	47634 47635	0.9999885559082031	O
11378	=	169 170	47636 47637	0.999988317489624	O
11379	0	171 172	47638 47639	0.9999884366989136	O
11380	.	172 173	47639 47640	0.999988317489624	O
11381	06	173 175	47640 47642	0.9999866485595703	O
11382	)	176 177	47643 47644	0.9999889135360718	O
11383	.	178 179	47645 47646	0.9999889135360718	O
11384	*	180 181	47647 47648	0.9999874830245972	O
11385	*	181 182	47648 47649	0.9999741315841675	O
11386	IGNORE	0 5	47650 47655	0.9999860525131226	O
11389	LINE	7 10	47657 47660	0.9999887943267822	O
11392	*	12 13	47662 47663	0.9999887943267822	O
11393	*	13 14	47663 47664	0.9999887943267822	O
11394	*	15 16	47665 47666	0.9999887943267822	O
11395	*	16 17	47666 47667	0.9999889135360718	O
11396	IGNORE	18 23	47668 47673	0.9999877214431763	O
11399	LINE	25 28	47675 47678	0.9999890327453613	O
11402	*	30 31	47680 47681	0.9999887943267822	O
11403	*	31 32	47681 47682	0.9999887943267822	O
11404	*	33 34	47683 47684	0.9999886751174927	O
11405	*	34 35	47684 47685	0.9999886751174927	O
11406	IGNORE	36 41	47686 47691	0.9999873638153076	O
11409	LINE	43 46	47693 47696	0.9999889135360718	O
11412	*	48 49	47698 47699	0.9999887943267822	O
11413	*	49 50	47699 47700	0.9999885559082031	O
11414	In	51 53	47701 47703	0.9999887943267822	O
11415	summary	54 61	47704 47711	0.9999852180480957	O
11416	,	62 63	47712 47713	0.9999889135360718	O
11417	MPs	64 67	47714 47717	0.9999769926071167	O
11418	and	68 71	47718 47721	0.999987006187439	O
11419	SAs	72 74	47722 47724	0.9999725818634033	O
11421	account	76 83	47726 47733	0.9999876022338867	O
11422	for	84 87	47734 47737	0.9999877214431763	O
11423	only	88 92	47738 47742	0.999984622001648	O
11424	about	93 98	47743 47748	0.9999860525131226	O
11425	2	99 100	47749 47750	0.9999814033508301	O
11426	%	101 102	47751 47752	0.9999861717224121	O
11427	of	103 105	47753 47755	0.9999852180480957	O
11428	colorectal	106 115	47756 47765	0.9999840259552002	O
11431	polyps	117 122	47767 47772	0.9999865293502808	O
11434	.	124 125	47774 47775	0.999967098236084	O
11435	Nevertheless	0 12	47776 47788	0.9999735355377197	O
11436	,	13 14	47789 47790	0.9999853372573853	O
11437	those	15 20	47791 47796	0.9999812841415405	O
11438	serrated	21 28	47797 47804	0.9999767541885376	O
11441	polyps	30 35	47806 47811	0.9999834299087524	O
11444	with	37 41	47813 47817	0.9999842643737793	O
11445	dysplasia	42 50	47818 47826	0.9999849796295166	O
11449	show	52 56	47828 47832	0.999984860420227	O
11450	frequent	57 65	47833 47841	0.9999867677688599	O
11451	mutation	66 74	47842 47850	0.9999867677688599	O
11452	of	75 77	47851 47853	0.9999884366989136	O
11453	either	78 84	47854 47860	0.9999878406524658	O
11454	KRAS	85 88	47861 47864	0.9999854564666748	O
11457	or	90 92	47866 47868	0.9999879598617554	O
11458	BRAF	93 96	47869 47872	0.9999843835830688	O
11460	and	98 101	47874 47877	0.9999867677688599	O
11461	frequent	102 110	47878 47886	0.9999872446060181	O
11462	loss	111 115	47887 47891	0.9999876022338867	O
11463	of	116 118	47892 47894	0.9999889135360718	O
11464	expression	119 129	47895 47905	0.9999885559082031	O
11465	of	130 132	47906 47908	0.9999889135360718	O
11466	MGMT	133 136	47909 47912	0.999983549118042	O
11468	(	138 139	47914 47915	0.9999887943267822	O
11469	particularly	140 152	47916 47928	0.9999864101409912	O
11470	MP	153 155	47929 47931	0.9999713897705078	O
11471	)	156 157	47932 47933	0.9999887943267822	O
11472	.	158 159	47934 47935	0.9999681711196899	O
11473	Additionally	0 12	47936 47948	0.9999786615371704	O
11474	,	13 14	47949 47950	0.9999862909317017	O
11475	four	15 19	47951 47955	0.9999724626541138	O
11476	of	20 22	47956 47958	0.9999860525131226	O
11477	25	23 25	47959 47961	0.999932050704956	O
11478	(	26 27	47962 47963	0.9999865293502808	O
11479	16	28 30	47964 47966	0.9999706745147705	O
11480	%	31 32	47967 47968	0.9999864101409912	O
11481	)	33 34	47969 47970	0.999987006187439	O
11482	showed	35 41	47971 47977	0.9999856948852539	O
11483	high	42 46	47978 47982	0.9999860525131226	O
11484	-	46 47	47982 47983	0.9999879598617554	O
11485	grade	47 52	47983 47988	0.9999854564666748	O
11486	dysplasia	53 61	47989 47997	0.9999871253967285	O
11490	and	63 66	47999 48002	0.9999864101409912	O
11491	in	67 69	48003 48005	0.9999872446060181	O
11492	three	70 75	48006 48011	0.9999759197235107	O
11493	of	76 78	48012 48014	0.999987006187439	O
11494	these	79 84	48015 48020	0.9999862909317017	O
11495	there	85 90	48021 48026	0.9999879598617554	O
11496	was	91 94	48027 48030	0.9999884366989136	O
11497	concordant	95 104	48031 48040	0.999988317489624	O
11500	aberrant	106 113	48042 48049	0.9999885559082031	O
11503	nuclear	115 122	48051 48058	0.9999867677688599	O
11504	expression	123 133	48059 48069	0.9999879598617554	O
11505	of	134 136	48070 48072	0.9999880790710449	O
11506	p53	137 139	48073 48075	0.9999878406524658	O
11508	.	141 142	48077 48078	0.9999606609344482	O
11509	Along	0 5	48079 48084	0.9999818801879883	O
11510	with	6 10	48085 48089	0.9999874830245972	O
11511	SSAs	11 14	48090 48093	0.9999834299087524	O
11513	,	16 17	48095 48096	0.9999855756759644	O
11514	these	18 23	48097 48102	0.9999843835830688	O
11515	rare	24 28	48103 48107	0.9999750852584839	O
11516	polyps	29 34	48108 48113	0.9999814033508301	O
11519	may	36 39	48115 48118	0.9999831914901733	O
11520	serve	40 45	48119 48124	0.9999854564666748	O
11521	as	46 48	48125 48127	0.9999871253967285	O
11522	the	49 52	48128 48131	0.9999872446060181	O
11523	precursors	53 62	48132 48141	0.9999806880950928	O
11525	of	64 66	48143 48145	0.999987006187439	O
11526	sporadic	67 74	48146 48153	0.999984860420227	O
11528	CRCs	76 79	48155 48158	0.9999804496765137	O
11530	with	81 85	48160 48164	0.9999885559082031	O
11531	BRAF	86 89	48165 48168	0.9999856948852539	O
11533	mutation	91 99	48170 48178	0.9999887943267822	O
11534	and	100 103	48179 48182	0.9999885559082031	O
11535	DNA	104 107	48183 48186	0.9999880790710449	O
11536	methylation	108 118	48187 48197	0.9999884366989136	O
11539	(	120 121	48199 48200	0.9999890327453613	O
11540	with	122 126	48201 48205	0.9999887943267822	O
11541	and	127 130	48206 48209	0.9999880790710449	O
11542	without	131 138	48210 48217	0.9999884366989136	O
11543	DNA	139 142	48218 48221	0.9999867677688599	O
11544	MSI	143 145	48222 48224	0.9999879598617554	O
11546	)	146 147	48225 48226	0.9999886751174927	O
11547	and	148 151	48227 48230	0.9999849796295166	O
11548	a	152 153	48231 48232	0.9999866485595703	O
11549	subset	154 160	48233 48239	0.9999850988388062	O
11550	of	161 163	48240 48242	0.9999867677688599	O
11551	CRCs	164 167	48243 48246	0.9999818801879883	O
11553	with	169 173	48248 48252	0.9999881982803345	O
11554	KRAS	174 177	48253 48256	0.9999839067459106	O
11557	mutation	179 187	48258 48266	0.9999878406524658	O
11558	.	188 189	48267 48268	0.9999622106552124	O
11559	Their	0 5	48269 48274	0.9999797344207764	O
11560	malignant	6 14	48275 48283	0.999983549118042	O
11563	potential	16 25	48285 48294	0.9999823570251465	O
11564	is	26 28	48295 48297	0.9999867677688599	O
11565	explained	29 38	48298 48307	0.9999847412109375	O
11566	by	39 41	48308 48310	0.9999876022338867	O
11567	the	42 45	48311 48314	0.9999877214431763	O
11568	accumulation	46 58	48315 48327	0.9999767541885376	O
11569	of	59 61	48328 48330	0.9999876022338867	O
11570	genetic	62 69	48331 48338	0.9999847412109375	O
11571	alterations	70 81	48339 48350	0.9999852180480957	O
11572	that	82 86	48351 48355	0.9999878406524658	O
11573	may	87 90	48356 48359	0.9999876022338867	O
11574	in	91 93	48360 48362	0.9999868869781494	O
11575	turn	94 98	48363 48367	0.9999828338623047	O
11576	depend	99 105	48368 48374	0.9999867677688599	O
11577	upon	106 110	48375 48379	0.9999865293502808	O
11578	the	111 114	48380 48383	0.9999874830245972	O
11579	inactivation	115 126	48384 48395	0.9999871253967285	O
11582	of	128 130	48397 48399	0.9999871253967285	O
11583	the	131 134	48400 48403	0.9999871253967285	O
11584	DNA	135 138	48404 48407	0.999984860420227	O
11585	repair	139 145	48408 48414	0.9999852180480957	O
11586	gene	146 150	48415 48419	0.9999874830245972	O
11587	MGMT	151 154	48420 48423	0.9999836683273315	O
11589	.	155 156	48424 48425	0.9999880790710449	O
11590	28	156 158	48425 48427	0.9999841451644897	O
11591	The	159 162	48428 48431	0.9999873638153076	O
11592	importance	163 173	48432 48442	0.9999861717224121	O
11593	of	174 176	48443 48445	0.9999862909317017	O
11594	these	177 182	48446 48451	0.999985933303833	O
11595	‘	183 184	48452 48453	0.9999809265136719	O
11596	fusion	184 190	48453 48459	0.9999792575836182	O
11597	’	191 192	48460 48461	0.9999748468399048	O
11598	polyps	193 198	48462 48467	0.9999849796295166	O
11601	as	200 202	48469 48471	0.9999850988388062	O
11602	cancer	203 209	48472 48478	0.9999792575836182	O
11603	precursors	210 219	48479 48488	0.9999825954437256	O
11605	may	221 224	48490 48493	0.9999868869781494	O
11606	be	225 227	48494 48496	0.9999878406524658	O
11607	under	228 233	48497 48502	0.9999865293502808	O
11608	-	233 234	48502 48503	0.9999874830245972	O
11609	appreciated	234 245	48503 48514	0.9999871253967285	O
11610	because	246 253	48515 48522	0.9999871253967285	O
11611	critical	254 262	48523 48531	0.9999849796295166	O
11612	rate	263 267	48532 48536	0.9999861717224121	O
11613	-	267 268	48536 48537	0.9999874830245972	O
11614	limiting	268 276	48537 48545	0.9999853372573853	O
11615	changes	277 284	48546 48553	0.999985933303833	O
11616	governing	285 294	48554 48563	0.9999827146530151	O
11617	malignant	295 303	48564 48572	0.9999856948852539	O
11620	transition	305 315	48574 48584	0.999985933303833	O
11621	,	316 317	48585 48586	0.9999874830245972	O
11622	particularly	318 330	48587 48599	0.9999865293502808	O
11623	in	331 333	48600 48602	0.9999874830245972	O
11624	association	334 345	48603 48614	0.9999873638153076	O
11625	with	346 350	48615 48619	0.9999874830245972	O
11626	loss	351 355	48620 48624	0.9999867677688599	O
11627	of	356 358	48625 48627	0.9999873638153076	O
11628	function	359 367	48628 48636	0.9999865293502808	O
11629	of	368 370	48637 48639	0.9999872446060181	O
11630	MLH1	371 374	48640 48643	0.9999866485595703	O
11633	of	376 378	48645 48647	0.9999865293502808	O
11634	p53	379 381	48648 48650	0.9999874830245972	O
11636	,	383 384	48652 48653	0.999985933303833	O
11637	occur	385 390	48654 48659	0.9999865293502808	O
11638	rapidly	391 398	48660 48667	0.9999856948852539	O
11639	and	399 402	48668 48671	0.9999873638153076	O
11640	can	403 406	48672 48675	0.9999855756759644	O
11641	rarely	407 413	48676 48682	0.9999818801879883	O
11642	be	414 416	48683 48685	0.9999873638153076	O
11643	‘	417 418	48686 48687	0.9999856948852539	O
11644	caught	418 424	48687 48693	0.999984860420227	O
11645	in	425 427	48694 48696	0.9999877214431763	O
11646	the	428 431	48697 48700	0.9999878406524658	O
11647	act	432 435	48701 48704	0.9999850988388062	O
11648	’	435 436	48704 48705	0.999976396560669	O
11649	.	437 438	48706 48707	0.9999878406524658	O
11650	*	439 440	48708 48709	0.9999861717224121	O
11651	*	440 441	48709 48710	0.9999713897705078	O
11652	IGNORE	0 5	48711 48716	0.9999861717224121	O
11655	LINE	7 10	48718 48721	0.9999884366989136	O
11658	*	12 13	48723 48724	0.9999885559082031	O
11659	*	13 14	48724 48725	0.9999885559082031	O
11660	*	15 16	48726 48727	0.9999885559082031	O
11661	*	16 17	48727 48728	0.9999885559082031	O
11662	IGNORE	18 23	48729 48734	0.9999874830245972	O
11665	LINE	25 28	48736 48739	0.9999886751174927	O
11668	*	30 31	48741 48742	0.999988317489624	O
11669	*	31 32	48742 48743	0.999988317489624	O
11670	*	33 34	48744 48745	0.9999881982803345	O
11671	*	34 35	48745 48746	0.9999881982803345	O
11672	IGNORE	36 41	48747 48752	0.999987006187439	O
11675	LINE	43 46	48754 48757	0.999988317489624	O
11678	*	48 49	48759 48760	0.9999881982803345	O
11679	*	49 50	48760 48761	0.9999881982803345	O
11680	Methods	51 57	48762 48768	0.9999864101409912	O
11682	Patients	59 66	48770 48777	0.9999873638153076	O
11684	A	68 69	48779 48780	0.9999873638153076	O
11685	large	70 75	48781 48786	0.9999483823776245	O
11686	colorectal	76 85	48787 48796	0.9999853372573853	O
11689	cancer	87 93	48798 48804	0.999985933303833	O
11690	family	94 100	48805 48811	0.9999793767929077	O
11691	(	101 102	48812 48813	0.9999890327453613	O
11692	Figure	103 109	48814 48820	0.999987006187439	O
11693	1	110 111	48821 48822	0.9999884366989136	O
11694	)	112 113	48823 48824	0.9999892711639404	O
11695	with	114 118	48825 48829	0.9999887943267822	O
11696	a	119 120	48830 48831	0.9999889135360718	O
11697	recently	121 129	48832 48840	0.9999874830245972	O
11698	identified	130 140	48841 48851	0.9999879598617554	O
11699	mutation	141 149	48852 48860	0.9999861717224121	O
11700	in	150 152	48861 48863	0.9999885559082031	O
11701	the	153 156	48864 48867	0.9999885559082031	O
11702	MLH1	157 160	48868 48871	0.9999865293502808	O
11705	gene	162 166	48873 48877	0.9999880790710449	O
11706	(	167 168	48878 48879	0.9999886751174927	O
11707	c	169 170	48880 48881	0.999988317489624	O
11708	.	170 171	48881 48882	0.9999889135360718	O
11709	1046dupT	171 178	48882 48889	0.9999861717224121	O
11714	,	180 181	48891 48892	0.9999884366989136	O
11715	p	182 183	48893 48894	0.9999867677688599	O
11716	.	183 184	48894 48895	0.9999765157699585	O
11717	Pro350fs	0 7	48895 48902	0.9999821186065674	O
11721	)	9 10	48904 48905	0.9999791383743286	O
11722	was	11 14	48906 48909	0.9999809265136719	O
11723	studied	15 22	48910 48917	0.999968409538269	O
11724	.	23 24	48918 48919	0.9999167919158936	O
11725	Nine	0 4	48920 48924	0.9999425411224365	O
11726	family	5 11	48925 48931	0.999953031539917	O
11727	members	12 19	48932 48939	0.9999653100967407	O
11728	are	20 23	48940 48943	0.9999717473983765	O
11729	affected	24 32	48944 48952	0.999966025352478	O
11730	with	33 37	48953 48957	0.9999761581420898	O
11731	colorectal	38 47	48958 48967	0.9999654293060303	O
11734	cancer	49 55	48969 48975	0.9999758005142212	O
11735	.	56 57	48976 48977	0.9998214840888977	O
11736	Another	0 7	48978 48985	0.9999816417694092	O
11737	two	8 11	48986 48989	0.9999836683273315	O
11738	family	12 18	48990 48996	0.9999740123748779	O
11739	members	19 26	48997 49004	0.9999816417694092	O
11740	are	27 30	49005 49008	0.9999864101409912	O
11741	affected	31 39	49009 49017	0.9999804496765137	O
11742	with	40 44	49018 49022	0.9999873638153076	O
11743	polyps	45 50	49023 49028	0.9999822378158569	O
11746	and	52 55	49030 49033	0.9999872446060181	O
11747	three	56 61	49034 49039	0.99997878074646	O
11748	cases	62 67	49040 49045	0.9999861717224121	O
11749	with	68 72	49046 49050	0.9999879598617554	O
11750	skin	73 77	49051 49055	0.9999725818634033	O
11751	cancer	78 84	49056 49062	0.9999880790710449	O
11752	(	85 86	49063 49064	0.9999890327453613	O
11753	non	87 90	49065 49068	0.9999886751174927	O
11754	-	90 91	49068 49069	0.9999887943267822	O
11755	specified	91 100	49069 49078	0.999988317489624	O
11756	)	101 102	49079 49080	0.9999887943267822	O
11757	and	103 106	49081 49084	0.9999879598617554	O
11758	one	107 110	49085 49088	0.9999839067459106	O
11759	case	111 115	49089 49093	0.9999868869781494	O
11760	with	116 120	49094 49098	0.9999880790710449	O
11761	endometrium	121 131	49099 49109	0.9999849796295166	O
11765	cancer	133 139	49111 49117	0.9999880790710449	O
11766	(	140 141	49118 49119	0.9999889135360718	O
11767	non	142 145	49120 49123	0.9999886751174927	O
11768	-	145 146	49123 49124	0.9999885559082031	O
11769	specified	146 155	49124 49133	0.999988317489624	O
11770	)	156 157	49134 49135	0.9999887943267822	O
11771	are	158 161	49136 49139	0.9999871253967285	O
11772	seen	162 166	49140 49144	0.9999853372573853	O
11773	as	167 169	49145 49147	0.9999864101409912	O
11774	well	170 174	49148 49152	0.9999866485595703	O
11775	.	175 176	49153 49154	0.9999644756317139	O
11776	Peripheral	0 9	49155 49164	0.9999701976776123	O
11780	blood	11 16	49166 49171	0.999971866607666	O
11781	lymphocytes	17 27	49172 49182	0.9999756813049316	O
11784	were	29 33	49184 49188	0.9999737739562988	O
11785	collected	34 43	49189 49198	0.9999719858169556	O
11786	from	44 48	49199 49203	0.9999769926071167	O
11787	the	49 52	49204 49207	0.999974250793457	O
11788	family	53 59	49208 49214	0.9999657869338989	O
11789	members	60 67	49215 49222	0.9999734163284302	O
11790	.	68 69	49223 49224	0.9998612403869629	O
11791	DNA	0 3	49225 49228	0.9999547004699707	O
11792	was	4 7	49229 49232	0.9999662637710571	O
11793	extracted	8 17	49233 49242	0.9999727010726929	O
11794	using	18 23	49243 49248	0.9999731779098511	O
11795	standard	24 32	49249 49257	0.999964714050293	O
11796	procedures	33 43	49258 49268	0.9999704360961914	O
11797	.	44 45	49269 49270	0.9997790455818176	O
11798	A	0 1	49271 49272	0.9999798536300659	O
11799	total	2 7	49273 49278	0.9999833106994629	O
11800	of	8 10	49279 49281	0.9999839067459106	O
11801	thirteen	11 19	49282 49290	0.9999630451202393	O
11802	family	20 26	49291 49297	0.9999692440032959	O
11803	members	27 34	49298 49305	0.9999725818634033	O
11804	were	35 39	49306 49310	0.9999825954437256	O
11805	genotyped	40 48	49311 49319	0.9999845027923584	O
11809	on	50 52	49321 49323	0.9999865293502808	O
11810	Affymetrix	53 62	49324 49333	0.9999881982803345	O
11814	GeneChip	64 71	49335 49342	0.9999871253967285	O
11817	Human	73 78	49344 49349	0.999982476234436	O
11818	Mapping	79 85	49350 49356	0.9999874830245972	O
11820	10K	87 89	49358 49360	0.9999868869781494	O
11822	2	91 92	49362 49363	0.9999873638153076	O
11823	.	92 93	49363 49364	0.9999884366989136	O
11824	0	93 94	49364 49365	0.9999872446060181	O
11825	SNP	95 97	49366 49368	0.9999876022338867	O
11827	arrays	99 104	49370 49375	0.9999874830245972	O
11829	.	106 107	49377 49378	0.9999620914459229	O
11830	The	0 3	49379 49382	0.9999774694442749	O
11831	arrays	4 9	49383 49388	0.9999639987945557	O
11833	were	11 15	49390 49394	0.9999784231185913	O
11834	processed	16 25	49395 49404	0.999976634979248	O
11835	according	26 35	49405 49414	0.999984860420227	O
11836	to	36 38	49415 49417	0.9999864101409912	O
11837	the	39 42	49418 49421	0.9999855756759644	O
11838	instructions	43 55	49422 49434	0.9999834299087524	O
11839	of	56 58	49435 49437	0.9999860525131226	O
11840	the	59 62	49438 49441	0.9999849796295166	O
11841	manufacturer	63 75	49442 49454	0.9999808073043823	O
11842	.	76 77	49455 49456	0.9999183416366577	O
11843	The	0 3	49457 49460	0.9999809265136719	O
11844	mean	4 8	49461 49465	0.9999783039093018	O
11845	SNP	9 11	49466 49468	0.9999830722808838	O
11847	call	13 17	49470 49474	0.9999839067459106	O
11848	rate	18 22	49475 49479	0.999984622001648	O
11849	was	23 26	49480 49483	0.9999840259552002	O
11850	96	27 29	49484 49486	0.9999854564666748	O
11851	.	29 30	49486 49487	0.9999872446060181	O
11852	3	30 31	49487 49488	0.9999836683273315	O
11853	%	32 33	49489 49490	0.9999872446060181	O
11854	(	34 35	49491 49492	0.999987006187439	O
11855	89	35 37	49492 49494	0.9999864101409912	O
11856	.	37 38	49494 49495	0.9999879598617554	O
11857	0	38 39	49495 49496	0.9999873638153076	O
11858	%	39 40	49496 49497	0.9999878406524658	O
11859	-	40 41	49497 49498	0.9999872446060181	O
11860	98	41 43	49498 49500	0.9999842643737793	O
11861	.	43 44	49500 49501	0.9999879598617554	O
11862	5	44 45	49501 49502	0.9999855756759644	O
11863	%	46 47	49503 49504	0.9999878406524658	O
11864	)	48 49	49505 49506	0.9999877214431763	O
11865	.	50 51	49507 49508	0.9999574422836304	O
11866	The	0 3	49509 49512	0.9999827146530151	O
11867	study	4 9	49513 49518	0.9999796152114868	O
11868	was	10 13	49519 49522	0.9999850988388062	O
11869	approved	14 22	49523 49531	0.9999823570251465	O
11870	by	23 25	49532 49534	0.9999856948852539	O
11871	the	26 29	49535 49538	0.999985933303833	O
11872	Medical	30 37	49539 49546	0.9999839067459106	O
11873	Ethical	38 44	49547 49553	0.9999860525131226	O
11875	Committee	46 55	49555 49564	0.9999842643737793	O
11876	of	56 58	49565 49567	0.9999860525131226	O
11877	the	59 62	49568 49571	0.9999867677688599	O
11878	LUMC	63 66	49572 49575	0.9999861717224121	O
11881	(	68 69	49577 49578	0.9999881982803345	O
11882	protocol	70 78	49579 49587	0.999985933303833	O
11883	P01	79 81	49588 49590	0.9999874830245972	O
11885	-	82 83	49591 49592	0.9999884366989136	O
11886	019	83 85	49592 49594	0.9999885559082031	O
11888	)	87 88	49596 49597	0.9999885559082031	O
11889	.	89 90	49598 49599	0.9999668598175049	O
11890	Workflow	0 7	49600 49607	0.9999881982803345	O
11892	We	9 11	49609 49611	0.9999836683273315	O
11893	processed	12 21	49612 49621	0.9999861717224121	O
11894	the	22 25	49622 49625	0.9999887943267822	O
11895	data	26 30	49626 49630	0.9999866485595703	O
11896	according	31 40	49631 49640	0.9999892711639404	O
11897	to	41 43	49641 49643	0.9999896287918091	O
11898	the	44 47	49644 49647	0.9999895095825195	O
11899	following	48 57	49648 49657	0.9999890327453613	O
11900	workflow	58 65	49658 49665	0.9999892711639404	O
11902	:	67 68	49667 49668	0.99998939037323	O
11903	1	69 70	49669 49670	0.9999862909317017	O
11904	)	71 72	49671 49672	0.9999895095825195	O
11905	First	73 78	49673 49678	0.9999880790710449	O
11906	,	79 80	49679 49680	0.99998939037323	O
11907	the	81 84	49681 49684	0.99998939037323	O
11908	genotype	85 92	49685 49692	0.9999879598617554	O
11911	data	94 98	49694 49698	0.9999891519546509	O
11912	were	99 103	49699 49703	0.99998939037323	O
11913	generated	104 113	49704 49713	0.99998939037323	O
11914	by	114 116	49714 49716	0.9999896287918091	O
11915	GeneChip	117 124	49717 49724	0.9999887943267822	O
11918	DNA	126 129	49726 49729	0.9999889135360718	O
11919	Analysis	130 138	49730 49738	0.9999892711639404	O
11920	Software	139 147	49739 49747	0.9999890327453613	O
11921	(	148 149	49748 49749	0.9999896287918091	O
11922	GDAS	150 153	49750 49753	0.9999881982803345	O
11925	)	155 156	49755 49756	0.9999896287918091	O
11926	from	157 161	49757 49761	0.9999891519546509	O
11927	Affymetrix	162 171	49762 49771	0.9999892711639404	O
11931	.	173 174	49773 49774	0.9999810457229614	O
11932	2	0 1	49775 49776	0.9999845027923584	O
11933	)	2 3	49777 49778	0.9999889135360718	O
11934	These	4 9	49779 49784	0.9999877214431763	O
11935	genotype	10 17	49785 49792	0.999987006187439	O
11938	data	19 23	49794 49798	0.9999868869781494	O
11939	were	24 28	49799 49803	0.9999887943267822	O
11940	combined	29 37	49804 49812	0.9999878406524658	O
11941	with	38 42	49813 49817	0.9999891519546509	O
11942	the	43 46	49818 49821	0.9999891519546509	O
11943	pedigree	47 54	49822 49829	0.9999886751174927	O
11947	and	56 59	49831 49834	0.999988317489624	O
11948	the	60 63	49835 49838	0.9999890327453613	O
11949	marker	64 70	49839 49845	0.9999867677688599	O
11950	information	71 82	49846 49857	0.9999886751174927	O
11951	in	83 85	49858 49860	0.9999890327453613	O
11952	Alohomora	86 94	49861 49869	0.9999874830245972	O
11956	.	96 97	49871 49872	0.9999772310256958	O
11957	3	0 1	49873 49874	0.9999819993972778	O
11958	)	2 3	49875 49876	0.9999885559082031	O
11959	In	4 6	49877 49879	0.9999881982803345	O
11960	this	7 11	49880 49884	0.9999885559082031	O
11961	program	12 19	49885 49892	0.999985933303833	O
11962	the	20 23	49893 49896	0.9999884366989136	O
11963	uninformative	24 36	49897 49909	0.9999886751174927	O
11967	SNPs	38 41	49911 49914	0.9999867677688599	O
11970	were	43 47	49916 49920	0.9999885559082031	O
11971	removed	48 55	49921 49928	0.9999873638153076	O
11972	as	56 58	49929 49931	0.9999868869781494	O
11973	well	59 63	49932 49936	0.9999877214431763	O
11974	.	64 65	49937 49938	0.9999755620956421	O
11975	4	0 1	49939 49940	0.9999845027923584	O
11976	)	2 3	49941 49942	0.9999892711639404	O
11977	To	4 6	49943 49945	0.9999886751174927	O
11978	be	7 9	49946 49948	0.9999891519546509	O
11979	able	10 14	49949 49953	0.9999872446060181	O
11980	to	15 17	49954 49956	0.9999891519546509	O
11981	perform	18 25	49957 49964	0.9999878406524658	O
11982	linkage	26 32	49965 49971	0.999984860420227	O
11984	analysis	34 42	49973 49981	0.9999885559082031	O
11985	in	43 45	49982 49984	0.9999895095825195	O
11986	the	46 49	49985 49988	0.9999898672103882	O
11987	desired	50 57	49989 49996	0.9999877214431763	O
11988	program	58 65	49997 50004	0.9999865293502808	O
11989	,	66 67	50005 50006	0.9999892711639404	O
11990	the	68 71	50007 50010	0.99998939037323	O
11991	output	72 78	50011 50017	0.9999874830245972	O
11992	files	79 84	50018 50023	0.9999881982803345	O
11993	(	85 86	50024 50025	0.9999898672103882	O
11994	in	87 89	50026 50028	0.9999895095825195	O
11995	Merlin	90 96	50029 50035	0.9999852180480957	O
11996	-	96 97	50035 50036	0.9999897480010986	O
11997	format	97 103	50036 50042	0.99998939037323	O
11998	)	104 105	50043 50044	0.9999897480010986	O
11999	of	106 108	50045 50047	0.9999896287918091	O
12000	Alohomora	109 117	50048 50056	0.9999881982803345	O
12004	were	119 123	50058 50062	0.9999891519546509	O
12005	by	124 126	50063 50065	0.9999896287918091	O
12006	Mega2	127 131	50066 50070	0.9999878406524658	O
12008	converted	133 142	50072 50081	0.9999891519546509	O
12009	to	143 145	50082 50084	0.9999895095825195	O
12010	the	146 149	50085 50088	0.9999896287918091	O
12011	proper	150 156	50089 50095	0.9999885559082031	O
12012	format	157 163	50096 50102	0.9999890327453613	O
12013	.	164 165	50103 50104	0.9999822378158569	O
12014	5	0 1	50105 50106	0.9999802112579346	O
12015	)	2 3	50107 50108	0.9999878406524658	O
12016	Mega2	4 8	50109 50113	0.9999849796295166	O
12018	also	10 14	50115 50119	0.999984860420227	O
12019	removed	15 22	50120 50127	0.9999823570251465	O
12020	the	23 26	50128 50131	0.9999864101409912	O
12021	Mendelian	27 35	50132 50140	0.9999837875366211	O
12024	inconsistent	37 49	50142 50154	0.9999852180480957	O
12025	errors	50 56	50155 50161	0.9999864101409912	O
12026	.	57 58	50162 50163	0.9999620914459229	O
12027	6	0 1	50164 50165	0.999985933303833	O
12028	)	2 3	50166 50167	0.9999895095825195	O
12029	The	4 7	50168 50171	0.9999886751174927	O
12030	files	8 13	50172 50177	0.9999819993972778	O
12031	were	14 18	50178 50182	0.9999887943267822	O
12032	then	19 23	50183 50187	0.9999868869781494	O
12033	ready	24 29	50188 50193	0.9999876022338867	O
12034	to	30 32	50194 50196	0.9999892711639404	O
12035	perform	33 40	50197 50204	0.9999890327453613	O
12036	parametric	41 50	50205 50214	0.99998939037323	O
12038	linkage	52 58	50216 50222	0.9999891519546509	O
12040	analysis	60 68	50224 50232	0.9999897480010986	O
12041	using	69 74	50233 50238	0.9999901056289673	O
12042	2	75 76	50239 50240	0.9999889135360718	O
12043	flanking	77 84	50241 50248	0.9999890327453613	O
12045	markers	86 93	50250 50257	0.99998939037323	O
12046	in	94 96	50258 50260	0.9999899864196777	O
12047	MENDEL	97 102	50261 50266	0.9999886751174927	O
12050	;	104 105	50268 50269	0.9999897480010986	O
12051	affected	106 114	50270 50278	0.999988317489624	O
12052	-	114 115	50278 50279	0.9999899864196777	O
12053	only	115 119	50279 50283	0.9999898672103882	O
12054	analysis	120 128	50284 50292	0.9999898672103882	O
12055	as	129 131	50293 50295	0.9999895095825195	O
12056	well	132 136	50296 50300	0.9999896287918091	O
12057	as	137 139	50301 50303	0.9999898672103882	O
12058	parametric	140 149	50304 50313	0.9999895095825195	O
12060	linkage	151 157	50315 50321	0.99998939037323	O
12062	analysis	159 167	50323 50331	0.9999897480010986	O
12063	using	168 173	50332 50337	0.9999898672103882	O
12064	liability	174 183	50338 50347	0.999982476234436	O
12065	classes	184 191	50348 50355	0.9999891519546509	O
12066	was	192 195	50356 50359	0.99998939037323	O
12067	performed	196 205	50360 50369	0.9999890327453613	O
12068	.	206 207	50370 50371	0.9999818801879883	O
12069	7	0 1	50372 50373	0.9999862909317017	O
12070	)	2 3	50374 50375	0.9999890327453613	O
12071	Based	4 9	50376 50381	0.9999887943267822	O
12072	on	10 12	50382 50384	0.9999891519546509	O
12073	the	13 16	50385 50388	0.99998939037323	O
12074	second	17 23	50389 50395	0.9999873638153076	O
12075	analysis	24 32	50396 50404	0.9999880790710449	O
12076	,	33 34	50405 50406	0.9999892711639404	O
12077	regions	35 42	50407 50414	0.9999878406524658	O
12078	of	43 45	50415 50417	0.9999892711639404	O
12079	interest	46 54	50418 50426	0.9999878406524658	O
12080	were	55 59	50427 50431	0.9999891519546509	O
12081	defined	60 67	50432 50439	0.9999872446060181	O
12082	that	68 72	50440 50444	0.9999891519546509	O
12083	were	73 77	50445 50449	0.9999891519546509	O
12084	further	78 85	50450 50457	0.9999887943267822	O
12085	tested	86 92	50458 50464	0.9999885559082031	O
12086	for	93 96	50465 50468	0.9999890327453613	O
12087	Mendelian	97 105	50469 50477	0.9999865293502808	O
12090	consistent	107 117	50479 50489	0.9999877214431763	O
12091	errors	118 124	50490 50496	0.9999889135360718	O
12092	and	125 128	50497 50500	0.99998939037323	O
12093	8	129 130	50501 50502	0.9999879598617554	O
12094	)	131 132	50503 50504	0.9999895095825195	O
12095	possible	133 141	50505 50513	0.9999889135360718	O
12096	linkage	142 148	50514 50520	0.9999884366989136	O
12098	disequilibrium	150 163	50522 50535	0.9999891519546509	O
12104	was	165 168	50537 50540	0.9999892711639404	O
12105	removed	169 176	50541 50548	0.9999886751174927	O
12106	in	177 179	50549 50551	0.9999891519546509	O
12107	SNPLINK	180 186	50552 50558	0.9999886751174927	O
12112	.	187 188	50559 50560	0.9999815225601196	O
12113	9	0 1	50561 50562	0.9999871253967285	O
12114	)	2 3	50563 50564	0.99998939037323	O
12115	Multipoint	4 13	50565 50574	0.9999889135360718	O
12117	parametric	15 24	50576 50585	0.9999887943267822	O
12119	linkage	26 32	50587 50593	0.9999881982803345	O
12121	analysis	34 42	50595 50603	0.9999892711639404	O
12122	using	43 48	50604 50609	0.99998939037323	O
12123	the	49 52	50610 50613	0.99998939037323	O
12124	liability	53 62	50614 50623	0.9999837875366211	O
12125	classes	63 70	50624 50631	0.9999887943267822	O
12126	was	71 74	50632 50635	0.99998939037323	O
12127	then	75 79	50636 50640	0.9999892711639404	O
12128	performed	80 89	50641 50650	0.9999890327453613	O
12129	in	90 92	50651 50653	0.9999895095825195	O
12130	Simwalk2	93 100	50654 50661	0.9999891519546509	O
12134	for	102 105	50663 50666	0.9999891519546509	O
12135	the	106 109	50667 50670	0.9999892711639404	O
12136	ROIs	110 113	50671 50674	0.9999890327453613	O
12140	and	115 118	50676 50679	0.9999891519546509	O
12141	10	119 121	50680 50682	0.999988317489624	O
12142	)	122 123	50683 50684	0.9999892711639404	O
12143	finally	124 131	50685 50692	0.9999885559082031	O
12144	,	132 133	50693 50694	0.9999891519546509	O
12145	the	134 137	50695 50698	0.99998939037323	O
12146	haplotypes	138 147	50699 50708	0.9999880790710449	O
12151	were	149 153	50710 50714	0.9999891519546509	O
12152	inferred	154 161	50715 50722	0.9999890327453613	O
12154	in	163 165	50724 50726	0.9999890327453613	O
12155	Simwalk2	166 173	50727 50734	0.9999889135360718	O
12159	.	175 176	50736 50737	0.9999798536300659	O
12160	Data	0 4	50738 50742	0.9999862909317017	O
12161	formatting	5 14	50743 50752	0.9999871253967285	O
12163	and	16 19	50754 50757	0.9999871253967285	O
12164	quality	20 27	50758 50765	0.9999879598617554	O
12165	control	28 35	50766 50773	0.9999864101409912	O
12166	Genotype	36 43	50774 50781	0.9999858140945435	O
12168	data	45 49	50783 50787	0.9999873638153076	O
12169	of	50 52	50788 50790	0.9999887943267822	O
12170	the	53 56	50791 50794	0.9999878406524658	O
12171	individual	57 67	50795 50805	0.9999843835830688	O
12172	family	68 74	50806 50812	0.9999853372573853	O
12173	members	75 82	50813 50820	0.9999855756759644	O
12174	were	83 87	50821 50825	0.9999885559082031	O
12175	generated	88 97	50826 50835	0.9999878406524658	O
12176	using	98 103	50836 50841	0.9999891519546509	O
12177	GeneChip	104 111	50842 50849	0.9999880790710449	O
12180	DNA	113 116	50851 50854	0.9999877214431763	O
12181	Analysis	117 125	50855 50863	0.9999885559082031	O
12182	Software	126 134	50864 50872	0.9999872446060181	O
12183	(	135 136	50873 50874	0.9999891519546509	O
12184	GDAS	137 140	50875 50878	0.9999866485595703	O
12187	)	142 143	50880 50881	0.9999895095825195	O
12188	from	144 148	50882 50886	0.9999886751174927	O
12189	Affymetrix	149 158	50887 50896	0.9999890327453613	O
12193	.	160 161	50898 50899	0.9999761581420898	O
12194	In	0 2	50900 50902	0.9999884366989136	O
12195	the	3 6	50903 50906	0.9999891519546509	O
12196	Alohomora	7 15	50907 50915	0.9999876022338867	O
12200	program	17 24	50917 50924	0.9999862909317017	O
12201	[	25 26	50925 50926	0.99998939037323	O
12202	32	26 28	50926 50928	0.9999842643737793	O
12203	]	29 30	50929 50930	0.9999881982803345	O
12204	the	31 34	50931 50934	0.9999891519546509	O
12205	pedigree	35 42	50935 50942	0.9999890327453613	O
12209	information	44 55	50944 50955	0.9999889135360718	O
12210	,	56 57	50956 50957	0.9999887943267822	O
12211	allele	58 63	50958 50963	0.9999887943267822	O
12213	frequencies	65 76	50965 50976	0.9999871253967285	O
12214	and	77 80	50977 50980	0.9999891519546509	O
12215	map	81 84	50981 50984	0.9999858140945435	O
12216	position	85 93	50985 50993	0.9999886751174927	O
12217	of	94 96	50994 50996	0.9999891519546509	O
12218	the	97 100	50997 51000	0.99998939037323	O
12219	SNPs	101 104	51001 51004	0.9999878406524658	O
12222	were	106 110	51006 51010	0.9999891519546509	O
12223	combined	111 119	51011 51019	0.9999889135360718	O
12224	with	120 124	51020 51024	0.9999892711639404	O
12225	the	125 128	51025 51028	0.9999895095825195	O
12226	genotype	129 136	51029 51036	0.9999885559082031	O
12229	data	138 142	51038 51042	0.9999892711639404	O
12230	generated	143 152	51043 51052	0.99998939037323	O
12231	by	153 155	51053 51055	0.9999895095825195	O
12232	GDAS	156 159	51056 51059	0.9999877214431763	O
12235	.	160 161	51060 51061	0.9999802112579346	O
12236	The	0 3	51062 51065	0.999988317489624	O
12237	uninformative	4 16	51066 51078	0.9999884366989136	O
12241	SNPs	18 21	51080 51083	0.9999872446060181	O
12244	in	23 25	51085 51087	0.9999881982803345	O
12245	this	26 30	51088 51092	0.9999876022338867	O
12246	pedigree	31 38	51093 51100	0.9999881982803345	O
12250	,	40 41	51102 51103	0.9999885559082031	O
12251	that	42 46	51104 51108	0.9999886751174927	O
12252	show	47 51	51109 51113	0.9999873638153076	O
12253	either	52 58	51114 51120	0.9999891519546509	O
12254	only	59 63	51121 51125	0.9999895095825195	O
12255	A	64 65	51126 51127	0.9999885559082031	O
12256	alleles	66 72	51128 51134	0.9999895095825195	O
12259	and	74 77	51136 51139	0.9999891519546509	O
12260	No	78 80	51140 51142	0.9999890327453613	O
12261	Calls	81 85	51143 51147	0.9999887943267822	O
12263	or	87 89	51149 51151	0.9999889135360718	O
12264	only	90 94	51152 51156	0.99998939037323	O
12265	B	95 96	51157 51158	0.9999878406524658	O
12266	alleles	97 103	51159 51165	0.9999892711639404	O
12269	and	105 108	51167 51170	0.9999891519546509	O
12270	No	109 111	51171 51173	0.9999885559082031	O
12271	Calls	112 116	51174 51178	0.9999881982803345	O
12273	,	118 119	51180 51181	0.9999877214431763	O
12274	were	120 124	51182 51186	0.9999880790710449	O
12275	removed	125 132	51187 51194	0.9999873638153076	O
12276	from	133 137	51195 51199	0.9999878406524658	O
12277	further	138 145	51200 51207	0.9999886751174927	O
12278	analysis	146 154	51208 51216	0.9999889135360718	O
12279	by	155 157	51217 51219	0.9999891519546509	O
12280	Alohomora	158 166	51220 51228	0.9999887943267822	O
12284	.	168 169	51230 51231	0.9999656677246094	O
12285	The	0 3	51232 51235	0.9999765157699585	O
12286	data	4 8	51236 51240	0.9999786615371704	O
12287	files	9 14	51241 51246	0.9999719858169556	O
12288	were	15 19	51247 51251	0.9999761581420898	O
12289	exported	20 28	51252 51260	0.9999585151672363	O
12290	in	29 31	51261 51263	0.9999818801879883	O
12291	Merlin	32 38	51264 51270	0.9999618530273438	O
12292	format	39 45	51271 51277	0.9999809265136719	O
12293	.	46 47	51278 51279	0.9998955726623535	O
12294	Subsequently	0 12	51280 51292	0.9999853372573853	O
12295	,	13 14	51293 51294	0.9999885559082031	O
12296	in	15 17	51295 51297	0.999988317489624	O
12297	Mega2	18 22	51298 51302	0.9999856948852539	O
12299	[	24 25	51304 51305	0.9999886751174927	O
12300	33	25 27	51305 51307	0.9999855756759644	O
12301	]	27 28	51307 51308	0.9999878406524658	O
12302	these	29 34	51309 51314	0.9999877214431763	O
12303	Alohomora	35 43	51315 51323	0.9999865293502808	O
12307	files	45 50	51325 51330	0.9999852180480957	O
12308	were	51 55	51331 51335	0.9999881982803345	O
12309	converted	56 65	51336 51345	0.9999865293502808	O
12310	into	66 70	51346 51350	0.9999874830245972	O
12311	the	71 74	51351 51354	0.999988317489624	O
12312	appropriate	75 86	51355 51366	0.9999878406524658	O
12313	format	87 93	51367 51373	0.9999874830245972	O
12314	for	94 97	51374 51377	0.9999874830245972	O
12315	the	98 101	51378 51381	0.9999879598617554	O
12316	programs	102 110	51382 51390	0.999985933303833	O
12317	used	111 115	51391 51395	0.9999876022338867	O
12318	for	116 119	51396 51399	0.9999881982803345	O
12319	linkage	120 126	51400 51406	0.9999852180480957	O
12321	analysis	128 136	51408 51416	0.9999880790710449	O
12322	,	137 138	51417 51418	0.9999878406524658	O
12323	i	139 140	51419 51420	0.999988317489624	O
12324	.	141 142	51421 51422	0.9999880790710449	O
12325	e	142 143	51422 51423	0.9999873638153076	O
12326	.	144 145	51424 51425	0.9999740123748779	O
12327	either	0 6	51426 51432	0.9999856948852539	O
12328	the	7 10	51433 51436	0.9999887943267822	O
12329	Mendel	11 16	51437 51442	0.9999864101409912	O
12331	5	18 19	51444 51445	0.9999874830245972	O
12332	format	20 26	51446 51452	0.9999890327453613	O
12333	or	27 29	51453 51455	0.9999871253967285	O
12334	the	30 33	51456 51459	0.9999886751174927	O
12335	SimWalk2	34 41	51460 51467	0.9999871253967285	O
12340	format	43 49	51469 51475	0.9999890327453613	O
12341	.	50 51	51476 51477	0.9999512434005737	O
12342	Mendelian	0 8	51478 51486	0.9999856948852539	O
12345	inconsistent	10 22	51488 51500	0.999987006187439	O
12346	errors	23 29	51501 51507	0.9999878406524658	O
12347	were	30 34	51508 51512	0.9999885559082031	O
12348	removed	35 42	51513 51520	0.9999868869781494	O
12349	from	43 47	51521 51525	0.9999880790710449	O
12350	analysis	48 56	51526 51534	0.9999886751174927	O
12351	with	57 61	51535 51539	0.9999892711639404	O
12352	Mega2	62 66	51540 51544	0.9999849796295166	O
12354	by	68 70	51546 51548	0.9999892711639404	O
12355	setting	71 78	51549 51556	0.9999887943267822	O
12356	all	79 82	51557 51560	0.9999890327453613	O
12357	genotypes	83 91	51561 51569	0.9999886751174927	O
12361	of	93 95	51571 51573	0.9999892711639404	O
12362	these	96 101	51574 51579	0.9999890327453613	O
12363	SNPs	102 105	51580 51583	0.9999871253967285	O
12366	to	107 109	51585 51587	0.9999885559082031	O
12367	unknown	110 117	51588 51595	0.9999889135360718	O
12368	.	118 119	51596 51597	0.9999898672103882	O
12369	*	120 121	51598 51599	0.9999891519546509	O
12370	*	121 122	51599 51600	0.9999856948852539	O
12371	IGNORE	0 5	51601 51606	0.9999865293502808	O
12374	LINE	7 10	51608 51611	0.9999892711639404	O
12377	*	12 13	51613 51614	0.9999892711639404	O
12378	*	13 14	51614 51615	0.9999891519546509	O
12379	*	15 16	51616 51617	0.9999891519546509	O
12380	*	16 17	51617 51618	0.9999892711639404	O
12381	IGNORE	18 23	51619 51624	0.9999879598617554	O
12384	LINE	25 28	51626 51629	0.99998939037323	O
12387	*	30 31	51631 51632	0.9999889135360718	O
12388	*	31 32	51632 51633	0.9999889135360718	O
12389	*	33 34	51634 51635	0.9999887943267822	O
12390	*	34 35	51635 51636	0.9999887943267822	O
12391	IGNORE	36 41	51637 51642	0.9999874830245972	O
12394	LINE	43 46	51644 51647	0.9999892711639404	O
12397	*	48 49	51649 51650	0.9999889135360718	O
12398	*	49 50	51650 51651	0.9999889135360718	O
12399	Results	51 58	51652 51659	0.9999876022338867	O
12400	HLA	59 61	51660 51662	0.9999890327453613	O
12402	class	63 68	51664 51669	0.9999891519546509	O
12403	I	69 70	51670 51671	0.9999891519546509	O
12404	,	71 72	51672 51673	0.9999895095825195	O
12405	β2m	73 75	51674 51676	0.9999885559082031	O
12408	and	77 80	51678 51681	0.9999895095825195	O
12409	APM	81 83	51682 51684	0.9999878406524658	O
12411	component	85 94	51686 51695	0.99998939037323	O
12412	expression	95 105	51696 51706	0.99998939037323	O
12413	In	106 108	51707 51709	0.9999892711639404	O
12414	order	109 114	51710 51715	0.9999878406524658	O
12415	to	115 117	51716 51718	0.99998939037323	O
12416	compare	118 125	51719 51726	0.9999871253967285	O
12417	the	126 129	51727 51730	0.9999896287918091	O
12418	expression	130 140	51731 51741	0.9999890327453613	O
12419	of	141 143	51742 51744	0.9999895095825195	O
12420	HLA	144 146	51745 51747	0.9999885559082031	O
12422	class	148 153	51749 51754	0.9999890327453613	O
12423	I	154 155	51755 51756	0.9999884366989136	O
12424	in	156 158	51757 51759	0.9999895095825195	O
12425	sporadic	159 166	51760 51767	0.9999866485595703	O
12427	MSI	168 170	51769 51771	0.9999876022338867	O
12429	-	171 172	51772 51773	0.9999892711639404	O
12430	H	172 173	51773 51774	0.9999808073043823	O
12431	and	174 177	51775 51778	0.9999854564666748	O
12432	MSS	178 180	51779 51781	0.9999850988388062	O
12434	right	182 187	51783 51788	0.9999853372573853	O
12435	sided	188 193	51789 51794	0.9999850988388062	O
12436	tumors	194 200	51795 51801	0.9999867677688599	O
12437	(	201 202	51802 51803	0.9999895095825195	O
12438	RS	203 205	51804 51806	0.9999849796295166	O
12439	T	206 207	51807 51808	0.9999884366989136	O
12440	)	208 209	51809 51810	0.99998939037323	O
12441	and	210 213	51811 51814	0.9999876022338867	O
12442	HNPCC	214 218	51815 51819	0.9999799728393555	O
12445	MSI	220 222	51821 51823	0.9999884366989136	O
12447	-	223 224	51824 51825	0.9999891519546509	O
12448	H	224 225	51825 51826	0.9999840259552002	O
12449	cases	226 231	51827 51832	0.9999880790710449	O
12450	,	232 233	51833 51834	0.9999891519546509	O
12451	we	234 236	51835 51837	0.9999887943267822	O
12452	used	237 241	51838 51842	0.9999887943267822	O
12453	an	242 244	51843 51845	0.9999895095825195	O
12454	antibody	245 252	51846 51853	0.9999881982803345	O
12456	panel	254 259	51855 51860	0.9999890327453613	O
12457	recognizing	260 271	51861 51872	0.9999886751174927	O
12458	monomorphic	272 282	51873 51883	0.9999889135360718	O
12460	determinants	284 295	51885 51896	0.9999896287918091	O
12464	expressed	297 306	51898 51907	0.9999891519546509	O
12465	on	307 309	51908 51910	0.9999890327453613	O
12466	HLA	310 312	51911 51913	0.9999881982803345	O
12468	class	314 319	51915 51920	0.9999890327453613	O
12469	I	320 321	51921 51922	0.9999891519546509	O
12470	heavy	322 327	51923 51928	0.9999886751174927	O
12471	chains	328 334	51929 51935	0.9999889135360718	O
12472	,	335 336	51936 51937	0.9999895095825195	O
12473	β2m	337 339	51938 51940	0.9999885559082031	O
12476	and	341 344	51942 51945	0.9999895095825195	O
12477	APM	345 347	51946 51948	0.9999876022338867	O
12479	components	349 359	51950 51960	0.9999892711639404	O
12480	(	360 361	51961 51962	0.9999896287918091	O
12481	Figure	362 368	51963 51969	0.9999858140945435	O
12482	1	369 370	51970 51971	0.9999885559082031	O
12483	)	371 372	51972 51973	0.9999897480010986	O
12484	.	373 374	51974 51975	0.9999809265136719	O
12485	In	0 2	51976 51978	0.9999878406524658	O
12486	total	3 8	51979 51984	0.9999825954437256	O
12487	,	9 10	51985 51986	0.9999876022338867	O
12488	we	11 13	51987 51989	0.999981164932251	O
12489	identified	14 24	51990 52000	0.9999858140945435	O
12490	loss	25 29	52001 52005	0.9999850988388062	O
12491	of	30 32	52006 52008	0.999988317489624	O
12492	HLA	33 35	52009 52011	0.9999850988388062	O
12494	class	37 42	52013 52018	0.9999876022338867	O
12495	I	43 44	52019 52020	0.9999864101409912	O
12496	expression	45 55	52021 52031	0.9999864101409912	O
12497	in	56 58	52032 52034	0.9999880790710449	O
12498	about	59 64	52035 52040	0.9999845027923584	O
12499	34	65 67	52041 52043	0.9999837875366211	O
12500	.	67 68	52043 52044	0.999988317489624	O
12501	6	68 69	52044 52045	0.9999854564666748	O
12502	%	70 71	52046 52047	0.9999878406524658	O
12503	of	72 74	52048 52050	0.9999878406524658	O
12504	the	75 78	52051 52054	0.9999866485595703	O
12505	RST	79 81	52055 52057	0.9999812841415405	O
12507	and	83 86	52059 52062	0.9999855756759644	O
12508	42	87 89	52063 52065	0.9999755620956421	O
12509	.	89 90	52065 52066	0.9999884366989136	O
12510	7	90 91	52066 52067	0.9999842643737793	O
12511	%	92 93	52068 52069	0.9999880790710449	O
12512	of	94 96	52070 52072	0.9999879598617554	O
12513	the	97 100	52073 52076	0.9999860525131226	O
12514	HNPCC	101 105	52077 52081	0.9999685287475586	O
12517	cases	107 112	52083 52088	0.9999855756759644	O
12518	.	113 114	52089 52090	0.9999617338180542	O
12519	The	0 3	52091 52094	0.9999850988388062	O
12520	frequency	4 13	52095 52104	0.9999821186065674	O
12521	of	14 16	52105 52107	0.9999858140945435	O
12522	alterations	17 28	52108 52119	0.9999734163284302	O
12523	differed	29 37	52120 52128	0.9999829530715942	O
12524	significantly	38 51	52129 52142	0.9999840259552002	O
12525	between	52 59	52143 52150	0.9999823570251465	O
12526	the	60 63	52151 52154	0.9999843835830688	O
12527	sporadic	64 71	52155 52162	0.9999853372573853	O
12529	MSS	73 75	52164 52166	0.9999804496765137	O
12531	and	77 80	52168 52171	0.9999836683273315	O
12532	MSI	81 83	52172 52174	0.999984622001648	O
12534	-	84 85	52175 52176	0.9999877214431763	O
12535	H	85 86	52176 52177	0.9999662637710571	O
12536	RST	87 89	52178 52180	0.9999861717224121	O
12538	.	90 91	52181 52182	0.9999570846557617	O
12539	The	0 3	52183 52186	0.9999877214431763	O
12540	lack	4 8	52187 52191	0.9999864101409912	O
12541	of	9 11	52192 52194	0.9999886751174927	O
12542	HLA	12 14	52195 52197	0.999985933303833	O
12544	class	16 21	52199 52204	0.9999885559082031	O
12545	I	22 23	52205 52206	0.9999879598617554	O
12546	expression	24 34	52207 52217	0.9999873638153076	O
12547	was	35 38	52218 52221	0.9999884366989136	O
12548	more	39 43	52222 52226	0.9999874830245972	O
12549	frequent	44 52	52227 52235	0.9999884366989136	O
12550	in	53 55	52236 52238	0.99998939037323	O
12551	MSI	56 58	52239 52241	0.9999860525131226	O
12553	-	59 60	52242 52243	0.9999892711639404	O
12554	H	60 61	52243 52244	0.9999760389328003	O
12555	sporadic	62 69	52245 52252	0.9999889135360718	O
12557	cases	71 76	52254 52259	0.9999886751174927	O
12558	than	77 81	52260 52264	0.999987006187439	O
12559	in	82 84	52265 52267	0.9999890327453613	O
12560	MSS	85 87	52268 52270	0.9999855756759644	O
12562	cases	89 94	52272 52277	0.9999892711639404	O
12563	(	95 96	52278 52279	0.9999897480010986	O
12564	p	97 98	52280 52281	0.9999890327453613	O
12565	<	99 100	52282 52283	0.9999890327453613	O
12566	0	101 102	52284 52285	0.9999895095825195	O
12567	.	102 103	52285 52286	0.9999892711639404	O
12568	0001	103 106	52286 52289	0.9999889135360718	O
12570	)	108 109	52291 52292	0.9999896287918091	O
12571	,	110 111	52293 52294	0.9999886751174927	O
12572	as	112 114	52295 52297	0.9999871253967285	O
12573	it	115 117	52298 52300	0.9999890327453613	O
12574	was	118 121	52301 52304	0.9999895095825195	O
12575	16	122 124	52305 52307	0.9999862909317017	O
12576	.	124 125	52307 52308	0.9999895095825195	O
12577	7	125 126	52308 52309	0.9999872446060181	O
12578	%	127 128	52310 52311	0.9999891519546509	O
12579	in	129 131	52312 52314	0.9999895095825195	O
12580	the	132 135	52315 52318	0.9999895095825195	O
12581	latter	136 142	52319 52325	0.9999862909317017	O
12582	group	143 148	52326 52331	0.9999889135360718	O
12583	,	149 150	52332 52333	0.9999881982803345	O
12584	but	151 154	52334 52337	0.9999874830245972	O
12585	60	155 157	52338 52340	0.9999814033508301	O
12586	.	157 158	52340 52341	0.99998939037323	O
12587	6	158 159	52341 52342	0.9999856948852539	O
12588	%	160 161	52343 52344	0.9999890327453613	O
12589	in	162 164	52345 52347	0.9999891519546509	O
12590	the	165 168	52348 52351	0.9999892711639404	O
12591	former	169 175	52352 52358	0.9999871253967285	O
12592	(	176 177	52359 52360	0.9999892711639404	O
12593	Table	178 183	52361 52366	0.9999864101409912	O
12594	2	184 185	52367 52368	0.9999876022338867	O
12595	)	186 187	52369 52370	0.9999895095825195	O
12596	.	188 189	52371 52372	0.999975323677063	O
12597	Subsequently	0 12	52373 52385	0.9999760389328003	O
12598	,	13 14	52386 52387	0.9999881982803345	O
12599	we	15 17	52388 52390	0.9999853372573853	O
12600	have	18 22	52391 52395	0.9999856948852539	O
12601	investigated	23 35	52396 52408	0.9999855756759644	O
12602	the	36 39	52409 52412	0.9999886751174927	O
12603	frequency	40 49	52413 52422	0.9999843835830688	O
12604	of	50 52	52423 52425	0.999988317489624	O
12605	a	53 54	52426 52427	0.9999885559082031	O
12606	concomitant	55 65	52428 52438	0.9999889135360718	O
12610	loss	67 71	52440 52444	0.9999864101409912	O
12611	of	72 74	52445 52447	0.9999890327453613	O
12612	HLA	75 77	52448 52450	0.9999853372573853	O
12614	class	79 84	52452 52457	0.999988317489624	O
12615	I	85 86	52458 52459	0.9999877214431763	O
12616	expression	87 97	52460 52470	0.999988317489624	O
12617	with	98 102	52471 52475	0.9999874830245972	O
12618	that	103 107	52476 52480	0.99998939037323	O
12619	of	108 110	52481 52483	0.9999892711639404	O
12620	either	111 117	52484 52490	0.9999887943267822	O
12621	the	118 121	52491 52494	0.9999892711639404	O
12622	β2m	122 124	52495 52497	0.9999881982803345	O
12625	molecule	126 134	52499 52507	0.9999886751174927	O
12626	or	135 137	52508 52510	0.9999871253967285	O
12627	of	138 140	52511 52513	0.9999887943267822	O
12628	any	141 144	52514 52517	0.9999871253967285	O
12629	APM	145 147	52518 52520	0.999985933303833	O
12631	component	149 158	52522 52531	0.9999891519546509	O
12632	.	159 160	52532 52533	0.9999700784683228	O
12633	In	0 2	52534 52536	0.9999877214431763	O
12634	the	3 6	52537 52540	0.9999878406524658	O
12635	sporadic	7 14	52541 52548	0.9999849796295166	O
12637	subset	16 22	52550 52556	0.9999866485595703	O
12638	,	23 24	52557 52558	0.9999881982803345	O
12639	loss	25 29	52559 52563	0.9999861717224121	O
12640	of	30 32	52564 52566	0.9999891519546509	O
12641	HLA	33 35	52567 52569	0.9999866485595703	O
12643	class	37 42	52571 52576	0.9999884366989136	O
12644	I	43 44	52577 52578	0.9999879598617554	O
12645	expression	45 55	52579 52589	0.9999877214431763	O
12646	was	56 59	52590 52593	0.9999884366989136	O
12647	more	60 64	52594 52598	0.9999866485595703	O
12648	often	65 70	52599 52604	0.9999885559082031	O
12649	associated	71 81	52605 52615	0.9999889135360718	O
12650	with	82 86	52616 52620	0.9999890327453613	O
12651	that	87 91	52621 52625	0.9999879598617554	O
12652	of	92 94	52626 52628	0.9999890327453613	O
12653	one	95 98	52629 52632	0.9999866485595703	O
12654	of	99 101	52633 52635	0.9999885559082031	O
12655	the	102 105	52636 52639	0.9999886751174927	O
12656	APM	106 108	52640 52642	0.999981164932251	O
12658	components	110 120	52644 52654	0.9999890327453613	O
12659	,	121 122	52655 52656	0.9999878406524658	O
12660	occurring	123 132	52657 52666	0.9999886751174927	O
12661	in	133 135	52667 52669	0.9999890327453613	O
12662	about	136 141	52670 52675	0.9999868869781494	O
12663	37	142 144	52676 52678	0.9999840259552002	O
12664	%	145 146	52679 52680	0.9999876022338867	O
12665	of	147 149	52681 52683	0.9999885559082031	O
12666	HLA	150 152	52684 52686	0.9999840259552002	O
12668	-	153 154	52687 52688	0.9999885559082031	O
12669	negative	154 162	52688 52696	0.9999754428863525	O
12670	tumors	163 169	52697 52703	0.9999840259552002	O
12671	regardless	170 180	52704 52714	0.9999873638153076	O
12672	of	181 183	52715 52717	0.9999887943267822	O
12673	their	184 189	52718 52723	0.9999878406524658	O
12674	mismatch	190 197	52724 52731	0.9999878406524658	O
12677	repair	199 205	52733 52739	0.9999867677688599	O
12678	status	206 212	52740 52746	0.9999885559082031	O
12679	(	213 214	52747 52748	0.9999891519546509	O
12680	Table	215 220	52749 52754	0.9999849796295166	O
12681	2	221 222	52755 52756	0.999987006187439	O
12682	)	223 224	52757 52758	0.99998939037323	O
12683	.	225 226	52759 52760	0.9999747276306152	O
12684	β2m	0 2	52761 52763	0.9999877214431763	O
12687	loss	4 8	52765 52769	0.999988317489624	O
12688	was	9 12	52770 52773	0.9999892711639404	O
12689	only	13 17	52774 52778	0.9999884366989136	O
12690	found	18 23	52779 52784	0.9999891519546509	O
12691	in	24 26	52785 52787	0.99998939037323	O
12692	one	27 30	52788 52791	0.9999874830245972	O
12693	HLA	31 33	52792 52794	0.9999867677688599	O
12695	class	35 40	52796 52801	0.9999887943267822	O
12696	I	41 42	52802 52803	0.9999885559082031	O
12697	negative	43 51	52804 52812	0.9999878406524658	O
12698	MSI	52 54	52813 52815	0.9999872446060181	O
12700	-	55 56	52816 52817	0.9999887943267822	O
12701	H	56 57	52817 52818	0.9999579191207886	O
12702	sporadic	58 65	52819 52826	0.9999825954437256	O
12704	tumor	67 72	52828 52833	0.9999858140945435	O
12705	(	73 74	52834 52835	0.9999895095825195	O
12706	case	75 79	52836 52840	0.9999884366989136	O
12707	65	80 82	52841 52843	0.999984622001648	O
12708	)	83 84	52844 52845	0.9999897480010986	O
12709	that	85 89	52846 52850	0.9999887943267822	O
12710	interestingly	90 102	52851 52863	0.9999866485595703	O
12712	also	104 108	52865 52869	0.9999889135360718	O
12713	presented	109 118	52870 52879	0.9999887943267822	O
12714	loss	119 123	52880 52884	0.9999886751174927	O
12715	of	124 126	52885 52887	0.9999892711639404	O
12716	the	127 130	52888 52891	0.9999890327453613	O
12717	APM	131 133	52892 52894	0.9999862909317017	O
12719	molecules	135 144	52896 52905	0.9999881982803345	O
12720	TAP2	145 148	52906 52909	0.9999887943267822	O
12723	,	150 151	52911 52912	0.9999885559082031	O
12724	Calreticulin	152 163	52913 52924	0.9999873638153076	O
12728	and	165 168	52926 52929	0.9999886751174927	O
12729	Tapasin	169 175	52930 52936	0.999985933303833	O
12732	(	177 178	52938 52939	0.99998939037323	O
12733	Figure	179 185	52940 52946	0.9999868869781494	O
12734	2	186 187	52947 52948	0.9999878406524658	O
12735	)	188 189	52949 52950	0.9999895095825195	O
12736	.	190 191	52951 52952	0.9999773502349854	O
12737	In	0 2	52953 52955	0.999987006187439	O
12738	contrast	3 11	52956 52964	0.999983549118042	O
12739	,	12 13	52965 52966	0.999988317489624	O
12740	loss	14 18	52967 52971	0.9999850988388062	O
12741	of	19 21	52972 52974	0.9999887943267822	O
12742	HLA	22 24	52975 52977	0.9999873638153076	O
12744	class	26 31	52979 52984	0.9999887943267822	O
12745	I	32 33	52985 52986	0.9999884366989136	O
12746	expression	34 44	52987 52997	0.9999873638153076	O
12747	in	45 47	52998 53000	0.9999881982803345	O
12748	HNPCC	48 52	53001 53005	0.9999759197235107	O
12751	cases	54 59	53007 53012	0.9999853372573853	O
12752	was	60 63	53013 53016	0.999988317489624	O
12753	more	64 68	53017 53021	0.9999866485595703	O
12754	frequently	69 79	53022 53032	0.9999884366989136	O
12755	associated	80 90	53033 53043	0.9999886751174927	O
12756	with	91 95	53044 53048	0.9999890327453613	O
12757	that	96 100	53049 53053	0.9999890327453613	O
12758	of	101 103	53054 53056	0.9999890327453613	O
12759	β2m	104 106	53057 53059	0.9999880790710449	O
12762	(	108 109	53061 53062	0.9999895095825195	O
12763	Table	110 115	53063 53068	0.9999874830245972	O
12764	2	116 117	53069 53070	0.9999884366989136	O
12765	)	118 119	53071 53072	0.9999895095825195	O
12766	,	120 121	53073 53074	0.9999881982803345	O
12767	as	122 124	53075 53077	0.9999861717224121	O
12768	it	125 127	53078 53080	0.9999889135360718	O
12769	was	128 131	53081 53084	0.9999890327453613	O
12770	found	132 137	53085 53090	0.999988317489624	O
12771	in	138 140	53091 53093	0.9999887943267822	O
12772	46	141 143	53094 53096	0.9999815225601196	O
12773	.	143 144	53096 53097	0.999988317489624	O
12774	9	144 145	53097 53098	0.9999834299087524	O
12775	%	146 147	53099 53100	0.999987006187439	O
12776	of	148 150	53101 53103	0.9999874830245972	O
12777	the	151 154	53104 53107	0.9999865293502808	O
12778	HLA	155 157	53108 53110	0.9999865293502808	O
12780	class	159 164	53112 53117	0.999988317489624	O
12781	I	165 166	53118 53119	0.9999879598617554	O
12782	-	166 167	53119 53120	0.9999887943267822	O
12783	negative	167 175	53120 53128	0.9999731779098511	O
12784	tumors	176 182	53129 53135	0.9999836683273315	O
12785	.	183 184	53136 53137	0.9999552965164185	O
12786	In	0 2	53138 53140	0.9999884366989136	O
12787	contrast	3 11	53141 53149	0.9999865293502808	O
12788	loss	12 16	53150 53154	0.9999879598617554	O
12789	of	17 19	53155 53157	0.9999890327453613	O
12790	any	20 23	53158 53161	0.9999862909317017	O
12791	APM	24 26	53162 53164	0.9999809265136719	O
12793	component	28 37	53166 53175	0.9999885559082031	O
12794	was	38 41	53176 53179	0.9999891519546509	O
12795	observed	42 50	53180 53188	0.9999889135360718	O
12796	in	51 53	53189 53191	0.99998939037323	O
12797	only	54 58	53192 53196	0.999987006187439	O
12798	6	59 60	53197 53198	0.9999845027923584	O
12799	%	61 62	53199 53200	0.9999885559082031	O
12800	of	63 65	53201 53203	0.9999885559082031	O
12801	these	66 71	53204 53209	0.9999868869781494	O
12802	cases	72 77	53210 53215	0.999987006187439	O
12803	(	78 79	53216 53217	0.9999896287918091	O
12804	h38	80 82	53218 53220	0.9999892711639404	O
12806	,	84 85	53222 53223	0.9999884366989136	O
12807	h49	86 88	53224 53226	0.9999895095825195	O
12810	)	90 91	53228 53229	0.99998939037323	O
12811	which	92 97	53230 53235	0.9999885559082031	O
12812	also	98 102	53236 53240	0.9999881982803345	O
12813	showed	103 109	53241 53247	0.9999889135360718	O
12814	loss	110 114	53248 53252	0.9999892711639404	O
12815	of	115 117	53253 53255	0.9999897480010986	O
12816	β2m	118 120	53256 53258	0.999988317489624	O
12819	expression	122 132	53260 53270	0.99998939037323	O
12820	.	133 134	53271 53272	0.9999748468399048	O
12821	In	0 2	53273 53275	0.9999858140945435	O
12822	sporadic	3 10	53276 53283	0.9999836683273315	O
12824	RST	12 14	53285 53287	0.9999775886535645	O
12826	,	16 17	53289 53290	0.9999879598617554	O
12827	the	18 21	53291 53294	0.9999885559082031	O
12828	simultaneous	22 34	53295 53307	0.9999829530715942	O
12829	loss	35 39	53308 53312	0.9999862909317017	O
12830	of	40 42	53313 53315	0.9999890327453613	O
12831	more	43 47	53316 53320	0.9999890327453613	O
12832	than	48 52	53321 53325	0.9999891519546509	O
12833	one	53 56	53326 53329	0.9999890327453613	O
12834	APM	57 59	53330 53332	0.9999817609786987	O
12836	molecule	61 69	53334 53342	0.9999866485595703	O
12837	per	70 73	53343 53346	0.9999889135360718	O
12838	case	74 78	53347 53351	0.9999884366989136	O
12839	was	79 82	53352 53355	0.9999880790710449	O
12840	frequent	83 91	53356 53364	0.9999876022338867	O
12841	(	92 93	53365 53366	0.9999887943267822	O
12842	Figure	94 100	53367 53373	0.9999840259552002	O
12843	2	101 102	53374 53375	0.999987006187439	O
12844	)	103 104	53376 53377	0.9999890327453613	O
12845	.	105 106	53378 53379	0.999976396560669	O
12846	Only	0 4	53380 53384	0.9999765157699585	O
12847	3	5 6	53385 53386	0.9999624490737915	O
12848	out	7 10	53387 53390	0.9999855756759644	O
12849	of	11 13	53391 53393	0.9999852180480957	O
12850	10	14 16	53394 53396	0.9999130964279175	O
12851	cases	17 22	53397 53402	0.9999768733978271	O
12852	lost	23 27	53403 53407	0.9999773502349854	O
12853	a	28 29	53408 53409	0.9999864101409912	O
12854	single	30 36	53410 53416	0.9999817609786987	O
12855	APM	37 39	53417 53419	0.9999417066574097	O
12857	component	41 50	53421 53430	0.9999854564666748	O
12858	.	51 52	53431 53432	0.9999105930328369	O
12859	The	0 3	53433 53436	0.9999881982803345	O
12860	TAP2	4 7	53437 53440	0.9999879598617554	O
12863	molecule	9 17	53442 53450	0.9999858140945435	O
12864	was	18 21	53451 53454	0.9999885559082031	O
12865	most	22 26	53455 53459	0.9999878406524658	O
12866	frequently	27 37	53460 53470	0.9999884366989136	O
12867	lost	38 42	53471 53475	0.9999842643737793	O
12868	(	43 44	53476 53477	0.99998939037323	O
12869	6	45 46	53478 53479	0.9999841451644897	O
12870	cases	47 52	53480 53485	0.99998939037323	O
12871	)	53 54	53486 53487	0.9999896287918091	O
12872	,	55 56	53488 53489	0.9999885559082031	O
12873	followed	57 65	53490 53498	0.9999877214431763	O
12874	by	66 68	53499 53501	0.9999891519546509	O
12875	TAP1	69 72	53502 53505	0.9999887943267822	O
12878	,	74 75	53507 53508	0.9999884366989136	O
12879	Tapasin	76 82	53509 53515	0.9999854564666748	O
12882	and	84 87	53517 53520	0.9999890327453613	O
12883	LMP2	88 91	53521 53524	0.9999880790710449	O
12886	(	93 94	53526 53527	0.9999896287918091	O
12887	5	95 96	53528 53529	0.9999858140945435	O
12888	cases	97 102	53530 53535	0.9999896287918091	O
12889	)	103 104	53536 53537	0.9999896287918091	O
12890	,	105 106	53538 53539	0.9999889135360718	O
12891	Calreticulin	107 118	53540 53551	0.9999884366989136	O
12895	(	120 121	53553 53554	0.9999897480010986	O
12896	4	122 123	53555 53556	0.9999856948852539	O
12897	cases	124 129	53557 53562	0.9999895095825195	O
12898	)	130 131	53563 53564	0.9999896287918091	O
12899	,	132 133	53565 53566	0.9999890327453613	O
12900	LMP7	134 137	53567 53570	0.9999881982803345	O
12903	(	139 140	53572 53573	0.9999895095825195	O
12904	2	141 142	53574 53575	0.9999860525131226	O
12905	cases	143 148	53576 53581	0.99998939037323	O
12906	)	149 150	53582 53583	0.9999895095825195	O
12907	,	151 152	53584 53585	0.9999887943267822	O
12908	and	153 156	53586 53589	0.9999891519546509	O
12909	Calnexin	157 164	53590 53597	0.9999884366989136	O
12912	and	166 169	53599 53602	0.9999890327453613	O
12913	ERp57	170 174	53603 53607	0.999982476234436	O
12917	(	176 177	53609 53610	0.9999895095825195	O
12918	1	178 179	53611 53612	0.9999878406524658	O
12919	case	180 184	53613 53617	0.9999891519546509	O
12920	)	185 186	53618 53619	0.9999895095825195	O
12921	.	187 188	53620 53621	0.9999688863754272	O
12922	Loss	0 4	53622 53626	0.9999715089797974	O
12923	of	5 7	53627 53629	0.9999808073043823	O
12924	the	8 11	53630 53633	0.9999788999557495	O
12925	LPM10	12 16	53634 53638	0.9999581575393677	O
12928	protein	18 25	53640 53647	0.9999444484710693	O
12929	was	26 29	53648 53651	0.9999767541885376	O
12930	detected	30 38	53652 53660	0.9999797344207764	O
12931	in	39 41	53661 53663	0.9999736547470093	O
12932	neither	42 49	53664 53671	0.999906063079834	O
12933	sporadic	50 57	53672 53679	0.9999580383300781	O
12935	RST	59 61	53681 53683	0.9999657869338989	O
12937	nor	63 66	53685 53688	0.9999617338180542	O
12938	HNPCC	67 71	53689 53693	0.9998401403427124	O
12941	tumors	73 79	53695 53701	0.9999711513519287	O
12942	.	80 81	53702 53703	0.9998121857643127	O
12943	The	0 3	53704 53707	0.9999821186065674	O
12944	HNPCC	4 8	53708 53712	0.9999555349349976	O
12947	cases	10 15	53714 53719	0.9999877214431763	O
12948	h38	16 18	53720 53722	0.9999890327453613	O
12950	and	20 23	53724 53727	0.9999880790710449	O
12951	h49	24 26	53728 53730	0.9999891519546509	O
12954	lost	28 32	53732 53736	0.999983549118042	O
12955	the	33 36	53737 53740	0.9999887943267822	O
12956	expression	37 47	53741 53751	0.9999881982803345	O
12957	of	48 50	53752 53754	0.9999889135360718	O
12958	TAP2	51 54	53755 53758	0.9999880790710449	O
12961	and	56 59	53760 53763	0.9999884366989136	O
12962	LMP7	60 63	53764 53767	0.9999854564666748	O
12965	respectively	65 77	53769 53781	0.9999874830245972	O
12966	.	78 79	53782 53783	0.9999697208404541	O
12967	LOH	0 2	53784 53786	0.999988317489624	O
12969	and	4 7	53788 53791	0.9999889135360718	O
12970	frameshift	8 17	53792 53801	0.9999879598617554	O
12973	analysis	19 27	53803 53811	0.9999891519546509	O
12974	Polymorphic	28 38	53812 53822	0.9999880790710449	O
12978	markers	40 47	53824 53831	0.9999885559082031	O
12979	around	48 54	53832 53838	0.9999885559082031	O
12980	the	55 58	53839 53842	0.9999892711639404	O
12981	classical	59 68	53843 53852	0.9999830722808838	O
12982	HLA	69 71	53853 53855	0.9999849796295166	O
12984	genes	73 78	53857 53862	0.9999890327453613	O
12985	(	79 80	53863 53864	0.9999895095825195	O
12986	A	81 82	53865 53866	0.9999885559082031	O
12987	,	83 84	53867 53868	0.9999887943267822	O
12988	B	85 86	53869 53870	0.9999871253967285	O
12989	and	87 90	53871 53874	0.9999887943267822	O
12990	C	91 92	53875 53876	0.9999872446060181	O
12991	)	92 93	53876 53877	0.9999897480010986	O
12992	,	94 95	53878 53879	0.99998939037323	O
12993	TAP	96 98	53880 53882	0.9999887943267822	O
12995	1	100 101	53884 53885	0.9999892711639404	O
12996	and	102 105	53886 53889	0.9999891519546509	O
12997	TAP2	106 109	53890 53893	0.9999889135360718	O
13000	genes	111 116	53895 53900	0.9999890327453613	O
13001	were	117 121	53901 53905	0.9999891519546509	O
13002	used	122 126	53906 53910	0.9999891519546509	O
13003	to	127 129	53911 53913	0.99998939037323	O
13004	study	130 135	53914 53919	0.9999889135360718	O
13005	LOH	136 138	53920 53922	0.9999887943267822	O
13007	and	140 143	53924 53927	0.99998939037323	O
13008	reveal	144 150	53928 53934	0.9999890327453613	O
13009	possible	151 159	53935 53943	0.9999890327453613	O
13010	chromosomal	160 170	53944 53954	0.9999891519546509	O
13014	aberrations	172 182	53956 53966	0.9999892711639404	O
13017	that	184 188	53968 53972	0.99998939037323	O
13018	could	189 194	53973 53978	0.9999886751174927	O
13019	relate	195 201	53979 53985	0.9999884366989136	O
13020	to	202 204	53986 53988	0.9999892711639404	O
13021	loss	205 209	53989 53993	0.9999872446060181	O
13022	of	210 212	53994 53996	0.9999892711639404	O
13023	HLA	213 215	53997 53999	0.9999856948852539	O
13025	class	217 222	54001 54006	0.9999881982803345	O
13026	I	223 224	54007 54008	0.9999876022338867	O
13027	expression	225 235	54009 54019	0.9999886751174927	O
13028	(	236 237	54020 54021	0.9999896287918091	O
13029	Figure	238 244	54022 54028	0.9999867677688599	O
13030	5A	245 246	54029 54030	0.9999887943267822	O
13032	)	248 249	54032 54033	0.9999896287918091	O
13033	.	250 251	54034 54035	0.9999738931655884	O
13034	In	0 2	54036 54038	0.999984860420227	O
13035	HNPCC	3 7	54039 54043	0.999970555305481	O
13038	cases	9 14	54045 54050	0.999983549118042	O
13039	,	15 16	54051 54052	0.9999885559082031	O
13040	LOH	17 19	54053 54055	0.9999873638153076	O
13042	analysis	21 29	54057 54065	0.9999886751174927	O
13043	was	30 33	54066 54069	0.9999890327453613	O
13044	only	34 38	54070 54074	0.9999876022338867	O
13045	performed	39 48	54075 54084	0.9999885559082031	O
13046	around	49 55	54085 54091	0.9999884366989136	O
13047	the	56 59	54092 54095	0.9999891519546509	O
13048	HLA	60 62	54096 54098	0.9999856948852539	O
13050	genes	64 69	54100 54105	0.9999876022338867	O
13051	since	70 75	54106 54111	0.9999872446060181	O
13052	loss	76 80	54112 54116	0.999988317489624	O
13053	of	81 83	54117 54119	0.9999890327453613	O
13054	the	84 87	54120 54123	0.9999889135360718	O
13055	TAP1	88 91	54124 54127	0.9999886751174927	O
13058	and	93 96	54129 54132	0.9999884366989136	O
13059	TAP2	97 100	54133 54136	0.9999885559082031	O
13062	proteins	102 110	54138 54146	0.9999873638153076	O
13063	was	111 114	54147 54150	0.9999887943267822	O
13064	rarely	115 121	54151 54157	0.9999853372573853	O
13065	associated	122 132	54158 54168	0.9999892711639404	O
13066	with	133 137	54169 54173	0.9999891519546509	O
13067	HLA	138 140	54174 54176	0.9999874830245972	O
13069	class	142 147	54178 54183	0.999988317489624	O
13070	I	148 149	54184 54185	0.9999868869781494	O
13071	loss	150 154	54186 54190	0.9999878406524658	O
13072	.	155 156	54191 54192	0.9999701976776123	O
13073	LOH	0 2	54193 54195	0.9999867677688599	O
13075	was	4 7	54197 54200	0.9999880790710449	O
13076	more	8 12	54201 54205	0.9999871253967285	O
13077	frequent	13 21	54206 54214	0.9999879598617554	O
13078	in	22 24	54215 54217	0.9999885559082031	O
13079	the	25 28	54218 54221	0.9999872446060181	O
13080	MSS	29 31	54222 54224	0.9999792575836182	O
13082	tumors	33 39	54226 54232	0.9999862909317017	O
13083	(	40 41	54233 54234	0.9999896287918091	O
13084	50	42 44	54235 54237	0.9999840259552002	O
13085	%	45 46	54238 54239	0.9999892711639404	O
13086	)	47 48	54240 54241	0.99998939037323	O
13087	than	49 53	54242 54246	0.999987006187439	O
13088	in	54 56	54247 54249	0.9999887943267822	O
13089	the	57 60	54250 54253	0.9999886751174927	O
13090	MSI	61 63	54254 54256	0.999987006187439	O
13092	-	64 65	54257 54258	0.9999887943267822	O
13093	H	65 66	54258 54259	0.9999781847000122	O
13094	sporadic	67 74	54260 54267	0.9999881982803345	O
13096	(	76 77	54269 54270	0.99998939037323	O
13097	20	78 80	54271 54273	0.9999845027923584	O
13098	%	81 82	54274 54275	0.99998939037323	O
13099	)	83 84	54276 54277	0.9999889135360718	O
13100	and	85 88	54278 54281	0.9999864101409912	O
13101	HNPCC	89 93	54282 54286	0.9999836683273315	O
13104	(	95 96	54288 54289	0.99998939037323	O
13105	6	97 98	54290 54291	0.9999834299087524	O
13106	%	99 100	54292 54293	0.9999892711639404	O
13107	)	101 102	54294 54295	0.9999889135360718	O
13108	tumors	103 109	54296 54302	0.9999871253967285	O
13109	with	110 114	54303 54307	0.9999884366989136	O
13110	loss	115 119	54308 54312	0.9999872446060181	O
13111	of	120 122	54313 54315	0.9999891519546509	O
13112	HLA	123 125	54316 54318	0.9999880790710449	O
13114	class	127 132	54320 54325	0.9999889135360718	O
13115	I	133 134	54326 54327	0.9999887943267822	O
13116	expression	135 145	54328 54338	0.9999881982803345	O
13117	(	146 147	54339 54340	0.9999896287918091	O
13118	P	148 149	54341 54342	0.9999890327453613	O
13119	<	150 151	54343 54344	0.9999889135360718	O
13120	0	152 153	54345 54346	0.99998939037323	O
13121	.	153 154	54346 54347	0.9999890327453613	O
13122	05	154 156	54347 54349	0.999988317489624	O
13123	)	157 158	54350 54351	0.9999895095825195	O
13124	(	159 160	54352 54353	0.99998939037323	O
13125	Figure	161 167	54354 54360	0.9999854564666748	O
13126	3	168 169	54361 54362	0.9999884366989136	O
13127	,	170 171	54363 54364	0.9999880790710449	O
13128	4	172 173	54365 54366	0.9999866485595703	O
13129	)	173 174	54366 54367	0.9999892711639404	O
13130	.	175 176	54368 54369	0.9999771118164062	O
13131	Furthermore	0 11	54370 54381	0.9999856948852539	O
13132	,	12 13	54382 54383	0.9999884366989136	O
13133	the	14 17	54384 54387	0.999988317489624	O
13134	patterns	18 26	54388 54396	0.9999854564666748	O
13135	of	27 29	54397 54399	0.9999884366989136	O
13136	LOH	30 32	54400 54402	0.999987006187439	O
13138	in	34 36	54404 54406	0.9999886751174927	O
13139	the	37 40	54407 54410	0.9999877214431763	O
13140	MSS	41 43	54411 54413	0.9999788999557495	O
13142	cases	45 50	54415 54420	0.9999880790710449	O
13143	might	51 56	54421 54426	0.9999878406524658	O
13144	indicate	57 65	54427 54435	0.9999886751174927	O
13145	loss	66 70	54436 54440	0.9999874830245972	O
13146	of	71 73	54441 54443	0.9999885559082031	O
13147	the	74 77	54444 54447	0.9999886751174927	O
13148	entire	78 84	54448 54454	0.9999877214431763	O
13149	6p21	85 88	54455 54458	0.9999871253967285	O
13152	.	89 90	54459 54460	0.9999884366989136	O
13153	3	90 91	54460 54461	0.9999871253967285	O
13154	region	92 98	54462 54468	0.9999879598617554	O
13155	,	99 100	54469 54470	0.9999886751174927	O
13156	in	101 103	54471 54473	0.9999886751174927	O
13157	contrast	104 112	54474 54482	0.9999871253967285	O
13158	to	113 115	54483 54485	0.9999884366989136	O
13159	the	116 119	54486 54489	0.9999881982803345	O
13160	MSI	120 122	54490 54492	0.9999860525131226	O
13162	-	123 124	54493 54494	0.9999884366989136	O
13163	H	124 125	54494 54495	0.9999815225601196	O
13164	cases	126 131	54496 54501	0.999988317489624	O
13165	(	132 133	54502 54503	0.9999884366989136	O
13166	hereditary	134 144	54504 54514	0.9999747276306152	O
13167	and	145 148	54515 54518	0.9999855756759644	O
13168	sporadic	149 156	54519 54526	0.9999841451644897	O
13170	forms	158 163	54528 54533	0.9999860525131226	O
13171	)	164 165	54534 54535	0.9999885559082031	O
13172	where	166 171	54536 54541	0.9999878406524658	O
13173	LOH	172 174	54542 54544	0.9999878406524658	O
13175	seems	176 181	54546 54551	0.9999881982803345	O
13176	to	182 184	54552 54554	0.9999881982803345	O
13177	be	185 187	54555 54557	0.9999884366989136	O
13178	limited	188 195	54558 54565	0.9999867677688599	O
13179	.	196 197	54566 54567	0.9999891519546509	O
13180	*	198 199	54568 54569	0.9999876022338867	O
13181	*	199 200	54569 54570	0.9999762773513794	O
13182	IGNORE	0 5	54571 54576	0.999985933303833	O
13185	LINE	7 10	54578 54581	0.999988317489624	O
13188	*	12 13	54583 54584	0.9999886751174927	O
13189	*	13 14	54584 54585	0.9999886751174927	O
13190	*	15 16	54586 54587	0.9999886751174927	O
13191	*	16 17	54587 54588	0.9999887943267822	O
13192	IGNORE	18 23	54589 54594	0.9999873638153076	O
13195	LINE	25 28	54596 54599	0.9999887943267822	O
13198	*	30 31	54601 54602	0.999988317489624	O
13199	*	31 32	54602 54603	0.999988317489624	O
13200	*	33 34	54604 54605	0.999988317489624	O
13201	*	34 35	54605 54606	0.999988317489624	O
13202	IGNORE	36 41	54607 54612	0.9999871253967285	O
13205	LINE	43 46	54614 54617	0.9999885559082031	O
13208	*	48 49	54619 54620	0.9999884366989136	O
13209	*	49 50	54620 54621	0.9999881982803345	O
13210	Discussion	51 60	54622 54631	0.9999879598617554	O
13213	Abnormalities	62 74	54633 54645	0.9999887943267822	O
13218	in	76 78	54647 54649	0.9999884366989136	O
13219	HLA	79 81	54650 54652	0.9999854564666748	O
13221	class	83 88	54654 54659	0.999988317489624	O
13222	I	89 90	54660 54661	0.9999879598617554	O
13223	cell	91 95	54662 54666	0.999988317489624	O
13224	surface	96 103	54667 54674	0.9999871253967285	O
13225	expression	104 114	54675 54685	0.9999880790710449	O
13226	are	115 118	54686 54689	0.9999878406524658	O
13227	commonly	119 127	54690 54698	0.999987006187439	O
13228	observed	128 136	54699 54707	0.9999867677688599	O
13229	in	137 139	54708 54710	0.9999845027923584	O
13230	tumors	140 146	54711 54717	0.9999771118164062	O
13231	and	147 150	54718 54721	0.999985933303833	O
13232	are	151 154	54722 54725	0.9999878406524658	O
13233	interpreted	155 166	54726 54737	0.9999853372573853	O
13234	as	167 169	54738 54740	0.9999880790710449	O
13235	a	170 171	54741 54742	0.9999885559082031	O
13236	mechanism	172 181	54743 54752	0.9999834299087524	O
13237	by	182 184	54753 54755	0.9999805688858032	O
13238	which	185 190	54756 54761	0.9999854564666748	O
13239	tumor	191 196	54762 54767	0.9999681711196899	O
13240	cells	197 202	54768 54773	0.9999687671661377	O
13241	evade	203 207	54774 54778	0.9999839067459106	O
13243	the	209 212	54780 54783	0.9999860525131226	O
13244	host	213 217	54784 54788	0.9999409914016724	O
13245	immune	218 224	54789 54795	0.9999778270721436	O
13246	system	225 231	54796 54802	0.9999840259552002	O
13247	[	232 233	54803 54804	0.9999889135360718	O
13248	1	233 234	54804 54805	0.9999843835830688	O
13249	]	234 235	54805 54806	0.9999884366989136	O
13250	.	236 237	54807 54808	0.9999750852584839	O
13251	In	0 2	54809 54811	0.9999818801879883	O
13252	colorectal	3 12	54812 54821	0.9999803304672241	O
13255	cancer	14 20	54823 54829	0.9999840259552002	O
13256	,	21 22	54830 54831	0.9999873638153076	O
13257	especially	23 33	54832 54842	0.9999865293502808	O
13258	in	34 36	54843 54845	0.9999879598617554	O
13259	MSI	37 39	54846 54848	0.9999837875366211	O
13261	-	40 41	54849 54850	0.9999881982803345	O
13262	H	41 42	54850 54851	0.9999176263809204	O
13263	tumors	43 49	54852 54858	0.9999841451644897	O
13264	,	50 51	54859 54860	0.9999874830245972	O
13265	the	52 55	54861 54864	0.9999878406524658	O
13266	high	56 60	54865 54869	0.9999867677688599	O
13267	degree	61 67	54870 54876	0.9999866485595703	O
13268	of	68 70	54877 54879	0.9999884366989136	O
13269	lymphocytic	71 81	54880 54890	0.9999877214431763	O
13273	infiltrate	83 92	54892 54901	0.9999889135360718	O
13277	in	94 96	54903 54905	0.9999887943267822	O
13278	some	97 101	54906 54910	0.9999862909317017	O
13279	cases	102 107	54911 54916	0.999987006187439	O
13280	may	108 111	54917 54920	0.9999871253967285	O
13281	suggest	112 119	54921 54928	0.9999860525131226	O
13282	an	120 122	54929 54931	0.9999885559082031	O
13283	active	123 129	54932 54938	0.9999842643737793	O
13284	immune	130 136	54939 54945	0.9999823570251465	O
13285	response	137 145	54946 54954	0.9999841451644897	O
13286	during	146 152	54955 54961	0.9999843835830688	O
13287	tumor	153 158	54962 54967	0.9999841451644897	O
13288	development	159 170	54968 54979	0.9999833106994629	O
13289	[	171 172	54980 54981	0.9999887943267822	O
13290	41	172 174	54981 54983	0.9999866485595703	O
13291	,	174 175	54983 54984	0.9999877214431763	O
13292	42	175 177	54984 54986	0.9999842643737793	O
13293	]	177 178	54986 54987	0.9999879598617554	O
13294	.	179 180	54988 54989	0.9999779462814331	O
13295	Moreover	0 8	54990 54998	0.9999839067459106	O
13296	,	9 10	54999 55000	0.9999877214431763	O
13297	MSI	11 13	55001 55003	0.9999829530715942	O
13299	-	14 15	55004 55005	0.9999877214431763	O
13300	H	15 16	55005 55006	0.9998998641967773	O
13301	tumors	17 23	55007 55013	0.9999837875366211	O
13302	might	24 29	55014 55019	0.9999840259552002	O
13303	cause	30 35	55020 55025	0.9999872446060181	O
13304	increased	36 45	55026 55035	0.9999850988388062	O
13305	immune	46 52	55036 55042	0.9999834299087524	O
13306	reactivity	53 62	55043 55052	0.9999868869781494	O
13308	as	64 66	55054 55056	0.9999884366989136	O
13309	a	67 68	55057 55058	0.9999891519546509	O
13310	consequence	69 80	55059 55070	0.9999879598617554	O
13311	of	81 83	55071 55073	0.9999885559082031	O
13312	the	84 87	55074 55077	0.9999878406524658	O
13313	high	88 92	55078 55082	0.9999821186065674	O
13314	amounts	93 100	55083 55090	0.999984622001648	O
13315	of	101 103	55091 55093	0.999988317489624	O
13316	aberrant	104 111	55094 55101	0.9999886751174927	O
13319	frameshift	113 122	55103 55112	0.9999881982803345	O
13322	peptides	124 131	55114 55121	0.9999889135360718	O
13325	they	133 137	55123 55127	0.9999876022338867	O
13326	generate	138 146	55128 55136	0.9999866485595703	O
13327	[	147 148	55137 55138	0.99998939037323	O
13328	8	148 149	55138 55139	0.9999884366989136	O
13329	,	149 150	55139 55140	0.9999881982803345	O
13330	18	150 152	55140 55142	0.9999865293502808	O
13331	]	152 153	55142 55143	0.9999887943267822	O
13332	.	154 155	55144 55145	0.9999802112579346	O
13333	A	0 1	55146 55147	0.9999831914901733	O
13334	selective	2 11	55148 55157	0.9999825954437256	O
13335	pressure	12 20	55158 55166	0.9999641180038452	O
13336	by	21 23	55167 55169	0.9999830722808838	O
13337	CTLs	24 27	55170 55173	0.9999774694442749	O
13340	upon	29 33	55175 55179	0.99993896484375	O
13341	these	34 39	55180 55185	0.9999690055847168	O
13342	tumors	40 46	55186 55192	0.9999771118164062	O
13343	would	47 52	55193 55198	0.9999731779098511	O
13344	favor	53 58	55199 55204	0.999977707862854	O
13345	the	59 62	55205 55208	0.9999839067459106	O
13346	outgrowth	63 71	55209 55217	0.9999839067459106	O
13349	of	73 75	55219 55221	0.999984622001648	O
13350	tumor	76 81	55222 55227	0.9999773502349854	O
13351	cells	82 87	55228 55233	0.9999818801879883	O
13352	that	88 92	55234 55238	0.9999849796295166	O
13353	lost	93 97	55239 55243	0.9999802112579346	O
13354	HLA	98 100	55244 55246	0.9999862909317017	O
13356	class	102 107	55248 55253	0.9999876022338867	O
13357	I	108 109	55254 55255	0.9999874830245972	O
13358	expression	110 120	55256 55266	0.9999876022338867	O
13359	at	121 123	55267 55269	0.9999874830245972	O
13360	the	124 127	55270 55273	0.9999878406524658	O
13361	cell	128 132	55274 55278	0.999987006187439	O
13362	surface	133 140	55279 55286	0.9999862909317017	O
13363	allowing	141 149	55287 55295	0.9999864101409912	O
13364	them	150 154	55296 55300	0.9999853372573853	O
13365	to	155 157	55301 55303	0.999987006187439	O
13366	surpass	158 164	55304 55310	0.9999854564666748	O
13368	the	166 169	55312 55315	0.9999866485595703	O
13369	action	170 176	55316 55322	0.9999755620956421	O
13370	of	177 179	55323 55325	0.9999865293502808	O
13371	the	180 183	55326 55329	0.9999856948852539	O
13372	immune	184 190	55330 55336	0.9999716281890869	O
13373	system	191 197	55337 55343	0.9999796152114868	O
13374	.	198 199	55344 55345	0.9999276399612427	O
13375	Applying	0 7	55346 55353	0.9999845027923584	O
13378	immunohistochemistry	9 28	55355 55374	0.999987006187439	O
13384	on	30 32	55376 55378	0.9999866485595703	O
13385	tissue	33 39	55379 55385	0.9999858140945435	O
13386	arrays	40 45	55386 55391	0.999984622001648	O
13388	,	47 48	55393 55394	0.999984860420227	O
13389	we	49 51	55395 55397	0.9999825954437256	O
13390	compared	52 60	55398 55406	0.9999810457229614	O
13391	HLA	61 63	55407 55409	0.9999854564666748	O
13393	class	65 70	55411 55416	0.9999879598617554	O
13394	I	71 72	55417 55418	0.9999864101409912	O
13395	expression	73 83	55419 55429	0.9999847412109375	O
13396	in	84 86	55430 55432	0.9999841451644897	O
13397	both	87 91	55433 55437	0.9999411106109619	O
13398	sporadic	92 99	55438 55445	0.9999666213989258	O
13400	RST	101 103	55447 55449	0.9999788999557495	O
13402	(	105 106	55451 55452	0.9999877214431763	O
13403	MSI	107 109	55453 55455	0.9999866485595703	O
13405	-	110 111	55456 55457	0.9999887943267822	O
13406	H	111 112	55457 55458	0.9999812841415405	O
13407	and	113 116	55459 55462	0.9999867677688599	O
13408	MSS	117 119	55463 55465	0.9999861717224121	O
13410	sub	121 124	55467 55470	0.9999887943267822	O
13411	-	124 125	55470 55471	0.9999885559082031	O
13412	groups	125 131	55471 55477	0.9999862909317017	O
13413	)	132 133	55478 55479	0.9999853372573853	O
13414	and	134 137	55480 55483	0.9999734163284302	O
13415	HNPCC	138 142	55484 55488	0.9998661279678345	O
13418	tumors	144 150	55490 55496	0.9999809265136719	O
13419	.	151 152	55497 55498	0.9999387264251709	O
13420	RST	0 2	55499 55501	0.9999790191650391	O
13422	were	4 8	55503 55507	0.9999865293502808	O
13423	chosen	9 15	55508 55514	0.9999840259552002	O
13424	because	16 23	55515 55522	0.9999864101409912	O
13425	of	24 26	55523 55525	0.9999880790710449	O
13426	the	27 30	55526 55529	0.9999879598617554	O
13427	high	31 35	55530 55534	0.9999874830245972	O
13428	percentage	36 46	55535 55545	0.9999874830245972	O
13429	of	47 49	55546 55548	0.9999889135360718	O
13430	MSI	50 52	55549 55551	0.9999866485595703	O
13432	-	53 54	55552 55553	0.9999891519546509	O
13433	H	54 55	55553 55554	0.9999810457229614	O
13434	cases	56 61	55555 55560	0.999988317489624	O
13435	in	62 64	55561 55563	0.9999880790710449	O
13436	this	65 69	55564 55568	0.999987006187439	O
13437	specific	70 78	55569 55577	0.9999836683273315	O
13438	tumor	79 84	55578 55583	0.999984860420227	O
13439	type	85 89	55584 55588	0.9999871253967285	O
13440	[	90 91	55589 55590	0.9999887943267822	O
13441	43	91 93	55590 55592	0.9999854564666748	O
13442	]	93 94	55592 55593	0.9999887943267822	O
13443	.	95 96	55594 55595	0.9999738931655884	O
13444	Indeed	0 6	55596 55602	0.9999767541885376	O
13445	,	7 8	55603 55604	0.9999887943267822	O
13446	immunohistochemical	9 27	55605 55623	0.9999885559082031	O
13452	staining	29 36	55625 55632	0.999988317489624	O
13454	with	38 42	55634 55638	0.9999885559082031	O
13455	mAb	43 45	55639 55641	0.9999877214431763	O
13458	showed	47 53	55643 55649	0.9999879598617554	O
13459	that	54 58	55650 55654	0.9999891519546509	O
13460	HLA	59 61	55655 55657	0.9999871253967285	O
13462	class	63 68	55659 55664	0.9999886751174927	O
13463	I	69 70	55665 55666	0.9999876022338867	O
13464	loss	71 75	55667 55671	0.9999871253967285	O
13465	was	76 79	55672 55675	0.9999885559082031	O
13466	frequent	80 88	55676 55684	0.9999871253967285	O
13467	in	89 91	55685 55687	0.9999892711639404	O
13468	the	92 95	55688 55691	0.9999887943267822	O
13469	MSI	96 98	55692 55694	0.9999858140945435	O
13471	-	99 100	55695 55696	0.9999890327453613	O
13472	H	100 101	55696 55697	0.9999737739562988	O
13473	cases	102 107	55698 55703	0.9999881982803345	O
13474	analyzed	108 116	55704 55712	0.9999871253967285	O
13475	when	117 121	55713 55717	0.999988317489624	O
13476	compared	122 130	55718 55726	0.9999878406524658	O
13477	to	131 133	55727 55729	0.999988317489624	O
13478	their	134 139	55730 55735	0.9999876022338867	O
13479	MSS	140 142	55736 55738	0.9999852180480957	O
13481	counterpart	144 155	55740 55751	0.9999850988388062	O
13482	.	156 157	55752 55753	0.9999712705612183	O
13483	This	0 4	55754 55758	0.999984860420227	O
13484	finding	5 12	55759 55766	0.9999833106994629	O
13485	supports	13 21	55767 55775	0.9999815225601196	O
13486	the	22 25	55776 55779	0.9999872446060181	O
13487	hypothesis	26 36	55780 55790	0.9999725818634033	O
13488	that	37 41	55791 55795	0.9999866485595703	O
13489	MSI	42 44	55796 55798	0.9999762773513794	O
13491	-	45 46	55799 55800	0.9999856948852539	O
13492	H	46 47	55800 55801	0.9999380111694336	O
13493	tumors	48 54	55802 55808	0.9999814033508301	O
13494	face	55 59	55809 55813	0.9999829530715942	O
13495	greater	60 67	55814 55821	0.9999803304672241	O
13496	selective	68 77	55822 55831	0.9999862909317017	O
13497	pressure	78 86	55832 55840	0.9999840259552002	O
13498	to	87 89	55841 55843	0.9999865293502808	O
13499	lose	90 94	55844 55848	0.9999816417694092	O
13500	HLA	95 97	55849 55851	0.9999841451644897	O
13502	class	99 104	55853 55858	0.9999872446060181	O
13503	I	105 106	55859 55860	0.9999867677688599	O
13504	expression	107 117	55861 55871	0.9999860525131226	O
13505	,	118 119	55872 55873	0.9999860525131226	O
13506	as	120 122	55874 55876	0.9999873638153076	O
13507	described	123 132	55877 55886	0.9999852180480957	O
13508	by	133 135	55887 55889	0.9999874830245972	O
13509	Kloor	136 140	55890 55894	0.9999767541885376	O
13512	et	142 144	55896 55898	0.9999873638153076	O
13513	al	145 147	55899 55901	0.9999867677688599	O
13514	[	147 148	55901 55902	0.9999876022338867	O
13515	8	148 149	55902 55903	0.9999842643737793	O
13516	]	149 150	55903 55904	0.9999872446060181	O
13517	.	151 152	55905 55906	0.9999748468399048	O
13518	However	0 7	55907 55914	0.9999793767929077	O
13519	,	8 9	55915 55916	0.9999856948852539	O
13520	we	10 12	55917 55919	0.999977707862854	O
13521	have	13 17	55920 55924	0.9999810457229614	O
13522	shown	18 23	55925 55930	0.9999798536300659	O
13523	for	24 27	55931 55934	0.9999865293502808	O
13524	the	28 31	55935 55938	0.9999871253967285	O
13525	first	32 37	55939 55944	0.9999860525131226	O
13526	time	38 42	55945 55949	0.9999853372573853	O
13527	that	43 47	55950 55954	0.9999853372573853	O
13528	distinct	48 56	55955 55963	0.9999715089797974	O
13529	molecular	57 66	55964 55973	0.9999756813049316	O
13530	mechanisms	67 77	55974 55984	0.9999799728393555	O
13531	underlie	78 85	55985 55992	0.999985933303833	O
13533	HLA	87 89	55994 55996	0.9999845027923584	O
13535	class	91 96	55998 56003	0.9999866485595703	O
13536	I	97 98	56004 56005	0.9999854564666748	O
13537	loss	99 103	56006 56010	0.9999797344207764	O
13538	in	104 106	56011 56013	0.999983549118042	O
13539	sporadic	107 114	56014 56021	0.9999819993972778	O
13541	MSI	116 118	56023 56025	0.999982476234436	O
13543	-	119 120	56026 56027	0.9999867677688599	O
13544	H	120 121	56027 56028	0.9999560117721558	O
13545	and	122 125	56029 56032	0.9999744892120361	O
13546	HNPCC	126 130	56033 56037	0.9999599456787109	O
13549	colon	132 136	56039 56043	0.9999802112579346	O
13551	cancers	138 144	56045 56051	0.9999840259552002	O
13553	.	146 147	56053 56054	0.9999414682388306	O
13554	In	0 2	56055 56057	0.9999889135360718	O
13555	the	3 6	56058 56061	0.9999887943267822	O
13556	latter	7 13	56062 56068	0.999985933303833	O
13557	,	14 15	56069 56070	0.99998939037323	O
13558	HLA	16 18	56071 56073	0.999988317489624	O
13560	class	20 25	56075 56080	0.9999895095825195	O
13561	I	26 27	56081 56082	0.9999891519546509	O
13562	loss	28 32	56083 56087	0.9999892711639404	O
13563	was	33 36	56088 56091	0.9999892711639404	O
13564	preferentially	37 50	56092 56105	0.9999890327453613	O
13567	associated	52 62	56107 56117	0.9999897480010986	O
13568	with	63 67	56118 56122	0.9999896287918091	O
13569	that	68 72	56123 56127	0.9999897480010986	O
13570	of	73 75	56128 56130	0.9999895095825195	O
13571	β2m	76 78	56131 56133	0.9999886751174927	O
13574	,	80 81	56135 56136	0.9999890327453613	O
13575	while	82 87	56137 56142	0.9999886751174927	O
13576	in	88 90	56143 56145	0.9999892711639404	O
13577	the	91 94	56146 56149	0.99998939037323	O
13578	former	95 101	56150 56156	0.9999850988388062	O
13579	HLA	102 104	56157 56159	0.9999891519546509	O
13581	class	106 111	56161 56166	0.9999895095825195	O
13582	I	112 113	56167 56168	0.9999891519546509	O
13583	loss	114 118	56169 56173	0.9999897480010986	O
13584	was	119 122	56174 56177	0.9999895095825195	O
13585	associated	123 133	56178 56188	0.9999896287918091	O
13586	with	134 138	56189 56193	0.9999896287918091	O
13587	that	139 143	56194 56198	0.9999896287918091	O
13588	of	144 146	56199 56201	0.99998939037323	O
13589	one	147 150	56202 56205	0.99998939037323	O
13590	or	151 153	56206 56208	0.9999885559082031	O
13591	more	154 158	56209 56213	0.9999889135360718	O
13592	APM	159 161	56214 56216	0.9999836683273315	O
13594	components	163 173	56218 56228	0.9999892711639404	O
13595	(	174 175	56229 56230	0.9999895095825195	O
13596	p	176 177	56231 56232	0.9999886751174927	O
13597	<	178 179	56233 56234	0.9999880790710449	O
13598	0	180 181	56235 56236	0.99998939037323	O
13599	.	181 182	56236 56237	0.9999890327453613	O
13600	0001	182 185	56237 56240	0.999988317489624	O
13602	)	187 188	56242 56243	0.99998939037323	O
13603	.	189 190	56244 56245	0.9999669790267944	O
13604	We	0 2	56246 56248	0.9999648332595825	O
13605	investigated	3 15	56249 56261	0.9999698400497437	O
13606	the	16 19	56262 56265	0.999980092048645	O
13607	genetic	20 27	56266 56273	0.9999632835388184	O
13608	abnormalities	28 40	56274 56286	0.9999773502349854	O
13610	underlying	42 52	56288 56298	0.9999808073043823	O
13611	the	53 56	56299 56302	0.9999806880950928	O
13612	HLA	57 59	56303 56305	0.999971866607666	O
13614	class	61 66	56307 56312	0.9999819993972778	O
13615	I	67 68	56313 56314	0.9999799728393555	O
13616	loss	69 73	56315 56319	0.9999818801879883	O
13617	of	74 76	56320 56322	0.999985933303833	O
13618	expression	77 87	56323 56333	0.9999817609786987	O
13619	.	88 89	56334 56335	0.9998641014099121	O
13620	They	0 4	56336 56340	0.9999842643737793	O
13621	included	5 13	56341 56349	0.9999884366989136	O
13622	LOH	14 16	56350 56352	0.9999868869781494	O
13624	on	18 20	56354 56356	0.9999887943267822	O
13625	chromosome	21 31	56357 56367	0.999988317489624	O
13626	region	32 38	56368 56374	0.9999885559082031	O
13627	6p21	39 42	56375 56378	0.9999880790710449	O
13630	.	43 44	56379 56380	0.9999885559082031	O
13631	3	44 45	56380 56381	0.9999874830245972	O
13632	(	46 47	56382 56383	0.9999892711639404	O
13633	encompassing	48 60	56384 56396	0.9999886751174927	O
13634	HLA	61 63	56397 56399	0.9999877214431763	O
13636	class	65 70	56401 56406	0.9999886751174927	O
13637	I	71 72	56407 56408	0.9999889135360718	O
13638	and	73 76	56409 56412	0.9999889135360718	O
13639	TAP	77 79	56413 56415	0.9999876022338867	O
13641	genes	81 86	56417 56422	0.9999890327453613	O
13642	)	87 88	56423 56424	0.9999895095825195	O
13643	,	89 90	56425 56426	0.9999889135360718	O
13644	mutations	91 100	56427 56436	0.9999872446060181	O
13645	in	101 103	56437 56439	0.9999891519546509	O
13646	APM	104 106	56440 56442	0.9999858140945435	O
13648	components	108 118	56444 56454	0.99998939037323	O
13649	and	119 122	56455 56458	0.9999889135360718	O
13650	mutations	123 132	56459 56468	0.9999879598617554	O
13651	in	133 135	56469 56471	0.9999890327453613	O
13652	β2m	136 138	56472 56474	0.9999878406524658	O
13655	.	140 141	56476 56477	0.9999793767929077	O
13656	Loss	0 4	56478 56482	0.9999850988388062	O
13657	of	5 7	56483 56485	0.9999873638153076	O
13658	heterozygosity	8 21	56486 56499	0.9999855756759644	O
13663	at	23 25	56501 56503	0.9999872446060181	O
13664	6p21	26 29	56504 56507	0.9999840259552002	O
13667	.	30 31	56508 56509	0.9999867677688599	O
13668	3	31 32	56509 56510	0.9999837875366211	O
13669	was	33 36	56511 56514	0.9999830722808838	O
13670	most	37 41	56515 56519	0.9999827146530151	O
13671	prevalent	42 51	56520 56529	0.9999831914901733	O
13672	in	52 54	56530 56532	0.9999802112579346	O
13673	MSS	55 57	56533 56535	0.9998202919960022	O
13675	tumors	59 65	56537 56543	0.9999806880950928	O
13676	.	66 67	56544 56545	0.9999105930328369	O
13677	This	0 4	56546 56550	0.9999815225601196	O
13678	is	5 7	56551 56553	0.9999841451644897	O
13679	consistent	8 18	56554 56564	0.9999830722808838	O
13680	with	19 23	56565 56569	0.9999862909317017	O
13681	the	24 27	56570 56573	0.9999855756759644	O
13682	observation	28 39	56574 56585	0.9999775886535645	O
13683	that	40 44	56586 56590	0.9999847412109375	O
13684	these	45 50	56591 56596	0.9999783039093018	O
13685	tumors	51 57	56597 56603	0.9999780654907227	O
13686	frequently	58 68	56604 56614	0.9999804496765137	O
13687	possess	69 76	56615 56622	0.9999822378158569	O
13688	gross	77 82	56623 56628	0.9999847412109375	O
13689	chromosomal	83 93	56629 56639	0.9999877214431763	O
13693	aberrations	95 105	56641 56651	0.9999880790710449	O
13696	and	107 110	56653 56656	0.999984622001648	O
13697	are	111 114	56657 56660	0.9999862909317017	O
13698	often	115 120	56661 56666	0.9999866485595703	O
13699	aneuploid	121 129	56667 56675	0.9999876022338867	O
13704	[	131 132	56677 56678	0.9999889135360718	O
13705	13	132 134	56678 56680	0.9999867677688599	O
13706	]	134 135	56680 56681	0.999988317489624	O
13707	.	136 137	56682 56683	0.9999682903289795	O
13708	Moreover	0 8	56684 56692	0.9999812841415405	O
13709	,	9 10	56693 56694	0.9999884366989136	O
13710	since	11 16	56695 56700	0.999981164932251	O
13711	LOH	17 19	56701 56703	0.9999861717224121	O
13713	events	21 27	56705 56711	0.9999854564666748	O
13714	in	28 30	56712 56714	0.9999855756759644	O
13715	MSS	31 33	56715 56717	0.9999326467514038	O
13717	tumors	35 41	56719 56725	0.9999821186065674	O
13718	normally	42 50	56726 56734	0.9999794960021973	O
13719	comprise	51 59	56735 56743	0.9999876022338867	O
13720	large	60 65	56744 56749	0.9999841451644897	O
13721	areas	66 71	56750 56755	0.9999867677688599	O
13722	of	72 74	56756 56758	0.9999880790710449	O
13723	a	75 76	56759 56760	0.9999878406524658	O
13724	chromosome	77 87	56761 56771	0.9999850988388062	O
13725	,	88 89	56772 56773	0.9999878406524658	O
13726	LOH	90 92	56774 56776	0.9999884366989136	O
13728	on	94 96	56778 56780	0.9999890327453613	O
13729	6p21	97 100	56781 56784	0.9999880790710449	O
13732	might	102 107	56786 56791	0.9999849796295166	O
13733	not	108 111	56792 56795	0.9999879598617554	O
13734	be	112 114	56796 56798	0.9999890327453613	O
13735	a	115 116	56799 56800	0.9999889135360718	O
13736	direct	117 123	56801 56807	0.9999868869781494	O
13737	consequence	124 135	56808 56819	0.9999886751174927	O
13738	of	136 138	56820 56822	0.9999889135360718	O
13739	selective	139 148	56823 56832	0.9999877214431763	O
13740	pressure	149 157	56833 56841	0.9999867677688599	O
13741	directed	158 166	56842 56850	0.9999886751174927	O
13742	to	167 169	56851 56853	0.9999889135360718	O
13743	the	170 173	56854 56857	0.9999886751174927	O
13744	loss	174 178	56858 56862	0.9999868869781494	O
13745	of	179 181	56863 56865	0.9999889135360718	O
13746	HLA	182 184	56866 56868	0.9999861717224121	O
13748	expression	186 196	56870 56880	0.9999877214431763	O
13749	but	197 200	56881 56884	0.9999866485595703	O
13750	instead	201 208	56885 56892	0.9999852180480957	O
13751	to	209 211	56893 56895	0.9999877214431763	O
13752	other	212 217	56896 56901	0.9999867677688599	O
13753	genes	218 223	56902 56907	0.9999873638153076	O
13754	within	224 230	56908 56914	0.999988317489624	O
13755	the	231 234	56915 56918	0.9999890327453613	O
13756	same	235 239	56919 56923	0.999987006187439	O
13757	chromosomal	240 250	56924 56934	0.9999884366989136	O
13761	region	252 258	56936 56942	0.9999878406524658	O
13762	.	259 260	56943 56944	0.9999513626098633	O
13763	The	0 3	56945 56948	0.9999862909317017	O
13764	general	4 11	56949 56956	0.9999842643737793	O
13765	absence	12 19	56957 56964	0.9999864101409912	O
13766	of	20 22	56965 56967	0.9999880790710449	O
13767	LOH	23 25	56968 56970	0.9999865293502808	O
13769	in	27 29	56972 56974	0.9999866485595703	O
13770	MSI	30 32	56975 56977	0.9999819993972778	O
13772	-	33 34	56978 56979	0.9999868869781494	O
13773	H	34 35	56979 56980	0.9998928308486938	O
13774	tumors	36 42	56981 56987	0.9999825954437256	O
13775	suggests	43 51	56988 56996	0.999977707862854	O
13776	that	52 56	56997 57001	0.9999873638153076	O
13777	this	57 61	57002 57006	0.9999866485595703	O
13778	is	62 64	57007 57009	0.9999867677688599	O
13779	not	65 68	57010 57013	0.999981164932251	O
13780	the	69 72	57014 57017	0.9999865293502808	O
13781	major	73 78	57018 57023	0.9999839067459106	O
13782	mechanism	79 88	57024 57033	0.9999828338623047	O
13783	by	89 91	57034 57036	0.9999794960021973	O
13784	which	92 97	57037 57042	0.9999862909317017	O
13785	the	98 101	57043 57046	0.9999829530715942	O
13786	cells	102 107	57047 57052	0.9999567270278931	O
13787	abrogate	108 115	57053 57060	0.999987006187439	O
13790	HLA	117 119	57062 57064	0.9999854564666748	O
13792	class	121 126	57066 57071	0.9999878406524658	O
13793	I	127 128	57072 57073	0.9999872446060181	O
13794	expression	129 139	57074 57084	0.9999872446060181	O
13795	.	140 141	57085 57086	0.9999569654464722	O
13796	The	0 3	57087 57090	0.9999858140945435	O
13797	genome	4 10	57091 57097	0.9999631643295288	O
13798	'	11 12	57098 57099	0.9999855756759644	O
13799	s	12 13	57099 57100	0.999985933303833	O
13800	coding	14 20	57101 57107	0.9999853372573853	O
13801	regions	21 28	57108 57115	0.9999853372573853	O
13802	contain	29 36	57116 57123	0.9999847412109375	O
13803	multiple	37 45	57124 57132	0.9999833106994629	O
13804	microsatellite	46 59	57133 57146	0.9999858140945435	O
13808	repeats	61 68	57148 57155	0.9999793767929077	O
13809	,	69 70	57156 57157	0.9999865293502808	O
13810	which	71 76	57158 57163	0.9999878406524658	O
13811	are	77 80	57164 57167	0.9999873638153076	O
13812	considered	81 91	57168 57178	0.9999847412109375	O
13813	hotspots	92 99	57179 57186	0.9999873638153076	O
13816	for	101 104	57188 57191	0.9999871253967285	O
13817	mutations	105 114	57192 57201	0.9999831914901733	O
13818	in	115 117	57202 57204	0.9999874830245972	O
13819	mismatch	118 125	57205 57212	0.9999861717224121	O
13822	repair	127 133	57214 57220	0.9999868869781494	O
13823	-	133 134	57220 57221	0.9999881982803345	O
13824	deficient	134 142	57221 57229	0.9999877214431763	O
13826	tumors	144 150	57231 57237	0.999985933303833	O
13827	[	151 152	57238 57239	0.9999887943267822	O
13828	43	152 154	57239 57241	0.9999852180480957	O
13829	]	154 155	57241 57242	0.9999880790710449	O
13830	.	156 157	57243 57244	0.9999728202819824	O
13831	Such	0 4	57245 57249	0.9999817609786987	O
13832	repeats	5 12	57250 57257	0.999945878982544	O
13833	are	13 16	57258 57261	0.9999831914901733	O
13834	also	17 21	57262 57266	0.9999829530715942	O
13835	present	22 29	57267 57274	0.9999856948852539	O
13836	within	30 36	57275 57281	0.9999841451644897	O
13837	the	37 40	57282 57285	0.9999865293502808	O
13838	exons	41 45	57286 57290	0.9999849796295166	O
13840	of	47 49	57292 57294	0.9999868869781494	O
13841	the	50 53	57295 57298	0.9999861717224121	O
13842	APM	54 56	57299 57301	0.9999803304672241	O
13844	components	58 68	57303 57313	0.9999880790710449	O
13845	,	69 70	57314 57315	0.9999876022338867	O
13846	β2m	71 73	57316 57318	0.9999866485595703	O
13849	,	75 76	57320 57321	0.9999879598617554	O
13850	HLA	77 79	57322 57324	0.9999865293502808	O
13852	-	80 81	57325 57326	0.999988317489624	O
13853	A	81 82	57326 57327	0.9999873638153076	O
13854	and	83 86	57328 57331	0.9999873638153076	O
13855	HLA	87 89	57332 57334	0.9999864101409912	O
13857	-	90 91	57335 57336	0.999988317489624	O
13858	B	91 92	57336 57337	0.9999856948852539	O
13859	genes	93 98	57338 57343	0.9999877214431763	O
13860	.	99 100	57344 57345	0.999955415725708	O
13861	In	0 2	57346 57348	0.9999872446060181	O
13862	about	3 8	57349 57354	0.9999852180480957	O
13863	half	9 13	57355 57359	0.9999842643737793	O
13864	of	14 16	57360 57362	0.9999874830245972	O
13865	the	17 20	57363 57366	0.9999861717224121	O
13866	MSI	21 23	57367 57369	0.999977707862854	O
13868	-	24 25	57370 57371	0.9999877214431763	O
13869	H	25 26	57371 57372	0.999915361404419	O
13870	cases	27 32	57373 57378	0.9999852180480957	O
13871	,	33 34	57379 57380	0.9999884366989136	O
13872	loss	35 39	57381 57385	0.9999879598617554	O
13873	of	40 42	57386 57388	0.9999895095825195	O
13874	expression	43 53	57389 57399	0.9999884366989136	O
13875	of	54 56	57400 57402	0.99998939037323	O
13876	HLA	57 59	57403 57405	0.9999867677688599	O
13878	class	61 66	57407 57412	0.9999885559082031	O
13879	I	67 68	57413 57414	0.9999878406524658	O
13880	was	69 72	57415 57418	0.9999891519546509	O
13881	concordant	73 82	57419 57428	0.9999895095825195	O
13884	with	84 88	57430 57434	0.9999892711639404	O
13885	the	89 92	57435 57438	0.99998939037323	O
13886	detection	93 102	57439 57448	0.9999885559082031	O
13887	of	103 105	57449 57451	0.99998939037323	O
13888	one	106 109	57452 57455	0.99998939037323	O
13889	or	110 112	57456 57458	0.9999886751174927	O
13890	more	113 117	57459 57463	0.9999887943267822	O
13891	mutations	118 127	57464 57473	0.9999862909317017	O
13892	in	128 130	57474 57476	0.9999891519546509	O
13893	these	131 136	57477 57482	0.9999887943267822	O
13894	genes	137 142	57483 57488	0.9999862909317017	O
13895	.	143 144	57489 57490	0.9999680519104004	O
13896	We	0 2	57491 57493	0.9999823570251465	O
13897	have	3 7	57494 57498	0.9999850988388062	O
13898	discovered	8 18	57499 57509	0.9999853372573853	O
13899	novel	19 24	57510 57515	0.9999817609786987	O
13900	mutations	25 34	57516 57525	0.9999809265136719	O
13901	in	35 37	57526 57528	0.9999868869781494	O
13902	the	38 41	57529 57532	0.9999868869781494	O
13903	antigen	42 48	57533 57539	0.9999819993972778	O
13905	presenting	50 60	57541 57551	0.9999849796295166	O
13906	machinery	61 70	57552 57561	0.9999858140945435	O
13907	genes	71 76	57562 57567	0.9999873638153076	O
13908	;	77 78	57568 57569	0.9999873638153076	O
13909	Tapasin	79 85	57570 57576	0.9999843835830688	O
13912	,	87 88	57578 57579	0.9999885559082031	O
13913	Erp57	89 93	57580 57584	0.9999880790710449	O
13917	,	95 96	57586 57587	0.999988317489624	O
13918	Calreticulin	97 108	57588 57599	0.9999881982803345	O
13922	and	110 113	57601 57604	0.9999880790710449	O
13923	Calnexin	114 121	57605 57612	0.9999880790710449	O
13926	in	123 125	57614 57616	0.9999878406524658	O
13927	colorectal	126 135	57617 57626	0.9999860525131226	O
13930	cancer	137 143	57628 57634	0.9999868869781494	O
13931	.	144 145	57635 57636	0.9999676942825317	O
13932	Previous	0 8	57637 57645	0.9999778270721436	O
13933	reports	9 16	57646 57653	0.9999806880950928	O
13934	associated	17 27	57654 57664	0.9999823570251465	O
13935	the	28 31	57665 57668	0.9999866485595703	O
13936	loss	32 36	57669 57673	0.9999842643737793	O
13937	of	37 39	57674 57676	0.9999880790710449	O
13938	HLA	40 42	57677 57679	0.9999828338623047	O
13940	class	44 49	57681 57686	0.9999868869781494	O
13941	I	50 51	57687 57688	0.9999866485595703	O
13942	expression	52 62	57689 57699	0.9999860525131226	O
13943	in	63 65	57700 57702	0.9999867677688599	O
13944	MSI	66 68	57703 57705	0.9999779462814331	O
13946	-	69 70	57706 57707	0.9999864101409912	O
13947	H	70 71	57707 57708	0.9998723268508911	O
13948	tumors	72 78	57709 57715	0.9999825954437256	O
13949	with	79 83	57716 57720	0.9999861717224121	O
13950	defects	84 91	57721 57728	0.9999825954437256	O
13951	on	92 94	57729 57731	0.9999876022338867	O
13952	β2m	95 97	57732 57734	0.999987006187439	O
13955	molecule	99 107	57736 57744	0.9999876022338867	O
13956	[	108 109	57745 57746	0.9999892711639404	O
13957	7	109 110	57746 57747	0.9999879598617554	O
13958	,	110 111	57747 57748	0.999988317489624	O
13959	9	111 112	57748 57749	0.9999872446060181	O
13960	]	112 113	57749 57750	0.9999884366989136	O
13961	.	114 115	57751 57752	0.9999788999557495	O
13962	However	0 7	57753 57760	0.9999797344207764	O
13963	,	8 9	57761 57762	0.9999843835830688	O
13964	the	10 13	57763 57766	0.9999817609786987	O
13965	authors	14 21	57767 57774	0.9999730587005615	O
13966	did	22 25	57775 57778	0.9999808073043823	O
13967	not	26 29	57779 57782	0.9999783039093018	O
13968	distinguish	30 41	57783 57794	0.9999736547470093	O
13969	the	42 45	57795 57798	0.999983549118042	O
13970	sporadic	46 53	57799 57806	0.999982476234436	O
13972	/	54 55	57807 57808	0.9999804496765137	O
13973	hereditary	55 65	57808 57818	0.9999364614486694	O
13974	nature	66 72	57819 57825	0.9999815225601196	O
13975	of	73 75	57826 57828	0.9999829530715942	O
13976	the	76 79	57829 57832	0.9999771118164062	O
13977	tumors	80 86	57833 57839	0.9999697208404541	O
13978	that	87 91	57840 57844	0.9999816417694092	O
13979	were	92 96	57845 57849	0.9999833106994629	O
13980	studied	97 104	57850 57857	0.9999707937240601	O
13981	.	105 106	57858 57859	0.9999097585678101	O
13982	We	0 2	57860 57862	0.9999833106994629	O
13983	cannot	3 9	57863 57869	0.9999828338623047	O
13984	exclude	10 17	57870 57877	0.9999793767929077	O
13985	that	18 22	57878 57882	0.9999877214431763	O
13986	the	23 26	57883 57886	0.9999872446060181	O
13987	MSI	27 29	57887 57889	0.9999839067459106	O
13989	-	30 31	57890 57891	0.9999884366989136	O
13990	H	31 32	57891 57892	0.999969482421875	O
13991	cases	33 38	57893 57898	0.999987006187439	O
13992	included	39 47	57899 57907	0.9999876022338867	O
13993	in	48 50	57908 57910	0.9999879598617554	O
13994	these	51 56	57911 57916	0.9999880790710449	O
13995	studies	57 64	57917 57924	0.9999821186065674	O
13996	were	65 69	57925 57929	0.9999872446060181	O
13997	mainly	70 76	57930 57936	0.9999858140945435	O
13998	HNPCC	77 81	57937 57941	0.9999786615371704	O
14001	tumors	83 89	57943 57949	0.9999852180480957	O
14002	.	90 91	57950 57951	0.9999881982803345	O
14003	*	92 93	57952 57953	0.9999872446060181	O
14004	*	93 94	57953 57954	0.9999806880950928	O
14005	IGNORE	0 5	57955 57960	0.9999845027923584	O
14008	LINE	7 10	57962 57965	0.9999881982803345	O
14011	*	12 13	57967 57968	0.9999881982803345	O
14012	*	13 14	57968 57969	0.9999880790710449	O
14013	*	15 16	57970 57971	0.9999880790710449	O
14014	*	16 17	57971 57972	0.999988317489624	O
14015	IGNORE	18 23	57973 57978	0.9999862909317017	O
14018	LINE	25 28	57980 57983	0.9999885559082031	O
14021	*	30 31	57985 57986	0.9999880790710449	O
14022	*	31 32	57986 57987	0.9999879598617554	O
14023	*	33 34	57988 57989	0.9999880790710449	O
14024	*	34 35	57989 57990	0.9999878406524658	O
14025	IGNORE	36 41	57991 57996	0.9999855756759644	O
14028	LINE	43 46	57998 58001	0.9999885559082031	O
14031	*	48 49	58003 58004	0.9999880790710449	O
14032	*	49 50	58004 58005	0.9999880790710449	O
14033	Dietary	51 57	58006 58012	0.9999805688858032	O
14035	fat	59 62	58014 58017	0.9999847412109375	O
14036	and	63 66	58018 58021	0.9999878406524658	O
14037	risk	67 71	58022 58026	0.9999858140945435	O
14038	of	72 74	58027 58029	0.9999877214431763	O
14039	colon	75 79	58030 58034	0.9999829530715942	O
14041	and	81 84	58036 58039	0.9999839067459106	O
14042	rectal	85 90	58040 58045	0.9999822378158569	O
14045	cancer	92 98	58047 58053	0.9999860525131226	O
14046	with	99 103	58054 58058	0.9999878406524658	O
14047	aberrant	104 111	58059 58066	0.9999885559082031	O
14050	MLH1	113 116	58068 58071	0.9999877214431763	O
14053	expression	118 128	58073 58083	0.9999885559082031	O
14054	,	129 130	58084 58085	0.9999867677688599	O
14055	or	131 133	58086 58088	0.9999876022338867	O
14056	genes	134 139	58089 58094	0.9999847412109375	O
14057	Abstract	140 147	58095 58102	0.9999864101409912	O
14060	Objective	149 157	58104 58112	0.9999860525131226	O
14063	To	159 161	58114 58116	0.9999850988388062	O
14064	investigate	162 173	58117 58128	0.9999865293502808	O
14065	baseline	174 181	58129 58136	0.9999865293502808	O
14067	fat	183 186	58138 58141	0.9999827146530151	O
14068	intake	187 193	58142 58148	0.9999862909317017	O
14069	and	194 197	58149 58152	0.9999874830245972	O
14070	the	198 201	58153 58156	0.9999873638153076	O
14071	risk	202 206	58157 58161	0.9999837875366211	O
14072	of	207 209	58162 58164	0.9999860525131226	O
14073	colon	210 214	58165 58169	0.9999810457229614	O
14075	and	216 219	58171 58174	0.999982476234436	O
14076	rectal	220 225	58175 58180	0.9999805688858032	O
14079	tumors	227 233	58182 58188	0.999984622001648	O
14080	lacking	234 241	58189 58196	0.9999834299087524	O
14081	MLH1	242 245	58197 58200	0.9999868869781494	O
14084	(	247 248	58202 58203	0.9999886751174927	O
14085	mutL	249 252	58204 58207	0.9999858140945435	O
14088	homolog	254 260	58209 58215	0.999988317489624	O
14091	1	262 263	58217 58218	0.9999884366989136	O
14092	,	264 265	58219 58220	0.9999865293502808	O
14093	colon	266 270	58221 58225	0.9999822378158569	O
14095	cancer	272 278	58227 58233	0.999985933303833	O
14096	,	279 280	58234 58235	0.9999865293502808	O
14097	nonpolyposis	281 292	58236 58247	0.9999847412109375	O
14102	type	294 298	58249 58253	0.9999884366989136	O
14103	2	299 300	58254 58255	0.9999862909317017	O
14104	)	301 302	58256 58257	0.9999877214431763	O
14105	repair	303 309	58258 58264	0.9999831914901733	O
14106	gene	310 314	58265 58269	0.999988317489624	O
14107	expression	315 325	58270 58280	0.9999880790710449	O
14108	and	326 329	58281 58284	0.9999876022338867	O
14109	harboring	330 338	58285 58293	0.9999867677688599	O
14111	mutations	340 349	58295 58304	0.999984860420227	O
14112	in	350 352	58305 58307	0.9999886751174927	O
14113	the	353 356	58308 58311	0.9999887943267822	O
14114	APC	357 359	58312 58314	0.9999827146530151	O
14116	(	361 362	58316 58317	0.9999887943267822	O
14117	adenomatous	362 372	58317 58327	0.9999833106994629	O
14121	polyposis	374 382	58329 58337	0.9999860525131226	O
14125	coli	384 387	58339 58342	0.999985933303833	O
14127	)	389 390	58344 58345	0.9999889135360718	O
14128	tumor	391 396	58346 58351	0.9999876022338867	O
14129	suppressor	397 406	58352 58361	0.999987006187439	O
14131	gene	408 412	58363 58367	0.9999887943267822	O
14132	and	413 416	58368 58371	0.9999885559082031	O
14133	in	417 419	58372 58374	0.9999881982803345	O
14134	the	420 423	58375 58378	0.9999884366989136	O
14135	KRAS	424 427	58379 58382	0.9999829530715942	O
14138	(	429 430	58384 58385	0.9999887943267822	O
14139	v	430 431	58385 58386	0.9999865293502808	O
14140	-	431 432	58386 58387	0.9999886751174927	O
14141	Ki	432 434	58387 58389	0.9999866485595703	O
14142	-	434 435	58389 58390	0.9999886751174927	O
14143	ras2	435 438	58390 58393	0.9999867677688599	O
14146	Kirsten	440 446	58395 58401	0.9999856948852539	O
14148	rat	448 451	58403 58406	0.9999802112579346	O
14149	sarcoma	452 458	58407 58413	0.9999860525131226	O
14152	viral	460 465	58415 58420	0.9999856948852539	O
14153	oncogene	466 473	58421 58428	0.9999880790710449	O
14156	homolog	475 481	58430 58436	0.9999879598617554	O
14159	)	483 484	58438 58439	0.9999884366989136	O
14160	oncogene	485 492	58440 58447	0.9999881982803345	O
14163	.	494 495	58449 58450	0.9999624490737915	O
14164	Methods	0 6	58451 58457	0.9999696016311646	O
14166	After	8 13	58459 58464	0.9999816417694092	O
14167	7	14 15	58465 58466	0.9999829530715942	O
14168	.	15 16	58466 58467	0.9999853372573853	O
14169	3	16 17	58467 58468	0.9999815225601196	O
14170	years	18 23	58469 58474	0.9999852180480957	O
14171	of	24 26	58475 58477	0.9999849796295166	O
14172	follow	27 33	58478 58484	0.9999852180480957	O
14173	-	33 34	58484 58485	0.9999877214431763	O
14174	up	34 36	58485 58487	0.9999856948852539	O
14175	of	37 39	58488 58490	0.999985933303833	O
14176	the	40 43	58491 58494	0.9999843835830688	O
14177	Netherlands	44 55	58495 58506	0.9984317421913147	O
14178	Cohort	56 61	58507 58512	0.999984860420227	O
14181	Study	63 68	58514 58519	0.9999815225601196	O
14182	(	69 70	58520 58521	0.9999877214431763	O
14183	n	71 72	58522 58523	0.9999877214431763	O
14184	=	73 74	58524 58525	0.9999868869781494	O
14185	120	75 78	58526 58529	0.9999760389328003	O
14186	,	78 79	58529 58530	0.9999842643737793	O
14187	852	79 81	58530 58532	0.9999834299087524	O
14189	)	83 84	58534 58535	0.9999872446060181	O
14190	,	85 86	58536 58537	0.9999853372573853	O
14191	adjusted	87 95	58538 58546	0.9999850988388062	O
14192	incidence	96 105	58547 58556	0.9999862909317017	O
14193	rate	106 110	58557 58561	0.9999879598617554	O
14194	ratios	111 117	58562 58568	0.9999867677688599	O
14195	(	118 119	58569 58570	0.9999881982803345	O
14196	RR	120 121	58571 58572	0.9999867677688599	O
14198	)	123 124	58574 58575	0.9999884366989136	O
14199	and	125 128	58576 58579	0.9999872446060181	O
14200	95	129 131	58580 58582	0.9999864101409912	O
14201	%	132 133	58583 58584	0.9999874830245972	O
14202	confidence	134 144	58585 58595	0.9999871253967285	O
14203	intervals	145 154	58596 58605	0.9999866485595703	O
14204	(	155 156	58606 58607	0.9999878406524658	O
14205	CI	157 158	58608 58609	0.9999860525131226	O
14207	)	159 160	58610 58611	0.9999884366989136	O
14208	were	161 165	58612 58616	0.9999861717224121	O
14209	computed	166 173	58617 58624	0.9999876022338867	O
14211	,	175 176	58626 58627	0.9999830722808838	O
14212	based	177 182	58628 58633	0.999987006187439	O
14213	on	183 185	58634 58636	0.9999865293502808	O
14214	401	186 189	58637 58640	0.9999592304229736	O
14215	colon	190 194	58641 58645	0.9999808073043823	O
14217	and	196 199	58647 58650	0.9999803304672241	O
14218	130	200 203	58651 58654	0.9999262094497681	O
14219	rectal	204 209	58655 58660	0.9999737739562988	O
14222	cancer	211 217	58662 58668	0.9999836683273315	O
14223	patients	218 226	58669 58677	0.9999686479568481	O
14224	.	227 228	58678 58679	0.9999445676803589	O
14225	Results	0 7	58680 58687	0.9999752044677734	O
14226	Total	8 13	58688 58693	0.9999793767929077	O
14227	,	14 15	58694 58695	0.9999834299087524	O
14228	saturated	16 25	58696 58705	0.9999794960021973	O
14229	and	26 29	58706 58709	0.9999831914901733	O
14230	monounsaturated	30 44	58710 58724	0.9999843835830688	O
14236	fat	46 49	58726 58729	0.9999797344207764	O
14237	were	50 54	58730 58734	0.999984622001648	O
14238	not	55 58	58735 58738	0.9999784231185913	O
14239	associated	59 69	58739 58749	0.9999855756759644	O
14240	with	70 74	58750 58754	0.9999858140945435	O
14241	the	75 78	58755 58758	0.999984622001648	O
14242	risk	79 83	58759 58763	0.9999804496765137	O
14243	of	84 86	58764 58766	0.9999858140945435	O
14244	colon	87 91	58767 58771	0.9999809265136719	O
14246	or	93 95	58773 58775	0.9999762773513794	O
14247	rectal	96 101	58776 58781	0.9999802112579346	O
14250	cancer	103 109	58783 58789	0.9999853372573853	O
14251	,	110 111	58790 58791	0.9999802112579346	O
14252	or	112 114	58792 58794	0.9999845027923584	O
14253	different	115 124	58795 58804	0.9999843835830688	O
14254	molecular	125 134	58805 58814	0.999976634979248	O
14255	subgroups	135 143	58815 58823	0.9999868869781494	O
14257	.	145 146	58825 58826	0.9999600648880005	O
14258	There	0 5	58827 58832	0.9999841451644897	O
14259	was	6 9	58833 58836	0.9999856948852539	O
14260	also	10 14	58837 58841	0.9999829530715942	O
14261	no	15 17	58842 58844	0.9999830722808838	O
14262	association	18 29	58845 58856	0.9999845027923584	O
14263	between	30 37	58857 58864	0.9999861717224121	O
14264	polyunsaturated	38 52	58865 58879	0.9999865293502808	O
14270	fat	54 57	58881 58884	0.9999829530715942	O
14271	and	58 61	58885 58888	0.9999862909317017	O
14272	the	62 65	58889 58892	0.9999862909317017	O
14273	risk	66 70	58893 58897	0.9999815225601196	O
14274	of	71 73	58898 58900	0.9999865293502808	O
14275	overall	74 81	58901 58908	0.9999843835830688	O
14276	or	82 84	58909 58911	0.9999778270721436	O
14277	subgroups	85 93	58912 58920	0.9999822378158569	O
14279	of	95 97	58922 58924	0.9999842643737793	O
14280	rectal	98 103	58925 58930	0.9999794960021973	O
14283	cancer	105 111	58932 58938	0.999984860420227	O
14284	.	112 113	58939 58940	0.9999592304229736	O
14285	Linoleic	0 7	58941 58948	0.9999837875366211	O
14288	acid	9 13	58950 58954	0.9999872446060181	O
14289	,	14 15	58955 58956	0.9999884366989136	O
14290	the	16 19	58957 58960	0.999988317489624	O
14291	most	20 24	58961 58965	0.9999880790710449	O
14292	abundant	25 33	58966 58974	0.9999872446060181	O
14293	polyunsaturated	34 48	58975 58989	0.999988317489624	O
14299	fatty	50 55	58991 58996	0.9999858140945435	O
14300	acid	56 60	58997 59001	0.9999880790710449	O
14301	in	61 63	59002 59004	0.9999880790710449	O
14302	the	64 67	59005 59008	0.9999872446060181	O
14303	diet	68 72	59009 59013	0.9998840093612671	O
14304	,	73 74	59014 59015	0.999987006187439	O
14305	was	75 78	59016 59019	0.9999877214431763	O
14306	associated	79 89	59020 59030	0.9999886751174927	O
14307	with	90 94	59031 59035	0.9999890327453613	O
14308	increased	95 104	59036 59045	0.9999842643737793	O
14309	risk	105 109	59046 59050	0.9999866485595703	O
14310	of	110 112	59051 59053	0.9999872446060181	O
14311	colon	113 117	59054 59058	0.9999761581420898	O
14313	tumors	119 125	59060 59066	0.9999860525131226	O
14314	with	126 130	59067 59071	0.9999890327453613	O
14315	only	131 135	59072 59076	0.9999887943267822	O
14316	a	136 137	59077 59078	0.9999889135360718	O
14317	KRAS	138 141	59079 59082	0.9999868869781494	O
14320	mutation	143 151	59084 59092	0.9999886751174927	O
14321	and	152 155	59093 59096	0.9999887943267822	O
14322	no	156 158	59097 59099	0.999988317489624	O
14323	additional	159 169	59100 59110	0.9999881982803345	O
14324	truncating	170 179	59111 59120	0.9999887943267822	O
14327	APC	181 183	59122 59124	0.9999867677688599	O
14329	mutation	185 193	59126 59134	0.9999885559082031	O
14330	or	194 196	59135 59137	0.9999887943267822	O
14331	lack	197 201	59138 59142	0.9999881982803345	O
14332	of	202 204	59143 59145	0.9999890327453613	O
14333	MLH1	205 208	59146 59149	0.9999876022338867	O
14336	expression	210 220	59151 59161	0.9999884366989136	O
14337	(	221 222	59162 59163	0.9999891519546509	O
14338	RR	223 224	59164 59165	0.9999886751174927	O
14340	=	226 227	59167 59168	0.9999881982803345	O
14341	1	228 229	59169 59170	0.9999884366989136	O
14342	.	229 230	59170 59171	0.9999887943267822	O
14343	41	230 232	59171 59173	0.9999821186065674	O
14344	,	233 234	59174 59175	0.9999886751174927	O
14345	95	235 237	59176 59178	0.9999878406524658	O
14346	%	238 239	59179 59180	0.9999881982803345	O
14347	CI	240 241	59181 59182	0.9999880790710449	O
14349	1	243 244	59184 59185	0.9999885559082031	O
14350	.	244 245	59185 59186	0.9999890327453613	O
14351	18	245 247	59186 59188	0.9999867677688599	O
14352	–	247 248	59188 59189	0.9999834299087524	O
14353	1	248 249	59189 59190	0.9999881982803345	O
14354	.	249 250	59190 59191	0.9999886751174927	O
14355	69	250 252	59191 59193	0.9999845027923584	O
14356	for	253 256	59194 59197	0.9999890327453613	O
14357	one	257 260	59198 59201	0.9999891519546509	O
14358	standard	261 269	59202 59210	0.9999886751174927	O
14359	deviation	270 278	59211 59219	0.9999885559082031	O
14361	(	280 281	59221 59222	0.9999868869781494	O
14362	i	282 283	59223 59224	0.9999890327453613	O
14363	.	284 285	59225 59226	0.9999880790710449	O
14364	e	285 286	59226 59227	0.9999865293502808	O
14365	.	287 288	59228 59229	0.9999877214431763	O
14366	,	289 290	59230 59231	0.9999834299087524	O
14367	7	0 1	59232 59233	0.9999876022338867	O
14368	.	1 2	59233 59234	0.9999887943267822	O
14369	5	2 3	59234 59235	0.9999879598617554	O
14370	g	4 5	59236 59237	0.9999873638153076	O
14371	/	5 6	59237 59238	0.9999889135360718	O
14372	day	6 9	59238 59241	0.9999868869781494	O
14373	)	10 11	59242 59243	0.999985933303833	O
14374	increase	12 20	59244 59252	0.999987006187439	O
14375	in	21 23	59253 59255	0.9999889135360718	O
14376	intake	24 30	59256 59262	0.9999845027923584	O
14377	,	31 32	59263 59264	0.9999886751174927	O
14378	p	33 34	59265 59266	0.9999891519546509	O
14379	-	34 35	59266 59267	0.9999895095825195	O
14380	trend	35 40	59267 59272	0.9999884366989136	O
14381	over	41 45	59273 59277	0.9999886751174927	O
14382	the	46 49	59278 59281	0.9999889135360718	O
14383	quartiles	50 58	59282 59290	0.9999895095825195	O
14387	of	60 62	59292 59294	0.9999886751174927	O
14388	intake	63 69	59295 59301	0.999988317489624	O
14389	<	70 71	59302 59303	0.9999889135360718	O
14390	0	71 72	59303 59304	0.9999895095825195	O
14391	.	72 73	59304 59305	0.9999891519546509	O
14392	001	73 75	59305 59307	0.9999892711639404	O
14394	)	77 78	59309 59310	0.9999873638153076	O
14395	.	79 80	59311 59312	0.9999769926071167	O
14396	Linoleic	0 7	59313 59320	0.9999767541885376	O
14399	acid	9 13	59322 59326	0.9999828338623047	O
14400	intake	14 20	59327 59333	0.9999775886535645	O
14401	was	21 24	59334 59337	0.9999805688858032	O
14402	not	25 28	59338 59341	0.9999734163284302	O
14403	associated	29 39	59342 59352	0.999983549118042	O
14404	with	40 44	59353 59357	0.9999853372573853	O
14405	risk	45 49	59358 59362	0.9999778270721436	O
14406	of	50 52	59363 59365	0.999984860420227	O
14407	colon	53 57	59366 59370	0.9999700784683228	O
14409	tumors	59 65	59372 59378	0.9999845027923584	O
14410	without	66 73	59379 59386	0.9999855756759644	O
14411	any	74 77	59387 59390	0.9999876022338867	O
14412	of	78 80	59391 59393	0.9999877214431763	O
14413	the	81 84	59394 59397	0.9999868869781494	O
14414	gene	85 89	59398 59402	0.999984622001648	O
14415	defects	90 97	59403 59410	0.999984860420227	O
14416	,	98 99	59411 59412	0.9999792575836182	O
14417	or	100 102	59413 59415	0.9999788999557495	O
14418	with	103 107	59416 59420	0.9999762773513794	O
14419	tumors	108 114	59421 59427	0.9999834299087524	O
14420	harboring	115 123	59428 59436	0.9999873638153076	O
14422	aberrations	125 135	59438 59448	0.9999880790710449	O
14425	in	137 139	59450 59452	0.9999878406524658	O
14426	either	140 146	59453 59459	0.9999879598617554	O
14427	MLH1	147 150	59460 59463	0.9999872446060181	O
14430	or	152 154	59465 59467	0.9999872446060181	O
14431	APC	155 157	59468 59470	0.9999852180480957	O
14433	.	158 159	59471 59472	0.9999558925628662	O
14434	Conclusion	0 9	59473 59482	0.9999867677688599	O
14437	Linoleic	11 18	59484 59491	0.9999818801879883	O
14440	acid	20 24	59493 59497	0.9999855756759644	O
14441	intake	25 31	59498 59504	0.9999805688858032	O
14442	is	32 34	59505 59507	0.9999853372573853	O
14443	associated	35 45	59508 59518	0.9999861717224121	O
14444	with	46 50	59519 59523	0.9999847412109375	O
14445	colon	51 55	59524 59528	0.9999686479568481	O
14447	tumors	57 63	59530 59536	0.9999841451644897	O
14448	with	64 68	59537 59541	0.9999873638153076	O
14449	an	69 71	59542 59544	0.9999880790710449	O
14450	aberrant	72 79	59545 59552	0.9999880790710449	O
14453	KRAS	81 84	59554 59557	0.9999853372573853	O
14456	gene	86 90	59559 59563	0.9999879598617554	O
14457	,	91 92	59564 59565	0.9999873638153076	O
14458	but	93 96	59566 59569	0.999985933303833	O
14459	an	97 99	59570 59572	0.9999878406524658	O
14460	intact	100 106	59573 59579	0.9999860525131226	O
14461	APC	107 109	59580 59582	0.9999865293502808	O
14463	gene	111 115	59584 59588	0.9999878406524658	O
14464	and	116 119	59589 59592	0.9999871253967285	O
14465	MLH1	120 123	59593 59596	0.9999862909317017	O
14468	expression	125 135	59598 59608	0.9999872446060181	O
14469	,	136 137	59609 59610	0.9999873638153076	O
14470	suggesting	138 148	59611 59621	0.9999856948852539	O
14471	a	149 150	59622 59623	0.9999876022338867	O
14472	unique	151 157	59624 59630	0.9999815225601196	O
14473	etiology	158 165	59631 59638	0.9999852180480957	O
14475	of	167 169	59640 59642	0.9999845027923584	O
14476	tumors	170 176	59643 59649	0.9999816417694092	O
14477	with	177 181	59650 59654	0.9999861717224121	O
14478	specific	182 190	59655 59663	0.9999854564666748	O
14479	genetic	191 198	59664 59671	0.9999860525131226	O
14480	aberrations	199 209	59672 59682	0.9999877214431763	O
14483	.	211 212	59684 59685	0.9999878406524658	O
14484	*	213 214	59686 59687	0.9999861717224121	O
14485	*	214 215	59687 59688	0.9999709129333496	O
14486	IGNORE	0 5	59689 59694	0.9999845027923584	O
14489	LINE	7 10	59696 59699	0.9999872446060181	O
14492	*	12 13	59701 59702	0.999987006187439	O
14493	*	13 14	59702 59703	0.9999868869781494	O
14494	*	15 16	59704 59705	0.9999868869781494	O
14495	*	16 17	59705 59706	0.9999871253967285	O
14496	IGNORE	18 23	59707 59712	0.9999855756759644	O
14499	LINE	25 28	59714 59717	0.9999873638153076	O
14502	*	30 31	59719 59720	0.9999865293502808	O
14503	*	31 32	59720 59721	0.9999865293502808	O
14504	*	33 34	59722 59723	0.9999865293502808	O
14505	*	34 35	59723 59724	0.9999865293502808	O
14506	IGNORE	36 41	59725 59730	0.9999850988388062	O
14509	LINE	43 46	59732 59735	0.9999871253967285	O
14512	*	48 49	59737 59738	0.9999867677688599	O
14513	*	49 50	59738 59739	0.9999865293502808	O
14514	These	51 56	59740 59745	0.9999865293502808	O
14515	observations	57 69	59746 59758	0.999980092048645	O
14516	and	70 73	59759 59762	0.9999847412109375	O
14517	hypotheses	74 83	59763 59772	0.9999862909317017	O
14521	prompted	85 93	59774 59782	0.999984622001648	O
14522	us	94 96	59783 59785	0.9999842643737793	O
14523	to	97 99	59786 59788	0.9999864101409912	O
14524	investigate	100 111	59789 59800	0.9999850988388062	O
14525	the	112 115	59801 59804	0.9999873638153076	O
14526	associations	116 128	59805 59817	0.9999866485595703	O
14527	between	129 136	59818 59825	0.9999872446060181	O
14528	the	137 140	59826 59829	0.9999867677688599	O
14529	intake	141 147	59830 59836	0.9999837875366211	O
14530	of	148 150	59837 59839	0.999987006187439	O
14531	total	151 156	59840 59845	0.9999845027923584	O
14532	fat	157 160	59846 59849	0.9999847412109375	O
14533	and	161 164	59850 59853	0.9999873638153076	O
14534	different	165 174	59854 59863	0.9999856948852539	O
14535	types	175 180	59864 59869	0.9999866485595703	O
14536	of	181 183	59870 59872	0.9999871253967285	O
14537	fat	184 187	59873 59876	0.9999836683273315	O
14538	and	188 191	59877 59880	0.999987006187439	O
14539	the	192 195	59881 59884	0.9999864101409912	O
14540	risk	196 200	59885 59889	0.9999808073043823	O
14541	of	201 203	59890 59892	0.9999855756759644	O
14542	colon	204 208	59893 59897	0.9999780654907227	O
14544	and	210 213	59899 59902	0.9999788999557495	O
14545	rectal	214 219	59903 59908	0.9999756813049316	O
14548	tumors	221 227	59910 59916	0.9999853372573853	O
14549	lacking	228 235	59917 59924	0.9999858140945435	O
14550	MLH1	236 239	59925 59928	0.9999866485595703	O
14553	expression	241 251	59930 59940	0.999987006187439	O
14554	and	252 255	59941 59944	0.9999865293502808	O
14555	with	256 260	59945 59949	0.9999871253967285	O
14556	and	261 264	59950 59953	0.9999864101409912	O
14557	without	265 272	59954 59961	0.9999867677688599	O
14558	APC	273 275	59962 59964	0.9999853372573853	O
14560	gene	277 281	59966 59970	0.999987006187439	O
14561	mutations	282 291	59971 59980	0.9999866485595703	O
14562	,	292 293	59981 59982	0.9999877214431763	O
14563	two	294 297	59983 59986	0.999982476234436	O
14564	early	298 303	59987 59992	0.9999858140945435	O
14565	events	304 310	59993 59999	0.9999854564666748	O
14566	in	311 313	60000 60002	0.9999864101409912	O
14567	colorectal	314 323	60003 60012	0.9999827146530151	O
14570	tumorigenesis	325 337	60014 60026	0.999984860420227	O
14574	,	339 340	60028 60029	0.9999871253967285	O
14575	independent	341 352	60030 60041	0.9999829530715942	O
14576	of	353 355	60042 60044	0.9999864101409912	O
14577	tumors	356 362	60045 60051	0.9999821186065674	O
14578	harboring	363 371	60052 60060	0.9999867677688599	O
14580	KRAS	373 376	60062 60065	0.999982476234436	O
14583	gene	378 382	60067 60071	0.9999866485595703	O
14584	mutations	383 392	60072 60081	0.9999865293502808	O
14585	.	393 394	60082 60083	0.9999872446060181	O
14586	*	395 396	60084 60085	0.9999842643737793	O
14587	*	396 397	60085 60086	0.9999655485153198	O
14588	IGNORE	0 5	60087 60092	0.9999860525131226	O
14591	LINE	7 10	60094 60097	0.9999885559082031	O
14594	*	12 13	60099 60100	0.9999881982803345	O
14595	*	13 14	60100 60101	0.9999881982803345	O
14596	*	15 16	60102 60103	0.9999881982803345	O
14597	*	16 17	60103 60104	0.999988317489624	O
14598	IGNORE	18 23	60105 60110	0.9999873638153076	O
14601	LINE	25 28	60112 60115	0.9999886751174927	O
14604	*	30 31	60117 60118	0.9999879598617554	O
14605	*	31 32	60118 60119	0.9999878406524658	O
14606	*	33 34	60120 60121	0.9999878406524658	O
14607	*	34 35	60121 60122	0.9999878406524658	O
14608	IGNORE	36 41	60123 60128	0.9999868869781494	O
14611	LINE	43 46	60130 60133	0.9999884366989136	O
14614	*	48 49	60135 60136	0.9999881982803345	O
14615	*	49 50	60136 60137	0.9999880790710449	O
14616	Materials	51 60	60138 60147	0.9999877214431763	O
14617	and	61 64	60148 60151	0.9999886751174927	O
14618	methods	65 72	60152 60159	0.9999867677688599	O
14619	Study	73 78	60160 60165	0.9999871253967285	O
14620	population	79 89	60166 60176	0.9999874830245972	O
14621	The	90 93	60177 60180	0.9999868869781494	O
14622	prospective	94 105	60181 60192	0.9999804496765137	O
14623	NLCS	106 109	60193 60196	0.999987006187439	O
14625	was	111 114	60198 60201	0.9999878406524658	O
14626	initiated	115 124	60202 60211	0.9999873638153076	O
14627	in	125 127	60212 60214	0.9999879598617554	O
14628	The	128 131	60215 60218	0.9999829530715942	O
14629	Netherlands	132 143	60219 60230	0.9998568296432495	O
14630	in	144 146	60231 60233	0.9999876022338867	O
14631	September	147 156	60234 60243	0.9999878406524658	O
14632	1986	157 161	60244 60248	0.9999849796295166	O
14633	.	162 163	60249 60250	0.9999706745147705	O
14634	The	0 3	60251 60254	0.9999761581420898	O
14635	study	4 9	60255 60260	0.9999725818634033	O
14636	design	10 16	60261 60267	0.9999725818634033	O
14637	has	17 20	60268 60271	0.999980092048645	O
14638	been	21 25	60272 60276	0.9999825954437256	O
14639	described	26 35	60277 60286	0.9999796152114868	O
14640	in	36 38	60287 60289	0.9999847412109375	O
14641	detail	39 45	60290 60296	0.9999822378158569	O
14642	elsewhere	46 55	60297 60306	0.9999790191650391	O
14643	[	56 57	60307 60308	0.9999858140945435	O
14644	23	57 59	60308 60310	0.9999799728393555	O
14645	]	59 60	60310 60311	0.9999843835830688	O
14646	.	61 62	60312 60313	0.999955415725708	O
14647	Briefly	0 6	60314 60320	0.9999773502349854	O
14650	,	8 9	60322 60323	0.9999865293502808	O
14651	at	10 12	60324 60326	0.9999831914901733	O
14652	baseline	13 20	60327 60334	0.9999805688858032	O
14654	a	22 23	60336 60337	0.9999856948852539	O
14655	total	24 29	60338 60343	0.9999841451644897	O
14656	of	30 32	60344 60346	0.9999843835830688	O
14657	58	33 35	60347 60349	0.9999721050262451	O
14658	,	35 36	60349 60350	0.9999841451644897	O
14659	279	36 38	60350 60352	0.9999792575836182	O
14661	men	40 43	60354 60357	0.9998565912246704	O
14662	and	44 47	60358 60361	0.9999819993972778	O
14663	62	48 50	60362 60364	0.9999645948410034	O
14664	,	50 51	60364 60365	0.9999847412109375	O
14665	573	51 53	60365 60367	0.9999806880950928	O
14667	women	55 60	60369 60374	0.9994937181472778	O
14668	,	61 62	60375 60376	0.9999799728393555	O
14669	between	63 70	60377 60384	0.9999788999557495	O
14670	the	71 74	60385 60388	0.9999849796295166	O
14671	ages	75 79	60389 60393	0.9999836683273315	O
14672	of	80 82	60394 60396	0.9999861717224121	O
14673	55	83 85	60397 60399	0.9999771118164062	O
14674	and	86 89	60400 60403	0.9999840259552002	O
14675	69	90 92	60404 60406	0.9999698400497437	O
14676	years	93 98	60407 60412	0.9999830722808838	O
14677	,	99 100	60413 60414	0.9999819993972778	O
14678	completed	101 110	60415 60424	0.999981164932251	O
14679	a	111 112	60425 60426	0.9999849796295166	O
14680	self	113 117	60427 60431	0.9999815225601196	O
14681	-	117 118	60431 60432	0.9999860525131226	O
14682	administered	118 130	60432 60444	0.9999781847000122	O
14683	food	131 135	60445 60449	0.9999710321426392	O
14684	frequency	136 145	60450 60459	0.9999790191650391	O
14685	and	146 149	60460 60463	0.9999812841415405	O
14686	lifestyle	150 159	60464 60473	0.9999539852142334	O
14687	questionnaire	160 172	60474 60486	0.9999814033508301	O
14689	.	174 175	60488 60489	0.9999500513076782	O
14690	Incident	0 8	60490 60498	0.9999649524688721	O
14691	cancer	9 15	60499 60505	0.9999778270721436	O
14692	cases	16 21	60506 60511	0.9999799728393555	O
14693	are	22 25	60512 60515	0.9999810457229614	O
14694	identified	26 36	60516 60526	0.9999839067459106	O
14695	by	37 39	60527 60529	0.9999865293502808	O
14696	monitoring	40 50	60530 60540	0.9999815225601196	O
14697	of	51 53	60541 60543	0.999987006187439	O
14698	the	54 57	60544 60547	0.9999868869781494	O
14699	entire	58 64	60548 60554	0.9999837875366211	O
14700	cohort	65 70	60555 60560	0.9999871253967285	O
14703	for	72 75	60562 60565	0.9999840259552002	O
14704	cancer	76 82	60566 60572	0.9999815225601196	O
14705	occurrence	83 93	60573 60583	0.9999852180480957	O
14706	through	94 101	60584 60591	0.9999872446060181	O
14707	annual	102 108	60592 60598	0.9999867677688599	O
14708	record	109 115	60599 60605	0.9999854564666748	O
14709	linkage	116 122	60606 60612	0.9999860525131226	O
14711	to	124 126	60614 60616	0.999988317489624	O
14712	the	127 130	60617 60620	0.9999871253967285	O
14713	National	131 139	60621 60629	0.9999749660491943	O
14714	Cancer	140 146	60630 60636	0.9999856948852539	O
14715	Registry	147 154	60637 60644	0.999987006187439	O
14717	(	156 157	60646 60647	0.9999880790710449	O
14718	NCR	157 159	60647 60649	0.9999865293502808	O
14720	)	161 162	60651 60652	0.9999885559082031	O
14721	,	163 164	60653 60654	0.9999868869781494	O
14722	consisting	165 175	60655 60665	0.9999879598617554	O
14723	of	176 178	60666 60668	0.999988317489624	O
14724	nine	179 183	60669 60673	0.9999808073043823	O
14725	regional	184 192	60674 60682	0.9999792575836182	O
14726	cancer	193 199	60683 60689	0.9999843835830688	O
14727	registries	200 209	60690 60699	0.9999885559082031	O
14730	throughout	211 221	60701 60711	0.9999817609786987	O
14731	The	222 225	60712 60715	0.9999724626541138	O
14732	Netherlands	226 237	60716 60727	0.9992353916168213	O
14733	,	238 239	60728 60729	0.9999849796295166	O
14734	and	240 243	60730 60733	0.9999874830245972	O
14735	to	244 246	60734 60736	0.9999879598617554	O
14736	PALGA	247 251	60737 60741	0.9999860525131226	O
14739	,	253 254	60743 60744	0.9999874830245972	O
14740	a	255 256	60745 60746	0.9999879598617554	O
14741	nationwide	257 267	60747 60757	0.9999802112579346	O
14742	network	268 275	60758 60765	0.9999850988388062	O
14743	and	276 279	60766 60769	0.9999866485595703	O
14744	registry	280 288	60770 60778	0.9999856948852539	O
14745	of	289 291	60779 60781	0.9999874830245972	O
14746	histo	292 296	60782 60786	0.9999867677688599	O
14748	-	298 299	60788 60789	0.9999874830245972	O
14749	and	300 303	60790 60793	0.9999867677688599	O
14750	cytopathology	304 316	60794 60806	0.9999878406524658	O
14755	[	318 319	60808 60809	0.9999884366989136	O
14756	24	319 321	60809 60811	0.9999852180480957	O
14757	]	321 322	60811 60812	0.9999880790710449	O
14758	.	323 324	60813 60814	0.9999731779098511	O
14759	The	0 3	60815 60818	0.9999872446060181	O
14760	NCR	4 6	60819 60821	0.9999865293502808	O
14762	and	8 11	60823 60826	0.9999880790710449	O
14763	PALGA	12 16	60827 60831	0.9999860525131226	O
14766	together	18 26	60833 60841	0.9999850988388062	O
14767	provide	27 34	60842 60849	0.9999864101409912	O
14768	a	35 36	60850 60851	0.9999879598617554	O
14769	near	37 41	60852 60856	0.9999867677688599	O
14770	100	42 45	60857 60860	0.9999843835830688	O
14771	%	46 47	60861 60862	0.9999880790710449	O
14772	coverage	48 56	60863 60871	0.9999853372573853	O
14773	of	57 59	60872 60874	0.9999874830245972	O
14774	the	60 63	60875 60878	0.9999867677688599	O
14775	204	64 67	60879 60882	0.9999722242355347	O
14776	municipalities	68 82	60883 60897	0.9999748468399048	O
14777	included	83 91	60898 60906	0.9999861717224121	O
14778	in	92 94	60907 60909	0.9999865293502808	O
14779	the	95 98	60910 60913	0.9999874830245972	O
14780	NLCS	99 102	60914 60917	0.9999840259552002	O
14782	.	103 104	60918 60919	0.9999711513519287	O
14783	Accumulation	0 11	60920 60931	0.9999880790710449	O
14787	of	13 15	60933 60935	0.9999887943267822	O
14788	person	16 22	60936 60942	0.9999864101409912	O
14789	-	22 23	60942 60943	0.9999890327453613	O
14790	time	23 27	60943 60947	0.9999865293502808	O
14791	in	28 30	60948 60950	0.9999877214431763	O
14792	the	31 34	60951 60954	0.9999868869781494	O
14793	cohort	35 40	60955 60960	0.9999868869781494	O
14796	was	42 45	60962 60965	0.9999871253967285	O
14797	estimated	46 55	60966 60975	0.9999862909317017	O
14798	through	56 63	60976 60983	0.9999879598617554	O
14799	biennial	64 71	60984 60991	0.9999885559082031	O
14801	vital	73 78	60993 60998	0.9999868869781494	O
14802	status	79 85	60999 61005	0.9999874830245972	O
14803	follow	86 92	61006 61012	0.9999879598617554	O
14804	-	92 93	61012 61013	0.9999891519546509	O
14805	up	93 95	61013 61015	0.9999884366989136	O
14806	of	96 98	61016 61018	0.9999881982803345	O
14807	a	99 100	61019 61020	0.9999884366989136	O
14808	subcohort	101 109	61021 61029	0.9999874830245972	O
14812	of	111 113	61031 61033	0.9999886751174927	O
14813	3	114 115	61034 61035	0.9999850988388062	O
14814	,	115 116	61035 61036	0.999987006187439	O
14815	500	116 119	61036 61039	0.9999758005142212	O
14816	men	120 123	61040 61043	0.9999127388000488	O
14817	and	124 127	61044 61047	0.9999834299087524	O
14818	women	128 133	61048 61053	0.9997968077659607	O
14819	who	134 137	61054 61057	0.9999876022338867	O
14820	were	138 142	61058 61062	0.9999884366989136	O
14821	randomly	143 151	61063 61071	0.9999853372573853	O
14822	selected	152 160	61072 61080	0.9999871253967285	O
14823	after	161 166	61081 61086	0.999987006187439	O
14824	baseline	167 174	61087 61094	0.9999878406524658	O
14826	exposure	176 184	61096 61104	0.999983549118042	O
14827	measurement	185 196	61105 61116	0.9999872446060181	O
14828	[	197 198	61117 61118	0.9999892711639404	O
14829	24	198 200	61118 61120	0.9999873638153076	O
14830	]	200 201	61120 61121	0.999988317489624	O
14831	.	202 203	61122 61123	0.999970555305481	O
14832	Cases	0 4	61124 61128	0.9999772310256958	O
14834	with	6 10	61130 61134	0.9999836683273315	O
14835	prevalent	11 20	61135 61144	0.9999083280563354	O
14836	cancer	21 27	61145 61151	0.9999831914901733	O
14837	other	28 33	61152 61157	0.9999866485595703	O
14838	than	34 38	61158 61162	0.9999866485595703	O
14839	non	39 42	61163 61166	0.9999673366546631	O
14840	-	42 43	61166 61167	0.999983549118042	O
14841	melanoma	43 50	61167 61174	0.9999594688415527	O
14844	skin	52 56	61176 61180	0.9999603033065796	O
14845	cancer	57 63	61181 61187	0.9999871253967285	O
14846	were	64 68	61188 61192	0.9999872446060181	O
14847	excluded	69 77	61193 61201	0.9999806880950928	O
14848	from	78 82	61202 61206	0.9999884366989136	O
14849	the	83 86	61207 61210	0.9999881982803345	O
14850	subcohort	87 95	61211 61219	0.9999878406524658	O
14854	,	97 98	61221 61222	0.9999880790710449	O
14855	which	99 104	61223 61228	0.9999885559082031	O
14856	left	105 109	61229 61233	0.9999860525131226	O
14857	3	110 111	61234 61235	0.9999865293502808	O
14858	,	111 112	61235 61236	0.9999871253967285	O
14859	346	112 114	61236 61238	0.9999841451644897	O
14861	men	116 119	61240 61243	0.9999676942825317	O
14862	and	120 123	61244 61247	0.9999855756759644	O
14863	women	124 129	61248 61253	0.9999446868896484	O
14864	for	130 133	61254 61257	0.999988317489624	O
14865	analysis	134 142	61258 61266	0.9999876022338867	O
14866	next	143 147	61267 61271	0.9999876022338867	O
14867	to	148 150	61272 61274	0.999988317489624	O
14868	all	151 154	61275 61278	0.9999866485595703	O
14869	colorectal	155 164	61279 61288	0.9999847412109375	O
14872	cancer	166 172	61290 61296	0.9999852180480957	O
14873	cases	173 178	61297 61302	0.9999860525131226	O
14874	from	179 183	61303 61307	0.9999878406524658	O
14875	the	184 187	61308 61311	0.9999886751174927	O
14876	entire	188 194	61312 61318	0.9999860525131226	O
14877	cohort	195 200	61319 61324	0.9999878406524658	O
14880	.	202 203	61326 61327	0.9999581575393677	O
14881	No	0 2	61328 61330	0.9999617338180542	O
14882	subcohort	3 11	61331 61339	0.9999749660491943	O
14886	members	13 20	61341 61348	0.9999573230743408	O
14887	were	21 25	61349 61353	0.9999715089797974	O
14888	lost	26 30	61354 61358	0.9999642372131348	O
14889	to	31 33	61359 61361	0.9999713897705078	O
14890	follow	34 40	61362 61368	0.9999802112579346	O
14891	-	40 41	61368 61369	0.9999821186065674	O
14892	up	41 43	61369 61371	0.9999797344207764	O
14893	.	44 45	61372 61373	0.9998254179954529	O
14894	A	0 1	61374 61375	0.999988317489624	O
14895	flow	2 6	61376 61380	0.9999853372573853	O
14896	diagram	7 14	61381 61388	0.9999755620956421	O
14897	of	15 17	61389 61391	0.9999878406524658	O
14898	subcohort	18 26	61392 61400	0.9999874830245972	O
14902	members	28 35	61402 61409	0.999983549118042	O
14903	and	36 39	61410 61413	0.9999850988388062	O
14904	patients	40 48	61414 61422	0.9999759197235107	O
14905	on	49 51	61423 61425	0.9999866485595703	O
14906	whom	52 56	61426 61430	0.9999879598617554	O
14907	the	57 60	61431 61434	0.9999889135360718	O
14908	analyses	61 69	61435 61443	0.9999840259552002	O
14909	are	70 73	61444 61447	0.9999886751174927	O
14910	based	74 79	61448 61453	0.9999878406524658	O
14911	is	80 82	61454 61456	0.9999878406524658	O
14912	given	83 88	61457 61462	0.9999876022338867	O
14913	in	89 91	61463 61465	0.9999889135360718	O
14914	Fig	92 94	61466 61468	0.9999866485595703	O
14916	.	96 97	61470 61471	0.9999829530715942	O
14917	1	0 1	61472 61473	0.9998414516448975	O
14918	.	2 3	61474 61475	0.9998109936714172	O
14919	Fig	0 2	61476 61478	0.9999687671661377	O
14921	.	4 5	61480 61481	0.9999572038650513	O
14922	1Flow	0 4	61482 61486	0.9999845027923584	O
14925	diagram	6 13	61488 61495	0.9999761581420898	O
14926	of	14 16	61496 61498	0.9999847412109375	O
14927	the	17 20	61499 61502	0.999985933303833	O
14928	number	21 27	61503 61509	0.9999849796295166	O
14929	of	28 30	61510 61512	0.9999858140945435	O
14930	subjects	31 39	61513 61521	0.9999744892120361	O
14931	on	40 42	61522 61524	0.9999841451644897	O
14932	whom	43 47	61525 61529	0.9999872446060181	O
14933	the	48 51	61530 61533	0.9999877214431763	O
14934	final	52 57	61534 61539	0.9999868869781494	O
14935	statistical	58 69	61540 61551	0.9999868869781494	O
14936	analyses	70 78	61552 61560	0.9999868869781494	O
14937	were	79 83	61561 61565	0.9999877214431763	O
14938	based	84 89	61566 61571	0.9999866485595703	O
14939	.	90 91	61572 61573	0.999945878982544	O
14940	aNetherlands	0 11	61574 61585	0.9999825954437256	O
14944	Cancer	13 19	61587 61593	0.9999805688858032	O
14945	Registry	20 27	61594 61601	0.9999785423278809	O
14947	.	29 30	61603 61604	0.9999455213546753	O
14948	bPathologisch	0 12	61605 61617	0.9999877214431763	O
14954	Anatomisch	14 23	61619 61628	0.9999885559082031	O
14957	Landelijk	25 33	61630 61638	0.9999878406524658	O
14960	Geautomatiseerd	35 49	61640 61654	0.9999877214431763	O
14966	Archief	51 57	61656 61662	0.9999555349349976	O
14968	.	59 60	61664 61665	0.9999802112579346	O
14969	cPatients	0 8	61666 61674	0.9999815225601196	O
14973	with	10 14	61676 61680	0.9999799728393555	O
14974	rectosigmoid	15 26	61681 61692	0.9999735355377197	O
14980	tumors	28 34	61694 61700	0.9999829530715942	O
14981	were	35 39	61701 61705	0.9999853372573853	O
14982	not	40 43	61706 61709	0.9999833106994629	O
14983	included	44 52	61710 61718	0.9999858140945435	O
14984	in	53 55	61719 61721	0.9999856948852539	O
14985	the	56 59	61722 61725	0.9999855756759644	O
14986	analyses	60 68	61726 61734	0.9999833106994629	O
14987	.	69 70	61735 61736	0.9999516010284424	O
14988	dmutL	0 4	61737 61741	0.9999862909317017	O
14992	homolog	6 12	61743 61749	0.9999874830245972	O
14995	1	14 15	61751 61752	0.9999860525131226	O
14996	,	16 17	61753 61754	0.999984622001648	O
14997	colon	18 22	61755 61759	0.9999818801879883	O
14999	cancer	24 30	61761 61767	0.9999866485595703	O
15000	,	31 32	61768 61769	0.9999847412109375	O
15001	nonpolyposis	33 44	61770 61781	0.999984860420227	O
15006	type	46 50	61783 61787	0.9999881982803345	O
15007	2	51 52	61788 61789	0.9999845027923584	O
15008	.	52 53	61789 61790	0.9999599456787109	O
15009	eAdenomatous	0 11	61791 61802	0.9999730587005615	O
15015	polyposis	13 21	61804 61812	0.9999719858169556	O
15019	coli	23 26	61814 61817	0.9999772310256958	O
15021	.	28 29	61819 61820	0.9997507929801941	O
15022	fMutation	0 8	61821 61829	0.9999856948852539	O
15026	cluster	10 17	61831 61838	0.999984860420227	O
15027	region	18 24	61839 61845	0.9999817609786987	O
15028	.	25 26	61846 61847	0.9999287128448486	O
15029	gv	0 1	61848 61849	0.9999850988388062	O
15031	-	2 3	61850 61851	0.9999865293502808	O
15032	Ki	3 5	61851 61853	0.9999840259552002	O
15033	-	5 6	61853 61854	0.9999866485595703	O
15034	ras2	6 9	61854 61857	0.9999839067459106	O
15037	Kirsten	11 17	61859 61865	0.9999796152114868	O
15039	rat	19 22	61867 61870	0.9989877343177795	O
15040	sarcoma	23 29	61871 61877	0.9999775886535645	O
15043	viral	31 36	61879 61884	0.9999815225601196	O
15044	oncogene	37 44	61885 61892	0.9999865293502808	O
15047	homolog	46 52	61894 61900	0.9999873638153076	O
15050	.	54 55	61902 61903	0.999946117401123	O
15051	hPatients	0 8	61904 61912	0.9999852180480957	O
15055	with	10 14	61914 61918	0.9999827146530151	O
15056	rectal	15 20	61919 61924	0.9999746084213257	O
15059	tumors	22 28	61926 61932	0.9999854564666748	O
15060	were	29 33	61933 61937	0.9999891519546509	O
15061	not	34 37	61938 61941	0.9999881982803345	O
15062	included	38 46	61942 61950	0.9999891519546509	O
15063	in	47 49	61951 61953	0.9999889135360718	O
15064	the	50 53	61954 61957	0.9999891519546509	O
15065	analysis	54 62	61958 61966	0.99998939037323	O
15066	according	63 72	61967 61976	0.99998939037323	O
15067	to	73 75	61977 61979	0.9999897480010986	O
15068	MLH1	76 79	61980 61983	0.9999887943267822	O
15071	expression	81 91	61985 61995	0.9999889135360718	O
15072	Flow	92 96	61996 62000	0.9999879598617554	O
15073	diagram	97 104	62001 62008	0.9999880790710449	O
15074	of	105 107	62009 62011	0.9999889135360718	O
15075	the	108 111	62012 62015	0.9999890327453613	O
15076	number	112 118	62016 62022	0.9999879598617554	O
15077	of	119 121	62023 62025	0.9999889135360718	O
15078	subjects	122 130	62026 62034	0.9999841451644897	O
15079	on	131 133	62035 62037	0.9999873638153076	O
15080	whom	134 138	62038 62042	0.9999885559082031	O
15081	the	139 142	62043 62046	0.9999892711639404	O
15082	final	143 148	62047 62052	0.9999887943267822	O
15083	statistical	149 160	62053 62064	0.9999889135360718	O
15084	analyses	161 169	62065 62073	0.9999891519546509	O
15085	were	170 174	62074 62078	0.9999889135360718	O
15086	based	175 180	62079 62084	0.9999885559082031	O
15087	.	181 182	62085 62086	0.9999749660491943	O
15088	aNetherlands	0 11	62087 62098	0.9999825954437256	O
15092	Cancer	13 19	62100 62106	0.9999805688858032	O
15093	Registry	20 27	62107 62114	0.9999785423278809	O
15095	.	29 30	62116 62117	0.9999455213546753	O
15096	bPathologisch	0 12	62118 62130	0.9999877214431763	O
15102	Anatomisch	14 23	62132 62141	0.9999885559082031	O
15105	Landelijk	25 33	62143 62151	0.9999878406524658	O
15108	Geautomatiseerd	35 49	62153 62167	0.9999877214431763	O
15114	Archief	51 57	62169 62175	0.9999555349349976	O
15116	.	59 60	62177 62178	0.9999802112579346	O
15117	cPatients	0 8	62179 62187	0.9999815225601196	O
15121	with	10 14	62189 62193	0.9999799728393555	O
15122	rectosigmoid	15 26	62194 62205	0.9999735355377197	O
15128	tumors	28 34	62207 62213	0.9999829530715942	O
15129	were	35 39	62214 62218	0.9999853372573853	O
15130	not	40 43	62219 62222	0.9999833106994629	O
15131	included	44 52	62223 62231	0.9999858140945435	O
15132	in	53 55	62232 62234	0.9999856948852539	O
15133	the	56 59	62235 62238	0.9999855756759644	O
15134	analyses	60 68	62239 62247	0.9999833106994629	O
15135	.	69 70	62248 62249	0.9999516010284424	O
15136	dmutL	0 4	62250 62254	0.9999862909317017	O
15140	homolog	6 12	62256 62262	0.9999874830245972	O
15143	1	14 15	62264 62265	0.9999860525131226	O
15144	,	16 17	62266 62267	0.999984622001648	O
15145	colon	18 22	62268 62272	0.9999818801879883	O
15147	cancer	24 30	62274 62280	0.9999866485595703	O
15148	,	31 32	62281 62282	0.9999847412109375	O
15149	nonpolyposis	33 44	62283 62294	0.999984860420227	O
15154	type	46 50	62296 62300	0.9999881982803345	O
15155	2	51 52	62301 62302	0.9999845027923584	O
15156	.	52 53	62302 62303	0.9999599456787109	O
15157	eAdenomatous	0 11	62304 62315	0.9999730587005615	O
15163	polyposis	13 21	62317 62325	0.9999719858169556	O
15167	coli	23 26	62327 62330	0.9999772310256958	O
15169	.	28 29	62332 62333	0.9997507929801941	O
15170	fMutation	0 8	62334 62342	0.9999856948852539	O
15174	cluster	10 17	62344 62351	0.999984860420227	O
15175	region	18 24	62352 62358	0.9999817609786987	O
15176	.	25 26	62359 62360	0.9999287128448486	O
15177	gv	0 1	62361 62362	0.9999850988388062	O
15179	-	2 3	62363 62364	0.9999865293502808	O
15180	Ki	3 5	62364 62366	0.9999840259552002	O
15181	-	5 6	62366 62367	0.9999866485595703	O
15182	ras2	6 9	62367 62370	0.9999839067459106	O
15185	Kirsten	11 17	62372 62378	0.9999796152114868	O
15187	rat	19 22	62380 62383	0.9989877343177795	O
15188	sarcoma	23 29	62384 62390	0.9999775886535645	O
15191	viral	31 36	62392 62397	0.9999815225601196	O
15192	oncogene	37 44	62398 62405	0.9999865293502808	O
15195	homolog	46 52	62407 62413	0.9999873638153076	O
15198	.	54 55	62415 62416	0.999946117401123	O
15199	hPatients	0 8	62417 62425	0.9999847412109375	O
15203	with	10 14	62427 62431	0.9999823570251465	O
15204	rectal	15 20	62432 62437	0.999974250793457	O
15207	tumors	22 28	62439 62445	0.9999854564666748	O
15208	were	29 33	62446 62450	0.9999890327453613	O
15209	not	34 37	62451 62454	0.9999884366989136	O
15210	included	38 46	62455 62463	0.9999892711639404	O
15211	in	47 49	62464 62466	0.9999889135360718	O
15212	the	50 53	62467 62470	0.9999891519546509	O
15213	analysis	54 62	62471 62479	0.9999892711639404	O
15214	according	63 72	62480 62489	0.9999895095825195	O
15215	to	73 75	62490 62492	0.9999897480010986	O
15216	MLH1	76 79	62493 62496	0.9999889135360718	O
15219	expression	81 91	62498 62508	0.9999891519546509	O
15220	The	92 95	62509 62512	0.9999884366989136	O
15221	first	96 101	62513 62518	0.99998939037323	O
15222	2	102 103	62519 62520	0.999988317489624	O
15223	.	103 104	62520 62521	0.9999886751174927	O
15224	3	104 105	62521 62522	0.9999876022338867	O
15225	years	106 111	62523 62528	0.99998939037323	O
15226	of	112 114	62529 62531	0.99998939037323	O
15227	follow	115 121	62532 62538	0.9999887943267822	O
15228	up	122 124	62539 62541	0.99998939037323	O
15229	were	125 129	62542 62546	0.9999889135360718	O
15230	excluded	130 138	62547 62555	0.9999877214431763	O
15231	because	139 146	62556 62563	0.9999891519546509	O
15232	of	147 149	62564 62566	0.9999897480010986	O
15233	possible	150 158	62567 62575	0.9999885559082031	O
15234	preclinical	159 169	62576 62586	0.9999896287918091	O
15238	disease	171 178	62588 62595	0.9999884366989136	O
15239	affecting	179 188	62596 62605	0.9999887943267822	O
15240	exposure	189 197	62606 62614	0.9999854564666748	O
15241	status	198 204	62615 62621	0.9999897480010986	O
15242	and	205 208	62622 62625	0.9999884366989136	O
15243	because	209 216	62626 62633	0.9999887943267822	O
15244	of	217 219	62634 62636	0.9999897480010986	O
15245	incomplete	220 230	62637 62647	0.9999889135360718	O
15246	nationwide	231 241	62648 62658	0.9999876022338867	O
15247	coverage	242 250	62659 62667	0.9999889135360718	O
15248	of	251 253	62668 62670	0.9999896287918091	O
15249	PALGA	254 258	62671 62675	0.9999885559082031	O
15252	alone	260 265	62677 62682	0.9999897480010986	O
15253	(	266 267	62683 62684	0.9999880790710449	O
15254	i	268 269	62685 62686	0.9999891519546509	O
15255	.	270 271	62687 62688	0.9999884366989136	O
15256	e	271 272	62688 62689	0.9999865293502808	O
15257	.	273 274	62690 62691	0.9999881982803345	O
15258	,	275 276	62692 62693	0.9999864101409912	O
15259	not	0 3	62694 62697	0.9999865293502808	O
15260	in	4 6	62698 62700	0.9999872446060181	O
15261	combination	7 18	62701 62712	0.999987006187439	O
15262	with	19 23	62713 62717	0.9999868869781494	O
15263	the	24 27	62718 62721	0.999987006187439	O
15264	NCR	28 30	62722 62724	0.9999855756759644	O
15266	)	32 33	62726 62727	0.9999806880950928	O
15267	in	34 36	62728 62730	0.9999829530715942	O
15268	some	37 41	62731 62735	0.9999804496765137	O
15269	of	42 44	62736 62738	0.999983549118042	O
15270	the	45 48	62739 62742	0.9999805688858032	O
15271	municipalities	49 63	62743 62757	0.999972939491272	O
15272	included	64 72	62758 62766	0.9999858140945435	O
15273	in	73 75	62767 62769	0.9999858140945435	O
15274	the	76 79	62770 62773	0.9999866485595703	O
15275	NLCS	80 83	62774 62777	0.9999823570251465	O
15277	.	84 85	62778 62779	0.9999603033065796	O
15278	Within	0 6	62780 62786	0.9999793767929077	O
15279	this	7 11	62787 62791	0.9999861717224121	O
15280	period	12 18	62792 62798	0.9999780654907227	O
15281	,	19 20	62799 62800	0.9999864101409912	O
15282	83	21 23	62801 62803	0.9999717473983765	O
15283	subcohort	24 32	62804 62812	0.999987006187439	O
15287	members	34 41	62814 62821	0.9999823570251465	O
15288	deceased	42 50	62822 62830	0.9999785423278809	O
15289	or	51 53	62831 62833	0.999976634979248	O
15290	were	54 58	62834 62838	0.9999867677688599	O
15291	diagnosed	59 68	62839 62848	0.9999854564666748	O
15292	with	69 73	62849 62853	0.9999873638153076	O
15293	cancer	74 80	62854 62860	0.9999862909317017	O
15294	other	81 86	62861 62866	0.9999874830245972	O
15295	than	87 91	62867 62871	0.9999878406524658	O
15296	non	92 95	62872 62875	0.9999788999557495	O
15297	-	95 96	62875 62876	0.9999854564666748	O
15298	melanoma	96 103	62876 62883	0.9999703168869019	O
15301	skin	105 109	62885 62889	0.9999775886535645	O
15302	cancer	110 116	62890 62896	0.9999877214431763	O
15303	,	117 118	62897 62898	0.9999860525131226	O
15304	leaving	119 126	62899 62906	0.9999847412109375	O
15305	3	127 128	62907 62908	0.9999855756759644	O
15306	,	128 129	62908 62909	0.999987006187439	O
15307	263	129 131	62909 62911	0.999984860420227	O
15309	subcohort	133 141	62913 62921	0.9999881982803345	O
15313	members	143 150	62923 62930	0.9999858140945435	O
15314	for	151 154	62931 62934	0.9999849796295166	O
15315	analysis	155 163	62935 62943	0.9999847412109375	O
15316	.	164 165	62944 62945	0.9999672174453735	O
15317	From	0 4	62946 62950	0.9999849796295166	O
15318	1989	5 9	62951 62955	0.9999802112579346	O
15319	to	10 12	62956 62958	0.9999871253967285	O
15320	1994	13 17	62959 62963	0.9999790191650391	O
15321	,	18 19	62964 62965	0.9999865293502808	O
15322	929	20 22	62966 62968	0.9999773502349854	O
15324	incident	24 32	62970 62978	0.9999654293060303	O
15325	cases	33 38	62979 62984	0.9999798536300659	O
15326	with	39 43	62985 62989	0.9999833106994629	O
15327	histologically	44 57	62990 63003	0.9999845027923584	O
15331	confirmed	59 68	63005 63014	0.9999833106994629	O
15332	colorectal	69 78	63015 63024	0.9999794960021973	O
15335	cancer	80 86	63026 63032	0.9999837875366211	O
15336	were	87 91	63033 63037	0.9999858140945435	O
15337	identified	92 102	63038 63048	0.9999854564666748	O
15338	within	103 109	63049 63055	0.9999852180480957	O
15339	the	110 113	63056 63059	0.9999873638153076	O
15340	entire	114 120	63060 63066	0.9999853372573853	O
15341	cohort	121 126	63067 63072	0.999987006187439	O
15344	,	128 129	63074 63075	0.9999861717224121	O
15345	of	130 132	63076 63078	0.9999871253967285	O
15346	whom	133 137	63079 63083	0.9999873638153076	O
15347	819	138 140	63084 63086	0.9999861717224121	O
15349	could	142 147	63088 63093	0.9999854564666748	O
15350	also	148 152	63094 63098	0.9999864101409912	O
15351	be	153 155	63099 63101	0.9999876022338867	O
15352	linked	156 162	63102 63108	0.9999867677688599	O
15353	to	163 165	63109 63111	0.9999884366989136	O
15354	a	166 167	63112 63113	0.9999884366989136	O
15355	PALGA	168 172	63114 63118	0.9999861717224121	O
15358	report	174 180	63120 63126	0.9999860525131226	O
15359	of	181 183	63127 63129	0.9999872446060181	O
15360	the	184 187	63130 63133	0.9999862909317017	O
15361	lesion	188 193	63134 63139	0.9999845027923584	O
15363	.	195 196	63141 63142	0.9999624490737915	O
15364	The	0 3	63143 63146	0.9999834299087524	O
15365	PALGA	4 8	63147 63151	0.9999837875366211	O
15368	reports	10 17	63153 63160	0.9999818801879883	O
15369	were	18 22	63161 63165	0.9999779462814331	O
15370	used	23 27	63166 63170	0.9999798536300659	O
15371	to	28 30	63171 63173	0.9999830722808838	O
15372	identify	31 39	63174 63182	0.999982476234436	O
15373	and	40 43	63183 63186	0.9999821186065674	O
15374	locate	44 50	63187 63193	0.999974250793457	O
15375	tumor	51 56	63194 63199	0.9999772310256958	O
15376	tissues	57 64	63200 63207	0.9999772310256958	O
15377	from	65 69	63208 63212	0.9999840259552002	O
15378	eligible	70 78	63213 63221	0.9999783039093018	O
15379	colorectal	79 88	63222 63231	0.9999814033508301	O
15382	cancer	90 96	63233 63239	0.9999821186065674	O
15383	patients	97 105	63240 63248	0.999976634979248	O
15384	in	106 108	63249 63251	0.9999806880950928	O
15385	54	109 111	63252 63254	0.9999474287033081	O
15386	pathology	112 120	63255 63263	0.9999822378158569	O
15388	laboratories	122 134	63265 63277	0.9999750852584839	O
15389	throughout	135 145	63278 63288	0.9999727010726929	O
15390	the	146 149	63289 63292	0.9999749660491943	O
15391	Netherlands	150 161	63293 63304	0.9996015429496765	O
15392	.	162 163	63305 63306	0.9999370574951172	O
15393	Cancers	0 6	63307 63313	0.9999767541885376	O
15395	were	8 12	63315 63319	0.9999866485595703	O
15396	classified	13 23	63320 63330	0.9999867677688599	O
15397	according	24 33	63331 63340	0.9999877214431763	O
15398	to	34 36	63341 63343	0.9999880790710449	O
15399	site	37 41	63344 63348	0.9999856948852539	O
15400	as	42 44	63349 63351	0.9999876022338867	O
15401	follows	45 52	63352 63359	0.9999867677688599	O
15402	,	53 54	63360 63361	0.999987006187439	O
15403	colon	55 59	63362 63366	0.9999860525131226	O
15405	:	61 62	63368 63369	0.9999873638153076	O
15406	cecum	63 67	63370 63374	0.9999868869781494	O
15409	through	69 76	63376 63383	0.9999865293502808	O
15410	sigmoid	77 83	63384 63390	0.9999808073043823	O
15414	colon	85 89	63392 63396	0.9999874830245972	O
15416	(	91 92	63398 63399	0.9999885559082031	O
15417	ICD	93 95	63400 63402	0.9999881982803345	O
15419	-	96 97	63403 63404	0.9999880790710449	O
15420	O	97 98	63404 63405	0.9999876022338867	O
15421	codes	99 104	63406 63411	0.9999880790710449	O
15422	153	105 108	63412 63415	0.9999871253967285	O
15423	:	108 109	63415 63416	0.9999878406524658	O
15424	0	109 110	63416 63417	0.9999876022338867	O
15425	,	111 112	63418 63419	0.9999877214431763	O
15426	153	113 116	63420 63423	0.9999862909317017	O
15427	.	116 117	63423 63424	0.9999879598617554	O
15428	1	117 118	63424 63425	0.999987006187439	O
15429	,	119 120	63426 63427	0.9999877214431763	O
15430	153	121 124	63428 63431	0.9999862909317017	O
15431	.	124 125	63431 63432	0.9999878406524658	O
15432	2	125 126	63432 63433	0.9999866485595703	O
15433	,	127 128	63434 63435	0.9999878406524658	O
15434	153	129 132	63436 63439	0.9999864101409912	O
15435	.	132 133	63439 63440	0.9999878406524658	O
15436	3	133 134	63440 63441	0.9999864101409912	O
15437	,	135 136	63442 63443	0.9999877214431763	O
15438	153	137 140	63444 63447	0.9999864101409912	O
15439	.	140 141	63447 63448	0.9999877214431763	O
15440	4	141 142	63448 63449	0.9999862909317017	O
15441	,	143 144	63450 63451	0.9999876022338867	O
15442	153	145 148	63452 63455	0.9999860525131226	O
15443	.	148 149	63455 63456	0.9999876022338867	O
15444	5	149 150	63456 63457	0.9999861717224121	O
15445	,	151 152	63458 63459	0.9999873638153076	O
15446	153	153 156	63460 63463	0.9999856948852539	O
15447	.	156 157	63463 63464	0.9999876022338867	O
15448	6	157 158	63464 63465	0.999985933303833	O
15449	,	159 160	63466 63467	0.9999873638153076	O
15450	153	161 164	63468 63471	0.9999860525131226	O
15451	.	164 165	63471 63472	0.9999879598617554	O
15452	7	165 166	63472 63473	0.9999864101409912	O
15453	)	167 168	63474 63475	0.999988317489624	O
15454	,	169 170	63476 63477	0.999988317489624	O
15455	proximal	171 178	63478 63485	0.9999866485595703	O
15457	colon	180 184	63487 63491	0.9999868869781494	O
15459	(	186 187	63493 63494	0.999988317489624	O
15460	ICD	188 190	63495 63497	0.9999880790710449	O
15462	-	191 192	63498 63499	0.9999878406524658	O
15463	O	192 193	63499 63500	0.9999873638153076	O
15464	codes	194 199	63501 63506	0.9999876022338867	O
15465	153	200 203	63507 63510	0.9999866485595703	O
15466	.	203 204	63510 63511	0.9999878406524658	O
15467	0	204 205	63511 63512	0.9999872446060181	O
15468	,	205 206	63512 63513	0.9999876022338867	O
15469	153	207 210	63514 63517	0.9999860525131226	O
15470	.	210 211	63517 63518	0.9999878406524658	O
15471	1	211 212	63518 63519	0.9999871253967285	O
15472	,	213 214	63520 63521	0.9999876022338867	O
15473	153	215 218	63522 63525	0.9999861717224121	O
15474	.	218 219	63525 63526	0.9999877214431763	O
15475	4	219 220	63526 63527	0.9999864101409912	O
15476	,	221 222	63528 63529	0.9999876022338867	O
15477	153	223 226	63530 63533	0.9999861717224121	O
15478	.	226 227	63533 63534	0.9999877214431763	O
15479	5	227 228	63534 63535	0.9999866485595703	O
15480	,	229 230	63536 63537	0.9999873638153076	O
15481	153	231 234	63538 63541	0.9999855756759644	O
15482	.	234 235	63541 63542	0.9999879598617554	O
15483	6	235 236	63542 63543	0.9999861717224121	O
15484	)	236 237	63543 63544	0.9999881982803345	O
15485	,	238 239	63545 63546	0.999988317489624	O
15486	distal	240 245	63547 63552	0.9999865293502808	O
15488	colon	247 251	63554 63558	0.9999866485595703	O
15490	(	253 254	63560 63561	0.9999884366989136	O
15491	ICD	255 257	63562 63564	0.9999881982803345	O
15493	-	258 259	63565 63566	0.9999879598617554	O
15494	O	259 260	63566 63567	0.9999876022338867	O
15495	codes	261 266	63568 63573	0.9999878406524658	O
15496	153	267 270	63574 63577	0.9999871253967285	O
15497	.	270 271	63577 63578	0.9999881982803345	O
15498	2	271 272	63578 63579	0.9999872446060181	O
15499	,	273 274	63580 63581	0.9999877214431763	O
15500	153	275 278	63582 63585	0.9999858140945435	O
15501	,	278 279	63585 63586	0.9999878406524658	O
15502	3	279 280	63586 63587	0.9999856948852539	O
15503	,	281 282	63588 63589	0.9999874830245972	O
15504	`	283 284	63590 63591	0.9999852180480957	O
15505	53	284 286	63591 63593	0.9999788999557495	O
15506	.	286 287	63593 63594	0.999988317489624	O
15507	7	287 288	63594 63595	0.9999867677688599	O
15508	)	289 290	63596 63597	0.9999884366989136	O
15509	,	291 292	63598 63599	0.9999881982803345	O
15510	rectosigmoid	293 304	63600 63611	0.9999874830245972	O
15516	(	306 307	63613 63614	0.999988317489624	O
15517	ICD	308 310	63615 63617	0.9999881982803345	O
15519	-	311 312	63618 63619	0.9999878406524658	O
15520	O	312 313	63619 63620	0.9999876022338867	O
15521	code	314 318	63621 63625	0.9999876022338867	O
15522	154	319 322	63626 63629	0.9999867677688599	O
15523	.	322 323	63629 63630	0.9999880790710449	O
15524	0	323 324	63630 63631	0.9999877214431763	O
15525	)	324 325	63631 63632	0.9999881982803345	O
15526	,	326 327	63633 63634	0.9999878406524658	O
15527	and	328 331	63635 63638	0.9999877214431763	O
15528	rectum	332 337	63639 63644	0.9999868869781494	O
15531	(	339 340	63646 63647	0.999988317489624	O
15532	ICD	341 343	63648 63650	0.9999881982803345	O
15534	-	344 345	63651 63652	0.9999879598617554	O
15535	O	345 346	63652 63653	0.9999877214431763	O
15536	code	347 351	63654 63658	0.9999876022338867	O
15537	154	352 355	63659 63662	0.999987006187439	O
15538	.	355 356	63662 63663	0.9999880790710449	O
15539	1	356 357	63663 63664	0.9999877214431763	O
15540	)	358 359	63665 63666	0.999988317489624	O
15541	.	360 361	63667 63668	0.9999884366989136	O
15542	*	362 363	63669 63670	0.9999861717224121	O
15543	*	363 364	63670 63671	0.9999749660491943	O
15544	IGNORE	0 5	63672 63677	0.9999867677688599	O
15547	LINE	7 10	63679 63682	0.9999891519546509	O
15550	*	12 13	63684 63685	0.9999895095825195	O
15551	*	13 14	63685 63686	0.9999892711639404	O
15552	*	15 16	63687 63688	0.9999892711639404	O
15553	*	16 17	63688 63689	0.99998939037323	O
15554	IGNORE	18 23	63690 63695	0.9999880790710449	O
15557	LINE	25 28	63697 63700	0.9999895095825195	O
15560	*	30 31	63702 63703	0.9999891519546509	O
15561	*	31 32	63703 63704	0.9999891519546509	O
15562	*	33 34	63705 63706	0.9999890327453613	O
15563	*	34 35	63706 63707	0.9999890327453613	O
15564	IGNORE	36 41	63708 63713	0.9999879598617554	O
15567	LINE	43 46	63715 63718	0.9999892711639404	O
15570	*	48 49	63720 63721	0.9999892711639404	O
15571	*	49 50	63721 63722	0.9999891519546509	O
15572	This	51 55	63723 63727	0.99998939037323	O
15573	still	56 61	63728 63733	0.9999871253967285	O
15574	does	62 66	63734 63738	0.9999886751174927	O
15575	not	67 70	63739 63742	0.9999886751174927	O
15576	satisfy	71 78	63743 63750	0.9999878406524658	O
15577	our	79 82	63751 63754	0.9999877214431763	O
15578	third	83 88	63755 63760	0.999987006187439	O
15579	query	89 93	63761 63765	0.9999885559082031	O
15581	,	95 96	63767 63768	0.9999886751174927	O
15582	i	97 98	63769 63770	0.9999890327453613	O
15583	.	99 100	63771 63772	0.9999884366989136	O
15584	e	100 101	63772 63773	0.9999872446060181	O
15585	.	102 103	63774 63775	0.9999879598617554	O
15586	,	104 105	63776 63777	0.999985933303833	O
15587	why	0 3	63778 63781	0.9999845027923584	O
15588	are	4 7	63782 63785	0.9999858140945435	O
15589	the	8 11	63786 63789	0.9999850988388062	O
15590	associations	12 24	63790 63802	0.9999781847000122	O
15591	specifically	25 37	63803 63815	0.9999868869781494	O
15592	confined	38 46	63816 63824	0.9999862909317017	O
15593	to	47 49	63825 63827	0.9999868869781494	O
15594	this	50 54	63828 63832	0.9999852180480957	O
15595	subgroup	55 63	63833 63841	0.9999819993972778	O
15596	of	64 66	63842 63844	0.9999833106994629	O
15597	colon	67 71	63845 63849	0.9999667406082153	O
15599	cancer	73 79	63851 63857	0.9999790191650391	O
15600	patients	80 88	63858 63866	0.9999748468399048	O
15601	whose	89 94	63867 63872	0.9999808073043823	O
15602	tumors	95 101	63873 63879	0.9999686479568481	O
15603	are	102 105	63880 63883	0.9999854564666748	O
15604	characterized	106 119	63884 63897	0.9999850988388062	O
15605	by	120 122	63898 63900	0.9999871253967285	O
15606	activating	123 132	63901 63910	0.999984860420227	O
15608	KRAS	134 137	63912 63915	0.9999831914901733	O
15611	mutations	139 148	63917 63926	0.9999871253967285	O
15612	,	149 150	63927 63928	0.9999852180480957	O
15613	and	151 154	63929 63932	0.9999874830245972	O
15614	not	155 158	63933 63936	0.999987006187439	O
15615	truncating	159 168	63937 63946	0.9999876022338867	O
15618	APC	170 172	63948 63950	0.9999864101409912	O
15620	mutations	174 183	63952 63961	0.9999880790710449	O
15621	or	184 186	63962 63964	0.9999865293502808	O
15622	lack	187 191	63965 63969	0.9999854564666748	O
15623	of	192 194	63970 63972	0.9999873638153076	O
15624	MLH1	195 198	63973 63976	0.9999849796295166	O
15627	expression	200 210	63978 63988	0.999987006187439	O
15628	?	211 212	63989 63990	0.9999715089797974	O
15629	It	0 2	63991 63993	0.9999866485595703	O
15630	is	3 5	63994 63996	0.9999872446060181	O
15631	speculative	6 16	63997 64007	0.9999872446060181	O
15633	,	18 19	64009 64010	0.9999877214431763	O
15634	but	20 23	64011 64014	0.9999840259552002	O
15635	plausible	24 33	64015 64024	0.9999858140945435	O
15636	,	34 35	64025 64026	0.999987006187439	O
15637	that	36 40	64027 64031	0.9999881982803345	O
15638	when	41 45	64032 64036	0.9999862909317017	O
15639	KRAS	46 49	64037 64040	0.999984622001648	O
15642	is	51 53	64042 64044	0.9999886751174927	O
15643	the	54 57	64045 64048	0.9999889135360718	O
15644	only	58 62	64049 64053	0.9999886751174927	O
15645	one	63 66	64054 64057	0.9999886751174927	O
15646	of	67 69	64058 64060	0.9999889135360718	O
15647	the	70 73	64061 64064	0.9999889135360718	O
15648	three	74 79	64065 64070	0.9999837875366211	O
15649	genes	80 85	64071 64076	0.9999845027923584	O
15650	affected	86 94	64077 64085	0.9999852180480957	O
15651	,	95 96	64086 64087	0.9999868869781494	O
15652	the	97 100	64088 64091	0.9999885559082031	O
15653	mutation	101 109	64092 64100	0.999983549118042	O
15654	may	110 113	64101 64104	0.9999878406524658	O
15655	more	114 118	64105 64109	0.9999873638153076	O
15656	likely	119 125	64110 64116	0.9999886751174927	O
15657	be	126 128	64117 64119	0.9999887943267822	O
15658	the	129 132	64120 64123	0.9999889135360718	O
15659	result	133 139	64124 64130	0.999988317489624	O
15660	of	140 142	64131 64133	0.9999890327453613	O
15661	exogenous	143 151	64134 64142	0.9999886751174927	O
15664	exposure	153 161	64144 64152	0.9999845027923584	O
15665	,	162 163	64153 64154	0.9999874830245972	O
15666	for	164 167	64155 64158	0.9999865293502808	O
15667	example	168 175	64159 64166	0.9999860525131226	O
15668	a	176 177	64167 64168	0.9999884366989136	O
15669	relatively	178 188	64169 64179	0.9999879598617554	O
15670	high	189 193	64180 64184	0.9999867677688599	O
15671	linoleic	194 201	64185 64192	0.9999872446060181	O
15675	acid	203 207	64194 64198	0.9999884366989136	O
15676	intake	208 214	64199 64205	0.9999876022338867	O
15677	.	215 216	64206 64207	0.9999686479568481	O
15678	In	0 2	64208 64210	0.9999871253967285	O
15679	contrast	3 11	64211 64219	0.999984860420227	O
15680	,	12 13	64220 64221	0.9999880790710449	O
15681	when	14 18	64222 64226	0.9999834299087524	O
15682	a	19 20	64227 64228	0.9999879598617554	O
15683	KRAS	21 24	64229 64232	0.9999842643737793	O
15686	mutation	26 34	64234 64242	0.9999872446060181	O
15687	co	35 37	64243 64245	0.9999881982803345	O
15688	-	37 38	64245 64246	0.9999885559082031	O
15689	occurs	38 44	64246 64252	0.9999880790710449	O
15690	with	45 49	64253 64257	0.9999877214431763	O
15691	a	50 51	64258 64259	0.9999884366989136	O
15692	mutation	52 60	64260 64268	0.9999872446060181	O
15693	in	61 63	64269 64271	0.9999884366989136	O
15694	APC	64 66	64272 64274	0.9999850988388062	O
15696	or	68 70	64276 64278	0.9999867677688599	O
15697	,	71 72	64279 64280	0.9999877214431763	O
15698	although	73 81	64281 64289	0.999983549118042	O
15699	more	82 86	64290 64294	0.999982476234436	O
15700	rarely	87 93	64295 64301	0.9999864101409912	O
15701	,	94 95	64302 64303	0.9999874830245972	O
15702	in	96 98	64304 64306	0.9999884366989136	O
15703	addition	99 107	64307 64315	0.9999864101409912	O
15704	to	108 110	64316 64318	0.9999884366989136	O
15705	a	111 112	64319 64320	0.9999881982803345	O
15706	defective	113 121	64321 64329	0.9999874830245972	O
15708	MLH1	123 126	64331 64334	0.9999866485595703	O
15711	,	128 129	64336 64337	0.9999877214431763	O
15712	these	130 135	64338 64343	0.9999872446060181	O
15713	other	136 141	64344 64349	0.9999849796295166	O
15714	early	142 147	64350 64355	0.9999831914901733	O
15715	gene	148 152	64356 64360	0.9999852180480957	O
15716	defects	153 160	64361 64368	0.9999860525131226	O
15717	also	161 165	64369 64373	0.9999853372573853	O
15718	had	166 169	64374 64377	0.9999862909317017	O
15719	a	170 171	64378 64379	0.9999884366989136	O
15720	role	172 176	64380 64384	0.9999856948852539	O
15721	in	177 179	64385 64387	0.9999873638153076	O
15722	tumor	180 185	64388 64393	0.9999852180480957	O
15723	formation	186 195	64394 64403	0.999985933303833	O
15724	and	196 199	64404 64407	0.9999867677688599	O
15725	may	200 203	64408 64411	0.9999878406524658	O
15726	have	204 208	64412 64416	0.999988317489624	O
15727	resulted	209 217	64417 64425	0.9999880790710449	O
15728	in	218 220	64426 64428	0.9999889135360718	O
15729	a	221 222	64429 64430	0.9999890327453613	O
15730	mutator	223 229	64431 64437	0.9999876022338867	O
15733	phenotype	231 239	64439 64447	0.9999886751174927	O
15736	leading	241 248	64449 64456	0.9999874830245972	O
15737	to	249 251	64457 64459	0.9999884366989136	O
15738	mutations	252 261	64460 64469	0.999987006187439	O
15739	in	262 264	64470 64472	0.9999886751174927	O
15740	other	265 270	64473 64478	0.9999858140945435	O
15741	genes	271 276	64479 64484	0.9999866485595703	O
15742	(	277 278	64485 64486	0.9999879598617554	O
15743	such	279 283	64487 64491	0.9999873638153076	O
15744	as	284 286	64492 64494	0.999988317489624	O
15745	the	287 290	64495 64498	0.9999879598617554	O
15746	KRAS	291 294	64499 64502	0.9999841451644897	O
15749	gene	296 300	64504 64508	0.9999880790710449	O
15750	)	301 302	64509 64510	0.9999884366989136	O
15751	irrespective	303 314	64511 64522	0.9999879598617554	O
15754	of	316 318	64524 64526	0.999988317489624	O
15755	exogenous	319 327	64527 64535	0.9999868869781494	O
15758	factors	329 336	64537 64544	0.9999853372573853	O
15759	.	337 338	64545 64546	0.9999262094497681	O
15760	Since	0 5	64547 64552	0.9999821186065674	O
15761	there	6 11	64553 64558	0.9999876022338867	O
15762	is	12 14	64559 64561	0.9999872446060181	O
15763	no	15 17	64562 64564	0.9999861717224121	O
15764	information	18 29	64565 64576	0.9999868869781494	O
15765	on	30 32	64577 64579	0.999988317489624	O
15766	the	33 36	64580 64583	0.9999884366989136	O
15767	timing	37 43	64584 64590	0.999984860420227	O
15768	of	44 46	64591 64593	0.999988317489624	O
15769	genetic	47 54	64594 64601	0.9999823570251465	O
15770	aberrations	55 65	64602 64612	0.999988317489624	O
15773	in	67 69	64614 64616	0.9999885559082031	O
15774	this	70 74	64617 64621	0.9999881982803345	O
15775	type	75 79	64622 64626	0.9999876022338867	O
15776	of	80 82	64627 64629	0.9999884366989136	O
15777	human	83 88	64630 64635	0.9199786186218262	O
15778	studies	89 96	64636 64643	0.9999790191650391	O
15779	,	97 98	64644 64645	0.9999864101409912	O
15780	we	99 101	64646 64648	0.9999839067459106	O
15781	cannot	102 108	64649 64655	0.9999823570251465	O
15782	verify	109 115	64656 64662	0.9999852180480957	O
15783	this	116 120	64663 64667	0.9999881982803345	O
15784	with	121 125	64668 64672	0.9999871253967285	O
15785	our	126 129	64673 64676	0.9999852180480957	O
15786	data	130 134	64677 64681	0.9999862909317017	O
15787	.	135 136	64682 64683	0.9999687671661377	O
15788	Aberrations	0 10	64684 64694	0.9999872446060181	O
15791	in	12 14	64696 64698	0.9999887943267822	O
15792	other	15 20	64699 64704	0.9999862909317017	O
15793	genes	21 26	64705 64710	0.9999854564666748	O
15794	,	27 28	64711 64712	0.9999885559082031	O
15795	not	29 32	64713 64716	0.9999886751174927	O
15796	available	33 42	64717 64726	0.9999881982803345	O
15797	for	43 46	64727 64730	0.9999873638153076	O
15798	this	47 51	64731 64735	0.9999891519546509	O
15799	study	52 57	64736 64741	0.9999871253967285	O
15800	,	58 59	64742 64743	0.9999877214431763	O
15801	but	60 63	64744 64747	0.9999847412109375	O
15802	possibly	64 72	64748 64756	0.9999887943267822	O
15803	involved	73 81	64757 64765	0.9999884366989136	O
15804	in	82 84	64766 64768	0.9999892711639404	O
15805	early	85 90	64769 64774	0.9999843835830688	O
15806	tumorigenesis	91 103	64775 64787	0.9999865293502808	O
15810	of	105 107	64789 64791	0.9999879598617554	O
15811	colorectal	108 117	64792 64801	0.9999856948852539	O
15814	cancer	119 125	64803 64809	0.9999871253967285	O
15815	,	126 127	64810 64811	0.9999881982803345	O
15816	could	128 133	64812 64817	0.9999881982803345	O
15817	not	134 137	64818 64821	0.9999884366989136	O
15818	be	138 140	64822 64824	0.9999891519546509	O
15819	accounted	141 150	64825 64834	0.9999891519546509	O
15820	for	151 154	64835 64838	0.9999889135360718	O
15821	in	155 157	64839 64841	0.9999889135360718	O
15822	analyses	158 166	64842 64850	0.9999858140945435	O
15823	and	167 170	64851 64854	0.9999867677688599	O
15824	may	171 174	64855 64858	0.9999874830245972	O
15825	have	175 179	64859 64863	0.9999878406524658	O
15826	influenced	180 190	64864 64874	0.9999843835830688	O
15827	results	191 198	64875 64882	0.9999856948852539	O
15828	.	199 200	64883 64884	0.9999721050262451	O
15829	However	0 7	64885 64892	0.9999855756759644	O
15830	,	8 9	64893 64894	0.9999889135360718	O
15831	a	10 11	64895 64896	0.9999885559082031	O
15832	recent	12 18	64897 64903	0.999987006187439	O
15833	systematic	19 29	64904 64914	0.9999872446060181	O
15834	sequence	30 38	64915 64923	0.9999866485595703	O
15835	analysis	39 47	64924 64932	0.9999884366989136	O
15836	of	48 50	64933 64935	0.9999889135360718	O
15837	13	51 53	64936 64938	0.9999881982803345	O
15838	,	53 54	64938 64939	0.9999889135360718	O
15839	023	54 56	64939 64941	0.9999876022338867	O
15841	exons	58 62	64943 64947	0.9999884366989136	O
15843	in	64 66	64949 64951	0.9999889135360718	O
15844	individual	67 77	64952 64962	0.9999797344207764	O
15845	colorectal	78 87	64963 64972	0.9999854564666748	O
15848	cancers	89 95	64974 64980	0.999985933303833	O
15850	showed	97 103	64982 64988	0.9999873638153076	O
15851	that	104 108	64989 64993	0.9999891519546509	O
15852	the	109 112	64994 64997	0.9999890327453613	O
15853	prevalence	113 123	64998 65008	0.9999871253967285	O
15854	of	124 126	65009 65011	0.9999885559082031	O
15855	mutations	127 136	65012 65021	0.9999871253967285	O
15856	other	137 142	65022 65027	0.9999884366989136	O
15857	than	143 147	65028 65032	0.9999890327453613	O
15858	in	148 150	65033 65035	0.9999886751174927	O
15859	APC	151 153	65036 65038	0.9999864101409912	O
15861	,	155 156	65040 65041	0.9999881982803345	O
15862	KRAS	157 160	65042 65045	0.9999852180480957	O
15865	and	162 165	65047 65050	0.9999880790710449	O
15866	TP53	166 169	65051 65054	0.9999876022338867	O
15869	is	171 173	65056 65058	0.9999889135360718	O
15870	rather	174 180	65059 65065	0.9999858140945435	O
15871	low	181 184	65066 65069	0.9999861717224121	O
15872	[	185 186	65070 65071	0.9999890327453613	O
15873	44	186 188	65071 65073	0.9999854564666748	O
15874	]	188 189	65073 65074	0.9999890327453613	O
15875	,	190 191	65075 65076	0.9999876022338867	O
15876	and	192 195	65077 65080	0.9999880790710449	O
15877	mutations	196 205	65081 65090	0.9999879598617554	O
15878	in	206 208	65091 65093	0.9999891519546509	O
15879	TP53	209 212	65094 65097	0.9999877214431763	O
15882	is	214 216	65099 65101	0.9999890327453613	O
15883	not	217 220	65102 65105	0.9999862909317017	O
15884	an	221 223	65106 65108	0.9999889135360718	O
15885	early	224 229	65109 65114	0.9999872446060181	O
15886	event	230 235	65115 65120	0.9999876022338867	O
15887	in	236 238	65121 65123	0.9999884366989136	O
15888	colorectal	239 248	65124 65133	0.9999842643737793	O
15891	carcinogenesis	250 263	65135 65148	0.9999871253967285	O
15895	.	265 266	65150 65151	0.9999676942825317	O
15896	Finally	0 7	65152 65159	0.9999868869781494	O
15897	,	8 9	65160 65161	0.9999887943267822	O
15898	results	10 17	65162 65169	0.9999862909317017	O
15899	are	18 21	65170 65173	0.999988317489624	O
15900	based	22 27	65174 65179	0.9999886751174927	O
15901	on	28 30	65180 65182	0.9999892711639404	O
15902	relatively	31 41	65183 65193	0.9999884366989136	O
15903	small	42 47	65194 65199	0.9999868869781494	O
15904	numbers	48 55	65200 65207	0.9999868869781494	O
15905	of	56 58	65208 65210	0.999988317489624	O
15906	patients	59 67	65211 65219	0.9999817609786987	O
15907	,	68 69	65220 65221	0.9999889135360718	O
15908	especially	70 80	65222 65232	0.9999887943267822	O
15909	in	81 83	65233 65235	0.9999892711639404	O
15910	the	84 87	65236 65239	0.9999895095825195	O
15911	reference	88 97	65240 65249	0.9999879598617554	O
15912	group	98 103	65250 65255	0.99998939037323	O
15913	of	104 106	65256 65258	0.9999892711639404	O
15914	polyunsaturated	107 121	65259 65273	0.99998939037323	O
15920	fat	123 126	65275 65278	0.99998939037323	O
15921	or	127 129	65279 65281	0.9999891519546509	O
15922	linoleic	130 137	65282 65289	0.9999887943267822	O
15926	acid	139 143	65291 65295	0.9999892711639404	O
15927	intake	144 150	65296 65302	0.9999895095825195	O
15928	(	151 152	65303 65304	0.9999897480010986	O
15929	four	153 157	65305 65309	0.9999858140945435	O
15930	patients	158 166	65310 65318	0.9999873638153076	O
15931	,	167 168	65319 65320	0.9999887943267822	O
15932	see	169 172	65321 65324	0.9999867677688599	O
15933	Table	173 178	65325 65330	0.9999871253967285	O
15934	4	179 180	65331 65332	0.9999880790710449	O
15935	)	180 181	65332 65333	0.99998939037323	O
15936	,	182 183	65334 65335	0.9999889135360718	O
15937	and	184 187	65336 65339	0.9999891519546509	O
15938	point	188 193	65340 65345	0.9999873638153076	O
15939	estimates	194 203	65346 65355	0.9999886751174927	O
15940	of	204 206	65356 65358	0.9999892711639404	O
15941	RRs	207 209	65359 65361	0.9999889135360718	O
15944	for	211 214	65363 65366	0.9999891519546509	O
15945	quartiles	215 223	65367 65375	0.9999891519546509	O
15949	of	225 227	65377 65379	0.9999891519546509	O
15950	intake	228 234	65380 65386	0.9999890327453613	O
15951	of	235 237	65387 65389	0.9999895095825195	O
15952	polyunstaturated	238 253	65390 65405	0.9999892711639404	O
15958	fat	255 258	65407 65410	0.9999889135360718	O
15959	or	259 261	65411 65413	0.9999891519546509	O
15960	linoleic	262 269	65414 65421	0.999988317489624	O
15964	acid	271 275	65423 65427	0.9999890327453613	O
15965	should	276 282	65428 65434	0.9999876022338867	O
15966	therefore	283 292	65435 65444	0.9999877214431763	O
15967	,	293 294	65445 65446	0.9999823570251465	O
15968	be	295 297	65447 65449	0.9999880790710449	O
15969	interpreted	298 309	65450 65461	0.9999868869781494	O
15970	cautiously	310 320	65462 65472	0.9999814033508301	O
15971	.	321 322	65473 65474	0.9999730587005615	O
15972	Nevertheless	0 12	65475 65487	0.999981164932251	O
15973	,	13 14	65488 65489	0.9999887943267822	O
15974	as	15 17	65490 65492	0.9999868869781494	O
15975	discussed	18 27	65493 65502	0.9999845027923584	O
15976	previously	28 38	65503 65513	0.9999827146530151	O
15977	,	39 40	65514 65515	0.9999881982803345	O
15978	the	41 44	65516 65519	0.999988317489624	O
15979	association	45 56	65520 65531	0.9999839067459106	O
15980	appears	57 64	65532 65539	0.9999874830245972	O
15981	to	65 67	65540 65542	0.9999889135360718	O
15982	be	68 70	65543 65545	0.9999892711639404	O
15983	robust	71 77	65546 65552	0.9999821186065674	O
15984	when	78 82	65553 65557	0.9999871253967285	O
15985	regarding	83 92	65558 65567	0.9999881982803345	O
15986	the	93 96	65568 65571	0.9999889135360718	O
15987	results	97 104	65572 65579	0.9999872446060181	O
15988	for	105 108	65580 65583	0.9999890327453613	O
15989	one	109 112	65584 65587	0.9999887943267822	O
15990	standard	113 121	65588 65596	0.9999884366989136	O
15991	deviation	122 130	65597 65605	0.9999886751174927	O
15993	increase	132 140	65607 65615	0.9999865293502808	O
15994	in	141 143	65616 65618	0.9999885559082031	O
15995	linoleic	144 151	65619 65626	0.999988317489624	O
15999	acid	153 157	65628 65632	0.9999886751174927	O
16000	intake	158 164	65633 65639	0.999988317489624	O
16001	(	165 166	65640 65641	0.9999892711639404	O
16002	based	167 172	65642 65647	0.9999889135360718	O
16003	on	173 175	65648 65650	0.99998939037323	O
16004	a	176 177	65651 65652	0.9999890327453613	O
16005	total	178 183	65653 65658	0.9999884366989136	O
16006	of	184 186	65659 65661	0.9999890327453613	O
16007	65	187 189	65662 65664	0.9999780654907227	O
16008	patients	190 198	65665 65673	0.999982476234436	O
16009	)	199 200	65674 65675	0.99998939037323	O
16010	.	201 202	65676 65677	0.9999759197235107	O
16011	Therefore	0 9	65678 65687	0.9999865293502808	O
16012	,	10 11	65688 65689	0.9999890327453613	O
16013	Breivik	12 18	65690 65696	0.9999880790710449	O
16017	and	20 23	65698 65701	0.9999890327453613	O
16018	Glaudernack	24 34	65702 65712	0.999987006187439	O
16023	’	35 36	65713 65714	0.9999809265136719	O
16024	s	36 37	65714 65715	0.9999892711639404	O
16025	hypothesis	38 48	65716 65726	0.9999878406524658	O
16026	for	49 52	65727 65730	0.9999889135360718	O
16027	distinct	53 61	65731 65739	0.9999836683273315	O
16028	carcinogens	62 72	65740 65750	0.9999861717224121	O
16032	to	74 76	65752 65754	0.9999886751174927	O
16033	exert	77 81	65755 65759	0.9999892711639404	O
16035	their	83 88	65761 65766	0.9999895095825195	O
16036	effect	89 95	65767 65773	0.9999887943267822	O
16037	on	96 98	65774 65776	0.9999891519546509	O
16038	two	99 102	65777 65780	0.9999867677688599	O
16039	proposed	103 111	65781 65789	0.9999839067459106	O
16040	types	112 117	65790 65795	0.9999885559082031	O
16041	of	118 120	65796 65798	0.9999889135360718	O
16042	genetic	121 128	65799 65806	0.999988317489624	O
16043	instability	129 140	65807 65818	0.9999873638153076	O
16044	,	141 142	65819 65820	0.9999886751174927	O
16045	i	143 144	65821 65822	0.9999891519546509	O
16046	.	145 146	65823 65824	0.9999886751174927	O
16047	e	146 147	65824 65825	0.9999872446060181	O
16048	.	148 149	65826 65827	0.9999878406524658	O
16049	,	150 151	65828 65829	0.9999861717224121	O
16050	microsatellite	0 13	65830 65843	0.9999879598617554	O
16054	instability	15 26	65845 65856	0.99998939037323	O
16055	and	27 30	65857 65860	0.9999885559082031	O
16056	chromosomal	31 41	65861 65871	0.9999874830245972	O
16060	instability	43 54	65873 65884	0.9999890327453613	O
16061	[	55 56	65885 65886	0.9999895095825195	O
16062	16	56 58	65886 65888	0.9999871253967285	O
16063	]	58 59	65888 65889	0.9999892711639404	O
16064	,	60 61	65890 65891	0.9999881982803345	O
16065	may	62 65	65892 65895	0.9999884366989136	O
16066	be	66 68	65896 65898	0.9999891519546509	O
16067	extended	69 77	65899 65907	0.9999878406524658	O
16068	to	78 80	65908 65910	0.9999889135360718	O
16069	the	81 84	65911 65914	0.99998939037323	O
16070	potential	85 94	65915 65924	0.9999878406524658	O
16071	effect	95 101	65925 65931	0.9999880790710449	O
16072	of	102 104	65932 65934	0.9999890327453613	O
16073	carcinogens	105 115	65935 65945	0.9999860525131226	O
16077	on	117 119	65947 65949	0.9999891519546509	O
16078	more	120 124	65950 65954	0.9999885559082031	O
16079	specific	125 133	65955 65963	0.9999890327453613	O
16080	genetic	134 141	65964 65971	0.9999885559082031	O
16081	pathways	142 150	65972 65980	0.999988317489624	O
16082	to	151 153	65981 65983	0.9999865293502808	O
16083	colorectal	154 163	65984 65993	0.9999862909317017	O
16086	tumorigenesis	165 177	65995 66007	0.9999865293502808	O
16090	,	179 180	66009 66010	0.9999881982803345	O
16091	as	181 183	66011 66013	0.9999879598617554	O
16092	for	184 187	66014 66017	0.9999876022338867	O
16093	example	188 195	66018 66025	0.9999878406524658	O
16094	the	196 199	66026 66029	0.9999891519546509	O
16095	KRAS	200 203	66030 66033	0.9999866485595703	O
16098	mutated	205 211	66035 66041	0.9999885559082031	O
16101	pathway	213 220	66043 66050	0.9999886751174927	O
16102	.	221 222	66051 66052	0.9999715089797974	O
16103	The	0 3	66053 66056	0.9999836683273315	O
16104	data	4 8	66057 66061	0.9999798536300659	O
16105	from	9 13	66062 66066	0.9999841451644897	O
16106	this	14 18	66067 66071	0.9999839067459106	O
16107	large	19 24	66072 66077	0.9999420642852783	O
16108	prospective	25 36	66078 66089	0.9999542236328125	O
16109	cohort	37 42	66090 66095	0.9999840259552002	O
16112	study	44 49	66097 66102	0.9999788999557495	O
16113	suggest	50 57	66103 66110	0.9999810457229614	O
16114	that	58 62	66111 66115	0.9999873638153076	O
16115	linoleic	63 70	66116 66123	0.9999852180480957	O
16119	acid	72 76	66125 66129	0.9999872446060181	O
16120	intake	77 83	66130 66136	0.9999817609786987	O
16121	is	84 86	66137 66139	0.9999865293502808	O
16122	strongly	87 95	66140 66148	0.9999828338623047	O
16123	associated	96 106	66149 66159	0.9999865293502808	O
16124	with	107 111	66160 66164	0.9999845027923584	O
16125	colon	112 116	66165 66169	0.9999722242355347	O
16127	tumors	118 124	66171 66177	0.9999830722808838	O
16128	with	125 129	66178 66182	0.9999878406524658	O
16129	an	130 132	66183 66185	0.9999887943267822	O
16130	aberrant	133 140	66186 66193	0.9999887943267822	O
16133	KRAS	142 145	66195 66198	0.9999872446060181	O
16136	gene	147 151	66200 66204	0.9999886751174927	O
16137	,	152 153	66205 66206	0.9999872446060181	O
16138	but	154 157	66207 66210	0.9999854564666748	O
16139	an	158 160	66211 66213	0.9999886751174927	O
16140	intact	161 167	66214 66220	0.9999866485595703	O
16141	APC	168 170	66221 66223	0.9999866485595703	O
16143	gene	172 176	66225 66229	0.9999884366989136	O
16144	and	177 180	66230 66233	0.9999866485595703	O
16145	MLH1	181 184	66234 66237	0.9999864101409912	O
16148	expression	186 196	66239 66249	0.9999867677688599	O
16149	.	197 198	66250 66251	0.9999521970748901	O
16150	Verification	0 11	66252 66263	0.9999818801879883	O
16153	in	13 15	66265 66267	0.999982476234436	O
16154	other	16 21	66268 66273	0.9999788999557495	O
16155	studies	22 29	66274 66281	0.9999767541885376	O
16156	is	30 32	66282 66284	0.9999756813049316	O
16157	warranted	33 41	66285 66293	0.9999781847000122	O
16159	.	43 44	66295 66296	0.9998959302902222	O
16160	Possibly	0 7	66297 66304	0.9999785423278809	O
16163	,	9 10	66306 66307	0.9999860525131226	O
16164	tumors	11 17	66308 66314	0.9999815225601196	O
16165	revealing	18 27	66315 66324	0.9999845027923584	O
16166	the	28 31	66325 66328	0.9999884366989136	O
16167	involvement	32 43	66329 66340	0.9999873638153076	O
16168	of	44 46	66341 66343	0.9999885559082031	O
16169	distinct	47 55	66344 66352	0.9999861717224121	O
16170	genetic	56 63	66353 66360	0.9999860525131226	O
16171	pathways	64 72	66361 66369	0.9999852180480957	O
16172	on	73 75	66370 66372	0.9999884366989136	O
16173	the	76 79	66373 66376	0.9999885559082031	O
16174	basis	80 85	66377 66382	0.9999884366989136	O
16175	of	86 88	66383 66385	0.9999886751174927	O
16176	specific	89 97	66386 66394	0.9999867677688599	O
16177	genetic	98 105	66395 66402	0.9999865293502808	O
16178	aberrations	106 116	66403 66413	0.9999881982803345	O
16181	,	118 119	66415 66416	0.9999822378158569	O
16182	may	120 123	66417 66420	0.9999854564666748	O
16183	have	124 128	66421 66425	0.999987006187439	O
16184	a	129 130	66426 66427	0.9999877214431763	O
16185	unique	131 137	66428 66434	0.999985933303833	O
16186	etiology	138 145	66435 66442	0.999987006187439	O
16188	.	147 148	66444 66445	0.9999886751174927	O
16189	*	149 150	66446 66447	0.9999874830245972	O
16190	*	150 151	66447 66448	0.9999809265136719	O
16191	IGNORE	0 5	66449 66454	0.9999865293502808	O
16194	LINE	7 10	66456 66459	0.9999886751174927	O
16197	*	12 13	66461 66462	0.9999887943267822	O
16198	*	13 14	66462 66463	0.9999887943267822	O
16199	*	15 16	66464 66465	0.9999887943267822	O
16200	*	16 17	66465 66466	0.9999887943267822	O
16201	IGNORE	18 23	66467 66472	0.9999877214431763	O
16204	LINE	25 28	66474 66477	0.9999889135360718	O
16207	*	30 31	66479 66480	0.9999885559082031	O
16208	*	31 32	66480 66481	0.9999885559082031	O
16209	*	33 34	66482 66483	0.9999886751174927	O
16210	*	34 35	66483 66484	0.9999885559082031	O
16211	IGNORE	36 41	66485 66490	0.9999874830245972	O
16214	LINE	43 46	66492 66495	0.9999887943267822	O
16217	*	48 49	66497 66498	0.9999886751174927	O
16218	*	49 50	66498 66499	0.9999885559082031	O
16219	Discussion	51 60	66500 66509	0.9999886751174927	O
16222	We	62 64	66511 66513	0.9999858140945435	O
16223	report	65 71	66514 66520	0.999987006187439	O
16224	the	72 75	66521 66524	0.9999886751174927	O
16225	analysis	76 84	66525 66533	0.999988317489624	O
16226	of	85 87	66534 66536	0.9999887943267822	O
16227	the	88 91	66537 66540	0.9999886751174927	O
16228	combined	92 100	66541 66549	0.9999868869781494	O
16229	miRNA	101 105	66550 66554	0.9999862909317017	O
16231	/	106 107	66555 66556	0.9999886751174927	O
16232	mRNA	107 110	66556 66559	0.9999877214431763	O
16234	expression	112 122	66561 66571	0.9999879598617554	O
16235	for	123 126	66572 66575	0.999987006187439	O
16236	the	127 130	66576 66579	0.9999885559082031	O
16237	discrimination	131 145	66580 66594	0.9999867677688599	O
16238	of	146 148	66595 66597	0.9999884366989136	O
16239	MSI	149 151	66598 66600	0.9999879598617554	O
16241	-	152 153	66601 66602	0.9999890327453613	O
16242	H	153 154	66602 66603	0.9999827146530151	O
16243	versus	155 161	66604 66610	0.9999850988388062	O
16244	MSS	162 164	66611 66613	0.9999856948852539	O
16246	human	166 171	66615 66620	0.9992538094520569	O
16247	colon	172 176	66621 66625	0.9999828338623047	O
16249	cancer	178 184	66627 66633	0.9999862909317017	O
16250	.	185 186	66634 66635	0.9999618530273438	O
16251	Because	0 7	66636 66643	0.9999622106552124	O
16252	colorectal	8 17	66644 66653	0.9999747276306152	O
16255	tumors	19 25	66655 66661	0.9999837875366211	O
16256	characterized	26 39	66662 66675	0.999987006187439	O
16257	by	40 42	66676 66678	0.999988317489624	O
16258	MSI	43 45	66679 66681	0.9999845027923584	O
16260	are	47 50	66683 66686	0.9999867677688599	O
16261	distinct	51 59	66687 66695	0.9999849796295166	O
16262	from	60 64	66696 66700	0.9999862909317017	O
16263	MSS	65 67	66701 66703	0.9999767541885376	O
16265	tumors	69 75	66705 66711	0.9999858140945435	O
16266	in	76 78	66712 66714	0.9999873638153076	O
16267	many	79 83	66715 66719	0.9999878406524658	O
16268	molecular	84 93	66720 66729	0.9999865293502808	O
16269	aspects	94 101	66730 66737	0.9999868869781494	O
16270	,	102 103	66738 66739	0.9999861717224121	O
16271	such	104 108	66740 66744	0.9999858140945435	O
16272	the	109 112	66745 66748	0.9999881982803345	O
16273	association	113 124	66749 66760	0.9999880790710449	O
16274	with	125 129	66761 66765	0.9999885559082031	O
16275	the	130 133	66766 66769	0.999988317489624	O
16276	methylator	134 143	66770 66779	0.9999874830245972	O
16279	phenotype	145 153	66781 66789	0.9999886751174927	O
16282	,	155 156	66791 66792	0.9999884366989136	O
16283	which	157 162	66793 66798	0.9999886751174927	O
16284	is	163 165	66799 66801	0.9999884366989136	O
16285	responsible	166 177	66802 66813	0.999988317489624	O
16286	for	178 181	66814 66817	0.9999885559082031	O
16287	MLH1	182 185	66818 66821	0.999987006187439	O
16290	methylation	187 197	66823 66833	0.9999881982803345	O
16293	,	199 200	66835 66836	0.9999884366989136	O
16294	the	201 204	66837 66840	0.999988317489624	O
16295	higher	205 211	66841 66847	0.999987006187439	O
16296	frequency	212 221	66848 66857	0.9999881982803345	O
16297	of	222 224	66858 66860	0.999988317489624	O
16298	BRAF	225 228	66861 66864	0.9999845027923584	O
16300	mutations	230 239	66866 66875	0.9999881982803345	O
16301	and	240 243	66876 66879	0.9999879598617554	O
16302	the	244 247	66880 66883	0.9999877214431763	O
16303	lower	248 253	66884 66889	0.9999833106994629	O
16304	frequencies	254 265	66890 66901	0.999987006187439	O
16305	of	266 268	66902 66904	0.9999880790710449	O
16306	KRAS	269 272	66905 66908	0.9999837875366211	O
16309	,	274 275	66910 66911	0.9999874830245972	O
16310	APC	276 278	66912 66914	0.9999849796295166	O
16312	and	280 283	66916 66919	0.9999874830245972	O
16313	TP53	284 287	66920 66923	0.9999853372573853	O
16316	mutations	289 298	66925 66934	0.9999876022338867	O
16317	,	299 300	66935 66936	0.9999853372573853	O
16318	MSI	301 303	66937 66939	0.9999862909317017	O
16320	and	305 308	66941 66944	0.9999825954437256	O
16321	MSS	309 311	66945 66947	0.9999829530715942	O
16323	colon	313 317	66949 66953	0.9999797344207764	O
16325	cancers	319 325	66955 66961	0.9999836683273315	O
16327	represent	327 336	66963 66972	0.9999774694442749	O
16328	tumors	337 343	66973 66979	0.9999833106994629	O
16329	with	344 348	66980 66984	0.9999878406524658	O
16330	a	349 350	66985 66986	0.9999880790710449	O
16331	different	351 360	66987 66996	0.999983549118042	O
16332	molecular	361 370	66997 67006	0.9999852180480957	O
16333	background	371 381	67007 67017	0.9999856948852539	O
16334	.	382 383	67018 67019	0.999941349029541	O
16335	Thus	0 4	67020 67024	0.999984622001648	O
16336	,	5 6	67025 67026	0.9999872446060181	O
16337	it	7 9	67027 67029	0.9999860525131226	O
16338	is	10 12	67030 67032	0.9999852180480957	O
16339	reasonable	13 23	67033 67043	0.9999815225601196	O
16340	that	24 28	67044 67048	0.9999880790710449	O
16341	their	29 34	67049 67054	0.9999866485595703	O
16342	overall	35 42	67055 67062	0.9999856948852539	O
16343	gene	43 47	67063 67067	0.9999862909317017	O
16344	expression	48 58	67068 67078	0.999985933303833	O
16345	pattern	59 66	67079 67086	0.9999868869781494	O
16346	(	67 68	67087 67088	0.9999884366989136	O
16347	including	69 78	67089 67098	0.999988317489624	O
16348	both	79 83	67099 67103	0.9999876022338867	O
16349	mRNAs	84 88	67104 67108	0.9999877214431763	O
16352	and	90 93	67110 67113	0.9999880790710449	O
16353	microRNAs	94 102	67114 67122	0.9999839067459106	O
16356	)	104 105	67124 67125	0.9999880790710449	O
16357	might	106 111	67126 67131	0.9999839067459106	O
16358	be	112 114	67132 67134	0.9999881982803345	O
16359	affected	115 123	67135 67143	0.9999855756759644	O
16360	by	124 126	67144 67146	0.999988317489624	O
16361	any	127 130	67147 67150	0.9999866485595703	O
16362	of	131 133	67151 67153	0.9999880790710449	O
16363	the	134 137	67154 67157	0.999988317489624	O
16364	above	138 143	67158 67163	0.9999868869781494	O
16365	mentioned	144 153	67164 67173	0.9999855756759644	O
16366	mechanisms	154 164	67174 67184	0.9999837875366211	O
16367	.	165 166	67185 67186	0.9999659061431885	O
16368	Indeed	0 6	67187 67193	0.9999597072601318	O
16369	,	7 8	67194 67195	0.9999842643737793	O
16370	our	9 12	67196 67199	0.9999598264694214	O
16371	analyses	13 21	67200 67208	0.9999287128448486	O
16372	identified	22 32	67209 67219	0.9999810457229614	O
16373	14	33 35	67220 67222	0.9999698400497437	O
16374	miRNAs	36 41	67223 67228	0.9999734163284302	O
16377	and	43 46	67230 67233	0.9999823570251465	O
16378	451	47 49	67234 67236	0.9999723434448242	O
16380	mRNAs	51 55	67238 67242	0.9999686479568481	O
16383	differentially	57 70	67244 67257	0.9999806880950928	O
16385	expressed	72 81	67259 67268	0.9999817609786987	O
16386	between	82 89	67269 67276	0.9999737739562988	O
16387	the	90 93	67277 67280	0.9999792575836182	O
16388	two	94 97	67281 67284	0.999957799911499	O
16389	genetically	98 109	67285 67296	0.999972939491272	O
16390	distinct	110 118	67297 67305	0.9999738931655884	O
16391	colon	119 123	67306 67310	0.9999606609344482	O
16393	cancer	125 131	67312 67318	0.9999786615371704	O
16394	classes	132 139	67319 67326	0.9999814033508301	O
16395	.	140 141	67327 67328	0.999919056892395	O
16396	These	0 5	67329 67334	0.9999868869781494	O
16397	results	6 13	67335 67342	0.999985933303833	O
16398	not	14 17	67343 67346	0.999988317489624	O
16399	only	18 22	67347 67351	0.9999878406524658	O
16400	indicate	23 31	67352 67360	0.9999880790710449	O
16401	the	32 35	67361 67364	0.9999889135360718	O
16402	existence	36 45	67365 67374	0.9999890327453613	O
16403	of	46 48	67375 67377	0.9999890327453613	O
16404	a	49 50	67378 67379	0.9999889135360718	O
16405	mRNA	51 54	67380 67383	0.9999887943267822	O
16407	/	55 56	67384 67385	0.9999887943267822	O
16408	miRNA	56 60	67385 67389	0.9999872446060181	O
16410	gene	62 66	67391 67395	0.9999886751174927	O
16411	expression	67 77	67396 67406	0.9999884366989136	O
16412	profile	78 85	67407 67414	0.999988317489624	O
16413	able	86 90	67415 67419	0.9999877214431763	O
16414	to	91 93	67420 67422	0.9999881982803345	O
16415	distinguish	94 105	67423 67434	0.9999873638153076	O
16416	MSS	106 108	67435 67437	0.9999876022338867	O
16418	versus	110 116	67439 67445	0.999984860420227	O
16419	MSI	117 119	67446 67448	0.9999876022338867	O
16421	colon	121 125	67450 67454	0.999983549118042	O
16423	cancers	127 133	67456 67462	0.9999860525131226	O
16425	,	135 136	67464 67465	0.9999877214431763	O
16426	but	137 140	67466 67469	0.9999874830245972	O
16427	also	141 145	67470 67474	0.9999880790710449	O
16428	indicate	146 154	67475 67483	0.9999880790710449	O
16429	that	155 159	67484 67488	0.9999891519546509	O
16430	the	160 163	67489 67492	0.9999887943267822	O
16431	combination	164 175	67493 67504	0.9999877214431763	O
16432	of	176 178	67505 67507	0.9999890327453613	O
16433	miRNA	179 183	67508 67512	0.9999874830245972	O
16435	/	184 185	67513 67514	0.9999885559082031	O
16436	mRNA	185 188	67514 67517	0.9999885559082031	O
16438	gene	190 194	67519 67523	0.9999887943267822	O
16439	expression	195 205	67524 67534	0.9999884366989136	O
16440	data	206 210	67535 67539	0.9999877214431763	O
16441	can	211 214	67540 67543	0.9999881982803345	O
16442	distinguish	215 226	67544 67555	0.9999880790710449	O
16443	microsatellite	227 240	67556 67569	0.9999880790710449	O
16447	instability	242 253	67571 67582	0.9999877214431763	O
16448	status	254 260	67583 67589	0.9999886751174927	O
16449	of	261 263	67590 67592	0.9999879598617554	O
16450	human	264 269	67593 67598	0.9988607168197632	O
16451	colorectal	270 279	67599 67608	0.9999847412109375	O
16454	cancers	281 287	67610 67616	0.999984860420227	O
16456	better	289 295	67618 67624	0.9999867677688599	O
16457	than	296 300	67625 67629	0.9999887943267822	O
16458	each	301 305	67630 67634	0.999988317489624	O
16459	RNA	306 309	67635 67638	0.9999876022338867	O
16460	class	310 315	67639 67644	0.9999886751174927	O
16461	independently	316 329	67645 67658	0.9999876022338867	O
16462	,	330 331	67659 67660	0.9999885559082031	O
16463	suggesting	332 342	67661 67671	0.9999878406524658	O
16464	that	343 347	67672 67676	0.9999891519546509	O
16465	the	348 351	67677 67680	0.9999886751174927	O
16466	combination	352 363	67681 67692	0.9999880790710449	O
16467	of	364 366	67693 67695	0.9999886751174927	O
16468	mRNA	367 370	67696 67699	0.999988317489624	O
16470	and	372 375	67701 67704	0.9999879598617554	O
16471	miRNA	376 380	67705 67709	0.9999861717224121	O
16473	expression	382 392	67711 67721	0.9999876022338867	O
16474	may	393 396	67722 67725	0.9999864101409912	O
16475	potentially	397 408	67726 67737	0.9999855756759644	O
16476	represent	409 418	67738 67747	0.9999874830245972	O
16477	a	419 420	67748 67749	0.9999887943267822	O
16478	general	421 428	67750 67757	0.9999853372573853	O
16479	approach	429 437	67758 67766	0.9999872446060181	O
16480	for	438 441	67767 67770	0.9999877214431763	O
16481	improving	442 451	67771 67780	0.9999865293502808	O
16482	characterization	452 468	67781 67797	0.999985933303833	O
16483	and	469 472	67798 67801	0.9999876022338867	O
16484	classification	473 487	67802 67816	0.9999862909317017	O
16485	of	488 490	67817 67819	0.999988317489624	O
16486	bio	491 494	67820 67823	0.9999840259552002	O
16487	-	494 495	67823 67824	0.9999868869781494	O
16488	molecular	495 504	67824 67833	0.9999845027923584	O
16489	and	505 508	67834 67837	0.9999853372573853	O
16490	possibly	509 517	67838 67846	0.9999854564666748	O
16491	clinical	518 526	67847 67855	0.999976634979248	O
16492	traits	527 533	67856 67862	0.9999840259552002	O
16493	associated	534 544	67863 67873	0.999988317489624	O
16494	with	545 549	67874 67878	0.9999878406524658	O
16495	human	550 555	67879 67884	0.9986408352851868	O
16496	cancer	556 562	67885 67891	0.9999843835830688	O
16497	.	563 564	67892 67893	0.9999605417251587	O
16498	We	0 2	67894 67896	0.9999849796295166	O
16499	also	3 7	67897 67901	0.9999861717224121	O
16500	examined	8 16	67902 67910	0.9999860525131226	O
16501	the	17 20	67911 67914	0.9999886751174927	O
16502	prediction	21 31	67915 67925	0.9999860525131226	O
16503	power	32 37	67926 67931	0.9999877214431763	O
16504	of	38 40	67932 67934	0.9999889135360718	O
16505	published	41 50	67935 67944	0.9999794960021973	O
16506	lists	51 56	67945 67950	0.9999873638153076	O
16507	of	57 59	67951 67953	0.9999886751174927	O
16508	genes	60 65	67954 67959	0.9999862909317017	O
16509	differentially	66 79	67960 67973	0.9999880790710449	O
16511	expressed	81 90	67975 67984	0.9999878406524658	O
16512	between	91 98	67985 67992	0.9999878406524658	O
16513	MSI	99 101	67993 67995	0.9999884366989136	O
16515	-	102 103	67996 67997	0.99998939037323	O
16516	H	103 104	67997 67998	0.999985933303833	O
16517	and	105 108	67999 68002	0.9999876022338867	O
16518	MSS	109 111	68003 68005	0.9999866485595703	O
16520	colorectal	113 122	68007 68016	0.9999872446060181	O
16523	cancers	124 130	68018 68024	0.9999873638153076	O
16525	[	132 133	68026 68027	0.9999895095825195	O
16526	34	133 135	68027 68029	0.9999885559082031	O
16527	-	135 136	68029 68030	0.99998939037323	O
16528	36	136 138	68030 68032	0.9999887943267822	O
16529	]	138 139	68032 68033	0.9999892711639404	O
16530	against	140 147	68034 68041	0.9999856948852539	O
16531	our	148 151	68042 68045	0.9999842643737793	O
16532	data	152 156	68046 68050	0.999987006187439	O
16533	set	157 160	68051 68054	0.9999880790710449	O
16534	.	161 162	68055 68056	0.9999736547470093	O
16535	Two	0 3	68057 68060	0.999984860420227	O
16536	published	4 13	68061 68070	0.9999816417694092	O
16537	lists	14 19	68071 68076	0.9999833106994629	O
16538	describe	20 28	68077 68085	0.9999850988388062	O
16539	differentially	29 42	68086 68099	0.9999853372573853	O
16541	expressed	44 53	68101 68110	0.9999850988388062	O
16542	genes	54 59	68111 68116	0.9999866485595703	O
16543	(	60 61	68117 68118	0.9999862909317017	O
16544	100	62 65	68119 68122	0.9999825954437256	O
16545	genes	66 71	68123 68128	0.999987006187439	O
16546	in	72 74	68129 68131	0.9999874830245972	O
16547	the	75 78	68132 68135	0.9999876022338867	O
16548	report	79 85	68136 68142	0.999987006187439	O
16549	from	86 90	68143 68147	0.9999876022338867	O
16550	Di	91 93	68148 68150	0.9999852180480957	O
16551	Pietro	94 100	68151 68157	0.9999669790267944	O
16552	et	101 103	68158 68160	0.9999878406524658	O
16553	al	104 106	68161 68163	0.9999874830245972	O
16554	.	107 108	68164 68165	0.9999743700027466	O
16555	2005	0 4	68166 68170	0.9999810457229614	O
16556	[	5 6	68171 68172	0.9999878406524658	O
16557	36	6 8	68172 68174	0.9999843835830688	O
16558	]	8 9	68174 68175	0.9999873638153076	O
16559	and	10 13	68176 68179	0.9999864101409912	O
16560	542	14 16	68180 68182	0.9999845027923584	O
16562	genes	18 23	68184 68189	0.999984860420227	O
16563	from	24 28	68190 68194	0.9999868869781494	O
16564	Banerjea	29 36	68195 68202	0.999983549118042	O
16568	et	38 40	68204 68206	0.9999877214431763	O
16569	al	41 43	68207 68209	0.999987006187439	O
16570	.	44 45	68210 68211	0.9999727010726929	O
16571	2004	0 4	68212 68216	0.9999816417694092	O
16572	[	5 6	68217 68218	0.9999886751174927	O
16573	35	6 8	68218 68220	0.9999843835830688	O
16574	]	8 9	68220 68221	0.9999881982803345	O
16575	)	10 11	68222 68223	0.9999885559082031	O
16576	and	12 15	68224 68227	0.9999881982803345	O
16577	one	16 19	68228 68231	0.9999884366989136	O
16578	is	20 22	68232 68234	0.9999887943267822	O
16579	a	23 24	68235 68236	0.9999890327453613	O
16580	short	25 30	68237 68242	0.9999880790710449	O
16581	list	31 35	68243 68247	0.9999891519546509	O
16582	of	36 38	68248 68250	0.9999890327453613	O
16583	predictors	39 48	68251 68260	0.9999878406524658	O
16585	(	50 51	68262 68263	0.9999891519546509	O
16586	9	52 53	68264 68265	0.9999876022338867	O
16587	genes	54 59	68266 68271	0.9999876022338867	O
16588	in	60 62	68272 68274	0.9999886751174927	O
16589	Kruhoffer	63 71	68275 68283	0.9999861717224121	O
16593	et	73 75	68285 68287	0.9999884366989136	O
16594	al	76 78	68288 68290	0.9999881982803345	O
16595	.	79 80	68291 68292	0.9999803304672241	O
16596	2005	0 4	68293 68297	0.9999680519104004	O
16597	[	5 6	68298 68299	0.999983549118042	O
16598	34	6 8	68299 68301	0.9999727010726929	O
16599	]	8 9	68301 68302	0.9999821186065674	O
16600	)	10 11	68303 68304	0.9999734163284302	O
16601	.	12 13	68305 68306	0.9999128580093384	O
16602	Although	0 8	68307 68315	0.9999778270721436	O
16603	these	9 14	68316 68321	0.9999833106994629	O
16604	studies	15 22	68322 68329	0.9999759197235107	O
16605	were	23 27	68330 68334	0.9999852180480957	O
16606	all	28 31	68335 68338	0.999982476234436	O
16607	performed	32 41	68339 68348	0.9999834299087524	O
16608	on	42 44	68349 68351	0.9999860525131226	O
16609	Affymetrix	45 54	68352 68361	0.9999860525131226	O
16613	platforms	56 65	68363 68372	0.9999823570251465	O
16614	,	66 67	68373 68374	0.9999812841415405	O
16615	they	68 72	68375 68379	0.9999843835830688	O
16616	generated	73 82	68380 68389	0.9999833106994629	O
16617	only	83 87	68390 68394	0.999983549118042	O
16618	partially	88 97	68395 68404	0.9999867677688599	O
16619	overlapping	98 109	68405 68416	0.9999843835830688	O
16620	results	110 117	68417 68424	0.9999833106994629	O
16621	.	118 119	68425 68426	0.9999450445175171	O
16622	The	0 3	68427 68430	0.9999850988388062	O
16623	list	4 8	68431 68435	0.9999816417694092	O
16624	of	9 11	68436 68438	0.9999850988388062	O
16625	genes	12 17	68439 68444	0.9999804496765137	O
16626	from	18 22	68445 68449	0.9999845027923584	O
16627	Di	23 25	68450 68452	0.9999765157699585	O
16628	Pietro	26 32	68453 68459	0.9999405145645142	O
16629	et	33 35	68460 68462	0.9999855756759644	O
16630	al	36 38	68463 68465	0.9999855756759644	O
16631	.	39 40	68466 68467	0.9999860525131226	O
16632	[	41 42	68468 68469	0.9999620914459229	O
16633	36	0 2	68469 68471	0.9999756813049316	O
16634	]	2 3	68471 68472	0.9999747276306152	O
16635	was	4 7	68473 68476	0.9999864101409912	O
16636	the	8 11	68477 68480	0.9999855756759644	O
16637	one	12 15	68481 68484	0.9999850988388062	O
16638	that	16 20	68485 68489	0.9999858140945435	O
16639	better	21 27	68490 68496	0.9999833106994629	O
16640	correlated	28 38	68497 68507	0.9999856948852539	O
16641	with	39 43	68508 68512	0.9999860525131226	O
16642	our	44 47	68513 68516	0.9999819993972778	O
16643	results	48 55	68517 68524	0.9999847412109375	O
16644	.	56 57	68525 68526	0.9999456405639648	O
16645	Twenty	0 6	68527 68533	0.9999850988388062	O
16646	two	7 10	68534 68537	0.9999864101409912	O
16647	of	11 13	68538 68540	0.9999879598617554	O
16648	their	14 19	68541 68546	0.9999860525131226	O
16649	100	20 23	68547 68550	0.9999779462814331	O
16650	genes	24 29	68551 68556	0.9999850988388062	O
16651	were	30 34	68557 68561	0.9999880790710449	O
16652	present	35 42	68562 68569	0.9999885559082031	O
16653	in	43 45	68570 68572	0.9999887943267822	O
16654	our	46 49	68573 68576	0.9999862909317017	O
16655	list	50 54	68577 68581	0.9999880790710449	O
16656	of	55 57	68582 68584	0.9999885559082031	O
16657	differentially	58 71	68585 68598	0.9999876022338867	O
16659	expressed	73 82	68600 68609	0.9999880790710449	O
16660	genes	83 88	68610 68615	0.999988317489624	O
16661	and	89 92	68616 68619	0.999988317489624	O
16662	,	93 94	68620 68621	0.9999874830245972	O
16663	for	95 98	68622 68625	0.9999878406524658	O
16664	all	99 102	68626 68629	0.9999884366989136	O
16665	the	103 106	68630 68633	0.9999880790710449	O
16666	remaining	107 116	68634 68643	0.9999866485595703	O
16667	genes	117 122	68644 68649	0.9999874830245972	O
16668	,	123 124	68650 68651	0.9999884366989136	O
16669	expression	125 135	68652 68662	0.9999878406524658	O
16670	tendency	136 144	68663 68671	0.9999868869781494	O
16671	completely	145 155	68672 68682	0.9999879598617554	O
16672	matched	156 163	68683 68690	0.999988317489624	O
16673	our	164 167	68691 68694	0.9999874830245972	O
16674	data	168 172	68695 68699	0.9999872446060181	O
16675	.	173 174	68700 68701	0.9999665021896362	O
16676	A	0 1	68702 68703	0.9999886751174927	O
16677	cluster	2 9	68704 68711	0.9999862909317017	O
16678	analysis	10 18	68712 68720	0.9999885559082031	O
16679	of	19 21	68721 68723	0.9999887943267822	O
16680	our	22 25	68724 68727	0.9999862909317017	O
16681	data	26 30	68728 68732	0.9999884366989136	O
16682	set	31 34	68733 68736	0.999988317489624	O
16683	using	35 40	68737 68742	0.9999891519546509	O
16684	the	41 44	68743 68746	0.99998939037323	O
16685	100	45 48	68747 68750	0.9999852180480957	O
16686	genes	49 54	68751 68756	0.9999872446060181	O
16687	from	55 59	68757 68761	0.9999895095825195	O
16688	the	60 63	68762 68765	0.9999896287918091	O
16689	Di	64 66	68766 68768	0.9999871253967285	O
16690	Pietro	67 73	68769 68775	0.999983549118042	O
16691	'	74 75	68776 68777	0.9999896287918091	O
16692	s	75 76	68777 68778	0.9999897480010986	O
16693	paper	77 82	68779 68784	0.999987006187439	O
16694	could	83 88	68785 68790	0.9999885559082031	O
16695	generate	89 97	68791 68799	0.9999884366989136	O
16696	a	98 99	68800 68801	0.9999895095825195	O
16697	good	100 104	68802 68806	0.9999878406524658	O
16698	,	105 106	68807 68808	0.9999889135360718	O
16699	although	107 115	68809 68817	0.9999880790710449	O
16700	not	116 119	68818 68821	0.9999889135360718	O
16701	perfect	120 127	68822 68829	0.9999890327453613	O
16702	,	128 129	68830 68831	0.9999890327453613	O
16703	separation	130 140	68832 68842	0.999988317489624	O
16704	between	141 148	68843 68850	0.9999892711639404	O
16705	MSS	149 151	68851 68853	0.9999892711639404	O
16707	versus	153 159	68855 68861	0.9999884366989136	O
16708	MSI	160 162	68862 68864	0.9999887943267822	O
16710	-	163 164	68865 68866	0.99998939037323	O
16711	H	164 165	68866 68867	0.9999744892120361	O
16712	tumors	166 172	68868 68874	0.9999858140945435	O
16713	and	173 176	68875 68878	0.9999887943267822	O
16714	performed	177 186	68879 68888	0.9999874830245972	O
16715	well	187 191	68889 68893	0.9999879598617554	O
16716	in	192 194	68894 68896	0.9999891519546509	O
16717	the	195 198	68897 68900	0.99998939037323	O
16718	prediction	199 209	68901 68911	0.999988317489624	O
16719	of	210 212	68912 68914	0.9999892711639404	O
16720	our	213 216	68915 68918	0.9999861717224121	O
16721	samples	217 224	68919 68926	0.9999885559082031	O
16722	(	225 226	68927 68928	0.9999897480010986	O
16723	36	227 229	68929 68931	0.9999864101409912	O
16724	of	230 232	68932 68934	0.9999895095825195	O
16725	39	233 235	68935 68937	0.9999765157699585	O
16726	samples	236 243	68938 68945	0.9999880790710449	O
16727	were	244 248	68946 68950	0.9999892711639404	O
16728	correctly	249 258	68951 68960	0.9999885559082031	O
16729	classified	259 269	68961 68971	0.9999887943267822	O
16730	using	270 275	68972 68977	0.9999890327453613	O
16731	the	276 279	68978 68981	0.9999892711639404	O
16732	SVM	280 282	68982 68984	0.9999843835830688	O
16734	prediction	284 294	68986 68996	0.9999890327453613	O
16735	)	295 296	68997 68998	0.9999887943267822	O
16736	(	297 298	68999 69000	0.9999895095825195	O
16737	data	299 303	69001 69005	0.9999878406524658	O
16738	not	304 307	69006 69009	0.9999892711639404	O
16739	shown	308 313	69010 69015	0.9999885559082031	O
16740	)	314 315	69016 69017	0.9999895095825195	O
16741	.	316 317	69018 69019	0.9999731779098511	O
16742	These	0 5	69020 69025	0.9999867677688599	O
16743	results	6 13	69026 69033	0.9999861717224121	O
16744	indicate	14 22	69034 69042	0.9999862909317017	O
16745	that	23 27	69043 69047	0.9999885559082031	O
16746	a	28 29	69048 69049	0.9999887943267822	O
16747	similar	30 37	69050 69057	0.9999855756759644	O
16748	set	38 41	69058 69061	0.9999876022338867	O
16749	of	42 44	69062 69064	0.9999881982803345	O
16750	genes	45 50	69065 69070	0.9999847412109375	O
16751	emerged	51 58	69071 69078	0.9999880790710449	O
16752	as	59 61	69079 69081	0.9999885559082031	O
16753	differentially	62 75	69082 69095	0.9999884366989136	O
16755	expressed	77 86	69097 69106	0.9999878406524658	O
16756	between	87 94	69107 69114	0.9999879598617554	O
16757	MSS	95 97	69115 69117	0.9999878406524658	O
16759	and	99 102	69119 69122	0.9999876022338867	O
16760	MSI	103 105	69123 69125	0.9999878406524658	O
16762	-	106 107	69126 69127	0.9999884366989136	O
16763	H	107 108	69127 69128	0.9999643564224243	O
16764	colon	109 113	69129 69133	0.9999845027923584	O
16766	cancers	115 121	69135 69141	0.9999865293502808	O
16768	in	123 125	69143 69145	0.999988317489624	O
16769	the	126 129	69146 69149	0.9999878406524658	O
16770	Di	130 132	69150 69152	0.9999830722808838	O
16771	Pietro	133 139	69153 69159	0.9999743700027466	O
16772	'	140 141	69160 69161	0.9999885559082031	O
16773	s	141 142	69161 69162	0.9999887943267822	O
16774	and	143 146	69163 69166	0.9999842643737793	O
16775	our	147 150	69167 69170	0.9999748468399048	O
16776	studies	151 158	69171 69178	0.9999830722808838	O
16777	,	159 160	69179 69180	0.999987006187439	O
16778	with	161 165	69181 69185	0.9999867677688599	O
16779	discrepancies	166 178	69186 69198	0.9999879598617554	O
16783	possibly	180 188	69200 69208	0.9999874830245972	O
16784	due	189 192	69209 69212	0.9999881982803345	O
16785	to	193 195	69213 69215	0.9999889135360718	O
16786	small	196 201	69216 69221	0.9999861717224121	O
16787	statistical	202 213	69222 69233	0.9999872446060181	O
16788	differences	214 225	69234 69245	0.9999878406524658	O
16789	.	226 227	69246 69247	0.999964714050293	O
16790	Discrepancies	0 12	69248 69260	0.9999876022338867	O
16794	between	14 21	69262 69269	0.9999874830245972	O
16795	results	22 29	69270 69277	0.9999878406524658	O
16796	obtained	30 38	69278 69286	0.9999887943267822	O
16797	with	39 43	69287 69291	0.9999889135360718	O
16798	different	44 53	69292 69301	0.9999878406524658	O
16799	microarray	54 63	69302 69311	0.9999885559082031	O
16802	platforms	65 74	69313 69322	0.9999847412109375	O
16803	are	75 78	69323 69326	0.999987006187439	O
16804	not	79 82	69327 69330	0.9999881982803345	O
16805	uncommon	83 91	69331 69339	0.9999879598617554	O
16806	and	92 95	69340 69343	0.999987006187439	O
16807	are	96 99	69344 69347	0.9999885559082031	O
16808	mainly	100 106	69348 69354	0.9999884366989136	O
16809	determined	107 117	69355 69365	0.99998939037323	O
16810	by	118 120	69366 69368	0.9999895095825195	O
16811	differences	121 132	69369 69380	0.9999880790710449	O
16812	in	133 135	69381 69383	0.9999895095825195	O
16813	microarray	136 145	69384 69393	0.9999890327453613	O
16816	probe	147 152	69395 69400	0.9999891519546509	O
16817	sequences	153 162	69401 69410	0.9999890327453613	O
16818	used	163 167	69411 69415	0.99998939037323	O
16819	to	168 170	69416 69418	0.9999892711639404	O
16820	detect	171 177	69419 69425	0.99998939037323	O
16821	mRNA	178 181	69426 69429	0.9999892711639404	O
16823	transcripts	183 193	69431 69441	0.9999895095825195	O
16825	[	195 196	69443 69444	0.99998939037323	O
16826	37	196 198	69444 69446	0.9999876022338867	O
16827	]	198 199	69446 69447	0.9999892711639404	O
16828	and	200 203	69448 69451	0.9999880790710449	O
16829	in	204 206	69452 69454	0.9999887943267822	O
16830	algorithms	207 217	69455 69465	0.9999856948852539	O
16831	used	218 222	69466 69470	0.9999889135360718	O
16832	for	223 226	69471 69474	0.9999892711639404	O
16833	predictor	227 235	69475 69483	0.999988317489624	O
16835	genes	237 242	69485 69490	0.999988317489624	O
16836	identification	243 257	69491 69505	0.9999891519546509	O
16837	.	258 259	69506 69507	0.9999741315841675	O
16838	Hence	0 5	69508 69513	0.9999865293502808	O
16839	,	6 7	69514 69515	0.9999891519546509	O
16840	the	8 11	69516 69519	0.9999889135360718	O
16841	parallel	12 20	69520 69528	0.9999839067459106	O
16842	between	21 28	69529 69536	0.9999884366989136	O
16843	Di	29 31	69537 69539	0.9999827146530151	O
16844	Pietro	32 38	69540 69546	0.9993255138397217	O
16845	'	39 40	69547 69548	0.9999891519546509	O
16846	s	40 41	69548 69549	0.9999891519546509	O
16847	and	42 45	69550 69553	0.999988317489624	O
16848	our	46 49	69554 69557	0.9999853372573853	O
16849	results	50 57	69558 69565	0.9999878406524658	O
16850	is	58 60	69566 69568	0.9999887943267822	O
16851	significant	61 72	69569 69580	0.9999889135360718	O
16852	given	73 78	69581 69586	0.9999879598617554	O
16853	that	79 83	69587 69591	0.9999891519546509	O
16854	data	84 88	69592 69596	0.9999871253967285	O
16855	were	89 93	69597 69601	0.9999890327453613	O
16856	generated	94 103	69602 69611	0.9999885559082031	O
16857	using	104 109	69612 69617	0.9999891519546509	O
16858	a	110 111	69618 69619	0.99998939037323	O
16859	different	112 121	69620 69629	0.9999876022338867	O
16860	set	122 125	69630 69633	0.9999889135360718	O
16861	of	126 128	69634 69636	0.9999889135360718	O
16862	samples	129 136	69637 69644	0.9999879598617554	O
16863	and	137 140	69645 69648	0.9999885559082031	O
16864	a	141 142	69649 69650	0.9999892711639404	O
16865	different	143 152	69651 69660	0.9999876022338867	O
16866	microarray	153 162	69661 69670	0.9999881982803345	O
16869	platform	164 172	69672 69680	0.999988317489624	O
16870	,	173 174	69681 69682	0.9999881982803345	O
16871	and	175 178	69683 69686	0.9999884366989136	O
16872	suggests	179 187	69687 69695	0.9999881982803345	O
16873	that	188 192	69696 69700	0.9999895095825195	O
16874	the	193 196	69701 69704	0.9999892711639404	O
16875	commonly	197 205	69705 69713	0.9999885559082031	O
16876	identified	206 216	69714 69724	0.9999891519546509	O
16877	set	217 220	69725 69728	0.9999891519546509	O
16878	of	221 223	69729 69731	0.9999892711639404	O
16879	genes	224 229	69732 69737	0.9999858140945435	O
16880	may	230 233	69738 69741	0.9999886751174927	O
16881	represent	234 243	69742 69751	0.9999890327453613	O
16882	the	244 247	69752 69755	0.9999892711639404	O
16883	most	248 252	69756 69760	0.9999891519546509	O
16884	significant	253 264	69761 69772	0.9999890327453613	O
16885	differences	265 276	69773 69784	0.9999886751174927	O
16886	between	277 284	69785 69792	0.9999890327453613	O
16887	MSI	285 287	69793 69795	0.9999890327453613	O
16889	-	288 289	69796 69797	0.9999895095825195	O
16890	H	289 290	69797 69798	0.9999865293502808	O
16891	and	291 294	69799 69802	0.999988317489624	O
16892	MSS	295 297	69803 69805	0.9999874830245972	O
16894	colon	299 303	69807 69811	0.999985933303833	O
16896	cancers	305 311	69813 69819	0.9999864101409912	O
16898	(	313 314	69821 69822	0.9999892711639404	O
16899	Additional	315 325	69823 69833	0.9999866485595703	O
16900	file	326 330	69834 69838	0.9999873638153076	O
16901	6	331 332	69839 69840	0.9999872446060181	O
16902	)	333 334	69841 69842	0.9999895095825195	O
16903	.	335 336	69843 69844	0.999976396560669	O
16904	Unfortunately	0 13	69845 69858	0.9999830722808838	O
16905	,	14 15	69859 69860	0.9999889135360718	O
16906	data	16 20	69861 69865	0.9999884366989136	O
16907	sets	21 25	69866 69870	0.9999878406524658	O
16908	from	26 30	69871 69875	0.9999878406524658	O
16909	published	31 40	69876 69885	0.999985933303833	O
16910	reports	41 48	69886 69893	0.9999876022338867	O
16911	were	49 53	69894 69898	0.9999889135360718	O
16912	not	54 57	69899 69902	0.9999889135360718	O
16913	available	58 67	69903 69912	0.9999886751174927	O
16914	for	68 71	69913 69916	0.9999892711639404	O
16915	cross	72 77	69917 69922	0.9999868869781494	O
16916	confirmation	78 90	69923 69935	0.9999891519546509	O
16917	of	91 93	69936 69938	0.99998939037323	O
16918	our	94 97	69939 69942	0.9999891519546509	O
16919	list	98 102	69943 69947	0.9999896287918091	O
16920	of	103 105	69948 69950	0.9999897480010986	O
16921	predictive	106 115	69951 69960	0.9999891519546509	O
16923	genes	117 122	69962 69967	0.9999879598617554	O
16924	on	123 125	69968 69970	0.9999889135360718	O
16925	published	126 135	69971 69980	0.9999858140945435	O
16926	microarray	136 145	69981 69990	0.999988317489624	O
16929	data	147 151	69992 69996	0.9999886751174927	O
16930	.	152 153	69997 69998	0.9999897480010986	O
16931	*	154 155	69999 70000	0.9999889135360718	O
16932	*	155 156	70000 70001	0.9999856948852539	O
16933	IGNORE	0 5	70002 70007	0.999985933303833	O
16936	LINE	7 10	70009 70012	0.9999889135360718	O
16939	*	12 13	70014 70015	0.9999889135360718	O
16940	*	13 14	70015 70016	0.9999889135360718	O
16941	*	15 16	70017 70018	0.9999889135360718	O
16942	*	16 17	70018 70019	0.9999890327453613	O
16943	IGNORE	18 23	70020 70025	0.9999876022338867	O
16946	LINE	25 28	70027 70030	0.9999890327453613	O
16949	*	30 31	70032 70033	0.9999887943267822	O
16950	*	31 32	70033 70034	0.9999887943267822	O
16951	*	33 34	70035 70036	0.9999887943267822	O
16952	*	34 35	70036 70037	0.9999886751174927	O
16953	IGNORE	36 41	70038 70043	0.9999871253967285	O
16956	LINE	43 46	70045 70048	0.9999889135360718	O
16959	*	48 49	70050 70051	0.9999886751174927	O
16960	*	49 50	70051 70052	0.9999886751174927	O
16961	Conclusion	51 60	70053 70062	0.999988317489624	O
16964	This	62 66	70064 70068	0.9999887943267822	O
16965	report	67 73	70069 70075	0.9999860525131226	O
16966	provides	74 82	70076 70084	0.9999878406524658	O
16967	the	83 86	70085 70088	0.9999887943267822	O
16968	first	87 92	70089 70094	0.9999878406524658	O
16969	study	93 98	70095 70100	0.9999856948852539	O
16970	on	99 101	70101 70103	0.9999881982803345	O
16971	microRNA	102 109	70104 70111	0.9999852180480957	O
16973	expression	111 121	70113 70123	0.9999864101409912	O
16974	in	122 124	70124 70126	0.9999876022338867	O
16975	MSI	125 127	70127 70129	0.9999862909317017	O
16977	versus	129 135	70131 70137	0.9999842643737793	O
16978	MSS	136 138	70138 70140	0.9999854564666748	O
16980	colon	140 144	70142 70146	0.9999847412109375	O
16982	cancer	146 152	70148 70154	0.9999862909317017	O
16983	.	153 154	70155 70156	0.9999685287475586	O
16984	We	0 2	70157 70159	0.9999854564666748	O
16985	identified	3 13	70160 70170	0.9999866485595703	O
16986	microRNAs	14 22	70171 70179	0.9999849796295166	O
16989	that	24 28	70181 70185	0.9999881982803345	O
16990	are	29 32	70186 70189	0.9999878406524658	O
16991	differentially	33 46	70190 70203	0.9999872446060181	O
16993	expressed	48 57	70205 70214	0.9999865293502808	O
16994	between	58 65	70215 70222	0.9999868869781494	O
16995	these	66 71	70223 70228	0.9999876022338867	O
16996	two	72 75	70229 70232	0.9999834299087524	O
16997	classes	76 83	70233 70240	0.9999868869781494	O
16998	of	84 86	70241 70243	0.9999866485595703	O
16999	tumors	87 93	70244 70250	0.9999833106994629	O
17000	;	94 95	70251 70252	0.9999880790710449	O
17001	moreover	96 103	70253 70260	0.9999868869781494	O
17003	,	105 106	70262 70263	0.9999889135360718	O
17004	the	107 110	70264 70267	0.9999889135360718	O
17005	addition	111 119	70268 70276	0.9999878406524658	O
17006	of	120 122	70277 70279	0.9999890327453613	O
17007	microRNAs	123 131	70280 70288	0.9999871253967285	O
17010	in	133 135	70290 70292	0.9999890327453613	O
17011	the	136 139	70293 70296	0.9999891519546509	O
17012	molecular	140 149	70297 70306	0.9999877214431763	O
17013	classifier	150 159	70307 70316	0.9999889135360718	O
17015	improves	161 168	70318 70325	0.9999876022338867	O
17017	the	170 173	70327 70330	0.9999887943267822	O
17018	separation	174 184	70331 70341	0.9999873638153076	O
17019	between	185 192	70342 70349	0.9999881982803345	O
17020	MSI	193 195	70350 70352	0.9999881982803345	O
17022	and	197 200	70354 70357	0.9999872446060181	O
17023	MSS	201 203	70358 70360	0.9999876022338867	O
17025	cancer	205 211	70362 70368	0.9999849796295166	O
17026	samples	212 219	70369 70376	0.9999872446060181	O
17027	,	220 221	70377 70378	0.9999881982803345	O
17028	suggesting	222 232	70379 70389	0.9999878406524658	O
17029	that	233 237	70390 70394	0.9999892711639404	O
17030	the	238 241	70395 70398	0.9999891519546509	O
17031	mRNA	242 245	70399 70402	0.9999880790710449	O
17033	/	246 247	70403 70404	0.9999887943267822	O
17034	miRNA	247 251	70404 70408	0.9999860525131226	O
17036	combination	253 264	70410 70421	0.9999876022338867	O
17037	could	265 270	70422 70427	0.9999866485595703	O
17038	provide	271 278	70428 70435	0.9999880790710449	O
17039	an	279 281	70436 70438	0.9999887943267822	O
17040	improved	282 290	70439 70447	0.9999867677688599	O
17041	stratification	291 304	70448 70461	0.9999889135360718	O
17045	of	306 308	70463 70465	0.9999879598617554	O
17046	tumor	309 314	70466 70471	0.999984622001648	O
17047	-	314 315	70471 70472	0.9999887943267822	O
17048	associated	315 325	70472 70482	0.999988317489624	O
17049	characters	326 336	70483 70493	0.9999841451644897	O
17050	.	337 338	70494 70495	0.9999610185623169	O
17051	Interestingly	0 12	70496 70508	0.9999850988388062	O
17053	,	14 15	70510 70511	0.9999867677688599	O
17054	the	16 19	70512 70515	0.999985933303833	O
17055	most	20 24	70516 70520	0.9999865293502808	O
17056	prominent	25 34	70521 70530	0.9999853372573853	O
17057	class	35 40	70531 70536	0.9999854564666748	O
17058	of	41 43	70537 70539	0.9999861717224121	O
17059	differentially	44 57	70540 70553	0.9999841451644897	O
17061	expressed	59 68	70555 70564	0.999983549118042	O
17062	miRNAs	69 74	70565 70570	0.9999806880950928	O
17065	includes	76 84	70572 70580	0.9999856948852539	O
17066	various	85 92	70581 70588	0.9999834299087524	O
17067	members	93 100	70589 70596	0.9999837875366211	O
17068	of	101 103	70597 70599	0.9999856948852539	O
17069	the	104 107	70600 70603	0.9999858140945435	O
17070	oncogenic	108 116	70604 70612	0.9999837875366211	O
17073	miR	118 120	70614 70616	0.9999842643737793	O
17075	-	121 122	70617 70618	0.9999873638153076	O
17076	17	122 124	70618 70620	0.9999804496765137	O
17077	-	124 125	70620 70621	0.9999876022338867	O
17078	92	125 127	70621 70623	0.9999814033508301	O
17079	family	128 134	70624 70630	0.9999856948852539	O
17080	,	135 136	70631 70632	0.9999866485595703	O
17081	suggesting	137 147	70633 70643	0.9999853372573853	O
17082	that	148 152	70644 70648	0.999987006187439	O
17083	these	153 158	70649 70654	0.9999858140945435	O
17084	microRNAs	159 167	70655 70663	0.9999760389328003	O
17087	have	169 173	70665 70669	0.9999858140945435	O
17088	a	174 175	70670 70671	0.9999864101409912	O
17089	role	176 180	70672 70676	0.9999839067459106	O
17090	in	181 183	70677 70679	0.9999864101409912	O
17091	bio	184 187	70680 70683	0.9999815225601196	O
17092	-	187 188	70683 70684	0.9999853372573853	O
17093	pathologic	188 197	70684 70693	0.999984860420227	O
17096	characteristics	199 214	70695 70710	0.9999842643737793	O
17097	that	215 219	70711 70715	0.9999861717224121	O
17098	distinguish	220 231	70716 70727	0.9999829530715942	O
17099	MSS	232 234	70728 70730	0.999984622001648	O
17101	versus	236 242	70732 70738	0.9999791383743286	O
17102	MSI	243 245	70739 70741	0.9999837875366211	O
17104	colon	247 251	70743 70747	0.9999804496765137	O
17106	cancers	253 259	70749 70755	0.9999825954437256	O
17108	.	261 262	70757 70758	0.9999877214431763	O
17109	*	263 264	70759 70760	0.9999854564666748	O
17110	*	264 265	70760 70761	0.9999724626541138	O
17111	IGNORE	0 5	70762 70767	0.9999861717224121	O
17114	LINE	7 10	70769 70772	0.9999887943267822	O
17117	*	12 13	70774 70775	0.9999892711639404	O
17118	*	13 14	70775 70776	0.9999891519546509	O
17119	*	15 16	70777 70778	0.9999890327453613	O
17120	*	16 17	70778 70779	0.9999891519546509	O
17121	IGNORE	18 23	70780 70785	0.9999877214431763	O
17124	LINE	25 28	70787 70790	0.9999892711639404	O
17127	*	30 31	70792 70793	0.9999889135360718	O
17128	*	31 32	70793 70794	0.9999889135360718	O
17129	*	33 34	70795 70796	0.9999889135360718	O
17130	*	34 35	70796 70797	0.9999889135360718	O
17131	IGNORE	36 41	70798 70803	0.9999874830245972	O
17134	LINE	43 46	70805 70808	0.9999891519546509	O
17137	*	48 49	70810 70811	0.9999890327453613	O
17138	*	49 50	70811 70812	0.9999890327453613	O
17139	Introduction	51 63	70813 70825	0.999987006187439	O
17140	Over	64 68	70826 70830	0.9999886751174927	O
17141	the	69 72	70831 70834	0.99998939037323	O
17142	past	73 77	70835 70839	0.9999889135360718	O
17143	ten	78 81	70840 70843	0.9999880790710449	O
17144	years	82 87	70844 70849	0.9999886751174927	O
17145	,	88 89	70850 70851	0.9999892711639404	O
17146	aberrant	90 97	70852 70859	0.9999889135360718	O
17149	DNA	99 102	70861 70864	0.9999872446060181	O
17150	methylation	103 113	70865 70875	0.9999881982803345	O
17153	has	115 118	70877 70880	0.9999891519546509	O
17154	been	119 123	70881 70885	0.9999887943267822	O
17155	recognized	124 134	70886 70896	0.9999866485595703	O
17156	as	135 137	70897 70899	0.9999889135360718	O
17157	one	138 141	70900 70903	0.9999890327453613	O
17158	of	142 144	70904 70906	0.9999884366989136	O
17159	the	145 148	70907 70910	0.9999884366989136	O
17160	most	149 153	70911 70915	0.9999880790710449	O
17161	common	154 160	70916 70922	0.9999862909317017	O
17162	molecular	161 170	70923 70932	0.9999755620956421	O
17163	abnormalities	171 183	70933 70945	0.9999876022338867	O
17165	in	185 187	70947 70949	0.9999862909317017	O
17166	breast	188 194	70950 70956	0.999981164932251	O
17167	cancer	195 201	70957 70963	0.9999871253967285	O
17168	[	202 203	70964 70965	0.99998939037323	O
17169	1	203 204	70965 70966	0.9999889135360718	O
17170	,	204 205	70966 70967	0.999988317489624	O
17171	2	205 206	70967 70968	0.9999871253967285	O
17172	]	206 207	70968 70969	0.9999890327453613	O
17173	.	208 209	70970 70971	0.999976396560669	O
17174	A	0 1	70972 70973	0.9999871253967285	O
17175	large	2 7	70974 70979	0.9999839067459106	O
17176	body	8 12	70980 70984	0.9999850988388062	O
17177	of	13 15	70985 70987	0.9999874830245972	O
17178	evidence	16 24	70988 70996	0.999982476234436	O
17179	implicates	25 34	70997 71006	0.9999878406524658	O
17182	potential	36 45	71008 71017	0.9999868869781494	O
17183	hypermethylation	46 61	71018 71033	0.9999887943267822	O
17188	of	63 65	71035 71037	0.9999885559082031	O
17189	CpG	66 68	71038 71040	0.9999885559082031	O
17192	islands	70 77	71042 71049	0.9999878406524658	O
17193	in	78 80	71050 71052	0.9999879598617554	O
17194	the	81 84	71053 71056	0.9999886751174927	O
17195	loss	85 89	71057 71061	0.9999866485595703	O
17196	of	90 92	71062 71064	0.9999885559082031	O
17197	expression	93 103	71065 71075	0.9999876022338867	O
17198	of	104 106	71076 71078	0.9999886751174927	O
17199	a	107 108	71079 71080	0.9999886751174927	O
17200	variety	109 116	71081 71088	0.9999871253967285	O
17201	of	117 119	71089 71091	0.999988317489624	O
17202	crucial	120 127	71092 71099	0.9999842643737793	O
17203	genes	128 133	71100 71105	0.9999854564666748	O
17204	.	134 135	71106 71107	0.9999665021896362	O
17205	Tumor	0 4	71108 71112	0.9999868869781494	O
17207	-	5 6	71113 71114	0.9999884366989136	O
17208	suppressor	6 15	71114 71123	0.999984860420227	O
17210	genes	17 22	71125 71130	0.9999876022338867	O
17211	with	23 27	71131 71135	0.9999868869781494	O
17212	aberrant	28 35	71136 71143	0.9999890327453613	O
17215	methylation	37 47	71145 71155	0.9999871253967285	O
17218	in	49 51	71157 71159	0.9999880790710449	O
17219	breast	52 58	71160 71166	0.999980092048645	O
17220	cancers	59 65	71167 71173	0.9999852180480957	O
17222	include	67 74	71175 71182	0.9999880790710449	O
17223	ARHI	75 78	71183 71186	0.9999864101409912	O
17226	[	80 81	71188 71189	0.99998939037323	O
17227	3	81 82	71189 71190	0.9999884366989136	O
17228	,	82 83	71190 71191	0.9999890327453613	O
17229	4	83 84	71191 71192	0.9999877214431763	O
17230	]	84 85	71192 71193	0.9999892711639404	O
17231	,	86 87	71194 71195	0.9999891519546509	O
17232	RASSF1A	88 94	71196 71202	0.9999873638153076	O
17237	[	96 97	71204 71205	0.9999891519546509	O
17238	5	97 98	71205 71206	0.9999881982803345	O
17239	]	98 99	71206 71207	0.9999891519546509	O
17240	,	100 101	71208 71209	0.9999890327453613	O
17241	HIN	102 104	71210 71212	0.999984622001648	O
17243	-	105 106	71213 71214	0.9999892711639404	O
17244	1	106 107	71214 71215	0.9999884366989136	O
17245	[	108 109	71216 71217	0.9999890327453613	O
17246	6	109 110	71217 71218	0.9999884366989136	O
17247	]	110 111	71218 71219	0.9999892711639404	O
17248	,	112 113	71220 71221	0.9999892711639404	O
17249	the	114 117	71222 71225	0.9999887943267822	O
17250	retinoic	118 125	71226 71233	0.9999873638153076	O
17253	acid	127 131	71235 71239	0.9999879598617554	O
17254	receptor	132 140	71240 71248	0.9999885559082031	O
17255	II	141 143	71249 71251	0.9999871253967285	O
17256	gene	144 148	71252 71256	0.9999890327453613	O
17257	(	149 150	71257 71258	0.9999892711639404	O
17258	RARβ2	150 154	71258 71262	0.9999866485595703	O
17262	)	156 157	71264 71265	0.9999891519546509	O
17263	[	158 159	71266 71267	0.9999890327453613	O
17264	7	159 160	71267 71268	0.9999880790710449	O
17265	]	160 161	71268 71269	0.9999892711639404	O
17266	,	162 163	71270 71271	0.9999891519546509	O
17267	hMLH1	164 168	71272 71276	0.9999866485595703	O
17270	[	170 171	71278 71279	0.9999891519546509	O
17271	8	171 172	71279 71280	0.9999881982803345	O
17272	]	172 173	71280 71281	0.9999890327453613	O
17273	,	174 175	71282 71283	0.9999892711639404	O
17274	14	176 178	71284 71286	0.999987006187439	O
17275	-	178 179	71286 71287	0.9999891519546509	O
17276	3	179 180	71287 71288	0.9999881982803345	O
17277	-	180 181	71288 71289	0.9999890327453613	O
17278	3	181 182	71289 71290	0.9999871253967285	O
17279	σ	183 184	71291 71292	0.9999876022338867	O
17280	[	185 186	71293 71294	0.9999889135360718	O
17281	9	186 187	71294 71295	0.9999881982803345	O
17282	]	187 188	71295 71296	0.9999892711639404	O
17283	,	189 190	71297 71298	0.9999891519546509	O
17284	RIZ1	191 194	71299 71302	0.9999879598617554	O
17288	[	196 197	71304 71305	0.9999891519546509	O
17289	10	197 199	71305 71307	0.9999884366989136	O
17290	]	199 200	71307 71308	0.9999892711639404	O
17291	,	201 202	71309 71310	0.9999891519546509	O
17292	p16	203 205	71311 71313	0.9999886751174927	O
17294	[	207 208	71315 71316	0.9999891519546509	O
17295	11	208 210	71316 71318	0.9999884366989136	O
17296	]	210 211	71318 71319	0.9999892711639404	O
17297	,	212 213	71320 71321	0.9999890327453613	O
17298	the	214 217	71322 71325	0.9999885559082031	O
17299	E	218 219	71326 71327	0.9999858140945435	O
17300	-	219 220	71327 71328	0.9999890327453613	O
17301	cadherin	220 227	71328 71335	0.9999866485595703	O
17305	gene	229 233	71337 71341	0.9999889135360718	O
17306	[	234 235	71342 71343	0.9999892711639404	O
17307	12	235 237	71343 71345	0.9999889135360718	O
17308	]	237 238	71345 71346	0.99998939037323	O
17309	,	239 240	71347 71348	0.9999891519546509	O
17310	PTEN	241 244	71349 71352	0.9999849796295166	O
17312	[	246 247	71354 71355	0.9999890327453613	O
17313	13	247 249	71355 71357	0.9999880790710449	O
17314	]	249 250	71357 71358	0.99998939037323	O
17315	,	251 252	71359 71360	0.9999886751174927	O
17316	and	253 256	71361 71364	0.9999886751174927	O
17317	BRCA1	257 261	71365 71369	0.9999856948852539	O
17320	[	263 264	71371 71372	0.9999891519546509	O
17321	14	264 266	71372 71374	0.9999880790710449	O
17322	]	266 267	71374 71375	0.99998939037323	O
17323	.	268 269	71376 71377	0.9999749660491943	O
17324	Methylation	0 10	71378 71388	0.9999831914901733	O
17327	in	12 14	71390 71392	0.9999819993972778	O
17328	breast	15 21	71393 71399	0.9999607801437378	O
17329	cancer	22 28	71400 71406	0.9999815225601196	O
17330	has	29 32	71407 71410	0.9999815225601196	O
17331	been	33 37	71411 71415	0.9999822378158569	O
17332	related	38 45	71416 71423	0.9999842643737793	O
17333	to	46 48	71424 71426	0.9999864101409912	O
17334	clinical	49 57	71427 71435	0.9999806880950928	O
17335	and	58 61	71436 71439	0.9999843835830688	O
17336	pathologic	62 71	71440 71449	0.9999842643737793	O
17339	characteristics	73 88	71451 71466	0.9999845027923584	O
17340	evident	89 96	71467 71474	0.9999850988388062	O
17341	at	97 99	71475 71477	0.9999868869781494	O
17342	presentation	100 112	71478 71490	0.999984860420227	O
17343	and	113 116	71491 71494	0.9999812841415405	O
17344	clinical	117 125	71495 71503	0.999970555305481	O
17345	outcomes	126 134	71504 71512	0.9999816417694092	O
17346	.	135 136	71513 71514	0.9999496936798096	O
17347	A	0 1	71515 71516	0.9999867677688599	O
17348	higher	2 8	71517 71523	0.999982476234436	O
17349	prevalence	9 19	71524 71534	0.9999843835830688	O
17350	of	20 22	71535 71537	0.999987006187439	O
17351	HIN	23 25	71538 71540	0.9999773502349854	O
17353	-	26 27	71541 71542	0.999988317489624	O
17354	1	27 28	71542 71543	0.9999867677688599	O
17355	and	29 32	71544 71547	0.9999866485595703	O
17356	RAR	33 35	71548 71550	0.9999850988388062	O
17358	β2	37 38	71552 71553	0.9999871253967285	O
17360	methylation	40 50	71555 71565	0.9999881982803345	O
17363	was	52 55	71567 71570	0.999987006187439	O
17364	found	56 61	71571 71576	0.9999871253967285	O
17365	in	62 64	71577 71579	0.9999873638153076	O
17366	the	65 68	71580 71583	0.9999862909317017	O
17367	lymph	69 73	71584 71588	0.9999862909317017	O
17369	nodes	75 80	71590 71595	0.9999850988388062	O
17370	,	81 82	71596 71597	0.9999854564666748	O
17371	bone	83 87	71598 71602	0.9999600648880005	O
17372	,	88 89	71603 71604	0.9999858140945435	O
17373	brain	90 95	71605 71610	0.9999637603759766	O
17374	,	96 97	71611 71612	0.9999853372573853	O
17375	and	98 101	71613 71616	0.9999861717224121	O
17376	lung	102 106	71617 71621	0.9999756813049316	O
17377	metastases	107 116	71622 71631	0.9999853372573853	O
17380	than	118 122	71633 71637	0.9999834299087524	O
17381	the	123 126	71638 71641	0.9999854564666748	O
17382	primary	127 134	71642 71649	0.9999825954437256	O
17383	tumor	135 140	71650 71655	0.9999849796295166	O
17384	[	141 142	71656 71657	0.9999886751174927	O
17385	15	142 144	71657 71659	0.9999845027923584	O
17386	]	144 145	71659 71660	0.9999880790710449	O
17387	.	146 147	71661 71662	0.999970555305481	O
17388	Widschwendter	0 12	71663 71675	0.9999822378158569	O
17394	and	14 17	71677 71680	0.9999864101409912	O
17395	colleagues	18 28	71681 71691	0.9999831914901733	O
17396	[	29 30	71692 71693	0.9999884366989136	O
17397	16	30 32	71693 71695	0.9999845027923584	O
17398	]	32 33	71695 71696	0.9999868869781494	O
17399	reported	34 42	71697 71705	0.9999876022338867	O
17400	that	43 47	71706 71710	0.9999887943267822	O
17401	the	48 51	71711 71714	0.9999890327453613	O
17402	methylation	52 62	71715 71725	0.9999879598617554	O
17405	of	64 66	71727 71729	0.9999890327453613	O
17406	certain	67 74	71730 71737	0.999988317489624	O
17407	genes	75 80	71738 71743	0.999985933303833	O
17408	was	81 84	71744 71747	0.9999886751174927	O
17409	associated	85 95	71748 71758	0.9999887943267822	O
17410	with	96 100	71759 71763	0.99998939037323	O
17411	hormone	101 108	71764 71771	0.999983549118042	O
17412	receptor	109 117	71772 71780	0.9999881982803345	O
17413	(	118 119	71781 71782	0.9999890327453613	O
17414	HR	120 121	71783 71784	0.999987006187439	O
17416	)	123 124	71786 71787	0.99998939037323	O
17417	status	125 131	71788 71794	0.9999891519546509	O
17418	,	132 133	71795 71796	0.9999877214431763	O
17419	in	134 136	71797 71799	0.9999891519546509	O
17420	addition	137 145	71800 71808	0.9999866485595703	O
17421	to	146 148	71809 71811	0.9999885559082031	O
17422	the	149 152	71812 71815	0.9999884366989136	O
17423	response	153 161	71816 71824	0.9999878406524658	O
17424	to	162 164	71825 71827	0.9999889135360718	O
17425	treatment	165 174	71828 71837	0.9999877214431763	O
17426	with	175 179	71838 71842	0.9999879598617554	O
17427	tamoxifen	180 188	71843 71851	0.9999866485595703	O
17431	.	190 191	71853 71854	0.999974250793457	O
17432	A	0 1	71855 71856	0.999987006187439	O
17433	high	2 6	71857 71861	0.999983549118042	O
17434	prevalence	7 17	71862 71872	0.9999834299087524	O
17435	of	18 20	71873 71875	0.9999872446060181	O
17436	PGR	21 23	71876 71878	0.9999829530715942	O
17438	,	25 26	71880 71881	0.9999881982803345	O
17439	HSD17B4	27 33	71882 71888	0.9999868869781494	O
17444	,	35 36	71890 71891	0.9999880790710449	O
17445	and	37 40	71892 71895	0.999988317489624	O
17446	CDH13	41 45	71896 71900	0.999988317489624	O
17449	methylation	47 57	71902 71912	0.9999881982803345	O
17452	has	59 62	71914 71917	0.9999873638153076	O
17453	been	63 67	71918 71922	0.9999876022338867	O
17454	associated	68 78	71923 71933	0.9999881982803345	O
17455	with	79 83	71934 71938	0.999988317489624	O
17456	HER	84 86	71939 71941	0.9999879598617554	O
17458	-	87 88	71942 71943	0.9999890327453613	O
17459	2	88 89	71943 71944	0.999987006187439	O
17460	/	89 90	71944 71945	0.9999887943267822	O
17461	neu	90 92	71945 71947	0.9999878406524658	O
17463	-	93 94	71948 71949	0.9999889135360718	O
17464	positive	94 102	71949 71957	0.9999880790710449	O
17465	breast	103 109	71958 71964	0.9999843835830688	O
17466	cancer	110 116	71965 71971	0.9999874830245972	O
17467	[	117 118	71972 71973	0.9999890327453613	O
17468	17	118 120	71973 71975	0.9999871253967285	O
17469	]	120 121	71975 71976	0.9999886751174927	O
17470	.	122 123	71977 71978	0.9999744892120361	O
17471	Methylation	0 10	71979 71989	0.9999861717224121	O
17474	-	11 12	71990 71991	0.9999884366989136	O
17475	specific	12 20	71991 71999	0.9999865293502808	O
17476	PCR	21 23	72000 72002	0.9999867677688599	O
17478	(	25 26	72004 72005	0.9999880790710449	O
17479	MSP	27 29	72006 72008	0.9999822378158569	O
17481	)	30 31	72009 72010	0.9999885559082031	O
17482	is	32 34	72011 72013	0.9999866485595703	O
17483	a	35 36	72014 72015	0.999988317489624	O
17484	sensitive	37 46	72016 72025	0.9999833106994629	O
17485	assay	47 51	72026 72030	0.9999877214431763	O
17487	used	53 57	72032 72036	0.999987006187439	O
17488	to	58 60	72037 72039	0.999988317489624	O
17489	detect	61 67	72040 72046	0.9999880790710449	O
17490	methylation	68 78	72047 72057	0.9999871253967285	O
17493	and	80 83	72059 72062	0.9999877214431763	O
17494	analyze	84 91	72063 72070	0.9999854564666748	O
17495	the	92 95	72071 72074	0.9999889135360718	O
17496	methylation	96 106	72075 72085	0.9999878406524658	O
17499	status	108 114	72087 72093	0.9999891519546509	O
17500	of	115 117	72094 72096	0.9999891519546509	O
17501	genes	118 123	72097 72102	0.9999876022338867	O
17502	of	124 126	72103 72105	0.9999891519546509	O
17503	interest	127 135	72106 72114	0.9999881982803345	O
17504	.	136 137	72115 72116	0.9999673366546631	O
17505	However	0 7	72117 72124	0.9999841451644897	O
17506	,	8 9	72125 72126	0.9999878406524658	O
17507	problems	10 18	72127 72135	0.9999858140945435	O
17508	inherent	19 27	72136 72144	0.9999850988388062	O
17509	to	28 30	72145 72147	0.9999872446060181	O
17510	this	31 35	72148 72152	0.9999880790710449	O
17511	assay	36 40	72153 72157	0.999985933303833	O
17513	(	42 43	72159 72160	0.9999885559082031	O
17514	such	44 48	72161 72165	0.9999879598617554	O
17515	as	49 51	72166 72168	0.9999885559082031	O
17516	those	52 57	72169 72174	0.9999886751174927	O
17517	caused	58 64	72175 72181	0.9999885559082031	O
17518	by	65 67	72182 72184	0.9999892711639404	O
17519	the	68 71	72185 72188	0.9999892711639404	O
17520	use	72 75	72189 72192	0.9999891519546509	O
17521	of	76 78	72193 72195	0.99998939037323	O
17522	different	79 88	72196 72205	0.9999879598617554	O
17523	primers	89 95	72206 72212	0.9999881982803345	O
17525	for	97 100	72214 72217	0.9999892711639404	O
17526	the	101 104	72218 72221	0.9999895095825195	O
17527	methylated	105 114	72222 72231	0.9999885559082031	O
17530	or	116 118	72233 72235	0.9999885559082031	O
17531	unmethylated	119 130	72236 72247	0.9999891519546509	O
17535	alleles	132 138	72249 72255	0.99998939037323	O
17538	,	140 141	72257 72258	0.9999880790710449	O
17539	the	142 145	72259 72262	0.9999889135360718	O
17540	gel	146 149	72263 72266	0.9999873638153076	O
17541	-	149 150	72266 72267	0.9999895095825195	O
17542	based	150 155	72267 72272	0.9999892711639404	O
17543	data	156 160	72273 72277	0.9999889135360718	O
17544	analysis	161 169	72278 72286	0.9999892711639404	O
17545	system	170 176	72287 72293	0.9999886751174927	O
17546	used	177 181	72294 72298	0.9999884366989136	O
17547	,	182 183	72299 72300	0.9999879598617554	O
17548	and	184 187	72301 72304	0.9999881982803345	O
17549	difficulties	188 200	72305 72317	0.9999873638153076	O
17550	in	201 203	72318 72320	0.9999889135360718	O
17551	quantitation	204 215	72321 72332	0.9999890327453613	O
17554	)	217 218	72334 72335	0.9999874830245972	O
17555	have	219 223	72336 72340	0.9999868869781494	O
17556	caused	224 230	72341 72347	0.9999867677688599	O
17557	frequent	231 239	72348 72356	0.9999852180480957	O
17558	false	240 245	72357 72362	0.9999872446060181	O
17559	-	245 246	72362 72363	0.9999890327453613	O
17560	positive	246 254	72363 72371	0.9999881982803345	O
17561	results	255 262	72372 72379	0.9999880790710449	O
17562	in	263 265	72380 72382	0.9999886751174927	O
17563	tissue	266 272	72383 72389	0.9999847412109375	O
17564	-	272 273	72389 72390	0.9999885559082031	O
17565	sample	273 279	72390 72396	0.9999872446060181	O
17566	analyses	280 288	72397 72405	0.9999872446060181	O
17567	.	289 290	72406 72407	0.9999685287475586	O
17568	A	0 1	72408 72409	0.9999879598617554	O
17569	new	2 5	72410 72413	0.9999853372573853	O
17570	technique	6 15	72414 72423	0.9999831914901733	O
17571	,	16 17	72424 72425	0.999988317489624	O
17572	pyrosequencing	18 31	72426 72439	0.9999873638153076	O
17576	,	33 34	72441 72442	0.9999877214431763	O
17577	has	35 38	72443 72446	0.9999874830245972	O
17578	been	39 43	72447 72451	0.9999880790710449	O
17579	adapted	44 51	72452 72459	0.999985933303833	O
17580	for	52 55	72460 72463	0.9999874830245972	O
17581	use	56 59	72464 72467	0.9999879598617554	O
17582	in	60 62	72468 72470	0.9999887943267822	O
17583	highly	63 69	72471 72477	0.9999885559082031	O
17584	sensitive	70 79	72478 72487	0.9999880790710449	O
17585	and	80 83	72488 72491	0.9999880790710449	O
17586	quantitative	84 96	72492 72504	0.999984622001648	O
17587	methylation	97 107	72505 72515	0.9999867677688599	O
17590	analyses	109 117	72517 72525	0.9999884366989136	O
17591	[	118 119	72526 72527	0.9999896287918091	O
17592	18	119 121	72527 72529	0.9999884366989136	O
17593	,	121 122	72529 72530	0.9999887943267822	O
17594	19	122 124	72530 72532	0.9999876022338867	O
17595	]	124 125	72532 72533	0.99998939037323	O
17596	.	126 127	72534 72535	0.9999778270721436	O
17597	Pyrosequencing	0 13	72536 72549	0.9999876022338867	O
17601	methylation	15 25	72551 72561	0.9999879598617554	O
17604	analysis	27 35	72563 72571	0.9999887943267822	O
17605	is	36 38	72572 72574	0.9999887943267822	O
17606	a	39 40	72575 72576	0.9999897480010986	O
17607	modification	41 53	72577 72589	0.9999884366989136	O
17608	of	54 56	72590 72592	0.9999891519546509	O
17609	the	57 60	72593 72596	0.9999896287918091	O
17610	combined	61 69	72597 72605	0.9999877214431763	O
17611	bisulfite	70 78	72606 72614	0.9999891519546509	O
17615	restriction	80 91	72616 72627	0.9999887943267822	O
17616	analysis	92 100	72628 72636	0.9999895095825195	O
17617	(	101 102	72637 72638	0.9999898672103882	O
17618	COBRA	103 107	72639 72643	0.9999891519546509	O
17621	)	109 110	72645 72646	0.9999899864196777	O
17622	that	111 115	72647 72651	0.9999897480010986	O
17623	compares	116 124	72652 72660	0.9999891519546509	O
17624	favorably	125 133	72661 72669	0.9999890327453613	O
17626	with	135 139	72671 72675	0.9999896287918091	O
17627	COBRA	140 144	72676 72680	0.99998939037323	O
17630	in	146 148	72682 72684	0.99998939037323	O
17631	sensitivity	149 160	72685 72696	0.9999892711639404	O
17632	,	161 162	72697 72698	0.99998939037323	O
17633	specificity	163 173	72699 72709	0.9999885559082031	O
17635	,	175 176	72711 72712	0.9999884366989136	O
17636	and	177 180	72713 72716	0.9999891519546509	O
17637	robustness	181 190	72717 72726	0.9999876022338867	O
17639	[	192 193	72728 72729	0.9999898672103882	O
17640	18	193 195	72729 72731	0.9999879598617554	O
17641	]	195 196	72731 72732	0.9999895095825195	O
17642	.	197 198	72733 72734	0.9999798536300659	O
17643	Tost	0 3	72735 72738	0.9999755620956421	O
17645	and	5 8	72740 72743	0.9999840259552002	O
17646	colleagues	9 19	72744 72754	0.9999768733978271	O
17647	also	20 24	72755 72759	0.999984860420227	O
17648	confirmed	25 34	72760 72769	0.9999867677688599	O
17649	that	35 39	72770 72774	0.9999889135360718	O
17650	the	40 43	72775 72778	0.9999886751174927	O
17651	pyrosequencing	44 57	72779 72792	0.9999878406524658	O
17655	technique	59 68	72794 72803	0.9999867677688599	O
17656	is	69 71	72804 72806	0.9999889135360718	O
17657	quantitative	72 84	72807 72819	0.9999872446060181	O
17658	,	85 86	72820 72821	0.9999877214431763	O
17659	amenable	87 94	72822 72829	0.9999881982803345	O
17662	to	96 98	72831 72833	0.9999880790710449	O
17663	the	99 102	72834 72837	0.9999884366989136	O
17664	analysis	103 111	72838 72846	0.9999878406524658	O
17665	of	112 114	72847 72849	0.9999891519546509	O
17666	bisulfite	115 123	72850 72858	0.9999880790710449	O
17670	-	124 125	72859 72860	0.9999891519546509	O
17671	treated	125 132	72860 72867	0.9999860525131226	O
17672	DNA	133 136	72868 72871	0.9999862909317017	O
17673	derived	137 144	72872 72879	0.9999891519546509	O
17674	from	145 149	72880 72884	0.9999891519546509	O
17675	paraffin	150 157	72885 72892	0.9999877214431763	O
17677	-	158 159	72893 72894	0.9999891519546509	O
17678	embedded	159 167	72894 72902	0.999987006187439	O
17679	tissue	168 174	72903 72909	0.9999867677688599	O
17680	samples	175 182	72910 72917	0.9999880790710449	O
17681	,	183 184	72918 72919	0.9999884366989136	O
17682	highly	185 191	72920 72926	0.9999881982803345	O
17683	reproducible	192 203	72927 72938	0.9999887943267822	O
17688	,	205 206	72940 72941	0.999987006187439	O
17689	and	207 210	72942 72945	0.999988317489624	O
17690	accurate	211 219	72946 72954	0.999987006187439	O
17691	[	220 221	72955 72956	0.9999890327453613	O
17692	19	221 223	72956 72958	0.999985933303833	O
17693	]	223 224	72958 72959	0.9999886751174927	O
17694	.	225 226	72960 72961	0.9999762773513794	O
17695	Bisulfite	0 8	72962 72970	0.9999865293502808	O
17699	pyrosequencing	10 23	72972 72985	0.9999885559082031	O
17703	has	25 28	72987 72990	0.9999876022338867	O
17704	been	29 33	72991 72995	0.9999881982803345	O
17705	used	34 38	72996 73000	0.9999872446060181	O
17706	in	39 41	73001 73003	0.9999885559082031	O
17707	clinical	42 50	73004 73012	0.9999862909317017	O
17708	trials	51 57	73013 73019	0.9999865293502808	O
17709	of	58 60	73020 73022	0.9999890327453613	O
17710	hypomethylating	61 75	73023 73037	0.9999884366989136	O
17716	drug	77 81	73039 73043	0.9999880790710449	O
17717	treatment	82 91	73044 73053	0.9999889135360718	O
17718	and	92 95	73054 73057	0.9999878406524658	O
17719	provides	96 104	73058 73066	0.9999873638153076	O
17720	accurate	105 113	73067 73075	0.999988317489624	O
17721	and	114 117	73076 73079	0.9999890327453613	O
17722	reliable	118 126	73080 73088	0.9999880790710449	O
17723	results	127 134	73089 73096	0.999988317489624	O
17724	[	135 136	73097 73098	0.9999895095825195	O
17725	20	136 138	73098 73100	0.9999877214431763	O
17726	]	138 139	73100 73101	0.9999891519546509	O
17727	.	140 141	73102 73103	0.9999803304672241	O
17728	To	0 2	73104 73106	0.9999858140945435	O
17729	investigate	3 14	73107 73118	0.9999850988388062	O
17730	methylation	15 25	73119 73129	0.9999847412109375	O
17733	profiles	27 35	73131 73139	0.9999855756759644	O
17734	in	36 38	73140 73142	0.9999856948852539	O
17735	breast	39 45	73143 73149	0.9999698400497437	O
17736	cancer	46 52	73150 73156	0.9999815225601196	O
17737	cells	53 58	73157 73162	0.9999468326568604	O
17738	,	59 60	73163 73164	0.9999871253967285	O
17739	we	61 63	73165 73167	0.999985933303833	O
17740	used	64 68	73168 73172	0.999987006187439	O
17741	bisulfite	69 77	73173 73181	0.9999877214431763	O
17745	pyrosequencing	79 92	73183 73196	0.9999884366989136	O
17749	to	94 96	73198 73200	0.999988317489624	O
17750	screen	97 103	73201 73207	0.9999860525131226	O
17751	12	104 106	73208 73210	0.9999849796295166	O
17752	known	107 112	73211 73216	0.9999713897705078	O
17753	tumor	113 118	73217 73222	0.9999837875366211	O
17754	-	118 119	73222 73223	0.9999878406524658	O
17755	suppressor	119 128	73223 73232	0.9999850988388062	O
17757	genes	130 135	73234 73239	0.9999861717224121	O
17758	in	136 138	73240 73242	0.9999880790710449	O
17759	90	139 141	73243 73245	0.9999741315841675	O
17760	pairs	142 147	73246 73251	0.9999719858169556	O
17761	of	148 150	73252 73254	0.9999839067459106	O
17762	breast	151 157	73255 73261	0.9999756813049316	O
17763	cancers	158 164	73262 73268	0.9999816417694092	O
17765	and	166 169	73270 73273	0.9999779462814331	O
17766	normal	170 176	73274 73280	0.9999557733535767	O
17767	tissues	177 184	73281 73288	0.9999791383743286	O
17768	.	185 186	73289 73290	0.999963641166687	O
17769	Although	0 8	73291 73299	0.9999847412109375	O
17770	all	9 12	73300 73303	0.9999876022338867	O
17771	12	13 15	73304 73306	0.9999796152114868	O
17772	genes	16 21	73307 73312	0.9999834299087524	O
17773	had	22 25	73313 73316	0.9999864101409912	O
17774	been	26 30	73317 73321	0.9999877214431763	O
17775	reported	31 39	73322 73330	0.9999847412109375	O
17776	to	40 42	73331 73333	0.9999879598617554	O
17777	exhibit	43 50	73334 73341	0.9999868869781494	O
17778	hypermethylation	51 66	73342 73357	0.9999881982803345	O
17783	in	68 70	73359 73361	0.9999889135360718	O
17784	a	71 72	73362 73363	0.9999887943267822	O
17785	fraction	73 81	73364 73372	0.9999847412109375	O
17786	of	82 84	73373 73375	0.9999867677688599	O
17787	breast	85 91	73376 73382	0.9999806880950928	O
17788	cancer	92 98	73383 73389	0.9999858140945435	O
17789	cases	99 104	73390 73395	0.9999855756759644	O
17790	,	105 106	73396 73397	0.9999865293502808	O
17791	our	107 110	73398 73401	0.9999834299087524	O
17792	assays	111 116	73402 73407	0.9999841451644897	O
17794	provided	118 126	73409 73417	0.9999876022338867	O
17795	a	127 128	73418 73419	0.9999890327453613	O
17796	comprehensive	129 142	73420 73433	0.999987006187439	O
17797	survey	143 149	73434 73440	0.9999877214431763	O
17798	of	150 152	73441 73443	0.9999884366989136	O
17799	their	153 158	73444 73449	0.999988317489624	O
17800	methylation	159 169	73450 73460	0.9999877214431763	O
17803	status	171 177	73462 73468	0.999988317489624	O
17804	and	178 181	73469 73472	0.9999880790710449	O
17805	confirmed	182 191	73473 73482	0.9999871253967285	O
17806	that	192 196	73483 73487	0.9999890327453613	O
17807	five	197 201	73488 73492	0.999983549118042	O
17808	genes	202 207	73493 73498	0.999985933303833	O
17809	could	208 213	73499 73504	0.9999862909317017	O
17810	be	214 216	73505 73507	0.9999885559082031	O
17811	useful	217 223	73508 73514	0.9999878406524658	O
17812	in	224 226	73515 73517	0.9999886751174927	O
17813	defining	227 235	73518 73526	0.9999880790710449	O
17814	a	236 237	73527 73528	0.9999890327453613	O
17815	methylation	238 248	73529 73539	0.9999874830245972	O
17818	profile	250 257	73541 73548	0.9999878406524658	O
17819	in	258 260	73549 73551	0.9999878406524658	O
17820	breast	261 267	73552 73558	0.9999812841415405	O
17821	cancer	268 274	73559 73565	0.9999852180480957	O
17822	cells	275 280	73566 73571	0.9999712705612183	O
17823	.	281 282	73572 73573	0.9999474287033081	O
17824	Our	0 3	73574 73577	0.9999827146530151	O
17825	findings	4 12	73578 73586	0.9999865293502808	O
17826	also	13 17	73587 73591	0.9999850988388062	O
17827	suggest	18 25	73592 73599	0.9999873638153076	O
17828	that	26 30	73600 73604	0.99998939037323	O
17829	two	31 34	73605 73608	0.9999864101409912	O
17830	panels	35 41	73609 73615	0.9999853372573853	O
17831	of	42 44	73616 73618	0.9999886751174927	O
17832	methylation	45 55	73619 73629	0.999987006187439	O
17835	profiles	57 65	73631 73639	0.9999880790710449	O
17836	correlated	66 76	73640 73650	0.9999877214431763	O
17837	,	77 78	73651 73652	0.9999885559082031	O
17838	either	79 85	73653 73659	0.9999884366989136	O
17839	positively	86 96	73660 73670	0.9999886751174927	O
17840	or	97 99	73671 73673	0.9999872446060181	O
17841	negatively	100 110	73674 73684	0.9999852180480957	O
17842	,	111 112	73685 73686	0.9999871253967285	O
17843	to	113 115	73687 73689	0.999988317489624	O
17844	HR	116 117	73690 73691	0.9999884366989136	O
17846	status	119 125	73693 73699	0.9999892711639404	O
17847	.	126 127	73700 73701	0.9999886751174927	O
17848	*	128 129	73702 73703	0.9999884366989136	O
17849	*	129 130	73703 73704	0.9999836683273315	O
17850	IGNORE	0 5	73705 73710	0.9999862909317017	O
17853	LINE	7 10	73712 73715	0.9999890327453613	O
17856	*	12 13	73717 73718	0.9999891519546509	O
17857	*	13 14	73718 73719	0.9999891519546509	O
17858	*	15 16	73720 73721	0.9999890327453613	O
17859	*	16 17	73721 73722	0.9999891519546509	O
17860	IGNORE	18 23	73723 73728	0.9999879598617554	O
17863	LINE	25 28	73730 73733	0.99998939037323	O
17866	*	30 31	73735 73736	0.9999889135360718	O
17867	*	31 32	73736 73737	0.9999889135360718	O
17868	*	33 34	73738 73739	0.9999887943267822	O
17869	*	34 35	73739 73740	0.9999887943267822	O
17870	IGNORE	36 41	73741 73746	0.9999876022338867	O
17873	LINE	43 46	73748 73751	0.9999891519546509	O
17876	*	48 49	73753 73754	0.9999890327453613	O
17877	*	49 50	73754 73755	0.9999887943267822	O
17878	Statistical	51 62	73756 73767	0.999988317489624	O
17879	methods	63 70	73768 73775	0.999988317489624	O
17880	and	71 74	73776 73779	0.9999884366989136	O
17881	analysis	75 83	73780 73788	0.999988317489624	O
17882	In	84 86	73789 73791	0.999987006187439	O
17883	the	87 90	73792 73795	0.9999873638153076	O
17884	studied	91 98	73796 73803	0.999983549118042	O
17885	cohort	99 104	73804 73809	0.9999886751174927	O
17888	,	106 107	73811 73812	0.9999878406524658	O
17889	adjacent	108 116	73813 73821	0.9999834299087524	O
17890	normal	117 123	73822 73828	0.9999825954437256	O
17891	breast	124 130	73829 73835	0.9999814033508301	O
17892	tissue	131 137	73836 73842	0.9999862909317017	O
17893	was	138 141	73843 73846	0.9999885559082031	O
17894	taken	142 147	73847 73852	0.9999872446060181	O
17895	from	148 152	73853 73857	0.9999885559082031	O
17896	each	153 157	73858 73862	0.9999884366989136	O
17897	of	158 160	73863 73865	0.9999884366989136	O
17898	90	161 163	73866 73868	0.999975323677063	O
17899	patients	164 172	73869 73877	0.9999814033508301	O
17900	during	173 179	73878 73884	0.9999866485595703	O
17901	surgery	180 187	73885 73892	0.9999842643737793	O
17902	.	188 189	73893 73894	0.9999635219573975	O
17903	Taking	0 6	73895 73901	0.9999874830245972	O
17904	advantage	7 16	73902 73911	0.9999864101409912	O
17905	of	17 19	73912 73914	0.9999887943267822	O
17906	paired	20 26	73915 73921	0.9999798536300659	O
17907	normal	27 33	73922 73928	0.9999815225601196	O
17908	/	33 34	73928 73929	0.999984622001648	O
17909	tumor	34 39	73929 73934	0.9999792575836182	O
17910	samples	40 47	73935 73942	0.9999877214431763	O
17911	in	48 50	73943 73945	0.9999885559082031	O
17912	this	51 55	73946 73950	0.9999886751174927	O
17913	study	56 61	73951 73956	0.9999876022338867	O
17914	,	62 63	73957 73958	0.9999872446060181	O
17915	we	64 66	73959 73961	0.9999861717224121	O
17916	chose	67 72	73962 73967	0.9999881982803345	O
17917	the	73 76	73968 73971	0.9999892711639404	O
17918	value	77 82	73972 73977	0.9999884366989136	O
17919	of	83 85	73978 73980	0.9999892711639404	O
17920	normal	86 92	73981 73987	0.9999853372573853	O
17921	samples	93 100	73988 73995	0.9999884366989136	O
17922	as	101 103	73996 73998	0.9999889135360718	O
17923	the	104 107	73999 74002	0.9999887943267822	O
17924	reference	108 117	74003 74012	0.9999867677688599	O
17925	.	118 119	74013 74014	0.9999737739562988	O
17926	If	0 2	74015 74017	0.9999855756759644	O
17927	using	3 8	74018 74023	0.999988317489624	O
17928	the	9 12	74024 74027	0.9999895095825195	O
17929	sample	13 19	74028 74034	0.9999877214431763	O
17930	mean	20 24	74035 74039	0.9999889135360718	O
17931	plus	25 29	74040 74044	0.9999890327453613	O
17932	two	30 33	74045 74048	0.9999886751174927	O
17933	times	34 39	74049 74054	0.9999891519546509	O
17934	the	40 43	74055 74058	0.9999896287918091	O
17935	standard	44 52	74059 74067	0.9999891519546509	O
17936	deviation	53 61	74068 74076	0.9999891519546509	O
17938	of	63 65	74078 74080	0.9999891519546509	O
17939	the	66 69	74081 74084	0.9999895095825195	O
17940	pooled	70 75	74085 74090	0.9999877214431763	O
17942	normal	77 83	74092 74098	0.9999868869781494	O
17943	samples	84 91	74099 74106	0.9999884366989136	O
17944	(	92 93	74107 74108	0.9999897480010986	O
17945	and	94 97	74109 74112	0.9999887943267822	O
17946	a	98 99	74113 74114	0.9999896287918091	O
17947	minimum	100 107	74115 74122	0.9999892711639404	O
17948	of	108 110	74123 74125	0.9999896287918091	O
17949	10	111 113	74126 74128	0.9999884366989136	O
17950	%	114 115	74129 74130	0.9999896287918091	O
17951	methylation	116 126	74131 74141	0.9999890327453613	O
17954	)	128 129	74143 74144	0.9999898672103882	O
17955	as	130 132	74145 74147	0.9999896287918091	O
17956	a	133 134	74148 74149	0.9999897480010986	O
17957	cut	135 138	74150 74153	0.9999896287918091	O
17958	-	138 139	74153 74154	0.9999897480010986	O
17959	off	139 142	74154 74157	0.99998939037323	O
17960	point	143 148	74158 74163	0.9999896287918091	O
17961	,	149 150	74164 74165	0.9999889135360718	O
17962	there	151 156	74166 74171	0.9999895095825195	O
17963	is	157 159	74172 74174	0.9999895095825195	O
17964	>	160 161	74175 74176	0.9999892711639404	O
17965	97	162 164	74177 74179	0.9999881982803345	O
17966	%	165 166	74180 74181	0.9999896287918091	O
17967	probability	167 178	74182 74193	0.9999892711639404	O
17968	that	179 183	74194 74198	0.9999895095825195	O
17969	the	184 187	74199 74202	0.9999897480010986	O
17970	methylation	188 198	74203 74213	0.9999890327453613	O
17973	level	200 205	74215 74220	0.9999896287918091	O
17974	for	206 209	74221 74224	0.99998939037323	O
17975	a	210 211	74225 74226	0.9999896287918091	O
17976	normal	212 218	74227 74233	0.9999873638153076	O
17977	tissue	219 225	74234 74240	0.9999867677688599	O
17978	will	226 230	74241 74245	0.9999880790710449	O
17979	be	231 233	74246 74248	0.9999895095825195	O
17980	lower	234 239	74249 74254	0.9999871253967285	O
17981	than	240 244	74255 74259	0.9999896287918091	O
17982	the	245 248	74260 74263	0.9999896287918091	O
17983	cut	249 252	74264 74267	0.9999895095825195	O
17984	-	252 253	74267 74268	0.9999897480010986	O
17985	off	253 256	74268 74271	0.9999890327453613	O
17986	point	257 262	74272 74277	0.99998939037323	O
17987	.	263 264	74278 74279	0.9999756813049316	O
17988	It	0 2	74280 74282	0.9999861717224121	O
17989	is	3 5	74283 74285	0.999984860420227	O
17990	reasonable	6 16	74286 74296	0.9999825954437256	O
17991	to	17 19	74297 74299	0.9999871253967285	O
17992	assume	20 26	74300 74306	0.999980092048645	O
17993	that	27 31	74307 74311	0.9999886751174927	O
17994	a	32 33	74312 74313	0.9999887943267822	O
17995	value	34 39	74314 74319	0.9999852180480957	O
17996	larger	40 46	74320 74326	0.9999884366989136	O
17997	than	47 51	74327 74331	0.9999891519546509	O
17998	the	52 55	74332 74335	0.9999890327453613	O
17999	cut	56 59	74336 74339	0.9999884366989136	O
18000	-	59 60	74339 74340	0.9999891519546509	O
18001	off	60 63	74340 74343	0.9999881982803345	O
18002	point	64 69	74344 74349	0.9999879598617554	O
18003	is	70 72	74350 74352	0.9999876022338867	O
18004	likely	73 79	74353 74359	0.9999885559082031	O
18005	to	80 82	74360 74362	0.999988317489624	O
18006	be	83 85	74363 74365	0.9999885559082031	O
18007	abnormal	86 94	74366 74374	0.9999864101409912	O
18008	(	95 96	74375 74376	0.9999886751174927	O
18009	or	97 99	74377 74379	0.9999871253967285	O
18010	positive	100 108	74380 74388	0.9999855756759644	O
18011	)	109 110	74389 74390	0.9999885559082031	O
18012	.	111 112	74391 74392	0.9999637603759766	O
18013	Panels	0 5	74393 74398	0.999987006187439	O
18015	of	7 9	74400 74402	0.9999890327453613	O
18016	genes	10 15	74403 74408	0.9999872446060181	O
18017	,	16 17	74409 74410	0.9999887943267822	O
18018	that	18 22	74411 74415	0.9999887943267822	O
18019	is	23 25	74416 74418	0.9999895095825195	O
18020	to	26 28	74419 74421	0.9999891519546509	O
18021	say	29 32	74422 74425	0.9999873638153076	O
18022	,	33 34	74426 74427	0.9999890327453613	O
18023	HIN	35 37	74428 74430	0.9999854564666748	O
18025	-	38 39	74431 74432	0.9999897480010986	O
18026	1	39 40	74432 74433	0.9999887943267822	O
18027	/	40 41	74433 74434	0.9999897480010986	O
18028	RASSF1A	41 47	74434 74440	0.9999877214431763	O
18033	and	49 52	74442 74445	0.9999892711639404	O
18034	RIL	53 55	74446 74448	0.9999866485595703	O
18036	/	56 57	74449 74450	0.9999896287918091	O
18037	CDH13	57 61	74450 74454	0.9999892711639404	O
18040	were	63 67	74456 74460	0.9999895095825195	O
18041	considered	68 78	74461 74471	0.9999895095825195	O
18042	positive	79 87	74472 74480	0.9999889135360718	O
18043	if	88 90	74481 74483	0.9999885559082031	O
18044	both	91 95	74484 74488	0.999988317489624	O
18045	markers	96 103	74489 74496	0.9999886751174927	O
18046	in	104 106	74497 74499	0.9999896287918091	O
18047	each	107 111	74500 74504	0.9999895095825195	O
18048	panel	112 117	74505 74510	0.999988317489624	O
18049	were	118 122	74511 74515	0.9999891519546509	O
18050	positive	123 131	74516 74524	0.9999880790710449	O
18051	.	132 133	74525 74526	0.9999736547470093	O
18052	Descriptive	0 10	74527 74537	0.9999827146530151	O
18055	analyses	12 20	74539 74547	0.9999794960021973	O
18056	were	21 25	74548 74552	0.9999827146530151	O
18057	performed	26 35	74553 74562	0.9999839067459106	O
18058	first	36 41	74563 74568	0.9999780654907227	O
18059	for	42 45	74569 74572	0.9999852180480957	O
18060	exploratory	46 56	74573 74583	0.9999868869781494	O
18064	purposes	58 66	74585 74593	0.9999841451644897	O
18065	.	67 68	74594 74595	0.9999490976333618	O
18066	Pair	0 3	74596 74599	0.9999878406524658	O
18068	-	4 5	74600 74601	0.9999889135360718	O
18069	wise	5 9	74601 74605	0.9999876022338867	O
18070	scatter	10 16	74606 74612	0.9999889135360718	O
18073	plots	18 23	74614 74619	0.9999810457229614	O
18074	are	24 27	74620 74623	0.9999853372573853	O
18075	presented	28 37	74624 74633	0.9999849796295166	O
18076	to	38 40	74634 74636	0.9999876022338867	O
18077	show	41 45	74637 74641	0.9999865293502808	O
18078	the	46 49	74642 74645	0.9999885559082031	O
18079	correlations	50 61	74646 74657	0.9999868869781494	O
18081	among	63 68	74659 74664	0.999988317489624	O
18082	the	69 72	74665 74668	0.999988317489624	O
18083	genes	73 78	74669 74674	0.9999877214431763	O
18084	methylated	79 88	74675 74684	0.9999885559082031	O
18087	.	90 91	74686 74687	0.9999719858169556	O
18088	Heat	0 4	74688 74692	0.9999827146530151	O
18089	maps	5 9	74693 74697	0.9999837875366211	O
18090	were	10 14	74698 74702	0.9999868869781494	O
18091	plotted	15 21	74703 74709	0.9999843835830688	O
18093	to	23 25	74711 74713	0.9999885559082031	O
18094	show	26 30	74714 74718	0.9999879598617554	O
18095	levels	31 37	74719 74725	0.9999874830245972	O
18096	of	38 40	74726 74728	0.9999886751174927	O
18097	gene	41 45	74729 74733	0.999988317489624	O
18098	expression	46 56	74734 74744	0.999988317489624	O
18099	or	57 59	74745 74747	0.9999880790710449	O
18100	methylation	60 70	74748 74758	0.9999876022338867	O
18103	using	72 77	74760 74765	0.9999891519546509	O
18104	hierarchical	78 89	74766 74777	0.9999890327453613	O
18108	clustering	91 100	74779 74788	0.9999884366989136	O
18110	to	102 104	74790 74792	0.9999889135360718	O
18111	visually	105 113	74793 74801	0.9999843835830688	O
18112	represent	114 123	74802 74811	0.9999878406524658	O
18113	the	124 127	74812 74815	0.9999891519546509	O
18114	association	128 139	74816 74827	0.9999877214431763	O
18115	of	140 142	74828 74830	0.9999891519546509	O
18116	different	143 152	74831 74840	0.9999876022338867	O
18117	genes	153 158	74841 74846	0.9999862909317017	O
18118	or	159 161	74847 74849	0.9999862909317017	O
18119	samples	162 169	74850 74857	0.9999839067459106	O
18120	by	170 172	74858 74860	0.9999872446060181	O
18121	histopathologic	173 187	74861 74875	0.9999872446060181	O
18126	tumor	189 194	74877 74882	0.9999822378158569	O
18127	characteristics	195 210	74883 74898	0.9999855756759644	O
18128	(	211 212	74899 74900	0.9999885559082031	O
18129	ERs	213 215	74901 74903	0.9999816417694092	O
18131	,	217 218	74905 74906	0.9999868869781494	O
18132	PRs	219 221	74907 74909	0.9999840259552002	O
18134	,	223 224	74911 74912	0.9999874830245972	O
18135	and	225 228	74913 74916	0.9999885559082031	O
18136	HER	229 231	74917 74919	0.9999874830245972	O
18138	-	232 233	74920 74921	0.9999891519546509	O
18139	2	233 234	74921 74922	0.9999858140945435	O
18140	/	234 235	74922 74923	0.9999887943267822	O
18141	neu	235 237	74923 74925	0.9999878406524658	O
18143	)	239 240	74927 74928	0.9999885559082031	O
18144	.	241 242	74929 74930	0.9999521970748901	O
18145	Chi	0 3	74931 74934	0.9999860525131226	O
18146	-	3 4	74934 74935	0.9999878406524658	O
18147	square	4 10	74935 74941	0.9999849796295166	O
18148	or	11 13	74942 74944	0.999985933303833	O
18149	Fisher	14 20	74945 74951	0.9999830722808838	O
18150	'	21 22	74952 74953	0.999988317489624	O
18151	s	22 23	74953 74954	0.9999885559082031	O
18152	exact	24 29	74955 74960	0.9999854564666748	O
18153	test	30 34	74961 74965	0.9999866485595703	O
18154	were	35 39	74966 74970	0.9999852180480957	O
18155	used	40 44	74971 74975	0.9999855756759644	O
18156	to	45 47	74976 74978	0.999987006187439	O
18157	assess	48 54	74979 74985	0.9999868869781494	O
18158	the	55 58	74986 74989	0.9999879598617554	O
18159	dependence	59 69	74990 75000	0.9999815225601196	O
18160	between	70 77	75001 75008	0.9999879598617554	O
18161	two	78 81	75009 75012	0.999984622001648	O
18162	categorical	82 92	75013 75023	0.9999879598617554	O
18165	variables	94 103	75025 75034	0.999985933303833	O
18166	.	104 105	75035 75036	0.9999567270278931	O
18167	Pearson	0 7	75037 75044	0.9999716281890869	O
18168	'	8 9	75045 75046	0.9999861717224121	O
18169	s	9 10	75046 75047	0.9999864101409912	O
18170	correlation	11 22	75048 75059	0.9999825954437256	O
18171	coefficient	23 34	75060 75071	0.9999847412109375	O
18172	was	35 38	75072 75075	0.9999822378158569	O
18173	used	39 43	75076 75080	0.9999818801879883	O
18174	to	44 46	75081 75083	0.9999845027923584	O
18175	assess	47 53	75084 75090	0.999983549118042	O
18176	the	54 57	75091 75094	0.9999860525131226	O
18177	relationship	58 70	75095 75107	0.9999831914901733	O
18178	between	71 78	75108 75115	0.9999860525131226	O
18179	two	79 82	75116 75119	0.9999794960021973	O
18180	continuous	83 93	75120 75130	0.9999744892120361	O
18181	variables	94 103	75131 75140	0.999981164932251	O
18182	.	104 105	75141 75142	0.9999297857284546	O
18183	The	0 3	75143 75146	0.9999861717224121	O
18184	Wilcoxon	4 11	75147 75154	0.9999781847000122	O
18186	rank	13 17	75156 75160	0.9999860525131226	O
18187	-	17 18	75160 75161	0.9999874830245972	O
18188	sum	18 21	75161 75164	0.9999864101409912	O
18189	test	22 26	75165 75169	0.9999847412109375	O
18190	was	27 30	75170 75173	0.9999845027923584	O
18191	used	31 35	75174 75178	0.9999847412109375	O
18192	to	36 38	75179 75181	0.9999866485595703	O
18193	compare	39 46	75182 75189	0.9999864101409912	O
18194	either	47 53	75190 75196	0.9999866485595703	O
18195	continuous	54 64	75197 75207	0.9999865293502808	O
18196	or	65 67	75208 75210	0.9999866485595703	O
18197	categorical	68 78	75211 75221	0.9999873638153076	O
18200	variables	80 89	75223 75232	0.999984860420227	O
18201	between	90 97	75233 75240	0.999987006187439	O
18202	two	98 101	75241 75244	0.9999833106994629	O
18203	groups	102 108	75245 75251	0.9999860525131226	O
18204	.	109 110	75252 75253	0.9999469518661499	O
18205	Analysis	0 8	75254 75262	0.9999867677688599	O
18206	of	9 11	75263 75265	0.9999876022338867	O
18207	variance	12 20	75266 75274	0.9999850988388062	O
18208	(	21 22	75275 75276	0.9999868869781494	O
18209	ANOVA	23 27	75277 75281	0.999984860420227	O
18212	)	29 30	75283 75284	0.9999865293502808	O
18213	was	31 34	75285 75288	0.9999854564666748	O
18214	applied	35 42	75289 75296	0.9999841451644897	O
18215	to	43 45	75297 75299	0.9999871253967285	O
18216	compare	46 53	75300 75307	0.9999850988388062	O
18217	the	54 57	75308 75311	0.9999879598617554	O
18218	values	58 64	75312 75318	0.9999849796295166	O
18219	of	65 67	75319 75321	0.9999879598617554	O
18220	gene	68 72	75322 75326	0.9999871253967285	O
18221	methylation	73 83	75327 75337	0.9999880790710449	O
18224	with	85 89	75339 75343	0.9999818801879883	O
18225	tumor	90 95	75344 75349	0.9999808073043823	O
18226	characteristics	96 111	75350 75365	0.9999830722808838	O
18227	.	112 113	75366 75367	0.9999644756317139	O
18228	Multivariate	0 11	75368 75379	0.999985933303833	O
18231	logistic	13 20	75381 75388	0.9999852180480957	O
18233	regression	22 31	75390 75399	0.9999868869781494	O
18235	was	33 36	75401 75404	0.9999855756759644	O
18236	used	37 41	75405 75409	0.9999866485595703	O
18237	to	42 44	75410 75412	0.9999880790710449	O
18238	assess	45 51	75413 75419	0.9999878406524658	O
18239	the	52 55	75420 75423	0.9999889135360718	O
18240	ability	56 63	75424 75431	0.9999885559082031	O
18241	of	64 66	75432 75434	0.9999890327453613	O
18242	various	67 74	75435 75442	0.9999874830245972	O
18243	levels	75 81	75443 75449	0.9999881982803345	O
18244	of	82 84	75450 75452	0.9999890327453613	O
18245	gene	85 89	75453 75457	0.9999879598617554	O
18246	methylation	90 100	75458 75468	0.9999884366989136	O
18249	to	102 104	75470 75472	0.9999881982803345	O
18250	predict	105 112	75473 75480	0.9999871253967285	O
18251	the	113 116	75481 75484	0.9999881982803345	O
18252	ER	117 119	75485 75487	0.9999855756759644	O
18253	,	120 121	75488 75489	0.9999874830245972	O
18254	PR	122 124	75490 75492	0.9999873638153076	O
18255	,	125 126	75493 75494	0.9999877214431763	O
18256	HR	127 128	75495 75496	0.9999874830245972	O
18258	,	130 131	75498 75499	0.9999876022338867	O
18259	or	132 134	75500 75502	0.9999879598617554	O
18260	HER	135 137	75503 75505	0.9999880790710449	O
18262	-	138 139	75506 75507	0.9999891519546509	O
18263	2	139 140	75507 75508	0.9999866485595703	O
18264	/	140 141	75508 75509	0.9999890327453613	O
18265	neu	141 143	75509 75511	0.9999881982803345	O
18267	status	145 151	75513 75519	0.9999884366989136	O
18268	.	152 153	75520 75521	0.9999637603759766	O
18269	All	0 3	75522 75525	0.9999862909317017	O
18270	reported	4 12	75526 75534	0.9999842643737793	O
18271	p	13 14	75535 75536	0.9999858140945435	O
18272	values	15 21	75537 75543	0.9999866485595703	O
18273	are	22 25	75544 75547	0.9999862909317017	O
18274	two	26 29	75548 75551	0.999985933303833	O
18275	-	29 30	75551 75552	0.9999877214431763	O
18276	sided	30 35	75552 75557	0.999987006187439	O
18277	and	36 39	75558 75561	0.9999871253967285	O
18278	considered	40 50	75562 75572	0.9999876022338867	O
18279	statistically	51 63	75573 75585	0.9999878406524658	O
18281	significant	65 76	75587 75598	0.9999879598617554	O
18282	if	77 79	75599 75601	0.999987006187439	O
18283	p	80 81	75602 75603	0.9999884366989136	O
18284	<	82 83	75604 75605	0.999988317489624	O
18285	0	84 85	75606 75607	0.999988317489624	O
18286	.	85 86	75607 75608	0.9999880790710449	O
18287	05	86 88	75608 75610	0.9999876022338867	O
18288	.	89 90	75611 75612	0.9999651908874512	O
18289	Analyses	0 7	75613 75620	0.9999839067459106	O
18292	were	9 13	75622 75626	0.9999876022338867	O
18293	performed	14 23	75627 75636	0.9999871253967285	O
18294	using	24 29	75637 75642	0.9999886751174927	O
18295	S	30 31	75643 75644	0.9999880790710449	O
18296	-	31 32	75644 75645	0.9999892711639404	O
18297	PLUS	32 35	75645 75648	0.999988317489624	O
18300	2000	37 41	75650 75654	0.9999880790710449	O
18301	software	42 50	75655 75663	0.9999833106994629	O
18302	(	51 52	75664 75665	0.9999890327453613	O
18303	Insightful	53 62	75666 75675	0.99998939037323	O
18306	Corp	64 68	75677 75681	0.9999871253967285	O
18307	.	68 69	75681 75682	0.9999884366989136	O
18308	,	70 71	75683 75684	0.9999881982803345	O
18309	Seattle	72 79	75685 75692	0.9999754428863525	O
18310	,	80 81	75693 75694	0.9999877214431763	O
18311	WA	82 84	75695 75697	0.9999676942825317	O
18312	,	85 86	75698 75699	0.9999885559082031	O
18313	USA	87 90	75700 75703	0.9999802112579346	O
18314	)	91 92	75704 75705	0.9999891519546509	O
18315	.	93 94	75706 75707	0.9999891519546509	O
18316	*	95 96	75708 75709	0.9999879598617554	O
18317	*	96 97	75709 75710	0.9999830722808838	O
18318	IGNORE	0 5	75711 75716	0.9999867677688599	O
18321	LINE	7 10	75718 75721	0.9999891519546509	O
18324	*	12 13	75723 75724	0.9999895095825195	O
18325	*	13 14	75724 75725	0.9999892711639404	O
18326	*	15 16	75726 75727	0.9999892711639404	O
18327	*	16 17	75727 75728	0.99998939037323	O
18328	IGNORE	18 23	75729 75734	0.9999880790710449	O
18331	LINE	25 28	75736 75739	0.99998939037323	O
18334	*	30 31	75741 75742	0.9999890327453613	O
18335	*	31 32	75742 75743	0.9999890327453613	O
18336	*	33 34	75744 75745	0.9999890327453613	O
18337	*	34 35	75745 75746	0.9999889135360718	O
18338	IGNORE	36 41	75747 75752	0.9999877214431763	O
18341	LINE	43 46	75754 75757	0.9999892711639404	O
18344	*	48 49	75759 75760	0.9999891519546509	O
18345	*	49 50	75760 75761	0.9999890327453613	O
18346	Discussion	51 60	75762 75771	0.9999889135360718	O
18349	Although	62 70	75773 75781	0.9999874830245972	O
18350	a	71 72	75782 75783	0.9999890327453613	O
18351	large	73 78	75784 75789	0.9999876022338867	O
18352	body	79 83	75790 75794	0.9999886751174927	O
18353	of	84 86	75795 75797	0.9999891519546509	O
18354	evidence	87 95	75798 75806	0.9999876022338867	O
18355	has	96 99	75807 75810	0.999988317489624	O
18356	demonstrated	100 112	75811 75823	0.9999880790710449	O
18357	that	113 117	75824 75828	0.9999895095825195	O
18358	aberrant	118 125	75829 75836	0.9999896287918091	O
18361	DNA	127 130	75838 75841	0.9999881982803345	O
18362	methylation	131 141	75842 75852	0.9999889135360718	O
18365	has	143 146	75854 75857	0.9999890327453613	O
18366	an	147 149	75858 75860	0.9999891519546509	O
18367	important	150 159	75861 75870	0.9999891519546509	O
18368	role	160 164	75871 75875	0.9999881982803345	O
18369	in	165 167	75876 75878	0.9999885559082031	O
18370	breast	168 174	75879 75885	0.9999810457229614	O
18371	carcinogenesis	175 188	75886 75899	0.9999872446060181	O
18375	,	190 191	75901 75902	0.9999873638153076	O
18376	variation	192 201	75903 75912	0.9999879598617554	O
18377	in	202 204	75913 75915	0.9999892711639404	O
18378	the	205 208	75916 75919	0.9999890327453613	O
18379	data	209 213	75920 75924	0.9999855756759644	O
18380	is	214 216	75925 75927	0.9999887943267822	O
18381	still	217 222	75928 75933	0.9999855756759644	O
18382	a	223 224	75934 75935	0.9999887943267822	O
18383	problem	225 232	75936 75943	0.9999873638153076	O
18384	.	233 234	75944 75945	0.9999685287475586	O
18385	In	0 2	75946 75948	0.9999855756759644	O
18386	this	3 7	75949 75953	0.999985933303833	O
18387	study	8 13	75954 75959	0.9999849796295166	O
18388	,	14 15	75960 75961	0.9999855756759644	O
18389	we	16 18	75962 75964	0.9999817609786987	O
18390	used	19 23	75965 75969	0.9999850988388062	O
18391	bisulfite	24 32	75970 75978	0.9999867677688599	O
18395	pyrosequencing	34 47	75980 75993	0.9999877214431763	O
18399	to	49 51	75995 75997	0.9999879598617554	O
18400	quantitate	52 61	75998 76007	0.9999881982803345	O
18403	the	63 66	76009 76012	0.9999874830245972	O
18404	methylation	67 77	76013 76023	0.9999861717224121	O
18407	of	79 81	76025 76027	0.9999877214431763	O
18408	12	82 84	76028 76030	0.9999836683273315	O
18409	known	85 90	76031 76036	0.9999692440032959	O
18410	tumor	91 96	76037 76042	0.9999852180480957	O
18411	-	96 97	76042 76043	0.9999877214431763	O
18412	suppressor	97 106	76043 76052	0.9999860525131226	O
18414	genes	108 113	76054 76059	0.9999864101409912	O
18415	in	114 116	76060 76062	0.9999856948852539	O
18416	breast	117 123	76063 76069	0.9999794960021973	O
18417	cancers	124 130	76070 76076	0.9999854564666748	O
18419	.	132 133	76078 76079	0.9999635219573975	O
18420	To	0 2	76080 76082	0.9999827146530151	O
18421	avoid	3 8	76083 76088	0.9999825954437256	O
18422	contamination	9 22	76089 76102	0.9999806880950928	O
18423	with	23 27	76103 76107	0.9999822378158569	O
18424	normal	28 34	76108 76114	0.999980092048645	O
18425	tissues	35 42	76115 76122	0.9999819993972778	O
18426	,	43 44	76123 76124	0.9999861717224121	O
18427	we	45 47	76125 76127	0.9999821186065674	O
18428	isolated	48 56	76128 76136	0.9999814033508301	O
18429	breast	57 63	76137 76143	0.9999758005142212	O
18430	cancer	64 70	76144 76150	0.9999839067459106	O
18431	cells	71 76	76151 76156	0.9999842643737793	O
18432	by	77 79	76157 76159	0.9999878406524658	O
18433	microdissection	80 94	76160 76174	0.9999867677688599	O
18436	and	96 99	76176 76179	0.9999864101409912	O
18437	compared	100 108	76180 76188	0.9999867677688599	O
18438	levels	109 115	76189 76195	0.9999874830245972	O
18439	of	116 118	76196 76198	0.9999881982803345	O
18440	methylation	119 129	76199 76209	0.9999868869781494	O
18443	with	131 135	76211 76215	0.9999860525131226	O
18444	those	136 141	76216 76221	0.999985933303833	O
18445	in	142 144	76222 76224	0.9999866485595703	O
18446	normal	145 151	76225 76231	0.9999810457229614	O
18447	breast	152 158	76232 76238	0.999983549118042	O
18448	epithelial	159 168	76239 76248	0.9999876022338867	O
18452	cells	170 175	76250 76255	0.9999862909317017	O
18453	from	176 180	76256 76260	0.9999873638153076	O
18454	the	181 184	76261 76264	0.9999876022338867	O
18455	same	185 189	76265 76269	0.9999816417694092	O
18456	patients	190 198	76270 76278	0.9999791383743286	O
18457	.	199 200	76279 76280	0.999956488609314	O
18458	Bisulfite	0 8	76281 76289	0.9999796152114868	O
18462	pyrosequencing	10 23	76291 76304	0.9999829530715942	O
18466	provided	25 33	76306 76314	0.9999725818634033	O
18467	sensitive	34 43	76315 76324	0.9999803304672241	O
18468	and	44 47	76325 76328	0.9999793767929077	O
18469	reproducible	48 59	76329 76340	0.9999834299087524	O
18474	measurements	61 73	76342 76354	0.9999727010726929	O
18475	.	74 75	76355 76356	0.9999107122421265	O
18476	The	0 3	76357 76360	0.9999830722808838	O
18477	variation	4 13	76361 76370	0.9999793767929077	O
18478	between	14 21	76371 76378	0.9999823570251465	O
18479	the	22 25	76379 76382	0.9999827146530151	O
18480	different	26 35	76383 76392	0.9999804496765137	O
18481	assays	36 41	76393 76398	0.9999806880950928	O
18483	was	43 46	76400 76403	0.9999827146530151	O
18484	<	47 48	76404 76405	0.9999793767929077	O
18485	6	49 50	76406 76407	0.9999831914901733	O
18486	%	51 52	76408 76409	0.9999849796295166	O
18487	.	53 54	76410 76411	0.9999111890792847	O
18488	Our	0 3	76412 76415	0.9999778270721436	O
18489	data	4 8	76416 76420	0.9999837875366211	O
18490	confirmed	9 18	76421 76430	0.9999827146530151	O
18491	that	19 23	76431 76435	0.9999879598617554	O
18492	RIL	24 26	76436 76438	0.9999839067459106	O
18494	,	28 29	76440 76441	0.9999873638153076	O
18495	HIN	30 32	76442 76444	0.9999773502349854	O
18497	-	33 34	76445 76446	0.9999892711639404	O
18498	1	34 35	76446 76447	0.9999873638153076	O
18499	,	36 37	76448 76449	0.9999881982803345	O
18500	RASSF1A	38 44	76450 76456	0.9999860525131226	O
18505	,	46 47	76458 76459	0.9999884366989136	O
18506	CDH13	48 52	76460 76464	0.9999886751174927	O
18509	,	54 55	76466 76467	0.9999879598617554	O
18510	and	56 59	76468 76471	0.9999884366989136	O
18511	RARβ2	60 64	76472 76476	0.9999864101409912	O
18515	were	66 70	76478 76482	0.9999878406524658	O
18516	frequently	71 81	76483 76493	0.9999878406524658	O
18517	methylated	82 91	76494 76503	0.9999877214431763	O
18520	in	93 95	76505 76507	0.9999873638153076	O
18521	breast	96 102	76508 76514	0.999980092048645	O
18522	cancers	103 109	76515 76521	0.9999841451644897	O
18524	but	111 114	76523 76526	0.9999840259552002	O
18525	not	115 118	76527 76530	0.9999816417694092	O
18526	in	119 121	76531 76533	0.9999860525131226	O
18527	normal	122 128	76534 76540	0.9999610185623169	O
18528	breast	129 135	76541 76547	0.999982476234436	O
18529	tissues	136 143	76548 76555	0.9999829530715942	O
18530	.	144 145	76556 76557	0.9999562501907349	O
18531	The	0 3	76558 76561	0.9999885559082031	O
18532	other	4 9	76562 76567	0.9999861717224121	O
18533	six	10 13	76568 76571	0.9999830722808838	O
18534	genes	14 19	76572 76577	0.9999855756759644	O
18535	were	20 24	76578 76582	0.999988317489624	O
18536	not	25 28	76583 76586	0.9999871253967285	O
18537	highly	29 35	76587 76593	0.999988317489624	O
18538	methylated	36 45	76594 76603	0.9999885559082031	O
18541	in	47 49	76605 76607	0.9999885559082031	O
18542	breast	50 56	76608 76614	0.999983549118042	O
18543	cancers	57 63	76615 76621	0.9999868869781494	O
18545	or	65 67	76623 76625	0.9999873638153076	O
18546	methylated	68 77	76626 76635	0.9999884366989136	O
18549	in	79 81	76637 76639	0.9999890327453613	O
18550	either	82 88	76640 76646	0.9999822378158569	O
18551	malignant	89 97	76647 76655	0.999987006187439	O
18554	and	99 102	76657 76660	0.9999849796295166	O
18555	normal	103 109	76661 76667	0.9999735355377197	O
18556	breast	110 116	76668 76674	0.9999860525131226	O
18557	tissues	117 124	76675 76682	0.9999873638153076	O
18558	;	125 126	76683 76684	0.999988317489624	O
18559	ARHI	127 130	76685 76688	0.9999865293502808	O
18562	,	132 133	76690 76691	0.9999895095825195	O
18563	as	134 136	76692 76694	0.99998939037323	O
18564	an	137 139	76695 76697	0.9999896287918091	O
18565	imprinted	140 148	76698 76706	0.9999841451644897	O
18567	gene	150 154	76708 76712	0.9999889135360718	O
18568	,	155 156	76713 76714	0.999988317489624	O
18569	has	157 160	76715 76718	0.9999886751174927	O
18570	a	161 162	76719 76720	0.9999892711639404	O
18571	different	163 172	76721 76730	0.9999864101409912	O
18572	methylation	173 183	76731 76741	0.999988317489624	O
18575	status	185 191	76743 76749	0.9999892711639404	O
18576	.	192 193	76750 76751	0.9999723434448242	O
18577	All	0 3	76752 76755	0.9999871253967285	O
18578	the	4 7	76756 76759	0.9999866485595703	O
18579	inconsistencies	8 22	76760 76774	0.9999884366989136	O
18583	indicate	24 32	76776 76784	0.9999858140945435	O
18584	that	33 37	76785 76789	0.9999889135360718	O
18585	these	38 43	76790 76795	0.9999884366989136	O
18586	seven	44 49	76796 76801	0.9999837875366211	O
18587	genes	50 55	76802 76807	0.9999852180480957	O
18588	are	56 59	76808 76811	0.9999880790710449	O
18589	unsuitable	60 69	76812 76821	0.9999874830245972	O
18592	for	71 74	76823 76826	0.9999874830245972	O
18593	methylation	75 85	76827 76837	0.9999881982803345	O
18596	profile	87 94	76839 76846	0.9999878406524658	O
18597	studies	95 102	76847 76854	0.9999880790710449	O
18598	.	103 104	76855 76856	0.9999712705612183	O
18599	In	0 2	76857 76859	0.9999871253967285	O
18600	the	3 6	76860 76863	0.9999877214431763	O
18601	past	7 11	76864 76868	0.99997878074646	O
18602	,	12 13	76869 76870	0.9999877214431763	O
18603	methylation	14 24	76871 76881	0.9999873638153076	O
18606	data	26 30	76883 76887	0.999985933303833	O
18607	have	31 35	76888 76892	0.9999876022338867	O
18608	been	36 40	76893 76897	0.9999878406524658	O
18609	correlated	41 51	76898 76908	0.9999873638153076	O
18610	to	52 54	76909 76911	0.9999884366989136	O
18611	clinical	55 63	76912 76920	0.9999837875366211	O
18612	pathologic	64 73	76921 76930	0.9999878406524658	O
18615	parameters	75 85	76932 76942	0.9999868869781494	O
18616	,	86 87	76943 76944	0.999984860420227	O
18617	to	88 90	76945 76947	0.9999884366989136	O
18618	clarify	91 97	76948 76954	0.9999889135360718	O
18621	the	99 102	76956 76959	0.9999890327453613	O
18622	role	103 107	76960 76964	0.9999878406524658	O
18623	of	108 110	76965 76967	0.9999892711639404	O
18624	methylation	111 121	76968 76978	0.9999874830245972	O
18627	in	123 125	76980 76982	0.9999878406524658	O
18628	breast	126 132	76983 76989	0.9999791383743286	O
18629	carcinogenesis	133 146	76990 77003	0.9999872446060181	O
18633	.	148 149	77005 77006	0.9999710321426392	O
18634	Our	0 3	77007 77010	0.9999843835830688	O
18635	most	4 8	77011 77015	0.9999866485595703	O
18636	interesting	9 20	77016 77027	0.9999868869781494	O
18637	finding	21 28	77028 77035	0.9999865293502808	O
18638	was	29 32	77036 77039	0.9999871253967285	O
18639	a	33 34	77040 77041	0.999988317489624	O
18640	correlation	35 46	77042 77053	0.9999867677688599	O
18641	between	47 54	77054 77061	0.9999886751174927	O
18642	gene	55 59	77062 77066	0.999987006187439	O
18643	methylation	60 70	77067 77077	0.9999880790710449	O
18646	and	72 75	77079 77082	0.999988317489624	O
18647	the	76 79	77083 77086	0.9999881982803345	O
18648	HR	80 81	77087 77088	0.9999862909317017	O
18650	status	83 89	77090 77096	0.9999879598617554	O
18651	.	90 91	77097 77098	0.9999619722366333	O
18652	Methylation	0 10	77099 77109	0.999985933303833	O
18655	in	12 14	77111 77113	0.9999868869781494	O
18656	breast	15 21	77114 77120	0.9999744892120361	O
18657	cancer	22 28	77121 77127	0.9999855756759644	O
18658	has	29 32	77128 77131	0.9999876022338867	O
18659	already	33 40	77132 77139	0.9999854564666748	O
18660	been	41 45	77140 77144	0.9999880790710449	O
18661	connected	46 55	77145 77154	0.9999860525131226	O
18662	to	56 58	77155 77157	0.999988317489624	O
18663	hormone	59 66	77158 77165	0.9999802112579346	O
18664	regulation	67 77	77166 77176	0.9999849796295166	O
18665	,	78 79	77177 77178	0.9999876022338867	O
18666	but	80 83	77179 77182	0.9999872446060181	O
18667	the	84 87	77183 77186	0.999988317489624	O
18668	correlation	88 99	77187 77198	0.9999856948852539	O
18669	is	100 102	77199 77201	0.999988317489624	O
18670	not	103 106	77202 77205	0.9999881982803345	O
18671	clear	107 112	77206 77211	0.9999878406524658	O
18672	yet	113 116	77212 77215	0.999987006187439	O
18673	.	117 118	77216 77217	0.9999693632125854	O
18674	Campan	0 5	77218 77223	0.9999382495880127	O
18676	and	7 10	77225 77228	0.9999840259552002	O
18677	colleagues	11 21	77229 77239	0.9999799728393555	O
18678	[	22 23	77240 77241	0.9999878406524658	O
18679	26	23 25	77241 77243	0.9999834299087524	O
18680	]	25 26	77243 77244	0.9999858140945435	O
18681	reviewed	27 35	77245 77253	0.999984622001648	O
18682	the	36 39	77254 77257	0.9999877214431763	O
18683	DNA	40 43	77258 77261	0.9999865293502808	O
18684	methylation	44 54	77262 77272	0.9999879598617554	O
18687	profiles	56 64	77274 77282	0.9999864101409912	O
18688	of	65 67	77283 77285	0.9999873638153076	O
18689	breast	68 74	77286 77292	0.9999798536300659	O
18690	,	75 76	77293 77294	0.999985933303833	O
18691	endometrial	77 87	77295 77305	0.9999854564666748	O
18695	,	89 90	77307 77308	0.9999864101409912	O
18696	ovarian	91 97	77309 77315	0.9999805688858032	O
18699	,	99 100	77317 77318	0.9999847412109375	O
18700	and	101 104	77319 77322	0.9999858140945435	O
18701	proximal	105 112	77323 77330	0.9999696016311646	O
18703	colon	114 118	77332 77336	0.9999783039093018	O
18705	cancers	120 126	77338 77344	0.9999854564666748	O
18707	but	128 131	77346 77349	0.9999854564666748	O
18708	did	132 135	77350 77353	0.9999861717224121	O
18709	not	136 139	77354 77357	0.9999861717224121	O
18710	find	140 144	77358 77362	0.9999862909317017	O
18711	evidence	145 153	77363 77371	0.9999872446060181	O
18712	for	154 157	77372 77375	0.9999884366989136	O
18713	global	158 164	77376 77382	0.9999843835830688	O
18714	hormone	165 172	77383 77390	0.9999802112579346	O
18715	-	172 173	77390 77391	0.9999890327453613	O
18716	specific	173 181	77391 77399	0.9999876022338867	O
18717	DNA	182 185	77400 77403	0.9999872446060181	O
18718	methylation	186 196	77404 77414	0.9999884366989136	O
18721	alterations	198 209	77416 77427	0.9999872446060181	O
18722	.	210 211	77428 77429	0.9999632835388184	O
18723	Widschwendter	0 12	77430 77442	0.9999810457229614	O
18729	and	14 17	77444 77447	0.9999864101409912	O
18730	colleagues	18 28	77448 77458	0.9999829530715942	O
18731	[	29 30	77459 77460	0.999988317489624	O
18732	16	30 32	77460 77462	0.9999830722808838	O
18733	]	32 33	77462 77463	0.9999873638153076	O
18734	reported	34 42	77464 77472	0.9999868869781494	O
18735	significant	43 54	77473 77484	0.9999880790710449	O
18736	differences	55 66	77485 77496	0.9999881982803345	O
18737	in	67 69	77497 77499	0.9999889135360718	O
18738	the	70 73	77500 77503	0.9999892711639404	O
18739	HR	74 75	77504 77505	0.9999879598617554	O
18741	status	77 83	77507 77513	0.9999891519546509	O
18742	between	84 91	77514 77521	0.9999871253967285	O
18743	clusters	92 100	77522 77530	0.9999880790710449	O
18744	of	101 103	77531 77533	0.9999886751174927	O
18745	DNA	104 107	77534 77537	0.9999876022338867	O
18746	methylation	108 118	77538 77548	0.9999889135360718	O
18749	profiles	120 128	77550 77558	0.9999884366989136	O
18750	.	129 130	77559 77560	0.9999769926071167	O
18751	Their	0 5	77561 77566	0.9999827146530151	O
18752	results	6 13	77567 77574	0.9999828338623047	O
18753	suggested	14 23	77575 77584	0.9999825954437256	O
18754	the	24 27	77585 77588	0.9999874830245972	O
18755	existence	28 37	77589 77598	0.9999852180480957	O
18756	of	38 40	77599 77601	0.9999878406524658	O
18757	an	41 43	77602 77604	0.9999878406524658	O
18758	interaction	44 55	77605 77616	0.9999843835830688	O
18759	between	56 63	77617 77624	0.9999872446060181	O
18760	DNA	64 67	77625 77628	0.9999856948852539	O
18761	methylation	68 78	77629 77639	0.9999871253967285	O
18764	and	80 83	77641 77644	0.9999874830245972	O
18765	HR	84 85	77645 77646	0.999983549118042	O
18767	biology	87 94	77648 77655	0.999982476234436	O
18768	in	95 97	77656 77658	0.9999852180480957	O
18769	breast	98 104	77659 77665	0.9999760389328003	O
18770	cancer	105 111	77666 77672	0.999983549118042	O
18771	cells	112 117	77673 77678	0.9999635219573975	O
18772	.	118 119	77679 77680	0.9999510049819946	O
18773	In	0 2	77681 77683	0.9999868869781494	O
18774	our	3 6	77684 77687	0.9999834299087524	O
18775	own	7 10	77688 77691	0.9999817609786987	O
18776	study	11 16	77692 77697	0.9999858140945435	O
18777	,	17 18	77698 77699	0.9999872446060181	O
18778	we	19 21	77700 77702	0.9999850988388062	O
18779	found	22 27	77703 77708	0.999987006187439	O
18780	that	28 32	77709 77713	0.9999889135360718	O
18781	the	33 36	77714 77717	0.9999887943267822	O
18782	ER	37 39	77718 77720	0.9999823570251465	O
18783	status	40 46	77721 77727	0.999988317489624	O
18784	was	47 50	77728 77731	0.9999890327453613	O
18785	positively	51 61	77732 77742	0.9999885559082031	O
18786	associated	62 72	77743 77753	0.99998939037323	O
18787	with	73 77	77754 77758	0.99998939037323	O
18788	the	78 81	77759 77762	0.9999895095825195	O
18789	methylation	82 92	77763 77773	0.9999891519546509	O
18792	of	94 96	77775 77777	0.99998939037323	O
18793	HIN	97 99	77778 77780	0.9999854564666748	O
18795	-	100 101	77781 77782	0.9999896287918091	O
18796	1	101 102	77782 77783	0.9999891519546509	O
18797	and	103 106	77784 77787	0.9999890327453613	O
18798	RASSF1A	107 113	77788 77794	0.9999867677688599	O
18803	but	115 118	77796 77799	0.9999866485595703	O
18804	negatively	119 129	77800 77810	0.9999823570251465	O
18805	correlated	130 140	77811 77821	0.9999889135360718	O
18806	to	141 143	77822 77824	0.9999895095825195	O
18807	the	144 147	77825 77828	0.99998939037323	O
18808	methylation	148 158	77829 77839	0.9999890327453613	O
18811	of	160 162	77841 77843	0.99998939037323	O
18812	RIL	163 165	77844 77846	0.999985933303833	O
18814	.	166 167	77847 77848	0.9999769926071167	O
18815	In	0 2	77849 77851	0.9999862909317017	O
18816	addition	3 11	77852 77860	0.9999828338623047	O
18817	,	12 13	77861 77862	0.9999879598617554	O
18818	the	14 17	77863 77866	0.9999874830245972	O
18819	PR	18 20	77867 77869	0.9999823570251465	O
18820	status	21 27	77870 77876	0.9999874830245972	O
18821	was	28 31	77877 77880	0.9999880790710449	O
18822	positively	32 42	77881 77891	0.9999867677688599	O
18823	associated	43 53	77892 77902	0.999988317489624	O
18824	with	54 58	77903 77907	0.999988317489624	O
18825	the	59 62	77908 77911	0.9999884366989136	O
18826	methylation	63 73	77912 77922	0.9999880790710449	O
18829	of	75 77	77924 77926	0.999988317489624	O
18830	HIN	78 80	77927 77929	0.9999849796295166	O
18832	-	81 82	77930 77931	0.9999886751174927	O
18833	1	82 83	77931 77932	0.9999880790710449	O
18834	and	84 87	77933 77936	0.9999878406524658	O
18835	negatively	88 98	77937 77947	0.9999786615371704	O
18836	associated	99 109	77948 77958	0.9999885559082031	O
18837	with	110 114	77959 77963	0.9999881982803345	O
18838	the	115 118	77964 77967	0.9999881982803345	O
18839	methylation	119 129	77968 77978	0.9999880790710449	O
18842	of	131 133	77980 77982	0.9999881982803345	O
18843	CDH13	134 138	77983 77987	0.9999881982803345	O
18846	.	140 141	77989 77990	0.9999669790267944	O
18847	Moreover	0 8	77991 77999	0.999984622001648	O
18848	,	9 10	78000 78001	0.9999892711639404	O
18849	if	11 13	78002 78004	0.9999847412109375	O
18850	data	14 18	78005 78009	0.9999868869781494	O
18851	from	19 23	78010 78014	0.9999886751174927	O
18852	the	24 27	78015 78018	0.9999890327453613	O
18853	methylation	28 38	78019 78029	0.9999884366989136	O
18856	of	40 42	78031 78033	0.9999892711639404	O
18857	individual	43 53	78034 78044	0.9999873638153076	O
18858	genes	54 59	78045 78050	0.9999865293502808	O
18859	were	60 64	78051 78055	0.999988317489624	O
18860	combined	65 73	78056 78064	0.9999878406524658	O
18861	into	74 78	78065 78069	0.9999892711639404	O
18862	two	79 82	78070 78073	0.9999871253967285	O
18863	panels	83 89	78074 78080	0.9999874830245972	O
18864	,	90 91	78081 78082	0.9999891519546509	O
18865	methylation	92 102	78083 78093	0.9999887943267822	O
18868	of	104 106	78095 78097	0.99998939037323	O
18869	the	107 110	78098 78101	0.9999892711639404	O
18870	HIN	111 113	78102 78104	0.9999866485595703	O
18872	-	114 115	78105 78106	0.9999896287918091	O
18873	1	115 116	78106 78107	0.9999887943267822	O
18874	/	116 117	78107 78108	0.9999891519546509	O
18875	RASSF1A	117 123	78108 78114	0.9999881982803345	O
18880	panel	125 130	78116 78121	0.9999890327453613	O
18881	strongly	131 139	78122 78130	0.9999887943267822	O
18882	predicted	140 149	78131 78140	0.9999892711639404	O
18883	the	150 153	78141 78144	0.99998939037323	O
18884	expression	154 164	78145 78155	0.9999887943267822	O
18885	of	165 167	78156 78158	0.9999895095825195	O
18886	ERs	168 170	78159 78161	0.9999860525131226	O
18888	,	172 173	78163 78164	0.9999884366989136	O
18889	PRs	174 176	78165 78167	0.9999864101409912	O
18891	,	178 179	78169 78170	0.999988317489624	O
18892	and	180 183	78171 78174	0.9999889135360718	O
18893	HRs	184 186	78175 78177	0.9999866485595703	O
18896	and	188 191	78179 78182	0.9999891519546509	O
18897	methylation	192 202	78183 78193	0.9999887943267822	O
18900	of	204 206	78195 78197	0.9999895095825195	O
18901	the	207 210	78198 78201	0.9999895095825195	O
18902	RIL	211 213	78202 78204	0.9999871253967285	O
18904	/	214 215	78205 78206	0.9999892711639404	O
18905	CDH13	215 219	78206 78210	0.9999886751174927	O
18908	panel	221 226	78212 78217	0.9999890327453613	O
18909	strongly	227 235	78218 78226	0.9999887943267822	O
18910	predicted	236 245	78227 78236	0.99998939037323	O
18911	the	246 249	78237 78240	0.9999895095825195	O
18912	negative	250 258	78241 78249	0.9999845027923584	O
18913	expression	259 269	78250 78260	0.9999889135360718	O
18914	of	270 272	78261 78263	0.9999892711639404	O
18915	ERs	273 275	78264 78266	0.9999865293502808	O
18917	,	277 278	78268 78269	0.999988317489624	O
18918	PRs	279 281	78270 78272	0.9999861717224121	O
18920	,	283 284	78274 78275	0.9999868869781494	O
18921	and	285 288	78276 78279	0.9999884366989136	O
18922	HRs	289 291	78280 78282	0.9999856948852539	O
18925	.	293 294	78284 78285	0.9999626874923706	O
18926	The	0 3	78286 78289	0.9999873638153076	O
18927	status	4 10	78290 78296	0.9999852180480957	O
18928	of	11 13	78297 78299	0.9999878406524658	O
18929	ERs	14 16	78300 78302	0.9999818801879883	O
18931	,	18 19	78304 78305	0.9999872446060181	O
18932	PRs	20 22	78306 78308	0.9999845027923584	O
18934	,	24 25	78310 78311	0.9999867677688599	O
18935	and	26 29	78312 78315	0.9999880790710449	O
18936	HRs	30 32	78316 78318	0.9999831914901733	O
18939	has	34 37	78320 78323	0.9999871253967285	O
18940	been	38 42	78324 78328	0.9999872446060181	O
18941	recognized	43 53	78329 78339	0.9999837875366211	O
18942	as	54 56	78340 78342	0.9999884366989136	O
18943	an	57 59	78343 78345	0.9999887943267822	O
18944	important	60 69	78346 78355	0.9999876022338867	O
18945	prognostic	70 79	78356 78365	0.9999879598617554	O
18948	factor	81 87	78367 78373	0.9999876022338867	O
18949	in	88 90	78374 78376	0.9999861717224121	O
18950	patients	91 99	78377 78385	0.9999737739562988	O
18951	with	100 104	78386 78390	0.9999845027923584	O
18952	breast	105 111	78391 78397	0.9999779462814331	O
18953	cancer	112 118	78398 78404	0.9999855756759644	O
18954	,	119 120	78405 78406	0.9999860525131226	O
18955	in	121 123	78407 78409	0.9999889135360718	O
18956	addition	124 132	78410 78418	0.999987006187439	O
18957	to	133 135	78419 78421	0.9999884366989136	O
18958	a	136 137	78422 78423	0.9999887943267822	O
18959	predictive	138 147	78424 78433	0.999988317489624	O
18961	marker	149 155	78435 78441	0.9999884366989136	O
18962	for	156 159	78442 78445	0.9999860525131226	O
18963	the	160 163	78446 78449	0.9999868869781494	O
18964	response	164 172	78450 78458	0.9999860525131226	O
18965	to	173 175	78459 78461	0.9999880790710449	O
18966	treatment	176 185	78462 78471	0.999987006187439	O
18967	with	186 190	78472 78476	0.9999866485595703	O
18968	endocrine	191 199	78477 78485	0.999987006187439	O
18971	therapy	201 208	78487 78494	0.999987006187439	O
18972	.	209 210	78495 78496	0.9999611377716064	O
18973	The	0 3	78497 78500	0.999985933303833	O
18974	presence	4 12	78501 78509	0.9999847412109375	O
18975	of	13 15	78510 78512	0.9999872446060181	O
18976	ERs	16 18	78513 78515	0.9999781847000122	O
18978	and	20 23	78517 78520	0.9999864101409912	O
18979	/	23 24	78520 78521	0.9999867677688599	O
18980	or	24 26	78521 78523	0.999987006187439	O
18981	PRs	27 29	78524 78526	0.9999769926071167	O
18983	is	31 33	78528 78530	0.9999855756759644	O
18984	predictive	34 43	78531 78540	0.9999866485595703	O
18986	of	45 47	78542 78544	0.9999867677688599	O
18987	the	48 51	78545 78548	0.9999860525131226	O
18988	response	52 60	78549 78557	0.9999858140945435	O
18989	to	61 63	78558 78560	0.9999868869781494	O
18990	treatment	64 73	78561 78570	0.9999858140945435	O
18991	with	74 78	78571 78575	0.9999867677688599	O
18992	the	79 82	78576 78579	0.9999850988388062	O
18993	antiestrogen	83 94	78580 78591	0.9999850988388062	O
18996	tamoxifen	96 104	78593 78601	0.9999862909317017	O
19000	[	106 107	78603 78604	0.9999889135360718	O
19001	27	107 109	78604 78606	0.9999868869781494	O
19002	]	109 110	78606 78607	0.9999884366989136	O
19003	.	111 112	78608 78609	0.9999738931655884	O
19004	ER	0 2	78610 78612	0.9999657869338989	O
19005	and	3 6	78613 78616	0.9999792575836182	O
19006	PR	7 9	78617 78619	0.9999691247940063	O
19007	expression	10 20	78620 78630	0.9999755620956421	O
19008	patterns	21 29	78631 78639	0.9999779462814331	O
19009	are	30 33	78640 78643	0.9999644756317139	O
19010	heavily	34 41	78644 78651	0.9999637603759766	O
19011	influenced	42 52	78652 78662	0.9999775886535645	O
19012	by	53 55	78663 78665	0.9999786615371704	O
19013	changes	56 63	78666 78673	0.9999698400497437	O
19014	in	64 66	78674 78676	0.9999796152114868	O
19015	the	67 70	78677 78680	0.9999814033508301	O
19016	chromatin	71 79	78681 78689	0.9999836683273315	O
19019	structure	81 90	78691 78700	0.9999707937240601	O
19020	during	91 97	78701 78707	0.9999814033508301	O
19021	transcription	98 111	78708 78721	0.999963641166687	O
19022	.	112 113	78722 78723	0.99982750415802	O
19023	Indeed	0 6	78724 78730	0.9999754428863525	O
19024	,	7 8	78731 78732	0.9999874830245972	O
19025	both	9 13	78733 78737	0.999984860420227	O
19026	the	14 17	78738 78741	0.9999866485595703	O
19027	predominant	18 29	78742 78753	0.9999748468399048	O
19028	mammalian	30 38	78754 78762	0.9998619556427002	O
19031	DNA	40 43	78764 78767	0.9999829530715942	O
19032	methyltransferase	44 60	78768 78784	0.9999847412109375	O
19038	and	62 65	78786 78789	0.999985933303833	O
19039	histone	66 72	78790 78796	0.9999697208404541	O
19041	deacetylases	74 85	78798 78809	0.9999874830245972	O
19046	have	87 91	78811 78815	0.9999862909317017	O
19047	crucial	92 99	78816 78823	0.9999843835830688	O
19048	roles	100 105	78824 78829	0.9999854564666748	O
19049	in	106 108	78830 78832	0.9999871253967285	O
19050	maintaining	109 120	78833 78844	0.9999829530715942	O
19051	transcriptionally	121 137	78845 78861	0.9999827146530151	O
19053	repressive	139 148	78863 78872	0.9999874830245972	O
19055	chromatin	150 158	78874 78882	0.9999871253967285	O
19058	by	160 162	78884 78886	0.9999868869781494	O
19059	forming	163 170	78887 78894	0.9999860525131226	O
19060	suppressive	171 181	78895 78905	0.9999829530715942	O
19062	complexes	183 192	78907 78916	0.9999830722808838	O
19063	at	193 195	78917 78919	0.9999852180480957	O
19064	replication	196 207	78920 78931	0.9999792575836182	O
19065	foci	208 211	78932 78935	0.9999872446060181	O
19068	[	213 214	78937 78938	0.9999889135360718	O
19069	28	214 216	78938 78940	0.9999864101409912	O
19070	]	216 217	78940 78941	0.9999885559082031	O
19071	.	218 219	78942 78943	0.999976396560669	O
19072	Our	0 3	78944 78947	0.9999861717224121	O
19073	current	4 11	78948 78955	0.999985933303833	O
19074	studies	12 19	78956 78963	0.9999849796295166	O
19075	provide	20 27	78964 78971	0.9999866485595703	O
19076	evidence	28 36	78972 78980	0.9999855756759644	O
19077	that	37 41	78981 78985	0.9999877214431763	O
19078	epigenetic	42 51	78986 78995	0.9999871253967285	O
19082	changes	53 60	78997 79004	0.9999862909317017	O
19083	are	61 64	79005 79008	0.9999874830245972	O
19084	tightly	65 72	79009 79016	0.9999865293502808	O
19085	connected	73 82	79017 79026	0.9999873638153076	O
19086	with	83 87	79027 79031	0.9999876022338867	O
19087	HR	88 89	79032 79033	0.999984860420227	O
19089	regulation	91 101	79035 79045	0.9999862909317017	O
19090	in	102 104	79046 79048	0.9999867677688599	O
19091	breast	105 111	79049 79055	0.9999823570251465	O
19092	cancer	112 118	79056 79062	0.9999862909317017	O
19093	.	119 120	79063 79064	0.9999880790710449	O
19094	*	121 122	79065 79066	0.999987006187439	O
19095	*	122 123	79066 79067	0.99997878074646	O
19096	IGNORE	0 5	79068 79073	0.9999854564666748	O
19099	LINE	7 10	79075 79078	0.9999880790710449	O
19102	*	12 13	79080 79081	0.9999881982803345	O
19103	*	13 14	79081 79082	0.9999881982803345	O
19104	*	15 16	79083 79084	0.9999881982803345	O
19105	*	16 17	79084 79085	0.9999881982803345	O
19106	IGNORE	18 23	79086 79091	0.9999868869781494	O
19109	LINE	25 28	79093 79096	0.999988317489624	O
19112	*	30 31	79098 79099	0.9999878406524658	O
19113	*	31 32	79099 79100	0.9999878406524658	O
19114	*	33 34	79101 79102	0.9999878406524658	O
19115	*	34 35	79102 79103	0.9999879598617554	O
19116	IGNORE	36 41	79104 79109	0.9999864101409912	O
19119	LINE	43 46	79111 79114	0.9999881982803345	O
19122	*	48 49	79116 79117	0.9999879598617554	O
19123	*	49 50	79117 79118	0.9999877214431763	O
19124	Tumors	51 56	79119 79124	0.9999853372573853	O
19127	negatively	58 68	79126 79136	0.999985933303833	O
19128	stained	69 76	79137 79144	0.999988317489624	O
19129	for	77 80	79145 79148	0.9999885559082031	O
19130	HCA2	81 84	79149 79152	0.999988317489624	O
19133	and	86 89	79154 79157	0.9999886751174927	O
19134	/	89 90	79157 79158	0.9999874830245972	O
19135	or	90 92	79158 79160	0.9999884366989136	O
19136	HC10	93 96	79161 79164	0.9999884366989136	O
19138	were	98 102	79166 79170	0.9999886751174927	O
19139	stained	103 110	79171 79178	0.9999878406524658	O
19140	for	111 114	79179 79182	0.9999885559082031	O
19141	mismatch	115 122	79183 79190	0.999987006187439	O
19144	repair	124 130	79192 79198	0.9999868869781494	O
19145	proteins	131 139	79199 79207	0.9999886751174927	O
19146	MLH1	140 143	79208 79211	0.9999880790710449	O
19149	and	145 148	79213 79216	0.9999878406524658	O
19150	PMS2	149 152	79217 79220	0.999984860420227	O
19153	.	154 155	79222 79223	0.9999550580978394	O
19154	MLH1	0 3	79224 79227	0.9999760389328003	O
19157	and	5 8	79229 79232	0.9999724626541138	O
19158	PMS2	9 12	79233 79236	0.999970555305481	O
19161	are	14 17	79238 79241	0.9999579191207886	O
19162	deficient	18 26	79242 79250	0.9999649524688721	O
19164	in	28 30	79252 79254	0.9999537467956543	O
19165	sporadic	31 38	79255 79262	0.999932050704956	O
19167	MSI	40 42	79264 79266	0.9999419450759888	O
19169	tumors	44 50	79268 79274	0.9999704360961914	O
19170	.	51 52	79275 79276	0.9991981387138367	O
19171	Therefore	0 9	79277 79286	0.9999843835830688	O
19172	,	10 11	79287 79288	0.9999873638153076	O
19173	the	12 15	79289 79292	0.999987006187439	O
19174	expression	16 26	79293 79303	0.9999841451644897	O
19175	of	27 29	79304 79306	0.9999872446060181	O
19176	these	30 35	79307 79312	0.9999864101409912	O
19177	proteins	36 44	79313 79321	0.999977707862854	O
19178	was	45 48	79322 79325	0.999985933303833	O
19179	used	49 53	79326 79330	0.999984860420227	O
19180	to	54 56	79331 79333	0.9999866485595703	O
19181	differentiate	57 70	79334 79347	0.9999833106994629	O
19182	MSI	71 73	79348 79350	0.9999860525131226	O
19184	and	75 78	79352 79355	0.9999833106994629	O
19185	MSS	79 81	79356 79358	0.9999840259552002	O
19187	rectal	83 88	79360 79365	0.9999817609786987	O
19190	cancers	90 96	79367 79373	0.9999842643737793	O
19192	.	98 99	79375 79376	0.9999557733535767	O
19193	Tissue	0 5	79377 79382	0.9999853372573853	O
19196	stromal	7 13	79384 79390	0.9999871253967285	O
19199	cells	15 20	79392 79397	0.9999862909317017	O
19200	,	21 22	79398 79399	0.999987006187439	O
19201	normal	23 29	79400 79406	0.9999771118164062	O
19202	epithelium	30 39	79407 79416	0.9999876022338867	O
19206	or	41 43	79418 79420	0.9999853372573853	O
19207	lymph	44 48	79421 79425	0.9999828338623047	O
19209	follicles	50 58	79427 79435	0.9999860525131226	O
19212	served	60 66	79437 79443	0.9999865293502808	O
19213	as	67 69	79444 79446	0.9999889135360718	O
19214	positive	70 78	79447 79455	0.9999874830245972	O
19215	internal	79 87	79456 79464	0.9999865293502808	O
19216	controls	88 96	79465 79473	0.9999874830245972	O
19217	when	97 101	79474 79478	0.9999884366989136	O
19218	analyzing	102 111	79479 79488	0.9999878406524658	O
19219	MLH1	112 115	79489 79492	0.9999887943267822	O
19222	,	117 118	79494 79495	0.9999877214431763	O
19223	PMS2	119 122	79496 79499	0.9999874830245972	O
19226	expression	124 134	79501 79511	0.9999889135360718	O
19227	.	135 136	79512 79513	0.9999672174453735	O
19228	The	0 3	79514 79517	0.9999889135360718	O
19229	expression	4 14	79518 79528	0.9999885559082031	O
19230	of	15 17	79529 79531	0.9999891519546509	O
19231	MLH1	18 21	79532 79535	0.9999886751174927	O
19234	and	23 26	79537 79540	0.9999890327453613	O
19235	PMS2	27 30	79541 79544	0.9999877214431763	O
19238	was	32 35	79546 79549	0.9999890327453613	O
19239	scored	36 42	79550 79556	0.9999862909317017	O
19240	positive	43 51	79557 79565	0.9999889135360718	O
19241	if	52 54	79566 79568	0.9999877214431763	O
19242	tumor	55 60	79569 79574	0.999987006187439	O
19243	cells	61 66	79575 79580	0.9999884366989136	O
19244	showed	67 73	79581 79587	0.9999891519546509	O
19245	expression	74 84	79588 79598	0.999988317489624	O
19246	,	85 86	79599 79600	0.9999879598617554	O
19247	and	87 90	79601 79604	0.9999886751174927	O
19248	negative	91 99	79605 79613	0.9999862909317017	O
19249	if	100 102	79614 79616	0.9999880790710449	O
19250	tumor	103 108	79617 79622	0.9999871253967285	O
19251	cells	109 114	79623 79628	0.9999884366989136	O
19252	showed	115 121	79629 79635	0.9999891519546509	O
19253	no	122 124	79636 79638	0.9999887943267822	O
19254	expression	125 135	79639 79649	0.9999889135360718	O
19255	of	136 138	79650 79652	0.9999892711639404	O
19256	either	139 145	79653 79659	0.9999891519546509	O
19257	MLH1	146 149	79660 79663	0.9999890327453613	O
19260	or	151 153	79665 79667	0.9999890327453613	O
19261	PMS2	154 157	79668 79671	0.9999881982803345	O
19264	,	159 160	79673 79674	0.9999887943267822	O
19265	provided	161 169	79675 79683	0.9999866485595703	O
19266	that	170 174	79684 79688	0.9999891519546509	O
19267	and	175 178	79689 79692	0.9999873638153076	O
19268	tissue	179 185	79693 79699	0.9999845027923584	O
19269	stromal	186 192	79700 79706	0.9999890327453613	O
19272	cells	194 199	79708 79713	0.999988317489624	O
19273	did	200 203	79714 79717	0.9999880790710449	O
19274	show	204 208	79718 79722	0.9999889135360718	O
19275	expression	209 219	79723 79733	0.9999885559082031	O
19276	,	220 221	79734 79735	0.99998939037323	O
19277	indicating	222 232	79736 79746	0.9999896287918091	O
19278	microsatellite	233 246	79747 79760	0.9999889135360718	O
19282	stable	248 254	79762 79768	0.9999891519546509	O
19283	(	255 256	79769 79770	0.9999896287918091	O
19284	MSS	257 259	79771 79773	0.9999889135360718	O
19286	)	260 261	79774 79775	0.99998939037323	O
19287	and	262 265	79776 79779	0.9999889135360718	O
19288	microsatellite	266 279	79780 79793	0.9999887943267822	O
19292	instable	281 288	79795 79802	0.9999892711639404	O
19294	(	290 291	79804 79805	0.9999896287918091	O
19295	MSI	292 294	79806 79808	0.9999885559082031	O
19297	)	295 296	79809 79810	0.9999886751174927	O
19298	tumors	297 303	79811 79817	0.9999853372573853	O
19299	,	304 305	79818 79819	0.9999887943267822	O
19300	respectively	306 318	79820 79832	0.9999871253967285	O
19301	[	319 320	79833 79834	0.9999891519546509	O
19302	7	320 321	79834 79835	0.9999860525131226	O
19303	]	321 322	79835 79836	0.9999887943267822	O
19304	.	323 324	79837 79838	0.9999728202819824	O
19305	Statistical	0 11	79839 79850	0.999985933303833	O
19306	analyses	12 20	79851 79859	0.9999873638153076	O
19307	All	21 24	79860 79863	0.9999841451644897	O
19308	analyses	25 33	79864 79872	0.9999854564666748	O
19309	were	34 38	79873 79877	0.9999880790710449	O
19310	performed	39 48	79878 79887	0.9999871253967285	O
19311	with	49 53	79888 79892	0.9999885559082031	O
19312	SPSS	54 57	79893 79896	0.9999867677688599	O
19314	statistical	59 70	79898 79909	0.9999886751174927	O
19315	software	71 79	79910 79918	0.9999868869781494	O
19316	(	80 81	79919 79920	0.9999892711639404	O
19317	version	81 88	79920 79927	0.9999886751174927	O
19318	12	89 91	79928 79930	0.9999885559082031	O
19319	.	91 92	79930 79931	0.9999889135360718	O
19320	0	92 93	79931 79932	0.9999886751174927	O
19321	for	94 97	79933 79936	0.9999886751174927	O
19322	Windows	98 105	79937 79944	0.9999847412109375	O
19323	,	106 107	79945 79946	0.9999885559082031	O
19324	SPSS	108 111	79947 79950	0.9999878406524658	O
19326	Inc	113 116	79952 79955	0.9999886751174927	O
19327	,	117 118	79956 79957	0.9999886751174927	O
19328	Chicago	119 126	79958 79965	0.999983549118042	O
19329	,	127 128	79966 79967	0.9999887943267822	O
19330	USA	129 132	79968 79971	0.9999867677688599	O
19331	)	133 134	79972 79973	0.9999891519546509	O
19332	.	135 136	79974 79975	0.9999728202819824	O
19333	Mann	0 4	79976 79980	0.9999818801879883	O
19334	–	4 5	79980 79981	0.99997878074646	O
19335	Whitney	6 13	79982 79989	0.9999829530715942	O
19336	U	14 15	79990 79991	0.9999833106994629	O
19337	,	15 16	79991 79992	0.9999865293502808	O
19338	t	17 18	79993 79994	0.9999850988388062	O
19339	test	19 23	79995 79999	0.9999868869781494	O
19340	and	24 27	80000 80003	0.9999865293502808	O
19341	χ2	28 29	80004 80005	0.9999825954437256	O
19343	-	30 31	80006 80007	0.9999860525131226	O
19344	tests	31 36	80007 80012	0.999984860420227	O
19345	were	37 41	80013 80017	0.9999840259552002	O
19346	used	42 46	80018 80022	0.9999852180480957	O
19347	to	47 49	80023 80025	0.9999853372573853	O
19348	compare	50 57	80026 80033	0.9999819993972778	O
19349	variables	58 67	80034 80043	0.9999779462814331	O
19350	.	68 69	80044 80045	0.9999330043792725	O
19351	Kaplan	0 6	80046 80052	0.9999775886535645	O
19352	–	6 7	80052 80053	0.9999672174453735	O
19353	Meier	7 11	80053 80057	0.9999808073043823	O
19355	analyses	13 21	80059 80067	0.9999750852584839	O
19356	were	22 26	80068 80072	0.9999749660491943	O
19357	performed	27 36	80073 80082	0.9999772310256958	O
19358	to	37 39	80083 80085	0.999980092048645	O
19359	analyze	40 47	80086 80093	0.999976634979248	O
19360	patient	48 55	80094 80101	0.9999716281890869	O
19361	survival	56 64	80102 80110	0.9999794960021973	O
19362	.	65 66	80111 80112	0.9998987913131714	O
19363	The	0 3	80113 80116	0.9999847412109375	O
19364	entry	4 9	80117 80122	0.9999828338623047	O
19365	date	10 14	80123 80127	0.9999847412109375	O
19366	for	15 18	80128 80131	0.9999847412109375	O
19367	the	19 22	80132 80135	0.9999854564666748	O
19368	survival	23 31	80136 80144	0.9999823570251465	O
19369	analyses	32 40	80145 80153	0.999981164932251	O
19370	was	41 44	80154 80157	0.9999839067459106	O
19371	the	45 48	80158 80161	0.9999860525131226	O
19372	time	49 53	80162 80166	0.9999856948852539	O
19373	of	54 56	80167 80169	0.9999872446060181	O
19374	surgery	57 64	80170 80177	0.99997878074646	O
19375	of	65 67	80178 80180	0.9999854564666748	O
19376	the	68 71	80181 80184	0.9999853372573853	O
19377	primary	72 79	80185 80192	0.9999837875366211	O
19378	tumor	80 85	80193 80198	0.9999814033508301	O
19379	.	86 87	80199 80200	0.9999394416809082	O
19380	Events	0 6	80201 80207	0.9999852180480957	O
19381	for	7 10	80208 80211	0.9999873638153076	O
19382	time	11 15	80212 80216	0.9999891519546509	O
19383	to	16 18	80217 80219	0.9999886751174927	O
19384	local	19 24	80220 80225	0.9999847412109375	O
19385	recurrence	25 34	80226 80235	0.99998939037323	O
19388	,	36 37	80237 80238	0.9999884366989136	O
19389	distant	38 45	80239 80246	0.9999823570251465	O
19390	recurrence	46 55	80247 80256	0.9999892711639404	O
19393	,	57 58	80258 80259	0.9999887943267822	O
19394	cancer	59 65	80260 80266	0.9999845027923584	O
19395	-	65 66	80266 80267	0.9999892711639404	O
19396	specific	66 74	80267 80275	0.999988317489624	O
19397	survival	75 83	80276 80284	0.9999887943267822	O
19398	,	84 85	80285 80286	0.9999884366989136	O
19399	disease	86 93	80287 80294	0.9999862909317017	O
19400	-	93 94	80294 80295	0.9999891519546509	O
19401	free	94 98	80295 80299	0.9999879598617554	O
19402	and	99 102	80300 80303	0.9999880790710449	O
19403	overall	103 110	80304 80311	0.9999867677688599	O
19404	survival	111 119	80312 80320	0.9999885559082031	O
19405	were	120 124	80321 80325	0.9999877214431763	O
19406	defined	125 132	80326 80333	0.9999874830245972	O
19407	as	133 135	80334 80336	0.9999887943267822	O
19408	follows	136 143	80337 80344	0.9999880790710449	O
19409	:	144 145	80345 80346	0.9999890327453613	O
19410	from	146 150	80347 80351	0.9999889135360718	O
19411	time	151 155	80352 80356	0.9999892711639404	O
19412	of	156 158	80357 80359	0.9999892711639404	O
19413	surgery	159 166	80360 80367	0.9999852180480957	O
19414	to	167 169	80368 80370	0.9999889135360718	O
19415	time	170 174	80371 80375	0.9999887943267822	O
19416	of	175 177	80376 80378	0.9999889135360718	O
19417	local	178 183	80379 80384	0.9999837875366211	O
19418	disease	184 191	80385 80392	0.999988317489624	O
19419	relapse	192 198	80393 80399	0.9999895095825195	O
19422	(	200 201	80401 80402	0.99998939037323	O
19423	for	202 205	80403 80406	0.9999887943267822	O
19424	local	206 211	80407 80412	0.9999864101409912	O
19425	recurrence	212 221	80413 80422	0.9999892711639404	O
19428	)	223 224	80424 80425	0.9999895095825195	O
19429	,	225 226	80426 80427	0.9999891519546509	O
19430	time	227 231	80428 80432	0.9999889135360718	O
19431	of	232 234	80433 80435	0.9999889135360718	O
19432	distant	235 242	80436 80443	0.9999858140945435	O
19433	disease	243 250	80444 80451	0.9999877214431763	O
19434	relapse	251 257	80452 80458	0.9999892711639404	O
19437	(	259 260	80460 80461	0.9999892711639404	O
19438	for	261 264	80462 80465	0.999988317489624	O
19439	distant	265 272	80466 80473	0.999987006187439	O
19440	recurrence	273 282	80474 80483	0.9999892711639404	O
19443	)	284 285	80485 80486	0.99998939037323	O
19444	,	286 287	80487 80488	0.9999891519546509	O
19445	time	288 292	80489 80493	0.9999889135360718	O
19446	of	293 295	80494 80496	0.9999890327453613	O
19447	disease	296 303	80497 80504	0.9999867677688599	O
19448	relapse	304 310	80505 80511	0.9999891519546509	O
19451	or	312 314	80513 80515	0.9999889135360718	O
19452	death	315 320	80516 80521	0.9999864101409912	O
19453	by	321 323	80522 80524	0.999987006187439	O
19454	disease	324 331	80525 80532	0.9999837875366211	O
19455	(	332 333	80533 80534	0.9999895095825195	O
19456	for	334 337	80535 80538	0.9999891519546509	O
19457	cancer	338 344	80539 80545	0.9999872446060181	O
19458	specific	345 353	80546 80554	0.9999886751174927	O
19459	survival	354 362	80555 80563	0.9999891519546509	O
19460	)	363 364	80564 80565	0.99998939037323	O
19461	,	365 366	80566 80567	0.9999889135360718	O
19462	time	367 371	80568 80572	0.9999889135360718	O
19463	of	372 374	80573 80575	0.9999890327453613	O
19464	disease	375 382	80576 80583	0.9999868869781494	O
19465	relapse	383 389	80584 80590	0.9999892711639404	O
19468	or	391 393	80592 80594	0.9999890327453613	O
19469	death	394 399	80595 80600	0.999987006187439	O
19470	(	400 401	80601 80602	0.9999892711639404	O
19471	for	402 405	80603 80606	0.9999889135360718	O
19472	disease	406 413	80607 80614	0.9999877214431763	O
19473	free	414 418	80615 80619	0.999988317489624	O
19474	survival	419 427	80620 80628	0.9999891519546509	O
19475	)	428 429	80629 80630	0.9999892711639404	O
19476	and	430 433	80631 80634	0.9999887943267822	O
19477	time	434 438	80635 80639	0.9999885559082031	O
19478	of	439 441	80640 80642	0.9999891519546509	O
19479	death	442 447	80643 80648	0.9999862909317017	O
19480	,	448 449	80649 80650	0.9999886751174927	O
19481	respectively	450 462	80651 80663	0.9999871253967285	O
19482	(	463 464	80664 80665	0.9999891519546509	O
19483	for	465 468	80666 80669	0.9999889135360718	O
19484	overall	469 476	80670 80677	0.9999877214431763	O
19485	survival	477 485	80678 80686	0.9999887943267822	O
19486	)	486 487	80687 80688	0.9999891519546509	O
19487	.	488 489	80689 80690	0.9999592304229736	O
19488	Non	0 3	80691 80694	0.9999827146530151	O
19489	-	3 4	80694 80695	0.9999884366989136	O
19490	irradiated	4 13	80695 80704	0.9999877214431763	O
19494	and	15 18	80706 80709	0.9999871253967285	O
19495	irradiated	19 28	80710 80719	0.9999858140945435	O
19499	patients	30 38	80721 80729	0.9999842643737793	O
19500	were	39 43	80730 80734	0.9999895095825195	O
19501	first	44 49	80735 80740	0.99998939037323	O
19502	separately	50 60	80741 80751	0.9999884366989136	O
19503	analyzed	61 69	80752 80760	0.9999896287918091	O
19504	in	70 72	80761 80763	0.9999898672103882	O
19505	univariate	73 82	80764 80773	0.9999897480010986	O
19509	analysis	84 92	80775 80783	0.9999897480010986	O
19510	and	93 96	80784 80787	0.9999891519546509	O
19511	second	97 103	80788 80794	0.9999881982803345	O
19512	,	104 105	80795 80796	0.9999891519546509	O
19513	variables	106 115	80797 80806	0.9999871253967285	O
19514	with	116 120	80807 80811	0.99998939037323	O
19515	a	121 122	80812 80813	0.9999895095825195	O
19516	P	123 124	80814 80815	0.99998939037323	O
19517	value	125 130	80816 80821	0.99998939037323	O
19518	of	131 133	80822 80824	0.9999891519546509	O
19519	<	134 135	80825 80826	0.99998939037323	O
19520	0	135 136	80826 80827	0.9999896287918091	O
19521	.	136 137	80827 80828	0.99998939037323	O
19522	10	137 139	80828 80830	0.9999877214431763	O
19523	in	140 142	80831 80833	0.99998939037323	O
19524	the	143 146	80834 80837	0.99998939037323	O
19525	univariate	147 156	80838 80847	0.99998939037323	O
19529	analyses	158 166	80849 80857	0.9999892711639404	O
19530	were	167 171	80858 80862	0.9999890327453613	O
19531	subjected	172 181	80863 80872	0.9999885559082031	O
19532	to	182 184	80873 80875	0.9999895095825195	O
19533	a	185 186	80876 80877	0.9999896287918091	O
19534	multivariate	187 198	80878 80889	0.9999887943267822	O
19537	analysis	200 208	80891 80899	0.9999895095825195	O
19538	.	209 210	80900 80901	0.9999700784683228	O
19539	Multivariate	0 11	80902 80913	0.9999871253967285	O
19542	analysis	13 21	80915 80923	0.9999879598617554	O
19543	was	22 25	80924 80927	0.9999877214431763	O
19544	performed	26 35	80928 80937	0.9999878406524658	O
19545	on	36 38	80938 80940	0.999988317489624	O
19546	the	39 42	80941 80944	0.9999891519546509	O
19547	whole	43 48	80945 80950	0.9999871253967285	O
19548	group	49 54	80951 80956	0.9999878406524658	O
19549	of	55 57	80957 80959	0.9999884366989136	O
19550	irradiated	58 67	80960 80969	0.9999886751174927	O
19554	and	69 72	80971 80974	0.999987006187439	O
19555	non	73 76	80975 80978	0.999985933303833	O
19556	-	76 77	80978 80979	0.9999880790710449	O
19557	irradiated	77 86	80979 80988	0.9999880790710449	O
19561	patients	88 96	80990 80998	0.9999856948852539	O
19562	with	97 101	80999 81003	0.9999878406524658	O
19563	the	102 105	81004 81007	0.9999887943267822	O
19564	following	106 115	81008 81017	0.999988317489624	O
19565	variables	116 125	81018 81027	0.9999866485595703	O
19566	:	126 127	81028 81029	0.9999892711639404	O
19567	HLA	128 130	81030 81032	0.9999886751174927	O
19569	class	132 137	81034 81039	0.9999892711639404	O
19570	I	138 139	81040 81041	0.9999891519546509	O
19571	,	140 141	81042 81043	0.99998939037323	O
19572	randomization	142 154	81044 81056	0.9999874830245972	O
19574	for	156 159	81058 81061	0.9999887943267822	O
19575	radiotherapy	160 171	81062 81073	0.9999877214431763	O
19579	,	173 174	81075 81076	0.9999886751174927	O
19580	TNM	175 177	81077 81079	0.9999881982803345	O
19583	and	179 182	81081 81084	0.9999885559082031	O
19584	circumferential	183 197	81085 81099	0.9999890327453613	O
19589	margin	199 205	81101 81107	0.9999887943267822	O
19590	.	206 207	81108 81109	0.9999656677246094	O
19591	Cox	0 3	81110 81113	0.9999833106994629	O
19592	’	4 5	81114 81115	0.9999152421951294	O
19593	regression	6 15	81116 81125	0.9999858140945435	O
19595	analyses	17 25	81127 81135	0.9999858140945435	O
19596	were	26 30	81136 81140	0.9999867677688599	O
19597	used	31 35	81141 81145	0.9999854564666748	O
19598	to	36 38	81146 81148	0.9999880790710449	O
19599	calculate	39 48	81149 81158	0.9999856948852539	O
19600	hazard	49 55	81159 81165	0.9999866485595703	O
19601	ratios	56 62	81166 81172	0.9999868869781494	O
19602	(	63 64	81173 81174	0.9999887943267822	O
19603	HR	65 66	81175 81176	0.9999868869781494	O
19605	)	68 69	81178 81179	0.9999890327453613	O
19606	with	70 74	81180 81184	0.9999881982803345	O
19607	95	75 77	81185 81187	0.9999874830245972	O
19608	%	78 79	81188 81189	0.9999884366989136	O
19609	confidence	80 90	81190 81200	0.9999879598617554	O
19610	intervals	91 100	81201 81210	0.999987006187439	O
19611	(	101 102	81211 81212	0.9999881982803345	O
19612	CI	103 104	81213 81214	0.9999867677688599	O
19614	)	105 106	81215 81216	0.9999890327453613	O
19615	.	107 108	81217 81218	0.9999885559082031	O
19616	*	109 110	81219 81220	0.999988317489624	O
19617	*	110 111	81220 81221	0.9999842643737793	O
19618	IGNORE	0 5	81222 81227	0.9999867677688599	O
19621	LINE	7 10	81229 81232	0.9999890327453613	O
19624	*	12 13	81234 81235	0.9999887943267822	O
19625	*	13 14	81235 81236	0.9999887943267822	O
19626	*	15 16	81237 81238	0.9999887943267822	O
19627	*	16 17	81238 81239	0.9999890327453613	O
19628	IGNORE	18 23	81240 81245	0.9999877214431763	O
19631	LINE	25 28	81247 81250	0.9999890327453613	O
19634	*	30 31	81252 81253	0.9999885559082031	O
19635	*	31 32	81253 81254	0.9999885559082031	O
19636	*	33 34	81255 81256	0.9999884366989136	O
19637	*	34 35	81256 81257	0.9999886751174927	O
19638	IGNORE	36 41	81258 81263	0.9999872446060181	O
19641	LINE	43 46	81265 81268	0.9999889135360718	O
19644	*	48 49	81270 81271	0.9999886751174927	O
19645	*	49 50	81271 81272	0.999988317489624	O
19646	Most	51 55	81273 81277	0.9999854564666748	O
19647	rectal	56 61	81278 81283	0.9999741315841675	O
19650	tumors	63 69	81285 81291	0.9999861717224121	O
19651	have	70 74	81292 81296	0.9999877214431763	O
19652	high	75 79	81297 81301	0.9999874830245972	O
19653	numbers	80 87	81302 81309	0.9999874830245972	O
19654	of	88 90	81310 81312	0.999988317489624	O
19655	tumor	91 96	81313 81318	0.9999878406524658	O
19656	cells	97 102	81319 81324	0.9999881982803345	O
19657	positive	103 111	81325 81333	0.9999887943267822	O
19658	for	112 115	81334 81337	0.9999892711639404	O
19659	HCA2	116 119	81338 81341	0.9999890327453613	O
19662	or	121 123	81343 81345	0.9999887943267822	O
19663	HC10	124 127	81346 81349	0.9999887943267822	O
19665	Numbers	129 136	81351 81358	0.9999842643737793	O
19666	(	137 138	81359 81360	0.9999892711639404	O
19667	N	139 140	81361 81362	0.9999866485595703	O
19668	)	141 142	81363 81364	0.9999895095825195	O
19669	of	143 145	81365 81367	0.9999885559082031	O
19670	patients	146 154	81368 81376	0.9999709129333496	O
19671	are	155 158	81377 81380	0.99998939037323	O
19672	indicated	159 168	81381 81390	0.9999887943267822	O
19673	with	169 173	81391 81395	0.9999892711639404	O
19674	percentages	174 184	81396 81406	0.9999885559082031	O
19676	shown	186 191	81408 81413	0.9999886751174927	O
19677	in	192 194	81414 81416	0.9999895095825195	O
19678	parentheses	195 205	81417 81427	0.999988317489624	O
19680	,	207 208	81429 81430	0.9999887943267822	O
19681	showing	209 216	81431 81438	0.9999889135360718	O
19682	:	217 218	81439 81440	0.9999892711639404	O
19683	expression	219 229	81441 81451	0.9999890327453613	O
19684	of	230 232	81452 81454	0.99998939037323	O
19685	HCA2	233 236	81455 81458	0.9999889135360718	O
19688	and	238 241	81460 81463	0.9999889135360718	O
19689	HC10	242 245	81464 81467	0.9999890327453613	O
19691	in	247 249	81469 81471	0.99998939037323	O
19692	more	250 254	81472 81476	0.9999892711639404	O
19693	than	255 259	81477 81481	0.99998939037323	O
19694	50	260 262	81482 81484	0.9999878406524658	O
19695	%	263 264	81485 81486	0.9999892711639404	O
19696	of	265 267	81487 81489	0.9999892711639404	O
19697	the	268 271	81490 81493	0.9999887943267822	O
19698	tumor	272 277	81494 81499	0.9999880790710449	O
19699	cells	278 283	81500 81505	0.9999884366989136	O
19700	(	284 285	81506 81507	0.9999896287918091	O
19701	high	286 290	81508 81512	0.9999886751174927	O
19702	)	291 292	81513 81514	0.9999895095825195	O
19703	,	293 294	81515 81516	0.9999895095825195	O
19704	expression	295 305	81517 81527	0.999988317489624	O
19705	in	306 308	81528 81530	0.9999895095825195	O
19706	less	309 313	81531 81535	0.9999889135360718	O
19707	than	314 318	81536 81540	0.99998939037323	O
19708	50	319 321	81541 81543	0.999987006187439	O
19709	%	322 323	81544 81545	0.9999891519546509	O
19710	of	324 326	81546 81548	0.9999891519546509	O
19711	the	327 330	81549 81552	0.9999884366989136	O
19712	tumor	331 336	81553 81558	0.9999876022338867	O
19713	cells	337 342	81559 81564	0.999988317489624	O
19714	(	343 344	81565 81566	0.99998939037323	O
19715	low	345 348	81567 81570	0.9999879598617554	O
19716	)	349 350	81571 81572	0.9999892711639404	O
19717	and	351 354	81573 81576	0.9999895095825195	O
19718	total	355 360	81577 81582	0.9999886751174927	O
19719	absence	361 368	81583 81590	0.9999891519546509	O
19720	(	369 370	81591 81592	0.9999892711639404	O
19721	absence	371 378	81593 81600	0.9999890327453613	O
19722	)	379 380	81601 81602	0.9999895095825195	O
19723	Examples	381 389	81603 81611	0.9999768733978271	O
19724	of	390 392	81612 81614	0.9999891519546509	O
19725	HCA2	393 396	81615 81618	0.9999890327453613	O
19728	and	398 401	81620 81623	0.9999887943267822	O
19729	HC10	402 405	81624 81627	0.9999890327453613	O
19731	immunohistochemical	407 425	81629 81647	0.9999887943267822	O
19737	staining	427 434	81649 81656	0.9999887943267822	O
19739	of	436 438	81658 81660	0.9999890327453613	O
19740	rectal	439 444	81661 81666	0.9999828338623047	O
19743	tumors	446 452	81668 81674	0.999987006187439	O
19744	;	453 454	81675 81676	0.9999895095825195	O
19745	a	455 456	81677 81678	0.9999892711639404	O
19746	–	456 457	81678 81679	0.9999877214431763	O
19747	c	457 458	81679 81680	0.9999887943267822	O
19748	HCA2	459 462	81681 81684	0.9999891519546509	O
19751	,	464 465	81686 81687	0.9999892711639404	O
19752	d	466 467	81688 81689	0.9999889135360718	O
19753	–	467 468	81689 81690	0.9999877214431763	O
19754	f	468 469	81690 81691	0.9999871253967285	O
19755	HC10	470 473	81692 81695	0.9999890327453613	O
19757	expression	475 485	81697 81707	0.9999890327453613	O
19758	.	486 487	81708 81709	0.9999810457229614	O
19759	a	0 1	81710 81711	0.9999879598617554	O
19760	,	2 3	81712 81713	0.9999892711639404	O
19761	d	4 5	81714 81715	0.9999860525131226	O
19762	Expression	6 15	81716 81725	0.9999887943267822	O
19764	of	17 19	81727 81729	0.9999891519546509	O
19765	HLA	20 22	81730 81732	0.9999885559082031	O
19767	class	24 29	81734 81739	0.9999889135360718	O
19768	I	30 31	81740 81741	0.9999889135360718	O
19769	in	32 34	81742 81744	0.9999896287918091	O
19770	>	35 36	81745 81746	0.9999889135360718	O
19771	50	36 38	81746 81748	0.999987006187439	O
19772	%	39 40	81749 81750	0.9999884366989136	O
19773	tumor	41 46	81751 81756	0.9999861717224121	O
19774	cells	47 52	81757 81762	0.9999871253967285	O
19775	;	53 54	81763 81764	0.99998939037323	O
19776	b	55 56	81765 81766	0.9999854564666748	O
19777	,	57 58	81767 81768	0.9999892711639404	O
19778	e	59 60	81769 81770	0.9999868869781494	O
19779	expression	61 71	81771 81781	0.9999887943267822	O
19780	of	72 74	81782 81784	0.9999891519546509	O
19781	HLA	75 77	81785 81787	0.9999887943267822	O
19783	class	79 84	81789 81794	0.9999887943267822	O
19784	I	85 86	81795 81796	0.9999887943267822	O
19785	in	87 89	81797 81799	0.99998939037323	O
19786	<	90 91	81800 81801	0.9999881982803345	O
19787	50	91 93	81801 81803	0.9999876022338867	O
19788	%	94 95	81804 81805	0.999988317489624	O
19789	tumor	96 101	81806 81811	0.9999874830245972	O
19790	cells	102 107	81812 81817	0.9999880790710449	O
19791	;	108 109	81818 81819	0.9999895095825195	O
19792	c	110 111	81820 81821	0.9999876022338867	O
19793	,	112 113	81822 81823	0.9999890327453613	O
19794	f	114 115	81824 81825	0.9999841451644897	O
19795	epithelial	116 125	81826 81835	0.9999884366989136	O
19799	cells	127 132	81837 81842	0.9999877214431763	O
19800	show	133 137	81843 81847	0.9999892711639404	O
19801	total	138 143	81848 81853	0.9999884366989136	O
19802	absence	144 151	81854 81861	0.9999884366989136	O
19803	for	152 155	81862 81865	0.9999889135360718	O
19804	HCA2	156 159	81866 81869	0.9999890327453613	O
19807	or	161 163	81871 81873	0.9999887943267822	O
19808	HC10	164 167	81874 81877	0.9999886751174927	O
19810	and	169 172	81879 81882	0.9999890327453613	O
19811	only	173 177	81883 81887	0.9999879598617554	O
19812	stromal	178 184	81888 81894	0.9999880790710449	O
19815	and	186 189	81896 81899	0.9999878406524658	O
19816	infiltrative	190 201	81900 81911	0.9999885559082031	O
19820	cells	203 208	81913 81918	0.9999878406524658	O
19821	show	209 213	81919 81923	0.9999890327453613	O
19822	positive	214 222	81924 81932	0.9999887943267822	O
19823	staining	223 230	81933 81940	0.9999887943267822	O
19825	for	232 235	81942 81945	0.9999890327453613	O
19826	HCA2	236 239	81946 81949	0.9999887943267822	O
19829	or	241 243	81951 81953	0.9999885559082031	O
19830	HC10	244 247	81954 81957	0.9999884366989136	O
19832	;	249 250	81959 81960	0.9999892711639404	O
19833	Original	251 259	81961 81969	0.9999837875366211	O
19834	magnification	260 272	81970 81982	0.9999866485595703	O
19837	×20	274 276	81984 81986	0.9999881982803345	O
19839	Analysis	278 286	81988 81996	0.9999879598617554	O
19840	of	287 289	81997 81999	0.9999890327453613	O
19841	HLA	290 292	82000 82002	0.9999885559082031	O
19843	class	294 299	82004 82009	0.9999887943267822	O
19844	I	300 301	82010 82011	0.9999887943267822	O
19845	expression	302 312	82012 82022	0.9999887943267822	O
19846	in	313 315	82023 82025	0.9999886751174927	O
19847	rectal	316 321	82026 82031	0.9999819993972778	O
19850	tumors	323 329	82033 82039	0.9999861717224121	O
19851	Together	330 338	82040 82048	0.999987006187439	O
19852	,	339 340	82049 82050	0.9999890327453613	O
19853	the	341 344	82051 82054	0.9999892711639404	O
19854	results	345 352	82055 82062	0.9999884366989136	O
19855	obtained	353 361	82063 82071	0.9999887943267822	O
19856	with	362 366	82072 82076	0.9999890327453613	O
19857	HCA2	367 370	82077 82080	0.9999890327453613	O
19860	and	372 375	82082 82085	0.9999889135360718	O
19861	HC10	376 379	82086 82089	0.9999886751174927	O
19863	are	381 384	82091 82094	0.9999890327453613	O
19864	expected	385 393	82095 82103	0.9999885559082031	O
19865	to	394 396	82104 82106	0.9999892711639404	O
19866	reflect	397 404	82107 82114	0.9999887943267822	O
19867	HLA	405 407	82115 82117	0.9999886751174927	O
19869	class	409 414	82119 82124	0.9999889135360718	O
19870	I	415 416	82125 82126	0.9999885559082031	O
19871	expression	417 427	82127 82137	0.9999886751174927	O
19872	in	428 430	82138 82140	0.9999884366989136	O
19873	rectal	431 436	82141 82146	0.9999839067459106	O
19876	cancer	438 444	82148 82154	0.9999866485595703	O
19877	.	445 446	82155 82156	0.9999767541885376	O
19878	In	0 2	82157 82159	0.9999814033508301	O
19879	a	3 4	82160 82161	0.9999825954437256	O
19880	group	5 10	82162 82167	0.9999778270721436	O
19881	of	11 13	82168 82170	0.9999822378158569	O
19882	64	14 16	82171 82173	0.999893069267273	O
19883	tumors	17 23	82174 82180	0.9999783039093018	O
19884	it	24 26	82181 82183	0.9999854564666748	O
19885	was	27 30	82184 82187	0.999984860420227	O
19886	studied	31 38	82188 82195	0.9999828338623047	O
19887	whether	39 46	82196 82203	0.9999866485595703	O
19888	an	47 49	82204 82206	0.9999880790710449	O
19889	additional	50 60	82207 82217	0.9999867677688599	O
19890	staining	61 68	82218 82225	0.9999880790710449	O
19892	for	70 73	82227 82230	0.9999885559082031	O
19893	β2	74 75	82231 82232	0.9999878406524658	O
19895	m	77 78	82234 82235	0.9999872446060181	O
19896	would	79 84	82236 82241	0.9999874830245972	O
19897	better	85 91	82242 82248	0.9999867677688599	O
19898	define	92 98	82249 82255	0.9999878406524658	O
19899	HLA	99 101	82256 82258	0.9999868869781494	O
19901	class	103 108	82260 82265	0.9999884366989136	O
19902	I	109 110	82266 82267	0.9999878406524658	O
19903	expression	111 121	82268 82278	0.9999880790710449	O
19904	.	122 123	82279 82280	0.9999672174453735	O
19905	The	0 3	82281 82284	0.9999880790710449	O
19906	results	4 11	82285 82292	0.9999876022338867	O
19907	of	12 14	82293 82295	0.9999884366989136	O
19908	the	15 18	82296 82299	0.9999886751174927	O
19909	addition	19 27	82300 82308	0.9999880790710449	O
19910	of	28 30	82309 82311	0.9999887943267822	O
19911	β2	31 32	82312 82313	0.9999871253967285	O
19913	m	34 35	82315 82316	0.9999865293502808	O
19914	to	36 38	82317 82319	0.9999886751174927	O
19915	HCA2	39 42	82320 82323	0.9999880790710449	O
19918	and	44 47	82325 82328	0.9999887943267822	O
19919	HC10	48 51	82329 82332	0.9999880790710449	O
19921	were	53 57	82334 82338	0.9999881982803345	O
19922	comparable	58 68	82339 82349	0.9999868869781494	O
19923	to	69 71	82350 82352	0.9999887943267822	O
19924	those	72 77	82353 82358	0.9999885559082031	O
19925	obtained	78 86	82359 82367	0.999988317489624	O
19926	with	87 91	82368 82372	0.9999885559082031	O
19927	HCA2	92 95	82373 82376	0.9999881982803345	O
19930	and	97 100	82378 82381	0.9999884366989136	O
19931	HC10	101 104	82382 82385	0.999988317489624	O
19933	,	106 107	82387 82388	0.999988317489624	O
19934	i	108 109	82389 82390	0.9999884366989136	O
19935	.	110 111	82391 82392	0.9999880790710449	O
19936	e	111 112	82392 82393	0.9999873638153076	O
19937	.	113 114	82394 82395	0.9999748468399048	O
19938	only	0 4	82396 82400	0.9999779462814331	O
19939	1	5 6	82401 82402	0.9999692440032959	O
19940	of	7 9	82403 82405	0.999983549118042	O
19941	64	10 12	82406 82408	0.9998375177383423	O
19942	tumors	13 19	82409 82415	0.9999701976776123	O
19943	was	20 23	82416 82419	0.9999819993972778	O
19944	differently	24 35	82420 82431	0.9999785423278809	O
19945	classified	36 46	82432 82442	0.9999809265136719	O
19946	.	47 48	82443 82444	0.9998902082443237	O
19947	Therefore	0 9	82445 82454	0.9999872446060181	O
19948	,	10 11	82455 82456	0.9999891519546509	O
19949	β2	12 13	82457 82458	0.999987006187439	O
19951	m	15 16	82460 82461	0.9999865293502808	O
19952	was	17 20	82462 82465	0.9999891519546509	O
19953	not	21 24	82466 82469	0.9999873638153076	O
19954	scored	25 31	82470 82476	0.999985933303833	O
19955	in	32 34	82477 82479	0.9999889135360718	O
19956	the	35 38	82480 82483	0.9999887943267822	O
19957	whole	39 44	82484 82489	0.9999868869781494	O
19958	cohort	45 50	82490 82495	0.9999886751174927	O
19961	and	52 55	82497 82500	0.9999886751174927	O
19962	HLA	56 58	82501 82503	0.9999867677688599	O
19964	class	60 65	82505 82510	0.9999884366989136	O
19965	I	66 67	82511 82512	0.9999880790710449	O
19966	expression	68 78	82513 82523	0.9999886751174927	O
19967	was	79 82	82524 82527	0.9999890327453613	O
19968	assessed	83 91	82528 82536	0.9999890327453613	O
19969	by	92 94	82537 82539	0.9999890327453613	O
19970	combining	95 104	82540 82549	0.9999881982803345	O
19971	HCA2	105 108	82550 82553	0.9999889135360718	O
19974	and	110 113	82555 82558	0.9999886751174927	O
19975	HC10	114 117	82559 82562	0.9999889135360718	O
19977	.	119 120	82564 82565	0.9999723434448242	O
19978	A	0 1	82566 82567	0.999985933303833	O
19979	total	2 7	82568 82573	0.999985933303833	O
19980	of	8 10	82574 82576	0.9999861717224121	O
19981	406	11 13	82577 82579	0.9999731779098511	O
19983	(	15 16	82581 82582	0.9999879598617554	O
19984	85	17 19	82583 82585	0.9999815225601196	O
19985	%	20 21	82586 82587	0.9999884366989136	O
19986	)	22 23	82588 82589	0.9999886751174927	O
19987	irradiated	24 33	82590 82599	0.9999862909317017	O
19991	and	35 38	82601 82604	0.9999856948852539	O
19992	445	39 41	82605 82607	0.9999750852584839	O
19994	(	43 44	82609 82610	0.9999884366989136	O
19995	84	45 47	82611 82613	0.99997878074646	O
19996	%	48 49	82614 82615	0.9999884366989136	O
19997	)	50 51	82616 82617	0.999988317489624	O
19998	non	52 55	82618 82621	0.9999767541885376	O
19999	-	55 56	82621 82622	0.9999868869781494	O
20000	irradiated	56 65	82622 82631	0.9999867677688599	O
20004	tumors	67 73	82633 82639	0.9999828338623047	O
20005	exhibited	74 83	82640 82649	0.9999876022338867	O
20006	expression	84 94	82650 82660	0.9999879598617554	O
20007	of	95 97	82661 82663	0.9999890327453613	O
20008	at	98 100	82664 82666	0.9999892711639404	O
20009	least	101 106	82667 82672	0.9999890327453613	O
20010	one	107 110	82673 82676	0.9999885559082031	O
20011	of	111 113	82677 82679	0.9999887943267822	O
20012	the	114 117	82680 82683	0.9999887943267822	O
20013	two	118 121	82684 82687	0.999982476234436	O
20014	markers	122 129	82688 82695	0.999984622001648	O
20015	showing	130 137	82696 82703	0.9999881982803345	O
20016	>	138 139	82704 82705	0.9999886751174927	O
20017	50	139 141	82705 82707	0.9999866485595703	O
20018	%	142 143	82708 82709	0.9999885559082031	O
20019	positive	144 152	82710 82718	0.9999879598617554	O
20020	staining	153 160	82719 82726	0.9999881982803345	O
20022	of	162 164	82728 82730	0.9999887943267822	O
20023	all	165 168	82731 82734	0.9999868869781494	O
20024	tumor	169 174	82735 82740	0.9999847412109375	O
20025	cells	175 180	82741 82746	0.9999849796295166	O
20026	(	181 182	82747 82748	0.9999885559082031	O
20027	further	183 190	82749 82756	0.9999874830245972	O
20028	referred	191 199	82757 82765	0.9999879598617554	O
20029	to	200 202	82766 82768	0.9999880790710449	O
20030	as	203 205	82769 82771	0.9999884366989136	O
20031	‘	206 207	82772 82773	0.9999876022338867	O
20032	the	207 210	82773 82776	0.9999886751174927	O
20033	HLA	211 213	82777 82779	0.999985933303833	O
20035	class	215 220	82781 82786	0.9999885559082031	O
20036	I	221 222	82787 82788	0.999988317489624	O
20037	high	223 227	82789 82793	0.9999874830245972	O
20038	expression	228 238	82794 82804	0.9999885559082031	O
20039	group	239 244	82805 82810	0.9999887943267822	O
20040	’	245 246	82811 82812	0.9999723434448242	O
20041	)	247 248	82813 82814	0.9999886751174927	O
20042	.	249 250	82815 82816	0.9999600648880005	O
20043	A	0 1	82817 82818	0.9999839067459106	O
20044	total	2 7	82819 82824	0.9999849796295166	O
20045	of	8 10	82825 82827	0.9999847412109375	O
20046	70	11 13	82828 82830	0.9999717473983765	O
20047	(	14 15	82831 82832	0.9999866485595703	O
20048	15	16 18	82833 82835	0.9999771118164062	O
20049	%	19 20	82836 82837	0.9999867677688599	O
20050	)	21 22	82838 82839	0.9999877214431763	O
20051	irradiated	23 32	82840 82849	0.9999849796295166	O
20055	and	34 37	82851 82854	0.999983549118042	O
20056	87	38 40	82855 82857	0.999970555305481	O
20057	(	41 42	82858 82859	0.9999874830245972	O
20058	16	43 45	82860 82862	0.9999731779098511	O
20059	%	46 47	82863 82864	0.9999874830245972	O
20060	)	48 49	82865 82866	0.9999872446060181	O
20061	non	50 53	82867 82870	0.9999730587005615	O
20062	-	53 54	82870 82871	0.9999853372573853	O
20063	irradiated	54 63	82871 82880	0.9999850988388062	O
20067	tumors	65 71	82882 82888	0.9999818801879883	O
20068	showed	72 78	82889 82895	0.9999839067459106	O
20069	reduced	79 86	82896 82903	0.9999817609786987	O
20070	numbers	87 94	82904 82911	0.9999847412109375	O
20071	(	95 96	82912 82913	0.9999878406524658	O
20072	≤50	97 99	82914 82916	0.9999860525131226	O
20074	%	101 102	82918 82919	0.9999876022338867	O
20075	)	103 104	82920 82921	0.999988317489624	O
20076	of	105 107	82922 82924	0.9999866485595703	O
20077	HLA	108 110	82925 82927	0.9999854564666748	O
20079	class	112 117	82929 82934	0.9999876022338867	O
20080	I	118 119	82935 82936	0.9999852180480957	O
20081	positive	120 128	82937 82945	0.9999841451644897	O
20082	tumor	129 134	82946 82951	0.9999837875366211	O
20083	cells	135 140	82952 82957	0.9999827146530151	O
20084	.	141 142	82958 82959	0.9999536275863647	O
20085	Only	0 4	82960 82964	0.999981164932251	O
20086	3	5 6	82965 82966	0.9999676942825317	O
20087	(	7 8	82967 82968	0.9999880790710449	O
20088	0	9 10	82969 82970	0.9999810457229614	O
20089	.	10 11	82970 82971	0.9999880790710449	O
20090	6	11 12	82971 82972	0.999980092048645	O
20091	%	13 14	82973 82974	0.9999885559082031	O
20092	)	15 16	82975 82976	0.9999886751174927	O
20093	irradiated	17 26	82977 82986	0.999984622001648	O
20097	tumors	28 34	82988 82994	0.9999860525131226	O
20098	and	35 38	82995 82998	0.9999845027923584	O
20099	8	39 40	82999 83000	0.9999727010726929	O
20100	(	41 42	83001 83002	0.9999885559082031	O
20101	1	43 44	83003 83004	0.999984860420227	O
20102	.	44 45	83004 83005	0.999988317489624	O
20103	5	45 46	83005 83006	0.9999845027923584	O
20104	%	47 48	83007 83008	0.9999889135360718	O
20105	)	49 50	83009 83010	0.9999885559082031	O
20106	non	51 54	83011 83014	0.99997878074646	O
20107	-	54 55	83014 83015	0.9999867677688599	O
20108	irradiated	55 64	83015 83024	0.9999867677688599	O
20112	tumors	66 72	83026 83032	0.999987006187439	O
20113	showed	73 79	83033 83039	0.9999876022338867	O
20114	total	80 85	83040 83045	0.999988317489624	O
20115	loss	86 90	83046 83050	0.9999881982803345	O
20116	of	91 93	83051 83053	0.9999890327453613	O
20117	HLA	94 96	83054 83056	0.9999880790710449	O
20119	class	98 103	83058 83063	0.9999889135360718	O
20120	I	104 105	83064 83065	0.9999886751174927	O
20121	(	106 107	83066 83067	0.9999890327453613	O
20122	negative	108 116	83068 83076	0.9999858140945435	O
20123	for	117 120	83077 83080	0.9999887943267822	O
20124	both	121 125	83081 83085	0.9999878406524658	O
20125	HCA2	126 129	83086 83089	0.9999887943267822	O
20128	and	131 134	83091 83094	0.9999873638153076	O
20129	HC10	135 138	83095 83098	0.9999885559082031	O
20131	)	140 141	83100 83101	0.9999877214431763	O
20132	.	142 143	83102 83103	0.9999599456787109	O
20133	Survival	0 8	83104 83112	0.9999833106994629	O
20134	results	9 16	83113 83120	0.9999854564666748	O
20135	of	17 19	83121 83123	0.9999868869781494	O
20136	patients	20 28	83124 83132	0.999983549118042	O
20137	with	29 33	83133 83137	0.9999884366989136	O
20138	total	34 39	83138 83143	0.9999864101409912	O
20139	absence	40 47	83144 83151	0.9999874830245972	O
20140	of	48 50	83152 83154	0.9999890327453613	O
20141	HLA	51 53	83155 83157	0.9999881982803345	O
20143	class	55 60	83159 83164	0.9999887943267822	O
20144	I	61 62	83165 83166	0.9999884366989136	O
20145	on	63 65	83167 83169	0.9999878406524658	O
20146	tumor	66 71	83170 83175	0.9999860525131226	O
20147	cells	72 77	83176 83181	0.999988317489624	O
20148	did	78 81	83182 83185	0.9999864101409912	O
20149	not	82 85	83186 83189	0.9999855756759644	O
20150	show	86 90	83190 83194	0.999987006187439	O
20151	significant	91 102	83195 83206	0.9999877214431763	O
20152	difference	103 113	83207 83217	0.999985933303833	O
20153	from	114 118	83218 83222	0.9999856948852539	O
20154	patients	119 127	83223 83231	0.9999840259552002	O
20155	with	128 132	83232 83236	0.9999885559082031	O
20156	reduced	133 140	83237 83244	0.9999845027923584	O
20157	numbers	141 148	83245 83252	0.9999877214431763	O
20158	of	149 151	83253 83255	0.9999889135360718	O
20159	HLA	152 154	83256 83258	0.999988317489624	O
20161	class	156 161	83260 83265	0.9999886751174927	O
20162	I	162 163	83266 83267	0.9999881982803345	O
20163	positive	164 172	83268 83276	0.999987006187439	O
20164	tumor	173 178	83277 83282	0.999985933303833	O
20165	cells	179 184	83283 83288	0.9999877214431763	O
20166	.	185 186	83289 83290	0.9999648332595825	O
20167	Therefore	0 9	83291 83300	0.9999872446060181	O
20168	,	10 11	83301 83302	0.9999886751174927	O
20169	these	12 17	83303 83308	0.9999878406524658	O
20170	groups	18 24	83309 83315	0.9999845027923584	O
20171	were	25 29	83316 83320	0.9999879598617554	O
20172	combined	30 38	83321 83329	0.9999853372573853	O
20173	and	39 42	83330 83333	0.9999874830245972	O
20174	will	43 47	83334 83338	0.9999862909317017	O
20175	be	48 50	83339 83341	0.9999881982803345	O
20176	further	51 58	83342 83349	0.9999871253967285	O
20177	referred	59 67	83350 83358	0.9999876022338867	O
20178	to	68 70	83359 83361	0.9999880790710449	O
20179	as	71 73	83362 83364	0.9999884366989136	O
20180	‘	74 75	83365 83366	0.9999885559082031	O
20181	the	75 78	83366 83369	0.9999887943267822	O
20182	HLA	79 81	83370 83372	0.9999871253967285	O
20184	class	83 88	83374 83379	0.9999889135360718	O
20185	I	89 90	83380 83381	0.9999884366989136	O
20186	low	91 94	83382 83385	0.9999884366989136	O
20187	-	94 95	83385 83386	0.9999889135360718	O
20188	expression	95 105	83386 83396	0.9999879598617554	O
20189	group	106 111	83397 83402	0.9999889135360718	O
20190	’	111 112	83402 83403	0.9999803304672241	O
20191	.	113 114	83404 83405	0.9999700784683228	O
20192	The	0 3	83406 83409	0.9999836683273315	O
20193	complete	4 12	83410 83418	0.9999825954437256	O
20194	results	13 20	83419 83426	0.9999827146530151	O
20195	are	21 24	83427 83430	0.9999819993972778	O
20196	shown	25 30	83431 83436	0.9999794960021973	O
20197	in	31 33	83437 83439	0.9999850988388062	O
20198	Table	34 39	83440 83445	0.999982476234436	O
20199	2	40 41	83446 83447	0.9999825954437256	O
20200	.	41 42	83447 83448	0.9999654293060303	O
20201	The	0 3	83449 83452	0.9999872446060181	O
20202	number	4 10	83453 83459	0.9999855756759644	O
20203	of	11 13	83460 83462	0.9999874830245972	O
20204	patients	14 22	83463 83471	0.9999823570251465	O
20205	in	23 25	83472 83474	0.9999881982803345	O
20206	the	26 29	83475 83478	0.9999878406524658	O
20207	group	30 35	83479 83484	0.9999867677688599	O
20208	of	36 38	83485 83487	0.9999878406524658	O
20209	the	39 42	83488 83491	0.9999887943267822	O
20210	HLA	43 45	83492 83494	0.9999885559082031	O
20212	class	47 52	83496 83501	0.9999892711639404	O
20213	I	53 54	83502 83503	0.9999891519546509	O
20214	high	55 59	83504 83508	0.9999887943267822	O
20215	-	59 60	83508 83509	0.99998939037323	O
20216	expression	60 70	83509 83519	0.9999890327453613	O
20217	group	71 76	83520 83525	0.9999890327453613	O
20218	and	77 80	83526 83529	0.9999872446060181	O
20219	the	81 84	83530 83533	0.9999889135360718	O
20220	HLA	85 87	83534 83536	0.9999885559082031	O
20222	class	89 94	83538 83543	0.9999890327453613	O
20223	I	95 96	83544 83545	0.9999889135360718	O
20224	low	97 100	83546 83549	0.9999884366989136	O
20225	-	100 101	83549 83550	0.9999892711639404	O
20226	expression	101 111	83550 83560	0.9999889135360718	O
20227	group	112 117	83561 83566	0.9999891519546509	O
20228	was	118 121	83567 83570	0.9999890327453613	O
20229	equally	122 129	83571 83578	0.9999884366989136	O
20230	distributed	130 141	83579 83590	0.9999892711639404	O
20231	between	142 149	83591 83598	0.9999880790710449	O
20232	irradiated	150 159	83599 83608	0.9999891519546509	O
20236	and	161 164	83610 83613	0.9999868869781494	O
20237	non	165 168	83614 83617	0.9999862909317017	O
20238	-	168 169	83617 83618	0.999988317489624	O
20239	irradiated	169 178	83618 83627	0.9999885559082031	O
20243	tumors	180 186	83629 83635	0.9999858140945435	O
20244	(	187 188	83636 83637	0.9999892711639404	O
20245	χ2	189 190	83638 83639	0.9999867677688599	O
20247	=	192 193	83641 83642	0.9999890327453613	O
20248	0	194 195	83643 83644	0.99998939037323	O
20249	.	195 196	83644 83645	0.9999891519546509	O
20250	519	196 198	83645 83647	0.9999861717224121	O
20252	,	200 201	83649 83650	0.9999880790710449	O
20253	P	202 203	83651 83652	0.9999886751174927	O
20254	=	204 205	83653 83654	0.9999886751174927	O
20255	0	206 207	83655 83656	0.9999890327453613	O
20256	.	207 208	83656 83657	0.9999889135360718	O
20257	471	208 210	83657 83659	0.9999825954437256	O
20259	)	212 213	83661 83662	0.9999889135360718	O
20260	,	214 215	83663 83664	0.9999881982803345	O
20261	indicating	216 226	83665 83675	0.999988317489624	O
20262	that	227 231	83676 83680	0.99998939037323	O
20263	irradiation	232 242	83681 83691	0.9999889135360718	O
20266	had	244 247	83693 83696	0.9999886751174927	O
20267	no	248 250	83697 83699	0.9999871253967285	O
20268	effect	251 257	83700 83706	0.999988317489624	O
20269	on	258 260	83707 83709	0.9999892711639404	O
20270	HLA	261 263	83710 83712	0.9999878406524658	O
20272	class	265 270	83714 83719	0.9999889135360718	O
20273	I	271 272	83720 83721	0.999988317489624	O
20274	expression	273 283	83722 83732	0.9999879598617554	O
20275	in	284 286	83733 83735	0.9999876022338867	O
20276	these	287 292	83736 83741	0.9999853372573853	O
20277	patients	293 301	83742 83750	0.9999812841415405	O
20278	.	302 303	83751 83752	0.9999661445617676	O
20279	Table	0 5	83753 83758	0.9999881982803345	O
20280	2Expression	6 16	83759 83769	0.9999880790710449	O
20285	of	18 20	83771 83773	0.9999892711639404	O
20286	HLA	21 23	83774 83776	0.9999878406524658	O
20288	class	25 30	83778 83783	0.9999887943267822	O
20289	I	31 32	83784 83785	0.9999880790710449	O
20290	in	33 35	83786 83788	0.9999891519546509	O
20291	rectal	36 41	83789 83794	0.9999828338623047	O
20294	cancer	43 49	83796 83802	0.999987006187439	O
20295	using	50 55	83803 83808	0.9999892711639404	O
20296	HCA2	56 59	83809 83812	0.9999892711639404	O
20299	and	61 64	83814 83817	0.9999890327453613	O
20300	HC10	65 68	83818 83821	0.9999891519546509	O
20302	antibodiesHCA2HC10HLA	70 90	83823 83843	0.999987006187439	O
20310	class	92 97	83845 83850	0.9999889135360718	O
20311	IHigh	98 102	83851 83855	0.9999887943267822	O
20314	(	104 105	83857 83858	0.99998939037323	O
20315	N	106 107	83859 83860	0.9999886751174927	O
20316	)	107 108	83860 83861	0.99998939037323	O
20317	Low	108 111	83861 83864	0.999988317489624	O
20318	+	112 113	83865 83866	0.9999892711639404	O
20319	absence	114 121	83867 83874	0.9999892711639404	O
20320	(	122 123	83875 83876	0.99998939037323	O
20321	N	124 125	83877 83878	0.9999887943267822	O
20322	)	125 126	83878 83879	0.9999892711639404	O
20323	N	126 127	83879 83880	0.9999886751174927	O
20324	(	128 129	83881 83882	0.9999892711639404	O
20325	%	130 131	83883 83884	0.9999892711639404	O
20326	)	131 132	83884 83885	0.9999892711639404	O
20327	IrradiatedHigh	132 145	83885 83898	0.9999889135360718	O
20333	(	147 148	83900 83901	0.9999892711639404	O
20334	N	149 150	83902 83903	0.9999889135360718	O
20335	)	150 151	83903 83904	0.9999895095825195	O
20336	27037406	151 158	83904 83911	0.9999874830245972	O
20340	(	160 161	83913 83914	0.9999892711639404	O
20341	85	162 164	83915 83917	0.9999876022338867	O
20342	%	165 166	83918 83919	0.9999895095825195	O
20343	)	167 168	83920 83921	0.9999892711639404	O
20344	Low	168 171	83921 83924	0.9999884366989136	O
20345	+	172 173	83925 83926	0.9999891519546509	O
20346	absence	174 181	83927 83934	0.9999892711639404	O
20347	(	182 183	83935 83936	0.9999892711639404	O
20348	N	184 185	83937 83938	0.9999885559082031	O
20349	)	185 186	83938 83939	0.9999892711639404	O
20350	997070	186 191	83939 83944	0.9999873638153076	O
20353	(	193 194	83946 83947	0.9999891519546509	O
20354	15	195 197	83948 83950	0.9999860525131226	O
20355	%	198 199	83951 83952	0.9999895095825195	O
20356	)	200 201	83953 83954	0.99998939037323	O
20357	Non	202 205	83955 83958	0.9999874830245972	O
20358	-	205 206	83958 83959	0.9999891519546509	O
20359	irradiatedHigh	206 219	83959 83972	0.9999890327453613	O
20365	(	221 222	83974 83975	0.99998939037323	O
20366	N	223 224	83976 83977	0.9999885559082031	O
20367	)	224 225	83977 83978	0.9999892711639404	O
20368	27732445	225 232	83978 83985	0.9999880790710449	O
20373	(	234 235	83987 83988	0.9999891519546509	O
20374	84	236 238	83989 83991	0.9999862909317017	O
20375	%	239 240	83992 83993	0.9999896287918091	O
20376	)	241 242	83994 83995	0.99998939037323	O
20377	Low	242 245	83995 83998	0.999988317489624	O
20378	+	246 247	83999 84000	0.9999891519546509	O
20379	absence	248 255	84001 84008	0.99998939037323	O
20380	(	256 257	84009 84010	0.99998939037323	O
20381	N	258 259	84011 84012	0.9999886751174927	O
20382	)	259 260	84012 84013	0.99998939037323	O
20383	1368787	260 266	84013 84019	0.9999868869781494	O
20388	(	268 269	84021 84022	0.9999891519546509	O
20389	16	270 272	84023 84025	0.9999860525131226	O
20390	%	273 274	84026 84027	0.9999895095825195	O
20391	)	275 276	84028 84029	0.9999892711639404	O
20392	Expression	276 285	84029 84038	0.9999889135360718	O
20394	of	287 289	84040 84042	0.9999895095825195	O
20395	results	290 297	84043 84050	0.9999887943267822	O
20396	of	298 300	84051 84053	0.9999895095825195	O
20397	HCA2	301 304	84054 84057	0.9999892711639404	O
20400	and	306 309	84059 84062	0.9999889135360718	O
20401	HC10	310 313	84063 84066	0.9999890327453613	O
20403	staining	315 322	84068 84075	0.9999889135360718	O
20405	in	324 326	84077 84079	0.9999896287918091	O
20406	a	327 328	84080 84081	0.9999895095825195	O
20407	cross	329 334	84082 84087	0.9999886751174927	O
20408	table	335 340	84088 84093	0.9999884366989136	O
20409	for	341 344	84094 84097	0.9999892711639404	O
20410	numbers	345 352	84098 84105	0.9999880790710449	O
20411	(	353 354	84106 84107	0.9999895095825195	O
20412	N	355 356	84108 84109	0.9999880790710449	O
20413	)	357 358	84110 84111	0.9999895095825195	O
20414	of	359 361	84112 84114	0.9999892711639404	O
20415	irradiated	362 371	84115 84124	0.9999890327453613	O
20419	and	373 376	84126 84129	0.9999881982803345	O
20420	non	377 380	84130 84133	0.9999880790710449	O
20421	-	380 381	84133 84134	0.9999889135360718	O
20422	irradiated	381 390	84134 84143	0.9999887943267822	O
20426	patients	392 400	84145 84153	0.9999866485595703	O
20427	;	401 402	84154 84155	0.9999895095825195	O
20428	expression	403 413	84156 84166	0.9999891519546509	O
20429	of	414 416	84167 84169	0.9999895095825195	O
20430	HCA2	417 420	84170 84173	0.9999889135360718	O
20433	and	422 425	84175 84178	0.9999887943267822	O
20434	HC10	426 429	84179 84182	0.9999886751174927	O
20436	in	431 433	84184 84186	0.9999897480010986	O
20437	more	434 438	84187 84191	0.9999892711639404	O
20438	than	439 443	84192 84196	0.99998939037323	O
20439	50	444 446	84197 84199	0.9999873638153076	O
20440	%	447 448	84200 84201	0.99998939037323	O
20441	of	449 451	84202 84204	0.9999895095825195	O
20442	the	452 455	84205 84208	0.9999887943267822	O
20443	tumor	456 461	84209 84214	0.9999877214431763	O
20444	cells	462 467	84215 84220	0.9999886751174927	O
20445	(	468 469	84221 84222	0.9999896287918091	O
20446	high	470 474	84223 84227	0.9999887943267822	O
20447	)	475 476	84228 84229	0.9999896287918091	O
20448	versus	477 483	84230 84236	0.9999881982803345	O
20449	expression	484 494	84237 84247	0.9999886751174927	O
20450	in	495 497	84248 84250	0.9999896287918091	O
20451	less	498 502	84251 84255	0.9999889135360718	O
20452	than	503 507	84256 84260	0.9999892711639404	O
20453	50	508 510	84261 84263	0.9999868869781494	O
20454	%	511 512	84264 84265	0.9999892711639404	O
20455	of	513 515	84266 84268	0.9999892711639404	O
20456	the	516 519	84269 84272	0.9999887943267822	O
20457	tumor	520 525	84273 84278	0.9999876022338867	O
20458	cells	526 531	84279 84284	0.9999885559082031	O
20459	(	532 533	84285 84286	0.9999895095825195	O
20460	low	534 537	84287 84290	0.9999862909317017	O
20461	)	538 539	84291 84292	0.9999895095825195	O
20462	is	540 542	84293 84295	0.9999892711639404	O
20463	shown	543 548	84296 84301	0.9999884366989136	O
20464	.	549 550	84302 84303	0.999970555305481	O
20465	A	0 1	84304 84305	0.9999878406524658	O
20466	significant	2 13	84306 84317	0.9999880790710449	O
20467	correlation	14 25	84318 84329	0.9999865293502808	O
20468	was	26 29	84330 84333	0.9999885559082031	O
20469	noted	30 35	84334 84339	0.9999864101409912	O
20470	between	36 43	84340 84347	0.9999887943267822	O
20471	HCA2	44 47	84348 84351	0.9999887943267822	O
20474	and	49 52	84353 84356	0.9999892711639404	O
20475	HC10	53 56	84357 84360	0.9999887943267822	O
20477	staining	58 65	84362 84369	0.9999890327453613	O
20479	for	67 70	84371 84374	0.9999896287918091	O
20480	both	71 75	84375 84379	0.9999867677688599	O
20481	irradiated	76 85	84380 84389	0.9999889135360718	O
20485	(	87 88	84391 84392	0.9999898672103882	O
20486	χ2	89 90	84393 84394	0.9999884366989136	O
20488	=	92 93	84396 84397	0.9999896287918091	O
20489	53	94 96	84398 84400	0.9999876022338867	O
20490	.	96 97	84400 84401	0.9999896287918091	O
20491	947	97 99	84401 84403	0.9999889135360718	O
20493	,	101 102	84405 84406	0.9999892711639404	O
20494	P	103 104	84407 84408	0.9999896287918091	O
20495	<	105 106	84409 84410	0.9999892711639404	O
20496	0	107 108	84411 84412	0.9999895095825195	O
20497	.	108 109	84412 84413	0.9999895095825195	O
20498	001	109 111	84413 84415	0.99998939037323	O
20500	)	113 114	84417 84418	0.9999895095825195	O
20501	and	115 118	84419 84422	0.999987006187439	O
20502	non	119 122	84423 84426	0.9999862909317017	O
20503	-	122 123	84426 84427	0.9999889135360718	O
20504	irradiated	123 132	84427 84436	0.9999887943267822	O
20508	patients	134 142	84438 84446	0.9999858140945435	O
20509	(	143 144	84447 84448	0.9999897480010986	O
20510	χ2	145 146	84449 84450	0.9999886751174927	O
20512	=	148 149	84452 84453	0.9999895095825195	O
20513	61	150 152	84454 84456	0.9999876022338867	O
20514	.	152 153	84456 84457	0.9999892711639404	O
20515	257	153 156	84457 84460	0.9999855756759644	O
20516	,	157 158	84461 84462	0.9999889135360718	O
20517	P	159 160	84463 84464	0.99998939037323	O
20518	<	161 162	84465 84466	0.999988317489624	O
20519	0	163 164	84467 84468	0.9999892711639404	O
20520	.	164 165	84468 84469	0.9999890327453613	O
20521	001	165 167	84469 84471	0.9999889135360718	O
20523	)	169 170	84473 84474	0.9999892711639404	O
20524	.	171 172	84475 84476	0.9999727010726929	O
20525	The	0 3	84477 84480	0.9999889135360718	O
20526	right	4 9	84481 84486	0.9999881982803345	O
20527	side	10 14	84487 84491	0.9999881982803345	O
20528	of	15 17	84492 84494	0.9999890327453613	O
20529	the	18 21	84495 84498	0.9999890327453613	O
20530	table	22 27	84499 84504	0.9999839067459106	O
20531	displays	28 36	84505 84513	0.9999876022338867	O
20532	HLA	37 39	84514 84516	0.9999877214431763	O
20534	class	41 46	84518 84523	0.9999891519546509	O
20535	I	47 48	84524 84525	0.9999886751174927	O
20536	expression	49 59	84526 84536	0.9999896287918091	O
20537	estimated	60 69	84537 84546	0.9999886751174927	O
20538	on	70 72	84547 84549	0.9999892711639404	O
20539	HCA2	73 76	84550 84553	0.99998939037323	O
20542	and	78 81	84555 84558	0.9999892711639404	O
20543	HC10	82 85	84559 84562	0.9999890327453613	O
20545	expression	87 97	84564 84574	0.9999895095825195	O
20546	.	98 99	84575 84576	0.9999756813049316	O
20547	A	0 1	84577 84578	0.9999843835830688	O
20548	total	2 7	84579 84584	0.9999849796295166	O
20549	of	8 10	84585 84587	0.9999849796295166	O
20550	406	11 13	84588 84590	0.9999707937240601	O
20552	(	15 16	84592 84593	0.9999872446060181	O
20553	85	17 19	84594 84596	0.9999794960021973	O
20554	%	20 21	84597 84598	0.9999876022338867	O
20555	)	22 23	84599 84600	0.9999879598617554	O
20556	irradiated	24 33	84601 84610	0.9999853372573853	O
20560	and	35 38	84612 84615	0.9999839067459106	O
20561	445	39 41	84616 84618	0.9999727010726929	O
20563	(	43 44	84620 84621	0.9999878406524658	O
20564	84	45 47	84622 84624	0.9999767541885376	O
20565	%	48 49	84625 84626	0.9999876022338867	O
20566	)	50 51	84627 84628	0.9999874830245972	O
20567	non	52 55	84629 84632	0.9999749660491943	O
20568	-	55 56	84632 84633	0.9999856948852539	O
20569	irradiated	56 65	84633 84642	0.9999861717224121	O
20573	tumors	67 73	84644 84650	0.9999808073043823	O
20574	exhibited	74 83	84651 84660	0.9999860525131226	O
20575	expression	84 94	84661 84671	0.9999871253967285	O
20576	of	95 97	84672 84674	0.999988317489624	O
20577	at	98 100	84675 84677	0.9999887943267822	O
20578	least	101 106	84678 84683	0.9999885559082031	O
20579	one	107 110	84684 84687	0.9999878406524658	O
20580	of	111 113	84688 84690	0.999988317489624	O
20581	the	114 117	84691 84694	0.9999880790710449	O
20582	two	118 121	84695 84698	0.9999792575836182	O
20583	markers	122 129	84699 84706	0.9999827146530151	O
20584	showing	130 137	84707 84714	0.9999864101409912	O
20585	>	138 139	84715 84716	0.9999876022338867	O
20586	50	139 141	84716 84718	0.9999850988388062	O
20587	%	142 143	84719 84720	0.9999877214431763	O
20588	positive	144 152	84721 84729	0.9999867677688599	O
20589	staining	153 160	84730 84737	0.999987006187439	O
20591	of	162 164	84739 84741	0.9999878406524658	O
20592	all	165 168	84742 84745	0.9999850988388062	O
20593	tumor	169 174	84746 84751	0.9999822378158569	O
20594	cells	175 180	84752 84757	0.9999812841415405	O
20595	.	181 182	84758 84759	0.9999455213546753	O
20596	A	0 1	84760 84761	0.9999839067459106	O
20597	total	2 7	84762 84767	0.9999849796295166	O
20598	of	8 10	84768 84770	0.9999847412109375	O
20599	70	11 13	84771 84773	0.9999715089797974	O
20600	(	14 15	84774 84775	0.9999866485595703	O
20601	15	16 18	84776 84778	0.9999772310256958	O
20602	%	19 20	84779 84780	0.9999868869781494	O
20603	)	21 22	84781 84782	0.9999878406524658	O
20604	irradiated	23 32	84783 84792	0.9999849796295166	O
20608	and	34 37	84794 84797	0.9999836683273315	O
20609	88	38 40	84798 84800	0.9999715089797974	O
20610	(	41 42	84801 84802	0.9999876022338867	O
20611	16	43 45	84803 84805	0.9999731779098511	O
20612	%	46 47	84806 84807	0.9999874830245972	O
20613	)	48 49	84808 84809	0.9999873638153076	O
20614	non	50 53	84810 84813	0.9999734163284302	O
20615	-	53 54	84813 84814	0.9999854564666748	O
20616	irradiated	54 63	84814 84823	0.9999850988388062	O
20620	tumors	65 71	84825 84831	0.9999818801879883	O
20621	showed	72 78	84832 84838	0.9999839067459106	O
20622	reduced	79 86	84839 84846	0.9999818801879883	O
20623	numbers	87 94	84847 84854	0.9999847412109375	O
20624	(	95 96	84855 84856	0.9999877214431763	O
20625	≤50	97 99	84857 84859	0.9999861717224121	O
20627	%	101 102	84861 84862	0.9999876022338867	O
20628	)	103 104	84863 84864	0.999988317489624	O
20629	of	105 107	84865 84867	0.9999866485595703	O
20630	HLA	108 110	84868 84870	0.9999854564666748	O
20632	class	112 117	84872 84877	0.9999876022338867	O
20633	I	118 119	84878 84879	0.9999852180480957	O
20634	positive	120 128	84880 84888	0.9999842643737793	O
20635	tumor	129 134	84889 84894	0.9999837875366211	O
20636	cells	135 140	84895 84900	0.9999827146530151	O
20637	.	141 142	84901 84902	0.9999536275863647	O
20638	The	0 3	84903 84906	0.999988317489624	O
20639	number	4 10	84907 84913	0.9999867677688599	O
20640	of	11 13	84914 84916	0.999988317489624	O
20641	patients	14 22	84917 84925	0.9999842643737793	O
20642	in	23 25	84926 84928	0.9999885559082031	O
20643	the	26 29	84929 84932	0.9999884366989136	O
20644	group	30 35	84933 84938	0.9999878406524658	O
20645	of	36 38	84939 84941	0.9999884366989136	O
20646	the	39 42	84942 84945	0.9999892711639404	O
20647	HLA	43 45	84946 84948	0.9999884366989136	O
20649	class	47 52	84950 84955	0.9999891519546509	O
20650	I	53 54	84956 84957	0.9999890327453613	O
20651	high	55 59	84958 84962	0.9999889135360718	O
20652	expression	60 70	84963 84973	0.9999892711639404	O
20653	group	71 76	84974 84979	0.99998939037323	O
20654	and	77 80	84980 84983	0.999988317489624	O
20655	the	81 84	84984 84987	0.9999891519546509	O
20656	HLA	85 87	84988 84990	0.9999885559082031	O
20658	class	89 94	84992 84997	0.9999889135360718	O
20659	I	95 96	84998 84999	0.9999887943267822	O
20660	low	97 100	85000 85003	0.999988317489624	O
20661	expression	101 111	85004 85014	0.9999891519546509	O
20662	group	112 117	85015 85020	0.9999891519546509	O
20663	was	118 121	85021 85024	0.9999891519546509	O
20664	equally	122 129	85025 85032	0.9999881982803345	O
20665	distributed	130 141	85033 85044	0.99998939037323	O
20666	between	142 149	85045 85052	0.999988317489624	O
20667	irradiated	150 159	85053 85062	0.9999892711639404	O
20671	and	161 164	85064 85067	0.9999879598617554	O
20672	non	165 168	85068 85071	0.9999872446060181	O
20673	-	168 169	85071 85072	0.9999886751174927	O
20674	irradiated	169 178	85072 85081	0.9999886751174927	O
20678	tumors	180 186	85083 85089	0.9999866485595703	O
20679	(	187 188	85090 85091	0.9999895095825195	O
20680	χ2	189 190	85092 85093	0.9999868869781494	O
20682	=	192 193	85095 85096	0.9999891519546509	O
20683	0	194 195	85097 85098	0.99998939037323	O
20684	.	195 196	85098 85099	0.9999892711639404	O
20685	519	196 198	85099 85101	0.9999865293502808	O
20687	,	200 201	85103 85104	0.9999886751174927	O
20688	P	202 203	85105 85106	0.9999887943267822	O
20689	=	204 205	85107 85108	0.9999889135360718	O
20690	0	206 207	85109 85110	0.9999890327453613	O
20691	.	207 208	85110 85111	0.9999890327453613	O
20692	471	208 210	85111 85113	0.9999823570251465	O
20694	)	212 213	85115 85116	0.9999892711639404	O
20695	*	214 215	85117 85118	0.9999892711639404	O
20696	*	215 216	85118 85119	0.9999890327453613	O
20697	IGNORE	217 222	85120 85125	0.9999884366989136	O
20700	LINE	224 227	85127 85130	0.99998939037323	O
20703	*	229 230	85132 85133	0.9999889135360718	O
20704	*	230 231	85133 85134	0.9999887943267822	O
20705	*	232 233	85135 85136	0.9999886751174927	O
20706	*	233 234	85136 85137	0.9999885559082031	O
20707	IGNORE	235 240	85138 85143	0.9999881982803345	O
20710	LINE	242 245	85145 85148	0.9999892711639404	O
20713	*	247 248	85150 85151	0.9999886751174927	O
20714	*	248 249	85151 85152	0.9999885559082031	O
20715	*	250 251	85153 85154	0.9999885559082031	O
20716	*	251 252	85154 85155	0.9999886751174927	O
20717	IGNORE	253 258	85156 85161	0.9999879598617554	O
20720	LINE	260 263	85163 85166	0.9999891519546509	O
20723	*	265 266	85168 85169	0.9999886751174927	O
20724	*	266 267	85169 85170	0.9999885559082031	O
20725	Examples	268 276	85171 85179	0.9999799728393555	O
20726	of	277 279	85180 85182	0.9999889135360718	O
20727	Kaplan	280 286	85183 85189	0.9999866485595703	O
20728	–	286 287	85189 85190	0.9999860525131226	O
20729	Meier	287 291	85190 85194	0.9999877214431763	O
20731	curves	293 299	85196 85202	0.9999865293502808	O
20732	showing	300 307	85203 85210	0.9999881982803345	O
20733	overall	308 315	85211 85218	0.9999889135360718	O
20734	survival	316 324	85219 85227	0.9999887943267822	O
20735	and	325 328	85228 85231	0.9999890327453613	O
20736	cancer	329 335	85232 85238	0.9999856948852539	O
20737	specific	336 344	85239 85247	0.9999884366989136	O
20738	survival	345 353	85248 85256	0.9999889135360718	O
20739	for	354 357	85257 85260	0.9999892711639404	O
20740	irradiated	358 367	85261 85270	0.9999891519546509	O
20744	and	369 372	85272 85275	0.9999880790710449	O
20745	non	373 376	85276 85279	0.9999877214431763	O
20746	-	376 377	85279 85280	0.9999889135360718	O
20747	irradiated	377 386	85280 85289	0.9999884366989136	O
20751	patients	388 396	85291 85299	0.9999867677688599	O
20752	(	397 398	85300 85301	0.9999897480010986	O
20753	a	399 400	85302 85303	0.99998939037323	O
20754	–	400 401	85303 85304	0.9999873638153076	O
20755	d	401 402	85304 85305	0.9999878406524658	O
20756	)	403 404	85306 85307	0.9999896287918091	O
20757	.	405 406	85308 85309	0.99997878074646	O
20758	Kaplan	0 6	85310 85316	0.9999861717224121	O
20759	–	6 7	85316 85317	0.9999816417694092	O
20760	Meier	7 11	85317 85321	0.9999867677688599	O
20762	curves	13 19	85323 85329	0.9999865293502808	O
20763	for	20 23	85330 85333	0.9999885559082031	O
20764	overall	24 31	85334 85341	0.9999881982803345	O
20765	survival	32 40	85342 85350	0.9999887943267822	O
20766	(	41 42	85351 85352	0.9999897480010986	O
20767	a	43 44	85353 85354	0.9999890327453613	O
20768	,	45 46	85355 85356	0.9999891519546509	O
20769	b	47 48	85357 85358	0.9999877214431763	O
20770	)	49 50	85359 85360	0.9999896287918091	O
20771	and	51 54	85361 85364	0.9999889135360718	O
20772	cancer	55 61	85365 85371	0.9999850988388062	O
20773	specific	62 70	85372 85380	0.9999886751174927	O
20774	survival	71 79	85381 85389	0.9999890327453613	O
20775	(	80 81	85390 85391	0.9999896287918091	O
20776	c	82 83	85392 85393	0.9999886751174927	O
20777	,	84 85	85394 85395	0.9999890327453613	O
20778	d	86 87	85396 85397	0.9999880790710449	O
20779	)	88 89	85398 85399	0.9999897480010986	O
20780	;	90 91	85400 85401	0.9999887943267822	O
20781	curves	92 98	85402 85408	0.9999858140945435	O
20782	show	99 103	85409 85413	0.9999876022338867	O
20783	prognosis	104 112	85414 85422	0.99998939037323	O
20786	for	114 117	85424 85427	0.9999896287918091	O
20787	non	118 121	85428 85431	0.9999877214431763	O
20788	-	121 122	85431 85432	0.9999891519546509	O
20789	irradiated	122 131	85432 85441	0.9999890327453613	O
20793	(	133 134	85443 85444	0.9999897480010986	O
20794	a	135 136	85445 85446	0.9999890327453613	O
20795	,	137 138	85447 85448	0.9999887943267822	O
20796	c	139 140	85449 85450	0.9999885559082031	O
20797	)	141 142	85451 85452	0.99998939037323	O
20798	and	143 146	85453 85456	0.9999887943267822	O
20799	irradiated	147 156	85457 85466	0.9999881982803345	O
20803	patients	158 166	85468 85476	0.999984860420227	O
20804	(	167 168	85477 85478	0.9999896287918091	O
20805	b	169 170	85479 85480	0.9999881982803345	O
20806	,	171 172	85481 85482	0.9999891519546509	O
20807	d	173 174	85483 85484	0.9999884366989136	O
20808	)	175 176	85485 85486	0.9999897480010986	O
20809	for	177 180	85487 85490	0.9999895095825195	O
20810	HLA	181 183	85491 85493	0.999988317489624	O
20812	class	185 190	85495 85500	0.9999891519546509	O
20813	I	191 192	85501 85502	0.9999889135360718	O
20814	expression	193 203	85503 85513	0.99998939037323	O
20815	in	204 206	85514 85516	0.9999898672103882	O
20816	more	207 211	85517 85521	0.9999895095825195	O
20817	than	212 216	85522 85526	0.9999896287918091	O
20818	50	217 219	85527 85529	0.9999878406524658	O
20819	%	220 221	85530 85531	0.9999892711639404	O
20820	of	222 224	85532 85534	0.9999892711639404	O
20821	the	225 228	85535 85538	0.9999881982803345	O
20822	tumor	229 234	85539 85544	0.9999872446060181	O
20823	cells	235 240	85545 85550	0.9999884366989136	O
20824	(	241 242	85551 85552	0.9999897480010986	O
20825	high	243 247	85553 85557	0.9999884366989136	O
20826	)	248 249	85558 85559	0.9999896287918091	O
20827	versus	250 256	85560 85566	0.9999867677688599	O
20828	expression	257 267	85567 85577	0.9999886751174927	O
20829	in	268 270	85578 85580	0.9999895095825195	O
20830	less	271 275	85581 85585	0.9999887943267822	O
20831	than	276 280	85586 85590	0.99998939037323	O
20832	50	281 283	85591 85593	0.9999866485595703	O
20833	%	284 285	85594 85595	0.9999890327453613	O
20834	of	286 288	85596 85598	0.9999890327453613	O
20835	the	289 292	85599 85602	0.9999878406524658	O
20836	tumor	293 298	85603 85608	0.999987006187439	O
20837	cells	299 304	85609 85614	0.9999884366989136	O
20838	(	305 306	85615 85616	0.9999896287918091	O
20839	low	307 310	85617 85620	0.9999860525131226	O
20840	)	311 312	85621 85622	0.9999896287918091	O
20841	.	313 314	85623 85624	0.9999699592590332	O
20842	P	0 1	85625 85626	0.9999877214431763	O
20843	value	2 7	85627 85632	0.9999880790710449	O
20844	is	8 10	85633 85635	0.9999876022338867	O
20845	based	11 16	85636 85641	0.9999884366989136	O
20846	on	17 19	85642 85644	0.9999891519546509	O
20847	univariate	20 29	85645 85654	0.9999891519546509	O
20851	log	31 34	85656 85659	0.9999879598617554	O
20852	rank	35 39	85660 85664	0.9999864101409912	O
20853	analyses	40 48	85665 85673	0.9999881982803345	O
20854	Both	49 53	85674 85678	0.9999830722808838	O
20855	irradiated	54 63	85679 85688	0.9999887943267822	O
20859	and	65 68	85690 85693	0.9999879598617554	O
20860	non	69 72	85694 85697	0.9999866485595703	O
20861	-	72 73	85697 85698	0.9999886751174927	O
20862	irradiated	73 82	85698 85707	0.9999884366989136	O
20866	patients	84 92	85709 85717	0.9999873638153076	O
20867	with	93 97	85718 85722	0.9999890327453613	O
20868	high	98 102	85723 85727	0.9999879598617554	O
20869	expression	103 113	85728 85738	0.9999889135360718	O
20870	of	114 116	85739 85741	0.9999892711639404	O
20871	HLA	117 119	85742 85744	0.9999890327453613	O
20873	class	121 126	85746 85751	0.99998939037323	O
20874	I	127 128	85752 85753	0.9999891519546509	O
20875	have	129 133	85754 85758	0.9999884366989136	O
20876	a	134 135	85759 85760	0.9999887943267822	O
20877	better	136 142	85761 85767	0.9999867677688599	O
20878	overall	143 150	85768 85775	0.9999885559082031	O
20879	,	151 152	85776 85777	0.999985933303833	O
20880	and	153 156	85778 85781	0.9999878406524658	O
20881	disease	157 164	85782 85789	0.9999871253967285	O
20882	free	165 169	85790 85794	0.9999879598617554	O
20883	survival	170 178	85795 85803	0.999988317489624	O
20884	Survival	179 187	85804 85812	0.9999850988388062	O
20885	and	188 191	85813 85816	0.9999880790710449	O
20886	recurrence	192 201	85817 85826	0.9999877214431763	O
20889	rates	203 208	85828 85833	0.9999887943267822	O
20890	indicated	209 218	85834 85843	0.9999878406524658	O
20891	in	219 221	85844 85846	0.9999891519546509	O
20892	percentages	222 232	85847 85857	0.9999876022338867	O
20894	after	234 239	85859 85864	0.9999886751174927	O
20895	5	240 241	85865 85866	0.9999884366989136	O
20896	-	241 242	85866 85867	0.9999891519546509	O
20897	years	242 247	85867 85872	0.9999886751174927	O
20898	of	248 250	85873 85875	0.9999887943267822	O
20899	follow	251 257	85876 85882	0.9999889135360718	O
20900	-	257 258	85882 85883	0.99998939037323	O
20901	up	258 260	85883 85885	0.9999889135360718	O
20902	for	261 264	85886 85889	0.99998939037323	O
20903	non	265 268	85890 85893	0.9999881982803345	O
20904	-	268 269	85893 85894	0.9999891519546509	O
20905	irradiated	269 278	85894 85903	0.9999886751174927	O
20909	and	280 283	85905 85908	0.9999881982803345	O
20910	irradiated	284 293	85909 85918	0.9999879598617554	O
20914	patients	295 303	85920 85928	0.9999867677688599	O
20915	for	304 307	85929 85932	0.9999889135360718	O
20916	HLA	308 310	85933 85935	0.9999886751174927	O
20918	class	312 317	85937 85942	0.9999889135360718	O
20919	I	318 319	85943 85944	0.9999889135360718	O
20920	expression	320 330	85945 85955	0.9999890327453613	O
20921	in	331 333	85956 85958	0.9999897480010986	O
20922	more	334 338	85959 85963	0.9999892711639404	O
20923	than	339 343	85964 85968	0.9999896287918091	O
20924	50	344 346	85969 85971	0.9999873638153076	O
20925	%	347 348	85972 85973	0.99998939037323	O
20926	of	349 351	85974 85976	0.9999892711639404	O
20927	the	352 355	85977 85980	0.9999886751174927	O
20928	tumor	356 361	85981 85986	0.9999874830245972	O
20929	cells	362 367	85987 85992	0.9999886751174927	O
20930	(	368 369	85993 85994	0.9999896287918091	O
20931	high	370 374	85995 85999	0.9999880790710449	O
20932	)	375 376	86000 86001	0.9999895095825195	O
20933	versus	377 383	86002 86008	0.9999852180480957	O
20934	expression	384 394	86009 86019	0.9999872446060181	O
20935	in	395 397	86020 86022	0.99998939037323	O
20936	less	398 402	86023 86027	0.9999887943267822	O
20937	than	403 407	86028 86032	0.99998939037323	O
20938	50	408 410	86033 86035	0.9999867677688599	O
20939	%	411 412	86036 86037	0.9999891519546509	O
20940	of	413 415	86038 86040	0.9999890327453613	O
20941	the	416 419	86041 86044	0.9999885559082031	O
20942	tumor	420 425	86045 86050	0.9999876022338867	O
20943	cells	426 431	86051 86056	0.9999886751174927	O
20944	(	432 433	86057 86058	0.99998939037323	O
20945	low	434 437	86059 86062	0.9999860525131226	O
20946	)	438 439	86063 86064	0.99998939037323	O
20947	.	440 441	86065 86066	0.9999734163284302	O
20948	P	0 1	86067 86068	0.9999889135360718	O
20949	value	2 7	86069 86074	0.9999890327453613	O
20950	is	8 10	86075 86077	0.9999886751174927	O
20951	based	11 16	86078 86083	0.9999891519546509	O
20952	on	17 19	86084 86086	0.9999895095825195	O
20953	univariate	20 29	86087 86096	0.99998939037323	O
20957	log	31 34	86098 86101	0.9999889135360718	O
20958	rank	35 39	86102 86106	0.9999877214431763	O
20959	analyses	40 48	86107 86115	0.9999887943267822	O
20960	for	49 52	86116 86119	0.9999891519546509	O
20961	overall	53 60	86120 86127	0.9999886751174927	O
20962	survival	61 69	86128 86136	0.9999892711639404	O
20963	,	70 71	86137 86138	0.9999891519546509	O
20964	disease	72 79	86139 86146	0.9999879598617554	O
20965	free	80 84	86147 86151	0.9999890327453613	O
20966	survival	85 93	86152 86160	0.9999895095825195	O
20967	,	94 95	86161 86162	0.9999890327453613	O
20968	cancer	96 102	86163 86169	0.9999865293502808	O
20969	specific	103 111	86170 86178	0.9999890327453613	O
20970	survival	112 120	86179 86187	0.9999892711639404	O
20971	,	121 122	86188 86189	0.9999886751174927	O
20972	local	123 128	86190 86195	0.9999873638153076	O
20973	recurrence	129 138	86196 86205	0.9999896287918091	O
20976	and	140 143	86207 86210	0.999988317489624	O
20977	distant	144 151	86211 86218	0.9999840259552002	O
20978	recurrence	152 161	86219 86228	0.99998939037323	O
20981	*	163 164	86230 86231	0.9999889135360718	O
20982	Statistical	165 176	86232 86243	0.9999891519546509	O
20983	significant	177 188	86244 86255	0.9999892711639404	O
20984	P	189 190	86256 86257	0.9999890327453613	O
20985	values	191 197	86258 86264	0.9999890327453613	O
20986	are	198 201	86265 86268	0.9999886751174927	O
20987	in	202 204	86269 86271	0.9999887943267822	O
20988	bold	205 209	86272 86276	0.9999872446060181	O
20989	Multivariate	210 221	86277 86288	0.9999887943267822	O
20992	analysis	223 231	86290 86298	0.9999887943267822	O
20993	Multivariate	232 243	86299 86310	0.9999880790710449	O
20996	analysis	245 253	86312 86320	0.9999892711639404	O
20997	was	254 257	86321 86324	0.9999890327453613	O
20998	performed	258 267	86325 86334	0.9999887943267822	O
20999	to	268 270	86335 86337	0.99998939037323	O
21000	identify	271 279	86338 86346	0.9999892711639404	O
21001	factors	280 287	86347 86354	0.999988317489624	O
21002	with	288 292	86355 86359	0.9999886751174927	O
21003	independent	293 304	86360 86371	0.9999880790710449	O
21004	prognostic	305 314	86372 86381	0.99998939037323	O
21007	significance	316 328	86383 86395	0.9999892711639404	O
21008	and	329 332	86396 86399	0.999988317489624	O
21009	to	333 335	86400 86402	0.99998939037323	O
21010	calculate	336 345	86403 86412	0.9999879598617554	O
21011	hazard	346 352	86413 86419	0.9999877214431763	O
21012	ratios	353 359	86420 86426	0.9999881982803345	O
21013	(	360 361	86427 86428	0.9999891519546509	O
21014	HR	362 363	86429 86430	0.9999880790710449	O
21016	)	365 366	86432 86433	0.99998939037323	O
21017	.	367 368	86434 86435	0.999971866607666	O
21018	Analyses	0 7	86436 86443	0.999987006187439	O
21021	included	9 17	86445 86453	0.9999889135360718	O
21022	TNM	18 20	86454 86456	0.9999880790710449	O
21025	,	22 23	86458 86459	0.99998939037323	O
21026	circumferential	24 38	86460 86474	0.9999895095825195	O
21031	margin	40 46	86476 86482	0.99998939037323	O
21032	,	47 48	86483 86484	0.99998939037323	O
21033	randomization	49 61	86485 86497	0.9999868869781494	O
21035	for	63 66	86499 86502	0.9999889135360718	O
21036	preoperative	67 78	86503 86514	0.99998939037323	O
21039	radiotherapy	80 91	86516 86527	0.9999871253967285	O
21043	and	93 96	86529 86532	0.9999891519546509	O
21044	HLA	97 99	86533 86535	0.9999891519546509	O
21046	class	101 106	86537 86542	0.9999895095825195	O
21047	I	107 108	86543 86544	0.99998939037323	O
21048	expression	109 119	86545 86555	0.9999891519546509	O
21049	(	120 121	86556 86557	0.9999897480010986	O
21050	low	122 125	86558 86561	0.999988317489624	O
21051	vs	126 128	86562 86564	0.9999887943267822	O
21052	.	128 129	86564 86565	0.9999889135360718	O
21053	high	130 134	86566 86570	0.9999837875366211	O
21054	HLA	135 137	86571 86573	0.9999886751174927	O
21056	class	139 144	86575 86580	0.9999891519546509	O
21057	I	145 146	86581 86582	0.9999885559082031	O
21058	positive	147 155	86583 86591	0.9999876022338867	O
21059	tumor	156 161	86592 86597	0.9999860525131226	O
21060	cells	162 167	86598 86603	0.9999873638153076	O
21061	)	168 169	86604 86605	0.9999897480010986	O
21062	(	170 171	86606 86607	0.99998939037323	O
21063	Table	172 177	86608 86613	0.999985933303833	O
21064	5	178 179	86614 86615	0.9999878406524658	O
21065	)	180 181	86616 86617	0.9999895095825195	O
21066	.	182 183	86618 86619	0.9999781847000122	O
21067	Advanced	0 8	86620 86628	0.9999741315841675	O
21068	pathological	9 20	86629 86640	0.999984860420227	O
21070	(	22 23	86642 86643	0.9999871253967285	O
21071	TNM	24 26	86644 86646	0.9999845027923584	O
21074	)	27 28	86647 86648	0.999988317489624	O
21075	stage	29 34	86649 86654	0.9999858140945435	O
21076	and	35 38	86655 86658	0.9999864101409912	O
21077	tumor	39 44	86659 86664	0.9999768733978271	O
21078	-	44 45	86664 86665	0.999988317489624	O
21079	positive	45 53	86665 86673	0.9999866485595703	O
21080	circumferential	54 68	86674 86688	0.9999887943267822	O
21085	resection	70 78	86690 86698	0.999988317489624	O
21087	margins	80 87	86700 86707	0.9999867677688599	O
21088	retained	88 96	86708 86716	0.9999825954437256	O
21089	their	97 102	86717 86722	0.9999881982803345	O
21090	strength	103 111	86723 86731	0.999983549118042	O
21091	as	112 114	86732 86734	0.9999876022338867	O
21092	independent	115 126	86735 86746	0.9999868869781494	O
21093	prognostic	127 136	86747 86756	0.9999885559082031	O
21096	factors	138 145	86758 86765	0.9999878406524658	O
21097	in	146 148	86766 86768	0.9999876022338867	O
21098	these	149 154	86769 86774	0.9999874830245972	O
21099	survival	155 163	86775 86783	0.9999854564666748	O
21100	analyses	164 172	86784 86792	0.9999847412109375	O
21101	.	173 174	86793 86794	0.9999582767486572	O
21102	HLA	0 2	86795 86797	0.9999837875366211	O
21104	class	4 9	86799 86804	0.9999877214431763	O
21105	I	10 11	86805 86806	0.9999858140945435	O
21106	expression	12 22	86807 86817	0.9999850988388062	O
21107	showed	23 29	86818 86824	0.9999856948852539	O
21108	independent	30 41	86825 86836	0.9999856948852539	O
21109	prognostic	42 51	86837 86846	0.9999884366989136	O
21112	value	53 58	86848 86853	0.9999868869781494	O
21113	for	59 62	86854 86857	0.9999880790710449	O
21114	overall	63 70	86858 86865	0.9999873638153076	O
21115	survival	71 79	86866 86874	0.999988317489624	O
21116	and	80 83	86875 86878	0.9999873638153076	O
21117	disease	84 91	86879 86886	0.9999852180480957	O
21118	-	91 92	86886 86887	0.9999887943267822	O
21119	free	92 96	86887 86891	0.9999873638153076	O
21120	survival	97 105	86892 86900	0.9999887943267822	O
21121	(	106 107	86901 86902	0.9999895095825195	O
21122	HR	108 109	86903 86904	0.9999889135360718	O
21124	:	111 112	86906 86907	0.9999891519546509	O
21125	1	113 114	86908 86909	0.9999889135360718	O
21126	.	114 115	86909 86910	0.9999890327453613	O
21127	3	115 116	86910 86911	0.9999865293502808	O
21128	,	117 118	86912 86913	0.9999885559082031	O
21129	P	119 120	86914 86915	0.9999891519546509	O
21130	=	121 122	86916 86917	0.9999891519546509	O
21131	0	123 124	86918 86919	0.9999892711639404	O
21132	.	124 125	86919 86920	0.9999890327453613	O
21133	042	125 127	86920 86922	0.9999878406524658	O
21135	and	129 132	86924 86927	0.9999880790710449	O
21136	HR	133 134	86928 86929	0.9999887943267822	O
21138	:	136 137	86931 86932	0.9999889135360718	O
21139	1	138 139	86933 86934	0.9999884366989136	O
21140	.	139 140	86934 86935	0.9999890327453613	O
21141	4	140 141	86935 86936	0.9999850988388062	O
21142	,	142 143	86937 86938	0.999988317489624	O
21143	P	144 145	86939 86940	0.9999890327453613	O
21144	=	146 147	86941 86942	0.9999887943267822	O
21145	0	148 149	86943 86944	0.9999891519546509	O
21146	.	149 150	86944 86945	0.9999890327453613	O
21147	006	150 152	86945 86947	0.9999889135360718	O
21149	,	154 155	86949 86950	0.9999885559082031	O
21150	respectively	156 168	86951 86963	0.9999878406524658	O
21151	)	169 170	86964 86965	0.9999885559082031	O
21152	,	171 172	86966 86967	0.9999867677688599	O
21153	but	173 176	86968 86971	0.9999853372573853	O
21154	not	177 180	86972 86975	0.9999825954437256	O
21155	for	181 184	86976 86979	0.9999866485595703	O
21156	cancer	185 191	86980 86986	0.999982476234436	O
21157	-	191 192	86986 86987	0.9999881982803345	O
21158	specific	192 200	86987 86995	0.9999872446060181	O
21159	survival	201 209	86996 87004	0.9999878406524658	O
21160	.	210 211	87005 87006	0.9999626874923706	O
21161	Table	0 5	87007 87012	0.9999879598617554	O
21162	5Multivariate	6 18	87013 87025	0.9999878406524658	O
21168	analysis	20 28	87027 87035	0.9999885559082031	O
21169	confirms	29 37	87036 87044	0.9999865293502808	O
21170	independent	38 49	87045 87056	0.9999868869781494	O
21171	better	50 56	87057 87063	0.9999860525131226	O
21172	overall	57 64	87064 87071	0.9999887943267822	O
21173	,	65 66	87072 87073	0.9999871253967285	O
21174	and	67 70	87074 87077	0.999988317489624	O
21175	disease	71 78	87078 87085	0.9999876022338867	O
21176	free	79 83	87086 87090	0.9999881982803345	O
21177	survival	84 92	87091 87099	0.9999884366989136	O
21178	for	93 96	87100 87103	0.9999887943267822	O
21179	rectal	97 102	87104 87109	0.9999828338623047	O
21182	cancer	104 110	87111 87117	0.9999802112579346	O
21183	patients	111 119	87118 87126	0.9999867677688599	O
21184	with	120 124	87127 87131	0.9999887943267822	O
21185	high	125 129	87132 87136	0.9999880790710449	O
21186	expression	130 140	87137 87147	0.999988317489624	O
21187	of	141 143	87148 87150	0.9999886751174927	O
21188	HLA	144 146	87151 87153	0.9999881982803345	O
21190	class	148 153	87155 87160	0.999988317489624	O
21191	IOverall	154 161	87161 87168	0.9999884366989136	O
21195	survivalDisease	163 177	87170 87184	0.9999881982803345	O
21199	free	179 183	87186 87190	0.9999880790710449	O
21200	survivalCancer	184 197	87191 87204	0.9999881982803345	O
21204	specific	199 207	87206 87214	0.9999880790710449	O
21205	survivalHR	208 217	87215 87224	0.999988317489624	O
21208	(	219 220	87226 87227	0.9999881982803345	O
21209	95	220 222	87227 87229	0.9999878406524658	O
21210	%	223 224	87230 87231	0.9999879598617554	O
21211	CI	225 226	87232 87233	0.9999877214431763	O
21213	)	227 228	87234 87235	0.9999879598617554	O
21214	P	229 230	87236 87237	0.9999885559082031	O
21215	valueHR	231 237	87238 87244	0.9999872446060181	O
21218	(	239 240	87246 87247	0.9999877214431763	O
21219	95	240 242	87247 87249	0.9999873638153076	O
21220	%	243 244	87250 87251	0.9999877214431763	O
21221	CI	245 246	87252 87253	0.9999873638153076	O
21223	)	247 248	87254 87255	0.9999876022338867	O
21224	P	249 250	87256 87257	0.999988317489624	O
21225	valueHR	251 257	87258 87264	0.9999871253967285	O
21228	(	259 260	87266 87267	0.9999876022338867	O
21229	95	260 262	87267 87269	0.9999872446060181	O
21230	%	263 264	87270 87271	0.9999873638153076	O
21231	CI	265 266	87272 87273	0.9999872446060181	O
21233	)	267 268	87274 87275	0.9999878406524658	O
21234	P	269 270	87276 87277	0.9999885559082031	O
21235	valueHLA	271 278	87278 87285	0.9999876022338867	O
21238	High10	280 285	87287 87292	0.9999874830245972	O
21240	.	286 287	87293 87294	0.9999886751174927	O
21241	04210	287 291	87294 87298	0.9999874830245972	O
21244	.	292 293	87299 87300	0.9999885559082031	O
21245	00610	293 297	87300 87304	0.9999880790710449	O
21248	.	298 299	87305 87306	0.9999886751174927	O
21249	653	299 301	87306 87308	0.9999867677688599	O
21251	Low1	303 306	87310 87313	0.999985933303833	O
21253	.	307 308	87314 87315	0.9999887943267822	O
21254	3	308 309	87315 87316	0.9999864101409912	O
21255	(	310 311	87317 87318	0.999988317489624	O
21256	1	312 313	87319 87320	0.9999876022338867	O
21257	.	313 314	87320 87321	0.9999885559082031	O
21258	0	314 315	87321 87322	0.9999874830245972	O
21259	–	315 316	87322 87323	0.9999873638153076	O
21260	1	316 317	87323 87324	0.9999873638153076	O
21261	.	317 318	87324 87325	0.9999885559082031	O
21262	6	318 319	87325 87326	0.9999868869781494	O
21263	)	319 320	87326 87327	0.9999885559082031	O
21264	1	320 321	87327 87328	0.9999881982803345	O
21265	.	321 322	87328 87329	0.9999889135360718	O
21266	4	322 323	87329 87330	0.9999871253967285	O
21267	(	324 325	87331 87332	0.999988317489624	O
21268	1	326 327	87333 87334	0.9999877214431763	O
21269	.	327 328	87334 87335	0.9999885559082031	O
21270	1	328 329	87335 87336	0.9999874830245972	O
21271	–	329 330	87336 87337	0.999987006187439	O
21272	1	330 331	87337 87338	0.9999874830245972	O
21273	.	331 332	87338 87339	0.9999885559082031	O
21274	8	332 333	87339 87340	0.9999872446060181	O
21275	)	333 334	87340 87341	0.999988317489624	O
21276	1	334 335	87341 87342	0.9999880790710449	O
21277	.	335 336	87342 87343	0.9999889135360718	O
21278	1	336 337	87343 87344	0.9999880790710449	O
21279	(	338 339	87345 87346	0.999988317489624	O
21280	0	340 341	87347 87348	0.9999878406524658	O
21281	.	341 342	87348 87349	0.999988317489624	O
21282	8	342 343	87349 87350	0.9999873638153076	O
21283	–	343 344	87350 87351	0.9999876022338867	O
21284	1	344 345	87351 87352	0.9999877214431763	O
21285	.	345 346	87352 87353	0.9999885559082031	O
21286	5	346 347	87353 87354	0.9999876022338867	O
21287	)	347 348	87354 87355	0.9999886751174927	O
21288	Randomization	348 360	87355 87367	0.9999865293502808	O
21290	TME10	362 366	87369 87373	0.9999884366989136	O
21293	.	367 368	87374 87375	0.9999886751174927	O
21294	63210	368 372	87375 87379	0.9999864101409912	O
21297	.	373 374	87380 87381	0.9999884366989136	O
21298	21410	374 378	87381 87385	0.999987006187439	O
21300	.	379 380	87386 87387	0.9999884366989136	O
21301	282	380 382	87387 87389	0.9999876022338867	O
21303	TME	384 386	87391 87393	0.9999881982803345	O
21305	+	388 389	87395 87396	0.9999880790710449	O
21306	RT1	390 392	87397 87399	0.9999880790710449	O
21309	(	394 395	87401 87402	0.9999881982803345	O
21310	0	396 397	87403 87404	0.9999877214431763	O
21311	.	397 398	87404 87405	0.9999880790710449	O
21312	8	398 399	87405 87406	0.999987006187439	O
21313	–	399 400	87406 87407	0.999987006187439	O
21314	1	400 401	87407 87408	0.9999871253967285	O
21315	.	401 402	87408 87409	0.9999881982803345	O
21316	2	402 403	87409 87410	0.9999864101409912	O
21317	)	403 404	87410 87411	0.9999879598617554	O
21318	0	404 405	87411 87412	0.9999878406524658	O
21319	.	405 406	87412 87413	0.999988317489624	O
21320	9	406 407	87413 87414	0.9999871253967285	O
21321	(	408 409	87415 87416	0.9999878406524658	O
21322	0	410 411	87417 87418	0.9999874830245972	O
21323	.	411 412	87418 87419	0.9999878406524658	O
21324	7	412 413	87419 87420	0.9999868869781494	O
21325	–	413 414	87420 87421	0.9999871253967285	O
21326	1	414 415	87421 87422	0.9999872446060181	O
21327	.	415 416	87422 87423	0.9999880790710449	O
21328	1	416 417	87423 87424	0.9999872446060181	O
21329	)	417 418	87424 87425	0.9999879598617554	O
21330	1	418 419	87425 87426	0.9999877214431763	O
21331	.	419 420	87426 87427	0.9999885559082031	O
21332	1	420 421	87427 87428	0.9999876022338867	O
21333	(	422 423	87429 87430	0.9999878406524658	O
21334	0	424 425	87431 87432	0.9999873638153076	O
21335	.	425 426	87432 87433	0.9999877214431763	O
21336	9	426 427	87433 87434	0.9999862909317017	O
21337	–	427 428	87434 87435	0.9999862909317017	O
21338	1	428 429	87435 87436	0.999987006187439	O
21339	.	429 430	87436 87437	0.9999881982803345	O
21340	5	430 431	87437 87438	0.9999860525131226	O
21341	)	431 432	87438 87439	0.9999881982803345	O
21342	TNM	432 434	87439 87441	0.999988317489624	O
21345	I111	436 439	87443 87446	0.9999879598617554	O
21348	II2	441 443	87448 87450	0.999987006187439	O
21350	.	444 445	87451 87452	0.9999886751174927	O
21351	2	445 446	87452 87453	0.9999871253967285	O
21352	(	447 448	87454 87455	0.9999881982803345	O
21353	1	449 450	87456 87457	0.9999872446060181	O
21354	.	450 451	87457 87458	0.9999880790710449	O
21355	7	451 452	87458 87459	0.999987006187439	O
21356	–	452 453	87459 87460	0.999987006187439	O
21357	3	453 454	87460 87461	0.9999858140945435	O
21358	.	454 455	87461 87462	0.9999881982803345	O
21359	0	455 456	87462 87463	0.9999872446060181	O
21360	)	456 457	87463 87464	0.9999877214431763	O
21361	<	457 458	87464 87465	0.9999880790710449	O
21362	0	458 459	87465 87466	0.9999877214431763	O
21363	.	459 460	87466 87467	0.9999881982803345	O
21364	0012	460 463	87467 87470	0.9999878406524658	O
21366	.	464 465	87471 87472	0.9999884366989136	O
21367	1	465 466	87472 87473	0.9999874830245972	O
21368	(	467 468	87474 87475	0.9999880790710449	O
21369	1	469 470	87476 87477	0.9999871253967285	O
21370	.	470 471	87477 87478	0.999988317489624	O
21371	6	471 472	87478 87479	0.9999866485595703	O
21372	–	472 473	87479 87480	0.9999872446060181	O
21373	2	473 474	87480 87481	0.9999864101409912	O
21374	.	474 475	87481 87482	0.9999881982803345	O
21375	8	475 476	87482 87483	0.9999868869781494	O
21376	)	477 478	87484 87485	0.9999880790710449	O
21377	<	478 479	87485 87486	0.999988317489624	O
21378	0	479 480	87486 87487	0.9999879598617554	O
21379	.	480 481	87487 87488	0.9999885559082031	O
21380	0013	481 484	87488 87491	0.9999880790710449	O
21382	.	485 486	87492 87493	0.9999886751174927	O
21383	5	486 487	87493 87494	0.9999878406524658	O
21384	(	488 489	87495 87496	0.9999881982803345	O
21385	2	490 491	87497 87498	0.999987006187439	O
21386	.	491 492	87498 87499	0.9999884366989136	O
21387	0	492 493	87499 87500	0.9999874830245972	O
21388	–	493 494	87500 87501	0.9999866485595703	O
21389	6	494 495	87501 87502	0.9999868869781494	O
21390	.	495 496	87502 87503	0.9999884366989136	O
21391	1	496 497	87503 87504	0.999987006187439	O
21392	)	498 499	87505 87506	0.9999878406524658	O
21393	<	499 500	87506 87507	0.999988317489624	O
21394	0	500 501	87507 87508	0.9999880790710449	O
21395	.	501 502	87508 87509	0.9999884366989136	O
21396	001	502 504	87509 87511	0.9999880790710449	O
21398	III3	506 509	87513 87516	0.9999868869781494	O
21400	.	510 511	87517 87518	0.9999887943267822	O
21401	1	511 512	87518 87519	0.9999881982803345	O
21402	(	513 514	87520 87521	0.9999884366989136	O
21403	2	515 516	87522 87523	0.9999872446060181	O
21404	.	516 517	87523 87524	0.9999885559082031	O
21405	4	517 518	87524 87525	0.9999872446060181	O
21406	–	518 519	87525 87526	0.9999874830245972	O
21407	4	519 520	87526 87527	0.9999868869781494	O
21408	.	520 521	87527 87528	0.9999885559082031	O
21409	1	521 522	87528 87529	0.9999876022338867	O
21410	)	523 524	87530 87531	0.9999880790710449	O
21411	<	524 525	87531 87532	0.999988317489624	O
21412	0	525 526	87532 87533	0.9999881982803345	O
21413	.	526 527	87533 87534	0.999988317489624	O
21414	0013	527 530	87534 87537	0.9999880790710449	O
21416	.	531 532	87538 87539	0.9999885559082031	O
21417	1	532 533	87539 87540	0.9999879598617554	O
21418	(	534 535	87541 87542	0.9999881982803345	O
21419	2	536 537	87543 87544	0.9999867677688599	O
21420	.	537 538	87544 87545	0.999988317489624	O
21421	3	538 539	87545 87546	0.9999864101409912	O
21422	–	539 540	87546 87547	0.9999866485595703	O
21423	4	540 541	87547 87548	0.9999860525131226	O
21424	.	541 542	87548 87549	0.9999885559082031	O
21425	0	542 543	87549 87550	0.9999876022338867	O
21426	)	543 544	87550 87551	0.9999880790710449	O
21427	<	544 545	87551 87552	0.999988317489624	O
21428	0	545 546	87552 87553	0.9999881982803345	O
21429	.	546 547	87553 87554	0.9999885559082031	O
21430	0019	547 550	87554 87557	0.9999880790710449	O
21432	.	551 552	87558 87559	0.9999886751174927	O
21433	0	552 553	87559 87560	0.9999880790710449	O
21434	(	554 555	87561 87562	0.999988317489624	O
21435	5	556 557	87563 87564	0.999987006187439	O
21436	.	557 558	87564 87565	0.9999884366989136	O
21437	4	558 559	87565 87566	0.999987006187439	O
21438	–	559 560	87566 87567	0.9999873638153076	O
21439	14	560 562	87567 87569	0.9999868869781494	O
21440	.	562 563	87569 87570	0.9999885559082031	O
21441	9	563 564	87570 87571	0.9999874830245972	O
21442	)	565 566	87572 87573	0.999988317489624	O
21443	<	566 567	87573 87574	0.9999885559082031	O
21444	0	567 568	87574 87575	0.9999884366989136	O
21445	.	568 569	87575 87576	0.9999885559082031	O
21446	001	569 571	87576 87578	0.9999881982803345	O
21448	IV11	573 576	87580 87583	0.9999877214431763	O
21450	.	577 578	87584 87585	0.9999886751174927	O
21451	8	578 579	87585 87586	0.9999878406524658	O
21452	(	580 581	87587 87588	0.999988317489624	O
21453	8	582 583	87589 87590	0.9999867677688599	O
21454	.	583 584	87590 87591	0.9999885559082031	O
21455	1	584 585	87591 87592	0.999987006187439	O
21456	–	585 586	87592 87593	0.9999860525131226	O
21457	17	586 588	87593 87595	0.9999850988388062	O
21458	.	588 589	87595 87596	0.9999886751174927	O
21459	1	589 590	87596 87597	0.9999876022338867	O
21460	)	591 592	87598 87599	0.9999881982803345	O
21461	<	592 593	87599 87600	0.9999886751174927	O
21462	0	593 594	87600 87601	0.999988317489624	O
21463	.	594 595	87601 87602	0.9999887943267822	O
21464	001	595 597	87602 87604	0.999988317489624	O
21466	–	598 599	87605 87606	0.9999864101409912	O
21467	–	599 600	87606 87607	0.9999871253967285	O
21468	50	600 602	87607 87609	0.9999852180480957	O
21469	.	602 603	87609 87610	0.9999889135360718	O
21470	3	603 604	87610 87611	0.9999874830245972	O
21471	(	605 606	87612 87613	0.999988317489624	O
21472	28	607 609	87614 87616	0.9999868869781494	O
21473	.	609 610	87616 87617	0.9999885559082031	O
21474	5	610 611	87617 87618	0.9999867677688599	O
21475	–	611 612	87618 87619	0.9999866485595703	O
21476	89	612 614	87619 87621	0.9999867677688599	O
21477	.	614 615	87621 87622	0.9999886751174927	O
21478	1	615 616	87622 87623	0.9999873638153076	O
21479	)	617 618	87624 87625	0.9999881982803345	O
21480	<	618 619	87625 87626	0.9999885559082031	O
21481	0	619 620	87626 87627	0.9999884366989136	O
21482	.	620 621	87627 87628	0.9999889135360718	O
21483	001CRM	621 626	87628 87633	0.9999884366989136	O
21487	Negative1	628 636	87635 87643	0.9999876022338867	O
21491	<	637 638	87644 87645	0.9999887943267822	O
21492	0	638 639	87645 87646	0.9999884366989136	O
21493	.	639 640	87646 87647	0.9999890327453613	O
21494	0011	640 643	87647 87650	0.9999887943267822	O
21496	<	644 645	87651 87652	0.9999887943267822	O
21497	0	645 646	87652 87653	0.9999884366989136	O
21498	.	646 647	87653 87654	0.9999887943267822	O
21499	0011	647 650	87654 87657	0.9999885559082031	O
21501	<	651 652	87658 87659	0.9999885559082031	O
21502	0	652 653	87659 87660	0.9999881982803345	O
21503	.	653 654	87660 87661	0.9999887943267822	O
21504	001	654 656	87661 87663	0.999988317489624	O
21506	Positive1	658 666	87665 87673	0.9999879598617554	O
21509	.	667 668	87674 87675	0.9999890327453613	O
21510	3	668 669	87675 87676	0.9999874830245972	O
21511	(	670 671	87677 87678	0.9999889135360718	O
21512	1	672 673	87679 87680	0.9999880790710449	O
21513	.	673 674	87680 87681	0.9999890327453613	O
21514	1	674 675	87681 87682	0.9999881982803345	O
21515	–	675 676	87682 87683	0.9999873638153076	O
21516	1	676 677	87683 87684	0.9999877214431763	O
21517	.	677 678	87684 87685	0.9999890327453613	O
21518	5	678 679	87685 87686	0.9999873638153076	O
21519	)	679 680	87686 87687	0.9999890327453613	O
21520	1	680 681	87687 87688	0.9999885559082031	O
21521	.	681 682	87688 87689	0.9999892711639404	O
21522	8	682 683	87689 87690	0.9999884366989136	O
21523	(	684 685	87691 87692	0.9999889135360718	O
21524	1	686 687	87693 87694	0.9999881982803345	O
21525	.	687 688	87694 87695	0.9999890327453613	O
21526	4	688 689	87695 87696	0.9999876022338867	O
21527	–	689 690	87696 87697	0.9999876022338867	O
21528	2	690 691	87697 87698	0.9999866485595703	O
21529	.	691 692	87698 87699	0.9999890327453613	O
21530	2	692 693	87699 87700	0.9999873638153076	O
21531	)	693 694	87700 87701	0.9999887943267822	O
21532	1	694 695	87701 87702	0.9999884366989136	O
21533	.	695 696	87702 87703	0.9999891519546509	O
21534	3	696 697	87703 87704	0.9999876022338867	O
21535	(	698 699	87705 87706	0.9999887943267822	O
21536	1	700 701	87707 87708	0.9999880790710449	O
21537	.	701 702	87708 87709	0.9999890327453613	O
21538	1	702 703	87709 87710	0.9999881982803345	O
21539	–	703 704	87710 87711	0.9999876022338867	O
21540	1	704 705	87711 87712	0.9999879598617554	O
21541	.	705 706	87712 87713	0.9999889135360718	O
21542	5	706 707	87713 87714	0.9999878406524658	O
21543	)	707 708	87714 87715	0.9999890327453613	O
21544	Multivariate	708 719	87715 87726	0.9999874830245972	O
21547	analysis	721 729	87728 87736	0.9999887943267822	O
21548	for	730 733	87737 87740	0.9999889135360718	O
21549	cancer	734 740	87741 87747	0.9999849796295166	O
21550	specific	741 749	87748 87756	0.9999886751174927	O
21551	,	750 751	87757 87758	0.9999884366989136	O
21552	overall	752 759	87759 87766	0.999988317489624	O
21553	and	760 763	87767 87770	0.9999879598617554	O
21554	disease	764 771	87771 87778	0.9999877214431763	O
21555	free	772 776	87779 87783	0.999988317489624	O
21556	survival	777 785	87784 87792	0.9999884366989136	O
21557	was	786 789	87793 87796	0.9999886751174927	O
21558	performed	790 799	87797 87806	0.9999884366989136	O
21559	to	800 802	87807 87809	0.9999891519546509	O
21560	identify	803 811	87810 87818	0.9999887943267822	O
21561	factors	812 819	87819 87826	0.9999878406524658	O
21562	with	820 824	87827 87831	0.9999881982803345	O
21563	independent	825 836	87832 87843	0.9999878406524658	O
21564	prognostic	837 846	87844 87853	0.9999886751174927	O
21567	significance	848 860	87855 87867	0.9999889135360718	O
21568	and	861 864	87868 87871	0.999988317489624	O
21569	to	865 867	87872 87874	0.9999891519546509	O
21570	calculate	868 877	87875 87884	0.9999879598617554	O
21571	hazard	878 884	87885 87891	0.9999877214431763	O
21572	ratios	885 891	87892 87898	0.9999880790710449	O
21573	(	892 893	87899 87900	0.9999889135360718	O
21574	HR	894 895	87901 87902	0.9999879598617554	O
21576	)	897 898	87904 87905	0.9999890327453613	O
21577	with	899 903	87906 87910	0.9999885559082031	O
21578	95	904 906	87911 87913	0.9999885559082031	O
21579	%	907 908	87914 87915	0.9999886751174927	O
21580	confidence	909 919	87916 87926	0.9999884366989136	O
21581	intervals	920 929	87927 87936	0.9999878406524658	O
21582	(	930 931	87937 87938	0.9999885559082031	O
21583	CI	932 933	87939 87940	0.9999879598617554	O
21585	)	934 935	87941 87942	0.9999887943267822	O
21586	shown	936 941	87943 87948	0.9999867677688599	O
21587	in	942 944	87949 87951	0.9999886751174927	O
21588	parentheses	945 955	87952 87962	0.999987006187439	O
21590	.	957 958	87964 87965	0.9999600648880005	O
21591	HLA	0 2	87966 87968	0.9999861717224121	O
21593	class	4 9	87970 87975	0.9999881982803345	O
21594	I	10 11	87976 87977	0.9999884366989136	O
21595	expression	12 22	87978 87988	0.9999891519546509	O
21596	in	23 25	87989 87991	0.9999897480010986	O
21597	more	26 30	87992 87996	0.9999891519546509	O
21598	than	31 35	87997 88001	0.99998939037323	O
21599	50	36 38	88002 88004	0.9999871253967285	O
21600	%	39 40	88005 88006	0.9999892711639404	O
21601	of	41 43	88007 88009	0.99998939037323	O
21602	the	44 47	88010 88013	0.9999886751174927	O
21603	tumor	48 53	88014 88019	0.9999876022338867	O
21604	cells	54 59	88020 88025	0.9999886751174927	O
21605	(	60 61	88026 88027	0.9999895095825195	O
21606	high	62 66	88028 88032	0.9999884366989136	O
21607	)	67 68	88033 88034	0.99998939037323	O
21608	versus	69 75	88035 88041	0.9999880790710449	O
21609	expression	76 86	88042 88052	0.9999884366989136	O
21610	in	87 89	88053 88055	0.99998939037323	O
21611	less	90 94	88056 88060	0.9999880790710449	O
21612	than	95 99	88061 88065	0.9999889135360718	O
21613	50	100 102	88066 88068	0.999985933303833	O
21614	%	103 104	88069 88070	0.9999890327453613	O
21615	of	105 107	88071 88073	0.9999890327453613	O
21616	the	108 111	88074 88077	0.9999887943267822	O
21617	tumor	112 117	88078 88083	0.9999877214431763	O
21618	cells	118 123	88084 88089	0.9999885559082031	O
21619	(	124 125	88090 88091	0.9999891519546509	O
21620	low	126 129	88092 88095	0.9999871253967285	O
21621	)	130 131	88096 88097	0.9999890327453613	O
21622	,	132 133	88098 88099	0.9999886751174927	O
21623	total	134 139	88100 88105	0.9999885559082031	O
21624	mesorectal	140 149	88106 88115	0.9999879598617554	O
21628	excision	151 158	88117 88124	0.9999887943267822	O
21630	(	160 161	88126 88127	0.9999892711639404	O
21631	TME	162 164	88128 88130	0.999988317489624	O
21633	)	165 166	88131 88132	0.9999889135360718	O
21634	,	167 168	88133 88134	0.9999886751174927	O
21635	Radiotherapy	169 180	88135 88146	0.9999839067459106	O
21639	(	182 183	88148 88149	0.9999890327453613	O
21640	RT	183 184	88149 88150	0.9999879598617554	O
21642	)	186 187	88152 88153	0.9999890327453613	O
21643	;	188 189	88154 88155	0.9999886751174927	O
21644	circumferential	190 204	88156 88170	0.9999885559082031	O
21649	margin	206 212	88172 88178	0.9999880790710449	O
21650	(	213 214	88179 88180	0.9999890327453613	O
21651	CRM	215 217	88181 88183	0.9999878406524658	O
21653	)	219 220	88185 88186	0.9999890327453613	O
21654	;	221 222	88187 88188	0.99998939037323	O
21655	P	223 224	88189 88190	0.9999895095825195	O
21656	value	225 230	88191 88196	0.9999891519546509	O
21657	is	231 233	88197 88199	0.9999891519546509	O
21658	based	234 239	88200 88205	0.9999887943267822	O
21659	on	240 242	88206 88208	0.9999892711639404	O
21660	Cox	243 246	88209 88212	0.9999877214431763	O
21661	’	247 248	88213 88214	0.999977707862854	O
21662	regression	249 258	88215 88224	0.9999887943267822	O
21664	analyses	260 268	88226 88234	0.9999881982803345	O
21665	*	268 269	88234 88235	0.9999886751174927	O
21666	Statistical	270 281	88236 88247	0.9999889135360718	O
21667	significant	282 293	88248 88259	0.9999890327453613	O
21668	P	294 295	88260 88261	0.99998939037323	O
21669	values	296 302	88262 88268	0.9999891519546509	O
21670	and	303 306	88269 88272	0.99998939037323	O
21671	HR	307 308	88273 88274	0.9999890327453613	O
21673	are	310 313	88276 88279	0.9999889135360718	O
21674	in	314 316	88280 88282	0.9999892711639404	O
21675	bold	317 321	88283 88287	0.9999886751174927	O
21676	*	322 323	88288 88289	0.9999887943267822	O
21677	*	323 324	88289 88290	0.9999885559082031	O
21678	IGNORE	325 330	88291 88296	0.9999880790710449	O
21681	LINE	332 335	88298 88301	0.9999891519546509	O
21684	*	337 338	88303 88304	0.9999885559082031	O
21685	*	338 339	88304 88305	0.9999884366989136	O
21686	*	340 341	88306 88307	0.999988317489624	O
21687	*	341 342	88307 88308	0.9999884366989136	O
21688	IGNORE	343 348	88309 88314	0.9999872446060181	O
21691	LINE	350 353	88316 88319	0.9999890327453613	O
21694	*	355 356	88321 88322	0.9999885559082031	O
21695	*	356 357	88322 88323	0.9999884366989136	O
21696	*	358 359	88324 88325	0.999988317489624	O
21697	*	359 360	88325 88326	0.999988317489624	O
21698	IGNORE	361 366	88327 88332	0.9999874830245972	O
21701	LINE	368 371	88334 88337	0.9999890327453613	O
21704	*	373 374	88339 88340	0.9999884366989136	O
21705	*	374 375	88340 88341	0.999988317489624	O
21706	Case	376 380	88342 88346	0.9999885559082031	O
21707	presentation	381 393	88347 88359	0.999988317489624	O
21708	In	394 396	88360 88362	0.9999889135360718	O
21709	November	397 405	88363 88371	0.9999879598617554	O
21710	2006	406 410	88372 88376	0.999988317489624	O
21711	,	411 412	88377 88378	0.9999890327453613	O
21712	a	413 414	88379 88380	0.9999887943267822	O
21713	56	415 417	88381 88383	0.9999854564666748	O
21714	-	417 418	88383 88384	0.9999890327453613	O
21715	year	418 422	88384 88388	0.9999881982803345	O
21716	old	423 426	88389 88392	0.9999881982803345	O
21717	woman	427 432	88393 88398	0.9999709129333496	O
21718	(	433 434	88399 88400	0.99998939037323	O
21719	III	435 438	88401 88404	0.9999874830245972	O
21720	-	438 439	88404 88405	0.9999892711639404	O
21721	1	439 440	88405 88406	0.9999887943267822	O
21722	in	441 443	88407 88409	0.9999889135360718	O
21723	pedigree	444 451	88410 88417	0.9999887943267822	O
21727	,	453 454	88419 88420	0.9999884366989136	O
21728	Figure	455 461	88421 88427	0.9999872446060181	O
21729	1	462 463	88428 88429	0.9999887943267822	O
21730	)	464 465	88430 88431	0.9999890327453613	O
21731	visited	466 473	88432 88439	0.9999865293502808	O
21732	our	474 477	88440 88443	0.9999861717224121	O
21733	clinic	478 484	88444 88450	0.9999880790710449	O
21734	for	485 488	88451 88454	0.9999889135360718	O
21735	genetic	489 496	88455 88462	0.9999877214431763	O
21736	counseling	497 507	88463 88473	0.9999886751174927	O
21737	because	508 515	88474 88481	0.9999881982803345	O
21738	she	516 519	88482 88485	0.9999856948852539	O
21739	was	520 523	88486 88489	0.9999886751174927	O
21740	worried	524 531	88490 88497	0.9999858140945435	O
21741	about	532 537	88498 88503	0.9999885559082031	O
21742	the	538 541	88504 88507	0.9999885559082031	O
21743	many	542 546	88508 88512	0.9999867677688599	O
21744	cases	547 552	88513 88518	0.9999876022338867	O
21745	of	553 555	88519 88521	0.9999878406524658	O
21746	cancer	556 562	88522 88528	0.9999842643737793	O
21747	that	563 567	88529 88533	0.9999886751174927	O
21748	had	568 571	88534 88537	0.9999874830245972	O
21749	occurred	572 580	88538 88546	0.9999884366989136	O
21750	in	581 583	88547 88549	0.9999884366989136	O
21751	her	584 587	88550 88553	0.9999793767929077	O
21752	family	588 594	88554 88560	0.9999830722808838	O
21753	.	595 596	88561 88562	0.9999690055847168	O
21754	The	0 3	88563 88566	0.999984622001648	O
21755	direct	4 10	88567 88573	0.9999769926071167	O
21756	reason	11 17	88574 88580	0.9999852180480957	O
21757	for	18 21	88581 88584	0.9999842643737793	O
21758	her	22 25	88585 88588	0.999962329864502	O
21759	visit	26 31	88589 88594	0.9999767541885376	O
21760	was	32 35	88595 88598	0.9999849796295166	O
21761	the	36 39	88599 88602	0.9999862909317017	O
21762	recent	40 46	88603 88609	0.999983549118042	O
21763	death	47 52	88610 88615	0.9999785423278809	O
21764	of	53 55	88616 88618	0.9999866485595703	O
21765	her	56 59	88619 88622	0.9999805688858032	O
21766	39	60 62	88623 88625	0.9999783039093018	O
21767	-	62 63	88625 88626	0.9999871253967285	O
21768	year	63 67	88626 88630	0.9999862909317017	O
21769	old	68 71	88631 88634	0.9999860525131226	O
21770	son	72 75	88635 88638	0.9999336004257202	O
21771	(	76 77	88639 88640	0.9999872446060181	O
21772	IV	78 80	88641 88643	0.9999794960021973	O
21773	-	80 81	88643 88644	0.9999878406524658	O
21774	1	81 82	88644 88645	0.9999847412109375	O
21775	)	83 84	88646 88647	0.9999868869781494	O
21776	with	85 89	88648 88652	0.9999830722808838	O
21777	a	90 91	88653 88654	0.9999839067459106	O
21778	symptomatic	92 102	88655 88665	0.9999853372573853	O
21783	,	104 105	88667 88668	0.9999816417694092	O
21784	and	106 109	88669 88672	0.9999821186065674	O
21785	already	110 117	88673 88680	0.9999769926071167	O
21786	metastasized	118 129	88681 88692	0.9999821186065674	O
21790	,	131 132	88694 88695	0.9999781847000122	O
21791	rectal	133 138	88696 88701	0.9999716281890869	O
21794	adenocarcinoma	140 153	88703 88716	0.9999812841415405	O
21799	.	155 156	88718 88719	0.9999488592147827	O
21800	The	0 3	88720 88723	0.9999809265136719	O
21801	counselee	4 12	88724 88732	0.9999762773513794	O
21803	had	14 17	88734 88737	0.9999828338623047	O
21804	been	18 22	88738 88742	0.9999865293502808	O
21805	diagnosed	23 32	88743 88752	0.9999847412109375	O
21806	with	33 37	88753 88757	0.999985933303833	O
21807	an	38 40	88758 88760	0.9999853372573853	O
21808	endometrial	41 51	88761 88771	0.9999822378158569	O
21812	and	53 56	88773 88776	0.9999819993972778	O
21813	a	57 58	88777 88778	0.9999836683273315	O
21814	sigmoid	59 65	88779 88785	0.9999576807022095	O
21818	carcinoma	67 75	88787 88795	0.9999852180480957	O
21821	at	77 79	88797 88799	0.9999877214431763	O
21822	age	80 83	88800 88803	0.9999867677688599	O
21823	53	84 86	88804 88806	0.9999812841415405	O
21824	-	86 87	88806 88807	0.9999881982803345	O
21825	and	88 91	88808 88811	0.999985933303833	O
21826	54	92 94	88812 88814	0.9999775886535645	O
21827	-	94 95	88814 88815	0.9999874830245972	O
21828	years	95 100	88815 88820	0.9999867677688599	O
21829	old	101 104	88821 88824	0.9999872446060181	O
21830	,	105 106	88825 88826	0.9999862909317017	O
21831	respectively	107 119	88827 88839	0.999985933303833	O
21832	.	120 121	88840 88841	0.9999589920043945	O
21833	She	0 3	88842 88845	0.9999473094940186	O
21834	reported	4 12	88846 88854	0.9999815225601196	O
21835	her	13 16	88855 88858	0.9999737739562988	O
21836	overwhelming	17 29	88859 88871	0.9999819993972778	O
21837	family	30 36	88872 88878	0.9999809265136719	O
21838	history	37 44	88879 88886	0.9999818801879883	O
21839	,	45 46	88887 88888	0.9999864101409912	O
21840	which	47 52	88889 88894	0.9999878406524658	O
21841	easily	53 59	88895 88901	0.9999803304672241	O
21842	fulfilled	60 69	88902 88911	0.9999862909317017	O
21843	the	70 73	88912 88915	0.9999884366989136	O
21844	criteria	74 82	88916 88924	0.9999872446060181	O
21845	that	83 87	88925 88929	0.9999880790710449	O
21846	enable	88 94	88930 88936	0.9999865293502808	O
21847	selection	95 104	88937 88946	0.999985933303833	O
21848	of	105 107	88947 88949	0.9999881982803345	O
21849	families	108 116	88950 88958	0.9999814033508301	O
21850	that	117 121	88959 88963	0.9999872446060181	O
21851	are	122 125	88964 88967	0.9999874830245972	O
21852	at	126 128	88968 88970	0.9999873638153076	O
21853	risk	129 133	88971 88975	0.9999873638153076	O
21854	for	134 137	88976 88979	0.9999881982803345	O
21855	Lynch	138 143	88980 88985	0.9999785423278809	O
21856	syndrome	144 152	88986 88994	0.9999878406524658	O
21857	(	153 154	88995 88996	0.9999885559082031	O
21858	Table	155 160	88997 89002	0.9999847412109375	O
21859	1	161 162	89003 89004	0.9999877214431763	O
21860	)	163 164	89005 89006	0.9999889135360718	O
21861	.	165 166	89007 89008	0.999976396560669	O
21862	Subsequent	0 10	89009 89019	0.9999607801437378	O
21863	IHC	11 13	89020 89022	0.9999833106994629	O
21865	-	14 15	89023 89024	0.9999793767929077	O
21866	analysis	15 23	89024 89032	0.9999823570251465	O
21867	on	24 26	89033 89035	0.9999805688858032	O
21868	archival	27 34	89036 89043	0.9999704360961914	O
21870	tumor	36 41	89045 89050	0.9999762773513794	O
21871	material	42 50	89051 89059	0.9999738931655884	O
21872	of	51 53	89060 89062	0.9999798536300659	O
21873	her	54 57	89063 89066	0.9954207539558411	O
21874	sigmoid	58 64	89067 89073	0.9999150037765503	O
21878	carcinoma	66 74	89075 89083	0.9999809265136719	O
21881	demonstrated	76 88	89085 89097	0.9999754428863525	O
21882	abrogation	89 98	89098 89107	0.9999855756759644	O
21885	of	100 102	89109 89111	0.9999865293502808	O
21886	the	103 106	89112 89115	0.9999865293502808	O
21887	MSH2	107 110	89116 89119	0.9999868869781494	O
21890	and	112 115	89121 89124	0.9999867677688599	O
21891	MSH6	116 119	89125 89128	0.9999867677688599	O
21894	proteins	121 129	89130 89138	0.9999865293502808	O
21895	,	130 131	89139 89140	0.9999854564666748	O
21896	which	132 137	89141 89146	0.999987006187439	O
21897	is	138 140	89147 89149	0.9999861717224121	O
21898	typically	141 150	89150 89159	0.999981164932251	O
21899	associated	151 161	89160 89170	0.9999878406524658	O
21900	with	162 166	89171 89175	0.9999876022338867	O
21901	a	167 168	89176 89177	0.9999864101409912	O
21902	germline	169 176	89178 89185	0.9999871253967285	O
21906	MSH2	178 181	89187 89190	0.9999854564666748	O
21909	mutation	183 191	89192 89200	0.9999850988388062	O
21910	.	192 193	89201 89202	0.9999343156814575	O
21911	Multiplex	0 8	89203 89211	0.9999845027923584	O
21913	ligation	10 17	89213 89220	0.9999872446060181	O
21916	-	18 19	89221 89222	0.9999887943267822	O
21917	dependent	19 28	89222 89231	0.9999867677688599	O
21918	probe	29 34	89232 89237	0.9999860525131226	O
21919	amplification	35 47	89238 89250	0.9999877214431763	O
21922	(	49 50	89252 89253	0.9999877214431763	O
21923	MLPA	51 54	89254 89257	0.9999839067459106	O
21926	)	56 57	89259 89260	0.9999886751174927	O
21927	,	58 59	89261 89262	0.9999876022338867	O
21928	in	60 62	89263 89265	0.9999871253967285	O
21929	DNA	63 66	89266 89269	0.9999818801879883	O
21930	extracted	67 76	89270 89279	0.9999877214431763	O
21931	from	77 81	89280 89284	0.9999881982803345	O
21932	peripheral	82 92	89285 89295	0.9999798536300659	O
21933	lymphocytes	93 103	89296 89306	0.9999860525131226	O
21936	,	105 106	89308 89309	0.9999877214431763	O
21937	identified	107 117	89310 89320	0.9999877214431763	O
21938	an	118 120	89321 89323	0.9999887943267822	O
21939	entire	121 127	89324 89330	0.999985933303833	O
21940	MSH2	128 131	89331 89334	0.9999849796295166	O
21943	gene	133 137	89336 89340	0.9999877214431763	O
21944	deletion	138 145	89341 89348	0.9999880790710449	O
21947	(	147 148	89350 89351	0.9999890327453613	O
21948	exons	149 153	89352 89356	0.9999884366989136	O
21950	1	155 156	89358 89359	0.9999886751174927	O
21951	–	156 157	89359 89360	0.9999855756759644	O
21952	16	157 159	89360 89362	0.9999837875366211	O
21953	)	160 161	89363 89364	0.9999892711639404	O
21954	and	162 165	89365 89368	0.9999876022338867	O
21955	confirmed	166 175	89369 89378	0.9999864101409912	O
21956	the	176 179	89379 89382	0.9999884366989136	O
21957	diagnosis	180 189	89383 89392	0.9999865293502808	O
21958	of	190 192	89393 89395	0.9999877214431763	O
21959	Lynch	193 198	89396 89401	0.999976634979248	O
21960	syndrome	199 207	89402 89410	0.9999856948852539	O
21961	.	208 209	89411 89412	0.9999613761901855	O
21962	Pedigree	0 7	89413 89420	0.9999783039093018	O
21966	of	9 11	89422 89424	0.999983549118042	O
21967	a	12 13	89425 89426	0.9999841451644897	O
21968	Lynch	14 19	89427 89432	0.9999622106552124	O
21969	syndrome	20 28	89433 89441	0.9999781847000122	O
21970	family	29 35	89442 89448	0.9999773502349854	O
21971	,	36 37	89449 89450	0.9999856948852539	O
21972	showing	38 45	89451 89458	0.999984622001648	O
21973	organ	46 51	89459 89464	0.9999836683273315	O
21974	systems	52 59	89465 89472	0.9999854564666748	O
21975	and	60 63	89473 89476	0.9999873638153076	O
21976	age	64 67	89477 89480	0.9999860525131226	O
21977	of	68 70	89481 89483	0.9999880790710449	O
21978	diagnosis	71 80	89484 89493	0.9999865293502808	O
21979	,	81 82	89494 89495	0.9999856948852539	O
21980	see	83 86	89496 89499	0.9999845027923584	O
21981	legend	87 93	89500 89506	0.9999825954437256	O
21982	.	94 95	89507 89508	0.999971866607666	O
21983	Year	0 4	89509 89513	0.9999873638153076	O
21984	,	5 6	89514 89515	0.9999884366989136	O
21985	year	7 11	89516 89520	0.9999878406524658	O
21986	of	12 14	89521 89523	0.9999885559082031	O
21987	diagnosis	15 24	89524 89533	0.9999880790710449	O
21988	/	24 25	89533 89534	0.9999880790710449	O
21989	diagnoses	25 33	89534 89542	0.9999879598617554	O
21993	;	35 36	89544 89545	0.9999892711639404	O
21994	asterisk	37 44	89546 89553	0.9999897480010986	O
21997	,	46 47	89555 89556	0.9999887943267822	O
21998	anamnestically	48 61	89557 89570	0.9999895095825195	O
22002	obtained	63 71	89572 89580	0.9999887943267822	O
22003	information	72 83	89581 89592	0.9999889135360718	O
22004	;	84 85	89593 89594	0.9999890327453613	O
22005	urinary	86 92	89595 89601	0.999988317489624	O
22008	tract	94 99	89603 89608	0.999988317489624	O
22009	,	100 101	89609 89610	0.9999879598617554	O
22010	urothelial	102 111	89611 89620	0.9999872446060181	O
22014	carcinoma	113 121	89622 89630	0.9999887943267822	O
22017	of	123 125	89632 89634	0.9999889135360718	O
22018	renal	126 130	89635 89639	0.9999878406524658	O
22020	pelvis	132 137	89641 89646	0.9999880790710449	O
22023	or	139 141	89648 89650	0.9999877214431763	O
22024	ureter	142 147	89651 89656	0.9999872446060181	O
22027	;	149 150	89658 89659	0.99998939037323	O
22028	skin	151 155	89660 89664	0.9999747276306152	O
22029	,	156 157	89665 89666	0.9999885559082031	O
22030	keratoacanthoma	158 172	89667 89681	0.9999867677688599	O
22037	;	174 175	89683 89684	0.9999895095825195	O
22038	asc	176 178	89685 89687	0.9999891519546509	O
22040	.	179 180	89688 89689	0.999988317489624	O
22041	,	181 182	89690 89691	0.9999839067459106	O
22042	ascending	0 9	89692 89701	0.9999805688858032	O
22043	colon	10 14	89702 89706	0.9999823570251465	O
22045	;	16 17	89708 89709	0.9999864101409912	O
22046	transv	18 23	89710 89715	0.999987006187439	O
22048	.	24 25	89716 89717	0.9999871253967285	O
22049	,	26 27	89718 89719	0.9999833106994629	O
22050	transverse	0 10	89720 89730	0.9999698400497437	O
22051	colon	11 15	89731 89735	0.9999839067459106	O
22053	;	17 18	89737 89738	0.9999862909317017	O
22054	desc	19 22	89739 89742	0.9999866485595703	O
22056	.	23 24	89743 89744	0.9999864101409912	O
22057	,	25 26	89745 89746	0.9999815225601196	O
22058	descending	0 10	89747 89757	0.9999102354049683	O
22059	colon	11 15	89758 89762	0.9999288320541382	O
22061	.	17 18	89764 89765	0.9943339824676514	O
22062	In	0 2	89766 89768	0.9999873638153076	O
22063	retrospect	3 12	89769 89778	0.999988317489624	O
22066	,	14 15	89780 89781	0.999987006187439	O
22067	some	16 20	89782 89786	0.9999856948852539	O
22068	doctors	21 28	89787 89794	0.9999784231185913	O
22069	had	29 32	89795 89798	0.9999861717224121	O
22070	indeed	33 39	89799 89805	0.9999790191650391	O
22071	signaled	40 48	89806 89814	0.999981164932251	O
22072	noteworthy	49 59	89815 89825	0.9999845027923584	O
22073	features	60 68	89826 89834	0.9999843835830688	O
22074	in	69 71	89835 89837	0.9999874830245972	O
22075	this	72 76	89838 89842	0.9999864101409912	O
22076	family	77 83	89843 89849	0.9999802112579346	O
22077	.	84 85	89850 89851	0.9999525547027588	O
22078	First	0 5	89852 89857	0.9999837875366211	O
22079	,	6 7	89858 89859	0.999988317489624	O
22080	in	8 10	89860 89862	0.9999876022338867	O
22081	1979	11 15	89863 89867	0.9999760389328003	O
22082	,	16 17	89868 89869	0.9999877214431763	O
22083	a	18 19	89870 89871	0.9999872446060181	O
22084	gynecologist	20 31	89872 89883	0.9999834299087524	O
22087	who	33 36	89885 89888	0.9999874830245972	O
22088	was	37 40	89889 89892	0.9999876022338867	O
22089	treating	41 49	89893 89901	0.9999860525131226	O
22090	patient	50 57	89902 89909	0.9999861717224121	O
22091	II	58 60	89910 89912	0.9999861717224121	O
22092	-	60 61	89912 89913	0.9999890327453613	O
22093	6	61 62	89913 89914	0.9999849796295166	O
22094	consulted	63 72	89915 89924	0.9999837875366211	O
22095	a	73 74	89925 89926	0.9999878406524658	O
22096	colleague	75 84	89927 89936	0.9999688863754272	O
22097	about	85 90	89937 89942	0.9999865293502808	O
22098	the	91 94	89943 89946	0.999988317489624	O
22099	very	95 99	89947 89951	0.9999867677688599	O
22100	early	100 105	89952 89957	0.9999873638153076	O
22101	onset	106 111	89958 89963	0.9999860525131226	O
22102	of	112 114	89964 89966	0.9999877214431763	O
22103	endometrial	115 125	89967 89977	0.9999814033508301	O
22107	carcinoma	127 135	89979 89987	0.9999872446060181	O
22110	.	137 138	89989 89990	0.9999691247940063	O
22111	His	0 3	89991 89994	0.9999614953994751	O
22112	colleague	4 13	89995 90004	0.9999219179153442	O
22113	reassured	14 22	90005 90013	0.9999735355377197	O
22115	him	24 27	90015 90018	0.999969482421875	O
22116	at	28 30	90019 90021	0.9999854564666748	O
22117	that	31 35	90022 90026	0.9999843835830688	O
22118	time	36 40	90027 90031	0.9999843835830688	O
22119	that	41 45	90032 90036	0.9999849796295166	O
22120	the	46 49	90037 90040	0.9999872446060181	O
22121	age	50 53	90041 90044	0.9999861717224121	O
22122	at	54 56	90045 90047	0.9999877214431763	O
22123	presentation	57 69	90048 90060	0.999984622001648	O
22124	,	70 71	90061 90062	0.9999867677688599	O
22125	41	72 74	90063 90065	0.9999816417694092	O
22126	years	75 80	90066 90071	0.9999871253967285	O
22127	old	81 84	90072 90075	0.9999864101409912	O
22128	,	85 86	90076 90077	0.999984622001648	O
22129	was	87 90	90078 90081	0.9999868869781494	O
22130	not	91 94	90082 90085	0.9999855756759644	O
22131	in	95 97	90086 90088	0.9999872446060181	O
22132	fact	98 102	90089 90093	0.999984622001648	O
22133	very	103 107	90094 90098	0.9999849796295166	O
22134	rare	108 112	90099 90103	0.9999855756759644	O
22135	.	113 114	90104 90105	0.9999374151229858	O
22136	Second	0 6	90106 90112	0.9999854564666748	O
22137	,	7 8	90113 90114	0.9999885559082031	O
22138	in	9 11	90115 90117	0.9999879598617554	O
22139	2005	12 16	90118 90122	0.999985933303833	O
22140	,	17 18	90123 90124	0.9999878406524658	O
22141	a	19 20	90125 90126	0.9999866485595703	O
22142	gastroenterologist	21 38	90127 90144	0.9999822378158569	O
22146	spoke	40 45	90146 90151	0.9999839067459106	O
22147	of	46 48	90152 90154	0.999988317489624	O
22148	possible	49 57	90155 90163	0.9999855756759644	O
22149	HNPCC	58 62	90164 90168	0.9999806880950928	O
22152	in	64 66	90170 90172	0.9999887943267822	O
22153	patient	67 74	90173 90180	0.9999847412109375	O
22154	III	75 78	90181 90184	0.9999868869781494	O
22155	-	78 79	90184 90185	0.9999886751174927	O
22156	2	79 80	90185 90186	0.9999829530715942	O
22157	,	81 82	90187 90188	0.9999873638153076	O
22158	who	83 86	90189 90192	0.9999866485595703	O
22159	was	87 90	90193 90196	0.9999879598617554	O
22160	diagnosed	91 100	90197 90206	0.9999852180480957	O
22161	with	101 105	90207 90211	0.9999876022338867	O
22162	carcinoma	106 114	90212 90220	0.9999852180480957	O
22165	of	116 118	90222 90224	0.9999876022338867	O
22166	the	119 122	90225 90228	0.999987006187439	O
22167	papilla	123 129	90229 90235	0.9999853372573853	O
22170	of	131 133	90237 90239	0.9999873638153076	O
22171	Vater	134 138	90240 90244	0.999984622001648	O
22173	after	140 145	90246 90251	0.9999862909317017	O
22174	she	146 149	90252 90255	0.9999754428863525	O
22175	had	150 153	90256 90259	0.9999873638153076	O
22176	developed	154 163	90260 90269	0.9999872446060181	O
22177	three	164 169	90270 90275	0.999984622001648	O
22178	separate	170 178	90276 90284	0.9999794960021973	O
22179	colon	179 183	90285 90289	0.9999750852584839	O
22181	carcinomas	185 194	90291 90300	0.9999858140945435	O
22185	,	196 197	90302 90303	0.9999871253967285	O
22186	but	198 201	90304 90307	0.9999867677688599	O
22187	no	202 204	90308 90310	0.9999866485595703	O
22188	further	205 212	90311 90318	0.999987006187439	O
22189	action	213 219	90319 90325	0.9999828338623047	O
22190	was	220 223	90326 90329	0.9999872446060181	O
22191	taken	224 229	90330 90335	0.9999849796295166	O
22192	.	230 231	90336 90337	0.9999667406082153	O
22193	Third	0 5	90338 90343	0.9999842643737793	O
22194	,	6 7	90344 90345	0.999988317489624	O
22195	in	8 10	90346 90348	0.9999878406524658	O
22196	2006	11 15	90349 90353	0.9999871253967285	O
22197	,	16 17	90354 90355	0.9999880790710449	O
22198	an	18 20	90356 90358	0.9999865293502808	O
22199	oncologist	21 30	90359 90368	0.9999833106994629	O
22201	treating	32 40	90370 90378	0.9999834299087524	O
22202	patient	41 48	90379 90386	0.9999858140945435	O
22203	IV	49 51	90387 90389	0.9999865293502808	O
22204	-	51 52	90389 90390	0.9999887943267822	O
22205	1	52 53	90390 90391	0.9999874830245972	O
22206	suggested	54 63	90392 90401	0.9999871253967285	O
22207	MSI	64 66	90402 90404	0.9999849796295166	O
22209	testing	68 75	90406 90413	0.9999862909317017	O
22210	on	76 78	90414 90416	0.9999874830245972	O
22211	tumor	79 84	90417 90422	0.9999850988388062	O
22212	material	85 93	90423 90431	0.9999860525131226	O
22213	after	94 99	90432 90437	0.9999868869781494	O
22214	his	100 103	90438 90441	0.9999706745147705	O
22215	mother	104 110	90442 90448	0.9999479055404663	O
22216	(	111 112	90449 90450	0.9999884366989136	O
22217	III	113 116	90451 90454	0.9999871253967285	O
22218	-	116 117	90454 90455	0.9999884366989136	O
22219	1	117 118	90455 90456	0.9999876022338867	O
22220	)	119 120	90457 90458	0.9999886751174927	O
22221	had	121 124	90459 90462	0.9999871253967285	O
22222	expressed	125 134	90463 90472	0.9999876022338867	O
22223	her	135 138	90473 90476	0.9999861717224121	O
22224	concern	139 146	90477 90484	0.9999868869781494	O
22225	about	147 152	90485 90490	0.9999880790710449	O
22226	the	153 156	90491 90494	0.9999879598617554	O
22227	family	157 163	90495 90501	0.9999831914901733	O
22228	history	164 171	90502 90509	0.9999878406524658	O
22229	,	172 173	90510 90511	0.9999872446060181	O
22230	but	174 177	90512 90515	0.9999858140945435	O
22231	did	178 181	90516 90519	0.9999874830245972	O
22232	not	182 185	90520 90523	0.999987006187439	O
22233	proceed	186 193	90524 90531	0.9999853372573853	O
22234	.	194 195	90532 90533	0.9999884366989136	O
22235	*	196 197	90534 90535	0.9999872446060181	O
22236	*	197 198	90535 90536	0.9999781847000122	O
22237	IGNORE	0 5	90537 90542	0.9999850988388062	O
22240	LINE	7 10	90544 90547	0.9999879598617554	O
22243	*	12 13	90549 90550	0.9999881982803345	O
22244	*	13 14	90550 90551	0.9999880790710449	O
22245	*	15 16	90552 90553	0.9999880790710449	O
22246	*	16 17	90553 90554	0.9999881982803345	O
22247	IGNORE	18 23	90555 90560	0.9999868869781494	O
22250	LINE	25 28	90562 90565	0.9999884366989136	O
22253	*	30 31	90567 90568	0.9999880790710449	O
22254	*	31 32	90568 90569	0.9999879598617554	O
22255	*	33 34	90570 90571	0.9999878406524658	O
22256	*	34 35	90571 90572	0.9999878406524658	O
22257	IGNORE	36 41	90573 90578	0.9999865293502808	O
22260	LINE	43 46	90580 90583	0.9999881982803345	O
22263	*	48 49	90585 90586	0.9999879598617554	O
22264	*	49 50	90586 90587	0.9999879598617554	O
22265	Discussion	51 60	90588 90597	0.9999880790710449	O
22268	This	62 66	90599 90603	0.9999868869781494	O
22269	family	67 73	90604 90610	0.9999735355377197	O
22270	is	74 76	90611 90613	0.9999868869781494	O
22271	a	77 78	90614 90615	0.9999880790710449	O
22272	fine	79 83	90616 90620	0.999980092048645	O
22273	example	84 91	90621 90628	0.9999821186065674	O
22274	of	92 94	90629 90631	0.999987006187439	O
22275	the	95 98	90632 90635	0.9999862909317017	O
22276	plethora	99 106	90636 90643	0.9999872446060181	O
22279	of	108 110	90645 90647	0.9999858140945435	O
22280	tumors	111 117	90648 90654	0.9999833106994629	O
22281	that	118 122	90655 90659	0.9999878406524658	O
22282	may	123 126	90660 90663	0.9999872446060181	O
22283	occur	127 132	90664 90669	0.9999873638153076	O
22284	in	133 135	90670 90672	0.9999876022338867	O
22285	Lynch	136 141	90673 90678	0.9999797344207764	O
22286	syndrome	142 150	90679 90687	0.9999873638153076	O
22287	and	151 154	90688 90691	0.9999868869781494	O
22288	demonstrates	155 167	90692 90704	0.9999830722808838	O
22289	why	168 171	90705 90708	0.9999852180480957	O
22290	the	172 175	90709 90712	0.9999874830245972	O
22291	term	176 180	90713 90717	0.9999821186065674	O
22292	Lynch	181 186	90718 90723	0.999977707862854	O
22293	syndrome	187 195	90724 90732	0.9999868869781494	O
22294	is	196 198	90733 90735	0.9999877214431763	O
22295	preferred	199 208	90736 90745	0.999984622001648	O
22296	nowadays	209 217	90746 90754	0.9999805688858032	O
22297	over	218 222	90755 90759	0.9999853372573853	O
22298	HNPCC	223 227	90760 90764	0.999982476234436	O
22301	(	229 230	90766 90767	0.9999878406524658	O
22302	hereditary	231 241	90768 90778	0.999934196472168	O
22303	non	242 245	90779 90782	0.9999853372573853	O
22304	-	245 246	90782 90783	0.9999871253967285	O
22305	polyposis	246 254	90783 90791	0.9999831914901733	O
22309	colorectal	256 265	90793 90802	0.9999858140945435	O
22312	cancer	267 273	90804 90810	0.9999868869781494	O
22313	)	274 275	90811 90812	0.9999880790710449	O
22314	,	276 277	90813 90814	0.9999878406524658	O
22315	which	278 283	90815 90820	0.9999881982803345	O
22316	only	284 288	90821 90825	0.999983549118042	O
22317	refers	289 295	90826 90832	0.9999850988388062	O
22318	to	296 298	90833 90835	0.9999876022338867	O
22319	CRC	299 301	90836 90838	0.9999822378158569	O
22321	.	302 303	90839 90840	0.9999499320983887	O
22322	The	0 3	90841 90844	0.9999812841415405	O
22323	organ	4 9	90845 90850	0.9999712705612183	O
22324	involvement	10 21	90851 90862	0.9999781847000122	O
22325	in	22 24	90863 90865	0.999984622001648	O
22326	this	25 29	90866 90870	0.9999828338623047	O
22327	family	30 36	90871 90877	0.9999592304229736	O
22328	included	37 45	90878 90886	0.9999828338623047	O
22329	seven	46 51	90887 90892	0.9999781847000122	O
22330	organ	52 57	90893 90898	0.9999821186065674	O
22331	systems	58 65	90899 90906	0.9999812841415405	O
22332	:	66 67	90907 90908	0.9999836683273315	O
22333	colon	68 72	90909 90913	0.9999831914901733	O
22335	,	74 75	90915 90916	0.9999847412109375	O
22336	uterus	76 81	90917 90922	0.9999830722808838	O
22339	,	83 84	90924 90925	0.9999856948852539	O
22340	skin	85 89	90926 90930	0.9999597072601318	O
22341	,	90 91	90931 90932	0.9999852180480957	O
22342	stomach	92 99	90933 90940	0.999980092048645	O
22343	,	100 101	90941 90942	0.9999856948852539	O
22344	urinary	102 108	90943 90949	0.999984860420227	O
22347	tract	110 115	90951 90956	0.9999868869781494	O
22348	,	116 117	90957 90958	0.9999855756759644	O
22349	pancreas	118 125	90959 90966	0.9999837875366211	O
22352	and	127 130	90968 90971	0.9999852180480957	O
22353	hepatobiliary	131 143	90972 90984	0.9999827146530151	O
22358	system	145 151	90986 90992	0.9999862909317017	O
22359	.	152 153	90993 90994	0.999933123588562	O
22360	The	0 3	90995 90998	0.9999833106994629	O
22361	manifestation	4 16	90999 91011	0.9999808073043823	O
22363	of	18 20	91013 91015	0.9999864101409912	O
22364	keratoacanthoma	21 35	91016 91030	0.9999778270721436	O
22371	in	37 39	91032 91034	0.9999866485595703	O
22372	this	40 44	91035 91039	0.9999837875366211	O
22373	family	45 51	91040 91046	0.9999569654464722	O
22374	enabled	52 59	91047 91054	0.9999827146530151	O
22375	a	60 61	91055 91056	0.9999880790710449	O
22376	sub	62 65	91057 91060	0.9999880790710449	O
22377	-	65 66	91060 91061	0.9999885559082031	O
22378	classification	66 80	91061 91075	0.9999866485595703	O
22379	to	81 83	91076 91078	0.9999849796295166	O
22380	Muir	84 88	91079 91083	0.9999790191650391	O
22381	Torre	89 94	91084 91089	0.9999802112579346	O
22382	syndrome	95 103	91090 91098	0.9999865293502808	O
22383	(	104 105	91099 91100	0.9999879598617554	O
22384	MTS	106 108	91101 91103	0.9999823570251465	O
22386	)	110 111	91105 91106	0.9999886751174927	O
22387	.	112 113	91107 91108	0.9999712705612183	O
22388	MTS	0 2	91109 91111	0.9999772310256958	O
22390	is	4 6	91113 91115	0.9999858140945435	O
22391	a	7 8	91116 91117	0.9999873638153076	O
22392	variant	9 16	91118 91125	0.999982476234436	O
22393	of	17 19	91126 91128	0.9999868869781494	O
22394	Lynch	20 25	91129 91134	0.999977707862854	O
22395	syndrome	26 34	91135 91143	0.9999855756759644	O
22396	and	35 38	91144 91147	0.9999856948852539	O
22397	germline	39 46	91148 91155	0.9999868869781494	O
22401	mutations	48 57	91157 91166	0.999984860420227	O
22402	in	58 60	91167 91169	0.9999876022338867	O
22403	the	61 64	91170 91173	0.9999876022338867	O
22404	three	65 70	91174 91179	0.9999836683273315	O
22405	main	71 75	91180 91184	0.9999847412109375	O
22406	Lynch	76 81	91185 91190	0.9999804496765137	O
22407	syndrome	82 90	91191 91199	0.9999858140945435	O
22408	genes	91 96	91200 91205	0.9999856948852539	O
22409	(	97 98	91206 91207	0.9999885559082031	O
22410	MLH1	99 102	91208 91211	0.9999853372573853	O
22413	,	104 105	91213 91214	0.9999873638153076	O
22414	MSH2	106 109	91215 91218	0.9999873638153076	O
22417	and	111 114	91220 91223	0.9999879598617554	O
22418	MSH6	115 118	91224 91227	0.9999872446060181	O
22421	)	120 121	91229 91230	0.9999890327453613	O
22422	have	122 126	91231 91235	0.999988317489624	O
22423	been	127 131	91236 91240	0.9999881982803345	O
22424	identified	132 142	91241 91251	0.9999877214431763	O
22425	in	143 145	91252 91254	0.999988317489624	O
22426	MTS	146 148	91255 91257	0.9999840259552002	O
22428	families	150 158	91259 91267	0.9999849796295166	O
22429	[	159 160	91268 91269	0.9999892711639404	O
22430	7	160 161	91269 91270	0.9999886751174927	O
22431	,	161 162	91270 91271	0.9999884366989136	O
22432	8	162 163	91271 91272	0.9999878406524658	O
22433	]	163 164	91272 91273	0.9999886751174927	O
22434	.	165 166	91274 91275	0.9999721050262451	O
22435	Keratoacanthoma	0 14	91276 91290	0.9999412298202515	O
22441	should	16 22	91292 91298	0.9999823570251465	O
22442	be	23 25	91299 91301	0.9999856948852539	O
22443	regarded	26 34	91302 91310	0.9999827146530151	O
22444	as	35 37	91311 91313	0.9999858140945435	O
22445	one	38 41	91314 91317	0.9999861717224121	O
22446	of	42 44	91318 91320	0.9999866485595703	O
22447	the	45 48	91321 91324	0.9999856948852539	O
22448	tumors	49 55	91325 91331	0.9999837875366211	O
22449	that	56 60	91332 91336	0.9999872446060181	O
22450	lie	61 64	91337 91340	0.9999852180480957	O
22451	in	65 67	91341 91343	0.9999878406524658	O
22452	the	68 71	91344 91347	0.999988317489624	O
22453	constellation	72 85	91348 91361	0.9999814033508301	O
22454	of	86 88	91362 91364	0.9999876022338867	O
22455	Lynch	89 94	91365 91370	0.9999799728393555	O
22456	syndrome	95 103	91371 91379	0.9999880790710449	O
22457	but	104 107	91380 91383	0.9999818801879883	O
22458	their	108 113	91384 91389	0.999987006187439	O
22459	manifestation	114 126	91390 91402	0.9999847412109375	O
22461	could	128 133	91404 91409	0.9999858140945435	O
22462	depend	134 140	91410 91416	0.9999884366989136	O
22463	on	141 143	91417 91419	0.9999890327453613	O
22464	modifier	144 151	91420 91427	0.9999887943267822	O
22467	genes	153 158	91429 91434	0.9999871253967285	O
22468	and	159 162	91435 91438	0.999988317489624	O
22469	/	162 163	91438 91439	0.9999874830245972	O
22470	or	163 165	91439 91441	0.9999879598617554	O
22471	environmental	166 179	91442 91455	0.9999806880950928	O
22472	factors	180 187	91456 91463	0.9999873638153076	O
22473	.	188 189	91464 91465	0.9999527931213379	O
22474	This	0 4	91466 91470	0.9999827146530151	O
22475	case	5 9	91471 91475	0.9999773502349854	O
22476	report	10 16	91476 91482	0.9999759197235107	O
22477	shows	17 22	91483 91488	0.999976396560669	O
22478	a	23 24	91489 91490	0.999984622001648	O
22479	considerable	25 37	91491 91503	0.9999769926071167	O
22480	delay	38 43	91504 91509	0.9999815225601196	O
22481	in	44 46	91510 91512	0.9999860525131226	O
22482	diagnosing	47 56	91513 91522	0.9999865293502808	O
22486	Lynch	58 63	91524 91529	0.999975323677063	O
22487	syndrome	64 72	91530 91538	0.9999837875366211	O
22488	which	73 78	91539 91544	0.9999850988388062	O
22489	negatively	79 89	91545 91555	0.9999786615371704	O
22490	influenced	90 100	91556 91566	0.9999834299087524	O
22491	the	101 104	91567 91570	0.9999862909317017	O
22492	management	105 115	91571 91581	0.9999803304672241	O
22493	of	116 118	91582 91584	0.9999866485595703	O
22494	many	119 123	91585 91589	0.9999831914901733	O
22495	family	124 130	91590 91596	0.9999793767929077	O
22496	members	131 138	91597 91604	0.9999796152114868	O
22497	.	139 140	91605 91606	0.9999492168426514	O
22498	None	0 4	91607 91611	0.9999802112579346	O
22499	of	5 7	91612 91614	0.9999865293502808	O
22500	the	8 11	91615 91618	0.9999825954437256	O
22501	family	12 18	91619 91625	0.999976396560669	O
22502	members	19 26	91626 91633	0.9999771118164062	O
22503	underwent	27 36	91634 91643	0.9999858140945435	O
22504	presymptomatic	37 50	91644 91657	0.9999885559082031	O
22509	screening	52 61	91659 91668	0.9999853372573853	O
22510	on	62 64	91669 91671	0.9999887943267822	O
22511	the	65 68	91672 91675	0.9999890327453613	O
22512	basis	69 74	91676 91681	0.9999887943267822	O
22513	of	75 77	91682 91684	0.9999887943267822	O
22514	the	78 81	91685 91688	0.9999886751174927	O
22515	family	82 88	91689 91695	0.9999858140945435	O
22516	history	89 96	91696 91703	0.9999878406524658	O
22517	,	97 98	91704 91705	0.9999877214431763	O
22518	while	99 104	91706 91711	0.9999878406524658	O
22519	clinical	105 113	91712 91720	0.999969482421875	O
22520	surveillance	114 126	91721 91733	0.9999871253967285	O
22521	has	127 130	91734 91737	0.9999885559082031	O
22522	been	131 135	91738 91742	0.9999881982803345	O
22523	shown	136 141	91743 91748	0.999987006187439	O
22524	to	142 144	91749 91751	0.9999889135360718	O
22525	decrease	145 153	91752 91760	0.9999850988388062	O
22526	mortality	154 163	91761 91770	0.9999830722808838	O
22527	in	164 166	91771 91773	0.9999889135360718	O
22528	Lynch	167 172	91774 91779	0.9999774694442749	O
22529	syndrome	173 181	91780 91788	0.9999866485595703	O
22530	families	182 190	91789 91797	0.9999878406524658	O
22531	[	191 192	91798 91799	0.9999889135360718	O
22532	9	192 193	91799 91800	0.9999878406524658	O
22533	]	193 194	91800 91801	0.9999886751174927	O
22534	.	195 196	91802 91803	0.999977707862854	O
22535	Remarkably	0 9	91804 91813	0.9999862909317017	O
22538	,	11 12	91815 91816	0.9999880790710449	O
22539	in	13 15	91817 91819	0.9999872446060181	O
22540	none	16 20	91820 91824	0.9999853372573853	O
22541	of	21 23	91825 91827	0.9999878406524658	O
22542	the	24 27	91828 91831	0.9999873638153076	O
22543	medical	28 35	91832 91839	0.9999781847000122	O
22544	reports	36 43	91840 91847	0.999987006187439	O
22545	we	44 46	91848 91850	0.9999876022338867	O
22546	obtained	47 55	91851 91859	0.9999861717224121	O
22547	was	56 59	91860 91863	0.9999881982803345	O
22548	a	60 61	91864 91865	0.9999889135360718	O
22549	family	62 68	91866 91872	0.9999849796295166	O
22550	history	69 76	91873 91880	0.9999884366989136	O
22551	reported	77 85	91881 91889	0.9999880790710449	O
22552	extending	86 95	91890 91899	0.9999877214431763	O
22553	further	96 103	91900 91907	0.9999868869781494	O
22554	than	104 108	91908 91912	0.9999889135360718	O
22555	first	109 114	91913 91918	0.9999879598617554	O
22556	-	114 115	91918 91919	0.9999887943267822	O
22557	degree	115 121	91919 91925	0.9999861717224121	O
22558	relatives	122 131	91926 91935	0.999984860420227	O
22559	.	132 133	91936 91937	0.9999890327453613	O
22560	*	134 135	91938 91939	0.9999874830245972	O
22561	*	135 136	91939 91940	0.9999817609786987	O
22562	IGNORE	0 5	91941 91946	0.9999850988388062	O
22565	LINE	7 10	91948 91951	0.999988317489624	O
22568	*	12 13	91953 91954	0.999988317489624	O
22569	*	13 14	91954 91955	0.9999881982803345	O
22570	*	15 16	91956 91957	0.9999881982803345	O
22571	*	16 17	91957 91958	0.9999884366989136	O
22572	IGNORE	18 23	91959 91964	0.999987006187439	O
22575	LINE	25 28	91966 91969	0.9999889135360718	O
22578	*	30 31	91971 91972	0.9999884366989136	O
22579	*	31 32	91972 91973	0.999988317489624	O
22580	*	33 34	91974 91975	0.999988317489624	O
22581	*	34 35	91975 91976	0.9999884366989136	O
22582	IGNORE	36 41	91977 91982	0.9999867677688599	O
22585	LINE	43 46	91984 91987	0.9999885559082031	O
22588	*	48 49	91989 91990	0.9999884366989136	O
22589	*	49 50	91990 91991	0.9999881982803345	O
22590	Conclusion	51 60	91992 92001	0.9999876022338867	O
22593	This	62 66	92003 92007	0.9999860525131226	O
22594	family	67 73	92008 92014	0.999970555305481	O
22595	clearly	74 81	92015 92022	0.9999828338623047	O
22596	illustrates	82 92	92023 92033	0.9999830722808838	O
22598	a	94 95	92035 92036	0.9999877214431763	O
22599	lack	96 100	92037 92041	0.9999858140945435	O
22600	of	101 103	92042 92044	0.999988317489624	O
22601	awareness	104 113	92045 92054	0.9999849796295166	O
22602	about	114 119	92055 92060	0.9999872446060181	O
22603	a	120 121	92061 92062	0.9999866485595703	O
22604	hereditary	122 132	92063 92073	0.9999699592590332	O
22605	tumor	133 138	92074 92079	0.9999837875366211	O
22606	syndrome	139 147	92080 92088	0.9999839067459106	O
22607	among	148 153	92089 92094	0.9999865293502808	O
22608	doctors	154 161	92095 92102	0.9999783039093018	O
22609	as	162 164	92103 92105	0.9999847412109375	O
22610	well	165 169	92106 92110	0.9999830722808838	O
22611	as	170 172	92111 92113	0.9999841451644897	O
22612	patients	173 181	92114 92122	0.9999512434005737	O
22613	.	182 183	92123 92124	0.9999493360519409	O
22614	In	0 2	92125 92127	0.9999865293502808	O
22615	general	3 10	92128 92135	0.9999845027923584	O
22616	,	11 12	92136 92137	0.9999868869781494	O
22617	it	13 15	92138 92140	0.9999861717224121	O
22618	is	16 18	92141 92143	0.9999864101409912	O
22619	prudent	19 25	92144 92150	0.999987006187439	O
22622	to	27 29	92152 92154	0.9999871253967285	O
22623	be	30 32	92155 92157	0.9999874830245972	O
22624	aware	33 38	92158 92163	0.9999856948852539	O
22625	of	39 41	92164 92166	0.9999889135360718	O
22626	classic	42 49	92167 92174	0.9999855756759644	O
22627	hereditary	50 60	92175 92185	0.9999785423278809	O
22628	features	61 69	92186 92194	0.9999871253967285	O
22629	,	70 71	92195 92196	0.9999881982803345	O
22630	like	72 76	92197 92201	0.9999873638153076	O
22631	young	77 82	92202 92207	0.9999880790710449	O
22632	age	83 86	92208 92211	0.9999887943267822	O
22633	at	87 89	92212 92214	0.9999889135360718	O
22634	diagnosis	90 99	92215 92224	0.9999880790710449	O
22635	,	100 101	92225 92226	0.9999868869781494	O
22636	multiple	102 110	92227 92235	0.9999773502349854	O
22637	tumors	111 117	92236 92242	0.9999864101409912	O
22638	in	118 120	92243 92245	0.9999887943267822	O
22639	multiple	121 129	92246 92254	0.9999886751174927	O
22640	organs	130 136	92255 92261	0.9999818801879883	O
22641	and	137 140	92262 92265	0.9999881982803345	O
22642	a	141 142	92266 92267	0.9999890327453613	O
22643	positive	143 151	92268 92276	0.9999877214431763	O
22644	family	152 158	92277 92283	0.9999871253967285	O
22645	history	159 166	92284 92291	0.9999886751174927	O
22646	,	167 168	92292 92293	0.9999873638153076	O
22647	and	169 172	92294 92297	0.9999873638153076	O
22648	to	173 175	92298 92300	0.9999874830245972	O
22649	refer	176 181	92301 92306	0.9999861717224121	O
22650	suspected	182 191	92307 92316	0.9999855756759644	O
22651	cases	192 197	92317 92322	0.9999860525131226	O
22652	for	198 201	92323 92326	0.9999867677688599	O
22653	genetic	202 209	92327 92334	0.9999861717224121	O
22654	counseling	210 220	92335 92345	0.9999867677688599	O
22655	.	221 222	92346 92347	0.9999692440032959	O
22656	More	0 4	92348 92352	0.9999860525131226	O
22657	specifically	5 17	92353 92365	0.9999864101409912	O
22658	,	18 19	92366 92367	0.9999876022338867	O
22659	these	20 25	92368 92373	0.9999867677688599	O
22660	features	26 34	92374 92382	0.9999843835830688	O
22661	can	35 38	92383 92386	0.9999860525131226	O
22662	be	39 41	92387 92389	0.999988317489624	O
22663	found	42 47	92390 92395	0.9999874830245972	O
22664	in	48 50	92396 92398	0.9999885559082031	O
22665	the	51 54	92399 92402	0.9999886751174927	O
22666	Amsterdam	55 64	92403 92412	0.9999822378158569	O
22667	and	65 68	92413 92416	0.9999878406524658	O
22668	Bethesda	69 76	92417 92424	0.9999865293502808	O
22671	criteria	78 86	92426 92434	0.9999879598617554	O
22672	(	87 88	92435 92436	0.9999887943267822	O
22673	Table	89 94	92437 92442	0.9999862909317017	O
22674	1	95 96	92443 92444	0.9999878406524658	O
22675	)	97 98	92445 92446	0.9999890327453613	O
22676	.	99 100	92447 92448	0.999975323677063	O
22677	Subsequently	0 12	92449 92461	0.999981164932251	O
22678	,	13 14	92462 92463	0.9999880790710449	O
22679	the	15 18	92464 92467	0.9999873638153076	O
22680	identification	19 33	92468 92482	0.9999868869781494	O
22681	of	34 36	92483 92485	0.9999881982803345	O
22682	at	37 39	92486 92488	0.999987006187439	O
22683	-	39 40	92488 92489	0.9999879598617554	O
22684	risk	40 44	92489 92493	0.9999855756759644	O
22685	persons	45 52	92494 92501	0.9999591112136841	O
22686	will	53 57	92502 92506	0.9999872446060181	O
22687	optimize	58 65	92507 92514	0.9999878406524658	O
22690	the	67 70	92516 92519	0.9999880790710449	O
22691	timing	71 77	92520 92526	0.9999866485595703	O
22692	and	78 81	92527 92530	0.9999876022338867	O
22693	efficiency	82 92	92531 92541	0.9999856948852539	O
22694	that	93 97	92542 92546	0.9999850988388062	O
22695	surveillance	98 110	92547 92559	0.9999854564666748	O
22696	and	111 114	92560 92563	0.9999868869781494	O
22697	treatment	115 124	92564 92573	0.999982476234436	O
22698	are	125 128	92574 92577	0.9999866485595703	O
22699	carried	129 136	92578 92585	0.9999867677688599	O
22700	out	137 140	92586 92589	0.9999871253967285	O
22701	.	141 142	92590 92591	0.9999885559082031	O
22702	*	143 144	92592 92593	0.9999874830245972	O
22703	*	144 145	92593 92594	0.9999816417694092	O
22704	IGNORE	0 5	92595 92600	0.9999852180480957	O
22707	LINE	7 10	92602 92605	0.9999884366989136	O
22710	*	12 13	92607 92608	0.9999891519546509	O
22711	*	13 14	92608 92609	0.9999891519546509	O
22712	*	15 16	92610 92611	0.9999890327453613	O
22713	*	16 17	92611 92612	0.9999891519546509	O
22714	IGNORE	18 23	92613 92618	0.9999873638153076	O
22717	LINE	25 28	92620 92623	0.9999890327453613	O
22720	*	30 31	92625 92626	0.9999889135360718	O
22721	*	31 32	92626 92627	0.9999889135360718	O
22722	*	33 34	92628 92629	0.9999889135360718	O
22723	*	34 35	92629 92630	0.9999889135360718	O
22724	IGNORE	36 41	92631 92636	0.9999868869781494	O
22727	LINE	43 46	92638 92641	0.9999887943267822	O
22730	*	48 49	92643 92644	0.9999891519546509	O
22731	*	49 50	92644 92645	0.9999890327453613	O
22732	The	51 54	92646 92649	0.9999889135360718	O
22733	DNA	55 58	92650 92653	0.999987006187439	O
22734	sequence	59 67	92654 92662	0.9999871253967285	O
22735	of	68 70	92663 92665	0.9999890327453613	O
22736	each	71 75	92666 92670	0.9999891519546509	O
22737	microsatellite	76 89	92671 92684	0.9999881982803345	O
22741	in	91 93	92686 92688	0.9999871253967285	O
22742	the	94 97	92689 92692	0.9999852180480957	O
22743	tumor	98 103	92693 92698	0.9999814033508301	O
22744	was	104 107	92699 92702	0.9999881982803345	O
22745	compared	108 116	92703 92711	0.9999873638153076	O
22746	with	117 121	92712 92716	0.9999879598617554	O
22747	that	122 126	92717 92721	0.9999886751174927	O
22748	of	127 129	92722 92724	0.9999884366989136	O
22749	the	130 133	92725 92728	0.9999880790710449	O
22750	matched	134 141	92729 92736	0.9999785423278809	O
22751	normal	142 148	92737 92743	0.9999803304672241	O
22752	mucosa	149 154	92744 92749	0.9999860525131226	O
22755	.	156 157	92751 92752	0.9999475479125977	O
22756	It	0 2	92753 92755	0.9999836683273315	O
22757	was	3 6	92756 92759	0.9999852180480957	O
22758	considered	7 17	92760 92770	0.9999855756759644	O
22759	as	18 20	92771 92773	0.999985933303833	O
22760	unstable	21 29	92774 92782	0.9999799728393555	O
22761	if	30 32	92783 92785	0.9999850988388062	O
22762	there	33 38	92786 92791	0.9999879598617554	O
22763	was	39 42	92792 92795	0.9999878406524658	O
22764	an	43 45	92796 92798	0.9999881982803345	O
22765	absence	46 53	92799 92806	0.9999867677688599	O
22766	,	54 55	92807 92808	0.9999856948852539	O
22767	shortening	56 65	92809 92818	0.999987006187439	O
22769	or	67 69	92820 92822	0.999987006187439	O
22770	prolongation	70 81	92823 92834	0.999988317489624	O
22773	of	83 85	92836 92838	0.9999881982803345	O
22774	the	86 89	92839 92842	0.9999885559082031	O
22775	DNA	90 93	92843 92846	0.9999843835830688	O
22776	sequence	94 102	92847 92855	0.9999861717224121	O
22777	.	103 104	92856 92857	0.9999583959579468	O
22778	MSI	0 2	92858 92860	0.9999877214431763	O
22780	-	3 4	92861 92862	0.9999895095825195	O
22781	L	4 5	92862 92863	0.9999827146530151	O
22782	was	6 9	92864 92867	0.9999892711639404	O
22783	defined	10 17	92868 92875	0.99998939037323	O
22784	as	18 20	92876 92878	0.9999896287918091	O
22785	1	21 22	92879 92880	0.99998939037323	O
22786	unstable	23 31	92881 92889	0.9999889135360718	O
22787	microsatellite	32 45	92890 92903	0.9999892711639404	O
22791	out	47 50	92905 92908	0.9999896287918091	O
22792	of	51 53	92909 92911	0.99998939037323	O
22793	5	54 55	92912 92913	0.999988317489624	O
22794	,	56 57	92914 92915	0.9999887943267822	O
22795	while	58 63	92916 92921	0.9999890327453613	O
22796	MSI	64 66	92922 92924	0.9999880790710449	O
22798	-	67 68	92925 92926	0.9999895095825195	O
22799	H	68 69	92926 92927	0.9999815225601196	O
22800	was	70 73	92928 92931	0.99998939037323	O
22801	defined	74 81	92932 92939	0.9999892711639404	O
22802	as	82 84	92940 92942	0.99998939037323	O
22803	more	85 89	92943 92947	0.9999892711639404	O
22804	than	90 94	92948 92952	0.99998939037323	O
22805	1	95 96	92953 92954	0.9999892711639404	O
22806	unstable	97 105	92955 92963	0.9999886751174927	O
22807	microsatellite	106 119	92964 92977	0.9999891519546509	O
22811	out	121 124	92979 92982	0.99998939037323	O
22812	of	125 127	92983 92985	0.9999891519546509	O
22813	5	128 129	92986 92987	0.9999884366989136	O
22814	.	130 131	92988 92989	0.9999774694442749	O
22815	If	0 2	92990 92992	0.9999815225601196	O
22816	the	3 6	92993 92996	0.9999877214431763	O
22817	tumor	7 12	92997 93002	0.999976396560669	O
22818	microsatellites	13 27	93003 93017	0.999988317489624	O
22822	were	29 33	93019 93023	0.9999887943267822	O
22823	identical	34 43	93024 93033	0.9999864101409912	O
22824	to	44 46	93034 93036	0.9999886751174927	O
22825	those	47 52	93037 93042	0.9999879598617554	O
22826	of	53 55	93043 93045	0.9999879598617554	O
22827	the	56 59	93046 93049	0.9999877214431763	O
22828	normal	60 66	93050 93056	0.9999847412109375	O
22829	tissue	67 73	93057 93063	0.9999866485595703	O
22830	,	74 75	93064 93065	0.9999881982803345	O
22831	the	76 79	93066 93069	0.9999892711639404	O
22832	microsatellite	80 93	93070 93083	0.9999886751174927	O
22836	was	95 98	93085 93088	0.9999891519546509	O
22837	considered	99 109	93089 93099	0.9999890327453613	O
22838	as	110 112	93100 93102	0.9999896287918091	O
22839	stable	113 119	93103 93109	0.9999864101409912	O
22840	(	120 121	93110 93111	0.9999896287918091	O
22841	MSS	122 124	93112 93114	0.9999880790710449	O
22843	)	125 126	93115 93116	0.9999897480010986	O
22844	.	127 128	93117 93118	0.999976634979248	O
22845	For	0 3	93119 93122	0.9999830722808838	O
22846	the	4 7	93123 93126	0.9999853372573853	O
22847	MSI	8 10	93127 93129	0.9999815225601196	O
22849	-	11 12	93130 93131	0.9999872446060181	O
22850	L	12 13	93131 93132	0.9999765157699585	O
22851	CRCs	14 17	93133 93136	0.9999806880950928	O
22853	,	19 20	93138 93139	0.9999872446060181	O
22854	BAT	21 23	93140 93142	0.9999847412109375	O
22856	-	24 25	93143 93144	0.9999890327453613	O
22857	40	25 27	93144 93146	0.999984860420227	O
22858	and	28 31	93147 93150	0.9999878406524658	O
22859	MYCL	32 35	93151 93154	0.9999864101409912	O
22862	were	37 41	93156 93160	0.9999879598617554	O
22863	detected	42 50	93161 93169	0.9999885559082031	O
22864	.	51 52	93170 93171	0.9999608993530273	O
22865	If	0 2	93172 93174	0.9999843835830688	O
22866	either	3 9	93175 93181	0.9999874830245972	O
22867	of	10 12	93182 93184	0.9999889135360718	O
22868	these	13 18	93185 93190	0.9999891519546509	O
22869	two	19 22	93191 93194	0.9999861717224121	O
22870	markers	23 30	93195 93202	0.9999872446060181	O
22871	was	31 34	93203 93206	0.9999887943267822	O
22872	unstable	35 43	93207 93215	0.9999829530715942	O
22873	,	44 45	93216 93217	0.9999886751174927	O
22874	this	46 50	93218 93222	0.9999881982803345	O
22875	colorectal	51 60	93223 93232	0.9999855756759644	O
22878	sample	62 68	93234 93240	0.9999871253967285	O
22879	was	69 72	93241 93244	0.9999892711639404	O
22880	considered	73 83	93245 93255	0.9999891519546509	O
22881	as	84 86	93256 93258	0.9999895095825195	O
22882	MSI	87 89	93259 93261	0.9999885559082031	O
22884	-	90 91	93262 93263	0.9999895095825195	O
22885	H	91 92	93263 93264	0.9999856948852539	O
22886	.	92 93	93264 93265	0.9999895095825195	O
22887	Immunohistochemical	94 112	93266 93284	0.9999892711639404	O
22893	staining	114 121	93286 93293	0.9999892711639404	O
22895	for	123 126	93295 93298	0.99998939037323	O
22896	MSH2	127 130	93299 93302	0.9999891519546509	O
22899	,	132 133	93304 93305	0.9999891519546509	O
22900	MSH6	134 137	93306 93309	0.9999889135360718	O
22903	and	139 142	93311 93314	0.9999891519546509	O
22904	MLH1	143 146	93315 93318	0.9999877214431763	O
22907	on	148 150	93320 93322	0.9999889135360718	O
22908	TMAs	151 154	93323 93326	0.9999886751174927	O
22911	The	156 159	93328 93331	0.9999878406524658	O
22912	CRC	160 162	93332 93334	0.9999828338623047	O
22914	microarray	164 173	93336 93345	0.9999889135360718	O
22917	was	175 178	93347 93350	0.9999892711639404	O
22918	constructed	179 190	93351 93362	0.9999878406524658	O
22919	as	191 193	93363 93365	0.9999887943267822	O
22920	previously	194 204	93366 93376	0.9999884366989136	O
22921	described	205 214	93377 93386	0.9999887943267822	O
22922	[	215 216	93387 93388	0.9999892711639404	O
22923	8	216 217	93388 93389	0.9999885559082031	O
22924	,	217 218	93389 93390	0.9999886751174927	O
22925	9	218 219	93390 93391	0.9999872446060181	O
22926	]	219 220	93391 93392	0.9999890327453613	O
22927	.	221 222	93393 93394	0.9999784231185913	O
22928	Briefly	0 6	93395 93401	0.9999738931655884	O
22931	,	8 9	93403 93404	0.9999874830245972	O
22932	formalin	10 17	93405 93412	0.9999819993972778	O
22934	-	18 19	93413 93414	0.9999881982803345	O
22935	fixed	19 24	93414 93419	0.9999823570251465	O
22936	paraffin	25 32	93420 93427	0.9999865293502808	O
22938	-	33 34	93428 93429	0.9999884366989136	O
22939	embedded	34 42	93429 93437	0.9999834299087524	O
22940	tissue	43 49	93438 93444	0.9999840259552002	O
22941	blocks	50 56	93445 93451	0.9999829530715942	O
22942	of	57 59	93452 93454	0.999984622001648	O
22943	CRC	60 62	93455 93457	0.9999648332595825	O
22945	resections	64 73	93459 93468	0.9999850988388062	O
22948	were	75 79	93470 93474	0.9999877214431763	O
22949	cut	80 83	93475 93478	0.9999852180480957	O
22950	from	84 88	93479 93483	0.999988317489624	O
22951	the	89 92	93484 93487	0.9999885559082031	O
22952	donor	93 98	93488 93493	0.9999818801879883	O
22953	block	99 104	93494 93499	0.9999868869781494	O
22954	and	105 108	93500 93503	0.9999877214431763	O
22955	stained	109 116	93504 93511	0.999987006187439	O
22956	with	117 121	93512 93516	0.9999887943267822	O
22957	hematoxylin	122 132	93517 93527	0.9999884366989136	O
22961	-	133 134	93528 93529	0.9999889135360718	O
22962	eosin	134 138	93529 93533	0.999988317489624	O
22965	(	140 141	93535 93536	0.9999890327453613	O
22966	HE	142 143	93537 93538	0.9999853372573853	O
22968	)	144 145	93539 93540	0.9999891519546509	O
22969	.	146 147	93541 93542	0.9999709129333496	O
22970	These	0 5	93543 93548	0.9999796152114868	O
22971	slides	6 12	93549 93555	0.9999583959579468	O
22972	were	13 17	93556 93560	0.9999779462814331	O
22973	used	18 22	93561 93565	0.9999779462814331	O
22974	to	23 25	93566 93568	0.999982476234436	O
22975	guide	26 31	93569 93574	0.9999710321426392	O
22976	the	32 35	93575 93578	0.9999816417694092	O
22977	sampling	36 44	93579 93587	0.9999791383743286	O
22978	from	45 49	93588 93592	0.9999836683273315	O
22979	morphologically	50 64	93593 93607	0.9999853372573853	O
22983	representative	66 80	93609 93623	0.9999834299087524	O
22984	regions	81 88	93624 93631	0.9999829530715942	O
22985	of	89 91	93632 93634	0.9999839067459106	O
22986	the	92 95	93635 93638	0.9999817609786987	O
22987	tissues	96 103	93639 93646	0.9999698400497437	O
22988	.	104 105	93647 93648	0.9998654127120972	O
22989	A	0 1	93649 93650	0.9999856948852539	O
22990	tissue	2 8	93651 93657	0.9999854564666748	O
22991	array	9 14	93658 93663	0.9999814033508301	O
22992	instrument	15 25	93664 93674	0.9999767541885376	O
22993	(	26 27	93675 93676	0.9999872446060181	O
22994	Beecher	28 34	93677 93683	0.9999853372573853	O
22996	Instruments	36 47	93685 93696	0.9999792575836182	O
22997	,	48 49	93697 93698	0.9999871253967285	O
22998	Silver	50 56	93699 93705	0.9999840259552002	O
22999	Spring	57 63	93706 93712	0.999985933303833	O
23000	,	64 65	93713 93714	0.9999878406524658	O
23001	MD	66 68	93715 93717	0.9999765157699585	O
23002	)	68 69	93717 93718	0.9999881982803345	O
23003	was	70 73	93719 93722	0.9999816417694092	O
23004	used	74 78	93723 93727	0.999982476234436	O
23005	to	79 81	93728 93730	0.9999866485595703	O
23006	create	82 88	93731 93737	0.9999834299087524	O
23007	holes	89 94	93738 93743	0.9999762773513794	O
23008	in	95 97	93744 93746	0.9999861717224121	O
23009	a	98 99	93747 93748	0.999987006187439	O
23010	recipient	100 109	93749 93758	0.9999685287475586	O
23011	paraffin	110 117	93759 93766	0.999985933303833	O
23013	block	119 124	93768 93773	0.999987006187439	O
23014	and	125 128	93774 93777	0.9999854564666748	O
23015	to	129 131	93778 93780	0.9999867677688599	O
23016	acquire	132 139	93781 93788	0.9999852180480957	O
23017	tissue	140 146	93789 93795	0.9999858140945435	O
23018	cores	147 151	93796 93800	0.9999868869781494	O
23020	from	153 157	93802 93806	0.9999881982803345	O
23021	the	158 161	93807 93810	0.9999879598617554	O
23022	donor	162 167	93811 93816	0.999982476234436	O
23023	block	168 173	93817 93822	0.9999873638153076	O
23024	by	174 176	93823 93825	0.9999868869781494	O
23025	a	177 178	93826 93827	0.9999881982803345	O
23026	thin	179 183	93828 93832	0.9999853372573853	O
23027	-	183 184	93832 93833	0.9999884366989136	O
23028	walled	184 190	93833 93839	0.9999842643737793	O
23029	needle	191 197	93840 93846	0.999980092048645	O
23030	with	198 202	93847 93851	0.9999871253967285	O
23031	an	203 205	93852 93854	0.9999884366989136	O
23032	inner	206 211	93855 93860	0.9999849796295166	O
23033	diameter	212 220	93861 93869	0.9999866485595703	O
23034	of	221 223	93870 93872	0.9999880790710449	O
23035	1	224 225	93873 93874	0.9999877214431763	O
23036	.	225 226	93874 93875	0.9999884366989136	O
23037	0	226 227	93875 93876	0.9999872446060181	O
23038	mm	228 230	93877 93879	0.999985933303833	O
23039	,	231 232	93880 93881	0.9999852180480957	O
23040	held	233 237	93882 93886	0.9999842643737793	O
23041	in	238 240	93887 93889	0.9999867677688599	O
23042	an	241 243	93890 93892	0.9999880790710449	O
23043	X	244 245	93893 93894	0.9999877214431763	O
23044	-	245 246	93894 93895	0.9999886751174927	O
23045	Y	246 247	93895 93896	0.9999840259552002	O
23046	precision	248 257	93897 93906	0.9999841451644897	O
23047	guide	258 263	93907 93912	0.9999833106994629	O
23048	.	264 265	93913 93914	0.9999467134475708	O
23049	The	0 3	93915 93918	0.9999804496765137	O
23050	cylindrical	4 15	93919 93930	0.9998652935028076	O
23051	samples	16 23	93931 93938	0.999975323677063	O
23052	were	24 28	93939 93943	0.999983549118042	O
23053	retrieved	29 38	93944 93953	0.9999792575836182	O
23054	from	39 43	93954 93958	0.9999847412109375	O
23055	the	44 47	93959 93962	0.9999855756759644	O
23056	selected	48 56	93963 93971	0.9999822378158569	O
23057	regions	57 64	93972 93979	0.9999829530715942	O
23058	in	65 67	93980 93982	0.9999845027923584	O
23059	the	68 71	93983 93986	0.9999841451644897	O
23060	donors	72 78	93987 93993	0.999968409538269	O
23061	and	79 82	93994 93997	0.999984622001648	O
23062	extruded	83 90	93998 94005	0.9999867677688599	O
23065	directly	92 100	94007 94015	0.9999860525131226	O
23066	into	101 105	94016 94020	0.9999871253967285	O
23067	the	106 109	94021 94024	0.9999862909317017	O
23068	recipient	110 119	94025 94034	0.9999161958694458	O
23069	blocks	120 126	94035 94041	0.9999803304672241	O
23070	with	127 131	94042 94046	0.9999876022338867	O
23071	defined	132 139	94047 94054	0.9999853372573853	O
23072	array	140 145	94055 94060	0.9999804496765137	O
23073	coordinates	146 157	94061 94072	0.9999839067459106	O
23074	.	158 159	94073 94074	0.9999473094940186	O
23075	Three	0 5	94075 94080	0.9999744892120361	O
23076	cores	6 10	94081 94085	0.9999786615371704	O
23078	were	12 16	94087 94091	0.9999792575836182	O
23079	obtained	17 25	94092 94100	0.9999815225601196	O
23080	from	26 30	94101 94105	0.9999825954437256	O
23081	each	31 35	94106 94110	0.9999806880950928	O
23082	sample	36 42	94111 94117	0.9999806880950928	O
23083	.	43 44	94118 94119	0.9998942613601685	O
23084	After	0 5	94120 94125	0.9999831914901733	O
23085	the	6 9	94126 94129	0.9999878406524658	O
23086	construction	10 22	94130 94142	0.9999856948852539	O
23087	of	23 25	94143 94145	0.9999880790710449	O
23088	the	26 29	94146 94149	0.9999877214431763	O
23089	array	30 35	94150 94155	0.9999812841415405	O
23090	block	36 41	94156 94161	0.9999823570251465	O
23091	,	42 43	94162 94163	0.9999871253967285	O
23092	multiple	44 52	94164 94172	0.9999864101409912	O
23093	4	53 54	94173 94174	0.9999874830245972	O
23094	-	54 55	94174 94175	0.9999890327453613	O
23095	mm	55 57	94175 94177	0.9999879598617554	O
23096	thick	58 63	94178 94183	0.9999871253967285	O
23097	sections	64 72	94184 94192	0.9999830722808838	O
23098	were	73 77	94193 94197	0.9999884366989136	O
23099	cut	78 81	94198 94201	0.9999845027923584	O
23100	with	82 86	94202 94206	0.9999874830245972	O
23101	a	87 88	94207 94208	0.99998939037323	O
23102	microtome	89 97	94209 94217	0.9999876022338867	O
23105	using	99 104	94219 94224	0.9999889135360718	O
23106	an	105 107	94225 94227	0.9999895095825195	O
23107	adhesive	108 115	94228 94235	0.9999886751174927	O
23109	-	116 117	94236 94237	0.9999895095825195	O
23110	coated	117 123	94237 94243	0.9999876022338867	O
23111	tape	124 128	94244 94248	0.9999862909317017	O
23112	sectioning	129 138	94249 94258	0.9999874830245972	O
23114	system	140 146	94260 94266	0.9999889135360718	O
23115	(	147 148	94267 94268	0.9999891519546509	O
23116	Instrumedics	149 160	94269 94280	0.999988317489624	O
23121	,	162 163	94282 94283	0.999988317489624	O
23122	Hackensack	164 173	94284 94293	0.9999849796295166	O
23126	,	175 176	94295 94296	0.9999884366989136	O
23127	NJ	177 179	94297 94299	0.9999784231185913	O
23128	)	179 180	94299 94300	0.9999890327453613	O
23129	.	181 182	94301 94302	0.9999697208404541	O
23130	In	0 2	94303 94305	0.9999861717224121	O
23131	our	3 6	94306 94309	0.9999792575836182	O
23132	analysis	7 15	94310 94318	0.9999864101409912	O
23133	the	16 19	94319 94322	0.9999868869781494	O
23134	rates	20 25	94323 94328	0.9999864101409912	O
23135	of	26 28	94329 94331	0.999988317489624	O
23136	lost	29 33	94332 94336	0.999984622001648	O
23137	cases	34 39	94337 94342	0.9999881982803345	O
23138	attributable	40 51	94343 94354	0.99998939037323	O
23142	to	53 55	94356 94358	0.9999889135360718	O
23143	tissue	56 62	94359 94365	0.9999872446060181	O
23144	damage	63 69	94366 94372	0.9999878406524658	O
23145	were	70 74	94373 94377	0.9999879598617554	O
23146	less	75 79	94378 94382	0.9999887943267822	O
23147	than	80 84	94383 94387	0.9999891519546509	O
23148	5	85 86	94388 94389	0.9999889135360718	O
23149	%	87 88	94390 94391	0.99998939037323	O
23150	for	89 92	94392 94395	0.9999887943267822	O
23151	the	93 96	94396 94399	0.9999887943267822	O
23152	different	97 106	94400 94409	0.9999858140945435	O
23153	markers	107 114	94410 94417	0.9999871253967285	O
23154	.	115 116	94418 94419	0.999972939491272	O
23155	TMA	0 2	94420 94422	0.999983549118042	O
23157	slides	4 10	94424 94430	0.9999798536300659	O
23158	were	11 15	94431 94435	0.9999871253967285	O
23159	stained	16 23	94436 94443	0.9999850988388062	O
23160	with	24 28	94444 94448	0.9999884366989136	O
23161	MLH1	29 32	94449 94452	0.999984860420227	O
23164	antibodies	34 44	94454 94464	0.9999860525131226	O
23165	(	45 46	94465 94466	0.9999876022338867	O
23166	1	47 48	94467 94468	0.9999886751174927	O
23167	:	48 49	94468 94469	0.9999887943267822	O
23168	50	49 51	94469 94471	0.9999868869781494	O
23169	dilution	52 59	94472 94479	0.9999880790710449	O
23171	,	61 62	94481 94482	0.9999884366989136	O
23172	No	63 65	94483 94485	0.9999868869781494	O
23173	.	65 66	94485 94486	0.9999774694442749	O
23174	sc	0 1	94487 94488	0.9999892711639404	O
23176	-	2 3	94489 94490	0.9999895095825195	O
23177	494	3 5	94490 94492	0.9999862909317017	O
23179	,	7 8	94494 94495	0.9999890327453613	O
23180	Santa	9 14	94496 94501	0.9999866485595703	O
23181	Cruz	15 19	94502 94506	0.9999856948852539	O
23182	,	20 21	94507 94508	0.9999889135360718	O
23183	Biotrade	22 29	94509 94516	0.9999879598617554	O
23186	Ltd	31 34	94518 94521	0.9999877214431763	O
23187	,	35 36	94522 94523	0.9999891519546509	O
23188	Shanghai	37 45	94524 94532	0.999976396560669	O
23189	,	46 47	94533 94534	0.9999886751174927	O
23190	China	48 53	94535 94540	0.9999517202377319	O
23191	)	54 55	94541 94542	0.9999891519546509	O
23192	and	56 59	94543 94546	0.9999892711639404	O
23193	MSH2	60 63	94547 94550	0.9999876022338867	O
23196	(	65 66	94552 94553	0.9999897480010986	O
23197	1	67 68	94554 94555	0.9999892711639404	O
23198	:	68 69	94555 94556	0.9999892711639404	O
23199	100	69 72	94556 94559	0.9999886751174927	O
23200	dilution	73 80	94560 94567	0.9999889135360718	O
23202	,	82 83	94569 94570	0.99998939037323	O
23203	No	84 86	94571 94573	0.9999889135360718	O
23204	.	86 87	94573 94574	0.9999834299087524	O
23205	sc	0 1	94575 94576	0.9999877214431763	O
23207	-	2 3	94577 94578	0.9999881982803345	O
23208	581	3 5	94578 94580	0.9999850988388062	O
23210	,	7 8	94582 94583	0.9999864101409912	O
23211	Santa	9 14	94584 94589	0.9999855756759644	O
23212	Cruz	15 19	94590 94594	0.9999852180480957	O
23213	,	20 21	94595 94596	0.9999868869781494	O
23214	Biotrade	22 29	94597 94604	0.9999866485595703	O
23217	Ltd	31 34	94606 94609	0.9999860525131226	O
23218	,	35 36	94610 94611	0.9999874830245972	O
23219	Shanghai	37 45	94612 94620	0.9999774694442749	O
23220	,	46 47	94621 94622	0.9999871253967285	O
23221	China	48 53	94623 94628	0.9999639987945557	O
23222	)	54 55	94629 94630	0.999984860420227	O
23223	.	56 57	94631 94632	0.9999393224716187	O
23224	IHC	0 2	94633 94635	0.9999874830245972	O
23226	staining	4 11	94637 94644	0.9999881982803345	O
23228	for	13 16	94646 94649	0.9999877214431763	O
23229	samples	17 24	94650 94657	0.9999849796295166	O
23230	on	25 27	94658 94660	0.9999881982803345	O
23231	the	28 31	94661 94664	0.9999885559082031	O
23232	tissue	32 38	94665 94671	0.9999866485595703	O
23233	microarray	39 48	94672 94681	0.9999890327453613	O
23236	was	50 53	94683 94686	0.999988317489624	O
23237	carried	54 61	94687 94694	0.9999890327453613	O
23238	out	62 65	94695 94698	0.99998939037323	O
23239	using	66 71	94699 94704	0.9999892711639404	O
23240	Envision	72 79	94705 94712	0.9999889135360718	O
23242	ready	81 86	94714 94719	0.9999892711639404	O
23243	-	86 87	94719 94720	0.9999896287918091	O
23244	to	87 89	94720 94722	0.9999890327453613	O
23245	-	89 90	94722 94723	0.99998939037323	O
23246	use	90 93	94723 94726	0.9999887943267822	O
23247	methods	94 101	94727 94734	0.9999889135360718	O
23248	(	102 103	94735 94736	0.9999895095825195	O
23249	Dako	104 107	94737 94740	0.9999884366989136	O
23251	Diagnostics	109 119	94742 94752	0.9999892711639404	O
23255	,	121 122	94754 94755	0.9999890327453613	O
23256	Zug	123 125	94756 94758	0.9999867677688599	O
23258	,	127 128	94760 94761	0.9999887943267822	O
23259	Switzerland	129 140	94762 94773	0.9999638795852661	O
23260	)	141 142	94774 94775	0.9999896287918091	O
23261	.	143 144	94776 94777	0.9999762773513794	O
23262	Slides	0 5	94778 94783	0.9999834299087524	O
23265	were	7 11	94785 94789	0.9999879598617554	O
23266	deparaffinized	12 25	94790 94803	0.9999885559082031	O
23271	in	27 29	94805 94807	0.999988317489624	O
23272	xylene	30 35	94808 94813	0.9999847412109375	O
23275	and	37 40	94815 94818	0.9999881982803345	O
23276	rehydrated	41 50	94819 94828	0.9999885559082031	O
23280	through	52 59	94830 94837	0.9999877214431763	O
23281	graded	60 66	94838 94844	0.9999833106994629	O
23282	concentrations	67 81	94845 94859	0.9999872446060181	O
23283	of	82 84	94860 94862	0.9999887943267822	O
23284	ethanol	85 92	94863 94870	0.9999856948852539	O
23285	to	93 95	94871 94873	0.9999877214431763	O
23286	distilled	96 104	94874 94882	0.9999889135360718	O
23290	water	106 111	94884 94889	0.9999884366989136	O
23291	,	112 113	94890 94891	0.9999878406524658	O
23292	and	114 117	94892 94895	0.9999889135360718	O
23293	endogenous	118 127	94896 94905	0.9999891519546509	O
23296	peroxidase	129 138	94907 94916	0.999988317489624	O
23300	activity	140 148	94918 94926	0.9999889135360718	O
23301	was	149 152	94927 94930	0.9999891519546509	O
23302	blocked	153 160	94931 94938	0.9999858140945435	O
23303	by	161 163	94939 94941	0.9999891519546509	O
23304	incubation	164 173	94942 94951	0.9999895095825195	O
23307	with	175 179	94953 94957	0.9999892711639404	O
23308	30	180 182	94958 94960	0.9999879598617554	O
23309	mL	183 184	94961 94962	0.9999890327453613	O
23311	/	185 186	94963 94964	0.9999891519546509	O
23312	L	186 187	94964 94965	0.9999886751174927	O
23313	H2O2	188 191	94966 94969	0.9999884366989136	O
23317	in	193 195	94971 94973	0.9999890327453613	O
23318	methanol	196 203	94974 94981	0.9999881982803345	O
23321	for	205 208	94983 94986	0.9999895095825195	O
23322	10	209 211	94987 94989	0.9999880790710449	O
23323	min	212 215	94990 94993	0.9999878406524658	O
23324	at	216 218	94994 94996	0.9999890327453613	O
23325	room	219 223	94997 95001	0.9999877214431763	O
23326	temperature	224 235	95002 95013	0.999988317489624	O
23327	.	236 237	95014 95015	0.9999687671661377	O
23328	Then	0 4	95016 95020	0.9999828338623047	O
23329	sections	5 13	95021 95029	0.9999681711196899	O
23330	were	14 18	95030 95034	0.9999874830245972	O
23331	submitted	19 28	95035 95044	0.9999839067459106	O
23332	to	29 31	95045 95047	0.9999872446060181	O
23333	antigen	32 38	95048 95054	0.999984860420227	O
23335	retrieval	40 48	95056 95064	0.9999889135360718	O
23338	in	50 52	95066 95068	0.9999878406524658	O
23339	a	53 54	95069 95070	0.9999887943267822	O
23340	pressure	55 63	95071 95079	0.9999861717224121	O
23341	cooker	64 69	95080 95085	0.9999830722808838	O
23343	containing	71 81	95087 95097	0.9999890327453613	O
23344	0	82 83	95098 95099	0.9999892711639404	O
23345	.	83 84	95099 95100	0.9999891519546509	O
23346	01	84 86	95100 95102	0.9999889135360718	O
23347	mmol	87 90	95103 95106	0.9999887943267822	O
23349	/	91 92	95107 95108	0.9999890327453613	O
23350	L	92 93	95108 95109	0.9999885559082031	O
23351	natrium	94 100	95110 95116	0.9999890327453613	O
23354	citricium	102 110	95118 95126	0.9999887943267822	O
23358	buffer	112 118	95128 95134	0.9999881982803345	O
23359	for	119 122	95135 95138	0.9999892711639404	O
23360	10	123 125	95139 95141	0.9999884366989136	O
23361	min	126 129	95142 95145	0.9999885559082031	O
23362	.	130 131	95146 95147	0.9999746084213257	O
23363	Slides	0 5	95148 95153	0.9999785423278809	O
23366	were	7 11	95155 95159	0.9999840259552002	O
23367	subsequently	12 24	95160 95172	0.9999816417694092	O
23368	incubated	25 33	95173 95181	0.999987006187439	O
23372	in	35 37	95183 95185	0.999985933303833	O
23373	100	38 41	95186 95189	0.9999853372573853	O
23374	mL	42 43	95190 95191	0.9999878406524658	O
23376	/	44 45	95192 95193	0.9999881982803345	O
23377	L	45 46	95193 95194	0.9999866485595703	O
23378	normal	47 53	95195 95201	0.999984622001648	O
23379	goat	54 58	95202 95206	0.9999616146087646	O
23380	serum	59 64	95207 95212	0.9999834299087524	O
23381	for	65 68	95213 95216	0.9999877214431763	O
23382	20	69 71	95217 95219	0.9999831914901733	O
23383	min	72 75	95220 95223	0.9999856948852539	O
23384	at	76 78	95224 95226	0.9999867677688599	O
23385	room	79 83	95227 95231	0.9999853372573853	O
23386	temperature	84 95	95232 95243	0.9999862909317017	O
23387	.	96 97	95244 95245	0.9999597072601318	O
23388	Sections	0 7	95246 95253	0.999963641166687	O
23390	were	9 13	95255 95259	0.9999839067459106	O
23391	permeabilized	14 26	95260 95272	0.9999867677688599	O
23396	in	28 30	95274 95276	0.999985933303833	O
23397	PBS	31 34	95277 95280	0.9999784231185913	O
23398	-	34 35	95280 95281	0.9999879598617554	O
23399	Triton	35 40	95281 95286	0.999984860420227	O
23401	and	42 45	95288 95291	0.9999861717224121	O
23402	incubated	46 54	95292 95300	0.9999880790710449	O
23406	overnight	56 65	95302 95311	0.9999839067459106	O
23407	with	66 70	95312 95316	0.9999877214431763	O
23408	primary	71 78	95317 95324	0.9999862909317017	O
23409	antibody	79 86	95325 95332	0.9999874830245972	O
23411	at	88 90	95334 95336	0.9999881982803345	O
23412	4°C	91 93	95337 95339	0.9999865293502808	O
23415	.	94 95	95340 95341	0.9999673366546631	O
23416	The	0 3	95342 95345	0.9999802112579346	O
23417	pathologist	4 14	95346 95356	0.9999798536300659	O
23419	and	16 19	95358 95361	0.9999808073043823	O
23420	technician	20 30	95362 95372	0.9999716281890869	O
23421	who	31 34	95373 95376	0.9999840259552002	O
23422	reviewed	35 43	95377 95385	0.9999825954437256	O
23423	the	44 47	95386 95389	0.9999861717224121	O
23424	immunostaining	48 61	95390 95403	0.9999858140945435	O
23428	of	63 65	95405 95407	0.9999862909317017	O
23429	the	66 69	95408 95411	0.9999850988388062	O
23430	tissue	70 76	95412 95418	0.9999818801879883	O
23431	samples	77 84	95419 95426	0.9999849796295166	O
23432	were	85 89	95427 95431	0.9999833106994629	O
23433	blinded	90 97	95432 95439	0.9999780654907227	O
23434	to	98 100	95440 95442	0.9999861717224121	O
23435	the	101 104	95443 95446	0.9999850988388062	O
23436	patient	105 112	95447 95454	0.9999798536300659	O
23437	'	113 114	95455 95456	0.9999873638153076	O
23438	s	114 115	95456 95457	0.9999873638153076	O
23439	information	116 127	95458 95469	0.9999854564666748	O
23440	.	128 129	95470 95471	0.9999619722366333	O
23441	Stained	0 6	95472 95478	0.9999816417694092	O
23444	slides	8 14	95480 95486	0.9999758005142212	O
23445	and	15 18	95487 95490	0.999982476234436	O
23446	individual	19 29	95491 95501	0.9999821186065674	O
23447	cores	30 34	95502 95506	0.9999798536300659	O
23449	were	36 40	95508 95512	0.9999858140945435	O
23450	scored	41 47	95513 95519	0.9999839067459106	O
23451	as	48 50	95520 95522	0.9999880790710449	O
23452	either	51 57	95523 95529	0.9999881982803345	O
23453	positive	58 66	95530 95538	0.9999871253967285	O
23454	(	67 68	95539 95540	0.9999889135360718	O
23455	showing	69 76	95541 95548	0.9999884366989136	O
23456	nuclear	77 84	95549 95556	0.9999885559082031	O
23457	staining	85 92	95557 95564	0.9999880790710449	O
23459	in	94 96	95566 95568	0.9999889135360718	O
23460	at	97 99	95569 95571	0.9999889135360718	O
23461	least	100 105	95572 95577	0.9999866485595703	O
23462	some	106 110	95578 95582	0.9999874830245972	O
23463	tumor	111 116	95583 95588	0.999981164932251	O
23464	cells	117 122	95589 95594	0.9999861717224121	O
23465	)	123 124	95595 95596	0.9999890327453613	O
23466	or	125 127	95597 95599	0.9999881982803345	O
23467	negative	128 136	95600 95608	0.9999858140945435	O
23468	.	137 138	95609 95610	0.9999890327453613	O
23469	*	139 140	95611 95612	0.9999884366989136	O
23470	*	140 141	95612 95613	0.9999840259552002	O
23471	IGNORE	0 5	95614 95619	0.9999849796295166	O
23474	LINE	7 10	95621 95624	0.9999873638153076	O
23477	*	12 13	95626 95627	0.9999876022338867	O
23478	*	13 14	95627 95628	0.9999874830245972	O
23479	*	15 16	95629 95630	0.9999874830245972	O
23480	*	16 17	95630 95631	0.9999879598617554	O
23481	IGNORE	18 23	95632 95637	0.9999865293502808	O
23484	LINE	25 28	95639 95642	0.9999879598617554	O
23487	*	30 31	95644 95645	0.9999873638153076	O
23488	*	31 32	95645 95646	0.9999873638153076	O
23489	*	33 34	95647 95648	0.9999873638153076	O
23490	*	34 35	95648 95649	0.9999876022338867	O
23491	IGNORE	36 41	95650 95655	0.9999860525131226	O
23494	LINE	43 46	95657 95660	0.9999877214431763	O
23497	*	48 49	95662 95663	0.9999877214431763	O
23498	*	49 50	95663 95664	0.9999877214431763	O
23499	Regarding	51 60	95665 95674	0.9999877214431763	O
23500	the	61 64	95675 95678	0.9999885559082031	O
23501	location	65 73	95679 95687	0.9999880790710449	O
23502	of	74 76	95688 95690	0.9999884366989136	O
23503	gene	77 81	95691 95695	0.9999874830245972	O
23504	mutations	82 91	95696 95705	0.9999879598617554	O
23505	,	92 93	95706 95707	0.9999884366989136	O
23506	we	94 96	95708 95710	0.9999862909317017	O
23507	found	97 102	95711 95716	0.9999871253967285	O
23508	that	103 107	95717 95721	0.999988317489624	O
23509	3	108 109	95722 95723	0.9999780654907227	O
23510	patients	110 118	95724 95732	0.9999799728393555	O
23511	bore	119 123	95733 95737	0.9999854564666748	O
23512	mutations	124 133	95738 95747	0.9999877214431763	O
23513	in	134 136	95748 95750	0.9999885559082031	O
23514	exon	137 140	95751 95754	0.999988317489624	O
23516	7	142 143	95756 95757	0.9999874830245972	O
23517	of	144 146	95758 95760	0.9999881982803345	O
23518	MSH2	147 150	95761 95764	0.9999877214431763	O
23521	,	152 153	95766 95767	0.9999884366989136	O
23522	2	154 155	95768 95769	0.9999815225601196	O
23523	had	156 159	95770 95773	0.9999880790710449	O
23524	mutations	160 169	95774 95783	0.9999878406524658	O
23525	in	170 172	95784 95786	0.999988317489624	O
23526	exon	173 176	95787 95790	0.9999881982803345	O
23528	12	178 180	95792 95794	0.9999866485595703	O
23529	of	181 183	95795 95797	0.9999880790710449	O
23530	MSH2	184 187	95798 95801	0.9999876022338867	O
23533	,	189 190	95803 95804	0.9999885559082031	O
23534	1	191 192	95805 95806	0.9999864101409912	O
23535	had	193 196	95807 95810	0.999988317489624	O
23536	a	197 198	95811 95812	0.9999879598617554	O
23537	mutation	199 207	95813 95821	0.9999877214431763	O
23538	in	208 210	95822 95824	0.9999880790710449	O
23539	exon	211 214	95825 95828	0.9999880790710449	O
23541	2	216 217	95830 95831	0.9999865293502808	O
23542	of	218 220	95832 95834	0.9999879598617554	O
23543	MSH6	221 224	95835 95838	0.9999877214431763	O
23546	,	226 227	95840 95841	0.9999877214431763	O
23547	and	228 231	95842 95845	0.999988317489624	O
23548	2	232 233	95846 95847	0.9999816417694092	O
23549	had	234 237	95848 95851	0.999988317489624	O
23550	mutations	238 247	95852 95861	0.9999872446060181	O
23551	in	248 250	95862 95864	0.999988317489624	O
23552	exon	251 254	95865 95868	0.9999881982803345	O
23554	5	256 257	95870 95871	0.999987006187439	O
23555	of	258 260	95872 95874	0.9999881982803345	O
23556	MSH6	261 264	95875 95878	0.9999877214431763	O
23559	.	266 267	95880 95881	0.9999573230743408	O
23560	No	0 2	95882 95884	0.9999572038650513	O
23561	MLH1	3 6	95885 95888	0.9999731779098511	O
23564	mutations	8 17	95890 95899	0.9999748468399048	O
23565	were	18 22	95900 95904	0.9999785423278809	O
23566	found	23 28	95905 95910	0.99997878074646	O
23567	in	29 31	95911 95913	0.9999760389328003	O
23568	our	32 35	95914 95917	0.9999432563781738	O
23569	cohort	36 41	95918 95923	0.9999792575836182	O
23572	.	43 44	95925 95926	0.9998617172241211	O
23573	All	0 3	95927 95930	0.9999849796295166	O
23574	8	4 5	95931 95932	0.9999693632125854	O
23575	mutations	6 15	95933 95942	0.9999814033508301	O
23576	were	16 20	95943 95947	0.9999833106994629	O
23577	considered	21 31	95948 95958	0.9999802112579346	O
23578	pathogenic	32 41	95959 95968	0.9999818801879883	O
23580	mutations	43 52	95970 95979	0.9999823570251465	O
23581	.	53 54	95980 95981	0.9999059438705444	O
23582	The	0 3	95982 95985	0.9999879598617554	O
23583	mutation	4 12	95986 95994	0.999985933303833	O
23584	of	13 15	95995 95997	0.9999885559082031	O
23585	C1886	16 20	95998 96002	0.9999880790710449	O
23588	A	22 23	96004 96005	0.9999879598617554	O
23589	>	24 25	96006 96007	0.9999889135360718	O
23590	G	26 27	96008 96009	0.9999871253967285	O
23591	,	28 29	96010 96011	0.9999885559082031	O
23592	C1668	30 34	96012 96016	0.9999887943267822	O
23596	C	36 37	96018 96019	0.999988317489624	O
23597	>	38 39	96020 96021	0.9999889135360718	O
23598	T	40 41	96022 96023	0.9999881982803345	O
23599	was	42 45	96024 96027	0.9999886751174927	O
23600	reported	46 54	96028 96036	0.9999879598617554	O
23601	as	55 57	96037 96039	0.9999889135360718	O
23602	a	58 59	96040 96041	0.9999892711639404	O
23603	pathogenic	60 69	96042 96051	0.9999878406524658	O
23605	mutation	71 79	96053 96061	0.9999873638153076	O
23606	previously	80 90	96062 96072	0.9999862909317017	O
23607	[	91 92	96073 96074	0.99998939037323	O
23608	22	92 94	96074 96076	0.9999880790710449	O
23609	-	94 95	96076 96077	0.9999895095825195	O
23610	25	95 97	96077 96079	0.9999876022338867	O
23611	]	97 98	96079 96080	0.9999892711639404	O
23612	.	99 100	96081 96082	0.9999754428863525	O
23613	However	0 7	96083 96090	0.999984860420227	O
23614	,	8 9	96091 96092	0.9999872446060181	O
23615	the	10 13	96093 96096	0.9999858140945435	O
23616	other	14 19	96097 96102	0.9999834299087524	O
23617	six	20 23	96103 96106	0.9999724626541138	O
23618	mutations	24 33	96107 96116	0.9999797344207764	O
23619	have	34 38	96117 96121	0.999985933303833	O
23620	not	39 42	96122 96125	0.9999871253967285	O
23621	been	43 47	96126 96130	0.9999874830245972	O
23622	reported	48 56	96131 96139	0.9999866485595703	O
23623	in	57 59	96140 96142	0.9999876022338867	O
23624	other	60 65	96143 96148	0.999985933303833	O
23625	publications	66 78	96149 96161	0.9999806880950928	O
23626	and	79 82	96162 96165	0.9999839067459106	O
23627	are	83 86	96166 96169	0.9999868869781494	O
23628	likely	87 93	96170 96176	0.9999868869781494	O
23629	to	94 96	96177 96179	0.9999872446060181	O
23630	be	97 99	96180 96182	0.9999872446060181	O
23631	novel	100 105	96183 96188	0.9999774694442749	O
23632	mutations	106 115	96189 96198	0.9999836683273315	O
23633	.	116 117	96199 96200	0.9999375343322754	O
23634	We	0 2	96201 96203	0.9999829530715942	O
23635	also	3 7	96204 96208	0.9999855756759644	O
23636	attempted	8 17	96209 96218	0.9999861717224121	O
23637	to	18 20	96219 96221	0.9999880790710449	O
23638	screen	21 27	96222 96228	0.9999849796295166	O
23639	for	28 31	96229 96232	0.9999872446060181	O
23640	the	32 35	96233 96236	0.9999881982803345	O
23641	presence	36 44	96237 96245	0.999987006187439	O
23642	of	45 47	96246 96248	0.9999879598617554	O
23643	all	48 51	96249 96252	0.9999868869781494	O
23644	these	52 57	96253 96258	0.9999865293502808	O
23645	mutations	58 67	96259 96268	0.9999796152114868	O
23646	in	68 70	96269 96271	0.9999886751174927	O
23647	50	71 73	96272 96274	0.9999794960021973	O
23648	randomly	74 82	96275 96283	0.9999853372573853	O
23649	selected	83 91	96284 96292	0.9999856948852539	O
23650	patients	92 100	96293 96301	0.999982476234436	O
23651	in	101 103	96302 96304	0.9999879598617554	O
23652	the	104 107	96305 96308	0.9999876022338867	O
23653	MSS	108 110	96309 96311	0.999975323677063	O
23655	group	112 117	96313 96318	0.9999873638153076	O
23656	and	118 121	96319 96322	0.9999854564666748	O
23657	in	122 124	96323 96325	0.999987006187439	O
23658	50	125 127	96326 96328	0.9999775886535645	O
23659	normal	128 134	96329 96335	0.999976396560669	O
23660	people	135 141	96336 96342	0.999974250793457	O
23661	.	142 143	96343 96344	0.9999548196792603	O
23662	The	0 3	96345 96348	0.9999881982803345	O
23663	result	4 10	96349 96355	0.9999876022338867	O
23664	of	11 13	96356 96358	0.9999885559082031	O
23665	this	14 18	96359 96363	0.999988317489624	O
23666	screen	19 25	96364 96370	0.9999823570251465	O
23667	was	26 29	96371 96374	0.9999884366989136	O
23668	negative	30 38	96375 96383	0.9999839067459106	O
23669	,	39 40	96384 96385	0.9999864101409912	O
23670	and	41 44	96386 96389	0.9999867677688599	O
23671	all	45 48	96390 96393	0.9999872446060181	O
23672	these	49 54	96394 96399	0.9999849796295166	O
23673	CRCs	55 58	96400 96403	0.9999749660491943	O
23675	with	60 64	96405 96409	0.9999881982803345	O
23676	mutations	65 74	96410 96419	0.9999867677688599	O
23677	stained	75 82	96420 96427	0.999988317489624	O
23678	negatively	83 93	96428 96438	0.9999880790710449	O
23679	for	94 97	96439 96442	0.9999890327453613	O
23680	MSH2	98 101	96443 96446	0.9999886751174927	O
23683	or	103 105	96448 96450	0.9999887943267822	O
23684	/	105 106	96450 96451	0.9999886751174927	O
23685	and	106 109	96451 96454	0.9999885559082031	O
23686	MSH6	110 113	96455 96458	0.9999884366989136	O
23689	,	115 116	96460 96461	0.9999884366989136	O
23690	indicating	117 127	96462 96472	0.9999886751174927	O
23691	that	128 132	96473 96477	0.99998939037323	O
23692	these	133 138	96478 96483	0.9999890327453613	O
23693	6	139 140	96484 96485	0.9999790191650391	O
23694	mutations	141 150	96486 96495	0.9999864101409912	O
23695	may	151 154	96496 96499	0.999988317489624	O
23696	be	155 157	96500 96502	0.9999889135360718	O
23697	pathogenic	158 167	96503 96512	0.9999878406524658	O
23699	mutations	169 178	96514 96523	0.9999873638153076	O
23700	but	179 182	96524 96527	0.9999866485595703	O
23701	not	183 186	96528 96531	0.9999874830245972	O
23702	polymorphisms	187 199	96532 96544	0.9999881982803345	O
23707	.	201 202	96546 96547	0.9999659061431885	O
23708	In	0 2	96548 96550	0.9999872446060181	O
23709	terms	3 8	96551 96556	0.9999856948852539	O
23710	of	9 11	96557 96559	0.9999874830245972	O
23711	the	12 15	96560 96563	0.9999866485595703	O
23712	clinical	16 24	96564 96572	0.9999825954437256	O
23713	features	25 33	96573 96581	0.9999860525131226	O
23714	of	34 36	96582 96584	0.9999879598617554	O
23715	the	37 40	96585 96588	0.9999876022338867	O
23716	8	41 42	96589 96590	0.9999758005142212	O
23717	cases	43 48	96591 96596	0.9999852180480957	O
23718	with	49 53	96597 96601	0.9999873638153076	O
23719	mutations	54 63	96602 96611	0.9999784231185913	O
23720	,	64 65	96612 96613	0.9999872446060181	O
23721	only	66 70	96614 96618	0.9999874830245972	O
23722	1	71 72	96619 96620	0.9999842643737793	O
23723	conformed	73 81	96621 96629	0.9999881982803345	O
23725	to	83 85	96631 96633	0.9999889135360718	O
23726	the	86 89	96634 96637	0.9999887943267822	O
23727	Amsterdam	90 99	96638 96647	0.9999823570251465	O
23728	criteria	100 108	96648 96656	0.9999884366989136	O
23729	II	109 111	96657 96659	0.9999865293502808	O
23730	;	112 113	96660 96661	0.9999876022338867	O
23731	all	114 117	96662 96665	0.9999877214431763	O
23732	the	118 121	96666 96669	0.9999868869781494	O
23733	others	122 128	96670 96676	0.9999812841415405	O
23734	did	129 132	96677 96680	0.9999860525131226	O
23735	not	133 136	96681 96684	0.9999868869781494	O
23736	have	137 141	96685 96689	0.9999878406524658	O
23737	any	142 145	96690 96693	0.9999873638153076	O
23738	family	146 152	96694 96700	0.999984622001648	O
23739	history	153 160	96701 96708	0.9999871253967285	O
23740	of	161 163	96709 96711	0.9999877214431763	O
23741	malignancy	164 173	96712 96721	0.9999873638153076	O
23745	.	175 176	96723 96724	0.9999673366546631	O
23746	Moreover	0 8	96725 96733	0.9999715089797974	O
23747	,	9 10	96734 96735	0.9999850988388062	O
23748	the	11 14	96736 96739	0.9999841451644897	O
23749	median	15 21	96740 96746	0.9999803304672241	O
23750	age	22 25	96747 96750	0.9999786615371704	O
23751	was	26 29	96751 96754	0.9999854564666748	O
23752	59	30 32	96755 96757	0.9999594688415527	O
23753	with	33 37	96758 96762	0.9999806880950928	O
23754	4	38 39	96763 96764	0.9999600648880005	O
23755	patients	40 48	96765 96773	0.9999784231185913	O
23756	that	49 53	96774 96778	0.9999845027923584	O
23757	were	54 58	96779 96783	0.9999855756759644	O
23758	older	59 64	96784 96789	0.9999818801879883	O
23759	than	65 69	96790 96794	0.9999865293502808	O
23760	60	70 72	96795 96797	0.9999784231185913	O
23761	years	73 78	96798 96803	0.9999855756759644	O
23762	old	79 82	96804 96807	0.9999849796295166	O
23763	.	83 84	96808 96809	0.9999388456344604	O
23764	One	0 3	96810 96813	0.9999829530715942	O
23765	limitation	4 14	96814 96824	0.9999809265136719	O
23766	of	15 17	96825 96827	0.9999852180480957	O
23767	this	18 22	96828 96832	0.9999852180480957	O
23768	study	23 28	96833 96838	0.9999805688858032	O
23769	is	29 31	96839 96841	0.9999829530715942	O
23770	that	32 36	96842 96846	0.9999845027923584	O
23771	it	37 39	96847 96849	0.9999845027923584	O
23772	is	40 42	96850 96852	0.999984622001648	O
23773	a	43 44	96853 96854	0.9999871253967285	O
23774	single	45 51	96855 96861	0.9999843835830688	O
23775	-	51 52	96861 96862	0.9999871253967285	O
23776	center	52 58	96862 96868	0.9999806880950928	O
23777	study	59 64	96869 96874	0.9999825954437256	O
23778	with	65 69	96875 96879	0.9999829530715942	O
23779	a	70 71	96880 96881	0.9999872446060181	O
23780	relatively	72 82	96882 96892	0.9999865293502808	O
23781	small	83 88	96893 96898	0.9999854564666748	O
23782	sample	89 95	96899 96905	0.999984622001648	O
23783	size	96 100	96906 96910	0.9999847412109375	O
23784	.	101 102	96911 96912	0.9999439716339111	O
23785	Therefore	0 9	96913 96922	0.9999862909317017	O
23786	,	10 11	96923 96924	0.9999874830245972	O
23787	the	12 15	96925 96928	0.9999873638153076	O
23788	results	16 23	96929 96936	0.999987006187439	O
23789	of	24 26	96937 96939	0.9999876022338867	O
23790	this	27 31	96940 96944	0.9999880790710449	O
23791	study	32 37	96945 96950	0.999984860420227	O
23792	need	38 42	96951 96955	0.9999858140945435	O
23793	to	43 45	96956 96958	0.9999864101409912	O
23794	be	46 48	96959 96961	0.9999871253967285	O
23795	confirmed	49 58	96962 96971	0.999985933303833	O
23796	by	59 61	96972 96974	0.9999878406524658	O
23797	a	62 63	96975 96976	0.9999880790710449	O
23798	well	64 68	96977 96981	0.9999874830245972	O
23799	designed	69 77	96982 96990	0.9999860525131226	O
23800	multi	78 83	96991 96996	0.9999871253967285	O
23801	-	83 84	96996 96997	0.9999880790710449	O
23802	center	84 90	96997 97003	0.9999849796295166	O
23803	study	91 96	97004 97009	0.9999862909317017	O
23804	,	97 98	97010 97011	0.9999874830245972	O
23805	which	99 104	97012 97017	0.9999876022338867	O
23806	is	105 107	97018 97020	0.9999871253967285	O
23807	one	108 111	97021 97024	0.9999876022338867	O
23808	of	112 114	97025 97027	0.9999868869781494	O
23809	our	115 118	97028 97031	0.9999812841415405	O
23810	ongoing	119 126	97032 97039	0.9999849796295166	O
23811	studies	127 134	97040 97047	0.999985933303833	O
23812	in	135 137	97048 97050	0.9999867677688599	O
23813	China	138 143	97051 97056	0.9998884201049805	O
23814	.	144 145	97057 97058	0.9999884366989136	O
23815	*	146 147	97059 97060	0.999987006187439	O
23816	*	147 148	97060 97061	0.9999734163284302	O
23817	IGNORE	0 5	97062 97067	0.999984860420227	O
23820	LINE	7 10	97069 97072	0.9999880790710449	O
23823	*	12 13	97074 97075	0.9999885559082031	O
23824	*	13 14	97075 97076	0.9999884366989136	O
23825	*	15 16	97077 97078	0.9999884366989136	O
23826	*	16 17	97078 97079	0.9999885559082031	O
23827	IGNORE	18 23	97080 97085	0.9999871253967285	O
23830	LINE	25 28	97087 97090	0.9999886751174927	O
23833	*	30 31	97092 97093	0.9999884366989136	O
23834	*	31 32	97093 97094	0.9999884366989136	O
23835	*	33 34	97095 97096	0.999988317489624	O
23836	*	34 35	97096 97097	0.999988317489624	O
23837	IGNORE	36 41	97098 97103	0.999987006187439	O
23840	LINE	43 46	97105 97108	0.9999885559082031	O
23843	*	48 49	97110 97111	0.9999884366989136	O
23844	*	49 50	97111 97112	0.9999885559082031	O
23845	Background	51 61	97113 97123	0.999983549118042	O
23846	The	62 65	97124 97127	0.9999829530715942	O
23847	colon	66 70	97128 97132	0.9999740123748779	O
23849	is	72 74	97134 97136	0.9999854564666748	O
23850	composed	75 83	97137 97145	0.9999862909317017	O
23851	of	84 86	97146 97148	0.9999861717224121	O
23852	a	87 88	97149 97150	0.999985933303833	O
23853	dynamic	89 96	97151 97158	0.999974250793457	O
23854	and	97 100	97159 97162	0.9999833106994629	O
23855	self	101 105	97163 97167	0.9999867677688599	O
23856	-	105 106	97167 97168	0.9999881982803345	O
23857	renewing	106 113	97168 97175	0.9999786615371704	O
23859	epithelium	115 124	97177 97186	0.9999862909317017	O
23863	that	126 130	97188 97192	0.9999872446060181	O
23864	turns	131 136	97193 97198	0.9999850988388062	O
23865	over	137 141	97199 97203	0.9999880790710449	O
23866	every	142 147	97204 97209	0.9999890327453613	O
23867	three	148 153	97210 97215	0.9999868869781494	O
23868	to	154 156	97216 97218	0.999987006187439	O
23869	five	157 161	97219 97223	0.9999840259552002	O
23870	days	162 166	97224 97228	0.9999850988388062	O
23871	.	167 168	97229 97230	0.9999433755874634	O
23872	It	0 2	97231 97233	0.9999873638153076	O
23873	is	3 5	97234 97236	0.999987006187439	O
23874	generally	6 15	97237 97246	0.9999845027923584	O
23875	accepted	16 24	97247 97255	0.999981164932251	O
23876	that	25 29	97256 97260	0.9999886751174927	O
23877	at	30 32	97261 97263	0.9999881982803345	O
23878	the	33 36	97264 97267	0.9999889135360718	O
23879	base	37 41	97268 97272	0.9999862909317017	O
23880	of	42 44	97273 97275	0.999988317489624	O
23881	the	45 48	97276 97279	0.9999884366989136	O
23882	crypt	49 53	97280 97284	0.9999881982803345	O
23884	,	55 56	97286 97287	0.9999881982803345	O
23885	variable	57 65	97288 97296	0.9999877214431763	O
23886	numbers	66 73	97297 97304	0.9999877214431763	O
23887	(	74 75	97305 97306	0.9999892711639404	O
23888	between	76 83	97307 97314	0.9999886751174927	O
23889	1	84 85	97315 97316	0.9999890327453613	O
23890	and	86 89	97317 97320	0.9999887943267822	O
23891	16	90 92	97321 97323	0.9999858140945435	O
23892	)	93 94	97324 97325	0.99998939037323	O
23893	of	95 97	97326 97328	0.9999884366989136	O
23894	slowly	98 104	97329 97335	0.999985933303833	O
23895	dividing	105 113	97336 97344	0.9999881982803345	O
23896	,	114 115	97345 97346	0.9999874830245972	O
23897	stationary	116 126	97347 97357	0.9999842643737793	O
23898	,	127 128	97358 97359	0.9999872446060181	O
23899	pluripotent	129 139	97360 97370	0.9999887943267822	O
23904	stem	141 145	97372 97376	0.9999878406524658	O
23905	cells	146 151	97377 97382	0.9999879598617554	O
23906	give	152 156	97383 97387	0.9999878406524658	O
23907	rise	157 161	97388 97392	0.9999887943267822	O
23908	to	162 164	97393 97395	0.9999887943267822	O
23909	more	165 169	97396 97400	0.9999866485595703	O
23910	rapidly	170 177	97401 97408	0.999987006187439	O
23911	proliferating	178 190	97409 97421	0.9999880790710449	O
23914	,	192 193	97423 97424	0.9999865293502808	O
23915	transient	194 202	97425 97433	0.9999880790710449	O
23917	amplifying	204 213	97435 97444	0.9999889135360718	O
23921	cells	215 220	97446 97451	0.9999860525131226	O
23922	.	221 222	97452 97453	0.9999698400497437	O
23923	These	0 5	97454 97459	0.9999816417694092	O
23924	cells	6 11	97460 97465	0.9999685287475586	O
23925	differentiate	12 25	97466 97479	0.9999754428863525	O
23926	chiefly	26 33	97480 97487	0.9999839067459106	O
23927	into	34 38	97488 97492	0.9999855756759644	O
23928	post	39 43	97493 97497	0.9999852180480957	O
23929	-	43 44	97497 97498	0.9999874830245972	O
23930	mitotic	44 50	97498 97504	0.9999867677688599	O
23932	columnar	52 59	97506 97513	0.9999845027923584	O
23934	colonocytes	61 71	97515 97525	0.9999833106994629	O
23937	,	73 74	97527 97528	0.9999860525131226	O
23938	mucin	75 79	97529 97533	0.9999817609786987	O
23941	-	80 81	97534 97535	0.9999873638153076	O
23942	secreting	81 89	97535 97543	0.9999865293502808	O
23944	goblet	91 96	97545 97550	0.9999853372573853	O
23947	cells	98 103	97552 97557	0.999987006187439	O
23948	,	104 105	97558 97559	0.9999861717224121	O
23949	and	106 109	97560 97563	0.9999871253967285	O
23950	enteroendocrine	110 124	97564 97578	0.9999828338623047	O
23955	cells	126 131	97580 97585	0.9999856948852539	O
23956	as	132 134	97586 97588	0.9999831914901733	O
23957	they	135 139	97589 97593	0.9999860525131226	O
23958	migrate	140 147	97594 97601	0.9999819993972778	O
23959	from	148 152	97602 97606	0.9999853372573853	O
23960	the	153 156	97607 97610	0.999985933303833	O
23961	crypt	157 161	97611 97615	0.9999842643737793	O
23963	base	163 167	97617 97621	0.9999854564666748	O
23964	to	168 170	97622 97624	0.9999850988388062	O
23965	the	171 174	97625 97628	0.9999874830245972	O
23966	surface	175 182	97629 97636	0.9999837875366211	O
23967	where	183 188	97637 97642	0.999985933303833	O
23968	they	189 193	97643 97647	0.9999861717224121	O
23969	are	194 197	97648 97651	0.9999855756759644	O
23970	sloughed	198 205	97652 97659	0.9999862909317017	O
23973	into	207 211	97661 97665	0.9999854564666748	O
23974	the	212 215	97666 97669	0.9999871253967285	O
23975	lumen	216 220	97670 97674	0.9999858140945435	O
23978	[	222 223	97676 97677	0.9999884366989136	O
23979	1	223 224	97677 97678	0.9999849796295166	O
23980	]	224 225	97678 97679	0.9999877214431763	O
23981	.	226 227	97680 97681	0.9999697208404541	O
23982	Several	0 7	97682 97689	0.9999736547470093	O
23983	signaling	8 17	97690 97699	0.9999548196792603	O
23984	pathways	18 26	97700 97708	0.9999759197235107	O
23985	,	27 28	97709 97710	0.9999842643737793	O
23986	notably	29 36	97711 97718	0.9999842643737793	O
23987	Wnt	37 39	97719 97721	0.9999645948410034	O
23989	,	41 42	97723 97724	0.9999837875366211	O
23990	Tgfβ	43 46	97725 97728	0.9999796152114868	O
23994	,	48 49	97730 97731	0.9999843835830688	O
23995	Bmp	50 52	97732 97734	0.999977707862854	O
23997	,	54 55	97736 97737	0.999984622001648	O
23998	Hedgehog	56 63	97738 97745	0.9999712705612183	O
24001	and	65 68	97747 97750	0.9999834299087524	O
24002	Notch	69 73	97751 97755	0.9999774694442749	O
24004	,	75 76	97757 97758	0.9999794960021973	O
24005	play	77 81	97759 97763	0.9999797344207764	O
24006	pivotal	82 89	97764 97771	0.9999790191650391	O
24007	roles	90 95	97772 97777	0.9999817609786987	O
24008	in	96 98	97778 97780	0.9999822378158569	O
24009	the	99 102	97781 97784	0.9999836683273315	O
24010	control	103 110	97785 97792	0.9999704360961914	O
24011	of	111 113	97793 97795	0.9999836683273315	O
24012	proliferation	114 127	97796 97809	0.9999781847000122	O
24013	and	128 131	97810 97813	0.9999825954437256	O
24014	differentiation	132 147	97814 97829	0.9999492168426514	O
24015	of	148 150	97830 97832	0.9999797344207764	O
24016	the	151 154	97833 97836	0.9999737739562988	O
24017	developing	155 165	97837 97847	0.9989398121833801	O
24018	and	166 169	97848 97851	0.9999668598175049	O
24019	adult	170 175	97852 97857	0.9929863810539246	O
24020	colon	176 180	97858 97862	0.9999685287475586	O
24022	[	182 183	97864 97865	0.9999872446060181	O
24023	2	183 184	97865 97866	0.9999774694442749	O
24024	]	184 185	97866 97867	0.9999858140945435	O
24025	.	186 187	97868 97869	0.9999608993530273	O
24026	Their	0 5	97870 97875	0.9999817609786987	O
24027	perturbation	6 17	97876 97887	0.9999855756759644	O
24030	,	19 20	97889 97890	0.9999853372573853	O
24031	via	21 24	97891 97894	0.9999854564666748	O
24032	mutation	25 33	97895 97903	0.9999829530715942	O
24033	or	34 36	97904 97906	0.9999855756759644	O
24034	epigenetic	37 46	97907 97916	0.9999873638153076	O
24038	modification	48 60	97918 97930	0.9999830722808838	O
24039	,	61 62	97931 97932	0.9999850988388062	O
24040	occurs	63 69	97933 97939	0.9999825954437256	O
24041	in	70 72	97940 97942	0.9999837875366211	O
24042	human	73 78	97943 97948	0.9701046943664551	species
24043	colorectal	79 88	97949 97958	0.9999793767929077	O
24046	cancer	90 96	97960 97966	0.9999854564666748	O
24047	(	97 98	97967 97968	0.9999837875366211	O
24048	CRC	99 101	97969 97971	0.9999780654907227	O
24050	)	103 104	97973 97974	0.9999877214431763	O
24051	and	105 108	97975 97978	0.9999839067459106	O
24052	the	109 112	97979 97982	0.999987006187439	O
24053	instillation	113 124	97983 97994	0.9999865293502808	O
24056	of	126 128	97996 97998	0.9999877214431763	O
24057	these	129 134	97999 98004	0.9999874830245972	O
24058	changes	135 142	98005 98012	0.9999840259552002	O
24059	via	143 146	98013 98016	0.999988317489624	O
24060	genetic	147 154	98017 98024	0.9999864101409912	O
24061	engineering	155 166	98025 98036	0.999985933303833	O
24062	in	167 169	98037 98039	0.9999876022338867	O
24063	mice	170 174	98040 98044	0.6343546509742737	species
24064	confers	175 181	98045 98051	0.9999861717224121	O
24066	a	183 184	98053 98054	0.9999879598617554	O
24067	correspondingly	185 199	98055 98069	0.9999805688858032	O
24069	high	201 205	98071 98075	0.9999825954437256	O
24070	risk	206 210	98076 98080	0.999984860420227	O
24071	for	211 214	98081 98084	0.999983549118042	O
24072	neoplasia	215 223	98085 98093	0.9999855756759644	O
24075	in	225 227	98095 98097	0.9999856948852539	O
24076	the	228 231	98098 98101	0.9999760389328003	O
24077	mouse	232 237	98102 98107	0.8112504482269287	species
24078	models	238 244	98108 98114	0.9999172687530518	O
24079	.	245 246	98115 98116	0.9999285936355591	O
24080	Moreover	0 8	98117 98125	0.9999821186065674	O
24081	,	9 10	98126 98127	0.9999872446060181	O
24082	tumor	11 16	98128 98133	0.9999823570251465	O
24083	cell	17 21	98134 98138	0.9999854564666748	O
24084	de	22 24	98139 98141	0.9999860525131226	O
24085	-	24 25	98141 98142	0.9999874830245972	O
24086	differentiation	25 40	98142 98157	0.999983549118042	O
24087	correlates	41 50	98158 98167	0.9999873638153076	O
24090	with	52 56	98169 98173	0.9999876022338867	O
24091	key	57 60	98174 98177	0.9999840259552002	O
24092	tumor	61 66	98178 98183	0.9999748468399048	O
24093	features	67 75	98184 98192	0.9999841451644897	O
24094	,	76 77	98193 98194	0.999987006187439	O
24095	such	78 82	98195 98199	0.9999866485595703	O
24096	as	83 85	98200 98202	0.9999874830245972	O
24097	tumor	86 91	98203 98208	0.9999771118164062	O
24098	progression	92 103	98209 98220	0.9999861717224121	O
24099	rates	104 109	98221 98226	0.999985933303833	O
24100	,	110 111	98227 98228	0.9999865293502808	O
24101	invasiveness	112 123	98229 98240	0.9999818801879883	O
24103	,	125 126	98242 98243	0.9999874830245972	O
24104	drug	127 131	98244 98248	0.9999841451644897	O
24105	resistance	132 142	98249 98259	0.9999855756759644	O
24106	and	143 146	98260 98263	0.9999865293502808	O
24107	metastatic	147 156	98264 98273	0.9999827146530151	O
24109	potential	158 167	98275 98284	0.9999861717224121	O
24110	[	168 169	98285 98286	0.9999890327453613	O
24111	3	169 170	98286 98287	0.9999876022338867	O
24112	-	170 171	98287 98288	0.9999886751174927	O
24113	5	171 172	98288 98289	0.9999873638153076	O
24114	]	172 173	98289 98290	0.9999884366989136	O
24115	.	174 175	98291 98292	0.9999732971191406	O
24116	A	0 1	98293 98294	0.9999790191650391	O
24117	variety	2 9	98295 98302	0.9999790191650391	O
24118	of	10 12	98303 98305	0.9999794960021973	O
24119	scientific	13 23	98306 98316	0.9999593496322632	O
24120	and	24 27	98317 98320	0.9999765157699585	O
24121	organizational	28 42	98321 98335	0.9999688863754272	O
24122	obstacles	43 52	98336 98345	0.9999680519104004	O
24123	make	53 57	98346 98350	0.9999784231185913	O
24124	it	58 60	98351 98353	0.9999830722808838	O
24125	a	61 62	98354 98355	0.9999853372573853	O
24126	challenging	63 74	98356 98367	0.9999783039093018	O
24127	proposition	75 86	98368 98379	0.9999806880950928	O
24128	to	87 89	98380 98382	0.9999831914901733	O
24129	undertake	90 99	98383 98392	0.9999815225601196	O
24130	large	100 105	98393 98398	0.9999842643737793	O
24131	-	105 106	98398 98399	0.9999872446060181	O
24132	scale	106 111	98399 98404	0.9999850988388062	O
24133	comparisons	112 123	98405 98416	0.9999765157699585	O
24134	of	124 126	98417 98419	0.9999845027923584	O
24135	human	127 132	98420 98425	0.9325466752052307	species
24136	cancer	133 139	98426 98432	0.9999818801879883	O
24137	to	140 142	98433 98435	0.9999828338623047	O
24138	the	143 146	98436 98439	0.9999862909317017	O
24139	wide	147 151	98440 98444	0.9999862909317017	O
24140	range	152 157	98445 98450	0.9999862909317017	O
24141	of	158 160	98451 98453	0.9999868869781494	O
24142	genetically	161 172	98454 98465	0.9999841451644897	O
24143	engineered	173 183	98466 98476	0.9999805688858032	O
24144	mouse	184 189	98477 98482	0.9768962264060974	O
24145	models	190 196	98483 98489	0.9999810457229614	O
24146	.	197 198	98490 98491	0.9999423027038574	O
24147	To	0 2	98492 98494	0.9999822378158569	O
24148	evaluate	3 11	98495 98503	0.9999780654907227	O
24149	the	12 15	98504 98507	0.9999855756759644	O
24150	potential	16 25	98508 98517	0.9999762773513794	O
24151	of	26 28	98518 98520	0.999985933303833	O
24152	this	29 33	98521 98525	0.9999856948852539	O
24153	approach	34 42	98526 98534	0.9999608993530273	O
24154	to	43 45	98535 98537	0.9999852180480957	O
24155	provide	46 53	98538 98545	0.9999864101409912	O
24156	integrated	54 64	98546 98556	0.9999796152114868	O
24157	views	65 70	98557 98562	0.9999819993972778	O
24158	of	71 73	98563 98565	0.9999862909317017	O
24159	the	74 77	98566 98569	0.999987006187439	O
24160	molecular	78 87	98570 98579	0.9999643564224243	O
24161	basis	88 93	98580 98585	0.9999865293502808	O
24162	of	94 96	98586 98588	0.9999866485595703	O
24163	cancer	97 103	98589 98595	0.9999734163284302	O
24164	risk	104 108	98596 98600	0.9999755620956421	O
24165	,	109 110	98601 98602	0.9999808073043823	O
24166	tumor	111 116	98603 98608	0.999961256980896	O
24167	development	117 128	98609 98620	0.999974250793457	O
24168	and	129 132	98621 98624	0.9999841451644897	O
24169	malignant	133 141	98625 98633	0.999975323677063	O
24172	progression	143 154	98635 98646	0.9999814033508301	O
24173	,	155 156	98647 98648	0.9999861717224121	O
24174	we	157 159	98649 98651	0.9999831914901733	O
24175	have	160 164	98652 98656	0.9999858140945435	O
24176	undertaken	165 175	98657 98667	0.9999858140945435	O
24177	a	176 177	98668 98669	0.9999873638153076	O
24178	comparative	178 189	98670 98681	0.999980092048645	O
24179	analysis	190 198	98682 98690	0.9999850988388062	O
24180	of	199 201	98691 98693	0.9999860525131226	O
24181	a	202 203	98694 98695	0.9999856948852539	O
24182	variety	204 211	98696 98703	0.9999803304672241	O
24183	of	212 214	98704 98706	0.9999790191650391	O
24184	individually	215 227	98707 98719	0.9993667006492615	O
24185	developed	228 237	98720 98729	0.9976746439933777	O
24186	mouse	238 243	98730 98735	0.963944673538208	species
24187	colon	244 248	98736 98740	0.9999487400054932	O
24189	tumor	250 255	98742 98747	0.9999709129333496	O
24190	models	256 262	98748 98754	0.999903678894043	O
24191	(	263 264	98755 98756	0.9999880790710449	O
24192	reviewed	265 273	98757 98765	0.9999828338623047	O
24193	in	274 276	98766 98768	0.9999877214431763	O
24194	[	277 278	98769 98770	0.9999880790710449	O
24195	6	278 279	98770 98771	0.9999867677688599	O
24196	,	279 280	98771 98772	0.9999867677688599	O
24197	7	280 281	98772 98773	0.9999858140945435	O
24198	]	281 282	98773 98774	0.9999872446060181	O
24199	)	283 284	98775 98776	0.9999874830245972	O
24200	to	285 287	98777 98779	0.9999617338180542	O
24201	human	288 293	98780 98785	0.9738141894340515	species
24202	CRC	294 296	98786 98788	0.9999686479568481	O
24204	.	297 298	98789 98790	0.9999560117721558	O
24205	The	0 3	98791 98794	0.9940715432167053	O
24206	ApcMin	4 9	98795 98800	0.9999823570251465	O
24211	/	10 11	98801 98802	0.9999668598175049	O
24212	+	11 12	98802 98803	0.9999740123748779	O
24213	(	13 14	98804 98805	0.9999480247497559	O
24214	multiple	15 23	98806 98814	0.9998329877853394	O
24215	intestinal	24 33	98815 98824	0.9999780654907227	O
24218	neoplasia	35 43	98826 98834	0.9999840259552002	O
24221	)	45 46	98836 98837	0.9999475479125977	O
24222	mouse	47 52	98838 98843	0.9084325432777405	species
24223	model	53 58	98844 98849	0.9823330044746399	O
24224	harbors	59 65	98850 98856	0.9998974800109863	O
24226	a	67 68	98858 98859	0.9999723434448242	O
24227	germline	69 76	98860 98867	0.9999831914901733	O
24231	mutation	78 86	98869 98877	0.9999712705612183	O
24232	in	87 89	98878 98880	0.9999821186065674	O
24233	the	90 93	98881 98884	0.9999825954437256	O
24234	Apc	94 96	98885 98887	0.9999831914901733	O
24237	tumor	98 103	98889 98894	0.9999847412109375	O
24238	suppressor	104 113	98895 98904	0.9999837875366211	O
24240	gene	115 119	98906 98910	0.9999833106994629	O
24241	and	120 123	98911 98914	0.9999127388000488	O
24242	exhibits	124 132	98915 98923	0.9967803955078125	O
24243	multiple	133 141	98924 98932	0.9994437098503113	O
24244	tumors	142 148	98933 98939	0.9999785423278809	O
24245	in	149 151	98940 98942	0.9999791383743286	O
24246	the	152 155	98943 98946	0.9999606609344482	O
24247	small	156 161	98947 98952	0.9999371767044067	O
24248	intestine	162 170	98953 98961	0.9999833106994629	O
24251	and	172 175	98963 98966	0.9999680519104004	O
24252	colon	176 180	98967 98971	0.9999769926071167	O
24254	[	182 183	98973 98974	0.9999872446060181	O
24255	8	183 184	98974 98975	0.9999821186065674	O
24256	]	184 185	98975 98976	0.9999856948852539	O
24257	.	186 187	98977 98978	0.999940037727356	O
24258	A	0 1	98979 98980	0.9999819993972778	O
24259	major	2 7	98981 98986	0.9999779462814331	O
24260	function	8 16	98987 98995	0.9999734163284302	O
24261	of	17 19	98996 98998	0.9999827146530151	O
24262	APC	20 22	98999 99001	0.9999746084213257	O
24264	is	24 26	99003 99005	0.9999781847000122	O
24265	to	27 29	99006 99008	0.9999783039093018	O
24266	regulate	30 38	99009 99017	0.9999595880508423	O
24267	the	39 42	99018 99021	0.9999821186065674	O
24268	canonical	43 52	99022 99031	0.999858021736145	O
24269	WNT	53 55	99032 99034	0.9999737739562988	O
24271	signaling	57 66	99036 99045	0.9999839067459106	O
24272	pathway	67 74	99046 99053	0.9999858140945435	O
24273	as	75 77	99054 99056	0.9999839067459106	O
24274	part	78 82	99057 99061	0.9999864101409912	O
24275	of	83 85	99062 99064	0.9999861717224121	O
24276	a	86 87	99065 99066	0.9999853372573853	O
24277	β	88 89	99067 99068	0.9999825954437256	O
24278	-	89 90	99068 99069	0.9999873638153076	O
24279	catenin	90 96	99069 99075	0.9999843835830688	O
24282	degradation	98 109	99077 99088	0.9999837875366211	O
24283	complex	110 117	99089 99096	0.9999860525131226	O
24284	.	118 119	99097 99098	0.9999346733093262	O
24285	Loss	0 4	99099 99103	0.9999680519104004	O
24286	of	5 7	99104 99106	0.9999830722808838	O
24287	APC	8 10	99107 99109	0.999976396560669	O
24289	results	12 19	99111 99118	0.9999784231185913	O
24290	in	20 22	99119 99121	0.9999841451644897	O
24291	a	23 24	99122 99123	0.9999827146530151	O
24292	failure	25 32	99124 99131	0.9999741315841675	O
24293	to	33 35	99132 99134	0.9999843835830688	O
24294	degrade	36 42	99135 99141	0.9999828338623047	O
24296	β	44 45	99143 99144	0.9999866485595703	O
24297	-	45 46	99144 99145	0.999988317489624	O
24298	catenin	46 52	99145 99151	0.9999861717224121	O
24301	,	54 55	99153 99154	0.9999872446060181	O
24302	which	56 61	99155 99160	0.9999876022338867	O
24303	instead	62 69	99161 99168	0.9999752044677734	O
24304	enters	70 76	99169 99175	0.9999853372573853	O
24305	the	77 80	99176 99179	0.9999874830245972	O
24306	nucleus	81 88	99180 99187	0.9999806880950928	O
24307	to	89 91	99188 99190	0.999987006187439	O
24308	act	92 95	99191 99194	0.999987006187439	O
24309	as	96 98	99195 99197	0.9999879598617554	O
24310	a	99 100	99198 99199	0.9999881982803345	O
24311	transcriptional	101 115	99200 99214	0.999983549118042	O
24313	co	117 119	99216 99218	0.9999879598617554	O
24314	-	119 120	99218 99219	0.9999879598617554	O
24315	activator	120 128	99219 99227	0.9999868869781494	O
24318	with	130 134	99229 99233	0.9999865293502808	O
24319	the	135 138	99234 99237	0.9999876022338867	O
24320	lymphoid	139 146	99238 99245	0.9999858140945435	O
24323	enhancer	148 155	99247 99254	0.9999836683273315	O
24325	factor	157 163	99256 99262	0.9999879598617554	O
24326	/	163 164	99262 99263	0.9999876022338867	O
24327	T	164 165	99263 99264	0.9999840259552002	O
24328	-	165 166	99264 99265	0.9999868869781494	O
24329	cell	166 170	99265 99269	0.999984622001648	O
24330	factor	171 177	99270 99276	0.9999876022338867	O
24331	(	178 179	99277 99278	0.999988317489624	O
24332	LEF	180 182	99279 99281	0.9999853372573853	O
24334	/	183 184	99282 99283	0.9999873638153076	O
24335	TCF	184 186	99283 99285	0.9999866485595703	O
24337	)	188 189	99287 99288	0.9999884366989136	O
24338	family	190 196	99289 99295	0.9999867677688599	O
24339	of	197 199	99296 99298	0.9999871253967285	O
24340	transcription	200 213	99299 99312	0.9999810457229614	O
24341	factors	214 221	99313 99320	0.9999856948852539	O
24342	[	222 223	99321 99322	0.9999886751174927	O
24343	9	223 224	99322 99323	0.9999852180480957	O
24344	]	224 225	99323 99324	0.9999879598617554	O
24345	.	226 227	99325 99326	0.9999703168869019	O
24346	The	0 3	99327 99330	0.9999672174453735	O
24347	localization	4 15	99331 99342	0.9999582767486572	O
24349	of	17 19	99344 99346	0.9999786615371704	O
24350	β	20 21	99347 99348	0.9999724626541138	O
24351	-	21 22	99348 99349	0.9999823570251465	O
24352	catenin	22 28	99349 99355	0.9999712705612183	O
24355	within	30 36	99357 99363	0.9999682903289795	O
24356	the	37 40	99364 99367	0.9999735355377197	O
24357	nucleus	41 48	99368 99375	0.9999444484710693	O
24358	indicates	49 58	99376 99385	0.9999327659606934	O
24359	activated	59 68	99386 99395	0.999886155128479	O
24360	canonical	69 78	99396 99405	0.9998610019683838	O
24361	WNT	79 81	99406 99408	0.9999592304229736	O
24363	signaling	83 92	99410 99419	0.9999681711196899	O
24364	.	93 94	99420 99421	0.9994681477546692	O
24365	In	0 2	99422 99424	0.999984622001648	O
24366	addition	3 11	99425 99433	0.9999827146530151	O
24367	to	12 14	99434 99436	0.9999842643737793	O
24368	germline	15 22	99437 99444	0.9999781847000122	O
24372	APC	24 26	99446 99448	0.9999744892120361	O
24374	mutations	28 37	99450 99459	0.9999752044677734	O
24375	that	38 42	99460 99464	0.9999855756759644	O
24376	occur	43 48	99465 99470	0.9999822378158569	O
24377	in	49 51	99471 99473	0.9999738931655884	O
24378	persons	52 59	99474 99481	0.6018466949462891	O
24379	with	60 64	99482 99486	0.9999690055847168	O
24380	familial	65 72	99487 99494	0.9998281002044678	O
24383	adenomatous	74 84	99496 99506	0.9999810457229614	O
24387	polyposis	86 94	99508 99516	0.9999808073043823	O
24391	coli	96 99	99518 99521	0.9999827146530151	O
24393	(	101 102	99523 99524	0.9999865293502808	O
24394	FAP	103 105	99525 99527	0.9999574422836304	O
24396	)	107 108	99529 99530	0.9999849796295166	O
24397	and	109 112	99531 99534	0.9999769926071167	O
24398	ApcMin	113 118	99535 99540	0.9999831914901733	O
24403	/	119 120	99541 99542	0.9999778270721436	O
24404	+	120 121	99542 99543	0.9999768733978271	O
24405	mice	122 126	99544 99548	0.8052796721458435	species
24406	,	127 128	99549 99550	0.9999850988388062	O
24407	loss	129 133	99551 99555	0.9999781847000122	O
24408	of	134 136	99556 99558	0.9999866485595703	O
24409	functional	137 147	99559 99569	0.999966025352478	O
24410	APC	148 150	99570 99572	0.999982476234436	O
24412	and	152 155	99574 99577	0.999984860420227	O
24413	activation	156 166	99578 99588	0.999971866607666	O
24414	of	167 169	99589 99591	0.999987006187439	O
24415	canonical	170 179	99592 99601	0.999968409538269	O
24416	WNT	180 182	99602 99604	0.9999786615371704	O
24418	signaling	184 193	99606 99615	0.9999843835830688	O
24419	occurs	194 200	99616 99622	0.9999841451644897	O
24420	in	201 203	99623 99625	0.9999855756759644	O
24421	more	204 208	99626 99630	0.9999842643737793	O
24422	than	209 213	99631 99635	0.9999864101409912	O
24423	80	214 216	99636 99638	0.9999735355377197	O
24424	%	217 218	99639 99640	0.999980092048645	O
24425	of	219 221	99641 99643	0.9999672174453735	O
24426	human	222 227	99644 99649	0.9497112035751343	species
24427	sporadic	228 235	99650 99657	0.9999381303787231	O
24429	CRCs	237 240	99659 99662	0.9999758005142212	O
24431	[	242 243	99664 99665	0.9999879598617554	O
24432	10	243 245	99665 99667	0.999981164932251	O
24433	]	245 246	99667 99668	0.9999845027923584	O
24434	.	247 248	99669 99670	0.9999680519104004	O
24435	Similar	0 7	99671 99678	0.9999779462814331	O
24436	to	8 10	99679 99681	0.9999837875366211	O
24437	the	11 14	99682 99685	0.9999843835830688	O
24438	ApcMin	15 20	99686 99691	0.9999854564666748	O
24443	/	21 22	99692 99693	0.9999845027923584	O
24444	+	22 23	99693 99694	0.9999806880950928	O
24445	model	24 29	99695 99700	0.9999756813049316	O
24446	,	30 31	99701 99702	0.9999803304672241	O
24447	tumors	32 38	99703 99709	0.999966025352478	O
24448	in	39 41	99710 99712	0.9999829530715942	O
24449	the	42 45	99713 99716	0.9999791383743286	O
24450	azoxymethane	46 57	99717 99728	0.9999834299087524	O
24455	(	59 60	99730 99731	0.999985933303833	O
24456	AOM	61 63	99732 99734	0.9999675750732422	O
24458	)	64 65	99735 99736	0.9999843835830688	O
24459	carcinogen	66 75	99737 99746	0.9999804496765137	O
24462	model	77 82	99748 99753	0.999964714050293	O
24463	,	83 84	99754 99755	0.9999840259552002	O
24464	which	85 90	99756 99761	0.9999834299087524	O
24465	occur	91 96	99762 99767	0.999980092048645	O
24466	predominantly	97 110	99768 99781	0.9999825954437256	O
24467	in	111 113	99782 99784	0.9999837875366211	O
24468	the	114 117	99785 99788	0.9999822378158569	O
24469	colon	118 122	99789 99793	0.9999741315841675	O
24471	[	124 125	99795 99796	0.999987006187439	O
24472	11	125 127	99796 99798	0.9999852180480957	O
24473	]	127 128	99798 99799	0.9999866485595703	O
24474	,	129 130	99800 99801	0.9999819993972778	O
24475	have	131 135	99802 99806	0.9999831914901733	O
24476	signaling	136 145	99807 99816	0.9999669790267944	O
24477	alterations	146 157	99817 99828	0.9999810457229614	O
24478	marked	158 164	99829 99835	0.9999858140945435	O
24479	by	165 167	99836 99838	0.9999862909317017	O
24480	activated	168 177	99839 99848	0.9999704360961914	O
24481	canonical	178 187	99849 99858	0.9999749660491943	O
24482	WNT	188 190	99859 99861	0.9999802112579346	O
24484	signaling	192 201	99863 99872	0.9999853372573853	O
24485	.	202 203	99873 99874	0.999985933303833	O
24486	*	204 205	99875 99876	0.9999836683273315	O
24487	*	205 206	99876 99877	0.9999545812606812	O
24488	IGNORE	0 5	99878 99883	0.9999850988388062	O
24491	LINE	7 10	99885 99888	0.9999879598617554	O
24494	*	12 13	99890 99891	0.9999879598617554	O
24495	*	13 14	99891 99892	0.9999878406524658	O
24496	*	15 16	99893 99894	0.9999878406524658	O
24497	*	16 17	99894 99895	0.9999880790710449	O
24498	IGNORE	18 23	99896 99901	0.9999873638153076	O
24501	LINE	25 28	99903 99906	0.999988317489624	O
24504	*	30 31	99908 99909	0.9999878406524658	O
24505	*	31 32	99909 99910	0.9999879598617554	O
24506	*	33 34	99911 99912	0.9999878406524658	O
24507	*	34 35	99912 99913	0.9999878406524658	O
24508	IGNORE	36 41	99914 99919	0.9999868869781494	O
24511	LINE	43 46	99921 99924	0.9999880790710449	O
24514	*	48 49	99926 99927	0.9999877214431763	O
24515	*	49 50	99927 99928	0.9999880790710449	O
24516	Results	51 58	99929 99936	0.9999872446060181	O
24517	Strategy	59 67	99937 99945	0.9999845027923584	O
24518	for	68 71	99946 99949	0.9999877214431763	O
24519	cross	72 77	99950 99955	0.9999849796295166	O
24520	-	77 78	99955 99956	0.9999879598617554	O
24521	species	78 85	99956 99963	0.9999258518218994	O
24522	analysis	86 94	99964 99972	0.9999880790710449	O
24523	Our	95 98	99973 99976	0.999985933303833	O
24524	strategy	99 107	99977 99985	0.9999847412109375	O
24525	for	108 111	99986 99989	0.9999861717224121	O
24526	the	112 115	99990 99993	0.9999867677688599	O
24527	characterization	116 132	99994 100010	0.9999723434448242	O
24528	of	133 135	100011 100013	0.9999847412109375	O
24529	mouse	136 141	100014 100019	0.8433210253715515	species
24530	models	142 148	100020 100026	0.9999009370803833	O
24531	of	149 151	100027 100029	0.999977707862854	O
24532	human	152 157	100030 100035	0.9681926369667053	species
24533	CRC	158 160	100036 100038	0.9999767541885376	O
24535	(	162 163	100040 100041	0.9999884366989136	O
24536	Figure	164 170	100042 100048	0.9999847412109375	O
24537	1	171 172	100049 100050	0.9999873638153076	O
24538	)	173 174	100051 100052	0.9999885559082031	O
24539	relies	175 181	100053 100059	0.9999861717224121	O
24540	on	182 184	100060 100062	0.9999878406524658	O
24541	gene	185 189	100063 100067	0.9999828338623047	O
24542	expression	190 200	100068 100078	0.9999783039093018	O
24543	differences	201 212	100079 100090	0.9999854564666748	O
24544	and	213 216	100091 100094	0.9999868869781494	O
24545	relative	217 225	100095 100103	0.9999803304672241	O
24546	patterning	226 235	100104 100113	0.999985933303833	O
24548	across	237 243	100115 100121	0.9999854564666748	O
24549	a	244 245	100122 100123	0.9999855756759644	O
24550	range	246 251	100124 100129	0.9999730587005615	O
24551	of	252 254	100130 100132	0.9999759197235107	O
24552	mouse	255 260	100133 100138	0.898679792881012	species
24553	CRC	261 263	100139 100141	0.9999767541885376	O
24555	models	265 271	100143 100149	0.9998612403869629	O
24556	,	272 273	100150 100151	0.9999761581420898	O
24557	normal	274 280	100152 100158	0.9992284774780273	O
24558	mouse	281 286	100159 100164	0.8373598456382751	species
24559	colon	287 291	100165 100169	0.9999735355377197	O
24561	developmental	293 306	100171 100184	0.9999607801437378	O
24562	stages	307 313	100185 100191	0.9999357461929321	O
24563	,	314 315	100192 100193	0.9999561309814453	O
24564	and	316 319	100194 100197	0.9999129772186279	O
24565	human	320 325	100198 100203	0.9686266183853149	species
24566	CRCs	326 329	100204 100207	0.9999675750732422	O
24568	.	331 332	100209 100210	0.9996757507324219	O
24569	Achieving	0 8	100211 100219	0.9999825954437256	O
24573	this	10 14	100221 100225	0.999985933303833	O
24574	comparison	15 25	100226 100236	0.9999681711196899	O
24575	was	26 29	100237 100240	0.9999837875366211	O
24576	facilitated	30 41	100241 100252	0.9999792575836182	O
24577	by	42 44	100253 100255	0.9999856948852539	O
24578	the	45 48	100256 100259	0.9999862909317017	O
24579	use	49 52	100260 100263	0.9999847412109375	O
24580	of	53 55	100264 100266	0.9999874830245972	O
24581	reference	56 65	100267 100276	0.9999786615371704	O
24582	RNAs	66 69	100277 100280	0.9999850988388062	O
24584	from	71 75	100282 100286	0.9999877214431763	O
24585	whole	76 81	100287 100292	0.9999833106994629	O
24586	-	81 82	100292 100293	0.9999874830245972	O
24587	mouse	82 87	100293 100298	0.9727174043655396	O
24588	and	88 91	100299 100302	0.9999867677688599	O
24589	normal	92 98	100303 100309	0.9999781847000122	O
24590	adult	99 104	100310 100315	0.9999258518218994	O
24591	colon	105 109	100316 100320	0.9999810457229614	O
24593	reference	111 120	100322 100331	0.9999864101409912	O
24594	RNAs	121 124	100332 100335	0.9999865293502808	O
24596	for	126 129	100337 100340	0.9999861717224121	O
24597	both	130 134	100341 100345	0.9999854564666748	O
24598	mouse	135 140	100346 100351	0.9201136231422424	O
24599	and	141 144	100352 100355	0.9999836683273315	O
24600	human	145 150	100356 100361	0.606144905090332	species
24601	measurements	151 163	100362 100374	0.9999639987945557	O
24602	.	164 165	100375 100376	0.9999574422836304	O
24603	Mouse	0 5	100377 100382	0.9560549855232239	species
24604	tumor	6 11	100383 100388	0.9999583959579468	O
24605	samples	12 19	100389 100396	0.9999599456787109	O
24606	were	20 24	100397 100401	0.9999712705612183	O
24607	profiled	25 32	100402 100409	0.9999781847000122	O
24609	on	34 36	100411 100413	0.9999834299087524	O
24610	cDNA	37 40	100414 100417	0.9999860525131226	O
24613	microarrays	42 52	100419 100429	0.9999834299087524	O
24616	using	54 59	100431 100436	0.9999867677688599	O
24617	the	60 63	100437 100440	0.9999873638153076	O
24618	embryonic	64 72	100441 100449	0.9999871253967285	O
24622	day	74 77	100451 100454	0.9999865293502808	O
24623	(	78 79	100455 100456	0.9999873638153076	O
24624	E	80 81	100457 100458	0.9999867677688599	O
24625	)	81 82	100458 100459	0.9999878406524658	O
24626	17	82 84	100459 100461	0.9999827146530151	O
24627	.	84 85	100461 100462	0.9999878406524658	O
24628	5	85 86	100462 100463	0.9999879598617554	O
24629	whole	87 92	100464 100469	0.9999865293502808	O
24630	mouse	93 98	100470 100475	0.9999239444732666	O
24631	reference	99 108	100476 100485	0.9999849796295166	O
24632	RNA	109 112	100486 100489	0.9999865293502808	O
24633	identical	113 122	100490 100499	0.9999876022338867	O
24634	to	123 125	100500 100502	0.9999880790710449	O
24635	that	126 130	100503 100507	0.9999877214431763	O
24636	used	131 135	100508 100512	0.9999868869781494	O
24637	previously	136 146	100513 100523	0.9999867677688599	O
24638	[	147 148	100524 100525	0.9999879598617554	O
24639	15	148 150	100525 100527	0.9999843835830688	O
24640	]	151 152	100528 100529	0.9999874830245972	O
24641	to	153 155	100530 100532	0.9999878406524658	O
24642	examine	156 163	100533 100540	0.9999862909317017	O
24643	embryonic	164 172	100541 100549	0.9999871253967285	O
24647	mouse	174 179	100551 100556	0.9997925162315369	O
24648	colon	180 184	100557 100561	0.9999840259552002	O
24650	gene	186 190	100563 100567	0.9999862909317017	O
24651	expression	191 201	100568 100578	0.9999849796295166	O
24652	dynamics	202 210	100579 100587	0.9999842643737793	O
24653	from	211 215	100588 100592	0.9999881982803345	O
24654	E13	216 218	100593 100595	0.9999872446060181	O
24656	.	219 220	100596 100597	0.9999871253967285	O
24657	5	220 221	100597 100598	0.9999868869781494	O
24658	to	222 224	100599 100601	0.9999871253967285	O
24659	E18	225 227	100602 100604	0.9999865293502808	O
24661	.	228 229	100605 100606	0.9999872446060181	O
24662	5	229 230	100606 100607	0.9999861717224121	O
24663	,	231 232	100608 100609	0.9999864101409912	O
24664	during	233 239	100610 100616	0.9999864101409912	O
24665	which	240 245	100617 100622	0.9999872446060181	O
24666	time	246 250	100623 100627	0.9999849796295166	O
24667	the	251 254	100628 100631	0.9999855756759644	O
24668	primitive	255 264	100632 100641	0.999971866607666	O
24669	,	265 266	100642 100643	0.999984622001648	O
24670	undifferentiated	267 282	100644 100659	0.9999853372573853	O
24675	,	284 285	100661 100662	0.9999802112579346	O
24676	pseudo	286 292	100663 100669	0.9999829530715942	O
24677	-	292 293	100669 100670	0.9999854564666748	O
24678	stratified	293 302	100670 100679	0.9999853372573853	O
24682	colonic	304 310	100681 100687	0.9999815225601196	O
24685	endoderm	312 319	100689 100696	0.9999862909317017	O
24688	becomes	321 328	100698 100705	0.9999825954437256	O
24689	a	329 330	100706 100707	0.9999866485595703	O
24690	differentiated	331 345	100708 100722	0.9999799728393555	O
24691	,	346 347	100723 100724	0.9999793767929077	O
24692	single	348 354	100725 100731	0.9999828338623047	O
24693	-	354 355	100731 100732	0.9999866485595703	O
24694	layered	355 362	100732 100739	0.9999755620956421	O
24695	epithelium	363 372	100740 100749	0.9999853372573853	O
24699	.	374 375	100751 100752	0.9998965263366699	O
24700	This	0 4	100753 100757	0.999969482421875	O
24701	strategy	5 13	100758 100766	0.9998618364334106	O
24702	allowed	14 21	100767 100774	0.9999791383743286	O
24703	us	22 24	100775 100777	0.9999576807022095	O
24704	to	25 27	100778 100780	0.9999828338623047	O
24705	construct	28 37	100781 100790	0.9999810457229614	O
24706	a	38 39	100791 100792	0.9999866485595703	O
24707	gene	40 44	100793 100797	0.9999834299087524	O
24708	expression	45 55	100798 100808	0.9999732971191406	O
24709	database	56 64	100809 100817	0.9999616146087646	O
24710	of	65 67	100818 100820	0.9999817609786987	O
24711	mouse	68 73	100821 100826	0.9482967257499695	species
24712	colon	74 78	100827 100831	0.9998230338096619	O
24714	tumors	80 86	100833 100839	0.9999769926071167	O
24715	in	87 89	100840 100842	0.9999855756759644	O
24716	which	90 95	100843 100848	0.9999868869781494	O
24717	gene	96 100	100849 100853	0.9999833106994629	O
24718	expression	101 111	100854 100864	0.9999783039093018	O
24719	levels	112 118	100865 100871	0.999982476234436	O
24720	of	119 121	100872 100874	0.999984860420227	O
24721	the	122 125	100875 100878	0.9999531507492065	O
24722	tumors	126 132	100879 100885	0.9999724626541138	O
24723	could	133 138	100886 100891	0.999983549118042	O
24724	be	139 141	100892 100894	0.9999871253967285	O
24725	referenced	142 152	100895 100905	0.9999806880950928	O
24726	,	153 154	100906 100907	0.9999852180480957	O
24727	ranked	155 161	100908 100914	0.999981164932251	O
24728	,	162 163	100915 100916	0.999984860420227	O
24729	and	164 167	100917 100920	0.9999868869781494	O
24730	statistically	168 180	100921 100933	0.9999866485595703	O
24732	compared	182 190	100935 100943	0.9999878406524658	O
24733	to	191 193	100944 100946	0.9999878406524658	O
24734	an	194 196	100947 100949	0.9999879598617554	O
24735	average	197 204	100950 100957	0.9999843835830688	O
24736	value	205 210	100958 100963	0.9999839067459106	O
24737	among	211 216	100964 100969	0.9999836683273315	O
24738	the	217 220	100970 100973	0.9999538660049438	O
24739	tumors	221 227	100974 100980	0.9999712705612183	O
24740	or	228 230	100981 100983	0.9999823570251465	O
24741	to	231 233	100984 100986	0.9999864101409912	O
24742	embryonic	234 242	100987 100995	0.9999867677688599	O
24746	or	244 246	100997 100999	0.9999868869781494	O
24747	adult	247 252	101000 101005	0.999981164932251	O
24748	colon	253 257	101006 101010	0.9999841451644897	O
24750	gene	259 263	101012 101016	0.9999866485595703	O
24751	expression	264 274	101017 101027	0.9999852180480957	O
24752	levels	275 281	101028 101034	0.9999877214431763	O
24753	on	282 284	101035 101037	0.9999878406524658	O
24754	a	285 286	101038 101039	0.9999878406524658	O
24755	per	287 290	101040 101043	0.9999864101409912	O
24756	-	290 291	101043 101044	0.9999872446060181	O
24757	gene	291 295	101044 101048	0.9999802112579346	O
24758	basis	296 301	101049 101054	0.9999866485595703	O
24759	.	302 303	101055 101056	0.999869704246521	O
24760	First	0 5	101057 101062	0.9999843835830688	O
24761	,	6 7	101063 101064	0.9999881982803345	O
24762	we	8 10	101065 101067	0.9999854564666748	O
24763	compared	11 19	101068 101076	0.9999836683273315	O
24764	the	20 23	101077 101080	0.9999871253967285	O
24765	four	24 28	101081 101085	0.9999721050262451	O
24766	models	29 35	101086 101092	0.9999346733093262	O
24767	with	36 40	101093 101097	0.9999865293502808	O
24768	each	41 45	101098 101102	0.9999874830245972	O
24769	other	46 51	101103 101108	0.9999868869781494	O
24770	,	52 53	101109 101110	0.9999879598617554	O
24771	then	54 58	101111 101115	0.9999847412109375	O
24772	to	59 61	101116 101118	0.9999874830245972	O
24773	mouse	62 67	101119 101124	0.9831847548484802	O
24774	colon	68 72	101125 101129	0.9999866485595703	O
24776	development	74 85	101131 101142	0.9999841451644897	O
24777	,	86 87	101143 101144	0.9999878406524658	O
24778	and	88 91	101145 101148	0.9999887943267822	O
24779	finally	92 99	101149 101156	0.9999866485595703	O
24780	to	100 102	101157 101159	0.9999836683273315	O
24781	human	103 108	101160 101165	0.9737803936004639	species
24782	CRCs	109 112	101166 101169	0.9999747276306152	O
24784	using	114 119	101171 101176	0.9999884366989136	O
24785	gene	120 124	101177 101181	0.9999834299087524	O
24786	ortholog	125 132	101182 101189	0.9999887943267822	O
24790	mapping	134 141	101191 101198	0.9999871253967285	O
24791	(	142 143	101199 101200	0.9999890327453613	O
24792	Figure	144 150	101201 101207	0.9999841451644897	O
24793	1	151 152	101208 101209	0.9999884366989136	O
24794	)	153 154	101210 101211	0.9999890327453613	O
24795	.	155 156	101212 101213	0.9999762773513794	O
24796	Stratification	0 13	101214 101227	0.9999295473098755	O
24799	of	15 17	101229 101231	0.9999234676361084	O
24800	murine	18 23	101232 101237	0.9476602673530579	species
24803	colon	25 29	101239 101243	0.9997324347496033	O
24805	tumor	31 36	101245 101250	0.9999274015426636	O
24806	models	37 43	101251 101257	0.9985633492469788	O
24807	by	44 46	101258 101260	0.9999723434448242	O
24808	localization	47 58	101261 101272	0.9999781847000122	O
24810	of	60 62	101274 101276	0.9999799728393555	O
24811	β	63 64	101277 101278	0.9999784231185913	O
24812	-	64 65	101278 101279	0.9999836683273315	O
24813	catenin	65 71	101279 101285	0.999980092048645	O
24816	and	73 76	101287 101290	0.9999780654907227	O
24817	plan	77 81	101291 101295	0.9999806880950928	O
24818	for	82 85	101296 101299	0.9999815225601196	O
24819	analysis	86 94	101300 101308	0.9999760389328003	O
24820	.	95 96	101309 101310	0.9987950325012207	O
24821	Colon	0 4	101311 101315	0.998130738735199	O
24823	tumors	6 12	101317 101323	0.9998570680618286	O
24824	from	13 17	101324 101328	0.9992004036903381	O
24825	four	18 22	101329 101333	0.9941436648368835	O
24826	etiologically	23 35	101334 101346	0.9997511506080627	O
24830	distinct	37 45	101348 101356	0.9919236302375793	O
24831	mouse	46 51	101357 101362	0.9291025996208191	species
24832	models	52 58	101363 101369	0.9149256348609924	O
24833	of	59 61	101370 101372	0.9988381266593933	O
24834	CRC	62 64	101373 101375	0.9998182654380798	O
24836	were	66 70	101377 101381	0.9997432827949524	O
24837	subjected	71 80	101382 101391	0.9999674558639526	O
24838	to	81 83	101392 101394	0.9999809265136719	O
24839	microarray	84 93	101395 101404	0.9999797344207764	O
24842	gene	95 99	101406 101410	0.999981164932251	O
24843	expression	100 110	101411 101421	0.9999784231185913	O
24844	profiling	111 119	101422 101430	0.9999833106994629	O
24847	.	121 122	101432 101433	0.9998620748519897	O
24848	The	0 3	101434 101437	0.9999747276306152	O
24849	gene	4 8	101438 101442	0.9999712705612183	O
24850	expression	9 19	101443 101453	0.9999587535858154	O
24851	profiles	20 28	101454 101462	0.9999629259109497	O
24852	from	29 33	101463 101467	0.9999674558639526	O
24853	the	34 37	101468 101471	0.9999277591705322	O
24854	different	38 47	101472 101481	0.9999446868896484	O
24855	mouse	48 53	101482 101487	0.9617726802825928	species
24856	model	54 59	101488 101493	0.5791841745376587	O
24857	tumors	60 66	101494 101500	0.9999663829803467	O
24858	were	67 71	101501 101505	0.9999691247940063	O
24859	compared	72 80	101506 101514	0.9999773502349854	O
24860	and	81 84	101515 101518	0.9999747276306152	O
24861	contrasted	85 95	101519 101529	0.9999759197235107	O
24862	to	96 98	101530 101532	0.9999847412109375	O
24863	each	99 103	101533 101537	0.9999858140945435	O
24864	other	104 109	101538 101543	0.9999842643737793	O
24865	,	110 111	101544 101545	0.9999797344207764	O
24866	as	112 114	101546 101548	0.9999833106994629	O
24867	well	115 119	101549 101553	0.9999837875366211	O
24868	as	120 122	101554 101556	0.9999840259552002	O
24869	to	123 125	101557 101559	0.9999829530715942	O
24870	those	126 131	101560 101565	0.9999845027923584	O
24871	from	132 136	101566 101570	0.9999845027923584	O
24872	embryonic	137 145	101571 101579	0.9999861717224121	O
24876	mouse	147 152	101581 101586	0.9999793767929077	O
24877	colon	153 157	101587 101591	0.9999868869781494	O
24879	development	159 170	101593 101604	0.9999858140945435	O
24880	and	171 174	101605 101608	0.9999819993972778	O
24881	100	175 178	101609 101612	0.9999346733093262	O
24882	human	179 184	101613 101618	0.979272723197937	species
24883	CRCs	185 188	101619 101622	0.9999614953994751	O
24885	.	190 191	101624 101625	0.9998154044151306	O
24886	Mouse	0 5	101626 101631	0.964168131351471	species
24887	colon	6 10	101632 101636	0.99788898229599	O
24889	tumors	12 18	101638 101644	0.9999629259109497	O
24890	partition	19 28	101645 101654	0.9999793767929077	O
24891	into	29 33	101655 101659	0.9999862909317017	O
24892	classes	34 41	101660 101667	0.9999834299087524	O
24893	reflecting	42 52	101668 101678	0.9999821186065674	O
24894	differential	53 65	101679 101691	0.9999767541885376	O
24895	canonical	66 75	101692 101701	0.9999387264251709	O
24896	WNT	76 78	101702 101704	0.9999771118164062	O
24898	signaling	80 89	101706 101715	0.9999805688858032	O
24899	activity	90 98	101716 101724	0.9999858140945435	O
24900	To	99 101	101725 101727	0.9999833106994629	O
24901	discover	102 110	101728 101736	0.9999845027923584	O
24902	gene	111 115	101737 101741	0.9999839067459106	O
24903	expression	116 126	101742 101752	0.9999833106994629	O
24904	programs	127 135	101753 101761	0.9999829530715942	O
24905	underlying	136 146	101762 101772	0.9999865293502808	O
24906	differences	147 158	101773 101784	0.9999804496765137	O
24907	between	159 166	101785 101792	0.9999790191650391	O
24908	etiologically	167 179	101793 101805	0.9999796152114868	O
24912	distinct	181 189	101807 101815	0.9999750852584839	O
24913	mouse	190 195	101816 101821	0.9485512971878052	species
24914	models	196 202	101822 101828	0.9999374151229858	O
24915	of	203 205	101829 101831	0.9999703168869019	O
24916	CRC	206 208	101832 101834	0.9999568462371826	O
24918	,	210 211	101836 101837	0.9999865293502808	O
24919	gene	212 216	101838 101842	0.9999861717224121	O
24920	expression	217 227	101843 101853	0.9999856948852539	O
24921	level	228 233	101854 101859	0.9999866485595703	O
24922	values	234 240	101860 101866	0.9999855756759644	O
24923	for	241 244	101867 101870	0.999987006187439	O
24924	each	245 249	101871 101875	0.9999880790710449	O
24925	transcript	250 259	101876 101885	0.9999825954437256	O
24927	in	261 263	101887 101889	0.9999868869781494	O
24928	each	264 268	101890 101894	0.9999847412109375	O
24929	tumor	269 274	101895 101900	0.9999678134918213	O
24930	sample	275 281	101901 101907	0.9999823570251465	O
24931	was	282 285	101908 101911	0.9999874830245972	O
24932	set	286 289	101912 101915	0.9999871253967285	O
24933	to	290 292	101916 101918	0.9999873638153076	O
24934	its	293 296	101919 101922	0.9999885559082031	O
24935	ratio	297 302	101923 101928	0.9999849796295166	O
24936	relative	303 311	101929 101937	0.9999878406524658	O
24937	to	312 314	101938 101940	0.9999880790710449	O
24938	its	315 318	101941 101944	0.9999880790710449	O
24939	median	319 325	101945 101951	0.9999778270721436	O
24940	across	326 332	101952 101958	0.999982476234436	O
24941	the	333 336	101959 101962	0.9999840259552002	O
24942	series	337 343	101963 101969	0.9999752044677734	O
24943	of	344 346	101970 101972	0.9999785423278809	O
24944	tumor	347 352	101973 101978	0.9999489784240723	O
24945	models	353 359	101979 101985	0.9999452829360962	O
24946	.	360 361	101986 101987	0.9999233484268188	O
24947	Using	0 5	101988 101993	0.9999802112579346	O
24948	non	6 9	101994 101997	0.9999818801879883	O
24949	-	9 10	101997 101998	0.999984860420227	O
24950	parametric	10 19	101998 102007	0.999980092048645	O
24952	statistical	21 32	102009 102020	0.9999809265136719	O
24953	analyses	33 41	102021 102029	0.9999784231185913	O
24954	,	42 43	102030 102031	0.9999837875366211	O
24955	1	44 45	102032 102033	0.9999833106994629	O
24956	,	45 46	102033 102034	0.9999845027923584	O
24957	798	46 48	102034 102036	0.9999796152114868	O
24959	cDNA	50 53	102038 102041	0.9999852180480957	O
24962	transcripts	55 65	102043 102053	0.9999850988388062	O
24964	were	67 71	102055 102059	0.9999843835830688	O
24965	identified	72 82	102060 102070	0.9999825954437256	O
24966	as	83 85	102071 102073	0.9999854564666748	O
24967	differentially	86 99	102074 102087	0.9999788999557495	O
24969	expressed	101 110	102089 102098	0.999977707862854	O
24970	among	111 116	102099 102104	0.9999798536300659	O
24971	the	117 120	102105 102108	0.9999699592590332	O
24972	four	121 125	102109 102113	0.999826967716217	O
24973	mouse	126 131	102114 102119	0.9380842447280884	species
24974	models	132 138	102120 102126	0.9998297691345215	O
24975	of	139 141	102127 102129	0.9999483823776245	O
24976	CRC	142 144	102130 102132	0.9999654293060303	O
24978	.	145 146	102133 102134	0.9999252557754517	O
24979	Five	0 4	102135 102139	0.9999856948852539	O
24980	major	5 10	102140 102145	0.9999867677688599	O
24981	gene	11 15	102146 102150	0.9999860525131226	O
24982	patterns	16 24	102151 102159	0.9999841451644897	O
24983	were	25 29	102160 102164	0.9999868869781494	O
24984	identified	30 40	102165 102175	0.9999868869781494	O
24985	using	41 46	102176 102181	0.9999877214431763	O
24986	K	47 48	102182 102183	0.9999864101409912	O
24987	-	48 49	102183 102184	0.9999891519546509	O
24988	means	49 54	102184 102189	0.9999871253967285	O
24989	clustering	55 64	102190 102199	0.9999881982803345	O
24991	(	66 67	102201 102202	0.9999895095825195	O
24992	clusters	68 76	102203 102211	0.9999886751174927	O
24993	C1	77 78	102212 102213	0.9999890327453613	O
24995	-	79 80	102214 102215	0.99998939037323	O
24996	C5	80 81	102215 102216	0.9999889135360718	O
24998	;	83 84	102218 102219	0.9999890327453613	O
24999	Figure	85 91	102220 102226	0.999985933303833	O
25000	2a	92 93	102227 102228	0.9999889135360718	O
25002	,	95 96	102230 102231	0.9999889135360718	O
25003	top	97 100	102232 102235	0.9999890327453613	O
25004	)	101 102	102236 102237	0.99998939037323	O
25005	.	103 104	102238 102239	0.9999762773513794	O
25006	Genes	0 4	102240 102244	0.9999762773513794	O
25008	belonging	6 15	102246 102255	0.9999873638153076	O
25009	to	16 18	102256 102258	0.9999874830245972	O
25010	these	19 24	102259 102264	0.9999867677688599	O
25011	clusters	25 33	102265 102273	0.9999754428863525	O
25012	were	34 38	102274 102278	0.9999847412109375	O
25013	strongly	39 47	102279 102287	0.9999821186065674	O
25014	associated	48 58	102288 102298	0.9999884366989136	O
25015	with	59 63	102299 102303	0.9999881982803345	O
25016	annotated	64 72	102304 102312	0.999988317489624	O
25019	gene	74 78	102314 102318	0.9999871253967285	O
25020	function	79 87	102319 102327	0.9999842643737793	O
25021	categories	88 98	102328 102338	0.9999877214431763	O
25022	(	99 100	102339 102340	0.9999887943267822	O
25023	see	101 104	102341 102344	0.9999836683273315	O
25024	Table	105 110	102345 102350	0.9999864101409912	O
25025	1	111 112	102351 102352	0.9999878406524658	O
25026	for	113 116	102353 102356	0.9999878406524658	O
25027	detailed	117 125	102357 102365	0.999985933303833	O
25028	biological	126 136	102366 102376	0.9999815225601196	O
25029	descriptions	137 149	102377 102389	0.9999874830245972	O
25030	and	150 153	102390 102393	0.9999878406524658	O
25031	associations	154 166	102394 102406	0.9999864101409912	O
25032	)	167 168	102407 102408	0.9999887943267822	O
25033	.	169 170	102409 102410	0.9999669790267944	O
25034	For	0 3	102411 102414	0.9999854564666748	O
25035	example	4 11	102415 102422	0.9999855756759644	O
25036	,	12 13	102423 102424	0.9999880790710449	O
25037	cluster	14 21	102425 102432	0.9999856948852539	O
25038	C1	22 23	102433 102434	0.9999871253967285	O
25040	,	25 26	102436 102437	0.9999876022338867	O
25041	composed	27 35	102438 102446	0.9999879598617554	O
25042	of	36 38	102447 102449	0.9999876022338867	O
25043	transcripts	39 49	102450 102460	0.9999874830245972	O
25045	that	51 55	102462 102466	0.9999876022338867	O
25046	exhibited	56 65	102467 102476	0.9999852180480957	O
25047	lower	66 71	102477 102482	0.9999833106994629	O
25048	expression	72 82	102483 102493	0.9999872446060181	O
25049	in	83 85	102494 102496	0.9999881982803345	O
25050	Smad3	86 90	102497 102501	0.9999861717224121	O
25053	-	91 92	102502 102503	0.9999798536300659	O
25054	/	92 93	102503 102504	0.9998648166656494	O
25055	-	93 94	102504 102505	0.999974250793457	O
25056	tumors	95 101	102506 102512	0.9999840259552002	O
25057	and	102 105	102513 102516	0.9999871253967285	O
25058	higher	106 112	102517 102523	0.9999843835830688	O
25059	expression	113 123	102524 102534	0.9999873638153076	O
25060	in	124 126	102535 102537	0.9999880790710449	O
25061	AOM	127 129	102538 102540	0.9999866485595703	O
25063	,	131 132	102542 102543	0.9999873638153076	O
25064	ApcMin	133 138	102544 102549	0.9999880790710449	O
25069	/	139 140	102550 102551	0.9999871253967285	O
25070	+	140 141	102551 102552	0.9999871253967285	O
25071	and	142 145	102553 102556	0.999987006187439	O
25072	Tgfb1	146 150	102557 102561	0.9999862909317017	O
25077	-	151 152	102562 102563	0.999987006187439	O
25078	/	152 153	102563 102564	0.9999792575836182	O
25079	-	153 154	102564 102565	0.9999872446060181	O
25080	;	154 155	102565 102566	0.9999853372573853	O
25081	Rag2	156 159	102567 102570	0.9999829530715942	O
25084	-	160 161	102571 102572	0.9999854564666748	O
25085	/	161 162	102572 102573	0.9999434947967529	O
25086	-	162 163	102573 102574	0.9999828338623047	O
25087	tumors	164 170	102575 102581	0.9999849796295166	O
25088	,	171 172	102582 102583	0.9999874830245972	O
25089	contains	173 181	102584 102592	0.9999880790710449	O
25090	391	182 184	102593 102595	0.999983549118042	O
25092	transcripts	186 196	102597 102607	0.9999874830245972	O
25094	,	198 199	102609 102610	0.9999874830245972	O
25095	including	200 209	102611 102620	0.9999881982803345	O
25096	Cdk4	210 213	102621 102624	0.9999878406524658	O
25100	,	215 216	102626 102627	0.9999877214431763	O
25101	Ctnnb1	217 222	102628 102633	0.9999873638153076	O
25106	,	224 225	102635 102636	0.9999876022338867	O
25107	Myc	226 228	102637 102639	0.9999806880950928	O
25109	,	230 231	102641 102642	0.9999876022338867	O
25110	Ezh2	232 235	102643 102646	0.9999856948852539	O
25114	,	237 238	102648 102649	0.9999876022338867	O
25115	Mcm2	239 242	102650 102653	0.9999845027923584	O
25119	and	244 247	102655 102658	0.9999873638153076	O
25120	Tcf3	248 251	102659 102662	0.9999860525131226	O
25124	.	253 254	102664 102665	0.9999594688415527	O
25125	Gene	0 4	102666 102670	0.9999867677688599	O
25126	list	5 9	102671 102675	0.9999850988388062	O
25127	over	10 14	102676 102680	0.9999879598617554	O
25128	-	14 15	102680 102681	0.999988317489624	O
25129	representation	15 29	102681 102695	0.999987006187439	O
25130	analysis	30 38	102696 102704	0.9999871253967285	O
25131	using	39 44	102705 102710	0.999987006187439	O
25132	Ingenuity	45 53	102711 102719	0.9999873638153076	O
25135	Pathway	55 61	102721 102727	0.9999868869781494	O
25137	Analysis	63 71	102729 102737	0.9999874830245972	O
25138	applications	72 84	102738 102750	0.9999839067459106	O
25139	demonstrated	85 97	102751 102763	0.9999830722808838	O
25140	highly	98 104	102764 102770	0.9999871253967285	O
25141	significant	105 116	102771 102782	0.9999881982803345	O
25142	associations	117 129	102783 102795	0.9999860525131226	O
25143	to	130 132	102796 102798	0.9999874830245972	O
25144	cell	133 137	102799 102803	0.9999866485595703	O
25145	cycle	138 143	102804 102809	0.9999866485595703	O
25146	progression	144 155	102810 102821	0.9999881982803345	O
25147	,	156 157	102822 102823	0.9999878406524658	O
25148	replication	158 169	102824 102835	0.9999862909317017	O
25149	,	170 171	102836 102837	0.9999884366989136	O
25150	post	172 176	102838 102842	0.9999889135360718	O
25151	-	176 177	102842 102843	0.9999890327453613	O
25152	transcriptional	177 191	102843 102857	0.9999880790710449	O
25154	control	193 200	102859 102866	0.9999886751174927	O
25155	and	201 204	102867 102870	0.9999873638153076	O
25156	cancer	205 211	102871 102877	0.9999808073043823	O
25157	.	212 213	102878 102879	0.9999638795852661	O
25158	Similarly	0 9	102880 102889	0.9999853372573853	O
25159	,	10 11	102890 102891	0.9999879598617554	O
25160	cluster	12 19	102892 102899	0.9999867677688599	O
25161	C2	20 21	102900 102901	0.9999868869781494	O
25163	,	23 24	102903 102904	0.9999874830245972	O
25164	composed	25 33	102905 102913	0.9999879598617554	O
25165	of	34 36	102914 102916	0.9999880790710449	O
25166	663	37 39	102917 102919	0.9999864101409912	O
25168	transcripts	41 51	102921 102931	0.9999873638153076	O
25170	that	53 57	102933 102937	0.9999878406524658	O
25171	exhibited	58 67	102938 102947	0.9999873638153076	O
25172	high	68 72	102948 102952	0.9999866485595703	O
25173	expression	73 83	102953 102963	0.9999864101409912	O
25174	in	84 86	102964 102966	0.9999879598617554	O
25175	AOM	87 89	102967 102969	0.999984622001648	O
25177	and	91 94	102971 102974	0.9999865293502808	O
25178	ApcMin	95 100	102975 102980	0.9999872446060181	O
25183	/	101 102	102981 102982	0.9999868869781494	O
25184	+	102 103	102982 102983	0.9999852180480957	O
25185	tumors	104 110	102984 102990	0.9999861717224121	O
25186	,	111 112	102991 102992	0.9999874830245972	O
25187	but	113 116	102993 102996	0.9999865293502808	O
25188	low	117 120	102997 103000	0.9999819993972778	O
25189	in	121 123	103001 103003	0.9999880790710449	O
25190	Smad3	124 128	103004 103008	0.9999866485595703	O
25193	-	129 130	103009 103010	0.9999867677688599	O
25194	/	130 131	103010 103011	0.9999686479568481	O
25195	-	131 132	103011 103012	0.9999865293502808	O
25196	and	133 136	103013 103016	0.9999872446060181	O
25197	Tgfb1	137 141	103017 103021	0.9999862909317017	O
25202	-	142 143	103022 103023	0.9999874830245972	O
25203	/	143 144	103023 103024	0.9999860525131226	O
25204	-	144 145	103024 103025	0.9999873638153076	O
25205	;	145 146	103025 103026	0.9999871253967285	O
25206	Rag2	147 150	103027 103030	0.999983549118042	O
25209	-	151 152	103031 103032	0.9999860525131226	O
25210	/	152 153	103032 103033	0.9999516010284424	O
25211	-	153 154	103033 103034	0.9999730587005615	O
25212	tumors	155 161	103035 103041	0.9999850988388062	O
25213	,	162 163	103042 103043	0.9999871253967285	O
25214	included	164 172	103044 103052	0.9999878406524658	O
25215	transcripts	173 183	103053 103063	0.9999876022338867	O
25217	for	185 188	103065 103068	0.9999873638153076	O
25218	contact	189 196	103069 103076	0.9999748468399048	O
25219	growth	197 203	103077 103083	0.9999860525131226	O
25220	inhibition	204 213	103084 103093	0.9999878406524658	O
25222	(	215 216	103095 103096	0.999988317489624	O
25223	Metap1	217 222	103097 103102	0.9999871253967285	O
25226	,	224 225	103104 103105	0.9999876022338867	O
25227	Pcyox1	226 231	103106 103111	0.9999872446060181	O
25231	)	233 234	103113 103114	0.999988317489624	O
25232	,	235 236	103115 103116	0.9999877214431763	O
25233	mitosis	237 243	103117 103123	0.9999860525131226	O
25235	(	245 246	103125 103126	0.9999877214431763	O
25236	Mif	247 249	103127 103129	0.9999797344207764	O
25238	,	251 252	103131 103132	0.9999876022338867	O
25239	Pik1	253 256	103133 103136	0.9999858140945435	O
25242	)	258 259	103138 103139	0.9999884366989136	O
25243	,	260 261	103140 103141	0.9999880790710449	O
25244	cell	262 266	103142 103146	0.9999858140945435	O
25245	cycle	267 272	103147 103152	0.9999866485595703	O
25246	progression	273 284	103153 103164	0.9999879598617554	O
25247	and	285 288	103165 103168	0.9999877214431763	O
25248	checkpoint	289 298	103169 103178	0.9999845027923584	O
25250	control	300 307	103180 103187	0.9999874830245972	O
25251	(	308 309	103188 103189	0.999988317489624	O
25252	Id2	310 312	103190 103192	0.999987006187439	O
25255	,	314 315	103194 103195	0.9999878406524658	O
25256	Ptp4A2	316 321	103196 103201	0.9999871253967285	O
25262	,	323 324	103203 103204	0.9999878406524658	O
25263	Tp53	325 328	103205 103208	0.9999865293502808	O
25266	)	330 331	103210 103211	0.9999884366989136	O
25267	.	332 333	103212 103213	0.9999834299087524	O
25268	*	334 335	103214 103215	0.999985933303833	O
25269	*	335 336	103215 103216	0.9999725818634033	O
25270	IGNORE	0 5	103217 103222	0.999987006187439	O
25273	LINE	7 10	103224 103227	0.9999889135360718	O
25276	*	12 13	103229 103230	0.9999891519546509	O
25277	*	13 14	103230 103231	0.9999891519546509	O
25278	*	15 16	103232 103233	0.9999890327453613	O
25279	*	16 17	103233 103234	0.9999892711639404	O
25280	IGNORE	18 23	103235 103240	0.9999880790710449	O
25283	LINE	25 28	103242 103245	0.9999892711639404	O
25286	*	30 31	103247 103248	0.9999889135360718	O
25287	*	31 32	103248 103249	0.9999889135360718	O
25288	*	33 34	103250 103251	0.9999889135360718	O
25289	*	34 35	103251 103252	0.9999889135360718	O
25290	IGNORE	36 41	103253 103258	0.9999877214431763	O
25293	LINE	43 46	103260 103263	0.9999890327453613	O
25296	*	48 49	103265 103266	0.9999890327453613	O
25297	*	49 50	103266 103267	0.9999889135360718	O
25298	Detailed	51 58	103268 103275	0.9999892711639404	O
25300	cluster	60 67	103277 103284	0.9999891519546509	O
25301	analysis	68 76	103285 103293	0.9999892711639404	O
25302	:	77 78	103294 103295	0.9999892711639404	O
25303	differential	79 91	103296 103308	0.9999884366989136	O
25304	and	92 95	103309 103312	0.9999890327453613	O
25305	statistically	96 108	103313 103325	0.9999887943267822	O
25307	significant	110 121	103327 103338	0.9999890327453613	O
25308	biological	122 132	103339 103349	0.9999821186065674	O
25309	functions	133 142	103350 103359	0.9999865293502808	O
25310	in	143 145	103360 103362	0.9999895095825195	O
25311	clusters	146 154	103363 103371	0.9999889135360718	O
25312	C11	155 157	103372 103374	0.9999891519546509	O
25314	-	158 159	103375 103376	0.9999896287918091	O
25315	C17	159 161	103376 103378	0.9999889135360718	O
25317	PS	163 165	103380 103382	0.9999890327453613	O
25318	,	166 167	103383 103384	0.9999881982803345	O
25319	ProbeSets	168 176	103385 103393	0.9999886751174927	O
25323	.	178 179	103395 103396	0.9999785423278809	O
25324	Human	0 5	103397 103402	0.933516263961792	species
25325	CRCs	6 9	103403 103406	0.9999352693557739	O
25327	exhibit	11 18	103408 103415	0.99991774559021	O
25328	gene	19 23	103416 103420	0.9999779462814331	O
25329	expression	24 34	103421 103431	0.9999717473983765	O
25330	profile	35 42	103432 103439	0.9999760389328003	O
25331	complexity	43 53	103440 103450	0.9999709129333496	O
25332	consistent	54 64	103451 103461	0.999968409538269	O
25333	with	65 69	103462 103466	0.9999679327011108	O
25334	significant	70 81	103467 103478	0.999902606010437	O
25335	tumor	82 87	103479 103484	0.9999392032623291	O
25336	subclasses	88 97	103485 103494	0.9999805688858032	O
25340	.	99 100	103496 103497	0.9995847344398499	O
25341	Genes	0 4	103498 103502	0.9999815225601196	O
25343	potentially	6 17	103504 103515	0.999985933303833	O
25344	able	18 22	103516 103520	0.9999847412109375	O
25345	to	23 25	103521 103523	0.9999861717224121	O
25346	distinguish	26 37	103524 103535	0.9999806880950928	O
25347	cancer	38 44	103536 103542	0.999968409538269	O
25348	subtypes	45 52	103543 103550	0.9999876022338867	O
25351	were	54 58	103552 103556	0.9999842643737793	O
25352	identified	59 69	103557 103567	0.9999864101409912	O
25353	from	70 74	103568 103572	0.9999878406524658	O
25354	Affymetrix	75 84	103573 103582	0.9999880790710449	O
25358	HG	86 87	103584 103585	0.9999866485595703	O
25360	-	88 89	103586 103587	0.9999886751174927	O
25361	U133	89 92	103587 103590	0.9999878406524658	O
25364	plus2	94 98	103592 103596	0.9999867677688599	O
25366	Genechip	100 107	103598 103605	0.9999868869781494	O
25369	expression	109 119	103607 103617	0.9999860525131226	O
25370	profiles	120 128	103618 103626	0.9999878406524658	O
25371	by	129 131	103627 103629	0.9999884366989136	O
25372	filtering	132 141	103630 103639	0.9999877214431763	O
25373	for	142 145	103640 103643	0.9999886751174927	O
25374	3	146 147	103644 103645	0.9999868869781494	O
25375	,	147 148	103645 103646	0.9999873638153076	O
25376	285	148 151	103646 103649	0.9999845027923584	O
25377	probe	152 157	103650 103655	0.9999827146530151	O
25378	sets	158 162	103656 103660	0.9999867677688599	O
25379	that	163 167	103661 103665	0.9999881982803345	O
25380	were	168 172	103666 103670	0.9999884366989136	O
25381	top	173 176	103671 103674	0.9999872446060181	O
25382	-	176 177	103674 103675	0.999988317489624	O
25383	ranked	177 183	103675 103681	0.9999872446060181	O
25384	by	184 186	103682 103684	0.9999879598617554	O
25385	raw	187 190	103685 103688	0.9999828338623047	O
25386	expression	191 201	103689 103699	0.9999865293502808	O
25387	and	202 205	103700 103703	0.9999871253967285	O
25388	their	206 211	103704 103709	0.9999878406524658	O
25389	differential	212 224	103710 103722	0.9999860525131226	O
25390	regulation	225 235	103723 103733	0.9999761581420898	O
25391	in	236 238	103734 103736	0.9999880790710449	O
25392	at	239 241	103737 103739	0.9999884366989136	O
25393	least	242 247	103740 103745	0.9999879598617554	O
25394	10	248 250	103746 103748	0.9999797344207764	O
25395	out	251 254	103749 103752	0.9999862909317017	O
25396	of	255 257	103753 103755	0.9999868869781494	O
25397	100	258 261	103756 103759	0.9998509883880615	O
25398	human	262 267	103760 103765	0.5951464176177979	species
25399	colorectal	268 277	103766 103775	0.9999634027481079	O
25402	cancer	279 285	103777 103783	0.9999785423278809	O
25403	tumors	286 292	103784 103790	0.9999783039093018	O
25404	.	293 294	103791 103792	0.9999287128448486	O
25405	Coordinately	0 11	103793 103804	0.9999852180480957	O
25409	regulated	13 22	103806 103815	0.9999628067016602	O
25410	transcripts	23 33	103816 103826	0.9999852180480957	O
25412	and	35 38	103828 103831	0.9999817609786987	O
25413	similarly	39 48	103832 103841	0.99997878074646	O
25414	behaving	49 56	103842 103849	0.9999842643737793	O
25416	samples	58 65	103851 103858	0.9999805688858032	O
25417	were	66 70	103859 103863	0.9999829530715942	O
25418	identified	71 81	103864 103874	0.9999842643737793	O
25419	via	82 85	103875 103878	0.9999856948852539	O
25420	hierarchical	86 97	103879 103890	0.9999874830245972	O
25424	tree	99 103	103892 103896	0.9999825954437256	O
25425	clustering	104 113	103897 103906	0.9999865293502808	O
25427	.	115 116	103908 103909	0.9999499320983887	O
25428	Seven	0 5	103910 103915	0.9999788999557495	O
25429	different	6 15	103916 103925	0.9999810457229614	O
25430	gene	16 20	103926 103930	0.9999808073043823	O
25431	clusters	21 29	103931 103939	0.9999812841415405	O
25432	(	30 31	103940 103941	0.9999864101409912	O
25433	C11	32 34	103942 103944	0.9999821186065674	O
25435	-	35 36	103945 103946	0.9999868869781494	O
25436	17	36 38	103946 103948	0.9999748468399048	O
25437	)	39 40	103949 103950	0.9999854564666748	O
25438	were	41 45	103951 103955	0.9999836683273315	O
25439	identified	46 56	103956 103966	0.9999819993972778	O
25440	that	57 61	103967 103971	0.9999843835830688	O
25441	distinguished	62 75	103972 103985	0.9999809265136719	O
25442	ten	76 79	103986 103989	0.9999732971191406	O
25443	or	80 82	103990 103992	0.9999834299087524	O
25444	more	83 87	103993 103997	0.9999816417694092	O
25445	tumors	88 94	103998 104004	0.999976634979248	O
25446	from	95 99	104005 104009	0.9999761581420898	O
25447	the	100 103	104010 104013	0.9999651908874512	O
25448	other	104 109	104014 104019	0.9999563694000244	O
25449	tumors	110 116	104020 104026	0.9999822378158569	O
25450	.	117 118	104027 104028	0.9999270439147949	O
25451	Gene	0 4	104029 104033	0.9999790191650391	O
25452	clusters	5 13	104034 104042	0.9999715089797974	O
25453	were	14 18	104043 104047	0.9999825954437256	O
25454	found	19 24	104048 104053	0.9999814033508301	O
25455	to	25 27	104054 104056	0.999984622001648	O
25456	be	28 30	104057 104059	0.9999853372573853	O
25457	highly	31 37	104060 104066	0.9999829530715942	O
25458	enriched	38 45	104067 104074	0.9999842643737793	O
25461	for	47 50	104076 104079	0.999984860420227	O
25462	gene	51 55	104080 104084	0.9999804496765137	O
25463	functions	56 65	104085 104094	0.9999738931655884	O
25464	listed	66 72	104095 104101	0.9999867677688599	O
25465	in	73 75	104102 104104	0.9999868869781494	O
25466	Table	76 81	104105 104110	0.999984860420227	O
25467	3	82 83	104111 104112	0.9999852180480957	O
25468	.	83 84	104112 104113	0.9999643564224243	O
25469	Data	0 4	104114 104118	0.9999808073043823	O
25470	were	5 9	104119 104123	0.9999858140945435	O
25471	processed	10 19	104124 104133	0.9999845027923584	O
25472	using	20 25	104134 104139	0.9999881982803345	O
25473	Robust	26 31	104140 104145	0.9999866485595703	O
25475	Microarray	33 42	104147 104156	0.9999839067459106	O
25478	Analysis	44 52	104158 104166	0.9999867677688599	O
25479	(	53 54	104167 104168	0.999988317489624	O
25480	RMA	55 57	104169 104171	0.999985933303833	O
25482	)	59 60	104173 104174	0.9999892711639404	O
25483	with	61 65	104175 104179	0.999988317489624	O
25484	expression	66 76	104180 104190	0.9999886751174927	O
25485	value	77 82	104191 104196	0.9999886751174927	O
25486	ratios	83 89	104197 104203	0.9999885559082031	O
25487	depicted	90 98	104204 104212	0.9999880790710449	O
25488	as	99 101	104213 104215	0.9999886751174927	O
25489	the	102 105	104216 104219	0.9999891519546509	O
25490	relative	106 114	104220 104228	0.9999889135360718	O
25491	expression	115 125	104229 104239	0.9999889135360718	O
25492	per	126 129	104240 104243	0.99998939037323	O
25493	probe	130 135	104244 104249	0.9999868869781494	O
25494	set	136 139	104250 104253	0.9999887943267822	O
25495	in	140 142	104254 104256	0.9999892711639404	O
25496	each	143 147	104257 104261	0.9999892711639404	O
25497	sample	148 154	104262 104268	0.9999881982803345	O
25498	relative	155 163	104269 104277	0.9999890327453613	O
25499	to	164 166	104278 104280	0.9999892711639404	O
25500	the	167 170	104281 104284	0.9999890327453613	O
25501	median	171 177	104285 104291	0.9999885559082031	O
25502	of	178 180	104292 104294	0.9999889135360718	O
25503	its	181 184	104295 104298	0.9999890327453613	O
25504	expression	185 195	104299 104309	0.9999878406524658	O
25505	across	196 202	104310 104316	0.9999866485595703	O
25506	the	203 206	104317 104320	0.9999868869781494	O
25507	100	207 210	104321 104324	0.9999573230743408	O
25508	CRCs	211 214	104325 104328	0.9999662637710571	O
25510	.	216 217	104330 104331	0.9999551773071289	O
25511	A	0 1	104332 104333	0.9999855756759644	O
25512	striking	2 10	104334 104342	0.9999840259552002	O
25513	heterogeneity	11 23	104343 104355	0.9999877214431763	O
25517	of	25 27	104357 104359	0.9999877214431763	O
25518	gene	28 32	104360 104364	0.9999872446060181	O
25519	expression	33 43	104365 104375	0.9999821186065674	O
25520	was	44 47	104376 104379	0.999985933303833	O
25521	observed	48 56	104380 104388	0.9999839067459106	O
25522	,	57 58	104389 104390	0.999987006187439	O
25523	including	59 68	104391 104400	0.9999886751174927	O
25524	metallothionein	69 83	104401 104415	0.9999817609786987	O
25529	genes	85 90	104417 104422	0.9999885559082031	O
25530	in	91 93	104423 104425	0.9999891519546509	O
25531	cluster	94 101	104426 104433	0.999988317489624	O
25532	C15	102 104	104434 104436	0.9999889135360718	O
25534	previously	106 116	104438 104448	0.9999885559082031	O
25535	shown	117 122	104449 104454	0.9999886751174927	O
25536	to	123 125	104455 104457	0.9999891519546509	O
25537	be	126 128	104458 104460	0.9999892711639404	O
25538	predictive	129 138	104461 104470	0.9999891519546509	O
25540	of	140 142	104472 104474	0.9999891519546509	O
25541	microsatellite	143 156	104475 104488	0.9999881982803345	O
25545	instability	158 169	104490 104501	0.9999889135360718	O
25546	(	170 171	104502 104503	0.9999892711639404	O
25547	indicated	172 181	104504 104513	0.9999891519546509	O
25548	by	182 184	104514 104516	0.9999891519546509	O
25549	asterisk	185 192	104517 104524	0.9999892711639404	O
25552	)	194 195	104526 104527	0.99998939037323	O
25553	,	196 197	104528 104529	0.9999884366989136	O
25554	and	198 201	104530 104533	0.9999887943267822	O
25555	C17	202 204	104534 104536	0.9999885559082031	O
25557	represented	206 217	104538 104549	0.9999889135360718	O
25558	by	218 220	104550 104552	0.9999892711639404	O
25559	734	221 223	104553 104555	0.9999885559082031	O
25561	probesets	225 233	104557 104565	0.9999878406524658	O
25563	rich	235 239	104567 104571	0.9999880790710449	O
25564	in	240 242	104572 104574	0.9999886751174927	O
25565	genes	243 248	104575 104580	0.9999868869781494	O
25566	associated	249 259	104581 104591	0.9999886751174927	O
25567	with	260 264	104592 104596	0.9999886751174927	O
25568	extracellular	265 277	104597 104609	0.9999864101409912	O
25570	matrix	279 285	104611 104617	0.9999867677688599	O
25571	and	286 289	104618 104621	0.9999866485595703	O
25572	connective	290 299	104622 104631	0.99997878074646	O
25574	tissue	301 307	104633 104639	0.9999860525131226	O
25575	,	308 309	104640 104641	0.9999856948852539	O
25576	tumor	310 315	104642 104647	0.9999823570251465	O
25577	invasion	316 324	104648 104656	0.9999831914901733	O
25578	and	325 328	104657 104660	0.9999860525131226	O
25579	malignancy	329 338	104661 104670	0.9999842643737793	O
25583	.	340 341	104672 104673	0.9999456405639648	O
25584	Tissue	0 5	104674 104679	0.9999608993530273	O
25587	groups	7 13	104681 104687	0.999977707862854	O
25588	:	14 15	104688 104689	0.9999806880950928	O
25589	AC	16 18	104690 104692	0.999969482421875	O
25590	,	19 20	104693 104694	0.9999854564666748	O
25591	adult	21 26	104695 104700	0.9998121857643127	O
25592	colon	27 31	104701 104705	0.9999774694442749	O
25594	;	33 34	104707 104708	0.9999821186065674	O
25595	CRC	35 37	104709 104711	0.9999803304672241	O
25597	,	39 40	104713 104714	0.9999845027923584	O
25598	human	41 46	104715 104720	0.9483644366264343	species
25599	CRC	47 49	104721 104723	0.9999796152114868	O
25601	.	50 51	104724 104725	0.9999459981918335	O
25602	Staging	0 6	104726 104732	0.9999816417694092	O
25604	:	8 9	104734 104735	0.9999831914901733	O
25605	nAC	10 12	104736 104738	0.9999823570251465	O
25607	,	14 15	104740 104741	0.9999854564666748	O
25608	normal	16 22	104742 104748	0.9998984336853027	O
25609	colon	23 27	104749 104753	0.9999791383743286	O
25611	;	29 30	104755 104756	0.9999853372573853	O
25612	Dukes	31 36	104757 104762	0.9999772310256958	O
25613	A	37 38	104763 104764	0.9999855756759644	O
25614	-	38 39	104764 104765	0.9999867677688599	O
25615	D	39 40	104765 104766	0.9999840259552002	O
25616	,	41 42	104767 104768	0.9999849796295166	O
25617	human	43 48	104769 104774	0.9495121240615845	species
25618	tumors	49 55	104775 104781	0.9999719858169556	O
25619	obtained	56 64	104782 104790	0.9999719858169556	O
25620	from	65 69	104791 104795	0.999974250793457	O
25621	individuals	70 81	104796 104807	0.9988873600959778	O
25622	.	82 83	104808 104809	0.9999490976333618	O
25623	Clusters	0 7	104810 104817	0.999988317489624	O
25626	C11	9 11	104819 104821	0.9999889135360718	O
25628	-	12 13	104822 104823	0.99998939037323	O
25629	C17	13 15	104823 104825	0.9999886751174927	O
25631	labeled	17 24	104827 104834	0.9999873638153076	O
25632	to	25 27	104835 104837	0.9999895095825195	O
25633	the	28 31	104838 104841	0.99998939037323	O
25634	right	32 37	104842 104847	0.9999879598617554	O
25635	of	38 40	104848 104850	0.9999891519546509	O
25636	the	41 44	104851 104854	0.9999895095825195	O
25637	heatmap	45 51	104855 104861	0.999988317489624	O
25640	correspond	53 63	104863 104873	0.9999890327453613	O
25641	to	64 66	104874 104876	0.9999895095825195	O
25642	the	67 70	104877 104880	0.9999895095825195	O
25643	K	71 72	104881 104882	0.9999878406524658	O
25644	-	72 73	104882 104883	0.9999896287918091	O
25645	means	73 78	104883 104888	0.9999886751174927	O
25646	functional	79 89	104889 104899	0.9999880790710449	O
25647	clusters	90 98	104900 104908	0.99998939037323	O
25648	listed	99 105	104909 104915	0.9999892711639404	O
25649	in	106 108	104916 104918	0.9999890327453613	O
25650	Table	109 114	104919 104924	0.999988317489624	O
25651	3	115 116	104925 104926	0.9999886751174927	O
25652	.	116 117	104926 104927	0.999983549118042	O
25653	To	0 2	104928 104930	0.9999819993972778	O
25654	evaluate	3 11	104931 104939	0.99997878074646	O
25655	if	12 14	104940 104942	0.9999818801879883	O
25656	similar	15 22	104943 104950	0.9999556541442871	O
25657	sets	23 27	104951 104955	0.999981164932251	O
25658	of	28 30	104956 104958	0.9999852180480957	O
25659	genes	31 36	104959 104964	0.9999768733978271	O
25660	are	37 40	104965 104968	0.9999841451644897	O
25661	systematically	41 55	104969 104983	0.9999792575836182	O
25662	activated	56 65	104984 104993	0.9999712705612183	O
25663	or	66 68	104994 104996	0.999983549118042	O
25664	repressed	69 77	104997 105005	0.9999818801879883	O
25666	in	79 81	105007 105009	0.9999823570251465	O
25667	human	82 87	105010 105015	0.9679586291313171	species
25668	CRC	88 90	105016 105018	0.9999723434448242	O
25670	,	92 93	105020 105021	0.9999794960021973	O
25671	as	94 96	105022 105024	0.9999737739562988	O
25672	in	97 99	105025 105027	0.9999756813049316	O
25673	the	100 103	105028 105031	0.9994378685951233	O
25674	mouse	104 109	105032 105037	0.9778433442115784	species
25675	colon	110 114	105038 105042	0.9999583959579468	O
25677	tumors	116 122	105044 105050	0.9999710321426392	O
25678	,	123 124	105051 105052	0.9999845027923584	O
25679	we	125 127	105053 105055	0.9999833106994629	O
25680	undertook	128 137	105056 105065	0.9999845027923584	O
25681	two	138 141	105066 105069	0.9999829530715942	O
25682	procedures	142 152	105070 105080	0.9999833106994629	O
25683	to	153 155	105081 105083	0.999985933303833	O
25684	align	156 160	105084 105088	0.9999855756759644	O
25686	the	162 165	105090 105093	0.9999865293502808	O
25687	data	166 170	105094 105098	0.9999743700027466	O
25688	.	171 172	105099 105100	0.9999638795852661	O
25689	First	0 5	105101 105106	0.9999843835830688	O
25690	,	6 7	105107 105108	0.9999862909317017	O
25691	gene	8 12	105109 105113	0.9999819993972778	O
25692	expression	13 23	105114 105124	0.9999713897705078	O
25693	values	24 30	105125 105131	0.9999790191650391	O
25694	for	31 34	105132 105135	0.9999784231185913	O
25695	the	35 38	105136 105139	0.9989011287689209	O
25696	mouse	39 44	105140 105145	0.9750105738639832	species
25697	and	45 48	105146 105149	0.9998935461044312	O
25698	human	49 54	105150 105155	0.9746081233024597	species
25699	tumors	55 61	105156 105162	0.9999607801437378	O
25700	were	62 66	105163 105167	0.9999865293502808	O
25701	separately	67 77	105168 105178	0.9999841451644897	O
25702	normalized	78 87	105179 105188	0.9999849796295166	O
25704	and	89 92	105190 105193	0.9999858140945435	O
25705	referenced	93 103	105194 105204	0.9999792575836182	O
25706	relative	104 112	105205 105213	0.9999868869781494	O
25707	to	113 115	105214 105216	0.9999874830245972	O
25708	their	116 121	105217 105222	0.9999843835830688	O
25709	respective	122 132	105223 105233	0.9999810457229614	O
25710	normal	133 139	105234 105240	0.99997878074646	O
25711	adult	140 145	105241 105246	0.9998917579650879	O
25712	colon	146 150	105247 105251	0.9999775886535645	O
25714	controls	152 160	105253 105261	0.9999591112136841	O
25715	;	161 162	105262 105263	0.9999877214431763	O
25716	second	163 169	105264 105270	0.9999860525131226	O
25717	,	170 171	105271 105272	0.9999877214431763	O
25718	mouse	172 177	105273 105278	0.9987649917602539	O
25719	and	178 181	105279 105282	0.9999865293502808	O
25720	human	182 187	105283 105288	0.7395291924476624	O
25721	gene	188 192	105289 105293	0.9999876022338867	O
25722	identifiers	193 203	105294 105304	0.9999884366989136	O
25726	were	205 209	105306 105310	0.9999880790710449	O
25727	reduced	210 217	105311 105318	0.9999853372573853	O
25728	to	218 220	105319 105321	0.9999881982803345	O
25729	a	221 222	105322 105323	0.9999884366989136	O
25730	single	223 229	105324 105330	0.9999862909317017	O
25731	ortholog	230 237	105331 105338	0.999988317489624	O
25735	gene	239 243	105340 105344	0.9999879598617554	O
25736	identifier	244 253	105345 105354	0.9999885559082031	O
25739	.	255 256	105356 105357	0.9999698400497437	O
25740	The	0 3	105358 105361	0.9999877214431763	O
25741	latter	4 10	105362 105368	0.999984622001648	O
25742	is	11 13	105369 105371	0.9999879598617554	O
25743	a	14 15	105372 105373	0.9999885559082031	O
25744	somewhat	16 24	105374 105382	0.9999841451644897	O
25745	complex	25 32	105383 105390	0.9999864101409912	O
25746	procedure	33 42	105391 105400	0.999987006187439	O
25747	that	43 47	105401 105405	0.999988317489624	O
25748	requires	48 56	105406 105414	0.9999872446060181	O
25749	identifying	57 68	105415 105426	0.9999881982803345	O
25750	microarray	69 78	105427 105436	0.9999881982803345	O
25753	probes	80 85	105438 105443	0.999988317489624	O
25755	from	87 91	105445 105449	0.9999889135360718	O
25756	each	92 96	105450 105454	0.9999892711639404	O
25757	platform	97 105	105455 105463	0.9999854564666748	O
25758	that	106 110	105464 105468	0.9999892711639404	O
25759	can	111 114	105469 105472	0.9999886751174927	O
25760	be	115 117	105473 105475	0.9999891519546509	O
25761	mapped	118 124	105476 105482	0.9999884366989136	O
25762	to	125 127	105483 105485	0.9999892711639404	O
25763	a	128 129	105486 105487	0.99998939037323	O
25764	single	130 136	105488 105494	0.9999889135360718	O
25765	gene	137 141	105495 105499	0.999988317489624	O
25766	ortholog	142 149	105500 105507	0.99998939037323	O
25770	and	151 154	105509 105512	0.9999881982803345	O
25771	undertaking	155 166	105513 105524	0.9999872446060181	O
25772	a	167 168	105525 105526	0.9999891519546509	O
25773	procedure	169 178	105527 105536	0.9999884366989136	O
25774	to	179 181	105537 105539	0.9999890327453613	O
25775	aggregate	182 191	105540 105549	0.9999873638153076	O
25776	redundant	192 201	105550 105559	0.9999871253967285	O
25777	probes	202 207	105560 105565	0.9999874830245972	O
25779	within	209 215	105567 105573	0.9999878406524658	O
25780	a	216 217	105574 105575	0.99998939037323	O
25781	platform	218 226	105576 105584	0.9999873638153076	O
25782	(	227 228	105585 105586	0.9999890327453613	O
25783	see	229 232	105587 105590	0.999984622001648	O
25784	Materials	233 242	105591 105600	0.9999847412109375	O
25785	and	243 246	105601 105604	0.9999879598617554	O
25786	methods	247 254	105605 105612	0.9999865293502808	O
25787	)	255 256	105613 105614	0.99998939037323	O
25788	.	257 258	105615 105616	0.999972939491272	O
25789	This	0 4	105617 105621	0.9999793767929077	O
25790	approach	5 13	105622 105630	0.9998935461044312	O
25791	allowed	14 21	105631 105638	0.9999810457229614	O
25792	the	22 25	105639 105642	0.999984860420227	O
25793	identification	26 40	105643 105657	0.9999854564666748	O
25794	of	41 43	105658 105660	0.9999872446060181	O
25795	8	44 45	105661 105662	0.9999867677688599	O
25796	,	45 46	105662 105663	0.9999866485595703	O
25797	621	46 48	105663 105665	0.9999842643737793	O
25799	gene	50 54	105667 105671	0.9999831914901733	O
25800	transcripts	55 65	105672 105682	0.9999876022338867	O
25802	on	67 69	105684 105686	0.9999876022338867	O
25803	the	70 73	105687 105690	0.999988317489624	O
25804	HG	74 75	105691 105692	0.9999860525131226	O
25806	-	76 77	105693 105694	0.9999890327453613	O
25807	U133	77 80	105694 105697	0.999988317489624	O
25810	plus2	82 86	105699 105703	0.9999861717224121	O
25812	and	88 91	105705 105708	0.9999872446060181	O
25813	Vanderbilt	92 102	105709 105719	0.9999711513519287	O
25814	NIA	103 105	105720 105722	0.9999871253967285	O
25816	20	107 109	105724 105726	0.9999877214431763	O
25817	K	110 111	105727 105728	0.9999864101409912	O
25818	cDNA	112 115	105729 105732	0.9999886751174927	O
25821	arrays	117 122	105734 105739	0.9999874830245972	O
25823	for	124 127	105741 105744	0.999987006187439	O
25824	which	128 133	105745 105750	0.9999881982803345	O
25825	relative	134 142	105751 105759	0.9999872446060181	O
25826	expression	143 153	105760 105770	0.9999841451644897	O
25827	values	154 160	105771 105777	0.9999866485595703	O
25828	could	161 166	105778 105783	0.9999865293502808	O
25829	be	167 169	105784 105786	0.9999880790710449	O
25830	mapped	170 176	105787 105793	0.9999830722808838	O
25831	for	177 180	105794 105797	0.9999866485595703	O
25832	nearly	181 187	105798 105804	0.9999852180480957	O
25833	all	188 191	105805 105808	0.9999865293502808	O
25834	mouse	192 197	105809 105814	0.5259116888046265	O
25835	and	198 201	105815 105818	0.9999663829803467	O
25836	human	202 207	105819 105824	0.8777004480361938	species
25837	samples	208 215	105825 105832	0.9999830722808838	O
25838	.	216 217	105833 105834	0.999943733215332	O
25839	A	0 1	105835 105836	0.9999816417694092	O
25840	clustering	2 11	105837 105846	0.9999836683273315	O
25842	-	12 13	105847 105848	0.9999864101409912	O
25843	based	13 18	105848 105853	0.9999840259552002	O
25844	assessment	19 29	105854 105864	0.9999785423278809	O
25845	of	30 32	105865 105867	0.9999854564666748	O
25846	expression	33 43	105868 105878	0.9999749660491943	O
25847	across	44 50	105879 105885	0.9999865293502808	O
25848	the	51 54	105886 105889	0.9999873638153076	O
25849	whole	55 60	105890 105895	0.9999858140945435	O
25850	mouse	61 66	105896 105901	0.9996744394302368	O
25851	-	66 67	105901 105902	0.9999879598617554	O
25852	human	67 72	105902 105907	0.9994679093360901	O
25853	ortholog	73 80	105908 105915	0.9999879598617554	O
25857	gene	82 86	105917 105921	0.9999873638153076	O
25858	set	87 90	105922 105925	0.9999862909317017	O
25859	identified	91 101	105926 105936	0.9999828338623047	O
25860	a	102 103	105937 105938	0.9999867677688599	O
25861	large	104 109	105939 105944	0.9999836683273315	O
25862	number	110 116	105945 105951	0.9999858140945435	O
25863	of	117 119	105952 105954	0.9999866485595703	O
25864	transcripts	120 130	105955 105965	0.9999829530715942	O
25866	behaving	132 139	105967 105974	0.9999862909317017	O
25868	similarly	141 150	105976 105985	0.9999805688858032	O
25869	across	151 157	105986 105992	0.9999698400497437	O
25870	colon	158 162	105993 105997	0.9999643564224243	O
25872	tumors	164 170	105999 106005	0.9999765157699585	O
25873	,	171 172	106006 106007	0.9999794960021973	O
25874	many	173 177	106008 106012	0.9999722242355347	O
25875	irrespective	178 189	106013 106024	0.9999861717224121	O
25878	,	191 192	106026 106027	0.9999805688858032	O
25879	but	193 196	106028 106031	0.9999735355377197	O
25880	some	197 201	106032 106036	0.9999825954437256	O
25881	respective	202 212	106037 106047	0.9987982511520386	O
25882	of	213 215	106048 106050	0.9999756813049316	O
25883	species	216 223	106051 106058	0.9937244057655334	O
25884	.	224 225	106059 106060	0.9999203681945801	O
25885	Notably	0 6	106061 106067	0.9999817609786987	O
25887	,	8 9	106069 106070	0.9999856948852539	O
25888	the	10 13	106071 106074	0.9999852180480957	O
25889	great	14 19	106075 106080	0.9999830722808838	O
25890	majority	20 28	106081 106089	0.9999845027923584	O
25891	of	29 31	106090 106092	0.9999862909317017	O
25892	genes	32 37	106093 106098	0.9999752044677734	O
25893	over	38 42	106099 106103	0.999987006187439	O
25894	-	42 43	106103 106104	0.9999876022338867	O
25895	expressed	43 52	106104 106113	0.9999853372573853	O
25896	in	53 55	106114 106116	0.9999860525131226	O
25897	all	56 59	106117 106120	0.9999736547470093	O
25898	tumors	60 66	106121 106127	0.999974250793457	O
25899	were	67 71	106128 106132	0.9999853372573853	O
25900	also	72 76	106133 106137	0.9999837875366211	O
25901	over	77 81	106138 106142	0.9999876022338867	O
25902	-	81 82	106142 106143	0.9999877214431763	O
25903	expressed	82 91	106143 106152	0.9999864101409912	O
25904	during	92 98	106153 106159	0.9999858140945435	O
25905	colon	99 103	106160 106164	0.9999792575836182	O
25907	development	105 116	106166 106177	0.9999750852584839	O
25908	(	117 118	106178 106179	0.9999880790710449	O
25909	Figure	119 125	106180 106186	0.9999818801879883	O
25910	6a	126 127	106187 106188	0.9999862909317017	O
25912	)	129 130	106190 106191	0.999988317489624	O
25913	.	131 132	106192 106193	0.9999703168869019	O
25914	To	0 2	106194 106196	0.9999868869781494	O
25915	evaluate	3 11	106197 106205	0.9999865293502808	O
25916	the	12 15	106206 106209	0.9999890327453613	O
25917	statistical	16 27	106210 106221	0.9999874830245972	O
25918	significance	28 40	106222 106234	0.9999881982803345	O
25919	of	41 43	106235 106237	0.9999885559082031	O
25920	this	44 48	106238 106242	0.9999886751174927	O
25921	pattern	49 56	106243 106250	0.9999833106994629	O
25922	,	57 58	106251 106252	0.9999880790710449	O
25923	we	59 61	106253 106255	0.9999850988388062	O
25924	used	62 66	106256 106260	0.9999877214431763	O
25925	a	67 68	106261 106262	0.9999892711639404	O
25926	Venn	69 72	106263 106266	0.9999891519546509	O
25929	overlap	74 81	106268 106275	0.9999886751174927	O
25930	filtering	82 91	106276 106285	0.999988317489624	O
25931	strategy	92 100	106286 106294	0.9999886751174927	O
25932	and	101 104	106295 106298	0.9999886751174927	O
25933	Fisher	105 111	106299 106305	0.999987006187439	O
25934	'	112 113	106306 106307	0.99998939037323	O
25935	s	113 114	106307 106308	0.99998939037323	O
25936	exact	115 120	106309 106314	0.9999877214431763	O
25937	test	121 125	106315 106319	0.9999884366989136	O
25938	analysis	126 134	106320 106328	0.9999895095825195	O
25939	.	135 136	106329 106330	0.9999735355377197	O
25940	Approximately	0 13	106331 106344	0.9999834299087524	O
25941	50	14 16	106345 106347	0.9999692440032959	O
25942	%	17 18	106348 106349	0.9999841451644897	O
25943	of	19 21	106350 106352	0.9999860525131226	O
25944	the	22 25	106353 106356	0.9999855756759644	O
25945	2	26 27	106357 106358	0.9999809265136719	O
25946	,	27 28	106358 106359	0.999984860420227	O
25947	212	28 31	106359 106362	0.9999685287475586	O
25948	ortholog	32 39	106363 106370	0.9999853372573853	O
25952	genes	41 46	106372 106377	0.9999778270721436	O
25953	over	47 51	106378 106382	0.999987006187439	O
25954	-	51 52	106382 106383	0.9999878406524658	O
25955	expressed	52 61	106383 106392	0.9999854564666748	O
25956	in	62 64	106393 106395	0.9999872446060181	O
25957	at	65 67	106396 106398	0.9999879598617554	O
25958	least	68 73	106399 106404	0.9999867677688599	O
25959	10	74 76	106405 106407	0.9999808073043823	O
25960	%	77 78	106408 106409	0.9999830722808838	O
25961	of	79 81	106410 106412	0.9999815225601196	O
25962	the	82 85	106413 106416	0.999940037727356	O
25963	human	86 91	106417 106422	0.9204677939414978	species
25964	cancers	92 98	106423 106429	0.9999783039093018	O
25966	relative	100 108	106431 106439	0.999982476234436	O
25967	to	109 111	106440 106442	0.9999855756759644	O
25968	adult	112 117	106443 106448	0.9997773766517639	O
25969	colon	118 122	106449 106453	0.9999836683273315	O
25971	were	124 128	106455 106459	0.9999831914901733	O
25972	also	129 133	106460 106464	0.9999823570251465	O
25973	over	134 138	106465 106469	0.9999872446060181	O
25974	-	138 139	106469 106470	0.9999877214431763	O
25975	expressed	139 148	106470 106479	0.999984622001648	O
25976	in	149 151	106480 106482	0.9999864101409912	O
25977	developing	152 162	106483 106493	0.9994063377380371	O
25978	colon	163 167	106494 106498	0.9999785423278809	O
25980	.	169 170	106500 106501	0.9999419450759888	O
25981	If	0 2	106502 106504	0.9999819993972778	O
25982	there	3 8	106505 106510	0.9999884366989136	O
25983	was	9 12	106511 106514	0.9999884366989136	O
25984	not	13 16	106515 106518	0.9999864101409912	O
25985	a	17 18	106519 106520	0.9999884366989136	O
25986	selection	19 28	106521 106530	0.999984622001648	O
25987	for	29 32	106531 106534	0.9999885559082031	O
25988	developmental	33 46	106535 106548	0.9999707937240601	O
25989	genes	47 52	106549 106554	0.9999871253967285	O
25990	among	53 58	106555 106560	0.9999876022338867	O
25991	those	59 64	106561 106566	0.9999877214431763	O
25992	over	65 69	106567 106571	0.9999878406524658	O
25993	-	69 70	106571 106572	0.9999887943267822	O
25994	expressed	70 79	106572 106581	0.9999860525131226	O
25995	in	80 82	106582 106584	0.9999861717224121	O
25996	tumors	83 89	106585 106591	0.9999799728393555	O
25997	,	90 91	106592 106593	0.9999879598617554	O
25998	the	92 95	106594 106597	0.9999890327453613	O
25999	expected	96 104	106598 106606	0.999987006187439	O
26000	overlap	105 112	106607 106614	0.9999873638153076	O
26001	would	113 118	106615 106620	0.999988317489624	O
26002	be	119 121	106621 106623	0.9999895095825195	O
26003	(	122 123	106624 106625	0.9999895095825195	O
26004	2	124 125	106626 106627	0.9999887943267822	O
26005	,	125 126	106627 106628	0.9999890327453613	O
26006	718	126 128	106628 106630	0.99998939037323	O
26008	/	129 130	106631 106632	0.9999890327453613	O
26009	8	130 131	106632 106633	0.999988317489624	O
26010	,	132 133	106634 106635	0.9999886751174927	O
26011	621	133 135	106635 106637	0.9999878406524658	O
26013	)	137 138	106639 106640	0.9999895095825195	O
26014	×	139 140	106641 106642	0.9999864101409912	O
26015	2	141 142	106643 106644	0.9999885559082031	O
26016	,	142 143	106644 106645	0.9999889135360718	O
26017	212	143 146	106645 106648	0.9999874830245972	O
26018	=	147 148	106649 106650	0.9999876022338867	O
26019	697	149 151	106651 106653	0.9999884366989136	O
26021	transcripts	153 163	106655 106665	0.9999887943267822	O
26023	.	165 166	106667 106668	0.9999756813049316	O
26024	Using	0 5	106669 106674	0.9999874830245972	O
26025	Fisher	6 12	106675 106681	0.999985933303833	O
26026	'	13 14	106682 106683	0.9999889135360718	O
26027	s	14 15	106683 106684	0.9999890327453613	O
26028	exact	16 21	106685 106690	0.9999868869781494	O
26029	test	22 26	106691 106695	0.999988317489624	O
26030	for	27 30	106696 106699	0.9999880790710449	O
26031	the	31 34	106700 106703	0.9999892711639404	O
26032	significance	35 47	106704 106716	0.9999886751174927	O
26033	of	48 50	106717 106719	0.9999889135360718	O
26034	the	51 54	106720 106723	0.9999891519546509	O
26035	increased	55 64	106724 106733	0.9999880790710449	O
26036	overlap	65 72	106734 106741	0.9999884366989136	O
26037	of	73 75	106742 106744	0.9999892711639404	O
26038	1	76 77	106745 106746	0.99998939037323	O
26039	,	77 78	106746 106747	0.99998939037323	O
26040	080	78 80	106747 106749	0.9999890327453613	O
26042	versus	82 88	106751 106757	0.9999887943267822	O
26043	697	89 91	106758 106760	0.9999872446060181	O
26045	transcripts	93 103	106762 106772	0.9999885559082031	O
26047	is	105 107	106774 106776	0.9999890327453613	O
26048	p	108 109	106777 106778	0.9999895095825195	O
26049	<	110 111	106779 106780	0.9999892711639404	O
26050	1e	112 113	106781 106782	0.9999892711639404	O
26052	-	114 115	106783 106784	0.9999892711639404	O
26053	300	115 118	106784 106787	0.9999887943267822	O
26054	.	119 120	106788 106789	0.99997878074646	O
26055	Similarly	0 9	106790 106799	0.9999839067459106	O
26056	,	10 11	106800 106801	0.9999876022338867	O
26057	genes	12 17	106802 106807	0.9999810457229614	O
26058	under	18 23	106808 106813	0.9999833106994629	O
26059	-	23 24	106813 106814	0.9999877214431763	O
26060	expressed	24 33	106814 106823	0.9999834299087524	O
26061	in	34 36	106824 106826	0.999987006187439	O
26062	mouse	37 42	106827 106832	0.5027928352355957	O
26063	colon	43 47	106833 106837	0.9999791383743286	O
26065	development	49 60	106839 106850	0.9999535083770752	O
26066	and	61 64	106851 106854	0.9999808073043823	O
26067	human	65 70	106855 106860	0.9726956486701965	species
26068	CRCs	71 74	106861 106864	0.9999666213989258	O
26070	also	76 80	106866 106870	0.9999862909317017	O
26071	strongly	81 89	106871 106879	0.9999861717224121	O
26072	overlapped	90 99	106880 106889	0.9999880790710449	O
26074	(	101 102	106891 106892	0.9999885559082031	O
26075	Figure	103 109	106893 106899	0.9999837875366211	O
26076	6b	110 111	106900 106901	0.9999874830245972	O
26078	;	113 114	106903 106904	0.9999886751174927	O
26079	431	115 117	106905 106907	0.9999877214431763	O
26081	of	119 121	106909 106911	0.9999885559082031	O
26082	737	122 125	106912 106915	0.9999873638153076	O
26083	,	126 127	106916 106917	0.9999881982803345	O
26084	p	128 129	106918 106919	0.9999887943267822	O
26085	<	130 131	106920 106921	0.999988317489624	O
26086	1e	132 133	106922 106923	0.9999885559082031	O
26088	-	134 135	106924 106925	0.9999887943267822	O
26089	76	135 137	106925 106927	0.9999874830245972	O
26090	)	138 139	106928 106929	0.9999889135360718	O
26091	.	140 141	106930 106931	0.9999707937240601	O
26092	This	0 4	106932 106936	0.9999866485595703	O
26093	result	5 11	106937 106943	0.9999830722808838	O
26094	is	12 14	106944 106946	0.9999864101409912	O
26095	significantly	15 28	106947 106960	0.9999865293502808	O
26096	greater	29 36	106961 106968	0.9999854564666748	O
26097	than	37 41	106969 106973	0.9999876022338867	O
26098	the	42 45	106974 106977	0.9999874830245972	O
26099	8	46 47	106978 106979	0.9999865293502808	O
26100	-	47 48	106979 106980	0.9999877214431763	O
26101	19	48 50	106980 106982	0.9999815225601196	O
26102	%	51 52	106983 106984	0.9999876022338867	O
26103	of	53 55	106985 106987	0.9999874830245972	O
26104	genes	56 61	106988 106993	0.9999818801879883	O
26105	that	62 66	106994 106998	0.999988317489624	O
26106	were	67 71	106999 107003	0.9999880790710449	O
26107	estimated	72 81	107004 107013	0.999985933303833	O
26108	to	82 84	107014 107016	0.9999874830245972	O
26109	be	85 87	107017 107019	0.9999878406524658	O
26110	over	88 92	107020 107024	0.9999864101409912	O
26111	-	92 93	107024 107025	0.9999878406524658	O
26112	expressed	93 102	107025 107034	0.9999822378158569	O
26113	in	103 105	107035 107037	0.9999772310256958	O
26114	human	106 111	107038 107043	0.9377610087394714	species
26115	colon	112 116	107044 107048	0.9999760389328003	O
26117	tumors	118 124	107050 107056	0.999983549118042	O
26118	and	125 128	107057 107060	0.9999867677688599	O
26119	fetal	129 133	107061 107065	0.9999723434448242	O
26121	gut	135 138	107067 107070	0.9999793767929077	O
26122	morphogenesis	139 151	107071 107083	0.9999881982803345	O
26127	based	153 158	107085 107090	0.9999880790710449	O
26128	upon	159 163	107091 107095	0.9999876022338867	O
26129	a	164 165	107096 107097	0.9999880790710449	O
26130	computational	166 179	107098 107111	0.9999662637710571	O
26131	extrapolation	180 192	107112 107124	0.9999877214431763	O
26134	of	194 196	107126 107128	0.9999878406524658	O
26135	SAGE	197 200	107129 107132	0.9999849796295166	O
26137	data	202 206	107134 107138	0.9999854564666748	O
26138	[	207 208	107139 107140	0.9999885559082031	O
26139	27	208 210	107140 107142	0.9999854564666748	O
26140	]	210 211	107142 107143	0.9999877214431763	O
26141	.	212 213	107144 107145	0.9999750852584839	O
26142	Thus	0 4	107146 107150	0.9999833106994629	O
26143	,	5 6	107151 107152	0.9999858140945435	O
26144	our	7 10	107153 107156	0.999976396560669	O
26145	findings	11 19	107157 107165	0.9999769926071167	O
26146	not	20 23	107166 107169	0.9999865293502808	O
26147	only	24 28	107170 107174	0.9999855756759644	O
26148	confirm	29 36	107175 107182	0.9999840259552002	O
26149	but	37 40	107183 107186	0.9999818801879883	O
26150	also	41 45	107187 107191	0.9999855756759644	O
26151	significantly	46 59	107192 107205	0.9999849796295166	O
26152	expand	60 66	107206 107212	0.9999812841415405	O
26153	and	67 70	107213 107216	0.9999845027923584	O
26154	experimentally	71 84	107217 107230	0.9999053478240967	O
26156	validate	86 93	107232 107239	0.9999816417694092	O
26158	the	95 98	107241 107244	0.9999861717224121	O
26159	previously	99 109	107245 107255	0.999980092048645	O
26160	suggested	110 119	107256 107265	0.9999788999557495	O
26161	recapitulation	120 133	107266 107279	0.9999861717224121	O
26165	of	135 137	107281 107283	0.9999864101409912	O
26166	embryonic	138 146	107284 107292	0.999985933303833	O
26170	signatures	148 158	107294 107304	0.9999845027923584	O
26171	by	159 161	107305 107307	0.999984860420227	O
26172	human	162 167	107308 107313	0.9207313060760498	species
26173	CRCs	168 171	107314 107317	0.9999781847000122	O
26175	.	173 174	107319 107320	0.9999873638153076	O
26176	*	175 176	107321 107322	0.9999850988388062	O
26177	*	176 177	107322 107323	0.9999699592590332	O
26178	IGNORE	0 5	107324 107329	0.9999856948852539	O
26181	LINE	7 10	107331 107334	0.9999886751174927	O
26184	*	12 13	107336 107337	0.9999889135360718	O
26185	*	13 14	107337 107338	0.9999889135360718	O
26186	*	15 16	107339 107340	0.9999889135360718	O
26187	*	16 17	107340 107341	0.9999890327453613	O
26188	IGNORE	18 23	107342 107347	0.9999877214431763	O
26191	LINE	25 28	107349 107352	0.9999890327453613	O
26194	*	30 31	107354 107355	0.9999887943267822	O
26195	*	31 32	107355 107356	0.9999887943267822	O
26196	*	33 34	107357 107358	0.9999887943267822	O
26197	*	34 35	107358 107359	0.9999887943267822	O
26198	IGNORE	36 41	107360 107365	0.9999873638153076	O
26201	LINE	43 46	107367 107370	0.9999887943267822	O
26204	*	48 49	107372 107373	0.9999889135360718	O
26205	*	49 50	107373 107374	0.9999889135360718	O
26206	All	51 54	107375 107378	0.9999878406524658	O
26207	overlaps	55 62	107379 107386	0.9999867677688599	O
26209	between	64 71	107388 107395	0.9999876022338867	O
26210	tumor	72 77	107396 107401	0.9999837875366211	O
26211	expression	78 88	107402 107412	0.9999856948852539	O
26212	and	89 92	107413 107416	0.9999880790710449	O
26213	development	93 104	107417 107428	0.9999767541885376	O
26214	were	105 109	107429 107433	0.9999885559082031	O
26215	pooled	110 115	107434 107439	0.9999876022338867	O
26217	to	117 119	107441 107443	0.9999891519546509	O
26218	form	120 124	107444 107448	0.9999892711639404	O
26219	a	125 126	107449 107450	0.99998939037323	O
26220	set	127 130	107451 107454	0.9999886751174927	O
26221	of	131 133	107455 107457	0.9999890327453613	O
26222	2	134 135	107458 107459	0.999987006187439	O
26223	,	135 136	107459 107460	0.9999876022338867	O
26224	116	136 139	107460 107463	0.9999825954437256	O
26225	ortholog	140 147	107464 107471	0.9999887943267822	O
26229	gene	149 153	107473 107477	0.9999877214431763	O
26230	transcripts	154 164	107478 107488	0.9999887943267822	O
26232	.	166 167	107490 107491	0.9999610185623169	O
26233	This	0 4	107492 107496	0.9999872446060181	O
26234	was	5 8	107497 107500	0.9999878406524658	O
26235	subjected	9 18	107501 107510	0.999984860420227	O
26236	to	19 21	107511 107513	0.9999891519546509	O
26237	hierarchical	22 33	107514 107525	0.9999891519546509	O
26241	tree	35 39	107527 107531	0.9999862909317017	O
26242	and	40 43	107532 107535	0.9999880790710449	O
26243	K	44 45	107536 107537	0.9999861717224121	O
26244	-	45 46	107537 107538	0.99998939037323	O
26245	means	46 51	107538 107543	0.9999876022338867	O
26246	clustering	52 61	107544 107553	0.9999885559082031	O
26248	to	63 65	107555 107557	0.99998939037323	O
26249	define	66 72	107558 107564	0.9999887943267822	O
26250	six	73 76	107565 107568	0.9999879598617554	O
26251	expression	77 87	107569 107579	0.999985933303833	O
26252	clusters	88 96	107580 107588	0.99998939037323	O
26253	,	97 98	107589 107590	0.9999885559082031	O
26254	C18	99 101	107591 107593	0.9999892711639404	O
26256	-	102 103	107594 107595	0.9999897480010986	O
26257	C23	103 105	107595 107597	0.9999892711639404	O
26259	(	107 108	107599 107600	0.9999897480010986	O
26260	Figure	109 115	107601 107607	0.9999873638153076	O
26261	6c	116 117	107608 107609	0.9999892711639404	O
26263	;	119 120	107611 107612	0.9999892711639404	O
26264	Table	121 126	107613 107618	0.9999878406524658	O
26265	4	127 128	107619 107620	0.9999886751174927	O
26266	)	128 129	107620 107621	0.9999896287918091	O
26267	.	130 131	107622 107623	0.9999797344207764	O
26268	These	0 5	107624 107629	0.9999831914901733	O
26269	clusters	6 14	107630 107638	0.9999711513519287	O
26270	provide	15 22	107639 107646	0.9999816417694092	O
26271	an	23 25	107647 107649	0.9999845027923584	O
26272	impressive	26 36	107650 107660	0.9999678134918213	O
26273	partitioning	37 48	107661 107672	0.9999804496765137	O
26275	of	50 52	107674 107676	0.9999850988388062	O
26276	groups	53 59	107677 107683	0.9999809265136719	O
26277	of	60 62	107684 107686	0.9999854564666748	O
26278	genes	63 68	107687 107692	0.9999823570251465	O
26279	associated	69 79	107693 107703	0.999987006187439	O
26280	with	80 84	107704 107708	0.9999867677688599	O
26281	different	85 94	107709 107718	0.9999814033508301	O
26282	biological	95 105	107719 107729	0.9999765157699585	O
26283	functions	106 115	107730 107739	0.9999816417694092	O
26284	critical	116 124	107740 107748	0.9999841451644897	O
26285	for	125 128	107749 107752	0.9999853372573853	O
26286	colon	129 133	107753 107757	0.9999791383743286	O
26288	development	135 146	107759 107770	0.9999821186065674	O
26289	,	147 148	107771 107772	0.999983549118042	O
26290	maturation	149 158	107773 107782	0.9999796152114868	O
26292	and	160 163	107784 107787	0.9999843835830688	O
26293	oncogenesis	164 174	107788 107798	0.9999839067459106	O
26296	.	176 177	107800 107801	0.9999183416366577	O
26297	Cluster	0 6	107802 107808	0.9999871253967285	O
26299	C22	8 10	107810 107812	0.9999864101409912	O
26301	(	12 13	107814 107815	0.999988317489624	O
26302	860	13 15	107815 107817	0.9999865293502808	O
26304	transcripts	17 27	107819 107829	0.9999866485595703	O
26306	of	29 31	107831 107833	0.9999868869781494	O
26307	genes	32 37	107834 107839	0.9999862909317017	O
26308	strongly	38 46	107840 107848	0.9999865293502808	O
26309	expressed	47 56	107849 107858	0.9999854564666748	O
26310	both	57 61	107859 107863	0.9999878406524658	O
26311	developmentally	62 76	107864 107878	0.9999761581420898	O
26313	and	78 81	107880 107883	0.9999867677688599	O
26314	across	82 88	107884 107890	0.9999798536300659	O
26315	all	89 92	107891 107894	0.9999803304672241	O
26316	tumors	93 99	107895 107901	0.9999786615371704	O
26317	)	100 101	107902 107903	0.9999873638153076	O
26318	is	102 104	107904 107906	0.999987006187439	O
26319	highly	105 111	107907 107913	0.9999876022338867	O
26320	enriched	112 119	107914 107921	0.9999879598617554	O
26323	with	121 125	107923 107927	0.9999879598617554	O
26324	genes	126 131	107928 107933	0.9999860525131226	O
26325	associated	132 142	107934 107944	0.9999877214431763	O
26326	with	143 147	107945 107949	0.9999878406524658	O
26327	cell	148 152	107950 107954	0.9999862909317017	O
26328	cycle	153 158	107955 107960	0.9999855756759644	O
26329	progression	159 170	107961 107972	0.9999871253967285	O
26330	,	171 172	107973 107974	0.9999873638153076	O
26331	replication	173 184	107975 107986	0.9999767541885376	O
26332	,	185 186	107987 107988	0.9999868869781494	O
26333	cancer	187 193	107989 107995	0.999963641166687	O
26334	,	194 195	107996 107997	0.9999854564666748	O
26335	tumor	196 201	107998 108003	0.9999783039093018	O
26336	morphology	202 212	108004 108014	0.999981164932251	O
26337	and	213 216	108015 108018	0.9999866485595703	O
26338	cellular	217 225	108019 108027	0.9999783039093018	O
26339	movement	226 234	108028 108036	0.9999769926071167	O
26340	.	235 236	108037 108038	0.9999536275863647	O
26341	Cluster	0 6	108039 108045	0.999984860420227	O
26343	C18	8 10	108047 108049	0.999984622001648	O
26345	(	12 13	108051 108052	0.9999861717224121	O
26346	258	14 17	108053 108056	0.9999711513519287	O
26347	transcripts	18 28	108057 108067	0.9999775886535645	O
26349	down	30 34	108069 108073	0.9999673366546631	O
26350	-	34 35	108073 108074	0.9999840259552002	O
26351	regulated	35 44	108074 108083	0.9999632835388184	O
26352	in	45 47	108084 108086	0.9999544620513916	O
26353	mouse	48 53	108087 108092	0.9727626442909241	species
26354	and	54 57	108093 108096	0.999790370464325	O
26355	human	58 63	108097 108102	0.9746270179748535	species
26356	tumors	64 70	108103 108109	0.9999701976776123	O
26357	,	71 72	108110 108111	0.9999752044677734	O
26358	as	73 75	108112 108114	0.9999806880950928	O
26359	well	76 80	108115 108119	0.9999839067459106	O
26360	as	81 83	108120 108122	0.999984622001648	O
26361	in	84 86	108123 108125	0.9999808073043823	O
26362	development	87 98	108126 108137	0.9996806383132935	O
26363	)	99 100	108138 108139	0.9999842643737793	O
26364	is	101 103	108140 108142	0.9999845027923584	O
26365	highly	104 110	108143 108149	0.9999852180480957	O
26366	enriched	111 118	108150 108157	0.9999856948852539	O
26369	in	120 122	108159 108161	0.9999855756759644	O
26370	genes	123 128	108162 108167	0.999975323677063	O
26371	associated	129 139	108168 108178	0.9999861717224121	O
26372	with	140 144	108179 108183	0.9999860525131226	O
26373	digestive	145 153	108184 108192	0.9999808073043823	O
26375	tract	155 160	108194 108199	0.9999817609786987	O
26376	function	161 169	108200 108208	0.9999802112579346	O
26377	,	170 171	108209 108210	0.9999840259552002	O
26378	biochemical	172 182	108211 108221	0.9999758005142212	O
26380	and	184 187	108223 108226	0.9999833106994629	O
26381	lipid	188 192	108227 108231	0.9999744892120361	O
26383	metabolism	194 204	108233 108243	0.9999814033508301	O
26384	.	205 206	108244 108245	0.9999407529830933	O
26385	This	0 4	108246 108250	0.9999814033508301	O
26386	cluster	5 12	108251 108258	0.9999616146087646	O
26387	is	13 15	108259 108261	0.9999815225601196	O
26388	clearly	16 23	108262 108269	0.9999691247940063	O
26389	composed	24 32	108270 108278	0.9999822378158569	O
26390	of	33 35	108279 108281	0.9999827146530151	O
26391	genes	36 41	108282 108287	0.9999659061431885	O
26392	associated	42 52	108288 108298	0.9999802112579346	O
26393	with	53 57	108299 108303	0.9999809265136719	O
26394	the	58 61	108304 108307	0.9999797344207764	O
26395	mature	62 68	108308 108314	0.999941349029541	O
26396	GI	69 70	108315 108316	0.9999536275863647	O
26398	tract	72 77	108318 108323	0.9999686479568481	O
26399	.	78 79	108324 108325	0.9998695850372314	O
26400	Thus	0 4	108326 108330	0.9999504089355469	O
26401	,	5 6	108331 108332	0.9999814033508301	O
26402	as	7 9	108333 108335	0.9999818801879883	O
26403	opposed	10 17	108336 108343	0.9999730587005615	O
26404	to	18 20	108344 108346	0.9999816417694092	O
26405	recapitulating	21 34	108347 108360	0.9999836683273315	O
26409	developmental	36 49	108362 108375	0.9999752044677734	O
26410	gene	50 54	108376 108380	0.9999840259552002	O
26411	activation	55 65	108381 108391	0.9999756813049316	O
26412	,	66 67	108392 108393	0.9999797344207764	O
26413	the	68 71	108394 108397	0.9999827146530151	O
26414	cluster	72 79	108398 108405	0.9999819993972778	O
26415	C18	80 82	108406 108408	0.9999855756759644	O
26417	pattern	84 91	108410 108417	0.9999791383743286	O
26418	indicates	92 101	108418 108427	0.9999743700027466	O
26419	a	102 103	108428 108429	0.999983549118042	O
26420	corresponding	104 117	108430 108443	0.9999589920043945	O
26421	arrest	118 124	108444 108450	0.9999425411224365	O
26422	of	125 127	108451 108453	0.999982476234436	O
26423	differentiation	128 143	108454 108469	0.9999479055404663	O
26424	in	144 146	108470 108472	0.9999351501464844	O
26425	both	147 151	108473 108477	0.9997647404670715	O
26426	mouse	152 157	108478 108483	0.9797900915145874	species
26427	and	158 161	108484 108487	0.9996086955070496	O
26428	human	162 167	108488 108493	0.9774423837661743	species
26429	tumors	168 174	108494 108500	0.9999661445617676	O
26430	.	175 176	108501 108502	0.9998231530189514	O
26431	Cluster	0 6	108503 108509	0.999984622001648	O
26433	C23	8 10	108511 108513	0.9999850988388062	O
26435	(	12 13	108515 108516	0.9999864101409912	O
26436	142	14 17	108517 108520	0.9999754428863525	O
26437	transcripts	18 28	108521 108531	0.9999827146530151	O
26439	over	30 34	108533 108537	0.9999843835830688	O
26440	-	34 35	108537 108538	0.9999861717224121	O
26441	expressed	35 44	108538 108547	0.9999799728393555	O
26442	in	45 47	108548 108550	0.9999849796295166	O
26443	all	48 51	108551 108554	0.9999791383743286	O
26444	mouse	52 57	108555 108560	0.9335598945617676	species
26445	models	58 64	108561 108567	0.9994683861732483	O
26446	and	65 68	108568 108571	0.9999531507492065	O
26447	human	69 74	108572 108577	0.9775803089141846	species
26448	CRC	75 77	108578 108580	0.9999649524688721	O
26450	,	79 80	108582 108583	0.9999837875366211	O
26451	but	81 84	108584 108587	0.9999817609786987	O
26452	with	85 89	108588 108592	0.9999843835830688	O
26453	low	90 93	108593 108596	0.9999816417694092	O
26454	expression	94 104	108597 108607	0.999982476234436	O
26455	in	105 107	108608 108610	0.999984622001648	O
26456	development	108 119	108611 108622	0.9999440908432007	O
26457	)	120 121	108623 108624	0.9999861717224121	O
26458	maps	122 126	108625 108629	0.9999806880950928	O
26459	to	127 129	108630 108632	0.9999866485595703	O
26460	genes	130 135	108633 108638	0.9999821186065674	O
26461	highly	136 142	108639 108645	0.9999864101409912	O
26462	associated	143 153	108646 108656	0.9999877214431763	O
26463	with	154 158	108657 108661	0.9999871253967285	O
26464	the	159 162	108662 108665	0.9999847412109375	O
26465	disruption	163 173	108666 108676	0.9999752044677734	O
26466	of	174 176	108677 108679	0.9999856948852539	O
26467	basement	177 185	108680 108688	0.9999717473983765	O
26468	membranes	186 194	108689 108697	0.9999784231185913	O
26470	,	196 197	108699 108700	0.9999825954437256	O
26471	invasion	198 206	108701 108709	0.999970555305481	O
26472	and	207 210	108710 108713	0.9999847412109375	O
26473	cell	211 215	108714 108718	0.999976634979248	O
26474	cycle	216 221	108719 108724	0.9999788999557495	O
26475	progression	222 233	108725 108736	0.9999840259552002	O
26476	,	234 235	108737 108738	0.9999850988388062	O
26477	as	236 238	108739 108741	0.9999860525131226	O
26478	well	239 243	108742 108746	0.9999873638153076	O
26479	as	244 246	108747 108749	0.9999873638153076	O
26480	altered	247 254	108750 108757	0.9999816417694092	O
26481	transcriptional	255 269	108758 108772	0.9999810457229614	O
26483	control	271 278	108774 108781	0.9999819993972778	O
26484	.	279 280	108782 108783	0.9999352693557739	O
26485	Cluster	0 6	108784 108790	0.9999872446060181	O
26487	C21	8 10	108792 108794	0.9999872446060181	O
26489	(	12 13	108796 108797	0.9999879598617554	O
26490	313	14 17	108798 108801	0.9999806880950928	O
26491	transcripts	18 28	108802 108812	0.9999855756759644	O
26493	in	30 32	108814 108816	0.9999856948852539	O
26494	which	33 38	108817 108822	0.9999847412109375	O
26495	human	39 44	108823 108828	0.9654433727264404	species
26496	tumors	45 51	108829 108835	0.9999808073043823	O
26497	somewhat	52 60	108836 108844	0.9999825954437256	O
26498	variably	61 68	108845 108852	0.9999866485595703	O
26500	express	70 77	108854 108861	0.9999865293502808	O
26501	a	78 79	108862 108863	0.9999881982803345	O
26502	set	80 83	108864 108867	0.9999876022338867	O
26503	of	84 86	108868 108870	0.9999881982803345	O
26504	genes	87 92	108871 108876	0.9999842643737793	O
26505	that	93 97	108877 108881	0.9999873638153076	O
26506	are	98 101	108882 108885	0.9999872446060181	O
26507	rarely	102 108	108886 108892	0.9999760389328003	O
26508	expressed	109 118	108893 108902	0.9999836683273315	O
26509	by	119 121	108903 108905	0.9999823570251465	O
26510	the	122 125	108906 108909	0.9999274015426636	O
26511	mouse	126 131	108910 108915	0.9762281179428101	species
26512	tumors	132 138	108916 108922	0.9999817609786987	O
26513	)	139 140	108923 108924	0.9999841451644897	O
26514	is	141 143	108925 108927	0.9999874830245972	O
26515	remarkable	144 154	108928 108938	0.999985933303833	O
26516	for	155 158	108939 108942	0.9999880790710449	O
26517	its	159 162	108943 108946	0.9999885559082031	O
26518	composition	163 174	108947 108958	0.9999861717224121	O
26519	of	175 177	108959 108961	0.9999879598617554	O
26520	genes	178 183	108962 108967	0.9999862909317017	O
26521	associated	184 194	108968 108978	0.9999877214431763	O
26522	with	195 199	108979 108983	0.9999873638153076	O
26523	cell	200 204	108984 108988	0.9999810457229614	O
26524	cycle	205 210	108989 108994	0.999974250793457	O
26525	proliferation	211 224	108995 109008	0.9999852180480957	O
26526	,	225 226	109009 109010	0.9999845027923584	O
26527	tissue	227 233	109011 109017	0.9999634027481079	O
26528	disruption	234 244	109018 109028	0.9999754428863525	O
26529	and	245 248	109029 109032	0.9999850988388062	O
26530	angiogenesis	249 260	109033 109044	0.9999834299087524	O
26533	.	262 263	109046 109047	0.9999433755874634	O
26534	Thus	0 4	109048 109052	0.9999843835830688	O
26535	,	5 6	109053 109054	0.999988317489624	O
26536	while	7 12	109055 109060	0.9999865293502808	O
26537	categorically	13 25	109061 109073	0.999987006187439	O
26541	quite	27 32	109075 109080	0.9999840259552002	O
26542	similar	33 40	109081 109088	0.9999872446060181	O
26543	to	41 43	109089 109091	0.9999878406524658	O
26544	cluster	44 51	109092 109099	0.9999879598617554	O
26545	C23	52 54	109100 109102	0.9999879598617554	O
26547	,	56 57	109104 109105	0.9999866485595703	O
26548	the	58 61	109106 109109	0.9999879598617554	O
26549	genes	62 67	109110 109115	0.9999858140945435	O
26550	in	68 70	109116 109118	0.9999887943267822	O
26551	cluster	71 78	109119 109126	0.9999884366989136	O
26552	C21	79 81	109127 109129	0.999988317489624	O
26554	represent	83 92	109131 109140	0.9999861717224121	O
26555	a	93 94	109141 109142	0.9999884366989136	O
26556	separately	95 105	109143 109153	0.9999817609786987	O
26557	regulated	106 115	109154 109163	0.9999682903289795	O
26558	module	116 122	109164 109170	0.9999786615371704	O
26559	that	123 127	109171 109175	0.9999878406524658	O
26560	is	128 130	109176 109178	0.9999878406524658	O
26561	enriched	131 138	109179 109186	0.9999876022338867	O
26564	for	140 143	109188 109191	0.9999876022338867	O
26565	genes	144 149	109192 109197	0.9999855756759644	O
26566	associated	150 160	109198 109208	0.9999880790710449	O
26567	with	161 165	109209 109213	0.9999879598617554	O
26568	invasion	166 174	109214 109222	0.9999804496765137	O
26569	.	175 176	109223 109224	0.9999566078186035	O
26570	Clusters	0 7	109225 109232	0.999984860420227	O
26573	C21	9 11	109234 109236	0.9999860525131226	O
26575	and	13 16	109238 109241	0.999984860420227	O
26576	C23	17 19	109242 109244	0.9999858140945435	O
26578	reveal	21 27	109246 109252	0.9999734163284302	O
26579	sets	28 32	109253 109257	0.9999781847000122	O
26580	of	33 35	109258 109260	0.999984622001648	O
26581	genes	36 41	109261 109266	0.9999786615371704	O
26582	likely	42 48	109267 109273	0.9999791383743286	O
26583	involved	49 57	109274 109282	0.9999806880950928	O
26584	in	58 60	109283 109285	0.9999830722808838	O
26585	tumor	61 66	109286 109291	0.9999746084213257	O
26586	progression	67 78	109292 109303	0.9999793767929077	O
26587	.	79 80	109304 109305	0.9998488426208496	O
26588	Cluster	0 6	109306 109312	0.9999862909317017	O
26590	C22	8 10	109314 109316	0.9999852180480957	O
26592	(	12 13	109318 109319	0.9999874830245972	O
26593	with	14 18	109320 109324	0.9999852180480957	O
26594	genes	19 24	109325 109330	0.9999831914901733	O
26595	over	25 29	109331 109335	0.999984860420227	O
26596	-	29 30	109335 109336	0.9999866485595703	O
26597	expressed	30 39	109336 109345	0.999981164932251	O
26598	in	40 42	109346 109348	0.9999836683273315	O
26599	all	43 46	109349 109352	0.9999682903289795	O
26600	mouse	47 52	109353 109358	0.9774945378303528	species
26601	and	53 56	109359 109362	0.9999209642410278	O
26602	human	57 62	109363 109368	0.9770199060440063	species
26603	tumors	63 69	109369 109375	0.9999781847000122	O
26604	and	70 73	109376 109379	0.9999842643737793	O
26605	strongly	74 82	109380 109388	0.9999823570251465	O
26606	expressed	83 92	109389 109398	0.9999845027923584	O
26607	in	93 95	109399 109401	0.9999876022338867	O
26608	embryonic	96 104	109402 109410	0.9999862909317017	O
26612	colon	106 110	109412 109416	0.9999867677688599	O
26614	)	112 113	109418 109419	0.9999866485595703	O
26615	represents	114 124	109420 109430	0.9999833106994629	O
26616	a	125 126	109431 109432	0.999987006187439	O
26617	group	127 132	109433 109438	0.9999868869781494	O
26618	of	133 135	109439 109441	0.9999877214431763	O
26619	genes	136 141	109442 109447	0.9999847412109375	O
26620	highly	142 148	109448 109454	0.9999862909317017	O
26621	correlated	149 159	109455 109465	0.9999858140945435	O
26622	with	160 164	109466 109470	0.999984860420227	O
26623	transformation	165 179	109471 109485	0.9999638795852661	O
26624	.	180 181	109486 109487	0.9999551773071289	O
26625	The	0 3	109488 109491	0.9999871253967285	O
26626	top	4 7	109492 109495	0.9999873638153076	O
26627	-	7 8	109495 109496	0.999988317489624	O
26628	ranked	8 14	109496 109502	0.9999831914901733	O
26629	transcription	15 28	109503 109516	0.9999736547470093	O
26630	factor	29 35	109517 109523	0.999982476234436	O
26631	present	36 43	109524 109531	0.9999878406524658	O
26632	in	44 46	109532 109534	0.9999881982803345	O
26633	this	47 51	109535 109539	0.9999887943267822	O
26634	cluster	52 59	109540 109547	0.9999830722808838	O
26635	,	60 61	109548 109549	0.9999871253967285	O
26636	with	62 66	109550 109554	0.9999849796295166	O
26637	regulation	67 77	109555 109565	0.9999790191650391	O
26638	independent	78 89	109566 109577	0.9999840259552002	O
26639	of	90 92	109578 109580	0.9999884366989136	O
26640	β	93 94	109581 109582	0.9999876022338867	O
26641	-	94 95	109582 109583	0.9999886751174927	O
26642	catenin	95 101	109583 109589	0.9999874830245972	O
26645	localization	103 114	109591 109602	0.9999880790710449	O
26647	,	116 117	109604 109605	0.9999856948852539	O
26648	is	118 120	109606 109608	0.9999862909317017	O
26649	Myc	121 123	109609 109611	0.9999821186065674	O
26651	/	124 125	109612 109613	0.9999879598617554	O
26652	MYC	125 127	109613 109615	0.9999862909317017	O
26655	(	129 130	109617 109618	0.9999892711639404	O
26656	Figure	131 137	109619 109625	0.9999858140945435	O
26657	7b	138 139	109626 109627	0.9999877214431763	O
26659	)	141 142	109629 109630	0.9999892711639404	O
26660	.	143 144	109631 109632	0.9999699592590332	O
26661	Although	0 8	109633 109641	0.9999618530273438	O
26662	Myc	9 11	109642 109644	0.9999427795410156	O
26664	was	13 16	109646 109649	0.9999715089797974	O
26665	lower	17 22	109650 109655	0.9997572302818298	O
26666	in	23 25	109656 109658	0.9999569654464722	O
26667	expression	26 36	109659 109669	0.9999213218688965	O
26668	in	37 39	109670 109672	0.9999724626541138	O
26669	the	40 43	109673 109676	0.9998748302459717	O
26670	Smad3	44 48	109677 109681	0.9999582767486572	O
26673	-	49 50	109682 109683	0.9993815422058105	O
26674	/	50 51	109683 109684	0.9931116104125977	O
26675	-	51 52	109684 109685	0.9952514171600342	O
26676	tumors	53 59	109686 109692	0.9998916387557983	O
26677	compared	60 68	109693 109701	0.9998903274536133	O
26678	to	69 71	109702 109704	0.9997668862342834	O
26679	tumors	72 78	109705 109711	0.9999619722366333	O
26680	from	79 83	109712 109716	0.9999145269393921	O
26681	the	84 87	109717 109720	0.9999638795852661	O
26682	other	88 93	109721 109726	0.999909520149231	O
26683	three	94 99	109727 109732	0.9996057152748108	O
26684	models	100 106	109733 109739	0.9993570446968079	O
26685	,	107 108	109740 109741	0.9999642372131348	O
26686	it	109 111	109742 109744	0.9999809265136719	O
26687	was	112 115	109745 109748	0.9999804496765137	O
26688	elevated	116 124	109749 109757	0.9999498128890991	O
26689	in	125 127	109758 109760	0.999982476234436	O
26690	all	128 131	109761 109764	0.9999829530715942	O
26691	four	132 136	109765 109769	0.9998855590820312	O
26692	models	137 143	109770 109776	0.9999223947525024	O
26693	relative	144 152	109777 109785	0.9999728202819824	O
26694	to	153 155	109786 109788	0.9999803304672241	O
26695	normal	156 162	109789 109795	0.9998552799224854	O
26696	adult	163 168	109796 109801	0.9889143109321594	O
26697	colon	169 173	109802 109806	0.9999457597732544	O
26699	.	175 176	109808 109809	0.9998817443847656	O
26700	Myc	0 2	109810 109812	0.9999608993530273	O
26702	/	3 4	109813 109814	0.999975323677063	O
26703	MYC	4 6	109814 109816	0.9999699592590332	O
26706	was	8 11	109818 109821	0.99994957447052	O
26707	over	12 16	109822 109826	0.9999634027481079	O
26708	-	16 17	109826 109827	0.9999759197235107	O
26709	expressed	17 26	109827 109836	0.9999549388885498	O
26710	in	27 29	109837 109839	0.9999412298202515	O
26711	all	30 33	109840 109843	0.9998251795768738	O
26712	mouse	34 39	109844 109849	0.9799888134002686	species
26713	and	40 43	109850 109853	0.9996222257614136	O
26714	human	44 49	109854 109859	0.9775251746177673	species
26715	tumors	50 56	109860 109866	0.9999700784683228	O
26716	as	57 59	109867 109869	0.9999651908874512	O
26717	well	60 64	109870 109874	0.999966025352478	O
26718	as	65 67	109875 109877	0.9999611377716064	O
26719	in	68 70	109878 109880	0.9999651908874512	O
26720	development	71 82	109881 109892	0.9976673722267151	O
26721	.	83 84	109893 109894	0.9998490810394287	O
26722	This	0 4	109895 109899	0.999980092048645	O
26723	contrasts	5 14	109900 109909	0.9999749660491943	O
26724	with	15 19	109910 109914	0.9999845027923584	O
26725	Sox4	20 23	109915 109918	0.9999771118164062	O
26727	,	25 26	109920 109921	0.999985933303833	O
26728	which	27 32	109922 109927	0.9999865293502808	O
26729	is	33 35	109928 109930	0.9999847412109375	O
26730	unaltered	36 44	109931 109939	0.9999827146530151	O
26732	in	46 48	109941 109943	0.9999821186065674	O
26733	expression	49 59	109944 109954	0.9999738931655884	O
26734	in	60 62	109955 109957	0.9999830722808838	O
26735	the	63 66	109958 109961	0.9998492002487183	O
26736	Smad3	67 71	109962 109966	0.9999818801879883	O
26739	-	72 73	109967 109968	0.9999654293060303	O
26740	/	73 74	109968 109969	0.9995349645614624	O
26741	-	74 75	109969 109970	0.9999479055404663	O
26742	and	76 79	109971 109974	0.9999829530715942	O
26743	Tgfb1	80 84	109975 109979	0.9999828338623047	O
26748	-	85 86	109980 109981	0.9999856948852539	O
26749	/	86 87	109981 109982	0.9999709129333496	O
26750	-	87 88	109982 109983	0.9999854564666748	O
26751	;	88 89	109983 109984	0.9999827146530151	O
26752	Rag2	90 93	109985 109988	0.9999774694442749	O
26755	-	94 95	109989 109990	0.9999814033508301	O
26756	/	95 96	109990 109991	0.9992130994796753	O
26757	-	96 97	109991 109992	0.9998774528503418	O
26758	tumors	98 104	109993 109999	0.9999748468399048	O
26759	but	105 108	110000 110003	0.9999771118164062	O
26760	is	109 111	110004 110006	0.999983549118042	O
26761	up	112 114	110007 110009	0.99997878074646	O
26762	-	114 115	110009 110010	0.9999860525131226	O
26763	regulated	115 124	110010 110019	0.9999806880950928	O
26764	in	125 127	110020 110022	0.999984622001648	O
26765	AOM	128 130	110023 110025	0.9999809265136719	O
26767	and	132 135	110027 110030	0.9999847412109375	O
26768	ApcMin	136 141	110031 110036	0.999985933303833	O
26773	/	142 143	110037 110038	0.9999781847000122	O
26774	+	143 144	110038 110039	0.9999401569366455	O
26775	tumors	145 151	110040 110046	0.9999804496765137	O
26776	relative	152 160	110047 110055	0.9999743700027466	O
26777	to	161 163	110056 110058	0.999982476234436	O
26778	normal	164 170	110059 110065	0.999962329864502	O
26779	adult	171 176	110066 110071	0.9998952150344849	O
26780	colon	177 181	110072 110076	0.9999761581420898	O
26782	(	183 184	110078 110079	0.9999877214431763	O
26783	Figure	185 191	110080 110086	0.9999817609786987	O
26784	7b	192 193	110087 110088	0.9999853372573853	O
26786	)	195 196	110090 110091	0.9999881982803345	O
26787	.	197 198	110092 110093	0.9999527931213379	O
26788	Myc	0 2	110094 110096	0.9999738931655884	O
26790	/	3 4	110097 110098	0.9999839067459106	O
26791	MYC	4 6	110098 110100	0.9999792575836182	O
26794	over	8 12	110102 110106	0.9999852180480957	O
26795	-	12 13	110106 110107	0.9999865293502808	O
26796	expression	13 23	110107 110117	0.9999842643737793	O
26797	may	24 27	110118 110121	0.9999723434448242	O
26798	be	28 30	110122 110124	0.9999818801879883	O
26799	independent	31 42	110125 110136	0.9999741315841675	O
26800	of	43 45	110137 110139	0.9999840259552002	O
26801	nuclear	46 53	110140 110147	0.9999780654907227	O
26802	β	54 55	110148 110149	0.9999852180480957	O
26803	-	55 56	110149 110150	0.9999872446060181	O
26804	catenin	56 62	110150 110156	0.9999849796295166	O
26807	status	64 70	110158 110164	0.9999866485595703	O
26808	.	71 72	110165 110166	0.9998495578765869	O
26809	Increased	0 8	110167 110175	0.9999830722808838	O
26811	Myc	10 12	110177 110179	0.9999804496765137	O
26813	/	13 14	110180 110181	0.9999874830245972	O
26814	MYC	14 16	110181 110183	0.9999842643737793	O
26817	expression	18 28	110185 110195	0.9999839067459106	O
26818	may	29 32	110196 110199	0.9999831914901733	O
26819	reflect	33 40	110200 110207	0.9999841451644897	O
26820	both	41 45	110208 110212	0.9999822378158569	O
26821	activation	46 56	110213 110223	0.9999788999557495	O
26822	of	57 59	110224 110226	0.9999873638153076	O
26823	canonical	60 69	110227 110236	0.9999585151672363	O
26824	Wnt	70 72	110237 110239	0.9999775886535645	O
26826	signaling	74 83	110241 110250	0.9999865293502808	O
26827	,	84 85	110251 110252	0.9999876022338867	O
26828	as	86 88	110253 110255	0.9999872446060181	O
26829	it	89 91	110256 110258	0.9999877214431763	O
26830	is	92 94	110259 110261	0.9999878406524658	O
26831	a	95 96	110262 110263	0.9999879598617554	O
26832	target	97 103	110264 110270	0.9999852180480957	O
26833	of	104 106	110271 110273	0.9999880790710449	O
26834	nuclear	107 114	110274 110281	0.9999827146530151	O
26835	β	115 116	110282 110283	0.999987006187439	O
26836	-	116 117	110283 110284	0.999988317489624	O
26837	catenin	117 123	110284 110290	0.9999868869781494	O
26840	/	124 125	110291 110292	0.9999878406524658	O
26841	TCF	125 127	110292 110294	0.9999868869781494	O
26843	[	129 130	110296 110297	0.9999885559082031	O
26844	28	130 132	110297 110299	0.9999872446060181	O
26845	]	132 133	110299 110300	0.9999884366989136	O
26846	,	134 135	110301 110302	0.9999861717224121	O
26847	and	136 139	110303 110306	0.9999874830245972	O
26848	deregulation	140 151	110307 110318	0.9999861717224121	O
26851	of	153 155	110320 110322	0.9999876022338867	O
26852	TGFβ	156 159	110323 110326	0.9999874830245972	O
26856	signaling	161 170	110328 110337	0.9999865293502808	O
26857	,	171 172	110338 110339	0.9999878406524658	O
26858	as	173 175	110340 110342	0.9999874830245972	O
26859	TGFβ1	176 180	110343 110347	0.9999877214431763	O
26864	is	182 184	110349 110351	0.999988317489624	O
26865	known	185 190	110352 110357	0.9999860525131226	O
26866	to	191 193	110358 110360	0.9999879598617554	O
26867	repress	194 200	110361 110367	0.9999856948852539	O
26869	Myc	202 204	110369 110371	0.9999834299087524	O
26871	/	205 206	110372 110373	0.9999877214431763	O
26872	MYC	206 208	110373 110375	0.9999856948852539	O
26875	[	210 211	110377 110378	0.9999885559082031	O
26876	29	211 213	110378 110380	0.9999872446060181	O
26877	-	213 214	110380 110381	0.9999884366989136	O
26878	31	214 216	110381 110383	0.9999867677688599	O
26879	]	216 217	110383 110384	0.9999884366989136	O
26880	.	218 219	110385 110386	0.999966025352478	O
26881	These	0 5	110387 110392	0.9999814033508301	O
26882	observations	6 18	110393 110405	0.9999682903289795	O
26883	suggest	19 26	110406 110413	0.9999752044677734	O
26884	a	27 28	110414 110415	0.9999850988388062	O
26885	fundamental	29 40	110416 110427	0.9999637603759766	O
26886	role	41 45	110428 110432	0.9999790191650391	O
26887	for	46 49	110433 110436	0.9999809265136719	O
26888	Myc	50 52	110437 110439	0.9999676942825317	O
26890	/	53 54	110440 110441	0.999983549118042	O
26891	MYC	54 56	110441 110443	0.9999785423278809	O
26894	in	58 60	110445 110447	0.9999769926071167	O
26895	colonic	61 67	110448 110454	0.9999632835388184	O
26898	neoplasia	69 77	110456 110464	0.9999821186065674	O
26901	.	79 80	110466 110467	0.9999852180480957	O
26902	*	81 82	110468 110469	0.9999829530715942	O
26903	*	82 83	110469 110470	0.9999728202819824	O
26904	IGNORE	0 5	110471 110476	0.9999868869781494	O
26907	LINE	7 10	110478 110481	0.9999891519546509	O
26910	*	12 13	110483 110484	0.9999891519546509	O
26911	*	13 14	110484 110485	0.9999891519546509	O
26912	*	15 16	110486 110487	0.9999891519546509	O
26913	*	16 17	110487 110488	0.99998939037323	O
26914	IGNORE	18 23	110489 110494	0.999988317489624	O
26917	LINE	25 28	110496 110499	0.99998939037323	O
26920	*	30 31	110501 110502	0.9999890327453613	O
26921	*	31 32	110502 110503	0.9999890327453613	O
26922	*	33 34	110504 110505	0.9999889135360718	O
26923	*	34 35	110505 110506	0.9999889135360718	O
26924	IGNORE	36 41	110507 110512	0.9999880790710449	O
26927	LINE	43 46	110514 110517	0.9999892711639404	O
26930	*	48 49	110519 110520	0.9999890327453613	O
26931	*	49 50	110520 110521	0.9999890327453613	O
26932	As	51 53	110522 110524	0.9999889135360718	O
26933	shown	54 59	110525 110530	0.9999885559082031	O
26934	in	60 62	110531 110533	0.9999892711639404	O
26935	Figure	63 69	110534 110540	0.9999884366989136	O
26936	2a	70 71	110541 110542	0.9999886751174927	O
26938	,	73 74	110544 110545	0.9999892711639404	O
26939	the	75 78	110546 110549	0.9999892711639404	O
26940	microarray	79 88	110550 110559	0.999988317489624	O
26943	patterns	90 98	110561 110569	0.9999891519546509	O
26944	of	99 101	110570 110572	0.9999892711639404	O
26945	gene	102 106	110573 110577	0.999988317489624	O
26946	expression	107 117	110578 110588	0.9999876022338867	O
26947	for	118 121	110589 110592	0.99998939037323	O
26948	AOM	122 124	110593 110595	0.9999876022338867	O
26950	and	126 129	110597 110600	0.999988317489624	O
26951	ApcMin	130 135	110601 110606	0.9999887943267822	O
26956	/	136 137	110607 110608	0.9999877214431763	O
26957	+	137 138	110608 110609	0.9999862909317017	O
26958	tumors	139 145	110610 110616	0.9999868869781494	O
26959	are	146 149	110617 110620	0.9999892711639404	O
26960	mirror	150 156	110621 110627	0.9999868869781494	O
26961	images	157 163	110628 110634	0.9999884366989136	O
26962	of	164 166	110635 110637	0.9999889135360718	O
26963	those	167 172	110638 110643	0.9999887943267822	O
26964	for	173 176	110644 110647	0.9999889135360718	O
26965	Tgfb1	177 181	110648 110652	0.9999879598617554	O
26970	-	182 183	110653 110654	0.9999890327453613	O
26971	/	183 184	110654 110655	0.999988317489624	O
26972	-	184 185	110655 110656	0.9999889135360718	O
26973	;	185 186	110656 110657	0.9999847412109375	O
26974	Rag2	187 190	110658 110661	0.9999821186065674	O
26977	-	191 192	110662 110663	0.999988317489624	O
26978	/	192 193	110663 110664	0.9999704360961914	O
26979	-	193 194	110664 110665	0.9999877214431763	O
26980	tumors	195 201	110666 110672	0.9999853372573853	O
26981	.	202 203	110673 110674	0.9999692440032959	O
26982	It	0 2	110675 110677	0.999985933303833	O
26983	is	3 5	110678 110680	0.9999862909317017	O
26984	perhaps	6 13	110681 110688	0.9999855756759644	O
26985	not	14 17	110689 110692	0.9999858140945435	O
26986	surprising	18 28	110693 110703	0.9999853372573853	O
26987	that	29 33	110704 110708	0.9999880790710449	O
26988	combining	34 43	110709 110718	0.9999852180480957	O
26989	these	44 49	110719 110724	0.9999879598617554	O
26990	two	50 53	110725 110728	0.9999853372573853	O
26991	transcriptional	54 68	110729 110743	0.9999808073043823	O
26993	programs	70 78	110745 110753	0.9999823570251465	O
26994	results	79 86	110754 110761	0.9999849796295166	O
26995	in	87 89	110762 110764	0.9999880790710449	O
26996	increased	90 99	110765 110774	0.9999809265136719	O
26997	number	100 106	110775 110781	0.9999799728393555	O
26998	and	107 110	110782 110785	0.9999821186065674	O
26999	invasiveness	111 122	110786 110797	0.9999755620956421	O
27001	of	124 126	110799 110801	0.9999830722808838	O
27002	colonic	127 133	110802 110808	0.9999479055404663	O
27005	tumors	135 141	110810 110816	0.9999819993972778	O
27006	as	142 144	110817 110819	0.9999864101409912	O
27007	recently	145 153	110820 110828	0.9999867677688599	O
27008	reported	154 162	110829 110837	0.9999874830245972	O
27009	for	163 166	110838 110841	0.9999884366989136	O
27010	ApcMin	167 172	110842 110847	0.9999881982803345	O
27015	/	173 174	110848 110849	0.9999872446060181	O
27016	+	174 175	110849 110850	0.9999873638153076	O
27017	mice	176 180	110851 110855	0.7529298663139343	species
27018	crossed	181 188	110856 110863	0.9999685287475586	O
27019	to	189 191	110864 110866	0.9999877214431763	O
27020	Smad3	192 196	110867 110871	0.9999864101409912	O
27023	-	197 198	110872 110873	0.9999873638153076	O
27024	/	198 199	110873 110874	0.9999783039093018	O
27025	-	199 200	110874 110875	0.9999868869781494	O
27026	mice	201 205	110876 110880	0.5103064179420471	species
27027	[	206 207	110881 110882	0.9999886751174927	O
27028	45	207 209	110882 110884	0.9999831914901733	O
27029	]	209 210	110884 110885	0.9999879598617554	O
27030	.	211 212	110886 110887	0.9999648332595825	O
27031	Moreover	0 8	110888 110896	0.9999805688858032	O
27032	,	9 10	110897 110898	0.9999862909317017	O
27033	combined	11 19	110899 110907	0.9999676942825317	O
27034	activation	20 30	110908 110918	0.9999768733978271	O
27035	of	31 33	110919 110921	0.9999864101409912	O
27036	canonical	34 43	110922 110931	0.999963641166687	O
27037	WNT	44 46	110932 110934	0.9999793767929077	O
27039	signaling	48 57	110936 110945	0.9999858140945435	O
27040	and	58 61	110946 110949	0.9999842643737793	O
27041	inhibition	62 71	110950 110959	0.9999828338623047	O
27043	of	73 75	110961 110963	0.9999861717224121	O
27044	TGFβ	76 79	110964 110967	0.9999852180480957	O
27048	signaling	81 90	110969 110978	0.9999847412109375	O
27049	also	91 95	110979 110983	0.9999818801879883	O
27050	results	96 103	110984 110991	0.9999593496322632	O
27051	in	104 106	110992 110994	0.9999794960021973	O
27052	more	107 111	110995 110999	0.9999723434448242	O
27053	advanced	112 120	111000 111008	0.9999634027481079	O
27054	intestinal	121 130	111009 111018	0.9999740123748779	O
27057	tumors	132 138	111020 111026	0.9999815225601196	O
27058	in	139 141	111027 111029	0.9999861717224121	O
27059	Apcdelta716	142 152	111030 111040	0.9999816417694092	O
27066	/	153 154	111041 111042	0.9999853372573853	O
27067	+	154 155	111042 111043	0.9999808073043823	O
27068	;	156 157	111044 111045	0.9999816417694092	O
27069	Smad4	158 162	111046 111050	0.9999842643737793	O
27072	+	163 164	111051 111052	0.9999871253967285	O
27073	/	164 165	111052 111053	0.9999657869338989	O
27074	-	166 167	111054 111055	0.9999747276306152	O
27075	mice	168 172	111056 111060	0.7723653316497803	species
27076	[	173 174	111061 111062	0.9999881982803345	O
27077	46	174 176	111062 111064	0.9999839067459106	O
27078	]	176 177	111064 111065	0.9999876022338867	O
27079	,	178 179	111066 111067	0.9999860525131226	O
27080	and	180 183	111068 111071	0.9999873638153076	O
27081	intestine	184 192	111072 111080	0.9999864101409912	O
27084	-	193 194	111081 111082	0.9999879598617554	O
27085	specific	194 202	111082 111090	0.9999839067459106	O
27086	deletion	203 210	111091 111098	0.9999797344207764	O
27089	of	212 214	111100 111102	0.9999861717224121	O
27090	the	215 218	111103 111106	0.9999862909317017	O
27091	type	219 223	111107 111111	0.9999873638153076	O
27092	II	224 226	111112 111114	0.9999755620956421	O
27093	TGFβ	227 230	111115 111118	0.9999856948852539	O
27097	receptor	232 240	111120 111128	0.9999860525131226	O
27098	in	241 243	111129 111131	0.9999877214431763	O
27099	Apc1638N	244 251	111132 111139	0.9999855756759644	O
27105	/	252 253	111140 111141	0.9999862909317017	O
27106	wt	253 254	111141 111142	0.9999657869338989	O
27108	mice	256 260	111144 111148	0.574621319770813	species
27109	[	261 262	111149 111150	0.9999880790710449	O
27110	47	262 264	111150 111152	0.9999821186065674	O
27111	]	264 265	111152 111153	0.9999867677688599	O
27112	.	266 267	111154 111155	0.9999498128890991	O
27113	The	0 3	111156 111159	0.9999685287475586	O
27114	findings	4 12	111160 111168	0.9999343156814575	O
27115	that	13 17	111169 111173	0.9999828338623047	O
27116	shared	18 24	111174 111180	0.9999626874923706	O
27117	over	25 29	111181 111185	0.9999841451644897	O
27118	-	29 30	111185 111186	0.9999858140945435	O
27119	expressed	30 39	111186 111195	0.9999769926071167	O
27120	signatures	40 50	111196 111206	0.9999808073043823	O
27121	are	51 54	111207 111210	0.9999829530715942	O
27122	identifiable	55 66	111211 111222	0.9999849796295166	O
27125	in	68 70	111224 111226	0.9999821186065674	O
27126	all	71 74	111227 111230	0.9999817609786987	O
27127	four	75 79	111231 111235	0.9998725652694702	O
27128	mouse	80 85	111236 111241	0.9553806185722351	species
27129	models	86 92	111242 111248	0.9978708028793335	O
27130	of	93 95	111249 111251	0.9998681545257568	O
27131	CRC	96 98	111252 111254	0.9999667406082153	O
27133	,	100 101	111256 111257	0.9999818801879883	O
27134	which	102 107	111258 111263	0.9999843835830688	O
27135	are	108 111	111264 111267	0.999980092048645	O
27136	also	112 116	111268 111272	0.9999804496765137	O
27137	representative	117 131	111273 111287	0.9999808073043823	O
27138	of	132 134	111288 111290	0.9999852180480957	O
27139	the	135 138	111291 111294	0.9999836683273315	O
27140	majority	139 147	111295 111303	0.9999828338623047	O
27141	of	148 150	111304 111306	0.999984622001648	O
27142	embryonic	151 159	111307 111315	0.9999822378158569	O
27146	colonic	161 167	111317 111323	0.9999837875366211	O
27149	over	169 173	111325 111329	0.9999853372573853	O
27150	-	173 174	111329 111330	0.9999866485595703	O
27151	expressed	174 183	111330 111339	0.9999809265136719	O
27152	signatures	184 194	111340 111350	0.9999829530715942	O
27153	,	195 196	111351 111352	0.9999796152114868	O
27154	and	197 200	111353 111356	0.999976396560669	O
27155	that	201 205	111357 111361	0.9999830722808838	O
27156	these	206 211	111362 111367	0.9999854564666748	O
27157	signatures	212 222	111368 111378	0.9999799728393555	O
27158	are	223 226	111379 111382	0.9999831914901733	O
27159	also	227 231	111383 111387	0.999980092048645	O
27160	present	232 239	111388 111395	0.9999842643737793	O
27161	in	240 242	111396 111398	0.9999842643737793	O
27162	all	243 246	111399 111402	0.999976634979248	O
27163	human	247 252	111403 111408	0.9742384552955627	species
27164	CRCs	253 256	111409 111412	0.9999716281890869	O
27166	,	258 259	111414 111415	0.9999769926071167	O
27167	suggest	260 267	111416 111423	0.99994957447052	O
27168	that	268 272	111424 111428	0.9999539852142334	O
27169	colon	273 277	111429 111433	0.9998664855957031	O
27171	tumors	279 285	111435 111441	0.9999607801437378	O
27172	may	286 289	111442 111445	0.9999624490737915	O
27173	arise	290 295	111446 111451	0.9999794960021973	O
27174	independently	296 309	111452 111465	0.9999788999557495	O
27175	of	310 312	111466 111468	0.9999852180480957	O
27176	canonical	313 322	111469 111478	0.9999130964279175	O
27177	WNT	323 325	111479 111481	0.9999711513519287	O
27179	signaling	327 336	111483 111492	0.9999790191650391	O
27180	status	337 343	111493 111499	0.999984622001648	O
27181	.	344 345	111500 111501	0.999754011631012	O
27182	A	0 1	111502 111503	0.9999815225601196	O
27183	likely	2 8	111504 111510	0.9999783039093018	O
27184	candidate	9 18	111511 111520	0.999954104423523	O
27185	to	19 21	111521 111523	0.9999783039093018	O
27186	impart	22 27	111524 111529	0.999984622001648	O
27188	this	29 33	111531 111535	0.9999834299087524	O
27189	oncogenic	34 42	111536 111544	0.9999765157699585	O
27192	signaling	44 53	111546 111555	0.9999094009399414	O
27193	is	54 56	111556 111558	0.9999829530715942	O
27194	Myc	57 59	111559 111561	0.9999632835388184	O
27196	,	61 62	111563 111564	0.9999860525131226	O
27197	which	63 68	111565 111570	0.9999872446060181	O
27198	is	69 71	111571 111573	0.9999861717224121	O
27199	an	72 74	111574 111576	0.9999871253967285	O
27200	embryonic	75 83	111577 111585	0.999981164932251	O
27204	up	85 87	111587 111589	0.9999850988388062	O
27205	-	87 88	111589 111590	0.9999878406524658	O
27206	regulated	88 97	111590 111599	0.999984860420227	O
27207	transcript	98 107	111600 111609	0.9999856948852539	O
27209	that	109 113	111611 111615	0.9999856948852539	O
27210	is	114 116	111616 111618	0.9999853372573853	O
27211	also	117 121	111619 111623	0.9999778270721436	O
27212	upregulated	122 132	111624 111634	0.9999853372573853	O
27216	in	134 136	111636 111638	0.9999778270721436	O
27217	all	137 140	111639 111642	0.9999439716339111	O
27218	human	141 146	111643 111648	0.9783543944358826	species
27219	CRCs	147 150	111649 111652	0.9999504089355469	O
27221	and	152 155	111654 111657	0.9997993111610413	O
27222	mouse	156 161	111658 111663	0.974135160446167	species
27223	tumor	162 167	111664 111669	0.9999343156814575	O
27224	models	168 174	111670 111676	0.9999017715454102	O
27225	independently	175 188	111677 111690	0.9999796152114868	O
27226	of	189 191	111691 111693	0.9999853372573853	O
27227	nuclear	192 199	111694 111701	0.9999730587005615	O
27228	β	200 201	111702 111703	0.9999849796295166	O
27229	-	201 202	111703 111704	0.9999877214431763	O
27230	catenin	202 208	111704 111710	0.9999849796295166	O
27233	status	210 216	111712 111718	0.9999841451644897	O
27234	.	217 218	111719 111720	0.9998769760131836	O
27235	Embryology	0 9	111721 111730	0.9999853372573853	O
27239	provides	11 19	111732 111740	0.9999707937240601	O
27240	insight	20 27	111741 111748	0.9999727010726929	O
27241	into	28 32	111749 111753	0.9999831914901733	O
27242	the	33 36	111754 111757	0.999984622001648	O
27243	biology	37 44	111758 111765	0.9999582767486572	O
27244	of	45 47	111766 111768	0.9999829530715942	O
27245	mouse	48 53	111769 111774	0.9650883674621582	species
27246	and	54 57	111775 111778	0.9999209642410278	O
27247	human	58 63	111779 111784	0.973747193813324	species
27248	colon	64 68	111785 111789	0.9999659061431885	O
27250	tumors	70 76	111791 111797	0.9999845027923584	O
27251	It	77 79	111798 111800	0.9999850988388062	O
27252	has	80 83	111801 111804	0.9999864101409912	O
27253	long	84 88	111805 111809	0.9999805688858032	O
27254	been	89 93	111810 111814	0.9999865293502808	O
27255	suggested	94 103	111815 111824	0.9999825954437256	O
27256	that	104 108	111825 111829	0.999987006187439	O
27257	cancer	109 115	111830 111836	0.9999803304672241	O
27258	represents	116 126	111837 111847	0.9999852180480957	O
27259	a	127 128	111848 111849	0.9999873638153076	O
27260	reversion	129 137	111850 111858	0.9999872446060181	O
27262	to	139 141	111860 111862	0.9999872446060181	O
27263	an	142 144	111863 111865	0.9999881982803345	O
27264	embryonic	145 153	111866 111874	0.9999872446060181	O
27268	state	155 160	111876 111881	0.9999874830245972	O
27269	,	161 162	111882 111883	0.9999867677688599	O
27270	partly	163 169	111884 111890	0.9999860525131226	O
27271	based	170 175	111891 111896	0.9999881982803345	O
27272	upon	176 180	111897 111901	0.9999878406524658	O
27273	the	181 184	111902 111905	0.9999874830245972	O
27274	observation	185 196	111906 111917	0.9999839067459106	O
27275	that	197 201	111918 111922	0.9999880790710449	O
27276	several	202 209	111923 111930	0.9999861717224121	O
27277	oncofetal	210 218	111931 111939	0.9999850988388062	O
27281	antigens	220 227	111941 111948	0.9999865293502808	O
27283	are	229 232	111950 111953	0.9999872446060181	O
27284	diagnostic	233 243	111954 111964	0.9999839067459106	O
27285	for	244 247	111965 111968	0.9999847412109375	O
27286	some	248 252	111969 111973	0.9999779462814331	O
27287	tumors	253 259	111974 111980	0.9999830722808838	O
27288	[	260 261	111981 111982	0.9999880790710449	O
27289	48	261 263	111982 111984	0.9999840259552002	O
27290	,	263 264	111984 111985	0.9999861717224121	O
27291	49	264 266	111985 111987	0.9999822378158569	O
27292	]	266 267	111987 111988	0.999987006187439	O
27293	.	268 269	111989 111990	0.9999676942825317	O
27294	To	0 2	111991 111993	0.9999707937240601	O
27295	assess	3 9	111994 112000	0.9999656677246094	O
27296	the	10 13	112001 112004	0.9999829530715942	O
27297	embryology	14 23	112005 112014	0.9999836683273315	O
27301	-	24 25	112015 112016	0.9999861717224121	O
27302	related	25 32	112016 112023	0.9999830722808838	O
27303	aspects	33 40	112024 112031	0.9999821186065674	O
27304	of	41 43	112032 112034	0.9999812841415405	O
27305	tumorigenesis	44 56	112035 112047	0.9999653100967407	O
27309	and	58 61	112049 112052	0.9999781847000122	O
27310	tumor	62 67	112053 112058	0.9999605417251587	O
27311	progression	68 79	112059 112070	0.9999755620956421	O
27312	in	80 82	112071 112073	0.9999581575393677	O
27313	CRC	83 85	112074 112076	0.999941349029541	O
27315	,	87 88	112078 112079	0.9999802112579346	O
27316	we	89 91	112080 112082	0.9999713897705078	O
27317	analyzed	92 100	112083 112091	0.999980092048645	O
27318	and	101 104	112092 112095	0.9999806880950928	O
27319	compared	105 113	112096 112104	0.9999713897705078	O
27320	the	114 117	112105 112108	0.9999828338623047	O
27321	transcriptomes	118 131	112109 112122	0.999983549118042	O
27325	of	133 135	112124 112126	0.9999810457229614	O
27326	normal	136 142	112127 112133	0.9987416863441467	O
27327	mouse	143 148	112134 112139	0.802845299243927	species
27328	colon	149 153	112140 112144	0.9999666213989258	O
27330	development	155 166	112146 112157	0.9997252821922302	O
27331	and	167 170	112158 112161	0.9998341798782349	O
27332	models	171 177	112162 112168	0.9150110483169556	O
27333	of	178 180	112169 112171	0.9991748929023743	O
27334	CRC	181 183	112172 112174	0.9999572038650513	O
27336	.	184 185	112175 112176	0.9998867511749268	O
27337	Our	0 3	112177 112180	0.9996860027313232	O
27338	data	4 8	112181 112185	0.9998327493667603	O
27339	show	9 13	112186 112190	0.9999520778656006	O
27340	that	14 18	112191 112195	0.9999828338623047	O
27341	developmentally	19 33	112196 112210	0.9999594688415527	O
27343	regulated	35 44	112212 112221	0.9999747276306152	O
27344	genes	45 50	112222 112227	0.9999762773513794	O
27345	represent	51 60	112228 112237	0.9999804496765137	O
27346	approximately	61 74	112238 112251	0.9999821186065674	O
27347	56	75 77	112252 112254	0.9999688863754272	O
27348	%	78 79	112255 112256	0.9999784231185913	O
27349	of	80 82	112257 112259	0.9999756813049316	O
27350	mouse	83 88	112260 112265	0.9483119249343872	species
27351	tumor	89 94	112266 112271	0.9999600648880005	O
27352	signatures	95 105	112272 112282	0.9999772310256958	O
27353	,	106 107	112283 112284	0.9999598264694214	O
27354	and	108 111	112285 112288	0.999956488609314	O
27355	that	112 116	112289 112293	0.9999754428863525	O
27356	the	117 120	112294 112297	0.9998747110366821	O
27357	tumor	121 126	112298 112303	0.9999473094940186	O
27358	signatures	127 137	112304 112314	0.9999794960021973	O
27359	from	138 142	112315 112319	0.9999747276306152	O
27360	the	143 146	112320 112323	0.9999654293060303	O
27361	four	147 151	112324 112328	0.9996935129165649	O
27362	mouse	152 157	112329 112334	0.9347014427185059	species
27363	models	158 164	112335 112341	0.9990609288215637	O
27364	recapitulate	165 176	112342 112353	0.9999825954437256	O
27368	approximately	178 191	112355 112368	0.9999861717224121	O
27369	85	192 194	112369 112371	0.9999804496765137	O
27370	%	195 196	112372 112373	0.9999866485595703	O
27371	of	197 199	112374 112376	0.9999861717224121	O
27372	developmentally	200 214	112377 112391	0.9999629259109497	O
27374	regulated	216 225	112393 112402	0.9999748468399048	O
27375	genes	226 231	112403 112408	0.9999794960021973	O
27376	.	232 233	112409 112410	0.9999202489852905	O
27377	There	0 5	112411 112416	0.9999845027923584	O
27378	are	6 9	112417 112420	0.999984622001648	O
27379	at	10 12	112421 112423	0.9999858140945435	O
27380	least	13 18	112424 112429	0.9999853372573853	O
27381	two	19 22	112430 112433	0.9999788999557495	O
27382	regulatory	23 33	112434 112444	0.999954342842102	O
27383	programs	34 42	112445 112453	0.9999716281890869	O
27384	that	43 47	112454 112458	0.9999849796295166	O
27385	determine	48 57	112459 112468	0.9999815225601196	O
27386	the	58 61	112469 112472	0.9999854564666748	O
27387	expression	62 72	112473 112483	0.9999815225601196	O
27388	of	73 75	112484 112486	0.9999865293502808	O
27389	developmental	76 89	112487 112500	0.9999575614929199	O
27390	genes	90 95	112501 112506	0.9999842643737793	O
27391	by	96 98	112507 112509	0.9999630451202393	O
27392	mouse	99 104	112510 112515	0.9617533683776855	species
27393	tumors	105 111	112516 112522	0.9999769926071167	O
27394	(	112 113	112523 112524	0.9999874830245972	O
27395	Figures	114 120	112525 112531	0.9999810457229614	O
27397	2	122 123	112533 112534	0.9999866485595703	O
27398	,	124 125	112535 112536	0.9999868869781494	O
27399	4	126 127	112537 112538	0.9999850988388062	O
27400	,	128 129	112539 112540	0.9999866485595703	O
27401	and	130 133	112541 112544	0.9999871253967285	O
27402	8	134 135	112545 112546	0.999984622001648	O
27403	)	136 137	112547 112548	0.9999878406524658	O
27404	.	138 139	112549 112550	0.9999653100967407	O
27405	The	0 3	112551 112554	0.9999853372573853	O
27406	simpler	4 11	112555 112562	0.9999692440032959	O
27407	program	12 19	112563 112570	0.9999594688415527	O
27408	is	20 22	112571 112573	0.999983549118042	O
27409	evident	23 30	112574 112581	0.9999825954437256	O
27410	by	31 33	112582 112584	0.9999868869781494	O
27411	the	34 37	112585 112588	0.999987006187439	O
27412	over	38 42	112589 112593	0.9999849796295166	O
27413	-	42 43	112593 112594	0.9999868869781494	O
27414	expression	43 53	112594 112604	0.9999840259552002	O
27415	of	54 56	112605 112607	0.9999876022338867	O
27416	the	57 60	112608 112611	0.9999868869781494	O
27417	earliest	61 69	112612 112620	0.9999814033508301	O
27418	genes	70 75	112621 112626	0.9999836683273315	O
27419	of	76 78	112627 112629	0.999984860420227	O
27420	colon	79 83	112630 112634	0.9999743700027466	O
27422	development	85 96	112636 112647	0.9999799728393555	O
27423	by	97 99	112648 112650	0.9999864101409912	O
27424	the	100 103	112651 112654	0.9999845027923584	O
27425	nuclear	104 111	112655 112662	0.9999791383743286	O
27426	β	112 113	112663 112664	0.9999860525131226	O
27427	-	113 114	112664 112665	0.999988317489624	O
27428	catenin	114 120	112665 112671	0.999985933303833	O
27431	-	121 122	112672 112673	0.9999881982803345	O
27432	positive	122 130	112673 112681	0.9999837875366211	O
27433	models	131 137	112682 112688	0.9999508857727051	O
27434	.	138 139	112689 112690	0.9999183416366577	O
27435	The	0 3	112691 112694	0.9999858140945435	O
27436	more	4 8	112695 112699	0.9999827146530151	O
27437	subtle	9 15	112700 112706	0.999980092048645	O
27438	program	16 23	112707 112714	0.9999589920043945	O
27439	could	24 29	112715 112720	0.9999843835830688	O
27440	be	30 32	112721 112723	0.9999874830245972	O
27441	detected	33 41	112724 112732	0.9999868869781494	O
27442	only	42 46	112733 112737	0.999984622001648	O
27443	in	47 49	112738 112740	0.999988317489624	O
27444	reference	50 59	112741 112750	0.9999836683273315	O
27445	to	60 62	112751 112753	0.9999880790710449	O
27446	adult	63 68	112754 112759	0.9999469518661499	O
27447	colon	69 73	112760 112764	0.9999836683273315	O
27449	and	75 78	112766 112769	0.9999829530715942	O
27450	is	79 81	112770 112772	0.9999861717224121	O
27451	highly	82 88	112773 112779	0.9999861717224121	O
27452	shared	89 95	112780 112786	0.9999849796295166	O
27453	by	96 98	112787 112789	0.9999866485595703	O
27454	nuclear	99 106	112790 112797	0.9999819993972778	O
27455	β	107 108	112798 112799	0.999987006187439	O
27456	-	108 109	112799 112800	0.9999884366989136	O
27457	catenin	109 115	112800 112806	0.9999865293502808	O
27460	-	116 117	112807 112808	0.9999881982803345	O
27461	negative	117 125	112808 112816	0.9999803304672241	O
27462	models	126 132	112817 112823	0.9999617338180542	O
27463	.	133 134	112824 112825	0.9999290704727173	O
27464	This	0 4	112826 112830	0.9999812841415405	O
27465	program	5 12	112831 112838	0.9999213218688965	O
27466	,	13 14	112839 112840	0.9999839067459106	O
27467	though	15 21	112841 112847	0.9999604225158691	O
27468	modified	22 30	112848 112856	0.9999750852584839	O
27469	by	31 33	112857 112859	0.9999829530715942	O
27470	nuclear	34 41	112860 112867	0.9999610185623169	O
27471	β	42 43	112868 112869	0.9999836683273315	O
27472	-	43 44	112869 112870	0.9999864101409912	O
27473	catenin	44 50	112870 112876	0.9999825954437256	O
27476	status	52 58	112878 112884	0.9999845027923584	O
27477	,	59 60	112885 112886	0.9999810457229614	O
27478	is	61 63	112887 112889	0.9999804496765137	O
27479	represented	64 75	112890 112901	0.9999794960021973	O
27480	by	76 78	112902 112904	0.9999856948852539	O
27481	a	79 80	112905 112906	0.9999856948852539	O
27482	large	81 86	112907 112912	0.9999775886535645	O
27483	scale	87 92	112913 112918	0.9999799728393555	O
27484	over	93 97	112919 112923	0.9999829530715942	O
27485	-	97 98	112923 112924	0.9999855756759644	O
27486	expression	98 108	112924 112934	0.999983549118042	O
27487	of	109 111	112935 112937	0.9999855756759644	O
27488	developmentally	112 126	112938 112952	0.9999706745147705	O
27490	expressed	128 137	112954 112963	0.9999836683273315	O
27491	genes	138 143	112964 112969	0.9999818801879883	O
27492	in	144 146	112970 112972	0.9999793767929077	O
27493	tumors	147 153	112973 112979	0.9999719858169556	O
27494	that	154 158	112980 112984	0.9999830722808838	O
27495	are	159 162	112985 112988	0.9999833106994629	O
27496	both	163 167	112989 112993	0.9999843835830688	O
27497	positive	168 176	112994 113002	0.9999840259552002	O
27498	and	177 180	113003 113006	0.9999829530715942	O
27499	negative	181 189	113007 113015	0.9999550580978394	O
27500	for	190 193	113016 113019	0.9999836683273315	O
27501	canonical	194 203	113020 113029	0.9999279975891113	O
27502	WNT	204 206	113030 113032	0.9999731779098511	O
27504	signaling	208 217	113034 113043	0.9999805688858032	O
27505	.	218 219	113044 113045	0.999897837638855	O
27506	Genes	0 4	113046 113050	0.9999752044677734	O
27508	found	6 11	113052 113057	0.9999829530715942	O
27509	within	12 18	113058 113064	0.9999821186065674	O
27510	this	19 23	113065 113069	0.9999855756759644	O
27511	signature	24 33	113070 113079	0.9999520778656006	O
27512	have	34 38	113080 113084	0.9999817609786987	O
27513	a	39 40	113085 113086	0.9999842643737793	O
27514	large	41 46	113087 113092	0.9999653100967407	O
27515	overlap	47 54	113093 113100	0.9999837875366211	O
27516	with	55 59	113101 113105	0.9999854564666748	O
27517	those	60 65	113106 113111	0.9999843835830688	O
27518	present	66 73	113112 113119	0.9999841451644897	O
27519	in	74 76	113120 113122	0.999984622001648	O
27520	the	77 80	113123 113126	0.999983549118042	O
27521	colon	81 85	113127 113131	0.9999784231185913	O
27523	at	87 89	113133 113135	0.9999850988388062	O
27524	later	90 95	113136 113141	0.9999706745147705	O
27525	developmental	96 109	113142 113155	0.9999634027481079	O
27526	stages	110 116	113156 113162	0.9999828338623047	O
27527	(	117 118	113163 113164	0.9999871253967285	O
27528	E16	119 121	113165 113167	0.9999871253967285	O
27530	.	122 123	113168 113169	0.9999876022338867	O
27531	5	123 124	113169 113170	0.9999872446060181	O
27532	-	124 125	113170 113171	0.9999871253967285	O
27533	E18	125 127	113171 113173	0.999987006187439	O
27535	.	128 129	113174 113175	0.9999873638153076	O
27536	5	129 130	113175 113176	0.9999871253967285	O
27537	)	131 132	113177 113178	0.9999880790710449	O
27538	.	133 134	113179 113180	0.9999463558197021	O
27539	An	0 2	113181 113183	0.9999747276306152	O
27540	integrated	3 13	113184 113194	0.9999524354934692	O
27541	view	14 18	113195 113199	0.9998927116394043	O
27542	of	19 21	113200 113202	0.9999672174453735	O
27543	colon	22 26	113203 113207	0.9999213218688965	O
27545	cancer	28 34	113209 113215	0.9999607801437378	O
27546	transcriptional	35 49	113216 113230	0.9999628067016602	O
27548	programs	51 59	113232 113240	0.999923586845398	O
27549	provides	60 68	113241 113249	0.9999412298202515	O
27550	novel	69 74	113250 113255	0.9999586343765259	O
27551	insight	75 82	113256 113263	0.9999605417251587	O
27552	into	83 87	113264 113268	0.9999551773071289	O
27553	neoplasia	88 96	113269 113277	0.9999639987945557	O
27556	.	98 99	113279 113280	0.998763918876648	O
27557	Murine	0 5	113281 113286	0.9710978269577026	species
27559	colon	7 11	113288 113292	0.9926203489303589	O
27561	tumor	13 18	113294 113299	0.9986414313316345	O
27562	adenomas	19 26	113300 113307	0.9999523162841797	O
27565	and	28 31	113309 113312	0.9983205199241638	O
27566	human	32 37	113313 113318	0.9724858999252319	species
27567	CRCs	38 41	113319 113322	0.9999282360076904	O
27569	both	43 47	113324 113328	0.999710738658905	O
27570	show	48 52	113329 113333	0.999804675579071	O
27571	adoption	53 61	113334 113342	0.9999746084213257	O
27572	and	62 65	113343 113346	0.9999624490737915	O
27573	dysregulation	66 78	113347 113359	0.999970555305481	O
27578	of	80 82	113361 113363	0.9999815225601196	O
27579	signatures	83 93	113364 113374	0.9999773502349854	O
27580	tightly	94 101	113375 113382	0.9999802112579346	O
27581	controlled	102 112	113383 113393	0.9999840259552002	O
27582	during	113 119	113394 113400	0.999982476234436	O
27583	embryonic	120 128	113401 113409	0.9999842643737793	O
27587	mouse	130 135	113411 113416	0.9999563694000244	O
27588	colon	136 140	113417 113421	0.9999845027923584	O
27590	development	142 153	113423 113434	0.9999822378158569	O
27591	.	154 155	113435 113436	0.998542070388794	O
27592	The	0 3	113437 113440	0.999962329864502	O
27593	use	4 7	113441 113444	0.9996678829193115	O
27594	of	8 10	113445 113447	0.9999147653579712	O
27595	etiologically	11 23	113448 113460	0.9999637603759766	O
27599	distinct	25 33	113462 113470	0.9993436932563782	O
27600	mouse	34 39	113471 113476	0.8895019888877869	species
27601	models	40 46	113477 113483	0.9994524121284485	O
27602	of	47 49	113484 113486	0.999901533126831	O
27603	colon	50 54	113487 113491	0.9999476671218872	O
27605	cancer	56 62	113493 113499	0.9999713897705078	O
27606	allows	63 69	113500 113506	0.9999662637710571	O
27607	for	70 73	113507 113510	0.9999717473983765	O
27608	the	74 77	113511 113514	0.9999747276306152	O
27609	identification	78 92	113515 113529	0.9999421834945679	O
27610	of	93 95	113530 113532	0.9999617338180542	O
27611	models	96 102	113533 113539	0.9997380375862122	O
27612	that	103 107	113540 113544	0.9999685287475586	O
27613	resemble	108 116	113545 113553	0.9998435974121094	O
27614	different	117 126	113554 113563	0.9999544620513916	O
27615	stages	127 133	113564 113570	0.9999786615371704	O
27616	of	134 136	113571 113573	0.9999819993972778	O
27617	embryonic	137 145	113574 113582	0.9999808073043823	O
27621	mouse	147 152	113584 113589	0.999931812286377	O
27622	colon	153 157	113590 113594	0.9999827146530151	O
27624	development	159 170	113596 113607	0.9999758005142212	O
27625	and	171 174	113608 113611	0.9999550580978394	O
27626	that	175 179	113612 113616	0.9999747276306152	O
27627	are	180 183	113617 113620	0.9999678134918213	O
27628	recapitulated	184 196	113621 113633	0.9998773336410522	O
27632	by	198 200	113635 113637	0.9999490976333618	O
27633	specific	201 209	113638 113646	0.9998917579650879	O
27634	tumor	210 215	113647 113652	0.9999426603317261	O
27635	types	216 221	113653 113658	0.999966025352478	O
27636	.	222 223	113659 113660	0.9999710321426392	O
27637	(	224 225	113661 113662	0.9992596507072449	O
27638	a	0 1	113663 113664	0.9999579191207886	O
27639	)	2 3	113665 113666	0.9999823570251465	O
27640	All	4 7	113667 113670	0.9998999834060669	O
27641	tumors	8 14	113671 113677	0.9999637603759766	O
27642	exhibit	15 22	113678 113685	0.9999715089797974	O
27643	large	23 28	113686 113691	0.9999439716339111	O
27644	-	28 29	113691 113692	0.9999836683273315	O
27645	scale	29 34	113692 113697	0.9999713897705078	O
27646	activation	35 45	113698 113708	0.9999485015869141	O
27647	of	46 48	113709 113711	0.9999823570251465	O
27648	developmental	49 62	113712 113725	0.9999523162841797	O
27649	patterns	63 71	113726 113734	0.9999724626541138	O
27650	.	72 73	113735 113736	0.999934196472168	O
27651	Nuclear	0 7	113737 113744	0.9999804496765137	O
27652	β	8 9	113745 113746	0.9999831914901733	O
27653	-	9 10	113746 113747	0.9999842643737793	O
27654	catenin	10 16	113747 113753	0.9999818801879883	O
27657	-	17 18	113754 113755	0.9999839067459106	O
27658	positive	18 26	113755 113763	0.9999821186065674	O
27659	(	27 28	113764 113765	0.999983549118042	O
27660	ApcMin	29 34	113766 113771	0.999983549118042	O
27665	/	35 36	113772 113773	0.9999837875366211	O
27666	+	36 37	113773 113774	0.9999825954437256	O
27667	and	38 41	113775 113778	0.999981164932251	O
27668	AOM	42 44	113779 113781	0.9999737739562988	O
27670	)	45 46	113782 113783	0.99997878074646	O
27671	tumors	47 53	113784 113790	0.9999773502349854	O
27672	map	54 57	113791 113794	0.9999785423278809	O
27673	more	58 62	113795 113799	0.9999828338623047	O
27674	strongly	63 71	113800 113808	0.9999805688858032	O
27675	to	72 74	113809 113811	0.9999847412109375	O
27676	early	75 80	113812 113817	0.9999840259552002	O
27677	development	81 92	113818 113829	0.9999819993972778	O
27678	stages	93 99	113830 113836	0.9999845027923584	O
27679	during	100 106	113837 113843	0.9999806880950928	O
27680	(	107 108	113844 113845	0.9999839067459106	O
27681	more	109 113	113846 113850	0.9999833106994629	O
27682	proliferative	114 126	113851 113863	0.9999841451644897	O
27685	,	128 129	113865 113866	0.9999815225601196	O
27686	less	130 134	113867 113871	0.9999804496765137	O
27687	differentiated	135 149	113872 113886	0.9999809265136719	O
27688	)	150 151	113887 113888	0.999984622001648	O
27689	,	152 153	113889 113890	0.9999829530715942	O
27690	whereas	154 161	113891 113898	0.9999841451644897	O
27691	nuclear	162 169	113899 113906	0.999982476234436	O
27692	β	170 171	113907 113908	0.9999837875366211	O
27693	-	171 172	113908 113909	0.999984622001648	O
27694	catenin	172 178	113909 113915	0.9999827146530151	O
27697	-	179 180	113916 113917	0.9999841451644897	O
27698	negative	180 188	113917 113925	0.9999818801879883	O
27699	(	189 190	113926 113927	0.9999839067459106	O
27700	Tgfb1	191 195	113928 113932	0.9999819993972778	O
27705	-	196 197	113933 113934	0.9999821186065674	O
27706	/	197 198	113934 113935	0.9999667406082153	O
27707	-	198 199	113935 113936	0.9999823570251465	O
27708	;	199 200	113936 113937	0.9999814033508301	O
27709	Rag2	201 204	113938 113941	0.999976634979248	O
27712	-	205 206	113942 113943	0.9999830722808838	O
27713	/	206 207	113943 113944	0.9999802112579346	O
27714	-	207 208	113944 113945	0.9999827146530151	O
27715	and	209 212	113946 113949	0.999982476234436	O
27716	Smad3	213 217	113950 113954	0.9999806880950928	O
27719	-	218 219	113955 113956	0.9999828338623047	O
27720	/	219 220	113956 113957	0.9999706745147705	O
27721	-	220 221	113957 113958	0.9999796152114868	O
27722	)	221 222	113958 113959	0.9999780654907227	O
27723	tumors	223 229	113960 113966	0.9999778270721436	O
27724	map	230 233	113967 113970	0.9999794960021973	O
27725	more	234 238	113971 113975	0.9999834299087524	O
27726	strongly	239 247	113976 113984	0.9999804496765137	O
27727	to	248 250	113985 113987	0.9999845027923584	O
27728	later	251 256	113988 113993	0.999980092048645	O
27729	stages	257 263	113994 114000	0.9999837875366211	O
27730	consistent	264 274	114001 114011	0.9999817609786987	O
27731	with	275 279	114012 114016	0.9999834299087524	O
27732	increased	280 289	114017 114026	0.9999697208404541	O
27733	epithelial	290 299	114027 114036	0.9999815225601196	O
27737	differentiation	301 316	114038 114053	0.9999794960021973	O
27738	.	317 318	114054 114055	0.9999759197235107	O
27739	(	319 320	114056 114057	0.999164342880249	species
27740	b	0 1	114058 114059	0.9999775886535645	O
27741	)	2 3	114060 114061	0.9999861717224121	O
27742	Overall	4 11	114062 114069	0.9999760389328003	O
27743	representation	12 26	114070 114084	0.9999698400497437	O
27744	of	27 29	114085 114087	0.9999818801879883	O
27745	the	30 33	114088 114091	0.9999833106994629	O
27746	relationship	34 46	114092 114104	0.9999701976776123	O
27747	of	47 49	114105 114107	0.9999805688858032	O
27748	mouse	50 55	114108 114113	0.9634084105491638	species
27749	colon	56 60	114114 114118	0.9998394250869751	O
27751	tumor	62 67	114120 114125	0.9999668598175049	O
27752	models	68 74	114126 114132	0.9998390674591064	O
27753	and	75 78	114133 114136	0.9999724626541138	O
27754	human	79 84	114137 114142	0.975510835647583	species
27755	CRC	85 87	114143 114145	0.9999526739120483	O
27757	to	89 91	114147 114149	0.9999808073043823	O
27758	development	92 103	114150 114161	0.9999814033508301	O
27759	and	104 107	114162 114165	0.9999805688858032	O
27760	non	108 111	114166 114169	0.999981164932251	O
27761	-	111 112	114169 114170	0.9999841451644897	O
27762	developmental	112 125	114170 114183	0.9999833106994629	O
27763	expression	126 136	114184 114194	0.9999790191650391	O
27764	patterns	137 145	114195 114203	0.9999850988388062	O
27765	.	146 147	114204 114205	0.999861478805542	O
27766	Gene	0 4	114206 114210	0.9999877214431763	O
27767	expression	5 15	114211 114221	0.9999853372573853	O
27768	clusters	16 24	114222 114230	0.9999872446060181	O
27769	mapped	25 31	114231 114237	0.99997878074646	O
27770	to	32 34	114238 114240	0.9999876022338867	O
27771	the	35 38	114241 114244	0.9999884366989136	O
27772	progression	39 50	114245 114256	0.9999842643737793	O
27773	of	51 53	114257 114259	0.9999878406524658	O
27774	adenomatous	54 64	114260 114270	0.9999818801879883	O
27778	and	66 69	114272 114275	0.9999836683273315	O
27779	carcinomatous	70 82	114276 114288	0.9999808073043823	O
27784	transformation	84 98	114290 114304	0.9999833106994629	O
27785	identified	99 109	114305 114315	0.9999886751174927	O
27786	in	110 112	114316 114318	0.9999892711639404	O
27787	Figures	113 119	114319 114325	0.9999868869781494	O
27789	5	121 122	114327 114328	0.9999889135360718	O
27790	and	123 126	114329 114332	0.999988317489624	O
27791	6	127 128	114333 114334	0.9999874830245972	O
27792	are	129 132	114335 114338	0.9999880790710449	O
27793	shown	133 138	114339 114344	0.999987006187439	O
27794	as	139 141	114345 114347	0.999988317489624	O
27795	the	142 145	114348 114351	0.9999886751174927	O
27796	clusters	146 154	114352 114360	0.9999881982803345	O
27797	of	155 157	114361 114363	0.9999887943267822	O
27798	genes	158 163	114364 114369	0.9999864101409912	O
27799	whose	164 169	114370 114375	0.9999886751174927	O
27800	expression	170 180	114376 114386	0.9999833106994629	O
27801	is	181 183	114387 114389	0.9999885559082031	O
27802	either	184 190	114390 114396	0.9999884366989136	O
27803	gained	191 197	114397 114403	0.9999866485595703	O
27804	or	198 200	114404 114406	0.9999871253967285	O
27805	lost	201 205	114407 114411	0.9999785423278809	O
27806	associated	206 216	114412 114422	0.9999889135360718	O
27807	with	217 221	114423 114427	0.9999887943267822	O
27808	the	222 225	114428 114431	0.9999886751174927	O
27809	stage	226 231	114432 114437	0.9999876022338867	O
27810	of	232 234	114438 114440	0.9999884366989136	O
27811	progression	235 246	114441 114452	0.9999866485595703	O
27812	.	247 248	114453 114454	0.9999668598175049	O
27813	For	0 3	114455 114458	0.9999849796295166	O
27814	example	4 11	114459 114466	0.999984860420227	O
27815	normal	12 18	114467 114473	0.9999834299087524	O
27816	development	19 30	114474 114485	0.9999839067459106	O
27817	could	31 36	114486 114491	0.9999842643737793	O
27818	be	37 39	114492 114494	0.9999872446060181	O
27819	considered	40 50	114495 114505	0.9999866485595703	O
27820	as	51 53	114506 114508	0.9999876022338867	O
27821	'	54 55	114509 114510	0.9999884366989136	O
27822	subverted	55 63	114510 114518	0.9999873638153076	O
27824	'	65 66	114520 114521	0.9999871253967285	O
27825	if	67 69	114522 114524	0.9999854564666748	O
27826	there	70 75	114525 114530	0.9999881982803345	O
27827	is	76 78	114531 114533	0.9999880790710449	O
27828	an	79 81	114534 114536	0.9999884366989136	O
27829	absence	82 89	114537 114544	0.999985933303833	O
27830	of	90 92	114545 114547	0.999988317489624	O
27831	expression	93 103	114548 114558	0.9999872446060181	O
27832	of	104 106	114559 114561	0.9999886751174927	O
27833	genes	107 112	114562 114567	0.9999871253967285	O
27834	normally	113 121	114568 114576	0.9999866485595703	O
27835	expressed	122 131	114577 114586	0.9999879598617554	O
27836	at	132 134	114587 114589	0.9999887943267822	O
27837	high	135 139	114590 114594	0.9999880790710449	O
27838	level	140 145	114595 114600	0.9999873638153076	O
27839	in	146 148	114601 114603	0.9999881982803345	O
27840	the	149 152	114604 114607	0.9999879598617554	O
27841	developing	153 163	114608 114618	0.9999736547470093	O
27842	colon	164 168	114619 114623	0.9999819993972778	O
27844	that	170 174	114625 114629	0.9999874830245972	O
27845	fail	175 179	114630 114634	0.9999810457229614	O
27846	to	180 182	114635 114637	0.9999868869781494	O
27847	be	183 185	114638 114640	0.9999873638153076	O
27848	expressed	186 195	114641 114650	0.9999794960021973	O
27849	in	196 198	114651 114653	0.9999839067459106	O
27850	tumors	199 205	114654 114660	0.9999794960021973	O
27851	(	206 207	114661 114662	0.9999887943267822	O
27852	for	208 211	114663 114666	0.9999860525131226	O
27853	example	212 219	114667 114674	0.9999865293502808	O
27854	,	220 221	114675 114676	0.9999877214431763	O
27855	C18	222 224	114677 114679	0.9999877214431763	O
27857	,	226 227	114681 114682	0.9999874830245972	O
27858	C19	228 230	114683 114685	0.9999879598617554	O
27860	)	232 233	114687 114688	0.9999891519546509	O
27861	,	234 235	114689 114690	0.9999843835830688	O
27862	or	236 238	114691 114693	0.9999830722808838	O
27863	that	239 243	114694 114698	0.9999879598617554	O
27864	are	244 247	114699 114702	0.9999877214431763	O
27865	activated	248 257	114703 114712	0.9999560117721558	O
27866	in	258 260	114713 114715	0.9999862909317017	O
27867	tumor	261 266	114716 114721	0.9999827146530151	O
27868	but	267 270	114722 114725	0.9999871253967285	O
27869	not	271 274	114726 114729	0.9999876022338867	O
27870	normally	275 283	114730 114738	0.9999868869781494	O
27871	expressed	284 293	114739 114748	0.9999876022338867	O
27872	in	294 296	114749 114751	0.999988317489624	O
27873	development	297 308	114752 114763	0.9999773502349854	O
27874	(	309 310	114764 114765	0.9999889135360718	O
27875	C20	311 313	114766 114768	0.9999876022338867	O
27877	)	315 316	114770 114771	0.9999889135360718	O
27878	.	317 318	114772 114773	0.9999569654464722	O
27879	Upregulated	0 10	114774 114784	0.9999818801879883	O
27883	clusters	12 20	114786 114794	0.9999823570251465	O
27884	are	21 24	114795 114798	0.9999816417694092	O
27885	enriched	25 32	114799 114806	0.9999840259552002	O
27888	for	34 37	114808 114811	0.9999849796295166	O
27889	genes	38 43	114812 114817	0.9999828338623047	O
27890	with	44 48	114818 114822	0.9999837875366211	O
27891	known	49 54	114823 114828	0.9999206066131592	O
27892	oncogenic	55 63	114829 114837	0.9999827146530151	O
27895	functions	65 74	114839 114848	0.9999791383743286	O
27896	and	75 78	114849 114852	0.9999854564666748	O
27897	down	79 83	114853 114857	0.9999809265136719	O
27898	-	83 84	114857 114858	0.999987006187439	O
27899	regulated	84 93	114858 114867	0.9999831914901733	O
27900	clusters	94 102	114868 114876	0.9999864101409912	O
27901	for	103 106	114877 114880	0.9999843835830688	O
27902	genes	107 112	114881 114886	0.9999808073043823	O
27903	associated	113 123	114887 114897	0.9999858140945435	O
27904	with	124 128	114898 114902	0.9999858140945435	O
27905	tumor	129 134	114903 114908	0.9999810457229614	O
27906	suppression	135 146	114909 114920	0.9999834299087524	O
27907	.	147 148	114921 114922	0.999891996383667	O
27908	Both	0 4	114923 114927	0.9998075366020203	O
27909	mouse	5 10	114928 114933	0.9712643027305603	species
27910	colon	11 15	114934 114938	0.9998319149017334	O
27912	tumor	17 22	114940 114945	0.9999500513076782	O
27913	models	23 29	114946 114952	0.998914361000061	O
27914	and	30 33	114953 114956	0.9998981952667236	O
27915	human	34 39	114957 114962	0.973924458026886	species
27916	CRC	40 42	114963 114965	0.9999438524246216	O
27918	share	44 49	114967 114972	0.9999827146530151	O
27919	in	50 52	114973 114975	0.999984860420227	O
27920	the	53 56	114976 114979	0.9999879598617554	O
27921	activation	57 67	114980 114990	0.9999842643737793	O
27922	of	68 70	114991 114993	0.999988317489624	O
27923	embryonic	71 79	114994 115002	0.9999874830245972	O
27927	colon	81 85	115004 115008	0.9999861717224121	O
27929	expression	87 97	115010 115020	0.9999867677688599	O
27930	(	98 99	115021 115022	0.9999886751174927	O
27931	C22	100 102	115023 115025	0.9999871253967285	O
27933	)	104 105	115027 115028	0.9999890327453613	O
27934	,	106 107	115029 115030	0.9999874830245972	O
27935	or	108 110	115031 115033	0.9999866485595703	O
27936	partially	111 120	115034 115043	0.9999866485595703	O
27937	overlap	121 128	115044 115051	0.9999877214431763	O
27938	(	129 130	115052 115053	0.9999885559082031	O
27939	C23	131 133	115054 115056	0.9999876022338867	O
27941	,	135 136	115058 115059	0.9999865293502808	O
27942	dotted	137 143	115060 115066	0.9999270439147949	O
27943	lines	144 149	115067 115072	0.9999854564666748	O
27944	)	150 151	115073 115074	0.9999881982803345	O
27945	the	152 155	115075 115078	0.9999878406524658	O
27946	loss	156 160	115079 115083	0.9999872446060181	O
27947	or	161 163	115084 115086	0.9999880790710449	O
27948	repression	164 174	115087 115097	0.9999806880950928	O
27949	of	175 177	115098 115100	0.9999886751174927	O
27950	adult	178 183	115101 115106	0.9999696016311646	O
27951	differentiation	184 199	115107 115122	0.9999828338623047	O
27952	-	199 200	115122 115123	0.9999885559082031	O
27953	associated	200 210	115123 115133	0.9999884366989136	O
27954	genes	211 216	115134 115139	0.9999884366989136	O
27955	(	217 218	115140 115141	0.9999889135360718	O
27956	C19	219 221	115142 115144	0.9999877214431763	O
27958	)	223 224	115146 115147	0.9999889135360718	O
27959	,	225 226	115148 115149	0.9999868869781494	O
27960	and	227 230	115150 115153	0.9999874830245972	O
27961	the	231 234	115154 115157	0.9999874830245972	O
27962	loss	235 239	115158 115162	0.9999849796295166	O
27963	of	240 242	115163 115165	0.999988317489624	O
27964	tumor	243 248	115166 115171	0.9999793767929077	O
27965	suppressor	249 258	115172 115181	0.9999833106994629	O
27967	genes	260 265	115183 115188	0.9999884366989136	O
27968	(	266 267	115189 115190	0.9999887943267822	O
27969	C18	268 270	115191 115193	0.9999876022338867	O
27971	)	272 273	115195 115196	0.9999887943267822	O
27972	.	274 275	115197 115198	0.9999287128448486	O
27973	Many	0 4	115199 115203	0.9999045133590698	O
27974	human	5 10	115204 115209	0.9547298550605774	species
27975	CRCs	11 14	115210 115213	0.9999704360961914	O
27977	also	16 20	115215 115219	0.999976634979248	O
27978	lack	21 25	115220 115224	0.9999796152114868	O
27979	the	26 29	115225 115228	0.9999865293502808	O
27980	expression	30 40	115229 115239	0.999984860420227	O
27981	of	41 43	115240 115242	0.9999871253967285	O
27982	additional	44 54	115243 115253	0.9999711513519287	O
27983	tumor	55 60	115254 115259	0.9999812841415405	O
27984	suppressor	61 70	115260 115269	0.9999836683273315	O
27986	programs	72 80	115271 115279	0.9999842643737793	O
27987	and	81 84	115280 115283	0.9999849796295166	O
27988	gain	85 89	115284 115288	0.9999823570251465	O
27989	the	90 93	115289 115292	0.9999871253967285	O
27990	expression	94 104	115293 115303	0.9999868869781494	O
27991	of	105 107	115304 115306	0.9999877214431763	O
27992	oncogenes	108 116	115307 115315	0.9999855756759644	O
27996	that	118 122	115317 115321	0.9999876022338867	O
27997	are	123 126	115322 115325	0.9999868869781494	O
27998	not	127 130	115326 115329	0.9999843835830688	O
27999	over	131 135	115330 115334	0.9999865293502808	O
28000	-	135 136	115334 115335	0.9999874830245972	O
28001	expressed	136 145	115335 115344	0.9999855756759644	O
28002	during	146 152	115345 115351	0.9999867677688599	O
28003	normal	153 159	115352 115358	0.9999852180480957	O
28004	developmental	160 173	115359 115372	0.9999830722808838	O
28005	morphogenesis	174 186	115373 115385	0.9999872446060181	O
28010	(	188 189	115387 115388	0.9999886751174927	O
28011	C21	190 192	115389 115391	0.9999866485595703	O
28013	)	194 195	115393 115394	0.9999887943267822	O
28014	.	196 197	115395 115396	0.9999880790710449	O
28015	*	198 199	115397 115398	0.9999867677688599	O
28016	*	199 200	115398 115399	0.9999792575836182	O
28017	IGNORE	0 5	115400 115405	0.9999839067459106	O
28020	LINE	7 10	115407 115410	0.9999871253967285	O
28023	*	12 13	115412 115413	0.9999874830245972	O
28024	*	13 14	115413 115414	0.9999873638153076	O
28025	*	15 16	115415 115416	0.9999873638153076	O
28026	*	16 17	115416 115417	0.9999877214431763	O
28027	IGNORE	18 23	115418 115423	0.9999864101409912	O
28030	LINE	25 28	115425 115428	0.9999881982803345	O
28033	*	30 31	115430 115431	0.9999877214431763	O
28034	*	31 32	115431 115432	0.9999878406524658	O
28035	*	33 34	115433 115434	0.9999877214431763	O
28036	*	34 35	115434 115435	0.9999877214431763	O
28037	IGNORE	36 41	115436 115441	0.9999860525131226	O
28040	LINE	43 46	115443 115446	0.9999880790710449	O
28043	*	48 49	115448 115449	0.9999877214431763	O
28044	*	49 50	115449 115450	0.9999874830245972	O
28045	How	51 54	115451 115454	0.9999828338623047	O
28046	do	55 57	115455 115457	0.9999856948852539	O
28047	genes	58 63	115458 115463	0.999984860420227	O
28048	tightly	64 71	115464 115471	0.9999839067459106	O
28049	regulated	72 81	115472 115481	0.9999858140945435	O
28050	during	82 88	115482 115488	0.9999854564666748	O
28051	mouse	89 94	115489 115494	0.9040322303771973	species
28052	colon	95 99	115495 115499	0.999976634979248	O
28054	development	101 112	115501 115512	0.9999120235443115	O
28055	become	113 119	115513 115519	0.9999639987945557	O
28056	activated	120 129	115520 115529	0.9999277591705322	O
28057	in	130 132	115530 115532	0.9997797608375549	O
28058	colon	133 137	115533 115537	0.9999314546585083	O
28060	tumors	139 145	115539 115545	0.999958872795105	O
28061	?	146 147	115546 115547	0.9999697208404541	O
28062	While	0 5	115548 115553	0.9999734163284302	O
28063	activated	6 15	115554 115563	0.9998301267623901	O
28064	canonical	16 25	115564 115573	0.9998999834060669	O
28065	WNT	26 28	115574 115576	0.9999656677246094	O
28067	signaling	30 39	115578 115587	0.9999740123748779	O
28068	imparts	40 46	115588 115594	0.9999783039093018	O
28071	a	48 49	115596 115597	0.9999785423278809	O
28072	strong	50 56	115598 115604	0.9999476671218872	O
28073	influence	57 66	115605 115614	0.9999758005142212	O
28074	,	67 68	115615 115616	0.9999743700027466	O
28075	its	69 72	115617 115620	0.9999841451644897	O
28076	absence	73 80	115621 115628	0.9998621940612793	O
28077	in	81 83	115629 115631	0.9999454021453857	O
28078	Tgfb1	84 88	115632 115636	0.9999817609786987	O
28083	-	89 90	115637 115638	0.9998458623886108	O
28084	/	90 91	115638 115639	0.9990800619125366	O
28085	-	91 92	115639 115640	0.9998329877853394	O
28086	;	92 93	115640 115641	0.9999748468399048	O
28087	Rag2	94 97	115642 115645	0.9999754428863525	O
28090	-	98 99	115646 115647	0.9999831914901733	O
28091	/	99 100	115647 115648	0.999968409538269	O
28092	-	100 101	115648 115649	0.9999821186065674	O
28093	and	102 105	115650 115653	0.9999821186065674	O
28094	Smad3	106 110	115654 115658	0.9999785423278809	O
28097	-	111 112	115659 115660	0.9999611377716064	O
28098	/	112 113	115660 115661	0.9963663816452026	O
28099	-	113 114	115661 115662	0.9934390187263489	O
28100	tumors	115 121	115663 115669	0.9999561309814453	O
28101	,	122 123	115670 115671	0.999981164932251	O
28102	as	124 126	115672 115674	0.9999831914901733	O
28103	determined	127 137	115675 115685	0.9999815225601196	O
28104	by	138 140	115686 115688	0.9999855756759644	O
28105	the	141 144	115689 115692	0.9999840259552002	O
28106	absence	145 152	115693 115700	0.9999710321426392	O
28107	of	153 155	115701 115703	0.9999849796295166	O
28108	nuclear	156 163	115704 115711	0.9999767541885376	O
28109	β	164 165	115712 115713	0.999984622001648	O
28110	-	165 166	115713 115714	0.9999867677688599	O
28111	catenin	166 172	115714 115720	0.9999852180480957	O
28114	,	174 175	115722 115723	0.999976396560669	O
28115	did	176 179	115724 115727	0.9998823404312134	O
28116	not	180 183	115728 115731	0.9999407529830933	O
28117	prevent	184 191	115732 115739	0.9999667406082153	O
28118	the	192 195	115740 115743	0.999975323677063	O
28119	large	196 201	115744 115749	0.9999728202819824	O
28120	scale	202 207	115750 115755	0.9999793767929077	O
28121	activation	208 218	115756 115766	0.9999724626541138	O
28122	of	219 221	115767 115769	0.9999842643737793	O
28123	developmental	222 235	115770 115783	0.9999788999557495	O
28124	/	235 236	115783 115784	0.999984860420227	O
28125	embryonic	236 244	115784 115792	0.9999822378158569	O
28129	gene	246 250	115794 115798	0.9999849796295166	O
28130	expression	251 261	115799 115809	0.999982476234436	O
28131	.	262 263	115810 115811	0.9998612403869629	O
28132	One	0 3	115812 115815	0.9999736547470093	O
28133	mechanism	4 13	115816 115825	0.9999704360961914	O
28134	may	14 17	115826 115829	0.9999740123748779	O
28135	be	18 20	115830 115832	0.9999790191650391	O
28136	through	21 28	115833 115840	0.9999635219573975	O
28137	epigenetic	29 38	115841 115850	0.9999788999557495	O
28141	alterations	40 51	115852 115863	0.9999747276306152	O
28142	.	52 53	115864 115865	0.9998805522918701	O
28143	In	0 2	115866 115868	0.9999361038208008	O
28144	human	3 8	115869 115874	0.9379037022590637	species
28145	CRCs	9 12	115875 115878	0.9999639987945557	O
28147	,	14 15	115880 115881	0.9999843835830688	O
28148	these	16 21	115882 115887	0.9999843835830688	O
28149	types	22 27	115888 115893	0.9999812841415405	O
28150	of	28 30	115894 115896	0.9999855756759644	O
28151	alterations	31 42	115897 115908	0.9999794960021973	O
28152	in	43 45	115909 115911	0.9999861717224121	O
28153	gene	46 50	115912 115916	0.9999843835830688	O
28154	expression	51 61	115917 115927	0.9999829530715942	O
28155	programs	62 70	115928 115936	0.9999861717224121	O
28156	[	71 72	115937 115938	0.9999878406524658	O
28157	50	72 74	115938 115940	0.9999779462814331	O
28158	]	74 75	115940 115941	0.9999856948852539	O
28159	suggest	76 83	115942 115949	0.9999797344207764	O
28160	a	84 85	115950 115951	0.9999868869781494	O
28161	link	86 90	115952 115956	0.9999792575836182	O
28162	between	91 98	115957 115964	0.9999833106994629	O
28163	cellular	99 107	115965 115973	0.9999558925628662	O
28164	homeostasis	108 118	115974 115984	0.9999845027923584	O
28167	and	120 123	115986 115989	0.9999839067459106	O
28168	tumorigenesis	124 136	115990 116002	0.9999747276306152	O
28172	.	138 139	116004 116005	0.9999656677246094	O
28173	The	0 3	116006 116009	0.9999817609786987	O
28174	recruitment	4 15	116010 116021	0.9999569654464722	O
28175	of	16 18	116022 116024	0.9999847412109375	O
28176	histone	19 25	116025 116031	0.9999785423278809	O
28178	acetyltransferases	27 44	116033 116050	0.9999862909317017	O
28185	and	46 49	116052 116055	0.9999855756759644	O
28186	histone	50 56	116056 116062	0.9999833106994629	O
28188	deacetylases	58 69	116064 116075	0.9999866485595703	O
28193	(	71 72	116077 116078	0.9999868869781494	O
28194	HDACs	73 77	116079 116083	0.9999808073043823	O
28197	)	79 80	116085 116086	0.9999874830245972	O
28198	are	81 84	116087 116090	0.9999843835830688	O
28199	key	85 88	116091 116094	0.9999836683273315	O
28200	steps	89 94	116095 116100	0.9999818801879883	O
28201	in	95 97	116101 116103	0.9999847412109375	O
28202	the	98 101	116104 116107	0.999985933303833	O
28203	regulation	102 112	116108 116118	0.9999629259109497	O
28204	of	113 115	116119 116121	0.9999850988388062	O
28205	cell	116 120	116122 116126	0.9999659061431885	O
28206	proliferation	121 134	116127 116140	0.9999854564666748	O
28207	and	135 138	116141 116144	0.999984860420227	O
28208	differentiation	139 154	116145 116160	0.999970555305481	O
28209	during	155 161	116161 116167	0.9999836683273315	O
28210	normal	162 168	116168 116174	0.9998717308044434	O
28211	development	169 180	116175 116186	0.9999167919158936	O
28212	and	181 184	116187 116190	0.9999740123748779	O
28213	carcinogenesis	185 198	116191 116204	0.9999797344207764	O
28217	[	200 201	116206 116207	0.9999879598617554	O
28218	51	201 203	116207 116209	0.9999797344207764	O
28219	]	203 204	116209 116210	0.9999867677688599	O
28220	.	205 206	116211 116212	0.9999738931655884	O
28221	Induction	0 8	116213 116221	0.999981164932251	O
28223	of	10 12	116223 116225	0.9999829530715942	O
28224	Hdac2	13 17	116226 116230	0.9999765157699585	O
28228	expression	19 29	116232 116242	0.9999805688858032	O
28229	occurs	30 36	116243 116249	0.9999721050262451	O
28230	in	37 39	116250 116252	0.9999842643737793	O
28231	82	40 42	116253 116255	0.9999678134918213	O
28232	%	43 44	116256 116257	0.9999796152114868	O
28233	of	45 47	116258 116260	0.9999666213989258	O
28234	human	48 53	116261 116266	0.9616183042526245	species
28235	CRCs	54 57	116267 116270	0.9999712705612183	O
28237	as	59 61	116272 116274	0.9999767541885376	O
28238	well	62 66	116275 116279	0.9999707937240601	O
28239	as	67 69	116280 116282	0.9999681711196899	O
28240	in	70 72	116283 116285	0.9999521970748901	O
28241	tumors	73 79	116286 116292	0.999955415725708	O
28242	from	80 84	116293 116297	0.9999597072601318	O
28243	ApcMin	85 90	116298 116303	0.9999798536300659	O
28248	/	91 92	116304 116305	0.9999769926071167	O
28249	+	92 93	116305 116306	0.9999797344207764	O
28250	mice	94 98	116307 116311	0.5112938284873962	species
28251	[	99 100	116312 116313	0.9999885559082031	O
28252	19	100 102	116313 116315	0.9999836683273315	O
28253	]	102 103	116315 116316	0.9999873638153076	O
28254	.	104 105	116317 116318	0.9999589920043945	O
28255	Alternatively	0 13	116319 116332	0.9999828338623047	O
28256	,	14 15	116333 116334	0.9999876022338867	O
28257	common	16 22	116335 116341	0.9999792575836182	O
28258	regulatory	23 33	116342 116352	0.9999707937240601	O
28259	controls	34 42	116353 116361	0.9999790191650391	O
28260	may	43 46	116362 116365	0.999987006187439	O
28261	operate	47 54	116366 116373	0.9999855756759644	O
28262	in	55 57	116374 116376	0.9999872446060181	O
28263	parallel	58 66	116377 116385	0.9999567270278931	O
28264	growth	67 73	116386 116392	0.9999833106994629	O
28265	and	74 77	116393 116396	0.999987006187439	O
28266	differentiation	78 93	116397 116412	0.999983549118042	O
28267	/	93 94	116412 116413	0.9999873638153076	O
28268	anti	94 98	116413 116417	0.9999818801879883	O
28269	-	98 99	116417 116418	0.9999876022338867	O
28270	diifferentiation	99 114	116418 116433	0.9999855756759644	O
28275	pathways	116 124	116435 116443	0.9999874830245972	O
28276	such	125 129	116444 116448	0.9999878406524658	O
28277	that	130 134	116449 116453	0.9999884366989136	O
28278	a	135 136	116454 116455	0.999988317489624	O
28279	single	137 143	116456 116462	0.9999878406524658	O
28280	or	144 146	116463 116465	0.9999874830245972	O
28281	small	147 152	116466 116471	0.9999833106994629	O
28282	subset	153 159	116472 116478	0.9999881982803345	O
28283	of	160 162	116479 116481	0.9999878406524658	O
28284	regulators	163 172	116482 116491	0.9999825954437256	O
28286	,	174 175	116493 116494	0.9999876022338867	O
28287	such	176 180	116495 116499	0.9999878406524658	O
28288	as	181 183	116500 116502	0.9999884366989136	O
28289	MYC	184 186	116503 116505	0.9999858140945435	O
28292	or	188 190	116507 116509	0.9999874830245972	O
28293	one	191 194	116510 116513	0.9999884366989136	O
28294	or	195 197	116514 116516	0.9999872446060181	O
28295	more	198 202	116517 116521	0.9999871253967285	O
28296	micro	203 208	116522 116527	0.9999841451644897	O
28297	RNAs	209 212	116528 116531	0.9999845027923584	O
28299	,	214 215	116533 116534	0.999985933303833	O
28300	may	216 219	116535 116538	0.9999878406524658	O
28301	be	220 222	116539 116541	0.9999880790710449	O
28302	responsible	223 234	116542 116553	0.9999872446060181	O
28303	for	235 238	116554 116557	0.9999877214431763	O
28304	the	239 242	116558 116561	0.9999877214431763	O
28305	control	243 250	116562 116569	0.9999837875366211	O
28306	of	251 253	116570 116572	0.9999879598617554	O
28307	multiple	254 262	116573 116581	0.9999785423278809	O
28308	pathways	263 271	116582 116590	0.9999806880950928	O
28309	.	272 273	116591 116592	0.9999281167984009	O
28310	Indeed	0 6	116593 116599	0.9999805688858032	O
28311	,	7 8	116600 116601	0.999987006187439	O
28312	consistent	9 19	116602 116612	0.9999849796295166	O
28313	with	20 24	116613 116617	0.9999867677688599	O
28314	our	25 28	116618 116621	0.9999731779098511	O
28315	observation	29 40	116622 116633	0.9999814033508301	O
28316	of	41 43	116634 116636	0.9999864101409912	O
28317	nuclear	44 51	116637 116644	0.9999823570251465	O
28318	β	52 53	116645 116646	0.999985933303833	O
28319	-	53 54	116646 116647	0.9999877214431763	O
28320	catenin	54 60	116647 116653	0.9999861717224121	O
28323	-	61 62	116654 116655	0.9999872446060181	O
28324	independent	62 73	116655 116666	0.9999682903289795	O
28325	activation	74 84	116667 116677	0.9999606609344482	O
28326	of	85 87	116678 116680	0.9999862909317017	O
28327	Myc	88 90	116681 116683	0.9999774694442749	O
28329	in	92 94	116685 116687	0.9999862909317017	O
28330	all	95 98	116688 116691	0.9999752044677734	O
28331	mouse	99 104	116692 116697	0.9429389238357544	species
28332	models	105 111	116698 116704	0.9999703168869019	O
28333	and	112 115	116705 116708	0.9999831914901733	O
28334	across	116 122	116709 116715	0.9999781847000122	O
28335	the	123 126	116716 116719	0.9999855756759644	O
28336	board	127 132	116720 116725	0.999968409538269	O
28337	for	133 136	116726 116729	0.9999736547470093	O
28338	human	137 142	116730 116735	0.9696014523506165	species
28339	CRC	143 145	116736 116738	0.9999793767929077	O
28341	,	147 148	116740 116741	0.9999860525131226	O
28342	deletion	149 156	116742 116749	0.999981164932251	O
28345	of	158 160	116751 116753	0.999985933303833	O
28346	Myc	161 163	116754 116756	0.9999790191650391	O
28348	has	165 168	116758 116761	0.9999868869781494	O
28349	recently	169 177	116762 116770	0.9999840259552002	O
28350	been	178 182	116771 116775	0.9999867677688599	O
28351	demonstrated	183 195	116776 116788	0.9999815225601196	O
28352	to	196 198	116789 116791	0.9999865293502808	O
28353	completely	199 209	116792 116802	0.9999822378158569	O
28354	abrogate	210 217	116803 116810	0.9999861717224121	O
28357	nuclear	219 226	116812 116819	0.9999819993972778	O
28358	β	227 228	116820 116821	0.9999860525131226	O
28359	-	228 229	116821 116822	0.9999876022338867	O
28360	catenin	229 235	116822 116828	0.9999858140945435	O
28363	-	236 237	116829 116830	0.9999873638153076	O
28364	driven	237 243	116830 116836	0.9999697208404541	O
28365	small	244 249	116837 116842	0.9999592304229736	O
28366	bowel	250 254	116843 116847	0.9999799728393555	O
28368	oncogenesis	256 266	116849 116859	0.9999847412109375	O
28371	in	268 270	116861 116863	0.9999865293502808	O
28372	mouse	271 276	116864 116869	0.9011279344558716	species
28373	models	277 283	116870 116876	0.9999821186065674	O
28374	[	284 285	116877 116878	0.9999876022338867	O
28375	52	285 287	116878 116880	0.9999785423278809	O
28376	]	287 288	116880 116881	0.9999862909317017	O
28377	.	289 290	116882 116883	0.9999691247940063	O
28378	Comparative	0 11	116884 116895	0.9999678134918213	O
28379	analysis	12 20	116896 116904	0.9999830722808838	O
28380	reveals	21 28	116905 116912	0.9999829530715942	O
28381	underlying	29 39	116913 116923	0.9999856948852539	O
28382	development	40 51	116924 116935	0.9999768733978271	O
28383	-	51 52	116935 116936	0.9999889135360718	O
28384	related	52 59	116936 116943	0.9999874830245972	O
28385	signatures	60 70	116944 116954	0.9999822378158569	O
28386	in	71 73	116955 116957	0.999981164932251	O
28387	human	74 79	116958 116963	0.9143112301826477	species
28388	CRCs	80 83	116964 116967	0.99997878074646	O
28390	As	85 87	116969 116971	0.9999874830245972	O
28391	shown	88 93	116972 116977	0.9999874830245972	O
28392	in	94 96	116978 116980	0.9999887943267822	O
28393	Figure	97 103	116981 116987	0.9999876022338867	O
28394	5	104 105	116988 116989	0.9999877214431763	O
28395	,	106 107	116990 116991	0.9999880790710449	O
28396	considerable	108 120	116992 117004	0.999987006187439	O
28397	and	121 124	117005 117008	0.9999865293502808	O
28398	intriguing	125 135	117009 117019	0.9999853372573853	O
28399	heterogeneity	136 148	117020 117032	0.9999878406524658	O
28403	of	150 152	117034 117036	0.9999866485595703	O
28404	human	153 158	117037 117042	0.8382973670959473	species
28405	CRC	159 161	117043 117045	0.9999812841415405	O
28407	is	163 165	117047 117049	0.9999876022338867	O
28408	observed	166 174	117050 117058	0.9999876022338867	O
28409	among	175 180	117059 117064	0.999988317489624	O
28410	genes	181 186	117065 117070	0.9999845027923584	O
28411	highly	187 193	117071 117077	0.9999884366989136	O
28412	relevant	194 202	117078 117086	0.9999884366989136	O
28413	for	203 206	117087 117090	0.9999881982803345	O
28414	differential	207 219	117091 117103	0.9999829530715942	O
28415	malignant	220 228	117104 117112	0.9999864101409912	O
28418	behavior	230 238	117114 117122	0.9999867677688599	O
28419	.	239 240	117123 117124	0.9999666213989258	O
28420	However	0 7	117125 117132	0.9999805688858032	O
28421	,	8 9	117133 117134	0.9999854564666748	O
28422	employing	10 19	117135 117144	0.9999744892120361	O
28423	between	20 27	117145 117152	0.9999785423278809	O
28424	-	27 28	117152 117153	0.9999794960021973	O
28425	tumors	28 34	117153 117159	0.9999827146530151	O
28426	normalization	35 47	117160 117172	0.9999860525131226	O
28428	and	49 52	117174 117177	0.999984622001648	O
28429	referencing	53 63	117178 117188	0.9999861717224121	O
28431	strategies	65 75	117190 117200	0.999984860420227	O
28432	prevents	76 84	117201 117209	0.9999686479568481	O
28433	the	85 88	117210 117213	0.9999867677688599	O
28434	detection	89 98	117214 117223	0.9999872446060181	O
28435	of	99 101	117224 117226	0.9999878406524658	O
28436	gene	102 106	117227 117231	0.9999876022338867	O
28437	expression	107 117	117232 117242	0.9999864101409912	O
28438	patterns	118 126	117243 117251	0.9999878406524658	O
28439	that	127 131	117252 117256	0.9999880790710449	O
28440	are	132 135	117257 117260	0.9999873638153076	O
28441	shared	136 142	117261 117267	0.9999828338623047	O
28442	between	143 150	117268 117275	0.999977707862854	O
28443	tumors	151 157	117276 117282	0.9999818801879883	O
28444	.	158 159	117283 117284	0.9999505281448364	O
28445	Using	0 5	117285 117290	0.9999867677688599	O
28446	the	6 9	117291 117294	0.9999866485595703	O
28447	adult	10 15	117295 117300	0.9995716214179993	O
28448	normal	16 22	117301 117307	0.9999662637710571	O
28449	colon	23 27	117308 117312	0.9999799728393555	O
28451	as	29 31	117314 117316	0.9999878406524658	O
28452	a	32 33	117317 117318	0.999988317489624	O
28453	reference	34 43	117319 117328	0.9999829530715942	O
28454	,	44 45	117329 117330	0.9999871253967285	O
28455	as	46 48	117331 117333	0.9999881982803345	O
28456	shown	49 54	117334 117339	0.9999873638153076	O
28457	in	55 57	117340 117342	0.9999886751174927	O
28458	Figure	58 64	117343 117349	0.9999860525131226	O
28459	6	65 66	117350 117351	0.9999872446060181	O
28460	,	67 68	117352 117353	0.999988317489624	O
28461	a	69 70	117354 117355	0.9999887943267822	O
28462	large	71 76	117356 117361	0.9999872446060181	O
28463	fraction	77 85	117362 117370	0.9999887943267822	O
28464	of	86 88	117371 117373	0.9999885559082031	O
28465	differential	89 101	117374 117386	0.9999865293502808	O
28466	gene	102 106	117387 117391	0.9999879598617554	O
28467	expression	107 117	117392 117402	0.9999878406524658	O
28468	relative	118 126	117403 117411	0.9999886751174927	O
28469	to	127 129	117412 117414	0.9999886751174927	O
28470	adult	130 135	117415 117420	0.9998818635940552	O
28471	colon	136 140	117421 117425	0.9999833106994629	O
28473	could	142 147	117427 117432	0.9999880790710449	O
28474	be	148 150	117433 117435	0.9999884366989136	O
28475	demonstrated	151 163	117436 117448	0.999988317489624	O
28476	that	164 168	117449 117453	0.9999889135360718	O
28477	recapitulated	169 181	117454 117466	0.9999885559082031	O
28481	developmental	183 196	117468 117481	0.9999817609786987	O
28482	gene	197 201	117482 117486	0.999988317489624	O
28483	expression	202 212	117487 117497	0.9999880790710449	O
28484	by	213 215	117498 117500	0.9999884366989136	O
28485	virtue	216 222	117501 117507	0.9999862909317017	O
28486	of	223 225	117508 117510	0.9999887943267822	O
28487	both	226 230	117511 117515	0.9999872446060181	O
28488	activating	231 240	117516 117525	0.9999880790710449	O
28490	embryonic	242 250	117527 117535	0.9999877214431763	O
28494	colon	252 256	117537 117541	0.9999872446060181	O
28496	gene	258 262	117543 117547	0.9999885559082031	O
28497	expression	263 273	117548 117558	0.999988317489624	O
28498	and	274 277	117559 117562	0.9999855756759644	O
28499	failing	278 285	117563 117570	0.9999818801879883	O
28500	to	286 288	117571 117573	0.9999873638153076	O
28501	express	289 296	117574 117581	0.999987006187439	O
28502	genes	297 302	117582 117587	0.9999868869781494	O
28503	associated	303 313	117588 117598	0.9999884366989136	O
28504	with	314 318	117599 117603	0.9999885559082031	O
28505	normal	319 325	117604 117610	0.9999822378158569	O
28506	colon	326 330	117611 117615	0.9999794960021973	O
28508	maturation	332 341	117617 117626	0.9999861717224121	O
28510	.	343 344	117628 117629	0.9999582767486572	O
28511	Within	0 6	117630 117636	0.9999765157699585	O
28512	these	7 12	117637 117642	0.9999864101409912	O
28513	developmentally	13 27	117643 117657	0.9999761581420898	O
28515	regulated	29 38	117659 117668	0.9999761581420898	O
28516	gene	39 43	117669 117673	0.9999828338623047	O
28517	sets	44 48	117674 117678	0.999984860420227	O
28518	,	49 50	117679 117680	0.9999842643737793	O
28519	our	51 54	117681 117684	0.9999680519104004	O
28520	analyses	55 63	117685 117693	0.9999425411224365	O
28521	revealed	64 72	117694 117702	0.9999837875366211	O
28522	little	73 79	117703 117709	0.9999781847000122	O
28523	evidence	80 88	117710 117718	0.9999810457229614	O
28524	of	89 91	117719 117721	0.9999856948852539	O
28525	CRC	92 94	117722 117724	0.9999663829803467	O
28527	subsets	96 102	117726 117732	0.9999847412109375	O
28529	,	104 105	117734 117735	0.9999853372573853	O
28530	including	106 115	117736 117745	0.9999862909317017	O
28531	those	116 121	117746 117751	0.9999856948852539	O
28532	suggestive	122 131	117752 117761	0.9999861717224121	O
28534	of	133 135	117763 117765	0.9999876022338867	O
28535	nuclear	136 143	117766 117773	0.9999799728393555	O
28536	β	144 145	117774 117775	0.9999871253967285	O
28537	-	145 146	117775 117776	0.9999884366989136	O
28538	catenin	146 152	117776 117782	0.9999867677688599	O
28541	negative	154 162	117784 117792	0.9999812841415405	O
28542	tumors	163 169	117793 117799	0.9999797344207764	O
28543	that	170 174	117800 117804	0.9999872446060181	O
28544	might	175 180	117805 117810	0.9999845027923584	O
28545	approximate	181 192	117811 117822	0.9999825954437256	O
28546	the	193 196	117823 117826	0.9999876022338867	O
28547	Smad3	197 201	117827 117831	0.9999865293502808	O
28550	-	202 203	117832 117833	0.9999881982803345	O
28551	/	203 204	117833 117834	0.9999867677688599	O
28552	-	204 205	117834 117835	0.9999881982803345	O
28553	and	206 209	117836 117839	0.9999866485595703	O
28554	Tgfb1	210 214	117840 117844	0.9999860525131226	O
28559	-	215 216	117845 117846	0.9999880790710449	O
28560	/	216 217	117846 117847	0.9999874830245972	O
28561	-	217 218	117847 117848	0.9999884366989136	O
28562	;	218 219	117848 117849	0.9999828338623047	O
28563	Rag2	220 223	117850 117853	0.9999814033508301	O
28566	-	224 225	117854 117855	0.9999881982803345	O
28567	/	225 226	117855 117856	0.9999861717224121	O
28568	-	226 227	117856 117857	0.9999880790710449	O
28569	signature	228 237	117858 117867	0.9999809265136719	O
28570	.	238 239	117868 117869	0.9999476671218872	O
28571	Our	0 3	117870 117873	0.9999828338623047	O
28572	inability	4 13	117874 117883	0.9999830722808838	O
28573	to	14 16	117884 117886	0.9999876022338867	O
28574	identify	17 25	117887 117895	0.9999877214431763	O
28575	distinct	26 34	117896 117904	0.9999854564666748	O
28576	subclasses	35 44	117905 117914	0.9999881982803345	O
28580	with	46 50	117916 117920	0.9999880790710449	O
28581	respect	51 58	117921 117928	0.9999884366989136	O
28582	to	59 61	117929 117931	0.9999887943267822	O
28583	developmental	62 75	117932 117945	0.999983549118042	O
28584	genes	76 81	117946 117951	0.999988317489624	O
28585	in	82 84	117952 117954	0.9999874830245972	O
28586	the	85 88	117955 117958	0.9999785423278809	O
28587	human	89 94	117959 117964	0.8352677822113037	species
28588	CRCs	95 98	117965 117968	0.9999792575836182	O
28590	is	100 102	117970 117972	0.9999881982803345	O
28591	perhaps	103 110	117973 117980	0.9999874830245972	O
28592	not	111 114	117981 117984	0.9999880790710449	O
28593	surprising	115 125	117985 117995	0.9999873638153076	O
28594	in	126 128	117996 117998	0.999988317489624	O
28595	that	129 133	117999 118003	0.9999884366989136	O
28596	over	134 138	118004 118008	0.999988317489624	O
28597	80	139 141	118009 118011	0.9999861717224121	O
28598	%	142 143	118012 118013	0.9999880790710449	O
28599	of	144 146	118014 118016	0.999988317489624	O
28600	microsatellite	147 160	118017 118030	0.9999879598617554	O
28604	-	161 162	118031 118032	0.9999891519546509	O
28605	unstable	162 170	118032 118040	0.9999858140945435	O
28606	(	171 172	118041 118042	0.9999890327453613	O
28607	MSI	173 175	118043 118045	0.9999871253967285	O
28609	+	176 177	118046 118047	0.9999880790710449	O
28610	)	178 179	118048 118049	0.9999884366989136	O
28611	CRCs	180 183	118050 118053	0.999981164932251	O
28613	from	185 189	118055 118059	0.999985933303833	O
28614	HNPCC	190 194	118060 118064	0.9999682903289795	O
28617	families	196 204	118066 118074	0.9999833106994629	O
28618	exhibit	205 212	118075 118082	0.9999874830245972	O
28619	nuclear	213 220	118083 118090	0.9999862909317017	O
28620	β	221 222	118091 118092	0.9999879598617554	O
28621	-	222 223	118092 118093	0.9999892711639404	O
28622	catenin	223 229	118093 118099	0.9999876022338867	O
28625	[	231 232	118101 118102	0.9999891519546509	O
28626	53	232 234	118102 118104	0.9999860525131226	O
28627	]	234 235	118104 118105	0.9999889135360718	O
28628	.	236 237	118106 118107	0.999974250793457	O
28629	In	0 2	118108 118110	0.9999876022338867	O
28630	addition	3 11	118111 118119	0.9999871253967285	O
28631	,	12 13	118120 118121	0.9999877214431763	O
28632	within	14 20	118122 118128	0.9999858140945435	O
28633	the	21 24	118129 118132	0.9999879598617554	O
28634	developmental	25 38	118133 118146	0.9999771118164062	O
28635	genes	39 44	118147 118152	0.999987006187439	O
28636	,	45 46	118153 118154	0.9999877214431763	O
28637	little	47 53	118155 118161	0.999987006187439	O
28638	evidence	54 62	118162 118170	0.9999868869781494	O
28639	was	63 66	118171 118174	0.9999878406524658	O
28640	apparent	67 75	118175 118183	0.9999880790710449	O
28641	for	76 79	118184 118187	0.9999885559082031	O
28642	signatures	80 90	118188 118198	0.999987006187439	O
28643	related	91 98	118199 118206	0.9999880790710449	O
28644	to	99 101	118207 118209	0.9999886751174927	O
28645	MSI	102 104	118210 118212	0.9999858140945435	O
28647	+	105 106	118213 118214	0.9999850988388062	O
28648	tumors	107 113	118215 118221	0.9999858140945435	O
28649	,	114 115	118222 118223	0.9999872446060181	O
28650	often	116 121	118224 118229	0.999987006187439	O
28651	associated	122 132	118230 118240	0.9999879598617554	O
28652	with	133 137	118241 118245	0.999988317489624	O
28653	HNPCC	138 142	118246 118250	0.9999843835830688	O
28656	,	144 145	118252 118253	0.9999877214431763	O
28657	although	146 154	118254 118262	0.9999881982803345	O
28658	some	155 159	118263 118267	0.9999880790710449	O
28659	of	160 162	118268 118270	0.9999878406524658	O
28660	this	163 167	118271 118275	0.9999884366989136	O
28661	type	168 172	118276 118280	0.9999876022338867	O
28662	of	173 175	118281 118283	0.9999880790710449	O
28663	signature	176 185	118284 118293	0.9999868869781494	O
28664	was	186 189	118294 118297	0.9999879598617554	O
28665	perhaps	190 197	118298 118305	0.9999876022338867	O
28666	apparent	198 206	118306 118314	0.9999879598617554	O
28667	in	207 209	118315 118317	0.9999880790710449	O
28668	the	210 213	118318 118321	0.9999884366989136	O
28669	median	214 220	118322 118328	0.9999856948852539	O
28670	normalized	221 230	118329 118338	0.9999872446060181	O
28672	depiction	232 241	118340 118349	0.9999837875366211	O
28673	of	242 244	118350 118352	0.999987006187439	O
28674	the	245 248	118353 118356	0.9999858140945435	O
28675	tumors	249 255	118357 118363	0.999983549118042	O
28676	as	256 258	118364 118366	0.9999877214431763	O
28677	highlighted	259 270	118367 118378	0.9999876022338867	O
28678	in	271 273	118379 118381	0.9999877214431763	O
28679	Figure	274 280	118382 118388	0.9999867677688599	O
28680	5	281 282	118389 118390	0.999987006187439	O
28681	.	283 284	118391 118392	0.9999881982803345	O
28682	*	285 286	118393 118394	0.9999872446060181	O
28683	*	286 287	118394 118395	0.999975323677063	O
28684	IGNORE	0 5	118396 118401	0.9999849796295166	O
28687	LINE	7 10	118403 118406	0.9999884366989136	O
28690	*	12 13	118408 118409	0.9999890327453613	O
28691	*	13 14	118409 118410	0.9999890327453613	O
28692	*	15 16	118411 118412	0.9999889135360718	O
28693	*	16 17	118412 118413	0.9999890327453613	O
28694	IGNORE	18 23	118414 118419	0.9999872446060181	O
28697	LINE	25 28	118421 118424	0.9999890327453613	O
28700	*	30 31	118426 118427	0.9999886751174927	O
28701	*	31 32	118427 118428	0.9999886751174927	O
28702	*	33 34	118429 118430	0.9999887943267822	O
28703	*	34 35	118430 118431	0.9999886751174927	O
28704	IGNORE	36 41	118432 118437	0.9999873638153076	O
28707	LINE	43 46	118439 118442	0.9999889135360718	O
28710	*	48 49	118444 118445	0.9999887943267822	O
28711	*	49 50	118445 118446	0.9999887943267822	O
28712	Inter	51 56	118447 118452	0.9999886751174927	O
28713	-	56 57	118452 118453	0.99998939037323	O
28714	organism	57 65	118453 118461	0.9999802112579346	O
28715	gene	66 70	118462 118466	0.999988317489624	O
28716	ortholog	71 78	118467 118474	0.9999891519546509	O
28720	and	80 83	118476 118479	0.9999887943267822	O
28721	inter	84 89	118480 118485	0.9999890327453613	O
28722	-	89 90	118485 118486	0.9999892711639404	O
28723	platform	90 98	118486 118494	0.9999847412109375	O
28724	comparison	99 109	118495 118505	0.9999884366989136	O
28725	strategy	110 118	118506 118514	0.9999885559082031	O
28726	Pairs	119 123	118515 118519	0.9999871253967285	O
28728	of	125 127	118521 118523	0.9999886751174927	O
28729	human	128 133	118524 118529	0.9998948574066162	O
28730	and	134 137	118530 118533	0.9999881982803345	O
28731	mouse	138 143	118534 118539	0.9997887015342712	O
28732	ortholog	144 151	118540 118547	0.9999889135360718	O
28736	genes	153 158	118549 118554	0.9999877214431763	O
28737	(	159 160	118555 118556	0.9999892711639404	O
28738	12	161 163	118557 118559	0.9999880790710449	O
28739	,	163 164	118559 118560	0.9999885559082031	O
28740	693	164 166	118560 118562	0.999987006187439	O
28742	)	168 169	118564 118565	0.9999892711639404	O
28743	were	170 174	118566 118570	0.9999876022338867	O
28744	curated	175 182	118571 118578	0.9999468326568604	O
28745	using	183 188	118579 118584	0.9999881982803345	O
28746	the	189 192	118585 118588	0.9999884366989136	O
28747	Mouse	193 198	118589 118594	0.9998712539672852	O
28748	Genome	199 204	118595 118600	0.9999877214431763	O
28750	Informatics	206 216	118602 118612	0.9999887943267822	O
28752	(	218 219	118614 118615	0.9999887943267822	O
28753	MGI	220 222	118616 118618	0.9999842643737793	O
28755	;	224 225	118620 118621	0.999988317489624	O
28756	The	226 229	118622 118625	0.9999865293502808	O
28757	Jackson	230 237	118626 118633	0.9999604225158691	O
28758	Laboratory	238 248	118634 118644	0.9999855756759644	O
28759	)	249 250	118645 118646	0.9999881982803345	O
28760	[	251 252	118647 118648	0.9999890327453613	O
28761	61	252 254	118648 118650	0.9999861717224121	O
28762	]	254 255	118650 118651	0.9999884366989136	O
28763	and	256 259	118652 118655	0.9999879598617554	O
28764	National	260 268	118656 118664	0.9999772310256958	O
28765	Center	269 275	118665 118671	0.9999868869781494	O
28766	for	276 279	118672 118675	0.9999879598617554	O
28767	Biotechnology	280 292	118676 118688	0.9999876022338867	O
28771	Information	294 305	118690 118701	0.9999880790710449	O
28772	(	306 307	118702 118703	0.9999886751174927	O
28773	NCBI	307 310	118703 118706	0.9999873638153076	O
28775	)	312 313	118708 118709	0.9999886751174927	O
28776	Homologene	314 323	118710 118719	0.9999873638153076	O
28780	[	325 326	118721 118722	0.9999889135360718	O
28781	62	326 328	118722 118724	0.9999853372573853	O
28782	]	328 329	118724 118725	0.9999890327453613	O
28783	databases	330 339	118726 118735	0.9999794960021973	O
28784	.	340 341	118736 118737	0.9999681711196899	O
28785	Individual	0 10	118738 118748	0.9999769926071167	O
28786	microarray	11 20	118749 118758	0.999981164932251	O
28789	elements	22 30	118760 118768	0.9999779462814331	O
28790	or	31 33	118769 118771	0.9999701976776123	O
28791	features	34 42	118772 118780	0.999976634979248	O
28792	were	43 47	118781 118785	0.9999735355377197	O
28793	mapped	48 54	118786 118792	0.999967098236084	O
28794	to	55 57	118793 118795	0.9999748468399048	O
28795	these	58 63	118796 118801	0.9999772310256958	O
28796	.	64 65	118802 118803	0.9998279809951782	O
28797	The	0 3	118804 118807	0.9999879598617554	O
28798	concatenated	4 15	118808 118819	0.9999880790710449	O
28801	human	17 22	118821 118826	0.9999030828475952	O
28802	and	23 26	118827 118830	0.9999867677688599	O
28803	mouse	27 32	118831 118836	0.9996296167373657	O
28804	RefSeq	33 38	118837 118842	0.9999880790710449	O
28809	IDs	40 42	118844 118846	0.9999877214431763	O
28811	was	44 47	118848 118851	0.999988317489624	O
28812	used	48 52	118852 118856	0.9999879598617554	O
28813	as	53 55	118857 118859	0.9999890327453613	O
28814	the	56 59	118860 118863	0.9999891519546509	O
28815	composite	60 69	118864 118873	0.9999819993972778	O
28816	ID	70 72	118874 118876	0.9999884366989136	O
28817	for	73 76	118877 118880	0.9999892711639404	O
28818	the	77 80	118881 118884	0.9999895095825195	O
28819	orthologous	81 91	118885 118895	0.99998939037323	O
28824	gene	93 97	118897 118901	0.9999886751174927	O
28825	pair	98 102	118902 118906	0.9999891519546509	O
28826	in	103 105	118907 118909	0.9999891519546509	O
28827	the	106 109	118910 118913	0.99998939037323	O
28828	ortholog	110 117	118914 118921	0.99998939037323	O
28832	genome	119 125	118923 118929	0.9999867677688599	O
28833	definition	126 136	118930 118940	0.9999880790710449	O
28834	.	137 138	118941 118942	0.9999691247940063	O
28835	NIA	0 2	118943 118945	0.999980092048645	O
28837	/	3 4	118946 118947	0.9999858140945435	O
28838	Research	4 12	118947 118955	0.9999490976333618	O
28839	Genetics	13 20	118956 118963	0.9999821186065674	O
28841	mouse	22 27	118965 118970	0.9984079003334045	O
28842	cDNAs	28 32	118971 118975	0.9999880790710449	O
28846	were	34 38	118977 118981	0.999987006187439	O
28847	mapped	39 45	118982 118988	0.9999850988388062	O
28848	to	46 48	118989 118991	0.9999886751174927	O
28849	human	49 54	118992 118997	0.999911904335022	O
28850	orthologs	55 63	118998 119006	0.9999890327453613	O
28854	using	65 70	119008 119013	0.9999885559082031	O
28855	a	71 72	119014 119015	0.9999885559082031	O
28856	variety	73 80	119016 119023	0.9999877214431763	O
28857	of	81 83	119024 119026	0.9999881982803345	O
28858	resources	84 93	119027 119036	0.999985933303833	O
28859	,	94 95	119037 119038	0.9999878406524658	O
28860	usually	96 103	119039 119046	0.9999874830245972	O
28861	via	104 107	119047 119050	0.999988317489624	O
28862	the	108 111	119051 119054	0.9999889135360718	O
28863	Stanford	112 120	119055 119063	0.9999737739562988	O
28864	Online	121 127	119064 119070	0.9999876022338867	O
28865	Universal	128 137	119071 119080	0.999988317489624	O
28866	Reference	138 147	119081 119090	0.9999877214431763	O
28867	resource	148 156	119091 119099	0.9999890327453613	O
28868	[	157 158	119100 119101	0.9999890327453613	O
28869	63	158 160	119101 119103	0.9999861717224121	O
28870	]	160 161	119103 119104	0.9999885559082031	O
28871	.	162 163	119105 119106	0.9999767541885376	O
28872	Gene	0 4	119107 119111	0.9999837875366211	O
28873	transcript	5 14	119112 119121	0.9999872446060181	O
28875	assignments	16 27	119123 119134	0.9999842643737793	O
28876	were	28 32	119135 119139	0.9999837875366211	O
28877	made	33 37	119140 119144	0.9999847412109375	O
28878	unique	38 44	119145 119151	0.9999855756759644	O
28879	by	45 47	119152 119154	0.9999862909317017	O
28880	choosing	48 56	119155 119163	0.9999855756759644	O
28881	the	57 60	119164 119167	0.9999880790710449	O
28882	longest	61 68	119168 119175	0.9999837875366211	O
28883	corresponding	69 82	119176 119189	0.9999864101409912	O
28884	transcript	83 92	119190 119199	0.9999873638153076	O
28886	.	94 95	119201 119202	0.999954342842102	O
28887	To	0 2	119203 119205	0.9999837875366211	O
28888	map	3 6	119206 119209	0.9999828338623047	O
28889	the	7 10	119210 119213	0.9999877214431763	O
28890	Affymetrix	11 20	119214 119223	0.9999861717224121	O
28894	human	22 27	119225 119230	0.9999340772628784	O
28895	and	28 31	119231 119234	0.9999856948852539	O
28896	mouse	32 37	119235 119240	0.9998185038566589	O
28897	array	38 43	119241 119246	0.9999839067459106	O
28898	data	44 48	119247 119251	0.9999812841415405	O
28899	into	49 53	119252 119256	0.9999856948852539	O
28900	the	54 57	119257 119260	0.9999885559082031	O
28901	ortholog	58 65	119261 119268	0.9999874830245972	O
28905	genome	67 73	119270 119276	0.999975323677063	O
28906	,	74 75	119277 119278	0.9999862909317017	O
28907	we	76 78	119279 119281	0.999983549118042	O
28908	used	79 83	119282 119286	0.9999861717224121	O
28909	a	84 85	119287 119288	0.9999878406524658	O
28910	sequence	86 94	119289 119297	0.9999853372573853	O
28911	matching	95 103	119298 119306	0.999987006187439	O
28912	approach	104 112	119307 119315	0.9999872446060181	O
28913	.	113 114	119316 119317	0.9999668598175049	O
28914	First	0 5	119318 119323	0.9999785423278809	O
28915	,	6 7	119324 119325	0.999988317489624	O
28916	we	8 10	119326 119328	0.999984860420227	O
28917	obtained	11 19	119329 119337	0.9999865293502808	O
28918	human	20 25	119338 119343	0.9999074935913086	O
28919	and	26 29	119344 119347	0.9999864101409912	O
28920	mouse	30 35	119348 119353	0.9875345230102539	O
28921	transcript	36 45	119354 119363	0.9999879598617554	O
28923	sequences	47 56	119365 119374	0.9999865293502808	O
28924	from	57 61	119375 119379	0.9999889135360718	O
28925	RefSeq	62 67	119380 119385	0.9999889135360718	O
28930	[	69 70	119387 119388	0.9999896287918091	O
28931	64	70 72	119388 119390	0.9999868869781494	O
28932	]	72 73	119390 119391	0.9999895095825195	O
28933	and	74 77	119392 119395	0.9999880790710449	O
28934	probe	78 83	119396 119401	0.9999829530715942	O
28935	sequences	84 93	119402 119411	0.9999878406524658	O
28936	from	94 98	119412 119416	0.9999889135360718	O
28937	the	99 102	119417 119420	0.9999890327453613	O
28938	manufacturer	103 115	119421 119433	0.9999853372573853	O
28939	'	116 117	119434 119435	0.9999890327453613	O
28940	s	117 118	119435 119436	0.9999890327453613	O
28941	website	119 126	119437 119444	0.9999866485595703	O
28942	[	127 128	119445 119446	0.99998939037323	O
28943	65	128 130	119446 119448	0.9999874830245972	O
28944	]	130 131	119448 119449	0.99998939037323	O
28945	.	132 133	119450 119451	0.999975323677063	O
28946	Next	0 4	119452 119456	0.9999805688858032	O
28947	,	5 6	119457 119458	0.9999872446060181	O
28948	we	7 9	119459 119461	0.9999830722808838	O
28949	computed	10 17	119462 119469	0.9999853372573853	O
28951	all	19 22	119471 119474	0.9999861717224121	O
28952	perfect	23 30	119475 119482	0.9999845027923584	O
28953	probe	31 36	119483 119488	0.999984622001648	O
28954	-	36 37	119488 119489	0.9999873638153076	O
28955	transcript	37 46	119489 119498	0.9999873638153076	O
28957	pairs	48 53	119500 119505	0.9999860525131226	O
28958	.	54 55	119506 119507	0.9999485015869141	O
28959	We	0 2	119508 119510	0.9999837875366211	O
28960	excluded	3 11	119511 119519	0.9999827146530151	O
28961	probes	12 17	119520 119525	0.9999855756759644	O
28963	that	19 23	119527 119531	0.9999881982803345	O
28964	matched	24 31	119532 119539	0.9999880790710449	O
28965	multiple	32 40	119540 119548	0.9999881982803345	O
28966	gene	41 45	119549 119553	0.9999878406524658	O
28967	symbols	46 53	119554 119561	0.9999862909317017	O
28968	but	54 57	119562 119565	0.9999855756759644	O
28969	accepted	58 66	119566 119574	0.9999849796295166	O
28970	probes	67 72	119575 119580	0.9999873638153076	O
28972	that	74 78	119582 119586	0.9999887943267822	O
28973	matched	79 86	119587 119594	0.9999886751174927	O
28974	multiple	87 95	119595 119603	0.9999880790710449	O
28975	transcripts	96 106	119604 119614	0.9999885559082031	O
28977	.	108 109	119616 119617	0.9999567270278931	O
28978	Probe	0 4	119618 119622	0.9999847412109375	O
28980	sets	6 10	119624 119628	0.999985933303833	O
28981	were	11 15	119629 119633	0.999987006187439	O
28982	assigned	16 24	119634 119642	0.9999873638153076	O
28983	to	25 27	119643 119645	0.9999887943267822	O
28984	represent	28 37	119646 119655	0.9999878406524658	O
28985	a	38 39	119656 119657	0.9999895095825195	O
28986	given	40 45	119658 119663	0.9999849796295166	O
28987	transcript	46 55	119664 119673	0.999988317489624	O
28989	if	57 59	119675 119677	0.9999850988388062	O
28990	at	60 62	119678 119680	0.9999890327453613	O
28991	least	63 68	119681 119686	0.99998939037323	O
28992	50	69 71	119687 119689	0.9999867677688599	O
28993	%	72 73	119690 119691	0.9999890327453613	O
28994	of	74 76	119692 119694	0.9999892711639404	O
28995	the	77 80	119695 119698	0.9999891519546509	O
28996	perfect	81 88	119699 119706	0.9999889135360718	O
28997	match	89 94	119707 119712	0.999988317489624	O
28998	probes	95 100	119713 119718	0.9999874830245972	O
29000	of	102 104	119720 119722	0.9999889135360718	O
29001	the	105 108	119723 119726	0.9999891519546509	O
29002	probe	109 114	119727 119732	0.9999881982803345	O
29003	set	115 118	119733 119736	0.9999889135360718	O
29004	matched	119 126	119737 119744	0.9999881982803345	O
29005	to	127 129	119745 119747	0.9999890327453613	O
29006	that	130 134	119748 119752	0.9999877214431763	O
29007	transcript	135 144	119753 119762	0.9999889135360718	O
29009	.	146 147	119764 119765	0.9999655485153198	O
29010	The	0 3	119766 119769	0.9999868869781494	O
29011	newly	4 9	119770 119775	0.9999860525131226	O
29012	assigned	10 18	119776 119784	0.9999849796295166	O
29013	transcript	19 28	119785 119794	0.9999866485595703	O
29015	identifiers	30 40	119796 119806	0.999988317489624	O
29019	were	42 46	119808 119812	0.9999852180480957	O
29020	then	47 51	119813 119817	0.9999812841415405	O
29021	used	52 56	119818 119822	0.9999860525131226	O
29022	to	57 59	119823 119825	0.9999880790710449	O
29023	map	60 63	119826 119829	0.9999866485595703	O
29024	probe	64 69	119830 119835	0.9999856948852539	O
29025	sets	70 74	119836 119840	0.999988317489624	O
29026	to	75 77	119841 119843	0.9999880790710449	O
29027	ortholog	78 85	119844 119851	0.9999886751174927	O
29031	genes	87 92	119853 119858	0.9999881982803345	O
29032	.	93 94	119859 119860	0.9999608993530273	O
29033	Since	0 5	119861 119866	0.9999816417694092	O
29034	some	6 10	119867 119871	0.9999865293502808	O
29035	transcripts	11 21	119872 119882	0.9999843835830688	O
29037	have	23 27	119884 119888	0.9999880790710449	O
29038	multiple	28 36	119889 119897	0.9999867677688599	O
29039	probe	37 42	119898 119903	0.9999878406524658	O
29040	-	42 43	119903 119904	0.9999891519546509	O
29041	set	43 46	119904 119907	0.9999881982803345	O
29042	representations	47 62	119908 119923	0.999985933303833	O
29043	on	63 65	119924 119926	0.9999880790710449	O
29044	both	66 70	119927 119931	0.9999886751174927	O
29045	the	71 74	119932 119935	0.9999890327453613	O
29046	Affymetrix	75 84	119936 119945	0.999988317489624	O
29050	and	86 89	119947 119950	0.9999878406524658	O
29051	cDNA	90 93	119951 119954	0.9999884366989136	O
29054	microarrays	95 105	119956 119966	0.999988317489624	O
29057	to	107 109	119968 119970	0.9999880790710449	O
29058	one	110 113	119971 119974	0.9999889135360718	O
29059	ortholog	114 121	119975 119982	0.9999891519546509	O
29063	identifier	123 132	119984 119993	0.9999891519546509	O
29066	,	134 135	119995 119996	0.9999876022338867	O
29067	we	136 138	119997 119999	0.9999864101409912	O
29068	employed	139 147	120000 120008	0.9999865293502808	O
29069	an	148 150	120009 120011	0.9999891519546509	O
29070	ad	151 153	120012 120014	0.9999889135360718	O
29071	hoc	154 156	120015 120017	0.9999885559082031	O
29073	strategy	158 166	120019 120027	0.9999879598617554	O
29074	to	167 169	120028 120030	0.9999887943267822	O
29075	use	170 173	120031 120034	0.9999885559082031	O
29076	the	174 177	120035 120038	0.9999892711639404	O
29077	average	178 185	120039 120046	0.9999861717224121	O
29078	of	186 188	120047 120049	0.9999887943267822	O
29079	those	189 194	120050 120055	0.999988317489624	O
29080	probe	195 200	120056 120061	0.9999874830245972	O
29081	sets	201 205	120062 120066	0.9999885559082031	O
29082	or	206 208	120067 120069	0.9999879598617554	O
29083	cDNAs	209 213	120070 120074	0.9999880790710449	O
29087	that	215 219	120076 120080	0.9999885559082031	O
29088	exhibited	220 229	120081 120090	0.9999867677688599	O
29089	consistent	230 240	120091 120101	0.9999864101409912	O
29090	regulation	241 251	120102 120112	0.9999743700027466	O
29091	across	252 258	120113 120119	0.9999874830245972	O
29092	a	259 260	120120 120121	0.9999887943267822	O
29093	sample	261 267	120122 120128	0.9999877214431763	O
29094	series	268 274	120129 120135	0.9999876022338867	O
29095	.	275 276	120136 120137	0.9999589920043945	O
29096	In	0 2	120138 120140	0.9999868869781494	O
29097	such	3 7	120141 120145	0.9999843835830688	O
29098	cases	8 13	120146 120151	0.9999868869781494	O
29099	,	14 15	120152 120153	0.9999877214431763	O
29100	the	16 19	120154 120157	0.9999886751174927	O
29101	signals	20 27	120158 120165	0.9999849796295166	O
29102	of	28 30	120166 120168	0.9999887943267822	O
29103	the	31 34	120169 120172	0.9999890327453613	O
29104	regulated	35 44	120173 120182	0.9999707937240601	O
29105	probe	45 50	120183 120188	0.999981164932251	O
29106	sets	51 55	120189 120193	0.9999877214431763	O
29107	that	56 60	120194 120198	0.9999889135360718	O
29108	were	61 65	120199 120203	0.9999895095825195	O
29109	interpreted	66 77	120204 120215	0.9999891519546509	O
29110	as	78 80	120216 120218	0.9999889135360718	O
29111	being	81 86	120219 120224	0.99998939037323	O
29112	in	87 89	120225 120227	0.99998939037323	O
29113	agreement	90 99	120228 120237	0.9999884366989136	O
29114	were	100 104	120238 120242	0.9999887943267822	O
29115	averaged	105 113	120243 120251	0.9999873638153076	O
29116	and	114 117	120252 120255	0.9999885559082031	O
29117	assigned	118 126	120256 120264	0.9999886751174927	O
29118	to	127 129	120265 120267	0.9999890327453613	O
29119	the	130 133	120268 120271	0.9999892711639404	O
29120	corresponding	134 147	120272 120285	0.9999880790710449	O
29121	ortholog	148 155	120286 120293	0.9999887943267822	O
29125	.	157 158	120295 120296	0.9999767541885376	O
29126	We	0 2	120297 120299	0.999985933303833	O
29127	excluded	3 11	120300 120308	0.9999866485595703	O
29128	probe	12 17	120309 120314	0.9999862909317017	O
29129	sets	18 22	120315 120319	0.999988317489624	O
29130	or	23 25	120320 120322	0.9999884366989136	O
29131	cDNAs	26 30	120323 120327	0.9999886751174927	O
29135	that	32 36	120329 120333	0.99998939037323	O
29136	we	37 39	120334 120336	0.9999891519546509	O
29137	were	40 44	120337 120341	0.99998939037323	O
29138	aware	45 50	120342 120347	0.9999876022338867	O
29139	corresponded	51 62	120348 120359	0.9999889135360718	O
29141	to	64 66	120361 120363	0.9999897480010986	O
29142	non	67 70	120364 120367	0.9999896287918091	O
29143	-	70 71	120367 120368	0.9999896287918091	O
29144	transcript	71 80	120368 120377	0.9999892711639404	O
29146	genomic	82 88	120379 120385	0.9999896287918091	O
29149	sequence	90 98	120387 120395	0.99998939037323	O
29150	as	99 101	120396 120398	0.9999896287918091	O
29151	tested	102 108	120399 120405	0.9999895095825195	O
29152	using	109 114	120406 120411	0.9999896287918091	O
29153	BLAT	115 118	120412 120415	0.99998939037323	O
29156	at	120 122	120417 120419	0.9999896287918091	O
29157	the	123 126	120420 120423	0.9999896287918091	O
29158	UCSC	127 130	120424 120427	0.9999877214431763	O
29160	Goldenpath	132 141	120429 120438	0.9999881982803345	O
29162	website	143 150	120440 120447	0.9999881982803345	O
29163	[	151 152	120448 120449	0.9999895095825195	O
29164	66	152 154	120449 120451	0.9999878406524658	O
29165	]	154 155	120451 120452	0.9999891519546509	O
29166	.	156 157	120453 120454	0.9999796152114868	O
29167	Mouse	0 5	120455 120460	0.9963656663894653	O
29168	-	5 6	120460 120461	0.9999879598617554	O
29169	human	6 11	120461 120466	0.9915295839309692	O
29170	RefSeq	12 17	120467 120472	0.9999874830245972	O
29175	gene	19 23	120474 120478	0.9999868869781494	O
29176	ortholog	24 31	120479 120486	0.9999887943267822	O
29180	assignments	33 44	120488 120499	0.9999855756759644	O
29181	can	45 48	120500 120503	0.9999855756759644	O
29182	be	49 51	120504 120506	0.9999885559082031	O
29183	found	52 57	120507 120512	0.9999884366989136	O
29184	at	58 60	120513 120515	0.9999889135360718	O
29185	GenomeTrafac	61 72	120516 120527	0.9999879598617554	O
29191	[	74 75	120529 120530	0.99998939037323	O
29192	67	75 77	120530 120532	0.9999864101409912	O
29193	,	77 78	120532 120533	0.9999885559082031	O
29194	68	78 80	120533 120535	0.9999874830245972	O
29195	]	80 81	120535 120536	0.9999891519546509	O
29196	.	82 83	120537 120538	0.999980092048645	O
29197	All	0 3	120539 120542	0.9999858140945435	O
29198	ortholog	4 11	120543 120550	0.9999884366989136	O
29202	assignments	13 24	120552 120563	0.9999876022338867	O
29203	and	25 28	120564 120567	0.9999876022338867	O
29204	cross	29 34	120568 120573	0.9999861717224121	O
29205	-	34 35	120573 120574	0.9999890327453613	O
29206	species	35 42	120574 120581	0.9999743700027466	O
29207	mapping	43 50	120582 120589	0.9999861717224121	O
29208	annotations	51 61	120590 120600	0.9999895095825195	O
29211	were	63 67	120602 120606	0.9999877214431763	O
29212	incorporated	68 80	120607 120619	0.9999886751174927	O
29213	into	81 85	120620 120624	0.9999895095825195	O
29214	annotations	86 96	120625 120635	0.9999895095825195	O
29217	associated	98 108	120637 120647	0.9999896287918091	O
29218	with	109 113	120648 120652	0.99998939037323	O
29219	the	114 117	120653 120656	0.99998939037323	O
29220	Affymetrix	118 127	120657 120666	0.9999891519546509	O
29224	HG	129 130	120668 120669	0.9999885559082031	O
29226	-	131 132	120670 120671	0.99998939037323	O
29227	U133	132 135	120671 120674	0.9999889135360718	O
29230	plus2	137 141	120676 120680	0.9999884366989136	O
29232	.	142 143	120681 120682	0.9999892711639404	O
29233	0	143 144	120682 120683	0.9999887943267822	O
29234	genome	145 151	120684 120690	0.9999881982803345	O
29235	.	152 153	120691 120692	0.9999792575836182	O
29236	Gene	0 4	120693 120697	0.9999833106994629	O
29237	expression	5 15	120698 120708	0.9999812841415405	O
29238	ratios	16 22	120709 120715	0.9999797344207764	O
29239	obtained	23 31	120716 120724	0.9999822378158569	O
29240	for	32 35	120725 120728	0.9999845027923584	O
29241	the	36 39	120729 120732	0.999980092048645	O
29242	mouse	40 45	120733 120738	0.6216863989830017	species
29243	samples	46 53	120739 120746	0.9999774694442749	O
29244	were	54 58	120747 120751	0.9999854564666748	O
29245	then	59 63	120752 120756	0.9999781847000122	O
29246	represented	64 75	120757 120768	0.9999845027923584	O
29247	as	76 78	120769 120771	0.9999879598617554	O
29248	expression	79 89	120772 120782	0.9999853372573853	O
29249	values	90 96	120783 120789	0.9999873638153076	O
29250	within	97 103	120790 120796	0.9999868869781494	O
29251	the	104 107	120797 120800	0.9999881982803345	O
29252	human	108 113	120801 120806	0.9992145299911499	O
29253	platform	114 122	120807 120815	0.9999815225601196	O
29254	for	123 126	120816 120819	0.9999872446060181	O
29255	all	127 130	120820 120823	0.999987006187439	O
29256	of	131 133	120824 120826	0.9999878406524658	O
29257	the	134 137	120827 120830	0.9999871253967285	O
29258	probe	138 143	120831 120836	0.9999775886535645	O
29259	sets	144 148	120837 120841	0.9999868869781494	O
29260	that	149 153	120842 120846	0.9999876022338867	O
29261	mapped	154 160	120847 120853	0.9999867677688599	O
29262	to	161 163	120854 120856	0.9999881982803345	O
29263	the	164 167	120857 120860	0.999988317489624	O
29264	corresponding	168 181	120861 120874	0.9999864101409912	O
29265	mouse	182 187	120875 120880	0.9998225569725037	O
29266	gene	188 192	120881 120885	0.9999874830245972	O
29267	ortholog	193 200	120886 120893	0.9999884366989136	O
29271	.	202 203	120895 120896	0.9999656677246094	O
29272	Data	0 4	120897 120901	0.9999823570251465	O
29273	for	5 8	120902 120905	0.9999871253967285	O
29274	the	9 12	120906 120909	0.9999880790710449	O
29275	primary	13 20	120910 120917	0.9999855756759644	O
29276	human	21 26	120918 120923	0.9999500513076782	O
29277	sample	27 33	120924 120930	0.9999873638153076	O
29278	series	34 40	120931 120937	0.999988317489624	O
29279	,	41 42	120938 120939	0.999987006187439	O
29280	as	43 45	120940 120942	0.999985933303833	O
29281	well	46 50	120943 120947	0.9999876022338867	O
29282	as	51 53	120948 120950	0.9999877214431763	O
29283	the	54 57	120951 120954	0.9999879598617554	O
29284	combined	58 66	120955 120963	0.9999865293502808	O
29285	mouse	67 72	120964 120969	0.9998377561569214	O
29286	-	72 73	120969 120970	0.9999880790710449	O
29287	human	73 78	120970 120975	0.9999520778656006	O
29288	data	79 83	120976 120980	0.9999879598617554	O
29289	sets	84 88	120981 120985	0.9999879598617554	O
29290	,	89 90	120986 120987	0.9999866485595703	O
29291	are	91 94	120988 120991	0.9999867677688599	O
29292	available	95 104	120992 121001	0.999987006187439	O
29293	in	105 107	121002 121004	0.9999874830245972	O
29294	the	108 111	121005 121008	0.9999877214431763	O
29295	Cincinnati	112 122	121009 121019	0.999885082244873	O
29296	Children	123 131	121020 121028	0.9999489784240723	O
29297	'	132 133	121029 121030	0.9999866485595703	O
29298	s	133 134	121030 121031	0.9999861717224121	O
29299	Hospital	135 143	121032 121040	0.999984860420227	O
29300	Medical	144 151	121041 121048	0.9999845027923584	O
29301	Center	152 158	121049 121055	0.999987006187439	O
29302	microarray	159 168	121056 121065	0.9999873638153076	O
29305	data	170 174	121067 121071	0.9999880790710449	O
29306	server	175 181	121072 121078	0.9999860525131226	O
29307	[	182 183	121079 121080	0.9999878406524658	O
29308	69	183 185	121080 121082	0.9999866485595703	O
29309	]	185 186	121082 121083	0.9999876022338867	O
29310	in	187 189	121084 121086	0.9999879598617554	O
29311	the	190 193	121087 121090	0.9999881982803345	O
29312	HG	194 195	121091 121092	0.999988317489624	O
29314	-	196 197	121093 121094	0.9999885559082031	O
29315	U133	197 200	121094 121097	0.999988317489624	O
29318	genome	202 208	121099 121105	0.9999876022338867	O
29319	under	209 214	121106 121111	0.9999881982803345	O
29320	the	215 218	121112 121115	0.9999881982803345	O
29321	KaiserEtAl	219 228	121116 121125	0.9999827146530151	O
29326	_	229 230	121126 121127	0.9999881982803345	O
29327	2006	230 234	121127 121131	0.9999879598617554	O
29328	folders	235 241	121132 121138	0.9999860525131226	O
29330	(	243 244	121140 121141	0.9999886751174927	O
29331	'	245 246	121142 121143	0.999988317489624	O
29332	guest	246 251	121143 121148	0.999985933303833	O
29333	'	252 253	121149 121150	0.9999880790710449	O
29334	login	254 258	121151 121155	0.9999880790710449	O
29336	;	260 261	121157 121158	0.999988317489624	O
29337	all	262 265	121159 121162	0.9999879598617554	O
29338	cross	266 271	121163 121168	0.9999881982803345	O
29339	-	271 272	121168 121169	0.9999885559082031	O
29340	platform	272 280	121169 121177	0.9999872446060181	O
29341	ortholog	281 288	121178 121185	0.9999881982803345	O
29345	gene	290 294	121187 121191	0.9999878406524658	O
29346	identifiers	295 305	121192 121202	0.9999878406524658	O
29350	are	307 310	121204 121207	0.9999874830245972	O
29351	contained	311 320	121208 121217	0.9999877214431763	O
29352	as	321 323	121218 121220	0.9999880790710449	O
29353	annotation	324 333	121221 121230	0.9999881982803345	O
29356	fields	335 341	121232 121238	0.9999868869781494	O
29357	within	342 348	121239 121245	0.9999876022338867	O
29358	the	349 352	121246 121249	0.9999881982803345	O
29359	HG	353 354	121250 121251	0.999988317489624	O
29361	-	355 356	121252 121253	0.9999884366989136	O
29362	U133	356 359	121253 121256	0.9999880790710449	O
29365	genome	361 367	121258 121264	0.9999871253967285	O
29366	table	368 373	121265 121270	0.9999861717224121	O
29367	)	374 375	121271 121272	0.9999885559082031	O
29368	.	376 377	121273 121274	0.9999887943267822	O
29369	*	378 379	121275 121276	0.9999877214431763	O
29370	*	379 380	121276 121277	0.999980092048645	O
29371	IGNORE	0 5	121278 121283	0.9999866485595703	O
29374	LINE	7 10	121285 121288	0.9999890327453613	O
29377	*	12 13	121290 121291	0.99998939037323	O
29378	*	13 14	121291 121292	0.99998939037323	O
29379	*	15 16	121293 121294	0.99998939037323	O
29380	*	16 17	121294 121295	0.99998939037323	O
29381	IGNORE	18 23	121296 121301	0.9999881982803345	O
29384	LINE	25 28	121303 121306	0.9999892711639404	O
29387	*	30 31	121308 121309	0.9999891519546509	O
29388	*	31 32	121309 121310	0.9999891519546509	O
29389	*	33 34	121311 121312	0.9999890327453613	O
29390	*	34 35	121312 121313	0.9999890327453613	O
29391	IGNORE	36 41	121314 121319	0.9999878406524658	O
29394	LINE	43 46	121321 121324	0.9999892711639404	O
29397	*	48 49	121326 121327	0.9999891519546509	O
29398	*	49 50	121327 121328	0.9999891519546509	O
29399	Statistical	51 62	121329 121340	0.9999887943267822	O
29400	and	63 66	121341 121344	0.9999891519546509	O
29401	data	67 71	121345 121349	0.9999885559082031	O
29402	visualization	72 84	121350 121362	0.9999889135360718	O
29404	approaches	86 96	121364 121374	0.9999889135360718	O
29405	Most	97 101	121375 121379	0.9999861717224121	O
29406	normalization	102 114	121380 121392	0.9999874830245972	O
29408	,	116 117	121394 121395	0.9999887943267822	O
29409	expression	118 128	121396 121406	0.9999879598617554	O
29410	-	128 129	121406 121407	0.9999896287918091	O
29411	level	129 134	121407 121412	0.9999892711639404	O
29412	referencing	135 145	121413 121423	0.9999895095825195	O
29414	,	147 148	121425 121426	0.9999892711639404	O
29415	statistical	149 160	121427 121438	0.9999872446060181	O
29416	comparisons	161 172	121439 121450	0.99998939037323	O
29417	,	173 174	121451 121452	0.9999891519546509	O
29418	and	175 178	121453 121456	0.9999895095825195	O
29419	data	179 183	121457 121461	0.9999879598617554	O
29420	visualization	184 196	121462 121474	0.9999886751174927	O
29422	were	198 202	121476 121480	0.9999890327453613	O
29423	performed	203 212	121481 121490	0.9999890327453613	O
29424	using	213 218	121491 121496	0.9999892711639404	O
29425	GeneSpring	219 228	121497 121506	0.9999885559082031	O
29429	v7	230 231	121508 121509	0.9999892711639404	O
29431	.	232 233	121510 121511	0.99998939037323	O
29432	0	233 234	121511 121512	0.9999885559082031	O
29433	(	235 236	121513 121514	0.9999895095825195	O
29434	Silicon	237 244	121515 121522	0.9999850988388062	O
29435	Genetics	245 252	121523 121530	0.9999880790710449	O
29437	-	253 254	121531 121532	0.9999892711639404	O
29438	Agilent	254 260	121532 121538	0.9999895095825195	O
29441	(	262 263	121540 121541	0.9999896287918091	O
29442	part	264 268	121542 121546	0.9999889135360718	O
29443	of	269 271	121547 121549	0.9999892711639404	O
29444	Agilent	272 278	121550 121556	0.9999890327453613	O
29447	Technologies	280 292	121558 121570	0.9999816417694092	O
29448	)	293 294	121571 121572	0.9999897480010986	O
29449	.	295 296	121573 121574	0.9999710321426392	O
29450	Fisher	0 6	121575 121581	0.9999867677688599	O
29451	'	7 8	121582 121583	0.9999895095825195	O
29452	s	8 9	121583 121584	0.9999892711639404	O
29453	exact	10 15	121585 121590	0.9999879598617554	O
29454	test	16 20	121591 121595	0.9999876022338867	O
29455	was	21 24	121596 121599	0.9999886751174927	O
29456	performed	25 34	121600 121609	0.9999884366989136	O
29457	online	35 41	121610 121616	0.9999849796295166	O
29458	at	42 44	121617 121619	0.9999889135360718	O
29459	the	45 48	121620 121623	0.9999895095825195	O
29460	MATFORSK	49 56	121624 121631	0.9999879598617554	O
29465	Fisher	58 64	121633 121639	0.9999885559082031	O
29466	'	65 66	121640 121641	0.99998939037323	O
29467	s	66 67	121641 121642	0.99998939037323	O
29468	Exact	68 72	121643 121647	0.9999891519546509	O
29470	Test	74 78	121649 121653	0.9999886751174927	O
29471	server	79 85	121654 121660	0.9999872446060181	O
29472	[	86 87	121661 121662	0.99998939037323	O
29473	70	87 89	121662 121664	0.9999878406524658	O
29474	]	89 90	121664 121665	0.9999890327453613	O
29475	.	91 92	121666 121667	0.9999803304672241	O
29476	To	0 2	121668 121670	0.9999862909317017	O
29477	identify	3 11	121671 121679	0.9999872446060181	O
29478	differentially	12 25	121680 121693	0.9999871253967285	O
29480	expressed	27 36	121695 121704	0.9999840259552002	O
29481	features	37 45	121705 121713	0.9999831914901733	O
29482	between	46 53	121714 121721	0.9999871253967285	O
29483	two	54 57	121722 121725	0.9999867677688599	O
29484	or	58 60	121726 121728	0.9999873638153076	O
29485	more	61 65	121729 121733	0.9999871253967285	O
29486	classes	66 73	121734 121741	0.9999866485595703	O
29487	,	74 75	121742 121743	0.9999876022338867	O
29488	we	76 78	121744 121746	0.9999858140945435	O
29489	applied	79 86	121747 121754	0.9999877214431763	O
29490	GeneSpring	87 96	121755 121764	0.9999880790710449	O
29494	'	98 99	121766 121767	0.9999892711639404	O
29495	s	99 100	121767 121768	0.9999891519546509	O
29496	Wilcoxon	101 108	121769 121776	0.9999856948852539	O
29498	-	109 110	121777 121778	0.9999892711639404	O
29499	Mann	110 114	121778 121782	0.999988317489624	O
29500	-	114 115	121782 121783	0.9999892711639404	O
29501	Whitney	115 122	121783 121790	0.9999874830245972	O
29502	or	123 125	121791 121793	0.9999878406524658	O
29503	the	126 129	121794 121797	0.9999890327453613	O
29504	Kruskal	130 136	121798 121804	0.9999876022338867	O
29507	-	137 138	121805 121806	0.9999892711639404	O
29508	Wallis	138 144	121806 121812	0.9999839067459106	O
29509	test	145 149	121813 121817	0.9999880790710449	O
29510	,	150 151	121818 121819	0.9999886751174927	O
29511	respectively	152 164	121820 121832	0.9999877214431763	O
29512	.	165 166	121833 121834	0.999972939491272	O
29513	For	0 3	121835 121838	0.9999872446060181	O
29514	three	4 9	121839 121844	0.9999877214431763	O
29515	or	10 12	121845 121847	0.9999871253967285	O
29516	more	13 17	121848 121852	0.9999885559082031	O
29517	classes	18 25	121853 121860	0.9999860525131226	O
29518	,	26 27	121861 121862	0.9999886751174927	O
29519	the	28 31	121863 121866	0.9999895095825195	O
29520	initial	32 39	121867 121874	0.9999885559082031	O
29521	non	40 43	121875 121878	0.9999895095825195	O
29522	-	43 44	121878 121879	0.9999895095825195	O
29523	parametric	44 53	121879 121888	0.9999880790710449	O
29525	test	55 59	121890 121894	0.9999889135360718	O
29526	was	60 63	121895 121898	0.9999890327453613	O
29527	followed	64 72	121899 121907	0.999988317489624	O
29528	by	73 75	121908 121910	0.9999896287918091	O
29529	the	76 79	121911 121914	0.9999897480010986	O
29530	Student	80 87	121915 121922	0.9999862909317017	O
29531	-	87 88	121922 121923	0.9999895095825195	O
29532	Newman	88 94	121923 121929	0.9999874830245972	O
29533	-	94 95	121929 121930	0.99998939037323	O
29534	Keuls	95 99	121930 121934	0.9999853372573853	O
29537	post	101 105	121936 121940	0.9999892711639404	O
29538	-	105 106	121940 121941	0.9999896287918091	O
29539	hoc	106 108	121941 121943	0.9999887943267822	O
29541	test	110 114	121945 121949	0.9999895095825195	O
29542	.	115 116	121950 121951	0.9999758005142212	O
29543	Results	0 7	121952 121959	0.9999868869781494	O
29544	from	8 12	121960 121964	0.9999879598617554	O
29545	the	13 16	121965 121968	0.9999885559082031	O
29546	primary	17 24	121969 121976	0.9999867677688599	O
29547	analyses	25 33	121977 121985	0.9999860525131226	O
29548	were	34 38	121986 121990	0.9999878406524658	O
29549	corrected	39 48	121991 122000	0.9999864101409912	O
29550	for	49 52	122001 122004	0.9999880790710449	O
29551	multiple	53 61	122005 122013	0.9999865293502808	O
29552	testing	62 69	122014 122021	0.9999868869781494	O
29553	effects	70 77	122022 122029	0.9999866485595703	O
29554	by	78 80	122030 122032	0.9999892711639404	O
29555	applying	81 89	122033 122041	0.9999885559082031	O
29556	Benjamini	90 98	122042 122050	0.9999855756759644	O
29558	and	100 103	122052 122055	0.9999890327453613	O
29559	Hochberg	104 111	122056 122063	0.999988317489624	O
29562	false	113 118	122065 122070	0.9999889135360718	O
29563	discovery	119 128	122071 122080	0.9999887943267822	O
29564	rate	129 133	122081 122085	0.9999891519546509	O
29565	(	134 135	122086 122087	0.9999891519546509	O
29566	FDR	136 138	122088 122090	0.9999872446060181	O
29568	)	139 140	122091 122092	0.9999897480010986	O
29569	correction	141 151	122093 122103	0.9999892711639404	O
29570	[	152 153	122104 122105	0.9999895095825195	O
29571	71	153 155	122105 122107	0.9999880790710449	O
29572	]	155 156	122107 122108	0.9999891519546509	O
29573	.	157 158	122109 122110	0.9999774694442749	O
29574	In	0 2	122111 122113	0.9999886751174927	O
29575	general	3 10	122114 122121	0.9999867677688599	O
29576	,	11 12	122122 122123	0.9999886751174927	O
29577	due	13 16	122124 122127	0.9999879598617554	O
29578	to	17 19	122128 122130	0.9999886751174927	O
29579	the	20 23	122131 122134	0.999988317489624	O
29580	referencing	24 34	122135 122145	0.9999880790710449	O
29582	strategies	36 46	122147 122157	0.9999874830245972	O
29583	,	47 48	122158 122159	0.9999884366989136	O
29584	good	49 53	122160 122164	0.999988317489624	O
29585	platform	54 62	122165 122173	0.9999861717224121	O
29586	technical	63 72	122174 122183	0.9999878406524658	O
29587	performances	73 85	122184 122196	0.9999873638153076	O
29588	,	86 87	122197 122198	0.9999885559082031	O
29589	and	88 91	122199 122202	0.9999887943267822	O
29590	moderately	92 102	122203 122213	0.9999872446060181	O
29591	low	103 106	122214 122217	0.9999884366989136	O
29592	within	107 113	122218 122224	0.9999886751174927	O
29593	-	113 114	122224 122225	0.9999890327453613	O
29594	group	114 119	122225 122230	0.999988317489624	O
29595	biological	120 130	122231 122241	0.9999878406524658	O
29596	variation	131 140	122242 122251	0.9999890327453613	O
29597	of	141 143	122252 122254	0.9999889135360718	O
29598	gene	144 148	122255 122259	0.9999884366989136	O
29599	expression	149 159	122260 122270	0.9999881982803345	O
29600	,	160 161	122271 122272	0.9999889135360718	O
29601	stringent	162 170	122273 122281	0.9999885559082031	O
29603	cutoffs	172 178	122283 122289	0.9999887943267822	O
29605	could	180 185	122291 122296	0.9999884366989136	O
29606	be	186 188	122297 122299	0.9999886751174927	O
29607	used	189 193	122300 122304	0.9999885559082031	O
29608	,	194 195	122305 122306	0.9999886751174927	O
29609	that	196 200	122307 122311	0.9999873638153076	O
29610	is	201 203	122312 122314	0.9999881982803345	O
29611	,	204 205	122315 122316	0.9999886751174927	O
29612	the	206 209	122317 122320	0.9999890327453613	O
29613	FDR	210 212	122321 122323	0.9999891519546509	O
29615	level	214 219	122325 122330	0.9999889135360718	O
29616	of	220 222	122331 122333	0.9999887943267822	O
29617	significance	223 235	122334 122346	0.9999886751174927	O
29618	was	236 239	122347 122350	0.9999889135360718	O
29619	set	240 243	122351 122354	0.9999887943267822	O
29620	between	244 251	122355 122362	0.9999889135360718	O
29621	FDR	252 254	122363 122365	0.9999891519546509	O
29623	<	256 257	122367 122368	0.9999891519546509	O
29624	5	258 259	122369 122370	0.9999886751174927	O
29625	.	259 260	122370 122371	0.9999889135360718	O
29626	10	260 262	122371 122373	0.9999885559082031	O
29627	-	262 263	122373 122374	0.9999886751174927	O
29628	5	263 264	122374 122375	0.9999880790710449	O
29629	and	265 268	122376 122379	0.9999886751174927	O
29630	FDR	269 271	122380 122382	0.9999889135360718	O
29632	<	273 274	122384 122385	0.9999889135360718	O
29633	5	275 276	122386 122387	0.9999884366989136	O
29634	.	276 277	122387 122388	0.9999889135360718	O
29635	10	277 279	122388 122390	0.9999884366989136	O
29636	-	279 280	122390 122391	0.9999886751174927	O
29637	4	280 281	122391 122392	0.9999861717224121	O
29638	.	281 282	122392 122393	0.999975323677063	O
29639	K	0 1	122394 122395	0.9999847412109375	O
29640	-	1 2	122395 122396	0.9999887943267822	O
29641	means	2 7	122396 122401	0.9999862909317017	O
29642	clustering	8 17	122402 122411	0.9999849796295166	O
29644	was	19 22	122413 122416	0.999984860420227	O
29645	performed	23 32	122417 122426	0.9999853372573853	O
29646	using	33 38	122427 122432	0.9999881982803345	O
29647	the	39 42	122433 122436	0.9999889135360718	O
29648	GeneSpring	43 52	122437 122446	0.9999868869781494	O
29652	K	54 55	122448 122449	0.9999881982803345	O
29653	-	55 56	122449 122450	0.9999892711639404	O
29654	means	56 61	122450 122455	0.9999887943267822	O
29655	tool	62 66	122456 122460	0.9999872446060181	O
29656	and	67 70	122461 122464	0.9999873638153076	O
29657	the	71 74	122465 122468	0.9999889135360718	O
29658	Pearson	75 82	122469 122476	0.9999839067459106	O
29659	correlation	83 94	122477 122488	0.999988317489624	O
29660	similarity	95 105	122489 122499	0.9999877214431763	O
29661	measure	106 113	122500 122507	0.9999884366989136	O
29662	.	114 115	122508 122509	0.9999594688415527	O
29663	Ontology	0 7	122510 122517	0.9999881982803345	O
29665	-	8 9	122518 122519	0.9999887943267822	O
29666	based	9 14	122519 122524	0.9999884366989136	O
29667	analysis	15 23	122525 122533	0.9999879598617554	O
29668	of	24 26	122534 122536	0.9999885559082031	O
29669	gene	27 31	122537 122541	0.9999866485595703	O
29670	cluster	32 39	122542 122549	0.9999885559082031	O
29671	-	39 40	122549 122550	0.9999890327453613	O
29672	associated	40 50	122550 122560	0.9999887943267822	O
29673	functional	51 61	122561 122571	0.9999843835830688	O
29674	correlates	62 71	122572 122581	0.9999890327453613	O
29677	Gene	73 77	122583 122587	0.9999877214431763	O
29678	expression	78 88	122588 122598	0.9999862909317017	O
29679	clusters	89 97	122599 122607	0.9999878406524658	O
29680	were	98 102	122608 122612	0.999988317489624	O
29681	analyzed	103 111	122613 122621	0.9999877214431763	O
29682	for	112 115	122622 122625	0.9999885559082031	O
29683	the	116 119	122626 122629	0.9999889135360718	O
29684	occurrence	120 130	122630 122640	0.9999867677688599	O
29685	of	131 133	122641 122643	0.9999887943267822	O
29686	multiple	134 142	122644 122652	0.9999836683273315	O
29687	genes	143 148	122653 122658	0.9999850988388062	O
29688	involved	149 157	122659 122667	0.9999887943267822	O
29689	in	158 160	122668 122670	0.9999889135360718	O
29690	related	161 168	122671 122678	0.9999877214431763	O
29691	gene	169 173	122679 122683	0.9999878406524658	O
29692	function	174 182	122684 122692	0.9999874830245972	O
29693	categories	183 193	122693 122703	0.999988317489624	O
29694	by	194 196	122704 122706	0.9999889135360718	O
29695	comparing	197 206	122707 122716	0.9999886751174927	O
29696	each	207 211	122717 122721	0.9999889135360718	O
29697	list	212 216	122722 122726	0.9999874830245972	O
29698	of	217 219	122727 122729	0.9999887943267822	O
29699	coordinately	220 231	122730 122741	0.9999853372573853	O
29701	regulated	233 242	122743 122752	0.9999836683273315	O
29702	clustered	243 251	122753 122761	0.9999885559082031	O
29704	genes	253 258	122763 122768	0.999987006187439	O
29705	to	259 261	122769 122771	0.9999881982803345	O
29706	categories	262 272	122772 122782	0.9999878406524658	O
29707	within	273 279	122783 122789	0.9999884366989136	O
29708	Gene	280 284	122790 122794	0.9999880790710449	O
29709	Ontology	285 292	122795 122802	0.9999884366989136	O
29711	,	294 295	122804 122805	0.9999880790710449	O
29712	pathways	296 304	122806 122814	0.9999831914901733	O
29713	,	305 306	122815 122816	0.9999879598617554	O
29714	or	307 309	122817 122819	0.9999871253967285	O
29715	literature	310 320	122820 122830	0.9999794960021973	O
29716	-	320 321	122830 122831	0.9999887943267822	O
29717	based	321 326	122831 122836	0.9999881982803345	O
29718	gene	327 331	122837 122841	0.9999862909317017	O
29719	associations	332 344	122842 122854	0.9999878406524658	O
29720	using	345 350	122855 122860	0.9999886751174927	O
29721	GATACA	351 356	122861 122866	0.9999881982803345	O
29724	[	358 359	122868 122869	0.9999889135360718	O
29725	72	359 361	122869 122871	0.9999880790710449	O
29726	]	361 362	122871 122872	0.9999887943267822	O
29727	,	363 364	122873 122874	0.9999887943267822	O
29728	Ontoexpress	365 375	122875 122885	0.9999884366989136	O
29732	[	377 378	122887 122888	0.9999887943267822	O
29733	73	378 380	122888 122890	0.9999876022338867	O
29734	]	380 381	122890 122891	0.9999886751174927	O
29735	,	382 383	122892 122893	0.9999889135360718	O
29736	and	384 387	122894 122897	0.9999887943267822	O
29737	Ingenuity	388 396	122898 122906	0.9999885559082031	O
29740	Pathway	398 404	122908 122914	0.999988317489624	O
29742	Analysis	406 414	122916 122924	0.9999884366989136	O
29743	,	415 416	122925 122926	0.9999884366989136	O
29744	version	417 424	122927 122934	0.9999881982803345	O
29745	3	425 426	122935 122936	0.9999877214431763	O
29746	(	427 428	122937 122938	0.9999889135360718	O
29747	IPA	429 432	122939 122942	0.9999836683273315	O
29748	,	433 434	122943 122944	0.999988317489624	O
29749	Ingenuity	435 443	122945 122953	0.9999885559082031	O
29752	Systems	445 452	122955 122962	0.9999860525131226	O
29753	,	453 454	122963 122964	0.999988317489624	O
29754	Redwood	455 461	122965 122971	0.9999850988388062	O
29756	City	463 467	122973 122977	0.9999845027923584	O
29757	,	468 469	122978 122979	0.9999876022338867	O
29758	CA	470 472	122980 122982	0.9999507665634155	O
29759	,	473 474	122983 122984	0.9999884366989136	O
29760	USA	475 478	122985 122988	0.9999686479568481	O
29761	)	479 480	122989 122990	0.9999877214431763	O
29762	[	481 482	122991 122992	0.9999887943267822	O
29763	74	482 484	122992 122994	0.9999858140945435	O
29764	]	484 485	122994 122995	0.9999885559082031	O
29765	.	486 487	122996 122997	0.9999767541885376	O
29766	To	0 2	122998 123000	0.999988317489624	O
29767	do	3 5	123001 123003	0.9999874830245972	O
29768	this	6 10	123004 123008	0.9999884366989136	O
29769	,	11 12	123009 123010	0.9999884366989136	O
29770	each	13 17	123011 123015	0.9999886751174927	O
29771	cluster	18 25	123016 123023	0.9999866485595703	O
29772	indicated	26 35	123024 123033	0.9999885559082031	O
29773	in	36 38	123034 123036	0.9999890327453613	O
29774	Figures	39 45	123037 123043	0.9999866485595703	O
29776	2	47 48	123045 123046	0.9999886751174927	O
29777	,	49 50	123047 123048	0.9999889135360718	O
29778	4	51 52	123049 123050	0.9999879598617554	O
29779	,	53 54	123051 123052	0.9999889135360718	O
29780	5	55 56	123053 123054	0.9999884366989136	O
29781	,	57 58	123055 123056	0.9999887943267822	O
29782	6	59 60	123057 123058	0.9999880790710449	O
29783	and	61 64	123059 123062	0.9999887943267822	O
29784	8	65 66	123063 123064	0.9999879598617554	O
29785	was	67 70	123065 123068	0.9999889135360718	O
29786	converted	71 80	123069 123078	0.9999880790710449	O
29787	to	81 83	123079 123081	0.9999890327453613	O
29788	a	84 85	123082 123083	0.9999892711639404	O
29789	list	86 90	123084 123088	0.9999891519546509	O
29790	of	91 93	123089 123091	0.9999892711639404	O
29791	gene	94 98	123092 123096	0.9999873638153076	O
29792	identifiers	99 109	123097 123107	0.99998939037323	O
29796	,	111 112	123109 123110	0.9999887943267822	O
29797	uploaded	113 121	123111 123119	0.9999873638153076	O
29798	to	122 124	123120 123122	0.9999890327453613	O
29799	the	125 128	123123 123126	0.9999889135360718	O
29800	application	129 140	123127 123138	0.9999873638153076	O
29801	,	141 142	123139 123140	0.9999880790710449	O
29802	and	143 146	123141 123144	0.9999892711639404	O
29803	examined	147 155	123145 123153	0.9999881982803345	O
29804	for	156 159	123154 123157	0.99998939037323	O
29805	over	160 164	123158 123162	0.9999892711639404	O
29806	-	164 165	123162 123163	0.9999895095825195	O
29807	representation	165 179	123163 123177	0.99998939037323	O
29808	of	180 182	123178 123180	0.99998939037323	O
29809	multiple	183 191	123181 123189	0.9999879598617554	O
29810	genes	192 197	123190 123195	0.9999853372573853	O
29811	from	198 202	123196 123200	0.9999891519546509	O
29812	one	203 206	123201 123204	0.9999892711639404	O
29813	or	207 209	123205 123207	0.9999886751174927	O
29814	more	210 214	123208 123212	0.9999886751174927	O
29815	molecular	215 224	123213 123222	0.9999837875366211	O
29816	networks	225 233	123223 123231	0.9999853372573853	O
29817	,	234 235	123232 123233	0.9999861717224121	O
29818	or	236 238	123234 123236	0.9999877214431763	O
29819	functional	239 249	123237 123247	0.9999669790267944	O
29820	or	250 252	123248 123250	0.9999871253967285	O
29821	disease	253 260	123251 123258	0.9999712705612183	O
29822	associations	261 273	123259 123271	0.9999876022338867	O
29823	as	274 276	123272 123274	0.9999886751174927	O
29824	developed	277 286	123275 123284	0.9999881982803345	O
29825	from	287 291	123285 123289	0.9999884366989136	O
29826	literature	292 302	123290 123300	0.9999799728393555	O
29827	mining	303 309	123301 123307	0.9999830722808838	O
29828	.	310 311	123308 123309	0.9999687671661377	O
29829	Networks	0 8	123310 123318	0.9999661445617676	O
29830	of	9 11	123319 123321	0.999985933303833	O
29831	these	12 17	123322 123327	0.9999855756759644	O
29832	focus	18 23	123328 123333	0.9999703168869019	O
29833	genes	24 29	123334 123339	0.9999836683273315	O
29834	were	30 34	123340 123344	0.9999850988388062	O
29835	algorithmically	35 49	123345 123359	0.9999833106994629	O
29837	generated	51 60	123361 123370	0.9999856948852539	O
29838	based	61 66	123371 123376	0.9999879598617554	O
29839	on	67 69	123377 123379	0.9999879598617554	O
29840	the	70 73	123380 123383	0.9999881982803345	O
29841	relationships	74 87	123384 123397	0.99997878074646	O
29842	of	88 90	123398 123400	0.9999880790710449	O
29843	individual	91 101	123401 123411	0.9999839067459106	O
29844	genes	102 107	123412 123417	0.9999827146530151	O
29845	as	108 110	123418 123420	0.9999880790710449	O
29846	derived	111 118	123421 123428	0.9999881982803345	O
29847	from	119 123	123429 123433	0.9999884366989136	O
29848	literature	124 134	123434 123444	0.9999814033508301	O
29849	review	135 141	123445 123451	0.9999864101409912	O
29850	and	142 145	123452 123455	0.9999849796295166	O
29851	used	146 150	123456 123460	0.9999864101409912	O
29852	to	151 153	123461 123463	0.9999879598617554	O
29853	identify	154 162	123464 123472	0.9999873638153076	O
29854	the	163 166	123473 123476	0.9999876022338867	O
29855	biological	167 177	123477 123487	0.9999759197235107	O
29856	functions	178 187	123488 123497	0.9999798536300659	O
29857	and	188 191	123498 123501	0.9999864101409912	O
29858	/	191 192	123501 123502	0.9999871253967285	O
29859	or	192 194	123502 123504	0.9999871253967285	O
29860	associated	195 205	123505 123515	0.9999853372573853	O
29861	pathological	206 217	123516 123527	0.9999850988388062	O
29863	processes	219 228	123529 123538	0.999987006187439	O
29864	most	229 233	123539 123543	0.999987006187439	O
29865	significant	234 245	123544 123555	0.9999880790710449	O
29866	for	246 249	123556 123559	0.9999874830245972	O
29867	each	250 254	123560 123564	0.9999879598617554	O
29868	gene	255 259	123565 123569	0.9999839067459106	O
29869	cluster	260 267	123570 123577	0.9999873638153076	O
29870	.	268 269	123578 123579	0.9999392032623291	O
29871	Fisher	0 6	123580 123586	0.9999810457229614	O
29872	'	7 8	123587 123588	0.9999886751174927	O
29873	s	8 9	123588 123589	0.9999885559082031	O
29874	exact	10 15	123590 123595	0.9999837875366211	O
29875	test	16 20	123596 123600	0.9999855756759644	O
29876	was	21 24	123601 123604	0.9999852180480957	O
29877	used	25 29	123605 123609	0.9999856948852539	O
29878	to	30 32	123610 123612	0.9999880790710449	O
29879	calculate	33 42	123613 123622	0.9999865293502808	O
29880	a	43 44	123623 123624	0.9999891519546509	O
29881	p	45 46	123625 123626	0.9999886751174927	O
29882	value	47 52	123627 123632	0.9999884366989136	O
29883	estimating	53 62	123633 123642	0.9999889135360718	O
29885	the	64 67	123644 123647	0.9999891519546509	O
29886	probability	68 79	123648 123659	0.9999884366989136	O
29887	that	80 84	123660 123664	0.9999891519546509	O
29888	a	85 86	123665 123666	0.99998939037323	O
29889	particular	87 97	123667 123677	0.9999887943267822	O
29890	functional	98 108	123678 123688	0.9999872446060181	O
29891	classification	109 123	123689 123703	0.9999892711639404	O
29892	or	124 126	123704 123706	0.9999889135360718	O
29893	category	127 135	123707 123715	0.9999885559082031	O
29894	of	136 138	123716 123718	0.9999892711639404	O
29895	genes	139 144	123719 123724	0.9999867677688599	O
29896	is	145 147	123725 123727	0.9999890327453613	O
29897	associated	148 158	123728 123738	0.9999892711639404	O
29898	with	159 163	123739 123743	0.99998939037323	O
29899	a	164 165	123744 123745	0.99998939037323	O
29900	particular	166 176	123746 123756	0.9999889135360718	O
29901	pattern	177 184	123757 123764	0.9999889135360718	O
29902	or	185 187	123765 123767	0.9999887943267822	O
29903	cluster	188 195	123768 123775	0.9999885559082031	O
29904	of	196 198	123776 123778	0.9999892711639404	O
29905	gene	199 203	123779 123783	0.999988317489624	O
29906	expression	204 214	123784 123794	0.9999874830245972	O
29907	more	215 219	123795 123799	0.9999887943267822	O
29908	than	220 224	123800 123804	0.9999885559082031	O
29909	would	225 230	123805 123810	0.9999866485595703	O
29910	be	231 233	123811 123813	0.9999887943267822	O
29911	expected	234 242	123814 123822	0.9999868869781494	O
29912	by	243 245	123823 123825	0.9999879598617554	O
29913	chance	246 252	123826 123832	0.9999850988388062	O
29914	.	253 254	123833 123834	0.9999644756317139	O
29915	For	0 3	123835 123838	0.9999823570251465	O
29916	each	4 8	123839 123843	0.9999854564666748	O
29917	cluster	9 16	123844 123851	0.9999793767929077	O
29918	,	17 18	123852 123853	0.999984860420227	O
29919	only	19 23	123854 123858	0.9999837875366211	O
29920	the	24 27	123859 123862	0.9999860525131226	O
29921	top	28 31	123863 123866	0.9999853372573853	O
29922	significant	32 43	123867 123878	0.999983549118042	O
29923	functional	44 54	123879 123889	0.9999673366546631	O
29924	classes	55 62	123890 123897	0.9999865293502808	O
29925	and	63 66	123898 123901	0.9999836683273315	O
29926	canonical	67 76	123902 123911	0.9999508857727051	O
29927	pathways	77 85	123912 123920	0.999982476234436	O
29928	are	86 89	123921 123924	0.9999839067459106	O
29929	shown	90 95	123925 123930	0.9999792575836182	O
29930	.	96 97	123931 123932	0.9999120235443115	O
29931	Figure	0 6	123933 123939	0.9999866485595703	O
29932	7a	7 8	123940 123941	0.9999867677688599	O
29934	shows	10 15	123943 123948	0.9999862909317017	O
29935	a	16 17	123949 123950	0.9999886751174927	O
29936	diagram	18 25	123951 123958	0.9999738931655884	O
29937	of	26 28	123959 123961	0.9999884366989136	O
29938	the	29 32	123962 123965	0.9999886751174927	O
29939	canonical	33 42	123966 123975	0.999964714050293	O
29940	WNT	43 45	123976 123978	0.9999806880950928	O
29942	signaling	47 56	123980 123989	0.9999872446060181	O
29943	pathway	57 64	123990 123997	0.999988317489624	O
29944	and	65 68	123998 124001	0.999988317489624	O
29945	an	69 71	124002 124004	0.9999891519546509	O
29946	associated	72 82	124005 124015	0.9999887943267822	O
29947	-	82 83	124015 124016	0.9999885559082031	O
29948	gene	83 87	124016 124020	0.999984622001648	O
29949	network	88 95	124021 124028	0.9999881982803345	O
29950	that	96 100	124029 124033	0.9999889135360718	O
29951	was	101 104	124034 124037	0.9999885559082031	O
29952	a	105 106	124038 124039	0.9999889135360718	O
29953	top	107 110	124040 124043	0.9999881982803345	O
29954	-	110 111	124043 124044	0.9999885559082031	O
29955	ranked	111 117	124044 124050	0.9999872446060181	O
29956	association	118 129	124051 124062	0.9999881982803345	O
29957	of	130 132	124063 124065	0.9999881982803345	O
29958	the	133 136	124066 124069	0.9999880790710449	O
29959	clusters	137 145	124070 124078	0.9999867677688599	O
29960	that	146 150	124079 124083	0.9999887943267822	O
29961	exhibited	151 160	124084 124093	0.9999880790710449	O
29962	significant	161 172	124094 124105	0.9999880790710449	O
29963	over	173 177	124106 124110	0.9999884366989136	O
29964	-	177 178	124110 124111	0.9999889135360718	O
29965	expression	178 188	124111 124121	0.9999874830245972	O
29966	in	189 191	124122 124124	0.9999884366989136	O
29967	AOM	192 194	124125 124127	0.9999853372573853	O
29969	and	196 199	124129 124132	0.9999876022338867	O
29970	ApcMin	200 205	124133 124138	0.9999886751174927	O
29975	/	206 207	124139 124140	0.9999879598617554	O
29976	+	207 208	124140 124141	0.9999873638153076	O
29977	versus	209 215	124142 124148	0.9999839067459106	O
29978	Smad3	216 220	124149 124153	0.9999874830245972	O
29981	-	221 222	124154 124155	0.9999881982803345	O
29982	/	222 223	124155 124156	0.9999805688858032	O
29983	-	223 224	124156 124157	0.9999877214431763	O
29984	and	225 228	124158 124161	0.9999861717224121	O
29985	Tgfb1	229 233	124162 124166	0.9999843835830688	O
29990	-	234 235	124167 124168	0.9999879598617554	O
29991	/	235 236	124168 124169	0.99997878074646	O
29992	-	236 237	124169 124170	0.9999878406524658	O
29993	;	237 238	124170 124171	0.9999829530715942	O
29994	Rag2	239 242	124172 124175	0.99997878074646	O
29997	-	243 244	124176 124177	0.9999873638153076	O
29998	/	244 245	124177 124178	0.9999710321426392	O
29999	-	245 246	124178 124179	0.9999840259552002	O
30000	mouse	247 252	124180 124185	0.8919240236282349	species
30001	models	253 259	124186 124192	0.999964714050293	O
30002	.	260 261	124193 124194	0.9999611377716064	O
30003	Genes	0 4	124195 124199	0.9999849796295166	O
30005	or	6 8	124201 124203	0.9999855756759644	O
30006	gene	9 13	124204 124208	0.9999866485595703	O
30007	products	14 22	124209 124217	0.9999841451644897	O
30008	are	23 26	124218 124221	0.9999853372573853	O
30009	represented	27 38	124222 124233	0.9999860525131226	O
30010	as	39 41	124234 124236	0.9999868869781494	O
30011	nodes	42 47	124237 124242	0.9999855756759644	O
30012	,	48 49	124243 124244	0.9999841451644897	O
30013	and	50 53	124245 124248	0.9999860525131226	O
30014	biological	54 64	124249 124259	0.9999839067459106	O
30015	relationships	65 78	124260 124273	0.9999877214431763	O
30016	between	79 86	124274 124281	0.9999878406524658	O
30017	nodes	87 92	124282 124287	0.9999867677688599	O
30018	are	93 96	124288 124291	0.999987006187439	O
30019	represented	97 108	124292 124303	0.9999871253967285	O
30020	as	109 111	124304 124306	0.9999874830245972	O
30021	edges	112 117	124307 124312	0.9999814033508301	O
30022	(	118 119	124313 124314	0.9999874830245972	O
30023	lines	120 125	124315 124320	0.9999855756759644	O
30024	)	126 127	124321 124322	0.9999884366989136	O
30025	.	128 129	124323 124324	0.9999650716781616	O
30026	All	0 3	124325 124328	0.9999865293502808	O
30027	edges	4 9	124329 124334	0.9999700784683228	O
30028	are	10 13	124335 124338	0.9999865293502808	O
30029	supported	14 23	124339 124348	0.999985933303833	O
30030	by	24 26	124349 124351	0.999988317489624	O
30031	at	27 29	124352 124354	0.9999886751174927	O
30032	least	30 35	124355 124360	0.9999885559082031	O
30033	one	36 39	124361 124364	0.999988317489624	O
30034	literature	40 50	124365 124375	0.9999847412109375	O
30035	reference	51 60	124376 124385	0.9999880790710449	O
30036	from	61 65	124386 124390	0.9999884366989136	O
30037	a	66 67	124391 124392	0.9999887943267822	O
30038	manuscript	68 78	124393 124403	0.9999840259552002	O
30039	,	79 80	124404 124405	0.9999858140945435	O
30040	or	81 83	124406 124408	0.9999866485595703	O
30041	from	84 88	124409 124413	0.999988317489624	O
30042	canonical	89 98	124414 124423	0.9999814033508301	O
30043	information	99 110	124424 124435	0.9999885559082031	O
30044	stored	111 117	124436 124442	0.9999884366989136	O
30045	in	118 120	124443 124445	0.9999885559082031	O
30046	the	121 124	124446 124449	0.9999887943267822	O
30047	Ingenuity	125 133	124450 124458	0.9999884366989136	O
30050	Pathways	135 142	124460 124467	0.9999874830245972	O
30052	Knowledge	144 153	124469 124478	0.999988317489624	O
30053	Base	154 158	124479 124483	0.9999884366989136	O
30054	.	159 160	124484 124485	0.9999892711639404	O
30055	*	161 162	124486 124487	0.9999877214431763	O
30056	*	162 163	124487 124488	0.9999827146530151	O
30057	IGNORE	0 5	124489 124494	0.9999843835830688	O
30060	LINE	7 10	124496 124499	0.9999881982803345	O
30063	*	12 13	124501 124502	0.999988317489624	O
30064	*	13 14	124502 124503	0.999988317489624	O
30065	*	15 16	124504 124505	0.9999881982803345	O
30066	*	16 17	124505 124506	0.9999884366989136	O
30067	IGNORE	18 23	124507 124512	0.999987006187439	O
30070	LINE	25 28	124514 124517	0.9999886751174927	O
30073	*	30 31	124519 124520	0.9999880790710449	O
30074	*	31 32	124520 124521	0.9999880790710449	O
30075	*	33 34	124522 124523	0.9999879598617554	O
30076	*	34 35	124523 124524	0.9999879598617554	O
30077	IGNORE	36 41	124525 124530	0.9999861717224121	O
30080	LINE	43 46	124532 124535	0.999988317489624	O
30083	*	48 49	124537 124538	0.9999880790710449	O
30084	*	49 50	124538 124539	0.9999881982803345	O
30085	promoter	51 59	124540 124548	0.9999887943267822	O
30086	methylation	60 70	124549 124559	0.9999886751174927	O
30089	in	72 74	124561 124563	0.9999889135360718	O
30090	peripheral	75 85	124564 124574	0.999984622001648	O
30091	blood	86 91	124575 124580	0.9999854564666748	O
30092	DNA	92 95	124581 124584	0.9999862909317017	O
30093	of	96 98	124585 124587	0.9999874830245972	O
30094	mutation	99 107	124588 124596	0.9999821186065674	O
30095	negative	108 116	124597 124605	0.9999829530715942	O
30096	familial	117 124	124606 124613	0.9999840259552002	O
30099	breast	126 132	124615 124621	0.9999809265136719	O
30100	cancer	133 139	124622 124628	0.9999860525131226	O
30101	patients	140 148	124629 124637	0.9999653100967407	O
30102	with	149 153	124638 124642	0.9999862909317017	O
30103	a	154 155	124643 124644	0.9999868869781494	O
30104	tumour	156 161	124645 124650	0.9999868869781494	O
30106	phenotype	163 171	124652 124660	0.999988317489624	O
30109	Abstract	173 180	124662 124669	0.9999868869781494	O
30112	Introduction	182 194	124671 124683	0.9999774694442749	O
30113	Individuals	195 206	124684 124695	0.9998370409011841	O
30114	with	207 211	124696 124700	0.9999861717224121	O
30115	germline	212 219	124701 124708	0.9999877214431763	O
30119	mutations	221 230	124710 124719	0.9999853372573853	O
30120	in	231 233	124720 124722	0.9999884366989136	O
30121	the	234 237	124723 124726	0.9999881982803345	O
30122	BRCA1	238 242	124727 124731	0.9999839067459106	O
30125	gene	244 248	124733 124737	0.9999873638153076	O
30126	have	249 253	124738 124742	0.999984622001648	O
30127	an	254 256	124743 124745	0.9999868869781494	O
30128	elevated	257 265	124746 124754	0.9999668598175049	O
30129	risk	266 270	124755 124759	0.9999816417694092	O
30130	of	271 273	124760 124762	0.9999847412109375	O
30131	developing	274 284	124763 124773	0.9999785423278809	O
30132	breast	285 291	124774 124780	0.9999783039093018	O
30133	cancer	292 298	124781 124787	0.9999845027923584	O
30134	,	299 300	124788 124789	0.9999805688858032	O
30135	and	301 304	124790 124793	0.9999814033508301	O
30136	often	305 310	124794 124799	0.9999814033508301	O
30137	display	311 318	124800 124807	0.9999822378158569	O
30138	characteristic	319 333	124808 124822	0.9999815225601196	O
30139	clinicopathological	334 352	124823 124841	0.9999843835830688	O
30143	features	354 362	124843 124851	0.9999842643737793	O
30144	.	363 364	124852 124853	0.9999315738677979	O
30145	We	0 2	124854 124856	0.9999780654907227	O
30146	hypothesised	3 14	124857 124868	0.9999716281890869	O
30148	that	16 20	124870 124874	0.9999873638153076	O
30149	inactivation	21 32	124875 124886	0.9999885559082031	O
30152	of	34 36	124888 124890	0.9999881982803345	O
30153	BRCA1	37 41	124891 124895	0.9999842643737793	O
30156	by	43 45	124897 124899	0.9999885559082031	O
30157	promoter	46 54	124900 124908	0.9999884366989136	O
30158	methylation	55 65	124909 124919	0.9999880790710449	O
30161	could	67 72	124921 124926	0.9999850988388062	O
30162	occur	73 78	124927 124932	0.9999886751174927	O
30163	as	79 81	124933 124935	0.999988317489624	O
30164	a	82 83	124936 124937	0.9999889135360718	O
30165	germline	84 91	124938 124945	0.9999880790710449	O
30169	or	93 95	124947 124949	0.9999839067459106	O
30170	an	96 98	124950 124952	0.9999889135360718	O
30171	early	99 104	124953 124958	0.9999862909317017	O
30172	somatic	105 111	124959 124965	0.9999868869781494	O
30174	event	113 118	124967 124972	0.9999878406524658	O
30175	that	119 123	124973 124977	0.9999885559082031	O
30176	predisposes	124 134	124978 124988	0.9999884366989136	O
30180	to	136 138	124990 124992	0.999987006187439	O
30181	breast	139 145	124993 124999	0.9999818801879883	O
30182	cancer	146 152	125000 125006	0.9999861717224121	O
30183	with	153 157	125007 125011	0.9999853372573853	O
30184	the	158 161	125012 125015	0.9999871253967285	O
30185	phenotype	162 170	125016 125024	0.9999881982803345	O
30188	normally	172 180	125026 125034	0.9999850988388062	O
30189	associated	181 191	125035 125045	0.9999886751174927	O
30190	with	192 196	125046 125050	0.9999886751174927	O
30191	BRCA1	197 201	125051 125055	0.9999858140945435	O
30194	germline	203 210	125057 125064	0.9999884366989136	O
30198	mutation	212 220	125066 125074	0.9999872446060181	O
30199	.	221 222	125075 125076	0.9999451637268066	O
30200	Methods	0 6	125077 125083	0.9999698400497437	O
30202	We	8 10	125085 125087	0.9999779462814331	O
30203	examined	11 19	125088 125096	0.9999794960021973	O
30204	seven	20 25	125097 125102	0.999951958656311	O
30205	cases	26 31	125103 125108	0.9999823570251465	O
30206	from	32 36	125109 125113	0.9999779462814331	O
30207	breast	37 43	125114 125120	0.9999727010726929	O
30208	-	43 44	125120 125121	0.9999810457229614	O
30209	ovarian	44 50	125121 125127	0.9999759197235107	O
30212	cancer	52 58	125129 125135	0.9999850988388062	O
30213	families	59 67	125136 125144	0.9999676942825317	O
30214	with	68 72	125145 125149	0.9999793767929077	O
30215	tumours	73 79	125150 125156	0.9999852180480957	O
30218	that	81 85	125158 125162	0.9999867677688599	O
30219	showed	86 92	125163 125169	0.9999858140945435	O
30220	BRCA1	93 97	125170 125174	0.9999865293502808	O
30223	-	98 99	125175 125176	0.9999887943267822	O
30224	like	99 103	125176 125180	0.9999878406524658	O
30225	pathology	104 112	125181 125189	0.9999886751174927	O
30227	but	114 117	125191 125194	0.9999871253967285	O
30228	did	118 121	125195 125198	0.9999864101409912	O
30229	not	122 125	125199 125202	0.9999861717224121	O
30230	have	126 130	125203 125207	0.9999877214431763	O
30231	detectable	131 140	125208 125217	0.9999879598617554	O
30233	BRCA1	142 146	125219 125223	0.9999873638153076	O
30236	or	148 150	125225 125227	0.9999861717224121	O
30237	BRCA2	151 155	125228 125232	0.9999865293502808	O
30240	germline	157 164	125234 125241	0.9999880790710449	O
30244	mutations	166 175	125243 125252	0.9999858140945435	O
30245	present	176 183	125253 125260	0.9999865293502808	O
30246	.	184 185	125261 125262	0.9999566078186035	O
30247	Methylation	0 10	125263 125273	0.9999847412109375	O
30250	levels	12 18	125275 125281	0.9999858140945435	O
30251	were	19 23	125282 125286	0.9999865293502808	O
30252	tested	24 30	125287 125293	0.9999864101409912	O
30253	by	31 33	125294 125296	0.9999880790710449	O
30254	several	34 41	125297 125304	0.9999867677688599	O
30255	quantitative	42 54	125305 125317	0.9999845027923584	O
30256	techniques	55 65	125318 125328	0.9999856948852539	O
30257	including	66 75	125329 125338	0.9999890327453613	O
30258	Methy	76 80	125339 125343	0.9999858140945435	O
30260	Light	82 87	125345 125350	0.9999830722808838	O
30261	,	88 89	125351 125352	0.9999878406524658	O
30262	methylation	90 100	125353 125363	0.9999880790710449	O
30265	-	101 102	125364 125365	0.99998939037323	O
30266	sensitive	102 111	125365 125374	0.9999879598617554	O
30267	high	112 116	125375 125379	0.9999886751174927	O
30268	resolution	117 127	125380 125390	0.9999884366989136	O
30269	melting	128 135	125391 125398	0.9999868869781494	O
30270	(	136 137	125399 125400	0.99998939037323	O
30271	MS	138 140	125401 125403	0.9999878406524658	O
30272	-	140 141	125403 125404	0.9999891519546509	O
30273	HRM	141 143	125404 125406	0.9999890327453613	O
30276	)	145 146	125408 125409	0.9999896287918091	O
30277	and	147 150	125410 125413	0.999988317489624	O
30278	a	151 152	125414 125415	0.9999892711639404	O
30279	newly	153 158	125416 125421	0.9999877214431763	O
30280	developed	159 168	125422 125431	0.9999878406524658	O
30281	digital	169 176	125432 125439	0.9999822378158569	O
30282	MS	177 179	125440 125442	0.9999880790710449	O
30283	-	179 180	125442 125443	0.9999891519546509	O
30284	HRM	180 182	125443 125445	0.9999885559082031	O
30287	assay	184 188	125447 125451	0.999988317489624	O
30289	.	190 191	125453 125454	0.9999711513519287	O
30290	Results	0 7	125455 125462	0.9999725818634033	O
30291	In	8 10	125463 125465	0.9999854564666748	O
30292	one	11 14	125466 125469	0.999975323677063	O
30293	patient	15 22	125470 125477	0.9999698400497437	O
30294	,	23 24	125478 125479	0.9999876022338867	O
30295	methylation	25 35	125480 125490	0.9999872446060181	O
30298	of	37 39	125492 125494	0.999988317489624	O
30299	10	40 42	125495 125497	0.9999850988388062	O
30300	%	43 44	125498 125499	0.9999880790710449	O
30301	of	45 47	125500 125502	0.9999885559082031	O
30302	the	48 51	125503 125506	0.9999877214431763	O
30303	BRCA1	52 56	125507 125511	0.9999804496765137	O
30306	alleles	58 64	125513 125519	0.9999887943267822	O
30309	was	66 69	125521 125524	0.9999878406524658	O
30310	detected	70 78	125525 125533	0.9999885559082031	O
30311	in	79 81	125534 125536	0.9999884366989136	O
30312	the	82 85	125537 125540	0.9999878406524658	O
30313	peripheral	86 96	125541 125551	0.999981164932251	O
30314	blood	97 102	125552 125557	0.9999849796295166	O
30315	DNA	103 106	125558 125561	0.999983549118042	O
30316	,	107 108	125562 125563	0.9999871253967285	O
30317	consistent	109 119	125564 125574	0.9999878406524658	O
30318	with	120 124	125575 125579	0.9999890327453613	O
30319	20	125 127	125580 125582	0.9999845027923584	O
30320	%	128 129	125583 125584	0.9999886751174927	O
30321	of	130 132	125585 125587	0.9999889135360718	O
30322	cells	133 138	125588 125593	0.9999847412109375	O
30323	having	139 145	125594 125600	0.9999887943267822	O
30324	one	146 149	125601 125604	0.9999879598617554	O
30325	methylated	150 159	125605 125614	0.9999879598617554	O
30328	allele	161 166	125616 125621	0.9999886751174927	O
30330	.	168 169	125623 125624	0.9999737739562988	O
30331	Buccal	0 5	125625 125630	0.999968409538269	O
30334	mucosa	7 12	125632 125637	0.9999771118164062	O
30337	DNA	14 17	125639 125642	0.9999754428863525	O
30338	from	18 22	125643 125647	0.9999805688858032	O
30339	this	23 27	125648 125652	0.9999656677246094	O
30340	individual	28 38	125653 125663	0.9998809099197388	O
30341	displayed	39 48	125664 125673	0.9999791383743286	O
30342	approximately	49 62	125674 125687	0.999985933303833	O
30343	5	63 64	125688 125689	0.9999854564666748	O
30344	%	65 66	125690 125691	0.9999849796295166	O
30345	BRCA1	67 71	125692 125696	0.999983549118042	O
30348	methylation	73 83	125698 125708	0.9999868869781494	O
30351	.	85 86	125710 125711	0.9999512434005737	O
30352	In	0 2	125712 125714	0.9999861717224121	O
30353	two	3 6	125715 125718	0.999972939491272	O
30354	other	7 12	125719 125724	0.9999786615371704	O
30355	patients	13 21	125725 125733	0.9999775886535645	O
30356	,	22 23	125734 125735	0.9999885559082031	O
30357	methylation	24 34	125736 125746	0.9999862909317017	O
30360	of	36 38	125748 125750	0.9999879598617554	O
30361	BRCA1	39 43	125751 125755	0.9999823570251465	O
30364	was	45 48	125757 125760	0.9999887943267822	O
30365	detected	49 57	125761 125769	0.9999891519546509	O
30366	in	58 60	125770 125772	0.9999892711639404	O
30367	the	61 64	125773 125776	0.9999889135360718	O
30368	peripheral	65 75	125777 125787	0.9999831914901733	O
30369	blood	76 81	125788 125793	0.9999853372573853	O
30370	at	82 84	125794 125796	0.9999887943267822	O
30371	significantly	85 98	125797 125810	0.9999881982803345	O
30372	lower	99 104	125811 125816	0.9999861717224121	O
30373	but	105 108	125817 125820	0.9999866485595703	O
30374	still	109 114	125821 125826	0.9999867677688599	O
30375	readily	115 122	125827 125834	0.9999879598617554	O
30376	detectable	123 132	125835 125844	0.9999885559082031	O
30378	levels	134 140	125846 125852	0.9999880790710449	O
30379	(	141 142	125853 125854	0.9999890327453613	O
30380	approximately	143 156	125855 125868	0.9999885559082031	O
30381	1	157 158	125869 125870	0.9999878406524658	O
30382	%	159 160	125871 125872	0.9999886751174927	O
30383	)	161 162	125873 125874	0.9999892711639404	O
30384	.	163 164	125875 125876	0.9999675750732422	O
30385	Tumour	0 5	125877 125882	0.9999662637710571	O
30387	DNAs	7 10	125884 125887	0.999966025352478	O
30389	from	12 16	125889 125893	0.9999613761901855	O
30390	these	17 22	125894 125899	0.9999685287475586	O
30391	three	23 28	125900 125905	0.9999053478240967	O
30392	patients	29 37	125906 125914	0.9999340772628784	O
30393	were	38 42	125915 125919	0.9999768733978271	O
30394	heavily	43 50	125920 125927	0.9999774694442749	O
30395	methylated	51 60	125928 125937	0.9999833106994629	O
30398	at	62 64	125939 125941	0.999983549118042	O
30399	BRCA1	65 69	125942 125946	0.9999803304672241	O
30402	.	71 72	125948 125949	0.9998922348022461	O
30403	The	0 3	125950 125953	0.9999732971191406	O
30404	other	4 9	125954 125959	0.9999676942825317	O
30405	patients	10 18	125960 125968	0.9999688863754272	O
30406	had	19 22	125969 125972	0.9999819993972778	O
30407	no	23 25	125973 125975	0.9999810457229614	O
30408	detectable	26 35	125976 125985	0.9999850988388062	O
30410	BRCA1	37 41	125987 125991	0.9999784231185913	O
30413	methylation	43 53	125993 126003	0.999984860420227	O
30416	in	55 57	126005 126007	0.9999853372573853	O
30417	their	58 63	126008 126013	0.9999833106994629	O
30418	peripheral	64 74	126014 126024	0.9999821186065674	O
30419	blood	75 80	126025 126030	0.9999828338623047	O
30420	.	81 82	126031 126032	0.9999170303344727	O
30421	One	0 3	126033 126036	0.9999827146530151	O
30422	of	4 6	126037 126039	0.9999862909317017	O
30423	seven	7 12	126040 126045	0.9999659061431885	O
30424	age	13 16	126046 126049	0.9999821186065674	O
30425	-	16 17	126049 126050	0.9999866485595703	O
30426	matched	17 24	126050 126057	0.9999715089797974	O
30427	controls	25 33	126058 126066	0.9999456405639648	O
30428	showed	34 40	126067 126073	0.9999843835830688	O
30429	extremely	41 50	126074 126083	0.999984860420227	O
30430	low	51 54	126084 126087	0.9999836683273315	O
30431	levels	55 61	126088 126094	0.9999876022338867	O
30432	of	62 64	126095 126097	0.9999876022338867	O
30433	methylation	65 75	126098 126108	0.9999865293502808	O
30436	in	77 79	126110 126112	0.9999871253967285	O
30437	their	80 85	126113 126118	0.9999825954437256	O
30438	peripheral	86 96	126119 126129	0.9999805688858032	O
30439	blood	97 102	126130 126135	0.9999836683273315	O
30440	(	103 104	126136 126137	0.9999879598617554	O
30441	approximately	105 118	126138 126151	0.9999861717224121	O
30442	0	119 120	126152 126153	0.9999858140945435	O
30443	.	120 121	126153 126154	0.9999874830245972	O
30444	1	121 122	126154 126155	0.9999853372573853	O
30445	%	123 124	126156 126157	0.9999873638153076	O
30446	)	125 126	126158 126159	0.9999879598617554	O
30447	.	127 128	126160 126161	0.99996018409729	O
30448	Conclusion	0 9	126162 126171	0.9999850988388062	O
30451	These	11 16	126173 126178	0.9999858140945435	O
30452	results	17 24	126179 126186	0.9999847412109375	O
30453	demonstrate	25 36	126187 126198	0.9999833106994629	O
30454	that	37 41	126199 126203	0.9999874830245972	O
30455	in	42 44	126204 126206	0.9999866485595703	O
30456	some	45 49	126207 126211	0.999983549118042	O
30457	cases	50 55	126212 126217	0.9999841451644897	O
30458	of	56 58	126218 126220	0.9999855756759644	O
30459	breast	59 65	126221 126227	0.9999816417694092	O
30460	cancer	66 72	126228 126234	0.9999855756759644	O
30461	,	73 74	126235 126236	0.9999876022338867	O
30462	low	75 78	126237 126240	0.9999871253967285	O
30463	-	78 79	126240 126241	0.999988317489624	O
30464	level	79 84	126241 126246	0.9999879598617554	O
30465	promoter	85 93	126247 126255	0.9999872446060181	O
30466	methylation	94 104	126256 126266	0.9999872446060181	O
30469	of	106 108	126268 126270	0.9999876022338867	O
30470	BRCA1	109 113	126271 126275	0.9999854564666748	O
30473	occurs	115 121	126277 126283	0.9999871253967285	O
30474	in	122 124	126284 126286	0.9999879598617554	O
30475	normal	125 131	126287 126293	0.9999833106994629	O
30476	tissues	132 139	126294 126301	0.9999852180480957	O
30477	of	140 142	126302 126304	0.9999866485595703	O
30478	the	143 146	126305 126308	0.9999873638153076	O
30479	body	147 151	126309 126313	0.999975323677063	O
30480	and	152 155	126314 126317	0.9999860525131226	O
30481	is	156 158	126318 126320	0.9999874830245972	O
30482	associated	159 169	126321 126331	0.9999876022338867	O
30483	with	170 174	126332 126336	0.9999877214431763	O
30484	the	175 178	126337 126340	0.9999871253967285	O
30485	development	179 190	126341 126352	0.9999823570251465	O
30486	of	191 193	126353 126355	0.9999871253967285	O
30487	BRCA1	194 198	126356 126360	0.9999842643737793	O
30490	-	199 200	126361 126362	0.9999877214431763	O
30491	like	200 204	126362 126366	0.999982476234436	O
30492	breast	205 211	126367 126373	0.9999827146530151	O
30493	cancer	212 218	126374 126380	0.9999852180480957	O
30494	.	219 220	126381 126382	0.9999874830245972	O
30495	*	221 222	126383 126384	0.9999860525131226	O
30496	*	222 223	126384 126385	0.9999706745147705	O
30497	IGNORE	0 5	126386 126391	0.9999862909317017	O
30500	LINE	7 10	126393 126396	0.9999890327453613	O
30503	*	12 13	126398 126399	0.9999890327453613	O
30504	*	13 14	126399 126400	0.9999890327453613	O
30505	*	15 16	126401 126402	0.9999890327453613	O
30506	*	16 17	126402 126403	0.9999891519546509	O
30507	IGNORE	18 23	126404 126409	0.9999877214431763	O
30510	LINE	25 28	126411 126414	0.9999892711639404	O
30513	*	30 31	126416 126417	0.9999887943267822	O
30514	*	31 32	126417 126418	0.9999887943267822	O
30515	*	33 34	126419 126420	0.9999887943267822	O
30516	*	34 35	126420 126421	0.9999887943267822	O
30517	IGNORE	36 41	126422 126427	0.9999876022338867	O
30520	LINE	43 46	126429 126432	0.9999890327453613	O
30523	*	48 49	126434 126435	0.9999889135360718	O
30524	*	49 50	126435 126436	0.9999889135360718	O
30525	Introduction	51 63	126437 126449	0.9999881982803345	O
30526	In	64 66	126450 126452	0.99998939037323	O
30527	1994	67 71	126453 126457	0.9999867677688599	O
30528	,	72 73	126458 126459	0.99998939037323	O
30529	BRCA1	74 78	126460 126464	0.9999867677688599	O
30532	was	80 83	126466 126469	0.9999892711639404	O
30533	identified	84 94	126470 126480	0.9999887943267822	O
30534	as	95 97	126481 126483	0.99998939037323	O
30535	the	98 101	126484 126487	0.9999895095825195	O
30536	first	102 107	126488 126493	0.9999887943267822	O
30537	major	108 113	126494 126499	0.9999867677688599	O
30538	gene	114 118	126500 126504	0.9999830722808838	O
30539	associated	119 129	126505 126515	0.9999890327453613	O
30540	with	130 134	126516 126520	0.9999891519546509	O
30541	familial	135 142	126521 126528	0.9999873638153076	O
30544	breast	144 150	126530 126536	0.9999829530715942	O
30545	cancer	151 157	126537 126543	0.9999867677688599	O
30546	predisposition	158 171	126544 126557	0.9999892711639404	O
30549	[	173 174	126559 126560	0.99998939037323	O
30550	1	174 175	126560 126561	0.9999880790710449	O
30551	]	175 176	126561 126562	0.9999890327453613	O
30552	.	177 178	126563 126564	0.9999775886535645	O
30553	Since	0 5	126565 126570	0.9999827146530151	O
30554	then	6 10	126571 126575	0.9999823570251465	O
30555	many	11 15	126576 126580	0.9999845027923584	O
30556	inactivating	16 27	126581 126592	0.9999868869781494	O
30559	mutations	29 38	126594 126603	0.9999823570251465	O
30560	in	39 41	126604 126606	0.9999866485595703	O
30561	BRCA1	42 46	126607 126611	0.9999805688858032	O
30564	have	48 52	126613 126617	0.9999864101409912	O
30565	been	53 57	126618 126622	0.9999871253967285	O
30566	identified	58 68	126623 126633	0.9999861717224121	O
30567	as	69 71	126634 126636	0.999987006187439	O
30568	breast	72 78	126637 126643	0.9999774694442749	O
30569	cancer	79 85	126644 126650	0.9999833106994629	O
30570	predisposition	86 99	126651 126664	0.9999871253967285	O
30573	alleles	101 107	126666 126672	0.9999873638153076	O
30576	.	109 110	126674 126675	0.9999583959579468	O
30577	Breast	0 5	126676 126681	0.9999644756317139	O
30580	cancers	7 13	126683 126689	0.9999817609786987	O
30582	associated	15 25	126691 126701	0.9999831914901733	O
30583	with	26 30	126702 126706	0.9999853372573853	O
30584	BRCA1	31 35	126707 126711	0.9999791383743286	O
30587	mutations	37 46	126713 126722	0.9999722242355347	O
30588	often	47 52	126723 126728	0.9999823570251465	O
30589	show	53 57	126729 126733	0.9999828338623047	O
30590	characteristic	58 72	126734 126748	0.9999852180480957	O
30591	histological	73 84	126749 126760	0.9999856948852539	O
30594	features	86 94	126762 126770	0.9999856948852539	O
30595	including	95 104	126771 126780	0.9999879598617554	O
30596	high	105 109	126781 126785	0.9999862909317017	O
30597	grade	110 115	126786 126791	0.9999853372573853	O
30598	,	116 117	126792 126793	0.9999876022338867	O
30599	high	118 122	126794 126798	0.9999862909317017	O
30600	mitotic	123 129	126799 126805	0.9999881982803345	O
30602	count	131 136	126807 126812	0.9999878406524658	O
30603	,	137 138	126813 126814	0.9999876022338867	O
30604	solid	139 144	126815 126820	0.9999847412109375	O
30605	architecture	145 157	126821 126833	0.9999871253967285	O
30606	and	158 161	126834 126837	0.9999874830245972	O
30607	prominent	162 171	126838 126847	0.9999833106994629	O
30608	lymphocytic	172 182	126848 126858	0.9999868869781494	O
30612	infiltrates	184 194	126860 126870	0.9999884366989136	O
30616	,	196 197	126872 126873	0.999984860420227	O
30617	all	198 201	126874 126877	0.9999858140945435	O
30618	features	202 210	126878 126886	0.9999860525131226	O
30619	resembling	211 221	126887 126897	0.9999845027923584	O
30620	so	222 224	126898 126900	0.9999872446060181	O
30621	-	224 225	126900 126901	0.9999877214431763	O
30622	called	225 231	126901 126907	0.9999858140945435	O
30623	medullary	232 240	126908 126916	0.9999809265136719	O
30627	cancer	242 248	126918 126924	0.9999852180480957	O
30628	[	249 250	126925 126926	0.9999886751174927	O
30629	2	250 251	126926 126927	0.9999868869781494	O
30630	-	251 252	126927 126928	0.9999881982803345	O
30631	4	252 253	126928 126929	0.9999856948852539	O
30632	]	253 254	126929 126930	0.9999879598617554	O
30633	.	255 256	126931 126932	0.9999663829803467	O
30634	BRCA1	0 4	126933 126937	0.9999761581420898	O
30637	-	5 6	126938 126939	0.9999871253967285	O
30638	associated	6 16	126939 126949	0.999984622001648	O
30639	tumours	17 23	126950 126956	0.9999823570251465	O
30642	are	25 28	126958 126961	0.9999841451644897	O
30643	usually	29 36	126962 126969	0.9999855756759644	O
30644	negative	37 45	126970 126978	0.9999810457229614	O
30645	by	46 48	126979 126981	0.9999880790710449	O
30646	immunohistochemistry	49 68	126982 127001	0.999988317489624	O
30652	for	70 73	127003 127006	0.9999880790710449	O
30653	the	74 77	127007 127010	0.999988317489624	O
30654	oestrogen	78 86	127011 127019	0.9999856948852539	O
30657	receptor	88 96	127021 127029	0.9999880790710449	O
30658	(	97 98	127030 127031	0.9999891519546509	O
30659	ER	99 101	127032 127034	0.9999847412109375	O
30660	)	102 103	127035 127036	0.9999889135360718	O
30661	,	104 105	127037 127038	0.9999879598617554	O
30662	the	106 109	127039 127042	0.9999879598617554	O
30663	progesterone	110 121	127043 127054	0.9999860525131226	O
30667	receptor	123 131	127056 127064	0.9999879598617554	O
30668	(	132 133	127065 127066	0.9999887943267822	O
30669	PR	134 136	127067 127069	0.9999860525131226	O
30670	)	137 138	127070 127071	0.9999885559082031	O
30671	and	139 142	127072 127075	0.9999876022338867	O
30672	HER2	143 146	127076 127079	0.9999827146530151	O
30675	[	148 149	127081 127082	0.9999891519546509	O
30676	5	149 150	127082 127083	0.9999876022338867	O
30677	-	150 151	127083 127084	0.9999887943267822	O
30678	7	151 152	127084 127085	0.999987006187439	O
30679	]	152 153	127085 127086	0.9999886751174927	O
30680	.	154 155	127087 127088	0.999964714050293	O
30681	However	0 7	127089 127096	0.9999805688858032	O
30682	,	8 9	127097 127098	0.9999842643737793	O
30683	the	10 13	127099 127102	0.9999834299087524	O
30684	majority	14 22	127103 127111	0.9999818801879883	O
30685	of	23 25	127112 127114	0.9999814033508301	O
30686	breast	26 32	127115 127121	0.999972939491272	O
30687	cancers	33 39	127122 127128	0.9999819993972778	O
30689	that	41 45	127130 127134	0.9999837875366211	O
30690	exhibit	46 53	127135 127142	0.9999827146530151	O
30691	a	54 55	127143 127144	0.9999862909317017	O
30692	BRCA1	56 60	127145 127149	0.9999839067459106	O
30695	-	61 62	127150 127151	0.9999874830245972	O
30696	like	62 66	127151 127155	0.9999867677688599	O
30697	phenotype	67 75	127156 127164	0.9999872446060181	O
30700	do	77 79	127166 127168	0.9999817609786987	O
30701	not	80 83	127169 127172	0.9999837875366211	O
30702	harbour	84 91	127173 127180	0.9999856948852539	O
30703	detectable	92 101	127181 127190	0.9999860525131226	O
30705	germline	103 110	127192 127199	0.9999864101409912	O
30709	mutations	112 121	127201 127210	0.999985933303833	O
30710	in	122 124	127211 127213	0.9999865293502808	O
30711	BRCA1	125 129	127214 127218	0.999984860420227	O
30714	.	131 132	127220 127221	0.9999582767486572	O
30715	Some	0 4	127222 127226	0.9999843835830688	O
30716	of	5 7	127227 127229	0.999987006187439	O
30717	this	8 12	127230 127234	0.9999872446060181	O
30718	discordance	13 23	127235 127245	0.9999873638153076	O
30721	may	25 28	127247 127250	0.9999850988388062	O
30722	be	29 31	127251 127253	0.9999876022338867	O
30723	due	32 35	127254 127257	0.9999877214431763	O
30724	to	36 38	127258 127260	0.9999880790710449	O
30725	epigenetic	39 48	127261 127270	0.9999881982803345	O
30729	defects	50 57	127272 127279	0.9999860525131226	O
30730	in	58 60	127280 127282	0.999988317489624	O
30731	breast	61 67	127283 127289	0.9999833106994629	O
30732	cancer	68 74	127290 127296	0.9999864101409912	O
30733	susceptibility	75 88	127297 127310	0.9999881982803345	O
30738	genes	90 95	127312 127317	0.9999877214431763	O
30739	such	96 100	127318 127322	0.9999879598617554	O
30740	as	101 103	127323 127325	0.9999885559082031	O
30741	BRCA1	104 108	127326 127330	0.9999864101409912	O
30744	contributing	110 122	127332 127344	0.9999884366989136	O
30745	to	123 125	127345 127347	0.9999885559082031	O
30746	breast	126 132	127348 127354	0.999984622001648	O
30747	cancer	133 139	127355 127361	0.9999867677688599	O
30748	predisposition	140 153	127362 127375	0.9999887943267822	O
30751	.	155 156	127377 127378	0.9999674558639526	O
30752	Recent	0 6	127379 127385	0.999984622001648	O
30753	reports	7 14	127386 127393	0.9999853372573853	O
30754	of	15 17	127394 127396	0.999988317489624	O
30755	somatic	18 24	127397 127403	0.9999876022338867	O
30757	methylation	26 36	127405 127415	0.9999879598617554	O
30760	(	38 39	127417 127418	0.9999889135360718	O
30761	or	40 42	127419 127421	0.9999879598617554	O
30762	epimutations	43 54	127422 127433	0.9999884366989136	O
30766	)	56 57	127435 127436	0.9999891519546509	O
30767	affecting	58 67	127437 127446	0.9999881982803345	O
30768	an	68 70	127447 127449	0.9999891519546509	O
30769	allele	71 76	127450 127455	0.9999884366989136	O
30771	of	78 80	127457 127459	0.999988317489624	O
30772	the	81 84	127460 127463	0.9999887943267822	O
30773	MLH1	85 88	127464 127467	0.9999852180480957	O
30776	gene	90 94	127469 127473	0.999988317489624	O
30777	in	95 97	127474 127476	0.9999878406524658	O
30778	patients	98 106	127477 127485	0.9999672174453735	O
30779	with	107 111	127486 127490	0.9999864101409912	O
30780	hereditary	112 122	127491 127501	0.9999597072601318	O
30781	non	123 126	127502 127505	0.9999849796295166	O
30782	-	126 127	127505 127506	0.9999868869781494	O
30783	polyposis	127 135	127506 127514	0.9999850988388062	O
30787	colorectal	137 146	127516 127525	0.9999860525131226	O
30790	cancer	148 154	127527 127533	0.9999867677688599	O
30791	indicate	155 163	127534 127542	0.9999858140945435	O
30792	inactivation	164 175	127543 127554	0.9999889135360718	O
30795	of	177 179	127556 127558	0.9999887943267822	O
30796	tumour	180 185	127559 127564	0.9999879598617554	O
30798	suppressor	187 196	127566 127575	0.9999862909317017	O
30800	genes	198 203	127577 127582	0.9999880790710449	O
30801	by	204 206	127583 127585	0.9999889135360718	O
30802	promoter	207 215	127586 127594	0.999988317489624	O
30803	methylation	216 226	127595 127605	0.9999884366989136	O
30806	can	228 231	127607 127610	0.9999850988388062	O
30807	occur	232 237	127611 127616	0.999988317489624	O
30808	early	238 243	127617 127622	0.9999881982803345	O
30809	in	244 246	127623 127625	0.9999889135360718	O
30810	development	247 258	127626 127637	0.9999850988388062	O
30811	or	259 261	127638 127640	0.9999854564666748	O
30812	possibly	262 270	127641 127649	0.9999866485595703	O
30813	in	271 273	127650 127652	0.999988317489624	O
30814	the	274 277	127653 127656	0.9999887943267822	O
30815	germline	278 285	127657 127664	0.9999876022338867	O
30819	[	287 288	127666 127667	0.99998939037323	O
30820	8	288 289	127667 127668	0.9999884366989136	O
30821	-	289 290	127668 127669	0.9999891519546509	O
30822	10	290 292	127669 127671	0.9999866485595703	O
30823	]	292 293	127671 127672	0.9999887943267822	O
30824	.	294 295	127673 127674	0.9999748468399048	O
30825	Allelic	0 6	127675 127681	0.9999874830245972	O
30828	methylation	8 18	127683 127693	0.9999871253967285	O
30831	is	20 22	127695 127697	0.9999867677688599	O
30832	functionally	23 34	127698 127709	0.9999823570251465	O
30834	equivalent	36 46	127711 127721	0.9999854564666748	O
30835	to	47 49	127722 127724	0.9999881982803345	O
30836	a	50 51	127725 127726	0.999988317489624	O
30837	mutation	52 60	127727 127735	0.9999845027923584	O
30838	in	61 63	127736 127738	0.9999885559082031	O
30839	that	64 68	127739 127743	0.9999878406524658	O
30840	loss	69 73	127744 127748	0.9999884366989136	O
30841	of	74 76	127749 127751	0.9999889135360718	O
30842	activity	77 85	127752 127760	0.9999876022338867	O
30843	of	86 88	127761 127763	0.9999889135360718	O
30844	the	89 92	127764 127767	0.9999890327453613	O
30845	second	93 99	127768 127774	0.999985933303833	O
30846	allele	100 105	127775 127780	0.999988317489624	O
30848	arising	107 114	127782 127789	0.9999889135360718	O
30849	from	115 119	127790 127794	0.9999886751174927	O
30850	a	120 121	127795 127796	0.9999885559082031	O
30851	mutation	122 130	127797 127805	0.9999860525131226	O
30852	,	131 132	127806 127807	0.9999873638153076	O
30853	loss	133 137	127808 127812	0.999988317489624	O
30854	of	138 140	127813 127815	0.9999887943267822	O
30855	heterozygosity	141 154	127816 127829	0.9999881982803345	O
30860	or	156 158	127831 127833	0.9999867677688599	O
30861	a	159 160	127834 127835	0.9999887943267822	O
30862	second	161 167	127836 127842	0.999984860420227	O
30863	methylation	168 178	127843 127853	0.999987006187439	O
30866	event	180 185	127855 127860	0.9999876022338867	O
30867	will	186 190	127861 127865	0.999985933303833	O
30868	inactivate	191 200	127866 127875	0.999988317489624	O
30871	the	202 205	127877 127880	0.999988317489624	O
30872	gene	206 210	127881 127885	0.9999840259552002	O
30873	.	211 212	127886 127887	0.9999492168426514	O
30874	Methylation	0 10	127888 127898	0.9999852180480957	O
30877	of	12 14	127900 127902	0.9999866485595703	O
30878	the	15 18	127903 127906	0.9999865293502808	O
30879	BRCA1	19 23	127907 127911	0.9999814033508301	O
30882	promoter	25 33	127913 127921	0.9999829530715942	O
30883	has	34 37	127922 127925	0.999985933303833	O
30884	been	38 42	127926 127930	0.9999866485595703	O
30885	shown	43 48	127931 127936	0.9999837875366211	O
30886	to	49 51	127937 127939	0.9999878406524658	O
30887	occur	52 57	127940 127945	0.9999873638153076	O
30888	in	58 60	127946 127948	0.9999876022338867	O
30889	approximately	61 74	127949 127962	0.9999873638153076	O
30890	20	75 77	127963 127965	0.9999818801879883	O
30891	%	78 79	127966 127967	0.9999860525131226	O
30892	of	80 82	127968 127970	0.9999839067459106	O
30893	breast	83 89	127971 127977	0.9999775886535645	O
30894	cancer	90 96	127978 127984	0.999983549118042	O
30895	patients	97 105	127985 127993	0.99997878074646	O
30896	[	106 107	127994 127995	0.9999889135360718	O
30897	11	107 109	127995 127997	0.9999885559082031	O
30898	-	109 110	127997 127998	0.9999890327453613	O
30899	14	110 112	127998 128000	0.9999874830245972	O
30900	]	112 113	128000 128001	0.9999887943267822	O
30901	.	114 115	128002 128003	0.9999712705612183	O
30902	Sporadic	0 7	128004 128011	0.9999606609344482	O
30904	tumours	9 15	128013 128019	0.9999831914901733	O
30907	with	17 21	128021 128025	0.999985933303833	O
30908	BRCA1	22 26	128026 128030	0.9999840259552002	O
30911	promoter	28 36	128032 128040	0.999988317489624	O
30912	methylation	37 47	128041 128051	0.9999877214431763	O
30915	have	49 53	128053 128057	0.999987006187439	O
30916	been	54 58	128058 128062	0.9999877214431763	O
30917	reported	59 67	128063 128071	0.9999861717224121	O
30918	to	68 70	128072 128074	0.999988317489624	O
30919	be	71 73	128075 128077	0.9999881982803345	O
30920	ER	74 76	128078 128080	0.9999842643737793	O
30921	and	77 80	128081 128084	0.9999878406524658	O
30922	PR	81 83	128085 128087	0.999984860420227	O
30923	negative	84 92	128088 128096	0.9999862909317017	O
30924	[	93 94	128097 128098	0.9999890327453613	O
30925	13	94 96	128098 128100	0.9999885559082031	O
30926	,	96 97	128100 128101	0.999988317489624	O
30927	14	97 99	128101 128103	0.9999881982803345	O
30928	]	99 100	128103 128104	0.9999891519546509	O
30929	,	101 102	128105 128106	0.9999850988388062	O
30930	or	103 105	128107 128109	0.999983549118042	O
30931	to	106 108	128110 128112	0.9999878406524658	O
30932	display	109 116	128113 128120	0.9999861717224121	O
30933	similar	117 124	128121 128128	0.9999873638153076	O
30934	pathological	125 136	128129 128140	0.9999861717224121	O
30936	features	138 146	128142 128150	0.9999865293502808	O
30937	to	147 149	128151 128153	0.9999877214431763	O
30938	those	150 155	128154 128159	0.9999876022338867	O
30939	of	156 158	128160 128162	0.9999872446060181	O
30940	BRCA1	159 163	128163 128167	0.9999852180480957	O
30943	-	164 165	128168 128169	0.9999881982803345	O
30944	mutated	165 171	128169 128175	0.9999840259552002	O
30947	hereditary	173 183	128177 128187	0.999829888343811	O
30948	breast	184 190	128188 128194	0.9999799728393555	O
30949	cancers	191 197	128195 128201	0.9999855756759644	O
30951	[	199 200	128203 128204	0.9999891519546509	O
30952	15	200 202	128204 128206	0.9999861717224121	O
30953	]	202 203	128206 128207	0.9999889135360718	O
30954	.	204 205	128208 128209	0.9999719858169556	O
30955	Furthermore	0 11	128210 128221	0.9999781847000122	O
30956	,	12 13	128222 128223	0.9999872446060181	O
30957	tumours	14 20	128224 128230	0.9999856948852539	O
30960	with	22 26	128232 128236	0.9999872446060181	O
30961	BRCA1	27 31	128237 128241	0.9999840259552002	O
30964	methylation	33 43	128243 128253	0.9999874830245972	O
30967	appear	45 51	128255 128261	0.9999871253967285	O
30968	to	52 54	128262 128264	0.9999886751174927	O
30969	have	55 59	128265 128269	0.9999886751174927	O
30970	similar	60 67	128270 128277	0.9999867677688599	O
30971	global	68 74	128278 128284	0.9999868869781494	O
30972	gene	75 79	128285 128289	0.9999880790710449	O
30973	expression	80 90	128290 128300	0.9999872446060181	O
30974	profiles	91 99	128301 128309	0.9999885559082031	O
30975	to	100 102	128310 128312	0.9999873638153076	O
30976	BRCA1	103 107	128313 128317	0.9999850988388062	O
30979	mutated	109 115	128319 128325	0.9999854564666748	O
30982	tumours	117 123	128327 128333	0.9999881982803345	O
30985	[	125 126	128335 128336	0.9999895095825195	O
30986	16	126 128	128336 128338	0.9999885559082031	O
30987	]	128 129	128338 128339	0.99998939037323	O
30988	and	130 133	128340 128343	0.9999866485595703	O
30989	similar	134 141	128344 128351	0.9999871253967285	O
30990	genomic	142 148	128352 128358	0.9999884366989136	O
30993	copy	150 154	128360 128364	0.9999885559082031	O
30994	number	155 161	128365 128371	0.9999881982803345	O
30995	profiles	162 170	128372 128380	0.9999889135360718	O
30996	[	171 172	128381 128382	0.9999892711639404	O
30997	17	172 174	128382 128384	0.9999876022338867	O
30998	]	174 175	128384 128385	0.9999892711639404	O
30999	.	176 177	128386 128387	0.9999747276306152	O
31000	Other	0 5	128388 128393	0.999983549118042	O
31001	authors	6 13	128394 128401	0.9999825954437256	O
31002	have	14 18	128402 128406	0.9999861717224121	O
31003	claimed	19 26	128407 128414	0.9999828338623047	O
31004	that	27 31	128415 128419	0.999988317489624	O
31005	BRCA1	32 36	128420 128424	0.9999837875366211	O
31008	methylated	38 47	128426 128435	0.9999853372573853	O
31011	tumours	49 55	128437 128443	0.9999881982803345	O
31014	have	57 61	128445 128449	0.9999866485595703	O
31015	distinct	62 70	128450 128458	0.9999836683273315	O
31016	pathologies	71 81	128459 128469	0.9999867677688599	O
31018	to	83 85	128471 128473	0.9999836683273315	O
31019	those	86 91	128474 128479	0.9999862909317017	O
31020	seen	92 96	128480 128484	0.9999831914901733	O
31021	in	97 99	128485 128487	0.9999871253967285	O
31022	BRCA1	100 104	128488 128492	0.999985933303833	O
31025	mutated	106 112	128494 128500	0.9999847412109375	O
31028	tumours	114 120	128502 128508	0.9999885559082031	O
31031	[	122 123	128510 128511	0.9999890327453613	O
31032	18	123 125	128511 128513	0.9999862909317017	O
31033	]	125 126	128513 128514	0.9999885559082031	O
31034	.	127 128	128515 128516	0.9999780654907227	O
31035	The	0 3	128517 128520	0.9999876022338867	O
31036	discrepancy	4 14	128521 128531	0.9999876022338867	O
31040	may	16 19	128533 128536	0.9999874830245972	O
31041	at	20 22	128537 128539	0.9999885559082031	O
31042	least	23 28	128540 128545	0.9999884366989136	O
31043	in	29 31	128546 128548	0.9999891519546509	O
31044	part	32 36	128549 128553	0.9999881982803345	O
31045	be	37 39	128554 128556	0.9999890327453613	O
31046	resolved	40 48	128557 128565	0.9999866485595703	O
31047	by	49 51	128566 128568	0.9999890327453613	O
31048	the	52 55	128569 128572	0.9999890327453613	O
31049	hypothesis	56 66	128573 128583	0.999987006187439	O
31050	that	67 71	128584 128588	0.9999891519546509	O
31051	the	72 75	128589 128592	0.9999892711639404	O
31052	timing	76 82	128593 128599	0.9999880790710449	O
31053	of	83 85	128600 128602	0.9999890327453613	O
31054	BRCA1	86 90	128603 128607	0.9999861717224121	O
31057	methylation	92 102	128609 128619	0.9999887943267822	O
31060	will	104 108	128621 128625	0.9999873638153076	O
31061	influence	109 118	128626 128635	0.9999877214431763	O
31062	tumour	119 124	128636 128641	0.9999878406524658	O
31064	phenotype	126 134	128643 128651	0.9999890327453613	O
31067	;	136 137	128653 128654	0.9999876022338867	O
31068	the	138 141	128655 128658	0.9999891519546509	O
31069	earlier	142 149	128659 128666	0.999988317489624	O
31070	in	150 152	128667 128669	0.9999884366989136	O
31071	tumorigenesis	153 165	128670 128682	0.9999860525131226	O
31075	methylation	167 177	128684 128694	0.9999891519546509	O
31078	occurs	179 185	128696 128702	0.9999885559082031	O
31079	,	186 187	128703 128704	0.9999876022338867	O
31080	the	188 191	128705 128708	0.9999885559082031	O
31081	greater	192 199	128709 128716	0.9999861717224121	O
31082	the	200 203	128717 128720	0.9999886751174927	O
31083	similarity	204 214	128721 128731	0.9999855756759644	O
31084	to	215 217	128732 128734	0.9999877214431763	O
31085	tumours	218 224	128735 128741	0.9999874830245972	O
31088	arising	226 233	128743 128750	0.9999886751174927	O
31089	from	234 238	128751 128755	0.9999885559082031	O
31090	germline	239 246	128756 128763	0.9999874830245972	O
31094	BRCA1	248 252	128765 128769	0.9999855756759644	O
31097	mutations	254 263	128771 128780	0.9999864101409912	O
31098	.	264 265	128781 128782	0.9999711513519287	O
31099	It	0 2	128783 128785	0.9999867677688599	O
31100	must	3 7	128786 128790	0.9999858140945435	O
31101	also	8 12	128791 128795	0.9999854564666748	O
31102	be	13 15	128796 128798	0.9999876022338867	O
31103	taken	16 21	128799 128804	0.9999871253967285	O
31104	into	22 26	128805 128809	0.9999876022338867	O
31105	consideration	27 40	128810 128823	0.9999873638153076	O
31106	that	41 45	128824 128828	0.999987006187439	O
31107	while	46 51	128829 128834	0.9999829530715942	O
31108	most	52 56	128835 128839	0.9999855756759644	O
31109	tumours	57 63	128840 128846	0.999985933303833	O
31112	arising	65 72	128848 128855	0.9999876022338867	O
31113	in	73 75	128856 128858	0.9999873638153076	O
31114	BRCA1	76 80	128859 128863	0.9999836683273315	O
31117	mutation	82 90	128865 128873	0.9999871253967285	O
31118	carriers	91 99	128874 128882	0.9999858140945435	O
31119	have	100 104	128883 128887	0.9999867677688599	O
31120	typical	105 112	128888 128895	0.9999836683273315	O
31121	pathology	113 121	128896 128904	0.9999881982803345	O
31123	,	123 124	128906 128907	0.9999860525131226	O
31124	a	125 126	128908 128909	0.9999879598617554	O
31125	sizeable	127 134	128910 128917	0.9999868869781494	O
31127	minority	136 144	128919 128927	0.9999868869781494	O
31128	do	145 147	128928 128930	0.9999856948852539	O
31129	not	148 151	128931 128934	0.9999862909317017	O
31130	.	152 153	128935 128936	0.9999580383300781	O
31131	We	0 2	128937 128939	0.9999793767929077	O
31132	hypothesised	3 14	128940 128951	0.999967098236084	O
31134	that	16 20	128953 128957	0.9999862909317017	O
31135	some	21 25	128958 128962	0.9999804496765137	O
31136	individuals	26 37	128963 128974	0.9977431297302246	O
31137	are	38 41	128975 128978	0.9999853372573853	O
31138	predisposed	42 52	128979 128989	0.9999861717224121	O
31141	to	54 56	128991 128993	0.9999855756759644	O
31142	develop	57 64	128994 129001	0.9999821186065674	O
31143	breast	65 71	129002 129008	0.9999809265136719	O
31144	cancer	72 78	129009 129015	0.9999855756759644	O
31145	with	79 83	129016 129020	0.9999865293502808	O
31146	the	84 87	129021 129024	0.9999865293502808	O
31147	features	88 96	129025 129033	0.9999860525131226	O
31148	associated	97 107	129034 129044	0.9999884366989136	O
31149	with	108 112	129045 129049	0.9999885559082031	O
31150	BRCA1	113 117	129050 129054	0.9999855756759644	O
31153	mutations	119 128	129056 129065	0.9999854564666748	O
31154	because	129 136	129066 129073	0.9999868869781494	O
31155	they	137 141	129074 129078	0.9999874830245972	O
31156	carry	142 147	129079 129084	0.9999872446060181	O
31157	a	148 149	129085 129086	0.9999887943267822	O
31158	methylated	150 159	129087 129096	0.9999873638153076	O
31161	BRCA1	161 165	129098 129102	0.9999867677688599	O
31164	allele	167 172	129104 129109	0.9999884366989136	O
31166	in	174 176	129111 129113	0.9999877214431763	O
31167	their	177 182	129114 129119	0.9999822378158569	O
31168	somatic	183 189	129120 129126	0.9999853372573853	O
31170	tissues	191 198	129128 129135	0.9999849796295166	O
31171	.	199 200	129136 129137	0.9999884366989136	O
31172	*	201 202	129138 129139	0.9999874830245972	O
31173	*	202 203	129139 129140	0.9999809265136719	O
31174	IGNORE	0 5	129141 129146	0.9999867677688599	O
31177	LINE	7 10	129148 129151	0.9999892711639404	O
31180	*	12 13	129153 129154	0.9999896287918091	O
31181	*	13 14	129154 129155	0.9999895095825195	O
31182	*	15 16	129156 129157	0.9999895095825195	O
31183	*	16 17	129157 129158	0.9999896287918091	O
31184	IGNORE	18 23	129159 129164	0.9999884366989136	O
31187	LINE	25 28	129166 129169	0.9999895095825195	O
31190	*	30 31	129171 129172	0.99998939037323	O
31191	*	31 32	129172 129173	0.99998939037323	O
31192	*	33 34	129174 129175	0.99998939037323	O
31193	*	34 35	129175 129176	0.99998939037323	O
31194	IGNORE	36 41	129177 129182	0.9999880790710449	O
31197	LINE	43 46	129184 129187	0.99998939037323	O
31200	*	48 49	129189 129190	0.9999895095825195	O
31201	*	49 50	129190 129191	0.99998939037323	O
31202	In	51 53	129192 129194	0.9999897480010986	O
31203	digital	54 61	129195 129202	0.9999873638153076	O
31204	MS	62 64	129203 129205	0.9999880790710449	O
31205	-	64 65	129205 129206	0.9999897480010986	O
31206	HRM	65 67	129206 129208	0.9999886751174927	O
31209	,	69 70	129210 129211	0.9999895095825195	O
31210	bisulfite	71 79	129212 129220	0.9999884366989136	O
31214	modified	81 89	129222 129230	0.999988317489624	O
31215	DNA	90 93	129231 129234	0.9999874830245972	O
31216	is	94 96	129235 129237	0.99998939037323	O
31217	diluted	97 103	129238 129244	0.999988317489624	O
31220	to	105 107	129246 129248	0.9999887943267822	O
31221	the	108 111	129249 129252	0.9999897480010986	O
31222	point	112 117	129253 129258	0.9999887943267822	O
31223	where	118 123	129259 129264	0.99998939037323	O
31224	the	124 127	129265 129268	0.99998939037323	O
31225	individual	128 138	129269 129279	0.9999873638153076	O
31226	PCR	139 141	129280 129282	0.9999879598617554	O
31228	reactions	143 152	129284 129293	0.9999868869781494	O
31229	contained	153 162	129294 129303	0.9999889135360718	O
31230	0	163 164	129304 129305	0.9999895095825195	O
31231	,	164 165	129305 129306	0.9999885559082031	O
31232	1	166 167	129307 129308	0.99998939037323	O
31233	or	168 170	129309 129311	0.9999880790710449	O
31234	occasionally	171 183	129312 129324	0.9999866485595703	O
31235	2	184 185	129325 129326	0.9999855756759644	O
31236	amplifiable	186 196	129327 129337	0.9999891519546509	O
31241	templates	198 206	129339 129347	0.9999877214431763	O
31243	.	208 209	129349 129350	0.9999704360961914	O
31244	This	0 4	129351 129355	0.9999843835830688	O
31245	eliminates	5 14	129356 129365	0.9999834299087524	O
31247	the	16 19	129367 129370	0.9999881982803345	O
31248	problem	20 27	129371 129378	0.9999834299087524	O
31249	of	28 30	129379 129381	0.9999879598617554	O
31250	PCR	31 33	129382 129384	0.9999876022338867	O
31252	bias	35 39	129386 129390	0.9999852180480957	O
31253	where	40 45	129391 129396	0.999987006187439	O
31254	unmethylated	46 57	129397 129408	0.9999891519546509	O
31258	or	59 61	129410 129412	0.9999881982803345	O
31259	methylated	62 71	129413 129422	0.9999880790710449	O
31262	templates	73 81	129424 129432	0.9999879598617554	O
31264	have	83 87	129434 129438	0.9999881982803345	O
31265	different	88 97	129439 129448	0.9999845027923584	O
31266	amplification	98 110	129449 129461	0.9999889135360718	O
31269	efficiencies	112 123	129463 129474	0.9999892711639404	O
31273	,	125 126	129476 129477	0.9999884366989136	O
31274	hence	127 132	129478 129483	0.9999880790710449	O
31275	skewing	133 139	129484 129490	0.9999890327453613	O
31278	the	141 144	129492 129495	0.9999891519546509	O
31279	actual	145 151	129496 129502	0.999987006187439	O
31280	methylated	152 161	129503 129512	0.9999889135360718	O
31283	to	163 165	129514 129516	0.9999874830245972	O
31284	unmethylated	166 177	129517 129528	0.9999891519546509	O
31288	ratios	179 185	129530 129536	0.9999886751174927	O
31289	.	186 187	129537 129538	0.999974250793457	O
31290	Multiple	0 8	129539 129547	0.9999852180480957	O
31291	replicates	9 18	129548 129557	0.9999865293502808	O
31293	of	20 22	129559 129561	0.9999881982803345	O
31294	the	23 26	129562 129565	0.9999878406524658	O
31295	diluted	27 33	129566 129572	0.999985933303833	O
31298	sample	35 41	129574 129580	0.9999845027923584	O
31299	are	42 45	129581 129584	0.9999874830245972	O
31300	amplified	46 54	129585 129593	0.9999890327453613	O
31302	by	56 58	129595 129597	0.9999892711639404	O
31303	PCR	59 61	129598 129600	0.9999871253967285	O
31305	where	63 68	129602 129607	0.9999884366989136	O
31306	it	69 71	129608 129610	0.9999890327453613	O
31307	is	72 74	129611 129613	0.999988317489624	O
31308	expected	75 83	129614 129622	0.9999871253967285	O
31309	that	84 88	129623 129627	0.9999890327453613	O
31310	many	89 93	129628 129632	0.9999877214431763	O
31311	reactions	94 103	129633 129642	0.9999836683273315	O
31312	will	104 108	129643 129647	0.9999885559082031	O
31313	not	109 112	129648 129651	0.9999878406524658	O
31314	amplify	113 119	129652 129658	0.9999889135360718	O
31317	because	121 128	129660 129667	0.999988317489624	O
31318	of	129 131	129668 129670	0.99998939037323	O
31319	the	132 135	129671 129674	0.9999892711639404	O
31320	absence	136 143	129675 129682	0.9999885559082031	O
31321	of	144 146	129683 129685	0.9999892711639404	O
31322	template	147 155	129686 129694	0.9999868869781494	O
31323	.	156 157	129695 129696	0.9999716281890869	O
31324	The	0 3	129697 129700	0.9999885559082031	O
31325	melting	4 11	129701 129708	0.9999845027923584	O
31326	profile	12 19	129709 129716	0.9999872446060181	O
31327	of	20 22	129717 129719	0.9999890327453613	O
31328	each	23 27	129720 129724	0.9999891519546509	O
31329	reaction	28 36	129725 129733	0.9999847412109375	O
31330	or	37 39	129734 129736	0.9999878406524658	O
31331	'	40 41	129737 129738	0.9999892711639404	O
31332	clone	41 46	129738 129743	0.9999876022338867	O
31333	'	47 48	129744 129745	0.9999887943267822	O
31334	is	49 51	129746 129748	0.9999862909317017	O
31335	then	52 56	129749 129753	0.999984622001648	O
31336	used	57 61	129754 129758	0.9999876022338867	O
31337	to	62 64	129759 129761	0.9999886751174927	O
31338	determine	65 74	129762 129771	0.9999884366989136	O
31339	its	75 78	129772 129775	0.9999886751174927	O
31340	methylation	79 89	129776 129786	0.9999868869781494	O
31343	status	91 97	129788 129794	0.9999886751174927	O
31344	.	98 99	129795 129796	0.9999649524688721	O
31345	The	0 3	129797 129800	0.9999879598617554	O
31346	proportion	4 14	129801 129811	0.9999850988388062	O
31347	of	15 17	129812 129814	0.9999886751174927	O
31348	methylation	18 28	129815 129825	0.9999873638153076	O
31351	in	30 32	129827 129829	0.9999886751174927	O
31352	a	33 34	129830 129831	0.9999877214431763	O
31353	sample	35 41	129832 129838	0.9999821186065674	O
31354	can	42 45	129839 129842	0.999984622001648	O
31355	be	46 48	129843 129845	0.9999879598617554	O
31356	readily	49 56	129846 129853	0.9999830722808838	O
31357	estimated	57 66	129854 129863	0.9999866485595703	O
31358	by	67 69	129864 129866	0.9999873638153076	O
31359	comparing	70 79	129867 129876	0.9999873638153076	O
31360	the	80 83	129877 129880	0.9999890327453613	O
31361	number	84 90	129881 129887	0.9999876022338867	O
31362	of	91 93	129888 129890	0.9999886751174927	O
31363	reactions	94 103	129891 129900	0.9999854564666748	O
31364	with	104 108	129901 129905	0.9999890327453613	O
31365	a	109 110	129906 129907	0.9999892711639404	O
31366	peak	111 115	129908 129912	0.9999889135360718	O
31367	with	116 120	129913 129917	0.9999892711639404	O
31368	elevated	121 129	129918 129926	0.9999878406524658	O
31369	melting	130 137	129927 129934	0.9999891519546509	O
31370	temperature	138 149	129935 129946	0.99998939037323	O
31371	characteristic	150 164	129947 129961	0.9999892711639404	O
31372	of	165 167	129962 129964	0.9999892711639404	O
31373	methylation	168 178	129965 129975	0.9999885559082031	O
31376	,	180 181	129977 129978	0.9999860525131226	O
31377	over	182 186	129979 129983	0.9999861717224121	O
31378	those	187 192	129984 129989	0.9999878406524658	O
31379	with	193 197	129990 129994	0.9999890327453613	O
31380	an	198 200	129995 129997	0.99998939037323	O
31381	lower	201 206	129998 130003	0.9999852180480957	O
31382	melting	207 214	130004 130011	0.9999889135360718	O
31383	temperature	215 226	130012 130023	0.9999890327453613	O
31384	unmethylated	227 238	130024 130035	0.9999890327453613	O
31388	peak	240 244	130037 130041	0.9999890327453613	O
31389	.	245 246	130042 130043	0.999970555305481	O
31390	Digital	0 7	130044 130051	0.9999762773513794	O
31391	MS	8 10	130052 130054	0.9999829530715942	O
31392	-	10 11	130054 130055	0.9999867677688599	O
31393	HRM	11 13	130055 130057	0.9999841451644897	O
31396	was	15 18	130059 130062	0.9999861717224121	O
31397	performed	19 28	130063 130072	0.9999862909317017	O
31398	on	29 31	130073 130075	0.9999865293502808	O
31399	peripheral	32 42	130076 130086	0.999982476234436	O
31400	blood	43 48	130087 130092	0.9999849796295166	O
31401	and	49 52	130093 130096	0.9999860525131226	O
31402	buccal	53 58	130097 130102	0.999982476234436	O
31405	mucosal	60 66	130104 130110	0.9999855756759644	O
31409	DNA	68 71	130112 130115	0.9999868869781494	O
31410	from	72 76	130116 130120	0.9999879598617554	O
31411	KCF3	77 80	130121 130124	0.9999822378158569	O
31414	.	82 83	130126 130127	0.9999661445617676	O
31415	For	0 3	130128 130131	0.9999858140945435	O
31416	the	4 7	130132 130135	0.9999881982803345	O
31417	peripheral	8 18	130136 130146	0.9999839067459106	O
31418	blood	19 24	130147 130152	0.9999860525131226	O
31419	DNA	25 28	130153 130156	0.9999829530715942	O
31420	,	29 30	130157 130158	0.999988317489624	O
31421	13	31 33	130159 130161	0.9999837875366211	O
31422	of	34 36	130162 130164	0.9999886751174927	O
31423	the	37 40	130165 130168	0.9999885559082031	O
31424	107	41 44	130169 130172	0.9999762773513794	O
31425	clones	45 50	130173 130178	0.9999865293502808	O
31427	had	52 55	130180 130183	0.9999887943267822	O
31428	a	56 57	130184 130185	0.9999892711639404	O
31429	methylated	58 67	130186 130195	0.9999889135360718	O
31432	peak	69 73	130197 130201	0.9999886751174927	O
31433	on	74 76	130202 130204	0.9999889135360718	O
31434	melting	77 84	130205 130212	0.9999854564666748	O
31435	analysis	85 93	130213 130221	0.99998939037323	O
31436	(	94 95	130222 130223	0.99998939037323	O
31437	Figure	96 102	130224 130230	0.9999867677688599	O
31438	3	103 104	130231 130232	0.9999889135360718	O
31439	)	105 106	130233 130234	0.9999897480010986	O
31440	,	107 108	130235 130236	0.9999890327453613	O
31441	equating	109 116	130237 130244	0.99998939037323	O
31444	to	118 120	130246 130248	0.9999892711639404	O
31445	12	121 123	130249 130251	0.9999887943267822	O
31446	%	124 125	130252 130253	0.9999892711639404	O
31447	BRCA1	126 130	130254 130258	0.9999872446060181	O
31450	methylation	132 142	130260 130270	0.9999891519546509	O
31453	in	144 146	130272 130274	0.9999896287918091	O
31454	the	147 150	130275 130278	0.99998939037323	O
31455	peripheral	151 161	130279 130289	0.9999861717224121	O
31456	blood	162 167	130290 130295	0.999987006187439	O
31457	.	168 169	130296 130297	0.9999788999557495	O
31458	In	0 2	130298 130300	0.9999833106994629	O
31459	the	3 6	130301 130304	0.9999833106994629	O
31460	buccal	7 12	130305 130310	0.999963641166687	O
31463	mucosa	14 19	130312 130317	0.9999799728393555	O
31466	,	21 22	130319 130320	0.9999862909317017	O
31467	4	23 24	130321 130322	0.9999781847000122	O
31468	of	25 27	130323 130325	0.9999880790710449	O
31469	the	28 31	130326 130329	0.9999874830245972	O
31470	69	32 34	130330 130332	0.9999748468399048	O
31471	clones	35 40	130333 130338	0.9999855756759644	O
31473	were	42 46	130340 130344	0.9999884366989136	O
31474	methylated	47 56	130345 130354	0.9999881982803345	O
31477	,	58 59	130356 130357	0.9999874830245972	O
31478	equating	60 67	130358 130365	0.9999890327453613	O
31481	to	69 71	130367 130369	0.9999890327453613	O
31482	6	72 73	130370 130371	0.9999878406524658	O
31483	%	74 75	130372 130373	0.9999891519546509	O
31484	methylation	76 86	130374 130384	0.9999889135360718	O
31487	.	88 89	130386 130387	0.999972939491272	O
31488	These	0 5	130388 130393	0.9999853372573853	O
31489	results	6 13	130394 130401	0.9999856948852539	O
31490	confirmed	14 23	130402 130411	0.9999855756759644	O
31491	the	24 27	130412 130415	0.9999887943267822	O
31492	level	28 33	130416 130421	0.9999868869781494	O
31493	of	34 36	130422 130424	0.9999884366989136	O
31494	BRCA1	37 41	130425 130429	0.9999822378158569	O
31497	methylation	43 53	130431 130441	0.9999873638153076	O
31500	estimated	55 64	130443 130452	0.9999877214431763	O
31501	by	65 67	130453 130455	0.9999887943267822	O
31502	both	68 72	130456 130460	0.9999881982803345	O
31503	MethyLight	73 82	130461 130470	0.9999878406524658	O
31507	and	84 87	130472 130475	0.9999879598617554	O
31508	MS	88 90	130476 130478	0.999984622001648	O
31509	-	90 91	130478 130479	0.9999885559082031	O
31510	HRM	91 93	130479 130481	0.9999872446060181	O
31513	.	95 96	130483 130484	0.9999773502349854	O
31514	When	0 4	130485 130489	0.9999876022338867	O
31515	considered	5 15	130490 130500	0.9999877214431763	O
31516	at	16 18	130501 130503	0.9999886751174927	O
31517	a	19 20	130504 130505	0.99998939037323	O
31518	cellular	21 29	130506 130514	0.9999868869781494	O
31519	rather	30 36	130515 130521	0.9999880790710449	O
31520	than	37 41	130522 130526	0.9999885559082031	O
31521	an	42 44	130527 130529	0.9999891519546509	O
31522	allelic	45 51	130530 130536	0.9999880790710449	O
31525	level	53 58	130538 130543	0.9999886751174927	O
31526	,	59 60	130544 130545	0.9999880790710449	O
31527	we	61 63	130546 130548	0.9999866485595703	O
31528	estimate	64 72	130549 130557	0.9999864101409912	O
31529	that	73 77	130558 130562	0.9999890327453613	O
31530	the	78 81	130563 130566	0.9999885559082031	O
31531	peripheral	82 92	130567 130577	0.99997878074646	O
31532	blood	93 98	130578 130583	0.999982476234436	O
31533	contains	99 107	130584 130592	0.9999890327453613	O
31534	approximately	108 121	130593 130606	0.9999891519546509	O
31535	25	122 124	130607 130609	0.9999861717224121	O
31536	%	125 126	130610 130611	0.9999889135360718	O
31537	of	127 129	130612 130614	0.9999884366989136	O
31538	cells	130 135	130615 130620	0.9999867677688599	O
31539	with	136 140	130621 130625	0.9999889135360718	O
31540	one	141 144	130626 130629	0.9999886751174927	O
31541	methylated	145 154	130630 130639	0.9999885559082031	O
31544	BRCA1	156 160	130641 130645	0.9999867677688599	O
31547	allele	162 167	130647 130652	0.9999890327453613	O
31549	and	169 172	130654 130657	0.9999872446060181	O
31550	that	173 177	130658 130662	0.9999886751174927	O
31551	the	178 181	130663 130666	0.9999879598617554	O
31552	buccal	182 187	130667 130672	0.9999792575836182	O
31555	mucosa	189 194	130674 130679	0.9999850988388062	O
31558	contains	196 204	130681 130689	0.9999891519546509	O
31559	approximately	205 218	130690 130703	0.9999891519546509	O
31560	10	219 221	130704 130706	0.9999866485595703	O
31561	%	222 223	130707 130708	0.9999890327453613	O
31562	methylated	224 233	130709 130718	0.999988317489624	O
31565	cells	235 240	130720 130725	0.9999881982803345	O
31566	.	241 242	130726 130727	0.9999673366546631	O
31567	Digital	0 7	130728 130735	0.9999772310256958	O
31568	methylation	8 18	130736 130746	0.9999850988388062	O
31571	-	19 20	130747 130748	0.9999861717224121	O
31572	sensitive	20 29	130748 130757	0.9999818801879883	O
31573	high	30 34	130758 130762	0.9999855756759644	O
31574	resolution	35 45	130763 130773	0.9999866485595703	O
31575	melting	46 53	130774 130781	0.9999821186065674	O
31576	(	54 55	130782 130783	0.9999873638153076	O
31577	MS	56 58	130784 130786	0.9999819993972778	O
31578	-	58 59	130786 130787	0.9999876022338867	O
31579	HRM	59 61	130787 130789	0.9999858140945435	O
31582	)	63 64	130791 130792	0.9999879598617554	O
31583	and	65 68	130793 130796	0.9999856948852539	O
31584	sequencing	69 78	130797 130806	0.9999842643737793	O
31586	for	80 83	130808 130811	0.9999855756759644	O
31587	KCF3	84 87	130812 130815	0.9999773502349854	O
31590	peripheral	89 99	130817 130827	0.9999836683273315	O
31591	blood	100 105	130828 130833	0.999984860420227	O
31592	DNA	106 109	130834 130837	0.9999845027923584	O
31593	.	110 111	130838 130839	0.9999492168426514	O
31594	The	0 3	130840 130843	0.9999881982803345	O
31595	blue	4 8	130844 130848	0.9999856948852539	O
31596	curve	9 14	130849 130854	0.9999850988388062	O
31597	indicates	15 24	130855 130864	0.9999852180480957	O
31598	the	25 28	130865 130868	0.999988317489624	O
31599	unmethylated	29 40	130869 130880	0.999988317489624	O
31603	control	42 49	130882 130889	0.9999847412109375	O
31604	.	50 51	130890 130891	0.9999570846557617	O
31605	The	0 3	130892 130895	0.9999879598617554	O
31606	black	4 9	130896 130901	0.9999841451644897	O
31607	curve	10 15	130902 130907	0.9999850988388062	O
31608	indicates	16 25	130908 130917	0.9999852180480957	O
31609	the	26 29	130918 130921	0.9999879598617554	O
31610	methylated	30 39	130922 130931	0.9999862909317017	O
31613	control	41 48	130933 130940	0.9999855756759644	O
31614	.	49 50	130941 130942	0.999962329864502	O
31615	The	0 3	130943 130946	0.9999860525131226	O
31616	green	4 9	130947 130952	0.9999836683273315	O
31617	curves	10 16	130953 130959	0.9999819993972778	O
31618	indicate	17 25	130960 130968	0.9999804496765137	O
31619	unmethylated	26 37	130969 130980	0.999987006187439	O
31623	amplicons	39 47	130982 130990	0.9999880790710449	O
31627	.	49 50	130992 130993	0.9999507665634155	O
31628	The	0 3	130994 130997	0.999984860420227	O
31629	red	4 7	130998 131001	0.9999806880950928	O
31630	curves	8 14	131002 131008	0.999976396560669	O
31631	indicate	15 23	131009 131017	0.9999792575836182	O
31632	methylated	24 33	131018 131027	0.9999828338623047	O
31635	amplicons	35 43	131029 131037	0.9999877214431763	O
31639	.	45 46	131039 131040	0.9999490976333618	O
31640	Sequencing	0 9	131041 131050	0.9999878406524658	O
31642	for	11 14	131052 131055	0.9999881982803345	O
31643	the	15 18	131056 131059	0.9999885559082031	O
31644	unmethylated	19 30	131060 131071	0.9999885559082031	O
31648	and	32 35	131073 131076	0.9999868869781494	O
31649	methylated	36 45	131077 131086	0.9999865293502808	O
31652	controls	47 55	131088 131096	0.9999834299087524	O
31653	are	56 59	131097 131100	0.9999872446060181	O
31654	shown	60 65	131101 131106	0.9999871253967285	O
31655	above	66 71	131107 131112	0.9999871253967285	O
31656	the	72 75	131113 131116	0.9999889135360718	O
31657	digital	76 83	131117 131124	0.9999818801879883	O
31658	MS	84 86	131125 131127	0.9999871253967285	O
31659	-	86 87	131127 131128	0.9999889135360718	O
31660	HRM	87 89	131128 131130	0.9999881982803345	O
31663	results	91 98	131132 131139	0.9999881982803345	O
31664	.	99 100	131140 131141	0.9999728202819824	O
31665	Sequences	0 8	131142 131150	0.9999879598617554	O
31668	of	10 12	131152 131154	0.9999885559082031	O
31669	the	13 16	131155 131158	0.9999890327453613	O
31670	indicated	17 26	131159 131168	0.9999866485595703	O
31671	red	27 30	131169 131172	0.9999847412109375	O
31672	amplicons	31 39	131173 131181	0.9999892711639404	O
31676	(	41 42	131183 131184	0.9999892711639404	O
31677	lettered	43 50	131185 131192	0.9999879598617554	O
31679	)	52 53	131194 131195	0.99998939037323	O
31680	are	54 57	131196 131199	0.9999877214431763	O
31681	shown	58 63	131200 131205	0.9999881982803345	O
31682	to	64 66	131206 131208	0.99998939037323	O
31683	right	67 72	131209 131214	0.999988317489624	O
31684	of	73 75	131215 131217	0.9999892711639404	O
31685	the	76 79	131218 131221	0.9999892711639404	O
31686	figure	80 86	131222 131228	0.9999861717224121	O
31687	where	87 92	131229 131234	0.9999889135360718	O
31688	the	93 96	131235 131238	0.9999895095825195	O
31689	letter	97 103	131239 131245	0.999988317489624	O
31690	to	104 106	131246 131248	0.99998939037323	O
31691	the	107 110	131249 131252	0.99998939037323	O
31692	right	111 116	131253 131258	0.9999885559082031	O
31693	of	117 119	131259 131261	0.99998939037323	O
31694	the	120 123	131262 131265	0.9999895095825195	O
31695	chromatograph	124 136	131266 131278	0.9999890327453613	O
31699	corresponds	138 149	131280 131291	0.9999887943267822	O
31700	to	150 152	131292 131294	0.9999890327453613	O
31701	the	153 156	131295 131298	0.9999892711639404	O
31702	curve	157 162	131299 131304	0.9999854564666748	O
31703	shown	163 168	131305 131310	0.9999876022338867	O
31704	.	169 170	131311 131312	0.9999768733978271	O
31705	Representative	0 14	131313 131327	0.9999854564666748	O
31706	methylated	15 24	131328 131337	0.9999873638153076	O
31709	and	26 29	131339 131342	0.9999868869781494	O
31710	unmethylated	30 41	131343 131354	0.9999879598617554	O
31714	clones	43 48	131356 131361	0.9999866485595703	O
31716	from	50 54	131363 131367	0.9999886751174927	O
31717	the	55 58	131368 131371	0.9999890327453613	O
31718	digital	59 66	131372 131379	0.9999825954437256	O
31719	MS	67 69	131380 131382	0.9999873638153076	O
31720	-	69 70	131382 131383	0.9999892711639404	O
31721	HRM	70 72	131383 131385	0.9999880790710449	O
31724	experiments	74 85	131387 131398	0.9999839067459106	O
31725	were	86 90	131399 131403	0.9999880790710449	O
31726	sequenced	91 99	131404 131412	0.9999852180480957	O
31728	to	101 103	131414 131416	0.9999887943267822	O
31729	confirm	104 111	131417 131424	0.9999887943267822	O
31730	the	112 115	131425 131428	0.9999895095825195	O
31731	methylation	116 126	131429 131439	0.9999879598617554	O
31734	status	128 134	131441 131447	0.9999895095825195	O
31735	(	135 136	131448 131449	0.9999896287918091	O
31736	Figure	137 143	131450 131456	0.9999861717224121	O
31737	3	144 145	131457 131458	0.9999886751174927	O
31738	)	146 147	131459 131460	0.9999896287918091	O
31739	.	148 149	131461 131462	0.9999799728393555	O
31740	A	0 1	131463 131464	0.9999822378158569	O
31741	stretch	2 9	131465 131472	0.9999759197235107	O
31742	of	10 12	131473 131475	0.999984622001648	O
31743	22	13 15	131476 131478	0.9999793767929077	O
31744	bases	16 21	131479 131484	0.9999780654907227	O
31745	containing	22 32	131485 131495	0.999984622001648	O
31746	four	33 37	131496 131500	0.9999749660491943	O
31747	CpG	38 40	131501 131503	0.9999809265136719	O
31750	sites	42 47	131505 131510	0.9999818801879883	O
31751	was	48 51	131511 131514	0.9999804496765137	O
31752	analysed	52 59	131515 131522	0.9999822378158569	O
31755	.	61 62	131524 131525	0.9999284744262695	O
31756	For	0 3	131526 131529	0.9999872446060181	O
31757	the	4 7	131530 131533	0.9999887943267822	O
31758	peripheral	8 18	131534 131544	0.999982476234436	O
31759	blood	19 24	131545 131550	0.9999855756759644	O
31760	DNA	25 28	131551 131554	0.9999856948852539	O
31761	of	29 31	131555 131557	0.9999886751174927	O
31762	KCF3	32 35	131558 131561	0.9999822378158569	O
31765	(	37 38	131563 131564	0.99998939037323	O
31766	Figure	39 45	131565 131571	0.9999854564666748	O
31767	3	46 47	131572 131573	0.9999878406524658	O
31768	)	48 49	131574 131575	0.9999895095825195	O
31769	,	50 51	131576 131577	0.9999887943267822	O
31770	four	52 56	131578 131582	0.9999877214431763	O
31771	of	57 59	131583 131585	0.99998939037323	O
31772	the	60 63	131586 131589	0.9999892711639404	O
31773	six	64 67	131590 131593	0.9999853372573853	O
31774	methylated	68 77	131594 131603	0.999988317489624	O
31777	clones	79 84	131605 131610	0.9999880790710449	O
31779	had	86 89	131612 131615	0.9999889135360718	O
31780	a	90 91	131616 131617	0.9999890327453613	O
31781	cytosine	92 99	131618 131625	0.9999890327453613	O
31785	present	101 108	131627 131634	0.9999895095825195	O
31786	at	109 111	131635 131637	0.9999892711639404	O
31787	all	112 115	131638 131641	0.9999895095825195	O
31788	four	116 120	131642 131646	0.9999878406524658	O
31789	CpGs	121 124	131647 131650	0.9999887943267822	O
31793	,	126 127	131652 131653	0.9999886751174927	O
31794	confirming	128 138	131654 131664	0.9999878406524658	O
31795	the	139 142	131665 131668	0.9999891519546509	O
31796	methylation	143 153	131669 131679	0.999988317489624	O
31799	seen	155 159	131681 131685	0.9999871253967285	O
31800	by	160 162	131686 131688	0.9999887943267822	O
31801	other	163 168	131689 131694	0.9999862909317017	O
31802	methodologies	169 181	131695 131707	0.9999876022338867	O
31804	.	183 184	131709 131710	0.9999712705612183	O
31805	One	0 3	131711 131714	0.9999816417694092	O
31806	clone	4 9	131715 131720	0.9999825954437256	O
31807	had	10 13	131721 131724	0.9999877214431763	O
31808	cytosines	14 22	131725 131733	0.999988317489624	O
31812	present	24 31	131735 131742	0.9999892711639404	O
31813	at	32 34	131743 131745	0.9999889135360718	O
31814	all	35 38	131746 131749	0.9999879598617554	O
31815	CpGs	39 42	131750 131753	0.9999877214431763	O
31819	sites	44 49	131755 131760	0.9999886751174927	O
31820	but	50 53	131761 131764	0.999984622001648	O
31821	also	54 58	131765 131769	0.9999843835830688	O
31822	had	59 62	131770 131773	0.999988317489624	O
31823	an	63 65	131774 131776	0.9999890327453613	O
31824	additional	66 76	131777 131787	0.9999868869781494	O
31825	cytosine	77 84	131788 131795	0.9999886751174927	O
31829	present	86 93	131797 131804	0.9999892711639404	O
31830	at	94 96	131805 131807	0.9999890327453613	O
31831	a	97 98	131808 131809	0.9999891519546509	O
31832	conversion	99 109	131810 131820	0.9999868869781494	O
31833	site	110 114	131821 131825	0.9999891519546509	O
31834	where	115 120	131826 131831	0.9999884366989136	O
31835	a	121 122	131832 131833	0.9999891519546509	O
31836	thymine	123 129	131834 131840	0.9999874830245972	O
31838	would	131 136	131842 131847	0.9999885559082031	O
31839	be	137 139	131848 131850	0.9999889135360718	O
31840	expected	140 148	131851 131859	0.9999874830245972	O
31841	,	149 150	131860 131861	0.9999861717224121	O
31842	preceding	151 160	131862 131871	0.9999853372573853	O
31843	a	161 162	131872 131873	0.9999891519546509	O
31844	CpG	163 165	131874 131876	0.9999879598617554	O
31847	site	167 171	131878 131882	0.9999884366989136	O
31848	.	172 173	131883 131884	0.9999603033065796	O
31849	The	0 3	131885 131888	0.9999872446060181	O
31850	other	4 9	131889 131894	0.9999852180480957	O
31851	non	10 13	131895 131898	0.9999873638153076	O
31852	-	13 14	131898 131899	0.9999889135360718	O
31853	CpG	14 16	131899 131901	0.9999877214431763	O
31856	cytosines	18 26	131903 131911	0.9999889135360718	O
31860	were	28 32	131913 131917	0.999988317489624	O
31861	converted	33 42	131918 131927	0.9999815225601196	O
31862	indicating	43 53	131928 131938	0.9999874830245972	O
31863	that	54 58	131939 131943	0.99998939037323	O
31864	this	59 63	131944 131948	0.9999889135360718	O
31865	corresponded	64 75	131949 131960	0.9999886751174927	O
31867	to	77 79	131962 131964	0.9999895095825195	O
31868	a	80 81	131965 131966	0.9999895095825195	O
31869	methylated	82 91	131967 131976	0.999987006187439	O
31872	allele	93 98	131978 131983	0.9999891519546509	O
31874	.	100 101	131985 131986	0.9999756813049316	O
31875	For	0 3	131987 131990	0.9999860525131226	O
31876	one	4 7	131991 131994	0.9999856948852539	O
31877	other	8 13	131995 132000	0.9999864101409912	O
31878	clone	14 19	132001 132006	0.9999868869781494	O
31879	only	20 24	132007 132011	0.9999868869781494	O
31880	two	25 28	132012 132015	0.9999839067459106	O
31881	of	29 31	132016 132018	0.9999877214431763	O
31882	the	32 35	132019 132022	0.9999874830245972	O
31883	CpGs	36 39	132023 132026	0.9999873638153076	O
31887	were	41 45	132028 132032	0.9999877214431763	O
31888	methylated	46 55	132033 132042	0.9999871253967285	O
31891	but	57 60	132044 132047	0.9999864101409912	O
31892	this	61 65	132048 132052	0.9999886751174927	O
31893	may	66 69	132053 132056	0.999988317489624	O
31894	have	70 74	132057 132061	0.9999878406524658	O
31895	been	75 79	132062 132066	0.999988317489624	O
31896	due	80 83	132067 132070	0.999988317489624	O
31897	to	84 86	132071 132073	0.9999887943267822	O
31898	incomplete	87 97	132074 132084	0.999988317489624	O
31899	conversion	98 108	132085 132095	0.9999872446060181	O
31900	.	109 110	132096 132097	0.9999887943267822	O
31901	*	111 112	132098 132099	0.9999880790710449	O
31902	*	112 113	132099 132100	0.9999791383743286	O
31903	IGNORE	0 5	132101 132106	0.9999861717224121	O
31906	LINE	7 10	132108 132111	0.9999885559082031	O
31909	*	12 13	132113 132114	0.9999891519546509	O
31910	*	13 14	132114 132115	0.9999891519546509	O
31911	*	15 16	132116 132117	0.9999891519546509	O
31912	*	16 17	132117 132118	0.9999891519546509	O
31913	IGNORE	18 23	132119 132124	0.9999877214431763	O
31916	LINE	25 28	132126 132129	0.9999891519546509	O
31919	*	30 31	132131 132132	0.9999889135360718	O
31920	*	31 32	132132 132133	0.9999889135360718	O
31921	*	33 34	132134 132135	0.9999890327453613	O
31922	*	34 35	132135 132136	0.9999889135360718	O
31923	IGNORE	36 41	132137 132142	0.9999876022338867	O
31926	LINE	43 46	132144 132147	0.9999890327453613	O
31929	*	48 49	132149 132150	0.9999891519546509	O
31930	*	49 50	132150 132151	0.9999890327453613	O
31931	The	51 54	132152 132155	0.9999872446060181	O
31932	assay	55 59	132156 132160	0.9999867677688599	O
31934	conditions	61 71	132162 132172	0.9999827146530151	O
31935	used	72 76	132173 132177	0.9999867677688599	O
31936	in	77 79	132178 132180	0.999988317489624	O
31937	this	80 84	132181 132185	0.9999886751174927	O
31938	study	85 90	132186 132191	0.9999865293502808	O
31939	could	91 96	132192 132197	0.9999873638153076	O
31940	not	97 100	132198 132201	0.9999842643737793	O
31941	distinguish	101 112	132202 132213	0.9999871253967285	O
31942	between	113 120	132214 132221	0.9999867677688599	O
31943	samples	121 128	132222 132229	0.9999860525131226	O
31944	with	129 133	132230 132234	0.9999890327453613	O
31945	pathogenic	134 143	132235 132244	0.9999887943267822	O
31947	BRCA1	145 149	132246 132250	0.9999866485595703	O
31950	mutations	151 160	132252 132261	0.9999890327453613	O
31951	and	161 164	132262 132265	0.9999862909317017	O
31952	those	165 170	132266 132271	0.9999879598617554	O
31953	with	171 175	132272 132276	0.9999886751174927	O
31954	pathogenic	176 185	132277 132286	0.999988317489624	O
31956	BRCA2	187 191	132288 132292	0.9999865293502808	O
31959	mutations	193 202	132294 132303	0.9999884366989136	O
31960	.	203 204	132304 132305	0.9999580383300781	O
31961	Ionising	0 7	132306 132313	0.9999856948852539	O
31963	radiation	9 18	132315 132324	0.9999845027923584	O
31964	has	19 22	132325 132328	0.9999868869781494	O
31965	previously	23 33	132329 132339	0.9999849796295166	O
31966	been	34 38	132340 132344	0.9999876022338867	O
31967	show	39 43	132345 132349	0.9999808073043823	O
31968	to	44 46	132350 132352	0.9999871253967285	O
31969	separate	47 55	132353 132361	0.9999862909317017	O
31970	fibroblast	56 65	132362 132371	0.999981164932251	O
31973	cells	67 72	132373 132378	0.9999823570251465	O
31974	which	73 78	132379 132384	0.9999878406524658	O
31975	carry	79 84	132385 132390	0.9999867677688599	O
31976	BRCA1	85 89	132391 132395	0.999987006187439	O
31979	or	91 93	132397 132399	0.9999874830245972	O
31980	BRCA2	94 98	132400 132404	0.9999867677688599	O
31983	mutations	100 109	132406 132415	0.9999868869781494	O
31984	from	110 114	132416 132420	0.9999874830245972	O
31985	sporadic	115 122	132421 132428	0.9999864101409912	O
31987	cases	124 129	132430 132435	0.9999872446060181	O
31988	with	130 134	132436 132440	0.999988317489624	O
31989	100	135 138	132441 132444	0.9999885559082031	O
31990	%	139 140	132445 132446	0.9999889135360718	O
31991	accuracy	141 149	132447 132455	0.9999885559082031	O
31992	[	150 151	132456 132457	0.9999891519546509	O
31993	31	151 153	132457 132459	0.9999885559082031	O
31994	]	153 154	132459 132460	0.9999890327453613	O
31995	,	155 156	132461 132462	0.9999880790710449	O
31996	but	157 160	132463 132466	0.9999864101409912	O
31997	our	161 164	132467 132470	0.9999833106994629	O
31998	experiment	165 175	132471 132481	0.9999744892120361	O
31999	differs	176 183	132482 132489	0.999984860420227	O
32000	in	184 186	132490 132492	0.9999877214431763	O
32001	several	187 194	132493 132500	0.9999876022338867	O
32002	respects	195 203	132501 132509	0.999987006187439	O
32003	.	204 205	132510 132511	0.9999734163284302	O
32004	We	0 2	132512 132514	0.9999872446060181	O
32005	compared	3 11	132515 132523	0.999987006187439	O
32006	BRCA1	12 16	132524 132528	0.9999867677688599	O
32009	and	18 21	132530 132533	0.9999877214431763	O
32010	BRCA2	22 26	132534 132538	0.9999871253967285	O
32013	cases	28 33	132540 132545	0.999988317489624	O
32014	to	34 36	132546 132548	0.9999874830245972	O
32015	familial	37 44	132549 132556	0.9999873638153076	O
32018	BRCAX	46 50	132558 132562	0.9999877214431763	O
32021	cases	52 57	132564 132569	0.9999889135360718	O
32022	as	58 60	132570 132572	0.9999891519546509	O
32023	an	61 63	132573 132575	0.9999891519546509	O
32024	appropriate	64 75	132576 132587	0.9999879598617554	O
32025	reference	76 85	132588 132597	0.9999865293502808	O
32026	group	86 91	132598 132603	0.9999884366989136	O
32027	for	92 95	132604 132607	0.9999886751174927	O
32028	familial	96 103	132608 132615	0.9999874830245972	O
32031	breast	105 111	132617 132623	0.9999847412109375	O
32032	cases	112 117	132624 132629	0.9999879598617554	O
32033	likely	118 124	132630 132636	0.9999886751174927	O
32034	to	125 127	132637 132639	0.9999885559082031	O
32035	be	128 130	132640 132642	0.9999886751174927	O
32036	identified	131 141	132643 132653	0.999988317489624	O
32037	as	142 144	132654 132656	0.9999885559082031	O
32038	carriers	145 153	132657 132665	0.999987006187439	O
32039	of	154 156	132666 132668	0.9999886751174927	O
32040	BRCA1	157 161	132669 132673	0.9999866485595703	O
32043	/	162 163	132674 132675	0.9999886751174927	O
32044	2	163 164	132675 132676	0.9999853372573853	O
32045	mutations	165 174	132677 132686	0.9999858140945435	O
32046	or	175 177	132687 132689	0.9999886751174927	O
32047	unclassified	178 189	132690 132701	0.999988317489624	O
32049	variants	191 199	132703 132711	0.9999880790710449	O
32050	,	200 201	132712 132713	0.9999887943267822	O
32051	we	202 204	132714 132716	0.9999889135360718	O
32052	used	205 209	132717 132721	0.9999885559082031	O
32053	LCLs	210 213	132722 132725	0.9999866485595703	O
32056	instead	215 222	132727 132734	0.9999881982803345	O
32057	of	223 225	132735 132737	0.9999886751174927	O
32058	fibroblasts	226 236	132738 132748	0.9999822378158569	O
32062	,	238 239	132750 132751	0.9999889135360718	O
32063	we	240 242	132752 132754	0.9999891519546509	O
32064	selected	243 251	132755 132763	0.9999889135360718	O
32065	a	252 253	132764 132765	0.9999891519546509	O
32066	lower	254 259	132766 132771	0.9999860525131226	O
32067	IR	260 261	132772 132773	0.999988317489624	O
32069	exposure	263 271	132775 132783	0.999988317489624	O
32070	(	272 273	132784 132785	0.9999891519546509	O
32071	10Gy	274 277	132786 132789	0.9999876022338867	O
32074	vs	279 281	132791 132793	0.9999876022338867	O
32075	15Gy	282 285	132794 132797	0.9999842643737793	O
32078	)	287 288	132799 132800	0.9999892711639404	O
32079	,	289 290	132801 132802	0.9999890327453613	O
32080	and	291 294	132803 132806	0.9999889135360718	O
32081	we	295 297	132807 132809	0.9999881982803345	O
32082	chose	298 303	132810 132815	0.9999889135360718	O
32083	a	304 305	132816 132817	0.9999892711639404	O
32084	relatively	306 316	132818 132828	0.99998939037323	O
32085	early	317 322	132829 132834	0.9999892711639404	O
32086	time	323 327	132835 132839	0.9999891519546509	O
32087	point	328 333	132840 132845	0.99998939037323	O
32088	of	334 336	132846 132848	0.9999890327453613	O
32089	30	337 339	132849 132851	0.9999886751174927	O
32090	mins	340 343	132852 132855	0.9999881982803345	O
32092	after	345 350	132857 132862	0.9999887943267822	O
32093	exposure	351 359	132863 132871	0.9999876022338867	O
32094	to	360 362	132872 132874	0.9999890327453613	O
32095	IR	363 364	132875 132876	0.9999881982803345	O
32097	in	366 368	132878 132880	0.99998939037323	O
32098	order	369 374	132881 132886	0.9999884366989136	O
32099	to	375 377	132887 132889	0.9999891519546509	O
32100	gain	378 382	132890 132894	0.9999878406524658	O
32101	a	383 384	132895 132896	0.9999891519546509	O
32102	better	385 391	132897 132903	0.9999885559082031	O
32103	understanding	392 405	132904 132917	0.9999876022338867	O
32104	of	406 408	132918 132920	0.9999890327453613	O
32105	the	409 412	132921 132924	0.9999891519546509	O
32106	functional	413 423	132925 132935	0.9999827146530151	O
32107	differences	424 435	132936 132947	0.9999878406524658	O
32108	in	436 438	132948 132950	0.9999890327453613	O
32109	response	439 447	132951 132959	0.9999878406524658	O
32110	to	448 450	132960 132962	0.9999890327453613	O
32111	IR	451 452	132963 132964	0.9999878406524658	O
32113	between	454 461	132966 132973	0.9999866485595703	O
32114	the	462 465	132974 132977	0.9999877214431763	O
32115	BRCA1	466 470	132978 132982	0.9999876022338867	O
32118	,	472 473	132984 132985	0.9999874830245972	O
32119	BRCA2	474 478	132986 132990	0.9999872446060181	O
32122	and	480 483	132992 132995	0.9999874830245972	O
32123	BRCAX	484 488	132996 133000	0.999987006187439	O
32126	cell	490 494	133002 133006	0.9999843835830688	O
32127	lines	495 500	133007 133012	0.9999850988388062	O
32128	.	501 502	133013 133014	0.9999721050262451	O
32129	Some	0 4	133015 133019	0.9999874830245972	O
32130	or	5 7	133020 133022	0.9999867677688599	O
32131	all	8 11	133023 133026	0.999987006187439	O
32132	of	12 14	133027 133029	0.9999878406524658	O
32133	these	15 20	133030 133035	0.9999874830245972	O
32134	factors	21 28	133036 133043	0.9999840259552002	O
32135	may	29 32	133044 133047	0.9999860525131226	O
32136	explain	33 40	133048 133055	0.9999868869781494	O
32137	the	41 44	133056 133059	0.9999886751174927	O
32138	difference	45 55	133060 133070	0.9999861717224121	O
32139	in	56 58	133071 133073	0.999988317489624	O
32140	the	59 62	133074 133077	0.9999887943267822	O
32141	ability	63 70	133078 133085	0.9999879598617554	O
32142	of	71 73	133086 133088	0.9999890327453613	O
32143	this	74 78	133089 133093	0.9999891519546509	O
32144	study	79 84	133094 133099	0.9999860525131226	O
32145	to	85 87	133100 133102	0.999988317489624	O
32146	distinguish	88 99	133103 133114	0.9999873638153076	O
32147	BRCA1	100 104	133115 133119	0.9999867677688599	O
32150	from	106 110	133121 133125	0.9999881982803345	O
32151	BRCA2	111 115	133126 133130	0.9999871253967285	O
32154	,	117 118	133132 133133	0.9999877214431763	O
32155	both	119 123	133134 133138	0.9999858140945435	O
32156	of	124 126	133139 133141	0.9999872446060181	O
32157	which	127 132	133142 133147	0.9999880790710449	O
32158	are	133 136	133148 133151	0.9999880790710449	O
32159	involved	137 145	133152 133160	0.9999880790710449	O
32160	in	146 148	133161 133163	0.999988317489624	O
32161	DNA	149 152	133164 133167	0.9999854564666748	O
32162	damage	153 159	133168 133174	0.9999862909317017	O
32163	repair	160 166	133175 133181	0.9999860525131226	O
32164	.	167 168	133182 133183	0.9999678134918213	O
32165	However	0 7	133184 133191	0.9999865293502808	O
32166	,	8 9	133192 133193	0.9999887943267822	O
32167	differences	10 21	133194 133205	0.9999860525131226	O
32168	in	22 24	133206 133208	0.9999886751174927	O
32169	post	25 29	133209 133213	0.9999873638153076	O
32170	-	29 30	133213 133214	0.9999890327453613	O
32171	irradiation	30 40	133214 133224	0.9999880790710449	O
32174	response	42 50	133226 133234	0.9999874830245972	O
32175	between	51 58	133235 133242	0.9999881982803345	O
32176	BRCAX	59 63	133243 133247	0.9999872446060181	O
32179	individuals	65 76	133249 133260	0.9999786615371704	O
32180	and	77 80	133261 133264	0.9999877214431763	O
32181	BRCA1	81 85	133265 133269	0.9999866485595703	O
32184	/	86 87	133270 133271	0.9999885559082031	O
32185	2	87 88	133271 133272	0.9999839067459106	O
32186	mutation	89 97	133273 133281	0.9999864101409912	O
32187	carriers	98 106	133282 133290	0.9999872446060181	O
32188	are	107 110	133291 133294	0.9999885559082031	O
32189	supported	111 120	133295 133304	0.9999886751174927	O
32190	by	121 123	133305 133307	0.99998939037323	O
32191	alternative	124 135	133308 133319	0.9999880790710449	O
32192	analysis	136 144	133320 133328	0.9999889135360718	O
32193	we	145 147	133329 133331	0.9999885559082031	O
32194	have	148 152	133332 133336	0.9999890327453613	O
32195	conducted	153 162	133337 133346	0.9999886751174927	O
32196	of	163 165	133347 133349	0.9999887943267822	O
32197	the	166 169	133350 133353	0.9999890327453613	O
32198	subset	170 176	133354 133360	0.9999889135360718	O
32199	of	177 179	133361 133363	0.9999889135360718	O
32200	genes	180 185	133364 133369	0.9999849796295166	O
32201	reported	186 194	133370 133378	0.9999872446060181	O
32202	to	195 197	133379 133381	0.9999885559082031	O
32203	be	198 200	133382 133384	0.9999886751174927	O
32204	involved	201 209	133385 133393	0.999988317489624	O
32205	in	210 212	133394 133396	0.9999887943267822	O
32206	post	213 217	133397 133401	0.9999878406524658	O
32207	-	217 218	133401 133402	0.9999887943267822	O
32208	irradiation	218 228	133402 133412	0.999988317489624	O
32211	response	230 238	133414 133422	0.9999884366989136	O
32212	,	239 240	133423 133424	0.9999886751174927	O
32213	comparing	241 250	133425 133434	0.9999877214431763	O
32214	mutation	251 259	133435 133443	0.9999862909317017	O
32215	-	259 260	133443 133444	0.9999891519546509	O
32216	negative	260 268	133444 133452	0.9999854564666748	O
32217	normal	269 275	133453 133459	0.9999825954437256	O
32218	female	276 282	133460 133466	0.9999712705612183	O
32219	controls	283 291	133467 133475	0.9999761581420898	O
32220	to	292 294	133476 133478	0.9999866485595703	O
32221	BRCAX	295 299	133479 133483	0.9999867677688599	O
32224	individuals	301 312	133485 133496	0.9999819993972778	O
32225	without	313 320	133497 133504	0.9999877214431763	O
32226	an	321 323	133505 133507	0.9999884366989136	O
32227	LCS	324 326	133508 133510	0.9999858140945435	O
32229	variant	328 335	133512 133519	0.9999881982803345	O
32230	,	336 337	133520 133521	0.9999856948852539	O
32231	or	338 340	133522 133524	0.9999865293502808	O
32232	to	341 343	133525 133527	0.999987006187439	O
32233	BRCA1	344 348	133528 133532	0.9999861717224121	O
32236	or	350 352	133534 133536	0.9999871253967285	O
32237	BRCA2	353 357	133537 133541	0.9999853372573853	O
32240	truncating	359 368	133543 133552	0.9999872446060181	O
32243	mutation	370 378	133554 133562	0.999983549118042	O
32244	carriers	379 387	133563 133571	0.9999864101409912	O
32245	.	388 389	133572 133573	0.9999552965164185	O
32246	Our	0 3	133574 133577	0.9999829530715942	O
32247	results	4 11	133578 133585	0.9999855756759644	O
32248	indicate	12 20	133586 133594	0.9999856948852539	O
32249	substantial	21 32	133595 133606	0.9999861717224121	O
32250	differences	33 44	133607 133618	0.9999867677688599	O
32251	in	45 47	133619 133621	0.9999880790710449	O
32252	radiation	48 57	133622 133631	0.999982476234436	O
32253	response	58 66	133632 133640	0.999984622001648	O
32254	between	67 74	133641 133648	0.9999876022338867	O
32255	normal	75 81	133649 133655	0.9999812841415405	O
32256	controls	82 90	133656 133664	0.9999831914901733	O
32257	and	91 94	133665 133668	0.9999862909317017	O
32258	the	95 98	133669 133672	0.9999853372573853	O
32259	patient	99 106	133673 133680	0.9999762773513794	O
32260	groups	107 113	133681 133687	0.9999864101409912	O
32261	,	114 115	133688 133689	0.9999866485595703	O
32262	and	116 119	133690 133693	0.9999878406524658	O
32263	also	120 124	133694 133698	0.9999877214431763	O
32264	considerable	125 137	133699 133711	0.9999872446060181	O
32265	differences	138 149	133712 133723	0.999988317489624	O
32266	between	150 157	133724 133731	0.9999884366989136	O
32267	the	158 161	133732 133735	0.9999885559082031	O
32268	BRCAX	162 166	133736 133740	0.9999876022338867	O
32271	group	168 173	133742 133747	0.9999886751174927	O
32272	and	174 177	133748 133751	0.9999885559082031	O
32273	BRCA1	178 182	133752 133756	0.9999878406524658	O
32276	and	184 187	133758 133761	0.9999880790710449	O
32277	BRCA2	188 192	133762 133766	0.9999873638153076	O
32280	carriers	194 202	133768 133776	0.9999880790710449	O
32281	[	203 204	133777 133778	0.9999891519546509	O
32282	37	204 206	133778 133780	0.9999860525131226	O
32283	]	206 207	133780 133781	0.9999889135360718	O
32284	.	208 209	133782 133783	0.9999722242355347	O
32285	Alternative	0 11	133784 133795	0.9999797344207764	O
32286	IR	12 13	133796 133797	0.9999854564666748	O
32288	exposures	15 23	133799 133807	0.9999822378158569	O
32290	and	25 28	133809 133812	0.9999852180480957	O
32291	/	28 29	133812 133813	0.999985933303833	O
32292	or	29 31	133813 133815	0.9999850988388062	O
32293	post	32 36	133816 133820	0.9999841451644897	O
32294	-	36 37	133820 133821	0.9999879598617554	O
32295	IR	37 38	133821 133822	0.9999878406524658	O
32297	timepoints	40 49	133824 133833	0.9999866485595703	O
32299	,	51 52	133835 133836	0.9999853372573853	O
32300	and	53 56	133837 133840	0.9999852180480957	O
32301	possibly	57 65	133841 133849	0.9999847412109375	O
32302	different	66 75	133850 133859	0.9999752044677734	O
32303	DNA	76 79	133860 133863	0.9999842643737793	O
32304	damaging	80 88	133864 133872	0.9999854564666748	O
32305	agents	89 95	133873 133879	0.9999862909317017	O
32306	,	96 97	133880 133881	0.9999843835830688	O
32307	should	98 104	133882 133888	0.9999814033508301	O
32308	be	105 107	133889 133891	0.9999856948852539	O
32309	considered	108 118	133892 133902	0.9999853372573853	O
32310	for	119 122	133903 133906	0.9999829530715942	O
32311	future	123 129	133907 133913	0.999982476234436	O
32312	experiments	130 141	133914 133925	0.9999685287475586	O
32313	.	142 143	133926 133927	0.9999548196792603	O
32314	The	0 3	133928 133931	0.9999850988388062	O
32315	ultimate	4 12	133932 133940	0.9999823570251465	O
32316	aim	13 16	133941 133944	0.9999845027923584	O
32317	of	17 19	133945 133947	0.9999855756759644	O
32318	this	20 24	133948 133952	0.9999854564666748	O
32319	experiment	25 35	133953 133963	0.9999675750732422	O
32320	was	36 39	133964 133967	0.9999856948852539	O
32321	to	40 42	133968 133970	0.9999858140945435	O
32322	identify	43 51	133971 133979	0.9999850988388062	O
32323	array	52 57	133980 133985	0.9999784231185913	O
32324	profiles	58 66	133986 133994	0.9999806880950928	O
32325	that	67 71	133995 133999	0.9999864101409912	O
32326	would	72 77	134000 134005	0.9999850988388062	O
32327	be	78 80	134006 134008	0.9999861717224121	O
32328	useful	81 87	134009 134015	0.9999852180480957	O
32329	for	88 91	134016 134019	0.9999858140945435	O
32330	the	92 95	134020 134023	0.9999862909317017	O
32331	classification	96 110	134024 134038	0.9999865293502808	O
32332	of	111 113	134039 134041	0.9999871253967285	O
32333	unclassified	114 125	134042 134053	0.9999872446060181	O
32335	sequence	127 135	134055 134063	0.9999852180480957	O
32336	variants	136 144	134064 134072	0.9999868869781494	O
32337	of	145 147	134073 134075	0.999987006187439	O
32338	BRCA1	148 152	134076 134080	0.999985933303833	O
32341	or	154 156	134082 134084	0.9999858140945435	O
32342	BRCA2	157 161	134085 134089	0.9999862909317017	O
32345	.	163 164	134091 134092	0.9999558925628662	O
32346	In	0 2	134093 134095	0.999977707862854	O
32347	the	3 6	134096 134099	0.9999802112579346	O
32348	clinical	7 15	134100 134108	0.9999681711196899	O
32349	setting	16 23	134109 134116	0.9999827146530151	O
32350	,	24 25	134117 134118	0.9999821186065674	O
32351	individuals	26 37	134119 134130	0.9991127848625183	O
32352	generally	38 47	134131 134140	0.9999803304672241	O
32353	present	48 55	134141 134148	0.9999823570251465	O
32354	with	56 60	134149 134153	0.9999876022338867	O
32355	full	61 65	134154 134158	0.9999872446060181	O
32356	sequencing	66 75	134159 134168	0.999987006187439	O
32358	of	77 79	134170 134172	0.999988317489624	O
32359	both	80 84	134173 134177	0.9999872446060181	O
32360	genes	85 90	134178 134183	0.999984622001648	O
32361	,	91 92	134184 134185	0.9999836683273315	O
32362	and	93 96	134186 134189	0.9999868869781494	O
32363	presence	97 105	134190 134198	0.9999879598617554	O
32364	of	106 108	134199 134201	0.999988317489624	O
32365	a	109 110	134202 134203	0.999988317489624	O
32366	variant	111 118	134204 134211	0.9999874830245972	O
32367	in	119 121	134212 134214	0.9999887943267822	O
32368	one	122 125	134215 134218	0.9999889135360718	O
32369	gene	126 130	134219 134223	0.9999867677688599	O
32370	or	131 133	134224 134226	0.9999845027923584	O
32371	the	134 137	134227 134230	0.9999880790710449	O
32372	other	138 143	134231 134236	0.9999871253967285	O
32373	.	144 145	134237 134238	0.9999603033065796	O
32374	We	0 2	134239 134241	0.9999797344207764	O
32375	thus	3 7	134242 134246	0.999982476234436	O
32376	assessed	8 16	134247 134255	0.9999809265136719	O
32377	the	17 20	134256 134259	0.9999854564666748	O
32378	ability	21 28	134260 134267	0.9999853372573853	O
32379	to	29 31	134268 134270	0.9999852180480957	O
32380	distinguish	32 43	134271 134282	0.9999837875366211	O
32381	BRCA1	44 48	134283 134287	0.9999865293502808	O
32384	or	50 52	134289 134291	0.9999816417694092	O
32385	BRCA2	53 57	134292 134296	0.9999866485595703	O
32388	,	59 60	134298 134299	0.9999858140945435	O
32389	separately	61 71	134300 134310	0.9999847412109375	O
32390	,	72 73	134311 134312	0.9999854564666748	O
32391	from	74 78	134313 134317	0.9999852180480957	O
32392	BRCAX	79 83	134318 134322	0.9999860525131226	O
32395	individuals	85 96	134324 134335	0.9999523162841797	O
32396	.	97 98	134336 134337	0.999940037727356	O
32397	Importantly	0 10	134338 134348	0.9999856948852539	O
32399	,	12 13	134350 134351	0.9999886751174927	O
32400	since	14 19	134352 134357	0.9999836683273315	O
32401	most	20 24	134358 134362	0.9999868869781494	O
32402	unclassified	25 36	134363 134374	0.9999877214431763	O
32404	variants	38 46	134376 134384	0.9999862909317017	O
32405	are	47 50	134385 134388	0.9999874830245972	O
32406	predicted	51 60	134389 134398	0.9999871253967285	O
32407	to	61 63	134399 134401	0.999988317489624	O
32408	cause	64 69	134402 134407	0.9999879598617554	O
32409	amino	70 75	134408 134413	0.9999843835830688	O
32410	acid	76 80	134414 134418	0.999988317489624	O
32411	substitutions	81 93	134419 134431	0.9999876022338867	O
32413	,	95 96	134433 134434	0.9999872446060181	O
32414	we	97 99	134435 134437	0.999987006187439	O
32415	also	100 104	134438 134442	0.9999877214431763	O
32416	assessed	105 113	134443 134451	0.9999876022338867	O
32417	the	114 117	134452 134455	0.9999887943267822	O
32418	relevance	118 127	134456 134465	0.9999879598617554	O
32419	of	128 130	134466 134468	0.9999890327453613	O
32420	mutation	131 139	134469 134477	0.9999880790710449	O
32421	effect	140 146	134478 134484	0.9999890327453613	O
32422	for	147 150	134485 134488	0.9999884366989136	O
32423	expression	151 161	134489 134499	0.9999873638153076	O
32424	profiles	162 170	134500 134508	0.9999890327453613	O
32425	.	171 172	134509 134510	0.9999746084213257	O
32426	We	0 2	134511 134513	0.9999786615371704	O
32427	found	3 8	134514 134519	0.999984622001648	O
32428	that	9 13	134520 134524	0.9999874830245972	O
32429	the	14 17	134525 134528	0.9999871253967285	O
32430	genes	18 23	134529 134534	0.9999856948852539	O
32431	which	24 29	134535 134540	0.9999876022338867	O
32432	significantly	30 43	134541 134554	0.9999877214431763	O
32433	differed	44 52	134555 134563	0.9999868869781494	O
32434	between	53 60	134564 134571	0.9999858140945435	O
32435	BRCA1	61 65	134572 134576	0.9999872446060181	O
32438	or	67 69	134578 134580	0.9999876022338867	O
32439	BRCA2	70 74	134581 134585	0.9999878406524658	O
32442	and	76 79	134587 134590	0.9999866485595703	O
32443	BRCAX	80 84	134591 134595	0.9999873638153076	O
32446	LCLs	86 89	134597 134600	0.9999868869781494	O
32449	were	91 95	134602 134606	0.9999872446060181	O
32450	dependent	96 105	134607 134616	0.9999879598617554	O
32451	on	106 108	134617 134619	0.9999890327453613	O
32452	mutation	109 117	134620 134628	0.9999872446060181	O
32453	effect	118 124	134629 134635	0.9999885559082031	O
32454	.	125 126	134636 134637	0.9999697208404541	O
32455	Accordingly	0 11	134638 134649	0.9999828338623047	O
32456	,	12 13	134650 134651	0.9999891519546509	O
32457	the	14 17	134652 134655	0.9999887943267822	O
32458	SVM	18 20	134656 134658	0.9999861717224121	O
32460	prediction	22 32	134660 134670	0.9999887943267822	O
32461	for	33 36	134671 134674	0.9999891519546509	O
32462	each	37 41	134675 134679	0.9999889135360718	O
32463	mutation	42 50	134680 134688	0.9999865293502808	O
32464	effect	51 57	134689 134695	0.999987006187439	O
32465	was	58 61	134696 134699	0.9999884366989136	O
32466	best	62 66	134700 134704	0.9999871253967285	O
32467	if	67 69	134705 134707	0.9999884366989136	O
32468	the	70 73	134708 134711	0.99998939037323	O
32469	appropriate	74 85	134712 134723	0.9999881982803345	O
32470	gene	86 90	134724 134728	0.9999887943267822	O
32471	list	91 95	134729 134733	0.9999892711639404	O
32472	was	96 99	134734 134737	0.9999889135360718	O
32473	used	100 104	134738 134742	0.9999886751174927	O
32474	,	105 106	134743 134744	0.999988317489624	O
32475	in	107 109	134745 134747	0.9999895095825195	O
32476	terms	110 115	134748 134753	0.9999890327453613	O
32477	of	116 118	134754 134756	0.9999895095825195	O
32478	both	119 123	134757 134761	0.9999884366989136	O
32479	accuracy	124 132	134762 134770	0.9999889135360718	O
32480	of	133 135	134771 134773	0.9999891519546509	O
32481	prediction	136 146	134774 134784	0.9999884366989136	O
32482	(	147 148	134785 134786	0.9999897480010986	O
32483	BRCA1	149 153	134787 134791	0.9999889135360718	O
32486	or	155 157	134793 134795	0.9999886751174927	O
32487	BRCA2	158 162	134796 134800	0.9999889135360718	O
32490	vs	164 166	134802 134804	0.9999876022338867	O
32491	BRCAX	167 171	134805 134809	0.9999887943267822	O
32494	)	173 174	134811 134812	0.9999895095825195	O
32495	and	175 178	134813 134816	0.9999886751174927	O
32496	confidence	179 189	134817 134827	0.9999876022338867	O
32497	in	190 192	134828 134830	0.9999891519546509	O
32498	the	193 196	134831 134834	0.9999890327453613	O
32499	classification	197 211	134835 134849	0.9999876022338867	O
32500	as	212 214	134850 134852	0.99998939037323	O
32501	determined	215 225	134853 134863	0.9999895095825195	O
32502	by	226 228	134864 134866	0.9999895095825195	O
32503	the	229 232	134867 134870	0.9999895095825195	O
32504	distance	233 241	134871 134879	0.999987006187439	O
32505	of	242 244	134880 134882	0.9999892711639404	O
32506	the	245 248	134883 134886	0.9999890327453613	O
32507	prediction	249 259	134887 134897	0.9999880790710449	O
32508	from	260 264	134898 134902	0.9999889135360718	O
32509	the	265 268	134903 134906	0.9999895095825195	O
32510	SVM	269 271	134907 134909	0.9999864101409912	O
32512	plane	273 278	134911 134916	0.9999817609786987	O
32513	.	279 280	134917 134918	0.9999706745147705	O
32514	Thus	0 4	134919 134923	0.9999861717224121	O
32515	we	5 7	134924 134926	0.999984860420227	O
32516	strongly	8 16	134927 134935	0.9999840259552002	O
32517	urge	17 21	134936 134940	0.999982476234436	O
32518	that	22 26	134941 134945	0.9999890327453613	O
32519	mutation	27 35	134946 134954	0.9999861717224121	O
32520	effect	36 42	134955 134961	0.9999879598617554	O
32521	is	43 45	134962 134964	0.9999884366989136	O
32522	taken	46 51	134965 134970	0.999988317489624	O
32523	into	52 56	134971 134975	0.9999886751174927	O
32524	account	57 64	134976 134983	0.9999881982803345	O
32525	if	65 67	134984 134986	0.9999866485595703	O
32526	this	68 72	134987 134991	0.9999886751174927	O
32527	type	73 77	134992 134996	0.9999880790710449	O
32528	of	78 80	134997 134999	0.9999886751174927	O
32529	assay	81 85	135000 135004	0.9999856948852539	O
32531	is	87 89	135006 135008	0.9999873638153076	O
32532	to	90 92	135009 135011	0.9999876022338867	O
32533	be	93 95	135012 135014	0.9999881982803345	O
32534	developed	96 105	135015 135024	0.9999861717224121	O
32535	for	106 109	135025 135028	0.9999867677688599	O
32536	use	110 113	135029 135032	0.9999867677688599	O
32537	in	114 116	135033 135035	0.9999880790710449	O
32538	predicting	117 126	135036 135045	0.9999880790710449	O
32540	the	128 131	135047 135050	0.9999887943267822	O
32541	clinical	132 140	135051 135059	0.9999868869781494	O
32542	significance	141 153	135060 135072	0.9999884366989136	O
32543	of	154 156	135073 135075	0.9999889135360718	O
32544	BRCA1	157 161	135076 135080	0.999984860420227	O
32547	/	162 163	135081 135082	0.9999884366989136	O
32548	2	163 164	135082 135083	0.9999839067459106	O
32549	variants	165 173	135084 135092	0.9999880790710449	O
32550	.	174 175	135093 135094	0.9999678134918213	O
32551	The	0 3	135095 135098	0.9999867677688599	O
32552	current	4 11	135099 135106	0.9999845027923584	O
32553	challenge	12 21	135107 135116	0.9999806880950928	O
32554	is	22 24	135117 135119	0.9999866485595703	O
32555	that	25 29	135120 135124	0.999987006187439	O
32556	few	30 33	135125 135128	0.999984860420227	O
32557	missense	34 41	135129 135136	0.9999879598617554	O
32559	variants	43 51	135138 135146	0.9999871253967285	O
32560	have	52 56	135147 135151	0.9999878406524658	O
32561	been	57 61	135152 135156	0.9999874830245972	O
32562	classified	62 72	135157 135167	0.9999874830245972	O
32563	with	73 77	135168 135172	0.9999872446060181	O
32564	respect	78 85	135173 135180	0.9999872446060181	O
32565	to	86 88	135181 135183	0.9999876022338867	O
32566	their	89 94	135184 135189	0.999988317489624	O
32567	clinical	95 103	135190 135198	0.9999872446060181	O
32568	significance	104 116	135199 135211	0.9999881982803345	O
32569	,	117 118	135212 135213	0.9999873638153076	O
32570	with	119 123	135214 135218	0.9999874830245972	O
32571	the	124 127	135219 135222	0.9999877214431763	O
32572	only	128 132	135223 135227	0.9999872446060181	O
32573	23	133 135	135228 135230	0.9999818801879883	O
32574	individual	136 146	135231 135241	0.999967098236084	O
32575	missense	147 154	135242 135249	0.9999877214431763	O
32577	variants	156 164	135251 135259	0.9999879598617554	O
32578	termed	165 171	135260 135266	0.9999878406524658	O
32579	clinically	172 181	135267 135276	0.9999877214431763	O
32581	important	183 192	135278 135287	0.9999881982803345	O
32582	by	193 195	135288 135290	0.9999878406524658	O
32583	BIC	196 198	135291 135293	0.9999877214431763	O
32585	,	200 201	135295 135296	0.9999880790710449	O
32586	17	202 204	135297 135299	0.9999812841415405	O
32587	in	205 207	135300 135302	0.9999877214431763	O
32588	BRCA1	208 212	135303 135307	0.9999868869781494	O
32591	and	214 217	135309 135312	0.9999876022338867	O
32592	six	218 221	135313 135316	0.9999815225601196	O
32593	in	222 224	135317 135319	0.9999877214431763	O
32594	BRCA2	225 229	135320 135324	0.9999864101409912	O
32597	.	231 232	135326 135327	0.9999531507492065	O
32598	Moreover	0 8	135328 135336	0.999984622001648	O
32599	,	9 10	135337 135338	0.9999886751174927	O
32600	these	11 16	135339 135344	0.9999867677688599	O
32601	are	17 20	135345 135348	0.999988317489624	O
32602	restricted	21 31	135349 135359	0.9999841451644897	O
32603	in	32 34	135360 135362	0.9999890327453613	O
32604	terms	35 40	135363 135368	0.999988317489624	O
32605	of	41 43	135369 135371	0.9999885559082031	O
32606	the	44 47	135372 135375	0.9999886751174927	O
32607	domains	48 55	135376 135383	0.9999879598617554	O
32608	/	55 56	135383 135384	0.9999874830245972	O
32609	regions	56 63	135384 135391	0.9999880790710449	O
32610	in	64 66	135392 135394	0.9999884366989136	O
32611	which	67 72	135395 135400	0.9999884366989136	O
32612	they	73 77	135401 135405	0.9999886751174927	O
32613	occur	78 83	135406 135411	0.9999874830245972	O
32614	,	84 85	135412 135413	0.9999878406524658	O
32615	residing	86 94	135414 135422	0.9999887943267822	O
32616	in	95 97	135423 135425	0.9999889135360718	O
32617	the	98 101	135426 135429	0.9999890327453613	O
32618	BRCA1	102 106	135430 135434	0.9999852180480957	O
32621	start	108 113	135436 135441	0.9999885559082031	O
32622	site	114 118	135442 135446	0.9999892711639404	O
32623	(	119 120	135447 135448	0.99998939037323	O
32624	n	121 122	135449 135450	0.9999892711639404	O
32625	=	123 124	135451 135452	0.99998939037323	O
32626	2	125 126	135453 135454	0.9999877214431763	O
32627	)	127 128	135455 135456	0.9999892711639404	O
32628	,	129 130	135457 135458	0.9999889135360718	O
32629	ring	131 135	135459 135463	0.9999874830245972	O
32630	finger	136 142	135464 135470	0.9999872446060181	O
32631	(	143 144	135471 135472	0.99998939037323	O
32632	n	145 146	135473 135474	0.9999890327453613	O
32633	=	147 148	135475 135476	0.9999892711639404	O
32634	4	149 150	135477 135478	0.9999876022338867	O
32635	)	151 152	135479 135480	0.9999889135360718	O
32636	or	153 155	135481 135483	0.999988317489624	O
32637	transactivation	156 170	135484 135498	0.9999877214431763	O
32640	domains	172 179	135500 135507	0.9999891519546509	O
32641	(	180 181	135508 135509	0.99998939037323	O
32642	n	182 183	135510 135511	0.9999891519546509	O
32643	=	184 185	135512 135513	0.9999892711639404	O
32644	11	186 188	135514 135516	0.9999868869781494	O
32645	)	189 190	135517 135518	0.99998939037323	O
32646	,	191 192	135519 135520	0.9999886751174927	O
32647	and	193 196	135521 135524	0.9999889135360718	O
32648	the	197 200	135525 135528	0.9999890327453613	O
32649	BRCA2	201 205	135529 135533	0.9999855756759644	O
32652	CDK2	207 210	135535 135538	0.9999872446060181	O
32655	phosphorylation	212 226	135540 135554	0.9999889135360718	O
32660	site	228 232	135556 135560	0.9999889135360718	O
32661	(	233 234	135561 135562	0.99998939037323	O
32662	n	235 236	135563 135564	0.9999891519546509	O
32663	=	237 238	135565 135566	0.9999892711639404	O
32664	3	239 240	135567 135568	0.9999884366989136	O
32665	)	241 242	135569 135570	0.9999890327453613	O
32666	or	243 245	135571 135573	0.9999881982803345	O
32667	at	246 248	135574 135576	0.9999886751174927	O
32668	one	249 252	135577 135580	0.9999886751174927	O
32669	codon	253 257	135581 135585	0.9999881982803345	O
32671	(	259 260	135587 135588	0.9999890327453613	O
32672	2336	261 264	135589 135592	0.999985933303833	O
32674	,	266 267	135594 135595	0.9999885559082031	O
32675	n	268 269	135596 135597	0.9999889135360718	O
32676	=	270 271	135598 135599	0.9999892711639404	O
32677	3	272 273	135600 135601	0.9999884366989136	O
32678	)	274 275	135602 135603	0.9999892711639404	O
32679	in	276 278	135604 135606	0.9999889135360718	O
32680	a	279 280	135607 135608	0.9999891519546509	O
32681	region	281 287	135609 135615	0.9999887943267822	O
32682	of	288 290	135616 135618	0.9999892711639404	O
32683	unknown	291 298	135619 135626	0.9999880790710449	O
32684	function	299 307	135627 135635	0.9999874830245972	O
32685	.	308 309	135636 135637	0.9999650716781616	O
32686	It	0 2	135638 135640	0.999984860420227	O
32687	will	3 7	135641 135645	0.9999840259552002	O
32688	thus	8 12	135646 135650	0.9999815225601196	O
32689	be	13 15	135651 135653	0.9999843835830688	O
32690	difficult	16 25	135654 135663	0.9999803304672241	O
32691	to	26 28	135664 135666	0.9999862909317017	O
32692	accrue	29 34	135667 135672	0.9999880790710449	O
32695	a	36 37	135674 135675	0.9999881982803345	O
32696	panel	38 43	135676 135681	0.999987006187439	O
32697	of	44 46	135682 135684	0.9999878406524658	O
32698	known	47 52	135685 135690	0.9999830722808838	O
32699	pathogenic	53 62	135691 135700	0.9999866485595703	O
32701	missense	64 71	135702 135709	0.9999884366989136	O
32703	variants	73 81	135711 135719	0.9999872446060181	O
32704	for	82 85	135720 135723	0.9999852180480957	O
32705	use	86 89	135724 135727	0.9999862909317017	O
32706	in	90 92	135728 135730	0.9999865293502808	O
32707	such	93 97	135731 135735	0.9999864101409912	O
32708	predictive	98 107	135736 135745	0.9999866485595703	O
32710	assays	109 114	135747 135752	0.9999862909317017	O
32712	,	116 117	135754 135755	0.9999852180480957	O
32713	and	118 121	135756 135759	0.9999860525131226	O
32714	will	122 126	135760 135764	0.9999864101409912	O
32715	require	127 134	135765 135772	0.9999876022338867	O
32716	a	135 136	135773 135774	0.999988317489624	O
32717	concerted	137 145	135775 135783	0.9999872446060181	O
32719	collaborative	147 160	135785 135798	0.9999862909317017	O
32720	effort	161 167	135799 135805	0.9999873638153076	O
32721	.	168 169	135806 135807	0.9999703168869019	O
32722	Assuming	0 7	135808 135815	0.9999864101409912	O
32724	sufficient	9 19	135817 135827	0.9999834299087524	O
32725	pathogenic	20 29	135828 135837	0.999985933303833	O
32727	variants	31 39	135839 135847	0.9999867677688599	O
32728	are	40 43	135848 135851	0.9999872446060181	O
32729	identified	44 54	135852 135862	0.9999868869781494	O
32730	,	55 56	135863 135864	0.9999856948852539	O
32731	the	57 60	135865 135868	0.9999886751174927	O
32732	successful	61 71	135869 135879	0.9999872446060181	O
32733	execution	72 81	135880 135889	0.9999878406524658	O
32734	of	82 84	135890 135892	0.9999891519546509	O
32735	such	85 89	135893 135897	0.9999891519546509	O
32736	a	90 91	135898 135899	0.9999891519546509	O
32737	study	92 97	135900 135905	0.9999865293502808	O
32738	may	98 101	135906 135909	0.9999872446060181	O
32739	eventually	102 112	135910 135920	0.999985933303833	O
32740	distinguish	113 124	135921 135932	0.9999871253967285	O
32741	missense	125 132	135933 135940	0.9999892711639404	O
32743	-	133 134	135941 135942	0.99998939037323	O
32744	associated	134 144	135942 135952	0.9999890327453613	O
32745	gene	145 149	135953 135957	0.9999885559082031	O
32746	expression	150 160	135958 135968	0.9999880790710449	O
32747	patterns	161 169	135969 135977	0.9999886751174927	O
32748	that	170 174	135978 135982	0.9999891519546509	O
32749	are	175 178	135983 135986	0.9999891519546509	O
32750	generic	179 186	135987 135994	0.9999879598617554	O
32751	to	187 189	135995 135997	0.9999889135360718	O
32752	missense	190 197	135998 136005	0.9999891519546509	O
32754	mutations	199 208	136007 136016	0.9999890327453613	O
32755	,	209 210	136017 136018	0.9999840259552002	O
32756	and	211 214	136019 136022	0.9999866485595703	O
32757	/	214 215	136022 136023	0.9999868869781494	O
32758	or	215 217	136023 136025	0.9999873638153076	O
32759	those	218 223	136026 136031	0.9999881982803345	O
32760	that	224 228	136032 136036	0.9999890327453613	O
32761	are	229 232	136037 136040	0.9999889135360718	O
32762	specific	233 241	136041 136049	0.9999889135360718	O
32763	to	242 244	136050 136052	0.9999892711639404	O
32764	the	245 248	136053 136056	0.99998939037323	O
32765	domain	249 255	136057 136063	0.9999876022338867	O
32766	location	256 264	136064 136072	0.9999885559082031	O
32767	of	265 267	136073 136075	0.9999889135360718	O
32768	missense	268 275	136076 136083	0.9999889135360718	O
32770	mutations	277 286	136085 136094	0.9999885559082031	O
32771	.	287 288	136095 136096	0.9999608993530273	O
32772	In	0 2	136097 136099	0.9999887943267822	O
32773	addition	3 11	136100 136108	0.9999876022338867	O
32774	,	12 13	136109 136110	0.9999887943267822	O
32775	a	14 15	136111 136112	0.9999891519546509	O
32776	possibly	16 24	136113 136121	0.9999879598617554	O
32777	greater	25 32	136122 136129	0.9999866485595703	O
32778	challenge	33 42	136130 136139	0.9999866485595703	O
32779	will	43 47	136140 136144	0.9999880790710449	O
32780	be	48 50	136145 136147	0.9999890327453613	O
32781	identifying	51 62	136148 136159	0.9999890327453613	O
32782	assay	63 67	136160 136164	0.9999880790710449	O
32784	conditions	69 79	136166 136176	0.9999856948852539	O
32785	(	80 81	136177 136178	0.9999895095825195	O
32786	cell	81 85	136178 136182	0.9999881982803345	O
32787	type	86 90	136183 136187	0.9999890327453613	O
32788	,	91 92	136188 136189	0.9999887943267822	O
32789	perturbation	93 104	136190 136201	0.9999892711639404	O
32792	,	106 107	136203 136204	0.9999890327453613	O
32793	time	108 112	136205 136209	0.9999887943267822	O
32794	-	112 113	136209 136210	0.9999895095825195	O
32795	point	113 118	136210 136215	0.9999885559082031	O
32796	etc	119 122	136216 136219	0.9999885559082031	O
32797	)	123 124	136220 136221	0.9999895095825195	O
32798	that	125 129	136222 136226	0.9999891519546509	O
32799	can	130 133	136227 136230	0.9999887943267822	O
32800	also	134 138	136231 136235	0.9999881982803345	O
32801	identify	139 147	136236 136244	0.9999895095825195	O
32802	gene	148 152	136245 136249	0.9999889135360718	O
32803	expression	153 163	136250 136260	0.9999885559082031	O
32804	differences	164 175	136261 136272	0.9999892711639404	O
32805	between	176 183	136273 136280	0.9999884366989136	O
32806	patients	184 192	136281 136289	0.9999866485595703	O
32807	with	193 197	136290 136294	0.9999896287918091	O
32808	rare	198 202	136295 136299	0.9999876022338867	O
32809	variants	203 211	136300 136308	0.9999887943267822	O
32810	of	212 214	136309 136311	0.9999896287918091	O
32811	low	215 218	136312 136315	0.9999881982803345	O
32812	clinical	219 227	136316 136324	0.9999889135360718	O
32813	significance	228 240	136325 136337	0.9999891519546509	O
32814	in	241 243	136338 136340	0.9999896287918091	O
32815	BRCA1	244 248	136341 136345	0.9999880790710449	O
32818	and	250 253	136347 136350	0.9999892711639404	O
32819	/	253 254	136350 136351	0.999988317489624	O
32820	or	254 256	136351 136353	0.9999890327453613	O
32821	BRCA2	257 261	136354 136358	0.9999873638153076	O
32824	and	263 266	136360 136363	0.9999878406524658	O
32825	those	267 272	136364 136369	0.9999886751174927	O
32826	with	273 277	136370 136374	0.9999892711639404	O
32827	truly	278 283	136375 136380	0.9999862909317017	O
32828	high	284 288	136381 136385	0.9999885559082031	O
32829	-	288 289	136385 136386	0.99998939037323	O
32830	risk	289 293	136386 136390	0.9999889135360718	O
32831	pathogenic	294 303	136391 136400	0.9999889135360718	O
32833	mutations	305 314	136402 136411	0.999988317489624	O
32834	(	315 316	136412 136413	0.99998939037323	O
32835	truncating	317 326	136414 136423	0.9999891519546509	O
32838	or	328 330	136425 136427	0.9999881982803345	O
32839	missense	331 338	136428 136435	0.9999889135360718	O
32841	)	340 341	136437 136438	0.9999891519546509	O
32842	in	342 344	136439 136441	0.9999892711639404	O
32843	these	345 350	136442 136447	0.9999892711639404	O
32844	genes	351 356	136448 136453	0.9999866485595703	O
32845	.	357 358	136454 136455	0.9999707937240601	O
32846	Our	0 3	136456 136459	0.999984622001648	O
32847	study	4 9	136460 136465	0.9999845027923584	O
32848	,	10 11	136466 136467	0.9999852180480957	O
32849	using	12 17	136468 136473	0.9999852180480957	O
32850	conditions	18 28	136474 136484	0.9999802112579346	O
32851	that	29 33	136485 136489	0.9999874830245972	O
32852	were	34 38	136490 136494	0.9999874830245972	O
32853	not	39 42	136495 136498	0.9999862909317017	O
32854	optimal	43 50	136499 136506	0.9999841451644897	O
32855	for	51 54	136507 136510	0.9999874830245972	O
32856	separating	55 65	136511 136521	0.9999872446060181	O
32857	BRCA1	66 70	136522 136526	0.9999864101409912	O
32860	and	72 75	136528 136531	0.9999864101409912	O
32861	BRCA2	76 80	136532 136536	0.9999854564666748	O
32864	mutations	82 91	136538 136547	0.9999876022338867	O
32865	nevertheless	92 104	136548 136560	0.999977707862854	O
32866	identified	105 115	136561 136571	0.9999874830245972	O
32867	gene	116 120	136572 136576	0.9999868869781494	O
32868	expression	121 131	136577 136587	0.9999862909317017	O
32869	differences	132 143	136588 136599	0.9999872446060181	O
32870	between	144 151	136600 136607	0.9999873638153076	O
32871	BRCA1	152 156	136608 136612	0.9999850988388062	O
32874	/	157 158	136613 136614	0.9999881982803345	O
32875	2	158 159	136614 136615	0.9999849796295166	O
32876	pathogenic	160 169	136616 136625	0.9999878406524658	O
32878	mutations	171 180	136627 136636	0.9999877214431763	O
32879	and	181 184	136637 136640	0.9999873638153076	O
32880	LCS	185 187	136641 136643	0.999985933303833	O
32882	variants	189 197	136645 136653	0.9999876022338867	O
32883	,	198 199	136654 136655	0.9999879598617554	O
32884	suggesting	200 210	136656 136666	0.9999876022338867	O
32885	that	211 215	136667 136671	0.9999884366989136	O
32886	larger	216 222	136672 136678	0.9999858140945435	O
32887	sample	223 229	136679 136685	0.9999865293502808	O
32888	sizes	230 235	136686 136691	0.9999867677688599	O
32889	and	236 239	136692 136695	0.9999858140945435	O
32890	further	240 247	136696 136703	0.999987006187439	O
32891	experimentation	248 263	136704 136719	0.9999803304672241	O
32892	may	264 267	136720 136723	0.9999877214431763	O
32893	identify	268 276	136724 136732	0.9999881982803345	O
32894	a	277 278	136733 136734	0.9999885559082031	O
32895	more	279 283	136735 136739	0.9999876022338867	O
32896	robust	284 290	136740 136746	0.9999868869781494	O
32897	gene	291 295	136747 136751	0.9999865293502808	O
32898	list	296 300	136752 136756	0.9999874830245972	O
32899	to	301 303	136757 136759	0.9999871253967285	O
32900	separate	304 312	136760 136768	0.9999862909317017	O
32901	pathogenic	313 322	136769 136778	0.9999867677688599	O
32903	mutations	324 333	136780 136789	0.9999845027923584	O
32904	,	334 335	136790 136791	0.9999866485595703	O
32905	variants	336 344	136792 136800	0.9999853372573853	O
32906	of	345 347	136801 136803	0.999988317489624	O
32907	low	348 351	136804 136807	0.999985933303833	O
32908	clinical	352 360	136808 136816	0.9999872446060181	O
32909	significance	361 373	136817 136829	0.9999877214431763	O
32910	,	374 375	136830 136831	0.999987006187439	O
32911	and	376 379	136832 136835	0.9999872446060181	O
32912	individuals	380 391	136836 136847	0.9999691247940063	O
32913	with	392 396	136848 136852	0.999988317489624	O
32914	no	397 399	136853 136855	0.9999874830245972	O
32915	sequence	400 408	136856 136864	0.9999858140945435	O
32916	alterations	409 420	136865 136876	0.9999871253967285	O
32917	in	421 423	136877 136879	0.9999884366989136	O
32918	BRCA1	424 428	136880 136884	0.9999845027923584	O
32921	/	429 430	136885 136886	0.9999880790710449	O
32922	2	430 431	136886 136887	0.9999850988388062	O
32923	.	432 433	136888 136889	0.9999871253967285	O
32924	*	434 435	136890 136891	0.9999864101409912	O
32925	*	435 436	136891 136892	0.9999750852584839	O
32926	IGNORE	0 5	136893 136898	0.9999854564666748	O
32929	LINE	7 10	136900 136903	0.9999876022338867	O
32932	*	12 13	136905 136906	0.9999876022338867	O
32933	*	13 14	136906 136907	0.9999877214431763	O
32934	*	15 16	136908 136909	0.9999877214431763	O
32935	*	16 17	136909 136910	0.9999879598617554	O
32936	IGNORE	18 23	136911 136916	0.9999866485595703	O
32939	LINE	25 28	136918 136921	0.9999879598617554	O
32942	*	30 31	136923 136924	0.9999872446060181	O
32943	*	31 32	136924 136925	0.9999872446060181	O
32944	*	33 34	136926 136927	0.9999873638153076	O
32945	*	34 35	136927 136928	0.9999874830245972	O
32946	IGNORE	36 41	136929 136934	0.9999858140945435	O
32949	LINE	43 46	136936 136939	0.9999877214431763	O
32952	*	48 49	136941 136942	0.9999874830245972	O
32953	*	49 50	136942 136943	0.9999876022338867	O
32954	27	51 53	136944 136946	0.9999836683273315	O
32955	LCLs	54 57	136947 136950	0.9999847412109375	O
32958	from	59 63	136952 136956	0.9999865293502808	O
32959	women	64 69	136957 136962	0.9999275207519531	O
32960	from	70 74	136963 136967	0.9999819993972778	O
32961	breast	75 81	136968 136974	0.9999802112579346	O
32962	cancer	82 88	136975 136981	0.9999839067459106	O
32963	families	89 97	136982 136990	0.9999748468399048	O
32964	that	98 102	136991 136995	0.9999877214431763	O
32965	have	103 107	136996 137000	0.9999873638153076	O
32966	tested	108 114	137001 137007	0.9999874830245972	O
32967	negative	115 123	137008 137016	0.9999834299087524	O
32968	for	124 127	137017 137020	0.9999878406524658	O
32969	pathogenic	128 137	137021 137030	0.9999873638153076	O
32971	mutations	139 148	137032 137041	0.9999868869781494	O
32972	in	149 151	137042 137044	0.999988317489624	O
32973	BRCA1	152 156	137045 137049	0.999987006187439	O
32976	or	158 160	137051 137053	0.9999868869781494	O
32977	BRCA2	161 165	137054 137058	0.9999860525131226	O
32980	(	167 168	137060 137061	0.9999881982803345	O
32981	BRCAX	169 173	137062 137066	0.9999860525131226	O
32984	)	175 176	137068 137069	0.9999886751174927	O
32985	after	177 182	137070 137075	0.9999867677688599	O
32986	complete	183 191	137076 137084	0.9999871253967285	O
32987	sequencing	192 201	137085 137094	0.9999867677688599	O
32989	and	203 206	137096 137099	0.9999880790710449	O
32990	multiplex	207 215	137100 137108	0.9999864101409912	O
32992	ligation	217 224	137110 137117	0.9999872446060181	O
32995	-	225 226	137118 137119	0.9999880790710449	O
32996	dependent	226 235	137119 137128	0.9999871253967285	O
32997	probe	236 241	137129 137134	0.9999868869781494	O
32998	amplification	242 254	137135 137147	0.9999874830245972	O
33001	gene	256 260	137149 137153	0.9999874830245972	O
33002	dosage	261 266	137154 137159	0.9999874830245972	O
33004	assay	268 272	137161 137165	0.9999873638153076	O
33006	(	274 275	137167 137168	0.9999874830245972	O
33007	MLPA	276 279	137169 137172	0.9999842643737793	O
33010	)	281 282	137174 137175	0.9999884366989136	O
33011	large	283 288	137176 137181	0.9999834299087524	O
33012	deletion	289 296	137182 137189	0.9999874830245972	O
33015	testing	298 305	137191 137198	0.9999872446060181	O
33016	of	306 308	137199 137201	0.9999879598617554	O
33017	BRCA1	309 313	137202 137206	0.9999865293502808	O
33020	and	315 318	137208 137211	0.9999867677688599	O
33021	BRCA2	319 323	137212 137216	0.9999861717224121	O
33024	.	325 326	137218 137219	0.9999586343765259	O
33025	Ten	0 3	137220 137223	0.9999759197235107	O
33026	samples	4 11	137224 137231	0.999984860420227	O
33027	,	12 13	137232 137233	0.9999860525131226	O
33028	carried	14 21	137234 137241	0.9999877214431763	O
33029	either	22 28	137242 137248	0.999988317489624	O
33030	BRCA1	29 33	137249 137253	0.9999853372573853	O
33033	or	35 37	137255 137257	0.9999884366989136	O
33034	BRCA2	38 42	137258 137262	0.999985933303833	O
33037	sequence	44 52	137264 137272	0.9999873638153076	O
33038	germline	53 60	137273 137280	0.9999886751174927	O
33042	variants	62 70	137282 137290	0.9999881982803345	O
33043	considered	71 81	137291 137301	0.9999891519546509	O
33044	from	82 86	137302 137306	0.9999889135360718	O
33045	multifactorial	87 100	137307 137320	0.9999885559082031	O
33049	likelihood	102 112	137322 137332	0.999988317489624	O
33050	classification	113 127	137333 137347	0.99998939037323	O
33051	to	128 130	137348 137350	0.9999891519546509	O
33052	be	131 133	137351 137353	0.9999892711639404	O
33053	LCS	134 136	137354 137356	0.9999879598617554	O
33055	(	138 139	137358 137359	0.9999895095825195	O
33056	BRCA1	140 144	137360 137364	0.9999872446060181	O
33059	3582	146 149	137366 137369	0.9999879598617554	O
33062	G	151 152	137371 137372	0.9999879598617554	O
33063	>	152 153	137372 137373	0.9999889135360718	O
33064	C	153 154	137373 137374	0.9999881982803345	O
33065	D1155H	155 160	137375 137380	0.9999889135360718	O
33069	,	162 163	137382 137383	0.9999891519546509	O
33070	1605	164 167	137384 137387	0.9999868869781494	O
33072	C	169 170	137389 137390	0.9999880790710449	O
33073	>	170 171	137390 137391	0.9999884366989136	O
33074	T	171 172	137391 137392	0.9999878406524658	O
33075	R496C	173 177	137393 137397	0.9999884366989136	O
33080	,	179 180	137399 137400	0.9999889135360718	O
33081	5236	181 184	137401 137404	0.999984622001648	O
33083	G	186 187	137406 137407	0.9999876022338867	O
33084	>	187 188	137407 137408	0.9999884366989136	O
33085	C	188 189	137408 137409	0.9999877214431763	O
33086	G1706A	190 195	137410 137415	0.9999878406524658	O
33091	(	197 198	137417 137418	0.99998939037323	O
33092	2	199 200	137419 137420	0.9999816417694092	O
33093	samples	201 208	137421 137428	0.9999884366989136	O
33094	)	209 210	137429 137430	0.9999895095825195	O
33095	;	211 212	137431 137432	0.9999889135360718	O
33096	BRCA2	213 217	137433 137437	0.9999867677688599	O
33099	353	219 221	137439 137441	0.9999884366989136	O
33101	A	223 224	137443 137444	0.9999884366989136	O
33102	>	224 225	137444 137445	0.9999886751174927	O
33103	G	225 226	137445 137446	0.9999876022338867	O
33104	Y42C	227 230	137447 137450	0.999987006187439	O
33107	,	232 233	137452 137453	0.9999891519546509	O
33108	2834	234 237	137454 137457	0.9999881982803345	O
33110	C	239 240	137459 137460	0.999988317489624	O
33111	>	240 241	137460 137461	0.9999885559082031	O
33112	T	241 242	137461 137462	0.9999878406524658	O
33113	S869L	243 247	137463 137467	0.9999885559082031	O
33117	,	249 250	137469 137470	0.9999890327453613	O
33118	3031	251 254	137471 137474	0.9999862909317017	O
33120	G	256 257	137476 137477	0.9999879598617554	O
33121	>	257 258	137477 137478	0.9999886751174927	O
33122	A	258 259	137478 137479	0.9999880790710449	O
33123	D935N	260 264	137480 137484	0.9999885559082031	O
33127	(	266 267	137486 137487	0.9999895095825195	O
33128	3	268 269	137488 137489	0.9999866485595703	O
33129	samples	270 277	137490 137497	0.9999885559082031	O
33130	)	278 279	137498 137499	0.9999895095825195	O
33131	,	280 281	137500 137501	0.9999892711639404	O
33132	8795	282 285	137502 137505	0.9999874830245972	O
33135	A	287 288	137507 137508	0.999988317489624	O
33136	>	288 289	137508 137509	0.9999884366989136	O
33137	C	289 290	137509 137510	0.9999879598617554	O
33138	E2856A	291 296	137511 137516	0.9999889135360718	O
33143	)	298 299	137518 137519	0.9999887943267822	O
33144	[	300 301	137520 137521	0.9999889135360718	O
33145	16	301 303	137521 137523	0.9999879598617554	O
33146	]	303 304	137523 137524	0.9999891519546509	O
33147	,	305 306	137525 137526	0.9999890327453613	O
33148	[	306 307	137526 137527	0.9999889135360718	O
33149	19	307 309	137527 137529	0.9999876022338867	O
33150	]	309 310	137529 137530	0.9999892711639404	O
33151	,	311 312	137531 137532	0.9999889135360718	O
33152	[	312 313	137532 137533	0.9999887943267822	O
33153	21	313 315	137533 137535	0.9999878406524658	O
33154	]	315 316	137535 137536	0.9999890327453613	O
33155	,	317 318	137537 137538	0.9999885559082031	O
33156	[	318 319	137538 137539	0.9999885559082031	O
33157	22	319 321	137539 137541	0.999987006187439	O
33158	]	321 322	137541 137542	0.9999891519546509	O
33159	(	322 323	137542 137543	0.9999892711639404	O
33160	unpublished	323 334	137543 137554	0.9999855756759644	O
33161	data	335 339	137555 137559	0.9999891519546509	O
33162	)	340 341	137560 137561	0.99998939037323	O
33163	.	342 343	137562 137563	0.9999754428863525	O
33164	The	0 3	137564 137567	0.9999802112579346	O
33165	remaining	4 13	137568 137577	0.9999808073043823	O
33166	17	14 16	137578 137580	0.9999419450759888	O
33167	samples	17 24	137581 137588	0.9999750852584839	O
33168	carried	25 32	137589 137596	0.9999822378158569	O
33169	no	33 35	137597 137599	0.9999810457229614	O
33170	BRCA1	36 40	137600 137604	0.9999842643737793	O
33173	or	42 44	137606 137608	0.999984860420227	O
33174	BRCA2	45 49	137609 137613	0.999984860420227	O
33177	sequence	51 59	137615 137623	0.999984860420227	O
33178	variants	60 68	137624 137632	0.999985933303833	O
33179	other	69 74	137633 137638	0.9999872446060181	O
33180	than	75 79	137639 137643	0.9999872446060181	O
33181	common	80 86	137644 137650	0.9999773502349854	O
33182	polymorphisms	87 99	137651 137663	0.9999879598617554	O
33187	.	101 102	137665 137666	0.999953031539917	O
33188	Gene	0 4	137667 137671	0.9999861717224121	O
33189	Expression	5 14	137672 137681	0.9999850988388062	O
33191	Profiling	16 24	137683 137691	0.9999812841415405	O
33193	LCLs	26 29	137693 137696	0.9999814033508301	O
33196	were	31 35	137698 137702	0.999984860420227	O
33197	grown	36 41	137703 137708	0.9999830722808838	O
33198	in	42 44	137709 137711	0.9999871253967285	O
33199	RPMI	45 48	137712 137715	0.9999871253967285	O
33202	1640	50 54	137717 137721	0.9999825954437256	O
33203	media	55 60	137722 137727	0.9999839067459106	O
33204	with	61 65	137728 137732	0.9999880790710449	O
33205	15	66 68	137733 137735	0.9999854564666748	O
33206	%	69 70	137736 137737	0.9999884366989136	O
33207	fetal	71 75	137738 137742	0.9999878406524658	O
33209	bovine	77 82	137744 137749	0.9999878406524658	O
33212	serum	84 89	137751 137756	0.9999865293502808	O
33213	,	90 91	137757 137758	0.999988317489624	O
33214	1	92 93	137759 137760	0.9999876022338867	O
33215	%	94 95	137761 137762	0.9999886751174927	O
33216	penicillin	96 105	137763 137772	0.999988317489624	O
33219	-	106 107	137773 137774	0.9999886751174927	O
33220	streptomycin	107 118	137774 137785	0.9999886751174927	O
33225	and	120 123	137787 137790	0.999988317489624	O
33226	1	124 125	137791 137792	0.9999879598617554	O
33227	%	126 127	137793 137794	0.9999885559082031	O
33228	L	128 129	137795 137796	0.9999873638153076	O
33229	-	129 130	137796 137797	0.9999887943267822	O
33230	glutamine	130 138	137797 137805	0.9999876022338867	O
33233	.	140 141	137807 137808	0.9999680519104004	O
33234	The	0 3	137809 137812	0.9999871253967285	O
33235	cell	4 8	137813 137817	0.9999860525131226	O
33236	number	9 15	137818 137824	0.9999856948852539	O
33237	was	16 19	137825 137828	0.999988317489624	O
33238	normalised	20 29	137829 137838	0.9999866485595703	O
33240	and	31 34	137840 137843	0.9999876022338867	O
33241	fresh	35 40	137844 137849	0.9999868869781494	O
33242	medium	41 47	137850 137856	0.9999839067459106	O
33243	was	48 51	137857 137860	0.9999886751174927	O
33244	added	52 57	137861 137866	0.999988317489624	O
33245	to	58 60	137867 137869	0.9999889135360718	O
33246	cells	61 66	137870 137875	0.9999880790710449	O
33247	24hr	67 70	137876 137879	0.9999886751174927	O
33249	prior	72 77	137881 137886	0.9999884366989136	O
33250	to	78 80	137887 137889	0.9999890327453613	O
33251	irradiation	81 91	137890 137900	0.9999881982803345	O
33254	with	93 97	137902 137906	0.9999889135360718	O
33255	10Gy	98 101	137907 137910	0.9999862909317017	O
33258	,	103 104	137912 137913	0.9999880790710449	O
33259	using	105 110	137914 137919	0.9999887943267822	O
33260	a	111 112	137920 137921	0.9999889135360718	O
33261	calibrated	113 122	137922 137931	0.9999886751174927	O
33265	Cs137	124 128	137933 137937	0.9999889135360718	O
33269	c	130 131	137939 137940	0.9999890327453613	O
33270	-	131 132	137940 137941	0.9999890327453613	O
33271	source	132 138	137941 137947	0.999988317489624	O
33272	delivering	139 149	137948 137958	0.9999881982803345	O
33273	1	150 151	137959 137960	0.9999886751174927	O
33274	Gy	152 153	137961 137962	0.999987006187439	O
33276	/	154 155	137963 137964	0.9999881982803345	O
33277	1	155 156	137964 137965	0.9999886751174927	O
33278	.	156 157	137965 137966	0.9999887943267822	O
33279	5	157 158	137966 137967	0.9999885559082031	O
33280	min	159 162	137968 137971	0.9999876022338867	O
33281	.	163 164	137972 137973	0.9999704360961914	O
33282	Total	0 5	137974 137979	0.9999819993972778	O
33283	RNA	6 9	137980 137983	0.999980092048645	O
33284	was	10 13	137984 137987	0.9999827146530151	O
33285	harvested	14 23	137988 137997	0.9999831914901733	O
33286	30min	24 28	137998 138002	0.9999837875366211	O
33288	later	30 35	138004 138009	0.9999827146530151	O
33289	using	36 41	138010 138015	0.9999852180480957	O
33290	an	42 44	138016 138018	0.9999877214431763	O
33291	RNeasy	45 50	138019 138024	0.9999856948852539	O
33295	kit	52 55	138026 138029	0.9999866485595703	O
33296	(	56 57	138030 138031	0.9999884366989136	O
33297	Qiagen	58 63	138032 138037	0.9999819993972778	O
33300	,	65 66	138039 138040	0.9999879598617554	O
33301	Doncaster	67 76	138041 138050	0.9999692440032959	O
33302	,	77 78	138051 138052	0.9999874830245972	O
33303	VIC	79 81	138053 138055	0.9999812841415405	O
33305	)	83 84	138057 138058	0.9999880790710449	O
33306	.	85 86	138059 138060	0.9999585151672363	O
33307	The	0 3	138061 138064	0.999987006187439	O
33308	Illumina	4 11	138065 138072	0.9999860525131226	O
33311	Totalprep	13 21	138074 138082	0.9999858140945435	O
33315	RNA	23 26	138084 138087	0.9999874830245972	O
33316	amplification	27 39	138088 138100	0.9999889135360718	O
33319	kit	41 44	138102 138105	0.9999873638153076	O
33320	(	45 46	138106 138107	0.9999886751174927	O
33321	Ambion	47 52	138108 138113	0.9999877214431763	O
33324	,	54 55	138115 138116	0.9999884366989136	O
33325	Austin	56 62	138117 138123	0.9999842643737793	O
33326	,	63 64	138124 138125	0.9999880790710449	O
33327	TX	65 67	138126 138128	0.9999783039093018	O
33328	)	68 69	138129 138130	0.9999891519546509	O
33329	was	70 73	138131 138134	0.9999864101409912	O
33330	used	74 78	138135 138139	0.9999861717224121	O
33331	to	79 81	138140 138142	0.9999881982803345	O
33332	amplify	82 88	138143 138149	0.9999889135360718	O
33335	and	90 93	138151 138154	0.9999877214431763	O
33336	biotinylate	94 104	138155 138165	0.9999874830245972	O
33340	450ng	106 110	138167 138171	0.9999839067459106	O
33342	of	112 114	138173 138175	0.9999880790710449	O
33343	total	115 120	138176 138181	0.9999872446060181	O
33344	RNA	121 124	138182 138185	0.9999860525131226	O
33345	.	125 126	138186 138187	0.999970555305481	O
33346	Biotinylated	0 11	138188 138199	0.9999819993972778	O
33351	RNA	13 16	138201 138204	0.9999803304672241	O
33352	was	17 20	138205 138208	0.9999843835830688	O
33353	hybridised	21 30	138209 138218	0.9999847412109375	O
33355	overnight	32 41	138220 138229	0.9999822378158569	O
33356	at	42 44	138230 138232	0.999987006187439	O
33357	55°C	45 48	138233 138236	0.999984622001648	O
33360	to	50 52	138238 138240	0.999988317489624	O
33361	Illumina	53 60	138241 138248	0.9999889135360718	O
33364	Human	62 67	138250 138255	0.9999836683273315	O
33365	-	67 68	138255 138256	0.9999891519546509	O
33366	6	68 69	138256 138257	0.9999878406524658	O
33367	version	70 77	138258 138265	0.9999885559082031	O
33368	1	78 79	138266 138267	0.999988317489624	O
33369	BeadChips	80 88	138268 138276	0.9999876022338867	O
33373	containing	90 100	138278 138288	0.9999889135360718	O
33374	>	101 102	138289 138290	0.9999885559082031	O
33375	46	102 104	138290 138292	0.9999876022338867	O
33376	,	104 105	138292 138293	0.9999886751174927	O
33377	000	105 108	138293 138296	0.9999884366989136	O
33378	probes	109 114	138297 138302	0.999987006187439	O
33380	(	116 117	138304 138305	0.9999890327453613	O
33381	Illumina	118 125	138306 138313	0.9999885559082031	O
33384	Inc	127 130	138315 138318	0.9999884366989136	O
33385	.	130 131	138318 138319	0.9999878406524658	O
33386	,	132 133	138320 138321	0.9999871253967285	O
33387	San	134 137	138322 138325	0.9999830722808838	O
33388	Diego	138 143	138326 138331	0.9999821186065674	O
33389	,	144 145	138332 138333	0.9999862909317017	O
33390	CA	146 148	138334 138336	0.9999701976776123	O
33391	)	149 150	138337 138338	0.9999889135360718	O
33392	.	151 152	138339 138340	0.9999665021896362	O
33393	The	0 3	138341 138344	0.9999803304672241	O
33394	microarrays	4 14	138345 138355	0.9999808073043823	O
33397	were	16 20	138357 138361	0.9999829530715942	O
33398	washed	21 27	138362 138368	0.9999717473983765	O
33399	,	28 29	138369 138370	0.9999845027923584	O
33400	stained	30 37	138371 138378	0.9999845027923584	O
33401	with	38 42	138379 138383	0.9999878406524658	O
33402	streptavidin	43 54	138384 138395	0.999988317489624	O
33407	-	55 56	138396 138397	0.9999886751174927	O
33408	Cy3	56 58	138397 138399	0.9999877214431763	O
33410	,	60 61	138401 138402	0.9999861717224121	O
33411	and	62 65	138403 138406	0.9999867677688599	O
33412	then	66 70	138407 138411	0.9999843835830688	O
33413	scanned	71 78	138412 138419	0.999981164932251	O
33414	with	79 83	138420 138424	0.9999872446060181	O
33415	an	84 86	138425 138427	0.9999885559082031	O
33416	Illumina	87 94	138428 138435	0.9999880790710449	O
33419	BeadArray	96 104	138437 138445	0.9999876022338867	O
33424	Scanner	106 112	138447 138453	0.999987006187439	O
33427	.	114 115	138455 138456	0.9999619722366333	O
33428	Duplicate	0 8	138457 138465	0.9999878406524658	O
33430	arrays	10 15	138467 138472	0.999982476234436	O
33432	were	17 21	138474 138478	0.9999884366989136	O
33433	performed	22 31	138479 138488	0.9999877214431763	O
33434	for	32 35	138489 138492	0.999988317489624	O
33435	eight	36 41	138493 138498	0.9999808073043823	O
33436	cell	42 46	138499 138503	0.9999748468399048	O
33437	lines	47 52	138504 138509	0.999984622001648	O
33438	across	53 59	138510 138516	0.9999879598617554	O
33439	the	60 63	138517 138520	0.9999890327453613	O
33440	different	64 73	138521 138530	0.9999878406524658	O
33441	groups	74 80	138531 138537	0.999985933303833	O
33442	for	81 84	138538 138541	0.9999884366989136	O
33443	quality	85 92	138542 138549	0.9999885559082031	O
33444	control	93 100	138550 138557	0.9999880790710449	O
33445	purposes	101 109	138558 138566	0.9999880790710449	O
33446	,	110 111	138567 138568	0.9999876022338867	O
33447	with	112 116	138569 138573	0.999988317489624	O
33448	duplicates	117 126	138574 138583	0.9999890327453613	O
33451	performed	128 137	138585 138594	0.9999890327453613	O
33452	on	138 140	138595 138597	0.9999895095825195	O
33453	different	141 150	138598 138607	0.9999889135360718	O
33454	days	151 155	138608 138612	0.9999872446060181	O
33455	.	156 157	138613 138614	0.9999740123748779	O
33456	All	0 3	138615 138618	0.9999874830245972	O
33457	duplicate	4 12	138619 138627	0.9999872446060181	O
33459	arrays	14 19	138629 138634	0.9999834299087524	O
33461	showed	21 27	138636 138642	0.9999876022338867	O
33462	highest	28 35	138643 138650	0.9999874830245972	O
33463	correlation	36 47	138651 138662	0.9999874830245972	O
33464	with	48 52	138663 138667	0.9999887943267822	O
33465	each	53 57	138668 138672	0.9999874830245972	O
33466	other	58 63	138673 138678	0.9999873638153076	O
33467	(	64 65	138679 138680	0.99998939037323	O
33468	correlation	66 77	138681 138692	0.9999881982803345	O
33469	>	78 79	138693 138694	0.9999889135360718	O
33470	0	79 80	138694 138695	0.99998939037323	O
33471	.	80 81	138695 138696	0.9999891519546509	O
33472	98	81 83	138696 138698	0.9999868869781494	O
33473	)	84 85	138699 138700	0.9999891519546509	O
33474	.	86 87	138701 138702	0.9999717473983765	O
33475	Duplicate	0 8	138703 138711	0.9999746084213257	O
33477	samples	10 17	138713 138720	0.9999773502349854	O
33478	were	18 22	138721 138725	0.9999783039093018	O
33479	not	23 26	138726 138729	0.9999747276306152	O
33480	included	27 35	138730 138738	0.9999836683273315	O
33481	in	36 38	138739 138741	0.9999816417694092	O
33482	analysis	39 47	138742 138750	0.9999809265136719	O
33483	.	48 49	138751 138752	0.9998588562011719	O
33484	Comparative	0 11	138753 138764	0.9999867677688599	O
33485	real	12 16	138765 138769	0.9999889135360718	O
33486	-	16 17	138769 138770	0.9999891519546509	O
33487	time	17 21	138770 138774	0.9999885559082031	O
33488	PCR	22 24	138775 138777	0.9999880790710449	O
33490	was	26 29	138779 138782	0.9999884366989136	O
33491	performed	30 39	138783 138792	0.9999884366989136	O
33492	for	40 43	138793 138796	0.9999890327453613	O
33493	ten	44 47	138797 138800	0.9999855756759644	O
33494	genes	48 53	138801 138806	0.9999865293502808	O
33495	on	54 56	138807 138809	0.9999895095825195	O
33496	6	57 58	138810 138811	0.9999890327453613	O
33497	–	58 59	138811 138812	0.9999860525131226	O
33498	8	59 60	138812 138813	0.9999872446060181	O
33499	samples	61 68	138814 138821	0.999988317489624	O
33500	,	69 70	138822 138823	0.9999890327453613	O
33501	using	71 76	138824 138829	0.9999892711639404	O
33502	GAPDH	77 81	138830 138834	0.999988317489624	O
33505	to	83 85	138836 138838	0.9999897480010986	O
33506	normalise	86 94	138839 138847	0.999988317489624	O
33508	all	96 99	138849 138852	0.9999895095825195	O
33509	data	100 104	138853 138857	0.9999880790710449	O
33510	,	105 106	138858 138859	0.9999881982803345	O
33511	and	107 110	138860 138863	0.9999890327453613	O
33512	the	111 114	138864 138867	0.99998939037323	O
33513	comparative	115 126	138868 138879	0.9999892711639404	O
33514	cycle	127 132	138880 138885	0.9999892711639404	O
33515	threshold	133 142	138886 138895	0.99998939037323	O
33516	method	143 149	138896 138902	0.9999892711639404	O
33517	for	150 153	138903 138906	0.99998939037323	O
33518	analysis	154 162	138907 138915	0.9999891519546509	O
33519	.	163 164	138916 138917	0.9999771118164062	O
33520	Paired	0 5	138918 138923	0.9999852180480957	O
33522	student	7 14	138925 138932	0.9999797344207764	O
33523	t	15 16	138933 138934	0.9999827146530151	O
33524	tests	17 22	138935 138940	0.9999821186065674	O
33525	were	23 27	138941 138945	0.9999821186065674	O
33526	performed	28 37	138946 138955	0.9999822378158569	O
33527	to	38 40	138956 138958	0.999984622001648	O
33528	determine	41 50	138959 138968	0.999984622001648	O
33529	the	51 54	138969 138972	0.999987006187439	O
33530	significance	55 67	138973 138985	0.999984622001648	O
33531	of	68 70	138986 138988	0.9999865293502808	O
33532	gene	71 75	138989 138993	0.999984622001648	O
33533	expression	76 86	138994 139004	0.9999839067459106	O
33534	changes	87 94	139005 139012	0.9999833106994629	O
33535	.	95 96	139013 139014	0.9999316930770874	O
33536	Expression	0 9	139015 139024	0.9999808073043823	O
33538	differences	11 22	139026 139037	0.9999792575836182	O
33539	were	23 27	139038 139042	0.9999825954437256	O
33540	validated	28 36	139043 139051	0.9999808073043823	O
33542	for	38 41	139053 139056	0.999984622001648	O
33543	8	42 43	139057 139058	0.9999812841415405	O
33544	/	43 44	139058 139059	0.9999856948852539	O
33545	10	44 46	139059 139061	0.9999778270721436	O
33546	genes	47 52	139062 139067	0.9999814033508301	O
33547	tested	53 59	139068 139074	0.9999834299087524	O
33548	.	60 61	139075 139076	0.999940037727356	O
33549	Data	0 4	139077 139081	0.9999878406524658	O
33550	Analysis	5 13	139082 139090	0.9999887943267822	O
33551	Raw	14 17	139091 139094	0.9999877214431763	O
33552	data	18 22	139095 139099	0.9999884366989136	O
33553	was	23 26	139100 139103	0.99998939037323	O
33554	imported	27 35	139104 139112	0.9999890327453613	O
33555	into	36 40	139113 139117	0.9999898672103882	O
33556	Illumina	41 48	139118 139125	0.9999895095825195	O
33559	Beadstudio	50 59	139127 139136	0.99998939037323	O
33563	and	61 64	139138 139141	0.9999896287918091	O
33564	then	65 69	139142 139146	0.9999887943267822	O
33565	exported	70 78	139147 139155	0.9999892711639404	O
33566	into	79 83	139156 139160	0.9999898672103882	O
33567	Genespring	84 93	139161 139170	0.9999891519546509	O
33570	v7	95 96	139172 139173	0.9999896287918091	O
33572	.	97 98	139174 139175	0.9999896287918091	O
33573	3	98 99	139175 139176	0.9999891519546509	O
33574	(	100 101	139177 139178	0.9999899864196777	O
33575	Agilent	102 108	139179 139185	0.9999896287918091	O
33578	Technologies	110 122	139187 139199	0.9999886751174927	O
33579	,	123 124	139200 139201	0.99998939037323	O
33580	Forest	125 131	139202 139208	0.999987006187439	O
33581	Hill	132 136	139209 139213	0.9999879598617554	O
33582	,	137 138	139214 139215	0.99998939037323	O
33583	VIC	139 141	139216 139218	0.9999874830245972	O
33585	)	143 144	139220 139221	0.9999899864196777	O
33586	for	145 148	139222 139225	0.9999892711639404	O
33587	further	149 156	139226 139233	0.9999887943267822	O
33588	analysis	157 165	139234 139242	0.9999889135360718	O
33589	.	166 167	139243 139244	0.9999808073043823	O
33590	Data	0 4	139245 139249	0.9999810457229614	O
33591	was	5 8	139250 139253	0.9999873638153076	O
33592	normalised	9 18	139254 139263	0.9999871253967285	O
33594	(	20 21	139265 139266	0.9999895095825195	O
33595	per	22 25	139267 139270	0.9999892711639404	O
33596	chip	26 30	139271 139275	0.9999865293502808	O
33597	normalized	31 40	139276 139285	0.9999892711639404	O
33599	to	42 44	139287 139289	0.99998939037323	O
33600	50th	45 49	139290 139294	0.9999884366989136	O
33601	percentile	50 59	139295 139304	0.9999891519546509	O
33603	and	61 64	139306 139309	0.9999891519546509	O
33604	per	65 68	139310 139313	0.9999892711639404	O
33605	gene	69 73	139314 139318	0.999987006187439	O
33606	normalized	74 83	139319 139328	0.9999890327453613	O
33608	to	85 87	139330 139332	0.9999892711639404	O
33609	median	88 94	139333 139339	0.9999874830245972	O
33610	)	95 96	139340 139341	0.9999895095825195	O
33611	and	97 100	139342 139345	0.9999885559082031	O
33612	filtered	101 109	139346 139354	0.999984860420227	O
33613	using	110 115	139355 139360	0.9999895095825195	O
33614	an	116 118	139361 139363	0.9999895095825195	O
33615	Illumina	119 126	139364 139371	0.9999887943267822	O
33618	detection	128 137	139373 139382	0.9999891519546509	O
33619	score	138 143	139383 139388	0.9999892711639404	O
33620	of	144 146	139389 139391	0.9999892711639404	O
33621	>	147 148	139392 139393	0.9999892711639404	O
33622	0	148 149	139393 139394	0.9999891519546509	O
33623	.	149 150	139394 139395	0.99998939037323	O
33624	99	150 152	139395 139397	0.9999874830245972	O
33625	in	153 155	139398 139400	0.9999895095825195	O
33626	at	156 158	139401 139403	0.99998939037323	O
33627	least	159 164	139404 139409	0.9999895095825195	O
33628	one	165 168	139410 139413	0.9999890327453613	O
33629	sample	169 175	139414 139420	0.9999884366989136	O
33630	,	176 177	139421 139422	0.9999890327453613	O
33631	which	178 183	139423 139428	0.9999895095825195	O
33632	yielded	184 191	139429 139436	0.9999895095825195	O
33633	20	192 194	139437 139439	0.9999880790710449	O
33634	,	194 195	139439 139440	0.9999889135360718	O
33635	874	195 197	139440 139442	0.9999884366989136	O
33637	probes	199 204	139444 139449	0.9999866485595703	O
33639	that	206 210	139451 139455	0.9999890327453613	O
33640	were	211 215	139456 139460	0.9999889135360718	O
33641	used	216 220	139461 139465	0.999988317489624	O
33642	in	221 223	139466 139468	0.9999886751174927	O
33643	all	224 227	139469 139472	0.9999887943267822	O
33644	further	228 235	139473 139480	0.9999877214431763	O
33645	analyses	236 244	139481 139489	0.9999867677688599	O
33646	.	245 246	139490 139491	0.9999673366546631	O
33647	The	0 3	139492 139495	0.9999871253967285	O
33648	majority	4 12	139496 139504	0.999985933303833	O
33649	of	13 15	139505 139507	0.9999878406524658	O
33650	these	16 21	139508 139513	0.9999861717224121	O
33651	probes	22 27	139514 139519	0.9999829530715942	O
33653	used	29 33	139521 139525	0.9999852180480957	O
33654	in	34 36	139526 139528	0.9999871253967285	O
33655	the	37 40	139529 139532	0.9999880790710449	O
33656	analysis	41 49	139533 139541	0.9999840259552002	O
33657	were	50 54	139542 139546	0.9999879598617554	O
33658	designed	55 63	139547 139555	0.9999877214431763	O
33659	by	64 66	139556 139558	0.9999884366989136	O
33660	Illumina	67 74	139559 139566	0.9999881982803345	O
33663	to	76 78	139568 139570	0.9999886751174927	O
33664	assay	79 83	139571 139575	0.9999887943267822	O
33666	the	85 88	139577 139580	0.9999889135360718	O
33667	curated	89 96	139581 139588	0.9999401569366455	O
33668	portion	97 104	139589 139596	0.9999881982803345	O
33669	of	105 107	139597 139599	0.9999889135360718	O
33670	the	108 111	139600 139603	0.9999890327453613	O
33671	NIH	112 114	139604 139606	0.9999864101409912	O
33674	Ref	116 118	139608 139610	0.9999889135360718	O
33676	sequence	120 128	139612 139620	0.999988317489624	O
33677	database	129 137	139621 139629	0.9999887943267822	O
33678	-	137 138	139629 139630	0.9999896287918091	O
33679	16	138 140	139630 139632	0.9999880790710449	O
33680	,	140 141	139632 139633	0.9999889135360718	O
33681	923	141 143	139633 139635	0.9999879598617554	O
33683	were	145 149	139637 139641	0.9999885559082031	O
33684	present	150 157	139642 139649	0.9999892711639404	O
33685	in	158 160	139650 139652	0.9999891519546509	O
33686	the	161 164	139653 139656	0.9999890327453613	O
33687	Ref	165 167	139657 139659	0.9999890327453613	O
33689	sequence	169 177	139661 139669	0.999988317489624	O
33690	database	178 186	139670 139678	0.9999885559082031	O
33691	,	187 188	139679 139680	0.9999889135360718	O
33692	comprising	189 199	139681 139691	0.9999890327453613	O
33693	65	200 202	139692 139694	0.9999830722808838	O
33694	%	203 204	139695 139696	0.9999892711639404	O
33695	of	205 207	139697 139699	0.9999892711639404	O
33696	all	208 211	139700 139703	0.9999890327453613	O
33697	Ref	212 214	139704 139706	0.9999887943267822	O
33699	sequence	216 224	139708 139716	0.9999886751174927	O
33700	-	224 225	139716 139717	0.9999892711639404	O
33701	listed	225 231	139717 139723	0.9999878406524658	O
33702	probes	232 237	139724 139729	0.9999861717224121	O
33704	on	239 241	139731 139733	0.9999876022338867	O
33705	the	242 245	139734 139737	0.9999889135360718	O
33706	array	246 251	139738 139743	0.9999823570251465	O
33707	.	252 253	139744 139745	0.99996018409729	O
33708	Transcripts	0 10	139746 139756	0.999987006187439	O
33710	which	12 17	139758 139763	0.9999881982803345	O
33711	had	18 21	139764 139767	0.9999886751174927	O
33712	a	22 23	139768 139769	0.9999890327453613	O
33713	>	24 25	139770 139771	0.9999886751174927	O
33714	2	25 26	139771 139772	0.999988317489624	O
33715	-	26 27	139772 139773	0.9999890327453613	O
33716	fold	27 31	139773 139777	0.9999880790710449	O
33717	change	32 38	139778 139784	0.9999877214431763	O
33718	versus	39 45	139785 139791	0.9999880790710449	O
33719	the	46 49	139792 139795	0.9999891519546509	O
33720	mean	50 54	139796 139800	0.9999852180480957	O
33721	were	55 59	139801 139805	0.9999886751174927	O
33722	visualised	60 69	139806 139815	0.9999872446060181	O
33724	using	71 76	139817 139822	0.9999892711639404	O
33725	unsupervised	77 88	139823 139834	0.999988317489624	O
33730	Hierarchical	90 101	139836 139847	0.9999885559082031	O
33734	Clustering	103 112	139849 139858	0.9999887943267822	O
33737	(	114 115	139860 139861	0.9999895095825195	O
33738	Figures	116 122	139862 139868	0.9999866485595703	O
33740	1	124 125	139870 139871	0.99998939037323	O
33741	and	126 129	139872 139875	0.9999881982803345	O
33742	2	130 131	139876 139877	0.9999884366989136	O
33743	)	132 133	139878 139879	0.9999895095825195	O
33744	.	134 135	139880 139881	0.9999791383743286	O
33745	The	0 3	139882 139885	0.9999814033508301	O
33746	clustering	4 13	139886 139895	0.9999839067459106	O
33748	method	15 21	139897 139903	0.9999858140945435	O
33749	used	22 26	139904 139908	0.9999790191650391	O
33750	was	27 30	139909 139912	0.9999854564666748	O
33751	a	31 32	139913 139914	0.999988317489624	O
33752	Pearson	33 40	139915 139922	0.9999837875366211	O
33753	correlation	41 52	139923 139934	0.9999874830245972	O
33754	similarity	53 63	139935 139945	0.9999858140945435	O
33755	measure	64 71	139946 139953	0.9999884366989136	O
33756	with	72 76	139954 139958	0.9999878406524658	O
33757	an	77 79	139959 139961	0.9999890327453613	O
33758	average	80 87	139962 139969	0.999985933303833	O
33759	linkage	88 94	139970 139976	0.9999881982803345	O
33761	clustering	96 105	139978 139987	0.999988317489624	O
33763	algorithm	107 116	139989 139998	0.999988317489624	O
33764	.	117 118	139999 140000	0.9999617338180542	O
33765	Two	0 3	140001 140004	0.9999865293502808	O
33766	different	4 13	140005 140014	0.9999862909317017	O
33767	methods	14 21	140015 140022	0.999985933303833	O
33768	were	22 26	140023 140027	0.9999876022338867	O
33769	used	27 31	140028 140032	0.9999866485595703	O
33770	to	32 34	140033 140035	0.999988317489624	O
33771	classify	35 42	140036 140043	0.9999866485595703	O
33773	LCLs	44 47	140045 140048	0.9999816417694092	O
33776	based	49 54	140050 140055	0.9999891519546509	O
33777	on	55 57	140056 140058	0.9999892711639404	O
33778	mutation	58 66	140059 140067	0.9999867677688599	O
33779	status	67 73	140068 140074	0.9999890327453613	O
33780	:	74 75	140075 140076	0.99998939037323	O
33781	(	76 77	140077 140078	0.99998939037323	O
33782	1	78 79	140079 140080	0.9999886751174927	O
33783	)	80 81	140081 140082	0.9999896287918091	O
33784	A	82 83	140083 140084	0.9999895095825195	O
33785	multi	84 89	140085 140090	0.9999881982803345	O
33786	comparison	90 100	140091 140101	0.9999880790710449	O
33787	Gaussian	101 108	140102 140109	0.9999887943267822	O
33790	Process	110 117	140111 140118	0.9999879598617554	O
33791	Classifier	118 127	140119 140128	0.9999879598617554	O
33793	(	129 130	140130 140131	0.9999892711639404	O
33794	GPC	131 133	140132 140134	0.9999873638153076	O
33796	)	135 136	140136 140137	0.9999896287918091	O
33797	[	137 138	140138 140139	0.9999892711639404	O
33798	42	138 140	140139 140141	0.9999873638153076	O
33799	]	140 141	140141 140142	0.9999892711639404	O
33800	with	142 146	140143 140147	0.99998939037323	O
33801	Leave	147 152	140148 140153	0.9999885559082031	O
33802	-	152 153	140153 140154	0.9999895095825195	O
33803	One	153 156	140154 140157	0.9999890327453613	O
33804	-	156 157	140157 140158	0.99998939037323	O
33805	Out	157 160	140158 140161	0.9999889135360718	O
33806	cross	161 166	140162 140167	0.9999890327453613	O
33807	-	166 167	140167 140168	0.99998939037323	O
33808	validation	167 176	140168 140177	0.9999880790710449	O
33810	to	178 180	140179 140181	0.9999892711639404	O
33811	determine	181 190	140182 140191	0.9999887943267822	O
33812	the	191 194	140192 140195	0.99998939037323	O
33813	prediction	195 205	140196 140206	0.9999881982803345	O
33814	errors	206 212	140207 140213	0.9999881982803345	O
33815	,	213 214	140214 140215	0.9999886751174927	O
33816	as	215 217	140216 140218	0.9999886751174927	O
33817	previously	218 228	140219 140229	0.9999876022338867	O
33818	used	229 233	140230 140234	0.9999886751174927	O
33819	to	234 236	140235 140237	0.9999890327453613	O
33820	predict	237 244	140238 140245	0.9999878406524658	O
33821	BRCA1	245 249	140246 140250	0.9999881982803345	O
33824	/	250 251	140251 140252	0.9999889135360718	O
33825	BRCA2	251 255	140252 140256	0.9999878406524658	O
33828	mutation	257 265	140258 140266	0.9999871253967285	O
33829	status	266 272	140267 140273	0.9999889135360718	O
33830	of	273 275	140274 140276	0.9999890327453613	O
33831	irradiated	276 285	140277 140286	0.9999874830245972	O
33835	fibroblasts	287 297	140288 140298	0.999985933303833	O
33839	[	299 300	140300 140301	0.9999891519546509	O
33840	31	300 302	140301 140303	0.9999868869781494	O
33841	]	302 303	140303 140304	0.9999890327453613	O
33842	;	304 305	140305 140306	0.9999892711639404	O
33843	(	306 307	140307 140308	0.99998939037323	O
33844	2	308 309	140309 140310	0.9999880790710449	O
33845	)	310 311	140311 140312	0.9999897480010986	O
33846	A	312 313	140313 140314	0.9999896287918091	O
33847	linear	314 320	140315 140321	0.9999853372573853	O
33848	classification	321 335	140322 140336	0.9999884366989136	O
33849	method	336 342	140337 140343	0.9999890327453613	O
33850	commonly	343 351	140344 140352	0.9999886751174927	O
33851	used	352 356	140353 140357	0.9999889135360718	O
33852	for	357 360	140358 140361	0.9999890327453613	O
33853	classification	361 375	140362 140376	0.9999880790710449	O
33854	of	376 378	140377 140379	0.9999892711639404	O
33855	microarray	379 388	140380 140389	0.9999872446060181	O
33858	data	390 394	140391 140395	0.9999866485595703	O
33859	,	395 396	140396 140397	0.9999892711639404	O
33860	Support	397 404	140398 140405	0.9999868869781494	O
33861	Vector	405 410	140406 140411	0.9999879598617554	O
33863	Machines	412 419	140413 140420	0.9999828338623047	O
33865	(	421 422	140422 140423	0.99998939037323	O
33866	SVM	423 425	140424 140426	0.9999849796295166	O
33868	)	427 428	140428 140429	0.9999895095825195	O
33869	[	429 430	140430 140431	0.9999890327453613	O
33870	43	430 432	140431 140433	0.9999868869781494	O
33871	]	432 433	140433 140434	0.9999891519546509	O
33872	with	434 438	140435 140439	0.9999892711639404	O
33873	Leave	439 444	140440 140445	0.9999884366989136	O
33874	-	444 445	140445 140446	0.9999896287918091	O
33875	One	445 448	140446 140449	0.9999890327453613	O
33876	-	448 449	140449 140450	0.99998939037323	O
33877	Out	449 452	140450 140453	0.9999890327453613	O
33878	cross	453 458	140454 140459	0.9999890327453613	O
33879	validation	459 468	140460 140469	0.9999885559082031	O
33881	.	470 471	140471 140472	0.9999819993972778	O
33882	The	0 3	140473 140476	0.9999880790710449	O
33883	GPC	4 6	140477 140479	0.9999845027923584	O
33885	analysis	8 16	140481 140489	0.9999885559082031	O
33886	used	17 21	140490 140494	0.9999884366989136	O
33887	2031	22 25	140495 140498	0.999987006187439	O
33889	genes	27 32	140500 140505	0.9999876022338867	O
33890	which	33 38	140506 140511	0.9999889135360718	O
33891	were	39 43	140512 140516	0.9999886751174927	O
33892	derived	44 51	140517 140524	0.9999885559082031	O
33893	from	52 56	140525 140529	0.9999885559082031	O
33894	a	57 58	140530 140531	0.9999889135360718	O
33895	t	59 60	140532 140533	0.9999884366989136	O
33896	-	60 61	140533 140534	0.9999889135360718	O
33897	test	61 65	140534 140538	0.9999884366989136	O
33898	to	66 68	140539 140541	0.9999889135360718	O
33899	select	69 75	140542 140548	0.9999878406524658	O
33900	the	76 79	140549 140552	0.9999887943267822	O
33901	genes	80 85	140553 140558	0.9999879598617554	O
33902	that	86 90	140559 140563	0.9999887943267822	O
33903	were	91 95	140564 140568	0.9999887943267822	O
33904	significantly	96 109	140569 140582	0.9999887943267822	O
33905	over	110 114	140583 140587	0.9999886751174927	O
33906	/	114 115	140587 140588	0.9999881982803345	O
33907	under	115 120	140588 140593	0.9999873638153076	O
33908	-	120 121	140593 140594	0.9999886751174927	O
33909	expressed	121 130	140594 140603	0.9999880790710449	O
33910	at	131 133	140604 140606	0.9999884366989136	O
33911	the	134 137	140607 140610	0.9999890327453613	O
33912	5	138 139	140611 140612	0.9999880790710449	O
33913	%	140 141	140613 140614	0.9999887943267822	O
33914	significance	142 154	140615 140627	0.9999886751174927	O
33915	,	155 156	140628 140629	0.9999890327453613	O
33916	while	157 162	140630 140635	0.9999889135360718	O
33917	the	163 166	140636 140639	0.9999890327453613	O
33918	SVM	167 169	140640 140642	0.9999862909317017	O
33920	used	171 175	140644 140648	0.9999881982803345	O
33921	genes	176 181	140649 140654	0.9999881982803345	O
33922	from	182 186	140655 140659	0.9999881982803345	O
33923	the	187 190	140660 140663	0.9999887943267822	O
33924	20	191 193	140664 140666	0.9999876022338867	O
33925	,	193 194	140666 140667	0.9999887943267822	O
33926	874	194 196	140667 140669	0.9999873638153076	O
33928	detected	198 206	140671 140679	0.9999880790710449	O
33929	probes	207 212	140680 140685	0.9999873638153076	O
33931	which	214 219	140687 140692	0.9999886751174927	O
33932	differed	220 228	140693 140701	0.9999885559082031	O
33933	between	229 236	140702 140709	0.9999884366989136	O
33934	groups	237 243	140710 140716	0.9999874830245972	O
33935	of	244 246	140717 140719	0.9999881982803345	O
33936	LCLs	247 250	140720 140723	0.9999860525131226	O
33939	using	252 257	140725 140730	0.9999887943267822	O
33940	a	258 259	140731 140732	0.9999887943267822	O
33941	t	260 261	140733 140734	0.9999881982803345	O
33942	-	261 262	140734 140735	0.9999889135360718	O
33943	test	262 266	140735 140739	0.9999884366989136	O
33944	p	267 268	140740 140741	0.9999885559082031	O
33945	of	269 271	140742 140744	0.9999884366989136	O
33946	0	272 273	140745 140746	0.9999886751174927	O
33947	.	273 274	140746 140747	0.9999885559082031	O
33948	05	274 276	140747 140749	0.9999879598617554	O
33949	.	277 278	140750 140751	0.999970555305481	O
33950	All	0 3	140752 140755	0.9999878406524658	O
33951	resulting	4 13	140756 140765	0.9999854564666748	O
33952	gene	14 18	140766 140770	0.9999819993972778	O
33953	lists	19 24	140771 140776	0.9999850988388062	O
33954	are	25 28	140777 140780	0.9999872446060181	O
33955	available	29 38	140781 140790	0.9999874830245972	O
33956	as	39 41	140791 140793	0.9999877214431763	O
33957	supplementary	42 54	140794 140806	0.9999849796295166	O
33959	data	56 60	140808 140812	0.9999879598617554	O
33960	and	61 64	140813 140816	0.9999879598617554	O
33961	all	65 68	140817 140820	0.9999886751174927	O
33962	data	69 73	140821 140825	0.9999868869781494	O
33963	is	74 76	140826 140828	0.9999884366989136	O
33964	available	77 86	140829 140838	0.9999887943267822	O
33965	via	87 90	140839 140842	0.9999881982803345	O
33966	GEO	91 93	140843 140845	0.9999860525131226	O
33968	:	95 96	140847 140848	0.9999887943267822	O
33969	Accession	97 105	140849 140857	0.9999880790710449	O
33971	number	107 113	140859 140865	0.9999879598617554	O
33972	GSE10905	114 121	140866 140873	0.9999879598617554	O
33977	.	123 124	140875 140876	0.9999890327453613	O
33978	*	125 126	140877 140878	0.9999889135360718	O
33979	*	126 127	140878 140879	0.9999849796295166	O
33980	IGNORE	0 5	140880 140885	0.9999855756759644	O
33983	LINE	7 10	140887 140890	0.9999880790710449	O
33986	*	12 13	140892 140893	0.999988317489624	O
33987	*	13 14	140893 140894	0.9999880790710449	O
33988	*	15 16	140895 140896	0.9999881982803345	O
33989	*	16 17	140896 140897	0.999988317489624	O
33990	IGNORE	18 23	140898 140903	0.999987006187439	O
33993	LINE	25 28	140905 140908	0.9999886751174927	O
33996	*	30 31	140910 140911	0.9999880790710449	O
33997	*	31 32	140911 140912	0.9999880790710449	O
33998	*	33 34	140913 140914	0.9999879598617554	O
33999	*	34 35	140914 140915	0.9999878406524658	O
34000	IGNORE	36 41	140916 140921	0.9999865293502808	O
34003	LINE	43 46	140923 140926	0.999988317489624	O
34006	*	48 49	140928 140929	0.9999880790710449	O
34007	*	49 50	140929 140930	0.9999881982803345	O
34008	In	51 53	140931 140933	0.9999868869781494	O
34009	the	54 57	140934 140937	0.9999861717224121	O
34010	present	58 65	140938 140945	0.9999853372573853	O
34011	study	66 71	140946 140951	0.9999868869781494	O
34012	patients	72 80	140952 140960	0.9999793767929077	O
34013	included	81 89	140961 140969	0.9999873638153076	O
34014	in	90 92	140970 140972	0.9999874830245972	O
34015	the	93 96	140973 140976	0.9999860525131226	O
34016	Swedish	97 104	140977 140984	0.993000864982605	O
34017	Polyposis	105 113	140985 140993	0.9999839067459106	O
34021	Registry	115 122	140995 141002	0.9999865293502808	O
34023	were	124 128	141004 141008	0.9999858140945435	O
34024	subjected	129 138	141009 141018	0.9999864101409912	O
34025	to	139 141	141019 141021	0.9999878406524658	O
34026	a	142 143	141022 141023	0.9999879598617554	O
34027	thorough	144 152	141024 141032	0.999985933303833	O
34028	clinical	153 161	141033 141041	0.9999814033508301	O
34029	characterization	162 178	141042 141058	0.9999874830245972	O
34030	and	179 182	141059 141062	0.9999881982803345	O
34031	mutational	183 192	141063 141072	0.9999837875366211	O
34033	screening	194 203	141074 141083	0.9999872446060181	O
34034	of	204 206	141084 141086	0.9999881982803345	O
34035	the	207 210	141087 141090	0.9999876022338867	O
34036	APC	211 213	141091 141093	0.9999808073043823	O
34038	gene	215 219	141095 141099	0.999987006187439	O
34039	including	220 229	141100 141109	0.9999880790710449	O
34040	screening	230 239	141110 141119	0.9999877214431763	O
34041	for	240 243	141120 141123	0.9999880790710449	O
34042	large	244 249	141124 141129	0.9999808073043823	O
34043	deletions	250 258	141130 141138	0.9999881982803345	O
34046	and	260 263	141140 141143	0.9999881982803345	O
34047	detection	264 273	141144 141153	0.9999876022338867	O
34048	of	274 276	141154 141156	0.9999885559082031	O
34049	low	277 280	141157 141160	0.9999872446060181	O
34050	-	280 281	141160 141161	0.9999880790710449	O
34051	frequency	281 290	141161 141170	0.9999874830245972	O
34052	alleles	291 297	141171 141177	0.9999877214431763	O
34055	caused	299 305	141179 141185	0.999988317489624	O
34056	by	306 308	141186 141188	0.9999881982803345	O
34057	germline	309 316	141189 141196	0.9999877214431763	O
34061	mosaicism	318 326	141198 141206	0.999985933303833	O
34063	.	328 329	141208 141209	0.9999282360076904	O
34064	Sixty	0 4	141210 141214	0.9999731779098511	O
34066	-	5 6	141215 141216	0.9999830722808838	O
34067	one	6 9	141216 141219	0.9999786615371704	O
34068	mutations	10 19	141220 141229	0.9999707937240601	O
34069	,	20 21	141230 141231	0.999984860420227	O
34070	including	22 31	141232 141241	0.9999853372573853	O
34071	27	32 34	141242 141244	0.9999732971191406	O
34072	not	35 38	141245 141248	0.9999850988388062	O
34073	described	39 48	141249 141258	0.9999831914901733	O
34074	previously	49 59	141259 141269	0.9999819993972778	O
34075	,	60 61	141270 141271	0.999980092048645	O
34076	are	62 65	141272 141275	0.9999797344207764	O
34077	reported	66 74	141276 141284	0.9999805688858032	O
34078	.	75 76	141285 141286	0.9998817443847656	O
34079	Among	0 5	141287 141292	0.9999865293502808	O
34080	the	6 9	141293 141296	0.9999874830245972	O
34081	characterized	10 23	141297 141310	0.9999781847000122	O
34082	mutations	24 33	141311 141320	0.999984622001648	O
34083	are	34 37	141321 141324	0.9999873638153076	O
34084	elusive	38 44	141325 141331	0.9999850988388062	O
34086	changes	46 53	141333 141340	0.9999861717224121	O
34087	such	54 58	141341 141345	0.9999878406524658	O
34088	as	59 61	141346 141348	0.9999887943267822	O
34089	a	62 63	141349 141350	0.999988317489624	O
34090	case	64 68	141351 141355	0.9999871253967285	O
34091	of	69 71	141356 141358	0.9999887943267822	O
34092	mosaicism	72 80	141359 141367	0.9999864101409912	O
34094	,	82 83	141369 141370	0.9999874830245972	O
34095	splicing	84 91	141371 141378	0.9999881982803345	O
34098	defects	93 100	141380 141387	0.9999891519546509	O
34099	,	101 102	141388 141389	0.999988317489624	O
34100	and	103 106	141390 141393	0.9999884366989136	O
34101	a	107 108	141394 141395	0.9999885559082031	O
34102	mutation	109 117	141396 141404	0.9999874830245972	O
34103	in	118 120	141405 141407	0.9999892711639404	O
34104	APC	121 123	141408 141410	0.9999864101409912	O
34106	exon	125 128	141412 141415	0.9999895095825195	O
34108	1	130 131	141417 141418	0.9999891519546509	O
34109	which	132 137	141419 141424	0.9999889135360718	O
34110	is	138 140	141425 141427	0.9999886751174927	O
34111	the	141 144	141428 141431	0.9999890327453613	O
34112	most	145 149	141432 141436	0.9999881982803345	O
34113	5	150 151	141437 141438	0.999988317489624	O
34114	'	151 152	141438 141439	0.9999876022338867	O
34115	APC	153 155	141440 141442	0.9999868869781494	O
34117	mutation	157 165	141444 141452	0.999988317489624	O
34118	hitherto	166 173	141453 141460	0.9999865293502808	O
34121	reported	175 183	141462 141470	0.9999855756759644	O
34122	.	184 185	141471 141472	0.9999572038650513	O
34123	The	0 3	141473 141476	0.9999855756759644	O
34124	detection	4 13	141477 141486	0.9999840259552002	O
34125	of	14 16	141487 141489	0.9999867677688599	O
34126	reduced	17 24	141490 141497	0.9999784231185913	O
34127	APC	25 27	141498 141500	0.9999783039093018	O
34129	expression	29 39	141502 141512	0.9999843835830688	O
34130	in	40 42	141513 141515	0.9999872446060181	O
34131	one	43 46	141516 141519	0.9999842643737793	O
34132	family	47 53	141520 141526	0.9999755620956421	O
34133	is	54 56	141527 141529	0.9999830722808838	O
34134	also	57 61	141530 141534	0.9999841451644897	O
34135	described	62 71	141535 141544	0.999982476234436	O
34136	.	72 73	141545 141546	0.9999392032623291	O
34137	A	0 1	141547 141548	0.9999867677688599	O
34138	combination	2 13	141549 141560	0.9999834299087524	O
34139	of	14 16	141561 141563	0.999987006187439	O
34140	mutation	17 25	141564 141572	0.999984860420227	O
34141	screening	26 35	141573 141582	0.9999865293502808	O
34142	techniques	36 46	141583 141593	0.999984860420227	O
34143	was	47 50	141594 141597	0.9999855756759644	O
34144	used	51 55	141598 141602	0.9999860525131226	O
34145	to	56 58	141603 141605	0.9999877214431763	O
34146	achieve	59 66	141606 141613	0.9999880790710449	O
34147	as	67 69	141614 141616	0.999988317489624	O
34148	high	70 74	141617 141621	0.9999876022338867	O
34149	a	75 76	141622 141623	0.9999887943267822	O
34150	mutation	77 85	141624 141632	0.9999866485595703	O
34151	-	85 86	141632 141633	0.9999884366989136	O
34152	detection	86 95	141633 141642	0.9999881982803345	O
34153	frequency	96 105	141643 141652	0.9999887943267822	O
34154	as	106 108	141653 141655	0.9999877214431763	O
34155	possible	109 117	141656 141664	0.999988317489624	O
34156	.	118 119	141665 141666	0.9999879598617554	O
34157	*	120 121	141667 141668	0.9999871253967285	O
34158	*	121 122	141668 141669	0.9999784231185913	O
34159	IGNORE	0 5	141670 141675	0.9999865293502808	O
34162	LINE	7 10	141677 141680	0.9999889135360718	O
34165	*	12 13	141682 141683	0.99998939037323	O
34166	*	13 14	141683 141684	0.9999892711639404	O
34167	*	15 16	141685 141686	0.9999892711639404	O
34168	*	16 17	141686 141687	0.99998939037323	O
34169	IGNORE	18 23	141688 141693	0.9999880790710449	O
34172	LINE	25 28	141695 141698	0.9999892711639404	O
34175	*	30 31	141700 141701	0.9999890327453613	O
34176	*	31 32	141701 141702	0.9999890327453613	O
34177	*	33 34	141703 141704	0.9999890327453613	O
34178	*	34 35	141704 141705	0.9999890327453613	O
34179	IGNORE	36 41	141706 141711	0.9999877214431763	O
34182	LINE	43 46	141713 141716	0.9999891519546509	O
34185	*	48 49	141718 141719	0.9999891519546509	O
34186	*	49 50	141719 141720	0.9999891519546509	O
34187	Seven	51 56	141721 141726	0.9999843835830688	O
34188	of	57 59	141727 141729	0.9999890327453613	O
34189	the	60 63	141730 141733	0.9999890327453613	O
34190	identified	64 74	141734 141744	0.9999878406524658	O
34191	APC	75 77	141745 141747	0.999983549118042	O
34193	mutations	79 88	141749 141758	0.9999861717224121	O
34194	were	89 93	141759 141763	0.9999886751174927	O
34195	large	94 99	141764 141769	0.9999793767929077	O
34196	deletions	100 108	141770 141778	0.9999890327453613	O
34199	,	110 111	141780 141781	0.9999885559082031	O
34200	ranging	112 119	141782 141789	0.9999887943267822	O
34201	from	120 124	141790 141794	0.9999891519546509	O
34202	a	125 126	141795 141796	0.99998939037323	O
34203	deletion	127 134	141797 141804	0.9999895095825195	O
34206	of	136 138	141806 141808	0.9999895095825195	O
34207	86	139 141	141809 141811	0.9999889135360718	O
34208	bp	142 143	141812 141813	0.9999889135360718	O
34210	in	145 147	141815 141817	0.9999895095825195	O
34211	exon	148 151	141818 141821	0.9999895095825195	O
34213	15	153 155	141823 141825	0.9999872446060181	O
34214	to	156 158	141826 141828	0.9999892711639404	O
34215	a	159 160	141829 141830	0.9999892711639404	O
34216	deletion	161 168	141831 141838	0.9999892711639404	O
34219	of	170 172	141840 141842	0.9999892711639404	O
34220	the	173 176	141843 141846	0.9999895095825195	O
34221	whole	177 182	141847 141852	0.9999876022338867	O
34222	APC	183 185	141853 141855	0.9999871253967285	O
34224	gene	187 191	141857 141861	0.9999890327453613	O
34225	(	192 193	141862 141863	0.9999895095825195	O
34226	Figure	194 200	141864 141870	0.9999862909317017	O
34227	1C	201 202	141871 141872	0.9999885559082031	O
34229	)	203 204	141873 141874	0.9999896287918091	O
34230	.	205 206	141875 141876	0.9999715089797974	O
34231	Three	0 5	141877 141882	0.9999769926071167	O
34232	of	6 8	141883 141885	0.9999860525131226	O
34233	these	9 14	141886 141891	0.9999852180480957	O
34234	deletions	15 23	141892 141900	0.9999781847000122	O
34237	have	25 29	141902 141906	0.999984622001648	O
34238	not	30 33	141907 141910	0.9999841451644897	O
34239	,	34 35	141911 141912	0.9999860525131226	O
34240	to	36 38	141913 141915	0.9999853372573853	O
34241	the	39 42	141916 141919	0.9999873638153076	O
34242	best	43 47	141920 141924	0.9999873638153076	O
34243	of	48 50	141925 141927	0.9999872446060181	O
34244	the	51 54	141928 141931	0.9999867677688599	O
34245	authors	55 62	141932 141939	0.9999856948852539	O
34246	'	63 64	141940 141941	0.999987006187439	O
34247	knowledge	65 74	141942 141951	0.999984860420227	O
34248	,	75 76	141952 141953	0.9999853372573853	O
34249	been	77 81	141954 141958	0.9999868869781494	O
34250	described	82 91	141959 141968	0.9999864101409912	O
34251	earlier	92 99	141969 141976	0.9999836683273315	O
34252	.	100 101	141977 141978	0.9999605417251587	O
34253	The	0 3	141979 141982	0.9999864101409912	O
34254	deletion	4 11	141983 141990	0.9999866485595703	O
34257	encompassing	13 25	141992 142004	0.9999871253967285	O
34258	APC	26 28	142005 142007	0.9999814033508301	O
34260	exon	30 33	142009 142012	0.9999887943267822	O
34262	4	35 36	142014 142015	0.9999853372573853	O
34263	in	37 39	142016 142018	0.9999886751174927	O
34264	patient	40 47	142019 142026	0.9999855756759644	O
34265	3765	48 51	142027 142030	0.9999866485595703	O
34267	,	53 54	142032 142033	0.9999884366989136	O
34268	c	55 56	142034 142035	0.9999885559082031	O
34269	.	56 57	142035 142036	0.9999887943267822	O
34270	423	57 59	142036 142038	0.9999866485595703	O
34272	-	60 61	142039 142040	0.9999889135360718	O
34273	1662	61 64	142040 142043	0.9999861717224121	O
34275	_	65 66	142044 142045	0.9999879598617554	O
34276	531	66 68	142045 142047	0.9999867677688599	O
34278	+	69 70	142048 142049	0.999988317489624	O
34279	1825del3595	70 80	142049 142059	0.9999852180480957	O
34284	,	82 83	142061 142062	0.9999881982803345	O
34285	was	84 87	142063 142066	0.9999881982803345	O
34286	detected	88 96	142067 142075	0.9999886751174927	O
34287	by	97 99	142076 142078	0.9999887943267822	O
34288	RNA	100 103	142079 142082	0.9999864101409912	O
34289	-	103 104	142082 142083	0.9999889135360718	O
34290	based	104 109	142083 142088	0.9999878406524658	O
34291	PTT	110 112	142089 142091	0.9999856948852539	O
34293	with	114 118	142093 142097	0.9999862909317017	O
34294	subsequent	119 129	142098 142108	0.9999853372573853	O
34295	cDNA	130 133	142109 142112	0.999988317489624	O
34298	sequencing	135 144	142114 142123	0.9999865293502808	O
34300	and	146 149	142125 142128	0.9999874830245972	O
34301	verified	150 158	142129 142137	0.9999858140945435	O
34302	by	159 161	142138 142140	0.9999887943267822	O
34303	long	162 166	142141 142145	0.9999881982803345	O
34304	-	166 167	142145 142146	0.9999889135360718	O
34305	range	167 172	142146 142151	0.9999872446060181	O
34306	PCR	173 175	142152 142154	0.9999868869781494	O
34308	on	177 179	142156 142158	0.9999862909317017	O
34309	genomic	180 186	142159 142165	0.9999877214431763	O
34312	DNA	188 191	142167 142170	0.999985933303833	O
34313	.	192 193	142171 142172	0.999951958656311	O
34314	We	0 2	142173 142175	0.9999837875366211	O
34315	could	3 8	142176 142181	0.999985933303833	O
34316	not	9 12	142182 142185	0.9999852180480957	O
34317	detect	13 19	142186 142192	0.9999876022338867	O
34318	this	20 24	142193 142197	0.9999877214431763	O
34319	deletion	25 32	142198 142205	0.9999872446060181	O
34322	with	34 38	142207 142211	0.9999880790710449	O
34323	MLPA	39 42	142212 142215	0.9999879598617554	O
34326	even	44 48	142217 142221	0.9999884366989136	O
34327	though	49 55	142222 142228	0.9999887943267822	O
34328	a	56 57	142229 142230	0.9999892711639404	O
34329	probe	58 63	142231 142236	0.9999880790710449	O
34330	for	64 67	142237 142240	0.99998939037323	O
34331	exon	68 71	142241 142244	0.9999892711639404	O
34333	4	73 74	142246 142247	0.9999873638153076	O
34334	is	75 77	142248 142250	0.9999890327453613	O
34335	included	78 86	142251 142259	0.99998939037323	O
34336	in	87 89	142260 142262	0.9999891519546509	O
34337	the	90 93	142263 142266	0.9999892711639404	O
34338	MLPA	94 97	142267 142270	0.9999874830245972	O
34341	kit	99 102	142272 142275	0.9999884366989136	O
34342	(	103 104	142276 142277	0.99998939037323	O
34343	see	105 108	142278 142281	0.9999873638153076	O
34344	the	109 112	142282 142285	0.9999890327453613	O
34345	discussion	113 123	142286 142296	0.9999880790710449	O
34346	)	124 125	142297 142298	0.99998939037323	O
34347	.	126 127	142299 142300	0.9999747276306152	O
34348	Detection	0 8	142301 142309	0.9999884366989136	O
34351	of	10 12	142311 142313	0.9999884366989136	O
34352	the	13 16	142314 142317	0.9999886751174927	O
34353	large	17 22	142318 142323	0.9999825954437256	O
34354	deletion	23 30	142324 142331	0.9999877214431763	O
34357	in	32 34	142333 142335	0.9999884366989136	O
34358	patient	35 42	142336 142343	0.9999837875366211	O
34359	C591	43 46	142344 142347	0.9999878406524658	O
34363	,	48 49	142349 142350	0.9999884366989136	O
34364	encompassing	50 62	142351 142363	0.999988317489624	O
34365	APC	63 65	142364 142366	0.9999853372573853	O
34367	exons	67 71	142368 142372	0.99998939037323	O
34369	13	73 75	142374 142376	0.9999873638153076	O
34370	through	76 83	142377 142384	0.999988317489624	O
34371	the	84 87	142385 142388	0.99998939037323	O
34372	5	88 89	142389 142390	0.9999886751174927	O
34373	'	89 90	142390 142391	0.9999887943267822	O
34374	part	91 95	142392 142396	0.99998939037323	O
34375	of	96 98	142397 142399	0.99998939037323	O
34376	exon	99 102	142400 142403	0.99998939037323	O
34378	15	104 106	142405 142407	0.9999881982803345	O
34379	,	107 108	142408 142409	0.9999881982803345	O
34380	was	109 112	142410 142413	0.9999884366989136	O
34381	carried	113 120	142414 142421	0.9999887943267822	O
34382	out	121 124	142422 142425	0.99998939037323	O
34383	with	125 129	142426 142430	0.9999885559082031	O
34384	MLPA	130 133	142431 142434	0.9999866485595703	O
34387	.	134 135	142435 142436	0.9999738931655884	O
34388	The	0 3	142437 142440	0.9999841451644897	O
34389	deletion	4 11	142441 142448	0.9999841451644897	O
34392	in	13 15	142450 142452	0.9999866485595703	O
34393	patient	16 23	142453 142460	0.999981164932251	O
34394	2136	24 27	142461 142464	0.9999839067459106	O
34396	was	29 32	142466 142469	0.9999855756759644	O
34397	identified	33 43	142470 142480	0.999985933303833	O
34398	by	44 46	142481 142483	0.9999866485595703	O
34399	PTT	47 49	142484 142486	0.9999854564666748	O
34401	and	51 54	142488 142491	0.9999850988388062	O
34402	subsequent	55 65	142492 142502	0.999983549118042	O
34403	DNA	66 69	142503 142506	0.9999841451644897	O
34404	sequencing	70 79	142507 142516	0.9999853372573853	O
34406	.	81 82	142518 142519	0.9999440908432007	O
34407	A	0 1	142520 142521	0.9999855756759644	O
34408	case	2 6	142522 142526	0.9999852180480957	O
34409	of	7 9	142527 142529	0.9999880790710449	O
34410	APC	10 12	142530 142532	0.9999808073043823	O
34412	mosaicism	14 22	142534 142542	0.999983549118042	O
34414	Three	24 29	142544 142549	0.9999791383743286	O
34415	patients	30 38	142550 142558	0.9999805688858032	O
34416	(	39 40	142559 142560	0.9999887943267822	O
34417	C107	41 44	142561 142564	0.999988317489624	O
34420	,	46 47	142566 142567	0.9999885559082031	O
34421	C257	48 51	142568 142571	0.9999887943267822	O
34424	,	53 54	142573 142574	0.999988317489624	O
34425	and	55 58	142575 142578	0.9999884366989136	O
34426	C505	59 62	142579 142582	0.9999885559082031	O
34429	)	64 65	142584 142585	0.9999885559082031	O
34430	,	66 67	142586 142587	0.9999872446060181	O
34431	negative	68 76	142588 142596	0.9999827146530151	O
34432	for	77 80	142597 142600	0.999988317489624	O
34433	mutations	81 90	142601 142610	0.9999845027923584	O
34434	in	91 93	142611 142613	0.999988317489624	O
34435	APC	94 96	142614 142616	0.9999855756759644	O
34437	,	98 99	142618 142619	0.9999872446060181	O
34438	were	100 104	142620 142624	0.9999886751174927	O
34439	reported	105 113	142625 142633	0.9999872446060181	O
34440	as	114 116	142634 142636	0.9999890327453613	O
34441	de	117 119	142637 142639	0.9999890327453613	O
34442	novo	120 123	142640 142643	0.9999887943267822	O
34444	cases	125 130	142645 142650	0.9999877214431763	O
34445	with	131 135	142651 142655	0.9999880790710449	O
34446	no	136 138	142656 142658	0.9999873638153076	O
34447	known	139 144	142659 142664	0.9999866485595703	O
34448	family	145 151	142665 142671	0.9999816417694092	O
34449	history	152 159	142672 142679	0.9999865293502808	O
34450	of	160 162	142680 142682	0.9999879598617554	O
34451	FAP	163 165	142683 142685	0.9999794960021973	O
34453	.	166 167	142686 142687	0.9999617338180542	O
34454	These	0 5	142688 142693	0.9999830722808838	O
34455	patients	6 14	142694 142702	0.9999796152114868	O
34456	where	15 20	142703 142708	0.9999847412109375	O
34457	all	21 24	142709 142712	0.9999855756759644	O
34458	screened	25 33	142713 142721	0.9999841451644897	O
34459	for	34 37	142722 142725	0.9999864101409912	O
34460	APC	38 40	142726 142728	0.9999806880950928	O
34462	mutations	42 51	142730 142739	0.9999840259552002	O
34463	present	52 59	142740 142747	0.9999867677688599	O
34464	as	60 62	142748 142750	0.9999880790710449	O
34465	low	63 66	142751 142754	0.999987006187439	O
34466	-	66 67	142754 142755	0.9999885559082031	O
34467	frequency	67 76	142755 142764	0.9999879598617554	O
34468	alleles	77 83	142765 142771	0.9999879598617554	O
34471	using	85 90	142773 142778	0.9999878406524658	O
34472	SSCP	91 94	142779 142782	0.9999872446060181	O
34474	/	95 96	142783 142784	0.9999881982803345	O
34475	HD	96 98	142784 142786	0.9999865293502808	O
34476	.	98 99	142786 142787	0.9999613761901855	O
34477	We	0 2	142788 142790	0.9999803304672241	O
34478	did	3 6	142791 142794	0.9999845027923584	O
34479	not	7 10	142795 142798	0.9999829530715942	O
34480	detect	11 17	142799 142805	0.9999850988388062	O
34481	any	18 21	142806 142809	0.9999847412109375	O
34482	signs	22 27	142810 142815	0.9999825954437256	O
34483	of	28 30	142816 142818	0.9999865293502808	O
34484	low	31 34	142819 142822	0.9999854564666748	O
34485	-	34 35	142822 142823	0.9999874830245972	O
34486	frequency	35 44	142823 142832	0.9999867677688599	O
34487	mutations	45 54	142833 142842	0.9999849796295166	O
34488	in	55 57	142843 142845	0.9999867677688599	O
34489	patients	58 66	142846 142854	0.9999840259552002	O
34490	C257	67 70	142855 142858	0.9999877214431763	O
34493	and	72 75	142860 142863	0.9999854564666748	O
34494	C505	76 79	142864 142867	0.9999873638153076	O
34497	.	81 82	142869 142870	0.9999490976333618	O
34498	However	0 7	142871 142878	0.9999819993972778	O
34499	,	8 9	142879 142880	0.9999878406524658	O
34500	in	10 12	142881 142883	0.999984860420227	O
34501	patient	13 20	142884 142891	0.9999620914459229	O
34502	C107	21 24	142892 142895	0.9999868869781494	O
34505	,	26 27	142897 142898	0.9999872446060181	O
34506	aberrant	28 35	142899 142906	0.999988317489624	O
34509	bands	37 42	142908 142913	0.9999831914901733	O
34510	,	43 44	142914 142915	0.9999871253967285	O
34511	possibly	45 53	142916 142924	0.9999884366989136	O
34512	originating	54 65	142925 142936	0.9999889135360718	O
34513	from	66 70	142937 142941	0.9999884366989136	O
34514	formation	71 80	142942 142951	0.9999879598617554	O
34515	of	81 83	142952 142954	0.9999887943267822	O
34516	heteroduplexes	84 97	142955 142968	0.9999880790710449	O
34521	,	99 100	142970 142971	0.9999864101409912	O
34522	was	101 104	142972 142975	0.9999884366989136	O
34523	detected	105 113	142976 142984	0.9999887943267822	O
34524	by	114 116	142985 142987	0.9999887943267822	O
34525	SSCP	117 120	142988 142991	0.9999879598617554	O
34527	/	121 122	142992 142993	0.9999886751174927	O
34528	HD	122 124	142993 142995	0.9999864101409912	O
34529	in	125 127	142996 142998	0.9999887943267822	O
34530	a	128 129	142999 143000	0.9999881982803345	O
34531	very	130 134	143001 143005	0.9999873638153076	O
34532	low	135 138	143006 143009	0.999985933303833	O
34533	fraction	139 147	143010 143018	0.9999876022338867	O
34534	of	148 150	143019 143021	0.9999864101409912	O
34535	her	151 154	143022 143025	0.9995031356811523	O
34536	blood	155 160	143026 143031	0.9999798536300659	O
34537	lymphocytes	161 171	143032 143042	0.9999853372573853	O
34540	.	173 174	143044 143045	0.9999638795852661	O
34541	The	0 3	143046 143049	0.9999879598617554	O
34542	c	4 5	143050 143051	0.999988317489624	O
34543	.	5 6	143051 143052	0.9999892711639404	O
34544	2700	6 9	143052 143055	0.9999881982803345	O
34546	_	10 11	143056 143057	0.9999877214431763	O
34547	2701delTC	11 19	143057 143065	0.9999880790710449	O
34551	mutation	21 29	143067 143075	0.9999867677688599	O
34552	,	30 31	143076 143077	0.9999891519546509	O
34553	which	32 37	143078 143083	0.9999891519546509	O
34554	results	38 45	143084 143091	0.9999885559082031	O
34555	in	46 48	143092 143094	0.9999891519546509	O
34556	frame	49 54	143095 143100	0.9999885559082031	O
34557	shift	55 60	143101 143106	0.9999886751174927	O
34558	at	61 63	143107 143109	0.9999890327453613	O
34559	codon	64 68	143110 143114	0.9999890327453613	O
34561	900	70 73	143116 143119	0.9999855756759644	O
34562	,	74 75	143120 143121	0.9999881982803345	O
34563	was	76 79	143122 143125	0.9999891519546509	O
34564	found	80 85	143126 143131	0.9999887943267822	O
34565	by	86 88	143132 143134	0.9999891519546509	O
34566	sequencing	89 98	143135 143144	0.9999877214431763	O
34568	of	100 102	143146 143148	0.9999892711639404	O
34569	the	103 106	143149 143152	0.99998939037323	O
34570	aberrant	107 114	143153 143160	0.9999895095825195	O
34573	bands	116 121	143162 143167	0.9999877214431763	O
34574	excised	122 128	143168 143174	0.9999892711639404	O
34577	from	130 134	143176 143180	0.9999892711639404	O
34578	the	135 138	143181 143184	0.99998939037323	O
34579	SSCP	139 142	143185 143188	0.9999880790710449	O
34581	/	143 144	143189 143190	0.9999890327453613	O
34582	HD	144 146	143190 143192	0.9999876022338867	O
34583	gel	147 150	143193 143196	0.9999878406524658	O
34584	(	151 152	143197 143198	0.9999895095825195	O
34585	Figure	153 159	143199 143205	0.999987006187439	O
34586	2A	160 161	143206 143207	0.9999881982803345	O
34588	)	163 164	143209 143210	0.9999895095825195	O
34589	.	165 166	143211 143212	0.9999734163284302	O
34590	The	0 3	143213 143216	0.9999860525131226	O
34591	mutation	4 12	143217 143225	0.9999827146530151	O
34592	was	13 16	143226 143229	0.9999880790710449	O
34593	detected	17 25	143230 143238	0.9999879598617554	O
34594	in	26 28	143239 143241	0.9999885559082031	O
34595	approximately	29 42	143242 143255	0.9999879598617554	O
34596	one	43 46	143256 143259	0.9999878406524658	O
34597	-	46 47	143259 143260	0.9999880790710449	O
34598	third	47 52	143260 143265	0.9999856948852539	O
34599	of	53 55	143266 143268	0.9999881982803345	O
34600	the	56 59	143269 143272	0.999987006187439	O
34601	analyzed	60 68	143273 143281	0.9999792575836182	O
34602	tumor	69 74	143282 143287	0.9999823570251465	O
34603	-	74 75	143287 143288	0.999988317489624	O
34604	derived	75 82	143288 143295	0.9999830722808838	O
34605	cells	83 88	143296 143301	0.999984860420227	O
34606	extracted	89 98	143302 143311	0.9999877214431763	O
34607	from	99 103	143312 143316	0.9999887943267822	O
34608	paraffin	104 111	143317 143324	0.9999858140945435	O
34610	-	112 113	143325 143326	0.9999886751174927	O
34611	embedded	113 121	143326 143334	0.999985933303833	O
34612	tissue	122 128	143335 143341	0.999985933303833	O
34613	by	129 131	143342 143344	0.9999889135360718	O
34614	DNA	132 135	143345 143348	0.9999862909317017	O
34615	sequencing	136 145	143349 143358	0.9999877214431763	O
34617	(	147 148	143360 143361	0.99998939037323	O
34618	Figure	149 155	143362 143368	0.9999860525131226	O
34619	2B	156 157	143369 143370	0.9999884366989136	O
34621	)	159 160	143372 143373	0.9999895095825195	O
34622	.	161 162	143374 143375	0.9999765157699585	O
34623	The	0 3	143376 143379	0.9999877214431763	O
34624	mutation	4 12	143380 143388	0.9999852180480957	O
34625	was	13 16	143389 143392	0.9999885559082031	O
34626	not	17 20	143393 143396	0.9999873638153076	O
34627	detectable	21 30	143397 143406	0.9999885559082031	O
34629	at	32 34	143408 143410	0.9999886751174927	O
34630	all	35 38	143411 143414	0.9999877214431763	O
34631	in	39 41	143415 143417	0.9999889135360718	O
34632	the	42 45	143418 143421	0.9999895095825195	O
34633	sequence	46 54	143422 143430	0.9999874830245972	O
34634	determination	55 68	143431 143444	0.9999895095825195	O
34635	of	69 71	143445 143447	0.99998939037323	O
34636	DNA	72 75	143448 143451	0.9999873638153076	O
34637	extracted	76 85	143452 143461	0.9999890327453613	O
34638	from	86 90	143462 143466	0.99998939037323	O
34639	blood	91 96	143467 143472	0.9999866485595703	O
34640	lymphocytes	97 107	143473 143483	0.999988317489624	O
34643	from	109 113	143485 143489	0.9999887943267822	O
34644	the	114 117	143490 143493	0.9999877214431763	O
34645	patient	118 125	143494 143501	0.9999810457229614	O
34646	(	126 127	143502 143503	0.9999895095825195	O
34647	Figure	128 134	143504 143510	0.9999862909317017	O
34648	2C	135 136	143511 143512	0.9999885559082031	O
34650	)	138 139	143514 143515	0.9999896287918091	O
34651	.	140 141	143516 143517	0.999977707862854	O
34652	Detection	0 8	143518 143526	0.9999830722808838	O
34655	of	10 12	143528 143530	0.999984860420227	O
34656	the	13 16	143531 143534	0.9999853372573853	O
34657	mosaic	17 23	143535 143541	0.9999799728393555	O
34658	c	24 25	143542 143543	0.9999872446060181	O
34659	.	25 26	143543 143544	0.9999879598617554	O
34660	2700	26 29	143544 143547	0.9999873638153076	O
34662	_	30 31	143548 143549	0.999987006187439	O
34663	2701delTC	31 39	143549 143557	0.9999872446060181	O
34667	mutation	41 49	143559 143567	0.9999860525131226	O
34668	in	50 52	143568 143570	0.999985933303833	O
34669	patient	53 60	143571 143578	0.9999810457229614	O
34670	C107	61 64	143579 143582	0.9999862909317017	O
34673	.	66 67	143584 143585	0.9999610185623169	O
34674	Nucleotide	0 9	143586 143595	0.9999867677688599	O
34678	2700	11 14	143597 143600	0.9999853372573853	O
34680	is	16 18	143602 143604	0.9999865293502808	O
34681	indicated	19 28	143605 143614	0.9999866485595703	O
34682	with	29 33	143615 143619	0.9999862909317017	O
34683	an	34 36	143620 143622	0.9999874830245972	O
34684	arrow	37 42	143623 143628	0.9999822378158569	O
34685	.	43 44	143629 143630	0.9999866485595703	O
34686	(	45 46	143631 143632	0.9999487400054932	O
34687	A	0 1	143633 143634	0.9999818801879883	O
34688	)	2 3	143635 143636	0.9999885559082031	O
34689	The	4 7	143637 143640	0.9999880790710449	O
34690	aberrant	8 15	143641 143648	0.9999881982803345	O
34693	bands	17 22	143650 143655	0.9999843835830688	O
34694	indicated	23 32	143656 143665	0.9999887943267822	O
34695	by	33 35	143666 143668	0.9999886751174927	O
34696	the	36 39	143669 143672	0.9999877214431763	O
34697	bracket	40 47	143673 143680	0.9999738931655884	O
34698	were	48 52	143681 143685	0.9999884366989136	O
34699	excised	53 59	143686 143692	0.999988317489624	O
34702	from	61 65	143694 143698	0.9999891519546509	O
34703	the	66 69	143699 143702	0.9999890327453613	O
34704	SSCP	70 73	143703 143706	0.9999871253967285	O
34706	/	74 75	143707 143708	0.9999887943267822	O
34707	HD	75 77	143708 143710	0.9999862909317017	O
34708	gel	78 81	143711 143714	0.9999862909317017	O
34709	.	82 83	143715 143716	0.9999785423278809	O
34710	The	0 3	143717 143720	0.9999840259552002	O
34711	resulting	4 13	143721 143730	0.9999831914901733	O
34712	DNA	14 17	143731 143734	0.999976634979248	O
34713	sequence	18 26	143735 143743	0.9999793767929077	O
34714	is	27 29	143744 143746	0.9999799728393555	O
34715	shown	30 35	143747 143752	0.9999810457229614	O
34716	to	36 38	143753 143755	0.9999837875366211	O
34717	the	39 42	143756 143759	0.9999847412109375	O
34718	right	43 48	143760 143765	0.9999822378158569	O
34719	.	49 50	143766 143767	0.9999833106994629	O
34720	(	51 52	143768 143769	0.9998732805252075	O
34721	B	0 1	143770 143771	0.9999748468399048	O
34722	)	2 3	143772 143773	0.9999861717224121	O
34723	DNA	4 7	143774 143777	0.9999817609786987	O
34724	sequence	8 16	143778 143786	0.9999825954437256	O
34725	from	17 21	143787 143791	0.9999829530715942	O
34726	DNA	22 25	143792 143795	0.9999701976776123	O
34727	extracted	26 35	143796 143805	0.999982476234436	O
34728	from	36 40	143806 143810	0.9999827146530151	O
34729	tumor	41 46	143811 143816	0.9999719858169556	O
34730	-	46 47	143816 143817	0.999983549118042	O
34731	derived	47 54	143817 143824	0.9999711513519287	O
34732	cells	55 60	143825 143830	0.9999762773513794	O
34733	from	61 65	143831 143835	0.9999818801879883	O
34734	the	66 69	143836 143839	0.9999791383743286	O
34735	patient	70 77	143840 143847	0.9999164342880249	O
34736	.	78 79	143848 143849	0.9999812841415405	O
34737	(	80 81	143850 143851	0.9993351101875305	O
34738	C	0 1	143852 143853	0.9999759197235107	O
34739	)	2 3	143854 143855	0.999987006187439	O
34740	The	4 7	143856 143859	0.9999842643737793	O
34741	DNA	8 11	143860 143863	0.999980092048645	O
34742	sequence	12 20	143864 143872	0.9999816417694092	O
34743	from	21 25	143873 143877	0.9999837875366211	O
34744	DNA	26 29	143878 143881	0.9999692440032959	O
34745	isolated	30 38	143882 143890	0.9999849796295166	O
34746	from	39 43	143891 143895	0.9999842643737793	O
34747	the	44 47	143896 143899	0.9999781847000122	O
34748	patient	48 55	143900 143907	0.9996447563171387	O
34749	'	56 57	143908 143909	0.9999805688858032	O
34750	s	57 58	143909 143910	0.9999825954437256	O
34751	blood	59 64	143911 143916	0.9999794960021973	O
34752	lymphocytes	65 75	143917 143927	0.9999829530715942	O
34755	.	77 78	143929 143930	0.9999470710754395	O
34756	Mutation	0 7	143931 143938	0.9999868869781494	O
34758	at	9 11	143940 143942	0.9999884366989136	O
34759	the	12 15	143943 143946	0.9999892711639404	O
34760	far	16 19	143947 143950	0.9999867677688599	O
34761	5	20 21	143951 143952	0.9999886751174927	O
34762	'	21 22	143952 143953	0.9999885559082031	O
34763	end	22 25	143953 143956	0.9999885559082031	O
34764	DNA	26 29	143957 143960	0.9999867677688599	O
34765	sequencing	30 39	143961 143970	0.9999873638153076	O
34767	of	41 43	143972 143974	0.9999889135360718	O
34768	APC	44 46	143975 143977	0.9999856948852539	O
34770	exon	48 51	143979 143982	0.99998939037323	O
34772	1	53 54	143984 143985	0.9999891519546509	O
34773	in	55 57	143986 143988	0.9999896287918091	O
34774	patient	58 65	143989 143996	0.9999868869781494	O
34775	C157	66 69	143997 144000	0.9999876022338867	O
34778	revealed	71 79	144002 144010	0.9999877214431763	O
34779	the	80 83	144011 144014	0.9999887943267822	O
34780	c	84 85	144015 144016	0.9999886751174927	O
34781	.	85 86	144016 144017	0.99998939037323	O
34782	70C	86 88	144017 144019	0.9999864101409912	O
34784	>	90 91	144021 144022	0.9999887943267822	O
34785	T	92 93	144023 144024	0.9999877214431763	O
34786	substitution	94 106	144025 144037	0.9999884366989136	O
34787	which	107 112	144038 144043	0.9999887943267822	O
34788	introduces	113 123	144044 144054	0.999983549118042	O
34789	a	124 125	144055 144056	0.9999887943267822	O
34790	nonsense	126 134	144057 144065	0.9999847412109375	O
34791	mutation	135 143	144066 144074	0.9999872446060181	O
34792	in	144 146	144075 144077	0.9999892711639404	O
34793	codon	147 151	144078 144082	0.9999887943267822	O
34795	24	153 155	144084 144086	0.9999854564666748	O
34796	(	156 157	144087 144088	0.99998939037323	O
34797	Figure	158 164	144089 144095	0.9999852180480957	O
34798	1	165 166	144096 144097	0.9999886751174927	O
34799	)	167 168	144098 144099	0.9999895095825195	O
34800	.	169 170	144100 144101	0.999977707862854	O
34801	The	0 3	144102 144105	0.9999871253967285	O
34802	mutation	4 12	144106 144114	0.9999853372573853	O
34803	was	13 16	144115 144118	0.9999890327453613	O
34804	also	17 21	144119 144123	0.9999878406524658	O
34805	detectable	22 31	144124 144133	0.9999892711639404	O
34807	by	33 35	144135 144137	0.99998939037323	O
34808	SSCP	36 39	144138 144141	0.9999873638153076	O
34810	/	40 41	144142 144143	0.9999885559082031	O
34811	HD	41 43	144143 144145	0.9999827146530151	O
34812	analysis	44 52	144146 144154	0.9999885559082031	O
34813	but	53 56	144155 144158	0.9999868869781494	O
34814	was	57 60	144159 144162	0.99998939037323	O
34815	not	61 64	144163 144166	0.9999884366989136	O
34816	detectable	65 74	144167 144176	0.9999891519546509	O
34818	by	76 78	144178 144180	0.9999890327453613	O
34819	PTT	79 81	144181 144183	0.9999876022338867	O
34821	due	83 86	144185 144188	0.9999891519546509	O
34822	to	87 89	144189 144191	0.9999891519546509	O
34823	its	90 93	144192 144195	0.9999891519546509	O
34824	localization	94 105	144196 144207	0.9999890327453613	O
34826	close	107 112	144209 144214	0.9999879598617554	O
34827	to	113 115	144215 144217	0.99998939037323	O
34828	the	116 119	144218 144221	0.99998939037323	O
34829	5	120 121	144222 144223	0.9999887943267822	O
34830	'	121 122	144223 144224	0.9999889135360718	O
34831	end	123 126	144225 144228	0.9999890327453613	O
34832	of	127 129	144229 144231	0.9999895095825195	O
34833	the	130 133	144232 144235	0.9999896287918091	O
34834	PTT	134 136	144236 144238	0.9999874830245972	O
34836	fragment	138 146	144240 144248	0.999988317489624	O
34837	.	147 148	144249 144250	0.9999634027481079	O
34838	However	0 7	144251 144258	0.9999865293502808	O
34839	,	8 9	144259 144260	0.999988317489624	O
34840	indication	10 20	144261 144271	0.9999871253967285	O
34841	for	21 24	144272 144275	0.999988317489624	O
34842	a	25 26	144276 144277	0.9999881982803345	O
34843	mutation	27 35	144278 144286	0.9999852180480957	O
34844	was	36 39	144287 144290	0.9999879598617554	O
34845	observed	40 48	144291 144299	0.9999878406524658	O
34846	as	49 51	144300 144302	0.9999885559082031	O
34847	lowered	52 59	144303 144310	0.9999867677688599	O
34848	intensity	60 69	144311 144320	0.9999873638153076	O
34849	of	70 72	144321 144323	0.9999884366989136	O
34850	the	73 76	144324 144327	0.9999887943267822	O
34851	full	77 81	144328 144332	0.9999881982803345	O
34852	-	81 82	144332 144333	0.9999887943267822	O
34853	length	82 88	144333 144339	0.9999881982803345	O
34854	fragment	89 97	144340 144348	0.9999876022338867	O
34855	.	98 99	144349 144350	0.9999890327453613	O
34856	*	100 101	144351 144352	0.9999873638153076	O
34857	*	101 102	144352 144353	0.9999738931655884	O
34858	IGNORE	0 5	144354 144359	0.9999861717224121	O
34861	LINE	7 10	144361 144364	0.9999879598617554	O
34864	*	12 13	144366 144367	0.9999877214431763	O
34865	*	13 14	144367 144368	0.9999877214431763	O
34866	*	15 16	144369 144370	0.9999877214431763	O
34867	*	16 17	144370 144371	0.9999878406524658	O
34868	IGNORE	18 23	144372 144377	0.9999873638153076	O
34871	LINE	25 28	144379 144382	0.9999884366989136	O
34874	*	30 31	144384 144385	0.9999878406524658	O
34875	*	31 32	144385 144386	0.9999877214431763	O
34876	*	33 34	144387 144388	0.9999877214431763	O
34877	*	34 35	144388 144389	0.9999877214431763	O
34878	IGNORE	36 41	144390 144395	0.9999871253967285	O
34881	LINE	43 46	144397 144400	0.9999881982803345	O
34884	*	48 49	144402 144403	0.9999878406524658	O
34885	*	49 50	144403 144404	0.9999878406524658	O
34886	Pedigree	51 58	144405 144412	0.9999873638153076	O
34890	presenting	60 70	144414 144424	0.9999867677688599	O
34891	a	71 72	144425 144426	0.9999873638153076	O
34892	part	73 77	144427 144431	0.9999874830245972	O
34893	of	78 80	144432 144434	0.9999874830245972	O
34894	family	81 87	144435 144441	0.9999853372573853	O
34895	1	88 89	144442 144443	0.9999871253967285	O
34896	of	90 92	144444 144446	0.9999871253967285	O
34897	the	93 96	144447 144450	0.999984860420227	O
34898	Swedish	97 104	144451 144458	0.9848667979240417	O
34899	Polyposis	105 113	144459 144467	0.9999821186065674	O
34903	Registry	115 122	144469 144476	0.9999867677688599	O
34905	.	124 125	144478 144479	0.999958872795105	O
34906	Family	0 6	144480 144486	0.9999829530715942	O
34907	members	7 14	144487 144494	0.9999855756759644	O
34908	where	15 20	144495 144500	0.9999874830245972	O
34909	positive	21 29	144501 144509	0.9999874830245972	O
34910	linkage	30 36	144510 144516	0.9999879598617554	O
34912	to	38 40	144518 144520	0.9999885559082031	O
34913	APC	41 43	144521 144523	0.9999860525131226	O
34915	has	45 48	144525 144528	0.9999886751174927	O
34916	been	49 53	144529 144533	0.9999884366989136	O
34917	confirmed	54 63	144534 144543	0.9999877214431763	O
34918	are	64 67	144544 144547	0.9999876022338867	O
34919	indicated	68 77	144548 144557	0.9999886751174927	O
34920	with	78 82	144558 144562	0.9999887943267822	O
34921	asterisks	83 91	144563 144571	0.9999889135360718	O
34925	.	93 94	144573 144574	0.9999890327453613	O
34926	*	95 96	144575 144576	0.9999872446060181	O
34927	*	96 97	144576 144577	0.9999781847000122	O
34928	IGNORE	0 5	144578 144583	0.999985933303833	O
34931	LINE	7 10	144585 144588	0.9999879598617554	O
34934	*	12 13	144590 144591	0.9999881982803345	O
34935	*	13 14	144591 144592	0.9999881982803345	O
34936	*	15 16	144593 144594	0.999988317489624	O
34937	*	16 17	144594 144595	0.999988317489624	O
34938	IGNORE	18 23	144596 144601	0.9999871253967285	O
34941	LINE	25 28	144603 144606	0.9999884366989136	O
34944	*	30 31	144608 144609	0.9999879598617554	O
34945	*	31 32	144609 144610	0.9999879598617554	O
34946	*	33 34	144611 144612	0.9999878406524658	O
34947	*	34 35	144612 144613	0.9999879598617554	O
34948	IGNORE	36 41	144614 144619	0.9999865293502808	O
34951	LINE	43 46	144621 144624	0.9999881982803345	O
34954	*	48 49	144626 144627	0.9999880790710449	O
34955	*	49 50	144627 144628	0.9999880790710449	O
34956	A	51 52	144629 144630	0.9999885559082031	O
34957	case	53 57	144631 144635	0.9999877214431763	O
34958	of	58 60	144636 144638	0.9999886751174927	O
34959	APC	61 63	144639 144641	0.9999860525131226	O
34961	mosaicism	65 73	144643 144651	0.9999872446060181	O
34963	Screening	75 83	144653 144661	0.9999868869781494	O
34965	for	85 88	144663 144666	0.9999886751174927	O
34966	mosaic	89 95	144667 144673	0.9999862909317017	O
34967	mutations	96 105	144674 144683	0.9999864101409912	O
34968	in	106 108	144684 144686	0.9999891519546509	O
34969	the	109 112	144687 144690	0.9999886751174927	O
34970	three	113 118	144691 144696	0.9999821186065674	O
34971	APC	119 121	144697 144699	0.9999860525131226	O
34973	-	122 123	144700 144701	0.9999886751174927	O
34974	and	124 127	144702 144705	0.9999876022338867	O
34975	MUTYH	128 132	144706 144710	0.9999861717224121	O
34979	-	133 134	144711 144712	0.9999887943267822	O
34980	negative	134 142	144712 144720	0.9999856948852539	O
34981	patients	143 151	144721 144729	0.9999830722808838	O
34982	with	152 156	144730 144734	0.9999880790710449	O
34983	de	157 159	144735 144737	0.9999884366989136	O
34984	novo	160 163	144738 144741	0.9999880790710449	O
34986	mutations	165 174	144743 144752	0.9999871253967285	O
34987	revealed	175 183	144753 144761	0.9999881982803345	O
34988	the	184 187	144762 144765	0.9999889135360718	O
34989	c	188 189	144766 144767	0.9999885559082031	O
34990	.	189 190	144767 144768	0.9999891519546509	O
34991	2700	190 193	144768 144771	0.9999881982803345	O
34993	_	194 195	144772 144773	0.9999877214431763	O
34994	2701delTC	195 203	144773 144781	0.9999877214431763	O
34998	mutation	205 213	144783 144791	0.9999885559082031	O
34999	in	214 216	144792 144794	0.9999890327453613	O
35000	patient	217 224	144795 144802	0.999984622001648	O
35001	C107	225 228	144803 144806	0.9999868869781494	O
35004	.	230 231	144808 144809	0.9999663829803467	O
35005	This	0 4	144810 144814	0.9999871253967285	O
35006	mutation	5 13	144815 144823	0.9999852180480957	O
35007	was	14 17	144824 144827	0.9999889135360718	O
35008	detected	18 26	144828 144836	0.9999887943267822	O
35009	in	27 29	144837 144839	0.9999892711639404	O
35010	a	30 31	144840 144841	0.9999892711639404	O
35011	very	32 36	144842 144846	0.9999873638153076	O
35012	low	37 40	144847 144850	0.9999856948852539	O
35013	fraction	41 49	144851 144859	0.9999879598617554	O
35014	of	50 52	144860 144862	0.999988317489624	O
35015	the	53 56	144863 144866	0.9999876022338867	O
35016	lymphocytes	57 67	144867 144877	0.9999866485595703	O
35019	and	69 72	144879 144882	0.9999878406524658	O
35020	was	73 76	144883 144886	0.99998939037323	O
35021	only	77 81	144887 144891	0.9999885559082031	O
35022	detectable	82 91	144892 144901	0.9999890327453613	O
35024	using	93 98	144903 144908	0.9999892711639404	O
35025	the	99 102	144909 144912	0.9999895095825195	O
35026	SSCP	103 106	144913 144916	0.9999881982803345	O
35028	/	107 108	144917 144918	0.99998939037323	O
35029	HD	108 110	144918 144920	0.9999881982803345	O
35030	analysis	111 119	144921 144929	0.9999897480010986	O
35031	(	120 121	144930 144931	0.9999896287918091	O
35032	Figure	122 128	144932 144938	0.9999871253967285	O
35033	2A	129 130	144939 144940	0.9999887943267822	O
35035	)	132 133	144942 144943	0.9999897480010986	O
35036	.	134 135	144944 144945	0.9999749660491943	O
35037	Owing	0 4	144946 144950	0.9999790191650391	O
35039	to	6 8	144952 144954	0.9999823570251465	O
35040	the	9 12	144955 144958	0.9999830722808838	O
35041	subtle	13 19	144959 144965	0.9999821186065674	O
35042	appearance	20 30	144966 144976	0.9999812841415405	O
35043	of	31 33	144977 144979	0.9999858140945435	O
35044	this	34 38	144980 144984	0.9999837875366211	O
35045	mutation	39 47	144985 144993	0.999976396560669	O
35046	it	48 50	144994 144996	0.9999815225601196	O
35047	could	51 56	144997 145002	0.9999760389328003	O
35048	easily	57 63	145003 145009	0.9999771118164062	O
35049	have	64 68	145010 145014	0.9999834299087524	O
35050	been	69 73	145015 145019	0.9999841451644897	O
35051	overlooked	74 84	145020 145030	0.9999774694442749	O
35052	.	85 86	145031 145032	0.9998869895935059	O
35053	The	0 3	145033 145036	0.999988317489624	O
35054	phenotype	4 12	145037 145045	0.9999881982803345	O
35057	of	14 16	145047 145049	0.999988317489624	O
35058	patient	17 24	145050 145057	0.9999829530715942	O
35059	C107	25 28	145058 145061	0.9999862909317017	O
35062	does	30 34	145063 145067	0.9999873638153076	O
35063	not	35 38	145068 145071	0.9999866485595703	O
35064	fit	39 42	145072 145075	0.9999874830245972	O
35065	the	43 46	145076 145079	0.9999889135360718	O
35066	generally	47 56	145080 145089	0.9999881982803345	O
35067	accepted	57 65	145090 145098	0.9999871253967285	O
35068	genotype	66 73	145099 145106	0.9999886751174927	O
35071	-	74 75	145107 145108	0.9999886751174927	O
35072	phenotype	75 83	145108 145116	0.9999885559082031	O
35075	correlation	85 96	145118 145129	0.9999884366989136	O
35076	of	97 99	145130 145132	0.9999889135360718	O
35077	AFAP	100 103	145133 145136	0.999985933303833	O
35080	,	105 106	145138 145139	0.9999887943267822	O
35081	in	107 109	145140 145142	0.9999890327453613	O
35082	which	110 115	145143 145148	0.9999892711639404	O
35083	the	116 119	145149 145152	0.9999892711639404	O
35084	disease	120 127	145153 145160	0.999987006187439	O
35085	-	127 128	145160 145161	0.9999892711639404	O
35086	causing	128 135	145161 145168	0.9999881982803345	O
35087	mutations	136 145	145169 145178	0.999987006187439	O
35088	are	146 149	145179 145182	0.9999889135360718	O
35089	situated	150 158	145183 145191	0.9999881982803345	O
35090	either	159 165	145192 145198	0.9999887943267822	O
35091	in	166 168	145199 145201	0.9999892711639404	O
35092	the	169 172	145202 145205	0.99998939037323	O
35093	5	173 174	145206 145207	0.9999886751174927	O
35094	'	174 175	145207 145208	0.9999887943267822	O
35095	or	176 178	145209 145211	0.9999884366989136	O
35096	3	179 180	145212 145213	0.9999879598617554	O
35097	'	180 181	145213 145214	0.9999886751174927	O
35098	regions	182 189	145215 145222	0.9999890327453613	O
35099	or	190 192	145223 145225	0.9999887943267822	O
35100	the	193 196	145226 145229	0.9999891519546509	O
35101	alternatively	197 210	145230 145243	0.9999884366989136	O
35102	spliced	211 217	145244 145250	0.9999891519546509	O
35106	part	219 223	145252 145256	0.9999891519546509	O
35107	of	224 226	145257 145259	0.9999892711639404	O
35108	exon	227 230	145260 145263	0.9999890327453613	O
35110	9	232 233	145265 145266	0.9999868869781494	O
35111	(	234 235	145267 145268	0.9999890327453613	O
35112	see	236 239	145269 145272	0.9999849796295166	O
35113	the	240 243	145273 145276	0.9999885559082031	O
35114	introduction	244 256	145277 145289	0.9999871253967285	O
35115	)	257 258	145290 145291	0.99998939037323	O
35116	.	259 260	145292 145293	0.9999759197235107	O
35117	A	0 1	145294 145295	0.9999867677688599	O
35118	speculative	2 12	145296 145306	0.9999845027923584	O
35120	reason	14 20	145308 145314	0.9999853372573853	O
35121	for	21 24	145315 145318	0.9999871253967285	O
35122	the	25 28	145319 145322	0.9999877214431763	O
35123	attenuated	29 38	145323 145332	0.9999877214431763	O
35126	phenotype	40 48	145334 145342	0.9999880790710449	O
35129	could	50 55	145344 145349	0.9999806880950928	O
35130	be	56 58	145350 145352	0.9999864101409912	O
35131	that	59 63	145353 145357	0.9999876022338867	O
35132	the	64 67	145358 145361	0.9999865293502808	O
35133	patient	68 75	145362 145369	0.9999721050262451	O
35134	is	76 78	145370 145372	0.9999878406524658	O
35135	mosaic	79 85	145373 145379	0.999981164932251	O
35136	in	86 88	145380 145382	0.9999865293502808	O
35137	the	89 92	145383 145386	0.9999872446060181	O
35138	epithelial	93 102	145387 145396	0.9999862909317017	O
35142	cells	104 109	145398 145403	0.9999856948852539	O
35143	of	110 112	145404 145406	0.9999871253967285	O
35144	the	113 116	145407 145410	0.9999872446060181	O
35145	colon	117 121	145411 145415	0.9999780654907227	O
35147	.	123 124	145417 145418	0.999954104423523	O
35148	The	0 3	145419 145422	0.9999735355377197	O
35149	parents	4 11	145423 145430	0.9999622106552124	O
35150	of	12 14	145431 145433	0.9999821186065674	O
35151	patient	15 22	145434 145441	0.9999735355377197	O
35152	C107	23 26	145442 145445	0.9999797344207764	O
35155	of	28 30	145447 145449	0.9999855756759644	O
35156	age	31 34	145450 145453	0.9999854564666748	O
35157	73	35 37	145454 145456	0.9999809265136719	O
35158	and	38 41	145457 145460	0.9999825954437256	O
35159	80	42 44	145461 145463	0.9999762773513794	O
35160	years	45 50	145464 145469	0.999983549118042	O
35161	as	51 53	145470 145472	0.9999810457229614	O
35162	well	54 58	145473 145477	0.9999830722808838	O
35163	as	59 61	145478 145480	0.9999804496765137	O
35164	her	62 65	145481 145484	0.9998051524162292	O
35165	three	66 71	145485 145490	0.9999642372131348	O
35166	children	72 80	145491 145499	0.9999433755874634	O
35167	,	81 82	145500 145501	0.9999843835830688	O
35168	age	83 86	145502 145505	0.9999852180480957	O
35169	31	87 89	145506 145508	0.9999816417694092	O
35170	–	89 90	145508 145509	0.9999750852584839	O
35171	40	90 92	145509 145511	0.999977707862854	O
35172	years	93 98	145512 145517	0.9999849796295166	O
35173	,	99 100	145518 145519	0.9999817609786987	O
35174	were	101 105	145520 145524	0.9999822378158569	O
35175	free	106 110	145525 145529	0.9999788999557495	O
35176	of	111 113	145530 145532	0.9999853372573853	O
35177	polyps	114 119	145533 145538	0.9999804496765137	O
35180	.	121 122	145540 145541	0.9999455213546753	O
35181	No	0 2	145542 145544	0.999964714050293	O
35182	CRC	3 5	145545 145547	0.9999651908874512	O
35184	has	7 10	145549 145552	0.9999810457229614	O
35185	been	11 15	145553 145557	0.9999841451644897	O
35186	diagnosed	16 25	145558 145567	0.9999841451644897	O
35187	on	26 28	145568 145570	0.999985933303833	O
35188	either	29 35	145571 145577	0.9999850988388062	O
35189	the	36 39	145578 145581	0.999987006187439	O
35190	maternal	40 48	145582 145590	0.999980092048645	O
35191	or	49 51	145591 145593	0.9999822378158569	O
35192	paternal	52 60	145594 145602	0.9999632835388184	O
35193	side	61 65	145603 145607	0.9999853372573853	O
35194	of	66 68	145608 145610	0.9999871253967285	O
35195	the	69 72	145611 145614	0.9999850988388062	O
35196	family	73 79	145615 145621	0.9999790191650391	O
35197	.	80 81	145622 145623	0.9999288320541382	O
35198	The	0 3	145624 145627	0.999980092048645	O
35199	mutation	4 12	145628 145636	0.9999769926071167	O
35200	was	13 16	145637 145640	0.9999816417694092	O
35201	not	17 20	145641 145644	0.9999791383743286	O
35202	detected	21 29	145645 145653	0.9999842643737793	O
35203	in	30 32	145654 145656	0.999984622001648	O
35204	blood	33 38	145657 145662	0.9999747276306152	O
35205	samples	39 46	145663 145670	0.9999828338623047	O
35206	from	47 51	145671 145675	0.9999833106994629	O
35207	the	52 55	145676 145679	0.9999744892120361	O
35208	patient	56 63	145680 145687	0.9999562501907349	O
35209	'	64 65	145688 145689	0.9999831914901733	O
35210	s	65 66	145689 145690	0.9999830722808838	O
35211	parents	67 74	145691 145698	0.9999749660491943	O
35212	or	75 77	145699 145701	0.9999765157699585	O
35213	from	78 82	145702 145706	0.9999829530715942	O
35214	her	83 86	145707 145710	0.9999020099639893	O
35215	three	87 92	145711 145716	0.9999674558639526	O
35216	children	93 101	145717 145725	0.999963641166687	O
35217	.	102 103	145726 145727	0.9999047517776489	O
35218	It	0 2	145728 145730	0.9999850988388062	O
35219	is	3 5	145731 145733	0.9999831914901733	O
35220	possible	6 14	145734 145742	0.999983549118042	O
35221	that	15 19	145743 145747	0.9999865293502808	O
35222	either	20 26	145748 145754	0.9999845027923584	O
35223	gonadal	27 33	145755 145761	0.999982476234436	O
35226	or	35 37	145763 145765	0.999984860420227	O
35227	somatic	38 44	145766 145772	0.9999849796295166	O
35229	mosaicism	46 54	145774 145782	0.9999849796295166	O
35231	exists	56 62	145784 145790	0.9999868869781494	O
35232	in	63 65	145791 145793	0.9999871253967285	O
35233	patient	66 73	145794 145801	0.9999831914901733	O
35234	C107	74 77	145802 145805	0.9999866485595703	O
35237	.	79 80	145807 145808	0.9999517202377319	O
35238	APC	0 2	145809 145811	0.9999779462814331	O
35240	mutational	4 13	145813 145822	0.9999854564666748	O
35242	mosaicism	15 23	145824 145832	0.9999858140945435	O
35244	could	25 30	145834 145839	0.999984622001648	O
35245	be	31 33	145840 145842	0.9999886751174927	O
35246	a	34 35	145843 145844	0.9999886751174927	O
35247	reason	36 42	145845 145851	0.9999868869781494	O
35248	for	43 46	145852 145855	0.999988317489624	O
35249	the	47 50	145856 145859	0.9999884366989136	O
35250	quite	51 56	145860 145865	0.9999861717224121	O
35251	large	57 62	145866 145871	0.999985933303833	O
35252	number	63 69	145872 145878	0.9999879598617554	O
35253	of	70 72	145879 145881	0.9999884366989136	O
35254	de	73 75	145882 145884	0.9999891519546509	O
35255	novo	76 79	145885 145888	0.9999887943267822	O
35257	or	81 83	145890 145892	0.9999855756759644	O
35258	sporadic	84 91	145893 145900	0.9999833106994629	O
35260	FAP	93 95	145902 145904	0.9999655485153198	O
35262	cases	97 102	145906 145911	0.9999867677688599	O
35263	that	103 107	145912 145916	0.9999880790710449	O
35264	exist	108 113	145917 145922	0.999988317489624	O
35265	[	114 115	145923 145924	0.9999890327453613	O
35266	23	115 117	145924 145926	0.999988317489624	O
35267	-	117 118	145926 145927	0.9999892711639404	O
35268	25	118 120	145927 145929	0.9999880790710449	O
35269	,	120 121	145929 145930	0.999988317489624	O
35270	40	121 123	145930 145932	0.9999868869781494	O
35271	]	123 124	145932 145933	0.9999886751174927	O
35272	.	125 126	145934 145935	0.9999758005142212	O
35273	In	0 2	145936 145938	0.9999871253967285	O
35274	the	3 6	145939 145942	0.9999867677688599	O
35275	family	7 13	145943 145949	0.9999829530715942	O
35276	of	14 16	145950 145952	0.9999878406524658	O
35277	C107	17 20	145953 145956	0.9999862909317017	O
35280	the	22 25	145958 145961	0.9999872446060181	O
35281	mutation	26 34	145962 145970	0.9999836683273315	O
35282	has	35 38	145971 145974	0.9999881982803345	O
35283	not	39 42	145975 145978	0.999988317489624	O
35284	been	43 47	145979 145983	0.9999885559082031	O
35285	passed	48 54	145984 145990	0.9999876022338867	O
35286	on	55 57	145991 145993	0.9999868869781494	O
35287	to	58 60	145994 145996	0.9999874830245972	O
35288	the	61 64	145997 146000	0.9999884366989136	O
35289	offspring	65 74	146001 146010	0.9999831914901733	O
35290	of	75 77	146011 146013	0.9999878406524658	O
35291	the	78 81	146014 146017	0.9999873638153076	O
35292	patient	82 89	146018 146025	0.9999792575836182	O
35293	and	90 93	146026 146029	0.9999880790710449	O
35294	,	94 95	146030 146031	0.9999877214431763	O
35295	thus	96 100	146032 146036	0.9999866485595703	O
35296	,	101 102	146037 146038	0.9999881982803345	O
35297	this	103 107	146039 146043	0.9999881982803345	O
35298	appears	108 115	146044 146051	0.9999871253967285	O
35299	to	116 118	146052 146054	0.9999879598617554	O
35300	be	119 121	146055 146057	0.9999884366989136	O
35301	a	122 123	146058 146059	0.9999884366989136	O
35302	sporadic	124 131	146060 146067	0.9999862909317017	O
35304	case	133 137	146069 146073	0.9999864101409912	O
35305	,	138 139	146074 146075	0.9999871253967285	O
35306	but	140 143	146076 146079	0.9999861717224121	O
35307	,	144 145	146080 146081	0.9999873638153076	O
35308	generally	146 155	146082 146091	0.9999827146530151	O
35309	,	156 157	146092 146093	0.9999879598617554	O
35310	the	158 161	146094 146097	0.999988317489624	O
35311	existence	162 171	146098 146107	0.9999879598617554	O
35312	of	172 174	146108 146110	0.9999887943267822	O
35313	mosaicism	175 183	146111 146119	0.9999854564666748	O
35315	is	185 187	146121 146123	0.9999881982803345	O
35316	a	188 189	146124 146125	0.9999885559082031	O
35317	risk	190 194	146126 146130	0.9999876022338867	O
35318	of	195 197	146131 146133	0.9999887943267822	O
35319	error	198 203	146134 146139	0.9999876022338867	O
35320	in	204 206	146140 146142	0.9999889135360718	O
35321	predictive	207 216	146143 146152	0.999988317489624	O
35323	diagnosis	218 227	146154 146163	0.9999878406524658	O
35324	in	228 230	146164 146166	0.9999886751174927	O
35325	FAP	231 233	146167 146169	0.9999804496765137	O
35327	/	234 235	146170 146171	0.9999867677688599	O
35328	AFAP	235 238	146171 146174	0.9999823570251465	O
35331	families	240 248	146176 146184	0.9999862909317017	O
35332	[	249 250	146185 146186	0.999988317489624	O
35333	43	250 252	146186 146188	0.9999821186065674	O
35334	]	252 253	146188 146189	0.9999878406524658	O
35335	.	254 255	146190 146191	0.9999713897705078	O
35336	In	0 2	146192 146194	0.9999889135360718	O
35337	the	3 6	146195 146198	0.9999891519546509	O
35338	initial	7 14	146199 146206	0.9999879598617554	O
35339	stages	15 21	146207 146213	0.9999877214431763	O
35340	,	22 23	146214 146215	0.9999881982803345	O
35341	the	24 27	146216 146219	0.9999886751174927	O
35342	molecular	28 37	146220 146229	0.9999864101409912	O
35343	screening	38 47	146230 146239	0.9999858140945435	O
35344	procedure	48 57	146240 146249	0.9999868869781494	O
35345	of	58 60	146250 146252	0.9999886751174927	O
35346	FAP	61 63	146253 146255	0.9999819993972778	O
35348	/	64 65	146256 146257	0.9999881982803345	O
35349	AFAP	65 68	146257 146260	0.9999850988388062	O
35352	patients	70 78	146262 146270	0.9999831914901733	O
35353	uses	79 83	146271 146275	0.9999865293502808	O
35354	mainly	84 90	146276 146282	0.9999876022338867	O
35355	PCR	91 93	146283 146285	0.9999885559082031	O
35357	-	94 95	146286 146287	0.9999896287918091	O
35358	based	95 100	146287 146292	0.9999892711639404	O
35359	methods	101 108	146293 146300	0.9999885559082031	O
35360	for	109 112	146301 146304	0.9999892711639404	O
35361	analysis	113 121	146305 146313	0.99998939037323	O
35362	of	122 124	146314 146316	0.9999896287918091	O
35363	the	125 128	146317 146320	0.9999895095825195	O
35364	APC	129 131	146321 146323	0.9999874830245972	O
35366	gene	133 137	146325 146329	0.99998939037323	O
35367	in	138 140	146330 146332	0.9999897480010986	O
35368	DNA	141 144	146333 146336	0.999988317489624	O
35369	from	145 149	146337 146341	0.99998939037323	O
35370	isolated	150 158	146342 146350	0.9999877214431763	O
35371	blood	159 164	146351 146356	0.9999849796295166	O
35372	samples	165 172	146357 146364	0.9999889135360718	O
35373	.	173 174	146365 146366	0.9999746084213257	O
35374	Therefore	0 9	146367 146376	0.9999841451644897	O
35375	,	10 11	146377 146378	0.9999867677688599	O
35376	the	12 15	146379 146382	0.9999861717224121	O
35377	chances	16 23	146383 146390	0.9999814033508301	O
35378	of	24 26	146391 146393	0.9999867677688599	O
35379	detecting	27 35	146394 146402	0.999987006187439	O
35381	pathogenic	37 46	146404 146413	0.9999868869781494	O
35383	low	48 51	146415 146418	0.9999868869781494	O
35384	-	51 52	146418 146419	0.9999887943267822	O
35385	frequency	52 61	146419 146428	0.9999879598617554	O
35386	APC	62 64	146429 146431	0.9999830722808838	O
35388	mutations	66 75	146433 146442	0.9999858140945435	O
35389	that	76 80	146443 146447	0.9999881982803345	O
35390	are	81 84	146448 146451	0.9999885559082031	O
35391	present	85 92	146452 146459	0.999988317489624	O
35392	only	93 97	146460 146464	0.9999880790710449	O
35393	in	98 100	146465 146467	0.9999891519546509	O
35394	a	101 102	146468 146469	0.9999890327453613	O
35395	small	103 108	146470 146475	0.999987006187439	O
35396	fraction	109 117	146476 146484	0.9999886751174927	O
35397	of	118 120	146485 146487	0.9999881982803345	O
35398	the	121 124	146488 146491	0.9999880790710449	O
35399	peripheral	125 135	146492 146502	0.9999842643737793	O
35400	blood	136 141	146503 146508	0.9999864101409912	O
35401	cells	142 147	146509 146514	0.9999871253967285	O
35402	or	148 150	146515 146517	0.999985933303833	O
35403	only	151 155	146518 146522	0.9999874830245972	O
35404	in	156 158	146523 146525	0.999988317489624	O
35405	the	159 162	146526 146529	0.9999885559082031	O
35406	colon	163 167	146530 146534	0.9999841451644897	O
35408	are	169 172	146536 146539	0.9999854564666748	O
35409	poor	173 177	146540 146544	0.9999805688858032	O
35410	.	178 179	146545 146546	0.9999642372131348	O
35411	Approximately	0 13	146547 146560	0.9999853372573853	O
35412	25	14 16	146561 146563	0.9999780654907227	O
35413	%	17 18	146564 146565	0.9999853372573853	O
35414	of	19 21	146566 146568	0.9999850988388062	O
35415	neurofibromatosis	22 38	146569 146585	0.9999661445617676	O
35421	type	40 44	146587 146591	0.9999872446060181	O
35422	2	45 46	146592 146593	0.9999772310256958	O
35423	(	47 48	146594 146595	0.9999864101409912	O
35424	NF2	49 51	146596 146598	0.9999780654907227	O
35427	)	53 54	146600 146601	0.999987006187439	O
35428	patients	55 63	146602 146610	0.9999672174453735	O
35429	have	64 68	146611 146615	0.9999862909317017	O
35430	been	69 73	146616 146620	0.9999874830245972	O
35431	shown	74 79	146621 146626	0.9999837875366211	O
35432	to	80 82	146627 146629	0.9999879598617554	O
35433	be	83 85	146630 146632	0.9999879598617554	O
35434	cases	86 91	146633 146638	0.9999860525131226	O
35435	of	92 94	146639 146641	0.999988317489624	O
35436	mosaicism	95 103	146642 146650	0.9999831914901733	O
35438	[	105 106	146652 146653	0.9999891519546509	O
35439	44	106 108	146653 146655	0.9999840259552002	O
35440	]	108 109	146655 146656	0.9999885559082031	O
35441	.	110 111	146657 146658	0.9999721050262451	O
35442	When	0 4	146659 146663	0.9999830722808838	O
35443	investigating	5 18	146664 146677	0.999983549118042	O
35444	NF2	19 21	146678 146680	0.9999814033508301	O
35447	mutational	23 32	146682 146691	0.999983549118042	O
35449	mosaicism	34 42	146693 146701	0.9999836683273315	O
35451	,	44 45	146703 146704	0.9999856948852539	O
35452	the	46 49	146705 146708	0.9999872446060181	O
35453	search	50 56	146709 146715	0.9999841451644897	O
35454	for	57 60	146716 146719	0.9999884366989136	O
35455	constitutional	61 75	146720 146734	0.9999847412109375	O
35456	mutations	76 85	146735 146744	0.9999854564666748	O
35457	is	86 88	146745 146747	0.9999853372573853	O
35458	preferably	89 98	146748 146757	0.9999866485595703	O
35460	carried	100 107	146759 146766	0.9999877214431763	O
35461	out	108 111	146767 146770	0.999988317489624	O
35462	initially	112 121	146771 146780	0.9999860525131226	O
35463	in	122 124	146781 146783	0.9999856948852539	O
35464	tumor	125 130	146784 146789	0.9999840259552002	O
35465	cells	131 136	146790 146795	0.9999841451644897	O
35466	.	137 138	146796 146797	0.9999539852142334	O
35467	Detected	0 7	146798 146805	0.9999847412109375	O
35470	mutations	9 18	146807 146816	0.9999812841415405	O
35471	could	19 24	146817 146822	0.9999781847000122	O
35472	subsequently	25 37	146823 146835	0.9999767541885376	O
35473	be	38 40	146836 146838	0.999984860420227	O
35474	verified	41 49	146839 146847	0.9999816417694092	O
35475	in	50 52	146848 146850	0.9999850988388062	O
35476	blood	53 58	146851 146856	0.9999810457229614	O
35477	leukocyte	59 67	146857 146865	0.9999852180480957	O
35481	samples	69 76	146867 146874	0.9999854564666748	O
35482	.	77 78	146875 146876	0.9999308586120605	O
35483	However	0 7	146877 146884	0.9999855756759644	O
35484	,	8 9	146885 146886	0.9999880790710449	O
35485	this	10 14	146887 146891	0.9999880790710449	O
35486	approach	15 23	146892 146900	0.9999834299087524	O
35487	would	24 29	146901 146906	0.9999856948852539	O
35488	not	30 33	146907 146910	0.9999840259552002	O
35489	be	34 36	146911 146913	0.9999873638153076	O
35490	applicable	37 47	146914 146924	0.9999812841415405	O
35491	for	48 51	146925 146928	0.9999872446060181	O
35492	FAP	52 54	146929 146931	0.999983549118042	O
35494	mosaisicm	56 64	146933 146941	0.9999886751174927	O
35499	as	66 68	146943 146945	0.9999856948852539	O
35500	somatic	69 75	146946 146952	0.9999877214431763	O
35502	APC	77 79	146954 146956	0.9999864101409912	O
35504	mutations	81 90	146958 146967	0.9999864101409912	O
35505	are	91 94	146968 146971	0.9999868869781494	O
35506	frequently	95 105	146972 146982	0.999985933303833	O
35507	found	106 111	146983 146988	0.9999865293502808	O
35508	in	112 114	146989 146991	0.9999861717224121	O
35509	tumors	115 121	146992 146998	0.9999828338623047	O
35510	.	122 123	146999 147000	0.9999591112136841	O
35511	Splice	0 5	147001 147006	0.9999862909317017	O
35514	-	6 7	147007 147008	0.9999880790710449	O
35515	site	7 11	147008 147012	0.9999872446060181	O
35516	affecting	12 21	147013 147022	0.9999816417694092	O
35517	mutations	22 31	147023 147032	0.9999847412109375	O
35518	Two	32 35	147033 147036	0.999970555305481	O
35519	novel	36 41	147037 147042	0.999977707862854	O
35520	germline	42 49	147043 147050	0.9999861717224121	O
35524	APC	51 53	147052 147054	0.9999799728393555	O
35526	mutations	55 64	147056 147065	0.9999866485595703	O
35527	that	65 69	147066 147070	0.999987006187439	O
35528	introduce	70 79	147071 147080	0.9999724626541138	O
35529	different	80 89	147081 147090	0.9999822378158569	O
35530	cryptic	90 96	147091 147097	0.9999880790710449	O
35532	splice	98 103	147099 147104	0.9999881982803345	O
35535	sites	105 110	147106 147111	0.9999874830245972	O
35536	are	111 114	147112 147115	0.9999854564666748	O
35537	characterized	115 128	147116 147129	0.9999842643737793	O
35538	in	129 131	147130 147132	0.9999877214431763	O
35539	this	132 136	147133 147137	0.9999880790710449	O
35540	study	137 142	147138 147143	0.9999855756759644	O
35541	.	143 144	147144 147145	0.9999586343765259	O
35542	Both	0 4	147146 147150	0.9999814033508301	O
35543	mutations	5 14	147151 147160	0.9999748468399048	O
35544	result	15 21	147161 147167	0.9999794960021973	O
35545	in	22 24	147168 147170	0.9999842643737793	O
35546	the	25 28	147171 147174	0.999984622001648	O
35547	aberrant	29 36	147175 147182	0.9999855756759644	O
35550	splicing	38 45	147184 147191	0.999987006187439	O
35553	of	47 49	147193 147195	0.9999873638153076	O
35554	APC	50 52	147196 147198	0.9999841451644897	O
35556	exons	54 58	147200 147204	0.9999886751174927	O
35558	7	60 61	147206 147207	0.9999873638153076	O
35559	and	62 65	147208 147211	0.999987006187439	O
35560	8	66 67	147212 147213	0.9999841451644897	O
35561	and	68 71	147214 147217	0.999985933303833	O
35562	prematurely	72 82	147218 147228	0.9999856948852539	O
35564	truncated	84 92	147230 147238	0.9999880790710449	O
35566	APC	94 96	147240 147242	0.9999850988388062	O
35568	protein	98 105	147244 147251	0.9999858140945435	O
35569	,	106 107	147252 147253	0.9999861717224121	O
35570	and	108 111	147254 147257	0.9999850988388062	O
35571	both	112 116	147258 147262	0.9999850988388062	O
35572	are	117 120	147263 147266	0.9999864101409912	O
35573	defined	121 128	147267 147274	0.9999836683273315	O
35574	as	129 131	147275 147277	0.9999873638153076	O
35575	pathogenic	132 141	147278 147287	0.9999847412109375	O
35577	.	143 144	147289 147290	0.9999619722366333	O
35578	The	0 3	147291 147294	0.9999876022338867	O
35579	aberrant	4 11	147295 147302	0.9999871253967285	O
35582	splicing	13 20	147304 147311	0.9999878406524658	O
35585	identified	22 32	147313 147323	0.9999865293502808	O
35586	in	33 35	147324 147326	0.9999873638153076	O
35587	patient	36 43	147327 147334	0.999976396560669	O
35588	C496	44 47	147335 147338	0.9999868869781494	O
35592	(	49 50	147340 147341	0.9999887943267822	O
35593	c	51 52	147342 147343	0.9999881982803345	O
35594	.	52 53	147343 147344	0.9999886751174927	O
35595	835	53 55	147344 147346	0.9999855756759644	O
35597	-	56 57	147347 147348	0.9999885559082031	O
35598	7T	57 58	147348 147349	0.9999871253967285	O
35600	>	60 61	147351 147352	0.9999878406524658	O
35601	G	62 63	147353 147354	0.9999867677688599	O
35602	)	64 65	147355 147356	0.9999889135360718	O
35603	is	66 68	147357 147359	0.9999872446060181	O
35604	caused	69 75	147360 147366	0.9999878406524658	O
35605	by	76 78	147367 147369	0.9999884366989136	O
35606	an	79 81	147370 147372	0.999988317489624	O
35607	introduction	82 94	147373 147385	0.9999876022338867	O
35608	of	95 97	147386 147388	0.9999887943267822	O
35609	a	98 99	147389 147390	0.9999885559082031	O
35610	new	100 103	147391 147394	0.9999868869781494	O
35611	active	104 110	147395 147401	0.9999864101409912	O
35612	splice	111 116	147402 147407	0.9999886751174927	O
35615	site	118 122	147409 147413	0.9999884366989136	O
35616	6	123 124	147414 147415	0.9999879598617554	O
35617	bp	125 126	147416 147417	0.9999877214431763	O
35619	upstream	128 136	147419 147427	0.9999876022338867	O
35620	of	137 139	147428 147430	0.9999885559082031	O
35621	the	140 143	147431 147434	0.999988317489624	O
35622	wildtype	144 151	147435 147442	0.999987006187439	O
35624	AG	153 155	147444 147446	0.999985933303833	O
35625	splice	156 161	147447 147452	0.9999887943267822	O
35628	site	163 167	147454 147458	0.9999884366989136	O
35629	of	168 170	147459 147461	0.9999885559082031	O
35630	intron	171 176	147462 147467	0.9999879598617554	O
35632	7	178 179	147469 147470	0.999987006187439	O
35633	.	179 180	147470 147471	0.9999675750732422	O
35634	This	0 4	147472 147476	0.9999856948852539	O
35635	acceptor	5 12	147477 147484	0.9999819993972778	O
35637	site	14 18	147486 147490	0.9999831914901733	O
35638	is	19 21	147491 147493	0.9999862909317017	O
35639	apparently	22 32	147494 147504	0.9999865293502808	O
35640	preferred	33 42	147505 147514	0.9999803304672241	O
35641	by	43 45	147515 147517	0.9999860525131226	O
35642	the	46 49	147518 147521	0.9999853372573853	O
35643	splicing	50 57	147522 147529	0.9999845027923584	O
35646	machinery	59 68	147531 147540	0.9999769926071167	O
35647	,	69 70	147541 147542	0.9999867677688599	O
35648	as	71 73	147543 147545	0.9999877214431763	O
35649	shown	74 79	147546 147551	0.9999865293502808	O
35650	by	80 82	147552 147554	0.9999880790710449	O
35651	the	83 86	147555 147558	0.9999884366989136	O
35652	results	87 94	147559 147566	0.9999873638153076	O
35653	of	95 97	147567 147569	0.9999884366989136	O
35654	the	98 101	147570 147573	0.9999873638153076	O
35655	cDNA	102 105	147574 147577	0.999988317489624	O
35658	sequencing	107 116	147579 147588	0.9999879598617554	O
35660	(	118 119	147590 147591	0.9999890327453613	O
35661	Figure	120 126	147592 147598	0.9999842643737793	O
35662	3	127 128	147599 147600	0.9999874830245972	O
35663	)	129 130	147601 147602	0.9999890327453613	O
35664	.	131 132	147603 147604	0.9999778270721436	O
35665	The	0 3	147605 147608	0.9999879598617554	O
35666	c	4 5	147609 147610	0.9999879598617554	O
35667	.	5 6	147610 147611	0.9999889135360718	O
35668	834G	6 9	147611 147614	0.999985933303833	O
35671	>	11 12	147616 147617	0.9999873638153076	O
35672	C	13 14	147618 147619	0.9999855756759644	O
35673	substitution	15 27	147620 147632	0.9999880790710449	O
35674	at	28 30	147633 147635	0.9999886751174927	O
35675	the	31 34	147636 147639	0.9999890327453613	O
35676	last	35 39	147640 147644	0.9999880790710449	O
35677	nucleotide	40 49	147645 147654	0.9999885559082031	O
35681	of	51 53	147656 147658	0.9999887943267822	O
35682	exon	54 57	147659 147662	0.9999886751174927	O
35684	7	59 60	147664 147665	0.9999878406524658	O
35685	in	61 63	147666 147668	0.9999892711639404	O
35686	patient	64 71	147669 147676	0.9999858140945435	O
35687	C633	72 75	147677 147680	0.999988317489624	O
35690	,	77 78	147682 147683	0.9999860525131226	O
35691	would	79 84	147684 147689	0.999987006187439	O
35692	theoretically	85 97	147690 147702	0.9999858140945435	O
35694	introduce	99 108	147704 147713	0.9999868869781494	O
35695	a	109 110	147714 147715	0.9999886751174927	O
35696	missense	111 118	147716 147723	0.999988317489624	O
35698	mutation	120 128	147725 147733	0.9999878406524658	O
35699	at	129 131	147734 147736	0.9999885559082031	O
35700	codon	132 136	147737 147741	0.999988317489624	O
35702	278	138 141	147743 147746	0.9999822378158569	O
35703	.	142 143	147747 147748	0.9999716281890869	O
35704	However	0 7	147749 147756	0.9999866485595703	O
35705	,	8 9	147757 147758	0.9999889135360718	O
35706	as	10 12	147759 147761	0.9999877214431763	O
35707	demonstrated	13 25	147762 147774	0.9999873638153076	O
35708	by	26 28	147775 147777	0.9999881982803345	O
35709	the	29 32	147778 147781	0.9999886751174927	O
35710	cDNA	33 36	147782 147785	0.9999885559082031	O
35713	sequencing	38 47	147787 147796	0.9999871253967285	O
35715	results	49 56	147798 147805	0.999988317489624	O
35716	(	57 58	147806 147807	0.9999890327453613	O
35717	Figure	59 65	147808 147814	0.9999854564666748	O
35718	4	66 67	147815 147816	0.9999871253967285	O
35719	)	68 69	147817 147818	0.9999892711639404	O
35720	the	70 73	147819 147822	0.9999886751174927	O
35721	mutation	74 82	147823 147831	0.9999843835830688	O
35722	leads	83 88	147832 147837	0.9999886751174927	O
35723	to	89 91	147838 147840	0.9999891519546509	O
35724	the	92 95	147841 147844	0.9999891519546509	O
35725	use	96 99	147845 147848	0.9999890327453613	O
35726	of	100 102	147849 147851	0.9999890327453613	O
35727	a	103 104	147852 147853	0.9999891519546509	O
35728	cryptic	105 111	147854 147860	0.9999891519546509	O
35730	splice	113 118	147862 147867	0.9999887943267822	O
35733	donor	120 125	147869 147874	0.9999889135360718	O
35734	site	126 130	147875 147879	0.9999890327453613	O
35735	11	131 133	147880 147882	0.9999887943267822	O
35736	bp	134 135	147883 147884	0.9999885559082031	O
35738	upstream	137 145	147886 147894	0.9999885559082031	O
35739	in	146 148	147895 147897	0.9999890327453613	O
35740	exon	149 152	147898 147901	0.9999886751174927	O
35742	7	154 155	147903 147904	0.9999879598617554	O
35743	.	155 156	147904 147905	0.9999778270721436	O
35744	This	0 4	147906 147910	0.999987006187439	O
35745	real	5 9	147911 147915	0.9999852180480957	O
35746	outcome	10 17	147916 147923	0.9999862909317017	O
35747	of	18 20	147924 147926	0.999988317489624	O
35748	the	21 24	147927 147930	0.9999878406524658	O
35749	mutation	25 33	147931 147939	0.9999847412109375	O
35750	would	34 39	147940 147945	0.9999818801879883	O
35751	easily	40 46	147946 147952	0.9999831914901733	O
35752	have	47 51	147953 147957	0.999985933303833	O
35753	been	52 56	147958 147962	0.9999872446060181	O
35754	overlooked	57 67	147963 147973	0.9999819993972778	O
35755	unless	68 74	147974 147980	0.9999814033508301	O
35756	the	75 78	147981 147984	0.999988317489624	O
35757	RNA	79 82	147985 147988	0.9999877214431763	O
35758	-	82 83	147988 147989	0.9999892711639404	O
35759	based	83 88	147989 147994	0.9999890327453613	O
35760	methods	89 96	147995 148002	0.999988317489624	O
35761	had	97 100	148003 148006	0.9999866485595703	O
35762	been	101 105	148007 148011	0.9999879598617554	O
35763	used	106 110	148012 148016	0.9999871253967285	O
35764	.	111 112	148017 148018	0.9999585151672363	O
35765	Other	0 5	148019 148024	0.9999815225601196	O
35766	examples	6 14	148025 148033	0.9999841451644897	O
35767	of	15 17	148034 148036	0.9999872446060181	O
35768	aberrant	18 25	148037 148044	0.9999874830245972	O
35771	splicing	27 34	148046 148053	0.9999878406524658	O
35774	of	36 38	148055 148057	0.9999880790710449	O
35775	the	39 42	148058 148061	0.9999880790710449	O
35776	APC	43 45	148062 148064	0.9999803304672241	O
35778	gene	47 51	148066 148070	0.9999868869781494	O
35779	due	52 55	148071 148074	0.9999889135360718	O
35780	to	56 58	148075 148077	0.9999887943267822	O
35781	missense	59 66	148078 148085	0.9999880790710449	O
35783	mutations	68 77	148087 148096	0.999985933303833	O
35784	have	78 82	148097 148101	0.9999876022338867	O
35785	recently	83 91	148102 148110	0.9999867677688599	O
35786	been	92 96	148111 148115	0.9999886751174927	O
35787	described	97 106	148116 148125	0.999988317489624	O
35788	[	107 108	148126 148127	0.9999891519546509	O
35789	16	108 110	148127 148129	0.9999868869781494	O
35790	]	110 111	148129 148130	0.9999885559082031	O
35791	.	112 113	148131 148132	0.9999752044677734	O
35792	One	0 3	148133 148136	0.9999843835830688	O
35793	case	4 8	148137 148141	0.9999871253967285	O
35794	of	9 11	148142 148144	0.9999887943267822	O
35795	use	12 15	148145 148148	0.9999877214431763	O
35796	of	16 18	148149 148151	0.9999890327453613	O
35797	aberrant	19 26	148152 148159	0.9999890327453613	O
35800	splice	28 33	148161 148166	0.9999892711639404	O
35803	-	34 35	148167 148168	0.9999892711639404	O
35804	acceptor	35 42	148168 148175	0.9999886751174927	O
35806	site	44 48	148177 148181	0.9999890327453613	O
35807	of	49 51	148182 148184	0.9999887943267822	O
35808	APC	52 54	148185 148187	0.9999855756759644	O
35810	exon	56 59	148189 148192	0.99998939037323	O
35812	8	61 62	148194 148195	0.9999878406524658	O
35813	has	63 66	148196 148199	0.9999885559082031	O
35814	been	67 71	148200 148204	0.9999889135360718	O
35815	reported	72 80	148205 148213	0.9999880790710449	O
35816	previously	81 91	148214 148224	0.9999860525131226	O
35817	in	92 94	148225 148227	0.999988317489624	O
35818	a	95 96	148228 148229	0.9999874830245972	O
35819	patient	97 104	148230 148237	0.9999796152114868	O
35820	with	105 109	148238 148242	0.9999880790710449	O
35821	classical	110 119	148243 148252	0.9999829530715942	O
35822	polyposis	120 128	148253 148261	0.9999862909317017	O
35826	[	130 131	148263 148264	0.9999895095825195	O
35827	15	131 133	148264 148266	0.9999861717224121	O
35828	]	133 134	148266 148267	0.9999890327453613	O
35829	.	135 136	148268 148269	0.999975323677063	O
35830	However	0 7	148270 148277	0.9999861717224121	O
35831	,	8 9	148278 148279	0.999988317489624	O
35832	an	10 12	148280 148282	0.9999881982803345	O
35833	alternative	13 24	148283 148294	0.9999878406524658	O
35834	acceptor	25 32	148295 148302	0.9999877214431763	O
35836	splice	34 39	148304 148309	0.999988317489624	O
35839	site	41 45	148311 148315	0.9999877214431763	O
35840	(	46 47	148316 148317	0.9999884366989136	O
35841	c	48 49	148318 148319	0.9999879598617554	O
35842	.	49 50	148319 148320	0.9999881982803345	O
35843	845	50 52	148320 148322	0.9999872446060181	O
35845	-	53 54	148323 148324	0.9999881982803345	O
35846	17A	54 56	148324 148326	0.9999855756759644	O
35848	>	58 59	148328 148329	0.9999873638153076	O
35849	G	60 61	148330 148331	0.9999868869781494	O
35850	)	62 63	148332 148333	0.9999886751174927	O
35851	in	64 66	148334 148336	0.9999884366989136	O
35852	intron	67 72	148337 148342	0.9999874830245972	O
35854	7	74 75	148344 148345	0.999987006187439	O
35855	has	76 79	148346 148349	0.9999881982803345	O
35856	been	80 84	148350 148354	0.9999878406524658	O
35857	reported	85 93	148355 148363	0.999987006187439	O
35858	from	94 98	148364 148368	0.9999855756759644	O
35859	a	99 100	148369 148370	0.9999873638153076	O
35860	patient	101 108	148371 148378	0.9999643564224243	O
35861	with	109 113	148379 148383	0.9999877214431763	O
35862	a	114 115	148384 148385	0.9999881982803345	O
35863	milder	116 121	148386 148391	0.9999823570251465	O
35865	phenotype	123 131	148393 148401	0.9999878406524658	O
35868	,	133 134	148403 148404	0.9999852180480957	O
35869	multiple	135 143	148405 148413	0.9999818801879883	O
35870	synchronous	144 154	148414 148424	0.9999881982803345	O
35875	colorectal	156 165	148426 148435	0.9999818801879883	O
35878	adenomas	167 174	148437 148444	0.9999849796295166	O
35881	[	176 177	148446 148447	0.9999884366989136	O
35882	45	177 179	148447 148449	0.9999839067459106	O
35883	]	179 180	148449 148450	0.9999878406524658	O
35884	.	181 182	148451 148452	0.9999886751174927	O
35885	*	183 184	148453 148454	0.9999867677688599	O
35886	*	184 185	148454 148455	0.9999746084213257	O
35887	IGNORE	0 5	148456 148461	0.9999866485595703	O
35890	LINE	7 10	148463 148466	0.9999887943267822	O
35893	*	12 13	148468 148469	0.99998939037323	O
35894	*	13 14	148469 148470	0.9999892711639404	O
35895	*	15 16	148471 148472	0.9999892711639404	O
35896	*	16 17	148472 148473	0.9999892711639404	O
35897	IGNORE	18 23	148474 148479	0.9999881982803345	O
35900	LINE	25 28	148481 148484	0.99998939037323	O
35903	*	30 31	148486 148487	0.9999891519546509	O
35904	*	31 32	148487 148488	0.9999891519546509	O
35905	*	33 34	148489 148490	0.9999891519546509	O
35906	*	34 35	148490 148491	0.9999891519546509	O
35907	IGNORE	36 41	148492 148497	0.9999879598617554	O
35910	LINE	43 46	148499 148502	0.9999892711639404	O
35913	*	48 49	148504 148505	0.9999892711639404	O
35914	*	49 50	148505 148506	0.9999892711639404	O
35915	Owing	51 55	148507 148511	0.9999874830245972	O
35917	to	57 59	148513 148515	0.99998939037323	O
35918	the	60 63	148516 148519	0.99998939037323	O
35919	fact	64 68	148520 148524	0.9999877214431763	O
35920	that	69 73	148525 148529	0.9999896287918091	O
35921	RNA	74 77	148530 148533	0.9999871253967285	O
35922	-	77 78	148533 148534	0.9999896287918091	O
35923	based	78 83	148534 148539	0.9999889135360718	O
35924	PTT	84 86	148540 148542	0.9999872446060181	O
35926	was	88 91	148544 148547	0.9999889135360718	O
35927	used	92 96	148548 148552	0.9999886751174927	O
35928	at	97 99	148553 148555	0.99998939037323	O
35929	the	100 103	148556 148559	0.9999897480010986	O
35930	initial	104 111	148560 148567	0.99998939037323	O
35931	stage	112 117	148568 148573	0.99998939037323	O
35932	of	118 120	148574 148576	0.9999895095825195	O
35933	the	121 124	148577 148580	0.9999892711639404	O
35934	mutational	125 134	148581 148590	0.9999867677688599	O
35936	screening	136 145	148592 148601	0.9999873638153076	O
35937	,	146 147	148602 148603	0.9999886751174927	O
35938	detection	148 157	148604 148613	0.9999874830245972	O
35939	of	158 160	148614 148616	0.9999891519546509	O
35940	the	161 164	148617 148620	0.9999887943267822	O
35941	disease	165 172	148621 148628	0.9999852180480957	O
35942	-	172 173	148628 148629	0.99998939037323	O
35943	causing	173 180	148629 148636	0.9999874830245972	O
35944	splice	181 186	148637 148642	0.99998939037323	O
35947	-	187 188	148643 148644	0.9999895095825195	O
35948	site	188 192	148644 148648	0.9999884366989136	O
35949	mutations	193 202	148649 148658	0.9999876022338867	O
35950	was	203 206	148659 148662	0.9999879598617554	O
35951	straightforward	207 222	148663 148678	0.9999823570251465	O
35952	.	223 224	148679 148680	0.9999648332595825	O
35953	Sequencing	0 9	148681 148690	0.9999867677688599	O
35955	of	11 13	148692 148694	0.9999885559082031	O
35956	genomic	14 20	148695 148701	0.9999881982803345	O
35959	DNA	22 25	148703 148706	0.9999858140945435	O
35960	was	26 29	148707 148710	0.999987006187439	O
35961	then	30 34	148711 148715	0.9999833106994629	O
35962	used	35 39	148716 148720	0.9999873638153076	O
35963	to	40 42	148721 148723	0.9999886751174927	O
35964	pinpoint	43 50	148724 148731	0.9999877214431763	O
35966	the	52 55	148733 148736	0.9999892711639404	O
35967	genetic	56 63	148737 148744	0.9999874830245972	O
35968	alteration	64 73	148745 148754	0.9999881982803345	O
35970	causing	75 82	148756 148763	0.9999872446060181	O
35971	the	83 86	148764 148767	0.9999891519546509	O
35972	aberrant	87 94	148768 148775	0.99998939037323	O
35975	mRNA	96 99	148777 148780	0.9999885559082031	O
35977	sequence	101 109	148782 148790	0.9999874830245972	O
35978	that	110 114	148791 148795	0.9999886751174927	O
35979	was	115 118	148796 148799	0.9999889135360718	O
35980	visualized	119 128	148800 148809	0.9999868869781494	O
35982	in	130 132	148811 148813	0.9999884366989136	O
35983	the	133 136	148814 148817	0.9999887943267822	O
35984	PTT	137 139	148818 148820	0.9999864101409912	O
35986	experiments	141 152	148822 148833	0.9999818801879883	O
35987	.	153 154	148834 148835	0.9999690055847168	O
35988	The	0 3	148836 148839	0.9999852180480957	O
35989	use	4 7	148840 148843	0.9999845027923584	O
35990	of	8 10	148844 148846	0.9999876022338867	O
35991	both	11 15	148847 148851	0.9999845027923584	O
35992	DNA	16 19	148852 148855	0.9999854564666748	O
35993	-	20 21	148856 148857	0.9999887943267822	O
35994	and	22 25	148858 148861	0.9999850988388062	O
35995	mRNA	26 29	148862 148865	0.9999862909317017	O
35997	-	30 31	148866 148867	0.9999886751174927	O
35998	based	31 36	148867 148872	0.9999877214431763	O
35999	methods	37 44	148873 148880	0.9999850988388062	O
36000	is	45 47	148881 148883	0.999983549118042	O
36001	a	48 49	148884 148885	0.999987006187439	O
36002	prerequisite	50 61	148886 148897	0.9999867677688599	O
36005	for	63 66	148899 148902	0.9999866485595703	O
36006	high	67 71	148903 148907	0.9999876022338867	O
36007	-	71 72	148907 148908	0.9999886751174927	O
36008	quality	72 79	148908 148915	0.999987006187439	O
36009	investigation	80 93	148916 148929	0.9999856948852539	O
36010	of	94 96	148930 148932	0.9999876022338867	O
36011	splice	97 102	148933 148938	0.999988317489624	O
36014	-	103 104	148939 148940	0.9999884366989136	O
36015	site	104 108	148940 148944	0.9999879598617554	O
36016	mutations	109 118	148945 148954	0.9999867677688599	O
36017	.	119 120	148955 148956	0.9999561309814453	O
36018	A	0 1	148957 148958	0.9999881982803345	O
36019	case	2 6	148959 148963	0.9999876022338867	O
36020	of	7 9	148964 148966	0.9999890327453613	O
36021	reduced	10 17	148967 148974	0.9999853372573853	O
36022	APC	18 20	148975 148977	0.9999843835830688	O
36024	expression	22 32	148979 148989	0.999988317489624	O
36025	The	33 36	148990 148993	0.9999889135360718	O
36026	study	37 42	148994 148999	0.9999885559082031	O
36027	of	43 45	149000 149002	0.9999895095825195	O
36028	mRNA	46 49	149003 149006	0.9999887943267822	O
36030	levels	51 57	149008 149014	0.9999892711639404	O
36031	was	58 61	149015 149018	0.9999890327453613	O
36032	the	62 65	149019 149022	0.9999895095825195	O
36033	next	66 70	149023 149027	0.9999886751174927	O
36034	step	71 75	149028 149032	0.9999889135360718	O
36035	in	76 78	149033 149035	0.99998939037323	O
36036	the	79 82	149036 149039	0.9999895095825195	O
36037	line	83 87	149040 149044	0.999988317489624	O
36038	of	88 90	149045 149047	0.99998939037323	O
36039	investigation	91 104	149048 149061	0.9999884366989136	O
36040	of	105 107	149062 149064	0.9999895095825195	O
36041	the	108 111	149065 149068	0.9999895095825195	O
36042	cause	112 117	149069 149074	0.9999886751174927	O
36043	of	118 120	149075 149077	0.9999889135360718	O
36044	disease	121 128	149078 149085	0.9999871253967285	O
36045	in	129 131	149086 149088	0.9999895095825195	O
36046	patients	132 140	149089 149097	0.9999872446060181	O
36047	with	141 145	149098 149102	0.9999896287918091	O
36048	no	146 148	149103 149105	0.9999890327453613	O
36049	detected	149 157	149106 149114	0.9999885559082031	O
36050	APC	158 160	149115 149117	0.9999865293502808	O
36052	mutation	162 170	149119 149127	0.9999885559082031	O
36053	.	171 172	149128 149129	0.9999775886535645	O
36054	Family	0 6	149130 149136	0.9999780654907227	O
36055	1	7 8	149137 149138	0.9999748468399048	O
36056	is	9 11	149139 149141	0.999984622001648	O
36057	the	12 15	149142 149145	0.999984860420227	O
36058	largest	16 23	149146 149153	0.9999586343765259	O
36059	kindred	24 30	149154 149160	0.9999773502349854	O
36061	in	32 34	149162 149164	0.999984860420227	O
36062	the	35 38	149165 149168	0.9999831914901733	O
36063	Swedish	39 46	149169 149176	0.9908872842788696	O
36064	Polyposis	47 55	149177 149185	0.9999818801879883	O
36068	Registry	57 64	149187 149194	0.9999849796295166	O
36070	;	66 67	149196 149197	0.9999842643737793	O
36071	this	68 72	149198 149202	0.9999840259552002	O
36072	family	73 79	149203 149209	0.9999728202819824	O
36073	includes	80 88	149210 149218	0.9999853372573853	O
36074	150	89 92	149219 149222	0.9999561309814453	O
36075	individuals	93 104	149223 149234	0.9998469352722168	O
36076	of	105 107	149235 149237	0.9999836683273315	O
36077	whom	108 112	149238 149242	0.9999845027923584	O
36078	57	113 115	149243 149245	0.9999656677246094	O
36079	are	116 119	149246 149249	0.9999860525131226	O
36080	affected	120 128	149250 149258	0.9999842643737793	O
36081	by	129 131	149259 149261	0.9999868869781494	O
36082	the	132 135	149262 149265	0.9999842643737793	O
36083	disease	136 143	149266 149273	0.9999833106994629	O
36084	(	144 145	149274 149275	0.9999881982803345	O
36085	Figure	146 152	149276 149282	0.9999855756759644	O
36086	6	153 154	149283 149284	0.9999879598617554	O
36087	shows	155 160	149285 149290	0.9999864101409912	O
36088	part	161 165	149291 149295	0.9999878406524658	O
36089	of	166 168	149296 149298	0.9999874830245972	O
36090	the	169 172	149299 149302	0.9999860525131226	O
36091	pedigree	173 180	149303 149310	0.9999877214431763	O
36095	)	182 183	149312 149313	0.9999868869781494	O
36096	.	184 185	149314 149315	0.9999700784683228	O
36097	However	0 7	149316 149323	0.9999884366989136	O
36098	,	8 9	149324 149325	0.9999892711639404	O
36099	no	10 12	149326 149328	0.9999880790710449	O
36100	pathogenic	13 22	149329 149338	0.9999879598617554	O
36102	mutation	24 32	149340 149348	0.999983549118042	O
36103	had	33 36	149349 149352	0.9999881982803345	O
36104	been	37 41	149353 149357	0.9999890327453613	O
36105	detected	42 50	149358 149366	0.9999889135360718	O
36106	after	51 56	149367 149372	0.9999885559082031	O
36107	screening	57 66	149373 149382	0.9999881982803345	O
36108	the	67 70	149383 149386	0.9999895095825195	O
36109	whole	71 76	149387 149392	0.999988317489624	O
36110	coding	77 83	149393 149399	0.9999891519546509	O
36111	region	84 90	149400 149406	0.9999891519546509	O
36112	of	91 93	149407 149409	0.9999892711639404	O
36113	the	94 97	149410 149413	0.9999895095825195	O
36114	APC	98 100	149414 149416	0.9999854564666748	O
36116	gene	102 106	149418 149422	0.9999889135360718	O
36117	but	107 110	149423 149426	0.9999879598617554	O
36118	as	111 113	149427 149429	0.9999865293502808	O
36119	the	114 117	149430 149433	0.9999874830245972	O
36120	family	118 124	149434 149440	0.9999741315841675	O
36121	did	125 128	149441 149444	0.9999879598617554	O
36122	show	129 133	149445 149449	0.9999890327453613	O
36123	positive	134 142	149450 149458	0.9999886751174927	O
36124	linkage	143 149	149459 149465	0.9999889135360718	O
36126	to	151 153	149467 149469	0.99998939037323	O
36127	the	154 157	149470 149473	0.9999895095825195	O
36128	APC	158 160	149474 149476	0.9999876022338867	O
36130	locus	162 166	149478 149482	0.9999891519546509	O
36132	we	168 170	149484 149486	0.9999887943267822	O
36133	decided	171 178	149487 149494	0.9999881982803345	O
36134	to	179 181	149495 149497	0.99998939037323	O
36135	perform	182 189	149498 149505	0.9999886751174927	O
36136	expression	190 200	149506 149516	0.9999876022338867	O
36137	analyses	201 209	149517 149525	0.999988317489624	O
36138	and	210 213	149526 149529	0.9999890327453613	O
36139	evidence	214 222	149530 149538	0.9999881982803345	O
36140	of	223 225	149539 149541	0.9999891519546509	O
36141	lowered	226 233	149542 149549	0.9999845027923584	O
36142	APC	234 236	149550 149552	0.9999865293502808	O
36144	expression	238 248	149554 149564	0.9999889135360718	O
36145	was	249 252	149565 149568	0.99998939037323	O
36146	obtained	253 261	149569 149577	0.9999892711639404	O
36147	by	262 264	149578 149580	0.99998939037323	O
36148	quantitative	265 277	149581 149593	0.999988317489624	O
36149	real	278 282	149594 149598	0.9999889135360718	O
36150	-	282 283	149598 149599	0.9999892711639404	O
36151	time	283 287	149599 149603	0.9999885559082031	O
36152	PCR	288 290	149604 149606	0.9999881982803345	O
36154	(	292 293	149608 149609	0.99998939037323	O
36155	Figure	294 300	149610 149616	0.9999862909317017	O
36156	5A	301 302	149617 149618	0.9999872446060181	O
36158	)	304 305	149620 149621	0.9999896287918091	O
36159	.	306 307	149622 149623	0.9999759197235107	O
36160	The	0 3	149624 149627	0.9999889135360718	O
36161	result	4 10	149628 149634	0.9999879598617554	O
36162	was	11 14	149635 149638	0.9999889135360718	O
36163	supported	15 24	149639 149648	0.9999876022338867	O
36164	by	25 27	149649 149651	0.99998939037323	O
36165	the	28 31	149652 149655	0.9999895095825195	O
36166	indication	32 42	149656 149666	0.9999885559082031	O
36167	of	43 45	149667 149669	0.9999897480010986	O
36168	a	46 47	149670 149671	0.9999897480010986	O
36169	lower	48 53	149672 149677	0.9999873638153076	O
36170	expression	54 64	149678 149688	0.9999887943267822	O
36171	from	65 69	149689 149693	0.9999896287918091	O
36172	the	70 73	149694 149697	0.9999899864196777	O
36173	T	74 75	149698 149699	0.9999885559082031	O
36174	-	75 76	149699 149700	0.9999898672103882	O
36175	allele	76 81	149700 149705	0.9999892711639404	O
36177	from	83 87	149707 149711	0.99998939037323	O
36178	analysis	88 96	149712 149720	0.99998939037323	O
36179	of	97 99	149721 149723	0.9999897480010986	O
36180	the	100 103	149724 149727	0.9999897480010986	O
36181	APC	104 106	149728 149730	0.9999872446060181	O
36183	c	108 109	149732 149733	0.9999897480010986	O
36184	.	109 110	149733 149734	0.9999898672103882	O
36185	5465A	110 114	149734 149738	0.9999877214431763	O
36188	>	116 117	149740 149741	0.9999889135360718	O
36189	T	118 119	149742 149743	0.9999885559082031	O
36190	polymorphism	120 131	149744 149755	0.9999896287918091	O
36194	in	133 135	149757 149759	0.9999895095825195	O
36195	the	136 139	149760 149763	0.9999896287918091	O
36196	cDNA	140 143	149764 149767	0.99998939037323	O
36199	sequencing	145 154	149769 149778	0.9999889135360718	O
36201	diagram	156 163	149780 149787	0.9999871253967285	O
36202	of	164 166	149788 149790	0.9999895095825195	O
36203	two	167 170	149791 149794	0.9999842643737793	O
36204	affected	171 179	149795 149803	0.9999865293502808	O
36205	family	180 186	149804 149810	0.9999861717224121	O
36206	members	187 194	149811 149818	0.9999873638153076	O
36207	(	195 196	149819 149820	0.9999897480010986	O
36208	Figure	197 203	149821 149827	0.999987006187439	O
36209	5B	204 205	149828 149829	0.9999889135360718	O
36211	)	207 208	149831 149832	0.9999897480010986	O
36212	.	209 210	149833 149834	0.9999765157699585	O
36213	The	0 3	149835 149838	0.9999881982803345	O
36214	search	4 10	149839 149845	0.9999855756759644	O
36215	for	11 14	149846 149849	0.9999886751174927	O
36216	mutations	15 24	149850 149859	0.9999842643737793	O
36217	in	25 27	149860 149862	0.9999887943267822	O
36218	the	28 31	149863 149866	0.9999890327453613	O
36219	DNA	32 35	149867 149870	0.9999860525131226	O
36220	sequence	36 44	149871 149879	0.9999855756759644	O
36221	of	45 47	149880 149882	0.9999881982803345	O
36222	the	48 51	149883 149886	0.9999884366989136	O
36223	APC	52 54	149887 149889	0.9999793767929077	O
36225	promoters	56 64	149891 149899	0.9999866485595703	O
36227	has	66 69	149901 149904	0.9999880790710449	O
36228	been	70 74	149905 149909	0.9999889135360718	O
36229	initiated	75 84	149910 149919	0.9999881982803345	O
36230	,	85 86	149920 149921	0.9999880790710449	O
36231	but	87 90	149922 149925	0.9999872446060181	O
36232	no	91 93	149926 149928	0.9999877214431763	O
36233	pathogenic	94 103	149929 149938	0.9999879598617554	O
36235	change	105 111	149940 149946	0.9999873638153076	O
36236	has	112 115	149947 149950	0.9999887943267822	O
36237	been	116 120	149951 149955	0.9999890327453613	O
36238	detected	121 129	149956 149964	0.9999887943267822	O
36239	to	130 132	149965 149967	0.9999871253967285	O
36240	this	133 137	149968 149972	0.9999889135360718	O
36241	date	138 142	149973 149977	0.999988317489624	O
36242	.	143 144	149978 149979	0.9999747276306152	O
36243	The	0 3	149980 149983	0.9999862909317017	O
36244	possibility	4 15	149984 149995	0.9999845027923584	O
36245	of	16 18	149996 149998	0.9999873638153076	O
36246	the	19 22	149999 150002	0.9999871253967285	O
36247	pathogenic	23 32	150003 150012	0.9999860525131226	O
36249	change	34 40	150014 150020	0.9999864101409912	O
36250	being	41 46	150021 150026	0.9999868869781494	O
36251	epigenetic	47 56	150027 150036	0.9999876022338867	O
36255	will	58 62	150038 150042	0.9999843835830688	O
36256	have	63 67	150043 150047	0.9999845027923584	O
36257	to	68 70	150048 150050	0.9999864101409912	O
36258	be	71 73	150051 150053	0.9999871253967285	O
36259	investigated	74 86	150054 150066	0.9999841451644897	O
36260	further	87 94	150067 150074	0.9999831914901733	O
36261	.	95 96	150075 150076	0.9999493360519409	O
36262	Hypermethylation	0 15	150077 150092	0.9999878406524658	O
36267	of	17 19	150094 150096	0.9999879598617554	O
36268	CpG	20 22	150097 150099	0.9999881982803345	O
36271	sites	24 29	150101 150106	0.9999867677688599	O
36272	in	30 32	150107 150109	0.9999884366989136	O
36273	the	33 36	150110 150113	0.9999886751174927	O
36274	promoter	37 45	150114 150122	0.999984622001648	O
36275	of	46 48	150123 150125	0.9999884366989136	O
36276	APC	49 51	150126 150128	0.9999829530715942	O
36278	has	53 56	150130 150133	0.9999881982803345	O
36279	been	57 61	150134 150138	0.9999884366989136	O
36280	reported	62 70	150139 150147	0.9999861717224121	O
36281	as	71 73	150148 150150	0.9999880790710449	O
36282	a	74 75	150151 150152	0.9999889135360718	O
36283	means	76 81	150153 150158	0.9999862909317017	O
36284	of	82 84	150159 150161	0.9999885559082031	O
36285	gene	85 89	150162 150166	0.9999864101409912	O
36286	silencing	90 98	150167 150175	0.9999868869781494	O
36289	in	100 102	150177 150179	0.9999876022338867	O
36290	colorectal	103 112	150180 150189	0.9999834299087524	O
36293	tumors	114 120	150191 150197	0.9999852180480957	O
36294	[	121 122	150198 150199	0.99998939037323	O
36295	46	122 124	150199 150201	0.9999873638153076	O
36296	-	124 125	150201 150202	0.9999891519546509	O
36297	49	125 127	150202 150204	0.9999850988388062	O
36298	]	127 128	150204 150205	0.9999890327453613	O
36299	.	129 130	150206 150207	0.9999750852584839	O
36300	To	0 2	150208 150210	0.9999854564666748	O
36301	the	3 6	150211 150214	0.9999880790710449	O
36302	best	7 11	150215 150219	0.9999866485595703	O
36303	of	12 14	150220 150222	0.9999865293502808	O
36304	the	15 18	150223 150226	0.9999867677688599	O
36305	authors	19 26	150227 150234	0.9999827146530151	O
36306	'	27 28	150235 150236	0.9999865293502808	O
36307	knowledge	29 38	150237 150246	0.9999856948852539	O
36308	no	39 41	150247 150249	0.9999856948852539	O
36309	germ	42 45	150250 150253	0.9999886751174927	O
36312	-	46 47	150254 150255	0.9999891519546509	O
36313	line	47 51	150255 150259	0.9999874830245972	O
36314	inactivation	52 63	150260 150271	0.9999890327453613	O
36317	of	65 67	150273 150275	0.9999885559082031	O
36318	APC	68 70	150276 150278	0.9999841451644897	O
36320	caused	72 78	150280 150286	0.9999887943267822	O
36321	by	79 81	150287 150289	0.9999890327453613	O
36322	promoter	82 90	150290 150298	0.999988317489624	O
36323	hypermethylation	91 106	150299 150314	0.9999892711639404	O
36328	has	108 111	150316 150319	0.9999873638153076	O
36329	been	112 116	150320 150324	0.9999876022338867	O
36330	reported	117 125	150325 150333	0.999987006187439	O
36331	.	126 127	150334 150335	0.9999717473983765	O
36332	However	0 7	150336 150343	0.9999855756759644	O
36333	,	8 9	150344 150345	0.9999884366989136	O
36334	cases	10 15	150346 150351	0.9999858140945435	O
36335	of	16 18	150352 150354	0.9999884366989136	O
36336	pathogenic	19 28	150355 150364	0.9999880790710449	O
36338	germline	30 37	150366 150373	0.9999880790710449	O
36342	epimutations	39 50	150375 150386	0.9999891519546509	O
36346	have	52 56	150388 150392	0.9999886751174927	O
36347	been	57 61	150393 150397	0.9999889135360718	O
36348	identified	62 72	150398 150408	0.9999885559082031	O
36349	in	73 75	150409 150411	0.9999887943267822	O
36350	the	76 79	150412 150415	0.9999889135360718	O
36351	MLH1	80 83	150416 150419	0.999984860420227	O
36354	gene	85 89	150421 150425	0.9999880790710449	O
36355	,	90 91	150426 150427	0.9999887943267822	O
36356	which	92 97	150428 150433	0.9999890327453613	O
36357	causes	98 104	150434 150440	0.9999874830245972	O
36358	hereditary	105 115	150441 150451	0.9999698400497437	O
36359	non	116 119	150452 150455	0.9999856948852539	O
36360	-	119 120	150455 150456	0.9999877214431763	O
36361	polyposis	120 128	150456 150464	0.9999854564666748	O
36365	CRC	130 132	150466 150468	0.9999845027923584	O
36367	[	134 135	150470 150471	0.99998939037323	O
36368	50	135 137	150471 150473	0.9999858140945435	O
36369	,	137 138	150473 150474	0.9999881982803345	O
36370	51	138 140	150474 150476	0.9999855756759644	O
36371	]	140 141	150476 150477	0.9999887943267822	O
36372	.	142 143	150478 150479	0.9999781847000122	O
36373	Mutation	0 7	150480 150487	0.9999856948852539	O
36375	-	8 9	150488 150489	0.9999867677688599	O
36376	detection	9 18	150489 150498	0.9999864101409912	O
36377	frequency	19 28	150499 150508	0.999984860420227	O
36378	The	29 32	150509 150512	0.9999786615371704	O
36379	61	33 35	150513 150515	0.9999738931655884	O
36380	different	36 45	150516 150525	0.9999812841415405	O
36381	APC	46 48	150526 150528	0.99997878074646	O
36383	mutations	50 59	150530 150539	0.999984860420227	O
36384	listed	60 66	150540 150546	0.9999877214431763	O
36385	in	67 69	150547 150549	0.9999885559082031	O
36386	Additional	70 80	150550 150560	0.999985933303833	O
36387	file	81 85	150561 150565	0.9999880790710449	O
36388	2	86 87	150566 150567	0.9999868869781494	O
36389	were	88 92	150568 150572	0.999988317489624	O
36390	identified	93 103	150573 150583	0.9999881982803345	O
36391	among	104 109	150584 150589	0.9999878406524658	O
36392	81	110 112	150590 150592	0.9999703168869019	O
36393	of	113 115	150593 150595	0.9999862909317017	O
36394	the	116 119	150596 150599	0.9999839067459106	O
36395	96	120 122	150600 150602	0.9999566078186035	O
36396	families	123 131	150603 150611	0.99997878074646	O
36397	of	132 134	150612 150614	0.9999861717224121	O
36398	the	135 138	150615 150618	0.9999841451644897	O
36399	Swedish	139 146	150619 150626	0.9982039928436279	O
36400	Polyposis	147 155	150627 150635	0.9999856948852539	O
36404	Registry	157 164	150637 150644	0.9999871253967285	O
36406	that	166 170	150646 150650	0.9999865293502808	O
36407	were	171 175	150651 150655	0.9999877214431763	O
36408	screened	176 184	150656 150664	0.9999841451644897	O
36409	for	185 188	150665 150668	0.9999872446060181	O
36410	APC	189 191	150669 150671	0.9999837875366211	O
36412	mutations	193 202	150673 150682	0.9999843835830688	O
36413	.	203 204	150683 150684	0.9999701976776123	O
36414	Fifteen	0 7	150685 150692	0.999974250793457	O
36415	of	8 10	150693 150695	0.9999879598617554	O
36416	the	11 14	150696 150699	0.9999871253967285	O
36417	cases	15 20	150700 150705	0.999987006187439	O
36418	shown	21 26	150706 150711	0.9999886751174927	O
36419	to	27 29	150712 150714	0.99998939037323	O
36420	be	30 32	150715 150717	0.9999892711639404	O
36421	APC	33 35	150718 150720	0.9999845027923584	O
36423	-	36 37	150721 150722	0.9999891519546509	O
36424	mutation	37 45	150722 150730	0.9999880790710449	O
36425	negative	46 54	150731 150739	0.9999867677688599	O
36426	where	55 60	150740 150745	0.9999880790710449	O
36427	all	61 64	150746 150749	0.9999885559082031	O
36428	subjected	65 74	150750 150759	0.9999884366989136	O
36429	to	75 77	150760 150762	0.99998939037323	O
36430	mutational	78 87	150763 150772	0.9999879598617554	O
36432	screening	89 98	150774 150783	0.999988317489624	O
36433	of	99 101	150784 150786	0.9999892711639404	O
36434	the	102 105	150787 150790	0.99998939037323	O
36435	MUTYH	106 110	150791 150795	0.999988317489624	O
36439	gene	112 116	150797 150801	0.9999891519546509	O
36440	and	117 120	150802 150805	0.9999879598617554	O
36441	six	121 124	150806 150809	0.9999845027923584	O
36442	of	125 127	150810 150812	0.9999891519546509	O
36443	them	128 132	150813 150817	0.9999885559082031	O
36444	were	133 137	150818 150822	0.9999891519546509	O
36445	shown	138 143	150823 150828	0.9999887943267822	O
36446	to	144 146	150829 150831	0.9999892711639404	O
36447	carry	147 152	150832 150837	0.9999886751174927	O
36448	biallelic	153 161	150838 150846	0.999988317489624	O
36451	MUTYH	163 167	150848 150852	0.9999889135360718	O
36455	mutations	169 178	150854 150863	0.9999887943267822	O
36456	(	179 180	150864 150865	0.9999892711639404	O
36457	reported	181 189	150866 150874	0.9999887943267822	O
36458	in	190 192	150875 150877	0.9999892711639404	O
36459	Kanter	193 198	150878 150883	0.9999864101409912	O
36461	Smoler	200 205	150885 150890	0.9999892711639404	O
36464	et	207 209	150892 150894	0.9999891519546509	O
36465	al	210 212	150895 150897	0.9999889135360718	O
36466	[	212 213	150897 150898	0.9999890327453613	O
36467	31	213 215	150898 150900	0.9999876022338867	O
36468	]	215 216	150900 150901	0.9999887943267822	O
36469	)	217 218	150902 150903	0.9999895095825195	O
36470	.	219 220	150904 150905	0.9999737739562988	O
36471	The	0 3	150906 150909	0.9999874830245972	O
36472	overall	4 11	150910 150917	0.9999872446060181	O
36473	mutation	12 20	150918 150926	0.9999839067459106	O
36474	-	20 21	150926 150927	0.9999879598617554	O
36475	detection	21 30	150927 150936	0.9999872446060181	O
36476	rate	31 35	150937 150941	0.9999877214431763	O
36477	in	36 38	150942 150944	0.9999880790710449	O
36478	APC	39 41	150945 150947	0.9999849796295166	O
36480	and	43 46	150949 150952	0.9999876022338867	O
36481	MUTYH	47 51	150953 150957	0.9999862909317017	O
36485	among	53 58	150959 150964	0.9999873638153076	O
36486	the	59 62	150965 150968	0.9999854564666748	O
36487	families	63 71	150969 150977	0.9999809265136719	O
36488	in	72 74	150978 150980	0.9999871253967285	O
36489	our	75 78	150981 150984	0.9999796152114868	O
36490	study	79 84	150985 150990	0.9999841451644897	O
36491	was	85 88	150991 150994	0.9999880790710449	O
36492	thus	89 93	150995 150999	0.9999858140945435	O
36493	90	94 96	151000 151002	0.9999855756759644	O
36494	%	97 98	151003 151004	0.9999880790710449	O
36495	.	99 100	151005 151006	0.9999701976776123	O
36496	In	0 2	151007 151009	0.9999871253967285	O
36497	total	3 8	151010 151015	0.9999836683273315	O
36498	,	9 10	151016 151017	0.9999873638153076	O
36499	84	11 13	151018 151020	0.9999754428863525	O
36500	%	14 15	151021 151022	0.9999860525131226	O
36501	of	16 18	151023 151025	0.9999855756759644	O
36502	the	19 22	151026 151029	0.999980092048645	O
36503	families	23 31	151030 151038	0.9999700784683228	O
36504	carried	32 39	151039 151046	0.9999862909317017	O
36505	APC	40 42	151047 151049	0.9999828338623047	O
36507	mutations	44 53	151051 151060	0.9999865293502808	O
36508	while	54 59	151061 151066	0.9999860525131226	O
36509	6	60 61	151067 151068	0.9999810457229614	O
36510	%	62 63	151069 151070	0.999988317489624	O
36511	where	64 69	151071 151076	0.9999868869781494	O
36512	positive	70 78	151077 151085	0.9999874830245972	O
36513	for	79 82	151086 151089	0.9999889135360718	O
36514	biallelic	83 91	151090 151098	0.9999877214431763	O
36517	MUTYH	93 97	151100 151104	0.9999881982803345	O
36521	mutations	99 108	151106 151115	0.9999887943267822	O
36522	.	109 110	151116 151117	0.9999744892120361	O
36523	The	0 3	151118 151121	0.9999852180480957	O
36524	mutation	4 12	151122 151130	0.999983549118042	O
36525	-	12 13	151130 151131	0.9999866485595703	O
36526	detection	13 22	151131 151140	0.9999860525131226	O
36527	rate	23 27	151141 151145	0.9999864101409912	O
36528	we	28 30	151146 151148	0.999984860420227	O
36529	have	31 35	151149 151153	0.9999855756759644	O
36530	reached	36 43	151154 151161	0.9999852180480957	O
36531	in	44 46	151162 151164	0.999985933303833	O
36532	this	47 51	151165 151169	0.9999865293502808	O
36533	study	52 57	151170 151175	0.9999827146530151	O
36534	is	58 60	151176 151178	0.999982476234436	O
36535	notably	61 68	151179 151186	0.9999809265136719	O
36536	high	69 73	151187 151191	0.9999827146530151	O
36537	.	74 75	151192 151193	0.9999346733093262	O
36538	In	0 2	151194 151196	0.9999878406524658	O
36539	fact	3 7	151197 151201	0.9999827146530151	O
36540	,	8 9	151202 151203	0.9999887943267822	O
36541	a	10 11	151204 151205	0.9999881982803345	O
36542	disease	12 19	151206 151213	0.9999828338623047	O
36543	-	19 20	151213 151214	0.9999892711639404	O
36544	causing	20 27	151214 151221	0.9999874830245972	O
36545	mutation	28 36	151222 151230	0.9999804496765137	O
36546	was	37 40	151231 151234	0.9999887943267822	O
36547	detected	41 49	151235 151243	0.999988317489624	O
36548	in	50 52	151244 151246	0.9999889135360718	O
36549	all	53 56	151247 151250	0.9999877214431763	O
36550	cases	57 62	151251 151256	0.999985933303833	O
36551	who	63 66	151257 151260	0.999987006187439	O
36552	presented	67 76	151261 151270	0.9999866485595703	O
36553	with	77 81	151271 151275	0.9999886751174927	O
36554	a	82 83	151276 151277	0.9999887943267822	O
36555	classical	84 93	151278 151287	0.999984622001648	O
36556	FAP	94 96	151288 151290	0.9999738931655884	O
36558	phenotype	98 106	151292 151300	0.9999887943267822	O
36561	(	108 109	151302 151303	0.9999895095825195	O
36562	except	110 116	151304 151310	0.9999855756759644	O
36563	for	117 120	151311 151314	0.9999890327453613	O
36564	family	121 127	151315 151321	0.9999855756759644	O
36565	1	128 129	151322 151323	0.999988317489624	O
36566	(	130 131	151324 151325	0.9999892711639404	O
36567	C152	132 135	151326 151329	0.9999876022338867	O
36570	)	137 138	151331 151332	0.9999892711639404	O
36571	,	139 140	151333 151334	0.9999887943267822	O
36572	where	141 146	151335 151340	0.9999880790710449	O
36573	we	147 149	151341 151343	0.9999860525131226	O
36574	have	150 154	151344 151348	0.9999885559082031	O
36575	clear	155 160	151349 151354	0.999988317489624	O
36576	indications	161 171	151355 151365	0.9999885559082031	O
36578	for	173 176	151367 151370	0.9999891519546509	O
36579	inactivation	177 188	151371 151382	0.9999890327453613	O
36582	of	190 192	151384 151386	0.9999892711639404	O
36583	the	193 196	151387 151390	0.9999891519546509	O
36584	APC	197 199	151391 151393	0.9999861717224121	O
36586	transcription	201 214	151395 151408	0.9999889135360718	O
36587	)	215 216	151409 151410	0.9999879598617554	O
36588	.	217 218	151411 151412	0.9999732971191406	O
36589	The	0 3	151413 151416	0.9999759197235107	O
36590	mutation	4 12	151417 151425	0.9999775886535645	O
36591	-	12 13	151425 151426	0.9999853372573853	O
36592	negative	13 21	151426 151434	0.9999758005142212	O
36593	patients	22 30	151435 151443	0.9999488592147827	O
36594	all	31 34	151444 151447	0.999966025352478	O
36595	display	35 42	151448 151455	0.9999666213989258	O
36596	an	43 45	151456 151458	0.9999816417694092	O
36597	attenuated	46 55	151459 151468	0.9999819993972778	O
36600	form	57 61	151470 151474	0.999982476234436	O
36601	of	62 64	151475 151477	0.9999837875366211	O
36602	disease	65 72	151478 151485	0.9999754428863525	O
36603	.	73 74	151486 151487	0.9998940229415894	O
36604	However	0 7	151488 151495	0.9999862909317017	O
36605	,	8 9	151496 151497	0.9999887943267822	O
36606	as	10 12	151498 151500	0.999984860420227	O
36607	we	13 15	151501 151503	0.9999867677688599	O
36608	have	16 20	151504 151508	0.9999879598617554	O
36609	also	21 25	151509 151513	0.9999880790710449	O
36610	found	26 31	151514 151519	0.9999881982803345	O
36611	subtle	32 38	151520 151526	0.9999871253967285	O
36612	mutations	39 48	151527 151536	0.9999866485595703	O
36613	in	49 51	151537 151539	0.9999887943267822	O
36614	the	52 55	151540 151543	0.9999886751174927	O
36615	APC	56 58	151544 151546	0.9999841451644897	O
36617	gene	60 64	151548 151552	0.9999874830245972	O
36618	in	65 67	151553 151555	0.9999890327453613	O
36619	patients	68 76	151556 151564	0.999984860420227	O
36620	with	77 81	151565 151569	0.9999889135360718	O
36621	attenuated	82 91	151570 151579	0.999988317489624	O
36624	FAP	93 95	151581 151583	0.9999834299087524	O
36626	,	97 98	151585 151586	0.9999881982803345	O
36627	we	99 101	151587 151589	0.9999884366989136	O
36628	have	102 106	151590 151594	0.999988317489624	O
36629	to	107 109	151595 151597	0.9999889135360718	O
36630	consider	110 118	151598 151606	0.9999877214431763	O
36631	inactivation	119 130	151607 151618	0.9999890327453613	O
36634	of	132 134	151620 151622	0.9999887943267822	O
36635	APC	135 137	151623 151625	0.9999867677688599	O
36637	to	139 141	151627 151629	0.9999889135360718	O
36638	be	142 144	151630 151632	0.9999890327453613	O
36639	responsible	145 156	151633 151644	0.9999886751174927	O
36640	for	157 160	151645 151648	0.9999889135360718	O
36641	some	161 165	151649 151653	0.9999852180480957	O
36642	of	166 168	151654 151656	0.9999880790710449	O
36643	these	169 174	151657 151662	0.9999872446060181	O
36644	FAP	175 177	151663 151665	0.9999788999557495	O
36646	cases	179 184	151667 151672	0.9999868869781494	O
36647	.	185 186	151673 151674	0.9999889135360718	O
36648	*	187 188	151675 151676	0.9999879598617554	O
36649	*	188 189	151676 151677	0.9999806880950928	O
36650	IGNORE	0 5	151678 151683	0.9999864101409912	O
36653	LINE	7 10	151685 151688	0.9999880790710449	O
36656	*	12 13	151690 151691	0.9999878406524658	O
36657	*	13 14	151691 151692	0.9999878406524658	O
36658	*	15 16	151693 151694	0.9999878406524658	O
36659	*	16 17	151694 151695	0.9999879598617554	O
36660	IGNORE	18 23	151696 151701	0.9999872446060181	O
36663	LINE	25 28	151703 151706	0.9999881982803345	O
36666	*	30 31	151708 151709	0.9999874830245972	O
36667	*	31 32	151709 151710	0.9999874830245972	O
36668	*	33 34	151711 151712	0.9999874830245972	O
36669	*	34 35	151712 151713	0.9999876022338867	O
36670	IGNORE	36 41	151714 151719	0.9999867677688599	O
36673	LINE	43 46	151721 151724	0.9999879598617554	O
36676	*	48 49	151726 151727	0.9999877214431763	O
36677	*	49 50	151727 151728	0.9999878406524658	O
36678	In	51 53	151729 151731	0.9999886751174927	O
36679	comparison	54 64	151732 151742	0.9999874830245972	O
36680	to	65 67	151743 151745	0.9999885559082031	O
36681	MLH1	68 71	151746 151749	0.999987006187439	O
36684	and	73 76	151751 151754	0.9999876022338867	O
36685	MSH2	77 80	151755 151758	0.9999877214431763	O
36688	,	82 83	151760 151761	0.9999886751174927	O
36689	the	84 87	151762 151765	0.9999881982803345	O
36690	phenotype	88 96	151766 151774	0.9999878406524658	O
36693	of	98 100	151776 151778	0.999988317489624	O
36694	MSH6	101 104	151779 151782	0.9999878406524658	O
36697	is	106 108	151784 151786	0.9999884366989136	O
36698	characterised	109 122	151787 151800	0.9999868869781494	O
36699	by	123 125	151801 151803	0.9999885559082031	O
36700	a	126 127	151804 151805	0.9999884366989136	O
36701	later	128 133	151806 151811	0.999987006187439	O
36702	age	134 137	151812 151815	0.9999878406524658	O
36703	of	138 140	151816 151818	0.9999881982803345	O
36704	onset	141 146	151819 151824	0.9999871253967285	O
36705	of	147 149	151825 151827	0.9999877214431763	O
36706	CRC	150 152	151828 151830	0.9999833106994629	O
36708	,	154 155	151832 151833	0.9999885559082031	O
36709	incomplete	156 166	151834 151844	0.9999873638153076	O
36710	penetrance	167 176	151845 151854	0.9999878406524658	O
36713	,	178 179	151856 151857	0.9999879598617554	O
36714	and	180 183	151858 151861	0.9999877214431763	O
36715	a	184 185	151862 151863	0.999988317489624	O
36716	higher	186 192	151864 151870	0.9999839067459106	O
36717	risk	193 197	151871 151875	0.9999868869781494	O
36718	and	198 201	151876 151879	0.9999876022338867	O
36719	later	202 207	151880 151885	0.9999865293502808	O
36720	age	208 211	151886 151889	0.9999879598617554	O
36721	of	212 214	151890 151892	0.9999881982803345	O
36722	onset	215 220	151893 151898	0.9999872446060181	O
36723	of	221 223	151899 151901	0.9999876022338867	O
36724	EC	224 226	151902 151904	0.9999805688858032	O
36725	in	227 229	151905 151907	0.999988317489624	O
36726	female	230 236	151908 151914	0.9999386072158813	O
36727	MSH6	237 240	151915 151918	0.9999864101409912	O
36730	carriers15	242 251	151920 151929	0.999984860420227	O
36732	,	252 253	151930 151931	0.9999873638153076	O
36733	21	253 255	151931 151933	0.9999825954437256	O
36734	.	256 257	151934 151935	0.999958872795105	O
36735	MSH6	0 3	151936 151939	0.9999841451644897	O
36738	mutation	5 13	151941 151949	0.9999855756759644	O
36739	carriers	14 22	151950 151958	0.9999821186065674	O
36740	may	23 26	151959 151962	0.999985933303833	O
36741	be	27 29	151963 151965	0.9999864101409912	O
36742	missed	30 36	151966 151972	0.999982476234436	O
36743	amongst	37 44	151973 151980	0.9999812841415405	O
36744	analysis	45 53	151981 151989	0.9999834299087524	O
36745	of	54 56	151990 151992	0.9999876022338867	O
36746	HNPCC	57 61	151993 151997	0.9999840259552002	O
36749	families	63 71	151999 152007	0.9999828338623047	O
36750	if	72 74	152008 152010	0.9999854564666748	O
36751	the	75 78	152011 152014	0.9999879598617554	O
36752	Amsterdam	79 88	152015 152024	0.9999834299087524	O
36753	criteria	89 97	152025 152033	0.9999874830245972	O
36754	are	98 101	152034 152037	0.9999867677688599	O
36755	used	102 106	152038 152042	0.9999865293502808	O
36756	as	107 109	152043 152045	0.9999878406524658	O
36757	selection	110 119	152046 152055	0.999987006187439	O
36758	criteria22	120 129	152056 152065	0.9999877214431763	O
36760	It	131 133	152067 152069	0.9999878406524658	O
36761	is	134 136	152070 152072	0.999987006187439	O
36762	likely	137 143	152073 152079	0.9999867677688599	O
36763	that	144 148	152080 152084	0.9999881982803345	O
36764	MSH6	149 152	152085 152088	0.9999854564666748	O
36767	mutations	154 163	152090 152099	0.999985933303833	O
36768	may	164 167	152100 152103	0.9999879598617554	O
36769	occur	168 173	152104 152109	0.9999877214431763	O
36770	at	174 176	152110 152112	0.999987006187439	O
36771	a	177 178	152113 152114	0.9999878406524658	O
36772	higher	179 185	152115 152121	0.9999860525131226	O
36773	prevalence	186 196	152122 152132	0.9999862909317017	O
36774	in	197 199	152133 152135	0.9999877214431763	O
36775	a	200 201	152136 152137	0.9999876022338867	O
36776	cohort	202 207	152138 152143	0.9999866485595703	O
36779	of	209 211	152145 152147	0.9999867677688599	O
36780	EC	212 214	152148 152150	0.9999713897705078	O
36781	patients	215 223	152151 152159	0.9999834299087524	O
36782	in	224 226	152160 152162	0.9999879598617554	O
36783	comparison	227 237	152163 152173	0.9999867677688599	O
36784	to	238 240	152174 152176	0.9999872446060181	O
36785	HNPCC	241 245	152177 152181	0.9999841451644897	O
36788	cohorts	247 253	152183 152189	0.9999864101409912	O
36791	that	255 259	152191 152195	0.9999877214431763	O
36792	have	260 264	152196 152200	0.9999873638153076	O
36793	been	265 269	152201 152205	0.9999878406524658	O
36794	selected	270 278	152206 152214	0.9999866485595703	O
36795	by	279 281	152215 152217	0.9999876022338867	O
36796	the	282 285	152218 152221	0.9999880790710449	O
36797	Amsterdam	286 295	152222 152231	0.9999825954437256	O
36798	criteria	296 304	152232 152240	0.9999872446060181	O
36799	which	305 310	152241 152246	0.9999874830245972	O
36800	are	311 314	152247 152250	0.9999873638153076	O
36801	characteristic	315 329	152251 152265	0.9999865293502808	O
36802	of	330 332	152266 152268	0.9999877214431763	O
36803	HNPCC	333 337	152269 152273	0.9999842643737793	O
36806	families	339 347	152275 152283	0.9999823570251465	O
36807	with	348 352	152284 152288	0.9999873638153076	O
36808	a	353 354	152289 152290	0.999987006187439	O
36809	mutation	355 363	152291 152299	0.9999839067459106	O
36810	in	364 366	152300 152302	0.9999871253967285	O
36811	MLH1	367 370	152303 152306	0.9999856948852539	O
36814	or	372 374	152308 152310	0.9999867677688599	O
36815	MSH2	375 378	152311 152314	0.9999855756759644	O
36818	.	380 381	152316 152317	0.9999372959136963	O
36819	A	0 1	152318 152319	0.999987006187439	O
36820	few	2 5	152320 152323	0.9999867677688599	O
36821	studies	6 13	152324 152331	0.999984622001648	O
36822	have	14 18	152332 152336	0.9999874830245972	O
36823	looked	19 25	152337 152343	0.9999860525131226	O
36824	at	26 28	152344 152346	0.9999880790710449	O
36825	the	29 32	152347 152350	0.9999880790710449	O
36826	prevalence	33 43	152351 152361	0.9999866485595703	O
36827	of	44 46	152362 152364	0.9999879598617554	O
36828	MSH6	47 50	152365 152368	0.9999829530715942	O
36831	mutations	52 61	152370 152379	0.9999860525131226	O
36832	in	62 64	152380 152382	0.999988317489624	O
36833	EC	65 67	152383 152385	0.9999829530715942	O
36834	patients	68 76	152386 152394	0.9999867677688599	O
36835	with	77 81	152395 152399	0.9999884366989136	O
36836	estimates	82 91	152400 152409	0.9999841451644897	O
36837	between	92 99	152410 152417	0.9999865293502808	O
36838	1	100 101	152418 152419	0.9999873638153076	O
36839	.	101 102	152419 152420	0.9999881982803345	O
36840	7	102 103	152420 152421	0.9999871253967285	O
36841	%	104 105	152422 152423	0.9999880790710449	O
36842	of	106 108	152424 152426	0.9999878406524658	O
36843	patients	109 117	152427 152435	0.999985933303833	O
36844	with	118 122	152436 152440	0.9999873638153076	O
36845	EC	123 125	152441 152443	0.9999855756759644	O
36846	less	126 130	152444 152448	0.9999885559082031	O
36847	than	131 135	152449 152453	0.9999887943267822	O
36848	50	136 138	152454 152456	0.9999871253967285	O
36849	years23	139 145	152457 152463	0.9999885559082031	O
36851	,	147 148	152465 152466	0.9999880790710449	O
36852	and	149 152	152467 152470	0.9999884366989136	O
36853	4	153 154	152471 152472	0.9999852180480957	O
36854	.	154 155	152472 152473	0.9999886751174927	O
36855	7	155 156	152473 152474	0.9999874830245972	O
36856	%	157 158	152475 152476	0.9999885559082031	O
36857	identified	159 169	152477 152487	0.9999881982803345	O
36858	in	170 172	152488 152490	0.9999879598617554	O
36859	EC	173 175	152491 152493	0.999985933303833	O
36860	patients	176 184	152494 152502	0.9999878406524658	O
36861	un	185 187	152503 152505	0.9999884366989136	O
36862	-	187 188	152505 152506	0.9999885559082031	O
36863	selected	188 196	152506 152514	0.9999881982803345	O
36864	for	197 200	152515 152518	0.9999886751174927	O
36865	age	201 204	152519 152522	0.9999873638153076	O
36866	or	205 207	152523 152525	0.9999884366989136	O
36867	family	208 214	152526 152532	0.9999853372573853	O
36868	history24	215 223	152533 152541	0.9999877214431763	O
36870	.	225 226	152543 152544	0.9999630451202393	O
36871	In	0 2	152545 152547	0.999984860420227	O
36872	this	3 7	152548 152552	0.9999858140945435	O
36873	study	8 13	152553 152558	0.9999841451644897	O
36874	we	14 16	152559 152561	0.9999805688858032	O
36875	sought	17 23	152562 152568	0.9999822378158569	O
36876	to	24 26	152569 152571	0.999985933303833	O
36877	determine	27 36	152572 152581	0.9999855756759644	O
36878	the	37 40	152582 152585	0.9999858140945435	O
36879	prevalence	41 51	152586 152596	0.9999856948852539	O
36880	of	52 54	152597 152599	0.9999866485595703	O
36881	MSH6	55 58	152600 152603	0.9999836683273315	O
36884	mutations	60 69	152605 152614	0.9999849796295166	O
36885	in	70 72	152615 152617	0.9999871253967285	O
36886	our	73 76	152618 152621	0.9999338388442993	O
36887	Northern	77 85	152622 152630	0.9999655485153198	O
36888	Ireland	86 93	152631 152638	0.983050525188446	O
36889	HNPCC	94 98	152639 152643	0.9999816417694092	O
36892	cohort	100 105	152645 152650	0.9999856948852539	O
36895	with	107 111	152652 152656	0.9999867677688599	O
36896	less	112 116	152657 152661	0.9999864101409912	O
36897	restrictive	117 127	152662 152672	0.9999874830245972	O
36899	inclusion	129 138	152674 152683	0.9999877214431763	O
36900	criteria	139 147	152684 152692	0.9999877214431763	O
36901	than	148 152	152693 152697	0.9999876022338867	O
36902	the	153 156	152698 152701	0.9999865293502808	O
36903	Amsterdam	157 166	152702 152711	0.9999792575836182	O
36904	II	167 169	152712 152714	0.9999862909317017	O
36905	criteria	170 178	152715 152723	0.9999876022338867	O
36906	,	179 180	152724 152725	0.9999867677688599	O
36907	in	181 183	152726 152728	0.9999871253967285	O
36908	an	184 186	152729 152731	0.9999872446060181	O
36909	attempt	187 194	152732 152739	0.9999868869781494	O
36910	to	195 197	152740 152742	0.9999872446060181	O
36911	include	198 205	152743 152750	0.9999878406524658	O
36912	as	206 208	152751 152753	0.9999864101409912	O
36913	many	209 213	152754 152758	0.9999868869781494	O
36914	MSH6	214 217	152759 152762	0.9999864101409912	O
36917	phenotype	219 227	152764 152772	0.9999874830245972	O
36920	families	229 237	152774 152782	0.9999834299087524	O
36921	as	238 240	152783 152785	0.9999861717224121	O
36922	possible	241 249	152786 152794	0.9999862909317017	O
36923	given	250 255	152795 152800	0.9999833106994629	O
36924	the	256 259	152801 152804	0.9999854564666748	O
36925	probable	260 268	152805 152813	0.9999785423278809	O
36926	later	269 274	152814 152819	0.9999810457229614	O
36927	onset	275 280	152820 152825	0.9999852180480957	O
36928	of	281 283	152826 152828	0.9999856948852539	O
36929	colon	284 288	152829 152833	0.9999827146530151	O
36931	cancers	290 296	152835 152841	0.9999849796295166	O
36933	;	298 299	152843 152844	0.9999865293502808	O
36934	and	300 303	152845 152848	0.9999874830245972	O
36935	also	304 308	152849 152853	0.9999867677688599	O
36936	determine	309 318	152854 152863	0.9999865293502808	O
36937	the	319 322	152864 152867	0.9999871253967285	O
36938	prevalence	323 333	152868 152878	0.9999872446060181	O
36939	of	334 336	152879 152881	0.9999878406524658	O
36940	mutations	337 346	152882 152891	0.9999836683273315	O
36941	in	347 349	152892 152894	0.9999880790710449	O
36942	an	350 352	152895 152897	0.9999866485595703	O
36943	unselected	353 362	152898 152907	0.9999867677688599	O
36947	cohort	364 369	152909 152914	0.9999868869781494	O
36950	of	371 373	152916 152918	0.999984622001648	O
36951	EC	374 376	152919 152921	0.9999756813049316	O
36952	patients	377 385	152922 152930	0.9999817609786987	O
36953	.	386 387	152931 152932	0.9999876022338867	O
36954	*	388 389	152933 152934	0.9999864101409912	O
36955	*	389 390	152934 152935	0.9999747276306152	O
36956	IGNORE	0 5	152936 152941	0.9999866485595703	O
36959	LINE	7 10	152943 152946	0.9999890327453613	O
36962	*	12 13	152948 152949	0.9999891519546509	O
36963	*	13 14	152949 152950	0.9999890327453613	O
36964	*	15 16	152951 152952	0.9999890327453613	O
36965	*	16 17	152952 152953	0.9999890327453613	O
36966	IGNORE	18 23	152954 152959	0.9999881982803345	O
36969	LINE	25 28	152961 152964	0.99998939037323	O
36972	*	30 31	152966 152967	0.9999890327453613	O
36973	*	31 32	152967 152968	0.9999890327453613	O
36974	*	33 34	152969 152970	0.9999889135360718	O
36975	*	34 35	152970 152971	0.9999889135360718	O
36976	IGNORE	36 41	152972 152977	0.9999878406524658	O
36979	LINE	43 46	152979 152982	0.9999891519546509	O
36982	*	48 49	152984 152985	0.9999890327453613	O
36983	*	49 50	152985 152986	0.9999890327453613	O
36984	All	51 54	152987 152990	0.9999878406524658	O
36985	DNA	55 58	152991 152994	0.9999849796295166	O
36986	was	59 62	152995 152998	0.9999892711639404	O
36987	or	63 65	152999 153001	0.9999847412109375	O
36988	had	66 69	153002 153005	0.9999881982803345	O
36989	been	70 74	153006 153010	0.9999892711639404	O
36990	extracted	75 84	153011 153020	0.9999886751174927	O
36991	by	85 87	153021 153023	0.9999890327453613	O
36992	the	88 91	153024 153027	0.9999885559082031	O
36993	Nucleic	92 98	153028 153034	0.9999873638153076	O
36997	Acid	100 103	153036 153039	0.9999880790710449	O
36999	Extraction	105 114	153041 153050	0.9999877214431763	O
37001	Centre	116 122	153052 153058	0.9999884366989136	O
37002	(	123 124	153059 153060	0.9999890327453613	O
37003	NAEC	125 128	153061 153064	0.9999872446060181	O
37006	)	130 131	153066 153067	0.99998939037323	O
37007	,	132 133	153068 153069	0.9999881982803345	O
37008	Belfast	134 141	153070 153077	0.9998890161514282	O
37009	City	142 146	153078 153082	0.999984622001648	O
37010	Hospital	147 155	153083 153091	0.9999864101409912	O
37011	,	156 157	153092 153093	0.9999868869781494	O
37012	and	158 161	153094 153097	0.9999865293502808	O
37013	stored	162 168	153098 153104	0.9999842643737793	O
37014	at	169 171	153105 153107	0.9999886751174927	O
37015	−80°C	172 176	153108 153112	0.9999840259552002	O
37019	.	177 178	153113 153114	0.999968409538269	O
37020	Working	0 7	153115 153122	0.9999852180480957	O
37021	dilutions	8 16	153123 153131	0.999987006187439	O
37024	in	18 20	153133 153135	0.9999884366989136	O
37025	X1	21 22	153136 153137	0.9999866485595703	O
37027	TE	24 25	153139 153140	0.9999879598617554	O
37029	were	27 31	153142 153146	0.9999880790710449	O
37030	made	32 36	153147 153151	0.9999871253967285	O
37031	at	37 39	153152 153154	0.999988317489624	O
37032	5ng	40 42	153155 153157	0.999985933303833	O
37034	/	43 44	153158 153159	0.9999889135360718	O
37035	μl	44 45	153159 153160	0.9999873638153076	O
37037	.	47 48	153162 153163	0.9999737739562988	O
37038	All	0 3	153164 153167	0.9999872446060181	O
37039	ten	4 7	153168 153171	0.9999802112579346	O
37040	exons	8 12	153172 153176	0.9999853372573853	O
37042	and	14 17	153178 153181	0.9999865293502808	O
37043	at	18 20	153182 153184	0.9999886751174927	O
37044	least	21 26	153185 153190	0.9999890327453613	O
37045	20	27 29	153191 153193	0.9999861717224121	O
37046	base	30 34	153194 153198	0.9999880790710449	O
37047	pair	35 39	153199 153203	0.9999874830245972	O
37048	(	40 41	153204 153205	0.999988317489624	O
37049	bp	42 43	153206 153207	0.9999868869781494	O
37051	)	45 46	153209 153210	0.9999889135360718	O
37052	of	47 49	153211 153213	0.9999884366989136	O
37053	flanking	50 57	153214 153221	0.9999872446060181	O
37055	intronic	59 66	153223 153230	0.9999874830245972	O
37057	sequence	68 76	153232 153240	0.9999877214431763	O
37058	was	77 80	153241 153244	0.9999874830245972	O
37059	subject	81 88	153245 153252	0.9999874830245972	O
37060	to	89 91	153253 153255	0.9999887943267822	O
37061	direct	92 98	153256 153262	0.9999860525131226	O
37062	sequencing	99 108	153263 153272	0.9999873638153076	O
37064	analysis	110 118	153274 153282	0.9999887943267822	O
37065	.	119 120	153283 153284	0.9999582767486572	O
37066	PCR	0 2	153285 153287	0.9999864101409912	O
37068	products	4 12	153289 153297	0.9999865293502808	O
37069	for	13 16	153298 153301	0.9999877214431763	O
37070	nine	17 21	153302 153306	0.9999853372573853	O
37071	of	22 24	153307 153309	0.9999889135360718	O
37072	ten	25 28	153310 153313	0.9999849796295166	O
37073	exons	29 33	153314 153318	0.9999884366989136	O
37075	of	35 37	153320 153322	0.9999886751174927	O
37076	MSH6	38 41	153323 153326	0.9999858140945435	O
37079	were	43 47	153328 153332	0.9999884366989136	O
37080	obtained	48 56	153333 153341	0.9999886751174927	O
37081	using	57 62	153342 153347	0.9999892711639404	O
37082	Applied	63 70	153348 153355	0.999987006187439	O
37083	Biosystems	71 80	153356 153365	0.9999887943267822	O
37088	[UNK]	82 94	153367 153379	0.9999867677688599	O
37089	Requencing	95 104	153380 153389	0.9999881982803345	O
37091	System	106 112	153391 153397	0.9999891519546509	O
37092	(	113 114	153398 153399	0.9999897480010986	O
37093	product	115 122	153400 153407	0.9999887943267822	O
37094	number	123 129	153408 153414	0.9999891519546509	O
37095	:	130 131	153415 153416	0.99998939037323	O
37096	RSS000012234	132 143	153417 153428	0.9999889135360718	O
37103	_	144 145	153429 153430	0.9999892711639404	O
37104	02	145 147	153430 153432	0.9999889135360718	O
37105	)	148 149	153433 153434	0.9999897480010986	O
37106	.	150 151	153435 153436	0.9999779462814331	O
37107	All	0 3	153437 153440	0.9999814033508301	O
37108	reactions	4 13	153441 153450	0.9999790191650391	O
37109	were	14 18	153451 153455	0.9999817609786987	O
37110	carried	19 26	153456 153463	0.999984622001648	O
37111	out	27 30	153464 153467	0.9999855756759644	O
37112	using	31 36	153468 153473	0.9999864101409912	O
37113	standard	37 45	153474 153482	0.9999841451644897	O
37114	reaction	46 54	153483 153491	0.9999866485595703	O
37115	mix	55 58	153492 153495	0.9999865293502808	O
37116	and	59 62	153496 153499	0.9999849796295166	O
37117	conditions	63 73	153500 153510	0.9999786615371704	O
37118	as	74 76	153511 153513	0.9999878406524658	O
37119	determined	77 87	153514 153524	0.9999879598617554	O
37120	by	88 90	153525 153527	0.9999880790710449	O
37121	ABI	91 93	153528 153530	0.9999862909317017	O
37123	.	94 95	153531 153532	0.9999593496322632	O
37124	Exon	0 3	153533 153536	0.9999889135360718	O
37126	1	5 6	153538 153539	0.9999889135360718	O
37127	primers	7 13	153540 153546	0.9999880790710449	O
37129	were	15 19	153548 153552	0.9999890327453613	O
37130	as	20 22	153553 153555	0.9999890327453613	O
37131	follows	23 30	153556 153563	0.9999887943267822	O
37132	:	31 32	153564 153565	0.9999892711639404	O
37133	1F	33 34	153566 153567	0.9999889135360718	O
37135	PCR	36 38	153569 153571	0.9999886751174927	O
37137	;	40 41	153573 153574	0.99998939037323	O
37138	TCCGTCCGACAGAACGGTTG	42 61	153575 153594	0.9999887943267822	O
37151	,	63 64	153596 153597	0.9999892711639404	O
37152	1R	65 66	153598 153599	0.9999887943267822	O
37154	PCR	68 70	153601 153603	0.9999886751174927	O
37156	;	72 73	153605 153606	0.9999892711639404	O
37157	ATGCTCCAGACTCGACCCG	74 92	153607 153625	0.9999887943267822	O
37168	,	94 95	153627 153628	0.99998939037323	O
37169	using	96 101	153629 153634	0.9999896287918091	O
37170	a	102 103	153635 153636	0.9999897480010986	O
37171	standard	104 112	153637 153645	0.9999891519546509	O
37172	25μl	113 116	153646 153649	0.999988317489624	O
37175	reaction	118 126	153651 153659	0.9999886751174927	O
37176	mix	127 130	153660 153663	0.9999890327453613	O
37177	with	131 135	153664 153668	0.99998939037323	O
37178	3	136 137	153669 153670	0.9999887943267822	O
37179	.	137 138	153670 153671	0.9999896287918091	O
37180	4μl	138 140	153671 153673	0.9999885559082031	O
37183	of	142 144	153675 153677	0.99998939037323	O
37184	25mm	145 148	153678 153681	0.9999885559082031	O
37186	MgCl2	150 154	153683 153687	0.9999884366989136	O
37191	and	156 159	153689 153692	0.9999895095825195	O
37192	0	160 161	153693 153694	0.9999890327453613	O
37193	.	161 162	153694 153695	0.9999895095825195	O
37194	4μl	162 164	153695 153697	0.9999881982803345	O
37197	of	166 168	153699 153701	0.99998939037323	O
37198	5U	169 170	153702 153703	0.999988317489624	O
37200	/	171 172	153704 153705	0.9999891519546509	O
37201	μl	172 173	153705 153706	0.9999878406524658	O
37203	Expand	175 180	153708 153713	0.9999887943267822	O
37206	DNA	182 185	153715 153718	0.999988317489624	O
37207	polymerase	186 195	153719 153728	0.9999884366989136	O
37209	(	197 198	153730 153731	0.9999895095825195	O
37210	ABI	199 201	153732 153734	0.9999876022338867	O
37212	)	203 204	153736 153737	0.9999896287918091	O
37213	at	205 207	153738 153740	0.99998939037323	O
37214	an	208 210	153741 153743	0.9999895095825195	O
37215	annealing	211 219	153744 153752	0.99998939037323	O
37218	temperature	221 232	153754 153765	0.9999879598617554	O
37219	of	233 235	153766 153768	0.9999891519546509	O
37220	60°C	236 239	153769 153772	0.999984622001648	O
37223	.	240 241	153773 153774	0.9999748468399048	O
37224	All	0 3	153775 153778	0.9999853372573853	O
37225	PCR	4 6	153779 153781	0.9999858140945435	O
37227	products	8 16	153783 153791	0.9999856948852539	O
37228	were	17 21	153792 153796	0.9999867677688599	O
37229	subject	22 29	153797 153804	0.999984860420227	O
37230	to	30 32	153805 153807	0.9999881982803345	O
37231	clean	33 38	153808 153813	0.9999862909317017	O
37232	up	39 41	153814 153816	0.999987006187439	O
37233	using	42 47	153817 153822	0.9999886751174927	O
37234	ExoSAPIT®	48 56	153823 153831	0.9999881982803345	O
37240	†	57 58	153832 153833	0.9999861717224121	O
37241	to	59 61	153834 153836	0.9999879598617554	O
37242	remove	62 68	153837 153843	0.9999868869781494	O
37243	excess	69 75	153844 153850	0.9999860525131226	O
37244	primer	76 81	153851 153856	0.9999878406524658	O
37246	dimer	83 87	153858 153862	0.9999889135360718	O
37248	,	89 90	153864 153865	0.9999877214431763	O
37249	unincorporated	91 105	153866 153880	0.999984860420227	O
37250	dNTPs	106 110	153881 153885	0.9999884366989136	O
37253	,	112 113	153887 153888	0.9999872446060181	O
37254	and	114 117	153889 153892	0.9999876022338867	O
37255	non	118 121	153893 153896	0.9999879598617554	O
37256	-	121 122	153896 153897	0.9999889135360718	O
37257	specific	122 130	153897 153905	0.9999879598617554	O
37258	DNA	131 134	153906 153909	0.9999862909317017	O
37259	products	135 143	153910 153918	0.9999877214431763	O
37260	.	144 145	153919 153920	0.9999628067016602	O
37261	Sequencing	0 9	153921 153930	0.999984860420227	O
37263	reactions	11 20	153932 153941	0.9999843835830688	O
37264	were	21 25	153942 153946	0.9999872446060181	O
37265	carried	26 33	153947 153954	0.9999880790710449	O
37266	out	34 37	153955 153958	0.9999885559082031	O
37267	using	38 43	153959 153964	0.9999890327453613	O
37268	BigDye®	44 50	153965 153971	0.9999856948852539	O
37272	terminator	52 61	153973 153982	0.9999885559082031	O
37274	Ready	63 68	153984 153989	0.9999880790710449	O
37275	Reaction	69 76	153990 153997	0.9999892711639404	O
37277	Mix	78 81	153999 154002	0.9999885559082031	O
37278	v1	82 83	154003 154004	0.9999896287918091	O
37280	.	84 85	154005 154006	0.9999891519546509	O
37281	1	85 86	154006 154007	0.9999891519546509	O
37282	from	87 91	154008 154012	0.9999891519546509	O
37283	ABI®	92 95	154013 154016	0.9999879598617554	O
37286	,	97 98	154018 154019	0.999988317489624	O
37287	according	99 108	154020 154029	0.9999886751174927	O
37288	to	109 111	154030 154032	0.9999896287918091	O
37289	manufacturer	112 124	154033 154045	0.999987006187439	O
37290	'	125 126	154046 154047	0.99998939037323	O
37291	s	126 127	154047 154048	0.9999895095825195	O
37292	instructions	128 140	154049 154061	0.9999887943267822	O
37293	.	141 142	154062 154063	0.999975323677063	O
37294	Additional	0 10	154064 154074	0.9999853372573853	O
37295	primers	11 17	154075 154081	0.9999858140945435	O
37297	were	19 23	154083 154087	0.9999884366989136	O
37298	required	24 32	154088 154096	0.9999879598617554	O
37299	to	33 35	154097 154099	0.999988317489624	O
37300	sequence	36 44	154100 154108	0.9999867677688599	O
37301	exons	45 49	154109 154113	0.9999892711639404	O
37303	7	51 52	154115 154116	0.9999886751174927	O
37304	and	53 56	154117 154120	0.9999884366989136	O
37305	8	57 58	154121 154122	0.9999864101409912	O
37306	because	59 66	154123 154130	0.9999889135360718	O
37307	of	67 69	154131 154133	0.9999892711639404	O
37308	a	70 71	154134 154135	0.9999890327453613	O
37309	poly	72 75	154136 154139	0.9999889135360718	O
37311	T	77 78	154141 154142	0.9999871253967285	O
37312	at	79 81	154143 154145	0.9999890327453613	O
37313	the	82 85	154146 154149	0.99998939037323	O
37314	5	86 87	154150 154151	0.9999881982803345	O
37315	′	87 88	154151 154152	0.9999879598617554	O
37316	end	89 92	154153 154156	0.9999885559082031	O
37317	of	93 95	154157 154159	0.9999892711639404	O
37318	exon	96 99	154160 154163	0.9999891519546509	O
37320	7	101 102	154165 154166	0.9999884366989136	O
37321	,	103 104	154167 154168	0.9999892711639404	O
37322	which	105 110	154169 154174	0.99998939037323	O
37323	resulted	111 119	154175 154183	0.9999890327453613	O
37324	in	120 122	154184 154186	0.9999891519546509	O
37325	slippage	123 130	154187 154194	0.999988317489624	O
37327	during	132 138	154196 154202	0.9999890327453613	O
37328	the	139 142	154203 154206	0.9999892711639404	O
37329	sequencing	143 152	154207 154216	0.9999872446060181	O
37331	reaction	154 162	154218 154226	0.9999874830245972	O
37332	,	163 164	154227 154228	0.9999886751174927	O
37333	and	165 168	154229 154232	0.9999889135360718	O
37334	polymorphisms	169 181	154233 154245	0.9999887943267822	O
37339	situated	183 191	154247 154255	0.9999886751174927	O
37340	at	192 194	154256 154258	0.9999890327453613	O
37341	the	195 198	154259 154262	0.9999892711639404	O
37342	3	199 200	154263 154264	0.9999879598617554	O
37343	′	200 201	154264 154265	0.9999876022338867	O
37344	,	202 203	154266 154267	0.9999890327453613	O
37345	(	204 205	154268 154269	0.99998939037323	O
37346	c	206 207	154270 154271	0.9999887943267822	O
37347	.	207 208	154271 154272	0.9999892711639404	O
37348	3646	208 211	154272 154275	0.9999885559082031	O
37350	+	213 214	154277 154278	0.9999889135360718	O
37351	35	214 216	154278 154280	0.9999879598617554	O
37352	_	216 217	154280 154281	0.9999887943267822	O
37353	38delATCT	217 225	154281 154289	0.9999873638153076	O
37357	)	226 227	154290 154291	0.9999892711639404	O
37358	of	228 230	154292 154294	0.9999892711639404	O
37359	exon	231 234	154295 154298	0.9999891519546509	O
37361	7	236 237	154300 154301	0.9999885559082031	O
37362	,	238 239	154302 154303	0.9999889135360718	O
37363	and	240 243	154304 154307	0.9999890327453613	O
37364	5	244 245	154308 154309	0.9999874830245972	O
37365	′	245 246	154309 154310	0.999987006187439	O
37366	,	247 248	154311 154312	0.9999889135360718	O
37367	(	249 250	154313 154314	0.9999892711639404	O
37368	c	251 252	154315 154316	0.9999887943267822	O
37369	.	252 253	154316 154317	0.9999892711639404	O
37370	3647	253 256	154317 154320	0.9999887943267822	O
37372	−51	258 260	154322 154324	0.9999871253967285	O
37374	_	261 262	154325 154326	0.9999890327453613	O
37375	−35	262 264	154326 154328	0.9999866485595703	O
37377	del	266 269	154330 154333	0.9999887943267822	O
37378	17	270 272	154334 154336	0.999987006187439	O
37379	)	273 274	154337 154338	0.9999891519546509	O
37380	,	275 276	154339 154340	0.9999889135360718	O
37381	and	277 280	154341 154344	0.9999891519546509	O
37382	3	281 282	154345 154346	0.9999876022338867	O
37383	′	282 283	154346 154347	0.999987006187439	O
37384	(	284 285	154348 154349	0.9999891519546509	O
37385	c	286 287	154350 154351	0.9999886751174927	O
37386	.	287 288	154351 154352	0.9999892711639404	O
37387	3802	288 291	154352 154355	0.9999877214431763	O
37389	–	292 293	154356 154357	0.9999864101409912	O
37390	42insT	293 298	154357 154362	0.9999861717224121	O
37393	)	300 301	154364 154365	0.9999892711639404	O
37394	end	302 305	154366 154369	0.9999886751174927	O
37395	of	306 308	154370 154372	0.9999892711639404	O
37396	exon	309 312	154373 154376	0.9999892711639404	O
37398	8	314 315	154378 154379	0.999988317489624	O
37399	,	316 317	154380 154381	0.9999895095825195	O
37400	which	318 323	154382 154387	0.9999895095825195	O
37401	made	324 328	154388 154392	0.9999881982803345	O
37402	sequence	329 337	154393 154401	0.9999872446060181	O
37403	of	338 340	154402 154404	0.9999891519546509	O
37404	the	341 344	154405 154408	0.9999891519546509	O
37405	exons	345 349	154409 154413	0.9999887943267822	O
37407	unreadable	351 360	154415 154424	0.9999892711639404	O
37410	when	362 366	154426 154430	0.9999891519546509	O
37411	the	367 370	154431 154434	0.9999890327453613	O
37412	polymorphisms	371 383	154435 154447	0.9999886751174927	O
37417	were	385 389	154449 154453	0.9999891519546509	O
37418	present	390 397	154454 154461	0.99998939037323	O
37419	in	398 400	154462 154464	0.9999892711639404	O
37420	the	401 404	154465 154468	0.99998939037323	O
37421	heterozygous	405 416	154469 154480	0.9999878406524658	O
37426	state	418 423	154482 154487	0.9999890327453613	O
37427	.	424 425	154488 154489	0.9999743700027466	O
37428	Additional	0 10	154490 154500	0.9999825954437256	O
37429	sequencing	11 20	154501 154510	0.9999868869781494	O
37431	primers	22 28	154512 154518	0.9999867677688599	O
37433	for	30 33	154520 154523	0.9999878406524658	O
37434	exon	34 37	154524 154527	0.9999889135360718	O
37436	7	39 40	154529 154530	0.9999878406524658	O
37437	(	41 42	154531 154532	0.99998939037323	O
37438	7F	43 44	154533 154534	0.999988317489624	O
37440	Seq	46 48	154536 154538	0.9999889135360718	O
37442	;	50 51	154540 154541	0.9999891519546509	O
37443	TTGTGATTTTTTTTTTTTTAAG	52 73	154542 154563	0.999988317489624	O
37456	,	75 76	154565 154566	0.9999889135360718	O
37457	7R	77 78	154567 154568	0.999988317489624	O
37459	Seq	80 82	154570 154572	0.9999887943267822	O
37461	;	84 85	154574 154575	0.9999891519546509	O
37462	TAGTCTTCAAATGAGAAG	86 103	154576 154593	0.9999881982803345	O
37472	)	105 106	154595 154596	0.9999892711639404	O
37473	and	107 110	154597 154600	0.9999890327453613	O
37474	8	111 112	154601 154602	0.9999868869781494	O
37475	(	113 114	154603 154604	0.99998939037323	O
37476	8F	114 115	154604 154605	0.999988317489624	O
37478	Seq	117 119	154607 154609	0.9999886751174927	O
37480	;	121 122	154611 154612	0.9999890327453613	O
37481	GAGTTACTTCCTTATGCA	123 140	154613 154630	0.9999867677688599	O
37491	,	142 143	154632 154633	0.9999887943267822	O
37492	8R	144 145	154634 154635	0.9999880790710449	O
37494	Seq	147 149	154637 154639	0.9999884366989136	O
37496	;	151 152	154641 154642	0.9999889135360718	O
37497	GAAGTGCCCTCTCAAAAAACC	153 173	154643 154663	0.9999853372573853	O
37508	)	175 176	154665 154666	0.9999889135360718	O
37509	were	177 181	154667 154671	0.9999871253967285	O
37510	designed	182 190	154672 154680	0.9999843835830688	O
37511	.	191 192	154681 154682	0.9999479055404663	O
37512	Electrophoresis	0 14	154683 154697	0.999984860420227	O
37518	was	16 19	154699 154702	0.9999856948852539	O
37519	carried	20 27	154703 154710	0.9999874830245972	O
37520	out	28 31	154711 154714	0.9999881982803345	O
37521	by	32 34	154715 154717	0.9999873638153076	O
37522	the	35 38	154718 154721	0.9999864101409912	O
37523	Queen	39 44	154722 154727	0.9999713897705078	O
37524	'	45 46	154728 154729	0.9999868869781494	O
37525	s	46 47	154729 154730	0.9999865293502808	O
37526	University	48 58	154731 154741	0.9999856948852539	O
37527	Belfast	59 66	154742 154749	0.9999527931213379	O
37528	genomic	67 73	154750 154756	0.9999879598617554	O
37531	core	75 79	154758 154762	0.9999886751174927	O
37532	facility	80 88	154763 154771	0.9999866485595703	O
37533	on	89 91	154772 154774	0.9999861717224121	O
37534	an	92 94	154775 154777	0.9999887943267822	O
37535	ABI	95 97	154778 154780	0.9999879598617554	O
37537	3730	99 102	154782 154785	0.999988317489624	O
37539	DNA	104 107	154787 154790	0.9999878406524658	O
37540	analyser	108 115	154791 154798	0.9999890327453613	O
37543	.	117 118	154800 154801	0.9999737739562988	O
37544	MLPA	0 3	154802 154805	0.9999877214431763	O
37547	Analysis	5 13	154807 154815	0.9999880790710449	O
37548	All	14 17	154816 154819	0.9999830722808838	O
37549	samples	18 25	154820 154827	0.9999847412109375	O
37550	were	26 30	154828 154832	0.9999886751174927	O
37551	subject	31 38	154833 154840	0.9999877214431763	O
37552	to	39 41	154841 154843	0.9999895095825195	O
37553	MLPA	42 45	154844 154847	0.9999886751174927	O
37556	analysis	47 55	154849 154857	0.99998939037323	O
37557	using	56 61	154858 154863	0.9999895095825195	O
37558	SALSA	62 66	154864 154868	0.9999887943267822	O
37561	MLPA	68 71	154870 154873	0.9999891519546509	O
37564	KIT	73 75	154875 154877	0.9999890327453613	O
37566	POO8	77 80	154879 154882	0.9999896287918091	O
37570	MSH6	82 85	154884 154887	0.9999896287918091	O
37573	/	86 87	154888 154889	0.9999895095825195	O
37574	PMS2	87 90	154889 154892	0.9999878406524658	O
37577	from	92 96	154894 154898	0.9999896287918091	O
37578	MRC	97 99	154899 154901	0.999988317489624	O
37580	-	100 101	154902 154903	0.9999897480010986	O
37581	Holland	101 108	154903 154910	0.9999856948852539	O
37582	.	109 110	154911 154912	0.9999791383743286	O
37583	Reaction	0 7	154913 154920	0.9999849796295166	O
37585	mix	9 12	154922 154925	0.9999830722808838	O
37586	and	13 16	154926 154929	0.9999839067459106	O
37587	conditions	17 27	154930 154940	0.9999747276306152	O
37588	are	28 31	154941 154944	0.9999842643737793	O
37589	as	32 34	154945 154947	0.9999860525131226	O
37590	determined	35 45	154948 154958	0.9999871253967285	O
37591	by	46 48	154959 154961	0.9999877214431763	O
37592	MRC	49 51	154962 154964	0.9999853372573853	O
37594	-	52 53	154965 154966	0.9999879598617554	O
37595	Holland	53 60	154966 154973	0.9999797344207764	O
37596	.	61 62	154974 154975	0.9999617338180542	O
37597	Electrophoresis	0 14	154976 154990	0.9999852180480957	O
37603	was	16 19	154992 154995	0.9999872446060181	O
37604	carried	20 27	154996 155003	0.9999874830245972	O
37605	on	28 30	155004 155006	0.9999889135360718	O
37606	an	31 33	155007 155009	0.9999895095825195	O
37607	ABI	34 36	155010 155012	0.9999874830245972	O
37609	3100	38 41	155014 155017	0.9999886751174927	O
37611	Avant	43 47	155019 155023	0.9999877214431763	O
37613	DNA	49 52	155025 155028	0.9999881982803345	O
37614	analyzer	53 60	155029 155036	0.999988317489624	O
37616	using	62 67	155038 155043	0.9999891519546509	O
37617	a	68 69	155044 155045	0.9999897480010986	O
37618	[UNK]	70 79	155046 155055	0.9999867677688599	O
37619	-	80 81	155056 155057	0.9999892711639404	O
37620	500	82 85	155058 155061	0.9999880790710449	O
37621	[UNK]	86 90	155062 155066	0.9999873638153076	O
37622	size	91 95	155067 155071	0.9999879598617554	O
37623	standard	96 104	155072 155080	0.9999886751174927	O
37624	.	105 106	155081 155082	0.9999737739562988	O
37625	From	0 4	155083 155087	0.9999880790710449	O
37626	the	5 8	155088 155091	0.9999892711639404	O
37627	raw	9 12	155092 155095	0.9999886751174927	O
37628	data	13 17	155096 155100	0.9999892711639404	O
37629	generated	18 27	155101 155110	0.9999877214431763	O
37630	,	28 29	155111 155112	0.9999890327453613	O
37631	peak	30 34	155113 155117	0.999988317489624	O
37632	heights	35 42	155118 155125	0.9999868869781494	O
37633	of	43 45	155126 155128	0.9999895095825195	O
37634	each	46 50	155129 155133	0.9999898672103882	O
37635	amplification	51 63	155134 155146	0.9999890327453613	O
37638	product	65 72	155148 155155	0.9999889135360718	O
37639	were	73 77	155156 155160	0.9999891519546509	O
37640	exported	78 86	155161 155169	0.9999886751174927	O
37641	to	87 89	155170 155172	0.9999897480010986	O
37642	Excel	90 94	155173 155177	0.99998939037323	O
37644	worksheets	96 105	155179 155188	0.99998939037323	O
37647	designed	107 115	155190 155198	0.9999895095825195	O
37648	by	116 118	155199 155201	0.99998939037323	O
37649	Dr	119 121	155202 155204	0.9999884366989136	O
37650	Andrew	122 128	155205 155211	0.9999889135360718	O
37651	Wallace	129 136	155212 155219	0.9999868869781494	O
37652	,	137 138	155220 155221	0.9999891519546509	O
37653	National	139 147	155222 155230	0.9999868869781494	O
37654	Genetics	148 155	155231 155238	0.9999878406524658	O
37656	Reference	157 166	155240 155249	0.9999885559082031	O
37657	Laboratory	167 177	155250 155260	0.99998939037323	O
37658	,	178 179	155261 155262	0.99998939037323	O
37659	Manchester	180 190	155263 155273	0.9999815225601196	O
37660	,	191 192	155274 155275	0.9999892711639404	O
37661	so	193 195	155276 155278	0.9999891519546509	O
37662	that	196 200	155279 155283	0.9999895095825195	O
37663	the	201 204	155284 155287	0.9999896287918091	O
37664	result	205 211	155288 155294	0.9999879598617554	O
37665	of	212 214	155295 155297	0.9999895095825195	O
37666	each	215 219	155298 155302	0.9999896287918091	O
37667	sample	220 226	155303 155309	0.9999885559082031	O
37668	could	227 232	155310 155315	0.9999890327453613	O
37669	be	233 235	155316 155318	0.9999895095825195	O
37670	‘	236 237	155319 155320	0.9999886751174927	O
37671	normalised	237 246	155320 155329	0.9999885559082031	O
37673	’	247 248	155330 155331	0.9999793767929077	O
37674	.	249 250	155332 155333	0.9999769926071167	O
37675	Statistical	0 11	155334 155345	0.9999818801879883	O
37676	Methods	12 18	155346 155352	0.9999834299087524	O
37678	The	20 23	155354 155357	0.9999876022338867	O
37679	cohort	24 29	155358 155363	0.9999873638153076	O
37682	sizes	31 36	155365 155370	0.9999843835830688	O
37683	necessary	37 46	155371 155380	0.9999878406524658	O
37684	to	47 49	155381 155383	0.999988317489624	O
37685	obtain	50 56	155384 155390	0.9999878406524658	O
37686	estimates	57 66	155391 155400	0.9999856948852539	O
37687	with	67 71	155401 155405	0.9999891519546509	O
37688	adequate	72 80	155406 155414	0.9999889135360718	O
37689	precision	81 90	155415 155424	0.9999881982803345	O
37690	were	91 95	155425 155429	0.9999889135360718	O
37691	initially	96 105	155430 155439	0.9999890327453613	O
37692	calculated	106 116	155440 155450	0.9999889135360718	O
37693	using	117 122	155451 155456	0.9999896287918091	O
37694	a	123 124	155457 155458	0.9999897480010986	O
37695	Normal	125 131	155459 155465	0.9999864101409912	O
37696	approximation	132 145	155466 155479	0.9999885559082031	O
37697	to	146 148	155480 155482	0.99998939037323	O
37698	the	149 152	155483 155486	0.9999897480010986	O
37699	binomial	153 160	155487 155494	0.9999887943267822	O
37702	sampling	162 170	155496 155504	0.9999892711639404	O
37703	distribution	171 183	155505 155517	0.9999896287918091	O
37704	provided	184 192	155518 155526	0.99998939037323	O
37705	by	193 195	155527 155529	0.9999892711639404	O
37706	the	196 199	155530 155533	0.9999897480010986	O
37707	StatCalc	200 207	155534 155541	0.9999892711639404	O
37712	program	209 216	155543 155550	0.9999880790710449	O
37713	in	217 219	155551 155553	0.9999892711639404	O
37714	the	220 223	155554 155557	0.9999895095825195	O
37715	EpiInfo	224 230	155558 155564	0.9999889135360718	O
37720	package	232 239	155566 155573	0.9999887943267822	O
37721	(	240 241	155574 155575	0.9999896287918091	O
37722	)	242 243	155576 155577	0.9999898672103882	O
37723	.	244 245	155578 155579	0.9999808073043823	O
37724	The	0 3	155580 155583	0.9999890327453613	O
37725	Stata	4 8	155584 155588	0.9999881982803345	O
37727	package	10 17	155590 155597	0.999988317489624	O
37728	(	18 19	155598 155599	0.9999896287918091	O
37729	)	20 21	155600 155601	0.9999896287918091	O
37730	was	22 25	155602 155605	0.9999885559082031	O
37731	used	26 30	155606 155610	0.9999885559082031	O
37732	to	31 33	155611 155613	0.9999892711639404	O
37733	give	34 38	155614 155618	0.9999887943267822	O
37734	the	39 42	155619 155622	0.9999895095825195	O
37735	exact	43 48	155623 155628	0.9999887943267822	O
37736	binomial	49 56	155629 155636	0.9999885559082031	O
37739	confidence	58 68	155638 155648	0.9999892711639404	O
37740	limits	69 75	155649 155655	0.99998939037323	O
37741	for	76 79	155656 155659	0.9999895095825195	O
37742	a	80 81	155660 155661	0.9999895095825195	O
37743	proportion	82 92	155662 155672	0.9999885559082031	O
37744	(	93 94	155673 155674	0.9999895095825195	O
37745	Table	95 100	155675 155680	0.9999881982803345	O
37746	I	101 102	155681 155682	0.9999890327453613	O
37747	)	103 104	155683 155684	0.9999896287918091	O
37748	.	105 106	155685 155686	0.9999897480010986	O
37749	*	107 108	155687 155688	0.9999891519546509	O
37750	*	108 109	155688 155689	0.999985933303833	O
37751	IGNORE	0 5	155690 155695	0.999985933303833	O
37754	LINE	7 10	155697 155700	0.999988317489624	O
37757	*	12 13	155702 155703	0.9999880790710449	O
37758	*	13 14	155703 155704	0.9999881982803345	O
37759	*	15 16	155705 155706	0.9999880790710449	O
37760	*	16 17	155706 155707	0.9999881982803345	O
37761	IGNORE	18 23	155708 155713	0.9999871253967285	O
37764	LINE	25 28	155715 155718	0.9999881982803345	O
37767	*	30 31	155720 155721	0.9999877214431763	O
37768	*	31 32	155721 155722	0.9999876022338867	O
37769	*	33 34	155723 155724	0.9999876022338867	O
37770	*	34 35	155724 155725	0.9999876022338867	O
37771	IGNORE	36 41	155726 155731	0.9999862909317017	O
37774	LINE	43 46	155733 155736	0.9999881982803345	O
37777	*	48 49	155738 155739	0.9999877214431763	O
37778	*	49 50	155739 155740	0.9999877214431763	O
37779	CONCLUSION	51 60	155741 155750	0.9999880790710449	O
37784	From	62 66	155752 155756	0.9999865293502808	O
37785	this	67 71	155757 155761	0.9999889135360718	O
37786	study	72 77	155762 155767	0.9999876022338867	O
37787	we	78 80	155768 155770	0.9999878406524658	O
37788	have	81 85	155771 155775	0.999988317489624	O
37789	identified	86 96	155776 155786	0.9999885559082031	O
37790	the	97 100	155787 155790	0.9999887943267822	O
37791	minimum	101 108	155791 155798	0.9999855756759644	O
37792	prevalence	109 119	155799 155809	0.999988317489624	O
37793	of	120 122	155810 155812	0.9999885559082031	O
37794	pathogenic	123 132	155813 155822	0.9999885559082031	O
37796	mutations	134 143	155824 155833	0.9999872446060181	O
37797	in	144 146	155834 155836	0.9999887943267822	O
37798	MSH6	147 150	155837 155840	0.9999877214431763	O
37801	to	152 154	155842 155844	0.9999884366989136	O
37802	be	155 157	155845 155847	0.9999885559082031	O
37803	higher	158 164	155848 155854	0.9999876022338867	O
37804	in	165 167	155855 155857	0.9999887943267822	O
37805	an	168 170	155858 155860	0.9999886751174927	O
37806	unselected	171 180	155861 155870	0.9999879598617554	O
37810	cohort	182 187	155872 155877	0.9999884366989136	O
37813	of	189 191	155879 155881	0.9999878406524658	O
37814	EC	192 194	155882 155884	0.999980092048645	O
37815	patients	195 203	155885 155893	0.9999866485595703	O
37816	,	204 205	155894 155895	0.9999864101409912	O
37817	than	206 210	155896 155900	0.9999877214431763	O
37818	a	211 212	155901 155902	0.9999884366989136	O
37819	cohort	213 218	155903 155908	0.9999879598617554	O
37822	of	220 222	155910 155912	0.9999878406524658	O
37823	HNPCC	223 227	155913 155917	0.9999810457229614	O
37826	patients	229 237	155919 155927	0.9999862909317017	O
37827	who	238 241	155928 155931	0.9999884366989136	O
37828	have	242 246	155932 155936	0.9999881982803345	O
37829	been	247 251	155937 155941	0.9999885559082031	O
37830	selected	252 260	155942 155950	0.9999881982803345	O
37831	by	261 263	155951 155953	0.9999885559082031	O
37832	criteria	264 272	155954 155962	0.9999878406524658	O
37833	‘	273 274	155963 155964	0.9999865293502808	O
37834	widened	274 281	155964 155971	0.9999868869781494	O
37835	’	282 283	155972 155973	0.9999698400497437	O
37836	from	284 288	155974 155978	0.9999880790710449	O
37837	the	289 292	155979 155982	0.9999885559082031	O
37838	traditional	293 304	155983 155994	0.9999876022338867	O
37839	Amsterdam	305 314	155995 156004	0.9999850988388062	O
37840	II	315 317	156005 156007	0.9999876022338867	O
37841	criteria	318 326	156008 156016	0.9999884366989136	O
37842	,	327 328	156017 156018	0.9999881982803345	O
37843	in	329 331	156019 156021	0.9999886751174927	O
37844	keeping	332 339	156022 156029	0.9999865293502808	O
37845	with	340 344	156030 156034	0.999988317489624	O
37846	the	345 348	156035 156038	0.9999886751174927	O
37847	described	349 358	156039 156048	0.9999856948852539	O
37848	phenotype	359 367	156049 156057	0.9999884366989136	O
37851	of	369 371	156059 156061	0.9999884366989136	O
37852	MSH6	372 375	156062 156065	0.9999878406524658	O
37855	.	377 378	156067 156068	0.9999679327011108	O
37856	Unlike	0 6	156069 156075	0.9999799728393555	O
37857	the	7 10	156076 156079	0.9999843835830688	O
37858	other	11 16	156080 156085	0.9999836683273315	O
37859	more	17 21	156086 156090	0.9999779462814331	O
37860	common	22 28	156091 156097	0.9999828338623047	O
37861	MMR	29 31	156098 156100	0.9999827146530151	O
37863	genes	33 38	156102 156107	0.9999854564666748	O
37864	,	39 40	156108 156109	0.9999831914901733	O
37865	genomic	41 47	156110 156116	0.9999861717224121	O
37868	rearrangements	49 62	156118 156131	0.9999872446060181	O
37872	do	64 66	156133 156135	0.9999814033508301	O
37873	not	67 70	156136 156139	0.9999775886535645	O
37874	contribute	71 81	156140 156150	0.9999858140945435	O
37875	to	82 84	156151 156153	0.9999867677688599	O
37876	a	85 86	156154 156155	0.999987006187439	O
37877	large	87 92	156156 156161	0.9999849796295166	O
37878	proportion	93 103	156162 156172	0.9999860525131226	O
37879	of	104 106	156173 156175	0.9999866485595703	O
37880	mutations	107 116	156176 156185	0.9999836683273315	O
37881	in	117 119	156186 156188	0.9999872446060181	O
37882	MSH6	120 123	156189 156192	0.9999853372573853	O
37885	.	125 126	156194 156195	0.9999620914459229	O
37886	HNPCC	0 4	156196 156200	0.9999752044677734	O
37889	families	6 14	156202 156210	0.9999722242355347	O
37890	may	15 18	156211 156214	0.9999802112579346	O
37891	not	19 22	156215 156218	0.9999816417694092	O
37892	be	23 25	156219 156221	0.9999845027923584	O
37893	identified	26 36	156222 156232	0.9999833106994629	O
37894	if	37 39	156233 156235	0.9999774694442749	O
37895	patients	40 48	156236 156244	0.9999438524246216	O
37896	present	49 56	156245 156252	0.9999815225601196	O
37897	with	57 61	156253 156257	0.9999864101409912	O
37898	HNPCC	62 66	156258 156262	0.9999815225601196	O
37901	associated	68 78	156264 156274	0.9999865293502808	O
37902	cancers	79 85	156275 156281	0.999984622001648	O
37904	,	87 88	156283 156284	0.9999858140945435	O
37905	such	89 93	156285 156289	0.9999855756759644	O
37906	as	94 96	156290 156292	0.9999876022338867	O
37907	gynaecological	97 110	156293 156306	0.9999806880950928	O
37911	cancer	112 118	156308 156314	0.999985933303833	O
37912	,	119 120	156315 156316	0.9999858140945435	O
37913	rather	121 127	156317 156323	0.9999862909317017	O
37914	than	128 132	156324 156328	0.9999865293502808	O
37915	the	133 136	156329 156332	0.9999864101409912	O
37916	more	137 141	156333 156337	0.9999834299087524	O
37917	commonly	142 150	156338 156346	0.9999861717224121	O
37918	recognised	151 161	156347 156357	0.9999797344207764	O
37919	phenotype	162 170	156358 156366	0.9999877214431763	O
37922	of	172 174	156368 156370	0.999985933303833	O
37923	CRC	175 177	156371 156373	0.9999806880950928	O
37925	.	178 179	156374 156375	0.9999551773071289	O
37926	Clinicians	0 9	156376 156385	0.9999697208404541	O
37928	should	11 17	156387 156393	0.9999743700027466	O
37929	be	18 20	156394 156396	0.99997878074646	O
37930	vigilant	21 28	156397 156404	0.9999794960021973	O
37933	to	30 32	156406 156408	0.9999661445617676	O
37934	this	33 37	156409 156413	0.9999829530715942	O
37935	possibility	38 49	156414 156425	0.9999786615371704	O
37936	when	50 54	156426 156430	0.9999775886535645	O
37937	presented	55 64	156431 156440	0.9999806880950928	O
37938	with	65 69	156441 156445	0.9999831914901733	O
37939	a	70 71	156446 156447	0.9999852180480957	O
37940	history	72 79	156448 156455	0.9999788999557495	O
37941	of	80 82	156456 156458	0.9999849796295166	O
37942	endometrial	83 93	156459 156469	0.9999808073043823	O
37946	cancer	95 101	156471 156477	0.999984860420227	O
37947	in	102 104	156478 156480	0.999984860420227	O
37948	young	105 110	156481 156486	0.9999732971191406	O
37949	women	111 116	156487 156492	0.9999628067016602	O
37950	.	117 118	156493 156494	0.9999269247055054	O
37951	Further	0 7	156495 156502	0.9999881982803345	O
37952	work	8 12	156503 156507	0.9999880790710449	O
37953	on	13 15	156508 156510	0.9999892711639404	O
37954	immunohistochemistry	16 35	156511 156530	0.9999891519546509	O
37960	of	37 39	156532 156534	0.9999891519546509	O
37961	possible	40 48	156535 156543	0.9999874830245972	O
37962	missense	49 56	156544 156551	0.9999886751174927	O
37964	variants	58 66	156553 156561	0.9999878406524658	O
37965	may	67 70	156562 156565	0.9999864101409912	O
37966	increase	71 79	156566 156574	0.9999873638153076	O
37967	the	80 83	156575 156578	0.9999891519546509	O
37968	true	84 88	156579 156583	0.9999847412109375	O
37969	frequency	89 98	156584 156593	0.999987006187439	O
37970	of	99 101	156594 156596	0.9999889135360718	O
37971	mutations	102 111	156597 156606	0.999985933303833	O
37972	in	112 114	156607 156609	0.9999891519546509	O
37973	MSH6	115 118	156610 156613	0.9999854564666748	O
37976	.	120 121	156615 156616	0.9999890327453613	O
37977	*	122 123	156617 156618	0.9999890327453613	O
37978	*	123 124	156618 156619	0.9999864101409912	O
37979	IGNORE	0 5	156620 156625	0.9999864101409912	O
37982	LINE	7 10	156627 156630	0.9999884366989136	O
37985	*	12 13	156632 156633	0.9999886751174927	O
37986	*	13 14	156633 156634	0.9999885559082031	O
37987	*	15 16	156635 156636	0.9999885559082031	O
37988	*	16 17	156636 156637	0.9999885559082031	O
37989	IGNORE	18 23	156638 156643	0.9999878406524658	O
37992	LINE	25 28	156645 156648	0.9999887943267822	O
37995	*	30 31	156650 156651	0.9999886751174927	O
37996	*	31 32	156651 156652	0.9999884366989136	O
37997	*	33 34	156653 156654	0.9999885559082031	O
37998	*	34 35	156654 156655	0.9999884366989136	O
37999	IGNORE	36 41	156656 156661	0.9999876022338867	O
38002	LINE	43 46	156663 156666	0.9999886751174927	O
38005	*	48 49	156668 156669	0.9999886751174927	O
38006	*	49 50	156669 156670	0.9999886751174927	O
38007	To	51 53	156671 156673	0.9999881982803345	O
38008	understand	54 64	156674 156684	0.9999880790710449	O
38009	more	65 69	156685 156689	0.9999886751174927	O
38010	precisely	70 79	156690 156699	0.999984860420227	O
38011	the	80 83	156700 156703	0.9999890327453613	O
38012	mechanistic	84 94	156704 156714	0.9999886751174927	O
38015	roles	96 101	156716 156721	0.9999876022338867	O
38016	that	102 106	156722 156726	0.9999889135360718	O
38017	Mlh3	107 110	156727 156730	0.9999877214431763	O
38021	and	112 115	156732 156735	0.9999885559082031	O
38022	Pms2	116 119	156736 156739	0.9999879598617554	O
38025	play	121 125	156741 156745	0.9999874830245972	O
38026	in	126 128	156746 156748	0.9999880790710449	O
38027	GI	129 130	156749 156750	0.9999791383743286	O
38029	tumor	132 137	156752 156757	0.9999847412109375	O
38030	suppression	138 149	156758 156769	0.9999860525131226	O
38031	,	150 151	156770 156771	0.9999885559082031	O
38032	we	152 154	156772 156774	0.999984622001648	O
38033	generated	155 164	156775 156784	0.9999674558639526	O
38034	Mlh3−	165 169	156785 156789	0.9999884366989136	O
38039	/	170 171	156790 156791	0.9999891519546509	O
38040	−	171 172	156791 156792	0.9999865293502808	O
38041	;	172 173	156792 156793	0.9999889135360718	O
38042	Apc1638N	173 180	156793 156800	0.9999886751174927	O
38048	(	182 183	156802 156803	0.9999890327453613	O
38049	MA	184 186	156804 156806	0.9999812841415405	O
38050	)	187 188	156807 156808	0.9999890327453613	O
38051	and	189 192	156809 156812	0.9999874830245972	O
38052	Mlh3−	193 197	156813 156817	0.999988317489624	O
38057	/	198 199	156818 156819	0.9999891519546509	O
38058	−	199 200	156819 156820	0.9999872446060181	O
38059	;	200 201	156820 156821	0.9999885559082031	O
38060	Pms2−	201 205	156821 156825	0.9999879598617554	O
38064	/	206 207	156826 156827	0.9999890327453613	O
38065	−	207 208	156827 156828	0.999987006187439	O
38066	;	208 209	156828 156829	0.9999887943267822	O
38067	Apc1638N	209 216	156829 156836	0.9999886751174927	O
38073	(	218 219	156838 156839	0.9999889135360718	O
38074	MPA	220 222	156840 156842	0.9999840259552002	O
38076	)	224 225	156844 156845	0.9999881982803345	O
38077	mice	226 230	156846 156850	0.5010048747062683	species
38078	.	231 232	156851 156852	0.9999520778656006	O
38079	We	0 2	156853 156855	0.9999780654907227	O
38080	show	3 7	156856 156860	0.9999748468399048	O
38081	that	8 12	156861 156865	0.9999877214431763	O
38082	in	13 15	156866 156868	0.9999879598617554	O
38083	vivo	16 19	156869 156872	0.999987006187439	O
38085	Mlh3	21 24	156874 156877	0.999984860420227	O
38089	mutations	26 35	156879 156888	0.9999864101409912	O
38090	significantly	36 49	156889 156902	0.9999853372573853	O
38091	increase	50 58	156903 156911	0.9999867677688599	O
38092	frameshift	59 68	156912 156921	0.9999878406524658	O
38095	mutation	70 78	156923 156931	0.9999879598617554	O
38096	rates	79 84	156932 156937	0.9999885559082031	O
38097	in	85 87	156938 156940	0.9999890327453613	O
38098	Apc	88 90	156941 156943	0.9999878406524658	O
38101	,	92 93	156945 156946	0.9999822378158569	O
38102	and	94 97	156947 156950	0.9999854564666748	O
38103	increase	98 106	156951 156959	0.9999840259552002	O
38104	GI	107 108	156960 156961	0.9999840259552002	O
38106	tumorigenesis	110 122	156963 156975	0.9999874830245972	O
38110	.	124 125	156977 156978	0.9999662637710571	O
38111	Unlike	0 6	156979 156985	0.9999818801879883	O
38112	typical	7 14	156986 156993	0.9999790191650391	O
38113	MSI	15 17	156994 156996	0.9999822378158569	O
38115	-	18 19	156997 156998	0.9999878406524658	O
38116	induced	19 26	156998 157005	0.9999755620956421	O
38117	mutations	27 36	157006 157015	0.9999833106994629	O
38118	,	37 38	157016 157017	0.999984860420227	O
38119	Mlh3	39 42	157018 157021	0.999984860420227	O
38123	deficiency	44 54	157023 157033	0.9999810457229614	O
38124	also	55 59	157034 157038	0.9999843835830688	O
38125	results	60 67	157039 157046	0.999984860420227	O
38126	in	68 70	157047 157049	0.9999884366989136	O
38127	frameshift	71 80	157050 157059	0.9999865293502808	O
38130	mutations	82 91	157061 157070	0.9999873638153076	O
38131	in	92 94	157071 157073	0.9999885559082031	O
38132	non	95 98	157074 157077	0.9999874830245972	O
38133	-	98 99	157077 157078	0.9999884366989136	O
38134	repetitive	99 109	157078 157088	0.9999827146530151	O
38135	sequences	110 119	157089 157098	0.9999873638153076	O
38136	,	120 121	157099 157100	0.9999856948852539	O
38137	a	122 123	157101 157102	0.9999887943267822	O
38138	unique	124 130	157103 157109	0.9999858140945435	O
38139	mutational	131 140	157110 157119	0.9999858140945435	O
38141	signature	142 151	157121 157130	0.9999880790710449	O
38142	among	152 157	157131 157136	0.9999880790710449	O
38143	MMR	158 160	157137 157139	0.999985933303833	O
38145	deficient	162 170	157141 157149	0.9999874830245972	O
38147	mice	172 176	157151 157155	0.5162262320518494	species
38148	found	177 182	157156 157161	0.9999874830245972	O
38149	only	183 187	157162 157166	0.999987006187439	O
38150	in	188 190	157167 157169	0.999988317489624	O
38151	Mlh3	191 194	157170 157173	0.9999871253967285	O
38155	deficient	196 204	157175 157183	0.9999873638153076	O
38157	mice	206 210	157185 157189	0.506830096244812	species
38158	.	211 212	157190 157191	0.9999374151229858	O
38159	Consistent	0 9	157192 157201	0.9999878406524658	O
38162	with	11 15	157203 157207	0.9999889135360718	O
38163	the	16 19	157208 157211	0.9999891519546509	O
38164	role	20 24	157212 157216	0.9999877214431763	O
38165	of	25 27	157217 157219	0.9999892711639404	O
38166	Pms2	28 31	157220 157223	0.9999886751174927	O
38169	in	33 35	157225 157227	0.9999891519546509	O
38170	SBR	36 38	157228 157230	0.9999886751174927	O
38172	,	40 41	157232 157233	0.9999891519546509	O
38173	combined	42 50	157234 157242	0.9999874830245972	O
38174	Mlh3	51 54	157243 157246	0.9999889135360718	O
38178	and	56 59	157248 157251	0.9999886751174927	O
38179	Pms2	60 63	157252 157255	0.9999881982803345	O
38182	mutations	65 74	157257 157266	0.9999891519546509	O
38183	proportionally	75 88	157267 157280	0.9999872446060181	O
38185	increase	90 98	157282 157290	0.9999878406524658	O
38186	point	99 104	157291 157296	0.9999881982803345	O
38187	mutations	105 114	157297 157306	0.9999892711639404	O
38188	and	115 118	157307 157310	0.9999891519546509	O
38189	show	119 123	157311 157315	0.9999884366989136	O
38190	a	124 125	157316 157317	0.99998939037323	O
38191	sequence	126 134	157318 157326	0.999988317489624	O
38192	preference	135 145	157327 157337	0.9999889135360718	O
38193	for	146 149	157338 157341	0.9999892711639404	O
38194	a	150 151	157342 157343	0.9999892711639404	O
38195	CpG	152 154	157344 157346	0.9999886751174927	O
38198	mutation	156 164	157348 157356	0.9999887943267822	O
38199	hotspot	165 171	157357 157363	0.9999886751174927	O
38202	also	173 177	157365 157369	0.9999889135360718	O
38203	previously	178 188	157370 157380	0.9999879598617554	O
38204	seen	189 193	157381 157385	0.9999889135360718	O
38205	in	194 196	157386 157388	0.99998939037323	O
38206	Mlh1−	197 201	157389 157393	0.9999884366989136	O
38211	/	202 203	157394 157395	0.9999886751174927	O
38212	−	204 205	157396 157397	0.9999850988388062	O
38213	mice	206 210	157398 157402	0.9999643564224243	O
38214	.	211 212	157403 157404	0.9999746084213257	O
38215	Because	0 7	157405 157412	0.9999698400497437	O
38216	MPA	8 10	157413 157415	0.9999674558639526	O
38218	mutant	12 18	157417 157423	0.9998843669891357	O
38219	mice	19 23	157424 157428	0.7351334691047668	species
38220	also	24 28	157429 157433	0.999954342842102	O
38221	have	29 33	157434 157438	0.9999703168869019	O
38222	significantly	34 47	157439 157452	0.9999768733978271	O
38223	increased	48 57	157453 157462	0.9999421834945679	O
38224	rates	58 63	157463 157468	0.9999758005142212	O
38225	of	64 66	157469 157471	0.9999809265136719	O
38226	GI	67 68	157472 157473	0.9999281167984009	O
38228	adenocarcinomas	70 84	157475 157489	0.9999717473983765	O
38234	vs	86 88	157491 157493	0.9999830722808838	O
38235	.	88 89	157493 157494	0.9999852180480957	O
38236	Apc1638N	90 97	157495 157502	0.9999849796295166	O
38242	or	99 101	157504 157506	0.9999843835830688	O
38243	MA	102 104	157507 157509	0.9999595880508423	O
38244	mice	105 109	157510 157514	0.9503907561302185	O
38245	,	110 111	157515 157516	0.9999819993972778	O
38246	we	112 114	157517 157519	0.9999792575836182	O
38247	investigated	115 127	157520 157532	0.9999793767929077	O
38248	mechanisms	128 138	157533 157543	0.9999786615371704	O
38249	of	139 141	157544 157546	0.9999837875366211	O
38250	tumor	142 147	157547 157552	0.999967098236084	O
38251	progression	148 159	157553 157564	0.9999767541885376	O
38252	.	160 161	157565 157566	0.9999377727508545	O
38253	Using	0 5	157567 157572	0.9999806880950928	O
38254	array	6 11	157573 157578	0.9999781847000122	O
38255	-	11 12	157578 157579	0.9999843835830688	O
38256	CGH	12 14	157579 157581	0.999981164932251	O
38259	,	16 17	157583 157584	0.9999821186065674	O
38260	we	18 20	157585 157587	0.9999686479568481	O
38261	identified	21 31	157588 157598	0.9999799728393555	O
38262	a	32 33	157599 157600	0.9999847412109375	O
38263	recurrent	34 42	157601 157609	0.9999843835830688	O
38265	5	44 45	157611 157612	0.999984860420227	O
38266	-	45 46	157612 157613	0.9999874830245972	O
38267	Mb	46 47	157613 157614	0.9999865293502808	O
38269	amplification	49 61	157616 157628	0.9999866485595703	O
38272	on	63 65	157630 157632	0.9999866485595703	O
38273	chromosome	66 76	157633 157643	0.999985933303833	O
38274	12	77 79	157644 157646	0.9999802112579346	O
38275	in	80 82	157647 157649	0.9999613761901855	O
38276	GI	83 84	157650 157651	0.9999139308929443	O
38278	tumors	86 92	157653 157659	0.9999756813049316	O
38279	from	93 97	157660 157664	0.9997557997703552	O
38280	MPA	98 100	157665 157667	0.9999159574508667	O
38282	mice	102 106	157669 157673	0.6300560235977173	species
38283	.	107 108	157674 157675	0.9999287128448486	O
38284	We	0 2	157676 157678	0.9999806880950928	O
38285	defined	3 10	157679 157686	0.9999727010726929	O
38286	the	11 14	157687 157690	0.9999868869781494	O
38287	amplicon	15 22	157691 157698	0.999987006187439	O
38291	critical	24 32	157700 157708	0.9999871253967285	O
38292	interval	33 41	157709 157717	0.9999852180480957	O
38293	and	42 45	157718 157721	0.9999836683273315	O
38294	demonstrated	46 58	157722 157734	0.9999749660491943	O
38295	that	59 63	157735 157739	0.9999862909317017	O
38296	it	64 66	157740 157742	0.9999872446060181	O
38297	contains	67 75	157743 157751	0.9999868869781494	O
38298	a	76 77	157752 157753	0.9999881982803345	O
38299	previously	78 88	157754 157764	0.9999877214431763	O
38300	uncharacterized	89 103	157765 157779	0.9999880790710449	O
38305	member	105 111	157781 157787	0.9999858140945435	O
38306	of	112 114	157788 157790	0.9999876022338867	O
38307	the	115 118	157791 157794	0.9999872446060181	O
38308	Transducin	119 128	157795 157804	0.9999853372573853	O
38311	enhancer	130 137	157806 157813	0.9999837875366211	O
38313	of	139 141	157815 157817	0.9999879598617554	O
38314	Split	142 147	157818 157823	0.9999837875366211	O
38315	(	148 149	157824 157825	0.999988317489624	O
38316	TLE	150 152	157826 157828	0.9999861717224121	O
38318	)	153 154	157829 157830	0.9999885559082031	O
38319	/	154 155	157830 157831	0.9999873638153076	O
38320	Groucho	155 161	157831 157837	0.9999816417694092	O
38323	family	163 169	157839 157845	0.9999873638153076	O
38324	of	170 172	157846 157848	0.9999874830245972	O
38325	transcriptional	173 187	157849 157863	0.9999829530715942	O
38327	co	189 191	157865 157867	0.9999872446060181	O
38328	-	191 192	157867 157868	0.9999873638153076	O
38329	regulators	192 201	157868 157877	0.9999831914901733	O
38331	,	203 204	157879 157880	0.9999874830245972	O
38332	Tle6	205 208	157881 157884	0.9999864101409912	O
38335	-	209 210	157885 157886	0.9999884366989136	O
38336	like	210 214	157886 157890	0.9999867677688599	O
38337	,	215 216	157891 157892	0.999987006187439	O
38338	that	217 221	157893 157897	0.9999864101409912	O
38339	contributes	222 233	157898 157909	0.9999773502349854	O
38340	to	234 236	157910 157912	0.999984860420227	O
38341	tumor	237 242	157913 157918	0.9999778270721436	O
38342	progression	243 254	157919 157930	0.999982476234436	O
38343	.	255 256	157931 157932	0.9999340772628784	O
38344	Tle6	0 3	157933 157936	0.9999783039093018	O
38347	-	4 5	157937 157938	0.9999834299087524	O
38348	like	5 9	157938 157942	0.9999769926071167	O
38349	overexpression	10 23	157943 157956	0.9999786615371704	O
38353	in	25 27	157958 157960	0.9999572038650513	O
38354	colon	28 32	157961 157965	0.9999114274978638	O
38356	cancer	34 40	157967 157973	0.9999711513519287	O
38357	cell	41 45	157974 157978	0.9999113082885742	O
38358	lines	46 51	157979 157984	0.9999165534973145	O
38359	increases	52 61	157985 157994	0.9999048709869385	O
38360	cell	62 66	157995 157999	0.9999591112136841	O
38361	proliferation	67 80	158000 158013	0.9999778270721436	O
38362	,	81 82	158014 158015	0.9999761581420898	O
38363	colony	83 89	158016 158022	0.9999521970748901	O
38364	-	89 90	158022 158023	0.9999833106994629	O
38365	formation	90 99	158023 158032	0.9999790191650391	O
38366	ability	100 107	158033 158040	0.9999827146530151	O
38367	,	108 109	158041 158042	0.9999779462814331	O
38368	cell	110 114	158043 158047	0.9999642372131348	O
38369	migration	115 124	158048 158057	0.9999513626098633	O
38370	and	125 128	158058 158061	0.9999731779098511	O
38371	xenograft	129 137	158062 158070	0.9996205568313599	O
38375	tumorigenicity	139 152	158072 158085	0.9999700784683228	O
38379	.	154 155	158087 158088	0.9996398687362671	O
38380	Human	0 5	158089 158094	0.9332337975502014	O
38381	TLE6D	6 10	158095 158099	0.9999873638153076	O
38385	,	12 13	158101 158102	0.999985933303833	O
38386	an	14 16	158103 158105	0.9999871253967285	O
38387	alternatively	17 30	158106 158119	0.9999866485595703	O
38388	spliced	31 37	158120 158126	0.9999877214431763	O
38392	isoform	39 45	158128 158134	0.9999885559082031	O
38395	of	47 49	158136 158138	0.9999878406524658	O
38396	TLE6	50 53	158139 158142	0.9999885559082031	O
38399	,	55 56	158144 158145	0.9999865293502808	O
38400	with	57 61	158146 158150	0.9999866485595703	O
38401	a	62 63	158151 158152	0.9999881982803345	O
38402	domain	64 70	158153 158159	0.9999873638153076	O
38403	structure	71 80	158160 158169	0.9999876022338867	O
38404	similar	81 88	158170 158177	0.9999884366989136	O
38405	to	89 91	158178 158180	0.9999885559082031	O
38406	Tle6	92 95	158181 158184	0.9999889135360718	O
38409	-	96 97	158185 158186	0.9999891519546509	O
38410	like	97 101	158186 158190	0.9999887943267822	O
38411	,	102 103	158191 158192	0.9999868869781494	O
38412	has	104 107	158193 158196	0.9999865293502808	O
38413	functional	108 118	158197 158207	0.9999873638153076	O
38414	activity	119 127	158208 158216	0.9999876022338867	O
38415	similar	128 135	158217 158224	0.9999878406524658	O
38416	to	136 138	158225 158227	0.9999889135360718	O
38417	Tle6	139 142	158228 158231	0.9999889135360718	O
38420	-	143 144	158232 158233	0.9999890327453613	O
38421	like	144 148	158233 158237	0.9999884366989136	O
38422	.	149 150	158238 158239	0.9999600648880005	O
38423	Both	0 4	158240 158244	0.9999867677688599	O
38424	Tle6	5 8	158245 158248	0.9999881982803345	O
38427	-	9 10	158249 158250	0.9999891519546509	O
38428	like	10 14	158250 158254	0.9999873638153076	O
38429	and	15 18	158255 158258	0.9999881982803345	O
38430	TLE6D	19 23	158259 158263	0.9999889135360718	O
38434	interact	25 33	158265 158273	0.9999866485595703	O
38435	with	34 38	158274 158278	0.9999886751174927	O
38436	GI	39 40	158279 158280	0.9999833106994629	O
38438	tumor	42 47	158282 158287	0.9999876022338867	O
38439	suppressor	48 57	158288 158297	0.9999879598617554	O
38441	,	59 60	158299 158300	0.9999885559082031	O
38442	RUNX3	61 65	158301 158305	0.9999887943267822	O
38446	[	67 68	158307 158308	0.9999892711639404	O
38447	34	68 70	158308 158310	0.9999874830245972	O
38448	]	70 71	158310 158311	0.9999892711639404	O
38449	,	72 73	158312 158313	0.9999885559082031	O
38450	and	74 77	158314 158317	0.9999877214431763	O
38451	antagonize	78 87	158318 158327	0.9999877214431763	O
38454	RUNX3	89 93	158329 158333	0.9999892711639404	O
38458	gene	95 99	158335 158339	0.9999886751174927	O
38459	target	100 106	158340 158346	0.9999885559082031	O
38460	tranactivation	107 120	158347 158360	0.9999895095825195	O
38464	.	122 123	158362 158363	0.9999707937240601	O
38465	TLE6D	0 4	158364 158368	0.9999865293502808	O
38469	is	6 8	158370 158372	0.9999867677688599	O
38470	overexpressed	9 21	158373 158385	0.9999873638153076	O
38473	in	23 25	158387 158389	0.9999873638153076	O
38474	multiple	26 34	158390 158398	0.9999828338623047	O
38475	human	35 40	158399 158404	0.9999493360519409	O
38476	microsatellite	41 54	158405 158418	0.9999879598617554	O
38480	stable	56 62	158420 158426	0.9999880790710449	O
38481	(	63 64	158427 158428	0.9999889135360718	O
38482	MSS	65 67	158429 158431	0.9999862909317017	O
38484	)	68 69	158432 158433	0.9999884366989136	O
38485	and	70 73	158434 158437	0.9999864101409912	O
38486	microsatellite	74 87	158438 158451	0.9999876022338867	O
38490	unstable	89 97	158453 158461	0.9999872446060181	O
38491	(	98 99	158462 158463	0.9999891519546509	O
38492	MSI	100 102	158464 158466	0.9999874830245972	O
38494	-	103 104	158467 158468	0.9999890327453613	O
38495	H	104 105	158468 158469	0.9999847412109375	O
38496	)	105 106	158469 158470	0.9999889135360718	O
38497	CRCs	107 110	158471 158474	0.999981164932251	O
38499	,	112 113	158476 158477	0.9999855756759644	O
38500	and	114 117	158478 158481	0.9999862909317017	O
38501	TLE6D	118 122	158482 158486	0.9999884366989136	O
38505	expression	124 134	158488 158498	0.9999886751174927	O
38506	levels	135 141	158499 158505	0.9999889135360718	O
38507	correlate	142 150	158506 158514	0.9999879598617554	O
38510	with	152 156	158516 158520	0.999988317489624	O
38511	RUNX3	157 161	158521 158525	0.9999871253967285	O
38515	expression	163 173	158527 158537	0.9999886751174927	O
38516	levels	174 180	158538 158544	0.9999887943267822	O
38517	.	181 182	158545 158546	0.9999443292617798	O
38518	Collectively	0 11	158547 158558	0.9999831914901733	O
38520	,	13 14	158560 158561	0.9999865293502808	O
38521	these	15 20	158562 158567	0.9999849796295166	O
38522	findings	21 29	158568 158576	0.9999821186065674	O
38523	provide	30 37	158577 158584	0.9999853372573853	O
38524	important	38 47	158585 158594	0.9999864101409912	O
38525	insights	48 56	158595 158603	0.9999836683273315	O
38526	into	57 61	158604 158608	0.9999866485595703	O
38527	the	62 65	158609 158612	0.999987006187439	O
38528	molecular	66 75	158613 158622	0.9999804496765137	O
38529	mechanisms	76 86	158623 158633	0.9999836683273315	O
38530	through	87 94	158634 158641	0.9999821186065674	O
38531	which	95 100	158642 158647	0.9999867677688599	O
38532	MMR	101 103	158648 158650	0.9999828338623047	O
38534	-	104 105	158651 158652	0.9999866485595703	O
38535	deficiency	105 115	158652 158662	0.9999836683273315	O
38536	contributes	116 127	158663 158674	0.9999791383743286	O
38537	to	128 130	158675 158677	0.9999865293502808	O
38538	GI	131 132	158678 158679	0.999977707862854	O
38540	tumorigenesis	134 146	158681 158693	0.9999852180480957	O
38544	and	148 151	158695 158698	0.9999858140945435	O
38545	implicate	152 160	158699 158707	0.9999874830245972	O
38548	a	162 163	158709 158710	0.9999877214431763	O
38549	novel	164 169	158711 158716	0.9999860525131226	O
38550	association	170 181	158717 158728	0.9999877214431763	O
38551	between	182 189	158729 158736	0.9999876022338867	O
38552	TLE6	190 193	158737 158740	0.9999871253967285	O
38555	isoforms	195 202	158742 158749	0.9999879598617554	O
38558	and	204 207	158751 158754	0.9999877214431763	O
38559	antagonism	208 217	158755 158764	0.9999865293502808	O
38562	of	219 221	158766 158768	0.9999872446060181	O
38563	RUNX	222 225	158769 158772	0.9999858140945435	O
38566	target	227 233	158774 158780	0.9999868869781494	O
38567	gene	234 238	158781 158785	0.9999873638153076	O
38568	expression	239 249	158786 158796	0.9999868869781494	O
38569	in	250 252	158797 158799	0.999984860420227	O
38570	CRC	253 255	158800 158802	0.9999771118164062	O
38572	tumor	257 262	158804 158809	0.9999819993972778	O
38573	progression	263 274	158810 158821	0.9999828338623047	O
38574	.	275 276	158822 158823	0.9999868869781494	O
38575	*	277 278	158824 158825	0.9999856948852539	O
38576	*	278 279	158825 158826	0.9999703168869019	O
38577	IGNORE	0 5	158827 158832	0.9999854564666748	O
38580	LINE	7 10	158834 158837	0.9999878406524658	O
38583	*	12 13	158839 158840	0.9999889135360718	O
38584	*	13 14	158840 158841	0.9999889135360718	O
38585	*	15 16	158842 158843	0.9999889135360718	O
38586	*	16 17	158843 158844	0.9999891519546509	O
38587	IGNORE	18 23	158845 158850	0.9999874830245972	O
38590	LINE	25 28	158852 158855	0.9999886751174927	O
38593	*	30 31	158857 158858	0.9999887943267822	O
38594	*	31 32	158858 158859	0.9999887943267822	O
38595	*	33 34	158860 158861	0.9999889135360718	O
38596	*	34 35	158861 158862	0.9999889135360718	O
38597	IGNORE	36 41	158863 158868	0.9999871253967285	O
38600	LINE	43 46	158870 158873	0.9999884366989136	O
38603	*	48 49	158875 158876	0.9999887943267822	O
38604	*	49 50	158876 158877	0.9999890327453613	O
38605	RUNX	51 54	158878 158881	0.9999874830245972	O
38608	family	56 62	158883 158889	0.9999877214431763	O
38609	genes	63 68	158890 158895	0.9999867677688599	O
38610	regulate	69 77	158896 158904	0.9999837875366211	O
38611	lineage	78 85	158905 158912	0.9999822378158569	O
38612	and	86 89	158913 158916	0.9999856948852539	O
38613	stage	90 95	158917 158922	0.999983549118042	O
38614	specific	96 104	158923 158931	0.9999873638153076	O
38615	gene	105 109	158932 158936	0.9999819993972778	O
38616	transcription	110 123	158937 158950	0.9999842643737793	O
38617	by	124 126	158951 158953	0.9999877214431763	O
38618	direct	127 133	158954 158960	0.999984622001648	O
38619	binding	134 141	158961 158968	0.9999821186065674	O
38620	to	142 144	158969 158971	0.9999873638153076	O
38621	DNA	145 148	158972 158975	0.9999840259552002	O
38622	promoters	149 157	158976 158984	0.9999877214431763	O
38624	and	159 162	158986 158989	0.9999872446060181	O
38625	enhancer	163 170	158990 158997	0.9999829530715942	O
38627	elements	172 180	158999 159007	0.9999874830245972	O
38628	[	181 182	159008 159009	0.99998939037323	O
38629	44	182 184	159009 159011	0.9999872446060181	O
38630	]	184 185	159011 159012	0.9999890327453613	O
38631	,	186 187	159013 159014	0.9999884366989136	O
38632	[	187 188	159014 159015	0.9999890327453613	O
38633	45	188 190	159015 159017	0.9999853372573853	O
38634	]	190 191	159017 159018	0.9999887943267822	O
38635	.	192 193	159019 159020	0.9999784231185913	O
38636	Loss	0 4	159021 159025	0.9996498823165894	O
38637	of	5 7	159026 159028	0.9999425411224365	O
38638	Runx3	8 12	159029 159033	0.9999600648880005	O
38641	in	14 16	159035 159037	0.9997685551643372	O
38642	the	17 20	159038 159041	0.9868409633636475	O
38643	mouse	21 26	159042 159047	0.9136839509010315	species
38644	results	27 34	159048 159055	0.9983906745910645	O
38645	in	35 37	159056 159058	0.9999319314956665	O
38646	the	38 41	159059 159062	0.999920129776001	O
38647	development	42 53	159063 159074	0.9999110698699951	O
38648	of	54 56	159075 159077	0.9999667406082153	O
38649	gastric	57 63	159078 159084	0.9998997449874878	O
38651	mucosal	65 71	159086 159092	0.9999676942825317	O
38655	hyperplasia	73 83	159094 159104	0.9999740123748779	O
38659	,	85 86	159106 159107	0.9999707937240601	O
38660	decreased	87 96	159108 159117	0.9999200105667114	O
38661	apoptosis	97 105	159118 159126	0.9999833106994629	O
38664	and	107 110	159128 159131	0.9999788999557495	O
38665	attenuated	111 120	159132 159141	0.999982476234436	O
38668	TGF	122 124	159143 159145	0.999984622001648	O
38671	-	125 126	159146 159147	0.9999856948852539	O
38672	β	126 127	159147 159148	0.9999806880950928	O
38673	anti	128 132	159149 159153	0.9999841451644897	O
38674	-	132 133	159153 159154	0.9999855756759644	O
38675	proliferative	133 145	159154 159166	0.9999822378158569	O
38678	signaling	147 156	159168 159177	0.9999678134918213	O
38679	.	157 158	159178 159179	0.9995155334472656	O
38680	Consistent	0 9	159180 159189	0.9999877214431763	O
38683	with	11 15	159191 159195	0.9999880790710449	O
38684	previous	16 24	159196 159204	0.999983549118042	O
38685	observations	25 37	159205 159217	0.9999850988388062	O
38686	of	38 40	159218 159220	0.9999884366989136	O
38687	interactions	41 53	159221 159233	0.9999841451644897	O
38688	between	54 61	159234 159241	0.9999889135360718	O
38689	RUNX3	62 66	159242 159246	0.9999880790710449	O
38693	and	68 71	159248 159251	0.9999885559082031	O
38694	TLE	72 74	159252 159254	0.9999867677688599	O
38696	family	76 82	159256 159262	0.9999877214431763	O
38697	members	83 90	159263 159270	0.9999872446060181	O
38698	mediated	91 99	159271 159279	0.9999879598617554	O
38699	through	100 107	159280 159287	0.9999885559082031	O
38700	the	108 111	159288 159291	0.9999885559082031	O
38701	Runt	112 115	159292 159295	0.9999825954437256	O
38703	and	117 120	159297 159300	0.999988317489624	O
38704	WD	121 122	159301 159302	0.9999841451644897	O
38706	repeat	124 130	159304 159310	0.9999852180480957	O
38707	domains	131 138	159311 159318	0.9999884366989136	O
38708	,	139 140	159319 159320	0.9999889135360718	O
38709	respectively	141 153	159321 159333	0.9999867677688599	O
38710	[	154 155	159334 159335	0.9999890327453613	O
38711	46	155 157	159335 159337	0.9999867677688599	O
38712	]	157 158	159337 159338	0.9999889135360718	O
38713	,	159 160	159339 159340	0.9999884366989136	O
38714	[	160 161	159340 159341	0.9999887943267822	O
38715	48	161 163	159341 159343	0.9999854564666748	O
38716	]	163 164	159343 159344	0.9999889135360718	O
38717	,	165 166	159345 159346	0.9999886751174927	O
38718	we	167 169	159347 159349	0.9999876022338867	O
38719	detected	170 178	159350 159358	0.9999880790710449	O
38720	an	179 181	159359 159361	0.9999887943267822	O
38721	interaction	182 193	159362 159373	0.999987006187439	O
38722	between	194 201	159374 159381	0.9999886751174927	O
38723	RUNX3	202 206	159382 159386	0.9999884366989136	O
38727	and	208 211	159388 159391	0.9999890327453613	O
38728	Tle6	212 215	159392 159395	0.9999884366989136	O
38731	-	216 217	159396 159397	0.9999892711639404	O
38732	like	217 221	159397 159401	0.9999881982803345	O
38733	/	221 222	159401 159402	0.9999889135360718	O
38734	TLE6D	222 226	159402 159406	0.9999884366989136	O
38738	by	228 230	159408 159410	0.9999886751174927	O
38739	co	231 233	159411 159413	0.9999885559082031	O
38740	-	233 234	159413 159414	0.9999890327453613	O
38741	immunoprecipitation	234 252	159414 159432	0.9999879598617554	O
38749	.	254 255	159434 159435	0.9999717473983765	O
38750	Furthermore	0 11	159436 159447	0.999972939491272	O
38751	,	12 13	159448 159449	0.9999865293502808	O
38752	we	14 16	159450 159452	0.9999784231185913	O
38753	demonstrated	17 29	159453 159465	0.9999798536300659	O
38754	that	30 34	159466 159470	0.9999877214431763	O
38755	Tle6	35 38	159471 159474	0.9999868869781494	O
38758	-	39 40	159475 159476	0.999988317489624	O
38759	like	40 44	159476 159480	0.9999858140945435	O
38760	/	44 45	159480 159481	0.9999876022338867	O
38761	TLE6D	45 49	159481 159485	0.9999880790710449	O
38765	antagonized	51 61	159487 159497	0.9999876022338867	O
38768	RUNX3	63 67	159499 159503	0.9999862909317017	O
38772	regulated	69 78	159505 159514	0.9999822378158569	O
38773	transcriptional	79 93	159515 159529	0.9999852180480957	O
38775	targets	95 102	159531 159538	0.9999854564666748	O
38776	.	103 104	159539 159540	0.9999538660049438	O
38777	However	0 7	159541 159548	0.9999797344207764	O
38778	,	8 9	159549 159550	0.9999847412109375	O
38779	while	10 15	159551 159556	0.9999803304672241	O
38780	these	16 21	159557 159562	0.9999806880950928	O
38781	experiments	22 33	159563 159574	0.9985138773918152	O
38782	show	34 38	159575 159579	0.9999790191650391	O
38783	an	39 41	159580 159582	0.9999856948852539	O
38784	association	42 53	159583 159594	0.9999836683273315	O
38785	between	54 61	159595 159602	0.9999854564666748	O
38786	[UNK]	62 73	159603 159614	0.9999673366546631	O
38787	interactions	74 86	159615 159627	0.9999659061431885	O
38788	and	87 90	159628 159631	0.9999849796295166	O
38789	tumor	91 96	159632 159637	0.9999730587005615	O
38790	progression	97 108	159638 159649	0.9999822378158569	O
38791	,	109 110	159650 159651	0.9999833106994629	O
38792	they	111 115	159652 159656	0.9999837875366211	O
38793	do	116 118	159657 159659	0.9999812841415405	O
38794	not	119 122	159660 159663	0.9999791383743286	O
38795	demonstrate	123 134	159664 159675	0.9999799728393555	O
38796	mechanistically	135 149	159676 159690	0.9999839067459106	O
38800	the	151 154	159692 159695	0.9999855756759644	O
38801	functional	155 165	159696 159706	0.9999693632125854	O
38802	importance	166 176	159707 159717	0.9999854564666748	O
38803	of	177 179	159718 159720	0.9999871253967285	O
38804	this	180 184	159721 159725	0.9999876022338867	O
38805	interaction	185 196	159726 159737	0.9999823570251465	O
38806	in	197 199	159738 159740	0.999984860420227	O
38807	accelerating	200 211	159741 159752	0.9999867677688599	O
38811	tumor	213 218	159754 159759	0.9999785423278809	O
38812	progression	219 230	159760 159771	0.9999830722808838	O
38813	.	231 232	159772 159773	0.999948263168335	O
38814	Alternative	0 11	159774 159785	0.9999854564666748	O
38815	mRNA	12 15	159786 159789	0.9999854564666748	O
38817	splicing	17 24	159791 159798	0.9999884366989136	O
38820	allows	26 32	159800 159806	0.9999864101409912	O
38821	multiple	33 41	159807 159815	0.9999724626541138	O
38822	gene	42 46	159816 159820	0.9999850988388062	O
38823	products	47 55	159821 159829	0.9999861717224121	O
38824	to	56 58	159830 159832	0.9999884366989136	O
38825	be	59 61	159833 159835	0.9999885559082031	O
38826	produced	62 70	159836 159844	0.9999878406524658	O
38827	from	71 75	159845 159849	0.9999884366989136	O
38828	a	76 77	159850 159851	0.9999890327453613	O
38829	single	78 84	159852 159858	0.9999877214431763	O
38830	coding	85 91	159859 159865	0.9999886751174927	O
38831	sequence	92 100	159866 159874	0.9999878406524658	O
38832	,	101 102	159875 159876	0.9999864101409912	O
38833	and	103 106	159877 159880	0.9999872446060181	O
38834	through	107 114	159881 159888	0.9999854564666748	O
38835	this	115 119	159889 159893	0.9999885559082031	O
38836	mechanism	120 129	159894 159903	0.9999868869781494	O
38837	a	130 131	159904 159905	0.9999886751174927	O
38838	higher	132 138	159906 159912	0.9999868869781494	O
38839	diversity	139 148	159913 159922	0.9999877214431763	O
38840	of	149 151	159923 159925	0.9999887943267822	O
38841	mammalian	152 160	159926 159934	0.9999864101409912	O
38844	genes	162 167	159936 159941	0.999987006187439	O
38845	is	168 170	159942 159944	0.9999886751174927	O
38846	generated	171 180	159945 159954	0.9999879598617554	O
38847	[	181 182	159955 159956	0.9999891519546509	O
38848	68	182 184	159956 159958	0.9999865293502808	O
38849	]	184 185	159958 159959	0.9999887943267822	O
38850	.	186 187	159960 159961	0.9999802112579346	O
38851	Several	0 7	159962 159969	0.9999850988388062	O
38852	distinct	8 16	159970 159978	0.9999819993972778	O
38853	TLE	17 19	159979 159981	0.9999858140945435	O
38855	/	20 21	159982 159983	0.9999872446060181	O
38856	Grg	21 23	159983 159985	0.9999841451644897	O
38858	gene	25 29	159987 159991	0.9999877214431763	O
38859	alternative	30 41	159992 160003	0.9999881982803345	O
38860	splice	42 47	160004 160009	0.99998939037323	O
38863	forms	49 54	160011 160016	0.9999878406524658	O
38864	,	55 56	160017 160018	0.9999889135360718	O
38865	such	57 61	160019 160023	0.9999889135360718	O
38866	as	62 64	160024 160026	0.99998939037323	O
38867	Grg	65 67	160027 160029	0.9999881982803345	O
38869	-	68 69	160030 160031	0.9999897480010986	O
38870	1s	69 70	160031 160032	0.9999891519546509	O
38872	,	72 73	160034 160035	0.9999886751174927	O
38873	QD	74 75	160036 160037	0.9999889135360718	O
38875	of	77 79	160039 160041	0.99998939037323	O
38876	TLE4	80 83	160042 160045	0.9999891519546509	O
38879	,	85 86	160047 160048	0.9999890327453613	O
38880	and	87 90	160049 160052	0.9999890327453613	O
38881	Grg3b	91 95	160053 160057	0.9999885559082031	O
38885	[	97 98	160059 160060	0.9999895095825195	O
38886	42	98 100	160060 160062	0.9999873638153076	O
38887	]	100 101	160062 160063	0.9999896287918091	O
38888	,	102 103	160064 160065	0.9999890327453613	O
38889	[	103 104	160065 160066	0.99998939037323	O
38890	69	104 106	160066 160068	0.9999879598617554	O
38891	]	106 107	160068 160069	0.9999896287918091	O
38892	,	108 109	160070 160071	0.9999885559082031	O
38893	[	109 110	160071 160072	0.99998939037323	O
38894	70	110 112	160072 160074	0.9999877214431763	O
38895	]	112 113	160074 160075	0.9999895095825195	O
38896	,	114 115	160076 160077	0.9999879598617554	O
38897	have	116 120	160078 160082	0.9999878406524658	O
38898	been	121 125	160083 160087	0.999988317489624	O
38899	reported	126 134	160088 160096	0.9999871253967285	O
38900	.	135 136	160097 160098	0.9999722242355347	O
38901	While	0 5	160099 160104	0.9999817609786987	O
38902	the	6 9	160105 160108	0.999984860420227	O
38903	human	10 15	160109 160114	0.9369193315505981	O
38904	genome	16 22	160115 160121	0.9999600648880005	O
38905	does	23 27	160122 160126	0.9999843835830688	O
38906	not	28 31	160127 160130	0.9999817609786987	O
38907	encode	32 37	160131 160136	0.9999868869781494	O
38909	a	39 40	160138 160139	0.9999874830245972	O
38910	TLE6	41 44	160140 160143	0.9999865293502808	O
38913	-	45 46	160144 160145	0.9999881982803345	O
38914	LIKE	46 49	160145 160148	0.9999871253967285	O
38917	ortholog	51 58	160150 160157	0.9999880790710449	O
38921	,	60 61	160159 160160	0.9999854564666748	O
38922	a	62 63	160161 160162	0.9999878406524658	O
38923	structurally	64 75	160163 160174	0.9999855756759644	O
38925	equivalent	77 87	160176 160186	0.9999871253967285	O
38926	protein	88 95	160187 160194	0.9999791383743286	O
38927	,	96 97	160195 160196	0.9999880790710449	O
38928	TLE6D	98 102	160197 160201	0.9999877214431763	O
38932	,	104 105	160203 160204	0.9999880790710449	O
38933	is	106 108	160205 160207	0.9999867677688599	O
38934	generated	109 118	160208 160217	0.9999867677688599	O
38935	through	119 126	160218 160225	0.9999864101409912	O
38936	alternative	127 138	160226 160237	0.9999862909317017	O
38937	splicing	139 146	160238 160245	0.9999873638153076	O
38940	.	148 149	160247 160248	0.9999499320983887	O
38941	The	0 3	160249 160252	0.9999768733978271	O
38942	observation	4 15	160253 160264	0.9999107122421265	O
38943	that	16 20	160265 160269	0.999972939491272	O
38944	GI	21 22	160270 160271	0.9998922348022461	O
38946	adenocarcinomas	24 38	160273 160287	0.9999668598175049	O
38952	from	40 44	160289 160293	0.9999291896820068	O
38953	both	45 49	160294 160298	0.9999486207962036	O
38954	humans	50 56	160299 160305	0.9331222176551819	species
38955	and	57 60	160306 160309	0.999940037727356	O
38956	mice	61 65	160310 160314	0.8898208141326904	species
38957	use	66 69	160315 160318	0.9999823570251465	O
38958	two	70 73	160319 160322	0.9999822378158569	O
38959	very	74 78	160323 160327	0.9999852180480957	O
38960	distinct	79 87	160328 160336	0.9999834299087524	O
38961	mechanisms	88 98	160337 160347	0.999984860420227	O
38962	to	99 101	160348 160350	0.999985933303833	O
38963	amplify	102 108	160351 160357	0.999988317489624	O
38966	Tle6	110 113	160359 160362	0.9999879598617554	O
38969	-	114 115	160363 160364	0.9999885559082031	O
38970	like	115 119	160364 160368	0.999988317489624	O
38971	/	119 120	160368 160369	0.999988317489624	O
38972	TLE6D	120 124	160369 160373	0.999988317489624	O
38976	activity	126 134	160375 160383	0.9999878406524658	O
38977	suggests	135 143	160384 160392	0.9999768733978271	O
38978	a	144 145	160393 160394	0.9999855756759644	O
38979	strong	146 152	160395 160401	0.999963641166687	O
38980	growth	153 159	160402 160408	0.9999837875366211	O
38981	advantage	160 169	160409 160418	0.999984622001648	O
38982	and	170 173	160419 160422	0.999983549118042	O
38983	selective	174 183	160423 160432	0.999982476234436	O
38984	pressure	184 192	160433 160441	0.9999758005142212	O
38985	for	193 196	160442 160445	0.9999850988388062	O
38986	this	197 201	160446 160450	0.9999880790710449	O
38987	TLE	202 204	160451 160453	0.9999873638153076	O
38989	isoform	206 212	160455 160461	0.9999885559082031	O
38992	in	214 216	160463 160465	0.9999814033508301	O
38993	tumor	217 222	160466 160471	0.9999750852584839	O
38994	progression	223 234	160472 160483	0.9999711513519287	O
38995	.	235 236	160484 160485	0.9999068975448608	O
38996	Similarly	0 9	160486 160495	0.9999831914901733	O
38997	,	10 11	160496 160497	0.9999878406524658	O
38998	the	12 15	160498 160501	0.9999871253967285	O
38999	correlation	16 27	160502 160513	0.9999829530715942	O
39000	between	28 35	160514 160521	0.9999876022338867	O
39001	TLE6D	36 40	160522 160526	0.9999877214431763	O
39005	and	42 45	160528 160531	0.999987006187439	O
39006	RUNX3	46 50	160532 160536	0.9999872446060181	O
39010	expression	52 62	160538 160548	0.9999830722808838	O
39011	in	63 65	160549 160551	0.9999831914901733	O
39012	human	66 71	160552 160557	0.9147062301635742	species
39013	CRC	72 74	160558 160560	0.999981164932251	O
39015	suggests	76 84	160562 160570	0.9999849796295166	O
39016	a	85 86	160571 160572	0.9999884366989136	O
39017	model	87 92	160573 160578	0.9999814033508301	O
39018	whereby	93 100	160579 160586	0.9999840259552002	O
39019	RUNX3	101 105	160587 160591	0.9999874830245972	O
39023	inactivation	107 118	160593 160604	0.999988317489624	O
39026	by	120 122	160606 160608	0.9999880790710449	O
39027	TLE6D	123 127	160609 160613	0.9999880790710449	O
39031	could	129 134	160615 160620	0.999983549118042	O
39032	be	135 137	160621 160623	0.9999880790710449	O
39033	an	138 140	160624 160626	0.9999881982803345	O
39034	important	141 150	160627 160636	0.9999858140945435	O
39035	factor	151 157	160637 160643	0.9999855756759644	O
39036	driving	158 165	160644 160651	0.9999817609786987	O
39037	this	166 170	160652 160656	0.9999858140945435	O
39038	growth	171 177	160657 160663	0.9999815225601196	O
39039	advantage	178 187	160664 160673	0.9999806880950928	O
39040	in	188 190	160674 160676	0.9999855756759644	O
39041	both	191 195	160677 160681	0.9999815225601196	O
39042	MSI	196 198	160682 160684	0.9999868869781494	O
39044	-	199 200	160685 160686	0.9999881982803345	O
39045	H	200 201	160686 160687	0.999981164932251	O
39046	and	202 205	160688 160691	0.9999829530715942	O
39047	MSS	206 208	160692 160694	0.9999850988388062	O
39049	CRC	210 212	160696 160698	0.9999814033508301	O
39051	.	213 214	160699 160700	0.9999388456344604	O
39052	Future	0 6	160701 160707	0.999984622001648	O
39053	studies	7 14	160708 160715	0.9999822378158569	O
39054	will	15 19	160716 160720	0.9999852180480957	O
39055	be	20 22	160721 160723	0.9999868869781494	O
39056	required	23 31	160724 160732	0.9999829530715942	O
39057	to	32 34	160733 160735	0.9999864101409912	O
39058	understand	35 45	160736 160746	0.9999852180480957	O
39059	the	46 49	160747 160750	0.9999878406524658	O
39060	mechanistic	50 60	160751 160761	0.9999874830245972	O
39063	implications	62 74	160763 160775	0.9999872446060181	O
39064	of	75 77	160776 160778	0.9999873638153076	O
39065	the	78 81	160779 160782	0.9999877214431763	O
39066	interaction	82 93	160783 160794	0.9999852180480957	O
39067	between	94 101	160795 160802	0.9999874830245972	O
39068	these	102 107	160803 160808	0.9999877214431763	O
39069	two	108 111	160809 160812	0.9999847412109375	O
39070	proteins	112 120	160813 160821	0.9999716281890869	O
39071	in	121 123	160822 160824	0.9999854564666748	O
39072	CRC	124 126	160825 160827	0.9999771118164062	O
39074	progression	128 139	160829 160840	0.9999852180480957	O
39075	in	140 142	160841 160843	0.9999881982803345	O
39076	more	143 147	160844 160848	0.9999877214431763	O
39077	precise	148 155	160849 160856	0.9999873638153076	O
39078	detail	156 162	160857 160863	0.9999852180480957	O
39079	.	163 164	160864 160865	0.9999885559082031	O
39080	*	165 166	160866 160867	0.9999868869781494	O
39081	*	166 167	160867 160868	0.9999779462814331	O
39082	IGNORE	0 5	160869 160874	0.9999845027923584	O
39085	LINE	7 10	160876 160879	0.9999876022338867	O
39088	*	12 13	160881 160882	0.999988317489624	O
39089	*	13 14	160882 160883	0.9999881982803345	O
39090	*	15 16	160884 160885	0.9999881982803345	O
39091	*	16 17	160885 160886	0.9999884366989136	O
39092	IGNORE	18 23	160887 160892	0.9999868869781494	O
39095	LINE	25 28	160894 160897	0.9999885559082031	O
39098	*	30 31	160899 160900	0.999988317489624	O
39099	*	31 32	160900 160901	0.9999881982803345	O
39100	*	33 34	160902 160903	0.9999880790710449	O
39101	*	34 35	160903 160904	0.9999880790710449	O
39102	IGNORE	36 41	160905 160910	0.9999864101409912	O
39105	LINE	43 46	160912 160915	0.9999881982803345	O
39108	*	48 49	160917 160918	0.9999881982803345	O
39109	*	49 50	160918 160919	0.9999881982803345	O
39110	Materials	51 60	160920 160929	0.9999845027923584	O
39111	and	61 64	160930 160933	0.9999880790710449	O
39112	Methods	65 71	160934 160940	0.9999843835830688	O
39114	Mouse	73 78	160942 160947	0.9914120435714722	O
39115	Lines	79 84	160948 160953	0.9999681711196899	O
39116	and	85 88	160954 160957	0.9999876022338867	O
39117	Survival	89 97	160958 160966	0.9999821186065674	O
39118	Analyses	98 105	160967 160974	0.9999879598617554	O
39121	,	107 108	160976 160977	0.999987006187439	O
39122	Tumor	109 113	160978 160982	0.999981164932251	O
39124	Analysis	115 123	160984 160992	0.9999854564666748	O
39125	,	124 125	160993 160994	0.9999884366989136	O
39126	and	126 129	160995 160998	0.9999886751174927	O
39127	Apc	130 132	160999 161001	0.9999889135360718	O
39130	Mutation	134 141	161003 161010	0.9999860525131226	O
39132	Analysis	143 151	161012 161020	0.9999876022338867	O
39133	Wild	152 156	161021 161025	0.9999873638153076	O
39134	-	156 157	161025 161026	0.9999886751174927	O
39135	type	157 161	161026 161030	0.9999867677688599	O
39136	(	162 163	161031 161032	0.9999881982803345	O
39137	Wt	164 165	161033 161034	0.999972939491272	O
39139	)	167 168	161036 161037	0.9999885559082031	O
39140	,	169 170	161038 161039	0.999985933303833	O
39141	Pms2	171 174	161040 161043	0.9999868869781494	O
39144	+	175 176	161044 161045	0.9999885559082031	O
39145	/	176 177	161045 161046	0.9999879598617554	O
39146	−	178 179	161047 161048	0.9999808073043823	O
39147	and	180 183	161049 161052	0.9999868869781494	O
39148	Mlh3	184 187	161053 161056	0.9999847412109375	O
39152	+	188 189	161057 161058	0.9999886751174927	O
39153	/	189 190	161058 161059	0.9999881982803345	O
39154	−	191 192	161060 161061	0.999983549118042	O
39155	mice	193 197	161062 161066	0.9954955577850342	O
39156	were	198 202	161067 161071	0.9999872446060181	O
39157	maintained	203 213	161072 161082	0.9999514818191528	O
39158	on	214 216	161083 161085	0.9999874830245972	O
39159	the	217 220	161086 161089	0.9999884366989136	O
39160	129	221 224	161090 161093	0.999866247177124	O
39161	Sv	225 226	161094 161095	0.9999881982803345	O
39163	/	227 228	161096 161097	0.9999885559082031	O
39164	Ev	228 229	161097 161098	0.9999866485595703	O
39166	genetic	231 238	161100 161107	0.9999843835830688	O
39167	background	239 249	161108 161118	0.9999699592590332	O
39168	and	250 253	161119 161122	0.9999878406524658	O
39169	intercrossed	254 265	161123 161134	0.9999867677688599	O
39172	to	267 269	161136 161138	0.999988317489624	O
39173	generate	270 278	161139 161147	0.9999853372573853	O
39174	Mlh3	279 282	161148 161151	0.9999871253967285	O
39178	+	283 284	161152 161153	0.9999887943267822	O
39179	/	284 285	161153 161154	0.9999884366989136	O
39180	−	285 286	161154 161155	0.9999802112579346	O
39181	;	286 287	161155 161156	0.999985933303833	O
39182	Pms2	287 290	161156 161159	0.9999872446060181	O
39185	+	291 292	161160 161161	0.9999887943267822	O
39186	/	292 293	161161 161162	0.9999886751174927	O
39187	−	294 295	161163 161164	0.9999806880950928	O
39188	mice	296 300	161165 161169	0.9998072981834412	O
39189	as	301 303	161170 161172	0.9999891519546509	O
39190	described	304 313	161173 161182	0.9999880790710449	O
39191	before	314 320	161183 161189	0.9999876022338867	O
39192	[	321 322	161190 161191	0.9999890327453613	O
39193	13	322 324	161191 161193	0.9999864101409912	O
39194	]	324 325	161193 161194	0.9999885559082031	O
39195	.	326 327	161195 161196	0.9999730587005615	O
39196	Apc1638N	0 7	161197 161204	0.9999880790710449	O
39202	mice	9 13	161206 161210	0.9957149624824524	O
39203	were	14 18	161211 161215	0.9999881982803345	O
39204	backcrossed	19 29	161216 161226	0.9999786615371704	O
39207	four	31 35	161228 161232	0.9999871253967285	O
39208	times	36 41	161233 161238	0.9999877214431763	O
39209	to	42 44	161239 161241	0.9999887943267822	O
39210	129	45 48	161242 161245	0.9999196529388428	O
39211	Sv	49 50	161246 161247	0.9999887943267822	O
39213	/	51 52	161248 161249	0.9999886751174927	O
39214	Ev	52 53	161249 161250	0.9999872446060181	O
39216	and	55 58	161252 161255	0.9999889135360718	O
39217	subsequently	59 71	161256 161268	0.9999864101409912	O
39218	intercrossed	72 83	161269 161280	0.9999879598617554	O
39221	with	85 89	161282 161286	0.9999890327453613	O
39222	Mlh3	90 93	161287 161290	0.9999884366989136	O
39226	+	94 95	161291 161292	0.9999890327453613	O
39227	/	95 96	161292 161293	0.9999890327453613	O
39228	−	96 97	161293 161294	0.9999879598617554	O
39229	;	98 99	161295 161296	0.9999891519546509	O
39230	Pms2	100 103	161297 161300	0.999988317489624	O
39233	+	104 105	161301 161302	0.9999890327453613	O
39234	/	105 106	161302 161303	0.9999890327453613	O
39235	−	107 108	161304 161305	0.9999876022338867	O
39236	to	109 111	161306 161308	0.9999891519546509	O
39237	generate	112 120	161309 161317	0.9999872446060181	O
39238	Mlh3−	121 125	161318 161322	0.9999884366989136	O
39243	/	126 127	161323 161324	0.9999891519546509	O
39244	−	127 128	161324 161325	0.9999872446060181	O
39245	;	128 129	161325 161326	0.9999891519546509	O
39246	Apc1638N	129 136	161326 161333	0.9999886751174927	O
39252	and	138 141	161335 161338	0.9999885559082031	O
39253	Mlh3−	142 146	161339 161343	0.9999877214431763	O
39258	/	147 148	161344 161345	0.9999889135360718	O
39259	−	148 149	161345 161346	0.9999866485595703	O
39260	;	149 150	161346 161347	0.9999889135360718	O
39261	Pms2−	150 154	161347 161351	0.9999881982803345	O
39265	/	155 156	161352 161353	0.9999889135360718	O
39266	−	156 157	161353 161354	0.9999868869781494	O
39267	;	157 158	161354 161355	0.9999884366989136	O
39268	Apc1638N	158 165	161355 161362	0.9999886751174927	O
39274	mice	167 171	161364 161368	0.9999405145645142	O
39275	.	172 173	161369 161370	0.9999701976776123	O
39276	Kaplan	0 6	161371 161377	0.9999854564666748	O
39277	-	6 7	161377 161378	0.9999886751174927	O
39278	Meier	7 11	161378 161382	0.9999867677688599	O
39280	survival	13 21	161384 161392	0.9999866485595703	O
39281	curves	22 28	161393 161399	0.9999828338623047	O
39282	were	29 33	161400 161404	0.9999867677688599	O
39283	generated	34 43	161405 161414	0.999984622001648	O
39284	and	44 47	161415 161418	0.999987006187439	O
39285	statistical	48 59	161419 161430	0.9999877214431763	O
39286	significance	60 72	161431 161443	0.9999881982803345	O
39287	between	73 80	161444 161451	0.9999868869781494	O
39288	genotypes	81 89	161452 161460	0.9999881982803345	O
39292	was	91 94	161462 161465	0.9999886751174927	O
39293	determined	95 105	161466 161476	0.999988317489624	O
39294	using	106 111	161477 161482	0.9999890327453613	O
39295	the	112 115	161483 161486	0.9999891519546509	O
39296	Log	116 118	161487 161489	0.9999879598617554	O
39298	Rank	120 124	161491 161495	0.9999852180480957	O
39299	test	125 129	161496 161500	0.9999881982803345	O
39300	as	130 132	161501 161503	0.999988317489624	O
39301	previously	133 143	161504 161514	0.9999874830245972	O
39302	performed	144 153	161515 161524	0.9999885559082031	O
39303	[	154 155	161525 161526	0.9999890327453613	O
39304	13	155 157	161526 161528	0.9999878406524658	O
39305	]	157 158	161528 161529	0.9999889135360718	O
39306	.	159 160	161530 161531	0.9999761581420898	O
39307	All	0 3	161532 161535	0.9999580383300781	O
39308	lines	4 9	161536 161541	0.9995875954627991	O
39309	of	10 12	161542 161544	0.9999504089355469	O
39310	mice	13 17	161545 161549	0.631427526473999	species
39311	were	18 22	161550 161554	0.9999701976776123	O
39312	necropsied	23 32	161555 161564	0.9999741315841675	O
39316	when	34 38	161566 161570	0.9999781847000122	O
39317	they	39 43	161571 161575	0.9999573230743408	O
39318	became	44 50	161576 161582	0.9999781847000122	O
39319	morbid	51 56	161583 161588	0.9999837875366211	O
39322	or	58 60	161590 161592	0.9999608993530273	O
39323	moribund	61 68	161593 161600	0.9999845027923584	O
39327	.	70 71	161602 161603	0.9998749494552612	O
39328	Sacrificed	0 9	161604 161613	0.9999734163284302	O
39333	mice	11 15	161615 161619	0.8768482208251953	species
39334	were	16 20	161620 161624	0.9999812841415405	O
39335	surveyed	21 29	161625 161633	0.9999785423278809	O
39336	for	30 33	161634 161637	0.9999802112579346	O
39337	tumors	34 40	161638 161644	0.9999808073043823	O
39338	and	41 44	161645 161648	0.9999821186065674	O
39339	suspicious	45 55	161649 161659	0.9999814033508301	O
39340	masses	56 62	161660 161666	0.9999828338623047	O
39341	were	63 67	161667 161671	0.9999871253967285	O
39342	histology	68 76	161672 161680	0.9999852180480957	O
39344	analyzed	78 86	161682 161690	0.999987006187439	O
39345	as	87 89	161691 161693	0.9999867677688599	O
39346	previously	90 100	161694 161704	0.9999852180480957	O
39347	performed	101 110	161705 161714	0.9999861717224121	O
39348	.	111 112	161715 161716	0.99994957447052	O
39349	Statistical	0 11	161717 161728	0.999984860420227	O
39350	analyses	12 20	161729 161737	0.9999827146530151	O
39351	of	21 23	161738 161740	0.9999854564666748	O
39352	tumor	24 29	161741 161746	0.9999810457229614	O
39353	onset	30 35	161747 161752	0.9999831914901733	O
39354	and	36 39	161753 161756	0.9999874830245972	O
39355	incidence	40 49	161757 161766	0.9999833106994629	O
39356	among	50 55	161767 161772	0.9999868869781494	O
39357	the	56 59	161773 161776	0.9999858140945435	O
39358	different	60 69	161777 161786	0.9999837875366211	O
39359	mouse	70 75	161787 161792	0.713266134262085	species
39360	lines	76 81	161793 161798	0.9999328851699829	O
39361	were	82 86	161799 161803	0.999987006187439	O
39362	performed	87 96	161804 161813	0.9999872446060181	O
39363	using	97 102	161814 161819	0.9999890327453613	O
39364	the	103 106	161820 161823	0.9999891519546509	O
39365	Mann	107 111	161824 161828	0.9999873638153076	O
39366	-	111 112	161828 161829	0.9999890327453613	O
39367	Whitney	112 119	161829 161836	0.9999847412109375	O
39368	test	120 124	161837 161841	0.9999881982803345	O
39369	as	125 127	161842 161844	0.9999884366989136	O
39370	previously	128 138	161845 161855	0.9999879598617554	O
39371	described	139 148	161856 161865	0.9999881982803345	O
39372	[	149 150	161866 161867	0.9999890327453613	O
39373	23	150 152	161867 161869	0.9999884366989136	O
39374	]	152 153	161869 161870	0.9999891519546509	O
39375	,	154 155	161871 161872	0.9999891519546509	O
39376	[	155 156	161872 161873	0.9999889135360718	O
39377	32	156 158	161873 161875	0.9999868869781494	O
39378	]	158 159	161875 161876	0.9999891519546509	O
39379	,	160 161	161877 161878	0.9999891519546509	O
39380	[	161 162	161878 161879	0.9999889135360718	O
39381	33	162 164	161879 161881	0.9999873638153076	O
39382	]	164 165	161881 161882	0.9999891519546509	O
39383	,	166 167	161883 161884	0.9999891519546509	O
39384	[	167 168	161884 161885	0.9999887943267822	O
39385	35	168 170	161885 161887	0.9999865293502808	O
39386	]	170 171	161887 161888	0.9999890327453613	O
39387	,	172 173	161889 161890	0.9999891519546509	O
39388	[	173 174	161890 161891	0.9999889135360718	O
39389	71	174 176	161891 161893	0.9999884366989136	O
39390	]	176 177	161893 161894	0.9999890327453613	O
39391	,	178 179	161895 161896	0.9999891519546509	O
39392	[	179 180	161896 161897	0.9999889135360718	O
39393	72	180 182	161897 161899	0.9999884366989136	O
39394	]	182 183	161899 161900	0.9999890327453613	O
39395	,	184 185	161901 161902	0.9999891519546509	O
39396	[	185 186	161902 161903	0.9999889135360718	O
39397	73	186 188	161903 161905	0.9999879598617554	O
39398	]	188 189	161905 161906	0.9999890327453613	O
39399	,	190 191	161907 161908	0.9999891519546509	O
39400	[	191 192	161908 161909	0.9999886751174927	O
39401	74	192 194	161909 161911	0.9999867677688599	O
39402	]	194 195	161911 161912	0.9999889135360718	O
39403	,	196 197	161913 161914	0.9999889135360718	O
39404	[	197 198	161914 161915	0.9999886751174927	O
39405	75	198 200	161915 161917	0.9999873638153076	O
39406	]	200 201	161917 161918	0.9999890327453613	O
39407	,	202 203	161919 161920	0.9999886751174927	O
39408	[	203 204	161920 161921	0.9999886751174927	O
39409	76	204 206	161921 161923	0.9999866485595703	O
39410	]	206 207	161923 161924	0.9999891519546509	O
39411	.	208 209	161925 161926	0.9999756813049316	O
39412	Tumors	0 5	161927 161932	0.9999489784240723	O
39415	from	7 11	161934 161938	0.9999771118164062	O
39416	stomach	12 19	161939 161946	0.9999600648880005	O
39417	,	20 21	161947 161948	0.9999819993972778	O
39418	small	22 27	161949 161954	0.9999212026596069	O
39419	intestine	28 36	161955 161963	0.9999840259552002	O
39422	,	38 39	161965 161966	0.9999818801879883	O
39423	and	40 43	161967 161970	0.9999828338623047	O
39424	colon	44 48	161971 161975	0.9999668598175049	O
39426	were	50 54	161977 161981	0.9999803304672241	O
39427	cut	55 58	161982 161985	0.9999792575836182	O
39428	into	59 63	161986 161990	0.999984622001648	O
39429	two	64 67	161991 161994	0.9999790191650391	O
39430	parts	68 73	161995 162000	0.9999825954437256	O
39431	.	74 75	162001 162002	0.9999167919158936	O
39432	One	0 3	162003 162006	0.9999850988388062	O
39433	part	4 8	162007 162011	0.9999855756759644	O
39434	of	9 11	162012 162014	0.9999847412109375	O
39435	the	12 15	162015 162018	0.9999809265136719	O
39436	tumor	16 21	162019 162024	0.9999723434448242	O
39437	was	22 25	162025 162028	0.9999862909317017	O
39438	processed	26 35	162029 162038	0.9999841451644897	O
39439	for	36 39	162039 162042	0.9999881982803345	O
39440	histopathological	40 56	162043 162059	0.9999843835830688	O
39444	analysis	58 66	162061 162069	0.9999874830245972	O
39445	and	67 70	162070 162073	0.9999868869781494	O
39446	the	71 74	162074 162077	0.9999878406524658	O
39447	other	75 80	162078 162083	0.9999865293502808	O
39448	part	81 85	162084 162088	0.9999878406524658	O
39449	was	86 89	162089 162092	0.9999881982803345	O
39450	used	90 94	162093 162097	0.9999872446060181	O
39451	for	95 98	162098 162101	0.9999884366989136	O
39452	DNA	99 102	162102 162105	0.9999858140945435	O
39453	/	102 103	162105 162106	0.9999880790710449	O
39454	RNA	103 106	162106 162109	0.9999850988388062	O
39455	extractions	107 117	162110 162120	0.9999874830245972	O
39457	.	119 120	162122 162123	0.9999663829803467	O
39458	Genomic	0 6	162124 162130	0.9999855756759644	O
39461	DNA	8 11	162132 162135	0.9999821186065674	O
39462	samples	12 19	162136 162143	0.999983549118042	O
39463	were	20 24	162144 162148	0.9999873638153076	O
39464	extracted	25 34	162149 162158	0.9999861717224121	O
39465	using	35 40	162159 162164	0.9999889135360718	O
39466	Puregene	41 48	162165 162172	0.999985933303833	O
39468	DNA	50 53	162174 162177	0.9999879598617554	O
39469	Isolation	54 62	162178 162186	0.9999891519546509	O
39472	kit	64 67	162188 162191	0.9999886751174927	O
39473	(	68 69	162192 162193	0.9999892711639404	O
39474	Gentra	70 75	162194 162199	0.9999885559082031	O
39476	Systems	77 84	162201 162208	0.9999878406524658	O
39477	,	85 86	162209 162210	0.9999886751174927	O
39478	Minneapolis	87 98	162211 162222	0.9999438524246216	O
39479	,	99 100	162223 162224	0.9999880790710449	O
39480	MN	101 102	162225 162226	0.9999842643737793	O
39482	)	103 104	162227 162228	0.9999895095825195	O
39483	and	105 108	162229 162232	0.9999879598617554	O
39484	subjected	109 118	162233 162242	0.9999878406524658	O
39485	to	119 121	162243 162245	0.9999891519546509	O
39486	mutational	122 131	162246 162255	0.9999873638153076	O
39488	analysis	133 141	162257 162265	0.9999890327453613	O
39489	of	142 144	162266 162268	0.99998939037323	O
39490	Apc	145 147	162269 162271	0.9999891519546509	O
39493	gene	149 153	162273 162277	0.9999889135360718	O
39494	between	154 161	162278 162285	0.9999886751174927	O
39495	codons	162 167	162286 162291	0.9999891519546509	O
39498	677	169 171	162293 162295	0.9999885559082031	O
39500	–	172 173	162296 162297	0.9999865293502808	O
39501	1674	173 176	162297 162300	0.9999876022338867	O
39503	as	178 180	162302 162304	0.9999891519546509	O
39504	previously	181 191	162305 162315	0.9999886751174927	O
39505	described	192 201	162316 162325	0.9999889135360718	O
39506	[	202 203	162326 162327	0.99998939037323	O
39507	33	203 205	162327 162329	0.9999868869781494	O
39508	]	205 206	162329 162330	0.9999890327453613	O
39509	.	207 208	162331 162332	0.9999762773513794	O
39510	Array	0 4	162333 162337	0.9999825954437256	O
39513	Comparative	6 17	162339 162350	0.9999842643737793	O
39514	Genomic	18 24	162351 162357	0.9999872446060181	O
39517	Hybridization	26 38	162359 162371	0.9999855756759644	O
39519	Analysis	40 48	162373 162381	0.9999858140945435	O
39520	Genomic	49 55	162382 162388	0.9999876022338867	O
39523	DNAs	57 60	162390 162393	0.9999841451644897	O
39525	were	62 66	162395 162399	0.9999879598617554	O
39526	isolated	67 75	162400 162408	0.9999871253967285	O
39527	from	76 80	162409 162413	0.9999861717224121	O
39528	tumor	81 86	162414 162419	0.999975323677063	O
39529	tissue	87 93	162420 162426	0.9999871253967285	O
39530	and	94 97	162427 162430	0.9999847412109375	O
39531	tail	98 102	162431 162435	0.9995707869529724	O
39532	tissue	103 109	162436 162442	0.9999878406524658	O
39533	from	110 114	162443 162447	0.9999885559082031	O
39534	each	115 119	162448 162452	0.9999866485595703	O
39535	mouse	120 125	162453 162458	0.5088112950325012	species
39536	using	126 131	162459 162464	0.9999890327453613	O
39537	PUREGENE	132 139	162465 162472	0.99998939037323	O
39542	DNA	141 144	162474 162477	0.9999884366989136	O
39543	Isolation	145 153	162478 162486	0.9999892711639404	O
39546	kit	155 158	162488 162491	0.9999889135360718	O
39547	(	159 160	162492 162493	0.9999892711639404	O
39548	Gentra	161 166	162494 162499	0.9999877214431763	O
39550	Systems	168 175	162501 162508	0.9999874830245972	O
39551	,	176 177	162509 162510	0.9999884366989136	O
39552	Minneapolis	178 189	162511 162522	0.99988853931427	O
39553	,	190 191	162523 162524	0.9999879598617554	O
39554	MN	192 193	162525 162526	0.9999840259552002	O
39556	)	194 195	162527 162528	0.9999890327453613	O
39557	.	196 197	162529 162530	0.9999691247940063	O
39558	DNAs	0 3	162531 162534	0.9999772310256958	O
39560	were	5 9	162536 162540	0.999984860420227	O
39561	digested	10 17	162541 162548	0.9999853372573853	O
39563	with	19 23	162550 162554	0.9999874830245972	O
39564	DpnII	24 28	162555 162559	0.9999865293502808	O
39568	and	30 33	162561 162564	0.9999868869781494	O
39569	subsequently	34 46	162565 162577	0.999985933303833	O
39570	purified	47 54	162578 162585	0.9999828338623047	O
39572	using	56 61	162587 162592	0.999988317489624	O
39573	the	62 65	162593 162596	0.9999887943267822	O
39574	QIAquick	66 73	162597 162604	0.9999871253967285	O
39578	PCR	75 77	162606 162608	0.9999877214431763	O
39580	Purification	79 90	162610 162621	0.9999871253967285	O
39583	kit	92 95	162623 162626	0.9999884366989136	O
39584	(	96 97	162627 162628	0.9999889135360718	O
39585	Qiagen	98 103	162629 162634	0.9999818801879883	O
39588	)	105 106	162636 162637	0.9999891519546509	O
39589	.	107 108	162638 162639	0.9999650716781616	O
39590	The	0 3	162640 162643	0.9999822378158569	O
39591	quality	4 11	162644 162651	0.9999817609786987	O
39592	of	12 14	162652 162654	0.999984860420227	O
39593	the	15 18	162655 162658	0.999982476234436	O
39594	DNA	19 22	162659 162662	0.9999784231185913	O
39595	samples	23 30	162663 162670	0.9999834299087524	O
39596	was	31 34	162671 162674	0.9999825954437256	O
39597	evaluated	35 44	162675 162684	0.9999831914901733	O
39598	using	45 50	162685 162690	0.9999864101409912	O
39599	the	51 54	162691 162694	0.9999873638153076	O
39600	Agilent	55 61	162695 162701	0.999987006187439	O
39603	2100	63 66	162703 162706	0.9999874830245972	O
39605	BioAnalyzer	68 78	162708 162718	0.9999877214431763	O
39611	.	80 81	162720 162721	0.9999676942825317	O
39612	The	0 3	162722 162725	0.9999860525131226	O
39613	purified	4 11	162726 162733	0.9999840259552002	O
39615	fragmented	13 22	162735 162744	0.9999854564666748	O
39617	DNA	24 27	162746 162749	0.9999837875366211	O
39618	samples	28 35	162750 162757	0.9999861717224121	O
39619	were	36 40	162758 162762	0.9999886751174927	O
39620	random	41 47	162763 162769	0.999987006187439	O
39621	-	47 48	162769 162770	0.9999890327453613	O
39622	prime	48 53	162770 162775	0.9999867677688599	O
39623	labeled	54 61	162776 162783	0.9999889135360718	O
39624	with	62 66	162784 162788	0.9999890327453613	O
39625	either	67 73	162789 162795	0.9999891519546509	O
39626	Cy5	74 76	162796 162798	0.9999886751174927	O
39628	or	78 80	162800 162802	0.9999886751174927	O
39629	Cy3	81 83	162803 162805	0.9999885559082031	O
39631	and	85 88	162807 162810	0.9999886751174927	O
39632	hybridized	89 98	162811 162820	0.9999868869781494	O
39634	as	100 102	162822 162824	0.9999886751174927	O
39635	previously	103 113	162825 162835	0.9999887943267822	O
39636	described	114 123	162836 162845	0.9999887943267822	O
39637	[	124 125	162846 162847	0.99998939037323	O
39638	77	125 127	162847 162849	0.9999873638153076	O
39639	]	127 128	162849 162850	0.9999891519546509	O
39640	Briefly	129 135	162851 162857	0.9999892711639404	O
39643	,	137 138	162859 162860	0.99998939037323	O
39644	for	139 142	162861 162864	0.9999885559082031	O
39645	each	143 147	162865 162869	0.9999892711639404	O
39646	labeling	148 155	162870 162877	0.9999877214431763	O
39648	reaction	157 165	162879 162887	0.9999881982803345	O
39649	,	166 167	162888 162889	0.9999890327453613	O
39650	2	168 169	162890 162891	0.9999868869781494	O
39651	µg	170 171	162892 162893	0.9999866485595703	O
39653	of	173 175	162895 162897	0.9999889135360718	O
39654	purified	176 183	162898 162905	0.9999873638153076	O
39656	digested	185 192	162907 162914	0.9999879598617554	O
39658	DNA	194 197	162916 162919	0.9999862909317017	O
39659	were	198 202	162920 162924	0.9999884366989136	O
39660	used	203 207	162925 162929	0.9999880790710449	O
39661	.	208 209	162930 162931	0.999972939491272	O
39662	Each	0 4	162932 162936	0.9999829530715942	O
39663	sample	5 11	162937 162943	0.999983549118042	O
39664	was	12 15	162944 162947	0.9999871253967285	O
39665	dye	16 19	162948 162951	0.9999856948852539	O
39666	-	19 20	162951 162952	0.9999885559082031	O
39667	swap	20 24	162952 162956	0.9999836683273315	O
39668	labeled	25 32	162957 162964	0.9999840259552002	O
39669	for	33 36	162965 162968	0.9999873638153076	O
39670	hybridization	37 49	162969 162981	0.9999866485595703	O
39672	to	51 53	162983 162985	0.9999885559082031	O
39673	mouse	54 59	162986 162991	0.9999452829360962	O
39674	70	60 62	162992 162994	0.9999881982803345	O
39675	-	62 63	162994 162995	0.99998939037323	O
39676	mer	63 65	162995 162997	0.999988317489624	O
39678	oligonucleotide	67 81	162999 163013	0.9999889135360718	O
39684	microarrays	83 93	163015 163025	0.9999880790710449	O
39687	(	95 96	163027 163028	0.9999887943267822	O
39688	Agilent	97 103	163029 163035	0.9999881982803345	O
39691	Technologies	105 117	163037 163049	0.999984622001648	O
39692	,	118 119	163050 163051	0.9999880790710449	O
39693	Palo	120 123	163052 163055	0.9999873638153076	O
39695	Alto	125 129	163057 163061	0.9999866485595703	O
39696	,	130 131	163062 163063	0.9999874830245972	O
39697	CA	132 134	163064 163066	0.9999819993972778	O
39698	)	135 136	163067 163068	0.9999895095825195	O
39699	containing	137 147	163069 163079	0.9999890327453613	O
39700	20	148 150	163080 163082	0.9999872446060181	O
39701	,	150 151	163082 163083	0.9999880790710449	O
39702	281	151 154	163083 163086	0.9999854564666748	O
39703	clones	155 160	163087 163092	0.999987006187439	O
39705	.	162 163	163094 163095	0.9999706745147705	O
39706	After	0 5	163096 163101	0.9999852180480957	O
39707	hybridization	6 18	163102 163114	0.9999847412109375	O
39709	,	20 21	163116 163117	0.9999879598617554	O
39710	the	22 25	163118 163121	0.9999873638153076	O
39711	arrays	26 31	163122 163127	0.9999798536300659	O
39713	were	33 37	163129 163133	0.9999881982803345	O
39714	scanned	38 45	163134 163141	0.999982476234436	O
39715	using	46 51	163142 163147	0.9999890327453613	O
39716	an	52 54	163148 163150	0.9999891519546509	O
39717	Agilent	55 61	163151 163157	0.9999889135360718	O
39720	Microarray	63 72	163159 163168	0.9999876022338867	O
39723	DNA	74 77	163170 163173	0.9999874830245972	O
39724	scanner	78 84	163174 163180	0.9999885559082031	O
39726	(	86 87	163182 163183	0.9999890327453613	O
39727	Agilent	88 94	163184 163190	0.9999890327453613	O
39730	Technologies	96 108	163192 163204	0.9999852180480957	O
39731	)	109 110	163205 163206	0.99998939037323	O
39732	and	111 114	163207 163210	0.9999885559082031	O
39733	the	115 118	163211 163214	0.9999887943267822	O
39734	spot	119 123	163215 163219	0.9999860525131226	O
39735	intensity	124 133	163220 163229	0.9999880790710449	O
39736	was	134 137	163230 163233	0.9999891519546509	O
39737	extracted	138 147	163234 163243	0.9999889135360718	O
39738	from	148 152	163244 163248	0.9999889135360718	O
39739	slide	153 158	163249 163254	0.9999840259552002	O
39740	images	159 165	163255 163261	0.9999873638153076	O
39741	using	166 171	163262 163267	0.9999890327453613	O
39742	Agilent	172 178	163268 163274	0.9999891519546509	O
39745	Feature	180 187	163276 163283	0.9999871253967285	O
39746	Extraction	188 197	163284 163293	0.9999884366989136	O
39748	Software	199 207	163295 163303	0.999987006187439	O
39749	7	208 209	163304 163305	0.9999884366989136	O
39750	.	209 210	163305 163306	0.9999890327453613	O
39751	0	210 211	163306 163307	0.9999878406524658	O
39752	.	211 212	163307 163308	0.9999747276306152	O
39753	The	0 3	163309 163312	0.9999830722808838	O
39754	data	4 8	163313 163317	0.999977707862854	O
39755	were	9 13	163318 163322	0.9999850988388062	O
39756	further	14 21	163323 163330	0.999984622001648	O
39757	analyzed	22 30	163331 163339	0.9999849796295166	O
39758	using	31 36	163340 163345	0.9999878406524658	O
39759	the	37 40	163346 163349	0.9999885559082031	O
39760	procedures	41 51	163350 163360	0.9999849796295166	O
39761	of	52 54	163361 163363	0.9999880790710449	O
39762	Automatic	55 64	163364 163373	0.9999843835830688	O
39763	Data	65 69	163374 163378	0.9999865293502808	O
39764	Analysis	70 78	163379 163387	0.9999878406524658	O
39765	Pipeline	79 86	163388 163395	0.9999879598617554	O
39768	(	88 89	163397 163398	0.9999886751174927	O
39769	ADAP	90 93	163399 163402	0.9999828338623047	O
39771	)	95 96	163404 163405	0.9999891519546509	O
39772	.	97 98	163406 163407	0.9999680519104004	O
39773	Only	0 4	163408 163412	0.9999871253967285	O
39774	spots	5 10	163413 163418	0.9999831914901733	O
39775	with	11 15	163419 163423	0.9999881982803345	O
39776	fluorescence	16 27	163424 163435	0.9999871253967285	O
39779	intensities	29 39	163437 163447	0.9999889135360718	O
39782	statistically	41 53	163449 163461	0.9999891519546509	O
39784	different	55 64	163463 163472	0.9999887943267822	O
39785	from	65 69	163473 163477	0.9999889135360718	O
39786	the	70 73	163478 163481	0.9999889135360718	O
39787	surrounding	74 85	163482 163493	0.9999871253967285	O
39788	background	86 96	163494 163504	0.9999856948852539	O
39789	(	97 98	163505 163506	0.9999895095825195	O
39790	P	99 100	163507 163508	0.9999892711639404	O
39791	<	100 101	163508 163509	0.9999889135360718	O
39792	0	101 102	163509 163510	0.9999892711639404	O
39793	.	102 103	163510 163511	0.9999891519546509	O
39794	001	103 105	163511 163513	0.9999891519546509	O
39796	)	107 108	163515 163516	0.9999892711639404	O
39797	were	109 113	163517 163521	0.999988317489624	O
39798	considered	114 124	163522 163532	0.9999886751174927	O
39799	reliable	125 133	163533 163541	0.9999878406524658	O
39800	,	134 135	163542 163543	0.9999884366989136	O
39801	taking	136 142	163544 163550	0.9999890327453613	O
39802	up	143 145	163551 163553	0.9999892711639404	O
39803	>	146 147	163554 163555	0.9999890327453613	O
39804	85	147 149	163555 163557	0.9999878406524658	O
39805	%	150 151	163558 163559	0.9999892711639404	O
39806	of	152 154	163560 163562	0.9999892711639404	O
39807	total	155 160	163563 163568	0.9999874830245972	O
39808	spots	161 166	163569 163574	0.9999862909317017	O
39809	on	167 169	163575 163577	0.9999880790710449	O
39810	the	170 173	163578 163581	0.9999889135360718	O
39811	chip	174 178	163582 163586	0.9999839067459106	O
39812	.	179 180	163587 163588	0.9999756813049316	O
39813	For	0 3	163589 163592	0.9999864101409912	O
39814	further	4 11	163593 163600	0.9999873638153076	O
39815	analysis	12 20	163601 163609	0.9999874830245972	O
39816	the	21 24	163610 163613	0.9999879598617554	O
39817	fluorescence	25 36	163614 163625	0.9999877214431763	O
39820	intensity	38 47	163627 163636	0.9999881982803345	O
39821	values	48 54	163637 163643	0.999988317489624	O
39822	of	55 57	163644 163646	0.9999890327453613	O
39823	reliable	58 66	163647 163655	0.9999868869781494	O
39824	spots	67 72	163656 163661	0.9999845027923584	O
39825	were	73 77	163662 163666	0.9999886751174927	O
39826	transformed	78 89	163667 163678	0.9999874830245972	O
39827	to	90 92	163679 163681	0.9999884366989136	O
39828	log2	93 96	163682 163685	0.9999873638153076	O
39830	.	98 99	163687 163688	0.9999735355377197	O
39831	To	0 2	163689 163691	0.9999867677688599	O
39832	minimize	3 11	163692 163700	0.9999802112579346	O
39833	the	12 15	163701 163704	0.9999889135360718	O
39834	effect	16 22	163705 163711	0.9999866485595703	O
39835	of	23 25	163712 163714	0.9999885559082031	O
39836	the	26 29	163715 163718	0.9999879598617554	O
39837	variations	30 40	163719 163729	0.9999856948852539	O
39838	,	41 42	163730 163731	0.9999877214431763	O
39839	the	43 46	163732 163735	0.9999885559082031	O
39840	log2	47 50	163736 163739	0.9999874830245972	O
39842	intensity	52 61	163741 163750	0.999988317489624	O
39843	ratios	62 68	163751 163757	0.9999884366989136	O
39844	of	69 71	163758 163760	0.9999892711639404	O
39845	remaining	72 81	163761 163770	0.9999867677688599	O
39846	spots	82 87	163771 163776	0.9999843835830688	O
39847	were	88 92	163777 163781	0.9999885559082031	O
39848	subjected	93 102	163782 163791	0.9999878406524658	O
39849	to	103 105	163792 163794	0.99998939037323	O
39850	normalization	106 118	163795 163807	0.9999877214431763	O
39852	by	120 122	163809 163811	0.9999889135360718	O
39853	Lowess	123 128	163812 163817	0.9999825954437256	O
39855	fitting	130 137	163819 163826	0.9999874830245972	O
39856	.	138 139	163827 163828	0.9999785423278809	O
39857	Gene	0 4	163829 163833	0.9999860525131226	O
39858	copy	5 9	163834 163838	0.9999885559082031	O
39859	number	10 16	163839 163845	0.999988317489624	O
39860	changes	17 24	163846 163853	0.9999876022338867	O
39861	for	25 28	163854 163857	0.9999889135360718	O
39862	each	29 33	163858 163862	0.9999880790710449	O
39863	sample	34 40	163863 163869	0.999985933303833	O
39864	was	41 44	163870 163873	0.9999885559082031	O
39865	calculated	45 55	163874 163884	0.9999877214431763	O
39866	by	56 58	163885 163887	0.9999890327453613	O
39867	taking	59 65	163888 163894	0.999988317489624	O
39868	the	66 69	163895 163898	0.9999895095825195	O
39869	median	70 76	163899 163905	0.9999878406524658	O
39870	of	77 79	163906 163908	0.9999891519546509	O
39871	the	80 83	163909 163912	0.9999895095825195	O
39872	normalized	84 93	163913 163922	0.9999890327453613	O
39874	log2	95 98	163924 163927	0.9999889135360718	O
39876	intensity	100 109	163929 163938	0.9999890327453613	O
39877	ratios	110 116	163939 163945	0.9999892711639404	O
39878	of	117 119	163946 163948	0.99998939037323	O
39879	dye	120 123	163949 163952	0.9999881982803345	O
39880	-	123 124	163952 163953	0.9999897480010986	O
39881	swapped	124 130	163953 163959	0.9999877214431763	O
39883	chip	132 136	163961 163965	0.9999881982803345	O
39884	experiments	137 148	163966 163977	0.9999874830245972	O
39885	for	149 152	163978 163981	0.9999889135360718	O
39886	the	153 156	163982 163985	0.9999895095825195	O
39887	corresponding	157 170	163986 163999	0.9999866485595703	O
39888	sample	171 177	164000 164006	0.9999885559082031	O
39889	.	178 179	164007 164008	0.9999709129333496	O
39890	The	0 3	164009 164012	0.9999858140945435	O
39891	gene	4 8	164013 164017	0.999984860420227	O
39892	copy	9 13	164018 164022	0.9999862909317017	O
39893	numbers	14 21	164023 164030	0.9999852180480957	O
39894	were	22 26	164031 164035	0.9999852180480957	O
39895	ordered	27 34	164036 164043	0.9999850988388062	O
39896	along	35 40	164044 164049	0.999987006187439	O
39897	chromosomes	41 51	164050 164060	0.9999834299087524	O
39899	by	53 55	164062 164064	0.999985933303833	O
39900	the	56 59	164065 164068	0.9999878406524658	O
39901	map	60 63	164069 164072	0.9999819993972778	O
39902	positions	64 73	164073 164082	0.9999865293502808	O
39903	of	74 76	164083 164085	0.9999881982803345	O
39904	corresponding	77 90	164086 164099	0.9999856948852539	O
39905	genes	91 96	164100 164105	0.9999845027923584	O
39906	.	97 98	164106 164107	0.9999206066131592	O
39907	To	0 2	164108 164110	0.9999885559082031	O
39908	eliminate	3 12	164111 164120	0.9999877214431763	O
39909	systematic	13 23	164121 164131	0.9999871253967285	O
39910	noise	24 29	164132 164137	0.999985933303833	O
39911	,	30 31	164138 164139	0.9999889135360718	O
39912	gene	32 36	164140 164144	0.9999880790710449	O
39913	copy	37 41	164145 164149	0.9999887943267822	O
39914	number	42 48	164150 164156	0.9999886751174927	O
39915	changes	49 56	164157 164164	0.999988317489624	O
39916	(	57 58	164165 164166	0.99998939037323	O
39917	log2Ratios	59 68	164167 164176	0.9999881982803345	O
39922	)	70 71	164178 164179	0.9999898672103882	O
39923	along	72 77	164180 164185	0.9999887943267822	O
39924	the	78 81	164186 164189	0.99998939037323	O
39925	chromosomes	82 92	164190 164200	0.9999842643737793	O
39927	were	94 98	164202 164206	0.9999890327453613	O
39928	smoothed	99 107	164207 164215	0.9999821186065674	O
39929	by	108 110	164216 164218	0.9999896287918091	O
39930	taking	111 117	164219 164225	0.9999895095825195	O
39931	a	118 119	164226 164227	0.9999896287918091	O
39932	moving	120 126	164228 164234	0.9999889135360718	O
39933	median	127 133	164235 164241	0.9999889135360718	O
39934	of	134 136	164242 164244	0.9999895095825195	O
39935	symmetric	137 146	164245 164254	0.9999885559082031	O
39936	5	147 148	164255 164256	0.9999892711639404	O
39937	-	148 149	164256 164257	0.9999896287918091	O
39938	nearest	149 156	164257 164264	0.9999892711639404	O
39939	neighbors	157 166	164265 164274	0.9999889135360718	O
39940	,	167 168	164275 164276	0.9999892711639404	O
39941	followed	169 177	164277 164285	0.9999887943267822	O
39942	by	178 180	164286 164288	0.9999897480010986	O
39943	Lowess	181 186	164289 164294	0.9999836683273315	O
39945	fitting	188 195	164296 164303	0.9999877214431763	O
39946	(	196 197	164304 164305	0.9999897480010986	O
39947	f	198 199	164306 164307	0.9999886751174927	O
39948	=	200 201	164308 164309	0.9999895095825195	O
39949	0	202 203	164310 164311	0.9999895095825195	O
39950	.	203 204	164311 164312	0.9999895095825195	O
39951	2	204 205	164312 164313	0.9999873638153076	O
39952	)	206 207	164314 164315	0.9999897480010986	O
39953	.	208 209	164316 164317	0.9999760389328003	O
39954	The	0 3	164318 164321	0.9999887943267822	O
39955	mean	4 8	164322 164326	0.9999880790710449	O
39956	and	9 12	164327 164330	0.9999884366989136	O
39957	standard	13 21	164331 164339	0.9999884366989136	O
39958	deviation	22 30	164340 164348	0.9999885559082031	O
39960	(	32 33	164350 164351	0.9999886751174927	O
39961	SD	34 36	164352 164354	0.9999867677688599	O
39962	)	37 38	164355 164356	0.9999890327453613	O
39963	of	39 41	164357 164359	0.9999887943267822	O
39964	smoothed	42 50	164360 164368	0.9999830722808838	O
39965	log2Ratios	51 60	164369 164378	0.9999890327453613	O
39970	for	62 65	164380 164383	0.99998939037323	O
39971	all	66 69	164384 164387	0.9999891519546509	O
39972	genes	70 75	164388 164393	0.9999862909317017	O
39973	in	76 78	164394 164396	0.99998939037323	O
39974	all	79 82	164397 164400	0.999988317489624	O
39975	the	83 86	164401 164404	0.9999874830245972	O
39976	samples	87 94	164405 164412	0.9999858140945435	O
39977	were	95 99	164413 164417	0.9999879598617554	O
39978	calculated	100 110	164418 164428	0.999987006187439	O
39979	.	111 112	164429 164430	0.9999769926071167	O
39980	The	0 3	164431 164434	0.9999881982803345	O
39981	copy	4 8	164435 164439	0.9999878406524658	O
39982	number	9 15	164440 164446	0.9999878406524658	O
39983	profiles	16 24	164447 164455	0.9999856948852539	O
39984	of	25 27	164456 164458	0.9999887943267822	O
39985	at	28 30	164459 164461	0.9999889135360718	O
39986	least	31 36	164462 164467	0.9999890327453613	O
39987	5	37 38	164468 164469	0.9999879598617554	O
39988	consecutive	39 50	164470 164481	0.9999834299087524	O
39989	genes	51 56	164482 164487	0.9999829530715942	O
39990	that	57 61	164488 164492	0.9999889135360718	O
39991	deviated	62 69	164493 164500	0.9999884366989136	O
39994	significantly	71 84	164502 164515	0.9999891519546509	O
39995	above	85 90	164516 164521	0.99998939037323	O
39996	mean	91 95	164522 164526	0.9999890327453613	O
39997	+	95 96	164526 164527	0.99998939037323	O
39998	3SD	96 98	164527 164529	0.9999891519546509	O
40000	were	100 104	164531 164535	0.9999885559082031	O
40001	interpreted	105 116	164536 164547	0.9999877214431763	O
40002	as	117 119	164548 164550	0.9999895095825195	O
40003	regional	120 128	164551 164559	0.9999879598617554	O
40004	gains	129 134	164560 164565	0.9999889135360718	O
40005	,	135 136	164566 164567	0.9999881982803345	O
40006	below	137 142	164568 164573	0.9999879598617554	O
40007	mean	143 147	164574 164578	0.9999890327453613	O
40008	-	147 148	164578 164579	0.9999895095825195	O
40009	3SD	148 150	164579 164581	0.9999890327453613	O
40011	as	152 154	164583 164585	0.9999892711639404	O
40012	regional	155 163	164586 164594	0.9999873638153076	O
40013	losses	164 170	164595 164601	0.9999868869781494	O
40014	.	171 172	164602 164603	0.999961256980896	O
40015	The	0 3	164604 164607	0.9999852180480957	O
40016	threshold	4 13	164608 164617	0.9999829530715942	O
40017	for	14 17	164618 164621	0.999985933303833	O
40018	whole	18 23	164622 164627	0.9999845027923584	O
40019	chromosomal	24 34	164628 164638	0.9999866485595703	O
40023	gain	36 40	164640 164644	0.9999872446060181	O
40024	/	40 41	164644 164645	0.999987006187439	O
40025	loss	41 45	164645 164649	0.9999858140945435	O
40026	was	46 49	164650 164653	0.9999867677688599	O
40027	mean±2SD	50 57	164654 164661	0.9999866485595703	O
40031	.	58 59	164662 164663	0.9999547004699707	O
40032	The	0 3	164664 164667	0.9999891519546509	O
40033	ideograms	4 12	164668 164676	0.9999895095825195	O
40037	of	14 16	164678 164680	0.9999887943267822	O
40038	chromosomal	17 27	164681 164691	0.9999881982803345	O
40042	aberrations	29 39	164693 164703	0.9999892711639404	O
40045	were	41 45	164705 164709	0.9999892711639404	O
40046	drawn	46 51	164710 164715	0.9999868869781494	O
40047	using	52 57	164716 164721	0.9999898672103882	O
40048	mapping	58 65	164722 164729	0.9999891519546509	O
40049	information	66 77	164730 164741	0.9999897480010986	O
40050	of	78 80	164742 164744	0.9999897480010986	O
40051	cytogenetic	81 91	164745 164755	0.99998939037323	O
40055	bands	93 98	164757 164762	0.9999889135360718	O
40056	to	99 101	164763 164765	0.9999898672103882	O
40057	the	102 105	164766 164769	0.9999898672103882	O
40058	mouse	106 111	164770 164775	0.9997338652610779	O
40059	genome	112 118	164776 164782	0.9999886751174927	O
40060	(	119 120	164783 164784	0.9999899864196777	O
40061	NCBI	120 123	164784 164787	0.9999892711639404	O
40063	Mapview	125 131	164789 164795	0.9999889135360718	O
40065	Build	133 137	164797 164801	0.9999895095825195	O
40067	32	139 141	164803 164805	0.9999886751174927	O
40068	)	142 143	164806 164807	0.9999902248382568	O
40069	.	144 145	164808 164809	0.9999898672103882	O
40070	*	146 147	164810 164811	0.9999889135360718	O
40071	*	147 148	164811 164812	0.9999862909317017	O
40072	IGNORE	0 5	164813 164818	0.9999862909317017	O
40075	LINE	7 10	164820 164823	0.9999887943267822	O
40078	*	12 13	164825 164826	0.9999890327453613	O
40079	*	13 14	164826 164827	0.9999890327453613	O
40080	*	15 16	164828 164829	0.9999890327453613	O
40081	*	16 17	164829 164830	0.9999890327453613	O
40082	IGNORE	18 23	164831 164836	0.9999877214431763	O
40085	LINE	25 28	164838 164841	0.9999890327453613	O
40088	*	30 31	164843 164844	0.9999887943267822	O
40089	*	31 32	164844 164845	0.9999887943267822	O
40090	*	33 34	164846 164847	0.9999886751174927	O
40091	*	34 35	164847 164848	0.9999886751174927	O
40092	IGNORE	36 41	164849 164854	0.9999874830245972	O
40095	LINE	43 46	164856 164859	0.9999889135360718	O
40098	*	48 49	164861 164862	0.9999890327453613	O
40099	*	49 50	164862 164863	0.9999889135360718	O
40100	Given	51 56	164864 164869	0.9999878406524658	O
40101	the	57 60	164870 164873	0.9999892711639404	O
40102	above	61 66	164874 164879	0.9999866485595703	O
40103	unanticipated	67 79	164880 164892	0.9999891519546509	O
40108	characteristics	81 96	164894 164909	0.9999881982803345	O
40109	of	97 99	164910 164912	0.9999889135360718	O
40110	the	100 103	164913 164916	0.9999889135360718	O
40111	newly	104 109	164917 164922	0.9999874830245972	O
40112	discovered	110 120	164923 164933	0.9999877214431763	O
40113	mutations	121 130	164934 164943	0.9999866485595703	O
40114	—	130 131	164943 164944	0.9999860525131226	O
40115	especially	131 141	164944 164954	0.9999871253967285	O
40116	their	142 147	164955 164960	0.9999885559082031	O
40117	low	148 151	164961 164964	0.9999879598617554	O
40118	frequency	152 161	164965 164974	0.9999886751174927	O
40119	and	162 165	164975 164978	0.9999878406524658	O
40120	high	166 170	164979 164983	0.9999879598617554	O
40121	rate	171 175	164984 164988	0.9999887943267822	O
40122	of	176 178	164989 164991	0.9999889135360718	O
40123	heterozygosity	179 192	164992 165005	0.9999881982803345	O
40128	—	193 194	165006 165007	0.9999816417694092	O
40129	we	194 196	165007 165009	0.9999880790710449	O
40130	performed	197 206	165010 165019	0.9999879598617554	O
40131	an	207 209	165020 165022	0.99998939037323	O
40132	initial	210 217	165023 165030	0.9999877214431763	O
40133	survey	218 224	165031 165037	0.999988317489624	O
40134	to	225 227	165038 165040	0.9999892711639404	O
40135	characterize	228 239	165041 165052	0.9999887943267822	O
40137	the	241 244	165054 165057	0.9999895095825195	O
40138	epigenetic	245 254	165058 165067	0.99998939037323	O
40142	status	256 262	165069 165075	0.9999890327453613	O
40143	of	263 265	165076 165078	0.9999890327453613	O
40144	genes	266 271	165079 165084	0.9999855756759644	O
40145	in	272 274	165085 165087	0.9999879598617554	O
40146	colon	275 279	165088 165092	0.9999827146530151	O
40148	cancer	281 287	165094 165100	0.9999860525131226	O
40149	on	288 290	165101 165103	0.9999887943267822	O
40150	a	291 292	165104 165105	0.99998939037323	O
40151	genome	293 299	165106 165112	0.999988317489624	O
40152	-	299 300	165112 165113	0.99998939037323	O
40153	wide	300 304	165113 165117	0.9999874830245972	O
40154	level	305 310	165118 165123	0.9999889135360718	O
40155	.	311 312	165124 165125	0.9999494552612305	O
40156	To	0 2	165126 165128	0.999985933303833	O
40157	this	3 7	165129 165133	0.9999885559082031	O
40158	end	8 11	165134 165137	0.9999865293502808	O
40159	,	12 13	165138 165139	0.9999874830245972	O
40160	we	14 16	165140 165142	0.999985933303833	O
40161	developed	17 26	165143 165152	0.9999860525131226	O
40162	an	27 29	165153 165155	0.9999884366989136	O
40163	expression	30 40	165156 165166	0.999985933303833	O
40164	microarray	41 50	165167 165176	0.9999874830245972	O
40167	technique	52 61	165178 165187	0.9999847412109375	O
40168	to	62 64	165188 165190	0.999988317489624	O
40169	characterize	65 76	165191 165202	0.9999885559082031	O
40171	the	78 81	165204 165207	0.9999890327453613	O
40172	spectrum	82 90	165208 165216	0.9999874830245972	O
40173	of	91 93	165217 165219	0.9999887943267822	O
40174	hypermethylated	94 108	165220 165234	0.9999886751174927	O
40179	genes	110 115	165236 165241	0.9999873638153076	O
40180	in	116 118	165242 165244	0.9999874830245972	O
40181	cancers	119 125	165245 165251	0.9999852180480957	O
40183	[	127 128	165253 165254	0.9999895095825195	O
40184	15	128 130	165254 165256	0.9999876022338867	O
40185	]	130 131	165256 165257	0.9999895095825195	O
40186	.	132 133	165258 165259	0.9999786615371704	O
40187	In	0 2	165260 165262	0.9999879598617554	O
40188	the	3 6	165263 165266	0.9999881982803345	O
40189	present	7 14	165267 165274	0.999988317489624	O
40190	paper	15 20	165275 165280	0.9999856948852539	O
40191	,	21 22	165281 165282	0.999988317489624	O
40192	we	23 25	165283 165285	0.9999868869781494	O
40193	have	26 30	165286 165290	0.9999876022338867	O
40194	utilized	31 39	165291 165299	0.999987006187439	O
40195	our	40 43	165300 165303	0.9999880790710449	O
40196	global	44 50	165304 165310	0.9999856948852539	O
40197	approach	51 59	165311 165319	0.9999884366989136	O
40198	to	60 62	165320 165322	0.9999891519546509	O
40199	comprehensively	63 77	165323 165337	0.9999879598617554	O
40201	compare	79 86	165339 165346	0.9999868869781494	O
40202	the	87 90	165347 165350	0.9999890327453613	O
40203	epigenetic	91 100	165351 165360	0.9999887943267822	O
40207	alteration	102 111	165362 165371	0.9999886751174927	O
40209	of	113 115	165373 165375	0.9999889135360718	O
40210	the	116 119	165376 165379	0.9999884366989136	O
40211	CAN	120 122	165380 165382	0.9999818801879883	O
40213	genes	124 129	165384 165389	0.9999871253967285	O
40214	in	130 132	165390 165392	0.9999890327453613	O
40215	both	133 137	165393 165397	0.999985933303833	O
40216	breast	138 144	165398 165404	0.9999806880950928	O
40217	and	145 148	165405 165408	0.9999853372573853	O
40218	colon	149 153	165409 165413	0.999980092048645	O
40220	cancers	155 161	165415 165421	0.9999864101409912	O
40222	,	163 164	165423 165424	0.9999873638153076	O
40223	and	165 168	165425 165428	0.9999885559082031	O
40224	included	169 177	165429 165437	0.9999885559082031	O
40225	analyses	178 186	165438 165446	0.9999860525131226	O
40226	in	187 189	165447 165449	0.9999887943267822	O
40227	the	190 193	165450 165453	0.9999886751174927	O
40228	specific	194 202	165454 165462	0.9999860525131226	O
40229	breast	203 209	165463 165469	0.9999815225601196	O
40230	cancer	210 216	165470 165476	0.9999865293502808	O
40231	lines	217 222	165477 165482	0.9999867677688599	O
40232	where	223 228	165483 165488	0.9999887943267822	O
40233	individual	229 239	165489 165499	0.9999822378158569	O
40234	mutations	240 249	165500 165509	0.999985933303833	O
40235	were	250 254	165510 165514	0.9999891519546509	O
40236	identified	255 265	165515 165525	0.99998939037323	O
40237	by	266 268	165526 165528	0.9999889135360718	O
40238	Sjoblom	269 275	165529 165535	0.9999886751174927	O
40243	et	277 279	165537 165539	0.9999886751174927	O
40244	al	280 282	165540 165542	0.9999881982803345	O
40245	.	283 284	165543 165544	0.9999886751174927	O
40246	[	285 286	165545 165546	0.9999767541885376	O
40247	7	0 1	165546 165547	0.9999749660491943	O
40248	]	1 2	165547 165548	0.999975323677063	O
40249	.	3 4	165549 165550	0.9999834299087524	O
40250	*	5 6	165551 165552	0.9999788999557495	O
40251	*	6 7	165552 165553	0.9999475479125977	O
40252	IGNORE	0 5	165554 165559	0.9999861717224121	O
40255	LINE	7 10	165561 165564	0.9999879598617554	O
40258	*	12 13	165566 165567	0.9999884366989136	O
40259	*	13 14	165567 165568	0.9999884366989136	O
40260	*	15 16	165569 165570	0.9999884366989136	O
40261	*	16 17	165570 165571	0.9999886751174927	O
40262	IGNORE	18 23	165572 165577	0.9999876022338867	O
40265	LINE	25 28	165579 165582	0.9999886751174927	O
40268	*	30 31	165584 165585	0.9999884366989136	O
40269	*	31 32	165585 165586	0.9999884366989136	O
40270	*	33 34	165587 165588	0.999988317489624	O
40271	*	34 35	165588 165589	0.9999881982803345	O
40272	IGNORE	36 41	165590 165595	0.999987006187439	O
40275	LINE	43 46	165597 165600	0.9999885559082031	O
40278	*	48 49	165602 165603	0.9999884366989136	O
40279	*	49 50	165603 165604	0.9999884366989136	O
40280	Genes	51 55	165605 165609	0.9999878406524658	O
40282	Targeted	57 64	165611 165618	0.9999884366989136	O
40284	by	66 68	165620 165622	0.9999885559082031	O
40285	Mutation	69 76	165623 165630	0.9999876022338867	O
40287	and	78 81	165632 165635	0.9999886751174927	O
40288	Hypermethylation	82 97	165636 165651	0.9999881982803345	O
40293	Common	99 105	165653 165659	0.9999865293502808	O
40294	Gene	106 110	165660 165664	0.9999872446060181	O
40295	Targets	111 117	165665 165671	0.999988317489624	O
40297	of	119 121	165673 165675	0.9999881982803345	O
40298	Mutation	122 129	165676 165683	0.9999874830245972	O
40300	and	131 134	165685 165688	0.9999884366989136	O
40301	Hypermethylation	135 150	165689 165704	0.9999877214431763	O
40306	in	152 154	165706 165708	0.9999872446060181	O
40307	Breast	155 160	165709 165714	0.9999828338623047	O
40310	Cancer	162 168	165716 165722	0.9999856948852539	O
40311	MSP	169 171	165723 165725	0.9999865293502808	O
40313	and	173 176	165727 165730	0.9999861717224121	O
40314	RT	177 178	165731 165732	0.9999877214431763	O
40316	-	179 180	165733 165734	0.9999885559082031	O
40317	PCR	180 182	165734 165736	0.9999879598617554	O
40319	expression	184 194	165738 165748	0.9999867677688599	O
40320	analysis	195 203	165749 165757	0.9999881982803345	O
40321	of	204 206	165758 165760	0.9999881982803345	O
40322	selected	207 215	165761 165769	0.9999856948852539	O
40323	genes	216 221	165770 165775	0.9999862909317017	O
40324	.	222 223	165776 165777	0.9998914003372192	O
40325	Each	0 4	165778 165782	0.9999860525131226	O
40326	set	5 8	165783 165786	0.9999873638153076	O
40327	of	9 11	165787 165789	0.9999877214431763	O
40328	MSP	12 14	165790 165792	0.9999849796295166	O
40330	and	16 19	165794 165797	0.999985933303833	O
40331	expression	20 30	165798 165808	0.9999759197235107	O
40332	analyses	31 39	165809 165817	0.9999836683273315	O
40333	are	40 43	165818 165821	0.9999856948852539	O
40334	labeled	44 51	165822 165829	0.9999830722808838	O
40335	with	52 56	165830 165834	0.9999881982803345	O
40336	the	57 60	165835 165838	0.9999887943267822	O
40337	corresponding	61 74	165839 165852	0.9999884366989136	O
40338	gene	75 79	165853 165857	0.9999885559082031	O
40339	name	80 84	165858 165862	0.9999886751174927	O
40340	.	85 86	165863 165864	0.9999606609344482	O
40341	U	0 1	165865 165866	0.9999797344207764	O
40342	denotes	2 9	165867 165874	0.9999877214431763	O
40343	the	10 13	165875 165878	0.9999892711639404	O
40344	unmethylated	14 25	165879 165890	0.9999884366989136	O
40348	band	27 31	165892 165896	0.9999885559082031	O
40349	,	32 33	165897 165898	0.9999871253967285	O
40350	and	34 37	165899 165902	0.9999881982803345	O
40351	M	38 39	165903 165904	0.9999843835830688	O
40352	denotes	40 47	165905 165912	0.9999887943267822	O
40353	the	48 51	165913 165916	0.9999892711639404	O
40354	methylated	52 61	165917 165926	0.9999871253967285	O
40357	band	63 67	165928 165932	0.9999889135360718	O
40358	.	68 69	165933 165934	0.9999693632125854	O
40359	In	0 2	165935 165937	0.9999868869781494	O
40360	vitro	3 7	165938 165942	0.9999873638153076	O
40363	methylated	9 18	165944 165953	0.9999872446060181	O
40366	DNA	20 23	165955 165958	0.9999855756759644	O
40367	(	24 25	165959 165960	0.9999886751174927	O
40368	IVD	26 28	165961 165963	0.9999842643737793	O
40370	)	30 31	165965 165966	0.9999890327453613	O
40371	was	32 35	165967 165970	0.9999864101409912	O
40372	used	36 40	165971 165975	0.9999866485595703	O
40373	as	41 43	165976 165978	0.9999884366989136	O
40374	a	44 45	165979 165980	0.9999892711639404	O
40375	positive	46 54	165981 165989	0.9999862909317017	O
40376	control	55 62	165990 165997	0.9999858140945435	O
40377	for	63 66	165998 166001	0.9999885559082031	O
40378	methylation	67 77	166002 166012	0.9999874830245972	O
40381	.	79 80	166014 166015	0.999969482421875	O
40382	cDNA	0 3	166016 166019	0.9999879598617554	O
40385	from	5 9	166021 166025	0.9999865293502808	O
40386	normal	10 16	166026 166032	0.999983549118042	O
40387	breast	17 23	166033 166039	0.9999823570251465	O
40388	(	24 25	166040 166041	0.9999885559082031	O
40389	NB	26 27	166042 166043	0.9999831914901733	O
40391	)	28 29	166044 166045	0.9999887943267822	O
40392	and	30 33	166046 166049	0.9999865293502808	O
40393	normal	34 40	166050 166056	0.9999849796295166	O
40394	colon	41 45	166057 166061	0.999982476234436	O
40396	(	47 48	166063 166064	0.9999887943267822	O
40397	NC	48 50	166064 166066	0.9999822378158569	O
40398	)	51 52	166067 166068	0.9999895095825195	O
40399	(	53 54	166069 166070	0.99998939037323	O
40400	Figure	55 61	166071 166077	0.9999856948852539	O
40401	3	62 63	166078 166079	0.9999874830245972	O
40402	)	64 65	166080 166081	0.99998939037323	O
40403	was	66 69	166082 166085	0.9999876022338867	O
40404	used	70 74	166086 166090	0.9999874830245972	O
40405	to	75 77	166091 166093	0.9999886751174927	O
40406	determine	78 87	166094 166103	0.9999886751174927	O
40407	the	88 91	166104 166107	0.9999892711639404	O
40408	expression	92 102	166108 166118	0.9999877214431763	O
40409	of	103 105	166119 166121	0.9999892711639404	O
40410	the	106 109	166122 166125	0.9999889135360718	O
40411	genes	110 115	166126 166131	0.9999862909317017	O
40412	in	116 118	166132 166134	0.9999885559082031	O
40413	normal	119 125	166135 166141	0.9999853372573853	O
40414	tissue	126 132	166142 166148	0.9999866485595703	O
40415	.	133 134	166149 166150	0.9999735355377197	O
40416	DKO	0 2	166151 166153	0.9999810457229614	O
40418	corresponds	4 15	166155 166166	0.9999791383743286	O
40419	to	16 18	166167 166169	0.999985933303833	O
40420	DNMT	19 22	166170 166173	0.999983549118042	O
40423	1	24 25	166175 166176	0.9999853372573853	O
40424	/	25 26	166176 166177	0.9999854564666748	O
40425	3b	26 27	166177 166178	0.9999802112579346	O
40427	double	29 35	166180 166186	0.9999712705612183	O
40428	knockout	36 44	166187 166195	0.9999524354934692	O
40429	HCT116	45 50	166196 166201	0.9999830722808838	O
40433	cells	52 57	166203 166208	0.9999762773513794	O
40434	.	58 59	166209 166210	0.9998852014541626	O
40435	All	0 3	166211 166214	0.999987006187439	O
40436	RT	4 5	166215 166216	0.9999872446060181	O
40438	-	6 7	166217 166218	0.9999884366989136	O
40439	PCR	7 9	166218 166220	0.9999877214431763	O
40441	experiments	11 22	166222 166233	0.9999828338623047	O
40442	were	23 27	166234 166238	0.9999890327453613	O
40443	performed	28 37	166239 166248	0.999988317489624	O
40444	in	38 40	166249 166251	0.9999895095825195	O
40445	parallel	41 49	166252 166260	0.9999865293502808	O
40446	without	50 57	166261 166268	0.9999889135360718	O
40447	reverse	58 65	166269 166276	0.9999889135360718	O
40448	transcriptase	66 78	166277 166289	0.9999892711639404	O
40451	as	80 82	166291 166293	0.99998939037323	O
40452	a	83 84	166294 166295	0.9999896287918091	O
40453	control	85 92	166296 166303	0.9999873638153076	O
40454	,	93 94	166304 166305	0.999988317489624	O
40455	and	95 98	166306 166309	0.9999891519546509	O
40456	in	99 101	166310 166312	0.9999892711639404	O
40457	all	102 105	166313 166316	0.9999887943267822	O
40458	cases	106 111	166317 166322	0.999988317489624	O
40459	,	112 113	166323 166324	0.9999887943267822	O
40460	no	114 116	166325 166327	0.9999887943267822	O
40461	PCR	117 119	166328 166330	0.9999880790710449	O
40463	product	121 128	166332 166339	0.999988317489624	O
40464	was	129 132	166340 166343	0.9999892711639404	O
40465	generated	133 142	166344 166353	0.9999885559082031	O
40466	(	143 144	166354 166355	0.9999895095825195	O
40467	unpublished	144 155	166355 166366	0.9999874830245972	O
40468	data	156 160	166367 166371	0.9999895095825195	O
40469	)	161 162	166372 166373	0.9999897480010986	O
40470	.	163 164	166374 166375	0.9999771118164062	O
40471	The	0 3	166376 166379	0.9999889135360718	O
40472	control	4 11	166380 166387	0.9999860525131226	O
40473	experiment	12 22	166388 166398	0.9999878406524658	O
40474	performed	23 32	166399 166408	0.9999887943267822	O
40475	without	33 40	166409 166416	0.9999887943267822	O
40476	RT	41 42	166417 166418	0.9999891519546509	O
40478	for	44 47	166420 166423	0.9999896287918091	O
40479	normal	48 54	166424 166430	0.9999868869781494	O
40480	breast	55 61	166431 166437	0.9999860525131226	O
40481	is	62 64	166438 166440	0.9999887943267822	O
40482	shown	65 70	166441 166446	0.9999880790710449	O
40483	(	71 72	166447 166448	0.9999899864196777	O
40484	NB	73 74	166449 166450	0.9999896287918091	O
40486	no	76 78	166452 166454	0.9999895095825195	O
40487	RT	79 80	166455 166456	0.9999895095825195	O
40489	)	82 83	166458 166459	0.9999898672103882	O
40490	for	84 87	166460 166463	0.9999896287918091	O
40491	each	88 92	166464 166468	0.9999896287918091	O
40492	gene	93 97	166469 166473	0.9999873638153076	O
40493	.	98 99	166474 166475	0.9999781847000122	O
40494	RT	0 1	166476 166477	0.9999876022338867	O
40496	-	2 3	166478 166479	0.9999887943267822	O
40497	PCR	3 5	166479 166481	0.9999877214431763	O
40499	was	7 10	166483 166486	0.999988317489624	O
40500	performed	11 20	166487 166496	0.9999880790710449	O
40501	for	21 24	166497 166500	0.9999887943267822	O
40502	all	25 28	166501 166504	0.9999862909317017	O
40503	cancer	29 35	166505 166511	0.9999819993972778	O
40504	lines	36 41	166512 166517	0.999985933303833	O
40505	with	42 46	166518 166522	0.9999890327453613	O
40506	beta	47 51	166523 166527	0.9999877214431763	O
40507	-	51 52	166527 166528	0.9999896287918091	O
40508	actin	52 56	166528 166532	0.9999877214431763	O
40510	primers	58 64	166534 166540	0.9999892711639404	O
40512	to	66 68	166542 166544	0.99998939037323	O
40513	control	69 76	166545 166552	0.9999887943267822	O
40514	for	77 80	166553 166556	0.99998939037323	O
40515	the	81 84	166557 166560	0.9999895095825195	O
40516	amount	85 91	166561 166567	0.9999885559082031	O
40517	of	92 94	166568 166570	0.99998939037323	O
40518	cDNA	95 98	166571 166574	0.99998939037323	O
40521	(	100 101	166576 166577	0.9999895095825195	O
40522	Figure	102 108	166578 166584	0.9999867677688599	O
40523	3	109 110	166585 166586	0.9999884366989136	O
40524	,	111 112	166587 166588	0.9999886751174927	O
40525	bottom	113 119	166589 166595	0.9999873638153076	O
40526	)	120 121	166596 166597	0.99998939037323	O
40527	.	122 123	166598 166599	0.999980092048645	O
40528	Common	0 6	166600 166606	0.9999748468399048	O
40529	Gene	7 11	166607 166611	0.9999840259552002	O
40530	Targets	12 18	166612 166618	0.999983549118042	O
40532	of	20 22	166620 166622	0.9999855756759644	O
40533	Mutation	23 30	166623 166630	0.9999836683273315	O
40535	and	32 35	166632 166635	0.999985933303833	O
40536	Hypermethylation	36 51	166636 166651	0.9999862909317017	O
40541	in	53 55	166653 166655	0.9999833106994629	O
40542	Colon	56 60	166656 166660	0.9999786615371704	O
40544	Cancer	62 68	166662 166668	0.9999855756759644	O
40545	MSP	69 71	166669 166671	0.9999864101409912	O
40547	and	73 76	166673 166676	0.9999849796295166	O
40548	RT	77 78	166677 166678	0.9999874830245972	O
40550	-	79 80	166679 166680	0.9999881982803345	O
40551	PCR	80 82	166680 166682	0.9999877214431763	O
40553	expression	84 94	166684 166694	0.9999871253967285	O
40554	analysis	95 103	166695 166703	0.9999877214431763	O
40555	of	104 106	166704 166706	0.9999873638153076	O
40556	selected	107 115	166707 166715	0.9999850988388062	O
40557	genes	116 121	166716 166721	0.999985933303833	O
40558	.	122 123	166722 166723	0.9999088048934937	O
40559	Each	0 4	166724 166728	0.9999860525131226	O
40560	set	5 8	166729 166732	0.9999873638153076	O
40561	of	9 11	166733 166735	0.9999877214431763	O
40562	MSP	12 14	166736 166738	0.9999849796295166	O
40564	and	16 19	166740 166743	0.999985933303833	O
40565	expression	20 30	166744 166754	0.9999759197235107	O
40566	analyses	31 39	166755 166763	0.9999836683273315	O
40567	are	40 43	166764 166767	0.9999856948852539	O
40568	labeled	44 51	166768 166775	0.9999830722808838	O
40569	with	52 56	166776 166780	0.9999881982803345	O
40570	the	57 60	166781 166784	0.9999887943267822	O
40571	corresponding	61 74	166785 166798	0.9999884366989136	O
40572	gene	75 79	166799 166803	0.9999885559082031	O
40573	name	80 84	166804 166808	0.9999886751174927	O
40574	.	85 86	166809 166810	0.9999606609344482	O
40575	U	0 1	166811 166812	0.9999797344207764	O
40576	denotes	2 9	166813 166820	0.9999877214431763	O
40577	the	10 13	166821 166824	0.9999892711639404	O
40578	unmethylated	14 25	166825 166836	0.9999884366989136	O
40582	band	27 31	166838 166842	0.9999885559082031	O
40583	,	32 33	166843 166844	0.9999871253967285	O
40584	and	34 37	166845 166848	0.9999881982803345	O
40585	M	38 39	166849 166850	0.9999843835830688	O
40586	denotes	40 47	166851 166858	0.9999887943267822	O
40587	the	48 51	166859 166862	0.9999892711639404	O
40588	methylated	52 61	166863 166872	0.9999871253967285	O
40591	band	63 67	166874 166878	0.9999889135360718	O
40592	.	68 69	166879 166880	0.9999693632125854	O
40593	In	0 2	166881 166883	0.9999868869781494	O
40594	vitro	3 7	166884 166888	0.9999873638153076	O
40597	methylated	9 18	166890 166899	0.9999872446060181	O
40600	DNA	20 23	166901 166904	0.9999855756759644	O
40601	(	24 25	166905 166906	0.9999886751174927	O
40602	IVD	26 28	166907 166909	0.9999842643737793	O
40604	)	30 31	166911 166912	0.9999890327453613	O
40605	was	32 35	166913 166916	0.9999864101409912	O
40606	used	36 40	166917 166921	0.9999866485595703	O
40607	as	41 43	166922 166924	0.9999884366989136	O
40608	a	44 45	166925 166926	0.9999892711639404	O
40609	positive	46 54	166927 166935	0.9999862909317017	O
40610	control	55 62	166936 166943	0.9999858140945435	O
40611	for	63 66	166944 166947	0.9999885559082031	O
40612	methylation	67 77	166948 166958	0.9999874830245972	O
40615	.	79 80	166960 166961	0.999969482421875	O
40616	cDNA	0 3	166962 166965	0.9999862909317017	O
40619	from	5 9	166967 166971	0.9999831914901733	O
40620	normal	10 16	166972 166978	0.9999790191650391	O
40621	breast	17 23	166979 166985	0.9999796152114868	O
40622	(	24 25	166986 166987	0.9999862909317017	O
40623	NB	26 27	166988 166989	0.9999791383743286	O
40625	)	28 29	166990 166991	0.9999872446060181	O
40626	and	30 33	166992 166995	0.9999823570251465	O
40627	normal	34 40	166996 167002	0.9999819993972778	O
40628	colon	41 45	167003 167007	0.9999791383743286	O
40630	(	47 48	167009 167010	0.9999865293502808	O
40631	NC	48 50	167010 167012	0.9999703168869019	O
40632	)	51 52	167013 167014	0.999988317489624	O
40633	was	53 56	167015 167018	0.999983549118042	O
40634	used	57 61	167019 167023	0.999983549118042	O
40635	to	62 64	167024 167026	0.9999867677688599	O
40636	determine	65 74	167027 167036	0.9999862909317017	O
40637	the	75 78	167037 167040	0.9999880790710449	O
40638	expression	79 89	167041 167051	0.9999849796295166	O
40639	of	90 92	167052 167054	0.9999881982803345	O
40640	the	93 96	167055 167058	0.999987006187439	O
40641	genes	97 102	167059 167064	0.9999831914901733	O
40642	in	103 105	167065 167067	0.9999864101409912	O
40643	normal	106 112	167068 167074	0.9999810457229614	O
40644	tissue	113 119	167075 167081	0.9999841451644897	O
40645	.	120 121	167082 167083	0.9999512434005737	O
40646	DKO	0 2	167084 167086	0.9999810457229614	O
40648	corresponds	4 15	167088 167099	0.9999791383743286	O
40649	to	16 18	167100 167102	0.999985933303833	O
40650	DNMT	19 22	167103 167106	0.999983549118042	O
40653	1	24 25	167108 167109	0.9999853372573853	O
40654	/	25 26	167109 167110	0.9999854564666748	O
40655	3b	26 27	167110 167111	0.9999802112579346	O
40657	double	29 35	167113 167119	0.9999712705612183	O
40658	knockout	36 44	167120 167128	0.9999524354934692	O
40659	HCT116	45 50	167129 167134	0.9999830722808838	O
40663	cells	52 57	167136 167141	0.9999762773513794	O
40664	.	58 59	167142 167143	0.9998852014541626	O
40665	All	0 3	167144 167147	0.999987006187439	O
40666	RT	4 5	167148 167149	0.9999872446060181	O
40668	-	6 7	167150 167151	0.9999884366989136	O
40669	PCR	7 9	167151 167153	0.9999877214431763	O
40671	experiments	11 22	167155 167166	0.9999828338623047	O
40672	were	23 27	167167 167171	0.9999890327453613	O
40673	performed	28 37	167172 167181	0.999988317489624	O
40674	in	38 40	167182 167184	0.9999895095825195	O
40675	parallel	41 49	167185 167193	0.9999865293502808	O
40676	without	50 57	167194 167201	0.9999889135360718	O
40677	reverse	58 65	167202 167209	0.9999889135360718	O
40678	transcriptase	66 78	167210 167222	0.9999892711639404	O
40681	as	80 82	167224 167226	0.99998939037323	O
40682	a	83 84	167227 167228	0.9999896287918091	O
40683	control	85 92	167229 167236	0.9999873638153076	O
40684	,	93 94	167237 167238	0.999988317489624	O
40685	and	95 98	167239 167242	0.9999891519546509	O
40686	in	99 101	167243 167245	0.9999892711639404	O
40687	all	102 105	167246 167249	0.9999887943267822	O
40688	cases	106 111	167250 167255	0.999988317489624	O
40689	,	112 113	167256 167257	0.9999887943267822	O
40690	no	114 116	167258 167260	0.9999887943267822	O
40691	PCR	117 119	167261 167263	0.9999880790710449	O
40693	product	121 128	167265 167272	0.999988317489624	O
40694	was	129 132	167273 167276	0.9999892711639404	O
40695	generated	133 142	167277 167286	0.9999885559082031	O
40696	(	143 144	167287 167288	0.9999895095825195	O
40697	unpublished	144 155	167288 167299	0.9999874830245972	O
40698	data	156 160	167300 167304	0.9999895095825195	O
40699	)	161 162	167305 167306	0.9999897480010986	O
40700	.	163 164	167307 167308	0.9999771118164062	O
40701	The	0 3	167309 167312	0.9999887943267822	O
40702	control	4 11	167313 167320	0.9999855756759644	O
40703	experiment	12 22	167321 167331	0.9999874830245972	O
40704	performed	23 32	167332 167341	0.9999885559082031	O
40705	without	33 40	167342 167349	0.9999887943267822	O
40706	RT	41 42	167350 167351	0.9999889135360718	O
40708	for	44 47	167353 167356	0.9999895095825195	O
40709	normal	48 54	167357 167363	0.9999861717224121	O
40710	colon	55 59	167364 167368	0.9999856948852539	O
40712	is	61 63	167370 167372	0.9999885559082031	O
40713	shown	64 69	167373 167378	0.9999876022338867	O
40714	(	70 71	167379 167380	0.9999897480010986	O
40715	NC	71 73	167380 167382	0.9999886751174927	O
40716	no	74 76	167383 167385	0.9999895095825195	O
40717	RT	77 78	167386 167387	0.99998939037323	O
40719	)	80 81	167389 167390	0.9999897480010986	O
40720	for	82 85	167391 167394	0.9999895095825195	O
40721	each	86 90	167395 167399	0.99998939037323	O
40722	gene	91 95	167400 167404	0.9999873638153076	O
40723	.	96 97	167405 167406	0.9999749660491943	O
40724	RT	0 1	167407 167408	0.999985933303833	O
40726	-	2 3	167409 167410	0.9999880790710449	O
40727	PCR	3 5	167410 167412	0.9999868869781494	O
40729	was	7 10	167414 167417	0.9999861717224121	O
40730	performed	11 20	167418 167427	0.9999864101409912	O
40731	for	21 24	167428 167431	0.9999874830245972	O
40732	all	25 28	167432 167435	0.9999834299087524	O
40733	cancer	29 35	167436 167442	0.9999788999557495	O
40734	lines	36 41	167443 167448	0.999984860420227	O
40735	with	42 46	167449 167453	0.9999881982803345	O
40736	beta	47 51	167454 167458	0.9999867677688599	O
40737	-	51 52	167458 167459	0.99998939037323	O
40738	actin	52 56	167459 167463	0.9999868869781494	O
40740	primers	58 64	167465 167471	0.9999887943267822	O
40742	to	66 68	167473 167475	0.9999889135360718	O
40743	control	69 76	167476 167483	0.9999879598617554	O
40744	for	77 80	167484 167487	0.9999889135360718	O
40745	the	81 84	167488 167491	0.9999891519546509	O
40746	amount	85 91	167492 167498	0.9999877214431763	O
40747	of	92 94	167499 167501	0.9999889135360718	O
40748	cDNA	95 98	167502 167505	0.9999889135360718	O
40751	.	100 101	167507 167508	0.9999698400497437	O
40752	From	0 4	167509 167513	0.999985933303833	O
40753	the	5 8	167514 167517	0.9999892711639404	O
40754	analysis	9 17	167518 167526	0.9999881982803345	O
40755	of	18 20	167527 167529	0.9999892711639404	O
40756	methylation	21 31	167530 167540	0.9999884366989136	O
40759	and	33 36	167542 167545	0.9999889135360718	O
40760	expression	37 47	167546 167556	0.9999873638153076	O
40761	status	48 54	167557 167563	0.9999892711639404	O
40762	of	55 57	167564 167566	0.9999891519546509	O
40763	the	58 61	167567 167570	0.9999892711639404	O
40764	36	62 64	167571 167573	0.9999805688858032	O
40765	common	65 71	167574 167580	0.9999867677688599	O
40766	target	72 78	167581 167587	0.9999864101409912	O
40767	genes	79 84	167588 167593	0.9999886751174927	O
40768	,	85 86	167594 167595	0.9999880790710449	O
40769	it	87 89	167596 167598	0.9999892711639404	O
40770	is	90 92	167599 167601	0.9999887943267822	O
40771	clear	93 98	167602 167607	0.9999876022338867	O
40772	that	99 103	167608 167612	0.9999896287918091	O
40773	,	104 105	167613 167614	0.99998939037323	O
40774	although	106 114	167615 167623	0.9999866485595703	O
40775	hypermethylation	115 130	167624 167639	0.99998939037323	O
40780	was	132 135	167641 167644	0.9999890327453613	O
40781	accompanied	136 147	167645 167656	0.9999896287918091	O
40782	by	148 150	167657 167659	0.9999897480010986	O
40783	loss	151 155	167660 167664	0.9999891519546509	O
40784	of	156 158	167665 167667	0.9999897480010986	O
40785	gene	159 163	167668 167672	0.99998939037323	O
40786	expression	164 174	167673 167683	0.9999892711639404	O
40787	in	175 177	167684 167686	0.9999898672103882	O
40788	nearly	178 184	167687 167693	0.9999886751174927	O
40789	all	185 188	167694 167697	0.9999886751174927	O
40790	cases	189 194	167698 167703	0.9999880790710449	O
40791	,	195 196	167704 167705	0.9999885559082031	O
40792	loss	197 201	167706 167710	0.9999892711639404	O
40793	of	202 204	167711 167713	0.9999897480010986	O
40794	gene	205 209	167714 167718	0.9999895095825195	O
40795	expression	210 220	167719 167729	0.99998939037323	O
40796	in	221 223	167730 167732	0.9999898672103882	O
40797	the	224 227	167733 167736	0.99998939037323	O
40798	overlap	228 235	167737 167744	0.9999855756759644	O
40799	genes	236 241	167745 167750	0.9999885559082031	O
40800	can	242 245	167751 167754	0.999988317489624	O
40801	occur	246 251	167755 167760	0.9999895095825195	O
40802	by	252 254	167761 167763	0.9999887943267822	O
40803	mechanisms	255 265	167764 167774	0.9999873638153076	O
40804	other	266 271	167775 167780	0.9999879598617554	O
40805	than	272 276	167781 167785	0.9999889135360718	O
40806	methylation	277 287	167786 167796	0.9999874830245972	O
40809	(	289 290	167798 167799	0.9999896287918091	O
40810	Table	291 296	167800 167805	0.9999872446060181	O
40811	S1	297 298	167806 167807	0.9999896287918091	O
40813	)	300 301	167809 167810	0.9999896287918091	O
40814	.	302 303	167811 167812	0.9999759197235107	O
40815	Potential	0 8	167813 167821	0.9999794960021973	O
40818	mechanisms	10 20	167823 167833	0.999976396560669	O
40819	include	21 28	167834 167841	0.9999831914901733	O
40820	repressive	29 38	167842 167851	0.9999853372573853	O
40822	chromatin	40 48	167853 167861	0.999987006187439	O
40825	modifications	50 63	167863 167876	0.9999818801879883	O
40826	,	64 65	167877 167878	0.9999856948852539	O
40827	mutational	66 75	167879 167888	0.9999823570251465	O
40829	changes	77 84	167890 167897	0.9999864101409912	O
40830	outside	85 92	167898 167905	0.9999850988388062	O
40831	the	93 96	167906 167909	0.9999877214431763	O
40832	coding	97 103	167910 167916	0.9999873638153076	O
40833	regions	104 111	167917 167924	0.9999879598617554	O
40834	that	112 116	167925 167929	0.9999872446060181	O
40835	destabilize	117 127	167930 167940	0.9999864101409912	O
40839	the	129 132	167942 167945	0.9999868869781494	O
40840	mRNA	133 136	167946 167949	0.9999862909317017	O
40842	,	138 139	167951 167952	0.9999830722808838	O
40843	or	140 142	167953 167955	0.9999812841415405	O
40844	coordinate	143 153	167956 167966	0.9999756813049316	O
40845	downregulation	154 167	167967 167980	0.9999849796295166	O
40849	of	169 171	167982 167984	0.9999876022338867	O
40850	relevant	172 180	167985 167993	0.9999830722808838	O
40851	pathways	181 189	167994 168002	0.9999809265136719	O
40852	.	190 191	168003 168004	0.9999303817749023	O
40853	For	0 3	168005 168008	0.9999840259552002	O
40854	example	4 11	168009 168016	0.9999836683273315	O
40855	,	12 13	168017 168018	0.9999873638153076	O
40856	p21	14 16	168019 168021	0.9999868869781494	O
40858	expression	18 28	168023 168033	0.9999854564666748	O
40859	is	29 31	168034 168036	0.9999862909317017	O
40860	frequently	32 42	168037 168047	0.999984860420227	O
40861	decreased	43 52	168048 168057	0.9999783039093018	O
40862	in	53 55	168058 168060	0.9999860525131226	O
40863	tumors	56 62	168061 168067	0.9999798536300659	O
40864	with	63 67	168068 168072	0.9999867677688599	O
40865	inactivating	68 79	168073 168084	0.9999885559082031	O
40868	p53	81 83	168086 168088	0.9999881982803345	O
40870	mutations	85 94	168090 168099	0.9999879598617554	O
40871	[	95 96	168100 168101	0.9999887943267822	O
40872	25	96 98	168101 168103	0.999984622001648	O
40873	]	98 99	168103 168104	0.999988317489624	O
40874	.	100 101	168105 168106	0.9999754428863525	O
40875	To	0 2	168107 168109	0.9999865293502808	O
40876	confirm	3 10	168110 168117	0.9999864101409912	O
40877	our	11 14	168118 168121	0.9999854564666748	O
40878	MSP	15 17	168122 168124	0.9999876022338867	O
40880	results	19 26	168126 168133	0.9999881982803345	O
40881	,	27 28	168134 168135	0.9999885559082031	O
40882	we	29 31	168136 168138	0.9999871253967285	O
40883	analyzed	32 40	168139 168147	0.9999885559082031	O
40884	the	41 44	168148 168151	0.9999892711639404	O
40885	methylation	45 55	168152 168162	0.9999880790710449	O
40888	status	57 63	168164 168170	0.99998939037323	O
40889	of	64 66	168171 168173	0.9999891519546509	O
40890	selected	67 75	168174 168182	0.9999874830245972	O
40891	genes	76 81	168183 168188	0.9999871253967285	O
40892	using	82 87	168189 168194	0.9999890327453613	O
40893	sequencing	88 97	168195 168204	0.9999878406524658	O
40895	of	99 101	168206 168208	0.9999891519546509	O
40896	bisulfite	102 110	168209 168217	0.9999891519546509	O
40900	-	111 112	168218 168219	0.9999896287918091	O
40901	treated	112 119	168219 168226	0.9999886751174927	O
40902	genomic	120 126	168227 168233	0.9999890327453613	O
40905	DNA	128 131	168235 168238	0.999988317489624	O
40906	from	132 136	168239 168243	0.9999887943267822	O
40907	samples	137 144	168244 168251	0.9999884366989136	O
40908	that	145 149	168252 168256	0.9999890327453613	O
40909	were	150 154	168257 168261	0.9999887943267822	O
40910	used	155 159	168262 168266	0.9999879598617554	O
40911	in	160 162	168267 168269	0.9999887943267822	O
40912	the	163 166	168270 168273	0.9999886751174927	O
40913	MSP	167 169	168274 168276	0.9999878406524658	O
40915	studies	171 178	168278 168285	0.9999885559082031	O
40916	.	179 180	168286 168287	0.9999740123748779	O
40917	In	0 2	168288 168290	0.9999881982803345	O
40918	all	3 6	168291 168294	0.9999864101409912	O
40919	cases	7 12	168295 168300	0.9999876022338867	O
40920	,	13 14	168301 168302	0.9999889135360718	O
40921	bisulfite	15 23	168303 168311	0.9999886751174927	O
40925	sequencing	25 34	168313 168322	0.9999884366989136	O
40927	confirmed	36 45	168324 168333	0.9999887943267822	O
40928	the	46 49	168334 168337	0.9999895095825195	O
40929	results	50 57	168338 168345	0.9999886751174927	O
40930	obtained	58 66	168346 168354	0.99998939037323	O
40931	with	67 71	168355 168359	0.9999896287918091	O
40932	MSP	72 74	168360 168362	0.9999878406524658	O
40934	(	76 77	168364 168365	0.9999896287918091	O
40935	Figure	78 84	168366 168372	0.999987006187439	O
40936	4	85 86	168373 168374	0.9999884366989136	O
40937	)	86 87	168374 168375	0.9999897480010986	O
40938	.	88 89	168376 168377	0.9999802112579346	O
40939	For	0 3	168378 168381	0.9999856948852539	O
40940	another	4 11	168382 168389	0.9999852180480957	O
40941	control	12 19	168390 168397	0.9999788999557495	O
40942	,	20 21	168398 168399	0.9999881982803345	O
40943	we	22 24	168400 168402	0.9999866485595703	O
40944	also	25 29	168403 168407	0.9999867677688599	O
40945	studied	30 37	168408 168415	0.9999871253967285	O
40946	the	38 41	168416 168419	0.9999889135360718	O
40947	methylation	42 52	168420 168430	0.9999878406524658	O
40950	and	54 57	168432 168435	0.9999881982803345	O
40951	expression	58 68	168436 168446	0.9999866485595703	O
40952	status	69 75	168447 168453	0.9999887943267822	O
40953	of	76 78	168454 168456	0.9999886751174927	O
40954	the	79 82	168457 168460	0.9999884366989136	O
40955	genes	83 88	168461 168466	0.9999860525131226	O
40956	in	89 91	168467 168469	0.999988317489624	O
40957	a	92 93	168470 168471	0.9999876022338867	O
40958	derivative	94 104	168472 168482	0.9999783039093018	O
40959	of	105 107	168483 168485	0.9999879598617554	O
40960	HCT116	108 113	168486 168491	0.9999861717224121	O
40964	human	115 120	168493 168498	0.9994052648544312	O
40965	colon	121 125	168499 168503	0.9999797344207764	O
40967	cancer	127 133	168505 168511	0.9999858140945435	O
40968	cells	134 139	168512 168517	0.999972939491272	O
40969	in	140 142	168518 168520	0.9999872446060181	O
40970	which	143 148	168521 168526	0.9999881982803345	O
40971	the	149 152	168527 168530	0.9999886751174927	O
40972	DNMT1	153 157	168531 168535	0.9999884366989136	O
40976	and	159 162	168537 168540	0.9999872446060181	O
40977	DNMT3b	163 168	168541 168546	0.9999884366989136	O
40982	DNA	170 173	168548 168551	0.9999866485595703	O
40983	methyltransferases	174 191	168552 168569	0.9999878406524658	O
40989	were	193 197	168571 168575	0.9999886751174927	O
40990	homozygously	198 209	168576 168587	0.9999880790710449	O
40996	deleted	211 218	168589 168596	0.9999860525131226	O
40997	(	219 220	168597 168598	0.999988317489624	O
40998	DKO	221 223	168599 168601	0.9999855756759644	O
41000	cells	225 230	168603 168608	0.9999856948852539	O
41001	)	231 232	168609 168610	0.9999890327453613	O
41002	.	233 234	168611 168612	0.9999632835388184	O
41003	These	0 5	168613 168618	0.9999858140945435	O
41004	simultaneous	6 18	168619 168631	0.9999793767929077	O
41005	deletions	19 27	168632 168640	0.9999850988388062	O
41008	result	29 35	168642 168648	0.9999867677688599	O
41009	in	36 38	168649 168651	0.9999889135360718	O
41010	nearly	39 45	168652 168658	0.9999880790710449	O
41011	complete	46 54	168659 168667	0.9999876022338867	O
41012	lack	55 59	168668 168672	0.9999872446060181	O
41013	of	60 62	168673 168675	0.9999887943267822	O
41014	DNA	63 66	168676 168679	0.9999874830245972	O
41015	methylation	67 77	168680 168690	0.9999884366989136	O
41018	and	79 82	168692 168695	0.9999881982803345	O
41019	the	83 86	168696 168699	0.9999885559082031	O
41020	promoter	87 95	168700 168708	0.9999871253967285	O
41021	DNA	96 99	168709 168712	0.9999881982803345	O
41022	demethylation	100 112	168713 168725	0.9999887943267822	O
41026	and	114 117	168727 168730	0.9999885559082031	O
41027	re	118 120	168731 168733	0.9999886751174927	O
41028	-	120 121	168733 168734	0.9999889135360718	O
41029	expression	121 131	168734 168744	0.9999886751174927	O
41030	of	132 134	168745 168747	0.9999890327453613	O
41031	all	135 138	168748 168751	0.9999886751174927	O
41032	known	139 144	168752 168757	0.9999860525131226	O
41033	DNA	145 148	168758 168761	0.9999876022338867	O
41034	hypermethylated	149 163	168762 168776	0.9999887943267822	O
41039	genes	165 170	168778 168783	0.9999877214431763	O
41040	examined	171 179	168784 168792	0.9999839067459106	O
41041	in	180 182	168793 168795	0.9999874830245972	O
41042	these	183 188	168796 168801	0.9999865293502808	O
41043	cells	189 194	168802 168807	0.9999715089797974	O
41044	[	195 196	168808 168809	0.9999892711639404	O
41045	26	196 198	168809 168811	0.9999865293502808	O
41046	]	198 199	168811 168812	0.9999884366989136	O
41047	.	200 201	168813 168814	0.9999746084213257	O
41048	In	0 2	168815 168817	0.9999880790710449	O
41049	all	3 6	168818 168821	0.999987006187439	O
41050	cases	7 12	168822 168827	0.9999860525131226	O
41051	,	13 14	168828 168829	0.9999879598617554	O
41052	the	15 18	168830 168833	0.9999886751174927	O
41053	loss	19 23	168834 168838	0.9999880790710449	O
41054	or	24 26	168839 168841	0.9999889135360718	O
41055	absence	27 34	168842 168849	0.999988317489624	O
41056	of	35 37	168850 168852	0.9999890327453613	O
41057	methylation	38 48	168853 168863	0.9999880790710449	O
41060	at	50 52	168865 168867	0.9999890327453613	O
41061	the	53 56	168868 168871	0.99998939037323	O
41062	promoter	57 65	168872 168880	0.9999884366989136	O
41063	regions	66 73	168881 168888	0.9999889135360718	O
41064	of	74 76	168889 168891	0.9999895095825195	O
41065	the	77 80	168892 168895	0.99998939037323	O
41066	36	81 83	168896 168898	0.9999850988388062	O
41067	DNA	84 87	168899 168902	0.9999867677688599	O
41068	hypermethylated	88 102	168903 168917	0.9999890327453613	O
41073	loci	104 107	168919 168922	0.99998939037323	O
41075	in	109 111	168924 168926	0.99998939037323	O
41076	DKO	112 114	168927 168929	0.999987006187439	O
41078	cells	116 121	168931 168936	0.9999836683273315	O
41079	was	122 125	168937 168940	0.9999886751174927	O
41080	associated	126 136	168941 168951	0.99998939037323	O
41081	with	137 141	168952 168956	0.9999892711639404	O
41082	expression	142 152	168957 168967	0.9999877214431763	O
41083	of	153 155	168968 168970	0.9999892711639404	O
41084	these	156 161	168971 168976	0.9999891519546509	O
41085	genes	162 167	168977 168982	0.9999858140945435	O
41086	(	168 169	168983 168984	0.9999891519546509	O
41087	Figures	170 176	168985 168991	0.9999850988388062	O
41089	2	178 179	168993 168994	0.9999889135360718	O
41090	and	180 183	168995 168998	0.9999885559082031	O
41091	3	184 185	168999 169000	0.9999880790710449	O
41092	and	186 189	169001 169004	0.9999879598617554	O
41093	unpublished	190 201	169005 169016	0.9999845027923584	O
41094	data	202 206	169017 169021	0.9999880790710449	O
41095	)	207 208	169022 169023	0.9999892711639404	O
41096	.	209 210	169024 169025	0.9999727010726929	O
41097	Importantly	0 10	169026 169036	0.999984860420227	O
41099	,	12 13	169038 169039	0.9999878406524658	O
41100	in	14 16	169040 169042	0.9999865293502808	O
41101	all	17 20	169043 169046	0.9999862909317017	O
41102	cases	21 26	169047 169052	0.999987006187439	O
41103	,	27 28	169053 169054	0.9999879598617554	O
41104	these	29 34	169055 169060	0.9999879598617554	O
41105	36	35 37	169061 169063	0.9999812841415405	O
41106	overlap	38 45	169064 169071	0.9999840259552002	O
41107	genes	46 51	169072 169077	0.9999849796295166	O
41108	were	52 56	169078 169082	0.9999879598617554	O
41109	also	57 61	169083 169087	0.9999872446060181	O
41110	found	62 67	169088 169093	0.9999876022338867	O
41111	to	68 70	169094 169096	0.9999877214431763	O
41112	be	71 73	169097 169099	0.9999878406524658	O
41113	expressed	74 83	169100 169109	0.9999861717224121	O
41114	in	84 86	169110 169112	0.9999879598617554	O
41115	normal	87 93	169113 169119	0.9999796152114868	O
41116	colon	94 98	169120 169124	0.999984860420227	O
41118	and	100 103	169126 169129	0.9999837875366211	O
41119	breast	104 110	169130 169136	0.9999793767929077	O
41120	tissue	111 117	169137 169143	0.9999871253967285	O
41121	(	118 119	169144 169145	0.9999885559082031	O
41122	Figures	120 126	169146 169152	0.9999868869781494	O
41124	2	128 129	169154 169155	0.9999879598617554	O
41125	and	130 133	169156 169159	0.9999878406524658	O
41126	3	134 135	169160 169161	0.999987006187439	O
41127	and	136 139	169162 169165	0.9999874830245972	O
41128	Table	140 145	169166 169171	0.9999865293502808	O
41129	S1	146 147	169172 169173	0.9999886751174927	O
41131	)	149 150	169175 169176	0.9999885559082031	O
41132	.	151 152	169177 169178	0.9999889135360718	O
41133	*	153 154	169179 169180	0.9999874830245972	O
41134	*	154 155	169180 169181	0.9999765157699585	O
41135	IGNORE	0 5	169182 169187	0.9999860525131226	O
41138	LINE	7 10	169189 169192	0.9999886751174927	O
41141	*	12 13	169194 169195	0.9999891519546509	O
41142	*	13 14	169195 169196	0.9999890327453613	O
41143	*	15 16	169197 169198	0.9999890327453613	O
41144	*	16 17	169198 169199	0.9999891519546509	O
41145	IGNORE	18 23	169200 169205	0.9999876022338867	O
41148	LINE	25 28	169207 169210	0.9999890327453613	O
41151	*	30 31	169212 169213	0.9999890327453613	O
41152	*	31 32	169213 169214	0.9999890327453613	O
41153	*	33 34	169215 169216	0.9999889135360718	O
41154	*	34 35	169216 169217	0.9999889135360718	O
41155	IGNORE	36 41	169218 169223	0.9999872446060181	O
41158	LINE	43 46	169225 169228	0.9999887943267822	O
41161	*	48 49	169230 169231	0.9999889135360718	O
41162	*	49 50	169231 169232	0.9999890327453613	O
41163	The	51 54	169233 169236	0.9999891519546509	O
41164	above	55 60	169237 169242	0.999987006187439	O
41165	data	61 65	169243 169247	0.9999861717224121	O
41166	may	66 69	169248 169251	0.9999879598617554	O
41167	be	70 72	169252 169254	0.9999890327453613	O
41168	particularly	73 85	169255 169267	0.9999878406524658	O
41169	significant	86 97	169268 169279	0.99998939037323	O
41170	because	98 105	169280 169287	0.9999874830245972	O
41171	the	106 109	169288 169291	0.9999885559082031	O
41172	vast	110 114	169292 169296	0.9999862909317017	O
41173	majority	115 123	169297 169305	0.9999868869781494	O
41174	of	124 126	169306 169308	0.9999885559082031	O
41175	CAN	127 129	169309 169311	0.9999847412109375	O
41177	gene	131 135	169313 169317	0.9999880790710449	O
41178	mutations	136 145	169318 169327	0.9999885559082031	O
41179	identified	146 156	169328 169338	0.9999877214431763	O
41180	are	157 160	169339 169342	0.999988317489624	O
41181	heterozygous	161 172	169343 169354	0.9999868869781494	O
41186	missense	174 181	169356 169363	0.9999886751174927	O
41188	mutations	183 192	169365 169374	0.999988317489624	O
41189	.	193 194	169375 169376	0.9999569654464722	O
41190	It	0 2	169377 169379	0.9999845027923584	O
41191	is	3 5	169380 169382	0.9999827146530151	O
41192	possible	6 14	169383 169391	0.9999806880950928	O
41193	that	15 19	169392 169396	0.9999831914901733	O
41194	many	20 24	169397 169401	0.9999771118164062	O
41195	of	25 27	169402 169404	0.999985933303833	O
41196	these	28 33	169405 169410	0.999983549118042	O
41197	mutations	34 43	169411 169420	0.9999747276306152	O
41198	result	44 50	169421 169427	0.9999845027923584	O
41199	in	51 53	169428 169430	0.999987006187439	O
41200	haploinsufficiency	54 71	169431 169448	0.9999864101409912	O
41206	or	73 75	169450 169452	0.9999783039093018	O
41207	cause	76 81	169453 169458	0.9999855756759644	O
41208	small	82 87	169459 169464	0.9999749660491943	O
41209	decreases	88 97	169465 169474	0.9999822378158569	O
41210	in	98 100	169475 169477	0.9999878406524658	O
41211	protein	101 108	169478 169485	0.9999760389328003	O
41212	or	109 111	169486 169488	0.9999867677688599	O
41213	transcript	112 121	169489 169498	0.9999878406524658	O
41215	abundance	123 132	169500 169509	0.999988317489624	O
41216	that	133 137	169510 169514	0.9999876022338867	O
41217	may	138 141	169515 169518	0.9999874830245972	O
41218	be	142 144	169519 169521	0.9999880790710449	O
41219	functionally	145 156	169522 169533	0.9999866485595703	O
41221	meaningful	158 168	169535 169545	0.9999866485595703	O
41222	for	169 172	169546 169549	0.9999866485595703	O
41223	driving	173 180	169550 169557	0.999976634979248	O
41224	tumorigenesis	181 193	169558 169570	0.9999827146530151	O
41228	.	195 196	169572 169573	0.9999586343765259	O
41229	Small	0 5	169574 169579	0.9999814033508301	O
41230	changes	6 13	169580 169587	0.9999862909317017	O
41231	in	14 16	169588 169590	0.9999876022338867	O
41232	expression	17 27	169591 169601	0.9999849796295166	O
41233	of	28 30	169602 169604	0.9999877214431763	O
41234	a	31 32	169605 169606	0.999988317489624	O
41235	number	33 39	169607 169613	0.9999871253967285	O
41236	of	40 42	169614 169616	0.9999878406524658	O
41237	tumor	43 48	169617 169622	0.9999829530715942	O
41238	suppressor	49 58	169623 169632	0.999984622001648	O
41240	genes	60 65	169634 169639	0.9999878406524658	O
41241	(	66 67	169640 169641	0.9999885559082031	O
41242	such	68 72	169642 169646	0.9999884366989136	O
41243	as	73 75	169647 169649	0.9999886751174927	O
41244	APC	76 78	169650 169652	0.9999853372573853	O
41246	,	80 81	169654 169655	0.9999884366989136	O
41247	SMAD4	82 86	169656 169660	0.9999854564666748	O
41250	,	88 89	169662 169663	0.9999885559082031	O
41251	MSH2	90 93	169664 169667	0.9999865293502808	O
41254	,	95 96	169669 169670	0.9999884366989136	O
41255	etc	97 100	169671 169674	0.999988317489624	O
41256	.	100 101	169674 169675	0.9999866485595703	O
41257	)	102 103	169676 169677	0.9999716281890869	O
41258	have	0 4	169678 169682	0.9999843835830688	O
41259	now	5 8	169683 169686	0.9999854564666748	O
41260	been	9 13	169687 169691	0.9999873638153076	O
41261	well	14 18	169692 169696	0.9999852180480957	O
41262	described	19 28	169697 169706	0.9999833106994629	O
41263	to	29 31	169707 169709	0.9999847412109375	O
41264	have	32 36	169710 169714	0.9999850988388062	O
41265	tumorigenic	37 47	169715 169725	0.9999780654907227	O
41268	effects	49 56	169727 169734	0.9999837875366211	O
41269	[	57 58	169735 169736	0.9999881982803345	O
41270	8	58 59	169736 169737	0.9999866485595703	O
41271	,	59 60	169737 169738	0.9999874830245972	O
41272	29	60 62	169738 169740	0.999984860420227	O
41273	,	62 63	169740 169741	0.9999871253967285	O
41274	30	63 65	169741 169743	0.9999834299087524	O
41275	]	65 66	169743 169744	0.9999866485595703	O
41276	.	67 68	169745 169746	0.9999687671661377	O
41277	Consistent	0 9	169747 169756	0.9999872446060181	O
41280	with	11 15	169758 169762	0.9999884366989136	O
41281	the	16 19	169763 169766	0.9999889135360718	O
41282	hemizygous	20 29	169767 169776	0.9999873638153076	O
41287	nature	31 37	169778 169784	0.9999880790710449	O
41288	of	38 40	169785 169787	0.9999890327453613	O
41289	the	41 44	169788 169791	0.9999889135360718	O
41290	mutations	45 54	169792 169801	0.9999843835830688	O
41291	,	55 56	169802 169803	0.999987006187439	O
41292	it	57 59	169804 169806	0.9999885559082031	O
41293	seems	60 65	169807 169812	0.9999867677688599	O
41294	likely	66 72	169813 169819	0.9999880790710449	O
41295	that	73 77	169820 169824	0.99998939037323	O
41296	DNA	78 81	169825 169828	0.9999880790710449	O
41297	methylation	82 92	169829 169839	0.9999887943267822	O
41300	deepens	94 100	169841 169847	0.999985933303833	O
41302	the	102 105	169849 169852	0.9999895095825195	O
41303	haploinsufficiency	106 123	169853 169870	0.9999887943267822	O
41309	status	125 131	169872 169878	0.99998939037323	O
41310	of	132 134	169879 169881	0.99998939037323	O
41311	the	135 138	169882 169885	0.9999892711639404	O
41312	genes	139 144	169886 169891	0.9999847412109375	O
41313	when	145 149	169892 169896	0.9999878406524658	O
41314	both	150 154	169897 169901	0.9999847412109375	O
41315	changes	155 162	169902 169909	0.9999877214431763	O
41316	are	163 166	169910 169913	0.9999885559082031	O
41317	found	167 172	169914 169919	0.9999880790710449	O
41318	in	173 175	169920 169922	0.999988317489624	O
41319	the	176 179	169923 169926	0.9999887943267822	O
41320	same	180 184	169927 169931	0.9999852180480957	O
41321	tumor	185 190	169932 169937	0.9999854564666748	O
41322	or	191 193	169938 169940	0.9999856948852539	O
41323	,	194 195	169941 169942	0.9999861717224121	O
41324	more	196 200	169943 169947	0.9999876022338867	O
41325	often	201 206	169948 169953	0.9999884366989136	O
41326	just	207 211	169954 169958	0.9999854564666748	O
41327	with	212 216	169959 169963	0.9999880790710449	O
41328	the	217 220	169964 169967	0.9999891519546509	O
41329	epigenetic	221 230	169968 169977	0.9999891519546509	O
41333	changes	232 239	169979 169986	0.9999890327453613	O
41334	alone	240 245	169987 169992	0.9999890327453613	O
41335	.	246 247	169993 169994	0.9999614953994751	O
41336	The	0 3	169995 169998	0.9999799728393555	O
41337	accompanying	4 16	169999 170011	0.9999748468399048	O
41338	loss	17 21	170012 170016	0.9999780654907227	O
41339	of	22 24	170017 170019	0.9999831914901733	O
41340	function	25 33	170020 170028	0.9999487400054932	O
41341	can	34 37	170029 170032	0.9999662637710571	O
41342	compound	38 46	170033 170041	0.9999431371688843	O
41343	,	47 48	170042 170043	0.9999758005142212	O
41344	and	49 52	170044 170047	0.999976396560669	O
41345	thus	53 57	170048 170052	0.999974250793457	O
41346	progressively	58 71	170053 170066	0.9997486472129822	O
41347	contribute	72 82	170067 170077	0.9999649524688721	O
41348	to	83 85	170078 170080	0.9999781847000122	O
41349	,	86 87	170081 170082	0.9999744892120361	O
41350	tumorigenesis	88 100	170083 170095	0.9999630451202393	O
41354	.	102 103	170097 170098	0.9998830556869507	O
41355	Functional	0 9	170099 170108	0.9999850988388062	O
41357	Associations	11 22	170110 170121	0.9999836683273315	O
41359	of	24 26	170123 170125	0.9999874830245972	O
41360	Common	27 33	170126 170132	0.9999850988388062	O
41361	Target	34 40	170133 170139	0.999987006187439	O
41362	Genes	41 45	170140 170144	0.9999868869781494	O
41364	Next	47 51	170146 170150	0.9999748468399048	O
41365	,	52 53	170151 170152	0.9999867677688599	O
41366	we	54 56	170153 170155	0.9999864101409912	O
41367	analyzed	57 65	170156 170164	0.9999871253967285	O
41368	the	66 69	170165 170168	0.9999885559082031	O
41369	functional	70 80	170169 170179	0.9999858140945435	O
41370	associations	81 93	170180 170192	0.9999873638153076	O
41371	of	94 96	170193 170195	0.9999884366989136	O
41372	the	97 100	170196 170199	0.9999878406524658	O
41373	18	101 103	170200 170202	0.9999778270721436	O
41374	common	104 110	170203 170209	0.9999849796295166	O
41375	target	111 117	170210 170216	0.9999858140945435	O
41376	genes	118 123	170217 170222	0.9999860525131226	O
41377	that	124 128	170223 170227	0.9999878406524658	O
41378	demonstrate	129 140	170228 170239	0.9999822378158569	O
41379	cancer	141 147	170240 170246	0.9999836683273315	O
41380	-	147 148	170246 170247	0.9999890327453613	O
41381	specific	148 156	170247 170255	0.9999872446060181	O
41382	hypermethylation	157 172	170256 170271	0.9999886751174927	O
41387	.	174 175	170273 170274	0.9999747276306152	O
41388	We	0 2	170275 170277	0.9999834299087524	O
41389	utilized	3 11	170278 170286	0.9999847412109375	O
41390	Gene	12 16	170287 170291	0.9999872446060181	O
41391	Ontology	17 24	170292 170299	0.9999872446060181	O
41393	(	26 27	170301 170302	0.9999884366989136	O
41394	GO	28 30	170303 170305	0.9999817609786987	O
41395	)	31 32	170306 170307	0.9999889135360718	O
41396	classification	33 47	170308 170322	0.9999865293502808	O
41397	and	48 51	170323 170326	0.9999872446060181	O
41398	available	52 61	170327 170336	0.9999831914901733	O
41399	data	62 66	170337 170341	0.9999868869781494	O
41400	in	67 69	170342 170344	0.9999880790710449	O
41401	the	70 73	170345 170348	0.9999884366989136	O
41402	literature	74 84	170349 170359	0.9999847412109375	O
41403	to	85 87	170360 170362	0.9999878406524658	O
41404	describe	88 96	170363 170371	0.9999868869781494	O
41405	the	97 100	170372 170375	0.9999884366989136	O
41406	functional	101 111	170376 170386	0.9999794960021973	O
41407	associations	112 124	170387 170399	0.999987006187439	O
41408	of	125 127	170400 170402	0.9999879598617554	O
41409	the	128 131	170403 170406	0.9999874830245972	O
41410	genes	132 137	170407 170412	0.9999841451644897	O
41411	(	138 139	170413 170414	0.9999887943267822	O
41412	Figure	140 146	170415 170421	0.9999845027923584	O
41413	8	147 148	170422 170423	0.9999876022338867	O
41414	)	149 150	170424 170425	0.9999891519546509	O
41415	.	151 152	170426 170427	0.9999738931655884	O
41416	A	0 1	170428 170429	0.9999794960021973	O
41417	number	2 8	170430 170436	0.9999769926071167	O
41418	of	9 11	170437 170439	0.9999817609786987	O
41419	genes	12 17	170440 170445	0.9999662637710571	O
41420	are	18 21	170446 170449	0.999980092048645	O
41421	involved	22 30	170450 170458	0.9999809265136719	O
41422	in	31 33	170459 170461	0.9999828338623047	O
41423	cell	34 38	170462 170466	0.9999414682388306	O
41424	adhesion	39 46	170467 170474	0.9999772310256958	O
41426	and	48 51	170476 170479	0.9999814033508301	O
41427	motility	52 59	170480 170487	0.9999781847000122	O
41430	and	61 64	170489 170492	0.999983549118042	O
41431	/	64 65	170492 170493	0.9999847412109375	O
41432	or	65 67	170493 170495	0.9999810457229614	O
41433	signal	68 74	170496 170502	0.9999630451202393	O
41434	transduction	75 86	170503 170514	0.9999837875366211	O
41436	.	88 89	170516 170517	0.9999370574951172	O
41437	Examination	0 11	170518 170529	0.9999778270721436	O
41438	of	12 14	170530 170532	0.9999861717224121	O
41439	the	15 18	170533 170536	0.9999858140945435	O
41440	literature	19 29	170537 170547	0.9999673366546631	O
41441	revealed	30 38	170548 170556	0.9999847412109375	O
41442	that	39 43	170557 170561	0.9999877214431763	O
41443	at	44 46	170562 170564	0.9999879598617554	O
41444	least	47 52	170565 170570	0.9999877214431763	O
41445	six	53 56	170571 170574	0.9999806880950928	O
41446	of	57 59	170575 170577	0.9999877214431763	O
41447	these	60 65	170578 170583	0.9999871253967285	O
41448	genes	66 71	170584 170589	0.9999779462814331	O
41449	possess	72 79	170590 170597	0.9999860525131226	O
41450	known	80 85	170598 170603	0.999983549118042	O
41451	tumor	86 91	170604 170609	0.9999842643737793	O
41452	suppressive	92 102	170610 170620	0.9999854564666748	O
41454	properties	104 114	170622 170632	0.9999871253967285	O
41455	,	115 116	170633 170634	0.9999872446060181	O
41456	defined	117 124	170635 170642	0.9999862909317017	O
41457	as	125 127	170643 170645	0.999988317489624	O
41458	the	128 131	170646 170649	0.999988317489624	O
41459	ability	132 139	170650 170657	0.9999873638153076	O
41460	to	140 142	170658 170660	0.9999884366989136	O
41461	modulate	143 150	170661 170668	0.9999879598617554	O
41464	known	152 157	170670 170675	0.9999853372573853	O
41465	tumor	158 163	170676 170681	0.9999856948852539	O
41466	suppressor	164 173	170682 170691	0.999987006187439	O
41468	(	175 176	170693 170694	0.9999843835830688	O
41469	i	177 178	170695 170696	0.9999886751174927	O
41470	.	179 180	170697 170698	0.9999876022338867	O
41471	e	180 181	170698 170699	0.9999867677688599	O
41472	.	182 183	170700 170701	0.9999866485595703	O
41473	,	184 185	170702 170703	0.9999842643737793	O
41474	p53	0 2	170704 170706	0.9999850988388062	O
41476	,	4 5	170708 170709	0.9999858140945435	O
41477	wnt	6 8	170710 170712	0.9999817609786987	O
41479	,	10 11	170714 170715	0.999985933303833	O
41480	etc	12 15	170716 170719	0.9999850988388062	O
41481	.	15 16	170719 170720	0.9999822378158569	O
41482	)	17 18	170721 170722	0.999886155128479	O
41483	function	0 8	170723 170731	0.9999711513519287	O
41484	or	9 11	170732 170734	0.9999699592590332	O
41485	inhibit	12 18	170735 170741	0.9999793767929077	O
41487	cancer	20 26	170743 170749	0.9999659061431885	O
41488	cell	27 31	170750 170754	0.9999715089797974	O
41489	growth	32 38	170755 170761	0.9999804496765137	O
41490	in	39 41	170762 170764	0.9999867677688599	O
41491	vitro	42 46	170765 170769	0.9999865293502808	O
41494	and	48 51	170771 170774	0.9999836683273315	O
41495	/	51 52	170774 170775	0.9999852180480957	O
41496	or	52 54	170775 170777	0.9999843835830688	O
41497	in	55 57	170778 170780	0.9999860525131226	O
41498	vivo	58 61	170781 170784	0.9999608993530273	O
41500	(	63 64	170786 170787	0.9999868869781494	O
41501	Figure	65 71	170788 170794	0.9999818801879883	O
41502	8	72 73	170795 170796	0.9999840259552002	O
41503	)	74 75	170797 170798	0.9999868869781494	O
41504	.	76 77	170799 170800	0.9999680519104004	O
41505	We	0 2	170801 170803	0.9999785423278809	O
41506	then	3 7	170804 170808	0.9999783039093018	O
41507	determined	8 18	170809 170819	0.9999847412109375	O
41508	the	19 22	170820 170823	0.9999872446060181	O
41509	chromosomal	23 33	170824 170834	0.9999874830245972	O
41513	location	35 43	170836 170844	0.9999827146530151	O
41514	of	44 46	170845 170847	0.999987006187439	O
41515	these	47 52	170848 170853	0.9999862909317017	O
41516	18	53 55	170854 170856	0.9999740123748779	O
41517	genes	56 61	170857 170862	0.9999823570251465	O
41518	.	62 63	170863 170864	0.9999191761016846	O
41519	We	0 2	170865 170867	0.9999755620956421	O
41520	compared	3 11	170868 170876	0.9999802112579346	O
41521	these	12 17	170877 170882	0.9999866485595703	O
41522	chromosomal	18 28	170883 170893	0.9999876022338867	O
41526	locations	30 39	170895 170904	0.9999798536300659	O
41527	to	40 42	170905 170907	0.9999842643737793	O
41528	those	43 48	170908 170913	0.999987006187439	O
41529	that	49 53	170914 170918	0.9999874830245972	O
41530	have	54 58	170919 170923	0.9999867677688599	O
41531	been	59 63	170924 170928	0.9999874830245972	O
41532	shown	64 69	170929 170934	0.9999845027923584	O
41533	to	70 72	170935 170937	0.9999879598617554	O
41534	be	73 75	170938 170940	0.9999880790710449	O
41535	deleted	76 83	170941 170948	0.9999836683273315	O
41536	in	84 86	170949 170951	0.9999866485595703	O
41537	primary	87 94	170952 170959	0.9999809265136719	O
41538	human	95 100	170960 170965	0.5966302752494812	species
41539	tumors	101 107	170966 170972	0.999983549118042	O
41540	in	108 110	170973 170975	0.9999872446060181	O
41541	the	111 114	170976 170979	0.9999876022338867	O
41542	literature	115 125	170980 170990	0.9999823570251465	O
41543	using	126 131	170991 170996	0.9999874830245972	O
41544	standard	132 140	170997 171005	0.9999852180480957	O
41545	genetic	141 148	171006 171013	0.9999877214431763	O
41546	mapping	149 156	171014 171021	0.9999877214431763	O
41547	or	157 159	171022 171024	0.9999867677688599	O
41548	comparative	160 171	171025 171036	0.9999849796295166	O
41549	genomic	172 178	171037 171043	0.9999873638153076	O
41552	hybridization	180 192	171045 171057	0.999987006187439	O
41554	(	194 195	171059 171060	0.999988317489624	O
41555	CGH	196 198	171061 171063	0.9999861717224121	O
41558	)	199 200	171064 171065	0.9999887943267822	O
41559	.	201 202	171066 171067	0.9999649524688721	O
41560	Sixteen	0 7	171068 171075	0.999977707862854	O
41561	out	8 11	171076 171079	0.9999879598617554	O
41562	of	12 14	171080 171082	0.9999879598617554	O
41563	18	15 17	171083 171085	0.9999756813049316	O
41564	(	18 19	171086 171087	0.9999874830245972	O
41565	89	19 21	171087 171089	0.9999831914901733	O
41566	%	22 23	171090 171091	0.9999877214431763	O
41567	,	24 25	171092 171093	0.9999874830245972	O
41568	next	26 30	171094 171098	0.9999878406524658	O
41569	to	31 33	171099 171101	0.9999886751174927	O
41570	last	34 38	171102 171106	0.9999872446060181	O
41571	panel	39 44	171107 171112	0.9999874830245972	O
41572	)	45 46	171113 171114	0.9999881982803345	O
41573	of	47 49	171115 171117	0.9999861717224121	O
41574	these	50 55	171118 171123	0.9999865293502808	O
41575	genes	56 61	171124 171129	0.9999793767929077	O
41576	map	62 65	171130 171133	0.9999830722808838	O
41577	to	66 68	171134 171136	0.9999874830245972	O
41578	loci	69 72	171137 171140	0.9999876022338867	O
41580	that	74 78	171142 171146	0.9999871253967285	O
41581	have	79 83	171147 171151	0.9999872446060181	O
41582	been	84 88	171152 171156	0.9999873638153076	O
41583	found	89 94	171157 171162	0.999985933303833	O
41584	to	95 97	171163 171165	0.9999877214431763	O
41585	be	98 100	171166 171168	0.9999878406524658	O
41586	deleted	101 108	171169 171176	0.9999823570251465	O
41587	in	109 111	171177 171179	0.9999868869781494	O
41588	cancers	112 118	171180 171186	0.9999819993972778	O
41590	(	120 121	171188 171189	0.9999866485595703	O
41591	including	122 131	171190 171199	0.9999861717224121	O
41592	colon	132 136	171200 171204	0.9999773502349854	O
41594	,	138 139	171206 171207	0.999983549118042	O
41595	breast	140 146	171208 171214	0.9999769926071167	O
41596	,	147 148	171215 171216	0.9999843835830688	O
41597	prostate	149 156	171217 171224	0.9999587535858154	O
41599	,	158 159	171226 171227	0.9999849796295166	O
41600	Wilm	160 163	171228 171231	0.9999293088912964	O
41603	'	165 166	171233 171234	0.9999854564666748	O
41604	s	166 167	171234 171235	0.9999854564666748	O
41605	tumor	168 173	171236 171241	0.9999864101409912	O
41606	,	174 175	171242 171243	0.999984860420227	O
41607	hematopoietic	176 188	171244 171256	0.9998908042907715	O
41612	tumors	190 196	171258 171264	0.9999849796295166	O
41613	,	197 198	171265 171266	0.9999828338623047	O
41614	and	199 202	171267 171270	0.9999849796295166	O
41615	medulloblastoma	203 217	171271 171285	0.9997319579124451	O
41620	)	219 220	171287 171288	0.9999853372573853	O
41621	.	221 222	171289 171290	0.9999269247055054	O
41622	For	0 3	171291 171294	0.9999722242355347	O
41623	example	4 11	171295 171302	0.9999691247940063	O
41624	,	12 13	171303 171304	0.9999779462814331	O
41625	Yang	14 18	171305 171309	0.9999295473098755	O
41626	et	19 21	171310 171312	0.9999767541885376	O
41627	al	22 24	171313 171315	0.9999759197235107	O
41628	.	25 26	171316 171317	0.9999432563781738	O
41629	demonstrated	0 12	171318 171330	0.9999841451644897	O
41630	that	13 17	171331 171335	0.9999886751174927	O
41631	19p13	18 22	171336 171340	0.9999833106994629	O
41634	.	23 24	171341 171342	0.9999878406524658	O
41635	3	24 25	171342 171343	0.999984622001648	O
41636	,	26 27	171344 171345	0.9999880790710449	O
41637	the	28 31	171346 171349	0.999988317489624	O
41638	location	32 40	171350 171358	0.999985933303833	O
41639	of	41 43	171359 171361	0.9999885559082031	O
41640	APC2	44 47	171362 171365	0.9999853372573853	O
41643	,	49 50	171367 171368	0.9999874830245972	O
41644	is	51 53	171369 171371	0.9999879598617554	O
41645	a	54 55	171372 171373	0.9999887943267822	O
41646	common	56 62	171374 171380	0.9999861717224121	O
41647	site	63 67	171381 171385	0.9999868869781494	O
41648	of	68 70	171386 171388	0.9999886751174927	O
41649	LOH	71 73	171389 171391	0.9999873638153076	O
41651	or	75 77	171393 171395	0.9999872446060181	O
41652	deletion	78 85	171396 171403	0.9999874830245972	O
41655	in	87 89	171405 171407	0.9999868869781494	O
41656	breast	90 96	171408 171414	0.99997878074646	O
41657	carcinoma	97 105	171415 171423	0.9999865293502808	O
41660	[	107 108	171425 171426	0.9999891519546509	O
41661	31	108 110	171426 171428	0.9999873638153076	O
41662	]	110 111	171428 171429	0.9999889135360718	O
41663	.	112 113	171430 171431	0.9999771118164062	O
41664	Similarly	0 9	171432 171441	0.9999842643737793	O
41665	,	10 11	171442 171443	0.9999885559082031	O
41666	SYNE1	12 16	171444 171448	0.9999853372573853	O
41670	localizes	18 26	171450 171458	0.9999877214431763	O
41672	to	28 30	171460 171462	0.9999885559082031	O
41673	6p25	31 34	171463 171466	0.999984860420227	O
41676	,	36 37	171468 171469	0.9999881982803345	O
41677	a	38 39	171470 171471	0.999988317489624	O
41678	location	40 48	171472 171480	0.9999839067459106	O
41679	that	49 53	171481 171485	0.9999881982803345	O
41680	is	54 56	171486 171488	0.9999885559082031	O
41681	subject	57 64	171489 171496	0.9999876022338867	O
41682	to	65 67	171497 171499	0.9999887943267822	O
41683	frequent	68 76	171500 171508	0.9999852180480957	O
41684	deletion	77 84	171509 171516	0.9999881982803345	O
41687	in	86 88	171518 171520	0.9999876022338867	O
41688	a	89 90	171521 171522	0.9999878406524658	O
41689	number	91 97	171523 171529	0.9999841451644897	O
41690	of	98 100	171530 171532	0.9999861717224121	O
41691	tumors	101 107	171533 171539	0.999983549118042	O
41692	[	108 109	171540 171541	0.9999887943267822	O
41693	32	109 111	171541 171543	0.9999852180480957	O
41694	,	111 112	171543 171544	0.9999881982803345	O
41695	33	112 114	171544 171546	0.9999865293502808	O
41696	]	114 115	171546 171547	0.9999886751174927	O
41697	.	116 117	171548 171549	0.999976396560669	O
41698	CHD5	0 3	171550 171553	0.9999743700027466	O
41701	is	5 7	171555 171557	0.9999860525131226	O
41702	a	8 9	171558 171559	0.9999877214431763	O
41703	well	10 14	171560 171564	0.999984622001648	O
41704	-	14 15	171564 171565	0.9999878406524658	O
41705	documented	15 25	171565 171575	0.9999786615371704	O
41706	tumor	26 31	171576 171581	0.9999816417694092	O
41707	suppressor	32 41	171582 171591	0.9999839067459106	O
41709	gene	43 47	171593 171597	0.9999858140945435	O
41710	located	48 55	171598 171605	0.9999880790710449	O
41711	on	56 58	171606 171608	0.999988317489624	O
41712	1p36	59 62	171609 171612	0.9999873638153076	O
41715	,	64 65	171614 171615	0.9999879598617554	O
41716	a	66 67	171616 171617	0.9999881982803345	O
41717	region	68 74	171618 171624	0.9999856948852539	O
41718	that	75 79	171625 171629	0.9999880790710449	O
41719	is	80 82	171630 171632	0.9999880790710449	O
41720	commonly	83 91	171633 171641	0.9999860525131226	O
41721	lost	92 96	171642 171646	0.9999779462814331	O
41722	in	97 99	171647 171649	0.999987006187439	O
41723	malignancies	100 111	171650 171661	0.9999861717224121	O
41727	of	113 115	171663 171665	0.9999867677688599	O
41728	epithelial	116 125	171666 171675	0.999984860420227	O
41732	,	127 128	171677 171678	0.9999841451644897	O
41733	neural	129 135	171679 171685	0.9999505281448364	O
41734	,	136 137	171686 171687	0.9999843835830688	O
41735	and	138 141	171688 171691	0.999984622001648	O
41736	hematopoietic	142 154	171692 171704	0.9999784231185913	O
41741	origin	156 162	171706 171712	0.9999868869781494	O
41742	[	163 164	171713 171714	0.9999885559082031	O
41743	34	164 166	171714 171716	0.9999845027923584	O
41744	]	166 167	171716 171717	0.9999880790710449	O
41745	.	168 169	171718 171719	0.9999687671661377	O
41746	Referenced	0 9	171720 171729	0.9999814033508301	O
41748	data	11 15	171731 171735	0.9999817609786987	O
41749	are	16 19	171736 171739	0.9999823570251465	O
41750	summarized	20 30	171740 171750	0.9999828338623047	O
41751	in	31 33	171751 171753	0.9999861717224121	O
41752	Table	34 39	171754 171759	0.9999818801879883	O
41753	S4	40 41	171760 171761	0.9999860525131226	O
41755	.	43 44	171763 171764	0.999969482421875	O
41756	Thus	0 4	171765 171769	0.9999849796295166	O
41757	,	5 6	171770 171771	0.9999864101409912	O
41758	the	7 10	171772 171775	0.9999858140945435	O
41759	18	11 13	171776 171778	0.9999746084213257	O
41760	genes	14 19	171779 171784	0.9999854564666748	O
41761	we	20 22	171785 171787	0.999984860420227	O
41762	have	23 27	171788 171792	0.9999847412109375	O
41763	identified	28 38	171793 171803	0.9999850988388062	O
41764	are	39 42	171804 171807	0.9999853372573853	O
41765	genes	43 48	171808 171813	0.9999849796295166	O
41766	that	49 53	171814 171818	0.9999866485595703	O
41767	are	54 57	171819 171822	0.9999865293502808	O
41768	found	58 63	171823 171828	0.999984622001648	O
41769	to	64 66	171829 171831	0.9999868869781494	O
41770	be	67 69	171832 171834	0.9999871253967285	O
41771	mutated	70 76	171835 171841	0.9999850988388062	O
41774	in	78 80	171843 171845	0.9999865293502808	O
41775	breast	81 87	171846 171852	0.999969482421875	O
41776	and	88 91	171853 171856	0.9999798536300659	O
41777	colon	92 96	171857 171861	0.9999738931655884	O
41779	cancer	98 104	171863 171869	0.9999855756759644	O
41780	,	105 106	171870 171871	0.9999865293502808	O
41781	silenced	107 114	171872 171879	0.9999852180480957	O
41783	by	116 118	171881 171883	0.9999877214431763	O
41784	hypermethylation	119 134	171884 171899	0.9999878406524658	O
41789	in	136 138	171901 171903	0.9999865293502808	O
41790	these	139 144	171904 171909	0.9999814033508301	O
41791	tumors	145 151	171910 171916	0.9999825954437256	O
41792	,	152 153	171917 171918	0.9999852180480957	O
41793	and	154 157	171919 171922	0.9999858140945435	O
41794	reside	158 164	171923 171929	0.999984622001648	O
41795	at	165 167	171930 171932	0.9999868869781494	O
41796	locations	168 177	171933 171942	0.9999829530715942	O
41797	subject	178 185	171943 171950	0.9999862909317017	O
41798	to	186 188	171951 171953	0.9999871253967285	O
41799	LOH	189 191	171954 171956	0.9999871253967285	O
41801	or	193 195	171958 171960	0.9999861717224121	O
41802	deletion	196 203	171961 171968	0.9999862909317017	O
41805	in	205 207	171970 171972	0.9999856948852539	O
41806	a	208 209	171973 171974	0.999983549118042	O
41807	number	210 216	171975 171981	0.9999743700027466	O
41808	of	217 219	171982 171984	0.9999798536300659	O
41809	human	220 225	171985 171990	0.8151136040687561	species
41810	neoplasms	226 234	171991 171999	0.9999804496765137	O
41814	.	236 237	172001 172002	0.9999868869781494	O
41815	*	238 239	172003 172004	0.9999856948852539	O
41816	*	239 240	172004 172005	0.9999703168869019	O
41817	IGNORE	0 5	172006 172011	0.9999864101409912	O
41820	LINE	7 10	172013 172016	0.9999892711639404	O
41823	*	12 13	172018 172019	0.9999896287918091	O
41824	*	13 14	172019 172020	0.9999896287918091	O
41825	*	15 16	172021 172022	0.9999895095825195	O
41826	*	16 17	172022 172023	0.9999896287918091	O
41827	IGNORE	18 23	172024 172029	0.9999881982803345	O
41830	LINE	25 28	172031 172034	0.9999895095825195	O
41833	*	30 31	172036 172037	0.99998939037323	O
41834	*	31 32	172037 172038	0.99998939037323	O
41835	*	33 34	172039 172040	0.9999892711639404	O
41836	*	34 35	172040 172041	0.9999892711639404	O
41837	IGNORE	36 41	172042 172047	0.9999878406524658	O
41840	LINE	43 46	172049 172052	0.9999895095825195	O
41843	*	48 49	172054 172055	0.99998939037323	O
41844	*	49 50	172055 172056	0.99998939037323	O
41845	Statistical	51 62	172057 172068	0.9999891519546509	O
41846	Analyses	63 70	172069 172076	0.9999892711639404	O
41849	Unpaired	72 79	172078 172085	0.9999891519546509	O
41852	t	81 82	172087 172088	0.9999890327453613	O
41853	test	83 87	172089 172093	0.9999895095825195	O
41854	,	88 89	172094 172095	0.99998939037323	O
41855	z	90 91	172096 172097	0.9999886751174927	O
41856	test	92 96	172098 172102	0.9999895095825195	O
41857	,	97 98	172103 172104	0.9999891519546509	O
41858	and	99 102	172105 172108	0.9999895095825195	O
41859	χ2	103 104	172109 172110	0.9999860525131226	O
41861	test	106 110	172112 172116	0.9999892711639404	O
41862	were	111 115	172117 172121	0.9999885559082031	O
41863	used	116 120	172122 172126	0.9999878406524658	O
41864	.	121 122	172127 172128	0.9999669790267944	O
41865	The	0 3	172129 172132	0.9999860525131226	O
41866	data	4 8	172133 172137	0.9999831914901733	O
41867	were	9 13	172138 172142	0.9999872446060181	O
41868	calculated	14 24	172143 172153	0.9999860525131226	O
41869	with	25 29	172154 172158	0.999988317489624	O
41870	Statistica	30 39	172159 172168	0.9999891519546509	O
41874	6	41 42	172170 172171	0.9999874830245972	O
41875	(	43 44	172172 172173	0.9999891519546509	O
41876	StatSoft	45 52	172174 172181	0.99998939037323	O
41880	,	54 55	172183 172184	0.9999887943267822	O
41881	Tulsa	56 61	172185 172190	0.9999803304672241	O
41882	,	62 63	172191 172192	0.9999886751174927	O
41883	OK	64 66	172193 172195	0.9999805688858032	O
41884	,	67 68	172196 172197	0.9999889135360718	O
41885	USA	69 72	172198 172201	0.9999843835830688	O
41886	)	73 74	172202 172203	0.9999887943267822	O
41887	.	75 76	172204 172205	0.9999722242355347	O
41888	Values	0 5	172206 172211	0.9999783039093018	O
41890	are	7 10	172213 172216	0.999984622001648	O
41891	presented	11 20	172217 172226	0.9999843835830688	O
41892	as	21 23	172227 172229	0.9999868869781494	O
41893	arithmetrical	24 36	172230 172242	0.9999877214431763	O
41897	mean	38 42	172244 172248	0.9999866485595703	O
41898	±	43 44	172249 172250	0.9999856948852539	O
41899	SEM	45 47	172251 172253	0.9999829530715942	O
41901	.	48 49	172254 172255	0.9999876022338867	O
41902	*	50 51	172256 172257	0.9999862909317017	O
41903	*	51 52	172257 172258	0.9999786615371704	O
41904	IGNORE	0 5	172259 172264	0.9999854564666748	O
41907	LINE	7 10	172266 172269	0.9999878406524658	O
41910	*	12 13	172271 172272	0.9999873638153076	O
41911	*	13 14	172272 172273	0.9999873638153076	O
41912	*	15 16	172274 172275	0.9999873638153076	O
41913	*	16 17	172275 172276	0.9999876022338867	O
41914	IGNORE	18 23	172277 172282	0.9999867677688599	O
41917	LINE	25 28	172284 172287	0.9999881982803345	O
41920	*	30 31	172289 172290	0.9999873638153076	O
41921	*	31 32	172290 172291	0.9999873638153076	O
41922	*	33 34	172292 172293	0.9999873638153076	O
41923	*	34 35	172293 172294	0.9999871253967285	O
41924	IGNORE	36 41	172295 172300	0.9999865293502808	O
41927	LINE	43 46	172302 172305	0.9999879598617554	O
41930	*	48 49	172307 172308	0.9999877214431763	O
41931	*	49 50	172308 172309	0.9999877214431763	O
41932	The	51 54	172310 172313	0.9999837875366211	O
41933	present	55 62	172314 172321	0.9999816417694092	O
41934	study	63 68	172322 172327	0.9999808073043823	O
41935	describes	69 78	172328 172337	0.9999827146530151	O
41936	a	79 80	172338 172339	0.9999856948852539	O
41937	population	81 91	172340 172350	0.9999804496765137	O
41938	based	92 97	172351 172356	0.9999853372573853	O
41939	analysis	98 106	172357 172365	0.9999856948852539	O
41940	of	107 109	172366 172368	0.999984860420227	O
41941	the	110 113	172369 172372	0.9999837875366211	O
41942	frequency	114 123	172373 172382	0.999984622001648	O
41943	of	124 126	172383 172385	0.9999853372573853	O
41944	variants	127 135	172386 172394	0.9999850988388062	O
41945	of	136 138	172395 172397	0.9999865293502808	O
41946	unknown	139 146	172398 172405	0.9999864101409912	O
41947	significance	147 159	172406 172418	0.9999867677688599	O
41948	in	160 162	172419 172421	0.9999867677688599	O
41949	hMLH1	163 167	172422 172426	0.9999881982803345	O
41952	and	169 172	172428 172431	0.9999868869781494	O
41953	hMSH2	173 177	172432 172436	0.9999874830245972	O
41957	in	179 181	172438 172440	0.9999822378158569	O
41958	Danish	182 188	172441 172447	0.7227279543876648	O
41959	patients	189 197	172448 172456	0.9998637437820435	O
41960	with	198 202	172457 172461	0.9999628067016602	O
41961	sporadic	203 210	172462 172469	0.9999556541442871	O
41963	CRC	212 214	172471 172473	0.9999754428863525	O
41965	and	216 219	172475 172478	0.9999762773513794	O
41966	in	220 222	172479 172481	0.9999831914901733	O
41967	a	223 224	172482 172483	0.9999805688858032	O
41968	sub	225 228	172484 172487	0.9999830722808838	O
41969	-	228 229	172487 172488	0.9999828338623047	O
41970	cohort	229 234	172488 172493	0.9999847412109375	O
41973	of	236 238	172495 172497	0.9999817609786987	O
41974	controls	239 247	172498 172506	0.999937891960144	O
41975	.	248 249	172507 172508	0.9998952150344849	O
41976	Some	0 4	172509 172513	0.9999831914901733	O
41977	of	5 7	172514 172516	0.999983549118042	O
41978	the	8 11	172517 172520	0.9999791383743286	O
41979	variants	12 20	172521 172529	0.9999814033508301	O
41980	have	21 25	172530 172534	0.999983549118042	O
41981	been	26 30	172535 172539	0.9999854564666748	O
41982	described	31 40	172540 172549	0.9999847412109375	O
41983	in	41 43	172550 172552	0.9999853372573853	O
41984	other	44 49	172553 172558	0.9999809265136719	O
41985	studies	50 57	172559 172566	0.9999774694442749	O
41986	,	58 59	172567 172568	0.9999798536300659	O
41987	and	60 63	172569 172572	0.9999816417694092	O
41988	some	64 68	172573 172577	0.9999850988388062	O
41989	are	69 72	172578 172581	0.9999853372573853	O
41990	,	73 74	172582 172583	0.9999834299087524	O
41991	to	75 77	172584 172586	0.9999837875366211	O
41992	our	78 81	172587 172590	0.9999849796295166	O
41993	knowledge	82 91	172591 172600	0.9999854564666748	O
41994	,	92 93	172601 172602	0.9999839067459106	O
41995	new	94 97	172603 172606	0.9999810457229614	O
41996	variants	98 106	172607 172615	0.9999852180480957	O
41997	unique	107 113	172616 172622	0.9999861717224121	O
41998	to	114 116	172623 172625	0.999982476234436	O
41999	the	117 120	172626 172629	0.9999786615371704	O
42000	Danish	121 127	172630 172636	0.9998027682304382	O
42001	population	128 138	172637 172647	0.999982476234436	O
42002	.	139 140	172648 172649	0.9999430179595947	O
42003	We	0 2	172650 172652	0.9999740123748779	O
42004	have	3 7	172653 172657	0.9999754428863525	O
42005	analyzed	8 16	172658 172666	0.9999840259552002	O
42006	the	17 20	172667 172670	0.9999843835830688	O
42007	allele	21 26	172671 172676	0.9999864101409912	O
42009	frequencies	28 39	172678 172689	0.9999852180480957	O
42010	of	40 42	172690 172692	0.9999868869781494	O
42011	29	43 45	172693 172695	0.9999750852584839	O
42012	variants	46 54	172696 172704	0.9999853372573853	O
42013	in	55 57	172705 172707	0.9999868869781494	O
42014	hMLH1	58 62	172708 172712	0.9999879598617554	O
42017	and	64 67	172714 172717	0.9999868869781494	O
42018	hMSH2	68 72	172718 172722	0.9999877214431763	O
42022	to	74 76	172724 172726	0.9999853372573853	O
42023	reveal	77 83	172727 172733	0.9999872446060181	O
42024	whether	84 91	172734 172741	0.9999865293502808	O
42025	they	92 96	172742 172746	0.9999867677688599	O
42026	cause	97 102	172747 172752	0.9999866485595703	O
42027	increased	103 112	172753 172762	0.9999842643737793	O
42028	susceptibility	113 126	172763 172776	0.9999872446060181	O
42033	to	128 130	172778 172780	0.9999854564666748	O
42034	sporadic	131 138	172781 172788	0.9999855756759644	O
42036	CRC	140 142	172790 172792	0.9999803304672241	O
42038	in	144 146	172794 172796	0.999984860420227	O
42039	the	147 150	172797 172800	0.9999817609786987	O
42040	Danish	151 157	172801 172807	0.9952954649925232	O
42041	population	158 168	172808 172818	0.9999823570251465	O
42042	or	169 171	172819 172821	0.9999840259552002	O
42043	whether	172 179	172822 172829	0.9999876022338867	O
42044	they	180 184	172830 172834	0.9999876022338867	O
42045	are	185 188	172835 172838	0.9999879598617554	O
42046	private	189 196	172839 172846	0.9999798536300659	O
42047	variants	197 205	172847 172855	0.9999876022338867	O
42048	/	205 206	172855 172856	0.9999868869781494	O
42049	mutations	206 215	172856 172865	0.9999837875366211	O
42050	found	216 221	172866 172871	0.9999881982803345	O
42051	only	222 226	172872 172876	0.9999871253967285	O
42052	in	227 229	172877 172879	0.9999877214431763	O
42053	the	230 233	172880 172883	0.9999840259552002	O
42054	families	234 242	172884 172892	0.9999821186065674	O
42055	where	243 248	172893 172898	0.9999866485595703	O
42056	they	249 253	172899 172903	0.9999877214431763	O
42057	were	254 258	172904 172908	0.9999877214431763	O
42058	originally	259 269	172909 172919	0.9999873638153076	O
42059	identified	270 280	172920 172930	0.9999874830245972	O
42060	.	281 282	172931 172932	0.9999524354934692	O
42061	In	0 2	172933 172935	0.999983549118042	O
42062	addition	3 11	172936 172944	0.9999799728393555	O
42063	to	12 14	172945 172947	0.9999812841415405	O
42064	the	15 18	172948 172951	0.9999796152114868	O
42065	29	19 21	172952 172954	0.999953031539917	O
42066	variants	22 30	172955 172963	0.9999825954437256	O
42067	identified	31 41	172964 172974	0.9999860525131226	O
42068	in	42 44	172975 172977	0.9999837875366211	O
42069	Danish	45 51	172978 172984	0.9995313882827759	O
42070	individuals	52 63	172985 172996	0.9997766613960266	O
42071	,	64 65	172997 172998	0.9999818801879883	O
42072	six	66 69	172999 173002	0.9999743700027466	O
42073	variants	70 78	173003 173011	0.9999850988388062	O
42074	identified	79 89	173012 173022	0.9999868869781494	O
42075	in	90 92	173023 173025	0.9999853372573853	O
42076	other	93 98	173026 173031	0.9999727010726929	O
42077	Caucasian	99 108	173032 173041	0.9998917579650879	O
42078	populations	109 120	173042 173053	0.9999724626541138	O
42079	were	121 125	173054 173058	0.9999837875366211	O
42080	also	126 130	173059 173063	0.9999810457229614	O
42081	investigated	131 143	173064 173076	0.9999825954437256	O
42082	.	144 145	173077 173078	0.9999865293502808	O
42083	*	146 147	173079 173080	0.9999849796295166	O
42084	*	147 148	173080 173081	0.9999768733978271	O
42085	IGNORE	0 5	173082 173087	0.9999858140945435	O
42088	LINE	7 10	173089 173092	0.9999887943267822	O
42091	*	12 13	173094 173095	0.9999890327453613	O
42092	*	13 14	173095 173096	0.9999889135360718	O
42093	*	15 16	173097 173098	0.9999887943267822	O
42094	*	16 17	173098 173099	0.9999890327453613	O
42095	IGNORE	18 23	173100 173105	0.9999874830245972	O
42098	LINE	25 28	173107 173110	0.9999890327453613	O
42101	*	30 31	173112 173113	0.9999885559082031	O
42102	*	31 32	173113 173114	0.9999885559082031	O
42103	*	33 34	173115 173116	0.9999885559082031	O
42104	*	34 35	173116 173117	0.9999885559082031	O
42105	IGNORE	36 41	173118 173123	0.9999868869781494	O
42108	LINE	43 46	173125 173128	0.9999889135360718	O
42111	*	48 49	173130 173131	0.9999884366989136	O
42112	*	49 50	173131 173132	0.9999885559082031	O
42113	MLH1	51 54	173133 173136	0.9999880790710449	O
42116	and	56 59	173138 173141	0.9999884366989136	O
42117	MSH2	60 63	173142 173145	0.9999877214431763	O
42120	variants	65 73	173147 173155	0.9999884366989136	O
42121	*	74 75	173156 173157	0.9999884366989136	O
42122	identified	76 86	173158 173168	0.9999886751174927	O
42123	in	87 89	173169 173171	0.9999881982803345	O
42124	CRC	90 92	173172 173174	0.9999768733978271	O
42126	families	94 102	173176 173184	0.9999827146530151	O
42127	from	103 107	173185 173189	0.9999868869781494	O
42128	other	108 113	173190 173195	0.9999828338623047	O
42129	Caucasian	114 123	173196 173205	0.9999470710754395	O
42130	populations	124 135	173206 173217	0.9999819993972778	O
42131	than	136 140	173218 173222	0.9999871253967285	O
42132	the	141 144	173223 173226	0.9999887943267822	O
42133	Danish	145 151	173227 173233	0.9999414682388306	O
42134	Genotyping	152 161	173234 173243	0.9999878406524658	O
42138	using	163 168	173245 173250	0.9999889135360718	O
42139	Single	169 175	173251 173257	0.9999880790710449	O
42140	Base	176 180	173258 173262	0.9999874830245972	O
42141	Extension	181 190	173263 173272	0.9999872446060181	O
42142	(	191 192	173273 173274	0.9999889135360718	O
42143	SBE	193 195	173275 173277	0.999987006187439	O
42145	)	196 197	173278 173279	0.9999892711639404	O
42146	-	197 198	173279 173280	0.9999892711639404	O
42147	tag	198 201	173280 173283	0.9999861717224121	O
42148	arrays	202 207	173284 173289	0.9999877214431763	O
42150	Primer	209 214	173291 173296	0.9999874830245972	O
42152	design	216 222	173298 173304	0.9999885559082031	O
42153	The	223 226	173305 173308	0.9999877214431763	O
42154	multiplex	227 235	173309 173317	0.9999872446060181	O
42156	PCR	237 239	173319 173321	0.9999878406524658	O
42158	primers	241 247	173323 173329	0.9999880790710449	O
42160	were	249 253	173331 173335	0.9999889135360718	O
42161	designed	254 262	173336 173344	0.999988317489624	O
42162	using	263 268	173345 173350	0.9999890327453613	O
42163	Oligo	269 273	173351 173355	0.999988317489624	O
42166	6	275 276	173357 173358	0.999988317489624	O
42167	[	277 278	173359 173360	0.9999892711639404	O
42168	22	278 280	173360 173362	0.9999868869781494	O
42169	]	280 281	173362 173363	0.9999890327453613	O
42170	.	282 283	173364 173365	0.9999734163284302	O
42171	The	0 3	173366 173369	0.9999772310256958	O
42172	PCR	4 6	173370 173372	0.9999798536300659	O
42174	products	8 16	173374 173382	0.999977707862854	O
42175	were	17 21	173383 173387	0.9999797344207764	O
42176	between	22 29	173388 173395	0.9999806880950928	O
42177	100	30 33	173396 173399	0.9999812841415405	O
42178	and	34 37	173400 173403	0.9999829530715942	O
42179	450	38 41	173404 173407	0.9999765157699585	O
42180	bp	42 43	173408 173409	0.9999833106994629	O
42182	.	45 46	173411 173412	0.9999299049377441	O
42183	The	0 3	173413 173416	0.9999876022338867	O
42184	optimal	4 11	173417 173424	0.999987006187439	O
42185	annealing	12 20	173425 173433	0.9999874830245972	O
42188	temperature	22 33	173435 173446	0.9999856948852539	O
42189	(	34 35	173447 173448	0.999988317489624	O
42190	Ta	36 38	173449 173451	0.9999847412109375	O
42191	)	39 40	173452 173453	0.9999887943267822	O
42192	was	41 44	173454 173457	0.9999879598617554	O
42193	set	45 48	173458 173461	0.9999868869781494	O
42194	to	49 51	173462 173464	0.9999879598617554	O
42195	~	52 53	173465 173466	0.9999889135360718	O
42196	50°C	53 56	173466 173469	0.9999860525131226	O
42199	,	58 59	173471 173472	0.999988317489624	O
42200	the	60 63	173473 173476	0.9999886751174927	O
42201	GC	64 65	173477 173478	0.9999876022338867	O
42203	content	67 74	173480 173487	0.9999890327453613	O
42204	to	75 77	173488 173490	0.9999887943267822	O
42205	~	78 79	173491 173492	0.9999889135360718	O
42206	40	79 81	173492 173494	0.9999876022338867	O
42207	%	82 83	173495 173496	0.9999887943267822	O
42208	and	84 87	173497 173500	0.9999885559082031	O
42209	the	88 91	173501 173504	0.9999886751174927	O
42210	primer	92 97	173505 173510	0.9999871253967285	O
42212	Tm	99 100	173512 173513	0.9999887943267822	O
42214	difference	102 112	173515 173525	0.9999887943267822	O
42215	to	113 115	173526 173528	0.9999887943267822	O
42216	≤1	116 117	173529 173530	0.9999885559082031	O
42218	.	119 120	173532 173533	0.9999762773513794	O
42219	The	0 3	173534 173537	0.999985933303833	O
42220	single	4 10	173538 173544	0.9999877214431763	O
42221	base	11 15	173545 173549	0.9999876022338867	O
42222	extension	16 25	173550 173559	0.9999855756759644	O
42223	(	26 27	173560 173561	0.9999881982803345	O
42224	SBE	28 30	173562 173564	0.9999849796295166	O
42226	)	32 33	173566 173567	0.999988317489624	O
42227	primers	34 40	173568 173574	0.9999858140945435	O
42229	contained	42 51	173576 173585	0.9999874830245972	O
42230	5	52 53	173586 173587	0.9999884366989136	O
42231	'	53 54	173587 173588	0.9999892711639404	O
42232	20	55 57	173589 173591	0.9999874830245972	O
42233	-	57 58	173591 173592	0.9999895095825195	O
42234	bp	58 59	173592 173593	0.9999886751174927	O
42236	'	61 62	173595 173596	0.9999895095825195	O
42237	tag	62 65	173596 173599	0.9999879598617554	O
42238	'	66 67	173600 173601	0.9999891519546509	O
42239	sequences	68 77	173602 173611	0.9999874830245972	O
42240	that	78 82	173612 173616	0.9999891519546509	O
42241	were	83 87	173617 173621	0.9999887943267822	O
42242	from	88 92	173622 173626	0.9999885559082031	O
42243	the	93 96	173627 173630	0.99998939037323	O
42244	Affymetrix	97 106	173631 173640	0.9999890327453613	O
42248	GeneChip	108 115	173642 173649	0.9999881982803345	O
42251	®	117 118	173651 173652	0.9999867677688599	O
42252	Tag	119 122	173653 173656	0.9999881982803345	O
42253	Collection	123 133	173657 173667	0.9999886751174927	O
42254	.	134 135	173668 173669	0.9999710321426392	O
42255	The	0 3	173670 173673	0.9999887943267822	O
42256	gene	4 8	173674 173678	0.9999879598617554	O
42257	specific	9 17	173679 173687	0.9999884366989136	O
42258	part	18 22	173688 173692	0.9999890327453613	O
42259	of	23 25	173693 173695	0.9999892711639404	O
42260	the	26 29	173696 173699	0.9999891519546509	O
42261	SBE	30 32	173700 173702	0.9999874830245972	O
42263	primers	34 40	173704 173710	0.9999876022338867	O
42265	had	42 45	173712 173715	0.999988317489624	O
42266	a	46 47	173716 173717	0.9999891519546509	O
42267	Tm	48 49	173718 173719	0.9999887943267822	O
42269	of	51 53	173721 173723	0.9999890327453613	O
42270	~	54 55	173724 173725	0.9999891519546509	O
42271	50	55 57	173725 173727	0.9999877214431763	O
42272	–	57 58	173727 173728	0.9999852180480957	O
42273	60°C	58 61	173728 173731	0.9999864101409912	O
42276	(	63 64	173733 173734	0.9999896287918091	O
42277	calculated	65 75	173735 173745	0.9999881982803345	O
42278	using	76 81	173746 173751	0.9999891519546509	O
42279	PrimerExpress	82 94	173752 173764	0.9999884366989136	O
42284	2	96 97	173766 173767	0.9999890327453613	O
42285	.	97 98	173767 173768	0.99998939037323	O
42286	0	98 99	173768 173769	0.9999891519546509	O
42287	)	99 100	173769 173770	0.9999896287918091	O
42288	(	100 101	173770 173771	0.9999895095825195	O
42289	Applied	102 109	173772 173779	0.9999849796295166	O
42290	Biosystems	110 119	173780 173789	0.9999889135360718	O
42295	,	121 122	173791 173792	0.9999886751174927	O
42296	Foster	123 129	173793 173799	0.9999700784683228	O
42297	City	130 134	173800 173804	0.999987006187439	O
42298	,	135 136	173805 173806	0.999988317489624	O
42299	CA	137 139	173807 173809	0.9999762773513794	O
42300	)	140 141	173810 173811	0.9999896287918091	O
42301	.	142 143	173812 173813	0.9999762773513794	O
42302	The	0 3	173814 173817	0.9999849796295166	O
42303	tagged	4 9	173818 173823	0.99997878074646	O
42305	SBE	11 13	173825 173827	0.9999841451644897	O
42307	primers	15 21	173829 173835	0.9999847412109375	O
42309	were	23 27	173837 173841	0.9999843835830688	O
42310	tested	28 34	173842 173848	0.9999836683273315	O
42311	for	35 38	173849 173852	0.9999861717224121	O
42312	major	39 44	173853 173858	0.9999836683273315	O
42313	hairpin	45 51	173859 173865	0.999987006187439	O
42315	loop	53 57	173867 173871	0.9999874830245972	O
42316	formation	58 67	173872 173881	0.9999874830245972	O
42317	using	68 73	173882 173887	0.9999876022338867	O
42318	Oligo6	74 79	173888 173893	0.9999873638153076	O
42322	.	81 82	173895 173896	0.9999616146087646	O
42323	All	0 3	173897 173900	0.9999803304672241	O
42324	variants	4 12	173901 173909	0.9999773502349854	O
42325	were	13 17	173910 173914	0.9999810457229614	O
42326	typed	18 23	173915 173920	0.9999810457229614	O
42327	using	24 29	173921 173926	0.9999839067459106	O
42328	SBE	30 32	173927 173929	0.999984622001648	O
42330	-	33 34	173930 173931	0.9999855756759644	O
42331	primers	34 40	173931 173937	0.999985933303833	O
42333	for	42 45	173939 173942	0.9999861717224121	O
42334	both	46 50	173943 173947	0.9999858140945435	O
42335	DNA	51 54	173948 173951	0.999985933303833	O
42336	strands	55 62	173952 173959	0.9999862909317017	O
42337	.	63 64	173960 173961	0.9999388456344604	O
42338	The	0 3	173962 173965	0.9999816417694092	O
42339	primers	4 10	173966 173972	0.9999833106994629	O
42341	were	12 16	173974 173978	0.9999822378158569	O
42342	synthesized	17 28	173979 173990	0.999983549118042	O
42343	by	29 31	173991 173993	0.9999858140945435	O
42344	DNA	32 35	173994 173997	0.9999841451644897	O
42345	Technology	36 46	173998 174008	0.9999812841415405	O
42346	(	47 48	174009 174010	0.999987006187439	O
42347	Aarhus	49 54	174011 174016	0.9999849796295166	O
42350	,	56 57	174018 174019	0.9999868869781494	O
42351	Denmark	58 65	174020 174027	0.9999754428863525	O
42352	)	66 67	174028 174029	0.9999877214431763	O
42353	.	68 69	174030 174031	0.999951958656311	O
42354	The	0 3	174032 174035	0.9999854564666748	O
42355	multiplex	4 12	174036 174044	0.9999850988388062	O
42357	PCR	14 16	174046 174048	0.999985933303833	O
42359	primer	18 23	174050 174055	0.9999872446060181	O
42361	and	25 28	174057 174060	0.9999849796295166	O
42362	the	29 32	174061 174064	0.9999865293502808	O
42363	SBE	33 35	174065 174067	0.9999849796295166	O
42365	primer	37 42	174069 174074	0.9999874830245972	O
42367	sequences	44 53	174076 174085	0.9999843835830688	O
42368	are	54 57	174086 174089	0.9999845027923584	O
42369	available	58 67	174090 174099	0.9999847412109375	O
42370	on	68 70	174100 174102	0.9999866485595703	O
42371	request	71 78	174103 174110	0.9999827146530151	O
42372	.	79 80	174111 174112	0.9999617338180542	O
42373	Multiplex	0 8	174113 174121	0.9999872446060181	O
42375	PCR	10 12	174123 174125	0.9999876022338867	O
42377	The	14 17	174127 174130	0.9999847412109375	O
42378	multiplex	18 26	174131 174139	0.9999877214431763	O
42380	PCR	28 30	174141 174143	0.9999878406524658	O
42382	amplification	32 44	174145 174157	0.9999886751174927	O
42385	was	46 49	174159 174162	0.9999880790710449	O
42386	performed	50 59	174163 174172	0.999988317489624	O
42387	with	60 64	174173 174177	0.9999890327453613	O
42388	6	65 66	174178 174179	0.9999889135360718	O
42389	–	66 67	174179 174180	0.9999858140945435	O
42390	9	67 68	174180 174181	0.999988317489624	O
42391	primer	69 74	174182 174187	0.9999887943267822	O
42393	pairs	76 81	174189 174194	0.9999887943267822	O
42394	per	82 85	174195 174198	0.9999890327453613	O
42395	reaction	86 94	174199 174207	0.999987006187439	O
42396	.	95 96	174208 174209	0.9999691247940063	O
42397	Twenty	0 6	174210 174216	0.9999861717224121	O
42398	ng	7 9	174217 174219	0.999984860420227	O
42399	of	10 12	174220 174222	0.9999874830245972	O
42400	genomic	13 19	174223 174229	0.9999878406524658	O
42403	DNA	21 24	174231 174234	0.9999861717224121	O
42404	with	25 29	174235 174239	0.9999887943267822	O
42405	0	30 31	174240 174241	0.9999890327453613	O
42406	.	31 32	174241 174242	0.9999890327453613	O
42407	5	32 33	174242 174243	0.999988317489624	O
42408	μl	34 35	174244 174245	0.9999887943267822	O
42410	[UNK]	37 47	174247 174257	0.9999872446060181	O
42411	DNA	48 51	174258 174261	0.9999880790710449	O
42412	polymerase	52 61	174262 174271	0.999988317489624	O
42414	(	63 64	174273 174274	0.9999891519546509	O
42415	Invitrogen	65 74	174275 174284	0.9999886751174927	O
42419	,	76 77	174286 174287	0.9999885559082031	O
42420	Carlsbad	78 85	174288 174295	0.9999809265136719	O
42423	,	87 88	174297 174298	0.9999880790710449	O
42424	CA	89 91	174299 174301	0.9999823570251465	O
42425	)	92 93	174302 174303	0.9999892711639404	O
42426	,	94 95	174304 174305	0.9999892711639404	O
42427	1×	96 97	174306 174307	0.9999889135360718	O
42429	[UNK]	99 109	174309 174319	0.9999879598617554	O
42430	Buffer	110 115	174320 174325	0.9999886751174927	O
42433	I	117 118	174327 174328	0.9999887943267822	O
42434	,	119 120	174329 174330	0.9999889135360718	O
42435	and	121 124	174331 174334	0.9999889135360718	O
42436	0	125 126	174335 174336	0.9999889135360718	O
42437	.	126 127	174336 174337	0.9999891519546509	O
42438	08	127 129	174337 174339	0.999988317489624	O
42439	–	129 130	174339 174340	0.9999865293502808	O
42440	1	130 131	174340 174341	0.9999885559082031	O
42441	μM	132 133	174342 174343	0.9999886751174927	O
42443	primers	135 141	174345 174351	0.9999879598617554	O
42445	was	143 146	174353 174356	0.9999886751174927	O
42446	amplified	147 155	174357 174365	0.9999886751174927	O
42448	in	157 159	174367 174369	0.9999891519546509	O
42449	25	160 162	174370 174372	0.9999874830245972	O
42450	μl	163 164	174373 174374	0.9999881982803345	O
42452	volumes	166 173	174376 174383	0.9999862909317017	O
42453	using	174 179	174384 174389	0.9999890327453613	O
42454	the	180 183	174390 174393	0.9999887943267822	O
42455	following	184 193	174394 174403	0.9999885559082031	O
42456	PCR	194 196	174404 174406	0.9999876022338867	O
42458	conditions	198 208	174408 174418	0.9999873638153076	O
42459	:	209 210	174419 174420	0.9999891519546509	O
42460	1	211 212	174421 174422	0.9999890327453613	O
42461	cycle	213 218	174423 174428	0.9999887943267822	O
42462	of	219 221	174429 174431	0.9999889135360718	O
42463	95°C	222 225	174432 174435	0.9999889135360718	O
42466	for	227 230	174437 174440	0.9999889135360718	O
42467	10	231 233	174441 174443	0.9999887943267822	O
42468	min	234 237	174444 174447	0.9999887943267822	O
42469	;	238 239	174448 174449	0.9999891519546509	O
42470	13	240 242	174450 174452	0.9999872446060181	O
42471	cycles	243 249	174453 174459	0.9999886751174927	O
42472	of	250 252	174460 174462	0.9999887943267822	O
42473	95°C	253 256	174463 174466	0.9999889135360718	O
42476	for	258 261	174468 174471	0.9999890327453613	O
42477	30	262 264	174472 174474	0.9999886751174927	O
42478	sec	265 267	174475 174477	0.9999889135360718	O
42480	.	268 269	174478 174479	0.9999885559082031	O
42481	,	270 271	174480 174481	0.9999736547470093	O
42482	67°C	0 3	174482 174485	0.9999746084213257	O
42485	(	5 6	174487 174488	0.9999864101409912	O
42486	-	6 7	174488 174489	0.9999854564666748	O
42487	1°C	7 9	174489 174491	0.9999809265136719	O
42490	/	10 11	174492 174493	0.9999866485595703	O
42491	cycle	11 16	174493 174498	0.9999792575836182	O
42492	)	17 18	174499 174500	0.9999843835830688	O
42493	for	19 22	174501 174504	0.9999854564666748	O
42494	45	23 25	174505 174507	0.9999822378158569	O
42495	sec	26 28	174508 174510	0.9999847412109375	O
42497	.	29 30	174511 174512	0.9999603033065796	O
42498	and	0 3	174513 174516	0.9999830722808838	O
42499	72°C	4 7	174517 174520	0.9999803304672241	O
42502	for	9 12	174522 174525	0.9999855756759644	O
42503	45	13 15	174526 174528	0.9999845027923584	O
42504	sec	16 18	174529 174531	0.9999862909317017	O
42506	.	19 20	174532 174533	0.9999858140945435	O
42507	;	21 22	174534 174535	0.9998786449432373	O
42508	20	0 2	174536 174538	0.9999847412109375	O
42509	cycles	3 9	174539 174545	0.9999854564666748	O
42510	of	10 12	174546 174548	0.9999866485595703	O
42511	95°C	13 16	174549 174552	0.9999850988388062	O
42514	for	18 21	174554 174557	0.9999872446060181	O
42515	30	22 24	174558 174560	0.9999868869781494	O
42516	sec	25 27	174561 174563	0.9999872446060181	O
42518	.	28 29	174564 174565	0.9999862909317017	O
42519	,	30 31	174566 174567	0.9999593496322632	O
42520	55°C	0 3	174568 174571	0.9999748468399048	O
42523	for	5 8	174573 174576	0.9999825954437256	O
42524	45	9 11	174577 174579	0.9999779462814331	O
42525	sec	12 14	174580 174582	0.9999825954437256	O
42527	.	15 16	174583 174584	0.9999462366104126	O
42528	and	0 3	174585 174588	0.9999830722808838	O
42529	72°C	4 7	174589 174592	0.9999803304672241	O
42532	for	9 12	174594 174597	0.9999855756759644	O
42533	45	13 15	174598 174600	0.9999845027923584	O
42534	sec	16 18	174601 174603	0.9999862909317017	O
42536	.	19 20	174604 174605	0.9999858140945435	O
42537	;	21 22	174606 174607	0.9998786449432373	O
42538	1	0 1	174608 174609	0.9999756813049316	O
42539	cycle	2 7	174610 174615	0.9999797344207764	O
42540	of	8 10	174616 174618	0.9999836683273315	O
42541	72°C	11 14	174619 174622	0.9999786615371704	O
42544	for	16 19	174624 174627	0.9999833106994629	O
42545	10	20 22	174628 174630	0.9999827146530151	O
42546	min	23 26	174631 174634	0.9999793767929077	O
42547	.	27 28	174635 174636	0.9999102354049683	O
42548	A	0 1	174637 174638	0.9999879598617554	O
42549	subset	2 8	174639 174645	0.999987006187439	O
42550	of	9 11	174646 174648	0.9999881982803345	O
42551	the	12 15	174649 174652	0.9999879598617554	O
42552	multiplex	16 24	174653 174661	0.9999873638153076	O
42554	PCR	26 28	174663 174665	0.9999877214431763	O
42556	products	30 38	174667 174675	0.9999867677688599	O
42557	were	39 43	174676 174680	0.999988317489624	O
42558	analysed	44 51	174681 174688	0.9999884366989136	O
42561	on	53 55	174690 174692	0.9999885559082031	O
42562	a	56 57	174693 174694	0.9999891519546509	O
42563	2100	58 61	174695 174698	0.9999877214431763	O
42565	Bioanalyzer	63 73	174700 174710	0.9999884366989136	O
42570	(	75 76	174712 174713	0.9999890327453613	O
42571	Agilent	77 83	174714 174720	0.9999886751174927	O
42574	Technologies	85 97	174722 174734	0.9999864101409912	O
42575	,	98 99	174735 174736	0.999988317489624	O
42576	Santa	100 105	174737 174742	0.9999849796295166	O
42577	Clara	106 111	174743 174748	0.999984860420227	O
42578	,	112 113	174749 174750	0.9999874830245972	O
42579	CA	114 116	174751 174753	0.9999740123748779	O
42580	)	117 118	174754 174755	0.9999892711639404	O
42581	to	119 121	174756 174758	0.9999889135360718	O
42582	test	122 126	174759 174763	0.9999881982803345	O
42583	the	127 130	174764 174767	0.9999892711639404	O
42584	performance	131 142	174768 174779	0.9999868869781494	O
42585	of	143 145	174780 174782	0.9999891519546509	O
42586	the	146 149	174783 174786	0.9999887943267822	O
42587	multiplex	150 158	174787 174795	0.9999877214431763	O
42589	PCR	160 162	174797 174799	0.9999878406524658	O
42591	.	163 164	174800 174801	0.9999709129333496	O
42592	The	0 3	174802 174805	0.9999849796295166	O
42593	multiplex	4 12	174806 174814	0.9999825954437256	O
42595	PCR	14 16	174816 174818	0.9999853372573853	O
42597	products	18 26	174820 174828	0.9999841451644897	O
42598	from	27 31	174829 174833	0.9999871253967285	O
42599	each	32 36	174834 174838	0.9999872446060181	O
42600	sample	37 43	174839 174845	0.9999845027923584	O
42601	were	44 48	174846 174850	0.9999852180480957	O
42602	pooled	49 54	174851 174856	0.9999856948852539	O
42604	for	56 59	174858 174861	0.9999854564666748	O
42605	further	60 67	174862 174869	0.9999866485595703	O
42606	analysis	68 76	174870 174878	0.9999861717224121	O
42607	.	77 78	174879 174880	0.9999419450759888	O
42608	Single	0 6	174881 174887	0.999988317489624	O
42609	Base	7 11	174888 174892	0.9999874830245972	O
42610	Extension	12 21	174893 174902	0.9999864101409912	O
42611	(	22 23	174903 174904	0.9999890327453613	O
42612	SBE	24 26	174905 174907	0.9999880790710449	O
42614	)	28 29	174909 174910	0.99998939037323	O
42615	reaction	30 38	174911 174919	0.9999885559082031	O
42616	The	39 42	174920 174923	0.9999876022338867	O
42617	pooled	43 48	174924 174929	0.999987006187439	O
42619	PCR	50 52	174931 174933	0.9999874830245972	O
42621	products	54 62	174935 174943	0.9999881982803345	O
42622	from	63 67	174944 174948	0.9999892711639404	O
42623	each	68 72	174949 174953	0.9999891519546509	O
42624	sample	73 79	174954 174960	0.9999881982803345	O
42625	were	80 84	174961 174965	0.9999892711639404	O
42626	treated	85 92	174966 174973	0.9999884366989136	O
42627	with	93 97	174974 174978	0.99998939037323	O
42628	Exonuclease	98 108	174979 174989	0.9999881982803345	O
42633	I	110 111	174991 174992	0.9999890327453613	O
42634	and	112 115	174993 174996	0.9999891519546509	O
42635	shrimp	116 122	174997 175003	0.9999713897705078	O
42636	alkaline	123 130	175004 175011	0.99998939037323	O
42639	phosphatase	132 142	175013 175023	0.99998939037323	O
42643	and	144 147	175025 175028	0.9999891519546509	O
42644	used	148 152	175029 175033	0.9999889135360718	O
42645	for	153 156	175034 175037	0.99998939037323	O
42646	template	157 165	175038 175046	0.9999874830245972	O
42647	in	166 168	175047 175049	0.9999890327453613	O
42648	the	169 172	175050 175053	0.99998939037323	O
42649	SBE	173 175	175054 175056	0.9999890327453613	O
42651	reaction	177 185	175058 175066	0.9999889135360718	O
42652	(	186 187	175067 175068	0.9999896287918091	O
42653	mini	188 192	175069 175073	0.9999881982803345	O
42654	-	192 193	175073 175074	0.9999895095825195	O
42655	sequencing	193 202	175074 175083	0.9999887943267822	O
42657	)	204 205	175085 175086	0.9999898672103882	O
42658	as	206 208	175087 175089	0.9999895095825195	O
42659	described	209 218	175090 175099	0.9999887943267822	O
42660	by	219 221	175100 175102	0.9999890327453613	O
42661	Lindross	222 229	175103 175110	0.999985933303833	O
42664	et	231 233	175112 175114	0.9999889135360718	O
42665	al	234 236	175115 175117	0.999988317489624	O
42666	.	237 238	175118 175119	0.9999885559082031	O
42667	[	239 240	175120 175121	0.9999778270721436	O
42668	23	0 2	175121 175123	0.999941349029541	O
42669	]	2 3	175123 175124	0.9999408721923828	O
42670	.	4 5	175125 175126	0.999764621257782	O
42671	The	0 3	175127 175130	0.9999874830245972	O
42672	fluorescent	4 15	175131 175142	0.999972939491272	O
42673	labelled	16 24	175143 175151	0.9999836683273315	O
42674	ddNTP	25 29	175152 175156	0.9999879598617554	O
42678	were	31 35	175158 175162	0.9999886751174927	O
42679	Cyanine	36 42	175163 175169	0.9999884366989136	O
42682	5	44 45	175171 175172	0.9999886751174927	O
42683	(	46 47	175173 175174	0.99998939037323	O
42684	Cy5	48 50	175175 175177	0.999988317489624	O
42686	)	51 52	175178 175179	0.9999890327453613	O
42687	-	52 53	175179 175180	0.9999892711639404	O
42688	ddCTP	53 57	175180 175184	0.9999886751174927	O
42692	,	59 60	175186 175187	0.9999886751174927	O
42693	TAMRA	61 65	175188 175192	0.9999884366989136	O
42696	-	66 67	175193 175194	0.9999892711639404	O
42697	ddUTP	67 71	175194 175198	0.9999886751174927	O
42701	,	73 74	175200 175201	0.9999889135360718	O
42702	Texas	75 80	175202 175207	0.9999873638153076	O
42703	Red®	81 84	175208 175211	0.9999884366989136	O
42705	-	85 86	175212 175213	0.9999891519546509	O
42706	5	86 87	175213 175214	0.9999879598617554	O
42707	-	87 88	175214 175215	0.9999891519546509	O
42708	ddATP	88 92	175215 175219	0.9999885559082031	O
42712	and	94 97	175221 175224	0.9999890327453613	O
42713	R110	98 101	175225 175228	0.999988317489624	O
42716	-	102 103	175229 175230	0.9999891519546509	O
42717	ddGTP	103 107	175230 175234	0.9999885559082031	O
42721	(	109 110	175236 175237	0.9999892711639404	O
42722	PerkinElmer	111 121	175238 175248	0.9999884366989136	O
42726	Life	123 127	175250 175254	0.9999885559082031	O
42727	and	128 131	175255 175258	0.9999886751174927	O
42728	Analytical	132 141	175259 175268	0.9999878406524658	O
42731	Sciences	143 151	175270 175278	0.9999866485595703	O
42732	,	152 153	175279 175280	0.9999887943267822	O
42733	Inc	154 157	175281 175284	0.9999872446060181	O
42734	,	158 159	175285 175286	0.9999885559082031	O
42735	Wellesley	160 168	175287 175295	0.9999163150787354	O
42737	,	170 171	175297 175298	0.9999881982803345	O
42738	Ma	172 174	175299 175301	0.9999816417694092	O
42739	)	175 176	175302 175303	0.9999887943267822	O
42740	.	177 178	175304 175305	0.999969482421875	O
42741	Preparation	0 10	175306 175316	0.9999877214431763	O
42744	of	12 14	175318 175320	0.9999886751174927	O
42745	microarrays	15 25	175321 175331	0.9999864101409912	O
42748	'	27 28	175333 175334	0.9999890327453613	O
42749	Anti	29 33	175335 175339	0.9999858140945435	O
42750	-	33 34	175339 175340	0.9999892711639404	O
42751	tag	34 37	175340 175343	0.9999881982803345	O
42752	'	38 39	175344 175345	0.9999889135360718	O
42753	oligonucleotides	40 55	175346 175361	0.9999889135360718	O
42760	complimentary	57 69	175363 175375	0.999988317489624	O
42762	to	71 73	175377 175379	0.9999891519546509	O
42763	the	74 77	175380 175383	0.9999892711639404	O
42764	'	78 79	175384 175385	0.99998939037323	O
42765	tag	79 82	175385 175388	0.9999879598617554	O
42766	'	83 84	175389 175390	0.9999891519546509	O
42767	sequences	85 94	175391 175400	0.9999878406524658	O
42768	of	95 97	175401 175403	0.9999892711639404	O
42769	the	98 101	175404 175407	0.9999891519546509	O
42770	SBE	102 104	175408 175410	0.9999881982803345	O
42772	primers	106 112	175412 175418	0.9999881982803345	O
42774	modified	114 122	175420 175428	0.9999884366989136	O
42775	with	123 127	175429 175433	0.9999889135360718	O
42776	NH2	128 130	175434 175436	0.9999861717224121	O
42778	groups	132 138	175438 175444	0.999988317489624	O
42779	in	139 141	175445 175447	0.9999889135360718	O
42780	their	142 147	175448 175453	0.9999890327453613	O
42781	3	148 149	175454 175455	0.9999887943267822	O
42782	'	149 150	175455 175456	0.9999890327453613	O
42783	ends	151 155	175457 175461	0.9999884366989136	O
42784	,	156 157	175462 175463	0.999988317489624	O
42785	and	158 161	175464 175467	0.9999881982803345	O
42786	containing	162 172	175468 175478	0.9999892711639404	O
42787	a	173 174	175479 175480	0.9999895095825195	O
42788	3	175 176	175481 175482	0.9999890327453613	O
42789	'	176 177	175482 175483	0.9999887943267822	O
42790	-	177 178	175483 175484	0.9999892711639404	O
42791	spacer	178 183	175484 175489	0.9999884366989136	O
42793	of	185 187	175491 175493	0.99998939037323	O
42794	15	188 190	175494 175496	0.9999877214431763	O
42795	T	191 192	175497 175498	0.9999878406524658	O
42796	residues	193 201	175499 175507	0.9999887943267822	O
42797	were	202 206	175508 175512	0.9999889135360718	O
42798	coupled	207 214	175513 175520	0.9999874830245972	O
42799	covalently	215 224	175521 175530	0.9999890327453613	O
42802	to	226 228	175532 175534	0.99998939037323	O
42803	CodeLink	229 236	175535 175542	0.999988317489624	O
42806	Activated	238 246	175544 175552	0.9999884366989136	O
42808	Slides	248 253	175554 175559	0.9999887943267822	O
42811	(	255 256	175561 175562	0.9999892711639404	O
42812	Amersham	257 264	175563 175570	0.999988317489624	O
42815	Biosciences	266 276	175572 175582	0.9999885559082031	O
42819	,	278 279	175584 175585	0.9999884366989136	O
42820	Uppsala	280 286	175586 175592	0.9999858140945435	O
42823	,	288 289	175594 175595	0.9999886751174927	O
42824	Sweden	290 296	175596 175602	0.9999176263809204	O
42825	)	297 298	175603 175604	0.9999887943267822	O
42826	according	299 308	175605 175614	0.9999887943267822	O
42827	to	309 311	175615 175617	0.9999895095825195	O
42828	manufacturer	312 324	175618 175630	0.9999858140945435	O
42829	instructions	325 337	175631 175643	0.999988317489624	O
42830	.	338 339	175644 175645	0.9999682903289795	O
42831	The	0 3	175646 175649	0.9999885559082031	O
42832	only	4 8	175650 175654	0.9999877214431763	O
42833	exception	9 18	175655 175664	0.9999788999557495	O
42834	was	19 22	175665 175668	0.9999884366989136	O
42835	that	23 27	175669 175673	0.9999887943267822	O
42836	the	28 31	175674 175677	0.9999886751174927	O
42837	'	32 33	175678 175679	0.9999892711639404	O
42838	anti	33 37	175679 175683	0.9999878406524658	O
42839	-	37 38	175683 175684	0.99998939037323	O
42840	tag	38 41	175684 175687	0.9999867677688599	O
42841	'	42 43	175688 175689	0.9999889135360718	O
42842	oligonucleotides	44 59	175690 175705	0.9999890327453613	O
42849	were	61 65	175707 175711	0.9999891519546509	O
42850	dissolved	66 75	175712 175721	0.9999862909317017	O
42851	in	76 78	175722 175724	0.9999891519546509	O
42852	150	79 82	175725 175728	0.9999873638153076	O
42853	mM	83 84	175729 175730	0.9999891519546509	O
42855	sodium	86 92	175732 175738	0.9999877214431763	O
42856	carbonate	93 101	175739 175747	0.9999879598617554	O
42858	buffer	103 109	175749 175755	0.999988317489624	O
42859	,	110 111	175756 175757	0.9999885559082031	O
42860	pH	112 114	175758 175760	0.999988317489624	O
42861	8	115 116	175761 175762	0.9999887943267822	O
42862	.	116 117	175762 175763	0.9999890327453613	O
42863	5	117 118	175763 175764	0.9999885559082031	O
42864	with	119 123	175765 175769	0.9999889135360718	O
42865	1	124 125	175770 175771	0.9999887943267822	O
42866	mM	126 127	175772 175773	0.9999889135360718	O
42868	betaine	129 135	175775 175781	0.9999865293502808	O
42870	at	137 139	175783 175785	0.9999892711639404	O
42871	a	140 141	175786 175787	0.99998939037323	O
42872	concentration	142 155	175788 175801	0.9999890327453613	O
42873	of	156 158	175802 175804	0.9999891519546509	O
42874	20	159 161	175805 175807	0.9999865293502808	O
42875	μM	162 163	175808 175809	0.9999864101409912	O
42877	.	164 165	175810 175811	0.9999891519546509	O
42878	The	166 169	175812 175815	0.9999886751174927	O
42879	oligonucleotides	170 185	175816 175831	0.9999885559082031	O
42886	were	187 191	175833 175837	0.9999891519546509	O
42887	printed	192 199	175838 175845	0.9999845027923584	O
42888	onto	200 204	175846 175850	0.999987006187439	O
42889	the	205 208	175851 175854	0.9999887943267822	O
42890	slides	209 215	175855 175861	0.9999794960021973	O
42891	using	216 221	175862 175867	0.9999892711639404	O
42892	a	222 223	175868 175869	0.99998939037323	O
42893	VersArray	224 232	175870 175878	0.9999885559082031	O
42898	ChipWriter	234 243	175880 175889	0.9999874830245972	O
42902	(	245 246	175891 175892	0.99998939037323	O
42903	BioRad	247 252	175893 175898	0.9999872446060181	O
42907	,	254 255	175900 175901	0.9999885559082031	O
42908	Hercules	256 264	175902 175910	0.9999748468399048	O
42909	,	265 266	175911 175912	0.9999879598617554	O
42910	CA	267 269	175913 175915	0.9999758005142212	O
42911	)	270 271	175916 175917	0.9999896287918091	O
42912	with	272 276	175918 175922	0.9999891519546509	O
42913	3	277 278	175923 175924	0.9999877214431763	O
42914	Stealth	279 285	175925 175931	0.9999887943267822	O
42917	Micro	287 292	175933 175938	0.9999880790710449	O
42918	Spotting	293 300	175939 175946	0.9999876022338867	O
42920	Pins	302 305	175948 175951	0.9999884366989136	O
42922	(	307 308	175953 175954	0.9999891519546509	O
42923	TeleChem	309 316	175955 175962	0.9999861717224121	O
42927	International	318 331	175964 175977	0.999987006187439	O
42928	Inc	332 335	175978 175981	0.9999886751174927	O
42929	.	335 336	175981 175982	0.999988317489624	O
42930	,	337 338	175983 175984	0.9999884366989136	O
42931	Sunnyvale	339 347	175985 175993	0.9999679327011108	O
42933	,	349 350	175995 175996	0.9999880790710449	O
42934	CA	351 353	175997 175999	0.9999773502349854	O
42935	)	354 355	176000 176001	0.9999890327453613	O
42936	.	356 357	176002 176003	0.9999767541885376	O
42937	Each	0 4	176004 176008	0.9999845027923584	O
42938	slide	5 10	176009 176014	0.9999707937240601	O
42939	consists	11 19	176015 176023	0.9999861717224121	O
42940	of	20 22	176024 176026	0.9999874830245972	O
42941	75	23 25	176027 176029	0.9999786615371704	O
42942	sub	26 29	176030 176033	0.9999878406524658	O
42943	-	29 30	176033 176034	0.9999873638153076	O
42944	arrays	30 35	176034 176039	0.9999831914901733	O
42946	with	37 41	176041 176045	0.9999862909317017	O
42947	13	42 44	176046 176048	0.999985933303833	O
42948	×	45 46	176049 176050	0.9999866485595703	O
42949	12	47 49	176051 176053	0.9999873638153076	O
42950	spots	50 55	176054 176059	0.9999831914901733	O
42951	in	56 58	176060 176062	0.9999873638153076	O
42952	each	59 63	176063 176067	0.9999880790710449	O
42953	subarray	64 71	176068 176075	0.9999886751174927	O
42956	.	73 74	176077 176078	0.9999417066574097	O
42957	The	0 3	176079 176082	0.9999860525131226	O
42958	spots	4 9	176083 176088	0.9999819993972778	O
42959	were	10 14	176089 176093	0.999988317489624	O
42960	130	15 18	176094 176097	0.9999860525131226	O
42961	–	18 19	176097 176098	0.9999818801879883	O
42962	150	19 22	176098 176101	0.9999841451644897	O
42963	μM	23 24	176102 176103	0.9999877214431763	O
42965	in	26 28	176105 176107	0.999988317489624	O
42966	diameter	29 37	176108 176116	0.999984622001648	O
42967	and	38 41	176117 176120	0.9999877214431763	O
42968	the	42 45	176121 176124	0.9999887943267822	O
42969	centre	46 52	176125 176131	0.9999878406524658	O
42970	-	52 53	176131 176132	0.9999891519546509	O
42971	to	53 55	176132 176134	0.9999887943267822	O
42972	-	55 56	176134 176135	0.9999889135360718	O
42973	centre	56 62	176135 176141	0.9999864101409912	O
42974	distance	63 71	176142 176150	0.9999880790710449	O
42975	between	72 79	176151 176158	0.9999884366989136	O
42976	two	80 83	176159 176162	0.9999842643737793	O
42977	spots	84 89	176163 176168	0.999985933303833	O
42978	was	90 93	176169 176172	0.9999884366989136	O
42979	200	94 97	176173 176176	0.9999850988388062	O
42980	μM	98 99	176177 176178	0.9999884366989136	O
42982	.	100 101	176179 176180	0.9999879598617554	O
42983	The	102 105	176181 176184	0.9999884366989136	O
42984	'	106 107	176185 176186	0.9999892711639404	O
42985	anti	107 111	176186 176190	0.9999874830245972	O
42986	-	111 112	176190 176191	0.9999892711639404	O
42987	tag	112 115	176191 176194	0.9999871253967285	O
42988	'	116 117	176195 176196	0.9999891519546509	O
42989	oligonucleotides	118 133	176197 176212	0.9999886751174927	O
42996	were	135 139	176214 176218	0.9999885559082031	O
42997	printed	140 147	176219 176226	0.9999827146530151	O
42998	in	148 150	176227 176229	0.9999887943267822	O
42999	duplicates	151 160	176230 176239	0.9999876022338867	O
43002	in	162 164	176241 176243	0.9999889135360718	O
43003	each	165 169	176244 176248	0.9999892711639404	O
43004	sub	170 173	176249 176252	0.99998939037323	O
43005	-	173 174	176252 176253	0.9999892711639404	O
43006	array	174 179	176253 176258	0.9999867677688599	O
43007	.	180 181	176259 176260	0.9999657869338989	O
43008	The	0 3	176261 176264	0.999985933303833	O
43009	spot	4 8	176265 176269	0.9999818801879883	O
43010	quality	9 16	176270 176277	0.9999854564666748	O
43011	was	17 20	176278 176281	0.9999861717224121	O
43012	tested	21 27	176282 176288	0.9999860525131226	O
43013	after	28 33	176289 176294	0.9999862909317017	O
43014	each	34 38	176295 176299	0.9999881982803345	O
43015	series	39 45	176300 176306	0.9999867677688599	O
43016	of	46 48	176307 176309	0.9999886751174927	O
43017	microarray	49 58	176310 176319	0.999985933303833	O
43020	preparation	60 71	176321 176332	0.9999873638153076	O
43021	using	72 77	176333 176338	0.9999887943267822	O
43022	a	78 79	176339 176340	0.9999891519546509	O
43023	Cy3	80 82	176341 176343	0.9999880790710449	O
43025	labelled	84 92	176345 176353	0.9999871253967285	O
43026	random	93 99	176354 176360	0.9999880790710449	O
43027	oligonucleotide	100 114	176361 176375	0.9999890327453613	O
43033	hybridizing	116 126	176377 176387	0.999988317489624	O
43035	to	128 130	176389 176391	0.9999890327453613	O
43036	all	131 134	176392 176395	0.9999886751174927	O
43037	spots	135 140	176396 176401	0.9999872446060181	O
43038	on	141 143	176402 176404	0.9999889135360718	O
43039	the	144 147	176405 176408	0.99998939037323	O
43040	slide	148 153	176409 176414	0.999985933303833	O
43041	independent	154 165	176415 176426	0.9999886751174927	O
43042	on	166 168	176427 176429	0.99998939037323	O
43043	the	169 172	176430 176433	0.9999896287918091	O
43044	'	173 174	176434 176435	0.9999896287918091	O
43045	anti	174 178	176435 176439	0.9999887943267822	O
43046	-	178 179	176439 176440	0.9999895095825195	O
43047	tag	179 182	176440 176443	0.9999886751174927	O
43048	'	183 184	176444 176445	0.9999892711639404	O
43049	sequence	185 193	176446 176454	0.9999885559082031	O
43050	.	194 195	176455 176456	0.9999696016311646	O
43051	The	0 3	176457 176460	0.9999802112579346	O
43052	printed	4 11	176461 176468	0.9999516010284424	O
43053	slides	12 18	176469 176475	0.9999443292617798	O
43054	were	19 23	176476 176480	0.9999827146530151	O
43055	stored	24 30	176481 176487	0.9999791383743286	O
43056	at	31 33	176488 176490	0.9999853372573853	O
43057	room	34 38	176491 176495	0.9999847412109375	O
43058	temperature	39 50	176496 176507	0.9999828338623047	O
43059	until	51 56	176508 176513	0.9999822378158569	O
43060	use	57 60	176514 176517	0.9999785423278809	O
43061	.	61 62	176518 176519	0.9999854564666748	O
43062	*	63 64	176520 176521	0.9999827146530151	O
43063	*	64 65	176521 176522	0.9999716281890869	O
43064	IGNORE	0 5	176523 176528	0.9999867677688599	O
43067	LINE	7 10	176530 176533	0.9999889135360718	O
43070	*	12 13	176535 176536	0.9999889135360718	O
43071	*	13 14	176536 176537	0.9999887943267822	O
43072	*	15 16	176538 176539	0.9999887943267822	O
43073	*	16 17	176539 176540	0.9999890327453613	O
43074	IGNORE	18 23	176541 176546	0.9999880790710449	O
43077	LINE	25 28	176548 176551	0.9999891519546509	O
43080	*	30 31	176553 176554	0.9999887943267822	O
43081	*	31 32	176554 176555	0.9999886751174927	O
43082	*	33 34	176556 176557	0.9999886751174927	O
43083	*	34 35	176557 176558	0.9999886751174927	O
43084	IGNORE	36 41	176559 176564	0.9999877214431763	O
43087	LINE	43 46	176566 176569	0.9999890327453613	O
43090	*	48 49	176571 176572	0.9999886751174927	O
43091	*	49 50	176572 176573	0.9999887943267822	O
43092	Linkage	51 57	176574 176580	0.9999880790710449	O
43094	disequilibrium	59 72	176582 176595	0.9999889135360718	O
43100	(	74 75	176597 176598	0.9999886751174927	O
43101	LD	76 77	176599 176600	0.9999885559082031	O
43103	)	79 80	176602 176603	0.9999892711639404	O
43104	analysis	81 89	176604 176612	0.9999887943267822	O
43105	showed	90 96	176613 176619	0.9999878406524658	O
43106	high	97 101	176620 176624	0.9999868869781494	O
43107	LD	102 103	176625 176626	0.9999886751174927	O
43109	in	105 107	176628 176630	0.9999895095825195	O
43110	the	108 111	176631 176634	0.9999890327453613	O
43111	genomic	112 118	176635 176641	0.9999891519546509	O
43114	regions	120 127	176643 176650	0.9999892711639404	O
43115	covering	128 136	176651 176659	0.99998939037323	O
43116	hMLH1	137 141	176660 176664	0.9999892711639404	O
43119	and	143 146	176666 176669	0.9999885559082031	O
43120	most	147 151	176670 176674	0.9999884366989136	O
43121	of	152 154	176675 176677	0.9999885559082031	O
43122	the	155 158	176678 176681	0.9999884366989136	O
43123	genomic	159 165	176682 176688	0.9999889135360718	O
43126	region	167 173	176690 176696	0.9999890327453613	O
43127	covering	174 182	176697 176705	0.9999890327453613	O
43128	hMSH2	183 187	176706 176710	0.9999892711639404	O
43132	in	189 191	176712 176714	0.999988317489624	O
43133	the	192 195	176715 176718	0.9999840259552002	O
43134	Danish	196 202	176719 176725	0.9873729348182678	O
43135	population	203 213	176726 176736	0.9999816417694092	O
43136	.	214 215	176737 176738	0.9999567270278931	O
43137	We	0 2	176739 176741	0.9999662637710571	O
43138	therefore	3 12	176742 176751	0.9999730587005615	O
43139	conclude	13 21	176752 176760	0.9999657869338989	O
43140	that	22 26	176761 176765	0.9999798536300659	O
43141	common	27 33	176766 176772	0.999969482421875	O
43142	variants	34 42	176773 176781	0.9999768733978271	O
43143	in	43 45	176782 176784	0.9999839067459106	O
43144	the	46 49	176785 176788	0.9999821186065674	O
43145	two	50 53	176789 176792	0.9999748468399048	O
43146	genes	54 59	176793 176798	0.9999701976776123	O
43147	in	60 62	176799 176801	0.9999845027923584	O
43148	general	63 70	176802 176809	0.9999721050262451	O
43149	are	71 74	176810 176813	0.9999775886535645	O
43150	not	75 78	176814 176817	0.9999679327011108	O
43151	associated	79 89	176818 176828	0.9999815225601196	O
43152	with	90 94	176829 176833	0.9999809265136719	O
43153	susceptibility	95 108	176834 176847	0.9999825954437256	O
43158	to	110 112	176849 176851	0.9999791383743286	O
43159	sporadic	113 120	176852 176859	0.9999784231185913	O
43161	CRC	122 124	176861 176863	0.9999727010726929	O
43163	in	126 128	176865 176867	0.9999712705612183	O
43164	a	129 130	176868 176869	0.9999558925628662	O
43165	Danish	131 137	176870 176876	0.9943910241127014	O
43166	population	138 148	176877 176887	0.9999611377716064	O
43167	.	149 150	176888 176889	0.9999196529388428	O
43168	The	0 3	176890 176893	0.999983549118042	O
43169	age	4 7	176894 176897	0.9999786615371704	O
43170	of	8 10	176898 176900	0.9999850988388062	O
43171	the	11 14	176901 176904	0.9999799728393555	O
43172	cohort	15 20	176905 176910	0.999984622001648	O
43175	of	22 24	176912 176914	0.9999815225601196	O
43176	cases	25 30	176915 176920	0.9999798536300659	O
43177	with	31 35	176921 176925	0.999983549118042	O
43178	sporadic	36 43	176926 176933	0.9999833106994629	O
43180	CRC	45 47	176935 176937	0.9999761581420898	O
43182	is	49 51	176939 176941	0.9999831914901733	O
43183	relatively	52 62	176942 176952	0.9999840259552002	O
43184	young	63 68	176953 176958	0.9999837875366211	O
43185	(	69 70	176959 176960	0.9999871253967285	O
43186	mean	71 75	176961 176965	0.999987006187439	O
43187	~	76 77	176966 176967	0.9999879598617554	O
43188	58	77 79	176967 176969	0.9999847412109375	O
43189	years	80 85	176970 176975	0.9999876022338867	O
43190	)	86 87	176976 176977	0.9999873638153076	O
43191	compared	88 96	176978 176986	0.9999850988388062	O
43192	to	97 99	176987 176989	0.9999853372573853	O
43193	the	100 103	176990 176993	0.9999855756759644	O
43194	mean	104 108	176994 176998	0.9999860525131226	O
43195	age	109 112	176999 177002	0.9999874830245972	O
43196	of	113 115	177003 177005	0.9999864101409912	O
43197	onset	116 121	177006 177011	0.9999861717224121	O
43198	of	122 124	177012 177014	0.9999855756759644	O
43199	colorectal	125 134	177015 177024	0.9999853372573853	O
43202	CRC	136 138	177026 177028	0.9999833106994629	O
43204	in	140 142	177030 177032	0.999985933303833	O
43205	the	143 146	177033 177036	0.9999815225601196	O
43206	general	147 154	177037 177044	0.9999666213989258	O
43207	Danish	155 161	177045 177051	0.9939549565315247	O
43208	population	162 172	177052 177062	0.9999812841415405	O
43209	(	173 174	177063 177064	0.9999868869781494	O
43210	mean	175 179	177065 177069	0.9999868869781494	O
43211	~	180 181	177070 177071	0.9999876022338867	O
43212	70	181 183	177071 177073	0.9999858140945435	O
43213	years	184 189	177074 177079	0.9999878406524658	O
43214	)	190 191	177080 177081	0.9999877214431763	O
43215	[	192 193	177082 177083	0.9999874830245972	O
43216	49	193 195	177083 177085	0.999980092048645	O
43217	]	195 196	177085 177086	0.9999871253967285	O
43218	.	197 198	177087 177088	0.9999686479568481	O
43219	Consequently	0 12	177089 177101	0.9999816417694092	O
43220	,	13 14	177102 177103	0.9999878406524658	O
43221	the	15 18	177104 177107	0.9999872446060181	O
43222	results	19 26	177108 177115	0.9999862909317017	O
43223	obtained	27 35	177116 177124	0.999985933303833	O
43224	in	36 38	177125 177127	0.9999872446060181	O
43225	the	39 42	177128 177131	0.9999876022338867	O
43226	present	43 50	177132 177139	0.9999862909317017	O
43227	study	51 56	177140 177145	0.999984622001648	O
43228	do	57 59	177146 177148	0.9999839067459106	O
43229	not	60 63	177149 177152	0.9999847412109375	O
43230	rule	64 68	177153 177157	0.9999839067459106	O
43231	out	69 72	177158 177161	0.9999872446060181	O
43232	that	73 77	177162 177166	0.9999881982803345	O
43233	variants	78 86	177167 177175	0.9999850988388062	O
43234	in	87 89	177176 177178	0.9999884366989136	O
43235	hMLH1	90 94	177179 177183	0.999988317489624	O
43238	and	96 99	177185 177188	0.9999873638153076	O
43239	hMSH2	100 104	177189 177193	0.9999878406524658	O
43243	might	106 111	177195 177200	0.999984860420227	O
43244	be	112 114	177201 177203	0.9999881982803345	O
43245	associated	115 125	177204 177214	0.9999879598617554	O
43246	with	126 130	177215 177219	0.9999878406524658	O
43247	sporadic	131 138	177220 177227	0.9999862909317017	O
43249	colorectal	140 149	177229 177238	0.9999853372573853	O
43252	cancer	151 157	177240 177246	0.999985933303833	O
43253	at	158 160	177247 177249	0.9999876022338867	O
43254	an	161 163	177250 177252	0.999988317489624	O
43255	older	164 169	177253 177258	0.9999856948852539	O
43256	age	170 173	177259 177262	0.9999862909317017	O
43257	.	174 175	177263 177264	0.9999635219573975	O
43258	However	0 7	177265 177272	0.9999788999557495	O
43259	,	8 9	177273 177274	0.9999841451644897	O
43260	generally	10 19	177275 177284	0.9999698400497437	O
43261	cancers	20 26	177285 177291	0.9999793767929077	O
43263	reflecting	28 38	177293 177303	0.999982476234436	O
43264	an	39 41	177304 177306	0.9999852180480957	O
43265	inherited	42 51	177307 177316	0.9999743700027466	O
43266	susceptibility	52 65	177317 177330	0.9999855756759644	O
43271	seem	67 71	177332 177336	0.999981164932251	O
43272	to	72 74	177337 177339	0.9999856948852539	O
43273	occur	75 80	177340 177345	0.9999862909317017	O
43274	in	81 83	177346 177348	0.9999850988388062	O
43275	a	84 85	177349 177350	0.9999865293502808	O
43276	relatively	86 96	177351 177361	0.9999849796295166	O
43277	young	97 102	177362 177367	0.9999828338623047	O
43278	age	103 106	177368 177371	0.9999825954437256	O
43279	.	107 108	177372 177373	0.9999438524246216	O
43280	Using	0 5	177374 177379	0.9999860525131226	O
43281	in	6 8	177380 177382	0.9999889135360718	O
43282	silico	9 14	177383 177388	0.9999873638153076	O
43285	analysis	16 24	177390 177398	0.9999867677688599	O
43286	several	25 32	177399 177406	0.9999837875366211	O
43287	of	33 35	177407 177409	0.9999877214431763	O
43288	the	36 39	177410 177413	0.9999873638153076	O
43289	analyzed	40 48	177414 177422	0.9999814033508301	O
43290	variants	49 57	177423 177431	0.9999828338623047	O
43291	were	58 62	177432 177436	0.9999878406524658	O
43292	predicted	63 72	177437 177446	0.9999873638153076	O
43293	to	73 75	177447 177449	0.999988317489624	O
43294	either	76 82	177450 177456	0.9999879598617554	O
43295	abolish	83 89	177457 177463	0.99998939037323	O
43298	or	91 93	177465 177467	0.9999861717224121	O
43299	introduce	94 103	177468 177477	0.9999836683273315	O
43300	ESEs	104 107	177478 177481	0.9999861717224121	O
43303	(	109 110	177483 177484	0.99998939037323	O
43304	data	111 115	177485 177489	0.9999876022338867	O
43305	not	116 119	177490 177493	0.99998939037323	O
43306	shown	120 125	177494 177499	0.9999886751174927	O
43307	)	126 127	177500 177501	0.9999896287918091	O
43308	.	128 129	177502 177503	0.999971866607666	O
43309	It	0 2	177504 177506	0.9999879598617554	O
43310	has	3 6	177507 177510	0.9999861717224121	O
43311	,	7 8	177511 177512	0.9999880790710449	O
43312	however	9 16	177513 177520	0.9999845027923584	O
43313	,	17 18	177521 177522	0.9999871253967285	O
43314	been	19 23	177523 177527	0.9999872446060181	O
43315	shown	24 29	177528 177533	0.9999845027923584	O
43316	that	30 34	177534 177538	0.9999881982803345	O
43317	only	35 39	177539 177543	0.9999855756759644	O
43318	a	40 41	177544 177545	0.9999887943267822	O
43319	minor	42 47	177546 177551	0.9999823570251465	O
43320	fraction	48 56	177552 177560	0.9999877214431763	O
43321	of	57 59	177561 177563	0.9999886751174927	O
43322	the	60 63	177564 177567	0.999988317489624	O
43323	variants	64 72	177568 177576	0.999987006187439	O
43324	predicted	73 82	177577 177586	0.999988317489624	O
43325	to	83 85	177587 177589	0.9999889135360718	O
43326	change	86 92	177590 177596	0.9999884366989136	O
43327	ESEs	93 96	177597 177600	0.9999879598617554	O
43330	in	98 100	177602 177604	0.99998939037323	O
43331	hMLH1	101 105	177605 177609	0.9999891519546509	O
43334	and	107 110	177611 177614	0.999988317489624	O
43335	hMSH2	111 115	177615 177619	0.9999886751174927	O
43339	using	117 122	177621 177626	0.9999887943267822	O
43340	in	123 125	177627 177629	0.99998939037323	O
43341	silico	126 131	177630 177635	0.9999885559082031	O
43344	analysis	133 141	177637 177645	0.9999889135360718	O
43345	do	142 144	177646 177648	0.9999864101409912	O
43346	indeed	145 151	177649 177655	0.9999852180480957	O
43347	change	152 158	177656 177662	0.9999880790710449	O
43348	the	159 162	177663 177666	0.9999890327453613	O
43349	pre	163 166	177667 177670	0.9999889135360718	O
43350	-	166 167	177670 177671	0.9999890327453613	O
43351	mRNA	167 170	177671 177674	0.9999886751174927	O
43353	splice	172 177	177676 177681	0.99998939037323	O
43356	pattern	179 186	177683 177690	0.9999890327453613	O
43357	in	187 189	177691 177693	0.99998939037323	O
43358	vivo	190 193	177694 177697	0.9999886751174927	O
43360	[	195 196	177699 177700	0.99998939037323	O
43361	14	196 198	177700 177702	0.999988317489624	O
43362	,	198 199	177702 177703	0.9999880790710449	O
43363	15	199 201	177703 177705	0.9999861717224121	O
43364	]	201 202	177705 177706	0.9999887943267822	O
43365	.	203 204	177707 177708	0.9999786615371704	O
43366	In	0 2	177709 177711	0.9999823570251465	O
43367	the	3 6	177712 177715	0.999984622001648	O
43368	study	7 12	177716 177721	0.9999797344207764	O
43369	by	13 15	177722 177724	0.999985933303833	O
43370	Auclair	16 22	177725 177731	0.9999737739562988	O
43373	et	24 26	177733 177735	0.9999867677688599	O
43374	al	27 29	177736 177738	0.9999865293502808	O
43375	.	30 31	177739 177740	0.9999866485595703	O
43376	,	32 33	177741 177742	0.9999755620956421	O
43377	only	0 4	177743 177747	0.999985933303833	O
43378	ESEs	5 8	177748 177751	0.9999827146530151	O
43381	at	10 12	177753 177755	0.9999881982803345	O
43382	or	13 15	177756 177758	0.9999858140945435	O
43383	close	16 21	177759 177764	0.9999854564666748	O
43384	to	22 24	177765 177767	0.999988317489624	O
43385	5	25 26	177768 177769	0.9999867677688599	O
43386	'	26 27	177769 177770	0.9999874830245972	O
43387	splice	28 33	177771 177776	0.9999886751174927	O
43390	sites	35 40	177778 177783	0.9999881982803345	O
43391	were	41 45	177784 177788	0.999987006187439	O
43392	found	46 51	177789 177794	0.9999855756759644	O
43393	to	52 54	177795 177797	0.9999867677688599	O
43394	cause	55 60	177798 177803	0.9999850988388062	O
43395	aberrant	61 68	177804 177811	0.9999874830245972	O
43398	splicing	70 77	177813 177820	0.9999868869781494	O
43401	.	79 80	177822 177823	0.9999487400054932	O
43402	None	0 4	177824 177828	0.9999738931655884	O
43403	of	5 7	177829 177831	0.999984622001648	O
43404	the	8 11	177832 177835	0.9999828338623047	O
43405	variants	12 20	177836 177844	0.9999806880950928	O
43406	analysed	21 28	177845 177852	0.9999854564666748	O
43409	in	30 32	177854 177856	0.9999855756759644	O
43410	the	33 36	177857 177860	0.9999855756759644	O
43411	present	37 44	177861 177868	0.9999833106994629	O
43412	study	45 50	177869 177874	0.9999815225601196	O
43413	affected	51 59	177875 177883	0.9999830722808838	O
43414	5	60 61	177884 177885	0.9999861717224121	O
43415	'	61 62	177885 177886	0.9999871253967285	O
43416	splice	63 68	177887 177892	0.9999877214431763	O
43419	sites	70 75	177894 177899	0.9999853372573853	O
43420	.	76 77	177900 177901	0.999956488609314	O
43421	Nevertheless	0 12	177902 177914	0.9999798536300659	O
43422	,	13 14	177915 177916	0.9999867677688599	O
43423	no	15 17	177917 177919	0.9999822378158569	O
43424	final	18 23	177920 177925	0.999983549118042	O
43425	conclusions	24 35	177926 177937	0.9999837875366211	O
43426	regarding	36 45	177938 177947	0.9999867677688599	O
43427	splicing	46 53	177948 177955	0.9999862909317017	O
43430	can	55 58	177957 177960	0.9999827146530151	O
43431	be	59 61	177961 177963	0.9999856948852539	O
43432	drawn	62 67	177964 177969	0.9999830722808838	O
43433	from	68 72	177970 177974	0.9999860525131226	O
43434	the	73 76	177975 177978	0.9999872446060181	O
43435	in	77 79	177979 177981	0.9999886751174927	O
43436	silico	80 85	177982 177987	0.9999872446060181	O
43439	analyses	87 95	177989 177997	0.9999858140945435	O
43440	.	96 97	177998 177999	0.9999442100524902	O
43441	Twenty	0 6	178000 178006	0.999980092048645	O
43442	two	7 10	178007 178010	0.9999814033508301	O
43443	variants	11 19	178011 178019	0.9999778270721436	O
43444	were	20 24	178020 178024	0.9999864101409912	O
43445	not	25 28	178025 178028	0.9999831914901733	O
43446	detected	29 37	178029 178037	0.9999855756759644	O
43447	in	38 40	178038 178040	0.9999853372573853	O
43448	the	41 44	178041 178044	0.9999810457229614	O
43449	sporadic	45 52	178045 178052	0.9999721050262451	O
43451	CRC	54 56	178054 178056	0.9999649524688721	O
43453	cases	58 63	178058 178063	0.9999833106994629	O
43454	and	64 67	178064 178067	0.9999806880950928	O
43455	in	68 70	178068 178070	0.9999861717224121	O
43456	the	71 74	178071 178074	0.9999849796295166	O
43457	sub	75 78	178075 178078	0.9999856948852539	O
43458	-	78 79	178078 178079	0.9999860525131226	O
43459	cohort	79 84	178079 178084	0.9999864101409912	O
43462	.	86 87	178086 178087	0.9999535083770752	O
43463	Among	0 5	178088 178093	0.9999856948852539	O
43464	those	6 11	178094 178099	0.9999853372573853	O
43465	were	12 16	178100 178104	0.9999874830245972	O
43466	the	17 20	178105 178108	0.999987006187439	O
43467	six	21 24	178109 178112	0.9999798536300659	O
43468	variants	25 33	178113 178121	0.9999825954437256	O
43469	originally	34 44	178122 178132	0.9999868869781494	O
43470	identified	45 55	178133 178143	0.9999865293502808	O
43471	more	56 60	178144 178148	0.9999886751174927	O
43472	or	61 63	178149 178151	0.9999861717224121	O
43473	less	64 68	178152 178156	0.9999865293502808	O
43474	frequently	69 79	178157 178167	0.9999868869781494	O
43475	in	80 82	178168 178170	0.9999873638153076	O
43476	other	83 88	178171 178176	0.9999840259552002	O
43477	populations	89 100	178177 178188	0.999981164932251	O
43478	(	101 102	178189 178190	0.9999884366989136	O
43479	Table	103 108	178191 178196	0.9999847412109375	O
43480	2	109 110	178197 178198	0.999987006187439	O
43481	)	111 112	178199 178200	0.9999890327453613	O
43482	.	113 114	178201 178202	0.9999731779098511	O
43483	All	0 3	178203 178206	0.9999808073043823	O
43484	except	4 10	178207 178213	0.9999823570251465	O
43485	one	11 14	178214 178217	0.9999839067459106	O
43486	variant	15 22	178218 178225	0.9999822378158569	O
43487	(	23 24	178226 178227	0.9999829530715942	O
43488	c	25 26	178228 178229	0.999984860420227	O
43489	.	26 27	178229 178230	0.999987006187439	O
43490	380	27 30	178230 178233	0.999984860420227	O
43491	A	31 32	178234 178235	0.999984860420227	O
43492	>	32 33	178235 178236	0.9999854564666748	O
43493	G	33 34	178236 178237	0.9999839067459106	O
43494	,	35 36	178238 178239	0.9999860525131226	O
43495	p	37 38	178240 178241	0.9999840259552002	O
43496	.	38 39	178241 178242	0.9999662637710571	O
43497	Asn127Ser	0 8	178242 178250	0.9999861717224121	O
43503	)	10 11	178252 178253	0.9999834299087524	O
43504	performed	12 21	178254 178263	0.9999833106994629	O
43505	very	22 26	178264 178268	0.999983549118042	O
43506	well	27 31	178269 178273	0.999984622001648	O
43507	in	32 34	178274 178276	0.999987006187439	O
43508	the	35 38	178277 178280	0.9999878406524658	O
43509	SBE	39 41	178281 178283	0.9999876022338867	O
43511	-	42 43	178284 178285	0.9999887943267822	O
43512	tag	43 46	178285 178288	0.9999861717224121	O
43513	array	47 52	178289 178294	0.9999873638153076	O
43514	assay	53 57	178295 178299	0.9999879598617554	O
43516	.	59 60	178301 178302	0.9999605417251587	O
43517	This	0 4	178303 178307	0.9999836683273315	O
43518	rules	5 10	178308 178313	0.999983549118042	O
43519	out	11 14	178314 178317	0.9999871253967285	O
43520	that	15 19	178318 178322	0.9999877214431763	O
43521	failure	20 27	178323 178330	0.999987006187439	O
43522	in	28 30	178331 178333	0.999988317489624	O
43523	detecting	31 39	178334 178342	0.9999878406524658	O
43525	the	41 44	178344 178347	0.9999878406524658	O
43526	variants	45 53	178348 178356	0.999984860420227	O
43527	caused	54 60	178357 178363	0.9999855756759644	O
43528	their	61 66	178364 178369	0.999988317489624	O
43529	absence	67 74	178370 178377	0.9999873638153076	O
43530	in	75 77	178378 178380	0.999988317489624	O
43531	the	78 81	178381 178384	0.9999880790710449	O
43532	present	82 89	178385 178392	0.9999858140945435	O
43533	cohorts	90 96	178393 178399	0.9999884366989136	O
43536	.	98 99	178401 178402	0.999950647354126	O
43537	Consequently	0 12	178403 178415	0.9999700784683228	O
43538	,	13 14	178416 178417	0.9999816417694092	O
43539	these	15 20	178418 178423	0.999981164932251	O
43540	six	21 24	178424 178427	0.9999676942825317	O
43541	variants	25 33	178428 178436	0.9999743700027466	O
43542	are	34 37	178437 178440	0.9999797344207764	O
43543	not	38 41	178441 178444	0.9999749660491943	O
43544	polymorphic	42 52	178445 178455	0.9999850988388062	O
43547	in	54 56	178457 178459	0.9999752044677734	O
43548	the	57 60	178460 178463	0.9999681711196899	O
43549	Danish	61 67	178464 178470	0.9995597004890442	O
43550	population	68 78	178471 178481	0.9999721050262451	O
43551	.	79 80	178482 178483	0.9998997449874878	O
43552	The	0 3	178484 178487	0.9999741315841675	O
43553	remaining	4 13	178488 178497	0.9999743700027466	O
43554	variants	14 22	178498 178506	0.9999779462814331	O
43555	were	23 27	178507 178511	0.9999767541885376	O
43556	rare	28 32	178512 178516	0.9999698400497437	O
43557	variants	33 41	178517 178525	0.9999823570251465	O
43558	in	42 44	178526 178528	0.9999774694442749	O
43559	the	45 48	178529 178532	0.9999657869338989	O
43560	Danish	49 55	178533 178539	0.9976812601089478	O
43561	population	56 66	178540 178550	0.9999717473983765	O
43562	.	67 68	178551 178552	0.9998466968536377	O
43563	They	0 4	178553 178557	0.9999850988388062	O
43564	were	5 9	178558 178562	0.9999880790710449	O
43565	only	10 14	178563 178567	0.9999853372573853	O
43566	detected	15 23	178568 178576	0.9999879598617554	O
43567	in	24 26	178577 178579	0.9999881982803345	O
43568	individuals	27 38	178580 178591	0.9999524354934692	O
43569	with	39 43	178592 178596	0.9999865293502808	O
43570	familiar	44 52	178597 178605	0.9999669790267944	O
43571	CRC	53 55	178606 178608	0.999977707862854	O
43573	and	57 60	178610 178613	0.9999862909317017	O
43574	some	61 65	178614 178618	0.9999872446060181	O
43575	of	66 68	178619 178621	0.9999885559082031	O
43576	them	69 73	178622 178626	0.9999877214431763	O
43577	have	74 78	178627 178631	0.9999886751174927	O
43578	been	79 83	178632 178636	0.9999890327453613	O
43579	classified	84 94	178637 178647	0.9999885559082031	O
43580	as	95 97	178648 178650	0.9999891519546509	O
43581	pathogenic	98 107	178651 178660	0.999988317489624	O
43583	mutations	109 118	178662 178671	0.999987006187439	O
43584	or	119 121	178672 178674	0.999988317489624	O
43585	neutral	122 129	178675 178682	0.9999852180480957	O
43586	variants	130 138	178683 178691	0.9999884366989136	O
43587	in	139 141	178692 178694	0.9999887943267822	O
43588	other	142 147	178695 178700	0.9999853372573853	O
43589	populations	148 159	178701 178712	0.9999827146530151	O
43590	(	160 161	178713 178714	0.9999892711639404	O
43591	see	162 165	178715 178718	0.9999865293502808	O
43592	Table	166 171	178719 178724	0.9999872446060181	O
43593	2	172 173	178725 178726	0.999988317489624	O
43594	for	174 177	178727 178730	0.9999885559082031	O
43595	references	178 188	178731 178741	0.9999885559082031	O
43596	)	189 190	178742 178743	0.99998939037323	O
43597	.	191 192	178744 178745	0.999975323677063	O
43598	Four	0 4	178746 178750	0.9999468326568604	O
43599	rare	5 9	178751 178755	0.9999650716781616	O
43600	missense	10 17	178756 178763	0.99997878074646	O
43602	variants	19 27	178765 178773	0.9999773502349854	O
43603	i	28 29	178774 178775	0.9999768733978271	O
43604	.	30 31	178776 178777	0.999981164932251	O
43605	e	31 32	178777 178778	0.999974250793457	O
43606	.	33 34	178779 178780	0.9999278783798218	O
43607	hMLH1	0 4	178781 178785	0.9999840259552002	O
43610	c	6 7	178787 178788	0.9999871253967285	O
43611	.	7 8	178788 178789	0.9999880790710449	O
43612	1379	8 11	178789 178792	0.9999843835830688	O
43614	A	13 14	178794 178795	0.9999860525131226	O
43615	>	14 15	178795 178796	0.9999864101409912	O
43616	C	15 16	178796 178797	0.999985933303833	O
43617	(	17 18	178798 178799	0.9999829530715942	O
43618	p	19 20	178800 178801	0.9999843835830688	O
43619	.	20 21	178801 178802	0.999972939491272	O
43620	Glu460Ala	0 8	178802 178810	0.9999860525131226	O
43626	)	10 11	178812 178813	0.9999881982803345	O
43627	and	12 15	178814 178817	0.9999874830245972	O
43628	c	16 17	178818 178819	0.9999871253967285	O
43629	.	17 18	178819 178820	0.999988317489624	O
43630	1689	18 22	178820 178824	0.9999845027923584	O
43631	A	23 24	178825 178826	0.9999871253967285	O
43632	>	24 25	178826 178827	0.9999872446060181	O
43633	G	25 26	178827 178828	0.9999864101409912	O
43634	(	27 28	178829 178830	0.9999881982803345	O
43635	p	29 30	178831 178832	0.9999865293502808	O
43636	.	30 31	178832 178833	0.9999767541885376	O
43637	Ile563Met	0 8	178833 178841	0.9999873638153076	O
43644	)	10 11	178843 178844	0.9999879598617554	O
43645	and	12 15	178845 178848	0.9999879598617554	O
43646	,	16 17	178849 178850	0.9999884366989136	O
43647	hMSH2	18 22	178851 178855	0.9999874830245972	O
43651	c	24 25	178857 178858	0.9999890327453613	O
43652	.	25 26	178858 178859	0.99998939037323	O
43653	2062	26 29	178859 178862	0.9999876022338867	O
43655	A	31 32	178864 178865	0.9999881982803345	O
43656	>	32 33	178865 178866	0.999988317489624	O
43657	G	33 34	178866 178867	0.9999871253967285	O
43658	(	35 36	178868 178869	0.9999885559082031	O
43659	p	37 38	178870 178871	0.9999877214431763	O
43660	.	38 39	178871 178872	0.9999809265136719	O
43661	Met688Val	0 8	178872 178880	0.9999861717224121	O
43667	)	10 11	178882 178883	0.9999880790710449	O
43668	and	12 15	178884 178887	0.9999876022338867	O
43669	c	16 17	178888 178889	0.9999874830245972	O
43670	.	17 18	178889 178890	0.9999886751174927	O
43671	2542	18 21	178890 178893	0.9999858140945435	O
43673	G	23 24	178895 178896	0.9999864101409912	O
43674	>	24 25	178896 178897	0.9999878406524658	O
43675	T	25 26	178897 178898	0.999987006187439	O
43676	(	27 28	178899 178900	0.9999880790710449	O
43677	p	29 30	178901 178902	0.9999866485595703	O
43678	.	30 31	178902 178903	0.999976396560669	O
43679	Ala848Ser	0 8	178903 178911	0.9999876022338867	O
43685	)	10 11	178913 178914	0.9999856948852539	O
43686	were	12 16	178915 178919	0.9999874830245972	O
43687	unclassified	17 28	178920 178931	0.9999878406524658	O
43689	and	30 33	178933 178936	0.9999866485595703	O
43690	have	34 38	178937 178941	0.999985933303833	O
43691	to	39 41	178942 178944	0.9999856948852539	O
43692	our	42 45	178945 178948	0.9999861717224121	O
43693	knowledge	46 55	178949 178958	0.9999865293502808	O
43694	never	56 61	178959 178964	0.9999876022338867	O
43695	been	62 66	178965 178969	0.9999880790710449	O
43696	described	67 76	178970 178979	0.9999877214431763	O
43697	previously	77 87	178980 178990	0.9999872446060181	O
43698	neither	88 95	178991 178998	0.9999833106994629	O
43699	in	96 98	178999 179001	0.9999871253967285	O
43700	the	99 102	179002 179005	0.9999834299087524	O
43701	Danish	103 109	179006 179012	0.9995556473731995	O
43702	population	110 120	179013 179023	0.9999861717224121	O
43703	nor	121 124	179024 179027	0.9999847412109375	O
43704	in	125 127	179028 179030	0.9999861717224121	O
43705	other	128 133	179031 179036	0.9999781847000122	O
43706	populations	134 145	179037 179048	0.9999818801879883	O
43707	.	146 147	179049 179050	0.9999594688415527	O
43708	Other	0 5	179051 179056	0.9999758005142212	O
43709	disease	6 13	179057 179064	0.9999819993972778	O
43710	causing	14 21	179065 179072	0.999983549118042	O
43711	mutations	22 31	179073 179082	0.9999786615371704	O
43712	have	32 36	179083 179087	0.9999840259552002	O
43713	been	37 41	179088 179092	0.999985933303833	O
43714	identified	42 52	179093 179103	0.999984622001648	O
43715	in	53 55	179104 179106	0.9999855756759644	O
43716	the	56 59	179107 179110	0.9999818801879883	O
43717	families	60 68	179111 179119	0.999963641166687	O
43718	harbouring	69 78	179120 179129	0.9999830722808838	O
43720	the	80 83	179131 179134	0.9999862909317017	O
43721	two	84 87	179135 179138	0.9999767541885376	O
43722	hMLH1	88 92	179139 179143	0.9999788999557495	O
43725	variants	94 102	179145 179153	0.999985933303833	O
43726	changing	103 111	179154 179162	0.9999837875366211	O
43727	non	112 115	179163 179166	0.9999866485595703	O
43728	-	115 116	179166 179167	0.9999877214431763	O
43729	conserved	116 125	179167 179176	0.999985933303833	O
43730	amino	126 131	179177 179182	0.9999843835830688	O
43731	acids	132 137	179183 179188	0.9999862909317017	O
43732	i	138 139	179189 179190	0.9999866485595703	O
43733	.	140 141	179191 179192	0.9999867677688599	O
43734	e	141 142	179192 179193	0.9999849796295166	O
43735	.	143 144	179194 179195	0.9999713897705078	O
43736	pGlu460Ala	0 9	179196 179205	0.999987006187439	O
43743	and	11 14	179207 179210	0.9999828338623047	O
43744	p	15 16	179211 179212	0.9999858140945435	O
43745	.	16 17	179212 179213	0.9999657869338989	O
43746	Ile563Met	0 8	179213 179221	0.9999872446060181	O
43753	(	10 11	179223 179224	0.9999887943267822	O
43754	unpublished	11 22	179224 179235	0.9999855756759644	O
43755	results	23 30	179236 179243	0.9999872446060181	O
43756	)	31 32	179244 179245	0.999988317489624	O
43757	consequently	33 45	179246 179258	0.9999861717224121	O
43758	,	46 47	179259 179260	0.9999876022338867	O
43759	these	48 53	179261 179266	0.9999871253967285	O
43760	variants	54 62	179267 179275	0.9999847412109375	O
43761	are	63 66	179276 179279	0.9999879598617554	O
43762	most	67 71	179280 179284	0.999988317489624	O
43763	likely	72 78	179285 179291	0.9999884366989136	O
43764	neutral	79 86	179292 179299	0.999983549118042	O
43765	and	87 90	179300 179303	0.9999849796295166	O
43766	not	91 94	179304 179307	0.999984622001648	O
43767	involved	95 103	179308 179316	0.9999868869781494	O
43768	in	104 106	179317 179319	0.9999874830245972	O
43769	HNPCC	107 111	179320 179324	0.9999840259552002	O
43772	.	112 113	179325 179326	0.9999697208404541	O
43773	However	0 7	179327 179334	0.9999855756759644	O
43774	,	8 9	179335 179336	0.9999874830245972	O
43775	no	10 12	179337 179339	0.9999839067459106	O
43776	other	13 18	179340 179345	0.9999798536300659	O
43777	disease	19 26	179346 179353	0.9999836683273315	O
43778	causing	27 34	179354 179361	0.9999850988388062	O
43779	mutations	35 44	179362 179371	0.9999817609786987	O
43780	have	45 49	179372 179376	0.999985933303833	O
43781	been	50 54	179377 179381	0.999987006187439	O
43782	identified	55 65	179382 179392	0.999985933303833	O
43783	in	66 68	179393 179395	0.9999864101409912	O
43784	the	69 72	179396 179399	0.999984860420227	O
43785	families	73 81	179400 179408	0.9999756813049316	O
43786	harbouring	82 91	179409 179418	0.9999852180480957	O
43788	the	93 96	179420 179423	0.999987006187439	O
43789	hMSH2	97 101	179424 179428	0.9999855756759644	O
43793	variants	103 111	179430 179438	0.9999858140945435	O
43794	changing	112 120	179439 179447	0.9999855756759644	O
43795	conserved	121 130	179448 179457	0.9999856948852539	O
43796	amino	131 136	179458 179463	0.9999860525131226	O
43797	acids	137 142	179464 179469	0.9999874830245972	O
43798	i	143 144	179470 179471	0.9999873638153076	O
43799	.	145 146	179472 179473	0.9999874830245972	O
43800	e	146 147	179473 179474	0.9999858140945435	O
43801	.	148 149	179475 179476	0.9999736547470093	O
43802	p	0 1	179477 179478	0.9999444484710693	O
43803	.	1 2	179478 179479	0.9998949766159058	O
43804	Met688Val	0 8	179479 179487	0.9999856948852539	O
43810	and	10 13	179489 179492	0.9999814033508301	O
43811	p	14 15	179493 179494	0.999982476234436	O
43812	.	15 16	179494 179495	0.9999691247940063	O
43813	Ala848Ser	0 8	179495 179503	0.9999840259552002	O
43819	variants	10 18	179505 179513	0.9999802112579346	O
43820	.	19 20	179514 179515	0.9998644590377808	O
43821	Further	0 7	179516 179523	0.9999852180480957	O
43822	characterization	8 24	179524 179540	0.9999841451644897	O
43823	of	25 27	179541 179543	0.9999865293502808	O
43824	these	28 33	179544 179549	0.9999866485595703	O
43825	variants	34 42	179550 179558	0.9999818801879883	O
43826	such	43 47	179559 179563	0.9999866485595703	O
43827	as	48 50	179564 179566	0.9999877214431763	O
43828	functional	51 61	179567 179577	0.9999711513519287	O
43829	studies	62 69	179578 179585	0.9999868869781494	O
43830	and	70 73	179586 179589	0.9999876022338867	O
43831	segregations	74 85	179590 179601	0.9999840259552002	O
43833	analysis	87 95	179603 179611	0.9999874830245972	O
43834	are	96 99	179612 179615	0.9999850988388062	O
43835	needed	100 106	179616 179622	0.9999855756759644	O
43836	before	107 113	179623 179629	0.9999834299087524	O
43837	any	114 117	179630 179633	0.9999866485595703	O
43838	final	118 123	179634 179639	0.9999864101409912	O
43839	conclusion	124 134	179640 179650	0.9999858140945435	O
43840	can	135 138	179651 179654	0.9999858140945435	O
43841	be	139 141	179655 179657	0.9999866485595703	O
43842	drawn	142 147	179658 179663	0.9999827146530151	O
43843	regarding	148 157	179664 179673	0.999987006187439	O
43844	their	158 163	179674 179679	0.9999874830245972	O
43845	pathogenicity	164 176	179680 179692	0.9999860525131226	O
43848	.	178 179	179694 179695	0.9999885559082031	O
43849	*	180 181	179696 179697	0.9999874830245972	O
43850	*	181 182	179697 179698	0.9999784231185913	O
43851	IGNORE	0 5	179699 179704	0.9999867677688599	O
43854	LINE	7 10	179706 179709	0.9999890327453613	O
43857	*	12 13	179711 179712	0.9999891519546509	O
43858	*	13 14	179712 179713	0.9999890327453613	O
43859	*	15 16	179714 179715	0.9999890327453613	O
43860	*	16 17	179715 179716	0.9999891519546509	O
43861	IGNORE	18 23	179717 179722	0.9999879598617554	O
43864	LINE	25 28	179724 179727	0.9999892711639404	O
43867	*	30 31	179729 179730	0.9999887943267822	O
43868	*	31 32	179730 179731	0.9999887943267822	O
43869	*	33 34	179732 179733	0.9999889135360718	O
43870	*	34 35	179733 179734	0.9999887943267822	O
43871	IGNORE	36 41	179735 179740	0.9999876022338867	O
43874	LINE	43 46	179742 179745	0.9999890327453613	O
43877	*	48 49	179747 179748	0.9999889135360718	O
43878	*	49 50	179748 179749	0.9999889135360718	O
43879	In	51 53	179750 179752	0.9999887943267822	O
43880	conclusion	54 64	179753 179763	0.999987006187439	O
43881	,	65 66	179764 179765	0.9999892711639404	O
43882	high	67 71	179766 179770	0.9999886751174927	O
43883	penetrance	72 81	179771 179780	0.9999890327453613	O
43886	cancer	83 89	179782 179788	0.9999853372573853	O
43887	susceptibility	90 103	179789 179802	0.9999889135360718	O
43892	genes	105 110	179804 179809	0.9999880790710449	O
43893	involved	111 119	179810 179818	0.999988317489624	O
43894	in	120 122	179819 179821	0.9999890327453613	O
43895	hereditary	123 133	179822 179832	0.9999805688858032	O
43896	syndromes	134 142	179833 179841	0.999985933303833	O
43898	have	144 148	179843 179847	0.9999886751174927	O
43899	rarely	149 155	179848 179854	0.9999872446060181	O
43900	emerged	156 163	179855 179862	0.9999887943267822	O
43901	as	164 166	179863 179865	0.9999891519546509	O
43902	definitive	167 177	179866 179876	0.9999867677688599	O
43903	low	178 181	179877 179880	0.999988317489624	O
43904	-	181 182	179880 179881	0.9999890327453613	O
43905	penetrance	182 191	179881 179890	0.9999885559082031	O
43908	genes	193 198	179892 179897	0.9999880790710449	O
43909	as	199 201	179898 179900	0.9999890327453613	O
43910	a	202 203	179901 179902	0.9999892711639404	O
43911	result	204 210	179903 179909	0.9999889135360718	O
43912	of	211 213	179910 179912	0.9999895095825195	O
43913	common	214 220	179913 179919	0.9999852180480957	O
43914	variants	221 229	179920 179928	0.9999854564666748	O
43915	increasing	230 240	179929 179939	0.9999831914901733	O
43916	disease	241 248	179940 179947	0.9999842643737793	O
43917	susceptibility	249 262	179948 179961	0.9999887943267822	O
43922	[	264 265	179963 179964	0.99998939037323	O
43923	19	265 267	179964 179966	0.9999849796295166	O
43924	]	267 268	179966 179967	0.9999889135360718	O
43925	.	269 270	179968 179969	0.9999749660491943	O
43926	The	0 3	179970 179973	0.9999836683273315	O
43927	results	4 11	179974 179981	0.9999843835830688	O
43928	shown	12 17	179982 179987	0.9999812841415405	O
43929	in	18 20	179988 179990	0.9999845027923584	O
43930	the	21 24	179991 179994	0.9999831914901733	O
43931	present	25 32	179995 180002	0.9999828338623047	O
43932	study	33 38	180003 180008	0.9999819993972778	O
43933	demonstrate	39 50	180009 180020	0.9999798536300659	O
43934	that	51 55	180021 180025	0.9999876022338867	O
43935	the	56 59	180026 180029	0.9999866485595703	O
43936	high	60 64	180030 180034	0.9999873638153076	O
43937	-	64 65	180034 180035	0.9999866485595703	O
43938	penetrance	65 74	180035 180044	0.9999874830245972	O
43941	HNPCC	76 80	180046 180050	0.9999861717224121	O
43944	genes	82 87	180052 180057	0.9999877214431763	O
43945	hMLH1	88 92	180058 180062	0.9999879598617554	O
43948	and	94 97	180064 180067	0.9999871253967285	O
43949	hMSH2	98 102	180068 180072	0.9999874830245972	O
43953	also	104 108	180074 180078	0.9999845027923584	O
43954	do	109 111	180079 180081	0.9999856948852539	O
43955	not	112 115	180082 180085	0.9999865293502808	O
43956	appear	116 122	180086 180092	0.999987006187439	O
43957	to	123 125	180093 180095	0.9999864101409912	O
43958	be	126 128	180096 180098	0.9999876022338867	O
43959	low	129 132	180099 180102	0.999987006187439	O
43960	penetrance	133 142	180103 180112	0.9999874830245972	O
43963	genes	144 149	180114 180119	0.9999871253967285	O
43964	involved	150 158	180120 180128	0.9999866485595703	O
43965	in	159 161	180129 180131	0.9999865293502808	O
43966	sporadic	162 169	180132 180139	0.9999853372573853	O
43968	CRC	171 173	180141 180143	0.999980092048645	O
43970	in	175 177	180145 180147	0.999985933303833	O
43971	the	178 181	180148 180151	0.9999821186065674	O
43972	Danish	182 188	180152 180158	0.9986342787742615	O
43973	population	189 199	180159 180169	0.9999831914901733	O
43974	.	200 201	180170 180171	0.9999876022338867	O
43975	*	202 203	180172 180173	0.9999856948852539	O
43976	*	203 204	180173 180174	0.9999711513519287	O
43977	IGNORE	0 5	180175 180180	0.9999872446060181	O
43980	LINE	7 10	180182 180185	0.9999892711639404	O
43983	*	12 13	180187 180188	0.9999895095825195	O
43984	*	13 14	180188 180189	0.99998939037323	O
43985	*	15 16	180190 180191	0.99998939037323	O
43986	*	16 17	180191 180192	0.9999895095825195	O
43987	IGNORE	18 23	180193 180198	0.9999885559082031	O
43990	LINE	25 28	180200 180203	0.9999895095825195	O
43993	*	30 31	180205 180206	0.9999891519546509	O
43994	*	31 32	180206 180207	0.9999891519546509	O
43995	*	33 34	180208 180209	0.9999891519546509	O
43996	*	34 35	180209 180210	0.9999890327453613	O
43997	IGNORE	36 41	180211 180216	0.999988317489624	O
44000	LINE	43 46	180218 180221	0.99998939037323	O
44003	*	48 49	180223 180224	0.9999891519546509	O
44004	*	49 50	180224 180225	0.9999891519546509	O
44005	Design	51 57	180226 180232	0.9999884366989136	O
44006	considerations	58 72	180233 180247	0.9999890327453613	O
44007	in	73 75	180248 180250	0.99998939037323	O
44008	a	76 77	180251 180252	0.9999895095825195	O
44009	sib	78 80	180253 180255	0.9999884366989136	O
44011	-	81 82	180256 180257	0.9999897480010986	O
44012	pair	82 86	180257 180261	0.9999884366989136	O
44013	study	87 92	180262 180267	0.9999891519546509	O
44014	of	93 95	180268 180270	0.99998939037323	O
44015	linkage	96 102	180271 180277	0.9999885559082031	O
44017	for	104 107	180279 180282	0.9999892711639404	O
44018	susceptibility	108 121	180283 180296	0.9999887943267822	O
44023	loci	123 126	180298 180301	0.9999891519546509	O
44025	in	128 130	180303 180305	0.99998939037323	O
44026	cancer	131 137	180306 180312	0.999987006187439	O
44027	Abstract	138 145	180313 180320	0.9999890327453613	O
44030	Background	147 157	180322 180332	0.9999866485595703	O
44031	Modern	158 164	180333 180339	0.9999842643737793	O
44032	approaches	165 175	180340 180350	0.9999871253967285	O
44033	to	176 178	180351 180353	0.9999880790710449	O
44034	identifying	179 190	180354 180365	0.9999889135360718	O
44035	new	191 194	180366 180369	0.9999871253967285	O
44036	genes	195 200	180370 180375	0.9999867677688599	O
44037	associated	201 211	180376 180386	0.9999891519546509	O
44038	with	212 216	180387 180391	0.9999889135360718	O
44039	disease	217 224	180392 180399	0.9999854564666748	O
44040	allow	225 230	180400 180405	0.9999878406524658	O
44041	very	231 235	180406 180410	0.9999887943267822	O
44042	fine	236 240	180411 180415	0.9999880790710449	O
44043	analysis	241 249	180416 180424	0.9999892711639404	O
44044	of	250 252	180425 180427	0.99998939037323	O
44045	associaton	253 262	180428 180437	0.99998939037323	O
44049	and	264 267	180439 180442	0.9999855756759644	O
44050	can	268 271	180443 180446	0.9999853372573853	O
44051	be	272 274	180447 180449	0.9999881982803345	O
44052	performed	275 284	180450 180459	0.999987006187439	O
44053	in	285 287	180460 180462	0.9999885559082031	O
44054	population	288 298	180463 180473	0.9999861717224121	O
44055	based	299 304	180474 180479	0.999988317489624	O
44056	case	305 309	180480 180484	0.9999864101409912	O
44057	-	309 310	180484 180485	0.9999890327453613	O
44058	control	310 317	180485 180492	0.9999841451644897	O
44059	studies	318 325	180493 180500	0.9999876022338867	O
44060	.	326 327	180501 180502	0.9999650716781616	O
44061	However	0 7	180503 180510	0.9999843835830688	O
44062	,	8 9	180511 180512	0.9999872446060181	O
44063	the	10 13	180513 180516	0.999987006187439	O
44064	sibpair	14 20	180517 180523	0.9999853372573853	O
44067	design	22 28	180525 180531	0.9999843835830688	O
44068	is	29 31	180532 180534	0.9999864101409912	O
44069	still	32 37	180535 180540	0.9999831914901733	O
44070	valuable	38 46	180541 180549	0.999985933303833	O
44071	because	47 54	180550 180557	0.9999860525131226	O
44072	it	55 57	180558 180560	0.9999876022338867	O
44073	requires	58 66	180561 180569	0.9999877214431763	O
44074	few	67 70	180570 180573	0.999987006187439	O
44075	assumptions	71 82	180574 180585	0.9999799728393555	O
44076	other	83 88	180586 180591	0.9999876022338867	O
44077	than	89 93	180592 180596	0.9999878406524658	O
44078	acceptably	94 103	180597 180606	0.999988317489624	O
44080	high	105 109	180608 180612	0.9999879598617554	O
44081	penetrance	110 119	180613 180622	0.9999887943267822	O
44084	to	121 123	180624 180626	0.9999881982803345	O
44085	identify	124 132	180627 180635	0.9999886751174927	O
44086	genetic	133 140	180636 180643	0.9999877214431763	O
44087	loci	141 144	180644 180647	0.9999887943267822	O
44089	.	146 147	180649 180650	0.9999607801437378	O
44090	Methods	0 6	180651 180657	0.9999749660491943	O
44092	We	8 10	180659 180661	0.9999752044677734	O
44093	conducted	11 20	180662 180671	0.9999809265136719	O
44094	simulation	21 31	180672 180682	0.9998626708984375	O
44095	studies	32 39	180683 180690	0.9999809265136719	O
44096	to	40 42	180691 180693	0.9999823570251465	O
44097	assess	43 49	180694 180700	0.9999815225601196	O
44098	the	50 53	180701 180704	0.9999858140945435	O
44099	impact	54 60	180705 180711	0.9999836683273315	O
44100	of	61 63	180712 180714	0.9999856948852539	O
44101	design	64 70	180715 180721	0.9999817609786987	O
44102	factors	71 78	180722 180729	0.9999852180480957	O
44103	on	79 81	180730 180732	0.999984860420227	O
44104	relative	82 90	180733 180741	0.9999860525131226	O
44105	efficiency	91 101	180742 180752	0.9999852180480957	O
44106	for	102 105	180753 180756	0.999983549118042	O
44107	a	106 107	180757 180758	0.9999849796295166	O
44108	linkage	108 114	180759 180765	0.9999817609786987	O
44110	study	116 121	180767 180772	0.9999828338623047	O
44111	of	122 124	180773 180775	0.9999864101409912	O
44112	colorectal	125 134	180776 180785	0.9999853372573853	O
44115	cancer	136 142	180787 180793	0.999985933303833	O
44116	.	143 144	180794 180795	0.9999634027481079	O
44117	We	0 2	180796 180798	0.9999854564666748	O
44118	considered	3 13	180799 180809	0.9999872446060181	O
44119	two	14 17	180810 180813	0.9999881982803345	O
44120	test	18 22	180814 180818	0.9999867677688599	O
44121	statistics	23 33	180819 180829	0.9999878406524658	O
44122	,	34 35	180830 180831	0.9999886751174927	O
44123	one	36 39	180832 180835	0.9999885559082031	O
44124	comparing	40 49	180836 180845	0.9999892711639404	O
44125	the	50 53	180846 180849	0.9999897480010986	O
44126	mean	54 58	180850 180854	0.99998939037323	O
44127	IBD	59 61	180855 180857	0.9999891519546509	O
44130	probability	63 74	180859 180870	0.9999898672103882	O
44131	in	75 77	180871 180873	0.9999899864196777	O
44132	affected	78 86	180874 180882	0.9999884366989136	O
44133	pairs	87 92	180883 180888	0.9999885559082031	O
44134	to	93 95	180889 180891	0.9999895095825195	O
44135	its	96 99	180892 180895	0.9999897480010986	O
44136	null	100 104	180896 180900	0.9999889135360718	O
44137	value	105 110	180901 180906	0.99998939037323	O
44138	of	111 113	180907 180909	0.9999895095825195	O
44139	0	114 115	180910 180911	0.9999895095825195	O
44140	.	115 116	180911 180912	0.9999896287918091	O
44141	5	116 117	180912 180913	0.9999889135360718	O
44142	,	118 119	180914 180915	0.9999886751174927	O
44143	and	120 123	180916 180919	0.9999891519546509	O
44144	one	124 127	180920 180923	0.9999890327453613	O
44145	comparing	128 137	180924 180933	0.9999892711639404	O
44146	the	138 141	180934 180937	0.9999896287918091	O
44147	mean	142 146	180938 180942	0.9999889135360718	O
44148	IBD	147 149	180943 180945	0.9999891519546509	O
44151	probabilities	151 163	180947 180959	0.9999896287918091	O
44154	between	165 172	180961 180968	0.9999891519546509	O
44155	affected	173 181	180969 180977	0.9999880790710449	O
44156	and	182 185	180978 180981	0.9999887943267822	O
44157	discordant	186 195	180982 180991	0.999988317489624	O
44160	pairs	197 202	180993 180998	0.999988317489624	O
44161	.	203 204	180999 181000	0.9999747276306152	O
44162	We	0 2	181001 181003	0.999981164932251	O
44163	varied	3 9	181004 181010	0.999984860420227	O
44164	numbers	10 17	181011 181018	0.9999874830245972	O
44165	of	18 20	181019 181021	0.9999880790710449	O
44166	parents	21 28	181022 181029	0.9999843835830688	O
44167	available	29 38	181030 181039	0.9999865293502808	O
44168	,	39 40	181040 181041	0.9999878406524658	O
44169	numbers	41 48	181042 181049	0.9999868869781494	O
44170	of	49 51	181050 181052	0.9999884366989136	O
44171	affected	52 60	181053 181061	0.9999860525131226	O
44172	and	61 64	181062 181065	0.999987006187439	O
44173	unaffected	65 74	181066 181075	0.9999864101409912	O
44176	siblings	76 84	181077 181085	0.9999818801879883	O
44177	,	85 86	181086 181087	0.9999886751174927	O
44178	reconstructing	87 100	181088 181101	0.9999889135360718	O
44183	the	102 105	181103 181106	0.9999891519546509	O
44184	genotype	106 113	181107 181114	0.999988317489624	O
44187	of	115 117	181116 181118	0.9999890327453613	O
44188	an	118 120	181119 181121	0.99998939037323	O
44189	unavailable	121 132	181122 181133	0.9999874830245972	O
44190	affected	133 141	181134 181142	0.9999868869781494	O
44191	sibling	142 149	181143 181150	0.999984622001648	O
44192	by	150 152	181151 181153	0.999988317489624	O
44193	a	153 154	181154 181155	0.9999890327453613	O
44194	spouse	155 161	181156 181162	0.9999842643737793	O
44195	and	162 165	181163 181166	0.9999872446060181	O
44196	offspring	166 175	181167 181176	0.9999833106994629	O
44197	,	176 177	181177 181178	0.9999886751174927	O
44198	and	178 181	181179 181182	0.9999890327453613	O
44199	elimination	182 193	181183 181194	0.9999840259552002	O
44200	of	194 196	181195 181197	0.9999887943267822	O
44201	sibships	197 204	181198 181205	0.9999850988388062	O
44204	where	206 211	181207 181212	0.9999884366989136	O
44205	the	212 215	181213 181216	0.9999885559082031	O
44206	proband	216 222	181217 181223	0.9999853372573853	O
44208	carries	224 231	181225 181232	0.9999878406524658	O
44209	a	232 233	181233 181234	0.9999890327453613	O
44210	mutation	234 242	181235 181243	0.9999865293502808	O
44211	at	243 245	181244 181246	0.9999887943267822	O
44212	another	246 253	181247 181254	0.9999868869781494	O
44213	locus	254 258	181255 181259	0.9999880790710449	O
44215	.	260 261	181261 181262	0.9999374151229858	O
44216	Results	0 7	181263 181270	0.9999822378158569	O
44217	Power	8 13	181271 181276	0.9999871253967285	O
44218	and	14 17	181277 181280	0.9999874830245972	O
44219	efficiency	18 28	181281 181291	0.9999831914901733	O
44220	were	29 33	181292 181296	0.9999873638153076	O
44221	most	34 38	181297 181301	0.9999855756759644	O
44222	affected	39 47	181302 181310	0.9999858140945435	O
44223	by	48 50	181311 181313	0.9999889135360718	O
44224	the	51 54	181314 181317	0.9999892711639404	O
44225	number	55 61	181318 181324	0.9999889135360718	O
44226	of	62 64	181325 181327	0.9999895095825195	O
44227	affected	65 73	181328 181336	0.9999877214431763	O
44228	sibs	74 77	181337 181340	0.9999879598617554	O
44230	,	79 80	181342 181343	0.9999886751174927	O
44231	the	81 84	181344 181347	0.9999892711639404	O
44232	number	85 91	181348 181354	0.9999890327453613	O
44233	of	92 94	181355 181357	0.9999892711639404	O
44234	sib	95 97	181358 181360	0.9999880790710449	O
44236	pairs	99 104	181362 181367	0.9999885559082031	O
44237	genotyped	105 113	181368 181376	0.9999891519546509	O
44241	,	115 116	181378 181379	0.9999884366989136	O
44242	and	117 120	181380 181383	0.9999889135360718	O
44243	the	121 124	181384 181387	0.99998939037323	O
44244	risk	125 129	181388 181392	0.9999890327453613	O
44245	attributable	130 141	181393 181404	0.99998939037323	O
44249	to	143 145	181406 181408	0.9999896287918091	O
44250	linked	146 152	181409 181415	0.9999890327453613	O
44251	and	153 156	181416 181419	0.9999887943267822	O
44252	unlinked	157 164	181420 181427	0.9999892711639404	O
44255	loci	166 169	181429 181432	0.9999891519546509	O
44257	.	171 172	181434 181435	0.9999717473983765	O
44258	Genotyping	0 9	181436 181445	0.9999865293502808	O
44262	unaffected	11 20	181447 181456	0.9999877214431763	O
44265	siblings	22 30	181458 181466	0.9999774694442749	O
44266	added	31 36	181467 181472	0.9999855756759644	O
44267	little	37 43	181473 181479	0.9999806880950928	O
44268	power	44 49	181480 181485	0.9999878406524658	O
44269	for	50 53	181486 181489	0.9999886751174927	O
44270	low	54 57	181490 181493	0.9999876022338867	O
44271	penetrance	58 67	181494 181503	0.9999889135360718	O
44274	models	69 75	181505 181511	0.9999880790710449	O
44275	,	76 77	181512 181513	0.9999872446060181	O
44276	but	78 81	181514 181517	0.9999860525131226	O
44277	improved	82 90	181518 181526	0.9999864101409912	O
44278	validity	91 99	181527 181535	0.9999867677688599	O
44279	of	100 102	181536 181538	0.9999887943267822	O
44280	tests	103 108	181539 181544	0.9999865293502808	O
44281	when	109 113	181545 181549	0.9999884366989136	O
44282	there	114 119	181550 181555	0.9999886751174927	O
44283	was	120 123	181556 181559	0.9999886751174927	O
44284	genetic	124 131	181560 181567	0.9999877214431763	O
44285	heterogeneity	132 144	181568 181580	0.9999891519546509	O
44289	and	146 149	181582 181585	0.9999872446060181	O
44290	for	150 153	181586 181589	0.9999880790710449	O
44291	multipoint	154 163	181590 181599	0.9999881982803345	O
44293	testing	165 172	181601 181608	0.9999886751174927	O
44294	.	173 174	181609 181610	0.9999725818634033	O
44295	The	0 3	181611 181614	0.9999872446060181	O
44296	efficiency	4 14	181615 181625	0.9999843835830688	O
44297	of	15 17	181626 181628	0.9999881982803345	O
44298	the	18 21	181629 181632	0.9999887943267822	O
44299	concordant	22 31	181633 181642	0.9999887943267822	O
44302	-	32 33	181643 181644	0.9999892711639404	O
44303	only	33 37	181644 181648	0.9999877214431763	O
44304	test	38 42	181649 181653	0.9999877214431763	O
44305	was	43 46	181654 181657	0.9999864101409912	O
44306	nearly	47 53	181658 181664	0.9999860525131226	O
44307	always	54 60	181665 181671	0.9999853372573853	O
44308	better	61 67	181672 181678	0.9999864101409912	O
44309	than	68 72	181679 181683	0.9999880790710449	O
44310	the	73 76	181684 181687	0.9999890327453613	O
44311	concordant	77 86	181688 181697	0.9999889135360718	O
44314	-	87 88	181698 181699	0.9999892711639404	O
44315	discordant	88 97	181699 181708	0.9999885559082031	O
44318	test	99 103	181710 181714	0.999988317489624	O
44319	.	104 105	181715 181716	0.9999703168869019	O
44320	Replacement	0 10	181717 181727	0.9999872446060181	O
44323	of	12 14	181729 181731	0.9999880790710449	O
44324	an	15 17	181732 181734	0.9999881982803345	O
44325	unavailable	18 29	181735 181746	0.999984860420227	O
44326	affected	30 38	181747 181755	0.9999831914901733	O
44327	sibling	39 46	181756 181763	0.9999817609786987	O
44328	by	47 49	181764 181766	0.9999862909317017	O
44329	a	50 51	181767 181768	0.9999872446060181	O
44330	spouse	52 58	181769 181775	0.9999771118164062	O
44331	and	59 62	181776 181779	0.9999856948852539	O
44332	offspring	63 72	181780 181789	0.9999786615371704	O
44333	recovered	73 82	181790 181799	0.9999862909317017	O
44334	some	83 87	181800 181804	0.9999876022338867	O
44335	linkage	88 94	181805 181811	0.9999867677688599	O
44337	information	96 107	181813 181824	0.9999878406524658	O
44338	,	108 109	181825 181826	0.9999877214431763	O
44339	particularly	110 122	181827 181839	0.9999864101409912	O
44340	if	123 125	181840 181842	0.9999855756759644	O
44341	several	126 133	181843 181850	0.9999865293502808	O
44342	offspring	134 143	181851 181860	0.9999796152114868	O
44343	were	144 148	181861 181865	0.999988317489624	O
44344	available	149 158	181866 181875	0.999987006187439	O
44345	.	159 160	181876 181877	0.9999579191207886	O
44346	In	0 2	181878 181880	0.9999889135360718	O
44347	multipoint	3 12	181881 181890	0.9999885559082031	O
44349	analysis	14 22	181892 181900	0.9999889135360718	O
44350	,	23 24	181901 181902	0.9999887943267822	O
44351	the	25 28	181903 181906	0.9999892711639404	O
44352	concordant	29 38	181907 181916	0.9999892711639404	O
44355	-	39 40	181917 181918	0.99998939037323	O
44356	only	40 44	181918 181922	0.9999886751174927	O
44357	test	45 49	181923 181927	0.9999887943267822	O
44358	was	50 53	181928 181931	0.9999887943267822	O
44359	showed	54 60	181932 181938	0.9999879598617554	O
44360	a	61 62	181939 181940	0.9999891519546509	O
44361	small	63 68	181941 181946	0.9999854564666748	O
44362	anticonservative	69 84	181947 181962	0.9999891519546509	O
44367	bias	86 90	181964 181968	0.9999885559082031	O
44368	at	91 93	181969 181971	0.9999891519546509	O
44369	5	94 95	181972 181973	0.9999886751174927	O
44370	cM	96 97	181974 181975	0.9999889135360718	O
44372	,	99 100	181977 181978	0.9999887943267822	O
44373	while	101 106	181979 181984	0.9999885559082031	O
44374	the	107 110	181985 181988	0.99998939037323	O
44375	multipoint	111 120	181989 181998	0.9999889135360718	O
44377	concordant	122 131	182000 182009	0.9999891519546509	O
44380	-	132 133	182010 182011	0.9999891519546509	O
44381	discordant	133 142	182011 182020	0.9999886751174927	O
44384	test	144 148	182022 182026	0.9999887943267822	O
44385	was	149 152	182027 182030	0.9999890327453613	O
44386	generally	153 162	182031 182040	0.9999878406524658	O
44387	the	163 166	182041 182044	0.9999890327453613	O
44388	most	167 171	182045 182049	0.9999885559082031	O
44389	powerful	172 180	182050 182058	0.9999852180480957	O
44390	test	181 185	182059 182063	0.9999880790710449	O
44391	,	186 187	182064 182065	0.9999878406524658	O
44392	and	188 191	182066 182069	0.999988317489624	O
44393	was	192 195	182070 182073	0.9999890327453613	O
44394	not	196 199	182074 182077	0.999988317489624	O
44395	biased	200 205	182078 182083	0.9999877214431763	O
44397	away	207 211	182085 182089	0.9999884366989136	O
44398	from	212 216	182090 182094	0.9999889135360718	O
44399	the	217 220	182095 182098	0.9999891519546509	O
44400	null	221 225	182099 182103	0.9999879598617554	O
44401	at	226 228	182104 182106	0.9999890327453613	O
44402	5	229 230	182107 182108	0.9999881982803345	O
44403	cM	231 232	182109 182110	0.9999886751174927	O
44405	.	233 234	182111 182112	0.9999880790710449	O
44406	Conclusion	235 244	182113 182122	0.9999872446060181	O
44409	Genotyping	246 255	182124 182133	0.999988317489624	O
44413	parents	257 264	182135 182142	0.9999861717224121	O
44414	and	265 268	182143 182146	0.9999881982803345	O
44415	unaffected	269 278	182147 182156	0.9999881982803345	O
44418	siblings	280 288	182158 182166	0.999976396560669	O
44419	is	289 291	182167 182169	0.9999878406524658	O
44420	useful	292 298	182170 182176	0.9999874830245972	O
44421	for	299 302	182177 182180	0.9999884366989136	O
44422	detecting	303 311	182181 182189	0.9999884366989136	O
44424	genotyping	313 322	182191 182200	0.9999874830245972	O
44428	errors	324 330	182202 182208	0.9999881982803345	O
44429	and	331 334	182209 182212	0.9999860525131226	O
44430	if	335 337	182213 182215	0.9999842643737793	O
44431	allele	338 343	182216 182221	0.9999881982803345	O
44433	frequencies	345 356	182223 182234	0.9999867677688599	O
44434	are	357 360	182235 182238	0.999988317489624	O
44435	uncertain	361 370	182239 182248	0.9999868869781494	O
44436	.	371 372	182249 182250	0.9999532699584961	O
44437	If	0 2	182251 182253	0.9999819993972778	O
44438	adequate	3 11	182254 182262	0.9999853372573853	O
44439	allele	12 17	182263 182268	0.9999867677688599	O
44441	frequency	19 28	182270 182279	0.9999866485595703	O
44442	data	29 33	182280 182284	0.9999866485595703	O
44443	are	34 37	182285 182288	0.9999858140945435	O
44444	available	38 47	182289 182298	0.9999856948852539	O
44445	,	48 49	182299 182300	0.999985933303833	O
44446	we	50 52	182301 182303	0.999984622001648	O
44447	suggest	53 60	182304 182311	0.9999867677688599	O
44448	a	61 62	182312 182313	0.9999880790710449	O
44449	single	63 69	182314 182320	0.9999879598617554	O
44450	-	69 70	182320 182321	0.9999881982803345	O
44451	point	70 75	182321 182326	0.9999878406524658	O
44452	affecteds	76 84	182327 182335	0.9999867677688599	O
44454	-	85 86	182336 182337	0.9999885559082031	O
44455	only	86 90	182337 182341	0.9999881982803345	O
44456	analysis	91 99	182342 182350	0.9999880790710449	O
44457	for	100 103	182351 182354	0.9999876022338867	O
44458	an	104 106	182355 182357	0.999988317489624	O
44459	initial	107 114	182358 182365	0.999988317489624	O
44460	scan	115 119	182366 182370	0.9999874830245972	O
44461	,	120 121	182371 182372	0.9999878406524658	O
44462	followed	122 130	182373 182381	0.9999876022338867	O
44463	by	131 133	182382 182384	0.9999880790710449	O
44464	a	134 135	182385 182386	0.9999880790710449	O
44465	multipoint	136 145	182387 182396	0.9999880790710449	O
44467	analysis	147 155	182398 182406	0.9999879598617554	O
44468	of	156 158	182407 182409	0.9999881982803345	O
44469	affected	159 167	182410 182418	0.9999865293502808	O
44470	and	168 171	182419 182422	0.9999877214431763	O
44471	unaffected	172 181	182423 182432	0.9999860525131226	O
44474	members	183 190	182434 182441	0.9999849796295166	O
44475	of	191 193	182442 182444	0.9999874830245972	O
44476	all	194 197	182445 182448	0.9999879598617554	O
44477	available	198 207	182449 182458	0.9999864101409912	O
44478	sibships	208 215	182459 182466	0.9999854564666748	O
44481	with	217 221	182468 182472	0.9999880790710449	O
44482	additional	222 232	182473 182483	0.9999874830245972	O
44483	markers	233 240	182484 182491	0.9999865293502808	O
44484	around	241 247	182492 182498	0.9999878406524658	O
44485	initial	248 255	182499 182506	0.9999881982803345	O
44486	hits	256 260	182507 182511	0.9999867677688599	O
44487	.	261 262	182512 182513	0.9999885559082031	O
44488	*	263 264	182514 182515	0.9999872446060181	O
44489	*	264 265	182515 182516	0.9999659061431885	O
44490	IGNORE	0 5	182517 182522	0.9999872446060181	O
44493	LINE	7 10	182524 182527	0.99998939037323	O
44496	*	12 13	182529 182530	0.9999896287918091	O
44497	*	13 14	182530 182531	0.9999896287918091	O
44498	*	15 16	182532 182533	0.9999896287918091	O
44499	*	16 17	182533 182534	0.9999897480010986	O
44500	IGNORE	18 23	182535 182540	0.9999884366989136	O
44503	LINE	25 28	182542 182545	0.9999896287918091	O
44506	*	30 31	182547 182548	0.9999892711639404	O
44507	*	31 32	182548 182549	0.9999892711639404	O
44508	*	33 34	182550 182551	0.99998939037323	O
44509	*	34 35	182551 182552	0.9999892711639404	O
44510	IGNORE	36 41	182553 182558	0.9999880790710449	O
44513	LINE	43 46	182560 182563	0.9999895095825195	O
44516	*	48 49	182565 182566	0.9999895095825195	O
44517	*	49 50	182566 182567	0.9999895095825195	O
44518	Methods	51 57	182568 182574	0.9999885559082031	O
44520	The	59 62	182576 182579	0.9999886751174927	O
44521	choice	63 69	182580 182586	0.9999879598617554	O
44522	of	70 72	182587 182589	0.9999891519546509	O
44523	sampling	73 81	182590 182598	0.9999884366989136	O
44524	schemes	82 89	182599 182606	0.9999878406524658	O
44525	for	90 93	182607 182610	0.9999886751174927	O
44526	a	94 95	182611 182612	0.9999891519546509	O
44527	colon	96 100	182613 182617	0.9999873638153076	O
44529	sibpair	102 108	182619 182625	0.9999877214431763	O
44532	study	110 115	182627 182632	0.9999881982803345	O
44533	requires	116 124	182633 182641	0.9999878406524658	O
44534	evaluation	125 135	182642 182652	0.9999872446060181	O
44535	,	136 137	182653 182654	0.9999878406524658	O
44536	as	138 140	182655 182657	0.9999891519546509	O
44537	several	141 148	182658 182665	0.9999892711639404	O
44538	different	149 158	182666 182675	0.9999884366989136	O
44539	options	159 166	182676 182683	0.9999886751174927	O
44540	exist	167 172	182684 182689	0.9999895095825195	O
44541	simultaneously	173 187	182690 182704	0.9999884366989136	O
44542	for	188 191	182705 182708	0.9999887943267822	O
44543	the	192 195	182709 182712	0.9999891519546509	O
44544	sampling	196 204	182713 182721	0.9999890327453613	O
44545	plan	205 209	182722 182726	0.99998939037323	O
44546	(	210 211	182727 182728	0.9999896287918091	O
44547	how	212 215	182729 182732	0.999988317489624	O
44548	many	216 220	182733 182737	0.9999891519546509	O
44549	families	221 229	182738 182746	0.9999876022338867	O
44550	and	230 233	182747 182750	0.9999873638153076	O
44551	which	234 239	182751 182756	0.9999884366989136	O
44552	relatives	240 249	182757 182766	0.9999865293502808	O
44553	to	250 252	182767 182769	0.9999886751174927	O
44554	sample	253 259	182770 182776	0.9999886751174927	O
44555	)	260 261	182777 182778	0.9999896287918091	O
44556	,	262 263	182779 182780	0.9999890327453613	O
44557	disease	264 271	182781 182788	0.9999867677688599	O
44558	model	272 277	182789 182794	0.9999895095825195	O
44559	(	278 279	182795 182796	0.9999897480010986	O
44560	penetrance	280 289	182797 182806	0.9999889135360718	O
44563	,	291 292	182808 182809	0.9999890327453613	O
44564	allele	293 298	182810 182815	0.9999889135360718	O
44566	frequency	300 309	182817 182826	0.9999890327453613	O
44567	,	310 311	182827 182828	0.9999887943267822	O
44568	etc	312 315	182829 182832	0.9999885559082031	O
44569	)	316 317	182833 182834	0.9999896287918091	O
44570	,	318 319	182835 182836	0.9999885559082031	O
44571	and	320 323	182837 182840	0.9999892711639404	O
44572	statistical	324 335	182841 182852	0.9999868869781494	O
44573	test	336 340	182853 182857	0.99998939037323	O
44574	of	341 343	182858 182860	0.9999895095825195	O
44575	linkage	344 350	182861 182867	0.9999885559082031	O
44577	.	352 353	182869 182870	0.999969482421875	O
44578	These	0 5	182871 182876	0.9999879598617554	O
44579	aspects	6 13	182877 182884	0.999987006187439	O
44580	,	14 15	182885 182886	0.9999880790710449	O
44581	in	16 18	182887 182889	0.9999887943267822	O
44582	addition	19 27	182890 182898	0.9999877214431763	O
44583	to	28 30	182899 182901	0.9999890327453613	O
44584	the	31 34	182902 182905	0.9999890327453613	O
44585	method	35 41	182906 182912	0.9999885559082031	O
44586	of	42 44	182913 182915	0.9999890327453613	O
44587	generating	45 55	182916 182926	0.9999886751174927	O
44588	the	56 59	182927 182930	0.9999892711639404	O
44589	data	60 64	182931 182935	0.9999877214431763	O
44590	sets	65 69	182936 182940	0.9999886751174927	O
44591	for	70 73	182941 182944	0.9999886751174927	O
44592	the	74 77	182945 182948	0.9999890327453613	O
44593	simulations	78 88	182949 182959	0.9999865293502808	O
44595	comprise	90 98	182961 182969	0.9999868869781494	O
44596	the	99 102	182970 182973	0.9999886751174927	O
44597	methods	103 110	182974 182981	0.9999874830245972	O
44598	of	111 113	182982 182984	0.9999889135360718	O
44599	determining	114 125	182985 182996	0.9999887943267822	O
44600	an	126 128	182997 182999	0.99998939037323	O
44601	optimal	129 136	183000 183007	0.9999879598617554	O
44602	design	137 143	183008 183014	0.9999878406524658	O
44603	strategy	144 152	183015 183023	0.9999885559082031	O
44604	for	153 156	183024 183027	0.9999885559082031	O
44605	a	157 158	183028 183029	0.9999890327453613	O
44606	colon	159 163	183030 183034	0.9999872446060181	O
44608	sibpair	165 171	183036 183042	0.9999878406524658	O
44611	study	173 178	183044 183049	0.9999871253967285	O
44612	.	179 180	183050 183051	0.9999697208404541	O
44613	In	0 2	183052 183054	0.999983549118042	O
44614	our	3 6	183055 183058	0.9999799728393555	O
44615	analysis	7 15	183059 183067	0.9999814033508301	O
44616	of	16 18	183068 183070	0.9999854564666748	O
44617	design	19 25	183071 183077	0.9999736547470093	O
44618	issues	26 32	183078 183084	0.9999836683273315	O
44619	we	33 35	183085 183087	0.9999823570251465	O
44620	have	36 40	183088 183092	0.9999817609786987	O
44621	pursued	41 48	183093 183100	0.9999792575836182	O
44622	a	49 50	183101 183102	0.999987006187439	O
44623	deterministic	51 63	183103 183115	0.9999868869781494	O
44627	simulation	65 75	183117 183127	0.9999759197235107	O
44628	approach	76 84	183128 183136	0.999982476234436	O
44629	.	85 86	183137 183138	0.9999535083770752	O
44630	The	0 3	183139 183142	0.9999879598617554	O
44631	first	4 9	183143 183148	0.9999849796295166	O
44632	step	10 14	183149 183153	0.9999849796295166	O
44633	was	15 18	183154 183157	0.9999874830245972	O
44634	to	19 21	183158 183160	0.999988317489624	O
44635	check	22 27	183161 183166	0.9999856948852539	O
44636	that	28 32	183167 183171	0.9999889135360718	O
44637	the	33 36	183172 183175	0.9999877214431763	O
44638	tests	37 42	183176 183181	0.9999842643737793	O
44639	we	43 45	183182 183184	0.9999877214431763	O
44640	considered	46 56	183185 183195	0.9999884366989136	O
44641	had	57 60	183196 183199	0.9999884366989136	O
44642	appropriate	61 72	183200 183211	0.9999877214431763	O
44643	size	73 77	183212 183216	0.9999853372573853	O
44644	,	78 79	183217 183218	0.9999868869781494	O
44645	using	80 85	183219 183224	0.9999885559082031	O
44646	extensive	86 95	183225 183234	0.9999858140945435	O
44647	simulations	96 106	183235 183245	0.9999843835830688	O
44649	.	108 109	183247 183248	0.9999723434448242	O
44650	For	0 3	183249 183252	0.9999823570251465	O
44651	those	4 9	183253 183258	0.9999861717224121	O
44652	tests	10 15	183259 183264	0.9999837875366211	O
44653	that	16 20	183265 183269	0.9999873638153076	O
44654	were	21 25	183270 183274	0.9999878406524658	O
44655	valid	26 31	183275 183280	0.9999833106994629	O
44656	,	32 33	183281 183282	0.9999874830245972	O
44657	we	34 36	183283 183285	0.9999858140945435	O
44658	then	37 41	183286 183290	0.9999833106994629	O
44659	performed	42 51	183291 183300	0.9999874830245972	O
44660	a	52 53	183301 183302	0.9999890327453613	O
44661	moderate	54 62	183303 183311	0.9999861717224121	O
44662	number	63 69	183312 183318	0.9999885559082031	O
44663	of	70 72	183319 183321	0.9999890327453613	O
44664	simulations	73 83	183322 183332	0.9999847412109375	O
44666	of	85 87	183334 183336	0.9999887943267822	O
44667	a	88 89	183337 183338	0.9999891519546509	O
44668	large	90 95	183339 183344	0.9999877214431763	O
44669	number	96 102	183345 183351	0.9999889135360718	O
44670	of	103 105	183352 183354	0.9999890327453613	O
44671	families	106 114	183355 183363	0.9999874830245972	O
44672	,	115 116	183364 183365	0.999984622001648	O
44673	to	117 119	183366 183368	0.9999889135360718	O
44674	obtain	120 126	183369 183375	0.9999881982803345	O
44675	the	127 130	183376 183379	0.9999891519546509	O
44676	noncentrality	131 143	183380 183392	0.9999891519546509	O
44680	parameters	145 155	183394 183404	0.9999878406524658	O
44681	describing	156 166	183405 183415	0.9999878406524658	O
44682	the	167 170	183416 183419	0.9999890327453613	O
44683	behavior	171 179	183420 183428	0.9999861717224121	O
44684	of	180 182	183429 183431	0.9999891519546509	O
44685	each	183 187	183432 183436	0.9999886751174927	O
44686	design	188 194	183437 183443	0.999984622001648	O
44687	configuration	195 208	183444 183457	0.9999858140945435	O
44688	and	209 212	183458 183461	0.9999866485595703	O
44689	test	213 217	183462 183466	0.9999865293502808	O
44690	.	218 219	183467 183468	0.9999715089797974	O
44691	We	0 2	183469 183471	0.9999837875366211	O
44692	were	3 7	183472 183476	0.9999867677688599	O
44693	then	8 12	183477 183481	0.9999815225601196	O
44694	able	13 17	183482 183486	0.999984622001648	O
44695	to	18 20	183487 183489	0.9999877214431763	O
44696	compare	21 28	183490 183497	0.9999856948852539	O
44697	the	29 32	183498 183501	0.999988317489624	O
44698	attributes	33 43	183502 183512	0.999983549118042	O
44699	of	44 46	183513 183515	0.9999881982803345	O
44700	these	47 52	183516 183521	0.9999872446060181	O
44701	studies	53 60	183522 183529	0.9999829530715942	O
44702	across	61 67	183530 183536	0.9999866485595703	O
44703	the	68 71	183537 183540	0.9999879598617554	O
44704	different	72 81	183541 183550	0.9999864101409912	O
44705	design	82 88	183551 183557	0.9999862909317017	O
44706	configurations	89 103	183558 183572	0.9999823570251465	O
44707	genetic	104 111	183573 183580	0.9999868869781494	O
44708	models	112 118	183581 183587	0.9999881982803345	O
44709	and	119 122	183588 183591	0.9999868869781494	O
44710	tests	123 128	183592 183597	0.9999854564666748	O
44711	by	129 131	183598 183600	0.9999881982803345	O
44712	fitting	132 139	183601 183608	0.9999867677688599	O
44713	regression	140 149	183609 183618	0.999988317489624	O
44715	models	151 157	183620 183626	0.9999887943267822	O
44716	,	158 159	183627 183628	0.9999879598617554	O
44717	as	160 162	183629 183631	0.9999885559082031	O
44718	further	163 170	183632 183639	0.999988317489624	O
44719	described	171 180	183640 183649	0.9999885559082031	O
44720	below	181 186	183650 183655	0.999987006187439	O
44721	.	187 188	183656 183657	0.9999735355377197	O
44722	Disease	0 7	183658 183665	0.9999812841415405	O
44723	Model	8 13	183666 183671	0.9999804496765137	O
44724	Parameter	14 22	183672 183680	0.9999854564666748	O
44726	Choices	24 30	183682 183688	0.9999841451644897	O
44728	Genetic	32 38	183690 183696	0.9999858140945435	O
44730	Heterogeneity	40 52	183698 183710	0.9999885559082031	O
44734	The	54 57	183712 183715	0.9999825954437256	O
44735	genetic	58 65	183716 183723	0.9999833106994629	O
44736	basis	66 71	183724 183729	0.9999842643737793	O
44737	of	72 74	183730 183732	0.999985933303833	O
44738	many	75 79	183733 183737	0.9999700784683228	O
44739	complex	80 87	183738 183745	0.9997352957725525	O
44740	human	88 93	183746 183751	0.9448035359382629	O
44741	diseases	94 102	183752 183760	0.9999659061431885	O
44742	,	103 104	183761 183762	0.9999842643737793	O
44743	including	105 114	183763 183772	0.9999834299087524	O
44744	some	115 119	183773 183777	0.9999772310256958	O
44745	common	120 126	183778 183784	0.9998165965080261	O
44746	cancers	127 133	183785 183791	0.9999759197235107	O
44748	,	135 136	183793 183794	0.9999836683273315	O
44749	is	137 139	183795 183797	0.9999866485595703	O
44750	known	140 145	183798 183803	0.9999845027923584	O
44751	to	146 148	183804 183806	0.9999880790710449	O
44752	include	149 156	183807 183814	0.9999878406524658	O
44753	mutations	157 166	183815 183824	0.9999841451644897	O
44754	in	167 169	183825 183827	0.9999885559082031	O
44755	loci	170 173	183828 183831	0.9999872446060181	O
44757	that	175 179	183833 183837	0.9999880790710449	O
44758	confer	180 185	183838 183843	0.999988317489624	O
44760	a	187 188	183845 183846	0.9999877214431763	O
44761	high	189 193	183847 183851	0.9999860525131226	O
44762	penetrance	194 203	183852 183861	0.9999877214431763	O
44765	to	205 207	183863 183865	0.9999862909317017	O
44766	carriers	208 216	183866 183874	0.9999817609786987	O
44767	.	217 218	183875 183876	0.999962568283081	O
44768	In	0 2	183877 183879	0.9999877214431763	O
44769	order	3 8	183880 183885	0.9999855756759644	O
44770	to	9 11	183886 183888	0.9999877214431763	O
44771	minimize	12 20	183889 183897	0.9999741315841675	O
44772	the	21 24	183898 183901	0.9999878406524658	O
44773	impact	25 31	183902 183908	0.9999876022338867	O
44774	that	32 36	183909 183913	0.9999880790710449	O
44775	such	37 41	183914 183918	0.9999872446060181	O
44776	genetic	42 49	183919 183926	0.9999876022338867	O
44777	heterogeneity	50 62	183927 183939	0.9999890327453613	O
44781	may	64 67	183941 183944	0.9999867677688599	O
44782	have	68 72	183945 183949	0.999987006187439	O
44783	on	73 75	183950 183952	0.9999876022338867	O
44784	the	76 79	183953 183956	0.9999884366989136	O
44785	statistical	80 91	183957 183968	0.9999872446060181	O
44786	efficiency	92 102	183969 183979	0.999988317489624	O
44787	to	103 105	183980 183982	0.9999890327453613	O
44788	identify	106 114	183983 183991	0.9999885559082031	O
44789	novel	115 120	183992 183997	0.9999877214431763	O
44790	loci	121 124	183998 184001	0.9999885559082031	O
44792	,	126 127	184003 184004	0.9999877214431763	O
44793	gene	128 132	184005 184009	0.999988317489624	O
44794	-	132 133	184009 184010	0.9999892711639404	O
44795	hunting	133 140	184010 184017	0.9999853372573853	O
44796	studies	141 148	184018 184025	0.9999880790710449	O
44797	are	149 152	184026 184029	0.999988317489624	O
44798	often	153 158	184030 184035	0.9999878406524658	O
44799	restricted	159 169	184036 184046	0.9999884366989136	O
44800	to	170 172	184047 184049	0.9999885559082031	O
44801	those	173 178	184050 184055	0.9999877214431763	O
44802	cases	179 184	184056 184061	0.9999864101409912	O
44803	that	185 189	184062 184066	0.9999890327453613	O
44804	have	190 194	184067 184071	0.9999891519546509	O
44805	been	195 199	184072 184076	0.9999892711639404	O
44806	determined	200 210	184077 184087	0.9999881982803345	O
44807	not	211 214	184088 184091	0.9999879598617554	O
44808	to	215 217	184092 184094	0.9999887943267822	O
44809	be	218 220	184095 184097	0.9999890327453613	O
44810	related	221 228	184098 184105	0.9999885559082031	O
44811	to	229 231	184106 184108	0.9999890327453613	O
44812	any	232 235	184109 184112	0.9999887943267822	O
44813	known	236 241	184113 184118	0.9999871253967285	O
44814	susceptibility	242 255	184119 184132	0.9999880790710449	O
44819	locus	257 261	184134 184138	0.9999890327453613	O
44821	.	263 264	184140 184141	0.99996018409729	O
44822	For	0 3	184142 184145	0.9999840259552002	O
44823	example	4 11	184146 184153	0.9999809265136719	O
44824	,	12 13	184154 184155	0.999987006187439	O
44825	the	14 17	184156 184159	0.9999868869781494	O
44826	second	18 24	184160 184166	0.9999501705169678	O
44827	susceptibility	25 38	184167 184180	0.9999847412109375	O
44832	locus	40 44	184182 184186	0.9999854564666748	O
44834	for	46 49	184188 184191	0.9999830722808838	O
44835	breast	50 56	184192 184198	0.9999693632125854	O
44836	cancer	57 63	184199 184205	0.9999819993972778	O
44837	,	64 65	184206 184207	0.9999860525131226	O
44838	BRCA2	66 70	184208 184212	0.9999809265136719	O
44841	,	72 73	184214 184215	0.9999871253967285	O
44842	was	74 77	184216 184219	0.9999876022338867	O
44843	mapped	78 84	184220 184226	0.9999798536300659	O
44844	by	85 87	184227 184229	0.9999873638153076	O
44845	Wooster	88 94	184230 184236	0.9999815225601196	O
44847	et	96 98	184238 184240	0.9999873638153076	O
44848	al	99 101	184241 184243	0.9999872446060181	O
44849	.	102 103	184244 184245	0.9999877214431763	O
44850	[	104 105	184246 184247	0.9999704360961914	O
44851	37	0 2	184247 184249	0.9999711513519287	O
44852	]	2 3	184249 184250	0.9999732971191406	O
44853	based	4 9	184251 184256	0.9999856948852539	O
44854	on	10 12	184257 184259	0.9999860525131226	O
44855	high	13 17	184260 184264	0.9999822378158569	O
44856	-	17 18	184264 184265	0.9999867677688599	O
44857	risk	18 22	184265 184269	0.999984860420227	O
44858	families	23 31	184270 184278	0.9999744892120361	O
44859	for	32 35	184279 184282	0.9999821186065674	O
44860	whom	36 40	184283 184287	0.9999834299087524	O
44861	BRCA1	41 45	184288 184292	0.9999819993972778	O
44864	linkage	47 53	184294 184300	0.9999873638153076	O
44866	was	55 58	184302 184305	0.9999872446060181	O
44867	excluded	59 67	184306 184314	0.9999847412109375	O
44868	.	68 69	184315 184316	0.9999539852142334	O
44869	Genetic	0 6	184317 184323	0.9999221563339233	O
44871	syndromes	8 16	184325 184333	0.9999790191650391	O
44873	such	18 22	184335 184339	0.9999868869781494	O
44874	as	23 25	184340 184342	0.9999878406524658	O
44875	juvenile	26 34	184343 184351	0.9997761845588684	O
44876	polyposis	35 43	184352 184360	0.9999856948852539	O
44880	,	45 46	184362 184363	0.9999871253967285	O
44881	Peutz	47 51	184364 184368	0.9999828338623047	O
44884	-	52 53	184369 184370	0.9999881982803345	O
44885	Jeghers	53 59	184370 184376	0.9999845027923584	O
44888	syndrome	61 69	184378 184386	0.9999880790710449	O
44889	and	70 73	184387 184390	0.9999871253967285	O
44890	familial	74 81	184391 184398	0.9999600648880005	O
44893	adenomatous	83 93	184400 184410	0.9999849796295166	O
44897	polyposis	95 103	184412 184420	0.9999876022338867	O
44901	can	105 108	184422 184425	0.9999856948852539	O
44902	be	109 111	184426 184428	0.9999881982803345	O
44903	readily	112 119	184429 184436	0.9999879598617554	O
44904	eliminated	120 130	184437 184447	0.9999871253967285	O
44905	prior	131 136	184448 184453	0.9999874830245972	O
44906	to	137 139	184454 184456	0.9999886751174927	O
44907	sample	140 146	184457 184463	0.999987006187439	O
44908	collection	147 157	184464 184474	0.999988317489624	O
44909	on	158 160	184475 184477	0.9999887943267822	O
44910	the	161 164	184478 184481	0.9999891519546509	O
44911	basis	165 170	184482 184487	0.9999890327453613	O
44912	of	171 173	184488 184490	0.9999890327453613	O
44913	phenotypic	174 183	184491 184500	0.9999892711639404	O
44916	characteristics	185 200	184502 184517	0.9999876022338867	O
44917	.	201 202	184518 184519	0.9999626874923706	O
44918	However	0 7	184520 184527	0.9999847412109375	O
44919	,	8 9	184528 184529	0.9999871253967285	O
44920	mutations	10 19	184530 184539	0.9999841451644897	O
44921	in	20 22	184540 184542	0.9999874830245972	O
44922	mismatch	23 30	184543 184550	0.9999843835830688	O
44925	repair	32 38	184552 184558	0.9999852180480957	O
44926	(	39 40	184559 184560	0.999987006187439	O
44927	MMR	41 43	184561 184563	0.9999817609786987	O
44929	)	45 46	184565 184566	0.9999877214431763	O
44930	loci	47 50	184567 184570	0.9999871253967285	O
44932	such	52 56	184572 184576	0.999987006187439	O
44933	as	57 59	184577 184579	0.9999874830245972	O
44934	hMSH2	60 64	184580 184584	0.9999872446060181	O
44938	or	66 68	184586 184588	0.999987006187439	O
44939	hMLH1	69 73	184589 184593	0.9999868869781494	O
44942	cannot	75 81	184595 184601	0.9999868869781494	O
44943	be	82 84	184602 184604	0.999987006187439	O
44944	excluded	85 93	184605 184613	0.9999865293502808	O
44945	without	94 101	184614 184621	0.9999865293502808	O
44946	performing	102 112	184622 184632	0.9999865293502808	O
44947	molecular	113 122	184633 184642	0.9999862909317017	O
44948	studies	123 130	184643 184650	0.9999872446060181	O
44949	.	131 132	184651 184652	0.9999862909317017	O
44950	(	133 134	184653 184654	0.9998377561569214	O
44951	Measures	0 7	184655 184662	0.9999819993972778	O
44953	of	9 11	184664 184666	0.9999843835830688	O
44954	tumor	12 17	184667 184672	0.9999810457229614	O
44955	microsatellite	18 31	184673 184686	0.9999861717224121	O
44959	instability	33 44	184688 184699	0.9999854564666748	O
44960	or	45 47	184700 184702	0.9999850988388062	O
44961	immunohistochemistry	48 67	184703 184722	0.9999860525131226	O
44967	can	69 72	184724 184727	0.9999831914901733	O
44968	be	73 75	184728 184730	0.9999861717224121	O
44969	helpful	76 83	184731 184738	0.999984622001648	O
44970	in	84 86	184739 184741	0.9999852180480957	O
44971	identifying	87 98	184742 184753	0.9999849796295166	O
44972	likely	99 105	184754 184760	0.9999822378158569	O
44973	carriers	106 114	184761 184769	0.9999840259552002	O
44974	,	115 116	184770 184771	0.9999849796295166	O
44975	but	117 120	184772 184775	0.9999821186065674	O
44976	are	121 124	184776 184779	0.9999854564666748	O
44977	neither	125 132	184780 184787	0.9999839067459106	O
44978	fully	133 138	184788 184793	0.9999852180480957	O
44979	sensitive	139 148	184794 184803	0.999985933303833	O
44980	nor	149 152	184804 184807	0.9999858140945435	O
44981	specific	153 161	184808 184816	0.9999853372573853	O
44982	.	162 163	184817 184818	0.9999855756759644	O
44983	)	164 165	184819 184820	0.9996519088745117	O
44984	Estimating	0 9	184821 184830	0.999983549118042	O
44987	the	11 14	184832 184835	0.9999864101409912	O
44988	proportion	15 25	184836 184846	0.9999849796295166	O
44989	of	26 28	184847 184849	0.9999865293502808	O
44990	affected	29 37	184850 184858	0.9999808073043823	O
44991	families	38 46	184859 184867	0.9999756813049316	O
44992	that	47 51	184868 184872	0.9999865293502808	O
44993	might	52 57	184873 184878	0.9999839067459106	O
44994	be	58 60	184879 184881	0.9999876022338867	O
44995	excluded	61 69	184882 184890	0.999987006187439	O
44996	from	70 74	184891 184895	0.9999880790710449	O
44997	analysis	75 83	184896 184904	0.9999871253967285	O
44998	because	84 91	184905 184912	0.9999862909317017	O
44999	they	92 96	184913 184917	0.9999865293502808	O
45000	carry	97 102	184918 184923	0.9999837875366211	O
45001	MMR	103 105	184924 184926	0.999984622001648	O
45003	mutations	107 116	184928 184937	0.9999855756759644	O
45004	is	117 119	184938 184940	0.9999774694442749	O
45005	difficult	120 129	184941 184950	0.9999786615371704	O
45006	.	130 131	184951 184952	0.9999350309371948	O
45007	Population	0 10	184953 184963	0.9999817609786987	O
45008	-	10 11	184963 184964	0.9999877214431763	O
45009	based	11 16	184964 184969	0.9999864101409912	O
45010	estimates	17 26	184970 184979	0.9999831914901733	O
45011	of	27 29	184980 184982	0.9999856948852539	O
45012	the	30 33	184983 184986	0.9999864101409912	O
45013	prevalence	34 44	184987 184997	0.9999818801879883	O
45014	of	45 47	184998 185000	0.9999866485595703	O
45015	germ	48 51	185001 185004	0.9999872446060181	O
45018	-	52 53	185005 185006	0.9999879598617554	O
45019	line	53 57	185006 185010	0.9999822378158569	O
45020	MMR	58 60	185011 185013	0.9999821186065674	O
45022	mutations	62 71	185015 185024	0.9999831914901733	O
45023	among	72 77	185025 185030	0.9999853372573853	O
45024	subjects	78 86	185031 185039	0.9998922348022461	O
45025	diagnosed	87 96	185040 185049	0.9999697208404541	O
45026	with	97 101	185050 185054	0.9999829530715942	O
45027	colorectal	102 111	185055 185064	0.9999827146530151	O
45030	cancer	113 119	185066 185072	0.9999847412109375	O
45031	vary	120 124	185073 185077	0.9999834299087524	O
45032	widely	125 131	185078 185084	0.9999862909317017	O
45033	even	132 136	185085 185089	0.9999868869781494	O
45034	within	137 143	185090 185096	0.9999858140945435	O
45035	populations	144 155	185097 185108	0.9999837875366211	O
45036	of	156 158	185109 185111	0.9999874830245972	O
45037	European	159 167	185112 185120	0.9999735355377197	O
45038	descent	168 175	185121 185128	0.9999860525131226	O
45039	[	176 177	185129 185130	0.9999887943267822	O
45040	38	177 179	185130 185132	0.9999876022338867	O
45041	-	179 180	185132 185133	0.9999887943267822	O
45042	41	180 182	185133 185135	0.9999877214431763	O
45043	]	182 183	185135 185136	0.9999886751174927	O
45044	,	184 185	185137 185138	0.9999872446060181	O
45045	and	186 189	185139 185142	0.9999874830245972	O
45046	only	190 194	185143 185147	0.9999871253967285	O
45047	a	195 196	185148 185149	0.999988317489624	O
45048	few	197 200	185150 185153	0.999987006187439	O
45049	estimates	201 210	185154 185163	0.9999841451644897	O
45050	are	211 214	185164 185167	0.9999876022338867	O
45051	available	215 224	185168 185177	0.9999872446060181	O
45052	for	225 228	185178 185181	0.9999866485595703	O
45053	other	229 234	185182 185187	0.9999836683273315	O
45054	ethnic	235 241	185188 185194	0.9999839067459106	O
45055	groups	242 248	185195 185201	0.999984622001648	O
45056	[	249 250	185202 185203	0.9999887943267822	O
45057	42	250 252	185203 185205	0.9999874830245972	O
45058	,	252 253	185205 185206	0.9999880790710449	O
45059	43	253 255	185206 185208	0.9999864101409912	O
45060	]	255 256	185208 185209	0.9999884366989136	O
45061	.	257 258	185210 185211	0.9999721050262451	O
45062	Moreover	0 8	185212 185220	0.9999818801879883	O
45063	,	9 10	185221 185222	0.9999879598617554	O
45064	recruiting	11 21	185223 185233	0.9999834299087524	O
45065	from	22 26	185234 185238	0.9999858140945435	O
45066	high	27 31	185239 185243	0.9999865293502808	O
45067	-	31 32	185243 185244	0.9999884366989136	O
45068	risk	32 36	185244 185248	0.9999872446060181	O
45069	clinics	37 44	185249 185256	0.999981164932251	O
45070	may	45 48	185257 185260	0.9999854564666748	O
45071	lead	49 53	185261 185265	0.9999874830245972	O
45072	to	54 56	185266 185268	0.9999885559082031	O
45073	disproportionate	57 72	185269 185284	0.9999886751174927	O
45079	over	74 78	185286 185290	0.999988317489624	O
45080	-	78 79	185290 185291	0.9999884366989136	O
45081	representation	79 93	185291 185305	0.9999873638153076	O
45082	of	94 96	185306 185308	0.9999871253967285	O
45083	families	97 105	185309 185317	0.9999798536300659	O
45084	who	106 109	185318 185321	0.999987006187439	O
45085	have	110 114	185322 185326	0.9999861717224121	O
45086	MMR	115 117	185327 185329	0.999984860420227	O
45088	mutations	119 128	185331 185340	0.9999849796295166	O
45089	.	129 130	185341 185342	0.9999699592590332	O
45090	One	0 3	185343 185346	0.999983549118042	O
45091	large	4 9	185347 185352	0.9999691247940063	O
45092	study	10 15	185353 185358	0.9999823570251465	O
45093	in	16 18	185359 185361	0.9999864101409912	O
45094	Finland	19 26	185362 185369	0.9997478127479553	O
45095	[	27 28	185370 185371	0.9999877214431763	O
45096	44	28 30	185371 185373	0.99997878074646	O
45097	]	30 31	185373 185374	0.999984622001648	O
45098	found	32 37	185375 185380	0.9999855756759644	O
45099	that	38 42	185381 185385	0.9999884366989136	O
45100	12	43 45	185386 185388	0.9999853372573853	O
45101	%	46 47	185389 185390	0.9999879598617554	O
45102	of	48 50	185391 185393	0.9999878406524658	O
45103	affected	51 59	185394 185402	0.9999841451644897	O
45104	sib	60 62	185403 185405	0.9999821186065674	O
45106	pairs	64 69	185407 185412	0.9999866485595703	O
45107	(	70 71	185413 185414	0.9999887943267822	O
45108	ASP	72 74	185415 185417	0.9999839067459106	O
45110	)	75 76	185418 185419	0.9999884366989136	O
45111	showed	77 83	185420 185426	0.9999864101409912	O
45112	MMR	84 86	185427 185429	0.999984860420227	O
45114	defects	88 95	185431 185438	0.999987006187439	O
45115	.	96 97	185439 185440	0.9999886751174927	O
45116	*	98 99	185441 185442	0.9999874830245972	O
45117	*	99 100	185442 185443	0.9999828338623047	O
45118	IGNORE	0 5	185444 185449	0.9999873638153076	O
45121	LINE	7 10	185451 185454	0.9999891519546509	O
45124	*	12 13	185456 185457	0.9999892711639404	O
45125	*	13 14	185457 185458	0.9999891519546509	O
45126	*	15 16	185459 185460	0.9999890327453613	O
45127	*	16 17	185460 185461	0.9999891519546509	O
45128	IGNORE	18 23	185462 185467	0.999988317489624	O
45131	LINE	25 28	185469 185472	0.9999892711639404	O
45134	*	30 31	185474 185475	0.9999889135360718	O
45135	*	31 32	185475 185476	0.9999889135360718	O
45136	*	33 34	185477 185478	0.9999889135360718	O
45137	*	34 35	185478 185479	0.9999889135360718	O
45138	IGNORE	36 41	185480 185485	0.9999879598617554	O
45141	LINE	43 46	185487 185490	0.9999891519546509	O
45144	*	48 49	185492 185493	0.9999891519546509	O
45145	*	49 50	185493 185494	0.9999890327453613	O
45146	The	51 54	185495 185498	0.99998939037323	O
45147	number	55 61	185499 185505	0.9999886751174927	O
45148	of	62 64	185506 185508	0.9999892711639404	O
45149	families	65 73	185509 185517	0.9999879598617554	O
45150	F	74 75	185518 185519	0.9999881982803345	O
45151	required	76 84	185520 185528	0.9999887943267822	O
45152	for	85 88	185529 185532	0.9999890327453613	O
45153	a	89 90	185533 185534	0.9999892711639404	O
45154	desired	91 98	185535 185542	0.9999867677688599	O
45155	level	99 104	185543 185548	0.9999890327453613	O
45156	of	105 107	185549 185551	0.9999895095825195	O
45157	power	108 113	185552 185557	0.9999885559082031	O
45158	sample	114 120	185558 185564	0.9999889135360718	O
45159	was	121 124	185565 185568	0.9999891519546509	O
45160	calculated	125 135	185569 185579	0.9999886751174927	O
45161	in	136 138	185580 185582	0.99998939037323	O
45162	the	139 142	185583 185586	0.99998939037323	O
45163	standard	143 151	185587 185595	0.9999892711639404	O
45164	way	152 155	185596 185599	0.9999889135360718	O
45165	[	156 157	185600 185601	0.9999892711639404	O
45166	59	157 159	185601 185603	0.9999871253967285	O
45167	]	159 160	185603 185604	0.9999890327453613	O
45168	by	161 163	185605 185607	0.9999895095825195	O
45169	solving	164 171	185608 185615	0.9999886751174927	O
45170	Zα	172 173	185616 185617	0.9999895095825195	O
45172	+	174 175	185618 185619	0.9999887943267822	O
45173	Z1−βF	175 179	185619 185623	0.9999890327453613	O
45178	=	180 181	185624 185625	0.9999890327453613	O
45179	ZsimFsim	181 188	185625 185632	0.9999890327453613	O
45185	for	190 193	185634 185637	0.9999892711639404	O
45186	F	194 195	185638 185639	0.999988317489624	O
45187	,	196 197	185640 185641	0.99998939037323	O
45188	where	198 203	185642 185647	0.9999891519546509	O
45189	Zα	204 205	185648 185649	0.9999889135360718	O
45191	and	207 210	185651 185654	0.9999889135360718	O
45192	Z1	211 212	185655 185656	0.9999887943267822	O
45194	-	213 214	185657 185658	0.9999891519546509	O
45195	β	214 215	185658 185659	0.9999879598617554	O
45196	are	216 219	185660 185663	0.9999890327453613	O
45197	the	220 223	185664 185667	0.9999891519546509	O
45198	quantiles	224 232	185668 185676	0.9999890327453613	O
45201	of	234 236	185678 185680	0.9999892711639404	O
45202	the	237 240	185681 185684	0.9999895095825195	O
45203	standard	241 249	185685 185693	0.9999890327453613	O
45204	normal	250 256	185694 185700	0.9999890327453613	O
45205	distribution	257 269	185701 185713	0.99998939037323	O
45206	for	270 273	185714 185717	0.99998939037323	O
45207	selected	274 282	185718 185726	0.9999880790710449	O
45208	values	283 289	185727 185733	0.9999889135360718	O
45209	of	290 292	185734 185736	0.99998939037323	O
45210	α	293 294	185737 185738	0.9999889135360718	O
45211	and	295 298	185739 185742	0.9999891519546509	O
45212	β	299 300	185743 185744	0.9999856948852539	O
45213	,	301 302	185745 185746	0.9999889135360718	O
45214	and	303 306	185747 185750	0.9999891519546509	O
45215	Zsim	307 310	185751 185754	0.9999890327453613	O
45218	is	312 314	185756 185758	0.99998939037323	O
45219	the	315 318	185759 185762	0.9999895095825195	O
45220	sample	319 325	185763 185769	0.99998939037323	O
45221	mean	326 330	185770 185774	0.9999892711639404	O
45222	of	331 333	185775 185777	0.99998939037323	O
45223	the	334 337	185778 185781	0.99998939037323	O
45224	Z	338 339	185782 185783	0.9999886751174927	O
45225	-	339 340	185783 185784	0.9999896287918091	O
45226	scores	340 346	185784 185790	0.9999887943267822	O
45227	(	347 348	185791 185792	0.9999896287918091	O
45228	Zc	349 350	185793 185794	0.9999887943267822	O
45230	or	352 354	185796 185798	0.9999880790710449	O
45231	Zp	355 356	185799 185800	0.9999884366989136	O
45233	)	358 359	185802 185803	0.9999896287918091	O
45234	based	360 365	185804 185809	0.99998939037323	O
45235	on	366 368	185810 185812	0.9999895095825195	O
45236	the	369 372	185813 185816	0.99998939037323	O
45237	sample	373 379	185817 185823	0.9999892711639404	O
45238	size	380 384	185824 185828	0.9999890327453613	O
45239	Fsim	385 388	185829 185832	0.9999892711639404	O
45242	of	390 392	185834 185836	0.9999892711639404	O
45243	the	393 396	185837 185840	0.99998939037323	O
45244	simulation	397 407	185841 185851	0.9999861717224121	O
45245	run	408 411	185852 185855	0.9999884366989136	O
45246	.	412 413	185856 185857	0.9999796152114868	O
45247	Comparison	0 9	185858 185867	0.9999873638153076	O
45251	of	11 13	185869 185871	0.9999881982803345	O
45252	Sampling	14 21	185872 185879	0.9999879598617554	O
45254	Strategies	23 32	185881 185890	0.9999880790710449	O
45257	The	34 37	185892 185895	0.9999873638153076	O
45258	relative	38 46	185896 185904	0.9999892711639404	O
45259	efficiency	47 57	185905 185915	0.9999889135360718	O
45260	and	58 61	185916 185919	0.9999889135360718	O
45261	absolute	62 70	185920 185928	0.9999884366989136	O
45262	power	71 76	185929 185934	0.9999884366989136	O
45263	comparisons	77 88	185935 185946	0.999988317489624	O
45264	were	89 93	185947 185951	0.9999879598617554	O
45265	evaluated	94 103	185952 185961	0.9999871253967285	O
45266	over	104 108	185962 185966	0.9999879598617554	O
45267	a	109 110	185967 185968	0.9999889135360718	O
45268	range	111 116	185969 185974	0.9999873638153076	O
45269	of	117 119	185975 185977	0.9999881982803345	O
45270	assumptions	120 131	185978 185989	0.9999798536300659	O
45271	about	132 137	185990 185995	0.9999887943267822	O
45272	disease	138 145	185996 186003	0.9999877214431763	O
45273	allele	146 151	186004 186009	0.9999895095825195	O
45275	frequency	153 162	186011 186020	0.9999892711639404	O
45276	,	163 164	186021 186022	0.9999881982803345	O
45277	penetrance	165 174	186023 186032	0.9999885559082031	O
45280	,	176 177	186034 186035	0.999988317489624	O
45281	and	178 181	186036 186039	0.9999887943267822	O
45282	heterogeneity	182 194	186040 186052	0.9999892711639404	O
45286	.	196 197	186054 186055	0.9999697208404541	O
45287	Summaries	0 8	186056 186064	0.9999845027923584	O
45290	are	10 13	186066 186069	0.9999836683273315	O
45291	provided	14 22	186070 186078	0.9999818801879883	O
45292	for	23 26	186079 186082	0.9999852180480957	O
45293	the	27 30	186083 186086	0.9999886751174927	O
45294	relative	31 39	186087 186095	0.999988317489624	O
45295	efficiency	40 50	186096 186106	0.9999860525131226	O
45296	from	51 55	186107 186111	0.9999878406524658	O
45297	the	56 59	186112 186115	0.9999891519546509	O
45298	non	60 63	186116 186119	0.9999891519546509	O
45299	-	63 64	186119 186120	0.9999892711639404	O
45300	null	64 68	186120 186124	0.9999880790710449	O
45301	simulations	69 79	186125 186135	0.9999874830245972	O
45303	of	81 83	186137 186139	0.9999892711639404	O
45304	each	84 88	186140 186144	0.9999892711639404	O
45305	combination	89 100	186145 186156	0.9999872446060181	O
45306	of	101 103	186157 186159	0.9999890327453613	O
45307	parameters	104 114	186160 186170	0.9999855756759644	O
45308	and	115 118	186171 186174	0.9999867677688599	O
45309	sample	119 125	186175 186181	0.9999868869781494	O
45310	sizes	126 131	186182 186187	0.9999873638153076	O
45311	required	132 140	186188 186196	0.9999890327453613	O
45312	to	141 143	186197 186199	0.9999887943267822	O
45313	attain	144 150	186200 186206	0.9999889135360718	O
45314	80	151 153	186207 186209	0.9999878406524658	O
45315	%	154 155	186210 186211	0.99998939037323	O
45316	power	156 161	186212 186217	0.9999878406524658	O
45317	.	162 163	186218 186219	0.9999685287475586	O
45318	Our	0 3	186220 186223	0.999972939491272	O
45319	simulations	4 14	186224 186234	0.9998955726623535	O
45321	involved	16 24	186236 186244	0.9999834299087524	O
45322	the	25 28	186245 186248	0.9999864101409912	O
45323	manipulation	29 41	186249 186261	0.9999767541885376	O
45324	of	42 44	186262 186264	0.9999879598617554	O
45325	16	45 47	186265 186267	0.9999810457229614	O
45326	parameters	48 58	186268 186278	0.9999812841415405	O
45327	,	59 60	186279 186280	0.9999861717224121	O
45328	with	61 65	186281 186285	0.9999873638153076	O
45329	over	66 70	186286 186290	0.9999879598617554	O
45330	725	71 73	186291 186293	0.9999877214431763	O
45332	,	74 75	186294 186295	0.9999876022338867	O
45333	000	75 78	186295 186298	0.9999874830245972	O
45334	possible	79 87	186299 186307	0.9999866485595703	O
45335	combinations	88 100	186308 186320	0.9999865293502808	O
45336	arising	101 108	186321 186328	0.9999886751174927	O
45337	just	109 113	186329 186333	0.9999881982803345	O
45338	among	114 119	186334 186339	0.9999884366989136	O
45339	the	120 123	186340 186343	0.9999887943267822	O
45340	limited	124 131	186344 186351	0.9999874830245972	O
45341	set	132 135	186352 186355	0.9999886751174927	O
45342	of	136 138	186356 186358	0.9999885559082031	O
45343	settings	139 147	186359 186367	0.9999867677688599	O
45344	we	148 150	186368 186370	0.9999885559082031	O
45345	chose	151 156	186371 186376	0.9999884366989136	O
45346	for	157 160	186377 186380	0.9999885559082031	O
45347	each	161 165	186381 186385	0.9999890327453613	O
45348	parameter	166 175	186386 186395	0.9999856948852539	O
45349	.	176 177	186396 186397	0.9999673366546631	O
45350	In	0 2	186398 186400	0.999984860420227	O
45351	practice	3 11	186401 186409	0.999972939491272	O
45352	,	12 13	186410 186411	0.999985933303833	O
45353	we	14 16	186412 186414	0.9999798536300659	O
45354	were	17 21	186415 186419	0.9999850988388062	O
45355	able	22 26	186420 186424	0.9999829530715942	O
45356	to	27 29	186425 186427	0.9999866485595703	O
45357	simulate	30 37	186428 186435	0.9999854564666748	O
45360	20	39 41	186437 186439	0.9999853372573853	O
45361	replicates	42 51	186440 186449	0.9999868869781494	O
45363	for	53 56	186451 186454	0.9999879598617554	O
45364	332	57 59	186455 186457	0.9999865293502808	O
45366	actual	61 67	186459 186465	0.9999823570251465	O
45367	parameter	68 77	186466 186475	0.9999819993972778	O
45368	combinations	78 90	186476 186488	0.9999873638153076	O
45369	.	91 92	186489 186490	0.9999655485153198	O
45370	In	0 2	186491 186493	0.9999886751174927	O
45371	order	3 8	186494 186499	0.9999871253967285	O
45372	to	9 11	186500 186502	0.9999891519546509	O
45373	assess	12 18	186503 186509	0.9999874830245972	O
45374	the	19 22	186510 186513	0.9999891519546509	O
45375	impact	23 29	186514 186520	0.9999881982803345	O
45376	of	30 32	186521 186523	0.99998939037323	O
45377	each	33 37	186524 186528	0.9999892711639404	O
45378	variable	38 46	186529 186537	0.9999854564666748	O
45379	parameter	47 56	186538 186547	0.9999879598617554	O
45380	setting	57 64	186548 186555	0.9999878406524658	O
45381	on	65 67	186556 186558	0.9999885559082031	O
45382	the	68 71	186559 186562	0.9999891519546509	O
45383	power	72 77	186563 186568	0.9999873638153076	O
45384	and	78 81	186569 186572	0.9999886751174927	O
45385	efficiency	82 92	186573 186583	0.999987006187439	O
45386	of	93 95	186584 186586	0.9999891519546509	O
45387	each	96 100	186587 186591	0.9999885559082031	O
45388	study	101 106	186592 186597	0.9999849796295166	O
45389	design	107 113	186598 186604	0.9999879598617554	O
45390	,	114 115	186605 186606	0.9999871253967285	O
45391	and	116 119	186607 186610	0.9999878406524658	O
45392	to	120 122	186611 186613	0.9999889135360718	O
45393	facilitate	123 133	186614 186624	0.9999867677688599	O
45394	generalization	134 147	186625 186638	0.9999866485595703	O
45396	of	149 151	186640 186642	0.9999887943267822	O
45397	our	152 155	186643 186646	0.9999876022338867	O
45398	results	156 163	186647 186654	0.9999878406524658	O
45399	to	164 166	186655 186657	0.9999872446060181	O
45400	other	167 172	186658 186663	0.9999873638153076	O
45401	similar	173 180	186664 186671	0.9999865293502808	O
45402	situations	181 191	186672 186682	0.9999864101409912	O
45403	that	192 196	186683 186687	0.999988317489624	O
45404	we	197 199	186688 186690	0.9999878406524658	O
45405	did	200 203	186691 186694	0.9999878406524658	O
45406	not	204 207	186695 186698	0.9999876022338867	O
45407	specifically	208 220	186699 186711	0.9999876022338867	O
45408	simulate	221 228	186712 186719	0.999988317489624	O
45411	,	230 231	186721 186722	0.999988317489624	O
45412	we	232 234	186723 186725	0.9999884366989136	O
45413	constructed	235 246	186726 186737	0.9999884366989136	O
45414	linear	247 253	186738 186744	0.9999876022338867	O
45415	regression	254 263	186745 186754	0.9999887943267822	O
45417	models	265 271	186756 186762	0.9999881982803345	O
45418	of	272 274	186763 186765	0.9999891519546509	O
45419	the	275 278	186766 186769	0.99998939037323	O
45420	square	279 285	186770 186776	0.9999886751174927	O
45421	root	286 290	186777 186781	0.9999881982803345	O
45422	of	291 293	186782 186784	0.9999890327453613	O
45423	the	294 297	186785 186788	0.99998939037323	O
45424	per	298 301	186789 186792	0.9999891519546509	O
45425	-	301 302	186792 186793	0.9999895095825195	O
45426	family	302 308	186793 186799	0.9999884366989136	O
45427	contribution	309 321	186800 186812	0.9999892711639404	O
45428	to	322 324	186813 186815	0.9999892711639404	O
45429	the	325 328	186816 186819	0.9999892711639404	O
45430	noncentrality	329 341	186820 186832	0.9999890327453613	O
45434	parameter	343 352	186834 186843	0.9999891519546509	O
45435	(	353 354	186844 186845	0.9999892711639404	O
45436	Zsim	355 358	186846 186849	0.9999884366989136	O
45439	/	359 360	186850 186851	0.9999889135360718	O
45440	Fsim	360 363	186851 186854	0.9999889135360718	O
45443	)	365 366	186856 186857	0.9999895095825195	O
45444	and	367 370	186858 186861	0.9999889135360718	O
45445	ARE	371 373	186862 186864	0.9999867677688599	O
45447	estimates	375 384	186866 186875	0.9999873638153076	O
45448	resulting	385 394	186876 186885	0.9999892711639404	O
45449	from	395 399	186886 186890	0.9999891519546509	O
45450	each	400 404	186891 186895	0.9999895095825195	O
45451	simulation	405 415	186896 186906	0.9999866485595703	O
45452	as	416 418	186907 186909	0.9999890327453613	O
45453	a	419 420	186910 186911	0.9999892711639404	O
45454	function	421 429	186912 186920	0.9999884366989136	O
45455	of	430 432	186921 186923	0.9999891519546509	O
45456	the	433 436	186924 186927	0.9999887943267822	O
45457	simulation	437 447	186928 186938	0.9999872446060181	O
45458	parameters	448 458	186939 186949	0.9999867677688599	O
45459	.	459 460	186950 186951	0.9999634027481079	O
45460	Residuals	0 8	186952 186960	0.9999872446060181	O
45464	from	10 14	186962 186966	0.9999862909317017	O
45465	the	15 18	186967 186970	0.9999867677688599	O
45466	models	19 25	186971 186977	0.999908447265625	O
45467	were	26 30	186978 186982	0.9999876022338867	O
45468	approximately	31 44	186983 186996	0.9999873638153076	O
45469	normally	45 53	186997 187005	0.9999881982803345	O
45470	distributed	54 65	187006 187017	0.9999879598617554	O
45471	,	66 67	187018 187019	0.9999853372573853	O
45472	and	68 71	187020 187023	0.9999874830245972	O
45473	scale	72 77	187024 187029	0.9999841451644897	O
45474	-	77 78	187029 187030	0.9999887943267822	O
45475	location	78 86	187030 187038	0.9999871253967285	O
45476	plots	87 92	187039 187044	0.9999860525131226	O
45477	did	93 96	187045 187048	0.9999874830245972	O
45478	not	97 100	187049 187052	0.999987006187439	O
45479	suggest	101 108	187053 187060	0.9999874830245972	O
45480	the	109 112	187061 187064	0.9999880790710449	O
45481	data	113 117	187065 187069	0.9999774694442749	O
45482	were	118 122	187070 187074	0.9999884366989136	O
45483	heteroscedastic	123 137	187075 187089	0.9999889135360718	O
45488	.	139 140	187091 187092	0.9999715089797974	O
45489	We	0 2	187093 187095	0.9999825954437256	O
45490	evaluated	3 12	187096 187105	0.999983549118042	O
45491	the	13 16	187106 187109	0.9999876022338867	O
45492	fit	17 20	187110 187113	0.9999821186065674	O
45493	of	21 23	187114 187116	0.9999881982803345	O
45494	alternative	24 35	187117 187128	0.9999827146530151	O
45495	regression	36 45	187129 187138	0.9999873638153076	O
45497	models	47 53	187140 187146	0.9999864101409912	O
45498	with	54 58	187147 187151	0.9999877214431763	O
45499	quadratic	59 67	187152 187160	0.9999890327453613	O
45502	,	69 70	187162 187163	0.9999885559082031	O
45503	inverse	71 78	187164 187171	0.999985933303833	O
45504	,	79 80	187172 187173	0.999988317489624	O
45505	or	81 83	187174 187176	0.9999880790710449	O
45506	logarithmic	84 94	187177 187187	0.999988317489624	O
45510	transformations	96 111	187189 187204	0.9999853372573853	O
45511	of	112 114	187205 187207	0.9999884366989136	O
45512	both	115 119	187208 187212	0.999988317489624	O
45513	the	120 123	187213 187216	0.9999889135360718	O
45514	predictor	124 132	187217 187225	0.9999871253967285	O
45516	and	134 137	187227 187230	0.9999873638153076	O
45517	outcome	138 145	187231 187238	0.999985933303833	O
45518	variables	146 155	187239 187248	0.9999872446060181	O
45519	;	156 157	187249 187250	0.9999868869781494	O
45520	none	158 162	187251 187255	0.9999828338623047	O
45521	fit	163 166	187256 187259	0.9999880790710449	O
45522	the	167 170	187260 187263	0.9999889135360718	O
45523	observed	171 179	187264 187272	0.9999837875366211	O
45524	data	180 184	187273 187277	0.9999860525131226	O
45525	better	185 191	187278 187284	0.9999865293502808	O
45526	than	192 196	187285 187289	0.9999885559082031	O
45527	a	197 198	187290 187291	0.9999887943267822	O
45528	simple	199 205	187292 187298	0.9999858140945435	O
45529	linear	206 212	187299 187305	0.999987006187439	O
45530	multiple	213 221	187306 187314	0.9999864101409912	O
45531	regression	222 231	187315 187324	0.9999887943267822	O
45533	model	233 238	187326 187331	0.999988317489624	O
45534	.	239 240	187332 187333	0.9999613761901855	O
45535	The	0 3	187334 187337	0.9999873638153076	O
45536	proportion	4 14	187338 187348	0.999987006187439	O
45537	of	15 17	187349 187351	0.9999886751174927	O
45538	variance	18 26	187352 187360	0.999987006187439	O
45539	in	27 29	187361 187363	0.99998939037323	O
45540	ZsimFsim	30 37	187364 187371	0.9999849796295166	O
45546	explained	39 48	187373 187382	0.9999886751174927	O
45547	by	49 51	187383 187385	0.99998939037323	O
45548	the	52 55	187386 187389	0.9999895095825195	O
45549	linear	56 62	187390 187396	0.9999868869781494	O
45550	regression	63 72	187397 187406	0.9999896287918091	O
45552	(	74 75	187408 187409	0.9999897480010986	O
45553	R2	76 77	187410 187411	0.9999891519546509	O
45555	)	79 80	187413 187414	0.9999896287918091	O
45556	ranged	81 87	187415 187421	0.999987006187439	O
45557	from	88 92	187422 187426	0.9999887943267822	O
45558	70	93 95	187427 187429	0.9999880790710449	O
45559	–	95 96	187429 187430	0.9999849796295166	O
45560	75	96 98	187430 187432	0.9999880790710449	O
45561	%	99 100	187433 187434	0.9999895095825195	O
45562	.	101 102	187435 187436	0.9999765157699585	O
45563	The	0 3	187437 187440	0.999983549118042	O
45564	open	4 8	187441 187445	0.999975323677063	O
45565	source	9 15	187446 187452	0.9999617338180542	O
45566	statistical	16 27	187453 187464	0.9999822378158569	O
45567	package	28 35	187465 187472	0.9999823570251465	O
45568	R	36 37	187473 187474	0.9999704360961914	O
45569	[	38 39	187475 187476	0.9999872446060181	O
45570	60	39 41	187476 187478	0.9999762773513794	O
45571	]	41 42	187478 187479	0.9999856948852539	O
45572	was	43 46	187480 187483	0.9999808073043823	O
45573	used	47 51	187484 187488	0.9999808073043823	O
45574	to	52 54	187489 187491	0.9999839067459106	O
45575	perform	55 62	187492 187499	0.9999828338623047	O
45576	all	63 66	187500 187503	0.9999822378158569	O
45577	regression	67 76	187504 187513	0.9999825954437256	O
45579	analyses	78 86	187515 187523	0.9999837875366211	O
45580	.	87 88	187524 187525	0.999936580657959	O
45581	In	0 2	187526 187528	0.9999884366989136	O
45582	order	3 8	187529 187534	0.9999868869781494	O
45583	to	9 11	187535 187537	0.9999880790710449	O
45584	facilitate	12 22	187538 187548	0.9999860525131226	O
45585	interpretation	23 37	187549 187563	0.999985933303833	O
45586	,	38 39	187564 187565	0.9999877214431763	O
45587	the	40 43	187566 187569	0.9999884366989136	O
45588	genetic	44 51	187570 187577	0.9999839067459106	O
45589	effects	52 59	187578 187585	0.9999858140945435	O
45590	(	60 61	187586 187587	0.9999890327453613	O
45591	baseline	62 69	187588 187595	0.9999871253967285	O
45593	disease	71 78	187597 187604	0.9999861717224121	O
45594	prevalence	79 89	187605 187615	0.9999881982803345	O
45595	,	90 91	187616 187617	0.9999887943267822	O
45596	allele	92 97	187618 187623	0.9999886751174927	O
45598	frequencies	99 110	187625 187636	0.9999881982803345	O
45599	,	111 112	187637 187638	0.9999887943267822	O
45600	and	113 116	187639 187642	0.9999892711639404	O
45601	relative	117 125	187643 187651	0.9999878406524658	O
45602	risks	126 131	187652 187657	0.9999887943267822	O
45603	of	132 134	187658 187660	0.9999892711639404	O
45604	the	135 138	187661 187664	0.9999897480010986	O
45605	linked	139 145	187665 187671	0.9999887943267822	O
45606	and	146 149	187672 187675	0.9999891519546509	O
45607	unlinked	150 157	187676 187683	0.99998939037323	O
45610	loci	159 162	187685 187688	0.9999892711639404	O
45612	)	163 164	187689 187690	0.9999896287918091	O
45613	were	165 169	187691 187695	0.9999891519546509	O
45614	collapsed	170 179	187696 187705	0.9999876022338867	O
45615	into	180 184	187706 187710	0.9999895095825195	O
45616	""""""""""	185 186	187711 187712	0.9999896287918091	O
45617	attributable	186 197	187712 187723	0.9999895095825195	O
45621	risks	199 204	187725 187730	0.9999886751174927	O
45622	""""""""""	205 206	187731 187732	0.9999891519546509	O
45623	(	207 208	187733 187734	0.9999896287918091	O
45624	AR	209 211	187735 187737	0.9999849796295166	O
45625	)	212 213	187738 187739	0.9999897480010986	O
45626	for	214 217	187740 187743	0.9999892711639404	O
45627	the	218 221	187744 187747	0.9999897480010986	O
45628	linked	222 228	187748 187754	0.9999886751174927	O
45629	and	229 232	187755 187758	0.9999892711639404	O
45630	unlinked	233 240	187759 187766	0.9999892711639404	O
45633	loci	242 245	187768 187771	0.99998939037323	O
45635	respectively	247 259	187773 187785	0.9999867677688599	O
45636	.	260 261	187786 187787	0.9999755620956421	O
45637	The	0 3	187788 187791	0.9999877214431763	O
45638	attributable	4 15	187792 187803	0.9999885559082031	O
45642	risk	17 21	187805 187809	0.9999871253967285	O
45643	is	22 24	187810 187812	0.9999871253967285	O
45644	the	25 28	187813 187816	0.9999880790710449	O
45645	proportion	29 39	187817 187827	0.9999858140945435	O
45646	of	40 42	187828 187830	0.9999885559082031	O
45647	the	43 46	187831 187834	0.9999889135360718	O
45648	total	47 52	187835 187840	0.9999864101409912	O
45649	disease	53 60	187841 187848	0.9999852180480957	O
45650	risk	61 65	187849 187853	0.9999891519546509	O
45651	attributable	66 77	187854 187865	0.9999891519546509	O
45655	to	79 81	187867 187869	0.9999892711639404	O
45656	variation	82 91	187870 187879	0.9999880790710449	O
45657	at	92 94	187880 187882	0.9999889135360718	O
45658	each	95 99	187883 187887	0.9999892711639404	O
45659	genetic	100 107	187888 187895	0.9999878406524658	O
45660	locus	108 112	187896 187900	0.9999887943267822	O
45662	.	114 115	187902 187903	0.9999703168869019	O
45663	The	0 3	187904 187907	0.9999881982803345	O
45664	fit	4 7	187908 187911	0.9999852180480957	O
45665	of	8 10	187912 187914	0.9999887943267822	O
45666	linear	11 17	187915 187921	0.9999847412109375	O
45667	regression	18 27	187922 187931	0.9999881982803345	O
45669	models	29 35	187933 187939	0.9999879598617554	O
45670	employing	36 45	187940 187949	0.9999881982803345	O
45671	the	46 49	187950 187953	0.9999890327453613	O
45672	two	50 53	187954 187957	0.9999873638153076	O
45673	AR	54 56	187958 187960	0.9999860525131226	O
45674	values	57 63	187961 187967	0.9999880790710449	O
45675	is	64 66	187968 187970	0.9999881982803345	O
45676	as	67 69	187971 187973	0.9999881982803345	O
45677	good	70 74	187974 187978	0.9999872446060181	O
45678	as	75 77	187979 187981	0.9999889135360718	O
45679	those	78 83	187982 187987	0.9999885559082031	O
45680	employing	84 93	187988 187997	0.9999874830245972	O
45681	the	94 97	187998 188001	0.9999890327453613	O
45682	five	98 102	188002 188006	0.9999879598617554	O
45683	original	103 111	188007 188015	0.9999887943267822	O
45684	terms	112 117	188016 188021	0.9999885559082031	O
45685	to	118 120	188022 188024	0.9999886751174927	O
45686	fit	121 124	188025 188028	0.9999881982803345	O
45687	the	125 128	188029 188032	0.9999889135360718	O
45688	data	129 133	188033 188037	0.9999871253967285	O
45689	,	134 135	188038 188039	0.9999881982803345	O
45690	using	136 141	188040 188045	0.9999889135360718	O
45691	the	142 145	188046 188049	0.9999891519546509	O
45692	Akaike	146 151	188050 188055	0.9999891519546509	O
45695	Information	153 164	188057 188068	0.9999886751174927	O
45696	Criterion	165 173	188069 188077	0.9999884366989136	O
45699	(	175 176	188079 188080	0.9999890327453613	O
45700	not	177 180	188081 188084	0.9999887943267822	O
45701	shown	181 186	188085 188090	0.9999881982803345	O
45702	;	187 188	188091 188092	0.9999885559082031	O
45703	[	189 190	188093 188094	0.9999887943267822	O
45704	61	190 192	188094 188096	0.999987006187439	O
45705	]	192 193	188096 188097	0.9999887943267822	O
45706	)	194 195	188098 188099	0.9999891519546509	O
45707	.	196 197	188100 188101	0.9999892711639404	O
45708	*	198 199	188102 188103	0.9999887943267822	O
45709	*	199 200	188103 188104	0.999981164932251	O
45710	IGNORE	0 5	188105 188110	0.9999871253967285	O
45713	LINE	7 10	188112 188115	0.9999887943267822	O
45716	*	12 13	188117 188118	0.9999890327453613	O
45717	*	13 14	188118 188119	0.9999890327453613	O
45718	*	15 16	188120 188121	0.9999890327453613	O
45719	*	16 17	188121 188122	0.9999890327453613	O
45720	IGNORE	18 23	188123 188128	0.9999880790710449	O
45723	LINE	25 28	188130 188133	0.9999892711639404	O
45726	*	30 31	188135 188136	0.9999889135360718	O
45727	*	31 32	188136 188137	0.9999889135360718	O
45728	*	33 34	188138 188139	0.9999887943267822	O
45729	*	34 35	188139 188140	0.9999887943267822	O
45730	IGNORE	36 41	188141 188146	0.9999878406524658	O
45733	LINE	43 46	188148 188151	0.9999890327453613	O
45736	*	48 49	188153 188154	0.9999889135360718	O
45737	*	49 50	188154 188155	0.9999890327453613	O
45738	Effect	51 57	188156 188162	0.9999885559082031	O
45739	of	58 60	188163 188165	0.99998939037323	O
45740	design	61 67	188166 188172	0.9999880790710449	O
45741	and	68 71	188173 188176	0.9999890327453613	O
45742	population	72 82	188177 188187	0.999988317489624	O
45743	parameters	83 93	188188 188198	0.99998939037323	O
45744	or	94 96	188199 188201	0.9999889135360718	O
45745	non	97 100	188202 188205	0.9999891519546509	O
45746	-	100 101	188205 188206	0.9999891519546509	O
45747	centrality	101 110	188206 188215	0.9999884366989136	O
45749	parameters	112 122	188217 188227	0.9999891519546509	O
45750	Multiple	123 131	188228 188236	0.9999876022338867	O
45751	linear	132 138	188237 188243	0.9999876022338867	O
45752	regression	139 148	188244 188253	0.9999890327453613	O
45754	of	150 152	188255 188257	0.9999892711639404	O
45755	Z	153 154	188258 188259	0.999988317489624	O
45756	/	154 155	188259 188260	0.99998939037323	O
45757	F	155 156	188260 188261	0.9999877214431763	O
45758	on	157 159	188262 188264	0.9999890327453613	O
45759	simulation	160 170	188265 188275	0.9999864101409912	O
45760	parameters	171 181	188276 188286	0.9999885559082031	O
45761	.	182 183	188287 188288	0.9999557733535767	O
45762	aStandard	0 8	188289 188297	0.9999898672103882	O
45767	error	10 15	188299 188304	0.9999889135360718	O
45768	of	16 18	188305 188307	0.9999897480010986	O
45769	Estimate	19 26	188308 188315	0.99998939037323	O
45772	;	28 29	188317 188318	0.9999897480010986	O
45773	bNumber	30 36	188319 188325	0.99998939037323	O
45777	available	38 47	188327 188336	0.9999901056289673	O
45778	for	48 51	188337 188340	0.9999901056289673	O
45779	Zc	52 53	188341 188342	0.9999887943267822	O
45781	,	55 56	188344 188345	0.9999898672103882	O
45782	number	57 63	188346 188352	0.99998939037323	O
45783	genotyped	64 72	188353 188361	0.9999896287918091	O
45787	for	74 77	188363 188366	0.9999901056289673	O
45788	Zp	78 79	188367 188368	0.9999889135360718	O
45790	;	81 82	188370 188371	0.9999897480010986	O
45791	cIndicator	83 92	188372 188381	0.9999898672103882	O
45796	variable	94 102	188383 188391	0.9999899864196777	O
45797	.	103 104	188392 188393	0.9999861717224121	O
45798	In	0 2	188394 188396	0.9999864101409912	O
45799	general	3 10	188397 188404	0.9999841451644897	O
45800	,	11 12	188405 188406	0.9999872446060181	O
45801	the	13 16	188407 188410	0.9999873638153076	O
45802	effects	17 24	188411 188418	0.9999860525131226	O
45803	on	25 27	188419 188421	0.9999879598617554	O
45804	power	28 33	188422 188427	0.9999866485595703	O
45805	of	34 36	188428 188430	0.9999884366989136	O
45806	changes	37 44	188431 188438	0.9999867677688599	O
45807	to	45 47	188439 188441	0.9999867677688599	O
45808	the	48 51	188442 188445	0.9999885559082031	O
45809	genetic	52 59	188446 188453	0.9999860525131226	O
45810	and	60 63	188454 188457	0.9999862909317017	O
45811	design	64 70	188458 188464	0.9999853372573853	O
45812	parameters	71 81	188465 188475	0.9999868869781494	O
45813	were	82 86	188476 188480	0.9999861717224121	O
45814	very	87 91	188481 188485	0.9999843835830688	O
45815	similar	92 99	188486 188493	0.9999821186065674	O
45816	for	100 103	188494 188497	0.9999862909317017	O
45817	the	104 107	188498 188501	0.999988317489624	O
45818	discordant	108 117	188502 188511	0.9999874830245972	O
45821	test	119 123	188513 188517	0.9999871253967285	O
45822	.	124 125	188518 188519	0.9999716281890869	O
45823	Increasing	0 9	188520 188529	0.9999885559082031	O
45826	the	11 14	188531 188534	0.9999892711639404	O
45827	number	15 21	188535 188541	0.9999891519546509	O
45828	of	22 24	188542 188544	0.99998939037323	O
45829	unaffected	25 34	188545 188554	0.9999879598617554	O
45832	sibs	36 39	188556 188559	0.999987006187439	O
45834	typed	41 46	188561 188566	0.9999841451644897	O
45835	did	47 50	188567 188570	0.9999865293502808	O
45836	yield	51 56	188571 188576	0.9999889135360718	O
45837	a	57 58	188577 188578	0.9999895095825195	O
45838	small	59 64	188579 188584	0.9999868869781494	O
45839	increase	65 73	188585 188593	0.9999889135360718	O
45840	in	74 76	188594 188596	0.9999895095825195	O
45841	power	77 82	188597 188602	0.9999880790710449	O
45842	,	83 84	188603 188604	0.999988317489624	O
45843	but	85 88	188605 188608	0.9999878406524658	O
45844	increasing	89 99	188609 188619	0.9999879598617554	O
45845	the	100 103	188620 188623	0.9999895095825195	O
45846	number	104 110	188624 188630	0.9999891519546509	O
45847	of	111 113	188631 188633	0.9999895095825195	O
45848	affected	114 122	188634 188642	0.9999865293502808	O
45849	sibs	123 126	188643 188646	0.9999876022338867	O
45851	,	128 129	188648 188649	0.9999886751174927	O
45852	parents	130 137	188650 188657	0.999987006187439	O
45853	or	138 140	188658 188660	0.9999885559082031	O
45854	offspring	141 150	188661 188670	0.9999858140945435	O
45855	proxies	151 157	188671 188677	0.9999891519546509	O
45858	increased	159 168	188679 188688	0.9999889135360718	O
45859	power	169 174	188689 188694	0.9999887943267822	O
45860	by	175 177	188695 188697	0.9999892711639404	O
45861	a	178 179	188698 188699	0.99998939037323	O
45862	larger	180 186	188700 188706	0.9999884366989136	O
45863	amount	187 193	188707 188713	0.9999881982803345	O
45864	,	194 195	188714 188715	0.9999880790710449	O
45865	even	196 200	188716 188720	0.9999880790710449	O
45866	with	201 205	188721 188725	0.9999892711639404	O
45867	the	206 209	188726 188729	0.9999895095825195	O
45868	discordant	210 219	188730 188739	0.9999891519546509	O
45871	pair	221 225	188741 188745	0.9999865293502808	O
45872	test	226 230	188746 188750	0.9999884366989136	O
45873	.	231 232	188751 188752	0.9999716281890869	O
45874	The	0 3	188753 188756	0.9999881982803345	O
45875	effect	4 10	188757 188763	0.9999862909317017	O
45876	of	11 13	188764 188766	0.9999887943267822	O
45877	experimental	14 26	188767 188779	0.999970555305481	O
45878	screening	27 36	188780 188789	0.9999864101409912	O
45879	for	37 40	188790 188793	0.9999889135360718	O
45880	the	41 44	188794 188797	0.99998939037323	O
45881	unlinked	45 52	188798 188805	0.9999889135360718	O
45884	syndrome	54 62	188807 188815	0.9999877214431763	O
45885	varied	63 69	188816 188822	0.9999860525131226	O
45886	substantially	70 83	188823 188836	0.9999861717224121	O
45887	depending	84 93	188837 188846	0.9999885559082031	O
45888	on	94 96	188847 188849	0.9999891519546509	O
45889	the	97 100	188850 188853	0.9999892711639404	O
45890	relative	101 109	188854 188862	0.9999879598617554	O
45891	magnitude	110 119	188863 188872	0.9999879598617554	O
45892	of	120 122	188873 188875	0.9999890327453613	O
45893	the	123 126	188876 188879	0.9999891519546509	O
45894	effects	127 134	188880 188887	0.9999874830245972	O
45895	of	135 137	188888 188890	0.9999892711639404	O
45896	the	138 141	188891 188894	0.99998939037323	O
45897	unlinked	142 149	188895 188902	0.9999887943267822	O
45900	syndrome	151 159	188904 188912	0.9999887943267822	O
45901	:	160 161	188913 188914	0.9999873638153076	O
45902	if	162 164	188915 188917	0.9999865293502808	O
45903	the	165 168	188918 188921	0.9999891519546509	O
45904	unlinked	169 176	188922 188929	0.9999889135360718	O
45907	syndrome	178 186	188931 188939	0.9999886751174927	O
45908	had	187 190	188940 188943	0.9999885559082031	O
45909	an	191 193	188944 188946	0.9999890327453613	O
45910	attributable	194 205	188947 188958	0.9999891519546509	O
45914	risk	207 211	188960 188964	0.9999885559082031	O
45915	greater	212 219	188965 188972	0.9999889135360718	O
45916	than	220 224	188973 188977	0.9999892711639404	O
45917	or	225 227	188978 188980	0.999988317489624	O
45918	equal	228 233	188981 188986	0.999988317489624	O
45919	to	234 236	188987 188989	0.9999891519546509	O
45920	that	237 241	188990 188994	0.9999891519546509	O
45921	of	242 244	188995 188997	0.9999890327453613	O
45922	the	245 248	188998 189001	0.9999891519546509	O
45923	linked	249 255	189002 189008	0.999985933303833	O
45924	syndrome	256 264	189009 189017	0.999988317489624	O
45925	,	265 266	189018 189019	0.999988317489624	O
45926	experimental	267 279	189020 189032	0.9999793767929077	O
45927	screening	280 289	189033 189042	0.9999864101409912	O
45928	resulted	290 298	189043 189051	0.9999887943267822	O
45929	in	299 301	189052 189054	0.9999891519546509	O
45930	a	302 303	189055 189056	0.9999892711639404	O
45931	large	304 309	189057 189062	0.9999865293502808	O
45932	increase	310 318	189063 189071	0.9999877214431763	O
45933	in	319 321	189072 189074	0.9999891519546509	O
45934	power	322 327	189075 189080	0.9999866485595703	O
45935	.	328 329	189081 189082	0.9999716281890869	O
45936	Otherwise	0 9	189083 189092	0.9999754428863525	O
45937	,	10 11	189093 189094	0.9999841451644897	O
45938	the	12 15	189095 189098	0.9999845027923584	O
45939	effect	16 22	189099 189105	0.9999815225601196	O
45940	of	23 25	189106 189108	0.9999850988388062	O
45941	experimental	26 38	189109 189121	0.9999403953552246	O
45942	screening	39 48	189122 189131	0.9999707937240601	O
45943	was	49 52	189132 189135	0.9999830722808838	O
45944	negligible	53 62	189136 189145	0.999982476234436	O
45947	.	64 65	189147 189148	0.999901533126831	O
45948	Power	0 5	189149 189154	0.9999879598617554	O
45949	for	6 9	189155 189158	0.9999891519546509	O
45950	a	10 11	189159 189160	0.9999895095825195	O
45951	given	12 17	189161 189166	0.9999874830245972	O
45952	sample	18 24	189167 189173	0.9999885559082031	O
45953	size	25 29	189174 189178	0.9999892711639404	O
45954	F	30 31	189179 189180	0.9999876022338867	O
45955	and	32 35	189181 189184	0.9999889135360718	O
45956	test	36 40	189185 189189	0.9999872446060181	O
45957	size	41 45	189190 189194	0.9999892711639404	O
45958	α	46 47	189195 189196	0.9999867677688599	O
45959	with	48 52	189197 189201	0.9999892711639404	O
45960	a	53 54	189202 189203	0.99998939037323	O
45961	specified	55 64	189204 189213	0.9999879598617554	O
45962	combination	65 76	189214 189225	0.9999881982803345	O
45963	of	77 79	189226 189228	0.9999891519546509	O
45964	design	80 86	189229 189235	0.9999876022338867	O
45965	and	87 90	189236 189239	0.9999889135360718	O
45966	genetic	91 98	189240 189247	0.9999872446060181	O
45967	parameters	99 109	189248 189258	0.9999884366989136	O
45968	can	110 113	189259 189262	0.9999879598617554	O
45969	be	114 116	189263 189265	0.9999892711639404	O
45970	derived	117 124	189266 189273	0.9999889135360718	O
45971	from	125 129	189274 189278	0.9999890327453613	O
45972	the	130 133	189279 189282	0.99998939037323	O
45973	regression	134 143	189283 189292	0.9999885559082031	O
45975	models	145 151	189294 189300	0.9999884366989136	O
45976	in	152 154	189301 189303	0.9999897480010986	O
45977	Table	155 160	189304 189309	0.9999891519546509	O
45978	5	161 162	189310 189311	0.9999892711639404	O
45979	by	163 165	189312 189314	0.9999895095825195	O
45980	first	166 171	189315 189320	0.9999891519546509	O
45981	obtaining	172 181	189321 189330	0.9999895095825195	O
45982	an	182 184	189331 189333	0.99998939037323	O
45983	estimate	185 193	189334 189342	0.9999889135360718	O
45984	of	194 196	189343 189345	0.9999895095825195	O
45985	the	197 200	189346 189349	0.9999895095825195	O
45986	noncentrality	201 213	189350 189362	0.9999891519546509	O
45990	parameter	215 224	189364 189373	0.9999890327453613	O
45991	Z	225 226	189374 189375	0.9999886751174927	O
45992	/	226 227	189375 189376	0.9999891519546509	O
45993	F	227 228	189376 189377	0.9999884366989136	O
45994	from	229 233	189378 189382	0.9999891519546509	O
45995	the	234 237	189383 189386	0.9999895095825195	O
45996	appropriate	238 249	189387 189398	0.999988317489624	O
45997	column	250 256	189399 189405	0.9999890327453613	O
45998	of	257 259	189406 189408	0.9999895095825195	O
45999	Table	260 265	189409 189414	0.9999889135360718	O
46000	4	266 267	189415 189416	0.9999887943267822	O
46001	,	268 269	189417 189418	0.99998939037323	O
46002	multiplying	270 280	189419 189429	0.9999887943267822	O
46005	by	282 284	189431 189433	0.9999890327453613	O
46006	F	285 286	189434 189435	0.9999884366989136	O
46007	to	287 289	189436 189438	0.9999892711639404	O
46008	obtain	290 296	189439 189445	0.9999895095825195	O
46009	z	297 298	189446 189447	0.9999890327453613	O
46010	^	298 299	189447 189448	0.999988317489624	O
46011	,	300 301	189449 189450	0.9999892711639404	O
46012	and	302 305	189451 189454	0.9999895095825195	O
46013	then	306 310	189455 189459	0.9999891519546509	O
46014	solving	311 318	189460 189467	0.9999884366989136	O
46015	for	319 322	189468 189471	0.99998939037323	O
46016	β	323 324	189472 189473	0.9999885559082031	O
46017	in	325 327	189474 189476	0.9999892711639404	O
46018	the	328 331	189477 189480	0.9999895095825195	O
46019	equation	332 340	189481 189489	0.9999872446060181	O
46020	below	341 346	189490 189495	0.9999867677688599	O
46021	:	347 348	189496 189497	0.9999891519546509	O
46022	β	349 350	189498 189499	0.9999884366989136	O
46023	=	350 351	189499 189500	0.9999886751174927	O
46024	Φ	351 352	189500 189501	0.9999891519546509	O
46025	(	352 353	189501 189502	0.9999895095825195	O
46026	Zα−z	354 357	189503 189506	0.9999887943267822	O
46030	^	358 359	189507 189508	0.9999886751174927	O
46031	)	360 361	189509 189510	0.99998939037323	O
46032	,	362 363	189511 189512	0.99998939037323	O
46033	where	364 369	189513 189518	0.9999887943267822	O
46034	β	370 371	189519 189520	0.9999878406524658	O
46035	is	372 374	189521 189523	0.9999891519546509	O
46036	the	375 378	189524 189527	0.9999892711639404	O
46037	probability	379 390	189528 189539	0.9999885559082031	O
46038	of	391 393	189540 189542	0.9999891519546509	O
46039	Type	394 398	189543 189547	0.9999885559082031	O
46040	II	399 401	189548 189550	0.9999874830245972	O
46041	error	402 407	189551 189556	0.9999887943267822	O
46042	(	408 409	189557 189558	0.9999895095825195	O
46043	hence	410 415	189559 189564	0.9999878406524658	O
46044	power	416 421	189565 189570	0.9999884366989136	O
46045	is	422 424	189571 189573	0.99998939037323	O
46046	1	425 426	189574 189575	0.9999884366989136	O
46047	-	426 427	189575 189576	0.9999890327453613	O
46048	β	427 428	189576 189577	0.999988317489624	O
46049	)	429 430	189578 189579	0.99998939037323	O
46050	and	431 434	189580 189583	0.9999889135360718	O
46051	Φ	435 436	189584 189585	0.9999885559082031	O
46052	(	436 437	189585 189586	0.9999891519546509	O
46053	z	437 438	189586 189587	0.9999880790710449	O
46054	)	439 440	189588 189589	0.99998939037323	O
46055	is	441 443	189590 189592	0.9999892711639404	O
46056	the	444 447	189593 189596	0.9999892711639404	O
46057	cumulative	448 458	189597 189607	0.9999880790710449	O
46058	standard	459 467	189608 189616	0.9999887943267822	O
46059	normal	468 474	189617 189623	0.9999885559082031	O
46060	distribution	475 487	189624 189636	0.9999887943267822	O
46061	.	488 489	189637 189638	0.9999756813049316	O
46062	A	0 1	189639 189640	0.9999864101409912	O
46063	script	2 8	189641 189647	0.9999265670776367	O
46064	for	9 12	189648 189651	0.9999853372573853	O
46065	computing	13 22	189652 189661	0.9999855756759644	O
46066	the	23 26	189662 189665	0.9999880790710449	O
46067	predicted	27 36	189666 189675	0.9999858140945435	O
46068	power	37 42	189676 189681	0.999987006187439	O
46069	for	43 46	189682 189685	0.9999874830245972	O
46070	any	47 50	189686 189689	0.9999866485595703	O
46071	particular	51 61	189690 189700	0.9999860525131226	O
46072	combination	62 73	189701 189712	0.9999854564666748	O
46073	of	74 76	189713 189715	0.9999879598617554	O
46074	these	77 82	189716 189721	0.9999877214431763	O
46075	parameters	83 93	189722 189732	0.9999839067459106	O
46076	,	94 95	189733 189734	0.9999874830245972	O
46077	using	96 101	189735 189740	0.9999878406524658	O
46078	the	102 105	189741 189744	0.9999881982803345	O
46079	statistical	106 117	189745 189756	0.9999858140945435	O
46080	languages	118 127	189757 189766	0.9999855756759644	O
46081	S	128 129	189767 189768	0.9999889135360718	O
46082	-	129 130	189768 189769	0.9999892711639404	O
46083	plus	130 134	189769 189773	0.9999868869781494	O
46084	or	135 137	189774 189776	0.9999876022338867	O
46085	R	138 139	189777 189778	0.9999731779098511	O
46086	is	140 142	189779 189781	0.9999872446060181	O
46087	also	143 147	189782 189786	0.9999884366989136	O
46088	available	148 157	189787 189796	0.999988317489624	O
46089	from	158 162	189797 189801	0.9999880790710449	O
46090	the	163 166	189802 189805	0.9999884366989136	O
46091	website	167 174	189806 189813	0.9999854564666748	O
46092	[	175 176	189814 189815	0.9999890327453613	O
46093	65	176 178	189815 189817	0.9999866485595703	O
46094	]	178 179	189817 189818	0.9999884366989136	O
46095	.	180 181	189819 189820	0.9999769926071167	O
46096	Figures	0 6	189821 189827	0.9999878406524658	O
46098	1	8 9	189829 189830	0.9999897480010986	O
46099	,	10 11	189831 189832	0.9999895095825195	O
46100	2	12 13	189833 189834	0.9999884366989136	O
46101	,	14 15	189835 189836	0.9999895095825195	O
46102	3	16 17	189837 189838	0.9999879598617554	O
46103	,	18 19	189839 189840	0.9999896287918091	O
46104	4	20 21	189841 189842	0.999987006187439	O
46105	,	22 23	189843 189844	0.9999895095825195	O
46106	5	24 25	189845 189846	0.9999881982803345	O
46107	,	26 27	189847 189848	0.9999892711639404	O
46108	6	28 29	189849 189850	0.9999884366989136	O
46109	show	30 34	189851 189855	0.9999889135360718	O
46110	estimated	35 44	189856 189865	0.9999897480010986	O
46111	power	45 50	189866 189871	0.9999887943267822	O
46112	of	51 53	189872 189874	0.9999897480010986	O
46113	the	54 57	189875 189878	0.9999901056289673	O
46114	Zc	58 59	189879 189880	0.9999879598617554	O
46116	test	61 65	189882 189886	0.9999892711639404	O
46117	for	66 69	189887 189890	0.9999897480010986	O
46118	varying	70 77	189891 189898	0.9999887943267822	O
46119	sample	78 84	189899 189905	0.9999890327453613	O
46120	sizes	85 90	189906 189911	0.9999892711639404	O
46121	given	91 96	189912 189917	0.9999892711639404	O
46122	several	97 104	189918 189925	0.99998939037323	O
46123	values	105 111	189926 189932	0.9999891519546509	O
46124	of	112 114	189933 189935	0.9999897480010986	O
46125	AR	115 117	189936 189938	0.9999886751174927	O
46126	for	118 121	189939 189942	0.9999898672103882	O
46127	the	122 125	189943 189946	0.9999899864196777	O
46128	linked	126 132	189947 189953	0.9999890327453613	O
46129	and	133 136	189954 189957	0.9999895095825195	O
46130	unlinked	137 144	189958 189965	0.9999895095825195	O
46133	loci	146 149	189967 189970	0.9999897480010986	O
46135	,	151 152	189972 189973	0.9999897480010986	O
46136	recombination	153 165	189974 189986	0.9999896287918091	O
46139	fraction	167 175	189988 189996	0.9999896287918091	O
46140	(	176 177	189997 189998	0.9999898672103882	O
46141	θ	178 179	189999 190000	0.9999876022338867	O
46142	)	180 181	190001 190002	0.9999899864196777	O
46143	,	182 183	190003 190004	0.9999898672103882	O
46144	number	184 190	190005 190011	0.9999895095825195	O
46145	of	191 193	190012 190014	0.9999897480010986	O
46146	parents	194 201	190015 190022	0.9999878406524658	O
46147	genotyped	202 210	190023 190031	0.9999896287918091	O
46151	,	212 213	190033 190034	0.9999889135360718	O
46152	and	214 217	190035 190038	0.9999896287918091	O
46153	number	218 224	190039 190045	0.9999895095825195	O
46154	of	225 227	190046 190048	0.9999897480010986	O
46155	offspring	228 237	190049 190058	0.9999854564666748	O
46156	proxies	238 244	190059 190065	0.9999895095825195	O
46159	.	246 247	190067 190068	0.9999798536300659	O
46160	Except	0 6	190069 190075	0.9999839067459106	O
46161	as	7 9	190076 190078	0.9999879598617554	O
46162	noted	10 15	190079 190084	0.9999879598617554	O
46163	,	16 17	190085 190086	0.9999885559082031	O
46164	the	18 21	190087 190090	0.9999885559082031	O
46165	power	22 27	190091 190096	0.999987006187439	O
46166	estimates	28 37	190097 190106	0.9999873638153076	O
46167	are	38 41	190107 190110	0.999988317489624	O
46168	based	42 47	190111 190116	0.9999891519546509	O
46169	on	48 50	190117 190119	0.9999895095825195	O
46170	the	51 54	190120 190123	0.9999896287918091	O
46171	following	55 64	190124 190133	0.9999886751174927	O
46172	settings	65 73	190134 190142	0.9999856948852539	O
46173	of	74 76	190143 190145	0.9999887943267822	O
46174	the	77 80	190146 190149	0.9999895095825195	O
46175	genetic	81 88	190150 190157	0.9999873638153076	O
46176	and	89 92	190158 190161	0.9999889135360718	O
46177	design	93 99	190162 190168	0.9999873638153076	O
46178	parameters	100 110	190169 190179	0.999988317489624	O
46179	:	111 112	190180 190181	0.9999895095825195	O
46180	two	113 116	190182 190185	0.9999877214431763	O
46181	total	117 122	190186 190191	0.9999886751174927	O
46182	affected	123 131	190192 190200	0.9999884366989136	O
46183	sibs	132 135	190201 190204	0.9999885559082031	O
46185	,	137 138	190206 190207	0.99998939037323	O
46186	both	139 143	190208 190212	0.9999885559082031	O
46187	sampled	144 151	190213 190220	0.9999884366989136	O
46188	,	152 153	190221 190222	0.9999895095825195	O
46189	two	154 157	190223 190226	0.9999880790710449	O
46190	unaffected	158 167	190227 190236	0.9999892711639404	O
46193	sibs	169 172	190238 190241	0.9999886751174927	O
46195	(	174 175	190243 190244	0.9999896287918091	O
46196	not	176 179	190245 190248	0.9999892711639404	O
46197	sampled	180 187	190249 190256	0.9999887943267822	O
46198	)	188 189	190257 190258	0.9999897480010986	O
46199	,	190 191	190259 190260	0.9999896287918091	O
46200	no	192 194	190261 190263	0.9999892711639404	O
46201	parents	195 202	190264 190271	0.9999881982803345	O
46202	or	203 205	190272 190274	0.9999892711639404	O
46203	offspring	206 215	190275 190284	0.999985933303833	O
46204	proxies	216 222	190285 190291	0.9999892711639404	O
46207	,	224 225	190293 190294	0.9999898672103882	O
46208	AR1	226 228	190295 190297	0.99998939037323	O
46210	(	230 231	190299 190300	0.9999897480010986	O
46211	linked	232 238	190301 190307	0.9999884366989136	O
46212	locus	239 243	190308 190312	0.9999892711639404	O
46214	)	245 246	190314 190315	0.9999895095825195	O
46215	=	247 248	190316 190317	0.9999895095825195	O
46216	0	249 250	190318 190319	0.99998939037323	O
46217	.	250 251	190319 190320	0.9999896287918091	O
46218	1	251 252	190320 190321	0.9999892711639404	O
46219	,	253 254	190322 190323	0.9999896287918091	O
46220	AR2	255 257	190324 190326	0.99998939037323	O
46222	(	259 260	190328 190329	0.9999897480010986	O
46223	unlinked	260 267	190329 190336	0.99998939037323	O
46226	locus	269 273	190338 190342	0.9999892711639404	O
46228	)	275 276	190344 190345	0.9999895095825195	O
46229	=	277 278	190346 190347	0.9999895095825195	O
46230	0	279 280	190348 190349	0.9999895095825195	O
46231	.	280 281	190349 190350	0.9999896287918091	O
46232	05	281 283	190350 190352	0.9999889135360718	O
46233	,	284 285	190353 190354	0.9999895095825195	O
46234	θ	286 287	190355 190356	0.9999865293502808	O
46235	=	288 289	190357 190358	0.99998939037323	O
46236	0	290 291	190359 190360	0.9999895095825195	O
46237	.	291 292	190360 190361	0.9999896287918091	O
46238	05	292 294	190361 190363	0.9999887943267822	O
46239	,	295 296	190364 190365	0.9999887943267822	O
46240	and	297 300	190366 190369	0.9999892711639404	O
46241	no	301 303	190370 190372	0.9999892711639404	O
46242	screening	304 313	190373 190382	0.9999879598617554	O
46243	to	314 316	190383 190385	0.9999896287918091	O
46244	exclude	317 324	190386 190393	0.9999878406524658	O
46245	unlinked	325 332	190394 190401	0.9999895095825195	O
46248	families	334 342	190403 190411	0.999988317489624	O
46249	.	343 344	190412 190413	0.999974250793457	O
46250	Effect	0 6	190414 190420	0.9999619722366333	O
46251	of	7 9	190421 190423	0.99997878074646	O
46252	sample	10 16	190424 190430	0.9999816417694092	O
46253	size	17 21	190431 190435	0.9999786615371704	O
46254	and	22 25	190436 190439	0.9999784231185913	O
46255	varying	26 33	190440 190447	0.9999614953994751	O
46256	attributable	34 45	190448 190459	0.9999862909317017	O
46260	risk	47 51	190461 190465	0.999985933303833	O
46261	at	52 54	190466 190468	0.9999862909317017	O
46262	the	55 58	190469 190472	0.9999871253967285	O
46263	linked	59 65	190473 190479	0.9999847412109375	O
46264	locus	66 70	190480 190484	0.9999866485595703	O
46266	on	72 74	190486 190488	0.9999817609786987	O
46267	estimated	75 84	190489 190498	0.9999843835830688	O
46268	power	85 90	190499 190504	0.9999852180480957	O
46269	.	91 92	190505 190506	0.9998041987419128	O
46270	Effect	0 6	190507 190513	0.9999649524688721	O
46271	of	7 9	190514 190516	0.9999804496765137	O
46272	sample	10 16	190517 190523	0.9999830722808838	O
46273	size	17 21	190524 190528	0.9999794960021973	O
46274	and	22 25	190529 190532	0.9999796152114868	O
46275	varying	26 33	190533 190540	0.9999634027481079	O
46276	attributable	34 45	190541 190552	0.9999867677688599	O
46280	risk	47 51	190554 190558	0.9999864101409912	O
46281	at	52 54	190559 190561	0.9999868869781494	O
46282	the	55 58	190562 190565	0.9999880790710449	O
46283	unlinked	59 66	190566 190573	0.9999879598617554	O
46286	locus	68 72	190575 190579	0.9999876022338867	O
46288	on	74 76	190581 190583	0.999982476234436	O
46289	estimated	77 86	190584 190593	0.9999845027923584	O
46290	power	87 92	190594 190599	0.9999853372573853	O
46291	.	93 94	190600 190601	0.9998655319213867	O
46292	Effect	0 6	190602 190608	0.9999501705169678	O
46293	of	7 9	190609 190611	0.9999759197235107	O
46294	sample	10 16	190612 190618	0.9999825954437256	O
46295	size	17 21	190619 190623	0.9999797344207764	O
46296	and	22 25	190624 190627	0.9999741315841675	O
46297	varying	26 33	190628 190635	0.999942421913147	O
46298	recombination	34 46	190636 190648	0.9999860525131226	O
46301	fraction	48 56	190650 190658	0.9999834299087524	O
46302	on	57 59	190659 190661	0.9999741315841675	O
46303	estimated	60 69	190662 190671	0.9999806880950928	O
46304	power	70 75	190672 190677	0.9999830722808838	O
46305	.	76 77	190678 190679	0.9995293617248535	O
46306	Effect	0 6	190680 190686	0.9999808073043823	O
46307	of	7 9	190687 190689	0.9999849796295166	O
46308	sample	10 16	190690 190696	0.999985933303833	O
46309	size	17 21	190697 190701	0.9999850988388062	O
46310	and	22 25	190702 190705	0.9999841451644897	O
46311	varying	26 33	190706 190713	0.9999767541885376	O
46312	number	34 40	190714 190720	0.9999872446060181	O
46313	of	41 43	190721 190723	0.9999877214431763	O
46314	typed	44 49	190724 190729	0.9999799728393555	O
46315	parents	50 57	190730 190737	0.9999827146530151	O
46316	on	58 60	190738 190740	0.9999845027923584	O
46317	estimated	61 70	190741 190750	0.9999864101409912	O
46318	power	71 76	190751 190756	0.9999861717224121	O
46319	.	77 78	190757 190758	0.9999880790710449	O
46320	*	79 80	190759 190760	0.9999865293502808	O
46321	*	80 81	190760 190761	0.9999792575836182	O
46322	IGNORE	0 5	190762 190767	0.9999867677688599	O
46325	LINE	7 10	190769 190772	0.9999885559082031	O
46328	*	12 13	190774 190775	0.9999889135360718	O
46329	*	13 14	190775 190776	0.9999889135360718	O
46330	*	15 16	190777 190778	0.9999889135360718	O
46331	*	16 17	190778 190779	0.9999890327453613	O
46332	IGNORE	18 23	190780 190785	0.9999878406524658	O
46335	LINE	25 28	190787 190790	0.9999890327453613	O
46338	*	30 31	190792 190793	0.9999889135360718	O
46339	*	31 32	190793 190794	0.9999889135360718	O
46340	*	33 34	190795 190796	0.9999889135360718	O
46341	*	34 35	190796 190797	0.9999887943267822	O
46342	IGNORE	36 41	190798 190803	0.9999874830245972	O
46345	LINE	43 46	190805 190808	0.9999889135360718	O
46348	*	48 49	190810 190811	0.9999889135360718	O
46349	*	49 50	190811 190812	0.9999890327453613	O
46350	Effect	51 57	190813 190819	0.9999881982803345	O
46351	of	58 60	190820 190822	0.99998939037323	O
46352	varying	61 68	190823 190830	0.999987006187439	O
46353	number	69 75	190831 190837	0.9999889135360718	O
46354	of	76 78	190838 190840	0.99998939037323	O
46355	offspring	79 88	190841 190850	0.9999866485595703	O
46356	proxies	89 95	190851 190857	0.9999886751174927	O
46359	on	97 99	190859 190861	0.9999886751174927	O
46360	power	100 105	190862 190867	0.9999860525131226	O
46361	for	106 109	190868 190871	0.9999874830245972	O
46362	families	110 118	190872 190880	0.9999853372573853	O
46363	of	119 121	190881 190883	0.9999886751174927	O
46364	two	122 125	190884 190887	0.9999840259552002	O
46365	affected	126 134	190888 190896	0.9999860525131226	O
46366	siblings	135 143	190897 190905	0.9999810457229614	O
46367	.	144 145	190906 190907	0.9999574422836304	O
46368	Effect	0 6	190908 190914	0.9999786615371704	O
46369	of	7 9	190915 190917	0.9999877214431763	O
46370	sample	10 16	190918 190924	0.9999872446060181	O
46371	size	17 21	190925 190929	0.9999867677688599	O
46372	and	22 25	190930 190933	0.9999872446060181	O
46373	varying	26 33	190934 190941	0.9999847412109375	O
46374	numbers	34 41	190942 190949	0.9999884366989136	O
46375	of	42 44	190950 190952	0.9999889135360718	O
46376	offspring	45 54	190953 190962	0.9999831914901733	O
46377	proxies	55 61	190963 190969	0.9999887943267822	O
46380	(	63 64	190971 190972	0.9999897480010986	O
46381	1	65 66	190973 190974	0.9999892711639404	O
46382	or	67 69	190975 190977	0.9999890327453613	O
46383	2	70 71	190978 190979	0.9999880790710449	O
46384	)	72 73	190980 190981	0.9999897480010986	O
46385	on	74 76	190982 190984	0.9999889135360718	O
46386	estimated	77 86	190985 190994	0.9999885559082031	O
46387	power	87 92	190995 191000	0.9999872446060181	O
46388	,	93 94	191001 191002	0.9999877214431763	O
46389	families	95 103	191003 191011	0.9999871253967285	O
46390	with	104 108	191012 191016	0.9999895095825195	O
46391	two	109 112	191017 191020	0.9999879598617554	O
46392	affected	113 121	191021 191029	0.9999885559082031	O
46393	sibs	122 125	191030 191033	0.9999880790710449	O
46395	,	127 128	191035 191036	0.9999890327453613	O
46396	with	129 133	191037 191041	0.9999895095825195	O
46397	only	134 138	191042 191046	0.9999895095825195	O
46398	one	139 142	191047 191050	0.9999891519546509	O
46399	available	143 152	191051 191060	0.9999892711639404	O
46400	for	153 156	191061 191064	0.99998939037323	O
46401	genotyping	157 166	191065 191074	0.9999890327453613	O
46405	(	168 169	191076 191077	0.9999896287918091	O
46406	1	170 171	191078 191079	0.9999891519546509	O
46407	or	172 174	191080 191082	0.9999889135360718	O
46408	2	175 176	191083 191084	0.9999879598617554	O
46409	)	177 178	191085 191086	0.9999896287918091	O
46410	,	179 180	191087 191088	0.9999886751174927	O
46411	compared	181 189	191089 191097	0.9999880790710449	O
46412	with	190 194	191098 191102	0.9999887943267822	O
46413	families	195 203	191103 191111	0.9999881982803345	O
46414	with	204 208	191112 191116	0.9999892711639404	O
46415	both	209 213	191117 191121	0.9999884366989136	O
46416	affected	214 222	191122 191130	0.9999884366989136	O
46417	sibs	223 226	191131 191134	0.999988317489624	O
46419	available	228 237	191136 191145	0.9999890327453613	O
46420	for	238 241	191146 191149	0.9999891519546509	O
46421	genotyping	242 251	191150 191159	0.9999887943267822	O
46425	(	253 254	191161 191162	0.9999896287918091	O
46426	S	255 256	191163 191164	0.9999891519546509	O
46427	=	257 258	191165 191166	0.99998939037323	O
46428	2	259 260	191167 191168	0.9999877214431763	O
46429	)	261 262	191169 191170	0.9999895095825195	O
46430	.	263 264	191171 191172	0.9999657869338989	O
46431	Effect	0 6	191173 191179	0.9999536275863647	O
46432	of	7 9	191180 191182	0.9999803304672241	O
46433	varying	10 17	191183 191190	0.9999687671661377	O
46434	number	18 24	191191 191197	0.9999828338623047	O
46435	of	25 27	191198 191200	0.9999850988388062	O
46436	offspring	28 37	191201 191210	0.9999746084213257	O
46437	proxies	38 44	191211 191217	0.9999837875366211	O
46440	on	46 48	191219 191221	0.9999798536300659	O
46441	power	49 54	191222 191227	0.9999791383743286	O
46442	for	55 58	191228 191231	0.9999817609786987	O
46443	families	59 67	191232 191240	0.9999786615371704	O
46444	of	68 70	191241 191243	0.9999850988388062	O
46445	three	71 76	191244 191249	0.9999682903289795	O
46446	affected	77 85	191250 191258	0.9999793767929077	O
46447	siblings	86 94	191259 191267	0.9999682903289795	O
46448	.	95 96	191268 191269	0.9995706677436829	O
46449	Effect	0 6	191270 191276	0.9999817609786987	O
46450	of	7 9	191277 191279	0.9999879598617554	O
46451	sample	10 16	191280 191286	0.9999876022338867	O
46452	size	17 21	191287 191291	0.9999873638153076	O
46453	and	22 25	191292 191295	0.9999878406524658	O
46454	varying	26 33	191296 191303	0.9999853372573853	O
46455	numbers	34 41	191304 191311	0.9999887943267822	O
46456	of	42 44	191312 191314	0.9999890327453613	O
46457	offspring	45 54	191315 191324	0.9999839067459106	O
46458	proxies	55 61	191325 191331	0.9999889135360718	O
46461	(	63 64	191333 191334	0.9999895095825195	O
46462	O	65 66	191335 191336	0.9999880790710449	O
46463	)	67 68	191337 191338	0.9999898672103882	O
46464	on	69 71	191339 191341	0.9999890327453613	O
46465	estimated	72 81	191342 191351	0.9999886751174927	O
46466	power	82 87	191352 191357	0.9999876022338867	O
46467	,	88 89	191358 191359	0.9999874830245972	O
46468	families	90 98	191360 191368	0.9999871253967285	O
46469	with	99 103	191369 191373	0.9999895095825195	O
46470	three	104 109	191374 191379	0.9999878406524658	O
46471	affected	110 118	191380 191388	0.9999881982803345	O
46472	sibs	119 122	191389 191392	0.9999880790710449	O
46474	,	124 125	191394 191395	0.9999889135360718	O
46475	with	126 130	191396 191400	0.9999895095825195	O
46476	only	131 135	191401 191405	0.9999897480010986	O
46477	two	136 139	191406 191409	0.9999880790710449	O
46478	available	140 149	191410 191419	0.99998939037323	O
46479	for	150 153	191420 191423	0.9999895095825195	O
46480	genotyping	154 163	191424 191433	0.9999891519546509	O
46484	(	165 166	191435 191436	0.9999898672103882	O
46485	O	167 168	191437 191438	0.9999891519546509	O
46486	=	169 170	191439 191440	0.9999896287918091	O
46487	0	171 172	191441 191442	0.99998939037323	O
46488	,	172 173	191442 191443	0.9999885559082031	O
46489	1	174 175	191444 191445	0.9999890327453613	O
46490	,	176 177	191446 191447	0.9999885559082031	O
46491	or	178 180	191448 191450	0.9999885559082031	O
46492	2	181 182	191451 191452	0.9999876022338867	O
46493	)	183 184	191453 191454	0.9999896287918091	O
46494	,	185 186	191455 191456	0.9999887943267822	O
46495	compared	187 195	191457 191465	0.9999884366989136	O
46496	with	196 200	191466 191470	0.9999890327453613	O
46497	families	201 209	191471 191479	0.9999881982803345	O
46498	with	210 214	191480 191484	0.9999892711639404	O
46499	all	215 218	191485 191488	0.9999895095825195	O
46500	three	219 224	191489 191494	0.9999879598617554	O
46501	affected	225 233	191495 191503	0.9999879598617554	O
46502	sibs	234 237	191504 191507	0.9999881982803345	O
46504	available	239 248	191509 191518	0.9999891519546509	O
46505	for	249 252	191519 191522	0.9999892711639404	O
46506	genotyping	253 262	191523 191532	0.9999887943267822	O
46510	(	264 265	191534 191535	0.9999897480010986	O
46511	S	266 267	191536 191537	0.9999892711639404	O
46512	=	268 269	191538 191539	0.9999896287918091	O
46513	3	270 271	191540 191541	0.9999878406524658	O
46514	)	272 273	191542 191543	0.9999895095825195	O
46515	.	274 275	191544 191545	0.9999715089797974	O
46516	Relative	0 7	191546 191553	0.9999874830245972	O
46518	Efficiency	9 18	191555 191564	0.9999886751174927	O
46521	of	20 22	191566 191568	0.9999884366989136	O
46522	Alternative	23 34	191569 191580	0.9999864101409912	O
46523	Designs	35 41	191581 191587	0.999985933303833	O
46525	Because	43 50	191589 191596	0.9999860525131226	O
46526	the	51 54	191597 191600	0.9999895095825195	O
46527	power	55 60	191601 191606	0.9999880790710449	O
46528	of	61 63	191607 191609	0.9999896287918091	O
46529	the	64 67	191610 191613	0.9999897480010986	O
46530	discordant	68 77	191614 191623	0.9999890327453613	O
46533	test	79 83	191625 191629	0.9999891519546509	O
46534	was	84 87	191630 191633	0.9999887943267822	O
46535	rarely	88 94	191634 191640	0.9999845027923584	O
46536	much	95 99	191641 191645	0.999988317489624	O
46537	greater	100 107	191646 191653	0.9999891519546509	O
46538	than	108 112	191654 191658	0.9999895095825195	O
46539	that	113 117	191659 191663	0.9999895095825195	O
46540	of	118 120	191664 191666	0.99998939037323	O
46541	the	121 124	191667 191670	0.9999896287918091	O
46542	concordant	125 134	191671 191680	0.99998939037323	O
46545	test	136 140	191682 191686	0.9999892711639404	O
46546	,	141 142	191687 191688	0.9999885559082031	O
46547	and	143 146	191689 191692	0.9999890327453613	O
46548	the	147 150	191693 191696	0.9999895095825195	O
46549	concordant	151 160	191697 191706	0.99998939037323	O
46552	test	162 166	191708 191712	0.9999890327453613	O
46553	requires	167 175	191713 191721	0.9999880790710449	O
46554	genotyping	176 185	191722 191731	0.9999889135360718	O
46558	of	187 189	191733 191735	0.9999895095825195	O
46559	only	190 194	191736 191740	0.9999885559082031	O
46560	the	195 198	191741 191744	0.9999895095825195	O
46561	affected	199 207	191745 191753	0.9999867677688599	O
46562	sibs	208 211	191754 191757	0.9999858140945435	O
46564	,	213 214	191759 191760	0.9999886751174927	O
46565	the	215 218	191761 191764	0.9999898672103882	O
46566	ARE	219 221	191765 191767	0.999988317489624	O
46568	of	223 225	191769 191771	0.9999896287918091	O
46569	the	226 229	191772 191775	0.9999897480010986	O
46570	concordant	230 239	191776 191785	0.99998939037323	O
46573	test	241 245	191787 191791	0.9999890327453613	O
46574	was	246 249	191792 191795	0.9999892711639404	O
46575	always	250 256	191796 191802	0.9999874830245972	O
46576	greater	257 264	191803 191810	0.9999887943267822	O
46577	on	265 267	191811 191813	0.9999895095825195	O
46578	average	268 275	191814 191821	0.9999890327453613	O
46579	than	276 280	191822 191826	0.9999895095825195	O
46580	that	281 285	191827 191831	0.9999895095825195	O
46581	of	286 288	191832 191834	0.99998939037323	O
46582	the	289 292	191835 191838	0.9999896287918091	O
46583	discordant	293 302	191839 191848	0.9999890327453613	O
46586	test	304 308	191850 191854	0.9999889135360718	O
46587	.	309 310	191855 191856	0.9999725818634033	O
46588	Nevertheless	0 12	191857 191869	0.9999802112579346	O
46589	,	13 14	191870 191871	0.9999876022338867	O
46590	we	15 17	191872 191874	0.9999843835830688	O
46591	were	18 22	191875 191879	0.9999861717224121	O
46592	interested	23 33	191880 191890	0.999983549118042	O
46593	in	34 36	191891 191893	0.9999885559082031	O
46594	specific	37 45	191894 191902	0.9999873638153076	O
46595	combinations	46 58	191903 191915	0.9999860525131226	O
46596	of	59 61	191916 191918	0.9999884366989136	O
46597	design	62 68	191919 191925	0.9999858140945435	O
46598	and	69 72	191926 191929	0.9999866485595703	O
46599	genetic	73 80	191930 191937	0.9999860525131226	O
46600	parameters	81 91	191938 191948	0.9999866485595703	O
46601	that	92 96	191949 191953	0.999988317489624	O
46602	might	97 102	191954 191959	0.9999864101409912	O
46603	have	103 107	191960 191964	0.9999880790710449	O
46604	resulted	108 116	191965 191973	0.9999881982803345	O
46605	in	117 119	191974 191976	0.9999887943267822	O
46606	better	120 126	191977 191983	0.9999873638153076	O
46607	relative	127 135	191984 191992	0.9999877214431763	O
46608	efficiency	136 146	191993 192003	0.9999874830245972	O
46609	for	147 150	192004 192007	0.9999868869781494	O
46610	the	151 154	192008 192011	0.9999879598617554	O
46611	discordant	155 164	192012 192021	0.9999878406524658	O
46614	test	166 170	192023 192027	0.9999865293502808	O
46615	.	171 172	192028 192029	0.9999734163284302	O
46616	Overall	0 7	192030 192037	0.9999836683273315	O
46617	,	8 9	192038 192039	0.9999880790710449	O
46618	the	10 13	192040 192043	0.9999881982803345	O
46619	ARE	14 16	192044 192046	0.9999849796295166	O
46621	for	18 21	192048 192051	0.9999886751174927	O
46622	the	22 25	192052 192055	0.99998939037323	O
46623	discordant	26 35	192056 192065	0.9999880790710449	O
46626	test	37 41	192067 192071	0.9999874830245972	O
46627	was	42 45	192072 192075	0.9999877214431763	O
46628	larger	46 52	192076 192082	0.9999864101409912	O
46629	than	53 57	192083 192087	0.9999887943267822	O
46630	that	58 62	192088 192092	0.9999891519546509	O
46631	for	63 66	192093 192096	0.9999889135360718	O
46632	the	67 70	192097 192100	0.99998939037323	O
46633	concordant	71 80	192101 192110	0.9999890327453613	O
46636	test	82 86	192112 192116	0.999988317489624	O
46637	in	87 89	192117 192119	0.9999890327453613	O
46638	13	90 92	192120 192122	0.999981164932251	O
46639	%	93 94	192123 192124	0.9999886751174927	O
46640	of	95 97	192125 192127	0.9999885559082031	O
46641	the	98 101	192128 192131	0.9999877214431763	O
46642	replications	102 113	192132 192143	0.9999842643737793	O
46644	.	115 116	192145 192146	0.9999685287475586	O
46645	We	0 2	192147 192149	0.9999849796295166	O
46646	used	3 7	192150 192154	0.9999866485595703	O
46647	a	8 9	192155 192156	0.99998939037323	O
46648	logistic	10 17	192157 192164	0.999987006187439	O
46650	regression	19 28	192166 192175	0.9999887943267822	O
46652	model	30 35	192177 192182	0.9999876022338867	O
46653	with	36 40	192183 192187	0.9999880790710449	O
46654	the	41 44	192188 192191	0.9999895095825195	O
46655	same	45 49	192192 192196	0.9999877214431763	O
46656	parameters	50 60	192197 192207	0.9999864101409912	O
46657	as	61 63	192208 192210	0.9999892711639404	O
46658	those	64 69	192211 192216	0.99998939037323	O
46659	in	70 72	192217 192219	0.99998939037323	O
46660	Tables	73 78	192220 192225	0.9999886751174927	O
46662	2	80 81	192227 192228	0.9999895095825195	O
46663	,	82 83	192229 192230	0.99998939037323	O
46664	3	84 85	192231 192232	0.9999890327453613	O
46665	and	86 89	192233 192236	0.9999890327453613	O
46666	4	90 91	192237 192238	0.9999880790710449	O
46667	to	92 94	192239 192241	0.9999895095825195	O
46668	predict	95 102	192242 192249	0.9999890327453613	O
46669	the	103 106	192250 192253	0.9999897480010986	O
46670	probability	107 118	192254 192265	0.9999885559082031	O
46671	that	119 123	192266 192270	0.9999895095825195	O
46672	Zp	124 125	192271 192272	0.9999887943267822	O
46674	would	127 132	192274 192279	0.9999889135360718	O
46675	outperform	133 142	192280 192289	0.99998939037323	O
46678	Zc	144 145	192291 192292	0.9999889135360718	O
46680	in	147 149	192294 192296	0.9999897480010986	O
46681	terms	150 155	192297 192302	0.9999891519546509	O
46682	of	156 158	192303 192305	0.9999896287918091	O
46683	relative	159 167	192306 192314	0.9999890327453613	O
46684	efficiency	168 178	192315 192325	0.9999881982803345	O
46685	(	179 180	192326 192327	0.9999897480010986	O
46686	not	181 184	192328 192331	0.99998939037323	O
46687	shown	185 190	192332 192337	0.9999889135360718	O
46688	)	191 192	192338 192339	0.9999898672103882	O
46689	.	193 194	192340 192341	0.9999775886535645	O
46690	Only	0 4	192342 192346	0.9999864101409912	O
46691	under	5 10	192347 192352	0.9999873638153076	O
46692	circumstances	11 24	192353 192366	0.9999873638153076	O
46693	that	25 29	192367 192371	0.9999885559082031	O
46694	would	30 35	192372 192377	0.9999872446060181	O
46695	result	36 42	192378 192384	0.9999887943267822	O
46696	in	43 45	192385 192387	0.99998939037323	O
46697	very	46 50	192388 192392	0.9999884366989136	O
46698	low	51 54	192393 192396	0.9999880790710449	O
46699	power	55 60	192397 192402	0.9999878406524658	O
46700	,	61 62	192403 192404	0.9999889135360718	O
46701	such	63 67	192405 192409	0.9999890327453613	O
46702	as	68 70	192410 192412	0.9999892711639404	O
46703	attributable	71 82	192413 192424	0.99998939037323	O
46707	risks	84 89	192426 192431	0.9999890327453613	O
46708	for	90 93	192432 192435	0.9999895095825195	O
46709	the	94 97	192436 192439	0.9999895095825195	O
46710	unlinked	98 105	192440 192447	0.9999889135360718	O
46713	locus	107 111	192449 192453	0.9999891519546509	O
46715	more	113 117	192455 192459	0.9999892711639404	O
46716	than	118 122	192460 192464	0.9999892711639404	O
46717	twice	123 128	192465 192470	0.9999885559082031	O
46718	as	129 131	192471 192473	0.9999886751174927	O
46719	large	132 137	192474 192479	0.9999886751174927	O
46720	as	138 140	192480 192482	0.9999890327453613	O
46721	attributable	141 152	192483 192494	0.9999890327453613	O
46725	risks	154 159	192496 192501	0.9999889135360718	O
46726	for	160 163	192502 192505	0.9999891519546509	O
46727	the	164 167	192506 192509	0.9999892711639404	O
46728	linked	168 174	192510 192516	0.9999868869781494	O
46729	locus	175 179	192517 192521	0.9999889135360718	O
46731	,	181 182	192523 192524	0.9999877214431763	O
46732	or	183 185	192525 192527	0.9999884366989136	O
46733	recombination	186 198	192528 192540	0.9999887943267822	O
46736	fractions	200 208	192542 192550	0.9999886751174927	O
46738	>	210 211	192552 192553	0.9999890327453613	O
46739	0	212 213	192554 192555	0.9999891519546509	O
46740	.	213 214	192555 192556	0.9999892711639404	O
46741	1	214 215	192556 192557	0.9999886751174927	O
46742	,	216 217	192558 192559	0.9999876022338867	O
46743	was	218 221	192560 192563	0.9999886751174927	O
46744	Zp	222 223	192564 192565	0.9999887943267822	O
46746	predicted	225 234	192567 192576	0.9999886751174927	O
46747	to	235 237	192577 192579	0.9999891519546509	O
46748	outperform	238 247	192580 192589	0.9999889135360718	O
46751	Zc	249 250	192591 192592	0.9999887943267822	O
46753	in	252 254	192594 192596	0.9999889135360718	O
46754	our	255 258	192597 192600	0.9999858140945435	O
46755	simulated	259 268	192601 192610	0.9999791383743286	O
46756	sample	269 275	192611 192617	0.999988317489624	O
46757	of	276 278	192618 192620	0.9999887943267822	O
46758	500	279 282	192621 192624	0.9999805688858032	O
46759	families	283 291	192625 192633	0.9999837875366211	O
46760	.	292 293	192634 192635	0.9999630451202393	O
46761	In	0 2	192636 192638	0.9999873638153076	O
46762	principle	3 12	192639 192648	0.9999778270721436	O
46763	,	13 14	192649 192650	0.9999866485595703	O
46764	including	15 24	192651 192660	0.999987006187439	O
46765	genotype	25 32	192661 192668	0.9999878406524658	O
46768	data	34 38	192670 192674	0.9999876022338867	O
46769	from	39 43	192675 192679	0.9999879598617554	O
46770	unaffected	44 53	192680 192689	0.9999868869781494	O
46773	siblings	55 63	192691 192699	0.999975323677063	O
46774	can	64 67	192700 192703	0.9999810457229614	O
46775	improve	68 75	192704 192711	0.9999860525131226	O
46776	the	76 79	192712 192715	0.999988317489624	O
46777	ability	80 87	192716 192723	0.9999881982803345	O
46778	to	88 90	192724 192726	0.999988317489624	O
46779	estimate	91 99	192727 192735	0.9999856948852539	O
46780	haplotypes	100 109	192736 192745	0.9999873638153076	O
46785	and	111 114	192747 192750	0.9999871253967285	O
46786	thereby	115 122	192751 192758	0.9999868869781494	O
46787	improve	123 130	192759 192766	0.9999874830245972	O
46788	power	131 136	192767 192772	0.999987006187439	O
46789	when	137 141	192773 192777	0.999987006187439	O
46790	multipoint	142 151	192778 192787	0.9999886751174927	O
46792	data	153 157	192789 192793	0.9999877214431763	O
46793	are	158 161	192794 192797	0.9999873638153076	O
46794	studied	162 169	192798 192805	0.9999861717224121	O
46795	.	170 171	192806 192807	0.9999678134918213	O
46796	Table	0 5	192808 192813	0.9999878406524658	O
46797	6	6 7	192814 192815	0.9999871253967285	O
46798	compares	8 16	192816 192824	0.9999864101409912	O
46799	estimates	17 26	192825 192834	0.9999877214431763	O
46800	of	27 29	192835 192837	0.9999896287918091	O
46801	Zc	30 31	192838 192839	0.9999886751174927	O
46803	and	33 36	192841 192844	0.9999895095825195	O
46804	Zp	37 38	192845 192846	0.9999886751174927	O
46806	for	40 43	192848 192851	0.9999895095825195	O
46807	a	44 45	192852 192853	0.9999897480010986	O
46808	selected	46 54	192854 192862	0.9999889135360718	O
46809	set	55 58	192863 192866	0.9999895095825195	O
46810	of	59 61	192867 192869	0.9999898672103882	O
46811	simulations	62 72	192870 192880	0.999984860420227	O
46813	with	74 78	192882 192886	0.9999895095825195	O
46814	multipoint	79 88	192887 192896	0.9999895095825195	O
46816	Zm	90 91	192898 192899	0.9999890327453613	O
46818	scores	93 99	192901 192907	0.9999896287918091	O
46819	for	100 103	192908 192911	0.9999896287918091	O
46820	the	104 107	192912 192915	0.9999895095825195	O
46821	same	108 112	192916 192920	0.9999872446060181	O
46822	families	113 121	192921 192929	0.9999873638153076	O
46823	as	122 124	192930 192932	0.9999896287918091	O
46824	calculated	125 135	192933 192943	0.9999891519546509	O
46825	by	136 138	192944 192946	0.99998939037323	O
46826	the	139 142	192947 192950	0.9999895095825195	O
46827	computer	143 151	192951 192959	0.9999856948852539	O
46828	program	152 159	192960 192967	0.999987006187439	O
46829	Merlin	160 166	192968 192974	0.9999841451644897	O
46830	[	167 168	192975 192976	0.9999895095825195	O
46831	58	168 170	192976 192978	0.9999868869781494	O
46832	]	170 171	192978 192979	0.9999892711639404	O
46833	.	172 173	192980 192981	0.999982476234436	O
46834	In	0 2	192982 192984	0.9999866485595703	O
46835	these	3 8	192985 192990	0.9999847412109375	O
46836	simulations	9 19	192991 193001	0.9998680353164673	O
46838	,	21 22	193003 193004	0.9999872446060181	O
46839	when	23 27	193005 193009	0.9999876022338867	O
46840	markers	28 35	193010 193017	0.9999831914901733	O
46841	were	36 40	193018 193022	0.9999880790710449	O
46842	spaced	41 47	193023 193029	0.999984622001648	O
46843	no	48 50	193030 193032	0.9999876022338867	O
46844	closer	51 57	193033 193039	0.9999880790710449	O
46845	than	58 62	193040 193044	0.9999891519546509	O
46846	10	63 65	193045 193047	0.9999880790710449	O
46847	cM	66 67	193048 193049	0.9999891519546509	O
46849	from	69 73	193051 193055	0.9999887943267822	O
46850	one	74 77	193056 193059	0.9999878406524658	O
46851	another	78 85	193060 193067	0.9999876022338867	O
46852	,	86 87	193068 193069	0.9999877214431763	O
46853	as	88 90	193070 193072	0.9999876022338867	O
46854	is	91 93	193073 193075	0.9999877214431763	O
46855	usually	94 101	193076 193083	0.9999850988388062	O
46856	the	102 105	193084 193087	0.9999879598617554	O
46857	case	106 110	193088 193092	0.9999868869781494	O
46858	in	111 113	193093 193095	0.9999885559082031	O
46859	an	114 116	193096 193098	0.9999890327453613	O
46860	initial	117 124	193099 193106	0.9999877214431763	O
46861	genome	125 131	193107 193113	0.9999866485595703	O
46862	scan	132 136	193114 193118	0.9999881982803345	O
46863	,	137 138	193119 193120	0.999988317489624	O
46864	we	139 141	193121 193123	0.9999873638153076	O
46865	observed	142 150	193124 193132	0.9999887943267822	O
46866	no	151 153	193133 193135	0.9999885559082031	O
46867	improvement	154 165	193136 193147	0.9999881982803345	O
46868	in	166 168	193148 193150	0.99998939037323	O
46869	power	169 174	193151 193156	0.9999881982803345	O
46870	with	175 179	193157 193161	0.9999889135360718	O
46871	the	180 183	193162 193165	0.9999892711639404	O
46872	concordant	184 193	193166 193175	0.9999892711639404	O
46875	multipoint	195 204	193177 193186	0.9999887943267822	O
46877	statistic	206 214	193188 193196	0.9999892711639404	O
46880	,	216 217	193198 193199	0.9999881982803345	O
46881	but	218 221	193200 193203	0.9999868869781494	O
46882	an	222 224	193204 193206	0.9999890327453613	O
46883	improvement	225 236	193207 193218	0.999988317489624	O
46884	in	237 239	193219 193221	0.9999891519546509	O
46885	power	240 245	193222 193227	0.9999881982803345	O
46886	with	246 250	193228 193232	0.9999884366989136	O
46887	the	251 254	193233 193236	0.9999890327453613	O
46888	discordant	255 264	193237 193246	0.9999886751174927	O
46891	test	266 270	193248 193252	0.9999878406524658	O
46892	.	271 272	193253 193254	0.9999698400497437	O
46893	When	0 4	193255 193259	0.999985933303833	O
46894	markers	5 12	193260 193267	0.9999827146530151	O
46895	were	13 17	193268 193272	0.9999880790710449	O
46896	spaced	18 24	193273 193279	0.9999854564666748	O
46897	at	25 27	193280 193282	0.9999889135360718	O
46898	5	28 29	193283 193284	0.9999881982803345	O
46899	cM	30 31	193285 193286	0.9999887943267822	O
46901	intervals	33 42	193288 193297	0.9999881982803345	O
46902	,	43 44	193298 193299	0.9999873638153076	O
46903	however	45 52	193300 193307	0.9999830722808838	O
46904	,	53 54	193308 193309	0.999988317489624	O
46905	the	55 58	193310 193313	0.9999887943267822	O
46906	power	59 64	193314 193319	0.9999886751174927	O
46907	of	65 67	193320 193322	0.99998939037323	O
46908	both	68 72	193323 193327	0.9999889135360718	O
46909	multipoint	73 82	193328 193337	0.9999890327453613	O
46911	statistics	84 94	193339 193349	0.9999891519546509	O
46912	to	95 97	193350 193352	0.9999892711639404	O
46913	detect	98 104	193353 193359	0.9999886751174927	O
46914	linkage	105 111	193360 193366	0.9999884366989136	O
46916	exceeded	113 121	193368 193376	0.9999865293502808	O
46917	that	122 126	193377 193381	0.9999889135360718	O
46918	of	127 129	193382 193384	0.9999890327453613	O
46919	both	130 134	193385 193389	0.9999886751174927	O
46920	Zc	135 136	193390 193391	0.9999880790710449	O
46922	and	138 141	193393 193396	0.9999884366989136	O
46923	Zp	142 143	193397 193398	0.9999879598617554	O
46925	.	145 146	193400 193401	0.9999784231185913	O
46926	The	0 3	193402 193405	0.9999890327453613	O
46927	conservative	4 16	193406 193418	0.9999854564666748	O
46928	bias	17 21	193419 193423	0.9999860525131226	O
46929	of	22 24	193424 193426	0.9999892711639404	O
46930	Zmc	25 27	193427 193429	0.9999867677688599	O
46933	noted	29 34	193431 193436	0.9999887943267822	O
46934	in	35 37	193437 193439	0.9999896287918091	O
46935	Tables	38 43	193440 193445	0.9999876022338867	O
46937	2	45 46	193447 193448	0.9999886751174927	O
46938	and	47 50	193449 193452	0.9999887943267822	O
46939	3	51 52	193453 193454	0.9999874830245972	O
46940	appears	53 60	193455 193462	0.9999873638153076	O
46941	to	61 63	193463 193465	0.99998939037323	O
46942	decrease	64 72	193466 193474	0.9999852180480957	O
46943	as	73 75	193475 193477	0.9999889135360718	O
46944	marker	76 82	193478 193484	0.9999867677688599	O
46945	intervals	83 92	193485 193494	0.9999881982803345	O
46946	become	93 99	193495 193501	0.9999878406524658	O
46947	smaller	100 107	193502 193509	0.9999873638153076	O
46948	.	108 109	193510 193511	0.9999767541885376	O
46949	To	0 2	193512 193514	0.9999868869781494	O
46950	test	3 7	193515 193519	0.9999837875366211	O
46951	this	8 12	193520 193524	0.9999880790710449	O
46952	,	13 14	193525 193526	0.9999878406524658	O
46953	we	15 17	193527 193529	0.9999866485595703	O
46954	conducted	18 27	193530 193539	0.9999865293502808	O
46955	additional	28 38	193540 193550	0.9999858140945435	O
46956	simulations	39 49	193551 193561	0.9999581575393677	O
46958	under	51 56	193563 193568	0.9999876022338867	O
46959	the	57 60	193569 193572	0.9999887943267822	O
46960	null	61 65	193573 193577	0.9999874830245972	O
46961	hypothesis	66 76	193578 193588	0.9999879598617554	O
46962	as	77 79	193589 193591	0.9999887943267822	O
46963	described	80 89	193592 193601	0.9999887943267822	O
46964	above	90 95	193602 193607	0.9999881982803345	O
46965	for	96 99	193608 193611	0.9999886751174927	O
46966	Tables	100 105	193612 193617	0.9999878406524658	O
46968	2	107 108	193619 193620	0.999988317489624	O
46969	and	109 112	193621 193624	0.9999878406524658	O
46970	3	113 114	193625 193626	0.9999866485595703	O
46971	,	115 116	193627 193628	0.9999880790710449	O
46972	with	117 121	193629 193633	0.9999887943267822	O
46973	1000	122 126	193634 193638	0.9999879598617554	O
46974	repetitions	127 137	193639 193649	0.9999879598617554	O
46976	and	139 142	193651 193654	0.9999885559082031	O
46977	markers	143 150	193655 193662	0.9999865293502808	O
46978	spaced	151 157	193663 193669	0.9999881982803345	O
46979	at	158 160	193670 193672	0.9999887943267822	O
46980	5	161 162	193673 193674	0.9999880790710449	O
46981	,	163 164	193675 193676	0.9999881982803345	O
46982	10	165 167	193677 193679	0.9999866485595703	O
46983	,	168 169	193680 193681	0.9999877214431763	O
46984	and	170 173	193682 193685	0.9999880790710449	O
46985	20	174 176	193686 193688	0.9999866485595703	O
46986	cM	177 178	193689 193690	0.9999886751174927	O
46988	.	179 180	193691 193692	0.9999889135360718	O
46989	The	181 184	193693 193696	0.9999886751174927	O
46990	magnitude	185 194	193697 193706	0.9999877214431763	O
46991	of	195 197	193707 193709	0.9999886751174927	O
46992	the	198 201	193710 193713	0.9999887943267822	O
46993	conservative	202 214	193714 193726	0.9999881982803345	O
46994	bias	215 219	193727 193731	0.9999877214431763	O
46995	in	220 222	193732 193734	0.9999891519546509	O
46996	Zmc	223 225	193735 193737	0.9999886751174927	O
46999	decreases	227 236	193739 193748	0.9999862909317017	O
47000	consistently	237 249	193749 193761	0.9999868869781494	O
47001	(	250 251	193762 193763	0.9999886751174927	O
47002	mean	252 256	193764 193768	0.9999872446060181	O
47003	Zmc	257 259	193769 193771	0.9999884366989136	O
47006	=	261 262	193773 193774	0.9999884366989136	O
47007	-	263 264	193775 193776	0.999988317489624	O
47008	0	264 265	193776 193777	0.9999885559082031	O
47009	.	265 266	193777 193778	0.9999887943267822	O
47010	58	266 268	193778 193780	0.9999850988388062	O
47011	at	269 271	193781 193783	0.9999886751174927	O
47012	20	272 274	193784 193786	0.9999872446060181	O
47013	cM	275 276	193787 193788	0.9999886751174927	O
47015	,	278 279	193790 193791	0.999988317489624	O
47016	-	280 281	193792 193793	0.9999879598617554	O
47017	0	281 282	193793 193794	0.9999881982803345	O
47018	.	282 283	193794 193795	0.9999885559082031	O
47019	23	283 285	193795 193797	0.999987006187439	O
47020	at	286 288	193798 193800	0.999988317489624	O
47021	10	289 291	193801 193803	0.9999871253967285	O
47022	cM	292 293	193804 193805	0.9999886751174927	O
47024	,	295 296	193807 193808	0.9999877214431763	O
47025	and	297 300	193809 193812	0.9999880790710449	O
47026	0	301 302	193813 193814	0.9999880790710449	O
47027	.	302 303	193814 193815	0.9999885559082031	O
47028	06	303 305	193815 193817	0.9999865293502808	O
47029	at	306 308	193818 193820	0.9999881982803345	O
47030	5	309 310	193821 193822	0.9999874830245972	O
47031	cM	311 312	193823 193824	0.9999886751174927	O
47033	)	314 315	193826 193827	0.9999878406524658	O
47034	as	316 318	193828 193830	0.9999880790710449	O
47035	marker	319 325	193831 193837	0.9999878406524658	O
47036	intervals	326 335	193838 193847	0.999988317489624	O
47037	contract	336 344	193848 193856	0.9999793767929077	O
47038	,	345 346	193857 193858	0.9999885559082031	O
47039	becoming	347 355	193859 193867	0.9999879598617554	O
47040	significantly	356 369	193868 193881	0.9999880790710449	O
47041	anti	370 374	193882 193886	0.9999880790710449	O
47042	-	374 375	193886 193887	0.9999887943267822	O
47043	conservative	375 387	193887 193899	0.9999877214431763	O
47044	at	388 390	193900 193902	0.9999886751174927	O
47045	5	391 392	193903 193904	0.9999879598617554	O
47046	cM	393 394	193905 193906	0.9999887943267822	O
47048	.	395 396	193907 193908	0.9999891519546509	O
47049	*	397 398	193909 193910	0.9999881982803345	O
47050	*	398 399	193910 193911	0.9999884366989136	O
47051	IGNORE	400 405	193912 193917	0.9999872446060181	O
47054	LINE	407 410	193919 193922	0.9999887943267822	O
47057	*	412 413	193924 193925	0.9999884366989136	O
47058	*	413 414	193925 193926	0.999988317489624	O
47059	*	415 416	193927 193928	0.9999881982803345	O
47060	*	416 417	193928 193929	0.999988317489624	O
47061	IGNORE	418 423	193930 193935	0.999987006187439	O
47064	LINE	425 428	193937 193940	0.9999886751174927	O
47067	*	430 431	193942 193943	0.9999881982803345	O
47068	*	431 432	193943 193944	0.9999881982803345	O
47069	*	433 434	193945 193946	0.9999880790710449	O
47070	*	434 435	193946 193947	0.9999881982803345	O
47071	IGNORE	436 441	193948 193953	0.9999877214431763	O
47074	LINE	443 446	193955 193958	0.9999886751174927	O
47077	*	448 449	193960 193961	0.9999881982803345	O
47078	*	449 450	193961 193962	0.9999881982803345	O
47079	Discussion	451 460	193963 193972	0.999988317489624	O
47082	In	462 464	193974 193976	0.9999865293502808	O
47083	studying	465 473	193977 193985	0.999984622001648	O
47084	a	474 475	193986 193987	0.9999877214431763	O
47085	disease	476 483	193988 193995	0.9999868869781494	O
47086	like	484 488	193996 194000	0.9999852180480957	O
47087	colon	489 493	194001 194005	0.999984622001648	O
47089	cancer	495 501	194007 194013	0.9999873638153076	O
47090	with	502 506	194014 194018	0.9999889135360718	O
47091	both	507 511	194019 194023	0.9999884366989136	O
47092	incomplete	512 522	194024 194034	0.9999886751174927	O
47093	penetrance	523 532	194035 194044	0.9999887943267822	O
47096	and	534 537	194046 194049	0.9999881982803345	O
47097	a	538 539	194050 194051	0.9999886751174927	O
47098	high	540 544	194052 194056	0.9999877214431763	O
47099	incidence	545 554	194057 194066	0.9999880790710449	O
47100	of	555 557	194067 194069	0.9999885559082031	O
47101	sporadics	558 566	194070 194078	0.999988317489624	O
47104	,	568 569	194080 194081	0.9999880790710449	O
47105	prior	570 575	194082 194087	0.9999831914901733	O
47106	studies	576 583	194088 194095	0.999987006187439	O
47107	have	584 588	194096 194100	0.9999877214431763	O
47108	shown	589 594	194101 194106	0.9999880790710449	O
47109	that	595 599	194107 194111	0.9999886751174927	O
47110	to	600 602	194112 194114	0.9999878406524658	O
47111	be	603 605	194115 194117	0.9999890327453613	O
47112	efficient	606 615	194118 194127	0.9999841451644897	O
47113	,	616 617	194128 194129	0.9999881982803345	O
47114	families	618 626	194130 194138	0.9999852180480957	O
47115	must	627 631	194139 194143	0.9999878406524658	O
47116	include	632 639	194144 194151	0.9999890327453613	O
47117	two	640 643	194152 194155	0.9999878406524658	O
47118	or	644 646	194156 194158	0.999988317489624	O
47119	more	647 651	194159 194163	0.9999885559082031	O
47120	individuals	652 663	194164 194175	0.9999822378158569	O
47121	with	664 668	194176 194180	0.9999885559082031	O
47122	the	669 672	194181 194184	0.9999889135360718	O
47123	same	673 677	194185 194189	0.9999879598617554	O
47124	disease	678 685	194190 194197	0.9999854564666748	O
47125	from	686 690	194198 194202	0.9999872446060181	O
47126	whom	691 695	194203 194207	0.9999877214431763	O
47127	samples	696 703	194208 194215	0.9999871253967285	O
47128	can	704 707	194216 194219	0.9999879598617554	O
47129	be	708 710	194220 194222	0.9999884366989136	O
47130	obtained	711 719	194223 194231	0.9999881982803345	O
47131	.	720 721	194232 194233	0.9999545812606812	O
47132	The	0 3	194234 194237	0.9999828338623047	O
47133	practical	4 13	194238 194247	0.999980092048645	O
47134	experience	14 24	194248 194258	0.999981164932251	O
47135	of	25 27	194259 194261	0.9999856948852539	O
47136	many	28 32	194262 194266	0.9999816417694092	O
47137	investigators	33 46	194267 194280	0.9999374151229858	O
47138	suggests	47 55	194281 194289	0.999977707862854	O
47139	that	56 60	194290 194294	0.9999872446060181	O
47140	once	61 65	194295 194299	0.9999839067459106	O
47141	an	66 68	194300 194302	0.9999884366989136	O
47142	initial	69 76	194303 194310	0.9999872446060181	O
47143	entree	77 82	194311 194316	0.9999889135360718	O
47145	is	84 86	194318 194320	0.9999876022338867	O
47146	gained	87 93	194321 194327	0.9999879598617554	O
47147	into	94 98	194328 194332	0.9999877214431763	O
47148	a	99 100	194333 194334	0.9999880790710449	O
47149	family	101 107	194335 194341	0.9999843835830688	O
47150	,	108 109	194342 194343	0.9999856948852539	O
47151	the	110 113	194344 194347	0.9999866485595703	O
47152	chances	114 121	194348 194355	0.9999825954437256	O
47153	of	122 124	194356 194358	0.9999876022338867	O
47154	enrolling	125 133	194359 194367	0.9999889135360718	O
47157	other	135 140	194369 194374	0.999984860420227	O
47158	members	141 148	194375 194382	0.9999836683273315	O
47159	are	149 152	194383 194386	0.9999860525131226	O
47160	quite	153 158	194387 194392	0.9999854564666748	O
47161	high	159 163	194393 194397	0.9999852180480957	O
47162	.	164 165	194398 194399	0.9999624490737915	O
47163	Close	0 5	194400 194405	0.999963641166687	O
47164	relatives	6 15	194406 194415	0.999971866607666	O
47165	are	16 19	194416 194419	0.9999818801879883	O
47166	often	20 25	194420 194425	0.9999829530715942	O
47167	very	26 30	194426 194430	0.9999839067459106	O
47168	motivated	31 40	194431 194440	0.9999784231185913	O
47169	to	41 43	194441 194443	0.9999856948852539	O
47170	participate	44 55	194444 194455	0.9999856948852539	O
47171	in	56 58	194456 194458	0.9999873638153076	O
47172	research	59 67	194459 194467	0.9999808073043823	O
47173	into	68 72	194468 194472	0.999987006187439	O
47174	a	73 74	194473 194474	0.9999880790710449	O
47175	disease	75 82	194475 194482	0.999985933303833	O
47176	that	83 87	194483 194487	0.9999885559082031	O
47177	has	88 91	194488 194491	0.9999876022338867	O
47178	afflicted	92 100	194492 194500	0.9999880790710449	O
47182	their	102 107	194502 194507	0.9999847412109375	O
47183	family	108 114	194508 194514	0.9999808073043823	O
47184	,	115 116	194515 194516	0.9999876022338867	O
47185	especially	117 127	194517 194527	0.9999872446060181	O
47186	when	128 132	194528 194532	0.999988317489624	O
47187	the	133 136	194533 194536	0.999988317489624	O
47188	commitment	137 147	194537 194547	0.9999843835830688	O
47189	is	148 150	194548 194550	0.9999887943267822	O
47190	minimal	151 158	194551 194558	0.999988317489624	O
47191	,	159 160	194559 194560	0.9999877214431763	O
47192	involving	161 170	194561 194570	0.9999889135360718	O
47193	only	171 175	194571 194575	0.9999887943267822	O
47194	a	176 177	194576 194577	0.9999890327453613	O
47195	blood	178 183	194578 194583	0.9999866485595703	O
47196	specimen	184 192	194584 194592	0.9999887943267822	O
47197	and	193 196	194593 194596	0.9999881982803345	O
47198	a	197 198	194597 194598	0.9999890327453613	O
47199	signed	199 205	194599 194605	0.9999864101409912	O
47200	consent	206 213	194606 194613	0.9999867677688599	O
47201	,	214 215	194614 194615	0.9999877214431763	O
47202	which	216 221	194616 194621	0.9999887943267822	O
47203	are	222 225	194622 194625	0.9999879598617554	O
47204	all	226 229	194626 194629	0.9999862909317017	O
47205	that	230 234	194630 194634	0.9999880790710449	O
47206	are	235 238	194635 194638	0.9999881982803345	O
47207	required	239 247	194639 194647	0.999987006187439	O
47208	for	248 251	194648 194651	0.9999881982803345	O
47209	a	252 253	194652 194653	0.9999887943267822	O
47210	linkage	254 260	194654 194660	0.9999854564666748	O
47212	study	262 267	194662 194667	0.9999871253967285	O
47213	of	268 270	194668 194670	0.9999886751174927	O
47214	diseases	271 279	194671 194679	0.9999834299087524	O
47215	that	280 284	194680 194684	0.9999881982803345	O
47216	have	285 289	194685 194689	0.9999874830245972	O
47217	an	290 292	194690 194692	0.9999886751174927	O
47218	easily	293 299	194693 194699	0.9999856948852539	O
47219	established	300 311	194700 194711	0.9999856948852539	O
47220	phenotype	312 320	194712 194720	0.9999885559082031	O
47223	,	322 323	194722 194723	0.9999854564666748	O
47224	like	324 328	194724 194728	0.9999841451644897	O
47225	cancer	329 335	194729 194735	0.9999823570251465	O
47226	.	336 337	194736 194737	0.9999498128890991	O
47227	In	0 2	194738 194740	0.9999822378158569	O
47228	our	3 6	194741 194744	0.999967098236084	O
47229	simulations	7 17	194745 194755	0.9998739957809448	O
47231	,	19 20	194757 194758	0.9999839067459106	O
47232	we	21 23	194759 194761	0.9999768733978271	O
47233	considered	24 34	194762 194772	0.999982476234436	O
47234	inclusion	35 44	194773 194782	0.9999843835830688	O
47235	of	45 47	194783 194785	0.9999877214431763	O
47236	unaffected	48 57	194786 194795	0.9999874830245972	O
47239	sibs	59 62	194797 194800	0.999985933303833	O
47241	and	64 67	194802 194805	0.9999864101409912	O
47242	the	68 71	194806 194809	0.9999873638153076	O
47243	use	72 75	194810 194813	0.9999861717224121	O
47244	of	76 78	194814 194816	0.9999885559082031	O
47245	spouse	79 85	194817 194823	0.9999854564666748	O
47246	and	86 89	194824 194827	0.9999876022338867	O
47247	offspring	90 99	194828 194837	0.9999849796295166	O
47248	to	100 102	194838 194840	0.9999873638153076	O
47249	replace	103 110	194841 194848	0.9999856948852539	O
47250	missing	111 118	194849 194856	0.9999876022338867	O
47251	affected	119 127	194857 194865	0.999987006187439	O
47252	sibs	128 131	194866 194869	0.9999866485595703	O
47254	.	133 134	194871 194872	0.999946117401123	O
47255	Including	0 9	194873 194882	0.9999866485595703	O
47256	unaffected	10 19	194883 194892	0.9999865293502808	O
47259	siblings	21 29	194894 194902	0.99997878074646	O
47260	in	30 32	194903 194905	0.999985933303833	O
47261	the	33 36	194906 194909	0.9999885559082031	O
47262	design	37 43	194910 194916	0.9999861717224121	O
47263	of	44 46	194917 194919	0.9999886751174927	O
47264	a	47 48	194920 194921	0.9999884366989136	O
47265	study	49 54	194922 194927	0.999984860420227	O
47266	can	55 58	194928 194931	0.999984860420227	O
47267	improve	59 66	194932 194939	0.9999858140945435	O
47268	the	67 70	194940 194943	0.9999885559082031	O
47269	power	71 76	194944 194949	0.9999881982803345	O
47270	to	77 79	194950 194952	0.9999884366989136	O
47271	detect	80 86	194953 194959	0.9999878406524658	O
47272	linkage	87 93	194960 194966	0.999987006187439	O
47274	for	95 98	194968 194971	0.9999885559082031	O
47275	highly	99 105	194972 194978	0.9999864101409912	O
47276	-	105 106	194978 194979	0.9999887943267822	O
47277	penetrant	106 114	194979 194987	0.9999874830245972	O
47280	diseases	116 124	194989 194997	0.9999854564666748	O
47281	[	125 126	194998 194999	0.99998939037323	O
47282	53	126 128	194999 195001	0.9999865293502808	O
47283	,	128 129	195001 195002	0.999988317489624	O
47284	66	129 131	195002 195004	0.9999873638153076	O
47285	]	131 132	195004 195005	0.9999889135360718	O
47286	.	133 134	195006 195007	0.9999808073043823	O
47287	However	0 7	195008 195015	0.999982476234436	O
47288	,	8 9	195016 195017	0.9999871253967285	O
47289	our	10 13	195018 195021	0.9999804496765137	O
47290	simulation	14 24	195022 195032	0.9998703002929688	O
47291	studies	25 32	195033 195040	0.9999840259552002	O
47292	demonstrate	33 44	195041 195052	0.9999794960021973	O
47293	that	45 49	195053 195057	0.9999885559082031	O
47294	for	50 53	195058 195061	0.9999866485595703	O
47295	the	54 57	195062 195065	0.9999885559082031	O
47296	model	58 63	195066 195071	0.999985933303833	O
47297	-	63 64	195071 195072	0.9999891519546509	O
47298	free	64 68	195072 195076	0.9999873638153076	O
47299	linkage	69 75	195077 195083	0.9999854564666748	O
47301	tests	77 82	195085 195090	0.9999879598617554	O
47302	we	83 85	195091 195093	0.9999871253967285	O
47303	studied	86 93	195094 195101	0.9999862909317017	O
47304	,	94 95	195102 195103	0.9999874830245972	O
47305	for	96 99	195104 195107	0.9999884366989136	O
47306	low	100 103	195108 195111	0.9999868869781494	O
47307	penetrance	104 113	195112 195121	0.9999884366989136	O
47310	loci	115 118	195123 195126	0.9999886751174927	O
47312	,	120 121	195128 195129	0.9999879598617554	O
47313	and	122 125	195130 195133	0.9999880790710449	O
47314	with	126 130	195134 195138	0.9999886751174927	O
47315	no	131 133	195139 195141	0.9999874830245972	O
47316	genotyping	134 143	195142 195151	0.9999885559082031	O
47320	error	145 150	195153 195158	0.9999887943267822	O
47321	,	151 152	195159 195160	0.9999884366989136	O
47322	little	153 159	195161 195167	0.9999861717224121	O
47323	increase	160 168	195168 195176	0.9999868869781494	O
47324	in	169 171	195177 195179	0.9999887943267822	O
47325	power	172 177	195180 195185	0.9999864101409912	O
47326	can	178 181	195186 195189	0.999987006187439	O
47327	be	182 184	195190 195192	0.9999885559082031	O
47328	gained	185 191	195193 195199	0.9999874830245972	O
47329	by	192 194	195200 195202	0.9999885559082031	O
47330	including	195 204	195203 195212	0.9999889135360718	O
47331	unaffected	205 214	195213 195222	0.9999874830245972	O
47334	siblings	216 224	195224 195232	0.9999818801879883	O
47335	in	225 227	195233 195235	0.999988317489624	O
47336	the	228 231	195236 195239	0.9999891519546509	O
47337	design	232 238	195240 195246	0.9999877214431763	O
47338	of	239 241	195247 195249	0.9999891519546509	O
47339	a	242 243	195250 195251	0.9999892711639404	O
47340	sib	244 246	195252 195254	0.9999853372573853	O
47342	-	247 248	195255 195256	0.9999889135360718	O
47343	pair	248 252	195256 195260	0.9999834299087524	O
47344	study	253 258	195261 195266	0.9999853372573853	O
47345	of	259 261	195267 195269	0.9999880790710449	O
47346	a	262 263	195270 195271	0.9999884366989136	O
47347	late	264 268	195272 195276	0.9999853372573853	O
47348	onset	269 274	195277 195282	0.9999874830245972	O
47349	,	275 276	195283 195284	0.9999834299087524	O
47350	complex	277 284	195285 195292	0.9999434947967529	O
47351	disease	285 292	195293 195300	0.9999858140945435	O
47352	such	293 297	195301 195305	0.9999867677688599	O
47353	as	298 300	195306 195308	0.9999884366989136	O
47354	colorectal	301 310	195309 195318	0.999984622001648	O
47357	cancer	312 318	195320 195326	0.9999860525131226	O
47358	.	319 320	195327 195328	0.9999555349349976	O
47359	The	0 3	195329 195332	0.999988317489624	O
47360	inclusion	4 13	195333 195342	0.9999867677688599	O
47361	of	14 16	195343 195345	0.9999892711639404	O
47362	unaffected	17 26	195346 195355	0.9999884366989136	O
47365	siblings	28 36	195357 195365	0.9999783039093018	O
47366	can	37 40	195366 195369	0.9999852180480957	O
47367	be	41 43	195370 195372	0.9999885559082031	O
47368	useful	44 50	195373 195379	0.9999879598617554	O
47369	,	51 52	195380 195381	0.9999881982803345	O
47370	however	53 60	195382 195389	0.9999843835830688	O
47371	,	61 62	195390 195391	0.9999881982803345	O
47372	in	63 65	195392 195394	0.9999891519546509	O
47373	reducing	66 74	195395 195403	0.9999880790710449	O
47374	anti	75 79	195404 195408	0.9999892711639404	O
47375	-	79 80	195408 195409	0.99998939037323	O
47376	conservative	80 92	195409 195421	0.9999887943267822	O
47377	biases	93 98	195422 195427	0.9999885559082031	O
47379	arising	100 107	195429 195436	0.9999895095825195	O
47380	from	108 112	195437 195441	0.9999892711639404	O
47381	heterogeneity	113 125	195442 195454	0.9999892711639404	O
47385	or	127 129	195456 195458	0.9999891519546509	O
47386	misspecification	130 145	195459 195474	0.9999891519546509	O
47389	of	147 149	195476 195478	0.9999891519546509	O
47390	marker	150 156	195479 195485	0.9999887943267822	O
47391	allele	157 162	195486 195491	0.9999891519546509	O
47393	frequencies	164 175	195493 195504	0.9999889135360718	O
47394	or	176 178	195505 195507	0.9999891519546509	O
47395	genotyping	179 188	195508 195517	0.9999886751174927	O
47399	errors	190 196	195519 195525	0.9999892711639404	O
47400	,	197 198	195526 195527	0.9999885559082031	O
47401	and	199 202	195528 195531	0.9999891519546509	O
47402	conservative	203 215	195532 195544	0.9999881982803345	O
47403	biases	216 221	195545 195550	0.9999885559082031	O
47405	arising	223 230	195552 195559	0.9999892711639404	O
47406	if	231 233	195560 195562	0.9999884366989136	O
47407	multipoint	234 243	195563 195572	0.9999895095825195	O
47409	statistics	245 255	195574 195584	0.9999892711639404	O
47410	are	256 259	195585 195588	0.9999890327453613	O
47411	used	260 264	195589 195593	0.9999889135360718	O
47412	with	265 269	195594 195598	0.9999887943267822	O
47413	an	270 272	195599 195601	0.9999895095825195	O
47414	insufficiently	273 286	195602 195615	0.9999885559082031	O
47416	dense	288 293	195617 195622	0.9999885559082031	O
47417	marker	294 300	195623 195629	0.9999885559082031	O
47418	set	301 304	195630 195633	0.9999891519546509	O
47419	.	305 306	195634 195635	0.9999656677246094	O
47420	Table	0 5	195636 195641	0.9999892711639404	O
47421	2	6 7	195642 195643	0.9999886751174927	O
47422	shows	8 13	195644 195649	0.9999886751174927	O
47423	that	14 18	195650 195654	0.9999898672103882	O
47424	,	19 20	195655 195656	0.9999892711639404	O
47425	with	21 25	195657 195661	0.9999892711639404	O
47426	markers	26 33	195662 195669	0.9999876022338867	O
47427	spaced	34 40	195670 195676	0.9999890327453613	O
47428	at	41 43	195677 195679	0.9999897480010986	O
47429	10	44 46	195680 195682	0.9999892711639404	O
47430	cM	47 48	195683 195684	0.9999896287918091	O
47432	intervals	50 59	195686 195695	0.9999896287918091	O
47433	,	60 61	195696 195697	0.9999897480010986	O
47434	Zmc	62 64	195698 195700	0.9999884366989136	O
47437	is	66 68	195702 195704	0.9999898672103882	O
47438	conservatively	69 82	195705 195718	0.9999890327453613	O
47440	biased	84 89	195720 195725	0.9999887943267822	O
47442	,	91 92	195727 195728	0.9999895095825195	O
47443	while	93 98	195729 195734	0.9999892711639404	O
47444	exhibiting	99 109	195735 195745	0.9999896287918091	O
47445	an	110 112	195746 195748	0.9999898672103882	O
47446	anticonservative	113 128	195749 195764	0.9999895095825195	O
47451	bias	130 134	195766 195770	0.9999896287918091	O
47452	in	135 137	195771 195773	0.9999898672103882	O
47453	Table	138 143	195774 195779	0.9999892711639404	O
47454	3	144 145	195780 195781	0.9999892711639404	O
47455	under	146 151	195782 195787	0.9999897480010986	O
47456	conditions	152 162	195788 195798	0.9999880790710449	O
47457	of	163 165	195799 195801	0.99998939037323	O
47458	heterogeneity	166 178	195802 195814	0.9999896287918091	O
47462	in	180 182	195816 195818	0.99998939037323	O
47463	marker	183 189	195819 195825	0.9999889135360718	O
47464	allele	190 195	195826 195831	0.9999896287918091	O
47466	frequencies	197 208	195833 195844	0.9999886751174927	O
47467	.	209 210	195845 195846	0.9999809265136719	O
47468	In	0 2	195847 195849	0.9999896287918091	O
47469	Table	3 8	195850 195855	0.9999885559082031	O
47470	6	9 10	195856 195857	0.9999884366989136	O
47471	,	11 12	195858 195859	0.9999895095825195	O
47472	Zmp	13 15	195860 195862	0.999985933303833	O
47474	outperforms	17 27	195864 195874	0.99998939037323	O
47478	with	29 33	195876 195880	0.9999892711639404	O
47479	markers	34 41	195881 195888	0.9999866485595703	O
47480	spaced	42 48	195889 195895	0.9999876022338867	O
47481	at	49 51	195896 195898	0.9999897480010986	O
47482	10	52 54	195899 195901	0.9999890327453613	O
47483	and	55 58	195902 195905	0.9999886751174927	O
47484	20	59 61	195906 195908	0.9999850988388062	O
47485	cM	62 63	195909 195910	0.9999891519546509	O
47487	.	64 65	195911 195912	0.9999892711639404	O
47488	At	66 68	195913 195915	0.9999895095825195	O
47489	5	69 70	195916 195917	0.999988317489624	O
47490	cM	71 72	195918 195919	0.9999892711639404	O
47492	,	74 75	195921 195922	0.9999896287918091	O
47493	Zmc	76 78	195923 195925	0.9999886751174927	O
47496	becomes	80 87	195927 195934	0.9999892711639404	O
47497	anticonservatively	88 105	195935 195952	0.99998939037323	O
47502	biased	107 112	195954 195959	0.9999887943267822	O
47504	,	114 115	195961 195962	0.9999887943267822	O
47505	as	116 118	195963 195965	0.9999892711639404	O
47506	noted	119 124	195966 195971	0.9999890327453613	O
47507	above	125 130	195972 195977	0.9999885559082031	O
47508	.	131 132	195978 195979	0.9999819993972778	O
47509	It	0 2	195980 195982	0.9999861717224121	O
47510	may	3 6	195983 195986	0.9999864101409912	O
47511	be	7 9	195987 195989	0.9999884366989136	O
47512	useful	10 16	195990 195996	0.9999871253967285	O
47513	to	17 19	195997 195999	0.9999879598617554	O
47514	perform	20 27	196000 196007	0.9999867677688599	O
47515	simulations	28 38	196008 196018	0.9999790191650391	O
47517	to	40 42	196020 196022	0.9999878406524658	O
47518	assess	43 49	196023 196029	0.9999872446060181	O
47519	the	50 53	196030 196033	0.9999890327453613	O
47520	characteristics	54 69	196034 196049	0.999985933303833	O
47521	of	70 72	196050 196052	0.999988317489624	O
47522	the	73 76	196053 196056	0.9999878406524658	O
47523	tests	77 82	196057 196062	0.9999837875366211	O
47524	when	83 87	196063 196067	0.9999873638153076	O
47525	the	88 91	196068 196071	0.9999884366989136	O
47526	marker	92 98	196072 196078	0.999985933303833	O
47527	spacing	99 105	196079 196085	0.9999881982803345	O
47529	decreases	107 116	196087 196096	0.9999825954437256	O
47530	,	117 118	196097 196098	0.9999866485595703	O
47531	as	119 121	196099 196101	0.9999876022338867	O
47532	would	122 127	196102 196107	0.9999873638153076	O
47533	be	128 130	196108 196110	0.9999889135360718	O
47534	possible	131 139	196111 196119	0.9999886751174927	O
47535	with	140 144	196120 196124	0.9999884366989136	O
47536	the	145 148	196125 196128	0.9999889135360718	O
47537	newer	149 154	196129 196134	0.9999855756759644	O
47538	SNP	155 157	196135 196137	0.9999885559082031	O
47540	array	159 164	196139 196144	0.9999887943267822	O
47541	-	164 165	196144 196145	0.99998939037323	O
47542	based	165 170	196145 196150	0.9999891519546509	O
47543	platforms	171 180	196151 196160	0.9999876022338867	O
47544	.	181 182	196161 196162	0.9999727010726929	O
47545	Further	0 7	196163 196170	0.9999865293502808	O
47546	,	8 9	196171 196172	0.9999887943267822	O
47547	since	10 15	196173 196178	0.999987006187439	O
47548	genome	16 22	196179 196185	0.999987006187439	O
47549	-	22 23	196185 196186	0.9999891519546509	O
47550	wide	23 27	196186 196190	0.9999868869781494	O
47551	-	27 28	196190 196191	0.9999886751174927	O
47552	association	28 39	196191 196202	0.9999852180480957	O
47553	studies	40 47	196203 196210	0.9999873638153076	O
47554	do	48 50	196211 196213	0.9999880790710449	O
47555	not	51 54	196214 196217	0.9999877214431763	O
47556	utilize	55 62	196218 196225	0.9999878406524658	O
47557	the	63 66	196226 196229	0.9999889135360718	O
47558	full	67 71	196230 196234	0.9999881982803345	O
47559	power	72 77	196235 196240	0.9999884366989136	O
47560	of	78 80	196241 196243	0.9999889135360718	O
47561	the	81 84	196244 196247	0.9999892711639404	O
47562	sibpair	85 91	196248 196254	0.9999885559082031	O
47565	design	93 99	196256 196262	0.9999890327453613	O
47566	,	100 101	196263 196264	0.9999881982803345	O
47567	future	102 108	196265 196271	0.9999871253967285	O
47568	research	109 117	196272 196280	0.9999842643737793	O
47569	should	118 124	196281 196287	0.9999885559082031	O
47570	be	125 127	196288 196290	0.9999890327453613	O
47571	aimed	128 133	196291 196296	0.9999887943267822	O
47572	at	134 136	196297 196299	0.9999889135360718	O
47573	assessing	137 146	196300 196309	0.9999887943267822	O
47574	the	147 150	196310 196313	0.9999892711639404	O
47575	optimal	151 158	196314 196321	0.9999887943267822	O
47576	setting	159 166	196322 196329	0.9999886751174927	O
47577	for	167 170	196330 196333	0.9999889135360718	O
47578	relying	171 178	196334 196341	0.9999889135360718	O
47579	on	179 181	196342 196344	0.9999892711639404	O
47580	the	182 185	196345 196348	0.9999891519546509	O
47581	sibpair	186 192	196349 196355	0.999988317489624	O
47584	design	194 200	196357 196363	0.9999890327453613	O
47585	,	201 202	196364 196365	0.9999885559082031	O
47586	as	203 205	196366 196368	0.999988317489624	O
47587	it	206 208	196369 196371	0.9999887943267822	O
47588	is	209 211	196372 196374	0.9999891519546509	O
47589	premature	212 221	196375 196384	0.9999858140945435	O
47590	to	222 224	196385 196387	0.9999891519546509	O
47591	move	225 229	196388 196392	0.9999889135360718	O
47592	completely	230 240	196393 196403	0.9999889135360718	O
47593	away	241 245	196404 196408	0.9999880790710449	O
47594	from	246 250	196409 196413	0.9999886751174927	O
47595	this	251 255	196414 196418	0.9999895095825195	O
47596	study	256 261	196419 196424	0.9999865293502808	O
47597	design	262 268	196425 196431	0.9999887943267822	O
47598	[	269 270	196432 196433	0.9999887943267822	O
47599	15	270 272	196433 196435	0.9999840259552002	O
47600	]	272 273	196435 196436	0.9999881982803345	O
47601	.	274 275	196437 196438	0.9999756813049316	O
47602	If	0 2	196439 196441	0.999984622001648	O
47603	a	3 4	196442 196443	0.9999889135360718	O
47604	secondary	5 14	196444 196453	0.9999868869781494	O
47605	goal	15 19	196454 196458	0.9999876022338867	O
47606	of	20 22	196459 196461	0.9999889135360718	O
47607	a	23 24	196462 196463	0.9999885559082031	O
47608	study	25 30	196464 196469	0.9999866485595703	O
47609	is	31 33	196470 196472	0.999988317489624	O
47610	to	34 36	196473 196475	0.9999891519546509	O
47611	estimate	37 45	196476 196484	0.9999873638153076	O
47612	the	46 49	196485 196488	0.9999891519546509	O
47613	penetrance	50 59	196489 196498	0.9999881982803345	O
47616	,	61 62	196500 196501	0.9999884366989136	O
47617	then	63 67	196502 196506	0.9999879598617554	O
47618	unaffected	68 77	196507 196516	0.9999881982803345	O
47621	relatives	79 88	196518 196527	0.999982476234436	O
47622	should	89 95	196528 196534	0.9999878406524658	O
47623	be	96 98	196535 196537	0.9999886751174927	O
47624	included	99 107	196538 196546	0.999988317489624	O
47625	in	108 110	196547 196549	0.999988317489624	O
47626	the	111 114	196550 196553	0.9999889135360718	O
47627	design	115 121	196554 196560	0.9999878406524658	O
47628	of	122 124	196561 196563	0.9999890327453613	O
47629	the	125 128	196564 196567	0.9999889135360718	O
47630	study	129 134	196568 196573	0.9999872446060181	O
47631	;	135 136	196574 196575	0.9999886751174927	O
47632	also	137 141	196576 196580	0.999988317489624	O
47633	unaffected	142 151	196581 196590	0.9999886751174927	O
47636	siblings	153 161	196592 196600	0.9999774694442749	O
47637	could	162 167	196601 196606	0.9999880790710449	O
47638	help	168 172	196607 196611	0.9999874830245972	O
47639	in	173 175	196612 196614	0.9999885559082031	O
47640	evaluating	176 186	196615 196625	0.9999872446060181	O
47641	the	187 190	196626 196629	0.9999889135360718	O
47642	impact	191 197	196630 196636	0.9999879598617554	O
47643	of	198 200	196637 196639	0.9999890327453613	O
47644	environmental	201 214	196640 196653	0.9999723434448242	O
47645	factors	215 222	196654 196661	0.9999873638153076	O
47646	upon	223 227	196662 196666	0.9999822378158569	O
47647	disease	228 235	196667 196674	0.9999831914901733	O
47648	risk	236 240	196675 196679	0.9999862909317017	O
47649	.	241 242	196680 196681	0.9999681711196899	O
47650	Genotyping	0 9	196682 196691	0.9999868869781494	O
47654	errors	11 17	196693 196699	0.9999858140945435	O
47655	for	18 21	196700 196703	0.9999868869781494	O
47656	microsatellites	22 36	196704 196718	0.9999865293502808	O
47660	scans	38 42	196720 196724	0.9999854564666748	O
47662	are	44 47	196726 196729	0.9999873638153076	O
47663	currently	48 57	196730 196739	0.9999877214431763	O
47664	very	58 62	196740 196744	0.9999876022338867	O
47665	low	63 66	196745 196748	0.9999865293502808	O
47666	but	67 70	196749 196752	0.9999843835830688	O
47667	are	71 74	196753 196756	0.9999872446060181	O
47668	hard	75 79	196757 196761	0.9999867677688599	O
47669	to	80 82	196762 196764	0.9999881982803345	O
47670	assess	83 89	196765 196771	0.9999864101409912	O
47671	without	90 97	196772 196779	0.9999847412109375	O
47672	the	98 101	196780 196783	0.9999868869781494	O
47673	availability	102 114	196784 196796	0.9999866485595703	O
47674	of	115 117	196797 196799	0.9999878406524658	O
47675	parents	118 125	196800 196807	0.9999843835830688	O
47676	or	126 128	196808 196810	0.9999861717224121	O
47677	siblings	129 137	196811 196819	0.9999750852584839	O
47678	.	138 139	196820 196821	0.9999610185623169	O
47679	Our	0 3	196822 196825	0.9999717473983765	O
47680	findings	4 12	196826 196834	0.9999740123748779	O
47681	parallel	13 21	196835 196843	0.9999712705612183	O
47682	those	22 27	196844 196849	0.9999830722808838	O
47683	of	28 30	196850 196852	0.9999829530715942	O
47684	Holmans	31 37	196853 196859	0.9999756813049316	O
47687	et	39 41	196861 196863	0.9999830722808838	O
47688	al	42 44	196864 196866	0.9999828338623047	O
47689	.	45 46	196867 196868	0.9999823570251465	O
47690	[	47 48	196869 196870	0.9999568462371826	O
47691	67	0 2	196870 196872	0.9999748468399048	O
47692	]	2 3	196872 196873	0.9999806880950928	O
47693	,	4 5	196874 196875	0.999987006187439	O
47694	who	6 9	196876 196879	0.9999843835830688	O
47695	suggested	10 19	196880 196889	0.9999862909317017	O
47696	that	20 24	196890 196894	0.9999881982803345	O
47697	genotyping	25 34	196895 196904	0.9999874830245972	O
47701	affected	36 44	196906 196914	0.9999849796295166	O
47702	individuals	45 56	196915 196926	0.999984860420227	O
47703	only	57 61	196927 196931	0.9999872446060181	O
47704	is	62 64	196932 196934	0.9999881982803345	O
47705	efficient	65 74	196935 196944	0.9999860525131226	O
47706	.	75 76	196945 196946	0.9999880790710449	O
47707	*	77 78	196947 196948	0.999985933303833	O
47708	*	78 79	196948 196949	0.999974250793457	O
47709	IGNORE	0 5	196950 196955	0.9999867677688599	O
47712	LINE	7 10	196957 196960	0.9999891519546509	O
47715	*	12 13	196962 196963	0.9999892711639404	O
47716	*	13 14	196963 196964	0.9999892711639404	O
47717	*	15 16	196965 196966	0.9999892711639404	O
47718	*	16 17	196966 196967	0.9999892711639404	O
47719	IGNORE	18 23	196968 196973	0.9999880790710449	O
47722	LINE	25 28	196975 196978	0.99998939037323	O
47725	*	30 31	196980 196981	0.9999890327453613	O
47726	*	31 32	196981 196982	0.9999890327453613	O
47727	*	33 34	196983 196984	0.9999890327453613	O
47728	*	34 35	196984 196985	0.9999890327453613	O
47729	IGNORE	36 41	196986 196991	0.9999876022338867	O
47732	LINE	43 46	196993 196996	0.9999892711639404	O
47735	*	48 49	196998 196999	0.9999892711639404	O
47736	*	49 50	196999 197000	0.9999891519546509	O
47737	Crude	51 55	197001 197005	0.9999891519546509	O
47740	stratification	57 70	197007 197020	0.9999895095825195	O
47744	by	72 74	197022 197024	0.99998939037323	O
47745	recruitment	75 86	197025 197036	0.9999855756759644	O
47746	center	87 93	197037 197043	0.9999878406524658	O
47747	is	94 96	197044 197046	0.9999884366989136	O
47748	unlikely	97 105	197047 197055	0.9999856948852539	O
47749	to	106 108	197056 197058	0.9999880790710449	O
47750	be	109 111	197059 197061	0.9999889135360718	O
47751	reliable	112 120	197062 197070	0.999988317489624	O
47752	enough	121 127	197071 197077	0.9999864101409912	O
47753	for	128 131	197078 197081	0.9999887943267822	O
47754	controlling	132 143	197082 197093	0.9999878406524658	O
47755	population	144 154	197094 197104	0.9999876022338867	O
47756	heterogeneity	155 167	197105 197117	0.9999895095825195	O
47760	without	169 176	197119 197126	0.9999880790710449	O
47761	additional	177 187	197127 197137	0.9999868869781494	O
47762	adjustment	188 198	197138 197148	0.9999856948852539	O
47763	.	199 200	197149 197150	0.9999579191207886	O
47764	Stratification	0 13	197151 197164	0.9999849796295166	O
47767	by	15 17	197166 197168	0.9999850988388062	O
47768	ethnicity	18 27	197169 197178	0.9999767541885376	O
47769	is	28 30	197179 197181	0.9999837875366211	O
47770	generally	31 40	197182 197191	0.9999827146530151	O
47771	more	41 45	197192 197196	0.9999865293502808	O
47772	crucial	46 53	197197 197204	0.9999816417694092	O
47773	than	54 58	197205 197209	0.9999831914901733	O
47774	by	59 61	197210 197212	0.9999853372573853	O
47775	geography	62 71	197213 197222	0.9999722242355347	O
47776	,	72 73	197223 197224	0.9999842643737793	O
47777	although	74 82	197225 197233	0.9999831914901733	O
47778	both	83 87	197234 197238	0.9999853372573853	O
47779	factors	88 95	197239 197246	0.9999852180480957	O
47780	should	96 102	197247 197253	0.999985933303833	O
47781	ideally	103 109	197254 197260	0.9999829530715942	O
47783	be	111 113	197262 197264	0.9999864101409912	O
47784	incorporated	114 126	197265 197277	0.9999842643737793	O
47785	.	127 128	197278 197279	0.999962329864502	O
47786	However	0 7	197280 197287	0.9999852180480957	O
47787	,	8 9	197288 197289	0.9999872446060181	O
47788	collection	10 20	197290 197300	0.9999850988388062	O
47789	of	21 23	197301 197303	0.9999878406524658	O
47790	ethnicity	24 33	197304 197313	0.999981164932251	O
47791	is	34 36	197314 197316	0.999985933303833	O
47792	not	37 40	197317 197320	0.999985933303833	O
47793	entirely	41 49	197321 197329	0.9999862909317017	O
47794	trivial	50 57	197330 197337	0.9999861717224121	O
47795	if	58 60	197338 197340	0.9999834299087524	O
47796	it	61 63	197341 197343	0.999987006187439	O
47797	is	64 66	197344 197346	0.9999867677688599	O
47798	to	67 69	197347 197349	0.9999847412109375	O
47799	be	70 72	197350 197352	0.9999874830245972	O
47800	worthwhile	73 82	197353 197362	0.9999862909317017	O
47802	.	84 85	197364 197365	0.999958872795105	O
47803	Although	0 8	197366 197374	0.9999871253967285	O
47804	various	9 16	197375 197382	0.9999865293502808	O
47805	coding	17 23	197383 197389	0.9999864101409912	O
47806	systems	24 31	197390 197397	0.9999878406524658	O
47807	have	32 36	197398 197402	0.9999871253967285	O
47808	been	37 41	197403 197407	0.9999873638153076	O
47809	established	42 53	197408 197419	0.9999874830245972	O
47810	by	54 56	197420 197422	0.9999871253967285	O
47811	different	57 66	197423 197432	0.9999828338623047	O
47812	agencies	67 75	197433 197441	0.9999836683273315	O
47813	,	76 77	197442 197443	0.9999872446060181	O
47814	no	78 80	197444 197446	0.9999872446060181	O
47815	consensus	81 90	197447 197456	0.9999852180480957	O
47816	has	91 94	197457 197460	0.9999876022338867	O
47817	been	95 99	197461 197465	0.9999877214431763	O
47818	established	100 111	197466 197477	0.9999873638153076	O
47819	regarding	112 121	197478 197487	0.9999881982803345	O
47820	the	122 125	197488 197491	0.9999880790710449	O
47821	level	126 131	197492 197497	0.999988317489624	O
47822	of	132 134	197498 197500	0.999988317489624	O
47823	detail	135 141	197501 197507	0.9999878406524658	O
47824	required	142 150	197508 197516	0.9999881982803345	O
47825	on	151 153	197517 197519	0.9999879598617554	O
47826	ethnicity	154 163	197520 197529	0.999987006187439	O
47827	data	164 168	197530 197534	0.9999886751174927	O
47828	in	169 171	197535 197537	0.9999885559082031	O
47829	genetic	172 179	197538 197545	0.999987006187439	O
47830	research	180 188	197546 197554	0.9999881982803345	O
47831	,	189 190	197555 197556	0.9999877214431763	O
47832	e	191 192	197557 197558	0.9999881982803345	O
47833	.	192 193	197558 197559	0.9999874830245972	O
47834	g	193 194	197559 197560	0.9999878406524658	O
47835	.	195 196	197561 197562	0.9999754428863525	O
47836	category	0 8	197563 197571	0.9999761581420898	O
47837	distinctions	9 20	197572 197583	0.9999805688858032	O
47839	,	22 23	197585 197586	0.9999693632125854	O
47840	mixed	24 29	197587 197592	0.9999812841415405	O
47841	-	29 30	197592 197593	0.9999843835830688	O
47842	race	30 34	197593 197597	0.9999774694442749	O
47843	marriages	35 44	197598 197607	0.9999767541885376	O
47844	.	45 46	197608 197609	0.9999313354492188	O
47845	Mandal	0 5	197610 197615	0.9999746084213257	O
47847	et	7 9	197617 197619	0.999981164932251	O
47848	al	10 12	197620 197622	0.9999791383743286	O
47849	.	13 14	197623 197624	0.9999808073043823	O
47850	[	15 16	197625 197626	0.9999359846115112	O
47851	81	0 2	197626 197628	0.999980092048645	O
47852	]	2 3	197628 197629	0.9999768733978271	O
47853	have	4 8	197630 197634	0.9999860525131226	O
47854	shown	9 14	197635 197640	0.9999868869781494	O
47855	that	15 19	197641 197645	0.9999889135360718	O
47856	marker	20 26	197646 197652	0.9999872446060181	O
47857	allele	27 32	197653 197658	0.9999890327453613	O
47859	frequencies	34 45	197660 197671	0.9999872446060181	O
47860	are	46 49	197672 197675	0.9999884366989136	O
47861	less	50 54	197676 197680	0.9999845027923584	O
47862	important	55 64	197681 197690	0.9999885559082031	O
47863	if	65 67	197691 197693	0.9999885559082031	O
47864	there	68 73	197694 197699	0.9999890327453613	O
47865	are	74 77	197700 197703	0.9999891519546509	O
47866	four	78 82	197704 197708	0.9999880790710449	O
47867	or	83 85	197709 197711	0.9999886751174927	O
47868	more	86 90	197712 197716	0.9999889135360718	O
47869	persons	91 98	197717 197724	0.9999825954437256	O
47870	per	99 102	197725 197728	0.9999887943267822	O
47871	family	103 109	197729 197735	0.9999858140945435	O
47872	,	110 111	197736 197737	0.9999881982803345	O
47873	especially	112 122	197738 197748	0.9999886751174927	O
47874	when	123 127	197749 197753	0.9999891519546509	O
47875	very	128 132	197754 197758	0.9999884366989136	O
47876	polymorphic	133 143	197759 197769	0.9999895095825195	O
47879	markers	145 152	197771 197778	0.9999885559082031	O
47880	are	153 156	197779 197782	0.9999889135360718	O
47881	used	157 161	197783 197787	0.9999889135360718	O
47882	.	162 163	197788 197789	0.9999774694442749	O
47883	When	0 4	197790 197794	0.9999865293502808	O
47884	the	5 8	197795 197798	0.9999877214431763	O
47885	parents	9 16	197799 197806	0.9999829530715942	O
47886	of	17 19	197807 197809	0.9999881982803345	O
47887	the	20 23	197810 197813	0.9999886751174927	O
47888	sibpair	24 30	197814 197820	0.999985933303833	O
47891	have	32 36	197822 197826	0.9999876022338867	O
47892	been	37 41	197827 197831	0.9999887943267822	O
47893	genotyped	42 50	197832 197840	0.999988317489624	O
47897	,	52 53	197842 197843	0.999988317489624	O
47898	then	54 58	197844 197848	0.9999880790710449	O
47899	there	59 64	197849 197854	0.9999887943267822	O
47900	is	65 67	197855 197857	0.9999885559082031	O
47901	no	68 70	197858 197860	0.9999884366989136	O
47902	dependence	71 81	197861 197871	0.9999877214431763	O
47903	on	82 84	197872 197874	0.9999890327453613	O
47904	population	85 95	197875 197885	0.9999879598617554	O
47905	marker	96 102	197886 197892	0.9999886751174927	O
47906	allele	103 108	197893 197898	0.9999889135360718	O
47908	frequencies	110 121	197900 197911	0.9999886751174927	O
47909	and	122 125	197912 197915	0.9999885559082031	O
47910	no	126 128	197916 197918	0.9999887943267822	O
47911	source	129 135	197919 197925	0.9999881982803345	O
47912	of	136 138	197926 197928	0.9999887943267822	O
47913	bias	139 143	197929 197933	0.9999880790710449	O
47914	in	144 146	197934 197936	0.9999891519546509	O
47915	linkage	147 153	197937 197943	0.9999877214431763	O
47917	analysis	155 163	197945 197953	0.9999890327453613	O
47918	.	164 165	197954 197955	0.9999892711639404	O
47919	*	166 167	197956 197957	0.9999881982803345	O
47920	*	167 168	197957 197958	0.9999798536300659	O
47921	IGNORE	0 5	197959 197964	0.9999862909317017	O
47924	LINE	7 10	197966 197969	0.9999886751174927	O
47927	*	12 13	197971 197972	0.9999886751174927	O
47928	*	13 14	197972 197973	0.9999885559082031	O
47929	*	15 16	197974 197975	0.9999885559082031	O
47930	*	16 17	197975 197976	0.9999886751174927	O
47931	IGNORE	18 23	197977 197982	0.9999876022338867	O
47934	LINE	25 28	197984 197987	0.9999887943267822	O
47937	*	30 31	197989 197990	0.9999881982803345	O
47938	*	31 32	197990 197991	0.9999881982803345	O
47939	*	33 34	197992 197993	0.9999881982803345	O
47940	*	34 35	197993 197994	0.9999880790710449	O
47941	IGNORE	36 41	197995 198000	0.9999868869781494	O
47944	LINE	43 46	198002 198005	0.9999886751174927	O
47947	*	48 49	198007 198008	0.9999884366989136	O
47948	*	49 50	198008 198009	0.9999885559082031	O
47949	CpG	51 53	198010 198012	0.9999886751174927	O
47952	Island	55 61	198014 198020	0.999988317489624	O
47953	Methylation	62 72	198021 198031	0.9999885559082031	O
47956	in	74 76	198033 198035	0.9999886751174927	O
47957	Familial	77 84	198036 198043	0.9999829530715942	O
47960	Colorectal	86 95	198045 198054	0.9999843835830688	O
47963	Cancer	97 103	198056 198062	0.999987006187439	O
47964	Patients	104 111	198063 198070	0.9999862909317017	O
47966	Not	113 116	198072 198075	0.9999861717224121	O
47967	Fulfilling	117 126	198076 198085	0.9999867677688599	O
47971	the	128 131	198087 198090	0.9999884366989136	O
47972	Amsterdam	132 141	198091 198100	0.9999815225601196	O
47973	Criteria	142 149	198101 198108	0.9999880790710449	O
47976	Abstract	151 158	198110 198117	0.9999871253967285	O
47979	To	160 162	198119 198121	0.9999876022338867	O
47980	determine	163 172	198122 198131	0.9999880790710449	O
47981	the	173 176	198132 198135	0.9999890327453613	O
47982	role	177 181	198136 198140	0.9999878406524658	O
47983	of	182 184	198141 198143	0.9999890327453613	O
47984	methylation	185 195	198144 198154	0.9999877214431763	O
47987	in	197 199	198156 198158	0.9999890327453613	O
47988	colorectal	200 209	198159 198168	0.9999860525131226	O
47991	cancer	211 217	198170 198176	0.9999868869781494	O
47992	patients	218 226	198177 198185	0.9999864101409912	O
47993	with	227 231	198186 198190	0.9999884366989136	O
47994	a	232 233	198191 198192	0.9999890327453613	O
47995	family	234 240	198193 198199	0.9999861717224121	O
47996	history	241 248	198200 198207	0.9999886751174927	O
47997	,	249 250	198208 198209	0.9999880790710449	O
47998	we	251 253	198210 198212	0.9999834299087524	O
47999	enrolled	254 262	198213 198221	0.9999823570251465	O
48000	25	263 265	198222 198224	0.9999549388885498	O
48001	colorectal	266 275	198225 198234	0.9999860525131226	O
48004	cancer	277 283	198236 198242	0.999987006187439	O
48005	patients	284 292	198243 198251	0.9999845027923584	O
48006	with	293 297	198252 198256	0.9999886751174927	O
48007	a	298 299	198257 198258	0.9999890327453613	O
48008	family	300 306	198259 198265	0.9999865293502808	O
48009	history	307 314	198266 198273	0.9999878406524658	O
48010	of	315 317	198274 198276	0.999988317489624	O
48011	colorectal	318 327	198277 198286	0.9999867677688599	O
48014	cancer	329 335	198288 198294	0.9999874830245972	O
48015	but	336 339	198295 198298	0.9999822378158569	O
48016	without	340 347	198299 198306	0.9999837875366211	O
48017	a	348 349	198307 198308	0.9999880790710449	O
48018	mutation	350 358	198309 198317	0.9999842643737793	O
48019	in	359 361	198318 198320	0.999988317489624	O
48020	the	362 365	198321 198324	0.9999886751174927	O
48021	hMLH1	366 370	198325 198329	0.9999889135360718	O
48024	and	372 375	198331 198334	0.9999884366989136	O
48025	hMSH2	376 380	198335 198339	0.9999885559082031	O
48029	genes	382 387	198341 198346	0.9999886751174927	O
48030	.	388 389	198347 198348	0.9999558925628662	O
48031	Thirty	0 6	198349 198355	0.9999196529388428	O
48032	patients	7 15	198356 198364	0.9999614953994751	O
48033	with	16 20	198365 198369	0.9999723434448242	O
48034	sporadic	21 28	198370 198377	0.9999642372131348	O
48036	colorectal	30 39	198379 198388	0.9999606609344482	O
48039	cancer	41 47	198390 198396	0.999976396560669	O
48040	were	48 52	198397 198401	0.9999775886535645	O
48041	included	53 61	198402 198410	0.9999768733978271	O
48042	as	62 64	198411 198413	0.9999803304672241	O
48043	control	65 72	198414 198421	0.9999622106552124	O
48044	.	73 74	198422 198423	0.9998701810836792	O
48045	The	0 3	198424 198427	0.9999856948852539	O
48046	methylation	4 14	198428 198438	0.9999860525131226	O
48049	status	16 22	198440 198446	0.9999864101409912	O
48050	of	23 25	198447 198449	0.999987006187439	O
48051	COX2	26 29	198450 198453	0.9999850988388062	O
48054	,	31 32	198455 198456	0.9999871253967285	O
48055	MGMT	33 36	198457 198460	0.9999825954437256	O
48057	,	38 39	198462 198463	0.9999873638153076	O
48058	hMLH1	40 44	198464 198468	0.9999868869781494	O
48061	,	46 47	198470 198471	0.9999876022338867	O
48062	TIMP3	48 52	198472 198476	0.9999871253967285	O
48066	,	54 55	198478 198479	0.9999877214431763	O
48067	p16	56 58	198480 198482	0.9999879598617554	O
48069	,	60 61	198484 198485	0.9999879598617554	O
48070	and	62 65	198486 198489	0.9999880790710449	O
48071	MINT2	66 70	198490 198494	0.9999831914901733	O
48074	in	72 74	198496 198498	0.9999865293502808	O
48075	normal	75 81	198499 198505	0.9999743700027466	O
48076	mucosa	82 87	198506 198511	0.9999828338623047	O
48079	and	89 92	198513 198516	0.9999755620956421	O
48080	tumor	93 98	198517 198522	0.9999741315841675	O
48081	were	99 103	198523 198527	0.9999854564666748	O
48082	assessed	104 112	198528 198536	0.9999858140945435	O
48083	using	113 118	198537 198542	0.9999865293502808	O
48084	methylation	119 129	198543 198553	0.9999866485595703	O
48087	-	130 131	198554 198555	0.9999884366989136	O
48088	specific	131 139	198555 198563	0.9999864101409912	O
48089	PCR	140 142	198564 198566	0.9999865293502808	O
48091	.	143 144	198567 198568	0.9999451637268066	O
48092	In	0 2	198569 198571	0.9999872446060181	O
48093	patients	3 11	198572 198580	0.9999834299087524	O
48094	with	12 16	198581 198585	0.9999880790710449	O
48095	a	17 18	198586 198587	0.999987006187439	O
48096	family	19 25	198588 198594	0.9999750852584839	O
48097	history	26 33	198595 198602	0.9999854564666748	O
48098	,	34 35	198603 198604	0.9999886751174927	O
48099	the	36 39	198605 198608	0.999988317489624	O
48100	methylation	40 50	198609 198619	0.9999865293502808	O
48103	frequency	52 61	198621 198630	0.9999880790710449	O
48104	ranged	62 68	198631 198637	0.9999889135360718	O
48105	from	69 73	198638 198642	0.9999885559082031	O
48106	4	74 75	198643 198644	0.9999873638153076	O
48107	.	75 76	198644 198645	0.9999890327453613	O
48108	0	76 77	198645 198646	0.9999877214431763	O
48109	%	78 79	198647 198648	0.9999887943267822	O
48110	for	80 83	198649 198652	0.9999886751174927	O
48111	TIMP3	84 88	198653 198657	0.9999884366989136	O
48115	to	90 92	198659 198661	0.9999887943267822	O
48116	44	93 95	198662 198664	0.9999833106994629	O
48117	.	95 96	198664 198665	0.9999887943267822	O
48118	4	96 97	198665 198666	0.9999865293502808	O
48119	%	98 99	198667 198668	0.9999885559082031	O
48120	for	100 103	198669 198672	0.9999885559082031	O
48121	MGMT	104 107	198673 198676	0.9999840259552002	O
48123	,	109 110	198678 198679	0.9999886751174927	O
48124	whereas	111 118	198680 198687	0.9999880790710449	O
48125	,	119 120	198688 198689	0.999988317489624	O
48126	in	121 123	198690 198692	0.9999879598617554	O
48127	patients	124 132	198693 198701	0.9999797344207764	O
48128	with	133 137	198702 198706	0.9999867677688599	O
48129	sporadic	138 145	198707 198714	0.9999816417694092	O
48131	colorectal	147 156	198716 198725	0.9999852180480957	O
48134	cancer	158 164	198727 198733	0.9999858140945435	O
48135	,	165 166	198734 198735	0.9999885559082031	O
48136	it	167 169	198736 198738	0.999988317489624	O
48137	ranged	170 176	198739 198745	0.9999889135360718	O
48138	from	177 181	198746 198750	0.9999885559082031	O
48139	6	182 183	198751 198752	0.999987006187439	O
48140	.	183 184	198752 198753	0.9999889135360718	O
48141	7	184 185	198753 198754	0.9999862909317017	O
48142	%	186 187	198755 198756	0.9999886751174927	O
48143	for	188 191	198757 198760	0.9999885559082031	O
48144	TIMP3	192 196	198761 198765	0.9999881982803345	O
48148	to	198 200	198767 198769	0.9999886751174927	O
48149	50	201 203	198770 198772	0.9999815225601196	O
48150	.	203 204	198772 198773	0.9999887943267822	O
48151	0	204 205	198773 198774	0.9999868869781494	O
48152	%	206 207	198775 198776	0.9999884366989136	O
48153	for	208 211	198777 198780	0.9999885559082031	O
48154	p16	212 214	198781 198783	0.999988317489624	O
48156	.	216 217	198785 198786	0.999971866607666	O
48157	Nine	0 4	198787 198791	0.9999758005142212	O
48158	of	5 7	198792 198794	0.9999886751174927	O
48159	the	8 11	198795 198798	0.9999880790710449	O
48160	25	12 14	198799 198801	0.9999480247497559	O
48161	patients	15 23	198802 198810	0.999984860420227	O
48162	with	24 28	198811 198815	0.9999891519546509	O
48163	family	29 35	198816 198822	0.9999833106994629	O
48164	history	36 43	198823 198830	0.9999873638153076	O
48165	(	44 45	198831 198832	0.9999895095825195	O
48166	36	46 48	198833 198835	0.9999809265136719	O
48167	.	48 49	198835 198836	0.9999891519546509	O
48168	0	49 50	198836 198837	0.9999864101409912	O
48169	%	51 52	198838 198839	0.9999892711639404	O
48170	)	53 54	198840 198841	0.99998939037323	O
48171	were	55 59	198842 198846	0.9999892711639404	O
48172	classified	60 70	198847 198857	0.9999881982803345	O
48173	as	71 73	198858 198860	0.9999896287918091	O
48174	methylation	74 84	198861 198871	0.9999885559082031	O
48177	-	85 86	198872 198873	0.9999897480010986	O
48178	prone	86 91	198873 198878	0.9999884366989136	O
48179	,	92 93	198879 198880	0.9999874830245972	O
48180	and	94 97	198881 198884	0.9999886751174927	O
48181	nine	98 102	198885 198889	0.9999840259552002	O
48182	of	103 105	198890 198892	0.9999892711639404	O
48183	the	106 109	198893 198896	0.9999885559082031	O
48184	30	110 112	198897 198899	0.9999663829803467	O
48185	patients	113 121	198900 198908	0.9999860525131226	O
48186	with	122 126	198909 198913	0.9999890327453613	O
48187	sporadic	127 134	198914 198921	0.9999877214431763	O
48189	cancers	136 142	198923 198929	0.9999856948852539	O
48191	(	144 145	198931 198932	0.9999895095825195	O
48192	30	146 148	198933 198935	0.9999849796295166	O
48193	.	148 149	198935 198936	0.99998939037323	O
48194	0	149 150	198936 198937	0.9999878406524658	O
48195	%	151 152	198938 198939	0.9999896287918091	O
48196	)	153 154	198940 198941	0.9999895095825195	O
48197	were	155 159	198942 198946	0.99998939037323	O
48198	as	160 162	198947 198949	0.9999895095825195	O
48199	methylation	163 173	198950 198960	0.9999889135360718	O
48202	-	174 175	198961 198962	0.9999896287918091	O
48203	prone	175 180	198962 198967	0.9999890327453613	O
48204	,	181 182	198968 198969	0.9999890327453613	O
48205	making	183 189	198970 198976	0.9999880790710449	O
48206	their	190 195	198977 198982	0.9999890327453613	O
48207	methylation	196 206	198983 198993	0.9999891519546509	O
48210	indices	208 214	198995 199001	0.9999895095825195	O
48212	0	216 217	199003 199004	0.9999896287918091	O
48213	.	217 218	199004 199005	0.9999896287918091	O
48214	19	218 220	199005 199007	0.9999879598617554	O
48215	and	221 224	199008 199011	0.9999878406524658	O
48216	0	225 226	199012 199013	0.9999895095825195	O
48217	.	226 227	199013 199014	0.9999895095825195	O
48218	16	227 229	199014 199016	0.9999866485595703	O
48219	,	230 231	199017 199018	0.9999884366989136	O
48220	respectively	232 244	199019 199031	0.9999880790710449	O
48221	(	245 246	199032 199033	0.9999892711639404	O
48222	p	247 248	199034 199035	0.99998939037323	O
48223	=	248 249	199035 199036	0.9999891519546509	O
48224	0	249 250	199036 199037	0.9999895095825195	O
48225	.	250 251	199037 199038	0.9999892711639404	O
48226	522	251 253	199038 199040	0.9999831914901733	O
48228	)	255 256	199042 199043	0.9999895095825195	O
48229	.	257 258	199044 199045	0.9999700784683228	O
48230	As	0 2	199046 199048	0.999984860420227	O
48231	for	3 6	199049 199052	0.9999880790710449	O
48232	the	7 10	199053 199056	0.999988317489624	O
48233	individual	11 21	199057 199067	0.9999837875366211	O
48234	genes	22 27	199068 199073	0.999984860420227	O
48235	,	28 29	199074 199075	0.9999880790710449	O
48236	the	30 33	199076 199079	0.9999889135360718	O
48237	methylation	34 44	199080 199090	0.9999885559082031	O
48240	rate	46 50	199092 199096	0.9999891519546509	O
48241	of	51 53	199097 199099	0.9999890327453613	O
48242	MGMT	54 57	199100 199103	0.9999823570251465	O
48244	was	59 62	199105 199108	0.9999889135360718	O
48245	higher	63 69	199109 199115	0.9999866485595703	O
48246	in	70 72	199116 199118	0.9999890327453613	O
48247	colorectal	73 82	199119 199128	0.999985933303833	O
48250	cancer	84 90	199130 199136	0.9999860525131226	O
48251	patients	91 99	199137 199145	0.9999858140945435	O
48252	with	100 104	199146 199150	0.9999891519546509	O
48253	family	105 111	199151 199157	0.9999866485595703	O
48254	history	112 119	199158 199165	0.9999891519546509	O
48255	(	120 121	199166 199167	0.9999895095825195	O
48256	44	122 124	199168 199170	0.9999849796295166	O
48257	.	124 125	199170 199171	0.9999895095825195	O
48258	0	125 126	199171 199172	0.9999887943267822	O
48259	%	127 128	199173 199174	0.9999892711639404	O
48260	vs	129 131	199175 199177	0.9999887943267822	O
48261	.	131 132	199177 199178	0.9999891519546509	O
48262	13	133 135	199179 199181	0.9999850988388062	O
48263	.	135 136	199181 199182	0.9999892711639404	O
48264	0	136 137	199182 199183	0.999988317489624	O
48265	%	138 139	199184 199185	0.9999892711639404	O
48266	,	140 141	199186 199187	0.9999890327453613	O
48267	p	142 143	199188 199189	0.9999896287918091	O
48268	=	143 144	199189 199190	0.9999891519546509	O
48269	0	144 145	199190 199191	0.9999895095825195	O
48270	.	145 146	199191 199192	0.9999895095825195	O
48271	016	146 148	199192 199194	0.9999887943267822	O
48273	)	150 151	199196 199197	0.9999896287918091	O
48274	,	152 153	199198 199199	0.9999887943267822	O
48275	whereas	154 161	199200 199207	0.9999880790710449	O
48276	the	162 165	199208 199211	0.99998939037323	O
48277	methylation	166 176	199212 199222	0.9999890327453613	O
48280	rate	178 182	199224 199228	0.99998939037323	O
48281	of	183 185	199229 199231	0.9999892711639404	O
48282	p16	186 188	199232 199234	0.9999886751174927	O
48284	was	190 193	199236 199239	0.9999892711639404	O
48285	higher	194 200	199240 199246	0.9999873638153076	O
48286	in	201 203	199247 199249	0.9999889135360718	O
48287	sporadic	204 211	199250 199257	0.9999850988388062	O
48289	colorectal	213 222	199259 199268	0.9999849796295166	O
48292	cancers	224 230	199270 199276	0.9999856948852539	O
48294	(	232 233	199278 199279	0.9999892711639404	O
48295	50	234 236	199280 199282	0.9999840259552002	O
48296	.	236 237	199282 199283	0.9999895095825195	O
48297	0	237 238	199283 199284	0.9999880790710449	O
48298	%	239 240	199285 199286	0.9999892711639404	O
48299	vs	241 243	199287 199289	0.9999885559082031	O
48300	.	243 244	199289 199290	0.9999891519546509	O
48301	8	245 246	199291 199292	0.9999847412109375	O
48302	.	246 247	199292 199293	0.9999891519546509	O
48303	7	247 248	199293 199294	0.9999847412109375	O
48304	%	249 250	199295 199296	0.9999889135360718	O
48305	,	251 252	199297 199298	0.9999885559082031	O
48306	p	253 254	199299 199300	0.9999892711639404	O
48307	=	254 255	199300 199301	0.9999887943267822	O
48308	0	255 256	199301 199302	0.99998939037323	O
48309	.	256 257	199302 199303	0.9999892711639404	O
48310	046	257 259	199303 199305	0.9999861717224121	O
48312	)	261 262	199307 199308	0.9999889135360718	O
48313	.	263 264	199309 199310	0.9999663829803467	O
48314	While	0 5	199311 199316	0.9999868869781494	O
48315	CpG	6 8	199317 199319	0.9999879598617554	O
48318	island	10 16	199321 199327	0.9999878406524658	O
48319	methylation	17 27	199328 199338	0.9999878406524658	O
48322	of	29 31	199340 199342	0.9999879598617554	O
48323	tumor	32 37	199343 199348	0.9999852180480957	O
48324	suppressor	38 47	199349 199358	0.9999849796295166	O
48326	genes	49 54	199360 199365	0.999988317489624	O
48327	may	55 58	199366 199369	0.9999880790710449	O
48328	play	59 63	199370 199374	0.9999885559082031	O
48329	a	64 65	199375 199376	0.9999885559082031	O
48330	role	66 70	199377 199381	0.9999880790710449	O
48331	in	71 73	199382 199384	0.999988317489624	O
48332	colorectal	74 83	199385 199394	0.9999839067459106	O
48335	carcinogenesis	85 98	199396 199409	0.9999867677688599	O
48339	,	100 101	199411 199412	0.9999879598617554	O
48340	the	102 105	199413 199416	0.9999885559082031	O
48341	genes	106 111	199417 199422	0.9999865293502808	O
48342	involved	112 120	199423 199431	0.9999877214431763	O
48343	may	121 124	199432 199435	0.9999886751174927	O
48344	be	125 127	199436 199438	0.9999886751174927	O
48345	different	128 137	199439 199448	0.9999874830245972	O
48346	between	138 145	199449 199456	0.9999805688858032	O
48347	tumors	146 152	199457 199463	0.9999827146530151	O
48348	of	153 155	199464 199466	0.9999833106994629	O
48349	patients	156 164	199467 199475	0.999974250793457	O
48350	with	165 169	199476 199480	0.9999880790710449	O
48351	and	170 173	199481 199484	0.9999854564666748	O
48352	without	174 181	199485 199492	0.9999852180480957	O
48353	a	182 183	199493 199494	0.9999879598617554	O
48354	family	184 190	199495 199501	0.9999806880950928	O
48355	history	191 198	199502 199509	0.9999873638153076	O
48356	of	199 201	199510 199512	0.9999879598617554	O
48357	colorectal	202 211	199513 199522	0.9999850988388062	O
48360	cancer	213 219	199524 199530	0.9999865293502808	O
48361	.	220 221	199531 199532	0.999988317489624	O
48362	*	222 223	199533 199534	0.999987006187439	O
48363	*	223 224	199534 199535	0.999976634979248	O
48364	IGNORE	0 5	199536 199541	0.9999858140945435	O
48367	LINE	7 10	199543 199546	0.9999884366989136	O
48370	*	12 13	199548 199549	0.9999885559082031	O
48371	*	13 14	199549 199550	0.9999884366989136	O
48372	*	15 16	199551 199552	0.9999884366989136	O
48373	*	16 17	199552 199553	0.9999886751174927	O
48374	IGNORE	18 23	199554 199559	0.9999877214431763	O
48377	LINE	25 28	199561 199564	0.9999889135360718	O
48380	*	30 31	199566 199567	0.999988317489624	O
48381	*	31 32	199567 199568	0.999988317489624	O
48382	*	33 34	199569 199570	0.999988317489624	O
48383	*	34 35	199570 199571	0.9999881982803345	O
48384	IGNORE	36 41	199572 199577	0.9999871253967285	O
48387	LINE	43 46	199579 199582	0.9999886751174927	O
48390	*	48 49	199584 199585	0.9999884366989136	O
48391	*	49 50	199585 199586	0.999988317489624	O
48392	RESULTS	51 57	199587 199593	0.9999885559082031	O
48397	Methylation	59 69	199595 199605	0.9999884366989136	O
48400	in	71 73	199607 199609	0.9999885559082031	O
48401	colorectal	74 83	199610 199619	0.999983549118042	O
48404	cancer	85 91	199621 199627	0.9999841451644897	O
48405	patients	92 100	199628 199636	0.9999845027923584	O
48406	with	101 105	199637 199641	0.9999886751174927	O
48407	family	106 112	199642 199648	0.9999868869781494	O
48408	history	113 120	199649 199656	0.999988317489624	O
48409	We	121 123	199657 199659	0.9999833106994629	O
48410	determined	124 134	199660 199670	0.9999865293502808	O
48411	CpG	135 137	199671 199673	0.9999886751174927	O
48414	island	139 145	199675 199681	0.9999879598617554	O
48415	methylation	146 156	199682 199692	0.9999885559082031	O
48418	at	158 160	199694 199696	0.9999881982803345	O
48419	six	161 164	199697 199700	0.9999861717224121	O
48420	loci	165 168	199701 199704	0.9999885559082031	O
48422	and	170 173	199706 199709	0.9999877214431763	O
48423	MSI	174 176	199710 199712	0.9999855756759644	O
48425	in	178 180	199714 199716	0.9999874830245972	O
48426	paired	181 187	199717 199723	0.9999698400497437	O
48427	normal	188 194	199724 199730	0.9999779462814331	O
48428	mucosa	195 200	199731 199736	0.9999858140945435	O
48431	and	202 205	199738 199741	0.9999806880950928	O
48432	tumor	206 211	199742 199747	0.999977707862854	O
48433	tissue	212 218	199748 199754	0.9999849796295166	O
48434	from	219 223	199755 199759	0.9999833106994629	O
48435	25	224 226	199760 199762	0.9999206066131592	O
48436	colorectal	227 236	199763 199772	0.9999797344207764	O
48439	cancer	238 244	199774 199780	0.9999815225601196	O
48440	patients	245 253	199781 199789	0.999972939491272	O
48441	with	254 258	199790 199794	0.9999867677688599	O
48442	family	259 265	199795 199801	0.9999825954437256	O
48443	history	266 273	199802 199809	0.9999874830245972	O
48444	.	274 275	199810 199811	0.9999487400054932	O
48445	Of	0 2	199812 199814	0.9999822378158569	O
48446	the	3 6	199815 199818	0.9999759197235107	O
48447	25	7 9	199819 199821	0.9996817111968994	O
48448	tumors	10 16	199822 199828	0.9999638795852661	O
48449	,	17 18	199829 199830	0.9999814033508301	O
48450	16	19 21	199831 199833	0.9999423027038574	O
48451	(	22 23	199834 199835	0.9999858140945435	O
48452	64	24 26	199836 199838	0.9999644756317139	O
48453	.	26 27	199838 199839	0.9999853372573853	O
48454	0	27 28	199839 199840	0.9999781847000122	O
48455	%	29 30	199841 199842	0.9999855756759644	O
48456	)	31 32	199843 199844	0.9999865293502808	O
48457	showed	33 39	199845 199851	0.9999852180480957	O
48458	promoter	40 48	199852 199860	0.9999872446060181	O
48459	methylation	49 59	199861 199871	0.9999876022338867	O
48462	of	61 63	199873 199875	0.9999880790710449	O
48463	at	64 66	199876 199878	0.9999884366989136	O
48464	least	67 72	199879 199884	0.9999884366989136	O
48465	one	73 76	199885 199888	0.9999881982803345	O
48466	gene	77 81	199889 199893	0.9999872446060181	O
48467	,	82 83	199894 199895	0.9999868869781494	O
48468	ranging	84 91	199896 199903	0.9999852180480957	O
48469	to	92 94	199904 199906	0.999987006187439	O
48470	four	95 99	199907 199911	0.999982476234436	O
48471	genes	100 105	199912 199917	0.9999865293502808	O
48472	.	106 107	199918 199919	0.999958872795105	O
48473	Seven	0 5	199920 199925	0.9999502897262573	O
48474	tumors	6 12	199926 199932	0.9999594688415527	O
48475	showed	13 19	199933 199939	0.9999858140945435	O
48476	methylation	20 30	199940 199950	0.9999860525131226	O
48479	at	32 34	199952 199954	0.9999886751174927	O
48480	one	35 38	199955 199958	0.9999887943267822	O
48481	gene	39 43	199959 199963	0.9999867677688599	O
48482	,	44 45	199964 199965	0.9999879598617554	O
48483	seven	46 51	199966 199971	0.999983549118042	O
48484	at	52 54	199972 199974	0.9999885559082031	O
48485	two	55 58	199975 199978	0.9999873638153076	O
48486	genes	59 64	199979 199984	0.9999879598617554	O
48487	,	65 66	199985 199986	0.999988317489624	O
48488	one	67 70	199987 199990	0.9999884366989136	O
48489	at	71 73	199991 199993	0.9999889135360718	O
48490	three	74 79	199994 199999	0.9999880790710449	O
48491	genes	80 85	200000 200005	0.9999884366989136	O
48492	,	86 87	200006 200007	0.9999873638153076	O
48493	and	88 91	200008 200011	0.9999885559082031	O
48494	one	92 95	200012 200015	0.999988317489624	O
48495	at	96 98	200016 200018	0.9999886751174927	O
48496	four	99 103	200019 200023	0.9999871253967285	O
48497	genes	104 109	200024 200029	0.9999878406524658	O
48498	.	110 111	200030 200031	0.9999542236328125	O
48499	In	0 2	200032 200034	0.9999858140945435	O
48500	contrast	3 11	200035 200043	0.999981164932251	O
48501	,	12 13	200044 200045	0.9999864101409912	O
48502	of	14 16	200046 200048	0.9999861717224121	O
48503	the	17 20	200049 200052	0.9999843835830688	O
48504	25	21 23	200053 200055	0.9999397993087769	O
48505	samples	24 31	200056 200063	0.9999855756759644	O
48506	of	32 34	200064 200066	0.9999853372573853	O
48507	normal	35 41	200067 200073	0.9999691247940063	O
48508	colonic	42 48	200074 200080	0.9999769926071167	O
48511	mucosa	50 55	200082 200087	0.9999849796295166	O
48514	,	57 58	200089 200090	0.999987006187439	O
48515	12	59 61	200091 200093	0.9999773502349854	O
48516	(	62 63	200094 200095	0.999988317489624	O
48517	48	64 66	200096 200098	0.9999799728393555	O
48518	.	66 67	200098 200099	0.9999884366989136	O
48519	0	67 68	200099 200100	0.9999864101409912	O
48520	%	69 70	200101 200102	0.9999887943267822	O
48521	)	71 72	200103 200104	0.9999891519546509	O
48522	showed	73 79	200105 200111	0.9999878406524658	O
48523	promoter	80 88	200112 200120	0.9999885559082031	O
48524	methylation	89 99	200121 200131	0.9999886751174927	O
48527	:	101 102	200133 200134	0.9999879598617554	O
48528	eight	103 108	200135 200140	0.9999839067459106	O
48529	samples	109 116	200141 200148	0.9999886751174927	O
48530	at	117 119	200149 200151	0.99998939037323	O
48531	one	120 123	200152 200155	0.9999892711639404	O
48532	gene	124 128	200156 200160	0.9999887943267822	O
48533	,	129 130	200161 200162	0.9999861717224121	O
48534	and	131 134	200163 200166	0.9999880790710449	O
48535	four	135 139	200167 200171	0.9999822378158569	O
48536	samples	140 147	200172 200179	0.999988317489624	O
48537	at	148 150	200180 200182	0.9999890327453613	O
48538	two	151 154	200183 200186	0.9999876022338867	O
48539	genes	155 160	200187 200192	0.999988317489624	O
48540	.	161 162	200193 200194	0.9999691247940063	O
48541	When	0 4	200195 200199	0.9999841451644897	O
48542	patients	5 13	200200 200208	0.9999815225601196	O
48543	with	14 18	200209 200213	0.9999880790710449	O
48544	a	19 20	200214 200215	0.9999881982803345	O
48545	family	21 27	200216 200222	0.9999816417694092	O
48546	history	28 35	200223 200230	0.9999867677688599	O
48547	were	36 40	200231 200235	0.999988317489624	O
48548	categorized	41 52	200236 200247	0.9999880790710449	O
48549	as	53 55	200248 200250	0.9999885559082031	O
48550	having	56 62	200251 200257	0.9999889135360718	O
48551	0	63 64	200258 200259	0.9999884366989136	O
48552	-	64 65	200259 200260	0.9999890327453613	O
48553	1	65 66	200260 200261	0.999988317489624	O
48554	(	67 68	200262 200263	0.9999892711639404	O
48555	MR	69 71	200264 200266	0.999981164932251	O
48556	group	72 77	200267 200272	0.99998939037323	O
48557	)	78 79	200273 200274	0.9999885559082031	O
48558	or	80 82	200275 200277	0.9999878406524658	O
48559	≥2	83 84	200278 200279	0.9999877214431763	O
48561	(	86 87	200281 200282	0.9999892711639404	O
48562	MP	88 90	200283 200285	0.9999819993972778	O
48563	group	91 96	200286 200291	0.9999891519546509	O
48564	)	97 98	200292 200293	0.9999892711639404	O
48565	methylated	99 108	200294 200303	0.9999884366989136	O
48568	loci	110 113	200305 200308	0.9999891519546509	O
48570	,	115 116	200310 200311	0.9999881982803345	O
48571	we	117 119	200312 200314	0.999985933303833	O
48572	found	120 125	200315 200320	0.9999876022338867	O
48573	that	126 130	200321 200325	0.9999887943267822	O
48574	36	131 133	200326 200328	0.9999822378158569	O
48575	.	133 134	200328 200329	0.9999887943267822	O
48576	0	134 135	200329 200330	0.9999852180480957	O
48577	%	136 137	200331 200332	0.9999886751174927	O
48578	of	138 140	200333 200335	0.9999878406524658	O
48579	the	141 144	200336 200339	0.9999841451644897	O
48580	tumors	145 151	200340 200346	0.9999803304672241	O
48581	and	152 155	200347 200350	0.9999874830245972	O
48582	16	156 158	200351 200353	0.9999834299087524	O
48583	.	158 159	200353 200354	0.9999890327453613	O
48584	0	159 160	200354 200355	0.9999868869781494	O
48585	%	161 162	200356 200357	0.9999890327453613	O
48586	of	163 165	200358 200360	0.999988317489624	O
48587	the	166 169	200361 200364	0.9999876022338867	O
48588	normal	170 176	200365 200371	0.999976396560669	O
48589	mucosa	177 182	200372 200377	0.999984622001648	O
48592	samples	184 191	200379 200386	0.9999850988388062	O
48593	could	192 197	200387 200392	0.9999879598617554	O
48594	be	198 200	200393 200395	0.9999887943267822	O
48595	categorized	201 212	200396 200407	0.9999880790710449	O
48596	as	213 215	200408 200410	0.9999887943267822	O
48597	MP	216 218	200411 200413	0.9999735355377197	O
48598	.	218 219	200413 200414	0.9999734163284302	O
48599	The	0 3	200415 200418	0.9999880790710449	O
48600	mean	4 8	200419 200423	0.9999866485595703	O
48601	methylation	9 19	200424 200434	0.9999877214431763	O
48604	index	21 26	200436 200441	0.9999881982803345	O
48605	(	27 28	200442 200443	0.9999889135360718	O
48606	the	29 32	200444 200447	0.9999891519546509	O
48607	number	33 39	200448 200454	0.9999890327453613	O
48608	of	40 42	200455 200457	0.9999891519546509	O
48609	methylated	43 52	200458 200467	0.999988317489624	O
48612	loci	54 57	200469 200472	0.9999891519546509	O
48614	divided	59 66	200474 200481	0.9999890327453613	O
48615	by	67 69	200482 200484	0.9999891519546509	O
48616	the	70 73	200485 200488	0.9999892711639404	O
48617	total	74 79	200489 200494	0.9999890327453613	O
48618	number	80 86	200495 200501	0.9999891519546509	O
48619	of	87 89	200502 200504	0.9999892711639404	O
48620	tested	90 96	200505 200511	0.9999871253967285	O
48621	loci	97 100	200512 200515	0.9999890327453613	O
48623	)	101 102	200516 200517	0.9999892711639404	O
48624	was	103 106	200518 200521	0.9999890327453613	O
48625	0	107 108	200522 200523	0.9999895095825195	O
48626	.	108 109	200523 200524	0.9999895095825195	O
48627	11	109 111	200524 200526	0.9999891519546509	O
48628	(	112 113	200527 200528	0.9999896287918091	O
48629	0	113 114	200528 200529	0.99998939037323	O
48630	-	114 115	200529 200530	0.9999895095825195	O
48631	0	115 116	200530 200531	0.99998939037323	O
48632	.	116 117	200531 200532	0.9999895095825195	O
48633	33	117 119	200532 200534	0.9999872446060181	O
48634	)	120 121	200535 200536	0.9999895095825195	O
48635	in	122 124	200537 200539	0.9999891519546509	O
48636	normal	125 131	200540 200546	0.9999805688858032	O
48637	mucosa	132 137	200547 200552	0.9999861717224121	O
48640	and	139 142	200554 200557	0.9999885559082031	O
48641	0	143 144	200558 200559	0.99998939037323	O
48642	.	144 145	200559 200560	0.9999895095825195	O
48643	19	145 147	200560 200562	0.999988317489624	O
48644	(	148 149	200563 200564	0.9999895095825195	O
48645	0	149 150	200564 200565	0.99998939037323	O
48646	-	150 151	200565 200566	0.99998939037323	O
48647	0	151 152	200566 200567	0.9999892711639404	O
48648	.	152 153	200567 200568	0.99998939037323	O
48649	66	153 155	200568 200570	0.9999867677688599	O
48650	)	156 157	200571 200572	0.99998939037323	O
48651	in	158 160	200573 200575	0.999987006187439	O
48652	tumors	161 167	200576 200582	0.9999744892120361	O
48653	(	168 169	200583 200584	0.9999895095825195	O
48654	p	170 171	200585 200586	0.99998939037323	O
48655	=	171 172	200586 200587	0.99998939037323	O
48656	0	172 173	200587 200588	0.9999896287918091	O
48657	.	173 174	200588 200589	0.99998939037323	O
48658	078	174 176	200589 200591	0.9999873638153076	O
48660	)	178 179	200593 200594	0.99998939037323	O
48661	.	180 181	200595 200596	0.999974250793457	O
48662	A	0 1	200597 200598	0.9999834299087524	O
48663	high	2 6	200599 200603	0.9999771118164062	O
48664	proportion	7 17	200604 200614	0.9999821186065674	O
48665	of	18 20	200615 200617	0.9999778270721436	O
48666	tumors	21 27	200618 200624	0.9999732971191406	O
48667	(	28 29	200625 200626	0.9999866485595703	O
48668	44	30 32	200627 200629	0.9999778270721436	O
48669	.	32 33	200629 200630	0.9999877214431763	O
48670	0	33 34	200630 200631	0.9999841451644897	O
48671	%	35 36	200632 200633	0.9999872446060181	O
48672	)	37 38	200634 200635	0.9999872446060181	O
48673	were	39 43	200636 200640	0.9999876022338867	O
48674	methylated	44 53	200641 200650	0.9999877214431763	O
48677	at	55 57	200652 200654	0.9999884366989136	O
48678	the	58 61	200655 200658	0.9999890327453613	O
48679	MGMT	62 65	200659 200662	0.9999825954437256	O
48681	locus	67 71	200664 200668	0.9999889135360718	O
48683	,	73 74	200670 200671	0.9999878406524658	O
48684	whereas	75 82	200672 200679	0.9999860525131226	O
48685	20	83 85	200680 200682	0.9999858140945435	O
48686	.	85 86	200682 200683	0.9999887943267822	O
48687	0	86 87	200683 200684	0.9999879598617554	O
48688	%	88 89	200685 200686	0.9999885559082031	O
48689	,	90 91	200687 200688	0.9999872446060181	O
48690	20	92 94	200689 200691	0.9999865293502808	O
48691	.	94 95	200691 200692	0.9999887943267822	O
48692	0	95 96	200692 200693	0.9999881982803345	O
48693	%	97 98	200694 200695	0.9999887943267822	O
48694	,	99 100	200696 200697	0.9999868869781494	O
48695	and	101 104	200698 200701	0.9999879598617554	O
48696	16	105 107	200702 200704	0.9999842643737793	O
48697	.	107 108	200704 200705	0.9999887943267822	O
48698	0	108 109	200705 200706	0.9999876022338867	O
48699	%	110 111	200707 200708	0.999988317489624	O
48700	were	112 116	200709 200713	0.9999885559082031	O
48701	methylated	117 126	200714 200723	0.9999880790710449	O
48704	at	128 130	200725 200727	0.9999885559082031	O
48705	the	131 134	200728 200731	0.9999889135360718	O
48706	COX2	135 138	200732 200735	0.9999864101409912	O
48709	,	140 141	200737 200738	0.999988317489624	O
48710	hMLH1	142 146	200739 200743	0.9999876022338867	O
48713	,	148 149	200745 200746	0.9999884366989136	O
48714	and	150 153	200747 200750	0.9999885559082031	O
48715	MINT2	154 158	200751 200755	0.9999836683273315	O
48718	loci	160 163	200757 200760	0.9999885559082031	O
48720	,	165 166	200762 200763	0.999988317489624	O
48721	respectively	167 179	200764 200776	0.9999867677688599	O
48722	.	180 181	200777 200778	0.9999558925628662	O
48723	In	0 2	200779 200781	0.9999877214431763	O
48724	contrast	3 11	200782 200790	0.9999858140945435	O
48725	,	12 13	200791 200792	0.9999890327453613	O
48726	only	14 18	200793 200797	0.999987006187439	O
48727	8	19 20	200798 200799	0.9999868869781494	O
48728	.	20 21	200799 200800	0.9999892711639404	O
48729	0	21 22	200800 200801	0.9999866485595703	O
48730	%	23 24	200802 200803	0.9999895095825195	O
48731	of	25 27	200804 200806	0.9999890327453613	O
48732	p16	28 30	200807 200809	0.9999891519546509	O
48734	loci	32 35	200811 200814	0.9999896287918091	O
48736	and	37 40	200816 200819	0.9999889135360718	O
48737	4	41 42	200820 200821	0.9999856948852539	O
48738	.	42 43	200821 200822	0.99998939037323	O
48739	0	43 44	200822 200823	0.9999886751174927	O
48740	%	45 46	200824 200825	0.9999895095825195	O
48741	of	47 49	200826 200828	0.9999892711639404	O
48742	TIMP3	50 54	200829 200833	0.9999886751174927	O
48746	loci	56 59	200835 200838	0.9999895095825195	O
48748	were	61 65	200840 200844	0.99998939037323	O
48749	methylated	66 75	200845 200854	0.9999881982803345	O
48752	(	77 78	200856 200857	0.9999881982803345	O
48753	Fig	79 81	200858 200860	0.9999872446060181	O
48755	.	83 84	200862 200863	0.9999834299087524	O
48756	2	0 1	200864 200865	0.9999523162841797	O
48757	)	2 3	200866 200867	0.9999760389328003	O
48758	.	4 5	200868 200869	0.9997958540916443	O
48759	We	0 2	200870 200872	0.9999810457229614	O
48760	found	3 8	200873 200878	0.9999860525131226	O
48761	that	9 13	200879 200883	0.9999887943267822	O
48762	the	14 17	200884 200887	0.9999886751174927	O
48763	COX2	18 21	200888 200891	0.9999849796295166	O
48766	,	23 24	200893 200894	0.9999885559082031	O
48767	MGMT	25 28	200895 200898	0.9999821186065674	O
48769	,	30 31	200900 200901	0.9999880790710449	O
48770	and	32 35	200902 200905	0.9999887943267822	O
48771	p16	36 38	200906 200908	0.9999887943267822	O
48773	loci	40 43	200910 200913	0.9999890327453613	O
48775	were	45 49	200915 200919	0.9999892711639404	O
48776	methylated	50 59	200920 200929	0.999988317489624	O
48779	at	61 63	200931 200933	0.9999895095825195	O
48780	28	64 66	200934 200936	0.9999855756759644	O
48781	.	66 67	200936 200937	0.99998939037323	O
48782	0	67 68	200937 200938	0.9999889135360718	O
48783	%	69 70	200939 200940	0.9999895095825195	O
48784	,	71 72	200941 200942	0.9999884366989136	O
48785	20	73 75	200943 200945	0.9999854564666748	O
48786	.	75 76	200945 200946	0.9999895095825195	O
48787	0	76 77	200946 200947	0.9999891519546509	O
48788	%	78 79	200948 200949	0.9999895095825195	O
48789	,	80 81	200950 200951	0.9999880790710449	O
48790	and	82 85	200952 200955	0.9999887943267822	O
48791	16	86 88	200956 200958	0.9999864101409912	O
48792	.	88 89	200958 200959	0.99998939037323	O
48793	0	89 90	200959 200960	0.9999887943267822	O
48794	%	91 92	200961 200962	0.9999895095825195	O
48795	,	93 94	200963 200964	0.999988317489624	O
48796	respectively	95 107	200965 200977	0.9999881982803345	O
48797	,	108 109	200978 200979	0.9999879598617554	O
48798	of	110 112	200980 200982	0.9999885559082031	O
48799	normal	113 119	200983 200989	0.9999828338623047	O
48800	mucosa	120 125	200990 200995	0.9999868869781494	O
48803	samples	127 134	200997 201004	0.9999872446060181	O
48804	of	135 137	201005 201007	0.9999876022338867	O
48805	patients	138 146	201008 201016	0.9999828338623047	O
48806	with	147 151	201017 201021	0.9999890327453613	O
48807	a	152 153	201022 201023	0.9999895095825195	O
48808	family	154 160	201024 201030	0.9999855756759644	O
48809	history	161 168	201031 201038	0.9999886751174927	O
48810	,	169 170	201039 201040	0.9999880790710449	O
48811	whereas	171 178	201041 201048	0.9999880790710449	O
48812	the	179 182	201049 201052	0.9999892711639404	O
48813	hMLH1	183 187	201053 201057	0.9999878406524658	O
48816	,	189 190	201059 201060	0.9999889135360718	O
48817	TIMP3	191 195	201061 201065	0.9999877214431763	O
48821	,	197 198	201067 201068	0.9999885559082031	O
48822	and	199 202	201069 201072	0.9999891519546509	O
48823	MINT2	203 207	201073 201077	0.9999836683273315	O
48826	loci	209 212	201079 201082	0.9999890327453613	O
48828	were	214 218	201084 201088	0.9999891519546509	O
48829	not	219 222	201089 201092	0.9999862909317017	O
48830	methylated	223 232	201093 201102	0.999988317489624	O
48833	in	234 236	201104 201106	0.9999892711639404	O
48834	any	237 240	201107 201110	0.999985933303833	O
48835	of	241 243	201111 201113	0.9999889135360718	O
48836	the	244 247	201114 201117	0.9999880790710449	O
48837	normal	248 254	201118 201124	0.9999816417694092	O
48838	mucosa	255 260	201125 201130	0.9999868869781494	O
48841	samples	262 269	201132 201139	0.999987006187439	O
48842	.	270 271	201140 201141	0.9999608993530273	O
48843	The	0 3	201142 201145	0.9999879598617554	O
48844	frequency	4 13	201146 201155	0.9999868869781494	O
48845	of	14 16	201156 201158	0.9999885559082031	O
48846	methylation	17 27	201159 201169	0.9999871253967285	O
48849	of	29 31	201171 201173	0.9999886751174927	O
48850	the	32 35	201174 201177	0.9999887943267822	O
48851	COX2	36 39	201178 201181	0.9999861717224121	O
48854	and	41 44	201183 201186	0.9999881982803345	O
48855	p16	45 47	201187 201189	0.9999881982803345	O
48857	loci	49 52	201191 201194	0.9999889135360718	O
48859	was	54 57	201196 201199	0.9999873638153076	O
48860	higher	58 64	201200 201206	0.999984622001648	O
48861	in	65 67	201207 201209	0.999988317489624	O
48862	normal	68 74	201210 201216	0.9999765157699585	O
48863	mucosa	75 80	201217 201222	0.9999837875366211	O
48866	than	82 86	201224 201228	0.9999828338623047	O
48867	in	87 89	201229 201231	0.9999867677688599	O
48868	tumor	90 95	201232 201237	0.9999794960021973	O
48869	,	96 97	201238 201239	0.9999865293502808	O
48870	but	98 101	201240 201243	0.9999860525131226	O
48871	the	102 105	201244 201247	0.9999884366989136	O
48872	difference	106 116	201248 201258	0.9999862909317017	O
48873	did	117 120	201259 201262	0.9999878406524658	O
48874	not	121 124	201263 201266	0.9999879598617554	O
48875	reach	125 130	201267 201272	0.9999868869781494	O
48876	a	131 132	201273 201274	0.9999886751174927	O
48877	statistical	133 144	201275 201286	0.9999881982803345	O
48878	significance	145 157	201287 201299	0.9999884366989136	O
48879	.	158 159	201300 201301	0.9999706745147705	O
48880	Methylation	0 10	201302 201312	0.9999847412109375	O
48883	in	12 14	201314 201316	0.9999855756759644	O
48884	sporadic	15 22	201317 201324	0.9999784231185913	O
48886	colorectal	24 33	201326 201335	0.9999747276306152	O
48889	cancer	35 41	201337 201343	0.999982476234436	O
48890	patients	42 50	201344 201352	0.9999780654907227	O
48891	We	51 53	201353 201355	0.9999817609786987	O
48892	also	54 58	201356 201360	0.999987006187439	O
48893	assayed	59 65	201361 201367	0.9999874830245972	O
48896	CpG	67 69	201369 201371	0.9999881982803345	O
48899	island	71 77	201373 201379	0.9999867677688599	O
48900	methylation	78 88	201380 201390	0.9999879598617554	O
48903	at	90 92	201392 201394	0.9999879598617554	O
48904	these	93 98	201395 201400	0.9999886751174927	O
48905	six	99 102	201401 201404	0.9999850988388062	O
48906	loci	103 106	201405 201408	0.9999878406524658	O
48908	and	108 111	201410 201413	0.9999878406524658	O
48909	MSI	112 114	201414 201416	0.9999856948852539	O
48911	in	116 118	201418 201420	0.9999868869781494	O
48912	paired	119 125	201421 201427	0.9998786449432373	O
48913	tumors	126 132	201428 201434	0.9999821186065674	O
48914	and	133 136	201435 201438	0.9999805688858032	O
48915	normal	137 143	201439 201445	0.9997283816337585	O
48916	mucosa	144 149	201446 201451	0.9999785423278809	O
48919	from	151 155	201453 201457	0.9999837875366211	O
48920	30	156 158	201458 201460	0.9999464750289917	O
48921	patients	159 167	201461 201469	0.9998763799667358	O
48922	with	168 172	201470 201474	0.9999788999557495	O
48923	sporadic	173 180	201475 201482	0.9999819993972778	O
48925	colorectal	182 191	201484 201493	0.9999779462814331	O
48928	cancer	193 199	201495 201501	0.9999817609786987	O
48929	.	200 201	201502 201503	0.9999450445175171	O
48930	We	0 2	201504 201506	0.9999685287475586	O
48931	found	3 8	201507 201512	0.999980092048645	O
48932	that	9 13	201513 201517	0.9999852180480957	O
48933	16	14 16	201518 201520	0.9999419450759888	O
48934	(	17 18	201521 201522	0.9999860525131226	O
48935	53	19 21	201523 201525	0.9999693632125854	O
48936	.	21 22	201525 201526	0.9999862909317017	O
48937	0	22 23	201526 201527	0.9999803304672241	O
48938	%	24 25	201528 201529	0.999985933303833	O
48939	)	26 27	201530 201531	0.999985933303833	O
48940	of	28 30	201532 201534	0.9999822378158569	O
48941	the	31 34	201535 201538	0.9999713897705078	O
48942	tumors	35 41	201539 201545	0.9999717473983765	O
48943	showed	42 48	201546 201552	0.9999858140945435	O
48944	promoter	49 57	201553 201561	0.9999878406524658	O
48945	methylation	58 68	201562 201572	0.9999881982803345	O
48948	of	70 72	201574 201576	0.9999885559082031	O
48949	at	73 75	201577 201579	0.9999887943267822	O
48950	least	76 81	201580 201585	0.9999889135360718	O
48951	one	82 85	201586 201589	0.9999884366989136	O
48952	gene	86 90	201590 201594	0.9999873638153076	O
48953	,	91 92	201595 201596	0.9999876022338867	O
48954	ranging	93 100	201597 201604	0.9999861717224121	O
48955	to	101 103	201605 201607	0.9999877214431763	O
48956	three	104 109	201608 201613	0.9999843835830688	O
48957	genes	110 115	201614 201619	0.9999871253967285	O
48958	.	116 117	201620 201621	0.9999681711196899	O
48959	Seven	0 5	201622 201627	0.999933123588562	O
48960	tumors	6 12	201628 201634	0.999956488609314	O
48961	showed	13 19	201635 201641	0.9999843835830688	O
48962	methylation	20 30	201642 201652	0.999984860420227	O
48965	at	32 34	201654 201656	0.9999879598617554	O
48966	one	35 38	201657 201660	0.9999878406524658	O
48967	locus	39 43	201661 201665	0.9999881982803345	O
48969	,	45 46	201667 201668	0.9999871253967285	O
48970	six	47 50	201669 201672	0.9999809265136719	O
48971	at	51 53	201673 201675	0.9999879598617554	O
48972	two	54 57	201676 201679	0.9999867677688599	O
48973	loci	58 61	201680 201683	0.9999885559082031	O
48975	,	63 64	201685 201686	0.9999861717224121	O
48976	and	65 68	201687 201690	0.9999877214431763	O
48977	one	69 72	201691 201694	0.9999856948852539	O
48978	at	73 75	201695 201697	0.9999879598617554	O
48979	three	76 81	201698 201703	0.9999865293502808	O
48980	loci	82 85	201704 201707	0.999988317489624	O
48982	.	87 88	201709 201710	0.9999444484710693	O
48983	In	0 2	201711 201713	0.9999853372573853	O
48984	contrast	3 11	201714 201722	0.9999817609786987	O
48985	,	12 13	201723 201724	0.9999866485595703	O
48986	only	14 18	201725 201729	0.9999829530715942	O
48987	7	19 20	201730 201731	0.999964714050293	O
48988	(	21 22	201732 201733	0.9999876022338867	O
48989	23	23 25	201734 201736	0.9999784231185913	O
48990	.	25 26	201736 201737	0.9999872446060181	O
48991	0	26 27	201737 201738	0.9999819993972778	O
48992	%	28 29	201739 201740	0.9999880790710449	O
48993	)	30 31	201741 201742	0.9999881982803345	O
48994	of	32 34	201743 201745	0.999985933303833	O
48995	the	35 38	201746 201749	0.999982476234436	O
48996	normal	39 45	201750 201756	0.9999583959579468	O
48997	colonic	46 52	201757 201763	0.9999730587005615	O
49000	mucosa	54 59	201765 201770	0.9999823570251465	O
49003	samples	61 68	201772 201779	0.9999827146530151	O
49004	showed	69 75	201780 201786	0.9999874830245972	O
49005	promoter	76 84	201787 201795	0.9999885559082031	O
49006	methylation	85 95	201796 201806	0.9999885559082031	O
49009	,	97 98	201808 201809	0.9999876022338867	O
49010	each	99 103	201810 201814	0.9999854564666748	O
49011	at	104 106	201815 201817	0.9999890327453613	O
49012	one	107 110	201818 201821	0.9999889135360718	O
49013	gene	111 115	201822 201826	0.9999874830245972	O
49014	.	116 117	201827 201828	0.999970555305481	O
49015	We	0 2	201829 201831	0.9999698400497437	O
49016	found	3 8	201832 201837	0.9999808073043823	O
49017	that	9 13	201838 201842	0.9999849796295166	O
49018	30	14 16	201843 201845	0.999971866607666	O
49019	.	16 17	201845 201846	0.9999858140945435	O
49020	0	17 18	201846 201847	0.9999779462814331	O
49021	%	19 20	201848 201849	0.9999854564666748	O
49022	of	21 23	201850 201852	0.999983549118042	O
49023	the	24 27	201853 201856	0.9999741315841675	O
49024	tumors	28 34	201857 201863	0.9999732971191406	O
49025	,	35 36	201864 201865	0.999983549118042	O
49026	and	37 40	201866 201869	0.9999839067459106	O
49027	none	41 45	201870 201874	0.9999799728393555	O
49028	of	46 48	201875 201877	0.999984860420227	O
49029	the	49 52	201878 201881	0.9999834299087524	O
49030	normal	53 59	201882 201888	0.9999707937240601	O
49031	mucosa	60 65	201889 201894	0.9999805688858032	O
49034	,	67 68	201896 201897	0.9999818801879883	O
49035	could	69 74	201898 201903	0.9999856948852539	O
49036	be	75 77	201904 201906	0.9999860525131226	O
49037	classified	78 88	201907 201917	0.999985933303833	O
49038	as	89 91	201918 201920	0.9999853372573853	O
49039	MP	92 94	201921 201923	0.9999303817749023	O
49040	.	94 95	201923 201924	0.9999681711196899	O
49041	The	0 3	201925 201928	0.9999865293502808	O
49042	mean	4 8	201929 201933	0.999985933303833	O
49043	methylation	9 19	201934 201944	0.9999868869781494	O
49046	index	21 26	201946 201951	0.9999873638153076	O
49047	was	27 30	201952 201955	0.9999879598617554	O
49048	0	31 32	201956 201957	0.9999887943267822	O
49049	.	32 33	201957 201958	0.9999889135360718	O
49050	04	33 35	201958 201960	0.9999864101409912	O
49051	(	36 37	201961 201962	0.9999892711639404	O
49052	0	37 38	201962 201963	0.9999890327453613	O
49053	-	38 39	201963 201964	0.9999891519546509	O
49054	0	39 40	201964 201965	0.9999892711639404	O
49055	.	40 41	201965 201966	0.9999892711639404	O
49056	17	41 43	201966 201968	0.9999865293502808	O
49057	)	44 45	201969 201970	0.9999891519546509	O
49058	in	46 48	201971 201973	0.9999876022338867	O
49059	normal	49 55	201974 201980	0.999963641166687	O
49060	mucosa	56 61	201981 201986	0.9999814033508301	O
49063	and	63 66	201988 201991	0.9999877214431763	O
49064	0	67 68	201992 201993	0.9999891519546509	O
49065	.	68 69	201993 201994	0.9999892711639404	O
49066	16	69 71	201994 201996	0.9999873638153076	O
49067	(	72 73	201997 201998	0.99998939037323	O
49068	0	73 74	201998 201999	0.9999892711639404	O
49069	-	74 75	201999 202000	0.9999892711639404	O
49070	0	75 76	202000 202001	0.99998939037323	O
49071	.	76 77	202001 202002	0.9999891519546509	O
49072	5	77 78	202002 202003	0.9999881982803345	O
49073	)	79 80	202004 202005	0.9999892711639404	O
49074	in	81 83	202006 202008	0.999985933303833	O
49075	tumors	84 90	202009 202015	0.9999706745147705	O
49076	(	91 92	202016 202017	0.9999890327453613	O
49077	p	93 94	202018 202019	0.9999891519546509	O
49078	<	94 95	202019 202020	0.999988317489624	O
49079	0	95 96	202020 202021	0.9999890327453613	O
49080	.	96 97	202021 202022	0.9999889135360718	O
49081	001	97 99	202022 202024	0.9999889135360718	O
49083	)	101 102	202026 202027	0.9999890327453613	O
49084	.	103 104	202028 202029	0.9999707937240601	O
49085	Methylation	0 10	202030 202040	0.9999880790710449	O
49088	of	12 14	202042 202044	0.9999886751174927	O
49089	the	15 18	202045 202048	0.9999889135360718	O
49090	p16	19 21	202049 202051	0.9999873638153076	O
49092	locus	23 27	202053 202057	0.9999890327453613	O
49094	was	29 32	202059 202062	0.9999886751174927	O
49095	observed	33 41	202063 202071	0.9999887943267822	O
49096	in	42 44	202072 202074	0.9999892711639404	O
49097	a	45 46	202075 202076	0.9999892711639404	O
49098	high	47 51	202077 202081	0.9999876022338867	O
49099	proportion	52 62	202082 202092	0.9999874830245972	O
49100	(	63 64	202093 202094	0.9999885559082031	O
49101	33	65 67	202095 202097	0.9999812841415405	O
49102	.	67 68	202097 202098	0.9999881982803345	O
49103	3	68 69	202098 202099	0.9999860525131226	O
49104	%	70 71	202100 202101	0.9999884366989136	O
49105	)	72 73	202102 202103	0.999988317489624	O
49106	of	74 76	202104 202106	0.9999867677688599	O
49107	sporadic	77 84	202107 202114	0.9999691247940063	O
49109	tumors	86 92	202116 202122	0.9999842643737793	O
49110	cases	93 98	202123 202128	0.9999860525131226	O
49111	,	99 100	202129 202130	0.9999878406524658	O
49112	whereas	101 108	202131 202138	0.9999879598617554	O
49113	methylation	109 119	202139 202149	0.9999885559082031	O
49116	of	121 123	202151 202153	0.9999890327453613	O
49117	the	124 127	202154 202157	0.9999890327453613	O
49118	COX2	128 131	202158 202161	0.9999872446060181	O
49121	,	133 134	202163 202164	0.9999886751174927	O
49122	MGMT	135 138	202165 202168	0.9999836683273315	O
49124	,	140 141	202170 202171	0.9999881982803345	O
49125	and	142 145	202172 202175	0.9999887943267822	O
49126	MINT2	146 150	202176 202180	0.9999834299087524	O
49129	loci	152 155	202182 202185	0.9999889135360718	O
49131	were	157 161	202187 202191	0.9999891519546509	O
49132	observed	162 170	202192 202200	0.9999892711639404	O
49133	in	171 173	202201 202203	0.9999892711639404	O
49134	20	174 176	202204 202206	0.9999837875366211	O
49135	.	176 177	202206 202207	0.9999892711639404	O
49136	0	177 178	202207 202208	0.9999864101409912	O
49137	%	179 180	202209 202210	0.9999891519546509	O
49138	,	181 182	202211 202212	0.9999876022338867	O
49139	13	183 185	202213 202215	0.9999849796295166	O
49140	.	185 186	202215 202216	0.9999891519546509	O
49141	3	186 187	202216 202217	0.9999871253967285	O
49142	%	188 189	202218 202219	0.9999891519546509	O
49143	,	190 191	202220 202221	0.9999873638153076	O
49144	and	192 195	202222 202225	0.9999874830245972	O
49145	13	196 198	202226 202228	0.9999855756759644	O
49146	.	198 199	202228 202229	0.9999889135360718	O
49147	3	199 200	202229 202230	0.9999872446060181	O
49148	%	201 202	202231 202232	0.9999887943267822	O
49149	,	203 204	202233 202234	0.9999880790710449	O
49150	respectively	205 217	202235 202247	0.9999872446060181	O
49151	,	218 219	202248 202249	0.9999871253967285	O
49152	of	220 222	202250 202252	0.999987006187439	O
49153	these	223 228	202253 202258	0.9999825954437256	O
49154	tumors	229 235	202259 202265	0.9999817609786987	O
49155	.	236 237	202266 202267	0.9999377727508545	O
49156	In	0 2	202268 202270	0.9999853372573853	O
49157	contrast	3 11	202271 202279	0.99997878074646	O
49158	,	12 13	202280 202281	0.9999856948852539	O
49159	only	14 18	202282 202286	0.9999775886535645	O
49160	6	19 20	202287 202288	0.9999750852584839	O
49161	.	20 21	202288 202289	0.9999856948852539	O
49162	7	21 22	202289 202290	0.9999785423278809	O
49163	%	23 24	202291 202292	0.9999837875366211	O
49164	of	25 27	202293 202295	0.9999781847000122	O
49165	tumors	28 34	202296 202302	0.9999368190765381	O
49166	were	35 39	202303 202307	0.9999854564666748	O
49167	methylated	40 49	202308 202317	0.9999858140945435	O
49170	at	51 53	202319 202321	0.9999867677688599	O
49171	the	54 57	202322 202325	0.9999874830245972	O
49172	TIMP3	58 62	202326 202330	0.9999856948852539	O
49176	promoter	64 72	202332 202340	0.9999864101409912	O
49177	(	73 74	202341 202342	0.9999861717224121	O
49178	Fig	75 77	202343 202345	0.9999842643737793	O
49180	.	79 80	202347 202348	0.9999816417694092	O
49181	3	0 1	202349 202350	0.9999406337738037	O
49182	)	2 3	202351 202352	0.999974250793457	O
49183	.	4 5	202353 202354	0.9998180270195007	O
49184	Methylation	0 10	202355 202365	0.999988317489624	O
49187	of	12 14	202367 202369	0.9999884366989136	O
49188	the	15 18	202370 202373	0.9999886751174927	O
49189	p16	19 21	202374 202376	0.9999880790710449	O
49191	,	23 24	202378 202379	0.9999886751174927	O
49192	COX2	25 28	202380 202383	0.999984860420227	O
49195	,	30 31	202385 202386	0.9999884366989136	O
49196	and	32 35	202387 202390	0.9999886751174927	O
49197	MGMT	36 39	202391 202394	0.9999819993972778	O
49199	loci	41 44	202396 202399	0.9999886751174927	O
49201	were	46 50	202401 202405	0.9999891519546509	O
49202	observed	51 59	202406 202414	0.9999889135360718	O
49203	in	60 62	202415 202417	0.9999895095825195	O
49204	13	63 65	202418 202420	0.9999858140945435	O
49205	.	65 66	202420 202421	0.9999891519546509	O
49206	3	66 67	202421 202422	0.9999872446060181	O
49207	%	68 69	202423 202424	0.99998939037323	O
49208	,	70 71	202425 202426	0.9999881982803345	O
49209	6	72 73	202427 202428	0.9999854564666748	O
49210	.	73 74	202428 202429	0.9999890327453613	O
49211	7	74 75	202429 202430	0.9999872446060181	O
49212	%	76 77	202431 202432	0.9999890327453613	O
49213	,	78 79	202433 202434	0.9999877214431763	O
49214	and	80 83	202435 202438	0.9999881982803345	O
49215	3	84 85	202439 202440	0.9999862909317017	O
49216	.	85 86	202440 202441	0.9999889135360718	O
49217	4	86 87	202441 202442	0.9999865293502808	O
49218	%	88 89	202443 202444	0.9999890327453613	O
49219	,	90 91	202445 202446	0.9999878406524658	O
49220	respectively	92 104	202447 202459	0.9999879598617554	O
49221	,	105 106	202460 202461	0.9999874830245972	O
49222	of	107 109	202462 202464	0.9999881982803345	O
49223	the	110 113	202465 202468	0.9999868869781494	O
49224	normal	114 120	202469 202475	0.9999796152114868	O
49225	mucosa	121 126	202476 202481	0.9999845027923584	O
49228	samples	128 135	202483 202490	0.9999865293502808	O
49229	,	136 137	202491 202492	0.9999886751174927	O
49230	whereas	138 145	202493 202500	0.9999885559082031	O
49231	we	146 148	202501 202503	0.9999874830245972	O
49232	did	149 152	202504 202507	0.9999890327453613	O
49233	not	153 156	202508 202511	0.9999880790710449	O
49234	observe	157 164	202512 202519	0.999988317489624	O
49235	methylation	165 175	202520 202530	0.9999885559082031	O
49238	of	177 179	202532 202534	0.9999889135360718	O
49239	the	180 183	202535 202538	0.9999889135360718	O
49240	hMLH1	184 188	202539 202543	0.9999881982803345	O
49243	,	190 191	202545 202546	0.9999886751174927	O
49244	TIMP3	192 196	202547 202551	0.9999878406524658	O
49248	,	198 199	202553 202554	0.9999884366989136	O
49249	and	200 203	202555 202558	0.9999887943267822	O
49250	MINT2	204 208	202559 202563	0.9999841451644897	O
49253	loci	210 213	202565 202568	0.9999886751174927	O
49255	in	215 217	202570 202572	0.9999890327453613	O
49256	any	218 221	202573 202576	0.9999865293502808	O
49257	of	222 224	202577 202579	0.9999881982803345	O
49258	these	225 230	202580 202585	0.9999867677688599	O
49259	tissues	231 238	202586 202593	0.9999831914901733	O
49260	.	239 240	202594 202595	0.9999890327453613	O
49261	*	241 242	202596 202597	0.9999866485595703	O
49262	*	242 243	202597 202598	0.9999788999557495	O
49263	IGNORE	0 5	202599 202604	0.9999867677688599	O
49266	LINE	7 10	202606 202609	0.9999892711639404	O
49269	*	12 13	202611 202612	0.9999895095825195	O
49270	*	13 14	202612 202613	0.9999895095825195	O
49271	*	15 16	202614 202615	0.99998939037323	O
49272	*	16 17	202615 202616	0.9999895095825195	O
49273	IGNORE	18 23	202617 202622	0.999988317489624	O
49276	LINE	25 28	202624 202627	0.9999895095825195	O
49279	*	30 31	202629 202630	0.9999892711639404	O
49280	*	31 32	202630 202631	0.9999892711639404	O
49281	*	33 34	202632 202633	0.9999891519546509	O
49282	*	34 35	202633 202634	0.9999891519546509	O
49283	IGNORE	36 41	202635 202640	0.9999881982803345	O
49286	LINE	43 46	202642 202645	0.99998939037323	O
49289	*	48 49	202647 202648	0.99998939037323	O
49290	*	49 50	202648 202649	0.9999891519546509	O
49291	Several	51 58	202650 202657	0.9999868869781494	O
49292	reports	59 66	202658 202665	0.9999866485595703	O
49293	have	67 71	202666 202670	0.9999886751174927	O
49294	described	72 81	202671 202680	0.9999881982803345	O
49295	an	82 84	202681 202683	0.99998939037323	O
49296	association	85 96	202684 202695	0.9999886751174927	O
49297	between	97 104	202696 202703	0.9999887943267822	O
49298	the	105 108	202704 202707	0.99998939037323	O
49299	methylation	109 119	202708 202718	0.9999881982803345	O
49302	status	121 127	202720 202726	0.9999892711639404	O
49303	of	128 130	202727 202729	0.99998939037323	O
49304	multiple	131 139	202730 202738	0.9999876022338867	O
49305	genes	140 145	202739 202744	0.9999867677688599	O
49306	and	146 149	202745 202748	0.9999884366989136	O
49307	a	150 151	202749 202750	0.9999886751174927	O
49308	familial	152 159	202751 202758	0.9999889135360718	O
49311	tendency	161 169	202760 202768	0.999985933303833	O
49312	to	170 172	202769 202771	0.9999868869781494	O
49313	colorectal	173 182	202772 202781	0.999987006187439	O
49316	cancer	184 190	202783 202789	0.999987006187439	O
49317	(	191 192	202790 202791	0.9999895095825195	O
49318	15	193 195	202792 202794	0.9999884366989136	O
49319	,	196 197	202795 202796	0.9999881982803345	O
49320	28	198 200	202797 202799	0.9999871253967285	O
49321	)	201 202	202800 202801	0.9999896287918091	O
49322	.	203 204	202802 202803	0.9999792575836182	O
49323	A	0 1	202804 202805	0.9999880790710449	O
49324	recent	2 8	202806 202812	0.9999847412109375	O
49325	large	9 14	202813 202818	0.999971866607666	O
49326	study	15 20	202819 202824	0.999983549118042	O
49327	,	21 22	202825 202826	0.9999877214431763	O
49328	however	23 30	202827 202834	0.9999834299087524	O
49329	,	31 32	202835 202836	0.9999860525131226	O
49330	found	33 38	202837 202842	0.9999843835830688	O
49331	no	39 41	202843 202845	0.9999829530715942	O
49332	evidence	42 50	202846 202854	0.9999817609786987	O
49333	that	51 55	202855 202859	0.9999864101409912	O
49334	patients	56 64	202860 202868	0.9999783039093018	O
49335	with	65 69	202869 202873	0.9999876022338867	O
49336	heavily	70 77	202874 202881	0.9999823570251465	O
49337	methylated	78 87	202882 202891	0.9999874830245972	O
49340	colorectal	89 98	202893 202902	0.9999861717224121	O
49343	cancers	100 106	202904 202910	0.9999876022338867	O
49345	were	108 112	202912 202916	0.9999867677688599	O
49346	more	113 117	202917 202921	0.999984860420227	O
49347	likely	118 124	202922 202928	0.9999874830245972	O
49348	to	125 127	202929 202931	0.9999873638153076	O
49349	develop	128 135	202932 202939	0.9999860525131226	O
49350	a	136 137	202940 202941	0.9999881982803345	O
49351	second	138 144	202942 202948	0.9999837875366211	O
49352	malignancy	145 154	202949 202958	0.9999884366989136	O
49356	or	156 158	202960 202962	0.9999849796295166	O
49357	have	159 163	202963 202967	0.9999872446060181	O
49358	a	164 165	202968 202969	0.9999886751174927	O
49359	positive	166 174	202970 202978	0.9999860525131226	O
49360	family	175 181	202979 202985	0.9999814033508301	O
49361	history	182 189	202986 202993	0.9999877214431763	O
49362	of	190 192	202994 202996	0.9999877214431763	O
49363	cancer	193 199	202997 203003	0.9999852180480957	O
49364	(	200 201	203004 203005	0.9999890327453613	O
49365	29	202 204	203006 203008	0.9999845027923584	O
49366	)	205 206	203009 203010	0.9999890327453613	O
49367	.	207 208	203011 203012	0.9999746084213257	O
49368	Aberrant	0 7	203013 203020	0.9999817609786987	O
49371	methylation	9 19	203022 203032	0.9999836683273315	O
49374	may	21 24	203034 203037	0.9999722242355347	O
49375	result	25 31	203038 203044	0.9999817609786987	O
49376	from	32 36	203045 203049	0.999982476234436	O
49377	an	37 39	203050 203052	0.999982476234436	O
49378	inherited	40 49	203053 203062	0.999957799911499	O
49379	defect	50 56	203063 203069	0.999977707862854	O
49380	in	57 59	203070 203072	0.999983549118042	O
49381	the	60 63	203073 203076	0.9999836683273315	O
49382	methylation	64 74	203077 203087	0.9999821186065674	O
49385	apparatus	76 85	203089 203098	0.9999765157699585	O
49386	.	86 87	203099 203100	0.9999202489852905	O
49387	In	0 2	203101 203103	0.9999861717224121	O
49388	this	3 7	203104 203108	0.9999864101409912	O
49389	study	8 13	203109 203114	0.9999819993972778	O
49390	,	14 15	203115 203116	0.9999872446060181	O
49391	considerable	16 28	203117 203129	0.9999830722808838	O
49392	proportions	29 40	203130 203141	0.9999822378158569	O
49393	of	41 43	203142 203144	0.9999868869781494	O
49394	cancer	44 50	203145 203151	0.9999821186065674	O
49395	in	51 53	203152 203154	0.9999877214431763	O
49396	both	54 58	203155 203159	0.9999830722808838	O
49397	groups	59 65	203160 203166	0.9999831914901733	O
49398	with	66 70	203167 203171	0.9999886751174927	O
49399	or	71 73	203172 203174	0.9999878406524658	O
49400	without	74 81	203175 203182	0.999988317489624	O
49401	familial	82 89	203183 203190	0.9999879598617554	O
49404	history	91 98	203192 203199	0.9999876022338867	O
49405	of	99 101	203200 203202	0.9999881982803345	O
49406	colorectal	102 111	203203 203212	0.9999861717224121	O
49409	cancer	113 119	203214 203220	0.999987006187439	O
49410	presented	120 129	203221 203230	0.9999842643737793	O
49411	the	130 133	203231 203234	0.9999887943267822	O
49412	methylated	134 143	203235 203244	0.9999881982803345	O
49415	genes	145 150	203246 203251	0.9999884366989136	O
49416	that	151 155	203252 203256	0.9999890327453613	O
49417	may	156 159	203257 203260	0.9999885559082031	O
49418	involved	160 168	203261 203269	0.9999891519546509	O
49419	in	169 171	203270 203272	0.9999891519546509	O
49420	carcinogenetic	172 185	203273 203286	0.9999874830245972	O
49424	pathways	187 195	203288 203296	0.9999880790710449	O
49425	.	196 197	203297 203298	0.9999691247940063	O
49426	It	0 2	203299 203301	0.9999876022338867	O
49427	still	3 8	203302 203307	0.9999843835830688	O
49428	remains	9 16	203308 203315	0.9999868869781494	O
49429	to	17 19	203316 203318	0.9999878406524658	O
49430	be	20 22	203319 203321	0.9999887943267822	O
49431	elucidated	23 32	203322 203331	0.9999887943267822	O
49434	whether	34 41	203333 203340	0.9999879598617554	O
49435	promoter	42 50	203341 203349	0.9999887943267822	O
49436	methylation	51 61	203350 203360	0.9999889135360718	O
49439	in	63 65	203362 203364	0.9999895095825195	O
49440	multiple	66 74	203365 203373	0.9999877214431763	O
49441	genes	75 80	203374 203379	0.9999880790710449	O
49442	is	81 83	203380 203382	0.9999885559082031	O
49443	one	84 87	203383 203386	0.9999891519546509	O
49444	of	88 90	203387 203389	0.999988317489624	O
49445	main	91 95	203390 203394	0.9999876022338867	O
49446	mechanism	96 105	203395 203404	0.9999879598617554	O
49447	to	106 108	203405 203407	0.9999879598617554	O
49448	evoke	109 113	203408 203412	0.9999885559082031	O
49450	cancer	115 121	203414 203420	0.9999856948852539	O
49451	or	122 124	203421 203423	0.9999874830245972	O
49452	simple	125 131	203424 203430	0.9999871253967285	O
49453	bystander	132 140	203431 203439	0.9999891519546509	O
49456	.	142 143	203441 203442	0.9999744892120361	O
49457	However	0 7	203443 203450	0.9999837875366211	O
49458	,	8 9	203451 203452	0.9999878406524658	O
49459	our	10 13	203453 203456	0.9999819993972778	O
49460	results	14 21	203457 203464	0.9999852180480957	O
49461	confirm	22 29	203465 203472	0.9999834299087524	O
49462	that	30 34	203473 203477	0.9999889135360718	O
49463	CpG	35 37	203478 203480	0.9999879598617554	O
49466	island	39 45	203482 203488	0.9999877214431763	O
49467	promoter	46 54	203489 203497	0.999988317489624	O
49468	methylation	55 65	203498 203508	0.999988317489624	O
49471	may	67 70	203510 203513	0.9999879598617554	O
49472	be	71 73	203514 203516	0.9999890327453613	O
49473	a	74 75	203517 203518	0.9999891519546509	O
49474	universal	76 85	203519 203528	0.9999855756759644	O
49475	event	86 91	203529 203534	0.9999865293502808	O
49476	in	92 94	203535 203537	0.9999877214431763	O
49477	sporadic	95 102	203538 203545	0.9999841451644897	O
49479	or	104 106	203547 203549	0.9999797344207764	O
49480	familial	107 114	203550 203557	0.999968409538269	O
49483	colorectal	116 125	203559 203568	0.9999833106994629	O
49486	cancer	127 133	203570 203576	0.9999855756759644	O
49487	,	134 135	203577 203578	0.9999856948852539	O
49488	and	136 139	203579 203582	0.9999865293502808	O
49489	is	140 142	203583 203585	0.9999885559082031	O
49490	suggested	143 152	203586 203595	0.9999842643737793	O
49491	as	153 155	203596 203598	0.9999887943267822	O
49492	one	156 159	203599 203602	0.9999887943267822	O
49493	of	160 162	203603 203605	0.9999881982803345	O
49494	the	163 166	203606 203609	0.9999884366989136	O
49495	mechanisms	167 177	203610 203620	0.9999876022338867	O
49496	for	178 181	203621 203624	0.9999873638153076	O
49497	'	182 183	203625 203626	0.9999886751174927	O
49498	second	183 189	203626 203632	0.9999868869781494	O
49499	hits	190 194	203633 203637	0.9999853372573853	O
49500	'	195 196	203638 203639	0.9999881982803345	O
49501	by	197 199	203640 203642	0.9999873638153076	O
49502	which	200 205	203643 203648	0.9999886751174927	O
49503	tumor	206 211	203649 203654	0.9999842643737793	O
49504	suppressor	212 221	203655 203664	0.9999854564666748	O
49506	genes	223 228	203666 203671	0.9999876022338867	O
49507	are	229 232	203672 203675	0.9999880790710449	O
49508	inactivated	233 244	203676 203687	0.9999799728393555	O
49509	.	245 246	203688 203689	0.9999569654464722	O
49510	Evidence	0 8	203690 203698	0.9999830722808838	O
49511	for	9 12	203699 203702	0.9999876022338867	O
49512	this	13 17	203703 203707	0.9999880790710449	O
49513	mechanism	18 27	203708 203717	0.9999822378158569	O
49514	in	28 30	203718 203720	0.9999872446060181	O
49515	familial	31 38	203721 203728	0.9999746084213257	O
49518	colorectal	40 49	203730 203739	0.9999803304672241	O
49521	cancers	51 57	203741 203747	0.9999847412109375	O
49523	was	59 62	203749 203752	0.9999881982803345	O
49524	previously	63 73	203753 203763	0.9999871253967285	O
49525	reported	74 82	203764 203772	0.9999885559082031	O
49526	in	83 85	203773 203775	0.9999892711639404	O
49527	studies	86 93	203776 203783	0.9999868869781494	O
49528	showing	94 101	203784 203791	0.9999884366989136	O
49529	aberrant	102 109	203792 203799	0.9999892711639404	O
49532	methylation	111 121	203801 203811	0.9999877214431763	O
49535	of	123 125	203813 203815	0.9999891519546509	O
49536	individual	126 136	203816 203826	0.9999858140945435	O
49537	genes	137 142	203827 203832	0.9999868869781494	O
49538	,	143 144	203833 203834	0.9999886751174927	O
49539	including	145 154	203835 203844	0.9999890327453613	O
49540	CDH1	155 158	203845 203848	0.9999884366989136	O
49542	,	160 161	203850 203851	0.999988317489624	O
49543	VHL	162 164	203852 203854	0.9999878406524658	O
49545	,	166 167	203856 203857	0.9999886751174927	O
49546	and	168 171	203858 203861	0.9999886751174927	O
49547	hMLH1	172 176	203862 203866	0.9999873638153076	O
49550	,	178 179	203868 203869	0.9999868869781494	O
49551	in	180 182	203870 203872	0.9999886751174927	O
49552	hereditary	183 193	203873 203883	0.999946117401123	O
49553	cancer	194 200	203884 203890	0.9999847412109375	O
49554	syndromes	201 209	203891 203899	0.9999837875366211	O
49556	(	211 212	203901 203902	0.9999895095825195	O
49557	30	213 215	203903 203905	0.9999874830245972	O
49558	-	215 216	203905 203906	0.9999891519546509	O
49559	32	216 218	203906 203908	0.9999840259552002	O
49560	)	219 220	203909 203910	0.9999895095825195	O
49561	.	221 222	203911 203912	0.9999740123748779	O
49562	Cancer	0 6	203913 203919	0.9999524354934692	O
49563	is	7 9	203920 203922	0.99996018409729	O
49564	a	10 11	203923 203924	0.9999598264694214	O
49565	genetic	12 19	203925 203932	0.999896764755249	O
49566	disease	20 27	203933 203940	0.9999580383300781	O
49567	.	28 29	203941 203942	0.9992316961288452	O
49568	Most	0 4	203943 203947	0.999980092048645	O
49569	cancer	5 11	203948 203954	0.9999771118164062	O
49570	-	11 12	203954 203955	0.9999860525131226	O
49571	causing	12 19	203955 203962	0.9999829530715942	O
49572	mutations	20 29	203963 203972	0.9999768733978271	O
49573	are	30 33	203973 203976	0.9999834299087524	O
49574	somatic	34 40	203977 203983	0.9999819993972778	O
49576	,	42 43	203985 203986	0.9999815225601196	O
49577	occurring	44 53	203987 203996	0.9999843835830688	O
49578	in	54 56	203997 203999	0.9999852180480957	O
49579	the	57 60	204000 204003	0.9999861717224121	O
49580	affected	61 69	204004 204012	0.9999814033508301	O
49581	tissue	70 76	204013 204019	0.9999808073043823	O
49582	during	77 83	204020 204026	0.999985933303833	O
49583	the	84 87	204027 204030	0.9999871253967285	O
49584	course	88 94	204031 204037	0.9999847412109375	O
49585	of	95 97	204038 204040	0.9999868869781494	O
49586	carcinogenesis	98 111	204041 204054	0.999984622001648	O
49590	.	113 114	204056 204057	0.9999508857727051	O
49591	However	0 7	204058 204065	0.9999793767929077	O
49592	,	8 9	204066 204067	0.9999853372573853	O
49593	most	10 14	204068 204072	0.9999812841415405	O
49594	cancers	15 21	204073 204079	0.9999784231185913	O
49596	also	23 27	204081 204085	0.9999819993972778	O
49597	have	28 32	204086 204090	0.9999858140945435	O
49598	a	33 34	204091 204092	0.9999873638153076	O
49599	hereditary	35 45	204093 204103	0.999976634979248	O
49600	component	46 55	204104 204113	0.9999847412109375	O
49601	,	56 57	204114 204115	0.9999854564666748	O
49602	caused	58 64	204116 204122	0.999987006187439	O
49603	by	65 67	204123 204125	0.9999877214431763	O
49604	predisposing	68 79	204126 204137	0.999987006187439	O
49608	mutations	81 90	204139 204148	0.999980092048645	O
49609	that	91 95	204149 204153	0.9999867677688599	O
49610	affect	96 102	204154 204160	0.9999853372573853	O
49611	the	103 106	204161 204164	0.9999877214431763	O
49612	germline	107 114	204165 204172	0.9999868869781494	O
49616	,	116 117	204174 204175	0.9999856948852539	O
49617	are	118 121	204176 204179	0.9999867677688599	O
49618	heritable	122 130	204180 204188	0.9999833106994629	O
49621	,	132 133	204190 204191	0.999985933303833	O
49622	contribute	134 144	204192 204202	0.9999854564666748	O
49623	to	145 147	204203 204205	0.9999878406524658	O
49624	the	148 151	204206 204209	0.9999877214431763	O
49625	initiation	152 162	204210 204220	0.9999858140945435	O
49626	of	163 165	204221 204223	0.9999873638153076	O
49627	carcinogenesis	166 179	204224 204237	0.9999856948852539	O
49631	,	181 182	204239 204240	0.9999837875366211	O
49632	and	183 186	204241 204244	0.9999849796295166	O
49633	influence	187 196	204245 204254	0.9999828338623047	O
49634	the	197 200	204255 204258	0.9999872446060181	O
49635	carcinogenesis	201 214	204259 204272	0.9999847412109375	O
49639	pathway	216 223	204274 204281	0.999983549118042	O
49640	.	224 225	204282 204283	0.9999308586120605	O
49641	Although	0 8	204284 204292	0.9999861717224121	O
49642	hypermethylation	9 24	204293 204308	0.9999884366989136	O
49647	is	26 28	204310 204312	0.9999886751174927	O
49648	not	29 32	204313 204316	0.9999861717224121	O
49649	a	33 34	204317 204318	0.9999890327453613	O
49650	rare	35 39	204319 204323	0.9999868869781494	O
49651	event	40 45	204324 204329	0.9999872446060181	O
49652	,	46 47	204330 204331	0.9999867677688599	O
49653	either	48 54	204332 204338	0.9999877214431763	O
49654	in	55 57	204339 204341	0.9999889135360718	O
49655	sporadic	58 65	204342 204349	0.9999872446060181	O
49657	colorectal	67 76	204351 204360	0.9999872446060181	O
49660	cancers	78 84	204362 204368	0.9999878406524658	O
49662	or	86 88	204370 204372	0.9999868869781494	O
49663	in	89 91	204373 204375	0.9999879598617554	O
49664	colorectal	92 101	204376 204385	0.9999862909317017	O
49667	cancers	103 109	204387 204393	0.9999877214431763	O
49669	with	111 115	204395 204399	0.9999887943267822	O
49670	family	116 122	204400 204406	0.9999864101409912	O
49671	history	123 130	204407 204414	0.9999892711639404	O
49672	,	131 132	204415 204416	0.9999881982803345	O
49673	predisposing	133 144	204417 204428	0.9999891519546509	O
49677	germline	146 153	204430 204437	0.9999886751174927	O
49681	alterations	155 166	204439 204450	0.9999880790710449	O
49682	can	167 170	204451 204454	0.9999860525131226	O
49683	affect	171 177	204455 204461	0.9999877214431763	O
49684	detailed	178 186	204462 204470	0.9999860525131226	O
49685	aspects	187 194	204471 204478	0.9999886751174927	O
49686	of	195 197	204479 204481	0.9999892711639404	O
49687	methylation	198 208	204482 204492	0.9999877214431763	O
49690	.	210 211	204494 204495	0.9999654293060303	O
49691	Our	0 3	204496 204499	0.9999812841415405	O
49692	data	4 8	204500 204504	0.9999843835830688	O
49693	showed	9 15	204505 204511	0.9999850988388062	O
49694	two	16 19	204512 204515	0.9999852180480957	O
49695	of	20 22	204516 204518	0.9999877214431763	O
49696	the	23 26	204519 204522	0.9999876022338867	O
49697	genes	27 32	204523 204528	0.9999868869781494	O
49698	methylated	33 42	204529 204538	0.9999877214431763	O
49701	at	44 46	204540 204542	0.9999877214431763	O
49702	their	47 52	204543 204548	0.999988317489624	O
49703	promoters	53 61	204549 204557	0.9999862909317017	O
49705	,	63 64	204559 204560	0.9999878406524658	O
49706	p16	65 67	204561 204563	0.999988317489624	O
49708	and	69 72	204565 204568	0.9999879598617554	O
49709	MGMT	73 76	204569 204572	0.9999819993972778	O
49711	,	78 79	204574 204575	0.9999854564666748	O
49712	differ	80 86	204576 204582	0.9999819993972778	O
49713	according	87 96	204583 204592	0.9999861717224121	O
49714	to	97 99	204593 204595	0.9999866485595703	O
49715	the	100 103	204596 204599	0.9999839067459106	O
49716	tumor	104 109	204600 204605	0.9999833106994629	O
49717	type	110 114	204606 204610	0.9999854564666748	O
49718	.	115 116	204611 204612	0.999958872795105	O
49719	These	0 5	204613 204618	0.999984622001648	O
49720	findings	6 14	204619 204627	0.9999829530715942	O
49721	suggest	15 22	204628 204635	0.9999829530715942	O
49722	that	23 27	204636 204640	0.9999879598617554	O
49723	the	28 31	204641 204644	0.9999878406524658	O
49724	methylation	32 42	204645 204655	0.9999873638153076	O
49727	of	44 46	204657 204659	0.9999885559082031	O
49728	p16	47 49	204660 204662	0.9999873638153076	O
49730	,	51 52	204664 204665	0.9999889135360718	O
49731	leading	53 60	204666 204673	0.9999884366989136	O
49732	to	61 63	204674 204676	0.9999889135360718	O
49733	its	64 67	204677 204680	0.9999889135360718	O
49734	loss	68 72	204681 204685	0.9999871253967285	O
49735	of	73 75	204686 204688	0.9999885559082031	O
49736	function	76 84	204689 204697	0.9999865293502808	O
49737	,	85 86	204698 204699	0.9999873638153076	O
49738	may	87 90	204700 204703	0.9999876022338867	O
49739	be	91 93	204704 204706	0.9999889135360718	O
49740	a	94 95	204707 204708	0.9999891519546509	O
49741	dominant	96 104	204709 204717	0.9999881982803345	O
49742	and	105 108	204718 204721	0.9999885559082031	O
49743	necessary	109 118	204722 204731	0.9999880790710449	O
49744	event	119 124	204732 204737	0.9999873638153076	O
49745	for	125 128	204738 204741	0.9999872446060181	O
49746	sporadic	129 136	204742 204749	0.9999873638153076	O
49748	colorectal	138 147	204751 204760	0.999984622001648	O
49751	carcinogenesis	149 162	204762 204775	0.9999873638153076	O
49755	,	164 165	204777 204778	0.9999876022338867	O
49756	whereas	166 173	204779 204786	0.9999876022338867	O
49757	methylation	174 184	204787 204797	0.9999879598617554	O
49760	of	186 188	204799 204801	0.9999886751174927	O
49761	MGMT	189 192	204802 204805	0.9999842643737793	O
49763	may	194 197	204807 204810	0.9999889135360718	O
49764	be	198 200	204811 204813	0.9999890327453613	O
49765	dominant	201 209	204814 204822	0.9999884366989136	O
49766	and	210 213	204823 204826	0.9999880790710449	O
49767	necessary	214 223	204827 204836	0.9999874830245972	O
49768	in	224 226	204837 204839	0.9999879598617554	O
49769	colorectal	227 236	204840 204849	0.9999856948852539	O
49772	carcinogenesis	238 251	204851 204864	0.9999872446060181	O
49776	in	253 255	204866 204868	0.9999879598617554	O
49777	individuals	256 267	204869 204880	0.9999299049377441	O
49778	with	268 272	204881 204885	0.9999879598617554	O
49779	a	273 274	204886 204887	0.9999885559082031	O
49780	family	275 281	204888 204894	0.9999815225601196	O
49781	history	282 289	204895 204902	0.9999872446060181	O
49782	.	290 291	204903 204904	0.9999523162841797	O
49783	It	0 2	204905 204907	0.9999879598617554	O
49784	was	3 6	204908 204911	0.9999876022338867	O
49785	reported	7 15	204912 204920	0.9999850988388062	O
49786	that	16 20	204921 204925	0.9999885559082031	O
49787	the	21 24	204926 204929	0.9999886751174927	O
49788	frequency	25 34	204930 204939	0.9999881982803345	O
49789	and	35 38	204940 204943	0.999988317489624	O
49790	pattern	39 46	204944 204951	0.9999879598617554	O
49791	of	47 49	204952 204954	0.9999887943267822	O
49792	gene	50 54	204955 204959	0.9999877214431763	O
49793	methylation	55 65	204960 204970	0.9999879598617554	O
49796	varied	67 73	204972 204978	0.9999867677688599	O
49797	between	74 81	204979 204986	0.999987006187439	O
49798	HNPCC	82 86	204987 204991	0.9999781847000122	O
49801	syndrome	88 96	204993 205001	0.9999778270721436	O
49802	and	97 100	205002 205005	0.999984622001648	O
49803	sporadic	101 108	205006 205013	0.9992327690124512	O
49805	adenomas	110 117	205015 205022	0.9999788999557495	O
49808	,	119 120	205024 205025	0.9999874830245972	O
49809	implying	121 129	205026 205034	0.9999866485595703	O
49810	differences	130 141	205035 205046	0.9999853372573853	O
49811	in	142 144	205047 205049	0.9999887943267822	O
49812	the	145 148	205050 205053	0.9999889135360718	O
49813	molecular	149 158	205054 205063	0.9999833106994629	O
49814	pathogenesis	159 170	205064 205075	0.9999886751174927	O
49817	of	172 174	205077 205079	0.9999865293502808	O
49818	tumors	175 181	205080 205086	0.999983549118042	O
49819	(	182 183	205087 205088	0.9999891519546509	O
49820	33	184 186	205089 205091	0.9999850988388062	O
49821	)	187 188	205092 205093	0.9999892711639404	O
49822	.	189 190	205094 205095	0.9999767541885376	O
49823	MGMT	0 3	205096 205099	0.9999809265136719	O
49825	has	5 8	205101 205104	0.9999886751174927	O
49826	been	9 13	205105 205109	0.9999879598617554	O
49827	considered	14 24	205110 205120	0.9999880790710449	O
49828	as	25 27	205121 205123	0.9999891519546509	O
49829	a	28 29	205124 205125	0.9999896287918091	O
49830	critical	30 38	205126 205134	0.9999879598617554	O
49831	step	39 43	205135 205139	0.9999865293502808	O
49832	of	44 46	205140 205142	0.9999890327453613	O
49833	genetic	47 54	205143 205150	0.9999884366989136	O
49834	instability	55 66	205151 205162	0.9999872446060181	O
49835	and	67 70	205163 205166	0.9999891519546509	O
49836	methylation	71 81	205167 205177	0.9999884366989136	O
49839	of	83 85	205179 205181	0.9999891519546509	O
49840	MGMT	86 89	205182 205185	0.9999853372573853	O
49842	are	91 94	205187 205190	0.999988317489624	O
49843	proposed	95 103	205191 205199	0.9999868869781494	O
49844	to	104 106	205200 205202	0.9999891519546509	O
49845	show	107 111	205203 205207	0.9999879598617554	O
49846	a	112 113	205208 205209	0.99998939037323	O
49847	distinctive	114 125	205210 205221	0.9999864101409912	O
49848	phenotype	126 134	205222 205230	0.9999890327453613	O
49851	of	136 138	205232 205234	0.9999891519546509	O
49852	MSI	139 141	205235 205237	0.9999867677688599	O
49854	-	142 143	205238 205239	0.99998939037323	O
49855	L	143 144	205239 205240	0.9999861717224121	O
49856	or	145 147	205241 205243	0.9999884366989136	O
49857	mild	148 152	205244 205248	0.9999840259552002	O
49858	family	153 159	205249 205255	0.9999842643737793	O
49859	history	160 167	205256 205263	0.9999887943267822	O
49860	of	168 170	205264 205266	0.999988317489624	O
49861	colorectal	171 180	205267 205276	0.9999866485595703	O
49864	cancer	182 188	205278 205284	0.9999871253967285	O
49865	(	189 190	205285 205286	0.9999896287918091	O
49866	34	191 193	205287 205289	0.9999878406524658	O
49867	,	194 195	205290 205291	0.9999880790710449	O
49868	35	196 198	205292 205294	0.9999873638153076	O
49869	)	199 200	205295 205296	0.9999896287918091	O
49870	.	201 202	205297 205298	0.9999771118164062	O
49871	The	0 3	205299 205302	0.9999878406524658	O
49872	present	4 11	205303 205310	0.9999871253967285	O
49873	study	12 17	205311 205316	0.9999866485595703	O
49874	also	18 22	205317 205321	0.9999856948852539	O
49875	showed	23 29	205322 205328	0.9999864101409912	O
49876	a	30 31	205329 205330	0.9999886751174927	O
49877	possibility	32 43	205331 205342	0.9999868869781494	O
49878	that	44 48	205343 205347	0.9999886751174927	O
49879	different	49 58	205348 205357	0.9999868869781494	O
49880	pathways	59 67	205358 205366	0.9999862909317017	O
49881	to	68 70	205367 205369	0.9999850988388062	O
49882	cancer	71 77	205370 205376	0.9999829530715942	O
49883	may	78 81	205377 205380	0.9999880790710449	O
49884	exit	82 86	205381 205385	0.9999849796295166	O
49885	according	87 96	205386 205395	0.9999884366989136	O
49886	to	97 99	205396 205398	0.9999891519546509	O
49887	the	100 103	205399 205402	0.9999890327453613	O
49888	molecular	104 113	205403 205412	0.9999872446060181	O
49889	background	114 124	205413 205423	0.9999879598617554	O
49890	and	125 128	205424 205427	0.9999856948852539	O
49891	some	129 133	205428 205432	0.999985933303833	O
49892	subgroup	134 142	205433 205441	0.9999855756759644	O
49893	of	143 145	205442 205444	0.9999879598617554	O
49894	familial	146 153	205445 205452	0.9999849796295166	O
49897	colorectal	155 164	205454 205463	0.9999854564666748	O
49900	cancer	166 172	205465 205471	0.9999868869781494	O
49901	are	173 176	205472 205475	0.9999878406524658	O
49902	related	177 184	205476 205483	0.9999885559082031	O
49903	to	185 187	205484 205486	0.9999890327453613	O
49904	the	188 191	205487 205490	0.9999886751174927	O
49905	loss	192 196	205491 205495	0.9999874830245972	O
49906	of	197 199	205496 205498	0.9999889135360718	O
49907	function	200 208	205499 205507	0.9999879598617554	O
49908	of	209 211	205508 205510	0.9999887943267822	O
49909	MGMT	212 215	205511 205514	0.9999828338623047	O
49911	.	216 217	205515 205516	0.9999704360961914	O
49912	Thus	0 4	205517 205521	0.9999793767929077	O
49913	,	5 6	205522 205523	0.9999841451644897	O
49914	genes	7 12	205524 205529	0.9999810457229614	O
49915	selected	13 21	205530 205538	0.9999755620956421	O
49916	for	22 25	205539 205542	0.9999852180480957	O
49917	methylation	26 36	205543 205553	0.9999805688858032	O
49920	-	37 38	205554 205555	0.9999872446060181	O
49921	induced	38 45	205555 205562	0.9999812841415405	O
49922	functional	46 56	205563 205573	0.9999754428863525	O
49923	loss	57 61	205574 205578	0.9999834299087524	O
49924	may	62 65	205579 205582	0.9999760389328003	O
49925	differ	66 72	205583 205589	0.9999819993972778	O
49926	according	73 82	205590 205599	0.9999842643737793	O
49927	to	83 85	205600 205602	0.9999854564666748	O
49928	the	86 89	205603 205606	0.9999842643737793	O
49929	genetic	90 97	205607 205614	0.9999827146530151	O
49930	background	98 108	205615 205625	0.999983549118042	O
49931	.	109 110	205626 205627	0.9999469518661499	O
49932	While	0 5	205628 205633	0.9999853372573853	O
49933	methylation	6 16	205634 205644	0.9999847412109375	O
49936	seems	18 23	205646 205651	0.9999840259552002	O
49937	to	24 26	205652 205654	0.9999874830245972	O
49938	be	27 29	205655 205657	0.9999884366989136	O
49939	a	30 31	205658 205659	0.9999885559082031	O
49940	universal	32 41	205660 205669	0.9999816417694092	O
49941	mechanism	42 51	205670 205679	0.9999864101409912	O
49942	by	52 54	205680 205682	0.9999861717224121	O
49943	which	55 60	205683 205688	0.9999880790710449	O
49944	gene	61 65	205689 205693	0.9999865293502808	O
49945	function	66 74	205694 205702	0.9999865293502808	O
49946	is	75 77	205703 205705	0.9999876022338867	O
49947	inactivated	78 89	205706 205717	0.9999806880950928	O
49948	,	90 91	205718 205719	0.9999858140945435	O
49949	the	92 95	205720 205723	0.9999856948852539	O
49950	germline	96 103	205724 205731	0.9999871253967285	O
49954	mutations	105 114	205733 205742	0.999981164932251	O
49955	in	115 117	205743 205745	0.9999860525131226	O
49956	familial	118 125	205746 205753	0.9999526739120483	O
49959	tumors	127 133	205755 205761	0.999984860420227	O
49960	confer	134 139	205762 205767	0.9999867677688599	O
49962	a	141 142	205769 205770	0.9999885559082031	O
49963	selective	143 152	205771 205780	0.9999841451644897	O
49964	advantage	153 162	205781 205790	0.9999854564666748	O
49965	for	163 166	205791 205794	0.9999825954437256	O
49966	their	167 172	205795 205800	0.999976634979248	O
49967	tumorigenic	173 183	205801 205811	0.9999831914901733	O
49970	growth	185 191	205813 205819	0.9999836683273315	O
49971	,	192 193	205820 205821	0.9999858140945435	O
49972	but	194 197	205822 205825	0.9999842643737793	O
49973	other	198 203	205826 205831	0.9999814033508301	O
49974	genetic	204 211	205832 205839	0.9999853372573853	O
49975	and	212 215	205840 205843	0.9999845027923584	O
49976	epigenetic	216 225	205844 205853	0.9999868869781494	O
49980	lesions	227 234	205855 205862	0.9999836683273315	O
49981	are	235 238	205863 205866	0.9999866485595703	O
49982	also	239 243	205867 205871	0.9999865293502808	O
49983	necessary	244 253	205872 205881	0.9999856948852539	O
49984	.	254 255	205882 205883	0.9999445676803589	O
49985	Genetic	0 6	205884 205890	0.9999842643737793	O
49987	predisposition	8 21	205892 205905	0.9999881982803345	O
49990	to	23 25	205907 205909	0.9999878406524658	O
49991	CpG	26 28	205910 205912	0.9999880790710449	O
49994	island	30 36	205914 205920	0.9999885559082031	O
49995	methylation	37 47	205921 205931	0.9999878406524658	O
49998	may	49 52	205933 205936	0.9999843835830688	O
49999	be	53 55	205937 205939	0.9999884366989136	O
50000	a	56 57	205940 205941	0.9999887943267822	O
50001	modifying	58 66	205942 205950	0.9999860525131226	O
50003	factor	68 74	205952 205958	0.9999886751174927	O
50004	that	75 79	205959 205963	0.9999884366989136	O
50005	contributes	80 91	205964 205975	0.9999865293502808	O
50006	to	92 94	205976 205978	0.9999880790710449	O
50007	the	95 98	205979 205982	0.9999881982803345	O
50008	penetrance	99 108	205983 205992	0.9999873638153076	O
50011	of	110 112	205994 205996	0.9999877214431763	O
50012	HNPCC	113 117	205997 206001	0.9999822378158569	O
50015	.	118 119	206002 206003	0.9999611377716064	O
50016	Our	0 3	206004 206007	0.9999823570251465	O
50017	findings	4 12	206008 206016	0.9999825954437256	O
50018	thus	13 17	206017 206021	0.9999845027923584	O
50019	expand	18 24	206022 206028	0.9999788999557495	O
50020	these	25 30	206029 206034	0.9999872446060181	O
50021	early	31 36	206035 206040	0.9999839067459106	O
50022	observations	37 49	206041 206053	0.9999822378158569	O
50023	on	50 52	206054 206056	0.9999861717224121	O
50024	methylation	53 63	206057 206067	0.9999856948852539	O
50027	in	65 67	206069 206071	0.9999854564666748	O
50028	familial	68 75	206072 206079	0.999980092048645	O
50031	colorectal	77 86	206081 206090	0.999984622001648	O
50034	cancer	88 94	206092 206098	0.9999861717224121	O
50035	and	95 98	206099 206102	0.9999845027923584	O
50036	highlight	99 108	206103 206112	0.9999816417694092	O
50037	the	109 112	206113 206116	0.9999876022338867	O
50038	selective	113 122	206117 206126	0.9999847412109375	O
50039	advantage	123 132	206127 206136	0.9999862909317017	O
50040	of	133 135	206137 206139	0.9999876022338867	O
50041	epigenetic	136 145	206140 206149	0.9999877214431763	O
50045	gene	147 151	206151 206155	0.9999872446060181	O
50046	silencing	152 160	206156 206164	0.9999868869781494	O
50049	.	162 163	206166 206167	0.9999878406524658	O
50050	*	164 165	206168 206169	0.9999866485595703	O
50051	*	165 166	206169 206170	0.9999765157699585	O
50052	IGNORE	0 5	206171 206176	0.9999858140945435	O
50055	LINE	7 10	206178 206181	0.9999887943267822	O
50058	*	12 13	206183 206184	0.9999891519546509	O
50059	*	13 14	206184 206185	0.9999890327453613	O
50060	*	15 16	206186 206187	0.9999890327453613	O
50061	*	16 17	206187 206188	0.9999891519546509	O
50062	IGNORE	18 23	206189 206194	0.9999873638153076	O
50065	LINE	25 28	206196 206199	0.9999891519546509	O
50068	*	30 31	206201 206202	0.9999887943267822	O
50069	*	31 32	206202 206203	0.9999887943267822	O
50070	*	33 34	206204 206205	0.9999887943267822	O
50071	*	34 35	206205 206206	0.9999887943267822	O
50072	IGNORE	36 41	206207 206212	0.999987006187439	O
50075	LINE	43 46	206214 206217	0.9999890327453613	O
50078	*	48 49	206219 206220	0.9999886751174927	O
50079	*	49 50	206220 206221	0.9999887943267822	O
50080	Impact	51 57	206222 206228	0.9999864101409912	O
50081	of	58 60	206229 206231	0.9999891519546509	O
50082	BRAF	61 64	206232 206235	0.9999876022338867	O
50084	,	66 67	206237 206238	0.9999881982803345	O
50085	MLH1	68 71	206239 206242	0.9999873638153076	O
50088	on	73 75	206244 206246	0.9999887943267822	O
50089	the	76 79	206247 206250	0.9999890327453613	O
50090	incidence	80 89	206251 206260	0.9999868869781494	O
50091	of	90 92	206261 206263	0.9999890327453613	O
50092	microsatellite	93 106	206264 206277	0.9999880790710449	O
50096	instability	108 119	206279 206290	0.9999881982803345	O
50097	high	120 124	206291 206295	0.9999840259552002	O
50098	colorectal	125 134	206296 206305	0.9999868869781494	O
50101	cancer	136 142	206307 206313	0.9999873638153076	O
50102	in	143 145	206314 206316	0.9999886751174927	O
50103	populations	146 157	206317 206328	0.9999840259552002	O
50104	based	158 163	206329 206334	0.9999873638153076	O
50105	study	164 169	206335 206340	0.999988317489624	O
50106	Abstract	170 177	206341 206348	0.9999871253967285	O
50109	We	179 181	206350 206352	0.999987006187439	O
50110	have	182 186	206353 206357	0.9999878406524658	O
50111	identified	187 197	206358 206368	0.9999884366989136	O
50112	an	198 200	206369 206371	0.9999895095825195	O
50113	alternative	201 212	206372 206383	0.9999878406524658	O
50114	pathway	213 220	206384 206391	0.9999877214431763	O
50115	of	221 223	206392 206394	0.9999880790710449	O
50116	tumorigenesis	224 236	206395 206407	0.9999858140945435	O
50120	in	238 240	206409 206411	0.9999881982803345	O
50121	sporadic	241 248	206412 206419	0.9999818801879883	O
50123	colon	250 254	206421 206425	0.9999797344207764	O
50125	cancer	256 262	206427 206433	0.9999855756759644	O
50126	,	263 264	206434 206435	0.9999879598617554	O
50127	involving	265 274	206436 206445	0.9999885559082031	O
50128	microsatellite	275 288	206446 206459	0.9999881982803345	O
50132	instability	290 301	206461 206472	0.9999884366989136	O
50133	due	302 305	206473 206476	0.9999895095825195	O
50134	to	306 308	206477 206479	0.99998939037323	O
50135	mismatched	309 318	206480 206489	0.9999885559082031	O
50138	repair	320 326	206491 206497	0.9999878406524658	O
50139	methylation	327 337	206498 206508	0.9999889135360718	O
50142	,	339 340	206510 206511	0.9999890327453613	O
50143	which	341 346	206512 206517	0.9999891519546509	O
50144	may	347 350	206518 206521	0.9999872446060181	O
50145	be	351 353	206522 206524	0.9999890327453613	O
50146	driven	354 360	206525 206531	0.9999873638153076	O
50147	by	361 363	206532 206534	0.9999890327453613	O
50148	mutations	364 373	206535 206544	0.9999854564666748	O
50149	in	374 376	206545 206547	0.9999887943267822	O
50150	the	377 380	206548 206551	0.9999889135360718	O
50151	BRAF	381 384	206552 206555	0.9999849796295166	O
50153	gene	386 390	206557 206561	0.9999889135360718	O
50154	(	391 392	206562 206563	0.9999892711639404	O
50155	V600E	393 397	206564 206568	0.9999878406524658	O
50159	)	399 400	206570 206571	0.9999895095825195	O
50160	.	401 402	206572 206573	0.9999697208404541	O
50161	Colorectal	0 9	206574 206583	0.999964714050293	O
50164	cancer	11 17	206585 206591	0.9999827146530151	O
50165	(	18 19	206592 206593	0.9999756813049316	O
50166	CRC	20 22	206594 206596	0.9999656677246094	O
50168	)	24 25	206598 206599	0.9999803304672241	O
50169	is	26 28	206600 206602	0.999976634979248	O
50170	the	29 32	206603 206606	0.9999810457229614	O
50171	most	33 37	206607 206611	0.9999816417694092	O
50172	common	38 44	206612 206618	0.9999715089797974	O
50173	cancer	45 51	206619 206625	0.9999805688858032	O
50174	in	52 54	206626 206628	0.999981164932251	O
50175	the	55 58	206629 206632	0.9999816417694092	O
50176	world	59 64	206633 206638	0.9999129772186279	O
50177	,	65 66	206639 206640	0.9999762773513794	O
50178	and	67 70	206641 206644	0.9999767541885376	O
50179	African	71 78	206645 206652	0.9972686767578125	O
50180	Americans	79 88	206653 206662	0.9991307854652405	O
50181	show	89 93	206663 206667	0.999970555305481	O
50182	a	94 95	206668 206669	0.9999827146530151	O
50183	higher	96 102	206670 206676	0.999974250793457	O
50184	incidence	103 112	206677 206686	0.9999812841415405	O
50185	than	113 117	206687 206691	0.9999798536300659	O
50186	other	118 123	206692 206697	0.9999643564224243	O
50187	populations	124 135	206698 206709	0.9999643564224243	O
50188	in	136 138	206710 206712	0.9999809265136719	O
50189	the	139 142	206713 206716	0.9999829530715942	O
50190	United	143 149	206717 206723	0.9999443292617798	O
50191	States	150 156	206724 206730	0.9999451637268066	O
50192	.	157 158	206731 206732	0.9999198913574219	O
50193	We	0 2	206733 206735	0.9999754428863525	O
50194	analyzed	3 11	206736 206744	0.9999809265136719	O
50195	sporadic	12 19	206745 206752	0.9999771118164062	O
50197	CRCs	21 24	206754 206757	0.9999673366546631	O
50199	in	26 28	206759 206761	0.9999843835830688	O
50200	Omani	29 33	206762 206766	0.999968409538269	O
50202	(	35 36	206768 206769	0.9999880790710449	O
50203	of	37 39	206770 206772	0.9999880790710449	O
50204	African	40 47	206773 206780	0.9999768733978271	O
50205	origin	48 54	206781 206787	0.9999881982803345	O
50206	,	55 56	206788 206789	0.9999877214431763	O
50207	N	57 58	206790 206791	0.9999879598617554	O
50208	=	59 60	206792 206793	0.9999879598617554	O
50209	61	61 63	206794 206796	0.999976634979248	O
50210	)	64 65	206797 206798	0.9999865293502808	O
50211	,	66 67	206799 206800	0.9999852180480957	O
50212	Iranian	68 75	206801 206808	0.9997738003730774	O
50213	(	76 77	206809 206810	0.999988317489624	O
50214	of	78 80	206811 206813	0.9999880790710449	O
50215	Caucasian	81 90	206814 206823	0.999868631362915	O
50216	origin	91 97	206824 206830	0.9999879598617554	O
50217	,	98 99	206831 206832	0.9999876022338867	O
50218	N	100 101	206833 206834	0.9999881982803345	O
50219	=	102 103	206835 206836	0.9999881982803345	O
50220	53	104 106	206837 206839	0.9999775886535645	O
50221	)	107 108	206840 206841	0.9999876022338867	O
50222	and	109 112	206842 206845	0.9999860525131226	O
50223	African	113 120	206846 206853	0.9999752044677734	O
50224	American	121 129	206854 206862	0.9999728202819824	O
50225	(	130 131	206863 206864	0.999988317489624	O
50226	N	132 133	206865 206866	0.9999878406524658	O
50227	=	134 135	206867 206868	0.9999877214431763	O
50228	95	136 138	206869 206871	0.9999748468399048	O
50229	)	139 140	206872 206873	0.9999880790710449	O
50230	patients	141 149	206874 206882	0.9999748468399048	O
50231	for	150 153	206883 206886	0.9999878406524658	O
50232	microsatellite	154 167	206887 206900	0.9999879598617554	O
50236	instability	169 180	206902 206913	0.9999879598617554	O
50237	,	181 182	206914 206915	0.9999884366989136	O
50238	expression	183 193	206916 206926	0.9999865293502808	O
50239	status	194 200	206927 206933	0.9999887943267822	O
50240	of	201 203	206934 206936	0.9999887943267822	O
50241	mismatched	204 213	206937 206946	0.9999880790710449	O
50244	repair	215 221	206948 206954	0.9999872446060181	O
50245	genes	222 227	206955 206960	0.9999885559082031	O
50246	(	228 229	206961 206962	0.9999886751174927	O
50247	hMLH1	230 234	206963 206967	0.999988317489624	O
50250	,	236 237	206969 206970	0.9999878406524658	O
50251	hMSH2	238 242	206971 206975	0.9999881982803345	O
50255	)	244 245	206977 206978	0.9999886751174927	O
50256	and	246 249	206979 206982	0.9999879598617554	O
50257	presence	250 258	206983 206991	0.999987006187439	O
50258	of	259 261	206992 206994	0.999988317489624	O
50259	the	262 265	206995 206998	0.9999876022338867	O
50260	BRAF	266 269	206999 207002	0.9999827146530151	O
50262	(	271 272	207004 207005	0.9999887943267822	O
50263	V600E	273 277	207006 207010	0.9999871253967285	O
50267	)	279 280	207012 207013	0.9999884366989136	O
50268	mutation	281 289	207014 207022	0.9999865293502808	O
50269	.	290 291	207023 207024	0.9999350309371948	O
50270	In	0 2	207025 207027	0.9999858140945435	O
50271	the	3 6	207028 207031	0.999984622001648	O
50272	Omani	7 11	207032 207036	0.9999700784683228	O
50274	group	13 18	207038 207043	0.9999847412109375	O
50275	,	19 20	207044 207045	0.9999872446060181	O
50276	all	21 24	207046 207049	0.9999843835830688	O
50277	tumors	25 31	207050 207056	0.9999833106994629	O
50278	with	32 36	207057 207061	0.9999880790710449	O
50279	BRAF	37 40	207062 207065	0.9999828338623047	O
50281	mutations	42 51	207067 207076	0.9999866485595703	O
50282	were	52 56	207077 207081	0.9999881982803345	O
50283	located	57 64	207082 207089	0.9999884366989136	O
50284	in	65 67	207090 207092	0.9999886751174927	O
50285	the	68 71	207093 207096	0.9999887943267822	O
50286	left	72 76	207097 207101	0.999984860420227	O
50287	side	77 81	207102 207106	0.9999872446060181	O
50288	of	82 84	207107 207109	0.9999880790710449	O
50289	the	85 88	207110 207113	0.9999879598617554	O
50290	colon	89 93	207114 207118	0.9999836683273315	O
50292	,	95 96	207120 207121	0.9999858140945435	O
50293	and	97 100	207122 207125	0.9999868869781494	O
50294	for	101 104	207126 207129	0.9999818801879883	O
50295	African	105 112	207130 207137	0.9999282360076904	O
50296	Americans	113 122	207138 207147	0.9999278783798218	O
50297	,	123 124	207148 207149	0.9999874830245972	O
50298	88	125 127	207150 207152	0.9999840259552002	O
50299	%	128 129	207153 207154	0.999988317489624	O
50300	[	130 131	207155 207156	0.9999873638153076	O
50301	7	131 132	207156 207157	0.9999814033508301	O
50302	]	133 134	207158 207159	0.999987006187439	O
50303	of	135 137	207160 207162	0.9999865293502808	O
50304	tumors	138 144	207163 207169	0.9999849796295166	O
50305	with	145 149	207170 207174	0.9999881982803345	O
50306	BRAF	150 153	207175 207178	0.9999837875366211	O
50308	mutations	155 164	207180 207189	0.9999864101409912	O
50309	were	165 169	207190 207194	0.9999881982803345	O
50310	found	170 175	207195 207200	0.9999880790710449	O
50311	in	176 178	207201 207203	0.9999885559082031	O
50312	the	179 182	207204 207207	0.9999886751174927	O
50313	right	183 188	207208 207213	0.999985933303833	O
50314	side	189 193	207214 207218	0.9999877214431763	O
50315	of	194 196	207219 207221	0.9999881982803345	O
50316	the	197 200	207222 207225	0.9999880790710449	O
50317	colon	201 205	207226 207230	0.9999842643737793	O
50319	.	207 208	207232 207233	0.9999536275863647	O
50320	In	0 2	207234 207236	0.9999819993972778	O
50321	African	3 10	207237 207244	0.9998906850814819	O
50322	Americans	11 20	207245 207254	0.9991344809532166	O
50323	,	21 22	207255 207256	0.9999860525131226	O
50324	31	23 25	207257 207259	0.9999676942825317	O
50325	%	26 27	207260 207261	0.9999843835830688	O
50326	of	28 30	207262 207264	0.9999833106994629	O
50327	tumors	31 37	207265 207271	0.9999794960021973	O
50328	displayed	38 47	207272 207281	0.9999854564666748	O
50329	microsatellite	48 61	207282 207295	0.9999877214431763	O
50333	instability	63 74	207297 207308	0.9999872446060181	O
50334	at	75 77	207309 207311	0.9999886751174927	O
50335	two	78 81	207312 207315	0.9999880790710449	O
50336	or	82 84	207316 207318	0.9999881982803345	O
50337	more	85 89	207319 207323	0.999988317489624	O
50338	markers	90 97	207324 207331	0.9999865293502808	O
50339	(	98 99	207332 207333	0.9999885559082031	O
50340	MSI	100 102	207334 207336	0.9999866485595703	O
50342	-	103 104	207337 207338	0.9999889135360718	O
50343	H	104 105	207338 207339	0.9999845027923584	O
50344	)	105 106	207339 207340	0.9999890327453613	O
50345	,	107 108	207341 207342	0.9999876022338867	O
50346	while	109 114	207343 207348	0.9999860525131226	O
50347	this	115 119	207349 207353	0.9999880790710449	O
50348	rate	120 124	207354 207358	0.9999866485595703	O
50349	was	125 128	207359 207362	0.9999876022338867	O
50350	26	129 131	207363 207365	0.9999837875366211	O
50351	%	132 133	207366 207367	0.9999880790710449	O
50352	and	134 137	207368 207371	0.999985933303833	O
50353	13	138 140	207372 207374	0.99997878074646	O
50354	%	141 142	207375 207376	0.9999874830245972	O
50355	for	143 146	207377 207380	0.9999819993972778	O
50356	tumors	147 153	207381 207387	0.9999825954437256	O
50357	in	154 156	207388 207390	0.999985933303833	O
50358	the	157 160	207391 207394	0.9999847412109375	O
50359	Iranian	161 168	207395 207402	0.9999076128005981	O
50360	and	169 172	207403 207406	0.9999840259552002	O
50361	Omani	173 177	207407 207411	0.999969482421875	O
50363	groups	179 185	207413 207419	0.999982476234436	O
50364	,	186 187	207420 207421	0.9999865293502808	O
50365	respectively	188 200	207422 207434	0.9999847412109375	O
50366	.	201 202	207435 207436	0.9999526739120483	O
50367	A	0 1	207437 207438	0.9999818801879883	O
50368	majority	2 10	207439 207447	0.999980092048645	O
50369	of	11 13	207448 207450	0.9999829530715942	O
50370	these	14 19	207451 207456	0.9999759197235107	O
50371	MSI	20 22	207457 207459	0.9999698400497437	O
50373	-	23 24	207460 207461	0.999981164932251	O
50374	H	24 25	207461 207462	0.9998134970664978	O
50375	tumors	26 32	207463 207469	0.9999771118164062	O
50376	were	33 37	207470 207474	0.9999849796295166	O
50377	located	38 45	207475 207482	0.9999862909317017	O
50378	in	46 48	207483 207485	0.9999860525131226	O
50379	the	49 52	207486 207489	0.9999868869781494	O
50380	proximal	53 60	207490 207497	0.9999841451644897	O
50382	colon	62 66	207499 207503	0.9999819993972778	O
50384	(	68 69	207505 207506	0.999988317489624	O
50385	right	70 75	207507 207512	0.9999853372573853	O
50386	side	76 80	207513 207517	0.9999867677688599	O
50387	)	81 82	207518 207519	0.9999878406524658	O
50388	in	83 85	207520 207522	0.9999867677688599	O
50389	African	86 93	207523 207530	0.9999566078186035	O
50390	American	94 102	207531 207539	0.9999551773071289	O
50391	and	103 106	207540 207543	0.9999774694442749	O
50392	Iranian	107 114	207544 207551	0.9979446530342102	O
50393	subjects	115 123	207552 207560	0.9999659061431885	O
50394	,	124 125	207561 207562	0.9999849796295166	O
50395	whereas	126 133	207563 207570	0.9999819993972778	O
50396	most	134 138	207571 207575	0.999983549118042	O
50397	were	139 143	207576 207580	0.9999853372573853	O
50398	located	144 151	207581 207588	0.9999864101409912	O
50399	in	152 154	207589 207591	0.9999862909317017	O
50400	the	155 158	207592 207595	0.9999867677688599	O
50401	distal	159 164	207596 207601	0.9999842643737793	O
50403	colon	166 170	207603 207607	0.9999831914901733	O
50405	(	172 173	207609 207610	0.9999880790710449	O
50406	left	174 178	207611 207615	0.9999814033508301	O
50407	side	179 183	207616 207620	0.9999867677688599	O
50408	)	184 185	207621 207622	0.9999874830245972	O
50409	in	186 188	207623 207625	0.9999865293502808	O
50410	Omani	189 193	207626 207630	0.9999676942825317	O
50412	subjects	195 203	207632 207640	0.9999769926071167	O
50413	.	204 205	207641 207642	0.9999266862869263	O
50414	Defects	0 6	207643 207649	0.999984622001648	O
50417	in	8 10	207651 207653	0.9999866485595703	O
50418	hMLH1	11 15	207654 207658	0.9999858140945435	O
50421	gene	17 21	207660 207664	0.9999874830245972	O
50422	expression	22 32	207665 207675	0.9999856948852539	O
50423	were	33 37	207676 207680	0.9999867677688599	O
50424	found	38 43	207681 207686	0.9999861717224121	O
50425	in	44 46	207687 207689	0.9999878406524658	O
50426	77	47 49	207690 207692	0.9999765157699585	O
50427	%	50 51	207693 207694	0.9999858140945435	O
50428	of	52 54	207695 207697	0.9999866485595703	O
50429	MSI	55 57	207698 207700	0.9999797344207764	O
50431	-	58 59	207701 207702	0.9999871253967285	O
50432	H	59 60	207702 207703	0.9999223947525024	O
50433	tumors	61 67	207704 207710	0.999984622001648	O
50434	in	68 70	207711 207713	0.9999865293502808	O
50435	both	71 75	207714 207718	0.9999788999557495	O
50436	African	76 83	207719 207726	0.9999444484710693	O
50437	Americans	84 93	207727 207736	0.9999583959579468	O
50438	and	94 97	207737 207740	0.9999819993972778	O
50439	Iranians	98 105	207741 207748	0.9990425705909729	O
50441	and	107 110	207750 207753	0.999984860420227	O
50442	in	111 113	207754 207756	0.9999866485595703	O
50443	38	114 116	207757 207759	0.999970555305481	O
50444	%	117 118	207760 207761	0.9999860525131226	O
50445	of	119 121	207762 207764	0.9999861717224121	O
50446	tumors	122 128	207765 207771	0.999984622001648	O
50447	in	129 131	207772 207774	0.9999865293502808	O
50448	Omanis	132 137	207775 207780	0.9999489784240723	O
50450	.	139 140	207782 207783	0.9999666213989258	O
50451	BRAF	0 3	207784 207787	0.9999735355377197	O
50453	mutations	5 14	207789 207798	0.9999821186065674	O
50454	were	15 19	207799 207803	0.999987006187439	O
50455	observed	20 28	207804 207812	0.9999858140945435	O
50456	in	29 31	207813 207815	0.9999862909317017	O
50457	all	32 35	207816 207819	0.9999819993972778	O
50458	subjects	36 44	207820 207828	0.999951958656311	O
50459	:	45 46	207829 207830	0.9999842643737793	O
50460	10	47 49	207831 207833	0.9999758005142212	O
50461	%	50 51	207834 207835	0.9999860525131226	O
50462	of	52 54	207836 207838	0.9999864101409912	O
50463	tumors	55 61	207839 207845	0.9999825954437256	O
50464	in	62 64	207846 207848	0.9999872446060181	O
50465	African	65 72	207849 207856	0.9998925924301147	O
50466	Americans	73 82	207857 207866	0.9999524354934692	O
50467	(	83 84	207867 207868	0.9999889135360718	O
50468	8	85 86	207869 207870	0.9999855756759644	O
50469	/	86 87	207870 207871	0.999988317489624	O
50470	8	87 88	207871 207872	0.999984622001648	O
50471	2	89 90	207873 207874	0.9999767541885376	O
50472	)	91 92	207875 207876	0.9999880790710449	O
50473	,	93 94	207877 207878	0.9999867677688599	O
50474	2	95 96	207879 207880	0.9999667406082153	O
50475	%	97 98	207881 207882	0.9999873638153076	O
50476	of	99 101	207883 207885	0.9999866485595703	O
50477	tumors	102 108	207886 207892	0.999984622001648	O
50478	in	109 111	207893 207895	0.9999878406524658	O
50479	Iranians	112 119	207896 207903	0.9998120665550232	O
50481	(	121 122	207905 207906	0.9999887943267822	O
50482	1	123 124	207907 207908	0.9999871253967285	O
50483	/	124 125	207908 207909	0.999988317489624	O
50484	53	125 127	207909 207911	0.9999791383743286	O
50485	)	128 129	207912 207913	0.9999884366989136	O
50486	,	130 131	207914 207915	0.9999861717224121	O
50487	and	132 135	207916 207919	0.9999865293502808	O
50488	19	136 138	207920 207922	0.9999568462371826	O
50489	%	139 140	207923 207924	0.9999871253967285	O
50490	of	141 143	207925 207927	0.9999865293502808	O
50491	tumors	144 150	207928 207934	0.9999837875366211	O
50492	in	151 153	207935 207937	0.9999874830245972	O
50493	Omanis	154 159	207938 207943	0.9999618530273438	O
50495	(	161 162	207945 207946	0.9999886751174927	O
50496	11	163 165	207947 207949	0.9999852180480957	O
50497	/	165 166	207949 207950	0.999988317489624	O
50498	59	166 168	207950 207952	0.9999735355377197	O
50499	)	169 170	207953 207954	0.999988317489624	O
50500	.	171 172	207955 207956	0.999958872795105	O
50501	Our	0 3	207957 207960	0.9999721050262451	O
50502	findings	4 12	207961 207969	0.9999804496765137	O
50503	suggest	13 20	207970 207977	0.9999772310256958	O
50504	that	21 25	207978 207982	0.9999823570251465	O
50505	CRC	26 28	207983 207985	0.9999706745147705	O
50507	occurs	30 36	207987 207993	0.999985933303833	O
50508	at	37 39	207994 207996	0.9999860525131226	O
50509	a	40 41	207997 207998	0.9999867677688599	O
50510	younger	42 49	207999 208006	0.999977707862854	O
50511	age	50 53	208007 208010	0.9999803304672241	O
50512	in	54 56	208011 208013	0.9999845027923584	O
50513	Omani	57 61	208014 208018	0.9999632835388184	O
50515	and	63 66	208020 208023	0.9999748468399048	O
50516	Iranian	67 74	208024 208031	0.9952552318572998	O
50517	patients	75 83	208032 208040	0.9999772310256958	O
50518	,	84 85	208041 208042	0.9999808073043823	O
50519	and	86 89	208043 208046	0.9999821186065674	O
50520	these	90 95	208047 208052	0.9999812841415405	O
50521	groups	96 102	208053 208059	0.9999649524688721	O
50522	showed	103 109	208060 208066	0.9999815225601196	O
50523	a	110 111	208067 208068	0.9999865293502808	O
50524	lower	112 117	208069 208074	0.9999754428863525	O
50525	occurrence	118 128	208075 208085	0.999985933303833	O
50526	of	129 131	208086 208088	0.9999872446060181	O
50527	MSI	132 134	208089 208091	0.9999829530715942	O
50529	-	135 136	208092 208093	0.9999877214431763	O
50530	H	136 137	208093 208094	0.9999754428863525	O
50531	than	138 142	208095 208099	0.9999854564666748	O
50532	did	143 146	208100 208103	0.9999847412109375	O
50533	African	147 154	208104 208111	0.9999520778656006	O
50534	American	155 163	208112 208120	0.9997974038124084	O
50535	patients	164 172	208121 208129	0.9999815225601196	O
50536	.	173 174	208130 208131	0.9999470710754395	O
50537	Our	0 3	208132 208135	0.9999818801879883	O
50538	multivariate	4 15	208136 208147	0.999984860420227	O
50541	model	17 22	208149 208154	0.9999797344207764	O
50542	suggests	23 31	208155 208163	0.9999819993972778	O
50543	an	32 34	208164 208166	0.9999878406524658	O
50544	important	35 44	208167 208176	0.9999866485595703	O
50545	and	45 48	208177 208180	0.9999854564666748	O
50546	significant	49 60	208181 208192	0.9999849796295166	O
50547	role	61 65	208193 208197	0.999984860420227	O
50548	of	66 68	208198 208200	0.9999873638153076	O
50549	hMLH1	69 73	208201 208205	0.9999867677688599	O
50552	expression	75 85	208207 208217	0.999988317489624	O
50553	and	86 89	208218 208221	0.9999874830245972	O
50554	BRAF	90 93	208222 208225	0.9999849796295166	O
50556	mutation	95 103	208227 208235	0.9999878406524658	O
50557	in	104 106	208236 208238	0.999987006187439	O
50558	MSI	107 109	208239 208241	0.999983549118042	O
50560	-	110 111	208242 208243	0.9999871253967285	O
50561	H	111 112	208243 208244	0.9999561309814453	O
50562	CRC	113 115	208245 208247	0.9999815225601196	O
50564	in	117 119	208249 208251	0.9999842643737793	O
50565	these	120 125	208252 208257	0.9999817609786987	O
50566	populations	126 137	208258 208269	0.9999747276306152	O
50567	.	138 139	208270 208271	0.9999494552612305	O
50568	The	0 3	208272 208275	0.9999796152114868	O
50569	high	4 8	208276 208280	0.9999730587005615	O
50570	occurrence	9 19	208281 208291	0.9999804496765137	O
50571	of	20 22	208292 208294	0.9999840259552002	O
50572	MSI	23 25	208295 208297	0.9999796152114868	O
50574	-	26 27	208298 208299	0.9999855756759644	O
50575	H	27 28	208299 208300	0.9999712705612183	O
50576	tumors	29 35	208301 208307	0.9999808073043823	O
50577	in	36 38	208308 208310	0.9999828338623047	O
50578	African	39 46	208311 208318	0.9999456405639648	O
50579	Americans	47 56	208319 208328	0.9999196529388428	O
50580	may	57 60	208329 208332	0.9999806880950928	O
50581	have	61 65	208333 208337	0.9999854564666748	O
50582	significant	66 77	208338 208349	0.9999843835830688	O
50583	implications	78 90	208350 208362	0.9999840259552002	O
50584	for	91 94	208363 208366	0.9999825954437256	O
50585	treatment	95 104	208367 208376	0.999980092048645	O
50586	,	105 106	208377 208378	0.9999829530715942	O
50587	since	107 112	208379 208384	0.9999790191650391	O
50588	patients	113 121	208385 208393	0.9999510049819946	O
50589	with	122 126	208394 208398	0.9999837875366211	O
50590	MSI	127 129	208399 208401	0.9999809265136719	O
50592	-	130 131	208402 208403	0.9999865293502808	O
50593	H	131 132	208403 208404	0.9999796152114868	O
50594	lesions	133 140	208405 208412	0.9999775886535645	O
50595	display	141 148	208413 208420	0.9999818801879883	O
50596	a	149 150	208421 208422	0.9999861717224121	O
50597	different	151 160	208423 208432	0.9999808073043823	O
50598	response	161 169	208433 208441	0.9999830722808838	O
50599	to	170 172	208442 208444	0.9999854564666748	O
50600	chemotherapeutic	173 188	208445 208460	0.9999840259552002	O
50607	agents	190 196	208462 208468	0.9999852180480957	O
50608	such	197 201	208469 208473	0.9999854564666748	O
50609	as	202 204	208474 208476	0.9999864101409912	O
50610	5	205 206	208477 208478	0.9999843835830688	O
50611	-	206 207	208478 208479	0.9999865293502808	O
50612	fluorouracil	207 218	208479 208490	0.999983549118042	O
50617	.	220 221	208492 208493	0.9999864101409912	O
50618	*	222 223	208494 208495	0.9999854564666748	O
50619	*	223 224	208495 208496	0.9999696016311646	O
50620	IGNORE	0 5	208497 208502	0.9999850988388062	O
50623	LINE	7 10	208504 208507	0.9999885559082031	O
50626	*	12 13	208509 208510	0.9999887943267822	O
50627	*	13 14	208510 208511	0.9999887943267822	O
50628	*	15 16	208512 208513	0.9999886751174927	O
50629	*	16 17	208513 208514	0.9999887943267822	O
50630	IGNORE	18 23	208515 208520	0.9999871253967285	O
50633	LINE	25 28	208522 208525	0.9999891519546509	O
50636	*	30 31	208527 208528	0.9999886751174927	O
50637	*	31 32	208528 208529	0.9999886751174927	O
50638	*	33 34	208530 208531	0.9999886751174927	O
50639	*	34 35	208531 208532	0.9999885559082031	O
50640	IGNORE	36 41	208533 208538	0.9999867677688599	O
50643	LINE	43 46	208540 208543	0.9999887943267822	O
50646	*	48 49	208545 208546	0.9999889135360718	O
50647	*	49 50	208546 208547	0.9999886751174927	O
50648	In	51 53	208548 208550	0.9999878406524658	O
50649	the	54 57	208551 208554	0.9999880790710449	O
50650	present	58 65	208555 208562	0.9999871253967285	O
50651	study	66 71	208563 208568	0.9999871253967285	O
50652	,	72 73	208569 208570	0.999988317489624	O
50653	we	74 76	208571 208573	0.9999855756759644	O
50654	analyzed	77 85	208574 208582	0.9999873638153076	O
50655	samples	86 93	208583 208590	0.9999840259552002	O
50656	from	94 98	208591 208595	0.9999878406524658	O
50657	two	99 102	208596 208599	0.9999805688858032	O
50658	different	103 112	208600 208609	0.9999834299087524	O
50659	populations	113 124	208610 208621	0.9999852180480957	O
50660	of	125 127	208622 208624	0.9999876022338867	O
50661	African	128 135	208625 208632	0.9999701976776123	O
50662	descent	136 143	208633 208640	0.9999850988388062	O
50663	(	144 145	208641 208642	0.9999880790710449	O
50664	African	146 153	208643 208650	0.9999791383743286	O
50665	American	154 162	208651 208659	0.9999825954437256	O
50666	and	163 166	208660 208663	0.9999856948852539	O
50667	Omani	167 171	208664 208668	0.99997878074646	O
50669	)	173 174	208670 208671	0.9999884366989136	O
50670	and	175 178	208672 208675	0.9999849796295166	O
50671	a	179 180	208676 208677	0.9999871253967285	O
50672	Caucasian	181 190	208678 208687	0.9998481273651123	O
50673	population	191 201	208688 208698	0.9999855756759644	O
50674	(	202 203	208699 208700	0.9999877214431763	O
50675	Iranian	204 211	208701 208708	0.9999146461486816	O
50676	)	212 213	208709 208710	0.9999876022338867	O
50677	for	214 217	208711 208714	0.9999868869781494	O
50678	microsatellite	218 231	208715 208728	0.9999873638153076	O
50682	instability	233 244	208730 208741	0.999987006187439	O
50683	and	245 248	208742 208745	0.9999866485595703	O
50684	BRAF	249 252	208746 208749	0.9999823570251465	O
50686	mutations	254 263	208751 208760	0.9999858140945435	O
50687	.	264 265	208761 208762	0.9999309778213501	O
50688	We	0 2	208763 208765	0.9999778270721436	O
50689	correlated	3 13	208766 208776	0.9999750852584839	O
50690	our	14 17	208777 208780	0.9999817609786987	O
50691	findings	18 26	208781 208789	0.9999833106994629	O
50692	with	27 31	208790 208794	0.9999852180480957	O
50693	the	32 35	208795 208798	0.9999865293502808	O
50694	silencing	36 44	208799 208807	0.9999849796295166	O
50697	of	46 48	208809 208811	0.9999873638153076	O
50698	genes	49 54	208812 208817	0.999984622001648	O
50699	involved	55 63	208818 208826	0.9999867677688599	O
50700	in	64 66	208827 208829	0.9999878406524658	O
50701	DNA	67 70	208830 208833	0.9999845027923584	O
50702	MMR	71 73	208834 208836	0.9999871253967285	O
50704	.	74 75	208837 208838	0.9999539852142334	O
50705	We	0 2	208839 208841	0.9999853372573853	O
50706	evaluated	3 12	208842 208851	0.9999861717224121	O
50707	and	13 16	208852 208855	0.9999858140945435	O
50708	compared	17 25	208856 208864	0.9999843835830688	O
50709	the	26 29	208865 208868	0.9999873638153076	O
50710	demographic	30 41	208869 208880	0.9999854564666748	O
50711	and	42 45	208881 208884	0.9999864101409912	O
50712	clinicopathological	46 64	208885 208903	0.9999843835830688	O
50716	data	66 70	208905 208909	0.9999862909317017	O
50717	in	71 73	208910 208912	0.999988317489624	O
50718	relation	74 82	208913 208921	0.999988317489624	O
50719	to	83 85	208922 208924	0.9999886751174927	O
50720	molecular	86 95	208925 208934	0.9999861717224121	O
50721	alterations	96 107	208935 208946	0.999987006187439	O
50722	in	108 110	208947 208949	0.9999890327453613	O
50723	specific	111 119	208950 208958	0.9999885559082031	O
50724	genes	120 125	208959 208964	0.9999874830245972	O
50725	(	126 127	208965 208966	0.9999885559082031	O
50726	BRAF	128 131	208967 208970	0.9999867677688599	O
50728	,	133 134	208972 208973	0.9999881982803345	O
50729	DNA	135 138	208974 208977	0.9999864101409912	O
50730	MMR	139 141	208978 208980	0.999988317489624	O
50732	)	143 144	208982 208983	0.9999891519546509	O
50733	to	145 147	208984 208986	0.9999877214431763	O
50734	improve	148 155	208987 208994	0.9999879598617554	O
50735	our	156 159	208995 208998	0.9999877214431763	O
50736	understanding	160 173	208999 209012	0.9999845027923584	O
50737	of	174 176	209013 209015	0.999987006187439	O
50738	colon	177 181	209016 209020	0.9999778270721436	O
50740	tumorgenesis	183 194	209022 209033	0.999983549118042	O
50742	in	196 198	209035 209037	0.9999872446060181	O
50743	people	199 205	209038 209044	0.9999548196792603	O
50744	living	206 212	209045 209051	0.9999850988388062	O
50745	in	213 215	209052 209054	0.9999873638153076	O
50746	different	216 225	209055 209064	0.999984860420227	O
50747	environments	226 238	209065 209077	0.9999786615371704	O
50748	.	239 240	209078 209079	0.9999885559082031	O
50749	*	241 242	209080 209081	0.9999871253967285	O
50750	*	242 243	209081 209082	0.9999793767929077	O
50751	IGNORE	0 5	209083 209088	0.9999841451644897	O
50754	LINE	7 10	209090 209093	0.9999884366989136	O
50757	*	12 13	209095 209096	0.9999881982803345	O
50758	*	13 14	209096 209097	0.9999880790710449	O
50759	*	15 16	209098 209099	0.9999880790710449	O
50760	*	16 17	209099 209100	0.9999880790710449	O
50761	IGNORE	18 23	209101 209106	0.9999860525131226	O
50764	LINE	25 28	209108 209111	0.9999886751174927	O
50767	*	30 31	209113 209114	0.9999880790710449	O
50768	*	31 32	209114 209115	0.9999878406524658	O
50769	*	33 34	209116 209117	0.9999878406524658	O
50770	*	34 35	209117 209118	0.9999877214431763	O
50771	IGNORE	36 41	209119 209124	0.999985933303833	O
50774	LINE	43 46	209126 209129	0.9999884366989136	O
50777	*	48 49	209131 209132	0.9999879598617554	O
50778	*	49 50	209132 209133	0.9999878406524658	O
50779	Methods	51 57	209134 209140	0.9999853372573853	O
50781	Patients	59 66	209142 209149	0.9999871253967285	O
50783	A	68 69	209151 209152	0.999985933303833	O
50784	total	70 75	209153 209158	0.9999847412109375	O
50785	of	76 78	209159 209161	0.9999862909317017	O
50786	95	79 81	209162 209164	0.9999245405197144	O
50787	African	82 89	209165 209172	0.9998923540115356	O
50788	American	90 98	209173 209181	0.9672719836235046	O
50789	CRC	99 101	209182 209184	0.999982476234436	O
50791	patients	103 111	209186 209194	0.9999843835830688	O
50792	(	112 113	209195 209196	0.9999881982803345	O
50793	from	114 118	209197 209201	0.9999864101409912	O
50794	Howard	119 125	209202 209208	0.9996167421340942	O
50795	University	126 136	209209 209219	0.999985933303833	O
50796	and	137 140	209220 209223	0.9999864101409912	O
50797	Johns	141 146	209224 209229	0.9999586343765259	O
50798	Hopkins	147 154	209230 209237	0.999961256980896	O
50799	Hospital	155 163	209238 209246	0.9999864101409912	O
50800	between	164 171	209247 209254	0.9999878406524658	O
50801	1997	172 176	209255 209259	0.9999817609786987	O
50802	and	177 180	209260 209263	0.9999880790710449	O
50803	2004	181 185	209264 209268	0.9999861717224121	O
50804	;	186 187	209269 209270	0.9999872446060181	O
50805	self	188 192	209271 209275	0.9999860525131226	O
50806	-	192 193	209275 209276	0.9999881982803345	O
50807	identified	193 203	209276 209286	0.9999880790710449	O
50808	as	204 206	209287 209289	0.9999880790710449	O
50809	African	207 214	209290 209297	0.9999722242355347	O
50810	American	215 223	209298 209306	0.9999735355377197	O
50811	)	224 225	209307 209308	0.9999871253967285	O
50812	,	226 227	209309 209310	0.9999860525131226	O
50813	61	228 230	209311 209313	0.999950647354126	O
50814	Omani	231 235	209314 209318	0.9999587535858154	O
50816	CRC	237 239	209320 209322	0.9999831914901733	O
50818	patients	241 249	209324 209332	0.9999853372573853	O
50819	(	250 251	209333 209334	0.9999881982803345	O
50820	from	252 256	209335 209339	0.999987006187439	O
50821	the	257 260	209340 209343	0.9999871253967285	O
50822	two	261 264	209344 209347	0.9999822378158569	O
50823	tertiary	265 273	209348 209356	0.9999696016311646	O
50824	referral	274 281	209357 209364	0.9999866485595703	O
50826	hospitals	283 292	209366 209375	0.9999860525131226	O
50827	in	293 295	209376 209378	0.9999873638153076	O
50828	Oman	296 300	209379 209383	0.9999711513519287	O
50829	Sultan	301 307	209384 209390	0.9999569654464722	O
50830	Qaboos	308 313	209391 209396	0.9999845027923584	O
50833	University	315 325	209398 209408	0.9999855756759644	O
50834	Hospital	326 334	209409 209417	0.9999868869781494	O
50835	and	335 338	209418 209421	0.9999856948852539	O
50836	the	339 342	209422 209425	0.9999855756759644	O
50837	Royal	343 348	209426 209431	0.9999673366546631	O
50838	Hospital	349 357	209432 209440	0.9999841451644897	O
50839	between	358 365	209441 209448	0.9999872446060181	O
50840	2000	366 370	209449 209453	0.9999850988388062	O
50841	and	371 374	209454 209457	0.9999877214431763	O
50842	2004	375 379	209458 209462	0.999984860420227	O
50843	who	380 383	209463 209466	0.9999849796295166	O
50844	underwent	384 393	209467 209476	0.9999867677688599	O
50845	surgical	394 402	209477 209485	0.9999784231185913	O
50846	resection	403 411	209486 209494	0.999987006187439	O
50848	)	413 414	209496 209497	0.9999873638153076	O
50849	and	415 418	209498 209501	0.9999862909317017	O
50850	53	419 421	209502 209504	0.9999533891677856	O
50851	Iranian	422 429	209505 209512	0.9822990298271179	O
50852	CRC	430 432	209513 209515	0.9999821186065674	O
50854	patients	434 442	209517 209525	0.9999845027923584	O
50855	(	443 444	209526 209527	0.9999885559082031	O
50856	from	445 449	209528 209532	0.9999873638153076	O
50857	the	450 453	209533 209536	0.9999879598617554	O
50858	two	454 457	209537 209540	0.9999843835830688	O
50859	referral	458 465	209541 209548	0.9999862909317017	O
50861	hospitals	467 476	209550 209559	0.9999861717224121	O
50862	in	477 479	209560 209562	0.9999873638153076	O
50863	Shiraz	480 485	209563 209568	0.9999794960021973	O
50865	,	487 488	209570 209571	0.9999862909317017	O
50866	Iran	489 493	209572 209576	0.9999366998672485	O
50867	Namazi	494 499	209577 209582	0.9999828338623047	O
50869	Hospital	501 509	209584 209592	0.9999872446060181	O
50870	and	510 513	209593 209596	0.9999868869781494	O
50871	Saadi	514 518	209597 209601	0.9999839067459106	O
50873	Hospital	520 528	209603 209611	0.9999867677688599	O
50874	)	529 530	209612 209613	0.9999873638153076	O
50875	were	531 535	209614 209618	0.9999871253967285	O
50876	included	536 544	209619 209627	0.9999860525131226	O
50877	in	545 547	209628 209630	0.9999872446060181	O
50878	this	548 552	209631 209635	0.9999880790710449	O
50879	study	553 558	209636 209641	0.9999860525131226	O
50880	.	559 560	209642 209643	0.9999555349349976	O
50881	Formalin	0 7	209644 209651	0.999984622001648	O
50884	-	8 9	209652 209653	0.9999884366989136	O
50885	fixed	9 14	209653 209658	0.9999817609786987	O
50886	,	15 16	209659 209660	0.9999864101409912	O
50887	paraffin	17 24	209661 209668	0.9999858140945435	O
50889	-	25 26	209669 209670	0.9999889135360718	O
50890	embedded	26 34	209670 209678	0.9999836683273315	O
50891	archival	35 42	209679 209686	0.9999853372573853	O
50893	tissue	44 50	209688 209694	0.9999837875366211	O
50894	was	51 54	209695 209698	0.9999885559082031	O
50895	collected	55 64	209699 209708	0.9999881982803345	O
50896	(	65 66	209709 209710	0.99998939037323	O
50897	with	67 71	209711 209715	0.9999889135360718	O
50898	approval	72 80	209716 209724	0.9999867677688599	O
50899	from	81 85	209725 209729	0.9999890327453613	O
50900	all	86 89	209730 209733	0.9999892711639404	O
50901	above	90 95	209734 209739	0.9999862909317017	O
50902	sites	96 101	209740 209745	0.9999872446060181	O
50903	'	102 103	209746 209747	0.9999880790710449	O
50904	Institutional	104 116	209748 209760	0.999987006187439	O
50906	Review	118 124	209762 209768	0.9999881982803345	O
50907	Boards	125 130	209769 209774	0.9999878406524658	O
50909	)	132 133	209776 209777	0.99998939037323	O
50910	and	134 137	209778 209781	0.9999885559082031	O
50911	clinical	138 146	209782 209790	0.9999837875366211	O
50912	data	147 151	209791 209795	0.9999879598617554	O
50913	was	152 155	209796 209799	0.9999890327453613	O
50914	obtained	156 164	209800 209808	0.9999884366989136	O
50915	(	165 166	209809 209810	0.9999891519546509	O
50916	including	167 176	209811 209820	0.9999891519546509	O
50917	race	177 181	209821 209825	0.9999842643737793	O
50918	,	182 183	209826 209827	0.9999881982803345	O
50919	age	184 187	209828 209831	0.9999806880950928	O
50920	,	188 189	209832 209833	0.999988317489624	O
50921	site	190 194	209834 209838	0.999987006187439	O
50922	of	195 197	209839 209841	0.9999881982803345	O
50923	primary	198 205	209842 209849	0.9999865293502808	O
50924	tumor	206 211	209850 209855	0.9999864101409912	O
50925	,	212 213	209856 209857	0.9999884366989136	O
50926	mucin	214 218	209858 209862	0.9999864101409912	O
50929	production	220 230	209864 209874	0.9999872446060181	O
50930	and	231 234	209875 209878	0.9999877214431763	O
50931	tumor	235 240	209879 209884	0.9999841451644897	O
50932	differentiation	241 256	209885 209900	0.9999850988388062	O
50933	)	257 258	209901 209902	0.9999890327453613	O
50934	.	259 260	209903 209904	0.9999654293060303	O
50935	In	0 2	209905 209907	0.999985933303833	O
50936	addition	3 11	209908 209916	0.999982476234436	O
50937	,	12 13	209917 209918	0.999987006187439	O
50938	the	14 17	209919 209922	0.9999854564666748	O
50939	family	18 24	209923 209929	0.9999791383743286	O
50940	history	25 32	209930 209937	0.9999852180480957	O
50941	of	33 35	209938 209940	0.9999872446060181	O
50942	cancer	36 42	209941 209947	0.999982476234436	O
50943	was	43 46	209948 209951	0.9999866485595703	O
50944	analyzed	47 55	209952 209960	0.999985933303833	O
50945	to	56 58	209961 209963	0.9999872446060181	O
50946	identify	59 67	209964 209972	0.9999862909317017	O
50947	those	68 73	209973 209978	0.9999856948852539	O
50948	pedigrees	74 82	209979 209987	0.9999874830245972	O
50953	that	84 88	209989 209993	0.9999861717224121	O
50954	met	89 92	209994 209997	0.9999865293502808	O
50955	either	93 99	209998 210004	0.9999868869781494	O
50956	the	100 103	210005 210008	0.9999878406524658	O
50957	Amsterdam	104 113	210009 210018	0.9999834299087524	O
50958	I	114 115	210019 210020	0.9999880790710449	O
50959	or	116 118	210021 210023	0.9999864101409912	O
50960	Amsterdam	119 128	210024 210033	0.9999862909317017	O
50961	II	129 131	210034 210036	0.9999862909317017	O
50962	criteria	132 140	210037 210045	0.9999864101409912	O
50963	for	141 144	210046 210049	0.9999871253967285	O
50964	HNPCC	145 149	210050 210054	0.9999853372573853	O
50967	.	150 151	210055 210056	0.9999598264694214	O
50968	The	0 3	210057 210060	0.9999788999557495	O
50969	study	4 9	210061 210066	0.9999730587005615	O
50970	was	10 13	210067 210070	0.9999799728393555	O
50971	performed	14 23	210071 210080	0.9999796152114868	O
50972	on	24 26	210081 210083	0.9999829530715942	O
50973	unselected	27 36	210084 210093	0.9999860525131226	O
50977	and	38 41	210095 210098	0.9999806880950928	O
50978	serially	42 49	210099 210106	0.9999802112579346	O
50980	collected	51 60	210108 210117	0.9999845027923584	O
50981	specimens	61 70	210118 210127	0.9999825954437256	O
50982	.	71 72	210128 210129	0.9998975992202759	O
50983	All	0 3	210130 210133	0.9999761581420898	O
50984	cases	4 9	210134 210139	0.9999786615371704	O
50985	underwent	10 19	210140 210149	0.9999823570251465	O
50986	surgery	20 27	210150 210157	0.999976634979248	O
50987	within	28 34	210158 210164	0.9999816417694092	O
50988	the	35 38	210165 210168	0.9999850988388062	O
50989	given	39 44	210169 210174	0.9999772310256958	O
50990	collection	45 55	210175 210185	0.9999788999557495	O
50991	.	56 57	210186 210187	0.9998815059661865	O
50992	DNA	0 3	210188 210191	0.9999840259552002	O
50993	isolation	4 13	210192 210201	0.999987006187439	O
50994	and	14 17	210202 210205	0.9999862909317017	O
50995	MSI	18 20	210206 210208	0.9999837875366211	O
50997	analysis	22 30	210210 210218	0.9999868869781494	O
50998	Archived	31 39	210219 210227	0.9999672174453735	O
50999	and	40 43	210228 210231	0.999980092048645	O
51000	fresh	44 49	210232 210237	0.9999760389328003	O
51001	tumor	50 55	210238 210243	0.9999781847000122	O
51002	blocks	56 62	210244 210250	0.9999809265136719	O
51003	were	63 67	210251 210255	0.9999871253967285	O
51004	cut	68 71	210256 210259	0.9999852180480957	O
51005	into	72 76	210260 210264	0.9999880790710449	O
51006	5	77 78	210265 210266	0.9999867677688599	O
51007	-	78 79	210266 210267	0.9999884366989136	O
51008	μm	79 80	210267 210268	0.9999858140945435	O
51010	sections	82 90	210270 210278	0.9999853372573853	O
51011	on	91 93	210279 210281	0.9999876022338867	O
51012	Superfrost	94 103	210282 210291	0.9999815225601196	O
51016	slides	105 111	210293 210299	0.9999850988388062	O
51017	(	112 113	210300 210301	0.9999886751174927	O
51018	Fisher	114 120	210302 210308	0.9999791383743286	O
51019	Scientific	121 131	210309 210319	0.9999868869781494	O
51020	,	132 133	210320 210321	0.9999881982803345	O
51021	Pittsburgh	134 144	210322 210332	0.9999758005142212	O
51022	,	145 146	210333 210334	0.9999878406524658	O
51023	PA	147 149	210335 210337	0.9999834299087524	O
51024	)	150 151	210338 210339	0.9999889135360718	O
51025	.	152 153	210340 210341	0.9999657869338989	O
51026	The	0 3	210342 210345	0.9999853372573853	O
51027	tumor	4 9	210346 210351	0.9999827146530151	O
51028	and	10 13	210352 210355	0.9999860525131226	O
51029	normal	14 20	210356 210362	0.9999821186065674	O
51030	area	21 25	210363 210367	0.9999872446060181	O
51031	were	26 30	210368 210372	0.9999873638153076	O
51032	diagnosed	31 40	210373 210382	0.9999873638153076	O
51033	by	41 43	210383 210385	0.9999880790710449	O
51034	a	44 45	210386 210387	0.9999880790710449	O
51035	pathologist	46 56	210388 210398	0.999984860420227	O
51037	using	58 63	210400 210405	0.9999887943267822	O
51038	the	64 67	210406 210409	0.9999891519546509	O
51039	H	68 69	210410 210411	0.9999879598617554	O
51040	&	69 70	210411 210412	0.9999884366989136	O
51041	E	70 71	210412 210413	0.9999884366989136	O
51042	matched	72 79	210414 210421	0.9999854564666748	O
51043	slide	80 85	210422 210427	0.9999878406524658	O
51044	and	86 89	210428 210431	0.9999876022338867	O
51045	microdissected	90 103	210432 210445	0.9999867677688599	O
51049	to	105 107	210447 210449	0.9999889135360718	O
51050	pinpoint	108 115	210450 210457	0.999988317489624	O
51052	the	117 120	210459 210462	0.9999884366989136	O
51053	tumor	121 126	210463 210468	0.9999842643737793	O
51054	areas	127 132	210469 210474	0.9999874830245972	O
51055	as	133 135	210475 210477	0.9999881982803345	O
51056	well	136 140	210478 210482	0.9999885559082031	O
51057	as	141 143	210483 210485	0.9999884366989136	O
51058	normal	144 150	210486 210492	0.9999827146530151	O
51059	areas	151 156	210493 210498	0.9999884366989136	O
51060	from	157 161	210499 210503	0.9999886751174927	O
51061	at	162 164	210504 210506	0.99998939037323	O
51062	least	165 170	210507 210512	0.99998939037323	O
51063	two	171 174	210513 210516	0.9999867677688599	O
51064	slides	175 181	210517 210523	0.999982476234436	O
51065	.	182 183	210524 210525	0.9999587535858154	O
51066	A	0 1	210526 210527	0.9999865293502808	O
51067	pinpoint	2 9	210528 210535	0.9999858140945435	O
51069	DNA	11 14	210537 210540	0.9999840259552002	O
51070	extraction	15 25	210541 210551	0.999985933303833	O
51071	kit	26 29	210552 210555	0.9999837875366211	O
51072	was	30 33	210556 210559	0.999984622001648	O
51073	used	34 38	210560 210564	0.9999856948852539	O
51074	as	39 41	210565 210567	0.9999874830245972	O
51075	recommended	42 53	210568 210579	0.9999871253967285	O
51076	by	54 56	210580 210582	0.999988317489624	O
51077	the	57 60	210583 210586	0.9999866485595703	O
51078	manufacturers	61 74	210587 210600	0.9999814033508301	O
51079	(	75 76	210601 210602	0.9999886751174927	O
51080	Zymo	77 80	210603 210606	0.9999862909317017	O
51083	Research	82 90	210608 210616	0.9999864101409912	O
51084	)	91 92	210617 210618	0.9999891519546509	O
51085	.	93 94	210619 210620	0.9999669790267944	O
51086	The	0 3	210621 210624	0.9999860525131226	O
51087	extracted	4 13	210625 210634	0.9999752044677734	O
51088	tumor	14 19	210635 210640	0.9999843835830688	O
51089	and	20 23	210641 210644	0.9999854564666748	O
51090	normal	24 30	210645 210651	0.9999837875366211	O
51091	matched	31 38	210652 210659	0.9999810457229614	O
51092	DNA	39 42	210660 210663	0.9999841451644897	O
51093	were	43 47	210664 210668	0.9999884366989136	O
51094	used	48 52	210669 210673	0.9999881982803345	O
51095	as	53 55	210674 210676	0.9999886751174927	O
51096	template	56 64	210677 210685	0.9999860525131226	O
51097	in	65 67	210686 210688	0.9999887943267822	O
51098	PCR	68 70	210689 210691	0.9999881982803345	O
51100	reactions	72 81	210693 210702	0.9999874830245972	O
51101	where	82 87	210703 210708	0.9999889135360718	O
51102	five	88 92	210709 210713	0.9999880790710449	O
51103	microsatellite	93 106	210714 210727	0.9999889135360718	O
51107	markers	108 115	210729 210736	0.9999890327453613	O
51108	(	116 117	210737 210738	0.99998939037323	O
51109	Cancer	118 124	210739 210745	0.9999867677688599	O
51110	Research	125 133	210746 210754	0.9999873638153076	O
51111	58	134 136	210755 210757	0.9999880790710449	O
51112	:	136 137	210757 210758	0.9999891519546509	O
51113	5248	137 140	210758 210761	0.9999885559082031	O
51115	–	141 142	210762 210763	0.9999876022338867	O
51116	5257	142 145	210763 210766	0.9999885559082031	O
51119	,	147 148	210768 210769	0.9999892711639404	O
51120	1998	149 153	210770 210774	0.999988317489624	O
51121	;	154 155	210775 210776	0.9999895095825195	O
51122	[	155 156	210776 210777	0.9999890327453613	O
51123	21	156 158	210777 210779	0.9999879598617554	O
51124	]	158 159	210779 210780	0.9999892711639404	O
51125	;	160 161	210781 210782	0.9999895095825195	O
51126	BAT25	162 166	210783 210787	0.9999887943267822	O
51129	,	168 169	210789 210790	0.9999891519546509	O
51130	BAT26	170 174	210791 210795	0.9999886751174927	O
51133	,	176 177	210797 210798	0.99998939037323	O
51134	D17S250	178 184	210799 210805	0.9999891519546509	O
51139	,	186 187	210807 210808	0.99998939037323	O
51140	D5S346	188 193	210809 210814	0.9999891519546509	O
51145	and	195 198	210816 210819	0.9999891519546509	O
51146	D2S123	199 204	210820 210825	0.9999890327453613	O
51151	)	206 207	210827 210828	0.9999880790710449	O
51152	were	208 212	210829 210833	0.9999892711639404	O
51153	used	213 217	210834 210838	0.9999889135360718	O
51154	to	218 220	210839 210841	0.9999892711639404	O
51155	evaluate	221 229	210842 210850	0.9999884366989136	O
51156	MSI	230 232	210851 210853	0.9999840259552002	O
51158	status	234 240	210855 210861	0.9999887943267822	O
51159	.	241 242	210862 210863	0.9999634027481079	O
51160	PCR	0 2	210864 210866	0.9999847412109375	O
51162	products	4 12	210868 210876	0.9999841451644897	O
51163	were	13 17	210877 210881	0.9999831914901733	O
51164	analyzed	18 26	210882 210890	0.9999845027923584	O
51165	in	27 29	210891 210893	0.9999852180480957	O
51166	a	30 31	210894 210895	0.9999864101409912	O
51167	3130	32 35	210896 210899	0.9999852180480957	O
51169	ABI	37 39	210901 210903	0.9999861717224121	O
51171	GeneScan	41 48	210905 210912	0.9999874830245972	O
51174	.	50 51	210914 210915	0.9999561309814453	O
51175	Those	0 5	210916 210921	0.9999879598617554	O
51176	displaying	6 16	210922 210932	0.9999886751174927	O
51177	DNA	17 20	210933 210936	0.9999847412109375	O
51178	instability	21 32	210937 210948	0.9999881982803345	O
51179	at	33 35	210949 210951	0.99998939037323	O
51180	only	36 40	210952 210956	0.9999891519546509	O
51181	one	41 44	210957 210960	0.9999890327453613	O
51182	of	45 47	210961 210963	0.99998939037323	O
51183	the	48 51	210964 210967	0.9999890327453613	O
51184	markers	52 59	210968 210975	0.9999884366989136	O
51185	(	60 61	210976 210977	0.9999891519546509	O
51186	including	62 71	210978 210987	0.9999889135360718	O
51187	the	72 75	210988 210991	0.9999891519546509	O
51188	dinucleotides	76 88	210992 211004	0.9999880790710449	O
51193	)	90 91	211006 211007	0.9999892711639404	O
51194	were	92 96	211008 211012	0.9999892711639404	O
51195	labeled	97 104	211013 211020	0.9999887943267822	O
51196	MSI	105 107	211021 211023	0.9999892711639404	O
51198	-	108 109	211024 211025	0.9999896287918091	O
51199	L	109 110	211025 211026	0.9999885559082031	O
51200	,	111 112	211027 211028	0.9999891519546509	O
51201	those	113 118	211029 211034	0.9999892711639404	O
51202	displaying	119 129	211035 211045	0.9999890327453613	O
51203	instability	130 141	211046 211057	0.9999885559082031	O
51204	with	142 146	211058 211062	0.9999895095825195	O
51205	two	147 150	211063 211066	0.9999889135360718	O
51206	or	151 153	211067 211069	0.9999890327453613	O
51207	more	154 158	211070 211074	0.9999890327453613	O
51208	markers	159 166	211075 211082	0.9999885559082031	O
51209	were	167 171	211083 211087	0.9999891519546509	O
51210	labeled	172 179	211088 211095	0.9999890327453613	O
51211	MSI	180 182	211096 211098	0.9999892711639404	O
51213	-	183 184	211099 211100	0.9999895095825195	O
51214	H	184 185	211100 211101	0.9999840259552002	O
51215	,	185 186	211101 211102	0.9999887943267822	O
51216	and	187 190	211103 211106	0.9999891519546509	O
51217	those	191 196	211107 211112	0.9999891519546509	O
51218	displaying	197 207	211113 211123	0.9999887943267822	O
51219	no	208 210	211124 211126	0.9999871253967285	O
51220	instability	211 222	211127 211138	0.9999884366989136	O
51221	with	223 227	211139 211143	0.9999890327453613	O
51222	any	228 231	211144 211147	0.99998939037323	O
51223	of	232 234	211148 211150	0.9999891519546509	O
51224	the	235 238	211151 211154	0.99998939037323	O
51225	five	239 243	211155 211159	0.999982476234436	O
51226	markers	244 251	211160 211167	0.9999884366989136	O
51227	tested	252 258	211168 211174	0.9999874830245972	O
51228	were	259 263	211175 211179	0.9999891519546509	O
51229	labeled	264 271	211180 211187	0.9999889135360718	O
51230	MSS	272 274	211188 211190	0.9999887943267822	O
51232	.	275 276	211191 211192	0.9999713897705078	O
51233	Due	0 3	211193 211196	0.9999868869781494	O
51234	to	4 6	211197 211199	0.9999891519546509	O
51235	unclear	7 14	211200 211207	0.9999878406524658	O
51236	characteristics	15 30	211208 211223	0.9999879598617554	O
51237	of	31 33	211224 211226	0.9999891519546509	O
51238	MSI	34 36	211227 211229	0.9999880790710449	O
51240	-	37 38	211230 211231	0.9999898672103882	O
51241	L	38 39	211231 211232	0.9999876022338867	O
51242	,	40 41	211233 211234	0.9999884366989136	O
51243	we	42 44	211235 211237	0.9999877214431763	O
51244	combined	45 53	211238 211246	0.9999886751174927	O
51245	MSS	54 56	211247 211249	0.999988317489624	O
51247	and	58 61	211251 211254	0.9999892711639404	O
51248	MSI	62 64	211255 211257	0.9999886751174927	O
51250	-	65 66	211258 211259	0.9999898672103882	O
51251	L	66 67	211259 211260	0.9999884366989136	O
51252	as	68 70	211261 211263	0.9999891519546509	O
51253	one	71 74	211264 211267	0.9999886751174927	O
51254	group	75 80	211268 211273	0.9999886751174927	O
51255	(	81 82	211274 211275	0.99998939037323	O
51256	non	83 86	211276 211279	0.9999886751174927	O
51257	-	86 87	211279 211280	0.9999895095825195	O
51258	MSI	87 89	211280 211282	0.9999880790710449	O
51260	-	90 91	211283 211284	0.9999896287918091	O
51261	H	91 92	211284 211285	0.9999804496765137	O
51262	)	92 93	211285 211286	0.9999896287918091	O
51263	.	94 95	211287 211288	0.9999771118164062	O
51264	Methylation	0 10	211289 211299	0.9999858140945435	O
51267	-	11 12	211300 211301	0.9999889135360718	O
51268	specific	12 20	211301 211309	0.9999868869781494	O
51269	PCR	21 23	211310 211312	0.9999871253967285	O
51271	The	25 28	211314 211317	0.9999867677688599	O
51272	presence	29 37	211318 211326	0.9999890327453613	O
51273	or	38 40	211327 211329	0.9999887943267822	O
51274	absence	41 48	211330 211337	0.9999880790710449	O
51275	of	49 51	211338 211340	0.9999890327453613	O
51276	hMLH1	52 56	211341 211345	0.9999878406524658	O
51279	and	58 61	211347 211350	0.9999880790710449	O
51280	p16	62 64	211351 211353	0.9999886751174927	O
51282	methylation	66 76	211355 211365	0.999988317489624	O
51285	in	78 80	211367 211369	0.9999885559082031	O
51286	cancers	81 87	211370 211376	0.9999809265136719	O
51288	was	89 92	211378 211381	0.9999889135360718	O
51289	determined	93 103	211382 211392	0.9999889135360718	O
51290	by	104 106	211393 211395	0.9999890327453613	O
51291	comparing	107 116	211396 211405	0.9999881982803345	O
51292	the	117 120	211406 211409	0.9999891519546509	O
51293	signals	121 128	211410 211417	0.9999858140945435	O
51294	from	129 133	211418 211422	0.9999887943267822	O
51295	tumor	134 139	211423 211428	0.9999845027923584	O
51296	-	139 140	211428 211429	0.9999890327453613	O
51297	derived	140 147	211429 211436	0.9999871253967285	O
51298	tissues	148 155	211437 211444	0.999987006187439	O
51299	with	156 160	211445 211449	0.9999871253967285	O
51300	those	161 166	211450 211455	0.9999880790710449	O
51301	from	167 171	211456 211460	0.9999879598617554	O
51302	normal	172 178	211461 211467	0.9999805688858032	O
51303	,	179 180	211468 211469	0.9999830722808838	O
51304	non	181 184	211470 211473	0.9999841451644897	O
51305	-	184 185	211473 211474	0.9999861717224121	O
51306	cancerous	185 193	211474 211482	0.9999853372573853	O
51308	tissues	195 202	211484 211491	0.9999864101409912	O
51309	,	203 204	211492 211493	0.9999878406524658	O
51310	as	205 207	211494 211496	0.9999886751174927	O
51311	previously	208 218	211497 211507	0.9999881982803345	O
51312	described	219 228	211508 211517	0.999988317489624	O
51313	[	229 230	211518 211519	0.9999892711639404	O
51314	3	230 231	211519 211520	0.9999871253967285	O
51315	,	231 232	211520 211521	0.999988317489624	O
51316	4	232 233	211521 211522	0.999984860420227	O
51317	]	233 234	211522 211523	0.9999890327453613	O
51318	.	235 236	211524 211525	0.9999765157699585	O
51319	DNA	0 3	211526 211529	0.9999790191650391	O
51320	was	4 7	211530 211533	0.9999876022338867	O
51321	extracted	8 17	211534 211543	0.9999872446060181	O
51322	from	18 22	211544 211548	0.9999879598617554	O
51323	the	23 26	211549 211552	0.9999858140945435	O
51324	samples	27 34	211553 211560	0.9999840259552002	O
51325	using	35 40	211561 211566	0.9999891519546509	O
51326	a	41 42	211567 211568	0.9999895095825195	O
51327	Gentra	43 48	211569 211574	0.9999885559082031	O
51329	DNA	50 53	211576 211579	0.9999878406524658	O
51330	extraction	54 64	211580 211590	0.9999887943267822	O
51331	kit	65 68	211591 211594	0.9999889135360718	O
51332	(	69 70	211595 211596	0.9999895095825195	O
51333	Gentra	71 76	211597 211602	0.9999885559082031	O
51335	)	78 79	211604 211605	0.9999898672103882	O
51336	and	80 83	211606 211609	0.9999880790710449	O
51337	was	84 87	211610 211613	0.9999892711639404	O
51338	modified	88 96	211614 211622	0.9999880790710449	O
51339	using	97 102	211623 211628	0.9999896287918091	O
51340	DNA	103 106	211629 211632	0.9999876022338867	O
51341	modification	107 119	211633 211645	0.9999881982803345	O
51342	kits	120 124	211646 211650	0.9999880790710449	O
51343	as	125 127	211651 211653	0.9999895095825195	O
51344	recommended	128 139	211654 211665	0.9999892711639404	O
51345	by	140 142	211666 211668	0.99998939037323	O
51346	the	143 146	211669 211672	0.9999886751174927	O
51347	manufacturers	147 160	211673 211686	0.999984860420227	O
51348	(	161 162	211687 211688	0.9999896287918091	O
51349	Zymo	163 166	211689 211692	0.9999877214431763	O
51352	Research	168 176	211694 211702	0.9999876022338867	O
51353	)	177 178	211703 211704	0.9999898672103882	O
51354	.	179 180	211705 211706	0.9999738931655884	O
51355	MSP	0 2	211707 211709	0.9999840259552002	O
51357	was	4 7	211711 211714	0.9999858140945435	O
51358	used	8 12	211715 211719	0.9999867677688599	O
51359	to	13 15	211720 211722	0.9999881982803345	O
51360	distinguish	16 27	211723 211734	0.9999876022338867	O
51361	unmethylated	28 39	211735 211746	0.9999886751174927	O
51365	from	41 45	211748 211752	0.9999876022338867	O
51366	methylated	46 55	211753 211762	0.9999867677688599	O
51369	alleles	57 63	211764 211770	0.9999887943267822	O
51372	,	65 66	211772 211773	0.999988317489624	O
51373	based	67 72	211774 211779	0.9999891519546509	O
51374	on	73 75	211780 211782	0.9999891519546509	O
51375	sequence	76 84	211783 211791	0.9999858140945435	O
51376	alterations	85 96	211792 211803	0.9999880790710449	O
51377	produced	97 105	211804 211812	0.999988317489624	O
51378	by	106 108	211813 211815	0.9999890327453613	O
51379	bisulfite	109 117	211816 211824	0.9999886751174927	O
51383	treatment	119 128	211826 211835	0.999988317489624	O
51384	of	129 131	211836 211838	0.9999885559082031	O
51385	DNA	132 135	211839 211842	0.9999862909317017	O
51386	,	136 137	211843 211844	0.9999873638153076	O
51387	to	138 140	211845 211847	0.9999892711639404	O
51388	convert	141 148	211848 211855	0.999987006187439	O
51389	unmethylated	149 160	211856 211867	0.9999886751174927	O
51393	cytosines	162 170	211869 211877	0.9999889135360718	O
51397	to	172 174	211879 211881	0.9999877214431763	O
51398	uracil	175 180	211882 211887	0.9999862909317017	O
51401	.	182 183	211889 211890	0.9999662637710571	O
51402	These	0 5	211891 211896	0.9999849796295166	O
51403	changes	6 13	211897 211904	0.9999837875366211	O
51404	are	14 17	211905 211908	0.999982476234436	O
51405	identified	18 28	211909 211919	0.999984622001648	O
51406	by	29 31	211920 211922	0.9999862909317017	O
51407	subsequent	32 42	211923 211933	0.9999810457229614	O
51408	PCR	43 45	211934 211936	0.9999861717224121	O
51410	using	47 52	211938 211943	0.9999867677688599	O
51411	primers	53 59	211944 211950	0.9999868869781494	O
51413	specific	61 69	211952 211960	0.9999884366989136	O
51414	to	70 72	211961 211963	0.999988317489624	O
51415	the	73 76	211964 211967	0.9999881982803345	O
51416	methylated	77 86	211968 211977	0.9999877214431763	O
51419	(	88 89	211979 211980	0.9999891519546509	O
51420	unchanged	89 98	211980 211989	0.9999887943267822	O
51421	)	99 100	211990 211991	0.9999889135360718	O
51422	or	101 103	211992 211994	0.9999841451644897	O
51423	unmethylated	104 115	211995 212006	0.9999879598617554	O
51427	(	117 118	212008 212009	0.9999892711639404	O
51428	changed	119 126	212010 212017	0.9999876022338867	O
51429	)	127 128	212018 212019	0.9999892711639404	O
51430	DNA	129 132	212020 212023	0.9999847412109375	O
51431	.	133 134	212024 212025	0.9999649524688721	O
51432	Briefly	0 6	212026 212032	0.9999711513519287	O
51435	,	8 9	212034 212035	0.999988317489624	O
51436	1	10 11	212036 212037	0.999985933303833	O
51437	μg	12 13	212038 212039	0.9999786615371704	O
51439	of	15 17	212041 212043	0.9999865293502808	O
51440	genomic	18 24	212044 212050	0.9999864101409912	O
51443	DNA	26 29	212052 212055	0.9999798536300659	O
51444	was	30 33	212056 212059	0.9999884366989136	O
51445	denatured	34 42	212060 212068	0.9999867677688599	O
51448	by	44 46	212070 212072	0.9999890327453613	O
51449	treatment	47 56	212073 212082	0.9999881982803345	O
51450	with	57 61	212083 212087	0.9999884366989136	O
51451	NaOH	62 65	212088 212091	0.9999855756759644	O
51453	and	67 70	212093 212096	0.9999874830245972	O
51454	was	71 74	212097 212100	0.9999887943267822	O
51455	modified	75 83	212101 212109	0.9999861717224121	O
51456	by	84 86	212110 212112	0.9999887943267822	O
51457	the	87 90	212113 212116	0.9999887943267822	O
51458	addition	91 99	212117 212125	0.9999872446060181	O
51459	of	100 102	212126 212128	0.9999889135360718	O
51460	sodium	103 109	212129 212135	0.9999877214431763	O
51461	bisulfite	110 118	212136 212144	0.999988317489624	O
51465	.	120 121	212146 212147	0.999974250793457	O
51466	DNA	0 3	212148 212151	0.9999773502349854	O
51467	samples	4 11	212152 212159	0.9999814033508301	O
51468	were	12 16	212160 212164	0.9999855756759644	O
51469	purified	17 24	212165 212172	0.9999843835830688	O
51471	using	26 31	212174 212179	0.9999878406524658	O
51472	Wizard	32 38	212180 212186	0.9999793767929077	O
51473	DNA	39 42	212187 212190	0.999985933303833	O
51474	purification	43 54	212191 212202	0.9999868869781494	O
51476	resin	56 60	212204 212208	0.999988317489624	O
51478	according	62 71	212210 212219	0.9999881982803345	O
51479	to	72 74	212220 212222	0.9999891519546509	O
51480	the	75 78	212223 212226	0.9999884366989136	O
51481	manufacturer	79 91	212227 212239	0.9999860525131226	O
51482	'	92 93	212240 212241	0.9999890327453613	O
51483	s	93 94	212241 212242	0.9999889135360718	O
51484	instructions	95 107	212243 212255	0.9999873638153076	O
51485	(	108 109	212256 212257	0.9999891519546509	O
51486	Promega	110 116	212258 212264	0.9999885559082031	O
51489	)	118 119	212266 212267	0.99998939037323	O
51490	.	120 121	212268 212269	0.9999693632125854	O
51491	These	0 5	212270 212275	0.9999827146530151	O
51492	DNA	6 9	212276 212279	0.9999721050262451	O
51493	samples	10 17	212280 212287	0.9999812841415405	O
51494	were	18 22	212288 212292	0.9999856948852539	O
51495	again	23 28	212293 212298	0.9999831914901733	O
51496	treated	29 36	212299 212306	0.9999837875366211	O
51497	with	37 41	212307 212311	0.9999864101409912	O
51498	NaOH	42 45	212312 212315	0.9999845027923584	O
51500	,	47 48	212317 212318	0.9999867677688599	O
51501	then	49 53	212319 212323	0.999984622001648	O
51502	precipitated	54 65	212324 212335	0.9999871253967285	O
51506	with	67 71	212337 212341	0.9999862909317017	O
51507	ethanol	72 79	212342 212349	0.9999812841415405	O
51508	and	80 83	212350 212353	0.9999864101409912	O
51509	resuspended	84 94	212354 212364	0.9999876022338867	O
51513	in	96 98	212366 212368	0.9999862909317017	O
51514	water	99 104	212369 212374	0.9999818801879883	O
51515	.	105 106	212375 212376	0.9999518394470215	O
51516	PCR	0 2	212377 212379	0.999984860420227	O
51518	reactions	4 13	212381 212390	0.9999840259552002	O
51519	were	14 18	212391 212395	0.9999874830245972	O
51520	performed	19 28	212396 212405	0.9999866485595703	O
51521	using	29 34	212406 212411	0.9999887943267822	O
51522	the	35 38	212412 212415	0.9999887943267822	O
51523	primer	39 44	212416 212421	0.9999874830245972	O
51525	pairs	46 51	212423 212428	0.9999872446060181	O
51526	described	52 61	212429 212438	0.9999885559082031	O
51527	below	62 67	212439 212444	0.9999843835830688	O
51528	in	68 70	212445 212447	0.9999886751174927	O
51529	the	71 74	212448 212451	0.99998939037323	O
51530	following	75 84	212452 212461	0.9999890327453613	O
51531	reaction	85 93	212462 212470	0.9999881982803345	O
51532	mix	94 97	212471 212474	0.9999884366989136	O
51533	:	98 99	212475 212476	0.9999890327453613	O
51534	10×	100 102	212477 212479	0.9999876022338867	O
51536	PCR	104 106	212481 212483	0.9999873638153076	O
51538	buffer	108 114	212485 212491	0.9999856948852539	O
51539	[	115 116	212492 212493	0.9999887943267822	O
51540	16	116 118	212493 212495	0.9999878406524658	O
51541	.	118 119	212495 212496	0.9999892711639404	O
51542	6	119 120	212496 212497	0.9999886751174927	O
51543	mM	121 122	212498 212499	0.9999887943267822	O
51545	ammonium	124 131	212501 212508	0.9999887943267822	O
51548	sulfate	133 139	212510 212516	0.9999885559082031	O
51551	,	141 142	212518 212519	0.9999887943267822	O
51552	67	143 145	212520 212522	0.999984622001648	O
51553	mM	146 147	212523 212524	0.9999887943267822	O
51555	Tris	149 152	212526 212529	0.9999858140945435	O
51557	(	154 155	212531 212532	0.9999891519546509	O
51558	pH	156 158	212533 212535	0.9999884366989136	O
51559	8	159 160	212536 212537	0.9999885559082031	O
51560	.	160 161	212537 212538	0.9999889135360718	O
51561	8	161 162	212538 212539	0.999988317489624	O
51562	)	163 164	212540 212541	0.9999891519546509	O
51563	,	165 166	212542 212543	0.9999889135360718	O
51564	6	167 168	212544 212545	0.9999881982803345	O
51565	.	168 169	212545 212546	0.9999891519546509	O
51566	7	169 170	212546 212547	0.9999880790710449	O
51567	mM	171 172	212548 212549	0.9999886751174927	O
51569	MgCl2	174 178	212551 212555	0.9999868869781494	O
51574	,	180 181	212557 212558	0.9999885559082031	O
51575	and	182 185	212559 212562	0.9999886751174927	O
51576	10	186 188	212563 212565	0.9999874830245972	O
51577	mM	189 190	212566 212567	0.9999887943267822	O
51579	2	192 193	212569 212570	0.9999873638153076	O
51580	-	193 194	212570 212571	0.9999889135360718	O
51581	mercaptoethanol	194 208	212571 212585	0.9999881982803345	O
51587	]	209 210	212586 212587	0.9999854564666748	O
51588	,	211 212	212588 212589	0.9999885559082031	O
51589	dNTPs	213 217	212590 212594	0.9999878406524658	O
51592	(	219 220	212596 212597	0.9999892711639404	O
51593	each	221 225	212598 212602	0.9999885559082031	O
51594	at	226 228	212603 212605	0.9999890327453613	O
51595	1	229 230	212606 212607	0.9999889135360718	O
51596	.	230 231	212607 212608	0.9999892711639404	O
51597	25	231 233	212608 212610	0.9999877214431763	O
51598	mM	234 235	212611 212612	0.9999887943267822	O
51600	)	236 237	212613 212614	0.99998939037323	O
51601	,	238 239	212615 212616	0.9999889135360718	O
51602	primers	240 246	212617 212623	0.9999871253967285	O
51604	(	248 249	212625 212626	0.9999892711639404	O
51605	50	250 252	212627 212629	0.9999877214431763	O
51606	pmol	253 256	212630 212633	0.9999881982803345	O
51608	each	258 262	212635 212639	0.9999889135360718	O
51609	per	263 266	212640 212643	0.9999887943267822	O
51610	reaction	267 275	212644 212652	0.999987006187439	O
51611	)	276 277	212653 212654	0.9999895095825195	O
51612	,	278 279	212655 212656	0.9999886751174927	O
51613	and	280 283	212657 212660	0.9999886751174927	O
51614	bisulfite	284 292	212661 212669	0.9999874830245972	O
51618	-	293 294	212670 212671	0.99998939037323	O
51619	modified	294 302	212671 212679	0.9999877214431763	O
51620	DNA	303 306	212680 212683	0.9999874830245972	O
51621	(	307 308	212684 212685	0.99998939037323	O
51622	50	309 311	212686 212688	0.9999874830245972	O
51623	ng	312 314	212689 212691	0.9999885559082031	O
51624	)	315 316	212692 212693	0.99998939037323	O
51625	in	317 319	212694 212696	0.9999892711639404	O
51626	a	320 321	212697 212698	0.99998939037323	O
51627	final	322 327	212699 212704	0.999988317489624	O
51628	volume	328 334	212705 212711	0.9999880790710449	O
51629	of	335 337	212712 212714	0.9999890327453613	O
51630	50	338 340	212715 212717	0.9999877214431763	O
51631	μl	341 342	212718 212719	0.9999864101409912	O
51633	.	344 345	212721 212722	0.9999738931655884	O
51634	Reactions	0 8	212723 212731	0.9999842643737793	O
51636	were	10 14	212733 212737	0.9999880790710449	O
51637	hot	15 18	212738 212741	0.999982476234436	O
51638	-	18 19	212741 212742	0.9999881982803345	O
51639	started	19 26	212742 212749	0.9999865293502808	O
51640	at	27 29	212750 212752	0.9999885559082031	O
51641	95°C	30 33	212753 212756	0.9999866485595703	O
51644	for	35 38	212758 212761	0.99998939037323	O
51645	5	39 40	212762 212763	0.999988317489624	O
51646	min	41 44	212764 212767	0.9999871253967285	O
51647	,	45 46	212768 212769	0.9999885559082031	O
51648	after	47 52	212770 212775	0.9999878406524658	O
51649	which	53 58	212776 212781	0.9999892711639404	O
51650	1	59 60	212782 212783	0.9999889135360718	O
51651	.	60 61	212783 212784	0.9999891519546509	O
51652	25	61 63	212784 212786	0.9999877214431763	O
51653	units	64 69	212787 212792	0.9999880790710449	O
51654	of	70 72	212793 212795	0.9999891519546509	O
51655	Taq	73 75	212796 212798	0.9999880790710449	O
51657	polymerase	77 86	212800 212809	0.999988317489624	O
51659	(	88 89	212811 212812	0.99998939037323	O
51660	Life	90 94	212813 212817	0.9999878406524658	O
51661	Technologies	95 107	212818 212830	0.9999868869781494	O
51662	,	108 109	212831 212832	0.9999885559082031	O
51663	Inc	110 113	212833 212836	0.9999889135360718	O
51664	.	113 114	212836 212837	0.9999884366989136	O
51665	)	115 116	212838 212839	0.9999896287918091	O
51666	were	117 121	212840 212844	0.9999890327453613	O
51667	added	122 127	212845 212850	0.999988317489624	O
51668	.	128 129	212851 212852	0.9999756813049316	O
51669	Amplification	0 12	212853 212865	0.9999868869781494	O
51672	was	14 17	212867 212870	0.9999876022338867	O
51673	carried	18 25	212871 212878	0.9999884366989136	O
51674	out	26 29	212879 212882	0.9999886751174927	O
51675	in	30 32	212883 212885	0.999988317489624	O
51676	an	33 35	212886 212888	0.9999885559082031	O
51677	Applied	36 43	212889 212896	0.9999818801879883	O
51678	Biosystem	44 52	212897 212905	0.9999865293502808	O
51682	temperature	54 65	212907 212918	0.9999876022338867	O
51683	cycler	66 71	212919 212924	0.999988317489624	O
51685	for	73 76	212926 212929	0.9999892711639404	O
51686	40	77 79	212930 212932	0.9999877214431763	O
51687	cycles	80 86	212933 212939	0.9999884366989136	O
51688	(	87 88	212940 212941	0.9999895095825195	O
51689	30	89 91	212942 212944	0.9999889135360718	O
51690	sec	92 94	212945 212947	0.9999892711639404	O
51692	at	96 98	212949 212951	0.9999892711639404	O
51693	95°C	99 102	212952 212955	0.999988317489624	O
51696	,	104 105	212957 212958	0.9999890327453613	O
51697	30	106 108	212959 212961	0.9999887943267822	O
51698	sec	109 111	212962 212964	0.9999890327453613	O
51700	at	113 115	212966 212968	0.9999892711639404	O
51701	59°C	116 119	212969 212972	0.9999852180480957	O
51704	then	121 125	212974 212978	0.9999877214431763	O
51705	30	126 128	212979 212981	0.9999885559082031	O
51706	sec	129 131	212982 212984	0.9999890327453613	O
51708	at	133 135	212986 212988	0.9999890327453613	O
51709	72°C	136 139	212989 212992	0.9999885559082031	O
51712	)	141 142	212994 212995	0.9999891519546509	O
51713	,	143 144	212996 212997	0.9999887943267822	O
51714	followed	145 153	212998 213006	0.9999885559082031	O
51715	by	154 156	213007 213009	0.9999892711639404	O
51716	a	157 158	213010 213011	0.99998939037323	O
51717	final	159 164	213012 213017	0.9999885559082031	O
51718	4	165 166	213018 213019	0.9999879598617554	O
51719	-	166 167	213019 213020	0.9999892711639404	O
51720	min	167 170	213020 213023	0.9999885559082031	O
51721	extension	171 180	213024 213033	0.9999876022338867	O
51722	at	181 183	213034 213036	0.9999891519546509	O
51723	72°C	184 187	213037 213040	0.9999880790710449	O
51726	.	188 189	213041 213042	0.9999673366546631	O
51727	Two	0 3	213043 213046	0.9999843835830688	O
51728	sets	4 8	213047 213051	0.9999862909317017	O
51729	of	9 11	213052 213054	0.9999884366989136	O
51730	primers	12 18	213055 213061	0.9999860525131226	O
51732	were	20 24	213063 213067	0.9999865293502808	O
51733	used	25 29	213068 213072	0.9999862909317017	O
51734	simultaneously	30 44	213073 213087	0.999984860420227	O
51735	to	45 47	213088 213090	0.9999884366989136	O
51736	check	48 53	213091 213096	0.9999865293502808	O
51737	for	54 57	213097 213100	0.9999886751174927	O
51738	methylated	58 67	213101 213110	0.9999877214431763	O
51741	or	69 71	213112 213114	0.9999877214431763	O
51742	unmethylated	72 83	213115 213126	0.9999886751174927	O
51746	CpG	85 87	213128 213130	0.9999885559082031	O
51749	islands	89 96	213132 213139	0.9999884366989136	O
51750	at	97 99	213140 213142	0.9999892711639404	O
51751	the	100 103	213143 213146	0.9999895095825195	O
51752	level	104 109	213147 213152	0.9999892711639404	O
51753	of	110 112	213153 213155	0.9999895095825195	O
51754	hMLH1	113 117	213156 213160	0.9999884366989136	O
51757	and	119 122	213162 213165	0.9999884366989136	O
51758	p16	123 125	213166 213168	0.9999891519546509	O
51760	promoters	127 135	213170 213178	0.9999885559082031	O
51762	.	137 138	213180 213181	0.9999644756317139	O
51763	The	0 3	213182 213185	0.9999827146530151	O
51764	primer	4 9	213186 213191	0.999982476234436	O
51766	sequences	11 20	213193 213202	0.9999802112579346	O
51767	were	21 25	213203 213207	0.9999836683273315	O
51768	as	26 28	213208 213210	0.9999815225601196	O
51769	in	29 31	213211 213213	0.999984860420227	O
51770	our	32 35	213214 213217	0.9999843835830688	O
51771	previous	36 44	213218 213226	0.9999823570251465	O
51772	study	45 50	213227 213232	0.9999845027923584	O
51773	[	51 52	213233 213234	0.9999876022338867	O
51774	4	52 53	213234 213235	0.999981164932251	O
51775	]	53 54	213235 213236	0.9999868869781494	O
51776	.	55 56	213237 213238	0.999964714050293	O
51777	Controls	0 7	213239 213246	0.9999483823776245	O
51779	for	9 12	213248 213251	0.9999817609786987	O
51780	methylated	13 22	213252 213261	0.999984860420227	O
51783	and	24 27	213263 213266	0.9999834299087524	O
51784	unmethylated	28 39	213267 213278	0.9999860525131226	O
51788	DNA	41 44	213280 213283	0.9999836683273315	O
51789	were	45 49	213284 213288	0.9999830722808838	O
51790	DNA	50 53	213289 213292	0.9999812841415405	O
51791	from	54 58	213293 213297	0.9999843835830688	O
51792	the	59 62	213298 213301	0.9999839067459106	O
51793	SW48	63 66	213302 213305	0.9999841451644897	O
51796	colon	68 72	213307 213311	0.9999784231185913	O
51798	cancer	74 80	213313 213319	0.9999823570251465	O
51799	cell	81 85	213320 213324	0.9999772310256958	O
51800	line	86 90	213325 213329	0.9999819993972778	O
51801	and	91 94	213330 213333	0.9999823570251465	O
51802	normal	95 101	213334 213340	0.9999700784683228	O
51803	lymphocytes	102 112	213341 213351	0.9999831914901733	O
51806	,	114 115	213353 213354	0.9999864101409912	O
51807	respectively	116 128	213355 213367	0.9999845027923584	O
51808	.	129 130	213368 213369	0.999950647354126	O
51809	Each	0 4	213370 213374	0.9999843835830688	O
51810	PCR	5 7	213375 213377	0.9999856948852539	O
51812	reaction	9 17	213379 213387	0.999983549118042	O
51813	product	18 25	213388 213395	0.9999843835830688	O
51814	(	26 27	213396 213397	0.9999874830245972	O
51815	10	28 30	213398 213400	0.9999855756759644	O
51816	μl	31 32	213401 213402	0.9999831914901733	O
51818	)	34 35	213404 213405	0.9999881982803345	O
51819	was	36 39	213406 213409	0.9999864101409912	O
51820	directly	40 48	213410 213418	0.9999861717224121	O
51821	loaded	49 55	213419 213425	0.9999858140945435	O
51822	into	56 60	213426 213430	0.9999874830245972	O
51823	a	61 62	213431 213432	0.9999884366989136	O
51824	2	63 64	213433 213434	0.9999852180480957	O
51825	%	65 66	213435 213436	0.9999878406524658	O
51826	agarose	67 73	213437 213443	0.999988317489624	O
51829	gel	75 78	213445 213448	0.9999854564666748	O
51830	,	79 80	213449 213450	0.9999876022338867	O
51831	which	81 86	213451 213456	0.999988317489624	O
51832	was	87 90	213457 213460	0.9999878406524658	O
51833	later	91 96	213461 213466	0.9999821186065674	O
51834	stained	97 104	213467 213474	0.9999854564666748	O
51835	with	105 109	213475 213479	0.9999878406524658	O
51836	ethidium	110 117	213480 213487	0.9999878406524658	O
51839	bromide	119 125	213489 213495	0.9999877214431763	O
51842	to	127 129	213497 213499	0.9999879598617554	O
51843	allow	130 135	213500 213505	0.9999873638153076	O
51844	DNA	136 139	213506 213509	0.999983549118042	O
51845	visualization	140 152	213510 213522	0.9999872446060181	O
51847	under	154 159	213524 213529	0.9999868869781494	O
51848	UV	160 162	213530 213532	0.9999854564666748	O
51849	illumination	163 175	213533 213545	0.9999858140945435	O
51850	.	176 177	213546 213547	0.9999603033065796	O
51851	The	0 3	213548 213551	0.9999885559082031	O
51852	presence	4 12	213552 213560	0.9999889135360718	O
51853	of	13 15	213561 213563	0.9999892711639404	O
51854	a	16 17	213564 213565	0.9999891519546509	O
51855	band	18 22	213566 213570	0.9999858140945435	O
51856	in	23 25	213571 213573	0.99998939037323	O
51857	unmethylated	26 37	213574 213585	0.9999890327453613	O
51861	tumor	39 44	213587 213592	0.9999861717224121	O
51862	and	45 48	213593 213596	0.9999878406524658	O
51863	matched	49 56	213597 213604	0.9999840259552002	O
51864	normal	57 63	213605 213611	0.9999821186065674	O
51865	with	64 68	213612 213616	0.9999889135360718	O
51866	the	69 72	213617 213620	0.9999895095825195	O
51867	absence	73 80	213621 213628	0.9999891519546509	O
51868	of	81 83	213629 213631	0.99998939037323	O
51869	a	84 85	213632 213633	0.9999892711639404	O
51870	methylation	86 96	213634 213644	0.9999877214431763	O
51873	band	98 102	213646 213650	0.999988317489624	O
51874	in	103 105	213651 213653	0.9999890327453613	O
51875	the	106 109	213654 213657	0.9999874830245972	O
51876	tumor	110 115	213658 213663	0.9999855756759644	O
51877	was	116 119	213664 213667	0.9999886751174927	O
51878	defined	120 127	213668 213675	0.9999880790710449	O
51879	as	128 130	213676 213678	0.9999895095825195	O
51880	unmethylated	131 142	213679 213690	0.9999890327453613	O
51884	.	144 145	213692 213693	0.9999701976776123	O
51885	However	0 7	213694 213701	0.9999871253967285	O
51886	,	8 9	213702 213703	0.9999885559082031	O
51887	when	10 14	213704 213708	0.9999879598617554	O
51888	a	15 16	213709 213710	0.9999886751174927	O
51889	methylated	17 26	213711 213720	0.9999880790710449	O
51892	band	28 32	213722 213726	0.9999872446060181	O
51893	was	33 36	213727 213730	0.9999886751174927	O
51894	present	37 44	213731 213738	0.999988317489624	O
51895	for	45 48	213739 213742	0.9999878406524658	O
51896	tumor	49 54	213743 213748	0.9999862909317017	O
51897	and	55 58	213749 213752	0.9999880790710449	O
51898	absent	59 65	213753 213759	0.999987006187439	O
51899	for	66 69	213760 213763	0.9999880790710449	O
51900	the	70 73	213764 213767	0.9999881982803345	O
51901	normal	74 80	213768 213774	0.9999841451644897	O
51902	,	81 82	213775 213776	0.9999889135360718	O
51903	we	83 85	213777 213779	0.999988317489624	O
51904	defined	86 93	213780 213787	0.9999879598617554	O
51905	the	94 97	213788 213791	0.9999879598617554	O
51906	sample	98 104	213792 213798	0.9999862909317017	O
51907	as	105 107	213799 213801	0.9999887943267822	O
51908	methylated	108 117	213802 213811	0.9999881982803345	O
51911	(	119 120	213813 213814	0.9999890327453613	O
51912	or	121 123	213815 213817	0.9999884366989136	O
51913	semi	124 128	213818 213822	0.9999874830245972	O
51914	-	128 129	213822 213823	0.9999886751174927	O
51915	methylated	129 138	213823 213832	0.9999879598617554	O
51918	if	140 142	213834 213836	0.999987006187439	O
51919	both	143 147	213837 213841	0.9999873638153076	O
51920	unmethylated	148 159	213842 213853	0.999988317489624	O
51924	or	161 163	213855 213857	0.9999880790710449	O
51925	methylated	164 173	213858 213867	0.9999876022338867	O
51928	bands	175 180	213869 213874	0.9999872446060181	O
51929	were	181 185	213875 213879	0.9999884366989136	O
51930	present	186 193	213880 213887	0.9999884366989136	O
51931	in	194 196	213888 213890	0.9999886751174927	O
51932	the	197 200	213891 213894	0.9999876022338867	O
51933	tumor	201 206	213895 213900	0.9999858140945435	O
51934	)	207 208	213901 213902	0.9999884366989136	O
51935	.	209 210	213903 213904	0.9999890327453613	O
51936	*	211 212	213905 213906	0.9999877214431763	O
51937	*	212 213	213906 213907	0.9999698400497437	O
51938	IGNORE	0 5	213908 213913	0.9999873638153076	O
51941	LINE	7 10	213915 213918	0.9999896287918091	O
51944	*	12 13	213920 213921	0.9999896287918091	O
51945	*	13 14	213921 213922	0.9999896287918091	O
51946	*	15 16	213923 213924	0.9999895095825195	O
51947	*	16 17	213924 213925	0.9999896287918091	O
51948	IGNORE	18 23	213926 213931	0.999988317489624	O
51951	LINE	25 28	213933 213936	0.9999897480010986	O
51954	*	30 31	213938 213939	0.99998939037323	O
51955	*	31 32	213939 213940	0.99998939037323	O
51956	*	33 34	213941 213942	0.9999892711639404	O
51957	*	34 35	213942 213943	0.9999892711639404	O
51958	IGNORE	36 41	213944 213949	0.9999879598617554	O
51961	LINE	43 46	213951 213954	0.9999896287918091	O
51964	*	48 49	213956 213957	0.9999892711639404	O
51965	*	49 50	213957 213958	0.9999892711639404	O
51966	Multivariate	51 62	213959 213970	0.99998939037323	O
51969	analysis	64 72	213972 213980	0.9999897480010986	O
51970	for	73 76	213981 213984	0.9999896287918091	O
51971	the	77 80	213985 213988	0.9999897480010986	O
51972	risk	81 85	213989 213993	0.9999892711639404	O
51973	factors	86 93	213994 214001	0.99998939037323	O
51974	associated	94 104	214002 214012	0.9999897480010986	O
51975	with	105 109	214013 214017	0.9999897480010986	O
51976	MSI	110 112	214018 214020	0.9999831914901733	O
51978	-	113 114	214021 214022	0.9999895095825195	O
51979	H	114 115	214022 214023	0.9999827146530151	O
51980	occurrence	116 126	214024 214034	0.999988317489624	O
51981	(	127 128	214035 214036	0.9999899864196777	O
51982	Model	129 134	214037 214042	0.9999885559082031	O
51983	including	135 144	214043 214052	0.9999898672103882	O
51984	single	145 151	214053 214059	0.9999895095825195	O
51985	term	152 156	214060 214064	0.9999897480010986	O
51986	and	157 160	214065 214068	0.9999891519546509	O
51987	interactions	161 173	214069 214081	0.9999884366989136	O
51988	effect	174 180	214082 214088	0.9999892711639404	O
51989	)	181 182	214089 214090	0.9999897480010986	O
51990	*	183 184	214091 214092	0.9999891519546509	O
51991	indicates	185 194	214093 214102	0.9999884366989136	O
51992	the	195 198	214103 214106	0.9999897480010986	O
51993	interaction	199 210	214107 214118	0.9999884366989136	O
51994	term	211 215	214119 214123	0.9999897480010986	O
51995	between	216 223	214124 214131	0.9999892711639404	O
51996	two	224 227	214132 214135	0.9999874830245972	O
51997	variables	228 237	214136 214145	0.9999866485595703	O
51998	.	238 239	214146 214147	0.9999752044677734	O
51999	Correlation	0 10	214148 214158	0.9999834299087524	O
52002	between	12 19	214160 214167	0.9999866485595703	O
52003	hMLH1	20 24	214168 214172	0.9999879598617554	O
52006	protein	26 33	214174 214181	0.999987006187439	O
52007	expression	34 44	214182 214192	0.9999877214431763	O
52008	and	45 48	214193 214196	0.9999881982803345	O
52009	MSI	49 51	214197 214199	0.9999858140945435	O
52011	status	53 59	214201 214207	0.9999881982803345	O
52012	Expression	60 69	214208 214217	0.9999872446060181	O
52014	of	71 73	214219 214221	0.9999884366989136	O
52015	the	74 77	214222 214225	0.9999877214431763	O
52016	hMLH1	78 82	214226 214230	0.9999885559082031	O
52019	and	84 87	214232 214235	0.9999876022338867	O
52020	hMSH2	88 92	214236 214240	0.9999884366989136	O
52024	nuclear	94 101	214242 214249	0.9999861717224121	O
52025	proteins	102 110	214250 214258	0.9999874830245972	O
52026	was	111 114	214259 214262	0.999988317489624	O
52027	examined	115 123	214263 214271	0.9999867677688599	O
52028	immunohistochemically	124 144	214272 214292	0.9999890327453613	O
52035	in	146 148	214294 214296	0.9999886751174927	O
52036	paraffin	149 156	214297 214304	0.9999871253967285	O
52038	-	157 158	214305 214306	0.9999891519546509	O
52039	embedded	158 166	214306 214314	0.9999864101409912	O
52040	tissue	167 173	214315 214321	0.9999866485595703	O
52041	sections	174 182	214322 214330	0.9999855756759644	O
52042	[	183 184	214331 214332	0.9999895095825195	O
52043	4	184 185	214332 214333	0.9999867677688599	O
52044	]	185 186	214333 214334	0.9999892711639404	O
52045	.	187 188	214335 214336	0.9999761581420898	O
52046	In	0 2	214337 214339	0.9999799728393555	O
52047	all	3 6	214340 214343	0.9999786615371704	O
52048	cases	7 12	214344 214349	0.9999808073043823	O
52049	,	13 14	214350 214351	0.9999841451644897	O
52050	non	15 18	214352 214355	0.9999740123748779	O
52051	-	18 19	214355 214356	0.9999812841415405	O
52052	neoplastic	19 28	214356 214365	0.9999804496765137	O
52055	cells	30 35	214367 214372	0.9999817609786987	O
52056	displayed	36 45	214373 214382	0.999984622001648	O
52057	positive	46 54	214383 214391	0.9999858140945435	O
52058	nuclear	55 62	214392 214399	0.9999865293502808	O
52059	staining	63 70	214400 214407	0.9999872446060181	O
52061	for	72 75	214409 214412	0.9999876022338867	O
52062	both	76 80	214413 214417	0.9999864101409912	O
52063	hMLH1	81 85	214418 214422	0.9999867677688599	O
52066	and	87 90	214424 214427	0.9999867677688599	O
52067	hMSH2	91 95	214428 214432	0.9999872446060181	O
52071	.	97 98	214434 214435	0.9999629259109497	O
52072	The	0 3	214436 214439	0.9999862909317017	O
52073	nuclear	4 11	214440 214447	0.999984622001648	O
52074	stained	12 19	214448 214455	0.999985933303833	O
52075	slides	20 26	214456 214462	0.9999827146530151	O
52076	were	27 31	214463 214467	0.9999876022338867	O
52077	read	32 36	214468 214472	0.9999868869781494	O
52078	by	37 39	214473 214475	0.9999886751174927	O
52079	two	40 43	214476 214479	0.9999839067459106	O
52080	different	44 53	214480 214489	0.9999841451644897	O
52081	pathologists	54 65	214490 214501	0.9999847412109375	O
52083	,	67 68	214503 214504	0.9999839067459106	O
52084	and	69 72	214505 214508	0.9999877214431763	O
52085	normal	73 79	214509 214515	0.9999833106994629	O
52086	tissue	80 86	214516 214522	0.9999872446060181	O
52087	on	87 89	214523 214525	0.9999892711639404	O
52088	slides	90 96	214526 214532	0.999987006187439	O
52089	where	97 102	214533 214538	0.9999887943267822	O
52090	no	103 105	214539 214541	0.9999881982803345	O
52091	primary	106 113	214542 214549	0.9999877214431763	O
52092	antibody	114 121	214550 214557	0.9999884366989136	O
52094	stained	123 130	214559 214566	0.9999877214431763	O
52095	was	131 134	214567 214570	0.9999887943267822	O
52096	used	135 139	214571 214575	0.9999887943267822	O
52097	as	140 142	214576 214578	0.9999889135360718	O
52098	negative	143 151	214579 214587	0.9999867677688599	O
52099	control	152 159	214588 214595	0.9999878406524658	O
52100	.	160 161	214596 214597	0.999962568283081	O
52101	In	0 2	214598 214600	0.9999815225601196	O
52102	total	3 8	214601 214606	0.9999791383743286	O
52103	,	9 10	214607 214608	0.9999808073043823	O
52104	76	11 13	214609 214611	0.9999418258666992	O
52105	African	14 21	214612 214619	0.9999555349349976	O
52106	American	22 30	214620 214628	0.9999622106552124	O
52107	,	31 32	214629 214630	0.9999810457229614	O
52108	61	33 35	214631 214633	0.9999517202377319	O
52109	Omani	36 40	214634 214638	0.9999494552612305	O
52111	,	42 43	214640 214641	0.9999812841415405	O
52112	and	44 47	214642 214645	0.9999797344207764	O
52113	25	48 50	214646 214648	0.9999457597732544	O
52114	Iranian	51 58	214649 214656	0.9991932511329651	O
52115	cases	59 64	214657 214662	0.9999752044677734	O
52116	were	65 69	214663 214667	0.999980092048645	O
52117	analyzed	70 78	214668 214676	0.999976634979248	O
52118	.	79 80	214677 214678	0.9998514652252197	O
52119	Thirty	0 6	214679 214685	0.9998824596405029	O
52120	-	6 7	214685 214686	0.9999802112579346	O
52121	five	7 11	214686 214690	0.9999711513519287	O
52122	and	12 15	214691 214694	0.9999758005142212	O
52123	11	16 18	214695 214697	0.999961256980896	O
52124	%	19 20	214698 214699	0.9999802112579346	O
52125	of	21 23	214700 214702	0.9999758005142212	O
52126	African	24 31	214703 214710	0.8127093315124512	O
52127	American	32 40	214711 214719	0.6758484244346619	species
52128	tumors	41 47	214720 214726	0.999981164932251	O
52129	assayed	48 54	214727 214733	0.9999841451644897	O
52132	showed	56 62	214735 214741	0.9999836683273315	O
52133	loss	63 67	214742 214746	0.999984860420227	O
52134	of	68 70	214747 214749	0.999987006187439	O
52135	staining	71 78	214750 214757	0.9999867677688599	O
52137	for	80 83	214759 214762	0.9999876022338867	O
52138	hMLH1	84 88	214763 214767	0.9999871253967285	O
52141	and	90 93	214769 214772	0.9999862909317017	O
52142	hMSH2	94 98	214773 214777	0.9999872446060181	O
52146	,	100 101	214779 214780	0.9999862909317017	O
52147	respectively	102 114	214781 214793	0.9999836683273315	O
52148	.	115 116	214794 214795	0.9999524354934692	O
52149	Moreover	0 8	214796 214804	0.9999830722808838	O
52150	,	9 10	214805 214806	0.9999889135360718	O
52151	loss	11 15	214807 214811	0.9999861717224121	O
52152	of	16 18	214812 214814	0.9999890327453613	O
52153	hMLH1	19 23	214815 214819	0.9999889135360718	O
52156	and	25 28	214821 214824	0.999988317489624	O
52157	hMSH2	29 33	214825 214829	0.9999890327453613	O
52161	staining	35 42	214831 214838	0.9999884366989136	O
52163	was	44 47	214840 214843	0.9999891519546509	O
52164	observed	48 56	214844 214852	0.9999890327453613	O
52165	in	57 59	214853 214855	0.99998939037323	O
52166	77	60 62	214856 214858	0.9999837875366211	O
52167	%	63 64	214859 214860	0.9999884366989136	O
52168	and	65 68	214861 214864	0.9999865293502808	O
52169	5	69 70	214865 214866	0.9999829530715942	O
52170	%	71 72	214867 214868	0.9999887943267822	O
52171	of	73 75	214869 214871	0.9999885559082031	O
52172	MSI	76 78	214872 214874	0.9999872446060181	O
52174	-	79 80	214875 214876	0.9999891519546509	O
52175	H	80 81	214876 214877	0.9999798536300659	O
52176	African	82 89	214878 214885	0.999983549118042	O
52177	American	90 98	214886 214894	0.9999207258224487	O
52178	tumors	99 105	214895 214901	0.9999853372573853	O
52179	,	106 107	214902 214903	0.9999886751174927	O
52180	respectively	108 120	214904 214916	0.9999878406524658	O
52181	(	121 122	214917 214918	0.9999892711639404	O
52182	Table	123 128	214919 214924	0.9999853372573853	O
52183	1	129 130	214925 214926	0.9999880790710449	O
52184	)	131 132	214927 214928	0.9999895095825195	O
52185	.	133 134	214929 214930	0.999977707862854	O
52186	The	0 3	214931 214934	0.9999873638153076	O
52187	loss	4 8	214935 214939	0.9999854564666748	O
52188	of	9 11	214940 214942	0.9999889135360718	O
52189	hMLH1	12 16	214943 214947	0.9999886751174927	O
52192	and	18 21	214949 214952	0.9999881982803345	O
52193	hMSH2	22 26	214953 214957	0.9999889135360718	O
52197	staining	28 35	214959 214966	0.9999880790710449	O
52199	was	37 40	214968 214971	0.9999884366989136	O
52200	observed	41 49	214972 214980	0.999988317489624	O
52201	in	50 52	214981 214983	0.9999889135360718	O
52202	17	53 55	214984 214986	0.9999839067459106	O
52203	%	56 57	214987 214988	0.9999880790710449	O
52204	and	58 61	214989 214992	0.9999864101409912	O
52205	13	62 64	214993 214995	0.9999809265136719	O
52206	%	65 66	214996 214997	0.999988317489624	O
52207	of	67 69	214998 215000	0.9999880790710449	O
52208	non	70 73	215001 215004	0.9999879598617554	O
52209	-	73 74	215004 215005	0.9999891519546509	O
52210	MSI	74 76	215005 215007	0.9999873638153076	O
52212	-	77 78	215008 215009	0.9999891519546509	O
52213	H	78 79	215009 215010	0.9999818801879883	O
52214	African	80 87	215011 215018	0.999983549118042	O
52215	American	88 96	215019 215027	0.9998358488082886	O
52216	tumors	97 103	215028 215034	0.9999854564666748	O
52217	,	104 105	215035 215036	0.9999885559082031	O
52218	respectively	106 118	215037 215049	0.9999878406524658	O
52219	(	119 120	215050 215051	0.9999892711639404	O
52220	Table	121 126	215052 215057	0.999984860420227	O
52221	1	127 128	215058 215059	0.9999878406524658	O
52222	)	129 130	215060 215061	0.99998939037323	O
52223	.	131 132	215062 215063	0.9999769926071167	O
52224	In	0 2	215064 215066	0.9999854564666748	O
52225	Omani	3 7	215067 215071	0.9999593496322632	O
52227	tumors	9 15	215073 215079	0.9999864101409912	O
52228	:	16 17	215080 215081	0.9999876022338867	O
52229	38	18 20	215082 215084	0.9999814033508301	O
52230	%	21 22	215085 215086	0.9999881982803345	O
52231	(	23 24	215087 215088	0.9999890327453613	O
52232	n	25 26	215089 215090	0.9999891519546509	O
52233	=	27 28	215091 215092	0.9999890327453613	O
52234	3	29 30	215093 215094	0.9999831914901733	O
52235	)	31 32	215095 215096	0.99998939037323	O
52236	of	33 35	215097 215099	0.9999885559082031	O
52237	the	36 39	215100 215103	0.999988317489624	O
52238	MSI	40 42	215104 215106	0.9999855756759644	O
52240	-	43 44	215107 215108	0.9999889135360718	O
52241	H	44 45	215108 215109	0.9999797344207764	O
52242	tumors	46 52	215110 215116	0.9999884366989136	O
52243	showed	53 59	215117 215123	0.999988317489624	O
52244	absences	60 67	215124 215131	0.9999873638153076	O
52246	of	69 71	215133 215135	0.9999890327453613	O
52247	hMLH1	72 76	215136 215140	0.9999887943267822	O
52250	expression	78 88	215142 215152	0.9999886751174927	O
52251	(	89 90	215153 215154	0.99998939037323	O
52252	Table	91 96	215155 215160	0.9999873638153076	O
52253	2	97 98	215161 215162	0.9999886751174927	O
52254	)	99 100	215163 215164	0.99998939037323	O
52255	;	101 102	215165 215166	0.9999889135360718	O
52256	30	103 105	215167 215169	0.9999834299087524	O
52257	%	106 107	215170 215171	0.9999887943267822	O
52258	(	108 109	215172 215173	0.9999889135360718	O
52259	n	110 111	215174 215175	0.9999891519546509	O
52260	=	112 113	215176 215177	0.9999885559082031	O
52261	16	114 116	215178 215180	0.9999797344207764	O
52262	)	117 118	215181 215182	0.9999892711639404	O
52263	of	119 121	215183 215185	0.9999886751174927	O
52264	the	122 125	215186 215189	0.9999880790710449	O
52265	non	126 129	215190 215193	0.9999860525131226	O
52266	-	129 130	215193 215194	0.9999884366989136	O
52267	MSI	130 132	215194 215196	0.9999866485595703	O
52269	-	133 134	215197 215198	0.9999890327453613	O
52270	H	134 135	215198 215199	0.9999836683273315	O
52271	tumors	136 142	215200 215206	0.9999884366989136	O
52272	had	143 146	215207 215210	0.9999887943267822	O
52273	negative	147 155	215211 215219	0.9999856948852539	O
52274	hMLH1	156 160	215220 215224	0.9999889135360718	O
52277	.	162 163	215226 215227	0.999976396560669	O
52278	Fifty	0 5	215228 215233	0.9999719858169556	O
52279	-	5 6	215233 215234	0.9999884366989136	O
52280	six	6 9	215234 215237	0.9999809265136719	O
52281	cases	10 15	215238 215243	0.9999878406524658	O
52282	of	16 18	215244 215246	0.9999877214431763	O
52283	Omani	19 23	215247 215251	0.99997878074646	O
52285	patient	25 32	215253 215260	0.9999858140945435	O
52286	tested	33 39	215261 215267	0.999988317489624	O
52287	for	40 43	215268 215271	0.9999887943267822	O
52288	the	44 47	215272 215275	0.9999892711639404	O
52289	presence	48 56	215276 215284	0.9999890327453613	O
52290	of	57 59	215285 215287	0.9999891519546509	O
52291	hMSH2	60 64	215288 215292	0.999988317489624	O
52295	protein	66 73	215294 215301	0.9999877214431763	O
52296	by	74 76	215302 215304	0.9999892711639404	O
52297	immunohistochemical	77 95	215305 215323	0.9999887943267822	O
52303	staining	97 104	215325 215332	0.9999887943267822	O
52305	,	106 107	215334 215335	0.9999884366989136	O
52306	seven	108 113	215336 215341	0.9999834299087524	O
52307	Omani	114 118	215342 215346	0.9999831914901733	O
52309	cases	120 125	215348 215353	0.9999886751174927	O
52310	were	126 130	215354 215358	0.9999889135360718	O
52311	MSI	131 133	215359 215361	0.9999879598617554	O
52313	-	134 135	215362 215363	0.9999892711639404	O
52314	H	135 136	215363 215364	0.9999874830245972	O
52315	.	136 137	215364 215365	0.99998939037323	O
52316	In	138 140	215366 215368	0.9999884366989136	O
52317	Iranian	141 148	215369 215376	0.9996477365493774	O
52318	patients	149 157	215377 215385	0.9999839067459106	O
52319	,	158 159	215386 215387	0.9999891519546509	O
52320	77	160 162	215388 215390	0.9999854564666748	O
52321	%	163 164	215391 215392	0.9999891519546509	O
52322	[	165 166	215393 215394	0.9999885559082031	O
52323	10	166 168	215394 215396	0.9999849796295166	O
52324	]	168 169	215396 215397	0.9999885559082031	O
52325	of	170 172	215398 215400	0.9999886751174927	O
52326	the	173 176	215401 215404	0.9999885559082031	O
52327	MSI	177 179	215405 215407	0.9999876022338867	O
52329	-	180 181	215408 215409	0.9999890327453613	O
52330	H	181 182	215409 215410	0.9999822378158569	O
52331	tumors	183 189	215411 215417	0.9999867677688599	O
52332	were	190 194	215418 215422	0.9999890327453613	O
52333	negative	195 203	215423 215431	0.9999852180480957	O
52334	for	204 207	215432 215435	0.9999890327453613	O
52335	hMLH1	208 212	215436 215440	0.9999884366989136	O
52338	expression	214 224	215442 215452	0.9999890327453613	O
52339	(	225 226	215453 215454	0.9999891519546509	O
52340	Table	227 232	215455 215460	0.999987006187439	O
52341	3	233 234	215461 215462	0.999988317489624	O
52342	)	235 236	215463 215464	0.9999895095825195	O
52343	;	237 238	215465 215466	0.9999891519546509	O
52344	all	239 242	215467 215470	0.999988317489624	O
52345	of	243 245	215471 215473	0.9999881982803345	O
52346	non	246 249	215474 215477	0.9999866485595703	O
52347	-	249 250	215477 215478	0.9999886751174927	O
52348	MSI	250 252	215478 215480	0.9999862909317017	O
52350	-	253 254	215481 215482	0.9999887943267822	O
52351	H	254 255	215482 215483	0.9999830722808838	O
52352	tumors	256 262	215484 215490	0.999987006187439	O
52353	were	263 267	215491 215495	0.9999891519546509	O
52354	positive	268 276	215496 215504	0.9999884366989136	O
52355	for	277 280	215505 215508	0.9999890327453613	O
52356	hMLH1	281 285	215509 215513	0.9999887943267822	O
52359	expression	287 297	215515 215525	0.9999889135360718	O
52360	,	298 299	215526 215527	0.9999891519546509	O
52361	while	300 305	215528 215533	0.9999887943267822	O
52362	for	306 309	215534 215537	0.999988317489624	O
52363	hMSH2	310 314	215538 215542	0.9999886751174927	O
52367	these	316 321	215544 215549	0.9999887943267822	O
52368	figures	322 329	215550 215557	0.9999858140945435	O
52369	were	330 334	215558 215562	0.9999889135360718	O
52370	8	335 336	215563 215564	0.9999865293502808	O
52371	%	337 338	215565 215566	0.9999890327453613	O
52372	[	339 340	215567 215568	0.9999886751174927	O
52373	1	340 341	215568 215569	0.9999878406524658	O
52374	]	342 343	215570 215571	0.9999884366989136	O
52375	and	344 347	215572 215575	0.9999876022338867	O
52376	0	348 349	215576 215577	0.9999836683273315	O
52377	,	349 350	215577 215578	0.9999880790710449	O
52378	respectively	351 363	215579 215591	0.9999876022338867	O
52379	.	364 365	215592 215593	0.9999738931655884	O
52380	In	0 2	215594 215596	0.9999886751174927	O
52381	multivariate	3 14	215597 215608	0.9999885559082031	O
52384	analysis	16 24	215610 215618	0.999988317489624	O
52385	,	25 26	215619 215620	0.999988317489624	O
52386	including	27 36	215621 215630	0.9999885559082031	O
52387	the	37 40	215631 215634	0.9999887943267822	O
52388	interaction	41 52	215635 215646	0.999981164932251	O
52389	terms	53 58	215647 215652	0.9999854564666748	O
52390	,	59 60	215653 215654	0.9999878406524658	O
52391	the	61 64	215655 215658	0.9999884366989136	O
52392	hMLH1	65 69	215659 215663	0.9999878406524658	O
52395	expression	71 81	215665 215675	0.9999885559082031	O
52396	has	82 85	215676 215679	0.9999885559082031	O
52397	a	86 87	215680 215681	0.9999891519546509	O
52398	significant	88 99	215682 215693	0.9999884366989136	O
52399	preventive	100 109	215694 215703	0.9999867677688599	O
52401	effect	111 117	215705 215711	0.999988317489624	O
52402	on	118 120	215712 215714	0.9999889135360718	O
52403	MSI	121 123	215715 215717	0.9999816417694092	O
52405	-	124 125	215718 215719	0.9999889135360718	O
52406	H	125 126	215719 215720	0.9999788999557495	O
52407	occurrence	127 137	215721 215731	0.9999874830245972	O
52408	(	138 139	215732 215733	0.9999897480010986	O
52409	OR	140 142	215734 215736	0.9999880790710449	O
52410	=	143 144	215737 215738	0.9999891519546509	O
52411	0	145 146	215739 215740	0.9999890327453613	O
52412	.	146 147	215740 215741	0.9999892711639404	O
52413	13	147 149	215741 215743	0.999987006187439	O
52414	(	149 150	215743 215744	0.9999892711639404	O
52415	0	150 151	215744 215745	0.9999890327453613	O
52416	.	151 152	215745 215746	0.99998939037323	O
52417	04	152 154	215746 215748	0.9999878406524658	O
52418	–	154 155	215748 215749	0.9999861717224121	O
52419	0	155 156	215749 215750	0.9999890327453613	O
52420	.	156 157	215750 215751	0.9999892711639404	O
52421	41	157 159	215751 215753	0.9999865293502808	O
52422	)	160 161	215754 215755	0.9999895095825195	O
52423	;	162 163	215756 215757	0.9999891519546509	O
52424	p	164 165	215758 215759	0.9999892711639404	O
52425	<	166 167	215760 215761	0.9999886751174927	O
52426	0	168 169	215762 215763	0.9999892711639404	O
52427	.	169 170	215763 215764	0.9999890327453613	O
52428	0001	170 173	215764 215767	0.9999886751174927	O
52430	;	175 176	215769 215770	0.9999890327453613	O
52431	(	177 178	215771 215772	0.9999892711639404	O
52432	Table	179 184	215773 215778	0.9999867677688599	O
52433	4	185 186	215779 215780	0.9999876022338867	O
52434	)	186 187	215780 215781	0.9999892711639404	O
52435	)	188 189	215782 215783	0.9999889135360718	O
52436	.	190 191	215784 215785	0.9999780654907227	O
52437	Correlation	0 10	215786 215796	0.9999845027923584	O
52440	between	12 19	215798 215805	0.999987006187439	O
52441	BRAF	20 23	215806 215809	0.9999830722808838	O
52443	mutation	25 33	215811 215819	0.9999860525131226	O
52444	and	34 37	215820 215823	0.9999877214431763	O
52445	MSI	38 40	215824 215826	0.999983549118042	O
52447	status	42 48	215828 215834	0.9999881982803345	O
52448	Samples	49 55	215835 215841	0.9999825954437256	O
52450	were	57 61	215843 215847	0.9999874830245972	O
52451	analyzed	62 70	215848 215856	0.9999874830245972	O
52452	for	71 74	215857 215860	0.9999881982803345	O
52453	the	75 78	215861 215864	0.9999887943267822	O
52454	presence	79 87	215865 215873	0.999988317489624	O
52455	of	88 90	215874 215876	0.9999886751174927	O
52456	a	91 92	215877 215878	0.999988317489624	O
52457	point	93 98	215879 215884	0.9999866485595703	O
52458	mutation	99 107	215885 215893	0.9999867677688599	O
52459	that	108 112	215894 215898	0.9999887943267822	O
52460	frequently	113 123	215899 215909	0.999987006187439	O
52461	occurs	124 130	215910 215916	0.9999881982803345	O
52462	in	131 133	215917 215919	0.9999879598617554	O
52463	the	134 137	215920 215923	0.9999885559082031	O
52464	oncogene	138 145	215924 215931	0.9999868869781494	O
52467	BRAF	147 150	215933 215936	0.9999861717224121	O
52469	leading	152 159	215938 215945	0.9999884366989136	O
52470	to	160 162	215946 215948	0.9999886751174927	O
52471	the	163 166	215949 215952	0.9999887943267822	O
52472	change	167 173	215953 215959	0.9999880790710449	O
52473	of	174 176	215960 215962	0.9999886751174927	O
52474	valine	177 182	215963 215968	0.9999874830245972	O
52477	to	184 186	215970 215972	0.9999868869781494	O
52478	glutamic	187 194	215973 215980	0.9999872446060181	O
52482	acid	196 200	215982 215986	0.9999885559082031	O
52483	at	201 203	215987 215989	0.9999889135360718	O
52484	position	204 212	215990 215998	0.9999886751174927	O
52485	600	213 216	215999 216002	0.999983549118042	O
52486	of	217 219	216003 216005	0.9999878406524658	O
52487	the	220 223	216006 216009	0.9999878406524658	O
52488	BRAF	224 227	216010 216013	0.9999842643737793	O
52490	protein	229 236	216015 216022	0.9999792575836182	O
52491	.	237 238	216023 216024	0.9999469518661499	O
52492	In	0 2	216025 216027	0.9999879598617554	O
52493	all	3 6	216028 216031	0.9999860525131226	O
52494	samples	7 14	216032 216039	0.9999864101409912	O
52495	only	15 19	216040 216044	0.9999872446060181	O
52496	10	20 22	216045 216047	0.9999867677688599	O
52497	%	23 24	216048 216049	0.9999891519546509	O
52498	[	25 26	216050 216051	0.9999887943267822	O
52499	8	26 27	216051 216052	0.999984860420227	O
52500	]	28 29	216053 216054	0.9999890327453613	O
52501	African	30 37	216055 216062	0.9999825954437256	O
52502	American	38 46	216063 216071	0.999983549118042	O
52503	,	47 48	216072 216073	0.9999885559082031	O
52504	19	49 51	216074 216076	0.9999797344207764	O
52505	%	52 53	216077 216078	0.9999896287918091	O
52506	[	54 55	216079 216080	0.9999891519546509	O
52507	11	55 57	216080 216082	0.9999878406524658	O
52508	]	57 58	216082 216083	0.99998939037323	O
52509	Omani	59 63	216084 216088	0.9999788999557495	O
52511	and	65 68	216090 216093	0.9999886751174927	O
52512	2	69 70	216094 216095	0.9999840259552002	O
52513	%	71 72	216096 216097	0.9999895095825195	O
52514	[	73 74	216098 216099	0.9999889135360718	O
52515	1	74 75	216099 216100	0.999988317489624	O
52516	]	76 77	216101 216102	0.9999892711639404	O
52517	Iranian	78 85	216103 216110	0.9997023940086365	O
52518	samples	86 93	216111 216118	0.9999881982803345	O
52519	displayed	94 103	216119 216128	0.999988317489624	O
52520	the	104 107	216129 216132	0.99998939037323	O
52521	mutation	108 116	216133 216141	0.9999874830245972	O
52522	by	117 119	216142 216144	0.99998939037323	O
52523	sequencing	120 129	216145 216154	0.9999885559082031	O
52525	(	131 132	216156 216157	0.9999896287918091	O
52526	Table	133 138	216158 216163	0.9999871253967285	O
52527	1	139 140	216164 216165	0.9999892711639404	O
52528	,	141 142	216166 216167	0.9999889135360718	O
52529	2	143 144	216168 216169	0.999988317489624	O
52530	,	145 146	216170 216171	0.9999885559082031	O
52531	3	147 148	216172 216173	0.9999880790710449	O
52532	)	149 150	216174 216175	0.99998939037323	O
52533	.	151 152	216176 216177	0.9999804496765137	O
52534	In	0 2	216178 216180	0.9999876022338867	O
52535	the	3 6	216181 216184	0.9999873638153076	O
52536	MSI	7 9	216185 216187	0.9999829530715942	O
52538	-	10 11	216188 216189	0.999988317489624	O
52539	H	11 12	216189 216190	0.9999605417251587	O
52540	group	13 18	216191 216196	0.999987006187439	O
52541	,	19 20	216197 216198	0.9999881982803345	O
52542	the	21 24	216199 216202	0.9999880790710449	O
52543	BRAF	25 28	216203 216206	0.9999823570251465	O
52545	mutation	30 38	216208 216216	0.9999874830245972	O
52546	was	39 42	216217 216220	0.9999890327453613	O
52547	32	43 45	216221 216223	0.9999849796295166	O
52548	%	46 47	216224 216225	0.9999892711639404	O
52549	[	48 49	216226 216227	0.9999890327453613	O
52550	7	49 50	216227 216228	0.9999873638153076	O
52551	]	51 52	216229 216230	0.9999890327453613	O
52552	in	53 55	216231 216233	0.9999889135360718	O
52553	African	56 63	216234 216241	0.999976396560669	O
52554	Americans	64 73	216242 216251	0.9999773502349854	O
52555	,	74 75	216252 216253	0.9999886751174927	O
52556	25	76 78	216254 216256	0.9999837875366211	O
52557	%	79 80	216257 216258	0.9999892711639404	O
52558	[	81 82	216259 216260	0.9999887943267822	O
52559	2	82 83	216260 216261	0.999985933303833	O
52560	]	84 85	216262 216263	0.9999890327453613	O
52561	in	86 88	216264 216266	0.9999891519546509	O
52562	Omani	89 93	216267 216271	0.9999821186065674	O
52564	,	95 96	216273 216274	0.999988317489624	O
52565	and	97 100	216275 216278	0.9999887943267822	O
52566	7	101 102	216279 216280	0.9999873638153076	O
52567	%	103 104	216281 216282	0.9999892711639404	O
52568	[	105 106	216283 216284	0.9999887943267822	O
52569	1	106 107	216284 216285	0.999988317489624	O
52570	]	108 109	216286 216287	0.9999886751174927	O
52571	in	110 112	216288 216290	0.9999887943267822	O
52572	Iranian	113 120	216291 216298	0.9999368190765381	O
52573	,	121 122	216299 216300	0.9999880790710449	O
52574	respectively	123 135	216301 216313	0.9999871253967285	O
52575	.	136 137	216314 216315	0.9999732971191406	O
52576	Eighteen	0 7	216316 216323	0.9999840259552002	O
52578	percent	9 16	216325 216332	0.9999855756759644	O
52579	and	17 20	216333 216336	0.999983549118042	O
52580	2	21 22	216337 216338	0.9999681711196899	O
52581	%	23 24	216339 216340	0.9999861717224121	O
52582	of	25 27	216341 216343	0.9999858140945435	O
52583	non	28 31	216344 216347	0.9999836683273315	O
52584	-	31 32	216347 216348	0.9999865293502808	O
52585	MSI	32 34	216348 216350	0.9999805688858032	O
52587	-	35 36	216351 216352	0.9999867677688599	O
52588	H	36 37	216352 216353	0.9997932314872742	O
52589	tumors	38 44	216354 216360	0.9999821186065674	O
52590	carry	45 50	216361 216366	0.9999865293502808	O
52591	the	51 54	216367 216370	0.9999879598617554	O
52592	BRAF	55 58	216371 216374	0.9999847412109375	O
52594	mutation	60 68	216376 216384	0.9999881982803345	O
52595	in	69 71	216385 216387	0.9999885559082031	O
52596	African	72 79	216388 216395	0.9999568462371826	O
52597	Americans	80 89	216396 216405	0.9999595880508423	O
52598	and	90 93	216406 216409	0.9999864101409912	O
52599	Omanis	94 99	216410 216415	0.999971866607666	O
52601	,	101 102	216417 216418	0.9999873638153076	O
52602	respectively	103 115	216419 216431	0.9999852180480957	O
52603	,	116 117	216432 216433	0.999987006187439	O
52604	while	118 123	216434 216439	0.9999860525131226	O
52605	none	124 128	216440 216444	0.9999831914901733	O
52606	of	129 131	216445 216447	0.9999867677688599	O
52607	the	132 135	216448 216451	0.9999853372573853	O
52608	Iranians	136 143	216452 216459	0.999658465385437	O
52610	carried	145 152	216461 216468	0.9999876022338867	O
52611	a	153 154	216469 216470	0.9999878406524658	O
52612	BRAF	155 158	216471 216474	0.9999853372573853	O
52614	mutation	160 168	216476 216484	0.9999879598617554	O
52615	in	169 171	216485 216487	0.9999878406524658	O
52616	this	172 176	216488 216492	0.9999865293502808	O
52617	group	177 182	216493 216498	0.9999841451644897	O
52618	.	183 184	216499 216500	0.9999611377716064	O
52619	A	0 1	216501 216502	0.9999880790710449	O
52620	BRAF	2 5	216503 216506	0.999983549118042	O
52622	mutation	7 15	216508 216516	0.9999871253967285	O
52623	is	16 18	216517 216519	0.9999881982803345	O
52624	a	19 20	216520 216521	0.9999884366989136	O
52625	significant	21 32	216522 216533	0.9999872446060181	O
52626	risk	33 37	216534 216538	0.9999876022338867	O
52627	factor	38 44	216539 216545	0.9999880790710449	O
52628	for	45 48	216546 216549	0.9999880790710449	O
52629	MSI	49 51	216550 216552	0.9999814033508301	O
52631	-	52 53	216553 216554	0.9999885559082031	O
52632	H	53 54	216554 216555	0.9999743700027466	O
52633	occurrence	55 65	216556 216566	0.9999874830245972	O
52634	even	66 70	216567 216571	0.9999884366989136	O
52635	after	71 76	216572 216577	0.999988317489624	O
52636	controlling	77 88	216578 216589	0.9999877214431763	O
52637	for	89 92	216590 216593	0.9999887943267822	O
52638	other	93 98	216594 216599	0.9999873638153076	O
52639	factors	99 106	216600 216607	0.9999880790710449	O
52640	in	107 109	216608 216610	0.9999887943267822	O
52641	the	110 113	216611 216614	0.9999890327453613	O
52642	multivariate	114 125	216615 216626	0.9999887943267822	O
52645	model	127 132	216628 216633	0.9999886751174927	O
52646	(	133 134	216634 216635	0.9999892711639404	O
52647	OR	135 137	216636 216638	0.9999881982803345	O
52648	=	138 139	216639 216640	0.9999885559082031	O
52649	12	140 142	216641 216643	0.999987006187439	O
52650	.	142 143	216643 216644	0.9999887943267822	O
52651	11	143 145	216644 216646	0.9999876022338867	O
52652	(	145 146	216646 216647	0.9999885559082031	O
52653	2	147 148	216648 216649	0.9999854564666748	O
52654	.	148 149	216649 216650	0.9999886751174927	O
52655	82	149 151	216650 216652	0.9999867677688599	O
52656	–	151 152	216652 216653	0.9999862909317017	O
52657	52	152 154	216653 216655	0.9999842643737793	O
52658	.	154 155	216655 216656	0.9999885559082031	O
52659	03	155 157	216656 216658	0.9999877214431763	O
52660	)	158 159	216659 216660	0.9999890327453613	O
52661	;	160 161	216661 216662	0.9999886751174927	O
52662	p	162 163	216663 216664	0.9999887943267822	O
52663	=	164 165	216665 216666	0.9999881982803345	O
52664	0	166 167	216667 216668	0.9999884366989136	O
52665	.	167 168	216668 216669	0.999988317489624	O
52666	001	168 170	216669 216671	0.999988317489624	O
52668	;	172 173	216673 216674	0.9999886751174927	O
52669	(	174 175	216675 216676	0.9999886751174927	O
52670	Table	176 181	216677 216682	0.9999874830245972	O
52671	4	182 183	216683 216684	0.9999876022338867	O
52672	)	183 184	216684 216685	0.9999887943267822	O
52673	)	185 186	216686 216687	0.9999887943267822	O
52674	.	187 188	216688 216689	0.9999890327453613	O
52675	*	189 190	216690 216691	0.9999876022338867	O
52676	*	190 191	216691 216692	0.9999788999557495	O
52677	IGNORE	0 5	216693 216698	0.9999864101409912	O
52680	LINE	7 10	216700 216703	0.9999889135360718	O
52683	*	12 13	216705 216706	0.9999895095825195	O
52684	*	13 14	216706 216707	0.99998939037323	O
52685	*	15 16	216708 216709	0.99998939037323	O
52686	*	16 17	216709 216710	0.9999896287918091	O
52687	IGNORE	18 23	216711 216716	0.9999880790710449	O
52690	LINE	25 28	216718 216721	0.9999895095825195	O
52693	*	30 31	216723 216724	0.99998939037323	O
52694	*	31 32	216724 216725	0.99998939037323	O
52695	*	33 34	216726 216727	0.99998939037323	O
52696	*	34 35	216727 216728	0.9999892711639404	O
52697	IGNORE	36 41	216729 216734	0.9999880790710449	O
52700	LINE	43 46	216736 216739	0.99998939037323	O
52703	*	48 49	216741 216742	0.99998939037323	O
52704	*	49 50	216742 216743	0.99998939037323	O
52705	Discussion	51 60	216744 216753	0.9999891519546509	O
52708	DNA	62 65	216755 216758	0.9999886751174927	O
52709	MMR	66 68	216759 216761	0.9999889135360718	O
52711	gene	70 74	216763 216767	0.9999892711639404	O
52712	silencing	75 83	216768 216776	0.9999895095825195	O
52715	and	85 88	216778 216781	0.9999892711639404	O
52716	/	88 89	216781 216782	0.9999889135360718	O
52717	or	89 91	216782 216784	0.9999892711639404	O
52718	mutation	92 100	216785 216793	0.9999877214431763	O
52719	are	101 104	216794 216797	0.9999889135360718	O
52720	the	105 108	216798 216801	0.9999891519546509	O
52721	main	109 113	216802 216806	0.9999876022338867	O
52722	factors	114 121	216807 216814	0.9999890327453613	O
52723	leading	122 129	216815 216822	0.9999885559082031	O
52724	to	130 132	216823 216825	0.9999890327453613	O
52725	accumulation	133 145	216826 216838	0.9999879598617554	O
52726	of	146 148	216839 216841	0.9999890327453613	O
52727	mutations	149 158	216842 216851	0.9999878406524658	O
52728	within	159 165	216852 216858	0.9999889135360718	O
52729	genes	166 171	216859 216864	0.9999867677688599	O
52730	and	172 175	216865 216868	0.9999873638153076	O
52731	general	176 183	216869 216876	0.9999828338623047	O
52732	genome	184 190	216877 216883	0.9999868869781494	O
52733	instability	191 202	216884 216895	0.999987006187439	O
52734	[	203 204	216896 216897	0.9999895095825195	O
52735	19	204 206	216897 216899	0.9999858140945435	O
52736	]	206 207	216899 216900	0.9999892711639404	O
52737	.	208 209	216901 216902	0.9999771118164062	O
52738	The	0 3	216903 216906	0.9999855756759644	O
52739	MSI	4 6	216907 216909	0.9999796152114868	O
52741	phenotype	8 16	216911 216919	0.9999873638153076	O
52744	resulting	18 27	216921 216930	0.9999856948852539	O
52745	from	28 32	216931 216935	0.999985933303833	O
52746	such	33 37	216936 216940	0.9999841451644897	O
52747	alterations	38 49	216941 216952	0.9999767541885376	O
52748	is	50 52	216953 216955	0.999983549118042	O
52749	one	53 56	216956 216959	0.9999866485595703	O
52750	of	57 59	216960 216962	0.9999864101409912	O
52751	the	60 63	216963 216966	0.9999866485595703	O
52752	early	64 69	216967 216972	0.9999833106994629	O
52753	events	70 76	216973 216979	0.9999856948852539	O
52754	leading	77 84	216980 216987	0.9999849796295166	O
52755	to	85 87	216988 216990	0.9999860525131226	O
52756	the	88 91	216991 216994	0.9999862909317017	O
52757	development	92 103	216995 217006	0.9999803304672241	O
52758	of	104 106	217007 217009	0.9999858140945435	O
52759	certain	107 114	217010 217017	0.9999796152114868	O
52760	cancers	115 121	217018 217024	0.9999793767929077	O
52762	.	123 124	217026 217027	0.999947190284729	O
52763	It	0 2	217028 217030	0.9999836683273315	O
52764	occurs	3 9	217031 217037	0.9999830722808838	O
52765	in	10 12	217038 217040	0.9999856948852539	O
52766	patients	13 21	217041 217049	0.9999773502349854	O
52767	with	22 26	217050 217054	0.9999850988388062	O
52768	Lynch	27 32	217055 217060	0.9999748468399048	O
52769	syndrome	33 41	217061 217069	0.9999841451644897	O
52770	and	42 45	217070 217073	0.9999796152114868	O
52771	in	46 48	217074 217076	0.9999847412109375	O
52772	those	49 54	217077 217082	0.9999825954437256	O
52773	that	55 59	217083 217087	0.999984860420227	O
52774	acquire	60 67	217088 217095	0.9999790191650391	O
52775	such	68 72	217096 217100	0.9999868869781494	O
52776	alterations	73 84	217101 217112	0.9999836683273315	O
52777	somatically	85 95	217113 217123	0.9999878406524658	O
52780	[	97 98	217125 217126	0.9999890327453613	O
52781	24	98 100	217126 217128	0.9999858140945435	O
52782	]	100 101	217128 217129	0.999988317489624	O
52783	.	102 103	217130 217131	0.9999741315841675	O
52784	Another	0 7	217132 217139	0.9999845027923584	O
52785	event	8 13	217140 217145	0.9999861717224121	O
52786	occurring	14 23	217146 217155	0.9999874830245972	O
52787	in	24 26	217156 217158	0.9999880790710449	O
52788	adenoma	27 33	217159 217165	0.9999819993972778	O
52791	polyp	35 39	217167 217171	0.9999873638153076	O
52794	is	41 43	217173 217175	0.9999885559082031	O
52795	mutation	44 52	217176 217184	0.999985933303833	O
52796	in	53 55	217185 217187	0.9999895095825195	O
52797	oncogenes	56 64	217188 217196	0.999988317489624	O
52801	,	66 67	217198 217199	0.999988317489624	O
52802	specifically	68 80	217200 217212	0.9999886751174927	O
52803	in	81 83	217213 217215	0.9999892711639404	O
52804	K	84 85	217216 217217	0.9999850988388062	O
52805	-	85 86	217217 217218	0.9999892711639404	O
52806	ras	86 88	217218 217220	0.9999871253967285	O
52808	and	90 93	217222 217225	0.9999884366989136	O
52809	BRAF	94 97	217226 217229	0.9999842643737793	O
52811	genes	99 104	217231 217236	0.9999889135360718	O
52812	in	105 107	217237 217239	0.99998939037323	O
52813	the	108 111	217240 217243	0.9999890327453613	O
52814	case	112 116	217244 217248	0.9999871253967285	O
52815	of	117 119	217249 217251	0.9999884366989136	O
52816	colon	120 124	217252 217256	0.9999827146530151	O
52818	cancer	126 132	217258 217264	0.9999872446060181	O
52819	[	133 134	217265 217266	0.99998939037323	O
52820	24	134 136	217266 217268	0.999988317489624	O
52821	-	136 137	217268 217269	0.9999892711639404	O
52822	26	137 139	217269 217271	0.9999874830245972	O
52823	]	139 140	217271 217272	0.9999889135360718	O
52824	.	141 142	217273 217274	0.9999713897705078	O
52825	The	0 3	217275 217278	0.9999873638153076	O
52826	linkage	4 10	217279 217285	0.9999853372573853	O
52828	between	12 19	217287 217294	0.9999878406524658	O
52829	BRAF	20 23	217295 217298	0.999981164932251	O
52831	mutations	25 34	217300 217309	0.9999854564666748	O
52832	and	35 38	217310 217313	0.9999879598617554	O
52833	MSI	39 41	217314 217316	0.9999823570251465	O
52835	was	43 46	217318 217321	0.9999878406524658	O
52836	previously	47 57	217322 217332	0.9999861717224121	O
52837	reported	58 66	217333 217341	0.9999880790710449	O
52838	[	67 68	217342 217343	0.9999891519546509	O
52839	27	68 70	217343 217345	0.9999876022338867	O
52840	-	70 71	217345 217346	0.9999890327453613	O
52841	30	71 73	217346 217348	0.9999864101409912	O
52842	]	73 74	217348 217349	0.9999886751174927	O
52843	.	75 76	217350 217351	0.9999715089797974	O
52844	In	0 2	217352 217354	0.9999829530715942	O
52845	general	3 10	217355 217362	0.9999809265136719	O
52846	,	11 12	217363 217364	0.9999837875366211	O
52847	Omani	13 17	217365 217369	0.9999556541442871	O
52849	people	19 25	217371 217377	0.9999639987945557	O
52850	have	26 30	217378 217382	0.9999828338623047	O
52851	a	31 32	217383 217384	0.999984860420227	O
52852	mixed	33 38	217385 217390	0.9999784231185913	O
52853	Asian	39 44	217391 217396	0.9999717473983765	O
52854	and	45 48	217397 217400	0.9999825954437256	O
52855	African	49 56	217401 217408	0.9999480247497559	O
52856	ethnic	57 63	217409 217415	0.9999847412109375	O
52857	background	64 74	217416 217426	0.9999837875366211	O
52858	[	75 76	217427 217428	0.9999879598617554	O
52859	10	76 78	217428 217430	0.9999821186065674	O
52860	]	78 79	217430 217431	0.9999867677688599	O
52861	and	80 83	217432 217435	0.9999836683273315	O
52862	Iranians	84 91	217436 217443	0.999864935874939	O
52864	are	93 96	217445 217448	0.9999852180480957	O
52865	of	97 99	217449 217451	0.999984860420227	O
52866	Caucasian	100 109	217452 217461	0.9999512434005737	O
52867	ethnicity	110 119	217462 217471	0.9999866485595703	O
52868	.	120 121	217472 217473	0.9999545812606812	O
52869	Here	0 4	217474 217478	0.9999725818634033	O
52870	we	5 7	217479 217481	0.999977707862854	O
52871	demonstrate	8 19	217482 217493	0.9999669790267944	O
52872	that	20 24	217494 217498	0.9999854564666748	O
52873	in	25 27	217499 217501	0.9999829530715942	O
52874	African	28 35	217502 217509	0.9999566078186035	O
52875	Americans	36 45	217510 217519	0.9999548196792603	O
52876	,	46 47	217520 217521	0.9999841451644897	O
52877	Omanis	48 53	217522 217527	0.9999614953994751	O
52879	and	55 58	217529 217532	0.9999827146530151	O
52880	Iranians	59 66	217533 217540	0.9995455145835876	O
52882	,	68 69	217542 217543	0.9999858140945435	O
52883	the	70 73	217544 217547	0.9999862909317017	O
52884	MSI	74 76	217548 217550	0.999980092048645	O
52886	phenotype	78 86	217552 217560	0.9999876022338867	O
52889	occurs	88 94	217562 217568	0.9999856948852539	O
52890	in	95 97	217569 217571	0.9999871253967285	O
52891	31	98 100	217572 217574	0.9999816417694092	O
52892	%	101 102	217575 217576	0.9999862909317017	O
52893	,	103 104	217577 217578	0.9999852180480957	O
52894	26	105 107	217579 217581	0.9999796152114868	O
52895	%	108 109	217582 217583	0.9999866485595703	O
52896	and	110 113	217584 217587	0.9999834299087524	O
52897	13	114 116	217588 217590	0.9999775886535645	O
52898	%	117 118	217591 217592	0.9999854564666748	O
52899	of	119 121	217593 217595	0.9999829530715942	O
52900	CRC	122 124	217596 217598	0.999967098236084	O
52902	tumors	126 132	217600 217606	0.9999810457229614	O
52903	,	133 134	217607 217608	0.9999847412109375	O
52904	respectively	135 147	217609 217621	0.9999854564666748	O
52905	.	148 149	217622 217623	0.9999496936798096	O
52906	In	0 2	217624 217626	0.9999866485595703	O
52907	addition	3 11	217627 217635	0.9999827146530151	O
52908	,	12 13	217636 217637	0.9999872446060181	O
52909	the	14 17	217638 217641	0.9999850988388062	O
52910	locations	18 27	217642 217651	0.9999761581420898	O
52911	of	28 30	217652 217654	0.999984622001648	O
52912	the	31 34	217655 217658	0.9999799728393555	O
52913	tumors	35 41	217659 217665	0.999980092048645	O
52914	in	42 44	217666 217668	0.9999868869781494	O
52915	African	45 52	217669 217676	0.9999796152114868	O
52916	Americans	53 62	217677 217686	0.9999831914901733	O
52917	and	63 66	217687 217690	0.9999855756759644	O
52918	Iranians	67 74	217691 217698	0.9999141693115234	O
52920	were	76 80	217700 217704	0.9999871253967285	O
52921	primarily	81 90	217705 217714	0.9999876022338867	O
52922	proximal	91 98	217715 217722	0.9999872446060181	O
52924	compared	100 108	217724 217732	0.9999860525131226	O
52925	to	109 111	217733 217735	0.9999871253967285	O
52926	distal	112 117	217736 217741	0.9999856948852539	O
52928	for	119 122	217743 217746	0.9999867677688599	O
52929	Omanis	123 128	217747 217752	0.9999817609786987	O
52931	;	130 131	217754 217755	0.9999868869781494	O
52932	and	132 135	217756 217759	0.9999874830245972	O
52933	BRAF	136 139	217760 217763	0.9999833106994629	O
52935	mutations	141 150	217765 217774	0.9999854564666748	O
52936	were	151 155	217775 217779	0.9999884366989136	O
52937	more	156 160	217780 217784	0.9999878406524658	O
52938	prevalent	161 170	217785 217794	0.9999884366989136	O
52939	in	171 173	217795 217797	0.9999884366989136	O
52940	Omanis	174 179	217798 217803	0.9999819993972778	O
52942	than	181 185	217805 217809	0.9999868869781494	O
52943	African	186 193	217810 217817	0.9999802112579346	O
52944	Americans	194 203	217818 217827	0.999981164932251	O
52945	or	204 206	217828 217830	0.9999845027923584	O
52946	Iranians	207 214	217831 217838	0.9999488592147827	O
52948	(	216 217	217840 217841	0.9999884366989136	O
52949	19	218 220	217842 217844	0.9999834299087524	O
52950	%	221 222	217845 217846	0.9999880790710449	O
52951	,	223 224	217847 217848	0.9999868869781494	O
52952	10	225 227	217849 217851	0.9999841451644897	O
52953	%	228 229	217852 217853	0.999988317489624	O
52954	and	230 233	217854 217857	0.9999861717224121	O
52955	2	234 235	217858 217859	0.9999822378158569	O
52956	%	236 237	217860 217861	0.9999879598617554	O
52957	,	238 239	217862 217863	0.9999872446060181	O
52958	respectively	240 252	217864 217876	0.9999865293502808	O
52959	)	253 254	217877 217878	0.9999878406524658	O
52960	.	255 256	217879 217880	0.9999591112136841	O
52961	While	0 5	217881 217886	0.9999850988388062	O
52962	the	6 9	217887 217890	0.9999874830245972	O
52963	MSI	10 12	217891 217893	0.9999791383743286	O
52965	phenotype	14 22	217895 217903	0.9999884366989136	O
52968	in	24 26	217905 217907	0.9999872446060181	O
52969	this	27 31	217908 217912	0.9999833106994629	O
52970	sample	32 38	217913 217919	0.9999727010726929	O
52971	of	39 41	217920 217922	0.9999845027923584	O
52972	African	42 49	217923 217930	0.9999557733535767	O
52973	Americans	50 59	217931 217940	0.9999715089797974	O
52974	is	60 62	217941 217943	0.9999872446060181	O
52975	less	63 67	217944 217948	0.999985933303833	O
52976	than	68 72	217949 217953	0.9999878406524658	O
52977	we	73 75	217954 217956	0.9999862909317017	O
52978	previously	76 86	217957 217967	0.9999837875366211	O
52979	reported	87 95	217968 217976	0.9999858140945435	O
52980	(	96 97	217977 217978	0.9999884366989136	O
52981	43	98 100	217979 217981	0.999985933303833	O
52982	–	100 101	217981 217982	0.9999853372573853	O
52983	45	101 103	217982 217984	0.999984622001648	O
52984	%	104 105	217985 217986	0.9999881982803345	O
52985	)	106 107	217987 217988	0.9999886751174927	O
52986	,	108 109	217989 217990	0.9999878406524658	O
52987	[	110 111	217991 217992	0.9999884366989136	O
52988	3	111 112	217992 217993	0.9999876022338867	O
52989	,	112 113	217993 217994	0.9999879598617554	O
52990	4	113 114	217994 217995	0.9999865293502808	O
52991	]	114 115	217995 217996	0.9999881982803345	O
52992	it	116 118	217997 217999	0.9999879598617554	O
52993	appears	119 126	218000 218007	0.9999879598617554	O
52994	to	127 129	218008 218010	0.9999879598617554	O
52995	be	130 132	218011 218013	0.9999884366989136	O
52996	more	133 137	218014 218018	0.9999874830245972	O
52997	prevalent	138 147	218019 218028	0.9999874830245972	O
52998	in	148 150	218029 218031	0.9999872446060181	O
52999	African	151 158	218032 218039	0.9999552965164185	O
53000	Americans	159 168	218040 218049	0.9999725818634033	O
53001	than	169 173	218050 218054	0.999984622001648	O
53002	in	174 176	218055 218057	0.9999866485595703	O
53003	others	177 183	218058 218064	0.999970555305481	O
53004	and	184 187	218065 218068	0.9999858140945435	O
53005	still	188 193	218069 218074	0.9999840259552002	O
53006	high	194 198	218075 218079	0.9999841451644897	O
53007	in	199 201	218080 218082	0.9999874830245972	O
53008	the	202 205	218083 218086	0.9999871253967285	O
53009	general	206 213	218087 218094	0.9999762773513794	O
53010	US	214 216	218095 218097	0.9998136162757874	O
53011	population	217 227	218098 218108	0.9999845027923584	O
53012	[	228 229	218109 218110	0.999988317489624	O
53013	31	229 231	218110 218112	0.999987006187439	O
53014	-	231 232	218112 218113	0.999988317489624	O
53015	33	232 234	218113 218115	0.9999845027923584	O
53016	]	234 235	218115 218116	0.9999877214431763	O
53017	.	236 237	218117 218118	0.9999675750732422	O
53018	The	0 3	218119 218122	0.9999761581420898	O
53019	current	4 11	218123 218130	0.9999555349349976	O
53020	sample	12 18	218131 218137	0.9999523162841797	O
53021	contained	19 28	218138 218147	0.9999758005142212	O
53022	more	29 33	218148 218152	0.9999731779098511	O
53023	African	34 41	218153 218160	0.9999285936355591	O
53024	Americans	42 51	218161 218170	0.9999556541442871	O
53025	and	52 55	218171 218174	0.9999715089797974	O
53026	more	56 60	218175 218179	0.9999773502349854	O
53027	right	61 66	218180 218185	0.9999792575836182	O
53028	-	66 67	218185 218186	0.9999840259552002	O
53029	sided	67 72	218186 218191	0.9999841451644897	O
53030	than	73 77	218192 218196	0.9999797344207764	O
53031	left	78 82	218197 218201	0.9999691247940063	O
53032	-	82 83	218201 218202	0.9999827146530151	O
53033	sided	83 88	218202 218207	0.9999814033508301	O
53034	tumors	89 95	218208 218214	0.9999775886535645	O
53035	.	96 97	218215 218216	0.9998517036437988	O
53036	The	0 3	218217 218220	0.999988317489624	O
53037	MSI	4 6	218221 218223	0.9999830722808838	O
53039	phenotype	8 16	218225 218233	0.9999890327453613	O
53042	was	18 21	218235 218238	0.9999877214431763	O
53043	more	22 26	218239 218243	0.9999868869781494	O
53044	common	27 33	218244 218250	0.9999877214431763	O
53045	in	34 36	218251 218253	0.9999879598617554	O
53046	proximal	37 44	218254 218261	0.9999842643737793	O
53048	tumors	46 52	218263 218269	0.9999858140945435	O
53049	than	53 57	218270 218274	0.9999862909317017	O
53050	in	58 60	218275 218277	0.9999886751174927	O
53051	distal	61 66	218278 218283	0.9999845027923584	O
53053	ones	68 72	218285 218289	0.9999858140945435	O
53054	(	73 74	218290 218291	0.9999896287918091	O
53055	p	75 76	218292 218293	0.99998939037323	O
53056	=	77 78	218294 218295	0.9999890327453613	O
53057	0	79 80	218296 218297	0.9999896287918091	O
53058	.	80 81	218297 218298	0.9999890327453613	O
53059	47	81 83	218298 218300	0.9999818801879883	O
53060	)	84 85	218301 218302	0.9999895095825195	O
53061	,	86 87	218303 218304	0.9999879598617554	O
53062	strengthening	88 101	218305 218318	0.9999858140945435	O
53063	earlier	102 109	218319 218326	0.9999862909317017	O
53064	findings	110 118	218327 218335	0.999988317489624	O
53065	of	119 121	218336 218338	0.9999889135360718	O
53066	such	122 126	218339 218343	0.9999885559082031	O
53067	an	127 129	218344 218346	0.9999891519546509	O
53068	association	130 141	218347 218358	0.9999884366989136	O
53069	[	142 143	218359 218360	0.9999895095825195	O
53070	31	143 145	218360 218362	0.9999881982803345	O
53071	-	145 146	218362 218363	0.9999895095825195	O
53072	33	146 148	218363 218365	0.9999877214431763	O
53073	]	148 149	218365 218366	0.9999890327453613	O
53074	.	150 151	218367 218368	0.9999796152114868	O
53075	The	0 3	218369 218372	0.9999853372573853	O
53076	prevalence	4 14	218373 218383	0.9999814033508301	O
53077	of	15 17	218384 218386	0.9999868869781494	O
53078	MSI	18 20	218387 218389	0.9999806880950928	O
53080	-	21 22	218390 218391	0.9999862909317017	O
53081	H	22 23	218391 218392	0.999929666519165	O
53082	tumors	24 30	218393 218399	0.999981164932251	O
53083	indicates	31 40	218400 218409	0.9999828338623047	O
53084	the	41 44	218410 218413	0.9999878406524658	O
53085	importance	45 55	218414 218424	0.9999854564666748	O
53086	of	56 58	218425 218427	0.9999878406524658	O
53087	BRAF	59 62	218428 218431	0.9999809265136719	O
53089	mutations	64 73	218433 218442	0.9999866485595703	O
53090	,	74 75	218443 218444	0.9999872446060181	O
53091	particularly	76 88	218445 218457	0.9999864101409912	O
53092	in	89 91	218458 218460	0.9999868869781494	O
53093	the	92 95	218461 218464	0.9999827146530151	O
53094	African	96 103	218465 218472	0.9999427795410156	O
53095	Americans	104 113	218473 218482	0.9999097585678101	O
53096	,	114 115	218483 218484	0.9999856948852539	O
53097	since	116 121	218485 218490	0.9999834299087524	O
53098	they	122 126	218491 218495	0.9999871253967285	O
53099	represent	127 136	218496 218505	0.9999871253967285	O
53100	a	137 138	218506 218507	0.999988317489624	O
53101	higher	139 145	218508 218514	0.9999860525131226	O
53102	mutation	146 154	218515 218523	0.9999858140945435	O
53103	profile	155 162	218524 218531	0.9999867677688599	O
53104	than	163 167	218532 218536	0.9999873638153076	O
53105	Iranians	168 175	218537 218544	0.9999452829360962	O
53107	and	177 180	218546 218549	0.999984860420227	O
53108	Omanis	181 186	218550 218555	0.9999717473983765	O
53110	.	188 189	218557 218558	0.99996018409729	O
53111	This	0 4	218559 218563	0.9999854564666748	O
53112	finding	5 12	218564 218571	0.9999852180480957	O
53113	suggests	13 21	218572 218580	0.9999818801879883	O
53114	that	22 26	218581 218585	0.9999873638153076	O
53115	,	27 28	218586 218587	0.9999872446060181	O
53116	at	29 31	218588 218590	0.9999866485595703	O
53117	least	32 37	218591 218596	0.9999829530715942	O
53118	within	38 44	218597 218603	0.9999845027923584	O
53119	the	45 48	218604 218607	0.9999877214431763	O
53120	MSI	49 51	218608 218610	0.9999840259552002	O
53122	-	52 53	218611 218612	0.9999884366989136	O
53123	H	53 54	218612 218613	0.9999712705612183	O
53124	group	55 60	218614 218619	0.999987006187439	O
53125	of	61 63	218620 218622	0.9999858140945435	O
53126	patients	64 72	218623 218631	0.9999767541885376	O
53127	,	73 74	218632 218633	0.9999861717224121	O
53128	the	75 78	218634 218637	0.9999864101409912	O
53129	BRAF	79 82	218638 218641	0.999982476234436	O
53131	V600E	84 88	218643 218647	0.9999876022338867	O
53135	mutation	90 98	218649 218657	0.9999880790710449	O
53136	in	99 101	218658 218660	0.9999891519546509	O
53137	exon	102 105	218661 218664	0.9999889135360718	O
53139	15	107 109	218666 218668	0.9999855756759644	O
53140	is	110 112	218669 218671	0.9999874830245972	O
53141	the	113 116	218672 218675	0.9999880790710449	O
53142	major	117 122	218676 218681	0.9999871253967285	O
53143	event	123 128	218682 218687	0.9999871253967285	O
53144	leading	129 136	218688 218695	0.9999856948852539	O
53145	to	137 139	218696 218698	0.999987006187439	O
53146	tumor	140 145	218699 218704	0.9999821186065674	O
53147	development	146 157	218705 218716	0.9999825954437256	O
53148	.	158 159	218717 218718	0.9999525547027588	O
53149	In	0 2	218719 218721	0.9999865293502808	O
53150	addition	3 11	218722 218730	0.9999837875366211	O
53151	,	12 13	218731 218732	0.9999879598617554	O
53152	the	14 17	218733 218736	0.9999872446060181	O
53153	distal	18 23	218737 218742	0.9999856948852539	O
53155	location	25 33	218744 218752	0.9999864101409912	O
53156	of	34 36	218753 218755	0.9999880790710449	O
53157	Omani	37 41	218756 218760	0.9999656677246094	O
53159	MSI	43 45	218762 218764	0.9999834299087524	O
53161	-	46 47	218765 218766	0.9999876022338867	O
53162	H	47 48	218766 218767	0.9999597072601318	O
53163	tumors	49 55	218768 218774	0.9999847412109375	O
53164	may	56 59	218775 218778	0.9999871253967285	O
53165	also	60 64	218779 218783	0.9999861717224121	O
53166	play	65 69	218784 218788	0.9999878406524658	O
53167	an	70 72	218789 218791	0.9999884366989136	O
53168	important	73 82	218792 218801	0.9999881982803345	O
53169	role	83 87	218802 218806	0.9999874830245972	O
53170	in	88 90	218807 218809	0.9999876022338867	O
53171	the	91 94	218810 218813	0.9999874830245972	O
53172	presentation	95 107	218814 218826	0.9999855756759644	O
53173	of	108 110	218827 218829	0.9999874830245972	O
53174	the	111 114	218830 218833	0.9999867677688599	O
53175	disease	115 122	218834 218841	0.9999831914901733	O
53176	compared	123 131	218842 218850	0.9999849796295166	O
53177	to	132 134	218851 218853	0.999987006187439	O
53178	proximal	135 142	218854 218861	0.999985933303833	O
53180	ones	144 148	218863 218867	0.9999839067459106	O
53181	in	149 151	218868 218870	0.9999872446060181	O
53182	the	152 155	218871 218874	0.9999855756759644	O
53183	African	156 163	218875 218882	0.9999740123748779	O
53184	American	164 172	218883 218891	0.9999738931655884	O
53185	and	173 176	218892 218895	0.9999827146530151	O
53186	Iranian	177 184	218896 218903	0.9997110962867737	O
53187	populations	185 196	218904 218915	0.9999812841415405	O
53188	.	197 198	218916 218917	0.9999574422836304	O
53189	The	0 3	218918 218921	0.9999858140945435	O
53190	lower	4 9	218922 218927	0.9999827146530151	O
53191	frequency	10 19	218928 218937	0.9999867677688599	O
53192	of	20 22	218938 218940	0.9999877214431763	O
53193	MSI	23 25	218941 218943	0.9999816417694092	O
53195	-	26 27	218944 218945	0.9999868869781494	O
53196	H	27 28	218945 218946	0.9999316930770874	O
53197	tumors	29 35	218947 218953	0.9999834299087524	O
53198	observed	36 44	218954 218962	0.9999868869781494	O
53199	in	45 47	218963 218965	0.999987006187439	O
53200	Omani	48 52	218966 218970	0.9999680519104004	O
53202	patients	54 62	218972 218980	0.9999798536300659	O
53203	could	63 68	218981 218986	0.9999834299087524	O
53204	be	69 71	218987 218989	0.9999880790710449	O
53205	related	72 79	218990 218997	0.9999877214431763	O
53206	to	80 82	218998 219000	0.9999879598617554	O
53207	the	83 86	219001 219004	0.9999879598617554	O
53208	higher	87 93	219005 219011	0.9999866485595703	O
53209	frequency	94 103	219012 219021	0.9999871253967285	O
53210	of	104 106	219022 219024	0.9999879598617554	O
53211	the	107 110	219025 219028	0.9999873638153076	O
53212	distal	111 116	219029 219034	0.9999862909317017	O
53214	location	118 126	219036 219044	0.9999868869781494	O
53215	.	127 128	219045 219046	0.9999700784683228	O
53216	This	0 4	219047 219051	0.9999765157699585	O
53217	needs	5 10	219052 219057	0.9999780654907227	O
53218	to	11 13	219058 219060	0.9999817609786987	O
53219	be	14 16	219061 219063	0.9999823570251465	O
53220	verified	17 25	219064 219072	0.9999654293060303	O
53221	in	26 28	219073 219075	0.9999815225601196	O
53222	a	29 30	219076 219077	0.9999837875366211	O
53223	larger	31 37	219078 219084	0.999977707862854	O
53224	sample	38 44	219085 219091	0.9999810457229614	O
53225	size	45 49	219092 219096	0.9999828338623047	O
53226	.	50 51	219097 219098	0.999906063079834	O
53227	The	0 3	219099 219102	0.9999849796295166	O
53228	absence	4 11	219103 219110	0.9999840259552002	O
53229	of	12 14	219111 219113	0.9999879598617554	O
53230	hMLH1	15 19	219114 219118	0.9999865293502808	O
53233	expression	21 31	219120 219130	0.9999867677688599	O
53234	was	32 35	219131 219134	0.9999855756759644	O
53235	more	36 40	219135 219139	0.9999822378158569	O
53236	pronounced	41 51	219140 219150	0.9999805688858032	O
53237	in	52 54	219151 219153	0.999985933303833	O
53238	MSI	55 57	219154 219156	0.9999814033508301	O
53240	-	58 59	219157 219158	0.9999872446060181	O
53241	H	59 60	219158 219159	0.9999202489852905	O
53242	tumors	61 67	219160 219166	0.9999841451644897	O
53243	from	68 72	219167 219171	0.9999830722808838	O
53244	African	73 80	219172 219179	0.9999465942382812	O
53245	American	81 89	219180 219188	0.9999574422836304	O
53246	and	90 93	219189 219192	0.9999744892120361	O
53247	Iranian	94 101	219193 219200	0.9863731861114502	O
53248	patients	102 110	219201 219209	0.9999629259109497	O
53249	(	111 112	219210 219211	0.9999861717224121	O
53250	77	113 115	219212 219214	0.9999780654907227	O
53251	%	116 117	219215 219216	0.9999866485595703	O
53252	of	118 120	219217 219219	0.9999853372573853	O
53253	tumors	121 127	219220 219226	0.9999830722808838	O
53254	in	128 130	219227 219229	0.9999862909317017	O
53255	these	131 136	219230 219235	0.9999860525131226	O
53256	groups	137 143	219236 219242	0.9999806880950928	O
53257	showed	144 150	219243 219249	0.9999866485595703	O
53258	no	151 153	219250 219252	0.9999862909317017	O
53259	hMLH1	154 158	219253 219257	0.9999879598617554	O
53262	expression	160 170	219259 219269	0.9999879598617554	O
53263	)	171 172	219270 219271	0.9999876022338867	O
53264	.	173 174	219272 219273	0.9999642372131348	O
53265	However	0 7	219274 219281	0.9999871253967285	O
53266	,	8 9	219282 219283	0.9999890327453613	O
53267	for	10 13	219284 219287	0.9999872446060181	O
53268	Omanis	14 19	219288 219293	0.9999769926071167	O
53270	,	21 22	219295 219296	0.9999886751174927	O
53271	the	23 26	219297 219300	0.9999890327453613	O
53272	moderate	27 35	219301 219309	0.9999853372573853	O
53273	hMLH1expression	36 50	219310 219324	0.9999890327453613	O
53279	(	52 53	219326 219327	0.9999896287918091	O
53280	62	54 56	219328 219330	0.9999858140945435	O
53281	%	57 58	219331 219332	0.99998939037323	O
53282	)	59 60	219333 219334	0.9999895095825195	O
53283	in	61 63	219335 219337	0.9999895095825195	O
53284	MSI	64 66	219338 219340	0.9999872446060181	O
53286	-	67 68	219341 219342	0.99998939037323	O
53287	H	68 69	219342 219343	0.999982476234436	O
53288	may	70 73	219344 219347	0.9999889135360718	O
53289	indicate	74 82	219348 219356	0.9999890327453613	O
53290	some	83 87	219357 219361	0.9999884366989136	O
53291	other	88 93	219362 219367	0.9999871253967285	O
53292	defects	94 101	219368 219375	0.9999871253967285	O
53293	in	102 104	219376 219378	0.9999895095825195	O
53294	the	105 108	219379 219382	0.9999892711639404	O
53295	component	109 118	219383 219392	0.99998939037323	O
53296	of	119 121	219393 219395	0.9999892711639404	O
53297	base	122 126	219396 219400	0.9999886751174927	O
53298	excision	127 134	219401 219408	0.99998939037323	O
53300	repair	136 142	219410 219416	0.9999885559082031	O
53301	(	143 144	219417 219418	0.9999895095825195	O
53302	Oxidative	145 153	219419 219427	0.9999864101409912	O
53306	DNA	155 158	219429 219432	0.9999879598617554	O
53307	damaged	159 166	219433 219440	0.9999873638153076	O
53308	markers	167 174	219441 219448	0.9999890327453613	O
53309	such	175 179	219449 219453	0.9999890327453613	O
53310	as	180 182	219454 219456	0.9999892711639404	O
53311	8	183 184	219457 219458	0.9999871253967285	O
53312	-	184 185	219458 219459	0.9999892711639404	O
53313	hydroxyguanosine	185 200	219459 219474	0.9999887943267822	O
53319	)	202 203	219476 219477	0.99998939037323	O
53320	,	204 205	219478 219479	0.9999877214431763	O
53321	or	206 208	219480 219482	0.9999884366989136	O
53322	distinct	209 217	219483 219491	0.9999868869781494	O
53323	lymphangiogenic	218 232	219492 219506	0.9999865293502808	O
53328	phenotype	234 242	219508 219516	0.99998939037323	O
53331	associated	244 254	219518 219528	0.99998939037323	O
53332	with	255 259	219529 219533	0.99998939037323	O
53333	MSI	260 262	219534 219536	0.9999852180480957	O
53335	other	264 269	219538 219543	0.9999889135360718	O
53336	than	270 274	219544 219548	0.9999885559082031	O
53337	in	275 277	219549 219551	0.9999890327453613	O
53338	mismatch	278 285	219552 219559	0.9999881982803345	O
53341	repair	287 293	219561 219567	0.999988317489624	O
53342	genes	294 299	219568 219573	0.9999889135360718	O
53343	.	300 301	219574 219575	0.9999744892120361	O
53344	The	0 3	219576 219579	0.9999740123748779	O
53345	tumors	4 10	219580 219586	0.9999814033508301	O
53346	that	11 15	219587 219591	0.999984622001648	O
53347	we	16 18	219592 219594	0.9999785423278809	O
53348	have	19 23	219595 219599	0.9999804496765137	O
53349	studied	24 31	219600 219607	0.9999803304672241	O
53350	included	32 40	219608 219616	0.9999842643737793	O
53351	MSI	41 43	219617 219619	0.9999834299087524	O
53353	-	44 45	219620 219621	0.9999879598617554	O
53354	H	45 46	219621 219622	0.9999343156814575	O
53355	tumors	47 53	219623 219629	0.9999853372573853	O
53356	that	54 58	219630 219634	0.9999881982803345	O
53357	were	59 63	219635 219639	0.9999887943267822	O
53358	negative	64 72	219640 219648	0.9999831914901733	O
53359	using	73 78	219649 219654	0.9999881982803345	O
53360	immunohistochemistry	79 98	219655 219674	0.9999885559082031	O
53366	for	100 103	219676 219679	0.9999884366989136	O
53367	hMLH1	104 108	219680 219684	0.9999871253967285	O
53370	.	110 111	219686 219687	0.9999730587005615	O
53371	This	0 4	219688 219692	0.9999849796295166	O
53372	incidence	5 14	219693 219702	0.9999797344207764	O
53373	is	15 17	219703 219705	0.9999858140945435	O
53374	less	18 22	219706 219710	0.999984622001648	O
53375	than	23 27	219711 219715	0.9999871253967285	O
53376	compared	28 36	219716 219724	0.9999855756759644	O
53377	to	37 39	219725 219727	0.9999871253967285	O
53378	that	40 44	219728 219732	0.9999872446060181	O
53379	described	45 54	219733 219742	0.9999858140945435	O
53380	in	55 57	219743 219745	0.9999868869781494	O
53381	the	58 61	219746 219749	0.9999868869781494	O
53382	literature	62 72	219750 219760	0.9999834299087524	O
53383	(	73 74	219761 219762	0.9999880790710449	O
53384	77	75 77	219763 219765	0.999984860420227	O
53385	%	78 79	219766 219767	0.9999881982803345	O
53386	[	80 81	219768 219769	0.9999878406524658	O
53387	34	81 83	219769 219771	0.9999839067459106	O
53388	]	83 84	219771 219772	0.9999878406524658	O
53389	)	85 86	219773 219774	0.999988317489624	O
53390	,	87 88	219775 219776	0.9999874830245972	O
53391	although	89 97	219777 219785	0.9999853372573853	O
53392	the	98 101	219786 219789	0.9999872446060181	O
53393	numbers	102 109	219790 219797	0.9999855756759644	O
53394	described	110 119	219798 219807	0.9999839067459106	O
53395	are	120 123	219808 219811	0.9999872446060181	O
53396	small	124 129	219812 219817	0.9999849796295166	O
53397	.	130 131	219818 219819	0.9999884366989136	O
53398	*	132 133	219820 219821	0.9999874830245972	O
53399	*	133 134	219821 219822	0.9999794960021973	O
53400	IGNORE	0 5	219823 219828	0.9999861717224121	O
53403	LINE	7 10	219830 219833	0.9999890327453613	O
53406	*	12 13	219835 219836	0.9999891519546509	O
53407	*	13 14	219836 219837	0.9999890327453613	O
53408	*	15 16	219838 219839	0.9999890327453613	O
53409	*	16 17	219839 219840	0.9999890327453613	O
53410	IGNORE	18 23	219841 219846	0.9999877214431763	O
53413	LINE	25 28	219848 219851	0.99998939037323	O
53416	*	30 31	219853 219854	0.9999889135360718	O
53417	*	31 32	219854 219855	0.9999889135360718	O
53418	*	33 34	219856 219857	0.9999887943267822	O
53419	*	34 35	219857 219858	0.9999886751174927	O
53420	IGNORE	36 41	219859 219864	0.9999874830245972	O
53423	LINE	43 46	219866 219869	0.9999892711639404	O
53426	*	48 49	219871 219872	0.9999889135360718	O
53427	*	49 50	219872 219873	0.9999885559082031	O
53428	Survival	51 59	219874 219882	0.9999849796295166	O
53429	of	60 62	219883 219885	0.9999886751174927	O
53430	hereditary	63 73	219886 219896	0.999980092048645	O
53431	non	74 77	219897 219900	0.9999880790710449	O
53432	-	77 78	219900 219901	0.9999887943267822	O
53433	polyposis	78 86	219901 219909	0.9999873638153076	O
53437	colorectal	88 97	219911 219920	0.9999880790710449	O
53440	cancer	99 105	219922 219928	0.9999880790710449	O
53441	patients	106 114	219929 219937	0.9999867677688599	O
53442	compared	115 123	219938 219946	0.9999874830245972	O
53443	with	124 128	219947 219951	0.9999877214431763	O
53444	sporadic	129 136	219952 219959	0.9999866485595703	O
53446	colorectal	138 147	219961 219970	0.9999876022338867	O
53449	cancer	149 155	219972 219978	0.9999879598617554	O
53450	patients	156 164	219979 219987	0.9999880790710449	O
53451	Abstract	165 172	219988 219995	0.9999879598617554	O
53454	Background	174 184	219997 220007	0.999983549118042	O
53455	Patients	185 192	220008 220015	0.9999860525131226	O
53457	with	194 198	220017 220021	0.9999871253967285	O
53458	hereditary	199 209	220022 220032	0.9999531507492065	O
53459	non	210 213	220033 220036	0.9999872446060181	O
53460	-	213 214	220036 220037	0.999988317489624	O
53461	poliposys	214 222	220037 220045	0.9999866485595703	O
53466	colorectal	224 233	220047 220056	0.9999872446060181	O
53469	cancer	235 241	220058 220064	0.9999879598617554	O
53470	(	242 243	220065 220066	0.9999884366989136	O
53471	HNPCC	244 248	220067 220071	0.9999691247940063	O
53474	)	250 251	220073 220074	0.9999891519546509	O
53475	have	252 256	220075 220079	0.999987006187439	O
53476	better	257 263	220080 220086	0.9999852180480957	O
53477	prognosis	264 272	220087 220095	0.9999879598617554	O
53480	than	274 278	220097 220101	0.9999868869781494	O
53481	sporadic	279 286	220102 220109	0.9999840259552002	O
53483	colorectal	288 297	220111 220120	0.9999864101409912	O
53486	cancer	299 305	220122 220128	0.9999879598617554	O
53487	(	306 307	220129 220130	0.9999874830245972	O
53488	CRC	308 310	220131 220133	0.9999825954437256	O
53490	)	312 313	220135 220136	0.9999886751174927	O
53491	.	314 315	220137 220138	0.9999674558639526	O
53492	Aim	0 2	220139 220141	0.9999793767929077	O
53494	of	4 6	220143 220145	0.9999856948852539	O
53495	our	7 10	220146 220149	0.9999780654907227	O
53496	retrospective	11 24	220150 220163	0.999980092048645	O
53497	study	25 30	220164 220169	0.9999816417694092	O
53498	was	31 34	220170 220173	0.9999843835830688	O
53499	to	35 37	220174 220176	0.9999843835830688	O
53500	compare	38 45	220177 220184	0.9999793767929077	O
53501	the	46 49	220185 220188	0.9999850988388062	O
53502	overall	50 57	220189 220196	0.9999855756759644	O
53503	survival	58 66	220197 220205	0.9999839067459106	O
53504	between	67 74	220206 220213	0.9999809265136719	O
53505	sporadic	75 82	220214 220221	0.9999829530715942	O
53507	CRC	84 86	220223 220225	0.9999748468399048	O
53509	and	88 91	220227 220230	0.9999786615371704	O
53510	HNPCC	92 96	220231 220235	0.9999550580978394	O
53513	patients	98 106	220237 220245	0.9999805688858032	O
53514	.	107 108	220246 220247	0.999940037727356	O
53515	Methods	0 6	220248 220254	0.9999701976776123	O
53517	We	8 10	220256 220258	0.9999785423278809	O
53518	analyzed	11 19	220259 220267	0.9999821186065674	O
53519	a	20 21	220268 220269	0.9999856948852539	O
53520	cohort	22 27	220270 220275	0.9999855756759644	O
53523	of	29 31	220277 220279	0.9999856948852539	O
53524	40	32 34	220280 220282	0.9999258518218994	O
53525	(	35 36	220283 220284	0.9999867677688599	O
53526	25	37 39	220285 220287	0.9999728202819824	O
53527	males	40 45	220288 220293	0.9999749660491943	O
53528	and	46 49	220294 220297	0.9999855756759644	O
53529	15	50 52	220298 220300	0.9999662637710571	O
53530	females	53 60	220301 220308	0.9999281167984009	O
53531	)	61 62	220309 220310	0.9999853372573853	O
53532	HNPCC	63 67	220311 220315	0.9999316930770874	O
53535	cases	69 74	220317 220322	0.9999833106994629	O
53536	with	75 79	220323 220327	0.9999841451644897	O
53537	a	80 81	220328 220329	0.9999867677688599	O
53538	hospital	82 90	220330 220338	0.9999728202819824	O
53539	consecutive	91 102	220339 220350	0.9999840259552002	O
53540	series	103 109	220351 220357	0.9999837875366211	O
53541	of	110 112	220358 220360	0.9999865293502808	O
53542	573	113 115	220361 220363	0.9999821186065674	O
53544	(	117 118	220365 220366	0.9999868869781494	O
53545	312	119 122	220367 220370	0.9999769926071167	O
53546	males	123 128	220371 220376	0.9999755620956421	O
53547	and	129 132	220377 220380	0.9999854564666748	O
53548	261	133 136	220381 220384	0.9999761581420898	O
53549	females	137 144	220385 220392	0.9999295473098755	O
53550	)	145 146	220393 220394	0.9999854564666748	O
53551	sporadic	147 154	220395 220402	0.9999827146530151	O
53553	CRC	156 158	220404 220406	0.9999721050262451	O
53555	observed	160 168	220408 220416	0.999984622001648	O
53556	during	169 175	220417 220423	0.9999853372573853	O
53557	the	176 179	220424 220427	0.9999861717224121	O
53558	period	180 186	220428 220434	0.9999840259552002	O
53559	1970	187 191	220435 220439	0.9999849796295166	O
53560	–	191 192	220439 220440	0.999984860420227	O
53561	1993	192 196	220440 220444	0.9999816417694092	O
53562	.	197 198	220445 220446	0.9999463558197021	O
53563	In	0 2	220447 220449	0.9999773502349854	O
53564	15	3 5	220450 220452	0.9998797178268433	O
53565	HNPCC	6 10	220453 220457	0.9999139308929443	O
53568	patients	12 20	220459 220467	0.9999697208404541	O
53569	we	21 23	220468 220470	0.9999788999557495	O
53570	performed	24 33	220471 220480	0.999983549118042	O
53571	mutational	34 43	220481 220490	0.9999809265136719	O
53573	analysis	45 53	220492 220500	0.999984622001648	O
53574	for	54 57	220501 220504	0.999983549118042	O
53575	microsatellite	58 71	220505 220518	0.9999843835830688	O
53579	instability	73 84	220520 220531	0.999984860420227	O
53580	.	85 86	220532 220533	0.9999206066131592	O
53581	Survival	0 8	220534 220542	0.9999793767929077	O
53582	rates	9 14	220543 220548	0.9999836683273315	O
53583	were	15 19	220549 220553	0.9999843835830688	O
53584	calculated	20 30	220554 220564	0.9999809265136719	O
53585	by	31 33	220565 220567	0.9999866485595703	O
53586	Kaplan	34 40	220568 220574	0.9999831914901733	O
53587	-	40 41	220574 220575	0.9999878406524658	O
53588	Meier	41 45	220575 220579	0.999984860420227	O
53590	method	47 53	220581 220587	0.9999825954437256	O
53591	and	54 57	220588 220591	0.9999837875366211	O
53592	compared	58 66	220592 220600	0.9999862909317017	O
53593	with	67 71	220601 220605	0.9999880790710449	O
53594	log	72 75	220606 220609	0.9999867677688599	O
53595	rank	76 80	220610 220614	0.9999862909317017	O
53596	test	81 85	220615 220619	0.9999866485595703	O
53597	.	86 87	220620 220621	0.9999340772628784	O
53598	Results	0 7	220622 220629	0.9999725818634033	O
53599	The	8 11	220630 220633	0.9999847412109375	O
53600	median	12 18	220634 220640	0.9999809265136719	O
53601	age	19 22	220641 220644	0.9999791383743286	O
53602	at	23 25	220645 220647	0.9999854564666748	O
53603	diagnosis	26 35	220648 220657	0.9999837875366211	O
53604	of	36 38	220658 220660	0.9999856948852539	O
53605	the	39 42	220661 220664	0.999983549118042	O
53606	primary	43 50	220665 220672	0.9999786615371704	O
53607	CRC	51 53	220673 220675	0.9999746084213257	O
53609	was	55 58	220677 220680	0.9999862909317017	O
53610	46	59 61	220681 220683	0.9999810457229614	O
53611	.	61 62	220683 220684	0.9999867677688599	O
53612	8	62 63	220684 220685	0.9999855756759644	O
53613	years	64 69	220686 220691	0.9999855756759644	O
53614	in	70 72	220692 220694	0.9999876022338867	O
53615	the	73 76	220695 220698	0.9999866485595703	O
53616	HNPCC	77 81	220699 220703	0.9999703168869019	O
53619	series	83 89	220705 220711	0.9999833106994629	O
53620	versus	90 96	220712 220718	0.9999856948852539	O
53621	61	97 99	220719 220721	0.9999773502349854	O
53622	years	100 105	220722 220727	0.9999867677688599	O
53623	in	106 108	220728 220730	0.9999876022338867	O
53624	sporadic	109 116	220731 220738	0.9999862909317017	O
53626	CRC	118 120	220740 220742	0.9999816417694092	O
53628	group	122 127	220744 220749	0.9999872446060181	O
53629	.	128 129	220750 220751	0.9999639987945557	O
53630	In	0 2	220752 220754	0.9999852180480957	O
53631	HNPCC	3 7	220755 220759	0.9999743700027466	O
53634	group	9 14	220761 220766	0.9999868869781494	O
53635	85	15 17	220767 220769	0.9999817609786987	O
53636	%	18 19	220770 220771	0.9999856948852539	O
53637	had	20 23	220772 220775	0.9999862909317017	O
53638	a	24 25	220776 220777	0.9999868869781494	O
53639	right	26 31	220778 220783	0.9999823570251465	O
53640	cancer	32 38	220784 220790	0.9999845027923584	O
53641	location	39 47	220791 220799	0.9999865293502808	O
53642	,	48 49	220800 220801	0.9999858140945435	O
53643	vs	50 52	220802 220804	0.9999854564666748	O
53644	.	52 53	220804 220805	0.9999874830245972	O
53645	57	54 56	220806 220808	0.9999752044677734	O
53646	%	57 58	220809 220810	0.9999876022338867	O
53647	in	59 61	220811 220813	0.9999873638153076	O
53648	the	62 65	220814 220817	0.9999861717224121	O
53649	sporadic	66 73	220818 220825	0.9999842643737793	O
53651	cancer	75 81	220827 220833	0.999985933303833	O
53652	group	82 87	220834 220839	0.9999879598617554	O
53653	.	88 89	220840 220841	0.9999600648880005	O
53654	In	0 2	220842 220844	0.9999865293502808	O
53655	the	3 6	220845 220848	0.9999860525131226	O
53656	sporadic	7 14	220849 220856	0.999983549118042	O
53658	cancer	16 22	220858 220864	0.9999852180480957	O
53659	group	23 28	220865 220870	0.9999877214431763	O
53660	61	29 31	220871 220873	0.9999819993972778	O
53661	.	31 32	220873 220874	0.9999877214431763	O
53662	6	32 33	220874 220875	0.9999837875366211	O
53663	%	34 35	220876 220877	0.9999872446060181	O
53664	were	36 40	220878 220882	0.9999879598617554	O
53665	early	41 46	220883 220888	0.9999874830245972	O
53666	-	46 47	220888 220889	0.9999886751174927	O
53667	stages	47 53	220889 220895	0.9999865293502808	O
53668	cancer	54 60	220896 220902	0.9999866485595703	O
53669	(	61 62	220903 220904	0.9999891519546509	O
53670	Dukes	63 68	220905 220910	0.9999819993972778	O
53671	'	69 70	220911 220912	0.9999889135360718	O
53672	A	71 72	220913 220914	0.9999887943267822	O
53673	and	73 76	220915 220918	0.9999876022338867	O
53674	B	77 78	220919 220920	0.9999860525131226	O
53675	)	78 79	220920 220921	0.9999886751174927	O
53676	vs	80 82	220922 220924	0.9999865293502808	O
53677	.	82 83	220924 220925	0.9999881982803345	O
53678	70	84 86	220926 220928	0.9999827146530151	O
53679	%	87 88	220929 220930	0.9999885559082031	O
53680	in	89 91	220931 220933	0.9999881982803345	O
53681	the	92 95	220934 220937	0.9999878406524658	O
53682	HNPCC	96 100	220938 220942	0.9999783039093018	O
53685	group	102 107	220944 220949	0.9999885559082031	O
53686	(	108 109	220950 220951	0.9999892711639404	O
53687	p	110 111	220952 220953	0.9999889135360718	O
53688	=	112 113	220954 220955	0.9999887943267822	O
53689	ns	114 115	220956 220957	0.9999885559082031	O
53691	)	117 118	220959 220960	0.9999891519546509	O
53692	.	119 120	220961 220962	0.9999681711196899	O
53693	The	0 3	220963 220966	0.9999860525131226	O
53694	crude	4 9	220967 220972	0.9999809265136719	O
53695	5	10 11	220973 220974	0.9999843835830688	O
53696	-	11 12	220974 220975	0.9999877214431763	O
53697	years	12 17	220975 220980	0.9999843835830688	O
53698	cumulative	18 28	220981 220991	0.999984622001648	O
53699	survival	29 37	220992 221000	0.9999839067459106	O
53700	after	38 43	221001 221006	0.9999839067459106	O
53701	the	44 47	221007 221010	0.9999845027923584	O
53702	primary	48 55	221011 221018	0.9999829530715942	O
53703	CRC	56 58	221019 221021	0.999974250793457	O
53705	was	60 63	221023 221026	0.9999867677688599	O
53706	94	64 66	221027 221029	0.9999831914901733	O
53707	.	66 67	221029 221030	0.9999884366989136	O
53708	2	67 68	221030 221031	0.9999849796295166	O
53709	%	69 70	221032 221033	0.9999881982803345	O
53710	in	71 73	221034 221036	0.9999872446060181	O
53711	HNPCC	74 78	221037 221041	0.9999760389328003	O
53714	patients	80 88	221043 221051	0.9999858140945435	O
53715	vs	89 91	221052 221054	0.9999871253967285	O
53716	.	91 92	221054 221055	0.9999881982803345	O
53717	75	93 95	221056 221058	0.999981164932251	O
53718	.	95 96	221058 221059	0.9999887943267822	O
53719	3	96 97	221059 221060	0.9999837875366211	O
53720	%	98 99	221061 221062	0.9999881982803345	O
53721	in	100 102	221063 221065	0.9999878406524658	O
53722	sporadic	103 110	221066 221073	0.9999852180480957	O
53724	cancer	112 118	221075 221081	0.999984860420227	O
53725	patients	119 127	221082 221090	0.9999865293502808	O
53726	(	128 129	221091 221092	0.999988317489624	O
53727	p	130 131	221093 221094	0.9999884366989136	O
53728	<	132 133	221095 221096	0.9999872446060181	O
53729	0	134 135	221097 221098	0.9999886751174927	O
53730	.	135 136	221098 221099	0.9999884366989136	O
53731	0001	136 139	221099 221102	0.9999874830245972	O
53733	)	141 142	221104 221105	0.9999884366989136	O
53734	.	143 144	221106 221107	0.9999690055847168	O
53735	Conclusion	0 9	221108 221117	0.9999783039093018	O
53738	Our	11 14	221119 221122	0.9999735355377197	O
53739	results	15 22	221123 221130	0.9999818801879883	O
53740	show	23 27	221131 221135	0.999976396560669	O
53741	that	28 32	221136 221140	0.9999842643737793	O
53742	overall	33 40	221141 221148	0.9999849796295166	O
53743	survival	41 49	221149 221157	0.9999817609786987	O
53744	of	50 52	221158 221160	0.999982476234436	O
53745	colorectal	53 62	221161 221170	0.9999785423278809	O
53748	cancer	64 70	221172 221178	0.9999827146530151	O
53749	in	71 73	221179 221181	0.9999829530715942	O
53750	patients	74 82	221182 221190	0.9999788999557495	O
53751	with	83 87	221191 221195	0.999982476234436	O
53752	HNPCC	88 92	221196 221200	0.9999632835388184	O
53755	is	94 96	221202 221204	0.9999825954437256	O
53756	better	97 103	221205 221211	0.9999803304672241	O
53757	than	104 108	221212 221216	0.9999815225601196	O
53758	sporadic	109 116	221217 221224	0.9999775886535645	O
53760	CRC	118 120	221226 221228	0.9999717473983765	O
53762	patients	122 130	221230 221238	0.999980092048645	O
53763	.	131 132	221239 221240	0.9999529123306274	O
53764	The	0 3	221241 221244	0.9999877214431763	O
53765	different	4 13	221245 221254	0.9999855756759644	O
53766	outcome	14 21	221255 221262	0.999984860420227	O
53767	probably	22 30	221263 221271	0.9999861717224121	O
53768	relates	31 38	221272 221279	0.9999850988388062	O
53769	to	39 41	221280 221282	0.9999879598617554	O
53770	the	42 45	221283 221286	0.9999877214431763	O
53771	specific	46 54	221287 221295	0.9999819993972778	O
53772	tumorigenesis	55 67	221296 221308	0.9999821186065674	O
53776	involving	69 78	221310 221319	0.9999871253967285	O
53777	DNA	79 82	221320 221323	0.999987006187439	O
53778	mismatch	83 90	221324 221331	0.9999884366989136	O
53781	repair	92 98	221333 221339	0.9999877214431763	O
53782	dysfunction	99 109	221340 221350	0.9999889135360718	O
53785	.	111 112	221352 221353	0.9999880790710449	O
53786	*	113 114	221354 221355	0.9999871253967285	O
53787	*	114 115	221355 221356	0.9999822378158569	O
53788	IGNORE	0 5	221357 221362	0.9999855756759644	O
53791	LINE	7 10	221364 221367	0.9999884366989136	O
53794	*	12 13	221369 221370	0.9999886751174927	O
53795	*	13 14	221370 221371	0.9999885559082031	O
53796	*	15 16	221372 221373	0.9999885559082031	O
53797	*	16 17	221373 221374	0.9999885559082031	O
53798	IGNORE	18 23	221375 221380	0.9999873638153076	O
53801	LINE	25 28	221382 221385	0.9999890327453613	O
53804	*	30 31	221387 221388	0.9999885559082031	O
53805	*	31 32	221388 221389	0.9999884366989136	O
53806	*	33 34	221390 221391	0.9999884366989136	O
53807	*	34 35	221391 221392	0.9999885559082031	O
53808	IGNORE	36 41	221393 221398	0.9999872446060181	O
53811	LINE	43 46	221400 221403	0.9999887943267822	O
53814	*	48 49	221405 221406	0.9999886751174927	O
53815	*	49 50	221406 221407	0.9999885559082031	O
53816	Background	51 61	221408 221418	0.999984860420227	O
53817	Colorectal	62 71	221419 221428	0.9999839067459106	O
53820	cancer	73 79	221430 221436	0.9999864101409912	O
53821	is	80 82	221437 221439	0.999985933303833	O
53822	one	83 86	221440 221443	0.9999858140945435	O
53823	of	87 89	221444 221446	0.9999850988388062	O
53824	the	90 93	221447 221450	0.9999849796295166	O
53825	most	94 98	221451 221455	0.9999849796295166	O
53826	common	99 105	221456 221462	0.9999769926071167	O
53827	neoplasm	106 113	221463 221470	0.9999860525131226	O
53831	in	115 117	221472 221474	0.999981164932251	O
53832	humans	118 124	221475 221481	0.7574007511138916	O
53833	[	125 126	221482 221483	0.9999891519546509	O
53834	1	126 127	221483 221484	0.9999886751174927	O
53835	,	127 128	221484 221485	0.9999880790710449	O
53836	2	128 129	221485 221486	0.9999868869781494	O
53837	]	129 130	221486 221487	0.9999884366989136	O
53838	.	131 132	221488 221489	0.9999769926071167	O
53839	It	0 2	221490 221492	0.9999886751174927	O
53840	'	3 4	221493 221494	0.9999877214431763	O
53841	s	4 5	221494 221495	0.9999889135360718	O
53842	known	6 11	221496 221501	0.9999864101409912	O
53843	that	12 16	221502 221506	0.9999891519546509	O
53844	a	17 18	221507 221508	0.9999895095825195	O
53845	definite	19 27	221509 221517	0.9999868869781494	O
53846	fraction	28 36	221518 221526	0.9999868869781494	O
53847	,	37 38	221527 221528	0.9999889135360718	O
53848	ranging	39 46	221529 221536	0.9999885559082031	O
53849	between	47 54	221537 221544	0.999988317489624	O
53850	1	55 56	221545 221546	0.9999886751174927	O
53851	and	57 60	221547 221550	0.9999887943267822	O
53852	5	61 62	221551 221552	0.9999858140945435	O
53853	%	63 64	221553 221554	0.9999886751174927	O
53854	of	65 67	221555 221557	0.9999886751174927	O
53855	all	68 71	221558 221561	0.9999874830245972	O
53856	cases	72 77	221562 221567	0.9999865293502808	O
53857	of	78 80	221568 221570	0.9999871253967285	O
53858	colorectal	81 90	221571 221580	0.9999830722808838	O
53861	tumors	92 98	221582 221588	0.9999854564666748	O
53862	,	99 100	221589 221590	0.9999880790710449	O
53863	is	101 103	221591 221593	0.9999891519546509	O
53864	transmitted	104 115	221594 221605	0.9999871253967285	O
53865	from	116 120	221606 221610	0.99998939037323	O
53866	one	121 124	221611 221614	0.99998939037323	O
53867	generation	125 135	221615 221625	0.9999881982803345	O
53868	to	136 138	221626 221628	0.9999886751174927	O
53869	another	139 146	221629 221636	0.9999886751174927	O
53870	in	147 149	221637 221639	0.9999896287918091	O
53871	accordance	150 160	221640 221650	0.9999892711639404	O
53872	with	161 165	221651 221655	0.9999895095825195	O
53873	an	166 168	221656 221658	0.99998939037323	O
53874	autosomal	169 177	221659 221667	0.9999876022338867	O
53877	dominant	179 187	221669 221677	0.999987006187439	O
53878	model	188 193	221678 221683	0.9999886751174927	O
53879	;	194 195	221684 221685	0.9999884366989136	O
53880	this	196 200	221686 221690	0.9999891519546509	O
53881	is	201 203	221691 221693	0.9999890327453613	O
53882	the	204 207	221694 221697	0.9999890327453613	O
53883	case	208 212	221698 221702	0.9999886751174927	O
53884	of	213 215	221703 221705	0.9999891519546509	O
53885	Hereditary	216 225	221706 221715	0.9999814033508301	O
53888	Non	227 230	221717 221720	0.9999855756759644	O
53889	-	230 231	221720 221721	0.9999885559082031	O
53890	Polyposis	231 239	221721 221729	0.9999868869781494	O
53894	Colorectal	241 250	221731 221740	0.9999842643737793	O
53897	Cancer	252 258	221742 221748	0.999985933303833	O
53898	(	259 260	221749 221750	0.9999887943267822	O
53899	HNPCC	261 265	221751 221755	0.9999717473983765	O
53902	)	267 268	221757 221758	0.9999892711639404	O
53903	and	269 272	221759 221762	0.9999885559082031	O
53904	of	273 275	221763 221765	0.9999885559082031	O
53905	Familial	276 283	221766 221773	0.9999821186065674	O
53908	Adenomatous	285 295	221775 221785	0.999983549118042	O
53912	Polyposis	297 305	221787 221795	0.9999868869781494	O
53916	(	307 308	221797 221798	0.9999887943267822	O
53917	FAP	309 311	221799 221801	0.9999773502349854	O
53919	)	313 314	221803 221804	0.9999890327453613	O
53920	[	315 316	221805 221806	0.9999889135360718	O
53921	2	316 317	221806 221807	0.999984860420227	O
53922	]	317 318	221807 221808	0.9999886751174927	O
53923	.	319 320	221809 221810	0.9999794960021973	O
53924	HNPCC	0 4	221811 221815	0.9999018907546997	O
53927	is	6 8	221817 221819	0.9999759197235107	O
53928	an	9 11	221820 221822	0.9999786615371704	O
53929	autosomal	12 20	221823 221831	0.9999653100967407	O
53932	dominant	22 30	221833 221841	0.9999659061431885	O
53933	disease	31 38	221842 221849	0.9999735355377197	O
53934	characterized	39 52	221850 221863	0.9999836683273315	O
53935	by	53 55	221864 221866	0.9999864101409912	O
53936	early	56 61	221867 221872	0.9999845027923584	O
53937	appearance	62 72	221873 221883	0.9999850988388062	O
53938	of	73 75	221884 221886	0.9999868869781494	O
53939	cancer	76 82	221887 221893	0.9999827146530151	O
53940	usually	83 90	221894 221901	0.9999830722808838	O
53941	of	91 93	221902 221904	0.9999868869781494	O
53942	the	94 97	221905 221908	0.9999871253967285	O
53943	right	98 103	221909 221914	0.9999817609786987	O
53944	colon	104 108	221915 221919	0.9999827146530151	O
53946	,	110 111	221921 221922	0.9999855756759644	O
53947	frequent	112 120	221923 221931	0.9999802112579346	O
53948	occurrence	121 131	221932 221942	0.9999858140945435	O
53949	of	132 134	221943 221945	0.9999872446060181	O
53950	multiple	135 143	221946 221954	0.9999728202819824	O
53951	lesions	144 151	221955 221962	0.999984622001648	O
53952	(	152 153	221963 221964	0.9999874830245972	O
53953	both	154 158	221965 221969	0.9999872446060181	O
53954	synchronous	159 169	221970 221980	0.9999877214431763	O
53959	and	171 174	221982 221985	0.999985933303833	O
53960	metachronous	175 186	221986 221997	0.9999864101409912	O
53964	)	188 189	221999 222000	0.999987006187439	O
53965	and	190 193	222001 222004	0.9999847412109375	O
53966	a	194 195	222005 222006	0.9999860525131226	O
53967	striking	196 204	222007 222015	0.9999779462814331	O
53968	association	205 216	222016 222027	0.999982476234436	O
53969	with	217 221	222028 222032	0.9999836683273315	O
53970	tumours	222 228	222033 222039	0.9999853372573853	O
53973	of	230 232	222041 222043	0.9999852180480957	O
53974	other	233 238	222044 222049	0.999980092048645	O
53975	organs	239 245	222050 222056	0.9999759197235107	O
53976	,	246 247	222057 222058	0.9999843835830688	O
53977	in	248 250	222059 222061	0.9999858140945435	O
53978	particular	251 261	222062 222072	0.9999829530715942	O
53979	endometrium	262 272	222073 222083	0.9999856948852539	O
53983	,	274 275	222085 222086	0.999985933303833	O
53984	urinary	276 282	222087 222093	0.9999840259552002	O
53987	tract	284 289	222095 222100	0.9999850988388062	O
53988	,	290 291	222101 222102	0.999985933303833	O
53989	ovary	292 296	222103 222107	0.9999823570251465	O
53991	,	298 299	222109 222110	0.9999847412109375	O
53992	stomach	300 307	222111 222118	0.9999779462814331	O
53993	and	308 311	222119 222122	0.9999823570251465	O
53994	small	312 317	222123 222128	0.9999614953994751	O
53995	bowel	318 322	222129 222133	0.9999798536300659	O
53997	.	324 325	222135 222136	0.9998070597648621	O
53998	The	0 3	222137 222140	0.9999867677688599	O
53999	Amsterdam	4 13	222141 222150	0.99997878074646	O
54000	criteria	14 22	222151 222159	0.9999823570251465	O
54001	,	23 24	222160 222161	0.9999866485595703	O
54002	currently	25 34	222162 222171	0.9999850988388062	O
54003	used	35 39	222172 222176	0.9999847412109375	O
54004	for	40 43	222177 222180	0.9999850988388062	O
54005	the	44 47	222181 222184	0.9999867677688599	O
54006	diagnosis	48 57	222185 222194	0.9999849796295166	O
54007	of	58 60	222195 222197	0.9999871253967285	O
54008	HNPCC	61 65	222198 222202	0.9999772310256958	O
54011	,	67 68	222204 222205	0.9999861717224121	O
54012	were	69 73	222206 222210	0.9999872446060181	O
54013	introduced	74 84	222211 222221	0.9999865293502808	O
54014	in	85 87	222222 222224	0.9999881982803345	O
54015	1989	88 92	222225 222229	0.9999837875366211	O
54016	to	93 95	222230 222232	0.9999880790710449	O
54017	provide	96 103	222233 222240	0.9999881982803345	O
54018	a	104 105	222241 222242	0.9999887943267822	O
54019	uniform	106 113	222243 222250	0.9999856948852539	O
54020	evaluation	114 124	222251 222261	0.9999873638153076	O
54021	of	125 127	222262 222264	0.9999887943267822	O
54022	familial	128 135	222265 222272	0.9999885559082031	O
54025	and	137 140	222274 222277	0.9999868869781494	O
54026	personal	141 149	222278 222286	0.9999836683273315	O
54027	history	150 157	222287 222294	0.9999876022338867	O
54028	.	158 159	222295 222296	0.9999663829803467	O
54029	They	0 4	222297 222301	0.9999864101409912	O
54030	were	5 9	222302 222306	0.9999885559082031	O
54031	revised	10 17	222307 222314	0.9999855756759644	O
54032	in	18 20	222315 222317	0.9999886751174927	O
54033	1999	21 25	222318 222322	0.9999845027923584	O
54034	and	26 29	222323 222326	0.9999873638153076	O
54035	included	30 38	222327 222335	0.9999873638153076	O
54036	various	39 46	222336 222343	0.9999849796295166	O
54037	extra	47 52	222344 222349	0.9999839067459106	O
54038	-	52 53	222349 222350	0.9999873638153076	O
54039	colonic	53 59	222350 222356	0.9999814033508301	O
54042	tumours	61 67	222358 222364	0.9999879598617554	O
54045	:	69 70	222366 222367	0.9999889135360718	O
54046	1	71 72	222368 222369	0.9999880790710449	O
54047	)	73 74	222370 222371	0.99998939037323	O
54048	at	75 77	222372 222374	0.9999892711639404	O
54049	least	78 83	222375 222380	0.9999895095825195	O
54050	three	84 89	222381 222386	0.9999884366989136	O
54051	or	90 92	222387 222389	0.9999886751174927	O
54052	more	93 97	222390 222394	0.9999886751174927	O
54053	relatives	98 107	222395 222404	0.999984622001648	O
54054	with	108 112	222405 222409	0.9999889135360718	O
54055	histological	113 124	222410 222421	0.9999881982803345	O
54058	verified	126 134	222423 222431	0.9999853372573853	O
54059	tumour	135 140	222432 222437	0.9999886751174927	O
54061	in	142 144	222439 222441	0.9999892711639404	O
54062	the	145 148	222442 222445	0.9999892711639404	O
54063	spectrum	149 157	222446 222454	0.9999871253967285	O
54064	of	158 160	222455 222457	0.9999887943267822	O
54065	HNPCC	161 165	222458 222462	0.999983549118042	O
54068	,	167 168	222464 222465	0.9999891519546509	O
54069	one	169 172	222466 222469	0.9999885559082031	O
54070	of	173 175	222470 222472	0.9999881982803345	O
54071	whom	176 180	222473 222477	0.9999872446060181	O
54072	is	181 183	222478 222480	0.9999890327453613	O
54073	a	184 185	222481 222482	0.9999892711639404	O
54074	first	186 191	222483 222488	0.9999889135360718	O
54075	-	191 192	222488 222489	0.9999890327453613	O
54076	degree	192 198	222489 222495	0.9999876022338867	O
54077	relative	199 207	222496 222504	0.9999877214431763	O
54078	of	208 210	222505 222507	0.9999886751174927	O
54079	the	211 214	222508 222511	0.9999886751174927	O
54080	other	215 220	222512 222517	0.9999878406524658	O
54081	two	221 224	222518 222521	0.9999845027923584	O
54082	;	225 226	222522 222523	0.9999891519546509	O
54083	2	227 228	222524 222525	0.9999861717224121	O
54084	)	229 230	222526 222527	0.99998939037323	O
54085	at	231 233	222528 222530	0.9999892711639404	O
54086	least	234 239	222531 222536	0.99998939037323	O
54087	two	240 243	222537 222540	0.999988317489624	O
54088	generations	244 255	222541 222552	0.9999819993972778	O
54089	should	256 262	222553 222559	0.9999886751174927	O
54090	be	263 265	222560 222562	0.9999891519546509	O
54091	affected	266 274	222563 222571	0.9999877214431763	O
54092	;	275 276	222572 222573	0.9999891519546509	O
54093	3	277 278	222574 222575	0.9999866485595703	O
54094	)	279 280	222576 222577	0.9999891519546509	O
54095	one	281 284	222578 222581	0.9999886751174927	O
54096	or	285 287	222582 222584	0.9999885559082031	O
54097	more	288 292	222585 222589	0.9999878406524658	O
54098	tumours	293 299	222590 222596	0.9999873638153076	O
54101	diagnosed	301 310	222598 222607	0.9999880790710449	O
54102	when	311 315	222608 222612	0.9999881982803345	O
54103	under	316 321	222613 222618	0.9999876022338867	O
54104	the	322 325	222619 222622	0.9999890327453613	O
54105	age	326 329	222623 222626	0.9999885559082031	O
54106	of	330 332	222627 222629	0.9999890327453613	O
54107	50	333 335	222630 222632	0.9999836683273315	O
54108	years	336 341	222633 222638	0.9999879598617554	O
54109	;	342 343	222639 222640	0.9999887943267822	O
54110	4	344 345	222641 222642	0.9999856948852539	O
54111	)	346 347	222643 222644	0.99998939037323	O
54112	FAP	348 350	222645 222647	0.9999830722808838	O
54114	should	352 358	222649 222655	0.9999891519546509	O
54115	be	359 361	222656 222658	0.9999891519546509	O
54116	excluded	362 370	222659 222667	0.999988317489624	O
54117	[	371 372	222668 222669	0.9999889135360718	O
54118	3	372 373	222669 222670	0.9999880790710449	O
54119	,	373 374	222670 222671	0.9999886751174927	O
54120	4	374 375	222671 222672	0.9999853372573853	O
54121	]	375 376	222672 222673	0.999988317489624	O
54122	.	377 378	222674 222675	0.9999735355377197	O
54123	Colorectal	0 9	222676 222685	0.9999730587005615	O
54126	tumours	11 17	222687 222693	0.9999840259552002	O
54129	with	19 23	222695 222699	0.9999871253967285	O
54130	microsatellite	24 37	222700 222713	0.9999866485595703	O
54134	instability	39 50	222715 222726	0.9999873638153076	O
54135	(	51 52	222727 222728	0.9999892711639404	O
54136	MS	53 55	222729 222731	0.9999845027923584	O
54137	I	56 57	222732 222733	0.999988317489624	O
54138	phenotype	58 66	222734 222742	0.9999891519546509	O
54141	)	68 69	222744 222745	0.9999873638153076	O
54142	have	70 74	222746 222750	0.9999862909317017	O
54143	mutations	75 84	222751 222760	0.9999867677688599	O
54144	in	85 87	222761 222763	0.9999889135360718	O
54145	mismatch	88 95	222764 222771	0.9999874830245972	O
54148	repair	97 103	222773 222779	0.9999877214431763	O
54149	(	104 105	222780 222781	0.9999891519546509	O
54150	MMR	106 108	222782 222784	0.999987006187439	O
54152	)	110 111	222786 222787	0.9999892711639404	O
54153	genes	112 117	222788 222793	0.9999891519546509	O
54154	and	118 121	222794 222797	0.9999886751174927	O
54155	in	122 124	222798 222800	0.9999889135360718	O
54156	particular	125 135	222801 222811	0.9999878406524658	O
54157	in	136 138	222812 222814	0.9999886751174927	O
54158	the	139 142	222815 222818	0.9999886751174927	O
54159	MSH2	143 146	222819 222822	0.9999877214431763	O
54162	and	148 151	222824 222827	0.9999884366989136	O
54163	MLH1	152 155	222828 222831	0.9999865293502808	O
54166	genes	157 162	222833 222838	0.9999887943267822	O
54167	,	163 164	222839 222840	0.9999887943267822	O
54168	respectively	165 177	222841 222853	0.999987006187439	O
54169	found	178 183	222854 222859	0.9999889135360718	O
54170	on	184 186	222860 222862	0.9999890327453613	O
54171	chromosome	187 197	222863 222873	0.9999890327453613	O
54172	arms	198 202	222874 222878	0.9999886751174927	O
54173	2p	203 204	222879 222880	0.999988317489624	O
54175	and	206 209	222882 222885	0.9999884366989136	O
54176	3p	210 211	222886 222887	0.9999865293502808	O
54178	[	213 214	222889 222890	0.99998939037323	O
54179	5	214 215	222890 222891	0.999988317489624	O
54180	-	215 216	222891 222892	0.99998939037323	O
54181	9	216 217	222892 222893	0.9999872446060181	O
54182	]	217 218	222893 222894	0.9999891519546509	O
54183	.	219 220	222895 222896	0.9999673366546631	O
54184	These	0 5	222897 222902	0.9999847412109375	O
54185	mutations	6 15	222903 222912	0.9999833106994629	O
54186	lead	16 20	222913 222917	0.9999830722808838	O
54187	to	21 23	222918 222920	0.9999872446060181	O
54188	inactivation	24 35	222921 222932	0.9999872446060181	O
54191	of	37 39	222934 222936	0.9999880790710449	O
54192	the	40 43	222937 222940	0.9999865293502808	O
54193	genes	44 49	222941 222946	0.9999845027923584	O
54194	and	50 53	222947 222950	0.9999867677688599	O
54195	thus	54 58	222951 222955	0.9999854564666748	O
54196	to	59 61	222956 222958	0.9999867677688599	O
54197	a	62 63	222959 222960	0.9999877214431763	O
54198	defect	64 70	222961 222967	0.9999860525131226	O
54199	in	71 73	222968 222970	0.999988317489624	O
54200	replication	74 85	222971 222982	0.9999876022338867	O
54201	/	85 86	222982 222983	0.9999884366989136	O
54202	repair	86 92	222983 222989	0.9999855756759644	O
54203	of	93 95	222990 222992	0.999988317489624	O
54204	DNA	96 99	222993 222996	0.9999867677688599	O
54205	and	100 103	222997 223000	0.9999867677688599	O
54206	an	104 106	223001 223003	0.9999878406524658	O
54207	accumulation	107 119	223004 223016	0.9999862909317017	O
54208	in	120 122	223017 223019	0.9999873638153076	O
54209	the	123 126	223020 223023	0.9999881982803345	O
54210	cancer	127 133	223024 223030	0.9999850988388062	O
54211	cell	134 138	223031 223035	0.999987006187439	O
54212	genome	139 145	223036 223042	0.9999873638153076	O
54213	of	146 148	223043 223045	0.9999880790710449	O
54214	ubiquitous	149 158	223046 223055	0.9999885559082031	O
54218	somatic	160 166	223057 223063	0.9999868869781494	O
54220	clonal	168 173	223065 223070	0.9999879598617554	O
54223	mutations	175 184	223072 223081	0.9999868869781494	O
54224	[	185 186	223082 223083	0.9999890327453613	O
54225	10	186 188	223083 223085	0.9999845027923584	O
54226	]	188 189	223085 223086	0.9999878406524658	O
54227	.	190 191	223087 223088	0.9999736547470093	O
54228	Constitutional	0 14	223089 223103	0.9999818801879883	O
54229	mutations	15 24	223104 223113	0.9999830722808838	O
54230	of	25 27	223114 223116	0.9999876022338867	O
54231	MMR	28 30	223117 223119	0.9999823570251465	O
54233	genes	32 37	223121 223126	0.9999856948852539	O
54234	are	38 41	223127 223130	0.9999874830245972	O
54235	found	42 47	223131 223136	0.9999878406524658	O
54236	in	48 50	223137 223139	0.9999889135360718	O
54237	50	51 53	223140 223142	0.9999860525131226	O
54238	–	53 54	223142 223143	0.9999831914901733	O
54239	70	54 56	223143 223145	0.999984622001648	O
54240	%	57 58	223146 223147	0.9999885559082031	O
54241	of	59 61	223148 223150	0.999988317489624	O
54242	hereditary	62 72	223151 223161	0.9999392032623291	O
54243	non	73 76	223162 223165	0.9999854564666748	O
54244	-	76 77	223165 223166	0.9999877214431763	O
54245	polyposis	77 85	223166 223174	0.9999849796295166	O
54249	colorectal	87 96	223176 223185	0.9999865293502808	O
54252	cancer	98 104	223187 223193	0.9999878406524658	O
54253	(	105 106	223194 223195	0.9999885559082031	O
54254	HNPCC	107 111	223196 223200	0.9999767541885376	O
54257	)	113 114	223202 223203	0.9999892711639404	O
54258	and	115 118	223204 223207	0.9999881982803345	O
54259	in	119 121	223208 223210	0.9999886751174927	O
54260	the	122 125	223211 223214	0.9999881982803345	O
54261	Muir	126 130	223215 223219	0.9999774694442749	O
54262	-	130 131	223219 223220	0.9999889135360718	O
54263	Torre	131 136	223220 223225	0.9999791383743286	O
54264	syndrome	137 145	223226 223234	0.9999872446060181	O
54265	;	146 147	223235 223236	0.9999881982803345	O
54266	90	148 150	223237 223239	0.999983549118042	O
54267	%	151 152	223240 223241	0.9999887943267822	O
54268	of	153 155	223242 223244	0.9999885559082031	O
54269	them	156 160	223245 223249	0.999987006187439	O
54270	MLH1	161 164	223250 223253	0.9999876022338867	O
54273	and	166 169	223255 223258	0.999988317489624	O
54274	MSH2	170 173	223259 223262	0.9999860525131226	O
54277	positive	175 183	223264 223272	0.9999879598617554	O
54278	[	184 185	223273 223274	0.9999892711639404	O
54279	11	185 187	223274 223276	0.9999889135360718	O
54280	,	187 188	223276 223277	0.9999884366989136	O
54281	12	188 190	223277 223279	0.9999884366989136	O
54282	]	190 191	223279 223280	0.9999890327453613	O
54283	.	192 193	223281 223282	0.9999746084213257	O
54284	A	0 1	223283 223284	0.9999853372573853	O
54285	certain	2 9	223285 223292	0.9999818801879883	O
54286	proportion	10 20	223293 223303	0.9999827146530151	O
54287	(	21 22	223304 223305	0.9999871253967285	O
54288	around	22 28	223305 223311	0.999985933303833	O
54289	12	29 31	223312 223314	0.9999874830245972	O
54290	–	31 32	223314 223315	0.9999816417694092	O
54291	15	32 34	223315 223317	0.9999817609786987	O
54292	%	35 36	223318 223319	0.9999868869781494	O
54293	)	37 38	223320 223321	0.9999871253967285	O
54294	of	39 41	223322 223324	0.9999837875366211	O
54295	sporadic	42 49	223325 223332	0.9999765157699585	O
54297	colon	51 55	223334 223338	0.9999593496322632	O
54299	cancers	57 63	223340 223346	0.9999823570251465	O
54301	also	65 69	223348 223352	0.9999836683273315	O
54302	display	70 77	223353 223360	0.9999855756759644	O
54303	MSI	78 80	223361 223363	0.9999825954437256	O
54305	phenotype	82 90	223365 223373	0.9999886751174927	O
54308	[	92 93	223375 223376	0.9999890327453613	O
54309	13	93 95	223376 223378	0.9999877214431763	O
54310	-	95 96	223378 223379	0.9999890327453613	O
54311	17	96 98	223379 223381	0.9999871253967285	O
54312	]	98 99	223381 223382	0.9999887943267822	O
54313	.	100 101	223383 223384	0.9999715089797974	O
54314	Otherwise	0 9	223385 223394	0.9999831914901733	O
54315	,	10 11	223395 223396	0.9999878406524658	O
54316	MSI	12 14	223397 223399	0.9999799728393555	O
54318	seems	16 21	223401 223406	0.9999843835830688	O
54319	to	22 24	223407 223409	0.9999874830245972	O
54320	be	25 27	223410 223412	0.9999880790710449	O
54321	important	28 37	223413 223422	0.9999861717224121	O
54322	in	38 40	223423 223425	0.999987006187439	O
54323	the	41 44	223426 223429	0.9999873638153076	O
54324	development	45 56	223430 223441	0.9999829530715942	O
54325	of	57 59	223442 223444	0.9999871253967285	O
54326	various	60 67	223445 223452	0.9999809265136719	O
54327	human	68 73	223453 223458	0.9947100877761841	O
54328	cancer	74 80	223459 223465	0.9999845027923584	O
54329	such	81 85	223466 223470	0.9999856948852539	O
54330	as	86 88	223471 223473	0.9999874830245972	O
54331	sporadic	89 96	223474 223481	0.9999831914901733	O
54333	endometrial	98 108	223483 223493	0.9999816417694092	O
54337	cancer	110 116	223495 223501	0.9999880790710449	O
54338	[	117 118	223502 223503	0.9999890327453613	O
54339	18	118 120	223503 223505	0.9999873638153076	O
54340	]	120 121	223505 223506	0.9999889135360718	O
54341	and	122 125	223507 223510	0.9999853372573853	O
54342	oral	126 130	223511 223515	0.9999634027481079	O
54343	squamous	131 138	223516 223523	0.9999855756759644	O
54346	cell	140 144	223525 223529	0.9999854564666748	O
54347	carcinoma	145 153	223530 223538	0.9999872446060181	O
54350	[	155 156	223540 223541	0.9999889135360718	O
54351	19	156 158	223541 223543	0.9999855756759644	O
54352	]	158 159	223543 223544	0.9999889135360718	O
54353	.	160 161	223545 223546	0.9999701976776123	O
54354	Colorectal	0 9	223547 223556	0.9999784231185913	O
54357	cancer	11 17	223558 223564	0.9999866485595703	O
54358	(	18 19	223565 223566	0.9999858140945435	O
54359	CRC	20 22	223567 223569	0.99997878074646	O
54361	)	24 25	223571 223572	0.9999881982803345	O
54362	in	26 28	223573 223575	0.9999873638153076	O
54363	HNPCC	29 33	223576 223580	0.9999810457229614	O
54366	more	35 39	223582 223586	0.9999860525131226	O
54367	often	40 45	223587 223592	0.9999860525131226	O
54368	have	46 50	223593 223597	0.9999874830245972	O
54369	a	51 52	223598 223599	0.9999886751174927	O
54370	better	53 59	223600 223606	0.9999872446060181	O
54371	prognosis	60 68	223607 223615	0.9999886751174927	O
54374	than	70 74	223617 223621	0.9999871253967285	O
54375	in	75 77	223622 223624	0.9999874830245972	O
54376	sporadic	78 85	223625 223632	0.9999831914901733	O
54378	colorectal	87 96	223634 223643	0.9999853372573853	O
54381	carcinoma	98 106	223645 223653	0.9999877214431763	O
54384	[	108 109	223655 223656	0.9999890327453613	O
54385	3	109 110	223656 223657	0.9999878406524658	O
54386	,	110 111	223657 223658	0.9999884366989136	O
54387	4	111 112	223658 223659	0.9999866485595703	O
54388	,	112 113	223659 223660	0.9999884366989136	O
54389	20	113 115	223660 223662	0.9999868869781494	O
54390	-	115 116	223662 223663	0.9999887943267822	O
54391	22	116 118	223663 223665	0.9999862909317017	O
54392	]	118 119	223665 223666	0.9999884366989136	O
54393	,	120 121	223667 223668	0.9999879598617554	O
54394	but	122 125	223669 223672	0.999985933303833	O
54395	it	126 128	223673 223675	0.9999881982803345	O
54396	has	129 132	223676 223679	0.9999879598617554	O
54397	been	133 137	223680 223684	0.9999878406524658	O
54398	unclear	138 145	223685 223692	0.9999865293502808	O
54399	whether	146 153	223693 223700	0.9999881982803345	O
54400	this	154 158	223701 223705	0.9999884366989136	O
54401	could	159 164	223706 223711	0.9999877214431763	O
54402	be	165 167	223712 223714	0.9999887943267822	O
54403	due	168 171	223715 223718	0.9999884366989136	O
54404	to	172 174	223719 223721	0.9999889135360718	O
54405	difference	175 185	223722 223732	0.999987006187439	O
54406	in	186 188	223733 223735	0.9999886751174927	O
54407	stage	189 194	223736 223741	0.9999874830245972	O
54408	at	195 197	223742 223744	0.9999880790710449	O
54409	diagnosis	198 207	223745 223754	0.9999877214431763	O
54410	or	208 210	223755 223757	0.9999865293502808	O
54411	to	211 213	223758 223760	0.9999881982803345	O
54412	a	214 215	223761 223762	0.9999887943267822	O
54413	more	216 220	223763 223767	0.9999876022338867	O
54414	favourable	221 231	223768 223778	0.9999853372573853	O
54415	prognosis	232 240	223779 223787	0.9999885559082031	O
54418	of	242 244	223789 223791	0.9999879598617554	O
54419	cancer	245 251	223792 223798	0.9999849796295166	O
54420	in	252 254	223799 223801	0.9999889135360718	O
54421	HNPCC	255 259	223802 223806	0.9999856948852539	O
54424	and	261 264	223808 223811	0.999987006187439	O
54425	FAP	265 267	223812 223814	0.9999797344207764	O
54427	.	268 269	223815 223816	0.9999650716781616	O
54428	The	0 3	223817 223820	0.9999862909317017	O
54429	aim	4 7	223821 223824	0.9999854564666748	O
54430	of	8 10	223825 223827	0.9999872446060181	O
54431	our	11 14	223828 223831	0.9999788999557495	O
54432	retrospective	15 28	223832 223845	0.9999809265136719	O
54433	study	29 34	223846 223851	0.9999834299087524	O
54434	was	35 38	223852 223855	0.9999866485595703	O
54435	to	39 41	223856 223858	0.9999871253967285	O
54436	compare	42 49	223859 223866	0.9999845027923584	O
54437	stage	50 55	223867 223872	0.999984622001648	O
54438	and	56 59	223873 223876	0.9999866485595703	O
54439	overall	60 67	223877 223884	0.9999860525131226	O
54440	survival	68 76	223885 223893	0.9999861717224121	O
54441	between	77 84	223894 223901	0.9999853372573853	O
54442	patients	85 93	223902 223910	0.9999822378158569	O
54443	with	94 98	223911 223915	0.9999847412109375	O
54444	hereditary	99 109	223916 223926	0.9986863732337952	O
54445	and	110 113	223927 223930	0.9999825954437256	O
54446	sporadic	114 121	223931 223938	0.9999722242355347	O
54448	colorectal	123 132	223940 223949	0.9999798536300659	O
54451	cancer	134 140	223951 223957	0.9999833106994629	O
54452	patients	141 149	223958 223966	0.9999840259552002	O
54453	.	150 151	223967 223968	0.9999880790710449	O
54454	*	152 153	223969 223970	0.9999871253967285	O
54455	*	153 154	223970 223971	0.9999834299087524	O
54456	IGNORE	0 5	223972 223977	0.9999856948852539	O
54459	LINE	7 10	223979 223982	0.9999886751174927	O
54462	*	12 13	223984 223985	0.9999886751174927	O
54463	*	13 14	223985 223986	0.9999886751174927	O
54464	*	15 16	223987 223988	0.9999886751174927	O
54465	*	16 17	223988 223989	0.9999886751174927	O
54466	IGNORE	18 23	223990 223995	0.9999876022338867	O
54469	LINE	25 28	223997 224000	0.9999887943267822	O
54472	*	30 31	224002 224003	0.9999884366989136	O
54473	*	31 32	224003 224004	0.9999884366989136	O
54474	*	33 34	224005 224006	0.999988317489624	O
54475	*	34 35	224006 224007	0.999988317489624	O
54476	IGNORE	36 41	224008 224013	0.9999872446060181	O
54479	LINE	43 46	224015 224018	0.9999886751174927	O
54482	*	48 49	224020 224021	0.9999885559082031	O
54483	*	49 50	224021 224022	0.9999884366989136	O
54484	Conclusion	51 60	224023 224032	0.999988317489624	O
54487	In	62 64	224034 224036	0.9999885559082031	O
54488	conclusion	65 75	224037 224047	0.9999871253967285	O
54489	,	76 77	224048 224049	0.9999885559082031	O
54490	our	78 81	224050 224053	0.9999841451644897	O
54491	findings	82 90	224054 224062	0.9999864101409912	O
54492	appear	91 97	224063 224069	0.999987006187439	O
54493	to	98 100	224070 224072	0.9999885559082031	O
54494	confirm	101 108	224073 224080	0.9999861717224121	O
54495	previous	109 117	224081 224089	0.9999836683273315	O
54496	studies	118 125	224090 224097	0.9999861717224121	O
54497	[	126 127	224098 224099	0.9999885559082031	O
54498	30	127 129	224099 224101	0.9999866485595703	O
54499	,	129 130	224101 224102	0.9999881982803345	O
54500	31	130 132	224102 224104	0.9999862909317017	O
54501	]	132 133	224104 224105	0.9999878406524658	O
54502	which	134 139	224106 224111	0.999987006187439	O
54503	detected	140 148	224112 224120	0.9999873638153076	O
54504	that	149 153	224121 224125	0.9999880790710449	O
54505	an	154 156	224126 224128	0.9999878406524658	O
54506	improved	157 165	224129 224137	0.9999860525131226	O
54507	survival	166 174	224138 224146	0.9999849796295166	O
54508	for	175 178	224147 224150	0.9999850988388062	O
54509	colon	179 183	224151 224155	0.9999797344207764	O
54511	cancer	185 191	224157 224163	0.9999861717224121	O
54512	in	192 194	224164 224166	0.9999861717224121	O
54513	HNPCC	195 199	224167 224171	0.999976396560669	O
54516	,	201 202	224173 224174	0.9999864101409912	O
54517	compared	203 211	224175 224183	0.999984860420227	O
54518	to	212 214	224184 224186	0.999984860420227	O
54519	sporadic	215 222	224187 224194	0.9999829530715942	O
54521	CRC	224 226	224196 224198	0.9999794960021973	O
54523	,	228 229	224200 224201	0.9999849796295166	O
54524	usually	230 237	224202 224209	0.9999834299087524	O
54525	occur	238 243	224210 224215	0.9999847412109375	O
54526	.	244 245	224216 224217	0.9999569654464722	O
54527	In	0 2	224218 224220	0.9999839067459106	O
54528	fact	3 7	224221 224225	0.9999736547470093	O
54529	,	8 9	224226 224227	0.9999860525131226	O
54530	our	10 13	224228 224231	0.9999709129333496	O
54531	series	14 20	224232 224238	0.9999723434448242	O
54532	of	21 23	224239 224241	0.999980092048645	O
54533	HNPCC	24 28	224242 224246	0.9999239444732666	O
54536	patients	30 38	224248 224256	0.9999752044677734	O
54537	reveals	39 46	224257 224264	0.9999792575836182	O
54538	a	47 48	224265 224266	0.9999871253967285	O
54539	marked	49 55	224267 224273	0.9999849796295166	O
54540	overall	56 63	224274 224281	0.9999862909317017	O
54541	survival	64 72	224282 224290	0.9999858140945435	O
54542	advantage	73 82	224291 224300	0.9999840259552002	O
54543	,	83 84	224301 224302	0.9999866485595703	O
54544	which	85 90	224303 224308	0.9999873638153076	O
54545	persisted	91 100	224309 224318	0.9999819993972778	O
54546	also	101 105	224319 224323	0.999982476234436	O
54547	after	106 111	224324 224329	0.999985933303833	O
54548	stratification	112 125	224330 224343	0.9999872446060181	O
54552	by	127 129	224345 224347	0.9999868869781494	O
54553	Dukes	130 135	224348 224353	0.9999816417694092	O
54554	'	136 137	224354 224355	0.9999879598617554	O
54555	stage	138 143	224356 224361	0.9999866485595703	O
54556	.	144 145	224362 224363	0.9999657869338989	O
54557	Therefore	0 9	224364 224373	0.9999812841415405	O
54558	,	10 11	224374 224375	0.9999858140945435	O
54559	survival	12 20	224376 224384	0.9999810457229614	O
54560	of	21 23	224385 224387	0.9999836683273315	O
54561	HNPCC	24 28	224388 224392	0.9999258518218994	O
54564	patients	30 38	224394 224402	0.9999749660491943	O
54565	not	39 42	224403 224406	0.9999858140945435	O
54566	always	43 49	224407 224413	0.9999803304672241	O
54567	depends	50 57	224414 224421	0.999983549118042	O
54568	on	58 60	224422 224424	0.9999872446060181	O
54569	an	61 63	224425 224427	0.9999867677688599	O
54570	early	64 69	224428 224433	0.9999864101409912	O
54571	diagnosis	70 79	224434 224443	0.9999847412109375	O
54572	,	80 81	224444 224445	0.999984860420227	O
54573	but	82 85	224446 224449	0.9999843835830688	O
54574	probably	86 94	224450 224458	0.9999847412109375	O
54575	also	95 99	224459 224463	0.9999858140945435	O
54576	on	100 102	224464 224466	0.9999872446060181	O
54577	distinct	103 111	224467 224475	0.9999810457229614	O
54578	biologic	112 119	224476 224483	0.9999842643737793	O
54581	features	121 129	224485 224493	0.9999849796295166	O
54582	.	130 131	224494 224495	0.9999552965164185	O
54583	In	0 2	224496 224498	0.9999862909317017	O
54584	this	3 7	224499 224503	0.999987006187439	O
54585	context	8 15	224504 224511	0.9999841451644897	O
54586	,	16 17	224512 224513	0.9999878406524658	O
54587	MSI	18 20	224514 224516	0.9999860525131226	O
54589	mutation	22 30	224518 224526	0.9999856948852539	O
54590	pattern	31 38	224527 224534	0.9999873638153076	O
54591	plays	39 44	224535 224540	0.9999860525131226	O
54592	an	45 47	224541 224543	0.999988317489624	O
54593	important	48 57	224544 224553	0.9999877214431763	O
54594	prognostic	58 67	224554 224563	0.9999885559082031	O
54597	role	69 73	224565 224569	0.9999877214431763	O
54598	since	74 79	224570 224575	0.9999821186065674	O
54599	colon	80 84	224576 224580	0.9999818801879883	O
54601	cancer	86 92	224582 224588	0.9999871253967285	O
54602	with	93 97	224589 224593	0.9999881982803345	O
54603	MSI	98 100	224594 224596	0.9999865293502808	O
54605	has	102 105	224598 224601	0.9999872446060181	O
54606	a	106 107	224602 224603	0.9999880790710449	O
54607	better	108 114	224604 224610	0.9999858140945435	O
54608	prognosis	115 123	224611 224619	0.9999880790710449	O
54611	than	125 129	224621 224625	0.999985933303833	O
54612	tumours	130 136	224626 224632	0.9999868869781494	O
54615	without	138 145	224634 224641	0.9999845027923584	O
54616	MSI	146 148	224642 224644	0.9999873638153076	O
54618	.	149 150	224645 224646	0.9999691247940063	O
54619	A	0 1	224647 224648	0.999985933303833	O
54620	large	2 7	224649 224654	0.999980092048645	O
54621	series	8 14	224655 224661	0.9999768733978271	O
54622	of	15 17	224662 224664	0.9999831914901733	O
54623	HNPCC	18 22	224665 224669	0.9999703168869019	O
54626	should	24 30	224671 224677	0.999981164932251	O
54627	be	31 33	224678 224680	0.9999861717224121	O
54628	examined	34 42	224681 224689	0.9999815225601196	O
54629	to	43 45	224690 224692	0.9999842643737793	O
54630	confirm	46 53	224693 224700	0.9999840259552002	O
54631	this	54 58	224701 224705	0.9999874830245972	O
54632	data	59 63	224706 224710	0.9999852180480957	O
54633	.	64 65	224711 224712	0.9999467134475708	O
54634	Furthermore	0 11	224713 224724	0.9999867677688599	O
54635	,	12 13	224725 224726	0.9999880790710449	O
54636	we	14 16	224727 224729	0.9999855756759644	O
54637	need	17 21	224730 224734	0.9999877214431763	O
54638	more	22 26	224735 224739	0.9999880790710449	O
54639	information	27 38	224740 224751	0.9999884366989136	O
54640	about	39 44	224752 224757	0.9999887943267822	O
54641	MSI	45 47	224758 224760	0.9999862909317017	O
54643	in	49 51	224762 224764	0.999988317489624	O
54644	all	52 55	224765 224768	0.9999874830245972	O
54645	kind	56 60	224769 224773	0.9999837875366211	O
54646	of	61 63	224774 224776	0.9999867677688599	O
54647	colorectal	64 73	224777 224786	0.9999839067459106	O
54650	carcinomas	75 84	224788 224797	0.9999862909317017	O
54654	,	86 87	224799 224800	0.9999873638153076	O
54655	in	88 90	224801 224803	0.9999881982803345	O
54656	order	91 96	224804 224809	0.999987006187439	O
54657	to	97 99	224810 224812	0.999988317489624	O
54658	establish	100 109	224813 224822	0.9999876022338867	O
54659	postoperative	110 122	224823 224835	0.9999878406524658	O
54662	surveillance	124 136	224837 224849	0.9999876022338867	O
54663	thus	137 141	224850 224854	0.9999872446060181	O
54664	improving	142 151	224855 224864	0.9999874830245972	O
54665	patients	152 160	224865 224873	0.9999834299087524	O
54666	'	161 162	224874 224875	0.9999877214431763	O
54667	prognosis	163 171	224876 224884	0.9999881982803345	O
54670	and	173 176	224886 224889	0.9999865293502808	O
54671	allowing	177 185	224890 224898	0.9999865293502808	O
54672	clinicians	186 195	224899 224908	0.9999852180480957	O
54674	to	197 199	224910 224912	0.9999873638153076	O
54675	plan	200 204	224913 224917	0.9999862909317017	O
54676	more	205 209	224918 224922	0.9999879598617554	O
54677	accurate	210 218	224923 224931	0.9999880790710449	O
54678	and	219 222	224932 224935	0.9999876022338867	O
54679	targeted	223 231	224936 224944	0.9999860525131226	O
54680	therapy	232 239	224945 224952	0.9999856948852539	O
54681	.	240 241	224953 224954	0.999988317489624	O
54682	*	242 243	224955 224956	0.9999872446060181	O
54683	*	243 244	224956 224957	0.9999735355377197	O
54684	IGNORE	0 5	224958 224963	0.9999847412109375	O
54687	LINE	7 10	224965 224968	0.9999873638153076	O
54690	*	12 13	224970 224971	0.9999878406524658	O
54691	*	13 14	224971 224972	0.9999878406524658	O
54692	*	15 16	224973 224974	0.9999878406524658	O
54693	*	16 17	224974 224975	0.9999879598617554	O
54694	IGNORE	18 23	224976 224981	0.9999861717224121	O
54697	LINE	25 28	224983 224986	0.9999879598617554	O
54700	*	30 31	224988 224989	0.9999874830245972	O
54701	*	31 32	224989 224990	0.9999874830245972	O
54702	*	33 34	224991 224992	0.9999876022338867	O
54703	*	34 35	224992 224993	0.9999876022338867	O
54704	IGNORE	36 41	224994 224999	0.9999854564666748	O
54707	LINE	43 46	225001 225004	0.9999877214431763	O
54710	*	48 49	225006 225007	0.9999876022338867	O
54711	*	49 50	225007 225008	0.9999877214431763	O
54712	Mutation	51 58	225009 225016	0.999987006187439	O
54714	Rates	60 64	225018 225022	0.9999871253967285	O
54716	of	66 68	225024 225026	0.9999876022338867	O
54717	and	69 72	225027 225030	0.9999868869781494	O
54718	Coding	73 78	225031 225036	0.9999874830245972	O
54720	Microsatellites	80 94	225038 225052	0.9999872446060181	O
54724	in	96 98	225054 225056	0.9999867677688599	O
54725	Human	99 104	225057 225062	0.9977731108665466	O
54726	Cells	105 109	225063 225067	0.9999504089355469	O
54728	with	111 115	225069 225073	0.9999871253967285	O
54729	Defective	116 124	225074 225082	0.9999853372573853	O
54732	DNA	126 129	225084 225087	0.9999864101409912	O
54733	Mismatch	130 137	225088 225095	0.9999866485595703	O
54736	Repair	139 144	225097 225102	0.999987006187439	O
54738	Abstract	146 153	225104 225111	0.9999873638153076	O
54741	Microsatellite	155 168	225113 225126	0.9999860525131226	O
54745	instability	170 181	225128 225139	0.999987006187439	O
54746	promotes	182 190	225140 225148	0.9999799728393555	O
54747	colonic	191 197	225149 225155	0.9999791383743286	O
54750	tumorigenesis	199 211	225157 225169	0.9999840259552002	O
54754	through	213 220	225171 225178	0.9999849796295166	O
54755	generating	221 231	225179 225189	0.9999840259552002	O
54756	frameshift	232 241	225190 225199	0.9999845027923584	O
54759	mutations	243 252	225201 225210	0.9999858140945435	O
54760	at	253 255	225211 225213	0.9999876022338867	O
54761	coding	256 262	225214 225220	0.9999868869781494	O
54762	microsatellites	263 277	225221 225235	0.9999874830245972	O
54766	of	279 281	225237 225239	0.999987006187439	O
54767	tumor	282 287	225240 225245	0.9999847412109375	O
54768	suppressor	288 297	225246 225255	0.9999855756759644	O
54770	genes	299 304	225257 225262	0.9999872446060181	O
54771	,	305 306	225263 225264	0.9999871253967285	O
54772	such	307 311	225265 225269	0.9999868869781494	O
54773	as	312 314	225270 225272	0.9999879598617554	O
54774	TGFBR2	315 320	225273 225278	0.9999860525131226	O
54779	and	322 325	225280 225283	0.9999873638153076	O
54780	ACVR2	326 330	225284 225288	0.9999840259552002	O
54783	.	332 333	225290 225291	0.9999605417251587	O
54784	As	0 2	225292 225294	0.9999773502349854	O
54785	a	3 4	225295 225296	0.9999836683273315	O
54786	consequence	5 16	225297 225308	0.9999752044677734	O
54787	,	17 18	225309 225310	0.9999806880950928	O
54788	signaling	19 28	225311 225320	0.9999428987503052	O
54789	through	29 36	225321 225328	0.9999802112579346	O
54790	these	37 42	225329 225334	0.9999814033508301	O
54791	TGFβ	43 46	225335 225338	0.9999774694442749	O
54795	family	48 54	225340 225346	0.9999792575836182	O
54796	receptors	55 64	225347 225356	0.999966025352478	O
54797	is	65 67	225357 225359	0.9999383687973022	O
54798	abrogated	68 76	225360 225368	0.9999468326568604	O
54801	in	78 80	225370 225372	0.9999516010284424	O
54802	DNA	81 84	225373 225376	0.9999818801879883	O
54803	Mismatch	85 92	225377 225384	0.9999758005142212	O
54806	repair	94 100	225386 225392	0.9999828338623047	O
54807	(	101 102	225393 225394	0.9999854564666748	O
54808	MMR	103 105	225395 225397	0.99997878074646	O
54810	)	106 107	225398 225399	0.9999847412109375	O
54811	-	107 108	225399 225400	0.999972939491272	O
54812	deficient	108 116	225400 225408	0.9999246597290039	O
54814	tumors	118 124	225410 225416	0.9999755620956421	O
54815	.	125 126	225417 225418	0.999866247177124	O
54816	How	0 3	225419 225422	0.999982476234436	O
54817	these	4 9	225423 225428	0.999984860420227	O
54818	mutations	10 19	225429 225438	0.9999831914901733	O
54819	occur	20 25	225439 225444	0.999985933303833	O
54820	in	26 28	225445 225447	0.9999877214431763	O
54821	real	29 33	225448 225452	0.9999867677688599	O
54822	time	34 38	225453 225457	0.9999878406524658	O
54823	and	39 42	225458 225461	0.9999836683273315	O
54824	mutational	43 52	225462 225471	0.9999849796295166	O
54826	rates	54 59	225473 225478	0.9999862909317017	O
54827	of	60 62	225479 225481	0.999987006187439	O
54828	these	63 68	225482 225487	0.9999873638153076	O
54829	human	69 74	225488 225493	0.9999759197235107	O
54830	coding	75 81	225494 225500	0.9999872446060181	O
54831	sequences	82 91	225501 225510	0.9999861717224121	O
54832	have	92 96	225511 225515	0.9999829530715942	O
54833	not	97 100	225516 225519	0.999984622001648	O
54834	previously	101 111	225520 225530	0.9999818801879883	O
54835	been	112 116	225531 225535	0.999984860420227	O
54836	studied	117 124	225536 225543	0.9999809265136719	O
54837	.	125 126	225544 225545	0.9999176263809204	O
54838	We	0 2	225546 225548	0.9999803304672241	O
54839	utilized	3 11	225549 225557	0.999974250793457	O
54840	cell	12 16	225558 225562	0.9999687671661377	O
54841	lines	17 22	225563 225568	0.9999815225601196	O
54842	with	23 27	225569 225573	0.9999867677688599	O
54843	different	28 37	225574 225583	0.9999817609786987	O
54844	MMR	38 40	225584 225586	0.9999864101409912	O
54846	deficiencies	42 53	225588 225599	0.9999887943267822	O
54849	(	55 56	225601 225602	0.9999890327453613	O
54850	hMLH1−	57 62	225603 225608	0.9999889135360718	O
54854	/	63 64	225609 225610	0.9999897480010986	O
54855	−	64 65	225610 225611	0.9999879598617554	O
54856	,	66 67	225612 225613	0.9999884366989136	O
54857	hMSH6−	68 73	225614 225619	0.9999892711639404	O
54862	/	74 75	225620 225621	0.9999896287918091	O
54863	−	75 76	225621 225622	0.9999881982803345	O
54864	,	77 78	225623 225624	0.9999886751174927	O
54865	hMSH3−	79 84	225625 225630	0.9999892711639404	O
54870	/	85 86	225631 225632	0.9999896287918091	O
54871	−	86 87	225632 225633	0.9999880790710449	O
54872	,	88 89	225634 225635	0.9999880790710449	O
54873	and	90 93	225636 225639	0.9999885559082031	O
54874	MMR	94 96	225640 225642	0.9999876022338867	O
54876	-	97 98	225643 225644	0.9999895095825195	O
54877	proficient	98 107	225644 225653	0.9999887943267822	O
54879	)	109 110	225655 225656	0.9999885559082031	O
54880	to	111 113	225657 225659	0.9999881982803345	O
54881	determine	114 123	225660 225669	0.9999873638153076	O
54882	mutation	124 132	225670 225678	0.9999879598617554	O
54883	rates	133 138	225679 225684	0.9999889135360718	O
54884	.	139 140	225685 225686	0.9999610185623169	O
54885	Plasmids	0 7	225687 225694	0.9999855756759644	O
54889	were	9 13	225696 225700	0.999987006187439	O
54890	constructed	14 25	225701 225712	0.9999827146530151	O
54891	in	26 28	225713 225715	0.9999871253967285	O
54892	which	29 34	225716 225721	0.9999881982803345	O
54893	exon	35 38	225722 225725	0.9999891519546509	O
54895	3	40 41	225727 225728	0.9999874830245972	O
54896	of	42 44	225729 225731	0.9999890327453613	O
54897	TGFBR2	45 50	225732 225737	0.9999885559082031	O
54902	and	52 55	225739 225742	0.9999885559082031	O
54903	exon	56 59	225743 225746	0.9999890327453613	O
54905	10	61 63	225748 225750	0.9999864101409912	O
54906	of	64 66	225751 225753	0.9999891519546509	O
54907	ACVR2	67 71	225754 225758	0.999985933303833	O
54910	were	73 77	225760 225764	0.9999887943267822	O
54911	cloned	78 83	225765 225770	0.999988317489624	O
54913	+	85 86	225772 225773	0.9999890327453613	O
54914	1	86 87	225773 225774	0.9999887943267822	O
54915	bp	88 89	225775 225776	0.9999885559082031	O
54917	out	91 94	225778 225781	0.9999890327453613	O
54918	of	95 97	225782 225784	0.99998939037323	O
54919	frame	98 103	225785 225790	0.9999886751174927	O
54920	,	104 105	225791 225792	0.9999884366989136	O
54921	immediately	106 117	225793 225804	0.9999890327453613	O
54922	after	118 123	225805 225810	0.9999887943267822	O
54923	the	124 127	225811 225814	0.9999891519546509	O
54924	translation	128 139	225815 225826	0.9999877214431763	O
54925	initiation	140 150	225827 225837	0.9999890327453613	O
54926	codon	151 155	225838 225842	0.9999885559082031	O
54928	of	157 159	225844 225846	0.9999890327453613	O
54929	an	160 162	225847 225849	0.9999892711639404	O
54930	enhanced	163 171	225850 225858	0.9999858140945435	O
54931	GFP	172 174	225859 225861	0.9999861717224121	O
54933	(	176 177	225863 225864	0.9999890327453613	O
54934	EGFP	178 181	225865 225868	0.9999867677688599	O
54937	)	183 184	225870 225871	0.9999892711639404	O
54938	gene	185 189	225872 225876	0.999988317489624	O
54939	,	190 191	225877 225878	0.9999889135360718	O
54940	allowing	192 200	225879 225887	0.9999886751174927	O
54941	a	201 202	225888 225889	0.9999892711639404	O
54942	−1	203 204	225890 225891	0.9999829530715942	O
54944	bp	206 207	225893 225894	0.9999884366989136	O
54946	frameshift	209 218	225896 225905	0.9999885559082031	O
54949	mutation	220 228	225907 225915	0.9999884366989136	O
54950	to	229 231	225916 225918	0.999988317489624	O
54951	drive	232 237	225919 225924	0.9999852180480957	O
54952	EGFP	238 241	225925 225928	0.9999879598617554	O
54955	expression	243 253	225930 225940	0.9999878406524658	O
54956	.	254 255	225941 225942	0.9999371767044067	O
54957	Mutation	0 7	225943 225950	0.9999837875366211	O
54959	-	8 9	225951 225952	0.9999876022338867	O
54960	resistant	9 18	225952 225961	0.999983549118042	O
54961	plasmids	19 26	225962 225969	0.9999861717224121	O
54965	were	28 32	225971 225975	0.999984860420227	O
54966	constructed	33 44	225976 225987	0.9999823570251465	O
54967	by	45 47	225988 225990	0.9999878406524658	O
54968	interrupting	48 60	225991 226003	0.9999872446060181	O
54969	the	61 64	226004 226007	0.9999889135360718	O
54970	coding	65 71	226008 226014	0.9999881982803345	O
54971	microsatellite	72 85	226015 226028	0.9999885559082031	O
54975	sequences	87 96	226030 226039	0.9999884366989136	O
54976	,	97 98	226040 226041	0.9999856948852539	O
54977	preventing	99 109	226042 226052	0.9999856948852539	O
54978	frameshift	110 119	226053 226062	0.9999871253967285	O
54981	mutation	121 129	226064 226072	0.9999872446060181	O
54982	.	130 131	226073 226074	0.9999686479568481	O
54983	Stable	0 5	226075 226080	0.9999721050262451	O
54985	cell	7 11	226082 226086	0.9999485015869141	O
54986	lines	12 17	226087 226092	0.9999575614929199	O
54987	were	18 22	226093 226097	0.9999817609786987	O
54988	established	23 34	226098 226109	0.9999603033065796	O
54989	containing	35 45	226110 226120	0.9999864101409912	O
54990	portions	46 54	226121 226129	0.9999833106994629	O
54991	of	55 57	226130 226132	0.9999874830245972	O
54992	TGFBR2	58 63	226133 226138	0.9999868869781494	O
54997	and	65 68	226140 226143	0.999987006187439	O
54998	ACVR2	69 73	226144 226148	0.9999837875366211	O
55001	,	75 76	226150 226151	0.9999849796295166	O
55002	and	77 80	226152 226155	0.9999867677688599	O
55003	nonfluorescent	81 94	226156 226169	0.9999841451644897	O
55008	cells	96 101	226171 226176	0.9999834299087524	O
55009	were	102 106	226177 226181	0.9999878406524658	O
55010	sorted	107 113	226182 226188	0.9999860525131226	O
55011	,	114 115	226189 226190	0.9999864101409912	O
55012	cultured	116 123	226191 226198	0.9999840259552002	O
55014	for	125 128	226200 226203	0.9999885559082031	O
55015	7	129 130	226204 226205	0.9999879598617554	O
55016	–	130 131	226205 226206	0.9999829530715942	O
55017	35	131 133	226206 226208	0.9999852180480957	O
55018	days	134 138	226209 226213	0.9999864101409912	O
55019	,	139 140	226214 226215	0.9999866485595703	O
55020	and	141 144	226216 226219	0.9999876022338867	O
55021	harvested	145 154	226220 226229	0.9999834299087524	O
55022	for	155 158	226230 226233	0.9999881982803345	O
55023	flow	159 163	226234 226238	0.9999858140945435	O
55024	cytometric	164 173	226239 226248	0.9999881982803345	O
55027	mutation	175 183	226250 226258	0.9999856948852539	O
55028	detection	184 193	226259 226268	0.9999884366989136	O
55029	and	194 197	226269 226272	0.9999878406524658	O
55030	DNA	198 201	226273 226276	0.9999865293502808	O
55031	sequencing	202 211	226277 226286	0.9999873638153076	O
55033	at	213 215	226288 226290	0.9999884366989136	O
55034	specific	216 224	226291 226299	0.9999856948852539	O
55035	time	225 229	226300 226304	0.9999872446060181	O
55036	points	230 236	226305 226311	0.9999872446060181	O
55037	.	237 238	226312 226313	0.9999312162399292	O
55038	DNA	0 3	226314 226317	0.9999849796295166	O
55039	sequencing	4 13	226318 226327	0.9999858140945435	O
55041	revealed	15 23	226329 226337	0.9999871253967285	O
55042	a	24 25	226338 226339	0.9999889135360718	O
55043	−1	26 27	226340 226341	0.9999812841415405	O
55045	bp	29 30	226343 226344	0.9999884366989136	O
55047	frameshift	32 41	226346 226355	0.9999884366989136	O
55050	mutation	43 51	226357 226365	0.9999872446060181	O
55051	(	52 53	226366 226367	0.9999890327453613	O
55052	A9	54 55	226368 226369	0.9999887943267822	O
55054	in	57 59	226371 226373	0.99998939037323	O
55055	TGFBR2	60 65	226374 226379	0.9999885559082031	O
55060	and	67 70	226381 226384	0.9999884366989136	O
55061	A7	71 72	226385 226386	0.9999885559082031	O
55063	in	74 76	226388 226390	0.9999895095825195	O
55064	ACVR2	77 81	226391 226395	0.9999878406524658	O
55067	)	83 84	226397 226398	0.9999884366989136	O
55068	in	85 87	226399 226401	0.9999890327453613	O
55069	the	88 91	226402 226405	0.9999881982803345	O
55070	fluorescent	92 103	226406 226417	0.999982476234436	O
55071	cells	104 109	226418 226423	0.9999873638153076	O
55072	.	110 111	226424 226425	0.9999723434448242	O
55073	Two	0 3	226426 226429	0.9999814033508301	O
55074	distinct	4 12	226430 226438	0.9999815225601196	O
55075	fluorescent	13 24	226439 226450	0.9999414682388306	O
55076	populations	25 36	226451 226462	0.9999847412109375	O
55077	,	37 38	226463 226464	0.9999865293502808	O
55078	M1	39 41	226465 226467	0.9999861717224121	O
55079	(	42 43	226468 226469	0.9999884366989136	O
55080	dim	44 47	226470 226473	0.9999865293502808	O
55081	,	48 49	226474 226475	0.9999877214431763	O
55082	representing	50 62	226476 226488	0.9999877214431763	O
55083	heteroduplexes	63 76	226489 226502	0.9999876022338867	O
55088	)	78 79	226504 226505	0.9999877214431763	O
55089	and	80 83	226506 226509	0.9999866485595703	O
55090	M2	84 85	226510 226511	0.9999865293502808	O
55092	(	87 88	226513 226514	0.9999885559082031	O
55093	bright	89 95	226515 226521	0.9999858140945435	O
55094	,	96 97	226522 226523	0.9999876022338867	O
55095	representing	98 110	226524 226536	0.9999876022338867	O
55096	full	111 115	226537 226541	0.9999872446060181	O
55097	mutants	116 122	226542 226548	0.9999856948852539	O
55099	)	124 125	226550 226551	0.9999885559082031	O
55100	were	126 130	226552 226556	0.9999873638153076	O
55101	identified	131 141	226557 226567	0.999985933303833	O
55102	,	142 143	226568 226569	0.999985933303833	O
55103	with	144 148	226570 226574	0.9999860525131226	O
55104	the	149 152	226575 226578	0.9999880790710449	O
55105	M2	153 154	226579 226580	0.9999868869781494	O
55107	fraction	156 164	226582 226590	0.9999861717224121	O
55108	accumulating	165 176	226591 226602	0.9999879598617554	O
55112	over	178 182	226604 226608	0.999988317489624	O
55113	time	183 187	226609 226613	0.9999868869781494	O
55114	.	188 189	226614 226615	0.9999589920043945	O
55115	hMLH1	0 4	226616 226620	0.9999873638153076	O
55118	deficiency	6 16	226622 226632	0.9999885559082031	O
55119	revealed	17 25	226633 226641	0.9999891519546509	O
55120	11	26 28	226642 226644	0.9999892711639404	O
55121	(	29 30	226645 226646	0.9999897480010986	O
55122	5	31 32	226647 226648	0.9999884366989136	O
55123	.	32 33	226648 226649	0.9999895095825195	O
55124	91×10−4	33 39	226649 226655	0.9999885559082031	O
55129	)	41 42	226657 226658	0.9999895095825195	O
55130	and	43 46	226659 226662	0.9999887943267822	O
55131	15	47 49	226663 226665	0.9999872446060181	O
55132	(	50 51	226666 226667	0.9999896287918091	O
55133	2	52 53	226668 226669	0.999988317489624	O
55134	.	53 54	226669 226670	0.9999895095825195	O
55135	18×10−4	54 60	226670 226676	0.9999878406524658	O
55140	)	62 63	226678 226679	0.9999896287918091	O
55141	times	64 69	226680 226685	0.9999880790710449	O
55142	higher	70 76	226686 226692	0.9999886751174927	O
55143	mutation	77 85	226693 226701	0.9999886751174927	O
55144	rates	86 91	226702 226707	0.9999896287918091	O
55145	for	92 95	226708 226711	0.9999896287918091	O
55146	the	96 99	226712 226715	0.9999895095825195	O
55147	TGFBR2	100 105	226716 226721	0.9999889135360718	O
55152	and	107 110	226723 226726	0.9999887943267822	O
55153	ACVR2	111 115	226727 226731	0.9999877214431763	O
55156	microsatellites	117 131	226733 226747	0.9999892711639404	O
55160	compared	133 141	226749 226757	0.9999890327453613	O
55161	to	142 144	226758 226760	0.99998939037323	O
55162	hMSH6	145 149	226761 226765	0.9999887943267822	O
55166	deficiency	151 161	226767 226777	0.9999892711639404	O
55167	,	162 163	226778 226779	0.9999889135360718	O
55168	respectively	164 176	226780 226792	0.9999879598617554	O
55169	.	177 178	226793 226794	0.999975323677063	O
55170	The	0 3	226795 226798	0.9999879598617554	O
55171	mutation	4 12	226799 226807	0.9999862909317017	O
55172	rate	13 17	226808 226812	0.9999881982803345	O
55173	of	18 20	226813 226815	0.9999887943267822	O
55174	the	21 24	226816 226819	0.9999889135360718	O
55175	TGFBR2	25 30	226820 226825	0.9999871253967285	O
55180	microsatellite	32 45	226827 226840	0.9999890327453613	O
55184	was	47 50	226842 226845	0.9999885559082031	O
55185	[UNK]	51 53	226846 226848	0.9999830722808838	O
55186	times	54 59	226849 226854	0.9999884366989136	O
55187	higher	60 66	226855 226861	0.9999879598617554	O
55188	in	67 69	226862 226864	0.99998939037323	O
55189	both	70 74	226865 226869	0.9999880790710449	O
55190	hMLH1	75 79	226870 226874	0.9999889135360718	O
55193	and	81 84	226876 226879	0.9999885559082031	O
55194	hMSH6	85 89	226880 226884	0.9999886751174927	O
55198	deficiencies	91 102	226886 226897	0.9999895095825195	O
55201	than	104 108	226899 226903	0.9999887943267822	O
55202	the	109 112	226904 226907	0.9999891519546509	O
55203	ACVR2	113 117	226908 226912	0.9999878406524658	O
55206	microsatellite	119 132	226914 226927	0.9999891519546509	O
55210	.	134 135	226929 226930	0.9999755620956421	O
55211	The	0 3	226931 226934	0.9999881982803345	O
55212	−1	4 5	226935 226936	0.9999830722808838	O
55214	bp	7 8	226938 226939	0.999988317489624	O
55216	frameshift	10 19	226941 226950	0.9999878406524658	O
55219	mutation	21 29	226952 226960	0.9999878406524658	O
55220	rates	30 35	226961 226966	0.9999879598617554	O
55221	of	36 38	226967 226969	0.9999885559082031	O
55222	TGFBR2	39 44	226970 226975	0.9999879598617554	O
55227	and	46 49	226977 226980	0.9999878406524658	O
55228	ACVR2	50 54	226981 226985	0.9999862909317017	O
55231	microsatellite	56 69	226987 227000	0.9999881982803345	O
55235	sequences	71 80	227002 227011	0.9999874830245972	O
55236	are	81 84	227012 227015	0.9999871253967285	O
55237	dependent	85 94	227016 227025	0.999988317489624	O
55238	upon	95 99	227026 227030	0.9999881982803345	O
55239	the	100 103	227031 227034	0.9999886751174927	O
55240	human	104 109	227035 227040	0.9999831914901733	O
55241	MMR	110 112	227041 227043	0.9999878406524658	O
55243	background	114 124	227045 227055	0.9999881982803345	O
55244	.	125 126	227056 227057	0.9999890327453613	O
55245	*	127 128	227058 227059	0.9999881982803345	O
55246	*	128 129	227059 227060	0.9999817609786987	O
55247	IGNORE	0 5	227061 227066	0.9999855756759644	O
55250	LINE	7 10	227068 227071	0.9999874830245972	O
55253	*	12 13	227073 227074	0.999988317489624	O
55254	*	13 14	227074 227075	0.9999881982803345	O
55255	*	15 16	227076 227077	0.9999881982803345	O
55256	*	16 17	227077 227078	0.999988317489624	O
55257	IGNORE	18 23	227079 227084	0.9999871253967285	O
55260	LINE	25 28	227086 227089	0.9999884366989136	O
55263	*	30 31	227091 227092	0.9999881982803345	O
55264	*	31 32	227092 227093	0.999988317489624	O
55265	*	33 34	227094 227095	0.9999881982803345	O
55266	*	34 35	227095 227096	0.999988317489624	O
55267	IGNORE	36 41	227097 227102	0.9999866485595703	O
55270	LINE	43 46	227104 227107	0.9999881982803345	O
55273	*	48 49	227109 227110	0.9999881982803345	O
55274	*	49 50	227110 227111	0.9999879598617554	O
55275	Colon	51 55	227112 227116	0.9999814033508301	O
55277	cancer	57 63	227118 227124	0.9999836683273315	O
55278	cell	64 68	227125 227129	0.9998660087585449	O
55279	models	69 75	227130 227136	0.9999251365661621	O
55280	highlight	76 85	227137 227146	0.9999780654907227	O
55281	the	86 89	227147 227150	0.9999880790710449	O
55282	relationship	90 102	227151 227163	0.9999871253967285	O
55283	between	103 110	227164 227171	0.999988317489624	O
55284	defective	111 119	227172 227180	0.999987006187439	O
55286	DNA	121 124	227182 227185	0.9999868869781494	O
55287	MMR	125 127	227186 227188	0.9999881982803345	O
55289	and	129 132	227190 227193	0.9999885559082031	O
55290	TGFBR2	133 138	227194 227199	0.9999880790710449	O
55295	and	140 143	227201 227204	0.999988317489624	O
55296	ACVR2	144 148	227205 227209	0.9999860525131226	O
55299	frameshift	150 159	227211 227220	0.9999873638153076	O
55302	mutations	161 170	227222 227231	0.9999874830245972	O
55303	.	171 172	227232 227233	0.9999440908432007	O
55304	Both	0 4	227234 227238	0.9999837875366211	O
55305	genes	5 10	227239 227244	0.9999808073043823	O
55306	commonly	11 19	227245 227253	0.9999822378158569	O
55307	have	20 24	227254 227258	0.9999843835830688	O
55308	a	25 26	227259 227260	0.9999880790710449	O
55309	−1	27 28	227261 227262	0.9999840259552002	O
55311	bp	30 31	227264 227265	0.9999880790710449	O
55313	frameshift	33 42	227267 227276	0.9999878406524658	O
55316	mutation	44 52	227278 227286	0.999987006187439	O
55317	with	53 57	227287 227291	0.9999864101409912	O
55318	defective	58 66	227292 227300	0.9999876022338867	O
55320	MMR	68 70	227302 227304	0.9999868869781494	O
55322	.	71 72	227305 227306	0.9999581575393677	O
55323	Restoration	0 11	227307 227318	0.9999531507492065	O
55324	of	12 14	227319 227321	0.9999849796295166	O
55325	wild	15 19	227322 227326	0.9999814033508301	O
55326	type	20 24	227327 227331	0.999984622001648	O
55327	(	25 26	227332 227333	0.9999861717224121	O
55328	WT	27 28	227334 227335	0.9999560117721558	O
55330	)	30 31	227337 227338	0.9999867677688599	O
55331	TGFBR2	32 37	227339 227344	0.9999862909317017	O
55336	and	39 42	227346 227349	0.9999867677688599	O
55337	ACVR2	43 47	227350 227354	0.999983549118042	O
55340	by	49 51	227356 227358	0.9999878406524658	O
55341	chromosome	52 62	227359 227369	0.9999861717224121	O
55342	transfer	63 71	227370 227378	0.9999865293502808	O
55343	reveals	72 79	227379 227386	0.9999808073043823	O
55344	growth	80 86	227387 227393	0.9999831914901733	O
55345	suppression	87 98	227394 227405	0.9999852180480957	O
55346	in	99 101	227406 227408	0.9999868869781494	O
55347	the	102 105	227409 227412	0.999984860420227	O
55348	cells	106 111	227413 227418	0.9999475479125977	O
55349	and	112 115	227419 227422	0.9999842643737793	O
55350	slower	116 122	227423 227429	0.9999494552612305	O
55351	growth	123 129	227430 227436	0.9999840259552002	O
55352	in	130 132	227437 227439	0.9999854564666748	O
55353	xenografts	133 142	227440 227449	0.9999611377716064	O
55357	in	144 146	227451 227453	0.9999842643737793	O
55358	nude	147 151	227454 227458	0.9994828701019287	O
55359	mice	152 156	227459 227463	0.8396860361099243	O
55360	[	157 158	227464 227465	0.9999886751174927	O
55361	22	158 160	227465 227467	0.9999865293502808	O
55362	]	160 161	227467 227468	0.9999881982803345	O
55363	,	162 163	227469 227470	0.9999867677688599	O
55364	[	164 165	227471 227472	0.999988317489624	O
55365	23	165 167	227472 227474	0.9999856948852539	O
55366	]	167 168	227474 227475	0.9999879598617554	O
55367	.	169 170	227476 227477	0.9999717473983765	O
55368	Interestingly	0 12	227478 227490	0.9999871253967285	O
55370	,	14 15	227492 227493	0.9999891519546509	O
55371	HCT116	16 21	227494 227499	0.9999847412109375	O
55375	+	22 23	227500 227501	0.9999885559082031	O
55376	chr3	23 26	227501 227504	0.9999873638153076	O
55379	cells	28 33	227506 227511	0.9999842643737793	O
55380	,	34 35	227512 227513	0.9999891519546509	O
55381	which	36 41	227514 227519	0.9999889135360718	O
55382	have	42 46	227520 227524	0.9999889135360718	O
55383	two	47 50	227525 227528	0.9999871253967285	O
55384	mutant	51 57	227529 227535	0.9999890327453613	O
55385	hMLH1	58 62	227536 227540	0.9999891519546509	O
55388	and	64 67	227542 227545	0.99998939037323	O
55389	two	68 71	227546 227549	0.9999877214431763	O
55390	mutant	72 78	227550 227556	0.9999889135360718	O
55391	TGFBR2	79 84	227557 227562	0.9999892711639404	O
55396	alleles	86 92	227564 227570	0.9999895095825195	O
55399	plus	94 98	227572 227576	0.99998939037323	O
55400	one	99 102	227577 227580	0.9999891519546509	O
55401	WT	103 104	227581 227582	0.999988317489624	O
55403	hMLH1	106 110	227584 227588	0.9999890327453613	O
55406	and	112 115	227590 227593	0.9999895095825195	O
55407	one	116 119	227594 227597	0.9999891519546509	O
55408	WT	120 121	227598 227599	0.9999878406524658	O
55410	TGFBR2	123 128	227601 227606	0.9999892711639404	O
55415	allele	130 135	227608 227613	0.9999895095825195	O
55417	,	137 138	227615 227616	0.9999885559082031	O
55418	express	139 146	227617 227624	0.9999887943267822	O
55419	[UNK]	147 150	227625 227628	0.9999872446060181	O
55420	%	151 152	227629 227630	0.9999897480010986	O
55421	WT	153 154	227631 227632	0.999988317489624	O
55423	TGFBR2	156 161	227634 227639	0.99998939037323	O
55428	mRNA	163 166	227641 227644	0.9999896287918091	O
55430	and	168 171	227646 227649	0.9999895095825195	O
55431	[UNK]	172 175	227650 227653	0.9999874830245972	O
55432	%	176 177	227654 227655	0.9999895095825195	O
55433	mutant	178 184	227656 227662	0.9999886751174927	O
55434	TGFBR2	185 190	227663 227668	0.99998939037323	O
55439	mRNA	192 195	227670 227673	0.9999896287918091	O
55441	(	197 198	227675 227676	0.9999891519546509	O
55442	unpublished	198 209	227676 227687	0.9999856948852539	O
55443	data	210 214	227688 227692	0.9999891519546509	O
55444	)	215 216	227693 227694	0.9999897480010986	O
55445	.	217 218	227695 227696	0.999975323677063	O
55446	On	0 2	227697 227699	0.9999881982803345	O
55447	the	3 6	227700 227703	0.9999890327453613	O
55448	other	7 12	227704 227709	0.9999878406524658	O
55449	hand	13 17	227710 227714	0.999988317489624	O
55450	,	18 19	227715 227716	0.99998939037323	O
55451	HCT116	20 25	227717 227722	0.9999868869781494	O
55455	+	26 27	227723 227724	0.9999887943267822	O
55456	chr2	27 30	227724 227727	0.9999886751174927	O
55459	cells	32 37	227729 227734	0.9999808073043823	O
55460	,	38 39	227735 227736	0.9999890327453613	O
55461	which	40 45	227737 227742	0.9999889135360718	O
55462	have	46 50	227743 227747	0.9999884366989136	O
55463	two	51 54	227748 227751	0.9999858140945435	O
55464	mutant	55 61	227752 227758	0.9999885559082031	O
55465	hMLH1	62 66	227759 227763	0.9999885559082031	O
55468	and	68 71	227765 227768	0.9999892711639404	O
55469	two	72 75	227769 227772	0.9999872446060181	O
55470	mutant	76 82	227773 227779	0.9999884366989136	O
55471	ACVR2	83 87	227780 227784	0.9999890327453613	O
55474	alleles	89 95	227786 227792	0.99998939037323	O
55477	plus	97 101	227794 227798	0.9999891519546509	O
55478	one	102 105	227799 227802	0.9999891519546509	O
55479	WT	106 107	227803 227804	0.9999878406524658	O
55481	ACVR2	109 113	227806 227810	0.9999892711639404	O
55484	allele	115 120	227812 227817	0.99998939037323	O
55486	,	122 123	227819 227820	0.9999881982803345	O
55487	express	124 131	227821 227828	0.9999885559082031	O
55488	[UNK]	132 135	227829 227832	0.9999853372573853	O
55489	%	136 137	227833 227834	0.9999892711639404	O
55490	WT	138 139	227835 227836	0.9999887943267822	O
55492	ACVR2	141 145	227838 227842	0.9999891519546509	O
55495	mRNA	147 150	227844 227847	0.9999895095825195	O
55497	[	152 153	227849 227850	0.9999895095825195	O
55498	22	153 155	227850 227852	0.9999879598617554	O
55499	]	155 156	227852 227853	0.9999891519546509	O
55500	,	157 158	227854 227855	0.9999892711639404	O
55501	suggesting	159 169	227856 227866	0.9999891519546509	O
55502	a	170 171	227867 227868	0.9999897480010986	O
55503	slow	172 176	227869 227873	0.9999871253967285	O
55504	but	177 180	227874 227877	0.9999884366989136	O
55505	steady	181 187	227878 227884	0.9999856948852539	O
55506	mutation	188 196	227885 227893	0.9999877214431763	O
55507	of	197 199	227894 227896	0.9999892711639404	O
55508	the	200 203	227897 227900	0.9999896287918091	O
55509	transferred	204 215	227901 227912	0.9999845027923584	O
55510	ACVR2	216 220	227913 227917	0.9999885559082031	O
55513	allele	222 227	227919 227924	0.9999891519546509	O
55515	in	229 231	227926 227928	0.9999891519546509	O
55516	hMLH1	232 236	227929 227933	0.9999878406524658	O
55519	deficiency	238 248	227935 227945	0.9999878406524658	O
55520	.	249 250	227946 227947	0.999972939491272	O
55521	Determining	0 10	227948 227958	0.9999881982803345	O
55525	mutation	12 20	227960 227968	0.999984860420227	O
55526	rates	21 26	227969 227974	0.9999871253967285	O
55527	of	27 29	227975 227977	0.9999884366989136	O
55528	actual	30 36	227978 227984	0.9999849796295166	O
55529	human	37 42	227985 227990	0.9999656677246094	O
55530	coding	43 49	227991 227997	0.9999868869781494	O
55531	genes	50 55	227998 228003	0.9999873638153076	O
55532	in	56 58	228004 228006	0.9999877214431763	O
55533	human	59 64	228007 228012	0.9878093004226685	O
55534	MMR	65 67	228013 228015	0.9999847412109375	O
55536	deficiency	69 79	228017 228027	0.9999860525131226	O
55537	has	80 83	228028 228031	0.9999881982803345	O
55538	not	84 87	228032 228035	0.9999879598617554	O
55539	been	88 92	228036 228040	0.999988317489624	O
55540	previously	93 103	228041 228051	0.9999866485595703	O
55541	performed	104 113	228052 228061	0.9999865293502808	O
55542	,	114 115	228062 228063	0.9999878406524658	O
55543	although	116 124	228064 228072	0.9999871253967285	O
55544	model	125 130	228073 228078	0.9999383687973022	O
55545	systems	131 138	228079 228086	0.999987006187439	O
55546	using	139 144	228087 228092	0.999988317489624	O
55547	noncoding	145 153	228093 228101	0.9999876022338867	O
55550	sequences	155 164	228103 228112	0.9999876022338867	O
55551	with	165 169	228113 228117	0.9999885559082031	O
55552	human	170 175	228118 228123	0.9998195767402649	O
55553	cell	176 180	228124 228128	0.9999829530715942	O
55554	and	181 184	228129 228132	0.9999873638153076	O
55555	yeast	185 190	228133 228138	0.9995935559272766	O
55556	MMR	191 193	228139 228141	0.9999867677688599	O
55558	systems	195 202	228143 228150	0.9999874830245972	O
55559	have	203 207	228151 228155	0.9999881982803345	O
55560	been	208 212	228156 228160	0.9999884366989136	O
55561	utilized	213 221	228161 228169	0.9999861717224121	O
55562	[	222 223	228170 228171	0.9999889135360718	O
55563	24	223 225	228171 228173	0.9999861717224121	O
55564	]	225 226	228173 228174	0.9999885559082031	O
55565	–	226 227	228174 228175	0.999980092048645	O
55566	[	227 228	228175 228176	0.9999886751174927	O
55567	27	228 230	228176 228178	0.999983549118042	O
55568	]	230 231	228178 228179	0.9999887943267822	O
55569	.	232 233	228180 228181	0.9999785423278809	O
55570	To	0 2	228182 228184	0.9999819993972778	O
55571	test	3 7	228185 228189	0.9999815225601196	O
55572	the	8 11	228190 228193	0.9999872446060181	O
55573	hypothesis	12 22	228194 228204	0.9999772310256958	O
55574	that	23 27	228205 228209	0.9999878406524658	O
55575	TGFBR2	28 33	228210 228215	0.999987006187439	O
55580	and	35 38	228217 228220	0.9999868869781494	O
55581	ACVR2	39 43	228221 228225	0.9999868869781494	O
55584	frameshift	45 54	228227 228236	0.9999879598617554	O
55587	mutations	56 65	228238 228247	0.9999873638153076	O
55588	are	66 69	228248 228251	0.9999878406524658	O
55589	dependent	70 79	228252 228261	0.9999876022338867	O
55590	on	80 82	228262 228264	0.999988317489624	O
55591	the	83 86	228265 228268	0.9999874830245972	O
55592	human	87 92	228269 228274	0.9999018907546997	O
55593	MMR	93 95	228275 228277	0.999985933303833	O
55595	background	97 107	228279 228289	0.9999866485595703	O
55596	,	108 109	228290 228291	0.999987006187439	O
55597	we	110 112	228292 228294	0.9999853372573853	O
55598	constructed	113 124	228295 228306	0.9999855756759644	O
55599	EGFP	125 128	228307 228310	0.9999872446060181	O
55602	plasmids	130 137	228312 228319	0.9999879598617554	O
55606	in	139 141	228321 228323	0.9999867677688599	O
55607	which	142 147	228324 228329	0.9999880790710449	O
55608	a	148 149	228330 228331	0.9999880790710449	O
55609	−1	150 151	228332 228333	0.9999810457229614	O
55611	bp	153 154	228335 228336	0.9999873638153076	O
55613	frameshift	156 165	228338 228347	0.9999879598617554	O
55616	mutation	167 175	228349 228357	0.9999879598617554	O
55617	at	176 178	228358 228360	0.9999881982803345	O
55618	coding	179 185	228361 228367	0.9999876022338867	O
55619	microsatellites	186 200	228368 228382	0.9999877214431763	O
55623	of	202 204	228384 228386	0.9999879598617554	O
55624	TGFBR2	205 210	228387 228392	0.9999872446060181	O
55629	exon	212 215	228394 228397	0.9999885559082031	O
55631	3	217 218	228399 228400	0.9999874830245972	O
55632	and	219 222	228401 228404	0.9999872446060181	O
55633	ACVR2	223 227	228405 228409	0.9999873638153076	O
55636	exon	229 232	228411 228414	0.9999885559082031	O
55638	10	234 236	228416 228418	0.9999856948852539	O
55639	was	237 240	228419 228422	0.9999877214431763	O
55640	detected	241 249	228423 228431	0.9999881982803345	O
55641	by	250 252	228432 228434	0.9999878406524658	O
55642	EGFP	253 256	228435 228438	0.999987006187439	O
55645	expression	258 268	228440 228450	0.9999853372573853	O
55646	in	269 271	228451 228453	0.999984622001648	O
55647	human	272 277	228454 228459	0.6547161340713501	O
55648	colon	278 282	228460 228464	0.9999747276306152	O
55650	cancer	284 290	228466 228472	0.9999825954437256	O
55651	cells	291 296	228473 228478	0.9999250173568726	O
55652	with	297 301	228479 228483	0.9999823570251465	O
55653	MMR	302 304	228484 228486	0.9999834299087524	O
55655	deficiency	306 316	228488 228498	0.9999829530715942	O
55656	.	317 318	228499 228500	0.9998905658721924	O
55657	With	0 4	228501 228505	0.9999849796295166	O
55658	this	5 9	228506 228510	0.9999880790710449	O
55659	new	10 13	228511 228514	0.9999849796295166	O
55660	cell	14 18	228515 228519	0.9999690055847168	O
55661	model	19 24	228520 228525	0.9999755620956421	O
55662	,	25 26	228526 228527	0.9999880790710449	O
55663	we	27 29	228528 228530	0.9999860525131226	O
55664	were	30 34	228531 228535	0.9999873638153076	O
55665	able	35 39	228536 228540	0.9999862909317017	O
55666	to	40 42	228541 228543	0.9999886751174927	O
55667	calculate	43 52	228544 228553	0.9999849796295166	O
55668	a	53 54	228554 228555	0.9999887943267822	O
55669	human	55 60	228556 228561	0.9999775886535645	O
55670	gene	61 65	228562 228566	0.9999874830245972	O
55671	mutation	66 74	228567 228575	0.9999884366989136	O
55672	rate	75 79	228576 228580	0.9999892711639404	O
55673	in	80 82	228581 228583	0.9999895095825195	O
55674	each	83 87	228584 228588	0.9999880790710449	O
55675	human	88 93	228589 228594	0.9999163150787354	O
55676	MMR	94 96	228595 228597	0.9999871253967285	O
55678	-	97 98	228598 228599	0.9999892711639404	O
55679	deficient	98 106	228599 228607	0.9999884366989136	O
55681	background	108 118	228609 228619	0.9999843835830688	O
55682	,	119 120	228620 228621	0.9999872446060181	O
55683	and	121 124	228622 228625	0.9999885559082031	O
55684	could	125 130	228626 228631	0.9999881982803345	O
55685	directly	131 139	228632 228640	0.9999868869781494	O
55686	compare	140 147	228641 228648	0.9999880790710449	O
55687	the	148 151	228649 228652	0.9999892711639404	O
55688	mutation	152 160	228653 228661	0.9999881982803345	O
55689	rate	161 165	228662 228666	0.9999892711639404	O
55690	between	166 173	228667 228674	0.9999885559082031	O
55691	TGFBR2	174 179	228675 228680	0.9999887943267822	O
55696	and	181 184	228682 228685	0.9999890327453613	O
55697	ACVR2	185 189	228686 228690	0.999987006187439	O
55700	.	191 192	228692 228693	0.9999890327453613	O
55701	*	193 194	228694 228695	0.9999887943267822	O
55702	*	194 195	228695 228696	0.9999839067459106	O
55703	IGNORE	0 5	228697 228702	0.9999853372573853	O
55706	LINE	7 10	228704 228707	0.9999877214431763	O
55709	*	12 13	228709 228710	0.9999877214431763	O
55710	*	13 14	228710 228711	0.9999877214431763	O
55711	*	15 16	228712 228713	0.9999877214431763	O
55712	*	16 17	228713 228714	0.9999878406524658	O
55713	IGNORE	18 23	228715 228720	0.9999867677688599	O
55716	LINE	25 28	228722 228725	0.9999879598617554	O
55719	*	30 31	228727 228728	0.9999873638153076	O
55720	*	31 32	228728 228729	0.9999874830245972	O
55721	*	33 34	228730 228731	0.9999873638153076	O
55722	*	34 35	228731 228732	0.9999873638153076	O
55723	IGNORE	36 41	228733 228738	0.9999861717224121	O
55726	LINE	43 46	228740 228743	0.9999878406524658	O
55729	*	48 49	228745 228746	0.9999874830245972	O
55730	*	49 50	228746 228747	0.9999874830245972	O
55731	EGFP	51 54	228748 228751	0.9999871253967285	O
55734	expression	56 66	228753 228763	0.9999876022338867	O
55735	of	67 69	228764 228766	0.9999879598617554	O
55736	stably	70 75	228767 228772	0.999984860420227	O
55738	transfected	77 87	228774 228784	0.9999871253967285	O
55740	HCT116	89 94	228786 228791	0.999984622001648	O
55744	cell	96 100	228793 228797	0.9999854564666748	O
55745	lines	101 106	228798 228803	0.9999868869781494	O
55746	(	107 108	228804 228805	0.9999878406524658	O
55747	hMLH1−	109 114	228806 228811	0.9999862909317017	O
55751	/	115 116	228812 228813	0.9999880790710449	O
55752	−	116 117	228813 228814	0.9999849796295166	O
55753	)	118 119	228815 228816	0.9999884366989136	O
55754	containing	120 130	228817 228827	0.9999881982803345	O
55755	exon	131 134	228828 228831	0.9999879598617554	O
55757	3	136 137	228833 228834	0.999985933303833	O
55758	of	138 140	228835 228837	0.9999874830245972	O
55759	TGFBR2	141 146	228838 228843	0.9999872446060181	O
55764	sequences	148 157	228845 228854	0.9999867677688599	O
55765	.	158 159	228855 228856	0.9999867677688599	O
55766	(	160 161	228857 228858	0.9998558759689331	O
55767	A	0 1	228859 228860	0.9999849796295166	O
55768	)	2 3	228861 228862	0.9999890327453613	O
55769	MR	4 6	228863 228865	0.9999842643737793	O
55770	TGFBR2	7 12	228866 228871	0.9999881982803345	O
55775	IF	14 16	228873 228875	0.9999815225601196	O
55776	cells	17 22	228876 228881	0.9999880790710449	O
55777	,	23 24	228882 228883	0.9999884366989136	O
55778	a	25 26	228884 228885	0.9999890327453613	O
55779	postive	27 33	228886 228892	0.9999845027923584	O
55781	control	35 42	228894 228901	0.9999868869781494	O
55782	,	43 44	228902 228903	0.9999877214431763	O
55783	showed	45 51	228904 228910	0.9999885559082031	O
55784	99	52 54	228911 228913	0.9999865293502808	O
55785	%	55 56	228914 228915	0.9999889135360718	O
55786	EGFP	57 60	228916 228919	0.9999878406524658	O
55789	expression	62 72	228921 228931	0.9999890327453613	O
55790	.	73 74	228932 228933	0.9999886751174927	O
55791	(	75 76	228934 228935	0.9999707937240601	O
55792	B	0 1	228936 228937	0.9999805688858032	O
55793	)	2 3	228938 228939	0.9999886751174927	O
55794	MR	4 6	228940 228942	0.9999833106994629	O
55795	TGFBR2	7 12	228943 228948	0.9999873638153076	O
55800	OF	14 16	228950 228952	0.9999788999557495	O
55801	cells	17 22	228953 228958	0.9999871253967285	O
55802	,	23 24	228959 228960	0.9999881982803345	O
55803	a	25 26	228961 228962	0.9999887943267822	O
55804	negative	27 35	228963 228971	0.9999853372573853	O
55805	control	36 43	228972 228979	0.999985933303833	O
55806	,	44 45	228980 228981	0.9999864101409912	O
55807	showed	46 52	228982 228988	0.9999874830245972	O
55808	no	53 55	228989 228991	0.9999862909317017	O
55809	visible	56 63	228992 228999	0.9999866485595703	O
55810	fluorescence	64 75	229000 229011	0.9999872446060181	O
55813	.	77 78	229013 229014	0.9999876022338867	O
55814	(	79 80	229015 229016	0.9999476671218872	O
55815	C	0 1	229017 229018	0.9999688863754272	O
55816	)	2 3	229019 229020	0.9999872446060181	O
55817	TGFBR2	4 9	229021 229026	0.9999861717224121	O
55822	OF	11 13	229028 229030	0.9999762773513794	O
55823	cells	14 19	229031 229036	0.9999865293502808	O
55824	showed	20 26	229037 229043	0.9999866485595703	O
55825	1	27 28	229044 229045	0.9999864101409912	O
55826	.	28 29	229045 229046	0.9999879598617554	O
55827	22	29 31	229046 229048	0.9999855756759644	O
55828	%	32 33	229049 229050	0.999988317489624	O
55829	net	34 37	229051 229054	0.999987006187439	O
55830	fluorescence	38 49	229055 229066	0.9999879598617554	O
55833	.	51 52	229068 229069	0.9999665021896362	O
55834	Photomicrographs	0 15	229070 229085	0.9999834299087524	O
55839	of	17 19	229087 229089	0.9999878406524658	O
55840	stable	20 26	229090 229096	0.9999856948852539	O
55841	HCT116	27 32	229097 229102	0.9999828338623047	O
55845	cell	34 38	229104 229108	0.9999856948852539	O
55846	lines	39 44	229109 229114	0.9999868869781494	O
55847	are	45 48	229115 229118	0.9999862909317017	O
55848	representative	49 63	229119 229133	0.9999854564666748	O
55849	of	64 66	229134 229136	0.9999884366989136	O
55850	the	67 70	229137 229140	0.9999873638153076	O
55851	other	71 76	229141 229146	0.999984622001648	O
55852	stable	77 83	229147 229153	0.9999867677688599	O
55853	cell	84 88	229154 229158	0.9999874830245972	O
55854	lines	89 94	229159 229164	0.9999885559082031	O
55855	containing	95 105	229165 229175	0.9999892711639404	O
55856	TGFBR2	106 111	229176 229181	0.9999890327453613	O
55861	exon	113 116	229183 229186	0.9999896287918091	O
55863	3	118 119	229188 229189	0.9999886751174927	O
55864	or	120 122	229190 229192	0.9999891519546509	O
55865	ACVR2	123 127	229193 229197	0.9999868869781494	O
55868	exon	129 132	229199 229202	0.9999895095825195	O
55870	10	134 136	229204 229206	0.9999874830245972	O
55871	sequences	137 146	229207 229216	0.9999885559082031	O
55872	.	147 148	229217 229218	0.9999628067016602	O
55873	Photomicrographs	0 15	229219 229234	0.9999871253967285	O
55878	in	17 19	229236 229238	0.99998939037323	O
55879	top	20 23	229239 229242	0.9999874830245972	O
55880	panels	24 30	229243 229249	0.9999865293502808	O
55881	were	31 35	229250 229254	0.9999890327453613	O
55882	taken	36 41	229255 229260	0.9999886751174927	O
55883	with	42 46	229261 229265	0.99998939037323	O
55884	a	47 48	229266 229267	0.9999896287918091	O
55885	fluorescence	49 60	229268 229279	0.9999884366989136	O
55888	microscope	62 71	229281 229290	0.9999887943267822	O
55890	(	73 74	229292 229293	0.99998939037323	O
55891	Zeiss	75 79	229294 229298	0.9999864101409912	O
55894	,	81 82	229300 229301	0.9999885559082031	O
55895	Germany	83 90	229302 229309	0.9999213218688965	O
55896	)	91 92	229310 229311	0.9999895095825195	O
55897	and	93 96	229312 229315	0.9999890327453613	O
55898	photomicrographs	97 112	229316 229331	0.9999885559082031	O
55903	in	114 116	229333 229335	0.9999896287918091	O
55904	bottom	117 123	229336 229342	0.9999860525131226	O
55905	panels	124 130	229343 229349	0.9999876022338867	O
55906	were	131 135	229350 229354	0.9999895095825195	O
55907	taken	136 141	229355 229360	0.9999886751174927	O
55908	with	142 146	229361 229365	0.9999890327453613	O
55909	a	147 148	229366 229367	0.9999895095825195	O
55910	light	149 154	229368 229373	0.9999876022338867	O
55911	microscope	155 164	229374 229383	0.9999886751174927	O
55913	of	166 168	229385 229387	0.9999891519546509	O
55914	the	169 172	229388 229391	0.9999892711639404	O
55915	identical	173 182	229392 229401	0.9999839067459106	O
55916	area	183 187	229402 229406	0.9999871253967285	O
55917	under	188 193	229407 229412	0.9999889135360718	O
55918	40×	194 196	229413 229415	0.9999880790710449	O
55920	magnification	198 210	229417 229429	0.9999881982803345	O
55923	.	212 213	229431 229432	0.9999629259109497	O
55924	TGFBR2	0 5	229433 229438	0.9999879598617554	O
55929	exon	7 10	229440 229443	0.9999895095825195	O
55931	3	12 13	229445 229446	0.9999874830245972	O
55932	and	14 17	229447 229450	0.9999880790710449	O
55933	ACVR2	18 22	229451 229455	0.999988317489624	O
55936	exon	24 27	229457 229460	0.99998939037323	O
55938	10	29 31	229462 229464	0.9999860525131226	O
55939	coding	32 38	229465 229471	0.9999891519546509	O
55940	microsatellite	39 52	229472 229485	0.9999884366989136	O
55944	mutations	54 63	229487 229496	0.999988317489624	O
55945	are	64 67	229497 229500	0.999988317489624	O
55946	dependent	68 77	229501 229510	0.9999889135360718	O
55947	on	78 80	229511 229513	0.9999895095825195	O
55948	the	81 84	229514 229517	0.99998939037323	O
55949	MMR	85 87	229518 229520	0.9999877214431763	O
55951	background	89 99	229522 229532	0.9999891519546509	O
55952	To	100 102	229533 229535	0.9999866485595703	O
55953	determine	103 112	229536 229545	0.9999885559082031	O
55954	mutation	113 121	229546 229554	0.9999873638153076	O
55955	frequencies	122 133	229555 229566	0.9999879598617554	O
55956	of	134 136	229567 229569	0.9999889135360718	O
55957	the	137 140	229570 229573	0.9999889135360718	O
55958	TGFBR2	141 146	229574 229579	0.999988317489624	O
55963	and	148 151	229581 229584	0.9999878406524658	O
55964	ACVR2	152 156	229585 229589	0.9999879598617554	O
55967	coding	158 164	229591 229597	0.9999887943267822	O
55968	microsatellites	165 179	229598 229612	0.9999885559082031	O
55972	in	181 183	229614 229616	0.99998939037323	O
55973	cells	184 189	229617 229622	0.9999852180480957	O
55974	with	190 194	229623 229627	0.9999890327453613	O
55975	different	195 204	229628 229637	0.9999867677688599	O
55976	MMR	205 207	229638 229640	0.9999871253967285	O
55978	backgrounds	209 220	229642 229653	0.9999872446060181	O
55979	(	221 222	229654 229655	0.99998939037323	O
55980	Table	223 228	229656 229661	0.9999858140945435	O
55981	S1	229 230	229662 229663	0.9999891519546509	O
55983	)	232 233	229665 229666	0.9999891519546509	O
55984	,	234 235	229667 229668	0.9999878406524658	O
55985	nonfluorescent	236 249	229669 229682	0.9999878406524658	O
55990	cells	251 256	229684 229689	0.9999873638153076	O
55991	containing	257 267	229690 229700	0.9999892711639404	O
55992	either	268 274	229701 229707	0.9999887943267822	O
55993	MR	275 277	229708 229710	0.999987006187439	O
55994	TGFBR2	278 283	229711 229716	0.9999889135360718	O
55999	OF	285 287	229718 229720	0.99998939037323	O
56000	,	288 289	229721 229722	0.999988317489624	O
56001	TGFBR2	290 295	229723 229728	0.9999884366989136	O
56006	OF	297 299	229730 229732	0.9999892711639404	O
56007	,	300 301	229733 229734	0.9999884366989136	O
56008	MR	302 304	229735 229737	0.9999867677688599	O
56009	ACVR2	305 309	229738 229742	0.9999890327453613	O
56012	OF	311 313	229744 229746	0.9999892711639404	O
56013	or	314 316	229747 229749	0.9999879598617554	O
56014	ACVR2	317 321	229750 229754	0.9999884366989136	O
56017	OF	323 325	229756 229758	0.9999887943267822	O
56018	were	326 330	229759 229763	0.9999884366989136	O
56019	sorted	331 337	229764 229770	0.9999865293502808	O
56020	and	338 341	229771 229774	0.9999879598617554	O
56021	exponentially	342 354	229775 229787	0.9999889135360718	O
56025	grown	356 361	229789 229794	0.9999874830245972	O
56026	for	362 365	229795 229798	0.99998939037323	O
56027	7	366 367	229799 229800	0.9999890327453613	O
56028	to	368 370	229801 229803	0.9999889135360718	O
56029	35	371 373	229804 229806	0.9999856948852539	O
56030	days	374 378	229807 229811	0.9999873638153076	O
56031	.	379 380	229812 229813	0.999962568283081	O
56032	At	0 2	229814 229816	0.999985933303833	O
56033	specific	3 11	229817 229825	0.9999849796295166	O
56034	time	12 16	229826 229830	0.9999862909317017	O
56035	points	17 23	229831 229837	0.9999874830245972	O
56036	(	24 25	229838 229839	0.9999879598617554	O
56037	day	26 29	229840 229843	0.9999868869781494	O
56038	7	30 31	229844 229845	0.999985933303833	O
56039	,	32 33	229846 229847	0.9999880790710449	O
56040	14	34 36	229848 229850	0.9999845027923584	O
56041	,	37 38	229851 229852	0.9999879598617554	O
56042	21	39 41	229853 229855	0.9999845027923584	O
56043	,	42 43	229856 229857	0.9999879598617554	O
56044	28	44 46	229858 229860	0.9999837875366211	O
56045	,	47 48	229861 229862	0.9999876022338867	O
56046	and	49 52	229863 229866	0.9999887943267822	O
56047	/	52 53	229866 229867	0.999988317489624	O
56048	or	53 55	229867 229869	0.999988317489624	O
56049	35	56 58	229870 229872	0.9999798536300659	O
56050	)	59 60	229873 229874	0.9999885559082031	O
56051	three	61 66	229875 229880	0.9999831914901733	O
56052	cultures	67 75	229881 229889	0.9999529123306274	O
56053	of	76 78	229890 229892	0.9999867677688599	O
56054	each	79 83	229893 229897	0.9999868869781494	O
56055	cell	84 88	229898 229902	0.9999780654907227	O
56056	line	89 93	229903 229907	0.9999815225601196	O
56057	were	94 98	229908 229912	0.9999881982803345	O
56058	analyzed	99 107	229913 229921	0.9999878406524658	O
56059	in	108 110	229922 229924	0.9999887943267822	O
56060	parallel	111 119	229925 229933	0.9999847412109375	O
56061	for	120 123	229934 229937	0.9999887943267822	O
56062	EGFP	124 127	229938 229941	0.9999880790710449	O
56065	expression	129 139	229943 229953	0.9999885559082031	O
56066	by	140 142	229954 229956	0.9999889135360718	O
56067	using	143 148	229957 229962	0.9999884366989136	O
56068	flow	149 153	229963 229967	0.9999867677688599	O
56069	cytometry	154 162	229968 229976	0.9999884366989136	O
56073	to	164 166	229978 229980	0.999988317489624	O
56074	detect	167 173	229981 229987	0.9999884366989136	O
56075	−1	174 175	229988 229989	0.999983549118042	O
56077	bp	177 178	229991 229992	0.9999885559082031	O
56079	frameshift	180 189	229994 230003	0.9999885559082031	O
56082	mutations	191 200	230005 230014	0.9999871253967285	O
56083	.	201 202	230015 230016	0.9999555349349976	O
56084	Three	0 5	230017 230022	0.9999808073043823	O
56085	different	6 15	230023 230032	0.9999842643737793	O
56086	populations	16 27	230033 230044	0.99997878074646	O
56087	were	28 32	230045 230049	0.9999866485595703	O
56088	identified	33 43	230050 230060	0.9999853372573853	O
56089	according	44 53	230061 230070	0.9999868869781494	O
56090	to	54 56	230071 230073	0.9999876022338867	O
56091	their	57 62	230074 230079	0.9999876022338867	O
56092	EGFP	63 66	230080 230083	0.9999858140945435	O
56095	fluorescence	68 79	230085 230096	0.999988317489624	O
56098	intensity	81 90	230098 230107	0.9999877214431763	O
56099	(	91 92	230108 230109	0.9999866485595703	O
56100	Fig	93 95	230110 230112	0.9999853372573853	O
56102	.	97 98	230114 230115	0.9999804496765137	O
56103	3	0 1	230116 230117	0.9999406337738037	O
56104	)	2 3	230118 230119	0.999974250793457	O
56105	.	4 5	230120 230121	0.9998180270195007	O
56106	The	0 3	230122 230125	0.9999884366989136	O
56107	population	4 14	230126 230136	0.999987006187439	O
56108	with	15 19	230137 230141	0.9999895095825195	O
56109	no	20 22	230142 230144	0.9999881982803345	O
56110	fluorescence	23 34	230145 230156	0.9999887943267822	O
56113	was	36 39	230158 230161	0.9999892711639404	O
56114	named	40 45	230162 230167	0.9999886751174927	O
56115	M0	46 47	230168 230169	0.9999891519546509	O
56117	,	49 50	230171 230172	0.9999891519546509	O
56118	the	51 54	230173 230176	0.99998939037323	O
56119	population	55 65	230177 230187	0.9999886751174927	O
56120	with	66 70	230188 230192	0.9999896287918091	O
56121	low	71 74	230193 230196	0.9999885559082031	O
56122	fluorescence	75 86	230197 230208	0.9999895095825195	O
56125	M1	88 90	230210 230212	0.9999891519546509	O
56126	,	91 92	230213 230214	0.9999886751174927	O
56127	and	93 96	230215 230218	0.9999890327453613	O
56128	the	97 100	230219 230222	0.9999892711639404	O
56129	population	101 111	230223 230233	0.9999886751174927	O
56130	with	112 116	230234 230238	0.9999892711639404	O
56131	high	117 121	230239 230243	0.9999880790710449	O
56132	fluorescence	122 133	230244 230255	0.9999892711639404	O
56135	M2	135 136	230257 230258	0.9999892711639404	O
56137	.	137 138	230259 230260	0.9999792575836182	O
56138	EGFP	0 3	230261 230264	0.9999871253967285	O
56141	histograms	5 14	230266 230275	0.99998939037323	O
56145	of	16 18	230277 230279	0.9999891519546509	O
56146	MR	19 21	230280 230282	0.9999840259552002	O
56147	TGFBR2	22 27	230283 230288	0.99998939037323	O
56152	OF	29 31	230290 230292	0.99998939037323	O
56153	and	32 35	230293 230296	0.9999889135360718	O
56154	TGFBR2	36 41	230297 230302	0.9999890327453613	O
56159	OF	43 45	230304 230306	0.9999890327453613	O
56160	cells	46 51	230307 230312	0.9999892711639404	O
56161	in	52 54	230313 230315	0.9999897480010986	O
56162	different	55 64	230316 230325	0.9999877214431763	O
56163	MMR	65 67	230326 230328	0.9999874830245972	O
56165	backgrounds	69 80	230330 230341	0.9999878406524658	O
56166	at	81 83	230342 230344	0.9999899864196777	O
56167	day	84 87	230345 230348	0.9999897480010986	O
56168	21	88 90	230349 230351	0.9999873638153076	O
56169	are	91 94	230352 230355	0.9999889135360718	O
56170	shown	95 100	230356 230361	0.9999891519546509	O
56171	in	101 103	230362 230364	0.9999898672103882	O
56172	Fig	104 106	230365 230367	0.9999881982803345	O
56174	.	108 109	230369 230370	0.9999850988388062	O
56175	3E	0 1	230371 230372	0.9999871253967285	O
56177	,	3 4	230374 230375	0.9999886751174927	O
56178	in	5 7	230376 230378	0.9999876022338867	O
56179	which	8 13	230379 230384	0.9999887943267822	O
56180	hMLH1−	14 19	230385 230390	0.9999872446060181	O
56184	/	20 21	230391 230392	0.999988317489624	O
56185	−	22 23	230393 230394	0.9999818801879883	O
56186	TGFBR2	24 29	230395 230400	0.999988317489624	O
56191	OF	31 33	230402 230404	0.9999865293502808	O
56192	cells	34 39	230405 230410	0.9999889135360718	O
56193	showed	40 46	230411 230417	0.9999884366989136	O
56194	2	47 48	230418 230419	0.9999861717224121	O
56195	distinct	49 57	230420 230428	0.9999878406524658	O
56196	EGFP	58 61	230429 230432	0.9999873638153076	O
56199	cell	63 67	230434 230438	0.9999885559082031	O
56200	populations	68 79	230439 230450	0.9999886751174927	O
56201	,	80 81	230451 230452	0.9999881982803345	O
56202	M1	82 84	230453 230455	0.9999880790710449	O
56203	and	85 88	230456 230459	0.9999879598617554	O
56204	M2	89 90	230460 230461	0.9999877214431763	O
56206	.	91 92	230462 230463	0.9999752044677734	O
56207	M2	0 1	230464 230465	0.9999828338623047	O
56209	cells	3 8	230467 230472	0.9999864101409912	O
56210	from	9 13	230473 230477	0.9999881982803345	O
56211	hMLH1−	14 19	230478 230483	0.9999814033508301	O
56215	/	20 21	230484 230485	0.9999884366989136	O
56216	−	22 23	230486 230487	0.9999775886535645	O
56217	TGFBR2	24 29	230488 230493	0.9999881982803345	O
56222	OF	31 33	230495 230497	0.9999842643737793	O
56223	showed	34 40	230498 230504	0.9999881982803345	O
56224	brighter	41 49	230505 230513	0.9999847412109375	O
56225	EGFP	50 53	230514 230517	0.9999884366989136	O
56228	expression	55 65	230519 230529	0.9999892711639404	O
56229	compared	66 74	230530 230538	0.9999886751174927	O
56230	to	75 77	230539 230541	0.9999886751174927	O
56231	M1	78 80	230542 230544	0.9999840259552002	O
56232	cells	81 86	230545 230550	0.9999885559082031	O
56233	(	87 88	230551 230552	0.9999886751174927	O
56234	Fig	89 91	230553 230555	0.9999868869781494	O
56236	.	93 94	230557 230558	0.9999855756759644	O
56237	S1	0 1	230559 230560	0.9999780654907227	O
56239	)	3 4	230562 230563	0.9999675750732422	O
56240	.	5 6	230564 230565	0.9996474981307983	O
56241	Mutation	0 7	230566 230573	0.9999674558639526	O
56243	analysis	9 17	230575 230583	0.999976634979248	O
56244	by	18 20	230584 230586	0.9999749660491943	O
56245	flow	21 25	230587 230591	0.999976634979248	O
56246	cytometry	26 34	230592 230600	0.9999808073043823	O
56250	.	36 37	230602 230603	0.9969896078109741	O
56251	Nonfluorescent	0 13	230604 230617	0.9999771118164062	O
56256	cells	15 20	230619 230624	0.9999773502349854	O
56257	were	21 25	230625 230629	0.9999810457229614	O
56258	sorted	26 32	230630 230636	0.999981164932251	O
56259	and	33 36	230637 230640	0.9999804496765137	O
56260	cells	37 42	230641 230646	0.9999781847000122	O
56261	were	43 47	230647 230651	0.999984860420227	O
56262	exponentially	48 60	230652 230664	0.9999871253967285	O
56266	grown	62 67	230666 230671	0.9999853372573853	O
56267	for	68 71	230672 230675	0.9999873638153076	O
56268	7	72 73	230676 230677	0.9999862909317017	O
56269	to	74 76	230678 230680	0.9999858140945435	O
56270	35	77 79	230681 230683	0.9999775886535645	O
56271	days	80 84	230684 230688	0.9999825954437256	O
56272	.	85 86	230689 230690	0.9999287128448486	O
56273	At	0 2	230691 230693	0.9999853372573853	O
56274	specific	3 11	230694 230702	0.9999833106994629	O
56275	time	12 16	230703 230707	0.999985933303833	O
56276	points	17 23	230708 230714	0.9999866485595703	O
56277	,	24 25	230715 230716	0.9999855756759644	O
56278	cells	26 31	230717 230722	0.9999629259109497	O
56279	were	32 36	230723 230727	0.9999865293502808	O
56280	harvested	37 46	230728 230737	0.999982476234436	O
56281	,	47 48	230738 230739	0.9999850988388062	O
56282	and	49 52	230740 230743	0.9999868869781494	O
56283	200	53 56	230744 230747	0.999981164932251	O
56284	,	56 57	230747 230748	0.9999861717224121	O
56285	000	57 60	230748 230751	0.9999833106994629	O
56286	cells	61 66	230752 230757	0.9999816417694092	O
56287	were	67 71	230758 230762	0.9999871253967285	O
56288	analyzed	72 80	230763 230771	0.9999854564666748	O
56289	for	81 84	230772 230775	0.9999876022338867	O
56290	EGFP	85 88	230776 230779	0.999985933303833	O
56293	expression	90 100	230781 230791	0.9999879598617554	O
56294	(	101 102	230792 230793	0.9999890327453613	O
56295	identifying	103 114	230794 230805	0.9999877214431763	O
56296	a	115 116	230806 230807	0.9999891519546509	O
56297	−1	117 118	230808 230809	0.9999816417694092	O
56299	bp	120 121	230811 230812	0.9999880790710449	O
56301	mutation	123 131	230814 230822	0.999987006187439	O
56302	)	132 133	230823 230824	0.9999890327453613	O
56303	by	134 136	230825 230827	0.9999879598617554	O
56304	flow	137 141	230828 230832	0.9999860525131226	O
56305	cytometry	142 150	230833 230841	0.9999881982803345	O
56309	.	152 153	230843 230844	0.9999676942825317	O
56310	For	0 3	230845 230848	0.9999878406524658	O
56311	example	4 11	230849 230856	0.9999873638153076	O
56312	,	12 13	230857 230858	0.99998939037323	O
56313	with	14 18	230859 230863	0.9999887943267822	O
56314	hMLH1−	19 24	230864 230869	0.9999884366989136	O
56318	/	25 26	230870 230871	0.9999886751174927	O
56319	−	27 28	230872 230873	0.9999822378158569	O
56320	ACVR2	29 33	230874 230878	0.9999885559082031	O
56323	OF	35 37	230880 230882	0.9999876022338867	O
56324	cells	38 43	230883 230888	0.9999891519546509	O
56325	,	44 45	230889 230890	0.9999892711639404	O
56326	region	46 52	230891 230897	0.9999890327453613	O
56327	R1	53 54	230898 230899	0.9999898672103882	O
56329	,	56 57	230901 230902	0.9999891519546509	O
56330	R3	58 59	230903 230904	0.9999896287918091	O
56332	,	61 62	230906 230907	0.9999890327453613	O
56333	and	63 66	230908 230911	0.9999896287918091	O
56334	R2	67 68	230912 230913	0.9999892711639404	O
56336	were	70 74	230915 230919	0.9999898672103882	O
56337	set	75 78	230920 230923	0.9999898672103882	O
56338	according	79 88	230924 230933	0.9999898672103882	O
56339	to	89 91	230934 230936	0.9999901056289673	O
56340	(	92 93	230937 230938	0.9999899864196777	O
56341	A	94 95	230939 230940	0.99998939037323	O
56342	)	96 97	230941 230942	0.9999899864196777	O
56343	cell	98 102	230943 230947	0.9999890327453613	O
56344	size	103 107	230948 230952	0.9999889135360718	O
56345	,	108 109	230953 230954	0.9999896287918091	O
56346	(	110 111	230955 230956	0.9999896287918091	O
56347	B	112 113	230957 230958	0.9999877214431763	O
56348	)	114 115	230959 230960	0.9999899864196777	O
56349	live	116 120	230961 230965	0.9999852180480957	O
56350	cells	121 126	230966 230971	0.9999892711639404	O
56351	,	127 128	230972 230973	0.9999890327453613	O
56352	and	129 132	230974 230977	0.9999897480010986	O
56353	(	133 134	230978 230979	0.9999896287918091	O
56354	C	135 136	230980 230981	0.9999874830245972	O
56355	)	137 138	230982 230983	0.9999899864196777	O
56356	fluorescence	139 150	230984 230995	0.9999887943267822	O
56359	.	152 153	230997 230998	0.9999812841415405	O
56360	Gated	0 4	230999 231003	0.9999822378158569	O
56362	R1	6 7	231005 231006	0.9999886751174927	O
56364	and	9 12	231008 231011	0.9999864101409912	O
56365	R3	13 14	231012 231013	0.9999886751174927	O
56367	(	16 17	231015 231016	0.9999889135360718	O
56368	live	18 22	231017 231021	0.9999798536300659	O
56369	cells	23 28	231022 231027	0.9999866485595703	O
56370	)	29 30	231028 231029	0.9999895095825195	O
56371	,	31 32	231030 231031	0.9999872446060181	O
56372	and	33 36	231032 231035	0.999988317489624	O
56373	R2	37 38	231036 231037	0.9999889135360718	O
56375	were	40 44	231039 231043	0.9999887943267822	O
56376	analyzed	45 53	231044 231052	0.9999877214431763	O
56377	on	54 56	231053 231055	0.999988317489624	O
56378	an	57 59	231056 231058	0.9999891519546509	O
56379	EGFP	60 63	231059 231062	0.9999881982803345	O
56382	histogram	65 73	231064 231072	0.9999892711639404	O
56385	(	75 76	231074 231075	0.9999891519546509	O
56386	D	77 78	231076 231077	0.9999858140945435	O
56387	)	78 79	231077 231078	0.9999895095825195	O
56388	and	80 83	231079 231082	0.999988317489624	O
56389	two	84 87	231083 231086	0.9999864101409912	O
56390	distinct	88 96	231087 231095	0.9999862909317017	O
56391	EGFP	97 100	231096 231099	0.9999885559082031	O
56394	populations	102 113	231101 231112	0.9999880790710449	O
56395	were	114 118	231113 231117	0.9999887943267822	O
56396	plotted	119 125	231118 231124	0.9999850988388062	O
56398	.	127 128	231126 231127	0.9999680519104004	O
56399	The	0 3	231128 231131	0.999988317489624	O
56400	population	4 14	231132 231142	0.9999878406524658	O
56401	displaying	15 25	231143 231153	0.9999881982803345	O
56402	no	26 28	231154 231156	0.9999878406524658	O
56403	fluorescence	29 40	231157 231168	0.9999877214431763	O
56406	was	42 45	231170 231173	0.9999887943267822	O
56407	designated	46 56	231174 231184	0.9999886751174927	O
56408	M0	57 58	231185 231186	0.9999889135360718	O
56410	,	60 61	231188 231189	0.9999889135360718	O
56411	the	62 65	231190 231193	0.9999890327453613	O
56412	population	66 76	231194 231204	0.9999887943267822	O
56413	with	77 81	231205 231209	0.9999892711639404	O
56414	dim	82 85	231210 231213	0.9999885559082031	O
56415	EGFP	86 89	231214 231217	0.9999891519546509	O
56418	expression	91 101	231219 231229	0.9999892711639404	O
56419	was	102 105	231230 231233	0.9999886751174927	O
56420	designated	106 116	231234 231244	0.9999885559082031	O
56421	M1	117 119	231245 231247	0.9999879598617554	O
56422	,	120 121	231248 231249	0.9999885559082031	O
56423	and	122 125	231250 231253	0.9999886751174927	O
56424	the	126 129	231254 231257	0.9999887943267822	O
56425	population	130 140	231258 231268	0.9999886751174927	O
56426	with	141 145	231269 231273	0.9999889135360718	O
56427	bright	146 152	231274 231280	0.9999878406524658	O
56428	EGFP	153 156	231281 231284	0.9999890327453613	O
56431	expression	158 168	231286 231296	0.9999889135360718	O
56432	was	169 172	231297 231300	0.9999886751174927	O
56433	designated	173 183	231301 231311	0.999988317489624	O
56434	M2	184 185	231312 231313	0.9999884366989136	O
56436	.	186 187	231314 231315	0.9999887943267822	O
56437	(	188 189	231316 231317	0.9999701976776123	O
56438	E	0 1	231318 231319	0.9999828338623047	O
56439	)	2 3	231320 231321	0.9999897480010986	O
56440	EGFP	4 7	231322 231325	0.9999880790710449	O
56443	histograms	9 18	231327 231336	0.9999896287918091	O
56447	of	20 22	231338 231340	0.9999896287918091	O
56448	MR	23 25	231341 231343	0.9999858140945435	O
56449	TGFBR2	26 31	231344 231349	0.9999896287918091	O
56454	OF	33 35	231351 231353	0.9999892711639404	O
56455	and	36 39	231354 231357	0.9999889135360718	O
56456	TGFBR2	40 45	231358 231363	0.9999891519546509	O
56461	OF	47 49	231365 231367	0.9999887943267822	O
56462	cells	50 55	231368 231373	0.9999892711639404	O
56463	in	56 58	231374 231376	0.9999898672103882	O
56464	different	59 68	231377 231386	0.9999878406524658	O
56465	MMR	69 71	231387 231389	0.999987006187439	O
56467	deficient	73 81	231391 231399	0.99998939037323	O
56469	backgrounds	83 94	231401 231412	0.9999871253967285	O
56470	at	95 97	231413 231415	0.9999899864196777	O
56471	day	98 101	231416 231419	0.9999896287918091	O
56472	21	102 104	231420 231422	0.9999876022338867	O
56473	were	105 109	231423 231427	0.99998939037323	O
56474	shown	110 115	231428 231433	0.9999886751174927	O
56475	as	116 118	231434 231436	0.99998939037323	O
56476	representatives	119 134	231437 231452	0.9999874830245972	O
56477	of	135 137	231453 231455	0.9999897480010986	O
56478	mutation	138 146	231456 231464	0.9999877214431763	O
56479	analysis	147 155	231465 231473	0.9999897480010986	O
56480	.	156 157	231474 231475	0.9999792575836182	O
56481	Scaling	0 6	231476 231482	0.9999873638153076	O
56483	of	8 10	231484 231486	0.9999885559082031	O
56484	cell	11 15	231487 231491	0.9999867677688599	O
56485	counts	16 22	231492 231498	0.9999873638153076	O
56486	in	23 25	231499 231501	0.99998939037323	O
56487	each	26 30	231502 231506	0.9999898672103882	O
56488	EGFP	31 34	231507 231510	0.9999872446060181	O
56491	histogram	36 44	231512 231520	0.9999897480010986	O
56494	is	46 48	231522 231524	0.9999880790710449	O
56495	different	49 58	231525 231534	0.9999876022338867	O
56496	for	59 62	231535 231538	0.9999889135360718	O
56497	each	63 67	231539 231543	0.99998939037323	O
56498	MMR	68 70	231544 231546	0.9999872446060181	O
56500	background	72 82	231548 231558	0.9999884366989136	O
56501	.	83 84	231559 231560	0.99998939037323	O
56502	*	85 86	231561 231562	0.999988317489624	O
56503	*	86 87	231562 231563	0.9999852180480957	O
56504	IGNORE	0 5	231564 231569	0.9999854564666748	O
56507	LINE	7 10	231571 231574	0.9999874830245972	O
56510	*	12 13	231576 231577	0.9999885559082031	O
56511	*	13 14	231577 231578	0.999988317489624	O
56512	*	15 16	231579 231580	0.9999884366989136	O
56513	*	16 17	231580 231581	0.9999886751174927	O
56514	IGNORE	18 23	231582 231587	0.9999873638153076	O
56517	LINE	25 28	231589 231592	0.9999886751174927	O
56520	*	30 31	231594 231595	0.9999885559082031	O
56521	*	31 32	231595 231596	0.9999885559082031	O
56522	*	33 34	231597 231598	0.9999884366989136	O
56523	*	34 35	231598 231599	0.9999884366989136	O
56524	IGNORE	36 41	231600 231605	0.9999868869781494	O
56527	LINE	43 46	231607 231610	0.999988317489624	O
56530	*	48 49	231612 231613	0.9999885559082031	O
56531	*	49 50	231613 231614	0.9999886751174927	O
56532	Frameshift	51 60	231615 231624	0.9999885559082031	O
56536	mutation	62 70	231626 231634	0.9999887943267822	O
56537	at	71 73	231635 231637	0.9999887943267822	O
56538	coding	74 80	231638 231644	0.9999884366989136	O
56539	microsatellites	81 95	231645 231659	0.9999884366989136	O
56543	of	97 99	231661 231663	0.9999885559082031	O
56544	TGFBR2	100 105	231664 231669	0.9999879598617554	O
56549	exon	107 110	231671 231674	0.9999891519546509	O
56551	3	112 113	231676 231677	0.9999881982803345	O
56552	and	114 117	231678 231681	0.9999885559082031	O
56553	ACVR2	118 122	231682 231686	0.9999861717224121	O
56556	exon	124 127	231688 231691	0.9999889135360718	O
56558	10	129 131	231693 231695	0.999984622001648	O
56559	in	132 134	231696 231698	0.9999843835830688	O
56560	different	135 144	231699 231708	0.9999775886535645	O
56561	human	145 150	231709 231714	0.9998583793640137	O
56562	MMR	151 153	231715 231717	0.9999849796295166	O
56564	deficient	155 163	231719 231727	0.9999853372573853	O
56566	backgrounds	165 176	231729 231740	0.9999815225601196	O
56567	.	177 178	231741 231742	0.9999078512191772	O
56568	Cells	0 4	231743 231747	0.9999792575836182	O
56570	from	6 10	231749 231753	0.9999849796295166	O
56571	the	11 14	231754 231757	0.9999880790710449	O
56572	M1	15 17	231758 231760	0.9999873638153076	O
56573	and	18 21	231761 231764	0.9999881982803345	O
56574	/	21 22	231764 231765	0.9999880790710449	O
56575	or	22 24	231765 231767	0.9999878406524658	O
56576	M2	25 26	231768 231769	0.9999845027923584	O
56578	populations	28 39	231771 231782	0.9999881982803345	O
56579	of	40 42	231783 231785	0.9999885559082031	O
56580	hMLH1−	43 48	231786 231791	0.9999872446060181	O
56584	/	49 50	231792 231793	0.99998939037323	O
56585	−	51 52	231794 231795	0.9999877214431763	O
56586	TGFBR2	53 58	231796 231801	0.9999890327453613	O
56591	OF	60 62	231803 231805	0.9999892711639404	O
56592	or	63 65	231806 231808	0.9999880790710449	O
56593	ACVR2	66 70	231809 231813	0.9999890327453613	O
56596	OF	72 74	231815 231817	0.9999892711639404	O
56597	cells	75 80	231818 231823	0.9999891519546509	O
56598	,	81 82	231824 231825	0.9999889135360718	O
56599	hMSH6−	83 88	231826 231831	0.999988317489624	O
56604	/	89 90	231832 231833	0.99998939037323	O
56605	−	91 92	231834 231835	0.9999868869781494	O
56606	TGFBR2	93 98	231836 231841	0.9999892711639404	O
56611	OF	100 102	231843 231845	0.9999891519546509	O
56612	or	103 105	231846 231848	0.9999885559082031	O
56613	ACVR2	106 110	231849 231853	0.9999887943267822	O
56616	OF	112 114	231855 231857	0.9999887943267822	O
56617	cells	115 120	231858 231863	0.9999890327453613	O
56618	,	121 122	231864 231865	0.999988317489624	O
56619	and	123 126	231866 231869	0.9999892711639404	O
56620	hMSH3−	127 132	231870 231875	0.9999885559082031	O
56625	/	133 134	231876 231877	0.99998939037323	O
56626	−	135 136	231878 231879	0.9999865293502808	O
56627	TGFBR2	137 142	231880 231885	0.9999891519546509	O
56632	OF	144 146	231887 231889	0.9999889135360718	O
56633	cells	147 152	231890 231895	0.9999889135360718	O
56634	were	153 157	231896 231900	0.9999862909317017	O
56635	sorted	158 164	231901 231907	0.9999865293502808	O
56636	and	165 168	231908 231911	0.9999868869781494	O
56637	cultured	169 176	231912 231919	0.9999815225601196	O
56639	.	178 179	231921 231922	0.9999151229858398	O
56640	DNA	0 3	231923 231926	0.9999816417694092	O
56641	from	4 8	231927 231931	0.9999861717224121	O
56642	each	9 13	231932 231936	0.9999861717224121	O
56643	cell	14 18	231937 231941	0.9999799728393555	O
56644	line	19 23	231942 231946	0.9999814033508301	O
56645	was	24 27	231947 231950	0.9999864101409912	O
56646	amplified	28 36	231951 231959	0.9999874830245972	O
56648	by	38 40	231961 231963	0.9999880790710449	O
56649	PCR	41 43	231964 231966	0.9999862909317017	O
56651	,	45 46	231968 231969	0.9999874830245972	O
56652	sub	47 50	231970 231973	0.9999880790710449	O
56653	-	50 51	231973 231974	0.999988317489624	O
56654	cloned	51 56	231974 231979	0.9999874830245972	O
56656	and	58 61	231981 231984	0.9999871253967285	O
56657	all	62 65	231985 231988	0.9999885559082031	O
56658	single	66 72	231989 231995	0.9999867677688599	O
56659	cell	73 77	231996 232000	0.9999872446060181	O
56660	clones	78 83	232001 232006	0.9999877214431763	O
56662	were	85 89	232008 232012	0.9999886751174927	O
56663	individually	90 102	232013 232025	0.9999871253967285	O
56664	sequenced	103 111	232026 232034	0.9999847412109375	O
56666	to	113 115	232036 232038	0.9999881982803345	O
56667	assess	116 122	232039 232045	0.9999877214431763	O
56668	for	123 126	232046 232049	0.9999885559082031	O
56669	frameshift	127 136	232050 232059	0.9999877214431763	O
56672	mutation	138 146	232061 232069	0.9999879598617554	O
56673	of	147 149	232070 232072	0.9999884366989136	O
56674	the	150 153	232073 232076	0.9999886751174927	O
56675	coding	154 160	232077 232083	0.9999879598617554	O
56676	microsatellites	161 175	232084 232098	0.999988317489624	O
56680	of	177 179	232100 232102	0.999988317489624	O
56681	TGFBR2	180 185	232103 232108	0.9999879598617554	O
56686	exon	187 190	232110 232113	0.9999886751174927	O
56688	3	192 193	232115 232116	0.9999880790710449	O
56689	and	194 197	232117 232120	0.999988317489624	O
56690	ACVR2	198 202	232121 232125	0.9999861717224121	O
56693	exon	204 207	232127 232130	0.9999885559082031	O
56695	10	209 211	232132 232134	0.9999852180480957	O
56696	.	212 213	232135 232136	0.9999516010284424	O
56697	Sequence	0 7	232137 232144	0.999987006187439	O
56699	analysis	9 17	232146 232154	0.9999876022338867	O
56700	of	18 20	232155 232157	0.999988317489624	O
56701	DNA	21 24	232158 232161	0.9999823570251465	O
56702	clones	25 30	232162 232167	0.9999868869781494	O
56704	from	32 36	232169 232173	0.9999879598617554	O
56705	hMLH1	37 41	232174 232178	0.9999887943267822	O
56708	and	43 46	232180 232183	0.999988317489624	O
56709	hMSH6	47 51	232184 232188	0.9999886751174927	O
56713	deficiencies	53 64	232190 232201	0.9999887943267822	O
56716	revealed	66 74	232203 232211	0.9999889135360718	O
56717	mostly	75 81	232212 232218	0.9999889135360718	O
56718	1	82 83	232219 232220	0.9999890327453613	O
56719	bp	84 85	232221 232222	0.9999884366989136	O
56721	deletion	87 94	232224 232231	0.9999892711639404	O
56724	at	96 98	232233 232235	0.99998939037323	O
56725	microsatellites	99 113	232236 232250	0.9999885559082031	O
56729	(	115 116	232252 232253	0.9999898672103882	O
56730	A9	117 118	232254 232255	0.99998939037323	O
56732	for	120 123	232257 232260	0.99998939037323	O
56733	TGFBR2	124 129	232261 232266	0.9999887943267822	O
56738	or	131 133	232268 232270	0.9999889135360718	O
56739	A7	134 135	232271 232272	0.9999892711639404	O
56741	for	137 140	232274 232277	0.9999895095825195	O
56742	ACVR2	141 145	232278 232282	0.9999884366989136	O
56745	)	147 148	232284 232285	0.9999898672103882	O
56746	,	149 150	232286 232287	0.9999890327453613	O
56747	shifting	151 159	232288 232296	0.999988317489624	O
56748	the	160 163	232297 232300	0.9999897480010986	O
56749	EGFP	164 167	232301 232304	0.9999879598617554	O
56752	gene	169 173	232306 232310	0.9999891519546509	O
56753	into	174 178	232311 232315	0.9999889135360718	O
56754	the	179 182	232316 232319	0.9999896287918091	O
56755	reading	183 190	232320 232327	0.9999889135360718	O
56756	frame	191 196	232328 232333	0.9999886751174927	O
56757	and	197 200	232334 232337	0.9999887943267822	O
56758	leading	201 208	232338 232345	0.9999884366989136	O
56759	to	209 211	232346 232348	0.99998939037323	O
56760	its	212 215	232349 232352	0.99998939037323	O
56761	expression	216 226	232353 232363	0.9999880790710449	O
56762	(	227 228	232364 232365	0.9999896287918091	O
56763	A	229 230	232366 232367	0.999988317489624	O
56764	)	231 232	232368 232369	0.9999898672103882	O
56765	.	233 234	232370 232371	0.9999736547470093	O
56766	Note	0 4	232372 232376	0.9999818801879883	O
56767	that	5 9	232377 232381	0.9999891519546509	O
56768	M2	10 11	232382 232383	0.9999871253967285	O
56770	clones	13 18	232385 232390	0.999988317489624	O
56772	from	20 24	232392 232396	0.9999889135360718	O
56773	hMLH1−	25 30	232397 232402	0.9999871253967285	O
56777	/	31 32	232403 232404	0.9999889135360718	O
56778	−	33 34	232405 232406	0.9999841451644897	O
56779	TGFBR2	35 40	232407 232412	0.9999886751174927	O
56784	OF	42 44	232414 232416	0.9999885559082031	O
56785	cells	45 50	232417 232422	0.9999892711639404	O
56786	revealed	51 59	232423 232431	0.9999895095825195	O
56787	100	60 63	232432 232435	0.9999879598617554	O
56788	%	64 65	232436 232437	0.9999897480010986	O
56789	A9	66 67	232438 232439	0.9999891519546509	O
56791	/	68 69	232440 232441	0.9999892711639404	O
56792	T9	69 70	232441 232442	0.9999886751174927	O
56794	microsatellite	72 85	232444 232457	0.9999895095825195	O
56798	sequences	87 96	232459 232468	0.9999890327453613	O
56799	,	97 98	232469 232470	0.9999890327453613	O
56800	termed	99 105	232471 232477	0.9999885559082031	O
56801	a	106 107	232478 232479	0.9999895095825195	O
56802	“	108 109	232480 232481	0.9999828338623047	O
56803	full	109 113	232481 232485	0.9999890327453613	O
56804	mutant	114 120	232486 232492	0.9999892711639404	O
56805	?	121 122	232493 232494	0.9999822378158569	O
56806	whereas	0 7	232495 232502	0.9999867677688599	O
56807	M1	8 10	232503 232505	0.9999860525131226	O
56808	clones	11 16	232506 232511	0.9999871253967285	O
56810	revealed	18 26	232513 232521	0.9999877214431763	O
56811	a	27 28	232522 232523	0.9999877214431763	O
56812	mixture	29 36	232524 232531	0.9999861717224121	O
56813	of	37 39	232532 232534	0.9999876022338867	O
56814	A10	40 42	232535 232537	0.9999873638153076	O
56816	/	43 44	232538 232539	0.9999877214431763	O
56817	T10	44 46	232539 232541	0.9999871253967285	O
56819	and	48 51	232543 232546	0.9999872446060181	O
56820	A9	52 53	232547 232548	0.999987006187439	O
56822	/	54 55	232549 232550	0.9999874830245972	O
56823	T9	55 56	232550 232551	0.9999868869781494	O
56825	microsatellite	58 71	232553 232566	0.9999872446060181	O
56829	sequences	73 82	232568 232577	0.9999873638153076	O
56830	,	83 84	232578 232579	0.9999877214431763	O
56831	which	85 90	232580 232585	0.9999881982803345	O
56832	suggests	91 99	232586 232594	0.9999874830245972	O
56833	the	100 103	232595 232598	0.9999877214431763	O
56834	presence	104 112	232599 232607	0.9999878406524658	O
56835	of	113 115	232608 232610	0.9999878406524658	O
56836	an	116 118	232611 232613	0.9999878406524658	O
56837	A10	119 121	232614 232616	0.9999871253967285	O
56839	/	122 123	232617 232618	0.9999877214431763	O
56840	T9	123 124	232618 232619	0.9999867677688599	O
56842	heteroduplex	126 137	232621 232632	0.9999877214431763	O
56846	,	139 140	232634 232635	0.9999874830245972	O
56847	termed	141 147	232636 232642	0.9999864101409912	O
56848	an	148 150	232643 232645	0.9999877214431763	O
56849	“	151 152	232646 232647	0.9999827146530151	O
56850	intermediate	152 164	232647 232659	0.999987006187439	O
56851	mutant	165 171	232660 232666	0.9999872446060181	O
56852	?	172 173	232667 232668	0.9999847412109375	O
56853	(	174 175	232669 232670	0.9999357461929321	O
56854	B	0 1	232671 232672	0.9998873472213745	O
56855	)	2 3	232673 232674	0.9999758005142212	O
56856	.	4 5	232675 232676	0.9998607635498047	O
56857	To	0 2	232677 232679	0.9999831914901733	O
56858	determine	3 12	232680 232689	0.999984860420227	O
56859	the	13 16	232690 232693	0.9999880790710449	O
56860	nature	17 23	232694 232700	0.9999842643737793	O
56861	of	24 26	232701 232703	0.999987006187439	O
56862	the	27 30	232704 232707	0.9999866485595703	O
56863	mutations	31 40	232708 232717	0.9999837875366211	O
56864	observed	41 49	232718 232726	0.9999845027923584	O
56865	in	50 52	232727 232729	0.9999873638153076	O
56866	the	53 56	232730 232733	0.9999873638153076	O
56867	M1	57 59	232734 232736	0.9999843835830688	O
56868	population	60 70	232737 232747	0.9999879598617554	O
56869	,	71 72	232748 232749	0.9999866485595703	O
56870	we	73 75	232750 232752	0.9999839067459106	O
56871	analyzed	76 84	232753 232761	0.9999872446060181	O
56872	pooled	85 90	232762 232767	0.9999874830245972	O
56874	cells	92 97	232769 232774	0.9999881982803345	O
56875	as	98 100	232775 232777	0.9999871253967285	O
56876	well	101 105	232778 232782	0.9999878406524658	O
56877	as	106 108	232783 232785	0.9999881982803345	O
56878	single	109 115	232786 232792	0.9999872446060181	O
56879	cell	116 120	232793 232797	0.9999879598617554	O
56880	clones	121 126	232798 232803	0.9999886751174927	O
56882	.	128 129	232805 232806	0.9999643564224243	O
56883	In	0 2	232807 232809	0.9999886751174927	O
56884	pooled	3 8	232810 232815	0.9999841451644897	O
56886	samples	10 17	232817 232824	0.9999855756759644	O
56887	,	18 19	232825 232826	0.9999890327453613	O
56888	unlike	20 26	232827 232833	0.9999864101409912	O
56889	fully	27 32	232834 232839	0.9999872446060181	O
56890	mutant	33 39	232840 232846	0.999987006187439	O
56891	sequences	40 49	232847 232856	0.9999874830245972	O
56892	observed	50 58	232857 232865	0.9999885559082031	O
56893	in	59 61	232866 232868	0.9999887943267822	O
56894	the	62 65	232869 232872	0.9999886751174927	O
56895	M2	66 67	232873 232874	0.9999866485595703	O
56897	populations	69 80	232876 232887	0.9999879598617554	O
56898	,	81 82	232888 232889	0.9999891519546509	O
56899	M1	83 85	232890 232892	0.9999867677688599	O
56900	population	86 96	232893 232903	0.9999887943267822	O
56901	sequences	97 106	232904 232913	0.9999878406524658	O
56902	often	107 112	232914 232919	0.9999890327453613	O
56903	revealed	113 121	232920 232928	0.9999892711639404	O
56904	two	122 125	232929 232932	0.9999871253967285	O
56905	overlapping	126 137	232933 232944	0.9999874830245972	O
56906	sequences	138 147	232945 232954	0.9999876022338867	O
56907	,	148 149	232955 232956	0.9999889135360718	O
56908	suggestive	150 159	232957 232966	0.9999886751174927	O
56910	of	161 163	232968 232970	0.9999892711639404	O
56911	heteroduplexes	164 177	232971 232984	0.9999887943267822	O
56916	(	179 180	232986 232987	0.9999896287918091	O
56917	A9	181 182	232988 232989	0.9999887943267822	O
56919	/	183 184	232990 232991	0.9999891519546509	O
56920	T10	184 186	232991 232993	0.9999885559082031	O
56922	in	188 190	232995 232997	0.9999892711639404	O
56923	TGFBR2	191 196	232998 233003	0.999988317489624	O
56928	and	198 201	233005 233008	0.9999890327453613	O
56929	A7	202 203	233009 233010	0.9999885559082031	O
56931	/	204 205	233011 233012	0.9999890327453613	O
56932	T8	205 206	233012 233013	0.999988317489624	O
56934	in	208 210	233015 233017	0.9999892711639404	O
56935	ACVR2	211 215	233018 233022	0.9999877214431763	O
56938	)	217 218	233024 233025	0.9999895095825195	O
56939	(	219 220	233026 233027	0.9999892711639404	O
56940	Fig	221 223	233028 233030	0.9999856948852539	O
56942	.	225 226	233032 233033	0.9999814033508301	O
56943	5B	0 1	233034 233035	0.9999761581420898	O
56945	)	3 4	233037 233038	0.9999772310256958	O
56946	.	5 6	233039 233040	0.9998859167098999	O
56947	Single	0 6	233041 233047	0.9999858140945435	O
56948	cell	7 11	233048 233052	0.9999865293502808	O
56949	clones	12 17	233053 233058	0.9999871253967285	O
56951	revealed	19 27	233060 233068	0.9999879598617554	O
56952	the	28 31	233069 233072	0.9999889135360718	O
56953	presence	32 40	233073 233081	0.9999876022338867	O
56954	of	41 43	233082 233084	0.9999889135360718	O
56955	both	44 48	233085 233089	0.9999878406524658	O
56956	WT	49 50	233090 233091	0.9999845027923584	O
56958	and	52 55	233093 233096	0.9999885559082031	O
56959	−1	56 57	233097 233098	0.999981164932251	O
56961	bp	59 60	233100 233101	0.9999887943267822	O
56963	frameshift	62 71	233103 233112	0.9999886751174927	O
56966	mutants	73 79	233114 233120	0.9999880790710449	O
56968	(	81 82	233122 233123	0.9999879598617554	O
56969	Fig	83 85	233124 233126	0.9999853372573853	O
56971	.	87 88	233128 233129	0.9999841451644897	O
56972	5B	0 1	233130 233131	0.9999850988388062	O
56974	)	2 3	233132 233133	0.9999843835830688	O
56975	,	4 5	233134 233135	0.9999861717224121	O
56976	consistent	6 16	233136 233146	0.9999843835830688	O
56977	with	17 21	233147 233151	0.9999871253967285	O
56978	heteroduplexes	22 35	233152 233165	0.9999860525131226	O
56983	that	37 41	233167 233171	0.9999854564666748	O
56984	weakly	42 48	233172 233178	0.9999614953994751	O
56985	drive	49 54	233179 233184	0.9999806880950928	O
56986	EGFP	55 58	233185 233188	0.9999842643737793	O
56989	expression	60 70	233190 233200	0.9999854564666748	O
56990	.	71 72	233201 233202	0.9999474287033081	O
56991	Overall	0 7	233203 233210	0.9999850988388062	O
56992	,	8 9	233211 233212	0.9999886751174927	O
56993	our	10 13	233213 233216	0.9999834299087524	O
56994	data	14 18	233217 233221	0.9999858140945435	O
56995	indicate	19 27	233222 233230	0.9999865293502808	O
56996	that	28 32	233231 233235	0.9999895095825195	O
56997	hMLH1	33 37	233236 233240	0.9999881982803345	O
57000	deficiency	39 49	233242 233252	0.999988317489624	O
57001	has	50 53	233253 233256	0.9999889135360718	O
57002	the	54 57	233257 233260	0.9999895095825195	O
57003	highest	58 65	233261 233268	0.9999884366989136	O
57004	susceptibility	66 79	233269 233282	0.9999892711639404	O
57009	for	81 84	233284 233287	0.99998939037323	O
57010	frameshift	85 94	233288 233297	0.9999884366989136	O
57013	mutation	96 104	233299 233307	0.9999891519546509	O
57014	at	105 107	233308 233310	0.9999895095825195	O
57015	the	108 111	233311 233314	0.9999896287918091	O
57016	coding	112 118	233315 233321	0.9999891519546509	O
57017	microsatellites	119 133	233322 233336	0.9999892711639404	O
57021	of	135 137	233338 233340	0.99998939037323	O
57022	TGFBR2	138 143	233341 233346	0.9999891519546509	O
57027	exon	145 148	233348 233351	0.9999896287918091	O
57029	3	150 151	233353 233354	0.9999887943267822	O
57030	and	152 155	233355 233358	0.9999891519546509	O
57031	ACVR2	156 160	233359 233363	0.9999879598617554	O
57034	exon	162 165	233365 233368	0.9999896287918091	O
57036	10	167 169	233370 233372	0.9999876022338867	O
57037	of	170 172	233373 233375	0.9999895095825195	O
57038	the	173 176	233376 233379	0.9999895095825195	O
57039	three	177 182	233380 233385	0.9999858140945435	O
57040	different	183 192	233386 233395	0.9999872446060181	O
57041	MMR	193 195	233396 233398	0.9999868869781494	O
57043	deficiencies	197 208	233400 233411	0.99998939037323	O
57046	(	210 211	233413 233414	0.9999896287918091	O
57047	hMLH1−	212 217	233415 233420	0.99998939037323	O
57051	/	218 219	233421 233422	0.9999899864196777	O
57052	−	219 220	233422 233423	0.9999885559082031	O
57053	,	221 222	233424 233425	0.9999884366989136	O
57054	hMSH6−	223 228	233426 233431	0.99998939037323	O
57059	/	229 230	233432 233433	0.9999898672103882	O
57060	−	231 232	233434 233435	0.9999889135360718	O
57061	and	233 236	233436 233439	0.9999887943267822	O
57062	hMSH3−	237 242	233440 233445	0.9999890327453613	O
57067	/	243 244	233446 233447	0.9999896287918091	O
57068	−	244 245	233447 233448	0.9999873638153076	O
57069	)	246 247	233449 233450	0.9999885559082031	O
57070	.	248 249	233451 233452	0.9999688863754272	O
57071	In	0 2	233453 233455	0.9999885559082031	O
57072	addition	3 11	233456 233464	0.9999871253967285	O
57073	,	12 13	233465 233466	0.9999895095825195	O
57074	the	14 17	233467 233470	0.99998939037323	O
57075	coding	18 24	233471 233477	0.9999886751174927	O
57076	microsatellite	25 38	233478 233491	0.9999890327453613	O
57080	of	40 42	233493 233495	0.9999891519546509	O
57081	TGFBR2	43 48	233496 233501	0.9999881982803345	O
57086	exon	50 53	233503 233506	0.9999897480010986	O
57088	3	55 56	233508 233509	0.9999884366989136	O
57089	has	57 60	233510 233513	0.9999889135360718	O
57090	a	61 62	233514 233515	0.9999895095825195	O
57091	higher	63 69	233516 233522	0.9999879598617554	O
57092	susceptibility	70 83	233523 233536	0.9999892711639404	O
57097	to	85 87	233538 233540	0.9999895095825195	O
57098	a	88 89	233541 233542	0.9999897480010986	O
57099	1	90 91	233543 233544	0.9999892711639404	O
57100	bp	92 93	233545 233546	0.9999890327453613	O
57102	frameshift	95 104	233548 233557	0.9999890327453613	O
57105	mutation	106 114	233559 233567	0.9999891519546509	O
57106	than	115 119	233568 233572	0.9999890327453613	O
57107	that	120 124	233573 233577	0.9999896287918091	O
57108	of	125 127	233578 233580	0.9999895095825195	O
57109	ACVR2	128 132	233581 233585	0.9999873638153076	O
57112	exon	134 137	233587 233590	0.9999895095825195	O
57114	10	139 141	233592 233594	0.9999867677688599	O
57115	in	142 144	233595 233597	0.9999898672103882	O
57116	hMLH1	145 149	233598 233602	0.9999891519546509	O
57119	,	151 152	233604 233605	0.9999889135360718	O
57120	hMSH6	153 157	233606 233610	0.9999892711639404	O
57124	,	159 160	233612 233613	0.9999876022338867	O
57125	(	161 162	233614 233615	0.9999881982803345	O
57126	and	163 166	233616 233619	0.9999885559082031	O
57127	hMSH3	167 171	233620 233624	0.9999889135360718	O
57131	)	173 174	233626 233627	0.9999891519546509	O
57132	deficiencies	175 186	233628 233639	0.9999890327453613	O
57135	.	188 189	233641 233642	0.999975323677063	O
57136	The	0 3	233643 233646	0.9999890327453613	O
57137	frameshift	4 13	233647 233656	0.9999873638153076	O
57140	mutation	15 23	233658 233666	0.9999880790710449	O
57141	rates	24 29	233667 233672	0.9999892711639404	O
57142	at	30 32	233673 233675	0.9999891519546509	O
57143	the	33 36	233676 233679	0.9999895095825195	O
57144	coding	37 43	233680 233686	0.999988317489624	O
57145	microsatellites	44 58	233687 233701	0.9999889135360718	O
57149	of	60 62	233703 233705	0.9999891519546509	O
57150	TGFBR2	63 68	233706 233711	0.9999887943267822	O
57155	exon	70 73	233713 233716	0.9999891519546509	O
57157	3	75 76	233718 233719	0.9999885559082031	O
57158	and	77 80	233720 233723	0.9999887943267822	O
57159	ACVR2	81 85	233724 233728	0.9999880790710449	O
57162	exon	87 90	233730 233733	0.9999890327453613	O
57164	10	92 94	233735 233737	0.9999879598617554	O
57165	are	95 98	233738 233741	0.9999885559082031	O
57166	dependent	99 108	233742 233751	0.99998939037323	O
57167	on	109 111	233752 233754	0.9999895095825195	O
57168	the	112 115	233755 233758	0.9999895095825195	O
57169	MMR	116 118	233759 233761	0.9999879598617554	O
57171	background	120 130	233763 233773	0.9999891519546509	O
57172	The	131 134	233774 233777	0.9999891519546509	O
57173	M2	135 136	233778 233779	0.9999877214431763	O
57175	population	138 148	233781 233791	0.9999885559082031	O
57176	(	149 150	233792 233793	0.9999895095825195	O
57177	full	151 155	233794 233798	0.9999885559082031	O
57178	mutants	156 162	233799 233805	0.9999886751174927	O
57180	)	164 165	233807 233808	0.9999896287918091	O
57181	was	166 169	233809 233812	0.9999891519546509	O
57182	used	170 174	233813 233817	0.9999890327453613	O
57183	to	175 177	233818 233820	0.99998939037323	O
57184	calculate	178 187	233821 233830	0.9999878406524658	O
57185	the	188 191	233831 233834	0.99998939037323	O
57186	mutation	192 200	233835 233843	0.9999879598617554	O
57187	rates	201 206	233844 233849	0.9999892711639404	O
57188	at	207 209	233850 233852	0.9999890327453613	O
57189	microsatellites	210 224	233853 233867	0.9999886751174927	O
57193	of	226 228	233869 233871	0.9999890327453613	O
57194	TGFBR2	229 234	233872 233877	0.9999887943267822	O
57199	exon	236 239	233879 233882	0.9999890327453613	O
57201	3	241 242	233884 233885	0.9999885559082031	O
57202	and	243 246	233886 233889	0.9999890327453613	O
57203	ACVR2	247 251	233890 233894	0.999988317489624	O
57206	exon	253 256	233896 233899	0.9999889135360718	O
57208	10	258 260	233901 233903	0.9999880790710449	O
57209	by	261 263	233904 233906	0.9999892711639404	O
57210	the	264 267	233907 233910	0.99998939037323	O
57211	“	268 269	233911 233912	0.9999830722808838	O
57212	method	269 275	233912 233918	0.9999887943267822	O
57213	of	276 278	233919 233921	0.9999890327453613	O
57214	the	279 282	233922 233925	0.9999891519546509	O
57215	mean	283 287	233926 233930	0.9999867677688599	O
57216	?	288 289	233931 233932	0.9999867677688599	O
57217	[	290 291	233933 233934	0.9999779462814331	O
57218	28	0 2	233934 233936	0.9999765157699585	O
57219	]	3 4	233937 233938	0.9999760389328003	O
57220	(	5 6	233939 233940	0.9999852180480957	O
57221	Table	7 12	233941 233946	0.9999799728393555	O
57222	1	13 14	233947 233948	0.9999830722808838	O
57223	)	15 16	233949 233950	0.9999858140945435	O
57224	.	17 18	233951 233952	0.9999583959579468	O
57225	A	0 1	233953 233954	0.9999892711639404	O
57226	single	2 8	233955 233961	0.9999872446060181	O
57227	mutation	9 17	233962 233970	0.999987006187439	O
57228	rate	18 22	233971 233975	0.9999886751174927	O
57229	was	23 26	233976 233979	0.9999890327453613	O
57230	calculated	27 37	233980 233990	0.9999877214431763	O
57231	by	38 40	233991 233993	0.99998939037323	O
57232	taking	41 47	233994 234000	0.9999890327453613	O
57233	a	48 49	234001 234002	0.9999897480010986	O
57234	weighted	50 58	234003 234011	0.9999889135360718	O
57235	average	59 66	234012 234019	0.9999876022338867	O
57236	of	67 69	234020 234022	0.9999891519546509	O
57237	the	70 73	234023 234026	0.9999895095825195	O
57238	mutation	74 82	234027 234035	0.9999878406524658	O
57239	rates	83 88	234036 234041	0.9999892711639404	O
57240	at	89 91	234042 234044	0.9999895095825195	O
57241	the	92 95	234045 234048	0.9999897480010986	O
57242	different	96 105	234049 234058	0.9999878406524658	O
57243	time	106 110	234059 234063	0.9999886751174927	O
57244	points	111 117	234064 234070	0.9999886751174927	O
57245	,	118 119	234071 234072	0.9999881982803345	O
57246	the	120 123	234073 234076	0.99998939037323	O
57247	weights	124 131	234077 234084	0.9999877214431763	O
57248	of	132 134	234085 234087	0.9999887943267822	O
57249	which	135 140	234088 234093	0.9999890327453613	O
57250	were	141 145	234094 234098	0.9999890327453613	O
57251	chosen	146 152	234099 234105	0.9999887943267822	O
57252	to	153 155	234106 234108	0.9999895095825195	O
57253	minimize	156 164	234109 234117	0.9999885559082031	O
57254	the	165 168	234118 234121	0.9999895095825195	O
57255	variance	169 177	234122 234130	0.99998939037323	O
57256	of	178 180	234131 234133	0.99998939037323	O
57257	the	181 184	234134 234137	0.99998939037323	O
57258	estimate	185 193	234138 234146	0.9999876022338867	O
57259	as	194 196	234147 234149	0.9999887943267822	O
57260	previously	197 207	234150 234160	0.9999885559082031	O
57261	described	208 217	234161 234170	0.9999884366989136	O
57262	[	218 219	234171 234172	0.9999891519546509	O
57263	25	219 221	234172 234174	0.999984622001648	O
57264	]	221 222	234174 234175	0.9999886751174927	O
57265	.	223 224	234176 234177	0.9999798536300659	O
57266	As	0 2	234178 234180	0.9999877214431763	O
57267	predicted	3 12	234181 234190	0.9999866485595703	O
57268	,	13 14	234191 234192	0.9999889135360718	O
57269	the	15 18	234193 234196	0.9999890327453613	O
57270	mutation	19 27	234197 234205	0.9999879598617554	O
57271	rate	28 32	234206 234210	0.9999887943267822	O
57272	at	33 35	234211 234213	0.9999889135360718	O
57273	the	36 39	234214 234217	0.99998939037323	O
57274	microsatellite	40 53	234218 234231	0.9999887943267822	O
57278	of	55 57	234233 234235	0.9999889135360718	O
57279	TGFBR2	58 63	234236 234241	0.9999890327453613	O
57284	in	65 67	234243 234245	0.9999896287918091	O
57285	the	68 71	234246 234249	0.99998939037323	O
57286	hMLH1−	72 77	234250 234255	0.9999884366989136	O
57290	/	78 79	234256 234257	0.9999896287918091	O
57291	−	80 81	234258 234259	0.9999874830245972	O
57292	background	82 92	234260 234270	0.9999892711639404	O
57293	was	93 96	234271 234274	0.99998939037323	O
57294	highest	97 104	234275 234282	0.999988317489624	O
57295	:	105 106	234283 234284	0.9999891519546509	O
57296	5	107 108	234285 234286	0.9999886751174927	O
57297	.	108 109	234286 234287	0.9999895095825195	O
57298	91×10−4±1	109 117	234287 234295	0.9999889135360718	O
57305	.	118 119	234296 234297	0.9999891519546509	O
57306	26×10−4	119 125	234297 234303	0.9999878406524658	O
57311	.	127 128	234305 234306	0.9999798536300659	O
57312	Mutation	0 7	234307 234314	0.9999880790710449	O
57314	at	9 11	234316 234318	0.9999891519546509	O
57315	the	12 15	234319 234322	0.9999896287918091	O
57316	A10	16 18	234323 234325	0.9999886751174927	O
57318	microsatellite	20 33	234327 234340	0.9999895095825195	O
57322	of	35 37	234342 234344	0.9999895095825195	O
57323	TGFBR2	38 43	234345 234350	0.9999886751174927	O
57328	is	45 47	234352 234354	0.9999890327453613	O
57329	[UNK]	48 50	234355 234357	0.9999852180480957	O
57330	times	51 56	234358 234363	0.9999885559082031	O
57331	more	57 61	234364 234368	0.9999886751174927	O
57332	frequent	62 70	234369 234377	0.9999889135360718	O
57333	than	71 75	234378 234382	0.9999889135360718	O
57334	mutation	76 84	234383 234391	0.9999886751174927	O
57335	at	85 87	234392 234394	0.9999895095825195	O
57336	the	88 91	234395 234398	0.9999896287918091	O
57337	A8	92 93	234399 234400	0.9999885559082031	O
57339	microsatellite	95 108	234402 234415	0.99998939037323	O
57343	of	110 112	234417 234419	0.9999896287918091	O
57344	ACVR2	113 117	234420 234424	0.9999884366989136	O
57347	in	119 121	234426 234428	0.9999896287918091	O
57348	hMLH1	122 126	234429 234433	0.9999881982803345	O
57351	deficiency	128 138	234435 234445	0.9999889135360718	O
57352	(	139 140	234446 234447	0.9999895095825195	O
57353	P	141 142	234448 234449	0.9999895095825195	O
57354	<	142 143	234449 234450	0.9999891519546509	O
57355	0	143 144	234450 234451	0.99998939037323	O
57356	.	144 145	234451 234452	0.9999892711639404	O
57357	01	145 147	234452 234454	0.9999886751174927	O
57358	)	148 149	234455 234456	0.9999895095825195	O
57359	.	150 151	234457 234458	0.9999735355377197	O
57360	In	0 2	234459 234461	0.9999885559082031	O
57361	addition	3 11	234462 234470	0.9999871253967285	O
57362	,	12 13	234471 234472	0.9999895095825195	O
57363	mutation	14 22	234473 234481	0.9999878406524658	O
57364	at	23 25	234482 234484	0.99998939037323	O
57365	the	26 29	234485 234488	0.9999898672103882	O
57366	microsatellite	30 43	234489 234502	0.9999889135360718	O
57370	of	45 47	234504 234506	0.9999895095825195	O
57371	TGFBR2	48 53	234507 234512	0.9999886751174927	O
57376	is	55 57	234514 234516	0.99998939037323	O
57377	[UNK]	58 60	234517 234519	0.9999853372573853	O
57378	times	61 66	234520 234525	0.9999889135360718	O
57379	higher	67 73	234526 234532	0.9999887943267822	O
57380	than	74 78	234533 234537	0.99998939037323	O
57381	mutation	79 87	234538 234546	0.9999884366989136	O
57382	at	88 90	234547 234549	0.9999895095825195	O
57383	the	91 94	234550 234553	0.9999896287918091	O
57384	microsatellite	95 108	234554 234567	0.9999889135360718	O
57388	of	110 112	234569 234571	0.9999895095825195	O
57389	ACVR2	113 117	234572 234576	0.9999881982803345	O
57392	in	119 121	234578 234580	0.9999897480010986	O
57393	hMSH6	122 126	234581 234585	0.9999885559082031	O
57397	deficiency	128 138	234587 234597	0.9999884366989136	O
57398	.	139 140	234598 234599	0.9999784231185913	O
57399	Furthermore	0 11	234600 234611	0.999983549118042	O
57400	,	12 13	234612 234613	0.9999887943267822	O
57401	mutations	14 23	234614 234623	0.999985933303833	O
57402	at	24 26	234624 234626	0.9999887943267822	O
57403	the	27 30	234627 234630	0.9999891519546509	O
57404	microsatellites	31 45	234631 234645	0.9999885559082031	O
57408	of	47 49	234647 234649	0.9999884366989136	O
57409	TGFBR2	50 55	234650 234655	0.9999879598617554	O
57414	and	57 60	234657 234660	0.9999884366989136	O
57415	ACVR2	61 65	234661 234665	0.9999865293502808	O
57418	are	67 70	234667 234670	0.9999890327453613	O
57419	[UNK]	71 74	234671 234674	0.9999849796295166	O
57420	–	74 75	234674 234675	0.9999825954437256	O
57421	15	75 77	234675 234677	0.9999858140945435	O
57422	times	78 83	234678 234683	0.999988317489624	O
57423	higher	84 90	234684 234690	0.9999874830245972	O
57424	in	91 93	234691 234693	0.9999896287918091	O
57425	hMLH1	94 98	234694 234698	0.9999887943267822	O
57428	deficiency	100 110	234700 234710	0.9999895095825195	O
57429	than	111 115	234711 234715	0.9999885559082031	O
57430	in	116 118	234716 234718	0.9999896287918091	O
57431	hMSH6	119 123	234719 234723	0.9999890327453613	O
57435	deficiency	125 135	234725 234735	0.9999895095825195	O
57436	(	136 137	234736 234737	0.9999895095825195	O
57437	P	138 139	234738 234739	0.9999891519546509	O
57438	<	139 140	234739 234740	0.9999890327453613	O
57439	0	140 141	234740 234741	0.99998939037323	O
57440	.	141 142	234741 234742	0.9999891519546509	O
57441	01	142 144	234742 234744	0.9999884366989136	O
57442	)	145 146	234745 234746	0.99998939037323	O
57443	.	147 148	234747 234748	0.999976396560669	O
57444	Mutation	0 7	234749 234756	0.9999865293502808	O
57446	rates	9 14	234758 234763	0.999988317489624	O
57447	from	15 19	234764 234768	0.9999887943267822	O
57448	hMSH3−	20 25	234769 234774	0.9999887943267822	O
57453	/	26 27	234775 234776	0.9999890327453613	O
57454	−	28 29	234777 234778	0.9999843835830688	O
57455	and	30 33	234779 234782	0.9999879598617554	O
57456	MMR	34 36	234783 234785	0.9999876022338867	O
57458	-	37 38	234786 234787	0.9999896287918091	O
57459	proficient	38 47	234787 234796	0.999988317489624	O
57461	cell	49 53	234798 234802	0.9999881982803345	O
57462	lines	54 59	234803 234808	0.9999886751174927	O
57463	were	60 64	234809 234813	0.9999889135360718	O
57464	not	65 68	234814 234817	0.9999884366989136	O
57465	calculated	69 79	234818 234828	0.9999867677688599	O
57466	due	80 83	234829 234832	0.9999892711639404	O
57467	to	84 86	234833 234835	0.9999896287918091	O
57468	a	87 88	234836 234837	0.9999895095825195	O
57469	lack	89 93	234838 234842	0.9999890327453613	O
57470	of	94 96	234843 234845	0.99998939037323	O
57471	net	97 100	234846 234849	0.9999886751174927	O
57472	fluorescent	101 112	234850 234861	0.9999874830245972	O
57473	M2	113 114	234862 234863	0.9999891519546509	O
57475	populations	116 127	234865 234876	0.99998939037323	O
57476	.	128 129	234877 234878	0.9999755620956421	O
57477	These	0 5	234879 234884	0.9999868869781494	O
57478	data	6 10	234885 234889	0.9999862909317017	O
57479	confirm	11 18	234890 234897	0.999985933303833	O
57480	that	19 23	234898 234902	0.9999890327453613	O
57481	hMLH1	24 28	234903 234907	0.999987006187439	O
57484	deficiency	30 40	234909 234919	0.9999878406524658	O
57485	allows	41 47	234920 234926	0.9999876022338867	O
57486	a	48 49	234927 234928	0.9999887943267822	O
57487	higher	50 56	234929 234935	0.9999881982803345	O
57488	susceptibility	57 70	234936 234949	0.9999885559082031	O
57493	for	72 75	234951 234954	0.9999889135360718	O
57494	mutation	76 84	234955 234963	0.9999878406524658	O
57495	at	85 87	234964 234966	0.9999884366989136	O
57496	the	88 91	234967 234970	0.9999889135360718	O
57497	coding	92 98	234971 234977	0.999988317489624	O
57498	microsatellites	99 113	234978 234992	0.999988317489624	O
57502	of	115 117	234994 234996	0.9999886751174927	O
57503	TGFBR2	118 123	234997 235002	0.9999884366989136	O
57508	exon	125 128	235004 235007	0.9999885559082031	O
57510	3	130 131	235009 235010	0.9999874830245972	O
57511	and	132 135	235011 235014	0.9999886751174927	O
57512	ACVR2	136 140	235015 235019	0.9999880790710449	O
57515	exon	142 145	235021 235024	0.9999886751174927	O
57517	10	147 149	235026 235028	0.9999871253967285	O
57518	than	150 154	235029 235033	0.9999885559082031	O
57519	hMSH6	155 159	235034 235038	0.9999881982803345	O
57523	and	161 164	235040 235043	0.9999879598617554	O
57524	hMSH3	165 169	235044 235048	0.9999874830245972	O
57528	deficiencies	171 182	235050 235061	0.999988317489624	O
57531	,	184 185	235063 235064	0.9999880790710449	O
57532	and	186 189	235065 235068	0.9999880790710449	O
57533	that	190 194	235069 235073	0.9999892711639404	O
57534	TGFBR2	195 200	235074 235079	0.9999881982803345	O
57539	exon	202 205	235081 235084	0.9999886751174927	O
57541	3	207 208	235086 235087	0.9999876022338867	O
57542	has	209 212	235088 235091	0.9999886751174927	O
57543	a	213 214	235092 235093	0.9999887943267822	O
57544	higher	215 221	235094 235100	0.9999881982803345	O
57545	susceptibility	222 235	235101 235114	0.9999884366989136	O
57550	to	237 239	235116 235118	0.9999887943267822	O
57551	mutation	240 248	235119 235127	0.9999876022338867	O
57552	at	249 251	235128 235130	0.999988317489624	O
57553	its	252 255	235131 235134	0.9999887943267822	O
57554	coding	256 262	235135 235141	0.9999881982803345	O
57555	microsatellite	263 276	235142 235155	0.999988317489624	O
57559	over	278 282	235157 235161	0.9999886751174927	O
57560	ACVR2	283 287	235162 235166	0.9999884366989136	O
57563	exon	289 292	235168 235171	0.9999885559082031	O
57565	10	294 296	235173 235175	0.999987006187439	O
57566	in	297 299	235176 235178	0.9999890327453613	O
57567	both	300 304	235179 235183	0.9999877214431763	O
57568	hMLH1	305 309	235184 235188	0.9999878406524658	O
57571	and	311 314	235190 235193	0.999988317489624	O
57572	hMSH6	315 319	235194 235198	0.9999877214431763	O
57576	deficiencies	321 332	235200 235211	0.9999884366989136	O
57579	.	334 335	235213 235214	0.9999885559082031	O
57580	*	336 337	235215 235216	0.999987006187439	O
57581	*	337 338	235216 235217	0.9999771118164062	O
57582	IGNORE	0 5	235218 235223	0.9999867677688599	O
57585	LINE	7 10	235225 235228	0.9999887943267822	O
57588	*	12 13	235230 235231	0.9999890327453613	O
57589	*	13 14	235231 235232	0.9999890327453613	O
57590	*	15 16	235233 235234	0.9999890327453613	O
57591	*	16 17	235234 235235	0.9999891519546509	O
57592	IGNORE	18 23	235236 235241	0.9999880790710449	O
57595	LINE	25 28	235243 235246	0.9999892711639404	O
57598	*	30 31	235248 235249	0.9999889135360718	O
57599	*	31 32	235249 235250	0.9999889135360718	O
57600	*	33 34	235251 235252	0.9999887943267822	O
57601	*	34 35	235252 235253	0.9999887943267822	O
57602	IGNORE	36 41	235254 235259	0.9999876022338867	O
57605	LINE	43 46	235261 235264	0.9999890327453613	O
57608	*	48 49	235266 235267	0.9999890327453613	O
57609	*	49 50	235267 235268	0.9999890327453613	O
57610	As	51 53	235269 235271	0.9999876022338867	O
57611	we	54 56	235272 235274	0.9999887943267822	O
57612	hypothesized	57 68	235275 235286	0.9999890327453613	O
57617	,	70 71	235288 235289	0.9999890327453613	O
57618	the	72 75	235290 235293	0.9999895095825195	O
57619	mutational	76 85	235294 235303	0.9999872446060181	O
57621	frequencies	87 98	235305 235316	0.9999885559082031	O
57622	and	99 102	235317 235320	0.9999887943267822	O
57623	rates	103 108	235321 235326	0.9999878406524658	O
57624	of	109 111	235327 235329	0.99998939037323	O
57625	TGFBR2	112 117	235330 235335	0.9999887943267822	O
57630	exon	119 122	235337 235340	0.99998939037323	O
57632	3	124 125	235342 235343	0.9999884366989136	O
57633	and	126 129	235344 235347	0.9999891519546509	O
57634	ACVR2	130 134	235348 235352	0.9999874830245972	O
57637	exon	136 139	235354 235357	0.9999892711639404	O
57639	10	141 143	235359 235361	0.999987006187439	O
57640	microsatellites	144 158	235362 235376	0.9999887943267822	O
57644	are	160 163	235378 235381	0.9999889135360718	O
57645	dependent	164 173	235382 235391	0.9999892711639404	O
57646	on	174 176	235392 235394	0.9999896287918091	O
57647	the	177 180	235395 235398	0.9999896287918091	O
57648	MMR	181 183	235399 235401	0.9999871253967285	O
57650	deficient	185 193	235403 235411	0.9999890327453613	O
57652	background	195 205	235413 235423	0.9999887943267822	O
57653	with	206 210	235424 235428	0.9999892711639404	O
57654	hMLH1−	211 216	235429 235434	0.9999890327453613	O
57658	/	217 218	235435 235436	0.9999896287918091	O
57659	−	218 219	235436 235437	0.9999881982803345	O
57660	>	219 220	235437 235438	0.9999891519546509	O
57661	hMSH6−	220 225	235438 235443	0.9999891519546509	O
57666	/	226 227	235444 235445	0.9999895095825195	O
57667	−	227 228	235445 235446	0.9999885559082031	O
57668	>	228 229	235446 235447	0.9999891519546509	O
57669	hMSH3−	229 234	235447 235452	0.9999889135360718	O
57674	/	235 236	235453 235454	0.99998939037323	O
57675	−	236 237	235454 235455	0.9999866485595703	O
57676	.	238 239	235456 235457	0.9999759197235107	O
57677	As	0 2	235458 235460	0.9999773502349854	O
57678	TGFBR2	3 8	235461 235466	0.9999837875366211	O
57683	and	10 13	235468 235471	0.9999855756759644	O
57684	ACVR2	14 18	235472 235476	0.9999821186065674	O
57687	mutations	20 29	235478 235487	0.9999847412109375	O
57688	may	30 33	235488 235491	0.9999858140945435	O
57689	drive	34 39	235492 235497	0.9999786615371704	O
57690	the	40 43	235498 235501	0.9999881982803345	O
57691	pathogenesis	44 55	235502 235513	0.9999872446060181	O
57694	of	57 59	235515 235517	0.9999865293502808	O
57695	colorectal	60 69	235518 235527	0.9999817609786987	O
57698	cancers	71 77	235529 235535	0.9999836683273315	O
57700	,	79 80	235537 235538	0.9999856948852539	O
57701	our	81 84	235539 235542	0.9999797344207764	O
57702	human	85 90	235543 235548	0.5384297966957092	species
57703	data	91 95	235549 235553	0.9999796152114868	O
57704	is	96 98	235554 235556	0.9999871253967285	O
57705	consistent	99 109	235557 235567	0.9999864101409912	O
57706	with	110 114	235568 235572	0.9999878406524658	O
57707	the	115 118	235573 235576	0.9999876022338867	O
57708	virulence	119 127	235577 235585	0.9999872446060181	O
57712	of	129 131	235587 235589	0.9999868869781494	O
57713	tumor	132 137	235590 235595	0.9999841451644897	O
57714	formation	138 147	235596 235605	0.9999836683273315	O
57715	in	148 150	235606 235608	0.9999861717224121	O
57716	Lynch	151 156	235609 235614	0.9999754428863525	O
57717	syndrome	157 165	235615 235623	0.9999862909317017	O
57718	.	166 167	235624 235625	0.9999674558639526	O
57719	Patients	0 7	235626 235633	0.999983549118042	O
57721	with	9 13	235635 235639	0.9999876022338867	O
57722	germline	14 21	235640 235647	0.9999886751174927	O
57726	mutation	23 31	235649 235657	0.9999873638153076	O
57727	in	32 34	235658 235660	0.9999885559082031	O
57728	hMLH1	35 39	235661 235665	0.9999877214431763	O
57731	may	41 44	235667 235670	0.9999836683273315	O
57732	present	45 52	235671 235678	0.9999853372573853	O
57733	with	53 57	235679 235683	0.9999858140945435	O
57734	cancer	58 64	235684 235690	0.9999843835830688	O
57735	at	65 67	235691 235693	0.999988317489624	O
57736	younger	68 75	235694 235701	0.9999854564666748	O
57737	ages	76 80	235702 235706	0.9999866485595703	O
57738	compared	81 89	235707 235715	0.9999876022338867	O
57739	to	90 92	235716 235718	0.9999876022338867	O
57740	those	93 98	235719 235724	0.9999878406524658	O
57741	with	99 103	235725 235729	0.9999884366989136	O
57742	a	104 105	235730 235731	0.999988317489624	O
57743	hMSH6	106 110	235732 235736	0.9999880790710449	O
57747	germline	112 119	235738 235745	0.9999887943267822	O
57751	mutation	121 129	235747 235755	0.9999886751174927	O
57752	[	130 131	235756 235757	0.9999891519546509	O
57753	29	131 133	235757 235759	0.9999868869781494	O
57754	]	133 134	235759 235760	0.9999889135360718	O
57755	.	135 136	235761 235762	0.9999730587005615	O
57756	Data	0 4	235763 235767	0.9999874830245972	O
57757	on	5 7	235768 235770	0.9999891519546509	O
57758	mutation	8 16	235771 235779	0.9999867677688599	O
57759	rates	17 22	235780 235785	0.9999886751174927	O
57760	for	23 26	235786 235789	0.9999892711639404	O
57761	TGFBR2	27 32	235790 235795	0.9999873638153076	O
57766	exon	34 37	235797 235800	0.9999899864196777	O
57768	3	39 40	235802 235803	0.9999886751174927	O
57769	and	41 44	235804 235807	0.9999892711639404	O
57770	ACVR2	45 49	235808 235812	0.9999852180480957	O
57773	exon	51 54	235814 235817	0.9999898672103882	O
57775	10	56 58	235819 235821	0.9999885559082031	O
57776	(	59 60	235822 235823	0.9999898672103882	O
57777	Table	61 66	235824 235829	0.9999871253967285	O
57778	1	67 68	235830 235831	0.9999891519546509	O
57779	)	69 70	235832 235833	0.9999899864196777	O
57780	showed	71 77	235834 235840	0.9999871253967285	O
57781	similar	78 85	235841 235848	0.9999861717224121	O
57782	results	86 93	235849 235856	0.9999889135360718	O
57783	.	94 95	235857 235858	0.9999817609786987	O
57784	hMLH1−	0 5	235859 235864	0.9999881982803345	O
57788	/	6 7	235865 235866	0.9999890327453613	O
57789	−	8 9	235867 235868	0.9999853372573853	O
57790	TGFBR2	10 15	235869 235874	0.9999884366989136	O
57795	showed	17 23	235876 235882	0.9999885559082031	O
57796	the	24 27	235883 235886	0.99998939037323	O
57797	highest	28 35	235887 235894	0.9999885559082031	O
57798	mutation	36 44	235895 235903	0.9999880790710449	O
57799	rate	45 49	235904 235908	0.99998939037323	O
57800	at	50 52	235909 235911	0.99998939037323	O
57801	its	53 56	235912 235915	0.9999896287918091	O
57802	coding	57 63	235916 235922	0.9999892711639404	O
57803	microsatellite	64 77	235923 235936	0.9999892711639404	O
57807	sequence	79 87	235938 235946	0.9999891519546509	O
57808	(	88 89	235947 235948	0.9999896287918091	O
57809	5	90 91	235949 235950	0.9999887943267822	O
57810	.	91 92	235950 235951	0.9999895095825195	O
57811	91×10−4	92 98	235951 235957	0.9999889135360718	O
57816	)	100 101	235959 235960	0.9999897480010986	O
57817	.	102 103	235961 235962	0.9999762773513794	O
57818	This	0 4	235963 235967	0.9999880790710449	O
57819	mutation	5 13	235968 235976	0.999987006187439	O
57820	rate	14 18	235977 235981	0.9999880790710449	O
57821	is	19 21	235982 235984	0.9999884366989136	O
57822	similar	22 29	235985 235992	0.9999871253967285	O
57823	to	30 32	235993 235995	0.9999891519546509	O
57824	that	33 37	235996 236000	0.9999892711639404	O
57825	calculated	38 48	236001 236011	0.9999841451644897	O
57826	for	49 52	236012 236015	0.99998939037323	O
57827	noncoding	53 61	236016 236024	0.9999890327453613	O
57830	(	63 64	236026 236027	0.9999897480010986	O
57831	CA	65 67	236028 236030	0.9999891519546509	O
57832	)	67 68	236030 236031	0.9999896287918091	O
57833	13	68 70	236031 236033	0.9999886751174927	O
57834	microsatellites	71 85	236034 236048	0.9999890327453613	O
57838	in	87 89	236050 236052	0.9999891519546509	O
57839	hMLH1−	90 95	236053 236058	0.9999884366989136	O
57843	/	96 97	236059 236060	0.9999891519546509	O
57844	−	98 99	236061 236062	0.9999862909317017	O
57845	cells	100 105	236063 236068	0.9999890327453613	O
57846	[	106 107	236069 236070	0.9999896287918091	O
57847	25	107 109	236070 236072	0.9999873638153076	O
57848	]	109 110	236072 236073	0.99998939037323	O
57849	,	111 112	236074 236075	0.9999889135360718	O
57850	suggesting	113 123	236076 236086	0.9999886751174927	O
57851	that	124 128	236087 236091	0.9999897480010986	O
57852	this	129 133	236092 236096	0.9999895095825195	O
57853	coding	134 140	236097 236103	0.9999887943267822	O
57854	A10	141 143	236104 236106	0.9999889135360718	O
57856	and	145 148	236108 236111	0.9999886751174927	O
57857	the	149 152	236112 236115	0.9999891519546509	O
57858	noncoding	153 161	236116 236124	0.9999887943267822	O
57861	(	163 164	236126 236127	0.9999896287918091	O
57862	CA	165 167	236128 236130	0.9999887943267822	O
57863	)	167 168	236130 236131	0.9999895095825195	O
57864	13	168 170	236131 236133	0.9999878406524658	O
57865	microsatellites	171 185	236134 236148	0.9999889135360718	O
57869	are	187 190	236150 236153	0.9999886751174927	O
57870	equally	191 198	236154 236161	0.9999809265136719	O
57871	vulnerable	199 209	236162 236172	0.9999852180480957	O
57872	to	210 212	236173 236175	0.9999881982803345	O
57873	hMLH1	213 217	236176 236180	0.9999873638153076	O
57876	deficiency	219 229	236182 236192	0.9999871253967285	O
57877	.	230 231	236193 236194	0.9999755620956421	O
57878	The	0 3	236195 236198	0.9999880790710449	O
57879	mutation	4 12	236199 236207	0.9999858140945435	O
57880	rate	13 17	236208 236212	0.9999878406524658	O
57881	for	18 21	236213 236216	0.9999887943267822	O
57882	TGFBR2	22 27	236217 236222	0.9999858140945435	O
57887	was	29 32	236224 236227	0.9999884366989136	O
57888	3	33 34	236228 236229	0.9999850988388062	O
57889	fold	35 39	236230 236234	0.9999884366989136	O
57890	higher	40 46	236235 236241	0.9999878406524658	O
57891	than	47 51	236242 236246	0.9999891519546509	O
57892	that	52 56	236247 236251	0.9999895095825195	O
57893	for	57 60	236252 236255	0.9999895095825195	O
57894	ACVR2	61 65	236256 236260	0.999987006187439	O
57897	in	67 69	236262 236264	0.9999897480010986	O
57898	both	70 74	236265 236269	0.9999871253967285	O
57899	hMLH1	75 79	236270 236274	0.9999887943267822	O
57902	(	81 82	236276 236277	0.9999898672103882	O
57903	5	83 84	236278 236279	0.9999890327453613	O
57904	.	84 85	236279 236280	0.9999897480010986	O
57905	91×10−4	85 91	236280 236286	0.9999892711639404	O
57910	)	93 94	236288 236289	0.9999896287918091	O
57911	and	95 98	236290 236293	0.9999884366989136	O
57912	hMSH6	99 103	236294 236298	0.9999887943267822	O
57916	(	105 106	236300 236301	0.9999898672103882	O
57917	0	107 108	236302 236303	0.99998939037323	O
57918	.	108 109	236303 236304	0.9999895095825195	O
57919	54×10−4	109 115	236304 236310	0.9999850988388062	O
57924	)	117 118	236312 236313	0.9999895095825195	O
57925	deficiencies	119 130	236314 236325	0.9999889135360718	O
57928	.	132 133	236327 236328	0.9999748468399048	O
57929	The	0 3	236329 236332	0.9999890327453613	O
57930	rapid	4 9	236333 236338	0.9999880790710449	O
57931	rate	10 14	236339 236343	0.9999886751174927	O
57932	for	15 18	236344 236347	0.9999887943267822	O
57933	TGFBR2	19 24	236348 236353	0.9999881982803345	O
57938	mutation	26 34	236355 236363	0.9999881982803345	O
57939	with	35 39	236364 236368	0.9999881982803345	O
57940	MMR	40 42	236369 236371	0.9999873638153076	O
57942	deficiency	44 54	236373 236383	0.9999885559082031	O
57943	might	55 60	236384 236389	0.9999871253967285	O
57944	be	61 63	236390 236392	0.99998939037323	O
57945	due	64 67	236393 236396	0.9999895095825195	O
57946	partly	68 74	236397 236403	0.9999886751174927	O
57947	to	75 77	236404 236406	0.9999896287918091	O
57948	TGFBR2	78 83	236407 236412	0.9999890327453613	O
57953	'	85 86	236414 236415	0.99998939037323	O
57954	s	86 87	236415 236416	0.9999896287918091	O
57955	longer	88 94	236417 236423	0.9999891519546509	O
57956	polyadenine	95 105	236424 236434	0.9999895095825195	O
57960	tract	107 112	236436 236441	0.99998939037323	O
57961	compared	113 121	236442 236450	0.9999895095825195	O
57962	to	122 124	236451 236453	0.9999896287918091	O
57963	ACVR2	125 129	236454 236458	0.9999879598617554	O
57966	,	131 132	236460 236461	0.9999885559082031	O
57967	as	133 135	236462 236464	0.9999887943267822	O
57968	longer	136 142	236465 236471	0.9999889135360718	O
57969	microsatellite	143 156	236472 236485	0.9999886751174927	O
57973	tracts	158 164	236487 236493	0.999988317489624	O
57974	mutate	165 170	236494 236499	0.9999890327453613	O
57977	more	172 176	236501 236505	0.9999885559082031	O
57978	frequently	177 187	236506 236516	0.9999890327453613	O
57979	in	188 190	236517 236519	0.99998939037323	O
57980	MMR	191 193	236520 236522	0.9999868869781494	O
57982	deficiency	195 205	236524 236534	0.9999885559082031	O
57983	[	206 207	236535 236536	0.9999892711639404	O
57984	7	207 208	236536 236537	0.9999872446060181	O
57985	]	208 209	236537 236538	0.9999890327453613	O
57986	.	210 211	236539 236540	0.999976634979248	O
57987	In	0 2	236541 236543	0.9999862909317017	O
57988	the	3 6	236544 236547	0.9999872446060181	O
57989	case	7 11	236548 236552	0.9999861717224121	O
57990	of	12 14	236553 236555	0.9999887943267822	O
57991	ACVR2	15 19	236556 236560	0.999983549118042	O
57994	exon	21 24	236562 236565	0.9999897480010986	O
57996	10	26 28	236567 236569	0.9999849796295166	O
57997	,	29 30	236570 236571	0.9999886751174927	O
57998	even	31 35	236572 236576	0.9999880790710449	O
57999	though	36 42	236577 236583	0.9999873638153076	O
58000	the	43 46	236584 236587	0.9999891519546509	O
58001	mutation	47 55	236588 236596	0.9999879598617554	O
58002	rate	56 60	236597 236601	0.9999886751174927	O
58003	is	61 63	236602 236604	0.9999889135360718	O
58004	slower	64 70	236605 236611	0.9999872446060181	O
58005	than	71 75	236612 236616	0.9999892711639404	O
58006	TGFBR2	76 81	236617 236622	0.9999884366989136	O
58011	exon	83 86	236624 236627	0.9999896287918091	O
58013	3	88 89	236629 236630	0.9999879598617554	O
58014	,	90 91	236631 236632	0.9999878406524658	O
58015	ultimately	92 102	236633 236643	0.9999873638153076	O
58016	fully	103 108	236644 236649	0.9999879598617554	O
58017	mutant	109 115	236650 236656	0.9999885559082031	O
58018	clones	116 121	236657 236662	0.9999886751174927	O
58020	accumulate	123 132	236664 236673	0.9999891519546509	O
58024	.	134 135	236675 236676	0.9999743700027466	O
58025	The	0 3	236677 236680	0.9999891519546509	O
58026	rapid	4 9	236681 236686	0.9999885559082031	O
58027	rate	10 14	236687 236691	0.9999886751174927	O
58028	for	15 18	236692 236695	0.9999892711639404	O
58029	TGFBR2	19 24	236696 236701	0.9999880790710449	O
58034	exon	26 29	236703 236706	0.9999897480010986	O
58036	3	31 32	236708 236709	0.9999874830245972	O
58037	mutation	33 41	236710 236718	0.9999892711639404	O
58038	is	42 44	236719 236721	0.9999891519546509	O
58039	probably	45 53	236722 236730	0.99998939037323	O
58040	most	54 58	236731 236735	0.9999887943267822	O
58041	reflective	59 69	236736 236746	0.9999839067459106	O
58042	in	70 72	236747 236749	0.99998939037323	O
58043	the	73 76	236750 236753	0.9999892711639404	O
58044	M1	77 79	236754 236756	0.999987006187439	O
58045	population	80 90	236757 236767	0.9999876022338867	O
58046	,	91 92	236768 236769	0.9999880790710449	O
58047	as	93 95	236770 236772	0.999988317489624	O
58048	there	96 101	236773 236778	0.9999895095825195	O
58049	is	102 104	236779 236781	0.9999895095825195	O
58050	a	105 106	236782 236783	0.9999896287918091	O
58051	rapid	107 112	236784 236789	0.9999886751174927	O
58052	heteroduplex	113 124	236790 236801	0.99998939037323	O
58056	formation	126 135	236803 236812	0.9999892711639404	O
58057	particularly	136 148	236813 236825	0.9999887943267822	O
58058	in	149 151	236826 236828	0.9999896287918091	O
58059	hMLH1	152 156	236829 236833	0.999988317489624	O
58062	deficiency	158 168	236835 236845	0.9999891519546509	O
58063	,	169 170	236846 236847	0.9999886751174927	O
58064	followed	171 179	236848 236856	0.9999877214431763	O
58065	by	180 182	236857 236859	0.99998939037323	O
58066	full	183 187	236860 236864	0.9999856948852539	O
58067	mutation	188 196	236865 236873	0.9999879598617554	O
58068	.	197 198	236874 236875	0.9999716281890869	O
58069	In	0 2	236876 236878	0.9999856948852539	O
58070	ACVR2	3 7	236879 236883	0.9999725818634033	O
58073	exon	9 12	236885 236888	0.9999876022338867	O
58075	10	14 16	236890 236892	0.9999786615371704	O
58076	,	17 18	236893 236894	0.9999856948852539	O
58077	heteroduplex	19 30	236895 236906	0.9999858140945435	O
58081	formation	32 41	236908 236917	0.9999856948852539	O
58082	is	42 44	236918 236920	0.9999836683273315	O
58083	relatively	45 55	236921 236931	0.9999818801879883	O
58084	slower	56 62	236932 236938	0.9999710321426392	O
58085	.	63 64	236939 236940	0.9999476671218872	O
58086	With	0 4	236941 236945	0.9999847412109375	O
58087	both	5 9	236946 236950	0.9999871253967285	O
58088	TGFBR2	10 15	236951 236956	0.9999873638153076	O
58093	and	17 20	236958 236961	0.9999878406524658	O
58094	ACVR2	21 25	236962 236966	0.9999849796295166	O
58097	constructs	27 36	236968 236977	0.9999866485595703	O
58099	,	38 39	236979 236980	0.9999884366989136	O
58100	heteroduplex	40 51	236981 236992	0.9999885559082031	O
58104	formation	53 62	236994 237003	0.9999889135360718	O
58105	and	63 66	237004 237007	0.9999881982803345	O
58106	subsequent	67 77	237008 237018	0.999984860420227	O
58107	full	78 82	237019 237023	0.9999877214431763	O
58108	mutation	83 91	237024 237032	0.9999877214431763	O
58109	are	92 95	237033 237036	0.9999878406524658	O
58110	slower	96 102	237037 237043	0.9999853372573853	O
58111	in	103 105	237044 237046	0.99998939037323	O
58112	the	106 109	237047 237050	0.99998939037323	O
58113	hMSH6−	110 115	237051 237056	0.9999890327453613	O
58118	/	116 117	237057 237058	0.9999896287918091	O
58119	−	118 119	237059 237060	0.9999879598617554	O
58120	background	120 130	237061 237071	0.9999895095825195	O
58121	compared	131 139	237072 237080	0.9999884366989136	O
58122	to	140 142	237081 237083	0.9999890327453613	O
58123	hMLH1−	143 148	237084 237089	0.9999886751174927	O
58127	/	149 150	237090 237091	0.9999895095825195	O
58128	−	151 152	237092 237093	0.9999866485595703	O
58129	background	153 163	237094 237104	0.9999891519546509	O
58130	.	164 165	237105 237106	0.9999703168869019	O
58131	It	0 2	237107 237109	0.9999880790710449	O
58132	has	3 6	237110 237113	0.9999868869781494	O
58133	been	7 11	237114 237118	0.9999876022338867	O
58134	shown	12 17	237119 237124	0.9999854564666748	O
58135	that	18 22	237125 237129	0.9999889135360718	O
58136	MSH6	23 26	237130 237133	0.999988317489624	O
58139	and	28 31	237135 237138	0.9999879598617554	O
58140	MSH3	32 35	237139 237142	0.999988317489624	O
58143	are	37 40	237144 237147	0.999988317489624	O
58144	redundant	41 50	237148 237157	0.9999833106994629	O
58145	in	51 53	237158 237160	0.999988317489624	O
58146	regard	54 60	237161 237167	0.9999873638153076	O
58147	to	61 63	237168 237170	0.9999884366989136	O
58148	frameshift	64 73	237171 237180	0.9999877214431763	O
58151	mutagenesis	75 85	237182 237192	0.9999879598617554	O
58154	in	87 89	237194 237196	0.9999887943267822	O
58155	a	90 91	237197 237198	0.9999880790710449	O
58156	yeast	92 97	237199 237204	0.9993389248847961	O
58157	model	98 103	237205 237210	0.9999862909317017	O
58158	[	104 105	237211 237212	0.9999891519546509	O
58159	30	105 107	237212 237214	0.9999856948852539	O
58160	]	107 108	237214 237215	0.9999890327453613	O
58161	,	109 110	237216 237217	0.9999889135360718	O
58162	which	111 116	237218 237223	0.99998939037323	O
58163	supports	117 125	237224 237232	0.9999879598617554	O
58164	our	126 129	237233 237236	0.9999871253967285	O
58165	finding	130 137	237237 237244	0.9999872446060181	O
58166	that	138 142	237245 237249	0.99998939037323	O
58167	hMSH6	143 147	237250 237254	0.9999880790710449	O
58171	and	149 152	237256 237259	0.9999879598617554	O
58172	hMSH3	153 157	237260 237264	0.9999877214431763	O
58176	defects	159 166	237266 237273	0.9999868869781494	O
58177	have	167 171	237274 237278	0.9999879598617554	O
58178	much	172 176	237279 237283	0.9999871253967285	O
58179	lower	177 182	237284 237289	0.9999831914901733	O
58180	frameshift	183 192	237290 237299	0.9999878406524658	O
58183	mutation	194 202	237301 237309	0.9999872446060181	O
58184	rates	203 208	237310 237315	0.9999874830245972	O
58185	than	209 213	237316 237320	0.9999884366989136	O
58186	the	214 217	237321 237324	0.9999881982803345	O
58187	hMLH1	218 222	237325 237329	0.9999872446060181	O
58190	defect	224 230	237331 237337	0.999988317489624	O
58191	that	231 235	237338 237342	0.9999887943267822	O
58192	completely	236 246	237343 237353	0.9999876022338867	O
58193	eliminates	247 256	237354 237363	0.9999877214431763	O
58195	MMR	258 260	237365 237367	0.9999873638153076	O
58197	.	261 262	237368 237369	0.9999738931655884	O
58198	Lower	0 5	237370 237375	0.9999878406524658	O
58199	frameshift	6 15	237376 237385	0.9999880790710449	O
58202	mutation	17 25	237387 237395	0.9999889135360718	O
58203	rate	26 30	237396 237400	0.99998939037323	O
58204	in	31 33	237401 237403	0.9999897480010986	O
58205	hMSH6	34 38	237404 237408	0.9999887943267822	O
58209	deficiency	40 50	237410 237420	0.999988317489624	O
58210	would	51 56	237421 237426	0.9999880790710449	O
58211	logically	57 65	237427 237435	0.9999864101409912	O
58213	predict	67 74	237437 237444	0.9999892711639404	O
58214	a	75 76	237445 237446	0.9999896287918091	O
58215	lower	77 82	237447 237452	0.9999880790710449	O
58216	penetrance	83 92	237453 237462	0.9999892711639404	O
58219	in	94 96	237464 237466	0.9999897480010986	O
58220	Lynch	97 102	237467 237472	0.9999818801879883	O
58221	syndrome	103 111	237473 237481	0.9999887943267822	O
58222	for	112 115	237482 237485	0.9999881982803345	O
58223	which	116 121	237486 237491	0.99998939037323	O
58224	no	122 124	237492 237494	0.9999887943267822	O
58225	germline	125 132	237495 237502	0.9999890327453613	O
58229	hMSH3	134 138	237504 237508	0.9999890327453613	O
58233	mutation	140 148	237510 237518	0.9999890327453613	O
58234	has	149 152	237519 237522	0.9999891519546509	O
58235	been	153 157	237523 237527	0.9999889135360718	O
58236	reported	158 166	237528 237536	0.9999880790710449	O
58237	.	167 168	237537 237538	0.9999788999557495	O
58238	In	0 2	237539 237541	0.9999880790710449	O
58239	summary	3 10	237542 237549	0.9999843835830688	O
58240	,	11 12	237550 237551	0.9999878406524658	O
58241	we	13 15	237552 237554	0.9999830722808838	O
58242	established	16 27	237555 237566	0.9999796152114868	O
58243	and	28 31	237567 237570	0.9999843835830688	O
58244	utilized	32 40	237571 237579	0.9999788999557495	O
58245	a	41 42	237580 237581	0.9999874830245972	O
58246	cell	43 47	237582 237586	0.9999512434005737	O
58247	model	48 53	237587 237592	0.999982476234436	O
58248	in	54 56	237593 237595	0.9999876022338867	O
58249	which	57 62	237596 237601	0.999988317489624	O
58250	actual	63 69	237602 237608	0.9999861717224121	O
58251	human	70 75	237609 237614	0.9999858140945435	O
58252	coding	76 82	237615 237621	0.9999886751174927	O
58253	microsatellite	83 96	237622 237635	0.9999885559082031	O
58257	sequences	98 107	237637 237646	0.9999876022338867	O
58258	of	108 110	237647 237649	0.9999886751174927	O
58259	TGFBR2	111 116	237650 237655	0.9999884366989136	O
58264	exon	118 121	237657 237660	0.99998939037323	O
58266	3	123 124	237662 237663	0.9999884366989136	O
58267	and	125 128	237664 237667	0.999988317489624	O
58268	ACVR2	129 133	237668 237672	0.9999865293502808	O
58271	exon	135 138	237674 237677	0.9999892711639404	O
58273	10	140 142	237679 237681	0.9999866485595703	O
58274	were	143 147	237682 237686	0.9999884366989136	O
58275	evaluated	148 157	237687 237696	0.9999881982803345	O
58276	in	158 160	237697 237699	0.9999890327453613	O
58277	real	161 165	237700 237704	0.999988317489624	O
58278	time	166 170	237705 237709	0.9999886751174927	O
58279	for	171 174	237710 237713	0.9999884366989136	O
58280	frameshift	175 184	237714 237723	0.9999878406524658	O
58283	mutation	186 194	237725 237733	0.999988317489624	O
58284	in	195 197	237734 237736	0.9999889135360718	O
58285	different	198 207	237737 237746	0.9999861717224121	O
58286	human	208 213	237747 237752	0.9999560117721558	O
58287	MMR	214 216	237753 237755	0.9999868869781494	O
58289	backgrounds	218 229	237757 237768	0.9999856948852539	O
58290	.	230 231	237769 237770	0.9999597072601318	O
58291	hMLH1	0 4	237771 237775	0.9999858140945435	O
58294	deficiency	6 16	237777 237787	0.9999860525131226	O
58295	confers	17 23	237788 237794	0.9999855756759644	O
58297	a	25 26	237796 237797	0.999988317489624	O
58298	significantly	27 40	237798 237811	0.999985933303833	O
58299	higher	41 47	237812 237818	0.9999852180480957	O
58300	mutation	48 56	237819 237827	0.9999864101409912	O
58301	rate	57 61	237828 237832	0.9999880790710449	O
58302	at	62 64	237833 237835	0.9999884366989136	O
58303	the	65 68	237836 237839	0.9999890327453613	O
58304	coding	69 75	237840 237846	0.9999885559082031	O
58305	microsatellites	76 90	237847 237861	0.9999890327453613	O
58309	of	92 94	237863 237865	0.9999887943267822	O
58310	TGFBR2	95 100	237866 237871	0.9999884366989136	O
58315	and	102 105	237873 237876	0.9999886751174927	O
58316	ACVR2	106 110	237877 237881	0.9999874830245972	O
58319	compared	112 120	237883 237891	0.9999878406524658	O
58320	to	121 123	237892 237894	0.9999889135360718	O
58321	hMSH6	124 128	237895 237899	0.9999889135360718	O
58325	and	130 133	237901 237904	0.9999884366989136	O
58326	hMSH3	134 138	237905 237909	0.9999884366989136	O
58330	deficiencies	140 151	237911 237922	0.9999886751174927	O
58333	.	153 154	237924 237925	0.9999532699584961	O
58334	In	0 2	237926 237928	0.9999871253967285	O
58335	addition	3 11	237929 237937	0.999984860420227	O
58336	,	12 13	237938 237939	0.9999885559082031	O
58337	TGFBR2	14 19	237940 237945	0.9999858140945435	O
58342	mutates	21 27	237947 237953	0.9999877214431763	O
58345	at	29 31	237955 237957	0.9999884366989136	O
58346	a	32 33	237958 237959	0.9999891519546509	O
58347	higher	34 40	237960 237966	0.9999872446060181	O
58348	rate	41 45	237967 237971	0.9999877214431763	O
58349	than	46 50	237972 237976	0.9999885559082031	O
58350	ACVR2	51 55	237977 237981	0.9999864101409912	O
58353	in	57 59	237983 237985	0.9999887943267822	O
58354	both	60 64	237986 237990	0.9999860525131226	O
58355	hMLH1	65 69	237991 237995	0.9999885559082031	O
58358	and	71 74	237997 238000	0.9999879598617554	O
58359	hMSH6	75 79	238001 238005	0.9999881982803345	O
58363	deficiencies	81 92	238007 238018	0.9999891519546509	O
58366	.	94 95	238020 238021	0.9999662637710571	O
58367	These	0 5	238022 238027	0.9999853372573853	O
58368	bona	6 9	238028 238031	0.9999860525131226	O
58370	-	10 11	238032 238033	0.9999871253967285	O
58371	fide	11 14	238033 238036	0.9999866485595703	O
58373	human	16 21	238038 238043	0.9998977184295654	O
58374	genes	22 27	238044 238049	0.9999852180480957	O
58375	targeted	28 36	238050 238058	0.9999853372573853	O
58376	for	37 40	238059 238062	0.9999872446060181	O
58377	mutation	41 49	238063 238071	0.9999852180480957	O
58378	in	50 52	238072 238074	0.9999873638153076	O
58379	MMR	53 55	238075 238077	0.9999836683273315	O
58381	deficiency	57 67	238079 238089	0.9999853372573853	O
58382	mutate	68 73	238090 238095	0.9999860525131226	O
58385	at	75 77	238097 238099	0.9999872446060181	O
58386	differing	78 87	238100 238109	0.9999802112579346	O
58387	rates	88 93	238110 238115	0.9999850988388062	O
58388	,	94 95	238116 238117	0.9999792575836182	O
58389	and	96 99	238118 238121	0.9999819993972778	O
58390	lose	100 104	238122 238126	0.9999781847000122	O
58391	expression	105 115	238127 238137	0.9999871253967285	O
58392	of	116 118	238138 238140	0.9999873638153076	O
58393	their	119 124	238141 238146	0.9999867677688599	O
58394	encoded	125 132	238147 238154	0.9999856948852539	O
58395	proteins	133 141	238155 238163	0.9999847412109375	O
58396	in	142 144	238164 238166	0.9999845027923584	O
58397	colonic	145 151	238167 238173	0.9999771118164062	O
58400	neoplastic	153 162	238175 238184	0.9999854564666748	O
58403	cells	164 169	238186 238191	0.9999822378158569	O
58404	.	170 171	238192 238193	0.9999253749847412	O
58405	Understanding	0 13	238194 238207	0.9999840259552002	O
58406	these	14 19	238208 238213	0.9999867677688599	O
58407	targeted	20 28	238214 238222	0.9999780654907227	O
58408	genes	29 34	238223 238228	0.9999829530715942	O
58409	in	35 37	238229 238231	0.999984622001648	O
58410	MMR	38 40	238232 238234	0.9999819993972778	O
58412	deficiency	42 52	238236 238246	0.9999798536300659	O
58413	has	53 56	238247 238250	0.9999805688858032	O
58414	implications	57 69	238251 238263	0.999982476234436	O
58415	in	70 72	238264 238266	0.9999849796295166	O
58416	understanding	73 86	238267 238280	0.999981164932251	O
58417	the	87 90	238281 238284	0.9999852180480957	O
58418	pathogenesis	91 102	238285 238296	0.9999841451644897	O
58421	of	104 106	238298 238300	0.9999843835830688	O
58422	MSI	107 109	238301 238303	0.999976396560669	O
58424	colorectal	111 120	238305 238314	0.9999804496765137	O
58427	tumors	122 128	238316 238322	0.9999827146530151	O
58428	.	129 130	238323 238324	0.9999383687973022	O
58429	Pedigree	0 7	238325 238332	0.9999817609786987	O
58433	for	9 12	238334 238337	0.9999860525131226	O
58434	Family	13 19	238338 238344	0.9999761581420898	O
58435	#	20 21	238345 238346	0.9999878406524658	O
58436	3	22 23	238347 238348	0.9999831914901733	O
58437	(	24 25	238349 238350	0.9999874830245972	O
58438	CRC	26 28	238351 238353	0.9999847412109375	O
58440	:	30 31	238355 238356	0.999988317489624	O
58441	Colorectal	32 41	238357 238366	0.9999865293502808	O
58444	cancer	43 49	238368 238374	0.9999879598617554	O
58445	;	50 51	238375 238376	0.9999884366989136	O
58446	ESC	52 54	238377 238379	0.9999849796295166	O
58448	:	56 57	238381 238382	0.9999884366989136	O
58449	Oesophageal	58 68	238383 238393	0.9999828338623047	O
58454	cancer	70 76	238395 238401	0.9999881982803345	O
58455	;	77 78	238402 238403	0.9999881982803345	O
58456	LC	79 80	238404 238405	0.9999843835830688	O
58458	:	82 83	238407 238408	0.9999881982803345	O
58459	Lung	84 87	238409 238412	0.9999799728393555	O
58461	cancer	89 95	238414 238420	0.9999877214431763	O
58462	)	96 97	238421 238422	0.9999880790710449	O
58463	.	98 99	238423 238424	0.999969482421875	O
58464	Of	0 2	238425 238427	0.999984860420227	O
58465	the	3 6	238428 238431	0.9999834299087524	O
58466	17	7 9	238432 238434	0.9998965263366699	O
58467	CRC	10 12	238435 238437	0.9999704360961914	O
58469	patients	14 22	238439 238447	0.99997878074646	O
58470	with	23 27	238448 238452	0.9999868869781494	O
58471	the	28 31	238453 238456	0.9999881982803345	O
58472	Lys618Ala	32 40	238457 238465	0.9999872446060181	O
58478	variant	42 49	238467 238474	0.9999868869781494	O
58479	,	50 51	238475 238476	0.9999867677688599	O
58480	two	52 55	238477 238480	0.9999796152114868	O
58481	had	56 59	238481 238484	0.999988317489624	O
58482	MSI	60 62	238485 238487	0.9999840259552002	O
58484	(	64 65	238489 238490	0.9999892711639404	O
58485	11	66 68	238491 238493	0.9999847412109375	O
58486	.	68 69	238493 238494	0.999988317489624	O
58487	8	69 70	238494 238495	0.9999867677688599	O
58488	%	71 72	238496 238497	0.9999890327453613	O
58489	)	73 74	238498 238499	0.9999892711639404	O
58490	,	75 76	238500 238501	0.9999881982803345	O
58491	one	77 80	238502 238505	0.9999868869781494	O
58492	in	81 83	238506 238508	0.9999885559082031	O
58493	the	84 87	238509 238512	0.9999884366989136	O
58494	familial	88 95	238513 238520	0.9999855756759644	O
58497	CRC	97 99	238522 238524	0.999984860420227	O
58499	group	101 106	238526 238531	0.9999885559082031	O
58500	(	107 108	238532 238533	0.9999892711639404	O
58501	1	109 110	238534 238535	0.9999881982803345	O
58502	/	110 111	238535 238536	0.9999887943267822	O
58503	8	111 112	238536 238537	0.9999862909317017	O
58504	)	113 114	238538 238539	0.9999891519546509	O
58505	and	115 118	238540 238543	0.9999874830245972	O
58506	one	119 122	238544 238547	0.999987006187439	O
58507	in	123 125	238548 238550	0.999988317489624	O
58508	the	126 129	238551 238554	0.9999879598617554	O
58509	sporadic	130 137	238555 238562	0.9999866485595703	O
58511	CRC	139 141	238564 238566	0.9999845027923584	O
58513	group	143 148	238568 238573	0.9999884366989136	O
58514	(	149 150	238574 238575	0.9999890327453613	O
58515	1	151 152	238576 238577	0.9999878406524658	O
58516	/	152 153	238577 238578	0.9999885559082031	O
58517	9	153 154	238578 238579	0.999983549118042	O
58518	)	155 156	238580 238581	0.9999889135360718	O
58519	.	157 158	238582 238583	0.9999533891677856	O
58520	The	0 3	238584 238587	0.999984622001648	O
58521	MSI	4 6	238588 238590	0.9999825954437256	O
58523	-	7 8	238591 238592	0.9999885559082031	O
58524	positive	8 16	238592 238600	0.9999856948852539	O
58525	patient	17 24	238601 238608	0.9999786615371704	O
58526	from	25 29	238609 238613	0.9999843835830688	O
58527	the	30 33	238614 238617	0.9999856948852539	O
58528	familial	34 41	238618 238625	0.9999790191650391	O
58531	CRC	43 45	238627 238629	0.9999760389328003	O
58533	group	47 52	238631 238636	0.9999858140945435	O
58534	showed	53 59	238637 238643	0.9999864101409912	O
58535	loss	60 64	238644 238648	0.9999867677688599	O
58536	of	65 67	238649 238651	0.9999886751174927	O
58537	immunohistochemical	68 86	238652 238670	0.9999886751174927	O
58543	expression	88 98	238672 238682	0.9999887943267822	O
58544	of	99 101	238683 238685	0.9999887943267822	O
58545	MLH1	102 105	238686 238689	0.9999874830245972	O
58548	.	107 108	238691 238692	0.9999712705612183	O
58549	This	0 4	238693 238697	0.999988317489624	O
58550	is	5 7	238698 238700	0.9999887943267822	O
58551	the	8 11	238701 238704	0.9999891519546509	O
58552	index	12 17	238705 238710	0.9999874830245972	O
58553	subject	18 25	238711 238718	0.999987006187439	O
58554	(	26 27	238719 238720	0.9999895095825195	O
58555	II	28 30	238721 238723	0.9999862909317017	O
58556	-	30 31	238723 238724	0.99998939037323	O
58557	3	31 32	238724 238725	0.9999877214431763	O
58558	)	33 34	238726 238727	0.9999896287918091	O
58559	for	35 38	238728 238731	0.9999889135360718	O
58560	the	39 42	238732 238735	0.9999895095825195	O
58561	third	43 48	238736 238741	0.9999873638153076	O
58562	family	49 55	238742 238748	0.9999866485595703	O
58563	(	56 57	238749 238750	0.99998939037323	O
58564	Figure	58 64	238751 238757	0.9999880790710449	O
58565	4	65 66	238758 238759	0.9999889135360718	O
58566	)	67 68	238760 238761	0.9999895095825195	O
58567	and	69 72	238762 238765	0.9999890327453613	O
58568	no	73 75	238766 238768	0.9999892711639404	O
58569	hypermethylation	76 91	238769 238784	0.9999892711639404	O
58574	of	93 95	238786 238788	0.9999892711639404	O
58575	MLH1	96 99	238789 238792	0.9999880790710449	O
58578	gene	101 105	238794 238798	0.9999892711639404	O
58579	promoter	106 114	238799 238807	0.99998939037323	O
58580	;	115 116	238808 238809	0.9999892711639404	O
58581	no	117 119	238810 238812	0.9999892711639404	O
58582	BRAF	120 123	238813 238816	0.9999861717224121	O
58584	p	125 126	238818 238819	0.99998939037323	O
58585	.	126 127	238819 238820	0.9999806880950928	O
58586	Val600Glu	0 8	238820 238828	0.9999840259552002	O
58591	mutation	10 18	238830 238838	0.9999839067459106	O
58592	were	19 23	238839 238843	0.9999822378158569	O
58593	detected	24 32	238844 238852	0.9999852180480957	O
58594	in	33 35	238853 238855	0.9999839067459106	O
58595	this	36 40	238856 238860	0.9999804496765137	O
58596	case	41 45	238861 238865	0.9999797344207764	O
58597	.	46 47	238866 238867	0.99991774559021	O
58598	As	0 2	238868 238870	0.9999785423278809	O
58599	most	3 7	238871 238875	0.9999842643737793	O
58600	disease	8 15	238876 238883	0.9999743700027466	O
58601	pedigrees	16 24	238884 238892	0.9999880790710449	O
58606	are	26 29	238894 238897	0.9999836683273315	O
58607	small	30 35	238898 238903	0.9999819993972778	O
58608	,	36 37	238904 238905	0.9999821186065674	O
58609	it	38 40	238906 238908	0.9999860525131226	O
58610	is	41 43	238909 238911	0.9999842643737793	O
58611	difficult	44 53	238912 238921	0.9999816417694092	O
58612	to	54 56	238922 238924	0.999985933303833	O
58613	obtain	57 63	238925 238931	0.9999867677688599	O
58614	a	64 65	238932 238933	0.9999884366989136	O
58615	sufficient	66 76	238934 238944	0.9999867677688599	O
58616	number	77 83	238945 238951	0.9999876022338867	O
58617	of	84 86	238952 238954	0.9999879598617554	O
58618	samples	87 94	238955 238962	0.9999861717224121	O
58619	from	95 99	238963 238967	0.999988317489624	O
58620	affected	100 108	238968 238976	0.9999878406524658	O
58621	and	109 112	238977 238980	0.9999861717224121	O
58622	informative	113 123	238981 238991	0.999987006187439	O
58624	unaffected	125 134	238993 239002	0.9999873638153076	O
58627	individuals	136 147	239004 239015	0.9999852180480957	O
58628	.	148 149	239016 239017	0.9999558925628662	O
58629	Moreover	0 8	239018 239026	0.9999706745147705	O
58630	,	9 10	239027 239028	0.9999852180480957	O
58631	LS	11 12	239029 239030	0.9999730587005615	O
58633	deleterious	14 24	239032 239042	0.9999864101409912	O
58636	variants	26 34	239044 239052	0.9999847412109375	O
58637	are	35 38	239053 239056	0.999982476234436	O
58638	not	39 42	239057 239060	0.9999818801879883	O
58639	completely	43 53	239061 239071	0.9999843835830688	O
58640	penetrant	54 62	239072 239080	0.9999847412109375	O
58643	.	64 65	239082 239083	0.9999239444732666	O
58644	For	0 3	239084 239087	0.9999746084213257	O
58645	these	4 9	239088 239093	0.9999829530715942	O
58646	reasons	10 17	239094 239101	0.9999834299087524	O
58647	,	18 19	239102 239103	0.9999825954437256	O
58648	it	20 22	239104 239106	0.9999850988388062	O
58649	is	23 25	239107 239109	0.9999840259552002	O
58650	rarely	26 32	239110 239116	0.9999768733978271	O
58651	possible	33 41	239117 239125	0.9999850988388062	O
58652	to	42 44	239126 239128	0.9999864101409912	O
58653	categorize	45 54	239129 239138	0.9999877214431763	O
58657	variants	56 64	239140 239148	0.9999850988388062	O
58658	as	65 67	239149 239151	0.9999865293502808	O
58659	deleterious	68 78	239152 239162	0.9999880790710449	O
58662	based	80 85	239164 239169	0.9999885559082031	O
58663	on	86 88	239170 239172	0.9999889135360718	O
58664	segregation	89 100	239173 239184	0.9999872446060181	O
58665	alone	101 106	239185 239190	0.9999886751174927	O
58666	.	107 108	239191 239192	0.9999550580978394	O
58667	The	0 3	239193 239196	0.9999871253967285	O
58668	co	4 6	239197 239199	0.9999873638153076	O
58669	-	6 7	239199 239200	0.9999881982803345	O
58670	occurrence	7 17	239200 239210	0.9999880790710449	O
58671	of	18 20	239211 239213	0.9999885559082031	O
58672	another	21 28	239214 239221	0.999985933303833	O
58673	known	29 34	239222 239227	0.999981164932251	O
58674	deleterious	35 45	239228 239238	0.9999876022338867	O
58677	variant	47 54	239240 239247	0.9999874830245972	O
58678	reduces	55 62	239248 239255	0.9999779462814331	O
58679	the	63 66	239256 239259	0.9999879598617554	O
58680	likelihood	67 77	239260 239270	0.9999861717224121	O
58681	that	78 82	239271 239275	0.9999885559082031	O
58682	an	83 85	239276 239278	0.9999887943267822	O
58683	UV	86 88	239279 239281	0.9999833106994629	O
58684	is	89 91	239282 239284	0.9999891519546509	O
58685	truly	92 97	239285 239290	0.9999865293502808	O
58686	deleterious	98 108	239291 239301	0.9999884366989136	O
58689	,	110 111	239303 239304	0.9999879598617554	O
58690	especially	112 122	239305 239315	0.999988317489624	O
58691	when	123 127	239316 239320	0.9999886751174927	O
58692	both	128 132	239321 239325	0.9999842643737793	O
58693	variants	133 141	239326 239334	0.9999874830245972	O
58694	are	142 145	239335 239338	0.9999890327453613	O
58695	located	146 153	239339 239346	0.9999890327453613	O
58696	in	154 156	239347 239349	0.9999892711639404	O
58697	trans	157 162	239350 239355	0.9999889135360718	O
58698	[	163 164	239356 239357	0.9999895095825195	O
58699	3	164 165	239357 239358	0.9999881982803345	O
58700	]	165 166	239358 239359	0.9999889135360718	O
58701	.	167 168	239360 239361	0.9999755620956421	O
58702	To	0 2	239362 239364	0.999982476234436	O
58703	our	3 6	239365 239368	0.9999855756759644	O
58704	knowledge	7 16	239369 239378	0.9999865293502808	O
58705	,	17 18	239379 239380	0.9999866485595703	O
58706	co	19 21	239381 239383	0.9999871253967285	O
58707	-	21 22	239383 239384	0.999988317489624	O
58708	occurrence	22 32	239384 239394	0.9999880790710449	O
58709	of	33 35	239395 239397	0.9999881982803345	O
58710	a	36 37	239398 239399	0.999988317489624	O
58711	deleterious	38 48	239400 239410	0.999987006187439	O
58714	variant	50 57	239412 239419	0.9999876022338867	O
58715	in	58 60	239420 239422	0.9999885559082031	O
58716	one	61 64	239423 239426	0.9999884366989136	O
58717	of	65 67	239427 239429	0.9999884366989136	O
58718	the	68 71	239430 239433	0.999988317489624	O
58719	LS	72 73	239434 239435	0.999983549118042	O
58721	genes	75 80	239437 239442	0.9999876022338867	O
58722	with	81 85	239443 239447	0.9999862909317017	O
58723	the	86 89	239448 239451	0.9999878406524658	O
58724	p	90 91	239452 239453	0.9999866485595703	O
58725	.	91 92	239453 239454	0.9999768733978271	O
58726	Lys618Ala	0 8	239454 239462	0.999984860420227	O
58732	variant	10 17	239464 239471	0.9999831914901733	O
58733	has	18 21	239472 239475	0.999982476234436	O
58734	been	22 26	239476 239480	0.9999853372573853	O
58735	observed	27 35	239481 239489	0.9999827146530151	O
58736	in	36 38	239490 239492	0.9999847412109375	O
58737	only	39 43	239493 239497	0.999982476234436	O
58738	two	44 47	239498 239501	0.999971866607666	O
58739	families	48 56	239502 239510	0.9999656677246094	O
58740	.	57 58	239511 239512	0.9999299049377441	O
58741	Liu	0 3	239513 239516	0.9999498128890991	O
58742	et	4 6	239517 239519	0.9999867677688599	O
58743	al	7 9	239520 239522	0.9999861717224121	O
58744	[	10 11	239523 239524	0.9999880790710449	O
58745	14	11 13	239524 239526	0.9999839067459106	O
58746	]	13 14	239526 239527	0.9999866485595703	O
58747	described	15 24	239528 239537	0.999987006187439	O
58748	an	25 27	239538 239540	0.9999886751174927	O
58749	index	28 33	239541 239546	0.9999845027923584	O
58750	subject	34 41	239547 239554	0.9999797344207764	O
58751	from	42 46	239555 239559	0.9999853372573853	O
58752	a	47 48	239560 239561	0.9999878406524658	O
58753	LS	49 50	239562 239563	0.9999816417694092	O
58755	family	52 58	239565 239571	0.9999799728393555	O
58756	with	59 63	239572 239576	0.9999886751174927	O
58757	two	64 67	239577 239580	0.999985933303833	O
58758	heterozygous	68 79	239581 239592	0.9999868869781494	O
58763	variants	81 89	239594 239602	0.9999873638153076	O
58764	(	90 91	239603 239604	0.9999892711639404	O
58765	c	92 93	239605 239606	0.9999887943267822	O
58766	.	93 94	239606 239607	0.9999891519546509	O
58767	546	94 96	239607 239609	0.999987006187439	O
58769	-	97 98	239610 239611	0.9999891519546509	O
58770	2A	98 99	239611 239612	0.9999872446060181	O
58772	>	100 101	239613 239614	0.9999884366989136	O
58773	G	101 102	239614 239615	0.9999874830245972	O
58774	and	103 106	239616 239619	0.9999886751174927	O
58775	c	107 108	239620 239621	0.9999886751174927	O
58776	.	108 109	239621 239622	0.9999891519546509	O
58777	1852	109 113	239622 239626	0.9999868869781494	O
58778	_	113 114	239626 239627	0.9999886751174927	O
58779	1853AA	114 119	239627 239632	0.9999868869781494	O
58781	>	120 121	239633 239634	0.9999884366989136	O
58782	GC	121 122	239634 239635	0.9999877214431763	O
58784	)	124 125	239637 239638	0.99998939037323	O
58785	;	126 127	239639 239640	0.9999880790710449	O
58786	only	128 132	239641 239645	0.9999881982803345	O
58787	the	133 136	239646 239649	0.9999890327453613	O
58788	former	137 143	239650 239656	0.9999845027923584	O
58789	segregated	144 154	239657 239667	0.9999860525131226	O
58790	with	155 159	239668 239672	0.9999879598617554	O
58791	LS	160 161	239673 239674	0.9999850988388062	O
58793	in	163 165	239676 239678	0.9999881982803345	O
58794	the	166 169	239679 239682	0.9999872446060181	O
58795	family	170 176	239683 239689	0.9999810457229614	O
58796	.	177 178	239690 239691	0.9999676942825317	O
58797	Similarly	0 9	239692 239701	0.9999833106994629	O
58798	,	10 11	239702 239703	0.9999864101409912	O
58799	Steinke	12 18	239704 239710	0.9999408721923828	O
58801	et	20 22	239712 239714	0.9999860525131226	O
58802	al	23 25	239715 239717	0.9999853372573853	O
58803	[	26 27	239718 239719	0.9999871253967285	O
58804	15	27 29	239719 239721	0.9999821186065674	O
58805	]	29 30	239721 239722	0.9999867677688599	O
58806	,	31 32	239723 239724	0.999984860420227	O
58807	described	33 42	239725 239734	0.9999842643737793	O
58808	the	43 46	239735 239738	0.9999871253967285	O
58809	co	47 49	239739 239741	0.9999862909317017	O
58810	-	49 50	239741 239742	0.9999872446060181	O
58811	occurrence	50 60	239742 239752	0.999985933303833	O
58812	of	61 63	239753 239755	0.9999858140945435	O
58813	the	64 67	239756 239759	0.9999855756759644	O
58814	p	68 69	239760 239761	0.9999831914901733	O
58815	.	69 70	239761 239762	0.9999691247940063	O
58816	Lys618Ala	0 8	239762 239770	0.9999868869781494	O
58822	(	10 11	239772 239773	0.9999890327453613	O
58823	c	12 13	239774 239775	0.9999881982803345	O
58824	.	13 14	239775 239776	0.9999889135360718	O
58825	1852	14 18	239776 239780	0.9999864101409912	O
58826	_	18 19	239780 239781	0.9999885559082031	O
58827	1853AA	19 24	239781 239786	0.9999867677688599	O
58829	>	25 26	239787 239788	0.9999881982803345	O
58830	GC	26 27	239788 239789	0.9999874830245972	O
58832	)	29 30	239791 239792	0.9999890327453613	O
58833	variant	31 38	239793 239800	0.9999876022338867	O
58834	with	39 43	239801 239805	0.9999867677688599	O
58835	the	44 47	239806 239809	0.9999878406524658	O
58836	MSH6	48 51	239810 239813	0.9999866485595703	O
58839	p	53 54	239815 239816	0.9999890327453613	O
58840	.	54 55	239816 239817	0.9999812841415405	O
58841	Arg1068X	0 7	239817 239824	0.999984860420227	O
58847	(	9 10	239826 239827	0.9999876022338867	O
58848	c	11 12	239828 239829	0.9999864101409912	O
58849	.	12 13	239829 239830	0.9999876022338867	O
58850	3202C	13 17	239830 239834	0.9999793767929077	O
58853	>	18 19	239835 239836	0.9999865293502808	O
58854	T	19 20	239836 239837	0.9999861717224121	O
58855	)	21 22	239838 239839	0.9999879598617554	O
58856	deleterious	23 33	239840 239850	0.9999866485595703	O
58859	variant	35 42	239852 239859	0.9999847412109375	O
58860	.	43 44	239860 239861	0.999927282333374	O
58861	Herein	0 5	239862 239867	0.9999836683273315	O
58863	,	7 8	239869 239870	0.9999839067459106	O
58864	we	9 11	239871 239873	0.9999779462814331	O
58865	describe	12 20	239874 239882	0.9999785423278809	O
58866	the	21 24	239883 239886	0.9999836683273315	O
58867	coexistence	25 35	239887 239897	0.9999794960021973	O
58871	of	37 39	239899 239901	0.9999836683273315	O
58872	the	40 43	239902 239905	0.9999837875366211	O
58873	p	44 45	239906 239907	0.9999808073043823	O
58874	.	45 46	239907 239908	0.9999644756317139	O
58875	Lys618Ala	0 8	239908 239916	0.9999827146530151	O
58881	variant	10 17	239918 239925	0.9999822378158569	O
58882	with	18 22	239926 239930	0.9999767541885376	O
58883	deleterious	23 33	239931 239941	0.9999821186065674	O
58886	variants	35 43	239943 239951	0.9999804496765137	O
58887	in	44 46	239952 239954	0.9999793767929077	O
58888	another	47 54	239955 239962	0.9999517202377319	O
58889	two	55 58	239963 239966	0.9999567270278931	O
58890	unrelated	59 68	239967 239976	0.9999570846557617	O
58891	LS	69 70	239977 239978	0.9999676942825317	O
58893	families	72 80	239980 239988	0.999967098236084	O
58894	.	81 82	239989 239990	0.999698281288147	O
58895	In	0 2	239991 239993	0.9999872446060181	O
58896	one	3 6	239994 239997	0.9999837875366211	O
58897	family	7 13	239998 240004	0.9999754428863525	O
58898	,	14 15	240005 240006	0.9999876022338867	O
58899	the	16 19	240007 240010	0.999988317489624	O
58900	allele	20 25	240011 240016	0.999987006187439	O
58902	distribution	27 39	240018 240030	0.9999858140945435	O
58903	of	40 42	240031 240033	0.9999884366989136	O
58904	the	43 46	240034 240037	0.9999886751174927	O
58905	pathogenic	47 56	240038 240047	0.9999866485595703	O
58907	and	58 61	240049 240052	0.999988317489624	O
58908	unclassified	62 73	240053 240064	0.999988317489624	O
58910	variant	75 82	240066 240073	0.9999879598617554	O
58911	was	83 86	240074 240077	0.9999885559082031	O
58912	in	87 89	240078 240080	0.9999887943267822	O
58913	trans	90 95	240081 240086	0.9999877214431763	O
58914	,	96 97	240087 240088	0.9999878406524658	O
58915	in	98 100	240089 240091	0.9999877214431763	O
58916	the	101 104	240092 240095	0.9999874830245972	O
58917	other	105 110	240096 240101	0.9999840259552002	O
58918	family	111 117	240102 240108	0.999984622001648	O
58919	the	118 121	240109 240112	0.9999884366989136	O
58920	pathogenic	122 131	240113 240122	0.9999873638153076	O
58922	variant	133 140	240124 240131	0.9999880790710449	O
58923	was	141 144	240132 240135	0.9999889135360718	O
58924	detected	145 153	240136 240144	0.9999884366989136	O
58925	in	154 156	240145 240147	0.9999886751174927	O
58926	the	157 160	240148 240151	0.9999887943267822	O
58927	MSH6	161 164	240152 240155	0.9999860525131226	O
58930	gene	166 170	240157 240161	0.9999877214431763	O
58931	and	171 174	240162 240165	0.9999880790710449	O
58932	only	175 179	240166 240170	0.9999871253967285	O
58933	the	180 183	240171 240174	0.9999885559082031	O
58934	deleterious	184 194	240175 240185	0.9999865293502808	O
58937	variant	196 203	240187 240194	0.9999872446060181	O
58938	co	204 206	240195 240197	0.9999885559082031	O
58939	-	206 207	240197 240198	0.9999885559082031	O
58940	segregated	207 217	240198 240208	0.9999864101409912	O
58941	with	218 222	240209 240213	0.9999860525131226	O
58942	the	223 226	240214 240217	0.9999868869781494	O
58943	disease	227 234	240218 240225	0.9999816417694092	O
58944	in	235 237	240226 240228	0.9999873638153076	O
58945	both	238 242	240229 240233	0.999982476234436	O
58946	families	243 251	240234 240242	0.9999780654907227	O
58947	.	252 253	240243 240244	0.9999264478683472	O
58948	This	0 4	240245 240249	0.9999697208404541	O
58949	evidence	5 13	240250 240258	0.9999208450317383	O
58950	indicates	14 23	240259 240268	0.9999617338180542	O
58951	that	24 28	240269 240273	0.9999754428863525	O
58952	the	29 32	240274 240277	0.9999717473983765	O
58953	p	33 34	240278 240279	0.9999639987945557	O
58954	.	34 35	240279 240280	0.9999387264251709	O
58955	Lys618Ala	0 8	240280 240288	0.9999841451644897	O
58961	variant	10 17	240290 240297	0.9999833106994629	O
58962	is	18 20	240298 240300	0.99997878074646	O
58963	not	21 24	240301 240304	0.9999727010726929	O
58964	deleterious	25 35	240305 240315	0.999984622001648	O
58967	.	37 38	240317 240318	0.9998676776885986	O
58968	The	0 3	240319 240322	0.9999858140945435	O
58969	molecular	4 13	240323 240332	0.9999797344207764	O
58970	hallmark	14 21	240333 240340	0.9999843835830688	O
58972	of	23 25	240342 240344	0.9999831914901733	O
58973	LS	26 27	240345 240346	0.9999450445175171	O
58975	tumours	29 35	240348 240354	0.9999825954437256	O
58978	is	37 39	240356 240358	0.9999852180480957	O
58979	an	40 42	240359 240361	0.9999872446060181	O
58980	MSI	43 45	240362 240364	0.9999831914901733	O
58982	phenotype	47 55	240366 240374	0.9999876022338867	O
58985	,	57 58	240376 240377	0.9999821186065674	O
58986	a	59 60	240378 240379	0.9999871253967285	O
58987	functional	61 71	240380 240390	0.999975323677063	O
58988	consequence	72 83	240391 240402	0.9999865293502808	O
58989	of	84 86	240403 240405	0.9999872446060181	O
58990	MMR	87 89	240406 240408	0.9999834299087524	O
58992	deficiency	91 101	240410 240420	0.999983549118042	O
58993	.	102 103	240421 240422	0.9999567270278931	O
58994	It	0 2	240423 240425	0.9999876022338867	O
58995	is	3 5	240426 240428	0.9999861717224121	O
58996	expected	6 14	240429 240437	0.9999852180480957	O
58997	that	15 19	240438 240442	0.9999891519546509	O
58998	the	20 23	240443 240446	0.9999886751174927	O
58999	putative	24 31	240447 240454	0.9999873638153076	O
59001	germ	33 36	240456 240459	0.999988317489624	O
59004	-	37 38	240460 240461	0.9999892711639404	O
59005	line	38 42	240461 240465	0.9999872446060181	O
59006	mutation	43 51	240466 240474	0.999987006187439	O
59007	responsible	52 63	240475 240486	0.9999887943267822	O
59008	for	64 67	240487 240490	0.9999890327453613	O
59009	LS	68 69	240491 240492	0.9999833106994629	O
59011	would	71 76	240494 240499	0.9999861717224121	O
59012	confer	77 82	240500 240505	0.9999886751174927	O
59014	the	84 87	240507 240510	0.9999884366989136	O
59015	MSI	88 90	240511 240513	0.9999806880950928	O
59017	phenotype	92 100	240515 240523	0.9999887943267822	O
59020	.	102 103	240525 240526	0.9999725818634033	O
59021	We	0 2	240527 240529	0.9999761581420898	O
59022	tested	3 9	240530 240536	0.9999815225601196	O
59023	the	10 13	240537 240540	0.9999862909317017	O
59024	MSI	14 16	240541 240543	0.9999842643737793	O
59026	status	18 24	240545 240551	0.9999864101409912	O
59027	of	25 27	240552 240554	0.9999855756759644	O
59028	17	28 30	240555 240557	0.9999388456344604	O
59029	tumours	31 37	240558 240564	0.9999833106994629	O
59032	from	39 43	240566 240570	0.9999819993972778	O
59033	p	44 45	240571 240572	0.9999837875366211	O
59034	.	45 46	240572 240573	0.9999657869338989	O
59035	Lys618Ala	0 8	240573 240581	0.9999874830245972	O
59041	carriers	10 18	240583 240591	0.9999879598617554	O
59042	and	19 22	240592 240595	0.9999862909317017	O
59043	detected	23 31	240596 240604	0.9999874830245972	O
59044	only	32 36	240605 240609	0.9999865293502808	O
59045	two	37 40	240610 240613	0.9999810457229614	O
59046	cases	41 46	240614 240619	0.9999878406524658	O
59047	of	47 49	240620 240622	0.9999880790710449	O
59048	MSI	50 52	240623 240625	0.9999847412109375	O
59050	(	54 55	240627 240628	0.9999891519546509	O
59051	11	56 58	240629 240631	0.999984860420227	O
59052	.	58 59	240631 240632	0.9999885559082031	O
59053	8	59 60	240632 240633	0.9999855756759644	O
59054	%	61 62	240634 240635	0.9999887943267822	O
59055	)	63 64	240636 240637	0.9999889135360718	O
59056	.	65 66	240638 240639	0.9999654293060303	O
59057	Taking	0 6	240640 240646	0.9999879598617554	O
59058	into	7 11	240647 240651	0.9999874830245972	O
59059	consideration	12 25	240652 240665	0.9999886751174927	O
59060	the	26 29	240666 240669	0.9999890327453613	O
59061	bias	30 34	240670 240674	0.999985933303833	O
59062	caused	35 41	240675 240681	0.999988317489624	O
59063	by	42 44	240682 240684	0.9999895095825195	O
59064	the	45 48	240685 240688	0.9999895095825195	O
59065	over	49 53	240689 240693	0.99998939037323	O
59066	-	53 54	240693 240694	0.99998939037323	O
59067	representation	54 68	240694 240708	0.9999887943267822	O
59068	of	69 71	240709 240711	0.9999895095825195	O
59069	Bethesda	72 79	240712 240719	0.9999881982803345	O
59072	Criteria	81 88	240721 240728	0.9999889135360718	O
59075	-	89 90	240729 240730	0.9999895095825195	O
59076	positive	90 98	240730 240738	0.9999878406524658	O
59077	tumours	99 105	240739 240745	0.9999881982803345	O
59080	in	107 109	240747 240749	0.9999895095825195	O
59081	this	110 114	240750 240754	0.9999885559082031	O
59082	subset	115 121	240755 240761	0.9999880790710449	O
59083	of	122 124	240762 240764	0.9999885559082031	O
59084	cases	125 130	240765 240770	0.9999884366989136	O
59085	(	131 132	240771 240772	0.9999897480010986	O
59086	8	133 134	240773 240774	0.9999885559082031	O
59087	/	134 135	240774 240775	0.9999895095825195	O
59088	17	135 137	240775 240777	0.9999843835830688	O
59089	)	138 139	240778 240779	0.9999896287918091	O
59090	,	140 141	240780 240781	0.9999889135360718	O
59091	the	142 145	240782 240785	0.9999895095825195	O
59092	MSI	146 148	240786 240788	0.9999878406524658	O
59094	frequency	150 159	240790 240799	0.9999881982803345	O
59095	was	160 163	240800 240803	0.9999891519546509	O
59096	not	164 167	240804 240807	0.9999876022338867	O
59097	significantly	168 181	240808 240821	0.9999885559082031	O
59098	different	182 191	240822 240831	0.9999886751174927	O
59099	from	192 196	240832 240836	0.9999889135360718	O
59100	that	197 201	240837 240841	0.9999887943267822	O
59101	in	202 204	240842 240844	0.9999892711639404	O
59102	the	205 208	240845 240848	0.99998939037323	O
59103	unselected	209 218	240849 240858	0.9999887943267822	O
59107	CRC	220 222	240860 240862	0.9999837875366211	O
59109	group	224 229	240864 240869	0.9999890327453613	O
59110	[	230 231	240870 240871	0.9999891519546509	O
59111	7	231 232	240871 240872	0.9999876022338867	O
59112	]	232 233	240872 240873	0.9999890327453613	O
59113	.	234 235	240874 240875	0.9999762773513794	O
59114	This	0 4	240876 240880	0.9999855756759644	O
59115	is	5 7	240881 240883	0.9999861717224121	O
59116	further	8 15	240884 240891	0.9999829530715942	O
59117	proof	16 21	240892 240897	0.9999821186065674	O
59118	that	22 26	240898 240902	0.9999868869781494	O
59119	the	27 30	240903 240906	0.9999876022338867	O
59120	presence	31 39	240907 240915	0.9999858140945435	O
59121	of	40 42	240916 240918	0.9999877214431763	O
59122	this	43 47	240919 240923	0.9999865293502808	O
59123	variant	48 55	240924 240931	0.9999828338623047	O
59124	is	56 58	240932 240934	0.9999864101409912	O
59125	irrelevant	59 69	240935 240945	0.9999822378158569	O
59126	to	70 72	240946 240948	0.9999858140945435	O
59127	the	73 76	240949 240952	0.999987006187439	O
59128	functional	77 87	240953 240963	0.9999849796295166	O
59129	inactivation	88 99	240964 240975	0.9999884366989136	O
59132	of	101 103	240977 240979	0.9999879598617554	O
59133	MLH1	104 107	240980 240983	0.999985933303833	O
59136	in	109 111	240985 240987	0.9999842643737793	O
59137	CRC	112 114	240988 240990	0.999976396560669	O
59139	patients	116 124	240992 241000	0.9999493360519409	O
59140	.	125 126	241001 241002	0.9999511241912842	O
59141	Nonetheless	0 11	241003 241014	0.9999796152114868	O
59142	,	12 13	241015 241016	0.9999874830245972	O
59143	we	14 16	241017 241019	0.9999843835830688	O
59144	cannot	17 23	241020 241026	0.9999817609786987	O
59145	exclude	24 31	241027 241034	0.9999823570251465	O
59146	the	32 35	241035 241038	0.9999871253967285	O
59147	possibility	36 47	241039 241050	0.9999864101409912	O
59148	that	48 52	241051 241055	0.9999879598617554	O
59149	this	53 57	241056 241060	0.9999878406524658	O
59150	variant	58 65	241061 241068	0.999984622001648	O
59151	may	66 69	241069 241072	0.9999868869781494	O
59152	result	70 76	241073 241079	0.9999878406524658	O
59153	in	77 79	241080 241082	0.999988317489624	O
59154	a	80 81	241083 241084	0.9999885559082031	O
59155	small	82 87	241085 241090	0.999983549118042	O
59156	increase	88 96	241091 241099	0.9999852180480957	O
59157	in	97 99	241100 241102	0.9999879598617554	O
59158	susceptibility	100 113	241103 241116	0.9999876022338867	O
59163	to	115 117	241118 241120	0.9999867677688599	O
59164	CRC	118 120	241121 241123	0.9999815225601196	O
59166	or	122 124	241125 241127	0.9999818801879883	O
59167	adenomas	125 132	241128 241135	0.9999836683273315	O
59170	,	134 135	241137 241138	0.9999871253967285	O
59171	as	136 138	241139 241141	0.9999871253967285	O
59172	was	139 142	241142 241145	0.9999884366989136	O
59173	suggested	143 152	241146 241155	0.9999878406524658	O
59174	by	153 155	241156 241158	0.9999885559082031	O
59175	Fearnhead	156 164	241159 241167	0.9999752044677734	O
59178	et	166 168	241169 241171	0.9999881982803345	O
59179	al	169 171	241172 241174	0.9999878406524658	O
59180	[	172 173	241175 241176	0.9999884366989136	O
59181	16	173 175	241176 241178	0.999985933303833	O
59182	]	175 176	241178 241179	0.9999877214431763	O
59183	.	177 178	241180 241181	0.9999741315841675	O
59184	Further	0 7	241182 241189	0.9999836683273315	O
59185	studies	8 15	241190 241197	0.9999821186065674	O
59186	with	16 20	241198 241202	0.9999819993972778	O
59187	appropriate	21 32	241203 241214	0.9999822378158569	O
59188	sample	33 39	241215 241221	0.9999839067459106	O
59189	sizes	40 45	241222 241227	0.9999788999557495	O
59190	are	46 49	241228 241231	0.9999808073043823	O
59191	required	50 58	241232 241240	0.9999815225601196	O
59192	to	59 61	241241 241243	0.9999821186065674	O
59193	address	62 69	241244 241251	0.9999805688858032	O
59194	the	70 73	241252 241255	0.9999871253967285	O
59195	low	74 77	241256 241259	0.9999854564666748	O
59196	penetrance	78 87	241260 241269	0.9999877214431763	O
59199	effect	89 95	241271 241277	0.999987006187439	O
59200	of	96 98	241278 241280	0.9999877214431763	O
59201	this	99 103	241281 241285	0.9999871253967285	O
59202	variant	104 111	241286 241293	0.9999830722808838	O
59203	in	112 114	241294 241296	0.9999842643737793	O
59204	CRC	115 117	241297 241299	0.9999754428863525	O
59206	.	118 119	241300 241301	0.9999490976333618	O
59207	Finally	0 7	241302 241309	0.9999796152114868	O
59208	,	8 9	241310 241311	0.9999858140945435	O
59209	we	10 12	241312 241314	0.9999778270721436	O
59210	hypothesize	13 23	241315 241325	0.9999849796295166	O
59215	that	25 29	241327 241331	0.9999871253967285	O
59216	the	30 33	241332 241335	0.9999874830245972	O
59217	clinical	34 42	241336 241344	0.9999847412109375	O
59218	significance	43 55	241345 241357	0.9999867677688599	O
59219	of	56 58	241358 241360	0.9999880790710449	O
59220	a	59 60	241361 241362	0.9999880790710449	O
59221	genetic	61 68	241363 241370	0.9999862909317017	O
59222	variant	69 76	241371 241378	0.9999868869781494	O
59223	may	77 80	241379 241382	0.9999853372573853	O
59224	differ	81 87	241383 241389	0.9999850988388062	O
59225	according	88 97	241390 241399	0.9999867677688599	O
59226	to	98 100	241400 241402	0.9999878406524658	O
59227	genetic	101 108	241403 241410	0.9999861717224121	O
59228	background	109 119	241411 241421	0.9999865293502808	O
59229	.	120 121	241422 241423	0.9999560117721558	O
59230	Gene	0 4	241424 241428	0.9999809265136719	O
59231	functionality	5 18	241429 241442	0.9999736547470093	O
59232	may	19 22	241443 241446	0.9999792575836182	O
59233	be	23 25	241447 241449	0.9999862909317017	O
59234	the	26 29	241450 241453	0.9999871253967285	O
59235	net	30 33	241454 241457	0.9999798536300659	O
59236	result	34 40	241458 241464	0.9999836683273315	O
59237	of	41 43	241465 241467	0.9999868869781494	O
59238	the	44 47	241468 241471	0.9999866485595703	O
59239	effects	48 55	241472 241479	0.9999830722808838	O
59240	of	56 58	241480 241482	0.999987006187439	O
59241	allelic	59 65	241483 241489	0.9999850988388062	O
59244	structures	67 77	241491 241501	0.999984622001648	O
59245	and	78 81	241502 241505	0.9999829530715942	O
59246	their	82 87	241506 241511	0.9999871253967285	O
59247	interactions	88 100	241512 241524	0.9999834299087524	O
59248	with	101 105	241525 241529	0.9999855756759644	O
59249	environmental	106 119	241530 241543	0.9999819993972778	O
59250	factors	120 127	241544 241551	0.9999841451644897	O
59251	.	128 129	241552 241553	0.9999433755874634	O
59252	It	0 2	241554 241556	0.9999858140945435	O
59253	is	3 5	241557 241559	0.9999843835830688	O
59254	possible	6 14	241560 241568	0.9999830722808838	O
59255	that	15 19	241569 241573	0.9999872446060181	O
59256	low	20 23	241574 241577	0.9999858140945435	O
59257	-	23 24	241577 241578	0.9999885559082031	O
59258	penetrance	24 33	241578 241587	0.9999878406524658	O
59261	variants	35 43	241589 241597	0.9999843835830688	O
59262	behave	44 50	241598 241604	0.9999864101409912	O
59263	differently	51 62	241605 241616	0.999984860420227	O
59264	in	63 65	241617 241619	0.9999881982803345	O
59265	different	66 75	241620 241629	0.9999839067459106	O
59266	populations	76 87	241630 241641	0.9999803304672241	O
59267	,	88 89	241642 241643	0.9999862909317017	O
59268	making	90 96	241644 241650	0.9999865293502808	O
59269	it	97 99	241651 241653	0.9999876022338867	O
59270	difficult	100 109	241654 241663	0.9999861717224121	O
59271	to	110 112	241664 241666	0.9999881982803345	O
59272	make	113 117	241667 241671	0.999987006187439	O
59273	predictions	118 129	241672 241683	0.999985933303833	O
59274	in	130 132	241684 241686	0.999988317489624	O
59275	terms	133 138	241687 241692	0.999988317489624	O
59276	of	139 141	241693 241695	0.9999887943267822	O
59277	conferred	142 151	241696 241705	0.9999845027923584	O
59278	risk	152 156	241706 241710	0.999988317489624	O
59279	.	157 158	241711 241712	0.9999724626541138	O
59280	Conclusions	0 10	241713 241723	0.9999841451644897	O
59284	Taken	12 16	241725 241729	0.9999871253967285	O
59286	together	18 26	241731 241739	0.9999873638153076	O
59287	,	27 28	241740 241741	0.9999880790710449	O
59288	the	29 32	241742 241745	0.9999877214431763	O
59289	results	33 40	241746 241753	0.9999868869781494	O
59290	of	41 43	241754 241756	0.9999881982803345	O
59291	this	44 48	241757 241761	0.9999885559082031	O
59292	study	49 54	241762 241767	0.9999864101409912	O
59293	and	55 58	241768 241771	0.9999868869781494	O
59294	others	59 65	241772 241778	0.9999825954437256	O
59295	indicate	66 74	241779 241787	0.9999868869781494	O
59296	that	75 79	241788 241792	0.9999892711639404	O
59297	the	80 83	241793 241796	0.9999890327453613	O
59298	c	84 85	241797 241798	0.9999891519546509	O
59299	.	85 86	241798 241799	0.9999892711639404	O
59300	1852	86 90	241799 241803	0.9999873638153076	O
59301	_	90 91	241803 241804	0.9999890327453613	O
59302	1853AA	91 96	241804 241809	0.9999874830245972	O
59304	>	97 98	241810 241811	0.9999880790710449	O
59305	GC	98 99	241811 241812	0.9999876022338867	O
59307	variant	101 108	241814 241821	0.9999892711639404	O
59308	should	109 115	241822 241828	0.9999881982803345	O
59309	be	116 118	241829 241831	0.9999889135360718	O
59310	considered	119 129	241832 241842	0.999988317489624	O
59311	a	130 131	241843 241844	0.99998939037323	O
59312	neutral	132 139	241845 241852	0.9999861717224121	O
59313	variant	140 147	241853 241860	0.9999887943267822	O
59314	for	148 151	241861 241864	0.9999874830245972	O
59315	LS	152 153	241865 241866	0.9999847412109375	O
59317	.	154 155	241867 241868	0.9999780654907227	O
59318	These	0 5	241869 241874	0.999976396560669	O
59319	findings	6 14	241875 241883	0.9999693632125854	O
59320	have	15 19	241884 241888	0.9999727010726929	O
59321	considerable	20 32	241889 241901	0.9999586343765259	O
59322	relevance	33 42	241902 241911	0.9999489784240723	O
59323	for	43 46	241912 241915	0.9999704360961914	O
59324	the	47 50	241916 241919	0.9999735355377197	O
59325	clinical	51 59	241920 241928	0.9999560117721558	O
59326	management	60 70	241929 241939	0.9999685287475586	O
59327	of	71 73	241940 241942	0.9999758005142212	O
59328	CRC	74 76	241943 241945	0.9999580383300781	O
59330	probands	78 85	241947 241954	0.9999778270721436	O
59333	and	87 90	241956 241959	0.9999704360961914	O
59334	their	91 96	241960 241965	0.9999754428863525	O
59335	relatives	97 106	241966 241975	0.9999375343322754	O
59336	.	107 108	241976 241977	0.9998435974121094	O
